PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kirwan, JR; Boers, M				Kirwan, John R.; Boers, Maarten			Biological treatment in rheumatoid arthritis: when to stop?	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; COMBINATION THERAPY; METHOTREXATE		[Kirwan, John R.] Univ Bristol, Acad Rheumatol Unit, Bristol Royal Infirm, Bristol BS8 2UR, Avon, England; [Boers, Maarten] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Bristol Royal Infirmary; University of Bristol; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Kirwan, JR (corresponding author), Univ Bristol, Acad Rheumatol Unit, Bristol Royal Infirm, Bristol BS8 2UR, Avon, England.	john.kirwan@bristol.ac.uk		Kirwan, John/0000-0002-6617-3217				Bakker MF, 2012, ANN INTERN MED, V156, P329, DOI 10.7326/0003-4819-156-5-201203060-00004; Goekoop-Ruiterman YPM, 2007, ANN INTERN MED, V146, P406, DOI 10.7326/0003-4819-146-6-200703200-00005; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P64, DOI 10.1136/annrheumdis-2011-201247; Kirwan JR, 2012, ANN INTERN MED, V156, P390, DOI 10.7326/0003-4819-156-5-201203060-00014; Kirwan JR, 2007, COCHRANE DB SYST REV, V1; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; National Collaborating Centre for Chronic Conditions, 2009, RHEUM ARTHR NAT CLIN; NICE, 2007, AD ET INFL TREATM RH; Smolen JS, 2013, LANCET	9	6	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					288	289		10.1016/S0140-6736(13)61941-8	http://dx.doi.org/10.1016/S0140-6736(13)61941-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24168959				2022-12-28	WOS:000330212600009
J	Currow, DC; Abernethy, AP				Currow, David C.; Abernethy, Amy P.			Lessons from the Liverpool Care Pathway-evidence is key	LANCET			English	Editorial Material							LIFE CARE; END		[Currow, David C.] Flinders Univ S Australia, Discipline Serv, Bedford Pk, SA 5042, Australia; [Currow, David C.] Flinders Univ S Australia, Palliat Serv, Bedford Pk, SA 5042, Australia; [Currow, David C.] Flinders Univ S Australia, Support Serv, Bedford Pk, SA 5042, Australia; [Abernethy, Amy P.] Duke Clin Res Inst, Duke Ctr Learning Hlth Care, Dept Med, Div Med Oncol, Durham, NC 27710 USA	Flinders University South Australia; Flinders University South Australia; Flinders University South Australia; Duke University	Abernethy, AP (corresponding author), Duke Clin Res Inst, Duke Ctr Learning Hlth Care, Dept Med, Div Med Oncol, Durham, NC 27710 USA.	amy.abernethy@duke.edu		Currow, David/0000-0003-1988-1250				Abernethy AP, 2009, ANN INTERN MED, V150, P336, DOI 10.7326/0003-4819-150-5-200903030-00107; Brownson RC, 2009, AM J PUBLIC HEALTH, V99, P1576, DOI 10.2105/AJPH.2008.156224; Chorley M, 2013, DAILY MAIL; Costantini M, 2013, LANCET; Costantini M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-13; Department of Health, 2013, MOR CAR LESS PATHW R; Duffy Anne, 2006, Nurs Older People, V18, P33; Miriovsky BJ, 2012, J CLIN ONCOL, V30, P4243, DOI 10.1200/JCO.2012.42.8011; MRC (Medical Research Council UK), 2008, DEV EVALUATING COMPL; Paterson BC, 2009, EMERG MED J, V26, P777, DOI 10.1136/emj.2008.067249; Phillips JL, 2011, J PAIN SYMPTOM MANAG, V41, P940, DOI 10.1016/j.jpainsymman.2010.07.020; Smith M, 2013, BEST CAR LOW COST PA; Walker R, 2010, INT J PALLIAT NURS, V16, P267, DOI 10.12968/ijpn.2010.16.6.48825	13	15	15	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					192	193		10.1016/S0140-6736(13)62039-5	http://dx.doi.org/10.1016/S0140-6736(13)62039-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294FC	24139707				2022-12-28	WOS:000330027500006
J	Elahi, S; Ertelt, JM; Kinder, JM; Jiang, TT; Zhang, XZ; Xin, LJ; Chaturvedi, V; Strong, BS; Qualls, JE; Steinbrecher, KA; Kalfa, TA; Shaaban, AF; Way, SS				Elahi, Shokrollah; Ertelt, James M.; Kinder, Jeremy M.; Jiang, Tony T.; Zhang, Xuzhe; Xin, Lijun; Chaturvedi, Vandana; Strong, Beverly S.; Qualls, Joseph E.; Steinbrecher, Kris A.; Kalfa, Theodosia A.; Shaaban, Aimen F.; Way, Sing Sing			Immunosuppressive CD71(+) erythroid cells compromise neonatal host defence against infection	NATURE			English	Article							RED-BLOOD-CELLS; TUMOR-NECROSIS-FACTOR; TNF-ALPHA; IMMUNE; RESPONSES; ACTIVATION; RESISTANCE; NEWBORNS; DISTINCT; FLORA	Newborn infants are highly susceptible to infection. This defect in host defence has generally been ascribed to the immaturity of neonatal immune cells; however, the degree of hyporesponsiveness is highly variable and depends on the stimulation conditions(1-7). These discordant responses illustrate the need for a more unified explanation for why immunity is compromised in neonates. Here we show that physiologically enriched CD71(+) erythroid cells in neonatalmice and human cord blood have distinctive immunosuppressive properties. The production of innate immune protective cytokines by adult cells is diminished after transfer to neonatal mice or after co-culture with neonatal splenocytes. Neonatal CD71(+) cells express the enzyme arginase-2, and arginase activity is essential for the immunosuppressive properties of these cells because molecular inhibition of this enzyme or supplementation with L-arginine overrides immunosuppression. In addition, the ablation of CD71(+) cells in neonatal mice, or the decline in number of these cells as postnatal development progresses parallels the loss of suppression, and restored resistance to the perinatal pathogens Listeria monocytogenes and Escherichia coli(8,9). However, CD71(+) cell-mediated susceptibility to infection is counterbalanced by CD71(+) cell-mediated protection against aberrant immune cell activation in the intestine, where colonization with commensal microorganisms occurs swiftly after parturition(10,11). Conversely, circumventing such colonization by using antimicrobials or gnotobiotic germ-free mice overrides these protective benefits. Thus, CD71(+) cells quench the excessive inflammation induced by abrupt colonization with commensal microorganisms after parturition. This finding challenges the idea that the susceptibility of neonates to infection reflects immune-cell-intrinsic defects and instead highlights processes that are developmentally more essential and inadvertently mitigate innate immune protection. We anticipate that these results will spark renewed investigation into the need for immunosuppression in neonates, as well as improved strategies for augmenting host defence in this vulnerable population.	[Elahi, Shokrollah; Ertelt, James M.; Kinder, Jeremy M.; Jiang, Tony T.; Zhang, Xuzhe; Xin, Lijun; Chaturvedi, Vandana; Qualls, Joseph E.; Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Elahi, Shokrollah; Ertelt, James M.; Kinder, Jeremy M.; Jiang, Tony T.; Zhang, Xuzhe; Xin, Lijun; Chaturvedi, Vandana; Qualls, Joseph E.; Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA; [Strong, Beverly S.; Shaaban, Aimen F.] Cincinnati Childrens Hosp Med Ctr, Ctr Fetal Cellular & Mol Therapy, Cincinnati, OH 45229 USA; [Steinbrecher, Kris A.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA; [Kalfa, Theodosia A.] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Way, SS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	singsing.way@cchmc.org	Zhang, Xuzhe/CAA-2560-2022	Kinder, Jeremy/0000-0001-5145-1344; Qualls, Joseph/0000-0002-0113-2166; Kalfa, Theodosia/0000-0002-0426-9686; Elahi, Shokrollah/0000-0002-7215-2009; Shaaban, Aimen/0000-0002-9459-107X; Way, Sing Sing/0000-0001-8948-1952	NIAID [R01AI087830, R01AI100934]; NHLBI [R01HL103745]; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103745, R01HL116352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100934, R01AI087830, R21AI107274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Haslam, M. Hostetter, L. Muglia, J. Whitsett and C. Wilson for discussions, J. Mortensen for help with anaerobic cultures, and K. Eaton, C. Schray and the University of Michigan Unit for Laboratory Animal Medicine for providing germ-free mice. We thank the Mount Auburn OB-GYN associates, OB-GYN residents, and the University and Christ Hospital labour and delivery nursing staff for collecting cord blood, the Cell Processing and Manipulation Core for obtaining peripheral blood from adult donors, and the CCHMC Translational Research Trials Office for providing the regulatory and administrative support for studies with human cells. This research was supported by NIAID (R01AI087830 and R01AI100934) (S. S. W.) and NHLBI (R01HL103745) (A. F. S.). S. S. W. holds an Investigator in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Akinosoglou KS, 2012, HEMATOLOGY, V17, P106, DOI 10.1179/102453312X13221316477336; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; DUCLUZEAU R, 1983, ANN RECH VET, V14, P354; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; HAVELL EA, 1989, J IMMUNOL, V143, P2894; Hermansen MC, 2001, ARCH DIS CHILD-FETAL, V84, pF211, DOI 10.1136/fn.84.3.F211; Jackson A, 2010, J IMMUNOL, V185, P6198, DOI 10.4049/jimmunol.1001198; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; Mold JE, 2012, ADV IMMUNOL, V115, P73, DOI 10.1016/B978-0-12-394299-9.00003-5; Morera D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-89; Morris SM, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3135pe27; Muszynski J, 2012, TRANSFUSION, V52, P794, DOI 10.1111/j.1537-2995.2011.03348.x; NAKANE A, 1988, INFECT IMMUN, V56, P2563, DOI 10.1128/IAI.56.10.2563-2569.1988; Opiela SJ, 2008, BLOOD, V112, P1530, DOI 10.1182/blood-2007-08-106500; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Prins HA, 2001, SHOCK, V16, P113, DOI 10.1097/00024382-200116020-00005; ROTIMI VO, 1981, J MED MICROBIOL, V14, P51, DOI 10.1099/00222615-14-1-51; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; VONKONIG CHW, 1988, INFECTION, V16, pS112, DOI 10.1007/BF01639732; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002	30	238	251	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					158	+		10.1038/nature12675	http://dx.doi.org/10.1038/nature12675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24196717	Green Accepted			2022-12-28	WOS:000327851700051
J	Ebner, M; Marone, F; Stampanoni, M; Wood, V				Ebner, Martin; Marone, Federica; Stampanoni, Marco; Wood, Vanessa			Visualization and Quantification of Electrochemical and Mechanical Degradation in Li Ion Batteries	SCIENCE			English	Article							IN-SITU OBSERVATION; X-RAY-DIFFRACTION; CRYSTALLINE SILICON; ELECTRODE MATERIALS; LITHIUM INSERTION/EXTRACTION; VOLUME CHANGES; ANODES; SNO; LITHIATION; MICROSCOPY	High-energy-density materials that undergo conversion and/or alloying reactions hold promise for next-generation lithium (Li) ion batteries. However, these materials experience substantial volume change during electrochemical operation, which causes mechanical fracture of the material and structural disintegration of the electrode, leading to capacity loss. In this work, we use x-ray tomography during battery operation to visualize and quantify the origins and evolution of electrochemical and mechanical degradation. Tomography provides the time-resolved, three-dimensional chemical composition and morphology within individual particles and throughout the electrode. In the model material tin(II) oxide, we witness distributions in onset and rate of core-shell lithiation, crack initiation and growth along preexisting defects, and irreversible distortion of the electrode, highlighting tomography as a tool to guide the development of durable materials and strain-tolerant electrodes.	[Ebner, Martin; Wood, Vanessa] ETH, Lab Nanoelect, CH-8092 Zurich, Switzerland; [Marone, Federica; Stampanoni, Marco] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Stampanoni, Marco] ETH, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wood, V (corresponding author), ETH, Lab Nanoelect, Gloriastr 35, CH-8092 Zurich, Switzerland.	vwood@ethz.ch	Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/GRR-9695-2022; Wood, Vanessa/C-3621-2014; Marone, Federica/J-4420-2013	Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Wood, Vanessa/0000-0001-6435-0227; Ebner, Martin/0000-0003-0267-0908				Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Balke N, 2010, NANO LETT, V10, P3420, DOI 10.1021/nl101439x; BAUDRY P, 1988, SOLID STATE IONICS, V28, P1567, DOI 10.1016/0167-2738(88)90421-3; Beaulieu LY, 2001, ELECTROCHEM SOLID ST, V4, pA137, DOI 10.1149/1.1388178; BESENHARD JO, 1995, J POWER SOURCES, V54, P228, DOI 10.1016/0378-7753(94)02073-C; Cabana J, 2010, ADV MATER, V22, pE170, DOI 10.1002/adma.201000717; Chan MKY, 2012, J AM CHEM SOC, V134, P14362, DOI 10.1021/ja301766z; Chao SC, 2011, J ELECTROCHEM SOC, V158, pA1335, DOI 10.1149/2.043112jes; Chao SC, 2011, J PHYS CHEM C, V115, P22040, DOI 10.1021/jp206829q; Chao SC, 2010, ELECTROCHEM COMMUN, V12, P234, DOI 10.1016/j.elecom.2009.12.002; Chen ZH, 2003, J ELECTROCHEM SOC, V150, pA1073, DOI 10.1149/1.1586922; Chouvin J, 2000, J ELECTROANAL CHEM, V494, P136, DOI 10.1016/S0022-0728(00)00357-0; Courtney IA, 1999, J ELECTROCHEM SOC, V146, P59, DOI 10.1149/1.1391565; Courtney IA, 1997, J ELECTROCHEM SOC, V144, P2045, DOI 10.1149/1.1837740; Courtney IA, 1997, J ELECTROCHEM SOC, V144, P2943, DOI 10.1149/1.1837941; Courtney IA, 1999, ELECTROCHIM ACTA, V45, P51, DOI 10.1016/S0013-4686(99)00192-9; Ebner M, 2013, ADV ENERGY MATER, V3, P845, DOI 10.1002/aenm.201200932; Goldman JL, 2011, ADV FUNCT MATER, V21, P2412, DOI 10.1002/adfm.201002487; Huang JY, 2010, SCIENCE, V330, P1515, DOI 10.1126/science.1195628; Lee SW, 2012, P NATL ACAD SCI USA, V109, P4080, DOI 10.1073/pnas.1201088109; Marone F, 2012, J SYNCHROTRON RADIAT, V19, P1029, DOI 10.1107/S0909049512032864; Obrovac MN, 2007, J ELECTROCHEM SOC, V154, pA849, DOI 10.1149/1.2752985; Obrovac MN, 2004, ELECTROCHEM SOLID ST, V7, pA93, DOI 10.1149/1.1652421; Ohzuku T, 1997, J ELECTROCHEM SOC, V144, P3496, DOI 10.1149/1.1838039; Oumellal Y, 2008, NAT MATER, V7, P916, DOI 10.1038/nmat2288; Poizot P, 2000, NATURE, V407, P496, DOI 10.1038/35035045; Sethuraman VA, 2010, J ELECTROCHEM SOC, V157, pA1253, DOI 10.1149/1.3489378; Sethuraman VA, 2013, J ELECTROCHEM SOC, V160, pA394, DOI 10.1149/2.008303jes; Shearing PR, 2012, J ELECTROCHEM SOC, V159, pA1023, DOI 10.1149/2.053207jes; Stampanoni M, 2006, PROC SPIE, V6318, DOI 10.1117/12.679497; Stournara ME, 2012, J POWER SOURCES, V208, P165, DOI 10.1016/j.jpowsour.2012.02.022; Wang JJ, 2013, CHEM COMMUN, V49, P6480, DOI 10.1039/c3cc42667j; Wang S, 2005, CHEM COMMUN, P507, DOI 10.1039/b414913k; Zhang WJ, 2011, J POWER SOURCES, V196, P877, DOI 10.1016/j.jpowsour.2010.08.114; Zhao KJ, 2012, J ELECTROCHEM SOC, V159, pA238, DOI 10.1149/2.020203jes	35	493	504	30	740	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					716	720		10.1126/science.1241882	http://dx.doi.org/10.1126/science.1241882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24136360				2022-12-28	WOS:000326647600037
J	Stimson, GV				Stimson, Gerry V.			The future of global health is urban health	LANCET			English	Editorial Material									[Stimson, Gerry V.] Knowledge Act Change, London WC2N 5BY, England; [Stimson, Gerry V.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Stimson, GV (corresponding author), Knowledge Act Change, London WC2N 5BY, England.	gerry.stimson@gmail.com						[Anonymous], 2006, REDUCING VIOLENCE AN; Bredenoord J, 2010, HABITAT INT, V34, P278, DOI 10.1016/j.habitatint.2009.12.001; Global Network of Sex Work Projects, PROMOTING HEALTH AND; Hughes K, 2011, ADDICTION, V106, P37, DOI 10.1111/j.1360-0443.2010.03316.x; Hyshka E, 2012, INT J DRUG POLICY, V23, P261, DOI 10.1016/j.drugpo.2012.03.006; Lawrence RJ, 2009, HEALTH PROMOT INT, V24, P11, DOI 10.1093/heapro/dap051; Medecins Sans Frontieres, 2002, AIDS ACTIVISTS FROM; Mougeot LJA, 2005, AGROPOLIS THE SOCIAL; Population Reference Bureau, 2013 WORLD POPULATIO; Salmon AM, 2010, ADDICTION, V105, P676, DOI 10.1111/j.1360-0443.2009.02837.x; Stimson GV, 2010, INT J DRUG POLICY, V21, P91, DOI 10.1016/j.drugpo.2010.02.002; UK Department of Health, THE NEW PUBLIC HEALT; UN-HABITAT, 2003, SLUMS OF THE WORLD T; WHO, GLOBAL HEALTH OBSERV	14	5	5	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1475	1475		10.1016/S0140-6736(13)62241-2	http://dx.doi.org/10.1016/S0140-6736(13)62241-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	24182531				2022-12-28	WOS:000326622500012
J	Hoornweg, D; Bhada-Tata, P; Kennedy, C				Hoornweg, Daniel; Bhada-Tata, Perinaz; Kennedy, Chris			Waste production must peak this century	NATURE			English	Editorial Material							URBAN		[Hoornweg, Daniel] Univ Ontario, Inst Technol, Oshawa, ON, Canada; [Kennedy, Chris] Univ Toronto, Toronto, ON M5S 1A1, Canada	Ontario Tech University; University of Toronto	Hoornweg, D (corresponding author), Univ Ontario, Inst Technol, Oshawa, ON, Canada.	daniel.hoornweg@uoit.ca		Hoornweg, Daniel/0000-0002-2340-7204; Kennedy, Christopher/0000-0001-8812-4451				Ausubel JH, 2008, P NATL ACAD SCI USA, V105, P12774, DOI 10.1073/pnas.0806099105; Dyson B, 2005, WASTE MANAGE, V25, P669, DOI 10.1016/j.wasman.2004.10.005; Eriksson O, 2005, J CLEAN PROD, V13, P241, DOI 10.1016/j.jclepro.2004.02.018; Hoornweg D., 2012, WHAT WASTE GLOBAL RE; International Institute for Applied Systems Analysis, 2012, SSP DAT; International Solid Waste Association, 2012, GLOB WAST MAN; Kennedy C, 2012, J IND ECOL, V16, P780, DOI 10.1111/j.1530-9290.2012.00548.x; Kriegler E, 2012, GLOBAL ENVIRON CHANG, V22, P807, DOI 10.1016/j.gloenvcha.2012.05.005; Van Behkel R, 2009, ENVIRON SCI TECHNOL, V43, P1271, DOI 10.1021/es803319r	9	336	350	16	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					615	617		10.1038/502615a	http://dx.doi.org/10.1038/502615a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24180015	Bronze			2022-12-28	WOS:000326293200021
J	Williams, SCP				Williams, Sarah C. P.			ALZHEIMER'S DISEASE Mapping the brain's decline	NATURE			English	Editorial Material																		Braskie MN, 2011, J NEUROSCI, V31, P6764, DOI 10.1523/JNEUROSCI.5794-10.2011; Guerreiro R., 2013, NEW ENGL J MED, V386, P117; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Ryan NS, 2013, BRAIN, V136, P1399, DOI 10.1093/brain/awt065; Vemuri P, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt47	6	11	11	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S84	S85		10.1038/502S84a	http://dx.doi.org/10.1038/502S84a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187700				2022-12-28	WOS:000326293200003
J	Lewin, GR				Lewin, Gary R.			Natural Selection and Pain Meet at a Sodium Channel	SCIENCE			English	Editorial Material									Max Delbruck Ctr Mol Med, Dept Neurosci, D-13122 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Robert Rossle Str 10, D-13122 Berlin, Germany.	glewin@mdc-berlin.de	Lewin, Gary R/B-8028-2011	Lewin, Gary/0000-0002-2890-6352				Momin A, 2008, CURR OPIN NEUROBIOL, V18, P383, DOI 10.1016/j.conb.2008.08.017; Rowe AH, 2013, SCIENCE, V342, P441, DOI 10.1126/science.1236451; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z	4	3	3	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					428	429		10.1126/science.1244375	http://dx.doi.org/10.1126/science.1244375			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159033				2022-12-28	WOS:000326042600026
J	Lajoie, MJ; Rovner, AJ; Goodman, DB; Aerni, HR; Haimovich, AD; Kuznetsov, G; Mercer, JA; Wang, HH; Carr, PA; Mosberg, JA; Rohland, N; Schultz, PG; Jacobson, JM; Rinehart, J; Church, GM; Isaacs, FJ				Lajoie, Marc J.; Rovner, Alexis J.; Goodman, Daniel B.; Aerni, Hans-Rudolf; Haimovich, Adrian D.; Kuznetsov, Gleb; Mercer, Jaron A.; Wang, Harris H.; Carr, Peter A.; Mosberg, Joshua A.; Rohland, Nadin; Schultz, Peter G.; Jacobson, Joseph M.; Rinehart, Jesse; Church, George M.; Isaacs, Farren J.			Genomically Recoded Organisms Expand Biological Functions	SCIENCE			English	Article							UNNATURAL AMINO-ACIDS; GENETIC-CODE; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; EVOLUTION; GENOME; PHOSPHOSERINE; REASSIGNMENT; SUPPRESSION; RIBOSOME	We describe the construction and characterization of a genomically recoded organism (GRO). We replaced all known UAG stop codons in Escherichia coli MG1655 with synonymous UAA codons, which permitted the deletion of release factor 1 and reassignment of UAG translation function. This GRO exhibited improved properties for incorporation of nonstandard amino acids that expand the chemical diversity of proteins in vivo. The GRO also exhibited increased resistance to T7 bacteriophage, demonstrating that new genetic codes could enable increased viral resistance.	[Lajoie, Marc J.; Goodman, Daniel B.; Kuznetsov, Gleb; Mosberg, Joshua A.; Rohland, Nadin; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lajoie, Marc J.; Mosberg, Joshua A.] Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA; [Rovner, Alexis J.; Haimovich, Adrian D.; Isaacs, Farren J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Rovner, Alexis J.; Aerni, Hans-Rudolf; Haimovich, Adrian D.; Rinehart, Jesse; Isaacs, Farren J.] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA; [Goodman, Daniel B.] Harvard Massachusetts Inst Technol MIT Div Hlth S, Program Med Engn & Med Phys, Cambridge, MA 02139 USA; [Aerni, Hans-Rudolf; Rinehart, Jesse] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Mercer, Jaron A.] Harvard Univ, Cambridge, MA 02138 USA; [Wang, Harris H.] Columbia Univ, Coll Phys & Surg, Dept Syst Biol, New York, NY 10032 USA; [Carr, Peter A.] MIT, Lincoln Lab, Lexington, MA 02420 USA; [Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Jacobson, Joseph M.] MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA; [Jacobson, Joseph M.] MIT, Media Lab, Cambridge, MA 02139 USA; [Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Yale University; Yale University; Yale University; Harvard University; Columbia University; Lincoln Laboratory; Massachusetts Institute of Technology (MIT); Scripps Research Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu; farren.isaacs@yale.edu		Jacobson, Joseph/0000-0002-1332-3197; Mercer, Jaron/0000-0001-7078-614X; church, george/0000-0001-6232-9969; Goodman, Daniel/0000-0003-3759-6883	U.S. Department of Energy [DE-FG02-02ER63445]; NSF [SA5283-11210]; NIH [NIDDK-K01DK089006, 1DP5OD009172-01]; Defense Advanced Research Projects Agency [N66001-12-C-4040, N66001-12-C-4020, N66001-12-C-4211]; Arnold and Mabel Beckman Foundation; U.S. Department of Defense National Defense Science and Engineering Graduate Fellowship; NSF; Assistant Secretary of Defense for Research and Engineering [FA8721-05-C-0002];  [NIH-MSTP-TG-T32GM07205]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK089006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES027306, F31ES027304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009172] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Arnold and Mabel Beckman Foundation; U.S. Department of Defense National Defense Science and Engineering Graduate Fellowship; NSF(National Science Foundation (NSF)); Assistant Secretary of Defense for Research and Engineering; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We dedicate this paper to the memory of our friend, colleague, and gifted scientist, Tara Gianoulis. We thank R. Kolter for JC411, D. Reich for help with sequencing libraries, and C. and J. Seidman for Covaris E210; J. Aach, S. Kosuri, and U. Laserson for bioinformatics; T. Young, F. Peters, and W. Barnes for NSAA incorporation advice; I. Molineux and S. Kosuri for phage advice; S. Vassallo and P. Mali for experimental support; and D. Soll, A. Forster, T. Wu, K. Oye, C. Gregg, M. Napolitano, U. Laserson, A. Briggs, D. Mandell, and R. Chari for helpful comments. Funding was from the U.S. Department of Energy (DE-FG02-02ER63445), NSF (SA5283-11210), NIH (NIDDK-K01DK089006 to J. R.), Defense Advanced Research Projects Agency (N66001-12-C-4040, N66001-12-C-4020, N66001-12-C-4211), Arnold and Mabel Beckman Foundation (F. J. I.), U.S. Department of Defense National Defense Science and Engineering Graduate Fellowship (M. J. L.), NIH-MSTP-TG-T32GM07205 (A. D. H.), NSF graduate fellowships (H. H. W. and D. B. G.), NIH Director's Early Independence Award (1DP5OD009172-01 to H. H. W.), and the Assistant Secretary of Defense for Research and Engineering (Air Force Contract no. FA8721-05-C-0002 to P. A. C.). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. government.	Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; BAIN JD, 1992, NATURE, V356, P537, DOI 10.1038/356537a0; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; EGGERTSSON G, 1988, MICROBIOL REV, V52, P354, DOI 10.1128/MMBR.52.3.354-374.1988; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; Heineman RH, 2005, J MOL EVOL, V61, P181, DOI 10.1007/s00239-004-0304-4; Heinemann IU, 2012, FEBS LETT, V586, P3716, DOI 10.1016/j.febslet.2012.08.031; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Krakauer DC, 2002, J THEOR BIOL, V218, P97, DOI 10.1006/jtbi.2002.3054; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Ngo JT, 2011, ACCOUNTS CHEM RES, V44, P677, DOI 10.1021/ar200144y; O'Donoghue P, 2012, FEBS LETT, V586, P3931, DOI 10.1016/j.febslet.2012.09.033; Ohtake K, 2012, J BACTERIOL, V194, P2606, DOI 10.1128/JB.00195-12; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Schafer MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025736; Schmidt M, 2012, FEBS LETT, V586, P2199, DOI 10.1016/j.febslet.2012.02.022; Sturino JM, 2006, NAT REV MICROBIOL, V4, P395, DOI 10.1038/nrmicro1393; Vetsigian K, 2006, P NATL ACAD SCI USA, V103, P10696, DOI 10.1073/pnas.0603780103; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	25	532	573	22	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					357	360		10.1126/science.1241459	http://dx.doi.org/10.1126/science.1241459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136966	Green Accepted			2022-12-28	WOS:000325755100044
J	Das, S; Marsden, PA				Das, Sunit; Marsden, Philip A.			Angiogenesis in Glioblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELLS; GROWTH		[Das, Sunit] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Das, Sunit] St Michaels Hosp, Dept Neurosurg, Toronto, ON M5B 1W8, Canada; [Das, Sunit] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Marsden, Philip A.] Univ Toronto, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Das, S (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Das, Sunit/J-3903-2015	Das, Sunit/0000-0002-2146-4168	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076540] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL076540] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Ricci-Vitiani L, 2011, NATURE, V469, P432, DOI 10.1038/nature09734; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624	5	158	159	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1561	1563		10.1056/NEJMcibr1309402	http://dx.doi.org/10.1056/NEJMcibr1309402			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24131182	Green Accepted			2022-12-28	WOS:000328101700017
J	Simon, MD; Pinter, SF; Fang, R; Sarma, K; Rutenberg-Schoenberg, M; Bowman, SK; Kesner, BA; Maier, VK; Kingston, RE; Lee, JT				Simon, Matthew D.; Pinter, Stefan F.; Fang, Rui; Sarma, Kavitha; Rutenberg-Schoenberg, Michael; Bowman, Sarah K.; Kesner, Barry A.; Maier, Verena K.; Kingston, Robert E.; Lee, Jeannie T.			High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation	NATURE			English	Article							FACULTATIVE HETEROCHROMATIN; RNA; GENE; CHROMATIN; LOCALIZATION; ANNOTATION; DOMAINS; DESIGN	TheXist long noncodingRNA(lncRNA) is essential for X-chromosome inactivation (XCI), the process by which mammals compensate for unequal numbers of sex chromosomes(1-3). During XCI, Xist coats the future inactiveXchromosome(Xi)(4) and recruitsPolycomb repressive complex 2 (PRC2) to the X-inactivation centre (Xic)(5). How Xist spreads silencing on a 150-megabases scale is unclear. Here we generate high-resolution maps of Xist binding on the X chromosome across a developmental time course using CHART-seq. In female cells undergoing XCI de novo, Xist follows a two-step mechanism, initially targeting gene-rich islands before spreading to intervening gene-poor domains. Xist is depleted from genes that escape XCI but may concentrate near escapee boundaries. Xist binding is linearly proportional to PRC2 density and H3 lysine 27 trimethylation (H3K27me3), indicating co-migration of Xist and PRC2. Interestingly, when Xist is acutely stripped off from the Xi in post-XCI cells, Xist recovers quickly within both gene-rich and gene-poor domains on a timescale of hours instead of days, indicating a previously primed Xi chromatin state. We conclude that Xist spreading takes distinct stage-specific forms. During initial establishment, Xist follows a two-step mechanism, but during maintenance, Xist spreads rapidly to both gene-rich and gene-poor regions.	[Simon, Matthew D.; Pinter, Stefan F.; Sarma, Kavitha; Bowman, Sarah K.; Kesner, Barry A.; Maier, Verena K.; Kingston, Robert E.; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Simon, Matthew D.; Pinter, Stefan F.; Sarma, Kavitha; Bowman, Sarah K.; Kesner, Barry A.; Maier, Verena K.; Kingston, Robert E.; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Simon, Matthew D.; Fang, Rui; Rutenberg-Schoenberg, Michael] Yale Univ, Dept Mol Biophys & Biochem, West Haven, CT 06516 USA; [Simon, Matthew D.; Fang, Rui; Rutenberg-Schoenberg, Michael] Yale Univ, Inst Chem Biol, West Haven, CT 06516 USA; [Pinter, Stefan F.; Sarma, Kavitha; Kesner, Barry A.; Maier, Verena K.; Lee, Jeannie T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Yale University; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Simon, MD (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	matthew.simon@yale.edu; kingston@molbio.mgh.harvard.edu; lee@molbio.mgh.harvard.edu	Simon, Matthew/ABF-9127-2020; Pinter, Stefan/O-9228-2019	Pinter, Stefan/0000-0003-4750-1403; Simon, Matthew/0000-0001-7423-5265	Yale University; Deutsche Forschungsgemeinschaft; MGH Fund for Medical Discovery; National Institutes of Health [F32-GM090765, RO1-GM043901, RO1-GM090278]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090765, T32GM007223, R01GM090278, R01GM043901] Funding Source: NIH RePORTER	Yale University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MGH Fund for Medical Discovery; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Overton, I. Tikhonova and A. Lopez, and the MGH Bioinformatics Core. We also acknowledge funding from Yale University start-up funds to M. D. S., the Deutsche Forschungsgemeinschaft to S. F. P. and V. K. M., the MGH Fund for Medical Discovery to S. F. P., and the National Institutes of Health (grant F32-GM090765 to K. S., RO1-GM043901 to R. E. K., and RO1-GM090278 to J. T. L.). J. T. L. is an Investigator of the Howard Hughes Medical Institute.	Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Calabrese JM, 2012, CELL, V151, P951, DOI 10.1016/j.cell.2012.10.037; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chadwick BP, 2003, HUM MOL GENET, V12, P2167, DOI 10.1093/hmg/ddg229; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Disteche CM, 2012, ANNU REV GENET, V46, P537, DOI 10.1146/annurev-genet-110711-155454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; FLICKINGER JL, 1992, NUCLEIC ACIDS RES, V20, P2382, DOI 10.1093/nar/20.9.2382; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huang WC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr592; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lyon MF, 2003, SEMIN CELL DEV BIOL, V14, P313, DOI 10.1016/j.semcdb.2003.09.015; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Pontier DB, 2011, HUM GENET, V130, P223, DOI 10.1007/s00439-011-1008-7; Sarma Kavitha, 2010, Proc Natl Acad Sci U S A, V107, P22196, DOI 10.1073/pnas.1009785107; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wernersson R, 2005, NUCLEIC ACIDS RES, V33, pW611, DOI 10.1093/nar/gki399; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Yildirim E, 2012, NAT STRUCT MOL BIOL, V19, P56, DOI 10.1038/nsmb.2195; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	43	271	292	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					465	+		10.1038/nature12719	http://dx.doi.org/10.1038/nature12719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24162848	Green Accepted, Green Submitted			2022-12-28	WOS:000328575300058
J	Qaseem, A; Hopkins, RH; Sweet, DE; Starkey, M; Shekelle, P				Qaseem, Amir; Hopkins, Robert H., Jr.; Sweet, Donna E.; Starkey, Melissa; Shekelle, Paul		Amer Coll Phys	Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE CONTROL; CONVERTING-ENZYME-INHIBITION; TYPE-2 DIABETES-MELLITUS; DIETARY-PROTEIN RESTRICTION; CHRONIC RENAL-INSUFFICIENCY; LIPID-LOWERING TREATMENT; CORONARY-HEART-DISEASE; 3RD NATIONAL-HEALTH; ALL-CAUSE MORTALITY; LOW-DOSE RAMIPRIL	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. Methods: This guideline is based on a systematic evidence review evaluating the published literature on this topic from 1985 through November 2011 that was identified by using MEDLINE and the Cochrane Database of Systematic Reviews. Searches were limited to English-language publications. The clinical outcomes evaluated for this guideline included all-cause mortality, cardiovascular mortality, myocardial infarction, stroke, chronic heart failure, composite vascular outcomes, composite renal outcomes, end-stage renal disease, quality of life, physical function, and activities of daily living. This guideline grades the evidence and recommendations by using ACP's clinical practice guidelines grading system. Recommendation 1: ACP recommends against screening for chronic kidney disease in asymptomatic adults without risk factors for chronic kidney disease. (Grade: weak recommendation, low-quality evidence) Recommendation 2: ACP recommends against testing for proteinuria in adults with or without diabetes who are currently taking an angiotensin-converting enzyme inhibitor or an angiotensin II-receptor blocker. (Grade: weak recommendation, low-quality evidence) Recommendation 3: ACP recommends that clinicians select pharmacologic therapy that includes either an angiotensin-converting enzyme inhibitor (moderate-quality evidence) or an angiotensin II-receptor blocker (high-quality evidence) in patients with hypertension and stage 1 to 3 chronic kidney disease. (Grade: strong recommendation) Recommendation 4: ACP recommends that clinicians choose statin therapy to manage elevated low-density lipoprotein in patients with stage 1 to 3 chronic kidney disease. (Grade: strong recommendation, moderate-quality evidence)	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA; Univ Kansas, Sch Med, Wichita, KS 67214 USA; West Los Angeles Vet Affairs Med Ctr, Los Angeles, CA USA	American College of Physicians; University of Arkansas System; University of Arkansas Medical Sciences; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Starkey, Melissa/0000-0002-5818-0265	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Anand IS, 2009, CIRCULATION, V120, P1577, DOI 10.1161/CIRCULATIONAHA.109.853648; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Bakris G, 2008, KIDNEY INT, V74, P364, DOI 10.1038/ki.2008.204; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Barrett BJ, 2011, CLIN J AM SOC NEPHRO, V6, P1241, DOI 10.2215/CJN.07160810; Bojestig M, 2001, DIABETES CARE, V24, P919, DOI 10.2337/diacare.24.5.919; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brugts JJ, 2007, J AM COLL CARDIOL, V50, P2148, DOI 10.1016/j.jacc.2007.08.029; Castagno D, 2010, EUR J HEART FAIL, V12, P607, DOI 10.1093/eurjhf/hfq038; Centers for Disease Control and Prevention, CHRON KIDN DIS SURV; Centers for Disease Control and Prevention (CDC), 2010, NAT CHRON KIDN DIS F; Chan JC, 2009, DIABETES CARE, V32, P977, DOI 10.2337/dc08-1908; Chonchol M, 2007, AM J KIDNEY DIS, V49, P373, DOI 10.1053/j.ajkd.2006.11.043; Cinotti GA, 2001, NEPHROL DIAL TRANSPL, V16, P961, DOI 10.1093/ndt/16.5.961; Cohen-Solal A, 2009, EUR J HEART FAIL, V11, P872, DOI 10.1093/eurjhf/hfp104; Colhoun HM, 2009, AM J KIDNEY DIS, V54, P810, DOI 10.1053/j.ajkd.2009.03.022; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Crepaldi G, 1998, DIABETES CARE, V21, P104, DOI 10.2337/diacare.21.1.104; Dussol B, 2005, J RENAL NUTR, V15, P398, DOI 10.1053/j.jrn.2005.07.003; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ensrud KE, 2007, ARCH INTERN MED, V167, P133, DOI 10.1001/archinte.167.2.133; Fassett RG, 2010, J ATHEROSCLER THROMB, V17, P235, DOI 10.5551/jat.2683; Fink HA, 2012, CHRONIC KIDNEY DIS S; Fink HA, 2012, ANN INTERN MED, V156, P570, DOI [10.7326/0003-4819-156-8-201204170-00008, 10.7326/0003-4819-156-8-201204170-00004]; Fogari R, 2002, AM J HYPERTENS, V15, P1042, DOI 10.1016/S0895-7061(02)03017-0; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2000, LANCET, V355, P253; Ghali JK, 2009, J CARD FAIL, V15, P310, DOI 10.1016/j.cardfail.2008.11.003; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; HANNEDOUCHE T, 1994, BRIT MED J, V309, P833, DOI 10.1136/bmj.309.6958.833; Harris LE, 1998, AM J MED, V105, P464, DOI 10.1016/S0002-9343(98)00329-5; Hou FF, 2007, J AM SOC NEPHROL, V18, P1889, DOI 10.1681/ASN.2006121372; Ishani A, 2008, OSTEOPOROSIS INT, V19, P1549, DOI 10.1007/s00198-008-0608-0; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Joss N, 2004, QJM-INT J MED, V97, P219, DOI 10.1093/qjmed/hch039; Kanno Y, 2006, CLIN J AM SOC NEPHRO, V1, P730, DOI 10.2215/CJN.01110905; Katayama S, 2002, DIABETES RES CLIN PR, V55, P113, DOI 10.1016/S0168-8227(01)00289-3; Khatri M, 2009, J AM SOC NEPHROL, V20, P2427, DOI 10.1681/ASN.2008101090; Kidney Disease: Improving Global Outcomes (KDIGO), 2013, KIDNEY INT SUPPL, V3, P1, DOI DOI 10.1038/KISUP.2012.76; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kopple JD, 1997, KIDNEY INT, V52, P778, DOI 10.1038/ki.1997.395; Koren MJ, 2009, AM J KIDNEY DIS, V53, P741, DOI 10.1053/j.ajkd.2008.11.025; Koya D, 2009, DIABETOLOGIA, V52, P2037, DOI 10.1007/s00125-009-1467-8; Lacourciere Y, 2000, KIDNEY INT, V58, P762, DOI 10.1046/j.1523-1755.2000.00224.x; LAFFEL LMB, 1995, AM J MED, V99, P497, DOI 10.1016/S0002-9343(99)80226-5; Lemos PA, 2005, AM J CARDIOL, V95, P445, DOI 10.1016/j.amjcard.2004.10.008; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lewis JB, 1999, AM J KIDNEY DIS, V34, P809, DOI 10.1016/S0272-6386(99)70036-3; LOCATELLI F, 1991, LANCET, V337, P1299, DOI 10.1016/0140-6736(91)92977-A; Marin R, 2001, J HYPERTENS, V19, P1871, DOI 10.1097/00004872-200110000-00023; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; Menne J, 2008, J HYPERTENS, V26, P1860, DOI 10.1097/HJH.0b013e32830508aa; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Muirhead N, 1999, CURR THER RES CLIN E, V60, P650, DOI 10.1016/S0011-393X(99)90003-6; Nakamura H, 2009, ATHEROSCLEROSIS, V206, P512, DOI 10.1016/j.atherosclerosis.2009.03.031; O'Hare JP, 2000, DIABETES CARE, V23, P1823, DOI 10.2337/diacare.23.12.1823; Ogawa S, 2007, HYPERTENS RES, V30, P325, DOI 10.1291/hypres.30.325; Pahor M, 1998, ARCH INTERN MED, V158, P1340, DOI 10.1001/archinte.158.12.1340; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Perkovic V, 2007, J AM SOC NEPHROL, V18, P2766, DOI 10.1681/ASN.2007020256; Rahman M, 2005, ARCH INTERN MED, V165, P936, DOI 10.1001/archinte.165.8.936; Rahman M, 2008, AM J KIDNEY DIS, V52, P412, DOI 10.1053/j.ajkd.2008.05.027; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; Ridker PM, 2010, J AM COLL CARDIOL, V55, P1266, DOI 10.1016/j.jacc.2010.01.020; ROSMAN JB, 1989, KIDNEY INT, V36, pS96; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Ryan TP, 2007, AM J MED, V120, P981, DOI 10.1016/j.amjmed.2007.05.012; Samuelsson O, 1997, NEPHRON, V75, P286, DOI 10.1159/000189551; SANO T, 1994, DIABETES CARE, V17, P420, DOI 10.2337/diacare.17.5.420; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Shepherd J, 2008, J AM COLL CARDIOL, V51, P1448, DOI 10.1016/j.jacc.2007.11.072; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; Solomon SD, 2006, CIRCULATION, V114, P26, DOI 10.1161/CIRCULATIONAHA.105.592733; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006254; Tobe SW, 2011, CIRCULATION, V123, P1098, DOI 10.1161/CIRCULATIONAHA.110.964171; Tonelli M, 2004, AM J KIDNEY DIS, V44, P832, DOI 10.1053/j.ajkd.2004.07.009; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; TOTO RD, 1995, KIDNEY INT, V48, P851, DOI 10.1038/ki.1995.361; TREVISAN R, 1995, AM J HYPERTENS, V8, P876, DOI 10.1016/0895-7061(95)00162-I; Upadhyay A, 2012, ANN INTERN MED, V157, P251, DOI 10.7326/0003-4819-157-4-201208210-00005; US Renal Data System, 2010, US REN DAT SYST 2010; vanEssen GG, 1997, KIDNEY INT, pS58; Wali RK, 2011, CIRC-HEART FAIL, V4, P18, DOI 10.1161/CIRCHEARTFAILURE.109.932558; Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021; Wilhelm-Leen ER, 2009, AM J MED, V122, P664, DOI 10.1016/j.amjmed.2009.01.026; WILSON JMG, 1968, WHO CHRON, V22, P473; Wright JT, 1996, CONTROL CLIN TRIALS, V17, pS3, DOI 10.1016/S0197-2456(96)00081-5; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; ZUCCHELLI P, 1992, KIDNEY INT, V42, P452, DOI 10.1038/ki.1992.309; ZUCCHELLI P, 1995, NEPHROL DIAL TRANSPL, V10, P46	105	125	129	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12					835	+		10.7326/0003-4819-159-12-201312170-00726	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-00726			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24145991				2022-12-28	WOS:000329735300016
J	Popova, OP; Jenniskens, P; Emel'yanenko, V; Kartashova, A; Biryukov, E; Khaibrakhmanov, S; Shuvalov, V; Rybnov, Y; Dudorov, A; Grokhovsky, VI; Badyukov, DD; Yin, QZ; Gural, PS; Albers, J; Granvik, M; Evers, LG; Kuiper, J; Kharlamov, V; Solovyov, A; Rusakov, YS; Korotkiy, S; Serdyuk, I; Korochantsev, AV; Larionov, MY; Glazachev, D; Mayer, AE; Gisler, G; Gladkovsky, SV; Wimpenny, J; Sanborn, ME; Yamakawa, A; Verosub, KL; Rowland, DJ; Roeske, S; Botto, NW; Friedrich, JM; Zolensky, ME; Le, L; Ross, D; Ziegler, K; Nakamura, T; Ahn, I; Lee, JI; Zhou, Q; Li, XH; Li, QL; Liu, Y; Tang, GQ; Hiroi, T; Sears, D; Weinstein, IA; Vokhmintsev, AS; Ishchenko, AV; Schmitt-Kopplin, P; Hertkorn, N; Nagao, K; Haba, MK; Komatsu, M; Mikouchi, T				Popova, Olga P.; Jenniskens, Peter; Emel'yanenko, Vacheslav; Kartashova, Anna; Biryukov, Eugeny; Khaibrakhmanov, Sergey; Shuvalov, Valery; Rybnov, Yurij; Dudorov, Alexandr; Grokhovsky, Victor I.; Badyukov, Dmitry D.; Yin, Qing-Zhu; Gural, Peter S.; Albers, Jim; Granvik, Mikael; Evers, Laslo G.; Kuiper, Jacob; Kharlamov, Vladimir; Solovyov, Andrey; Rusakov, Yuri S.; Korotkiy, Stanislav; Serdyuk, Ilya; Korochantsev, Alexander V.; Larionov, Michail Yu.; Glazachev, Dmitry; Mayer, Alexander E.; Gisler, Galen; Gladkovsky, Sergei V.; Wimpenny, Josh; Sanborn, Matthew E.; Yamakawa, Akane; Verosub, Kenneth L.; Rowland, Douglas J.; Roeske, Sarah; Botto, Nicholas W.; Friedrich, Jon M.; Zolensky, Michael E.; Le, Loan; Ross, Daniel; Ziegler, Karen; Nakamura, Tomoki; Ahn, Insu; Lee, Jong Ik; Zhou, Qin; Li, Xian-Hua; Li, Qiu-Li; Liu, Yu; Tang, Guo-Qiang; Hiroi, Takahiro; Sears, Derek; Weinstein, Ilya A.; Vokhmintsev, Alexander S.; Ishchenko, Alexei V.; Schmitt-Kopplin, Phillipe; Hertkorn, Norbert; Nagao, Keisuke; Haba, Makiko K.; Komatsu, Mutsumi; Mikouchi, Takashi		Chelyabinsk Airburst Consortiu	Chelyabinsk Airburst, Damage Assessment, Meteorite Recovery, and Characterization	SCIENCE			English	Article							L-CHONDRITES; METEOROIDS; PHOSPHATES; ITOKAWA; ORIGIN; FAMILY	The asteroid impact near the Russian city of Chelyabinsk on 15 February 2013 was the largest airburst on Earth since the 1908 Tunguska event, causing a natural disaster in an area with a population exceeding one million. Because it occurred in an era with modern consumer electronics, field sensors, and laboratory techniques, unprecedented measurements were made of the impact event and the meteoroid that caused it. Here, we document the account of what happened, as understood now, using comprehensive data obtained from astronomy, planetary science, geophysics, meteorology, meteoritics, and cosmochemistry and from social science surveys. A good understanding of the Chelyabinsk incident provides an opportunity to calibrate the event, with implications for the study of near-Earth objects and developing hazard mitigation strategies for planetary protection.	[Popova, Olga P.; Shuvalov, Valery; Rybnov, Yurij; Kharlamov, Vladimir; Glazachev, Dmitry] Russian Acad Sci, Inst Dynam Geospheres, Moscow 119334, Russia; [Jenniskens, Peter; Gural, Peter S.; Albers, Jim] SETI Inst, Mountain View, CA 94043 USA; [Emel'yanenko, Vacheslav; Kartashova, Anna] Russian Acad Sci, Inst Astron, Moscow 119017, Russia; [Biryukov, Eugeny] South Ural State Univ, Dept Theoret Mech, Chelyabinsk 454080, Russia; [Khaibrakhmanov, Sergey; Dudorov, Alexandr; Mayer, Alexander E.] Chelyabinsk State Univ, Chelyabinsk 454001, Russia; [Grokhovsky, Victor I.; Larionov, Michail Yu.; Weinstein, Ilya A.; Vokhmintsev, Alexander S.; Ishchenko, Alexei V.] Ural Fed Univ, Inst Phys & Technol, Ekaterinburg 620002, Russia; [Badyukov, Dmitry D.; Korochantsev, Alexander V.] RAS, Vernadsky Inst Geochem & Analyt Chem, Moscow 119991, Russia; [Yin, Qing-Zhu; Wimpenny, Josh; Sanborn, Matthew E.; Yamakawa, Akane; Verosub, Kenneth L.; Roeske, Sarah; Botto, Nicholas W.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Granvik, Mikael] Univ Helsinki, Dept Phys, Helsinki 00014, Finland; [Evers, Laslo G.; Kuiper, Jacob] Koninklijk Nederlands Meteorol Inst, NL-3730 AE De Bilt, Netherlands; [Evers, Laslo G.] Delft Univ Technol, Fac Civil Engn & Geosci, Dept Geosci & Engn, NL-2600 GA Delft, Netherlands; [Solovyov, Andrey] Tomsk State Univ, Tomsk 634050, Russia; [Rusakov, Yuri S.] Res & Prod Assoc Typhoon, Obninsk 249032, Russia; [Korotkiy, Stanislav] Support Fdn Astron Ka Dar, Razvilka 142717, Russia; [Weinstein, Ilya A.] Social & Youth Initiat Org, Sci & Technol Ctr, Moscow 119415, Russia; [Gisler, Galen] Univ Oslo, N-0316 Oslo, Norway; [Gladkovsky, Sergei V.] Russian Acad Sci, Inst Engn Sci, Urals Branch, Ekaterinburg 620049, Russia; [Rowland, Douglas J.] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA; [Friedrich, Jon M.] Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 10024 USA; [Friedrich, Jon M.] Fordham Univ, Dept Chem, Bronx, NY 10458 USA; [Zolensky, Michael E.; Le, Loan; Ross, Daniel] NASA, Johnson Space Ctr, Houston, TX 77058 USA; [Le, Loan; Ross, Daniel] Jacobs Technol, Houston, TX 77058 USA; [Ziegler, Karen] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Nakamura, Tomoki; Ahn, Insu] Tohoku Univ, Dept Earth & Planetary Mat Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Lee, Jong Ik] Korea Polar Res Inst, Div Polar Earth Syst Sci, Inchon 406840, South Korea; [Zhou, Qin] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Zhou, Qin; Li, Xian-Hua; Li, Qiu-Li; Liu, Yu; Tang, Guo-Qiang] Chinese Acad Sci, Inst Geol & Geophys, State Key Lab Lithospher Evolut, Beijing 100029, Peoples R China; [Hiroi, Takahiro] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Schmitt-Kopplin, Phillipe; Hertkorn, Norbert] Helmoltz Zentrum Muenchen, D-85764 Obeschleissheim, Germany; [Schmitt-Kopplin, Phillipe] Tech Univ Munich, D-85354 Freising Weihenstephan, Germany; [Nagao, Keisuke; Haba, Makiko K.] Univ Tokyo, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan; [Komatsu, Mutsumi] Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, Tokyo 1698050, Japan; [Mikouchi, Takashi] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Institute of Astronomy of the Russian Academy of Sciences; Russian Academy of Sciences; South Ural State University; Chelyabinsk State University; Ural Federal University; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; University of California System; University of California Davis; University of Helsinki; Royal Netherlands Meteorological Institute; Delft University of Technology; Tomsk State University; University of Oslo; Russian Academy of Sciences; Institute of Engineering Science, RAS (Ural Branch); University of California System; University of California Davis; American Museum of Natural History (AMNH); Fordham University; National Aeronautics & Space Administration (NASA); University of New Mexico; Tohoku University; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Chinese Academy of Sciences; National Astronomical Observatory, CAS; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Brown University; Technical University of Munich; University of Tokyo; Waseda University; University of Tokyo	Jenniskens, P (corresponding author), SETI Inst, 189 Bernardo Ave, Mountain View, CA 94043 USA.	petrus.m.jenniskens@nasa.gov	Badyukov, Dmitry/AAN-7296-2020; Kartashova, Anna/N-3468-2013; Khaibrakhmanov, Sergey A/G-7264-2015; Solovyov, Andrey/U-3916-2018; Solovyov, Andrey/G-8268-2014; Glazachev, Dmitry/Y-5615-2018; Grokhovsky, Victor I/B-4388-2014; Schmitt-Kopplin, Philippe/H-6271-2011; Popova, Olga P/K-1885-2012; Gladkovsky, Sergei/E-5731-2016; Evers, Läslo/E-5707-2011; Komatsu, Mutsumi/N-9483-2019; Weinstein, Ilya A./K-8178-2012; Shuvalov, Valery/ABC-5902-2020; Yin, Qing-Zhu/B-8198-2009; Soloviev, Andrey V./P-1761-2014; Rowland, Douglas J/F-3104-2014; Ishchenko, Aleksey/E-1017-2014; Zhou, Qin/AFK-0169-2022; Dudorov, Alexander E./P-4773-2015; Emel'yanenko, Vacheslav/A-4087-2014; Li, Qiuli/A-8874-2012; Larionov, Mikhail/F-7770-2017; Mayer, Alexander/I-3069-2013; Hertkorn, Norbert/AAA-5990-2022; Shuvalov, Valery/C-6618-2014; haba, makiko/GRX-2377-2022; Biryukov, Eugeny/AAJ-1432-2020; Mikouchi, Takashi/AAY-7355-2021; Zhou, Qin/AAF-7236-2022; Vokhmintsev, Alexander/E-1013-2014	Kartashova, Anna/0000-0003-4320-5105; Khaibrakhmanov, Sergey A/0000-0002-4439-6831; Glazachev, Dmitry/0000-0001-9475-3430; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Gladkovsky, Sergei/0000-0002-3542-6242; Evers, Läslo/0000-0003-2825-6211; Komatsu, Mutsumi/0000-0003-4659-8418; Weinstein, Ilya A./0000-0002-5573-7128; Yin, Qing-Zhu/0000-0002-4445-5096; Rowland, Douglas J/0000-0001-8059-6905; Ishchenko, Aleksey/0000-0002-9883-6652; Zhou, Qin/0000-0001-8562-9737; Li, Qiuli/0000-0002-7280-5508; Larionov, Mikhail/0000-0003-1172-6950; Mayer, Alexander/0000-0002-8765-6373; Zhou, Qin/0000-0001-8562-9737; Mikouchi, Takashi/0000-0002-9998-8754; Wimpenny, Josh/0000-0002-7637-0978; Granvik, Mikael/0000-0002-5624-1888; Vokhmintsev, Alexander/0000-0003-2529-3770; Biryukov, Eugeny/0000-0002-2428-1770; Haba, Makiko/0000-0003-2554-7849; Zolensky, Michael/0000-0002-3181-1303; Popova, Olga/0000-0003-4874-6701; Sanborn, Matthew/0000-0003-3218-1195	Institute for Dynamics of Geospheres; Federal Targeted Program Scientific and Educational Human Resources of Innovation-Driven Russia; RAS Presidium Program Fundamental Problems of Investigation and Exploration of the Solar System; NASA; Grants-in-Aid for Scientific Research [11J08649] Funding Source: KAKEN	Institute for Dynamics of Geospheres; Federal Targeted Program Scientific and Educational Human Resources of Innovation-Driven Russia; RAS Presidium Program Fundamental Problems of Investigation and Exploration of the Solar System; NASA(National Aeronautics & Space Administration (NASA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Russian Academy of Sciences (RAS) field study of the Chelyabinsk airburst was supported by the Institute for Dynamics of Geospheres and grants of the Federal Targeted Program Scientific and Educational Human Resources of Innovation-Driven Russia and the RAS Presidium Program Fundamental Problems of Investigation and Exploration of the Solar System. The office of Chelyabinsk Oblast Governor Mikhail Yurevich provided assistance. S. Petukhov and I. Talyukin from the Universe History Museum in Dedovsk contributed samples, as did M. Boslough of Sandia National Laboratories. U. Johann (Astrium Satellites GmbH) calculated the Chebarkul hole position from Pleiades 1A satellite observations. D. F. Blake provided use of a petrographic microscope. P.J. acknowledges support from the NASA Near Earth Object Observation Program, Q.Z.Y. and M.E.Z. from the NASA Cosmochemistry Program, and M. G. from the Academy of Finland.	Amelin Y, 2005, SCIENCE, V310, P839, DOI 10.1126/science.1117919; [Anonymous], 1977, EFFECTS NUCL WEAPONS; Bischoff A., 2006, METEORITES EARLY SOL, P679; Borovicka J., 2013, 3423 CBET INT ASTR U; Boslough MBE, 1997, ANN NY ACAD SCI, V822, P236, DOI 10.1111/j.1749-6632.1997.tb48345.x; Bottke W. F., 2000, ICARUS, V156, P339; Christie DR, 2010, INFRASOUND MONITORING FOR ATMOSPHERIC STUDIES, P29, DOI 10.1007/978-1-4020-9508-5_2; CLAYTON RN, 1991, GEOCHIM COSMOCHIM AC, V55, P2317, DOI 10.1016/0016-7037(91)90107-G; Consolmagno GJ, 2008, CHEM ERDE-GEOCHEM, V68, P1, DOI 10.1016/j.chemer.2008.01.003; Dunn TL, 2013, ICARUS, V222, P273, DOI 10.1016/j.icarus.2012.11.007; Ens TA, 2012, J ATMOS SOL-TERR PHY, V80, P208, DOI 10.1016/j.jastp.2012.01.018; Friedrich JM, 2004, GEOCHIM COSMOCHIM AC, V68, P2889, DOI 10.1016/j.gca.2004.01.010; Friedrich JM, 2003, GEOCHIM COSMOCHIM AC, V67, P2467, DOI 10.1016/S0016-7307(03)00024-3; GOPEL C, 1994, EARTH PLANET SC LETT, V121, P153, DOI 10.1016/0012-821X(94)90038-8; HARTMETZ CP, 1987, METEORITICS, V22, P400; Huang MW, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/483562; Jenniskens P, 2012, SCIENCE, V338, P1583, DOI 10.1126/science.1227163; Michel P, 2006, ASTRON ASTROPHYS, V449, P817, DOI 10.1051/0004-6361:20054319; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Nazarov M. A., 2013, CHELYABINSK METEORIT; Nemtchinov IV, 1997, ICARUS, V130, P259, DOI 10.1006/icar.1997.5821; Nesvorny D, 2002, ICARUS, V157, P155, DOI 10.1006/icar.2002.6830; Popova O, 2011, METEORIT PLANET SCI, V46, P1525, DOI 10.1111/j.1945-5100.2011.01247.x; Reddy V, 2011, ICARUS, V216, P184, DOI 10.1016/j.icarus.2011.08.027; ReVelle DO, 2001, ESA SPEC PUBL, V495, P507; Rochette P, 2003, METEORIT PLANET SCI, V38, P251, DOI 10.1111/j.1945-5100.2003.tb00263.x; Schmitt-Kopplin P, 2010, P NATL ACAD SCI USA, V107, P2763, DOI 10.1073/pnas.0912157107; Schunova E, 2012, ICARUS, V220, P1050, DOI 10.1016/j.icarus.2012.06.042; SEARS DW, 1973, NATURE-PHYS SCI, V242, P25, DOI 10.1038/physci242025a0; STOFFLER D, 1991, GEOCHIM COSMOCHIM AC, V55, P3845, DOI 10.1016/0016-7037(91)90078-J; Svetsov V., 2008, CATASTROPHIC EVENTS, P227; Tagliaferri E., 1998, HAZARDS DUE COMETS A, P199; Terada K, 2009, ASTROPHYS J LETT, V699, pL68, DOI 10.1088/0004-637X/699/2/L68; Trinquier A, 2007, ASTROPHYS J, V655, P1179, DOI 10.1086/510360; Troiano J, 2011, GEOCHIM COSMOCHIM AC, V75, P6511, DOI 10.1016/j.gca.2011.08.033; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066; Zinn J, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010575	39	393	412	7	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1069	1073		10.1126/science.1242642	http://dx.doi.org/10.1126/science.1242642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24200813	Green Submitted, Green Published			2022-12-28	WOS:000327518600050
J	Chien, AT; Rosenthal, MB				Chien, Alyna T.; Rosenthal, Meredith B.			Medicare's Physician Value-Based Payment Modifier - Will the Tectonic Shift Create Waves?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							QUALITY-OF-CARE; PERFORMANCE; PAY	Medicare's new Physician Value-Based Payment Modifier will financially reward physicians who provide high-quality, low-cost health care. Will this tectonic shift in physician payment set off a new wave of efforts to improve quality and cost performance? For at least two decades, the Centers for Medicare and Medicaid Services (CMS) has been transforming itself from a passive payer to an active purchaser of health care, a process that was accelerated by the passage of the 2010 Affordable Care Act (ACA). One ACA provision ushered in a new payment paradigm for physicians the Physician Value-Based Payment Modifier (PVBM).(1) The PVBM seeks to financially reward physicians who provide health care that is high value both high in quality and low in cost.(2) Although the PVBM is being rolled out to physicians in large groups first, the legislation ...	[Chien, Alyna T.] Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA; [Chien, Alyna T.] Harvard Univ, Sch Med, Boston, MA USA; [Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Chien, AT (corresponding author), Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA.			Chien, Alyna/0000-0002-9302-8015; Rosenthal, Meredith/0000-0003-3410-0184				Bardach NS, 2013, JAMA-J AM MED ASSOC, V310, P1051, DOI 10.1001/jama.2013.277353; Chien AT, 2010, HEALTH SERV RES, V45, P1934, DOI 10.1111/j.1475-6773.2010.01168.x; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; VanLare JM, 2012, JAMA-J AM MED ASSOC, V308, P2089, DOI 10.1001/jama.2012.14834	4	34	34	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2076	2078		10.1056/NEJMp1311957	http://dx.doi.org/10.1056/NEJMp1311957			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	258OB	24195501				2022-12-28	WOS:000327467500004
J	Sia, GM; Clem, RL; Huganir, RL				Sia, G. M.; Clem, R. L.; Huganir, R. L.			The Human Language-Associated Gene SRPX2 Regulates Synapse Formation and Vocalization in Mice	SCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; ULTRASONIC VOCALIZATION; HIKARU-GENKI; SPEECH; FOXP2; DISORDERS; PROTEIN; AUTISM; DIFFERENTIATION; DROSOPHILA	Synapse formation in the developing brain depends on the coordinated activity of synaptogenic proteins, some of which have been implicated in a number of neurodevelopmental disorders. Here, we show that the sushi repeat-containing protein X-linked 2 (SRPX2) gene encodes a protein that promotes synaptogenesis in the cerebral cortex. In humans, SRPX2 is an epilepsy- and language-associated gene that is a target of the foxhead box protein P2 (FoxP2) transcription factor. We also show that FoxP2 modulates synapse formation through regulating SRPX2 levels and that SRPX2 reduction impairs development of ultrasonic vocalization in mice. Our results suggest FoxP2 modulates the development of neural circuits through regulating synaptogenesis and that SRPX2 is a synaptogenic factor that plays a role in the pathogenesis of language disorders.	[Sia, G. M.; Huganir, R. L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Sia, G. M.; Huganir, R. L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Clem, R. L.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, 725 North Wolfe St, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Sia, Gek Ming/0000-0001-9333-0065	National Institutes of Health [P50MH084020, NS050274]; Millipore; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020, R01MH095058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millipore; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Pletnikov and J. Yocum of the Behavioral Core Facility and M. Pucak of the Multiphoton/Electrophysiology Core Facility. We also thank H. Vega, S. Yang, N. O'Sullivan, and X. Wang for technical assistance. This study was supported by National Institutes of Health grant P50MH084020 to R.L.H. and grant NS050274 to the Multiphoton Core Facility. Under a licensing agreement between Millipore and the Johns Hopkins University, R.L.H. is entitled to a share of royalties received by the University on sales of products described in this article. R.L.H. is a paid consultant to Millipore. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict-of-interest policies.	Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; French CA, 2007, GENESIS, V45, P440, DOI 10.1002/dvg.20305; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; HOSHINO M, 1993, NEURON, V10, P395, DOI 10.1016/0896-6273(93)90329-P; Hoshino M, 1996, DEVELOPMENT, V122, P589; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Reimers-Kipping S, 2011, NEUROSCIENCE, V175, P75, DOI 10.1016/j.neuroscience.2010.11.042; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174	32	93	102	0	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					987	991		10.1126/science.1245079	http://dx.doi.org/10.1126/science.1245079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24179158	Green Accepted			2022-12-28	WOS:000327223500045
J	Navarese, EP; Tandjung, K; Claessen, B; Andreotti, F; Kowalewski, M; Kandzari, DE; Kereiakes, DJ; Waksman, R; Mauri, L; Meredith, IT; Finn, AV; Kim, HS; Kubica, J; Suryapranata, H; Aprami, TM; Di Pasquale, G; von Birgelen, C; Kedhi, E				Navarese, Eliano P.; Tandjung, Kenneth; Claessen, Bimmer; Andreotti, Felicita; Kowalewski, Mariusz; Kandzari, David E.; Kereiakes, Dean J.; Waksman, Ron; Mauri, Laura; Meredith, Ian T.; Finn, Aloke V.; Kim, Hyo-Soo; Kubica, Jacek; Suryapranata, Harry; Aprami, Toni Mustahsani; Di Pasquale, Giuseppe; von Birgelen, Clemens; Kedhi, Elvin			Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; BARE-METAL STENT; DUAL ANTIPLATELET THERAPY; REAL-WORLD PATIENTS; 5-YEAR FOLLOW-UP; XIENCE V STENTS; ARTERY-DISEASE; DIABETES-MELLITUS	Objectives To investigate the safety and efficacy of durable polymer drug eluting stents (DES) and biodegradable polymer biolimus eluting stents (biolimus-ES). Design Network meta-analysis of randomised controlled trials. Data sources and study selection Medline, Google Scholar, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) database search for randomised controlled trials comparing at least two of durable polymer sirolimus eluting stents (sirolimus-ES) and paclitaxel eluting stents (paclitaxel-ES), newer durable polymer everolimus eluting stents (everolimus-ES), Endeavor and Resolute zotarolimus eluting stents (zotarolimus-ES), and biodegradable polymer biolimus-ES. Primary outcomes Safety (death, myocardial infarction, definite or probable stent thrombosis) and efficacy (target lesion and target vessel revascularisation) assessed at up to one year and beyond. Results 60 randomised controlled trials were compared involving 63 242 patients with stable coronary artery disease or acute coronary syndrome treated with a DES. At one year, there were no differences in mortality among devices. Resolute and Endeavor zotarolimus-ES, everolimus-ES, and sirolimus-ES, but not biodegradable polymer biolimus-ES, were associated with significantly reduced odds of myocardial infarction (by 29-34%) compared with paclitaxel-ES. Compared with everolimus-ES, biodegradable polymer biolimus-ES were associated with significantly increased odds of myocardial infarction (by 29%), while Endeavor zotarolimus-ES and paclitaxel-ES were associated with significantly increased odds of stent thrombosis. All investigated DES were similar with regards to efficacy endpoints, except for Endeavor zotarolimus-ES and paclitaxel-ES, which were associated with significantly increased the odds of target lesion and target vessel revascularisations compared with other devices. Direction of results beyond one year did not diverge from the findings for up to one year follow-up. Bayesian probability curves showed a gradient in the magnitude of effect, with everolimus-ES and Resolute zotarolimus-ES offering the highest safety profiles. Conclusions The newer durable polymer everolimus-ES and Resolute zotarolimus-ES and the biodegradable polymer biolimus-ES maintain the efficacy of sirolimus-ES; however, for safety endpoints, differences become apparent, with everolimus-ES and Resolute zotarolimus-ES emerging as the safest stents to date.	[Navarese, Eliano P.; Kowalewski, Mariusz; Kubica, Jacek] Nicholas Copernicus Univ, Ludwik Rydygier Coll Med, Dept Cardiol & Internal Med, Bydgoszcz, Poland; [Tandjung, Kenneth; von Birgelen, Clemens] Med Spectrum Twente, Thoraxcentrum Twente, Dept Cardiol, Enschede, Netherlands; [Claessen, Bimmer] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1012 WX Amsterdam, Netherlands; [Andreotti, Felicita] Catholic Univ, Dept Cardiovasc Sci, Rome, Italy; [Kandzari, David E.] Piedmont Heart Inst, Atlanta, GA USA; [Kereiakes, Dean J.] Christ Hosp Heart, Dept Cardiol, Cincinnati, OH USA; [Kereiakes, Dean J.] Lindner Res Ctr, Vasc Ctr, Cincinnati, OH USA; [Waksman, Ron] MedStar Washington Hosp Ctr, Div Cardiol, Washington, DC USA; [Mauri, Laura] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Cardiol, Boston, MA 02115 USA; [Meredith, Ian T.] Monash Med Ctr, Dept Cardiol, MonashHeart, Melbourne, Vic, Australia; [Finn, Aloke V.] Emory Univ, Sch Med, Dept Cardiol, Atlanta, GA USA; [Kim, Hyo-Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 151, South Korea; [Suryapranata, Harry] Radboud Univ Nijmegen Med Ctr, Dept Cardiol, Nijmegen, Netherlands; [Aprami, Toni Mustahsani] Padjadjaran Univ Hosp Hasan Sadikin, Dept Cardiol, Bandung, Indonesia; [Di Pasquale, Giuseppe] Osped Maggiore Bologna, Unita Osped Cardiol, Bologna, Italy; [von Birgelen, Clemens] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [Kedhi, Elvin] Isala Klin, Dept Cardiol, NL-8025 AB Zwolle, Netherlands	Nicolaus Copernicus University; Medical Spectrum Twente; University of Amsterdam; Academic Medical Center Amsterdam; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Piedmont Heart Institute; Christ Hospital - Ohio; MedStar Washington Hospital Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Monash University; Emory University; Seoul National University (SNU); Radboud University Nijmegen; Universitas Padjadjaran; AUSL di Bologna; University of Twente; Isala Clinics	Kedhi, E (corresponding author), Isala Klin, Dept Cardiol, NL-8025 AB Zwolle, Netherlands.	ekedhi@yahoo.com	Kowalewski, Mariusz/AAA-6845-2020; Andreotti, Felicita/A-9962-2019; Kubica, Jacek/D-6906-2014; mauri, laura/GPS-4868-2022; Suryapranata, H./H-8095-2014; Claessen, Bimmer E. P. M./K-3870-2018; Kedhi, Elvin/GNW-5801-2022; Kim, Hyo Soo/J-2753-2012	Andreotti, Felicita/0000-0002-1456-6430; Kubica, Jacek/0000-0001-8250-754X; Claessen, Bimmer E. P. M./0000-0002-1703-7921; Navarese, Eliano/0000-0002-2355-4589; Pasquale, Giuseppe/0000-0002-5427-4504	Boston Scientific; Medtronic; Abbott Vascular; Biotronik; Medtronic Vascular; Terumo Europe	Boston Scientific(Boston Scientific); Medtronic(Medtronic); Abbott Vascular(Abbott Laboratories); Biotronik; Medtronic Vascular; Terumo Europe	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that DEK has received research/grant support from Boston Scientific, Medtronic, and Abbott Vascular and has served as consultant for Boston Scientific, Medtronic, and Micell Technologies; DJK has received grant/research support from, been a consultant to, and served on the advisory board for Abbott Vascular and Boston Scientific; CvB is a consultant to and/or has received lecture fees or travel expenses from Abbott Vascular, Boston Scientific, and Medtronic; The Cardiology Research Department of Thoraxcentrum Twente has received educational and/or research grants from Abbott Vascular, Biotronik, Boston Scientific, and Medtronic; AVF has sponsored research agreements with Boston Scientific and Medtronic Vascular and serves on the advisory board for Medtronic Vascular; EK is a consultant to and/or has received lecture fees or travel expenses from Abbott Vascular, and Medtronic; The Maasstad Cardiology Department (previous working place) has received educational and/or research grants funded by Abbott Vascular, Boston Scientific, Terumo Europe, and Medtronic; ITM serves as a consultant to Boston Scientific and Medtronic. All the other authors report no conflict of interest related to the present article.	Ahn JM, 2012, CIRC-CARDIOVASC INTE, V5, P633, DOI 10.1161/CIRCINTERVENTIONS.111.965673; Applegate R, 2010, CATHETER CARDIO INTE, V76, P644, DOI 10.1002/ccd.22606; Applegate RJ, 2011, AM J CARDIOL, V107, P833, DOI 10.1016/j.amjcard.2010.10.069; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Basalus MWZ, 2009, EUROINTERVENTION, V5, P157, DOI 10.4244/EIJV5I1A24; Basalus MWZ, 2012, INTERVENTIONAL CARDI, V6, P661; Berger A, 2007, CATHETER CARDIO INTE, V70, P163, DOI 10.1002/ccd.21195; Bin Song Y, 2010, J AM COLL CARDIOL, V55, P1742, DOI 10.1016/j.jacc.2010.02.008; Briguori C, 2011, CIRC-CARDIOVASC INTE, V4, P121, DOI 10.1161/CIRCINTERVENTIONS.110.959924; Burzotta F, 2011, JACC-CARDIOVASC INTE, V4, P327, DOI 10.1016/j.jcin.2010.12.005; Byrne RA, 2010, J AM COLL CARDIOL, V55, P2536, DOI 10.1016/j.jacc.2010.03.020; Byrne RA, 2009, EUR HEART J, V30, P923, DOI 10.1093/eurheartj/ehp044; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1; Chevalier Bernard, 2007, EuroIntervention, V2, P426; Chevalier B, 2009, CIRC-CARDIOVASC INTE, V2, P188, DOI 10.1161/CIRCINTERVENTIONS.108.823443; Chevalier B, 2008, JACC-CARDIOVASC INTE, V1, P524, DOI 10.1016/j.jcin.2008.08.010; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Cooper NJ, 2011, VALUE HEALTH, V14, P371, DOI 10.1016/j.jval.2010.09.001; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; de Lezo JS, 2005, J AM COLL CARDIOL, V45, p75A; Desch S, 2011, JACC-CARDIOVASC INTE, V4, P452, DOI 10.1016/j.jcin.2010.11.016; Di Lorenzo E, 2009, AM HEART J, V158, DOI 10.1016/j.ahj.2009.03.016; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; Galloe AM, 2008, JAMA-J AM MED ASSOC, V299, P409, DOI 10.1001/jama.299.4.409; Goy JJ, 2005, J AM COLL CARDIOL, V45, P308, DOI 10.1016/j.jacc.2004.10.062; Grube E, 2012, AM HEART J, V163, P867, DOI 10.1016/j.ahj.2012.02.006; Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6; Hausleiter J, 2003, AM HEART J, V146, P882, DOI 10.1016/S0002-8703(03)00435-6; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hofma SH, 2012, J AM COLL CARDIOL, V60, P381, DOI 10.1016/j.jacc.2012.01.073; Hong SJ, 2010, CATHETER CARDIO INTE, V76, P924, DOI 10.1002/ccd.22369; Jensen LO, 2012, J AM COLL CARDIOL, V60, P1140, DOI 10.1016/j.jacc.2012.07.004; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Jensen LO, 2011, EUROINTERVENTION, V7, P323, DOI 10.4244/EIJV7I3A56; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Juwana YB, 2009, AM J CARDIOL, V104, P205, DOI 10.1016/j.amjcard.2009.03.015; Kadota K, 2012, CATHETER CARDIO INTE, V80, P789, DOI 10.1002/ccd.23280; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406; Kamoi D, 2013, INT J CARDIOL, V165, P533, DOI 10.1016/j.ijcard.2011.09.078; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Kandzari DE, 2011, JACC-CARDIOVASC INTE, V4, P543, DOI 10.1016/j.jcin.2010.12.014; Kang WC, 2011, EUROINTERVENTION, V7, P936, DOI 10.4244/EIJV7I8A148; Kedhi E, 2012, EUROINTERVENTION, V8, P599, DOI 10.4244/EIJV8I5A92; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kereiakes DJ, 2010, J AM COLL CARDIOL, V56, P2084, DOI 10.1016/j.jacc.2010.10.006; Kereiakes DJ, 2010, J AM COLL CARDIOL, V56, P264, DOI 10.1016/j.jacc.2010.04.011; Kim HS, 2012, CATHETER CARDIO INTE, V80, P799, DOI 10.1002/ccd.23440; Kim HS, 2011, INT J CARDIOL, V147, P253, DOI 10.1016/j.ijcard.2009.09.466; Kim MH, 2008, J INTERV CARDIOL, V21, P225, DOI 10.1111/j.1540-8183.2008.00353.x; Kim WJ, 2011, CIRCULATION, V124, P886, DOI 10.1161/CIRCULATIONAHA.110.015453; Kim YH, 2006, CIRCULATION, V114, P2148, DOI 10.1161/CIRCULATIONAHA.106.666396; Kimura T, 2012, J AM COLL CARDIOL S, V17S, pB216; Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059; Kirtane A, 2013, J AM COLL CARDIOL, V61, pE1862, DOI 10.1016/S0735-1097(13)61862-8; Kirtane AJ, 2013, JACC-CARDIOVASC INTE, V6, P325, DOI 10.1016/j.jcin.2012.12.123; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Lee CW, 2009, AM J CARDIOL, V104, P1370, DOI 10.1016/j.amjcard.2009.06.059; Lee JH, 2008, CATHETER CARDIO INTE, V72, P25, DOI 10.1002/ccd.21510; Lee SW, 2011, JACC-CARDIOVASC INTE, V4, P310, DOI 10.1016/j.jcin.2010.12.006; Lee SW, 2009, J AM COLL CARDIOL, V53, P812, DOI 10.1016/j.jacc.2008.11.028; Leon MB, 2010, J AM COLL CARDIOL, V55, P543, DOI 10.1016/j.jacc.2009.08.067; Maeng M, 2012, JACC-CARDIOVASC INTE, V5, P812, DOI 10.1016/j.jcin.2012.04.008; Maeng M, 2009, AM J CARDIOL, V103, P345, DOI 10.1016/j.amjcard.2008.09.084; Massberg S, 2011, CIRCULATION, V124, P624, DOI 10.1161/CIRCULATIONAHA.111.026732; Mehilli J, 2006, EUR HEART J, V27, P260, DOI 10.1093/eurheartj/ehi721; Mehilli J, 2013, J AM COLL CARDIOL, DOI S0735-1097(13)03074-X; Mehilli J, 2008, EUR HEART J, V29, P1975, DOI 10.1093/eurheartj/ehn253; Mehilli J, 2009, J AM COLL CARDIOL, V53, P1760, DOI 10.1016/j.jacc.2009.01.035; Moreno R, 2013, CIRC-CARDIOVASC INTE, V6, P21, DOI 10.1161/CIRCINTERVENTIONS.112.000076; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; Nakatani S, 2013, CATHETER CARDIO INTE, V81, P776, DOI 10.1002/ccd.24401; Nakazawa G, 2007, AM J CARDIOL, V100, p36M, DOI 10.1016/j.amjcard.2007.08.020; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Navarese EP, 2013, MINERVA CARDIOANGIOL, V61, P243; Navarese EP, 2011, EUROINTERVENTION, V7, P985, DOI 10.4244/EIJV7I8A155; Ng VG, 2011, AM J CARDIOL, V107, P841, DOI 10.1016/j.amjcard.2010.10.068; Onuma Y, 2013, EUROINTERVENTION, V8, P1047, DOI 10.4244/EIJV8I9A161; Ormiston JA, 2010, CIRC-CARDIOVASC INTE, V3, P556, DOI 10.1161/CIRCINTERVENTIONS.110.946426; Otake H, 2010, AM J CARDIOL, V106, P492, DOI 10.1016/j.amjcard.2010.03.059; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Pan M, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.017; Park DW, 2011, JACC-CARDIOVASC INTE, V4, P1096, DOI 10.1016/j.jcin.2011.05.024; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park HJ, 2012, CIRC J, V76, P868, DOI 10.1253/circj.CJ-11-1021; Park KW, 2011, J AM COLL CARDIOL, V58, P1844, DOI 10.1016/j.jacc.2011.07.031; Petronio AS, 2007, J AM COLL CARDIOL, V49, P539, DOI 10.1016/j.jacc.2006.09.042; Raber L, 2011, CIRCULATION, V123, P2819, DOI 10.1161/CIRCULATIONAHA.110.004762; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Separham A, 2011, J CARDIOVASC THORAC, V3, P113, DOI 10.5681/jcvtr.2011.025; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Silber S, 2011, LANCET, V377, P1241, DOI 10.1016/S0140-6736(11)60395-4; Smits PC, 2011, J AM COLL CARDIOL, V58, P11, DOI 10.1016/j.jacc.2011.02.023; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; Stone GW, 2011, J AM COLL CARDIOL, V57, P1700, DOI 10.1016/j.jacc.2011.02.016; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Tada T, 2013, AM HEART J, V165, P80, DOI 10.1016/j.ahj.2012.10.019; Tandjung K, 2013, J AM COLL CARDIOL, V61, P2406, DOI 10.1016/j.jacc.2013.04.005; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tomai F, 2008, DIABETES CARE, V31, P15, DOI 10.2337/dc07-1377; Van den Branden BJ, 2013, EUROINTERVENTION, DOI 20120819-01; Vicenzi MN, 2006, BRIT J ANAESTH, V96, P686, DOI 10.1093/bja/ael083; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Waksman R, 2012, AM J CARDIOL, V109, P1288, DOI 10.1016/j.amjcard.2011.12.019; Wang LF, 2011, J AM COLL CARDIOL, V58, pB216; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Xu B, 2013, JACC-CARDIOVASC INTE, V6, P664, DOI 10.1016/j.jcin.2013.03.001; Zhang Q, 2006, CHINESE MED J-PEKING, V119, P165, DOI 10.1097/00029330-200601020-00013	121	163	169	2	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2013	347								f6530	10.1136/bmj.f6530	http://dx.doi.org/10.1136/bmj.f6530			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XO	24196498	Green Published, hybrid			2022-12-28	WOS:000326890300001
J	Phillips, A; Baker, J; Lundgren, J				Phillips, Andrew; Baker, Jason; Lundgren, Jens			Are antiretrovirals enough for people living with HIV?	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; RENAL-FUNCTION; INFECTION; RISK; THERAPY; EXPOSURE		[Phillips, Andrew] UCL, Res Dept Infect & Populat Hlth, London NW3 2PF, England; [Baker, Jason] Univ Minnesota, Dept Med, Hennepin Cty Med Ctr, Minneapolis, MN 55455 USA; [Lundgren, Jens] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	University of London; University College London; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Rigshospitalet; University of Copenhagen	Phillips, A (corresponding author), UCL, Res Dept Infect & Populat Hlth, Royal Free Campus, London NW3 2PF, England.	andrew.phillips@ucl.ac.uk	Lundgren, Jens/AAE-6876-2019; Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; Lundgren, Jens/0000-0001-8901-7850				Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Borges AH, 2013, AIDS, V27, P1433, DOI 10.1097/QAD.0b013e32835f6b0c; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Piketty C, 2012, J CLIN ONCOL, V30, P4360, DOI 10.1200/JCO.2012.44.5486; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Trevillyan JM, 2013, SEX HEALTH, V10, P97, DOI 10.1071/SH12081	12	2	3	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1466	1467		10.1016/S0140-6736(13)62072-3	http://dx.doi.org/10.1016/S0140-6736(13)62072-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	24182530				2022-12-28	WOS:000326622500007
J	Park, HJ; Friston, KJ				Park, Hae-Jeong; Friston, Karl J.			Structural and Functional Brain Networks: From Connections to Cognition	SCIENCE			English	Review							RICH-CLUB ORGANIZATION; RESTING-STATE; SMALL-WORLD; ARCHITECTURE; RECONFIGURATION; INFORMATION; INTEGRATION; DEGENERACY; DYNAMICS	How rich functionality emerges from the invariant structural architecture of the brain remains a major mystery in neuroscience. Recent applications of network theory and theoretical neuroscience to large-scale brain networks have started to dissolve this mystery. Network analyses suggest that hierarchical modular brain networks are particularly suited to facilitate local (segregated) neuronal operations and the global integration of segregated functions. Although functional networks are constrained by structural connections, context-sensitive integration during cognition tasks necessarily entails a divergence between structural and functional networks. This degenerate (many-to-one) function-structure mapping is crucial for understanding the nature of brain networks. The emergence of dynamic functional networks from static structural connections calls for a formal (computational) approach to neuronal information processing that may resolve this dialectic between structure and function.	[Park, Hae-Jeong] Yonsei Univ, Coll Med, Dept Nucl Med, Project Med Sci BK21,Severance Biomed Sci Inst, Seoul, South Korea; [Friston, Karl J.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England	Yonsei University; Yonsei University Health System; University of London; University College London	Park, HJ (corresponding author), Yonsei Univ, Coll Med, Dept Nucl Med, Project Med Sci BK21,Severance Biomed Sci Inst, Seoul, South Korea.	parkhj@yuhs.ac	Friston, Karl/D-9230-2011	Friston, Karl/0000-0001-7984-8909; Park, Hae-Jeong/0000-0002-4633-0756	National Research Foundation of Korea; Ministry of Science, ICT, and Future Planning [20100018839]; Wellcome trust	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT, and Future Planning; Wellcome trust(Wellcome TrustEuropean Commission)	This research was supported by the Brain Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning (20100018839 for H.J.P.). K. F. is supported by the Wellcome trust. The authors thank L. Quattrocki Knight, D.-J. Kim, B. Park, and two anonymous reviewers for helpful discussions and suggestions; especially B. Park for preparing the material for this review.	Adachi Y, 2012, CEREB CORTEX, V22, P1586, DOI 10.1093/cercor/bhr234; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BRESSLER SL, 2007, UNDERST COMPLEX SYST, P403; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Ekman M, 2012, P NATL ACAD SCI USA, V109, P16714, DOI 10.1073/pnas.1207523109; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; GERSTEIN GL, 1989, IEEE T BIO-MED ENG, V36, P4, DOI 10.1109/10.16444; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Laird AR, 2013, NEUROIMAGE, V80, P505, DOI 10.1016/j.neuroimage.2013.04.073; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Park B, 2012, NEUROIMAGE, V59, P456, DOI 10.1016/j.neuroimage.2011.07.049; Park HJ, 2004, AM J NEURORADIOL, V25, P1318; Pinotsis DA, 2012, NEUROIMAGE, V59, P1261, DOI [10.1016/j.neuroimage.2011.08.020, 10.1016/j.neuroimage.2010.12.039]; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Shen K, 2012, J NEUROSCI, V32, P17465, DOI 10.1523/JNEUROSCI.2709-12.2012; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0	48	1051	1072	38	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					579	+		10.1126/science.1238411	http://dx.doi.org/10.1126/science.1238411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179229				2022-12-28	WOS:000326334300036
J	Bair-Merritt, M; Zuckerman, B; Augustyn, M; Cronholm, PF				Bair-Merritt, Megan; Zuckerman, Barry; Augustyn, Marilyn; Cronholm, Peter F.			Silent Victims - An Epidemic of Childhood Exposure to Domestic Violence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXPRESSION; CHILDREN; STRESS	More than 15 million U.S. children live in families affected by intimate partner violence; about 7 million witness severe violence, such as the assault of one parent by another. Exposure to such violence has been linked to higher rates of physical health problems. Since August 2012, the Affordable Care Act has required private insurance companies to cover routine screening and counseling for intimate partner violence (IPV) as an essential health service for women at no additional cost to the patient. This requirement reflects recent, evidence-based recommendations from the Institute of Medicine and the U.S. Preventive Services Task Force and represents important forward movement in mitigating the health effects of IPV. Discussions about health care providers' role in IPV screening and intervention, however, often fail to consider the profound effects of childhood exposure to IPV an omission that renders these children silent victims. ...	[Bair-Merritt, Megan] Johns Hopkins Med Ctr, Dept Pediat, Baltimore, MD 21218 USA; [Zuckerman, Barry; Augustyn, Marilyn] Boston Med Ctr, Dept Pediat, Boston, MA USA; [Zuckerman, Barry; Augustyn, Marilyn] Boston Univ, Sch Med, Boston, MA 02118 USA; [Cronholm, Peter F.] Univ Penn, Dept Family Med & Community Hlth, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Boston Medical Center; Boston University; University of Pennsylvania	Bair-Merritt, M (corresponding author), Johns Hopkins Med Ctr, Dept Pediat, Baltimore, MD 21218 USA.			Bair-Merritt, Megan/0000-0002-1876-9817				Keeshin BR, 2012, TRAUMA VIOLENCE ABUS, V13, P41, DOI 10.1177/1524838011426152; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; McDonald R, 2006, J FAM PSYCHOL, V20, P137, DOI 10.1037/0893-3200.20.1.137; Miller GE, 2006, P NATL ACAD SCI USA, V103, P5496, DOI 10.1073/pnas.0506312103; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006	5	24	24	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1673	1675		10.1056/NEJMp1307643	http://dx.doi.org/10.1056/NEJMp1307643			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243IY	24171514				2022-12-28	WOS:000326311300002
J	Engel, C; Sainsbury, S; Cheung, AC; Kostrewa, D; Cramer, P				Engel, Christoph; Sainsbury, Sarah; Cheung, Alan C.; Kostrewa, Dirk; Cramer, Patrick			RNA polymerase I structure and transcription regulation	NATURE			English	Article							CROSS-LINKING; DNA-BINDING; ARCHITECTURE; SUBUNITS; SUBCOMPLEX; COMPLEX; TFIIF; PHOSPHORYLATION; CRYSTALLIZATION; RECRUITMENT	Transcription of ribosomal RNA by RNA polymerase (Pol) I initiates ribosome biogenesis and regulates eukaryotic cell growth. The crystal structure of Pol I from the yeast Saccharomyces cerevisiae at 2.8 angstrom resolution reveals all 14 subunits of the 590-kilodalton enzyme, and shows differences to Pol II. An 'expander' element occupies the DNA template site and stabilizes an expanded active centre cleft with an unwound bridge helix. A 'connector' element invades the cleft of an adjacent polymerase and stabilizes an inactive polymerase dimer. The connector and expander must detach during Pol I activation to enable transcription initiation and cleft contraction by convergent movement of the polymerase 'core' and 'shelf' modules. Conversion between an inactive expanded and an active contracted polymerase state may generally underlie transcription. Regulatory factors can modulate the core-shelf interface that includes a 'composite' active site for RNA chain initiation, elongation, proofreading and termination.	[Engel, Christoph; Sainsbury, Sarah; Cheung, Alan C.; Kostrewa, Dirk; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Engel, Christoph; Sainsbury, Sarah; Cheung, Alan C.; Kostrewa, Dirk; Cramer, Patrick] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci Munich CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de		Engel, Christoph/0000-0001-8451-3599; Cheung, Alan/0000-0001-6430-5127	Boehringer Ingelheim Fonds; Elite Network Bavaria program 'Protein Dynamics in Health and Disease'; Graduate Research Academy 'RNA Biology' of SFB960; Alexander-von-Humboldt Foundation; Deutsche Forschungsgemeinschaft [SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM]; European Research Council; Jung-Stiftung; Vallee Foundation	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Elite Network Bavaria program 'Protein Dynamics in Health and Disease'; Graduate Research Academy 'RNA Biology' of SFB960; Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Jung-Stiftung; Vallee Foundation	We thank C. Kuhn, who obtained the first Pol I crystals. We thank C. Bajen, S. Benkert, S. Geiger, S. Jennebach, T. Gubbey and K. Maier. We thank the crystallization facility (Conti Department) and the Jentsch Department of the Max-Planck-Institut for Biochemistry. Part of this work was performed at the European Synchrotron Radiation Facility at Grenoble, France, and at the Swiss Light Source at the Paul-Scherrer-Institut, Villigen, Switzerland. C. E. was supported by a PhD student fellowship of the Boehringer Ingelheim Fonds, the Elite Network Bavaria program 'Protein Dynamics in Health and Disease', and the Graduate Research Academy 'RNA Biology' of SFB960. S. S. was supported by a postdoctoral fellowship of the Alexander-von-Humboldt Foundation. P. C. was supported by the Deutsche Forschungsgemeinschaft (SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM), an Advanced Grant of the European Research Council, the Jung-Stiftung, and the Vallee Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; Arimbasseri AG, 2013, BBA-GENE REGUL MECH, V1829, P318, DOI 10.1016/j.bbagrm.2012.10.006; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Beckouet F, 2011, FEBS LETT, V585, P3355, DOI 10.1016/j.febslet.2011.09.011; Bischler N, 1998, BIOPHYS J, V74, P1522, DOI 10.1016/S0006-3495(98)77864-6; Bischler N, 2002, EMBO J, V21, P4136, DOI 10.1093/emboj/cdf392; Blattner C, 2011, GENE DEV, V25, P2093, DOI 10.1101/gad.17363311; BUHLER JM, 1974, J BIOL CHEM, V249, P5963; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Clemente-Blanco A, 2009, NATURE, V458, P219, DOI 10.1038/nature07652; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Geiger SR, 2008, ACTA CRYSTALLOGR F, V64, P413, DOI 10.1107/S174430910800972X; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Gerber J, 2008, NUCLEIC ACIDS RES, V36, P793, DOI 10.1093/nar/gkm1093; Hirata A, 2008, MOL MICROBIOL, V70, P623, DOI 10.1111/j.1365-2958.2008.06430.x; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Knutson BA, 2011, SCIENCE, V333, P1637, DOI 10.1126/science.1207699; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; Naidu S, 2011, SCIENCE, V333, P1640, DOI 10.1126/science.1207656; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SCHULTZ P, 1993, EMBO J, V12, P2601, DOI 10.1002/j.1460-2075.1993.tb05920.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SMID A, 1995, J BIOL CHEM, V270, P13534, DOI 10.1074/jbc.270.22.13534; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Tschochner H, 1996, P NATL ACAD SCI USA, V93, P12914, DOI 10.1073/pnas.93.23.12914; Van Mullem V, 2002, MOL MICROBIOL, V43, P1105; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212; Zuo YH, 2013, MOL CELL, V50, P430, DOI 10.1016/j.molcel.2013.03.020	63	138	156	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					650	+		10.1038/nature12712	http://dx.doi.org/10.1038/nature12712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153182	Green Published, Green Submitted			2022-12-28	WOS:000326293200040
J	Gandhi, JS				Gandhi, Jagdeep Singh			Neovascular Festoons on the Iris	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 74-year-old man with hypertension presented with vision reduced to only light perception in his right eye. A relative afferent papillary defect was observed, and retinal examination showed an occlusion of the central retinal vein. A 74-year-old man with hypertension presented with vision reduced to only light perception in his right eye. A relative afferent pupillary defect was observed, and retinal examination showed an occlusion of the central retinal vein. The abnormal pupillary response was caused by retinal ischemia. A hypoperfused retina exudes angiogenic factors such as vascular endothelial growth factor (VEGF). New vessels formed on the pupil (Panels A and B show low and high magnification, respectively) and also in the angle, the aqueous drainage system that surrounds the iris. Angiogenesis in the angle can occlude the drainage pathway, causing glaucoma and the complication ...	Worcester Royal Hosp, Worcester, England		Gandhi, JS (corresponding author), Worcester Royal Hosp, Worcester, England.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					E24	E24		10.1056/NEJMicm1214985	http://dx.doi.org/10.1056/NEJMicm1214985			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24171541				2022-12-28	WOS:000326311300001
J	Stiff, PJ; Unger, JM; Cook, JR; Constine, LS; Couban, S; Stewart, DA; Shea, TC; Porcu, P; Winter, JN; Kahl, BS; Miller, TP; Tubbs, RR; Marcellus, D; Friedberg, JW; Barton, KP; Mills, GM; LeBlanc, M; Rimsza, LM; Forman, SJ; Fisher, RI				Stiff, Patrick J.; Unger, Joseph M.; Cook, James R.; Constine, Louis S.; Couban, Stephen; Stewart, Douglas A.; Shea, Thomas C.; Porcu, Pierluigi; Winter, Jane N.; Kahl, Brad S.; Miller, Thomas P.; Tubbs, Raymond R.; Marcellus, Deborah; Friedberg, Jonathan W.; Barton, Kevin P.; Mills, Glenn M.; LeBlanc, Michael; Rimsza, Lisa M.; Forman, Stephen J.; Fisher, Richard I.			Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DOSE CHEMOTHERAPY; BONE-MARROW-TRANSPLANTATION; B-CELL LYMPHOMA; POSITRON-EMISSION-TOMOGRAPHY; PHASE-III TRIAL; POOR-PROGNOSIS; HIGH-RISK; CHOP CHEMOTHERAPY; INITIAL TREATMENT; PLUS RITUXIMAB	BackgroundThe efficacy of autologous stem-cell transplantation during the first remission in patients with diffuse, aggressive non-Hodgkin's lymphoma classified as high-intermediate risk or high risk on the International Prognostic Index remains controversial and is untested in the rituximab era. MethodsWe treated 397 patients who had disease with an age-adjusted classification of high risk or high-intermediate risk with five cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP plus rituximab. Patients with a response were randomly assigned to receive three additional cycles of induction chemotherapy (control group) or one additional cycle of induction chemotherapy followed by autologous stem-cell transplantation (transplantation group). The primary efficacy end points were 2-year progression-free survival and overall survival. ResultsOf 370 induction-eligible patients, 253 were randomly assigned to the transplantation group (125) or the control group (128). Forty-six patients in the transplantation group and 68 in the control group had disease progression or died, with 2-year progression-free survival rates of 69 and 55%, respectively (hazard ratio in the control group vs. the transplantation group, 1.72; 95% confidence interval [CI], 1.18 to 2.51; P=0.005). Thirty-seven patients in the transplantation group and 47 in the control group died, with 2-year overall survival rates of 74 and 71%, respectively (hazard ratio, 1.26; 95% CI, 0.82 to 1.94; P=0.30). Exploratory analyses showed a differential treatment effect according to risk level for both progression-free survival (P=0.04 for interaction) and overall survival (P=0.01 for interaction). Among high-risk patients, the 2-year overall survival rate was 82% in the transplantation group and 64% in the control group. ConclusionsEarly autologous stem-cell transplantation improved progression-free survival among patients with high-intermediate-risk or high-risk disease who had a response to induction therapy. Overall survival after transplantation was not improved, probably because of the effectiveness of salvage transplantation. (Funded by the National Cancer Institute, Department of Health and Human Services, and others; SWOG-9704 ClinicalTrials.gov number, NCT00004031.) This randomized study showed that including autologous transplantation as part of primary treatment improved progression-free survival but not overall survival among high-intermediate-risk and high-risk patients with aggressive lymphoma. Autologous stem-cell transplantation has long been known to improve both progression-free survival and overall survival among patients with diffuse, aggressive non-Hodgkin's lymphoma in second remission.(1) When it became possible to identify patients at diagnosis who have less than a 50% chance of sustained remission, as defined by the International Prognostic Index(2) (IPI) (see Table S1 in the Supplementary Appendix, available with the full text of this article at NEJM.org), trials of up-front transplantation in this group were conducted. In the first trial, LNH-87, patients received full-course induction chemotherapy, regardless of their IPI risk category; those with a complete response were randomly ...	[Stiff, Patrick J.; Barton, Kevin P.] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Unger, Joseph M.; LeBlanc, Michael] Fred Hutchinson Canc Res Ctr, Southwest Oncol Grp Stat Ctr, Seattle, WA 98104 USA; [Cook, James R.; Tubbs, Raymond R.] Cleveland Clin, Cleveland, OH 44106 USA; [Constine, Louis S.; Friedberg, Jonathan W.; Fisher, Richard I.] Univ Rochester, Rochester, NY USA; [Couban, Stephen] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Couban, Stephen] Dalhousie Univ, Halifax, NS, Canada; [Stewart, Douglas A.] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada; [Marcellus, Deborah] Margaret & Charles Juravinski Canc Ctr, Hamilton, ON, Canada; [Shea, Thomas C.] Univ N Carolina, Chapel Hill, NC USA; [Porcu, Pierluigi] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Winter, Jane N.] Northwestern Univ, Chicago, IL 60611 USA; [Kahl, Brad S.] Univ Wisconsin, Madison, WI 53706 USA; [Miller, Thomas P.; Rimsza, Lisa M.] Univ Arizona, Tucson, AZ USA; [Mills, Glenn M.] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA 71105 USA; [Forman, Stephen J.] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Fisher, Richard I.] Temple Univ, Sch Med, Fox Chase Canc Ctr Temple Hlth, Philadelphia, PA 19122 USA	Loyola University Chicago; Fred Hutchinson Cancer Center; Southwest Oncology Group; Cleveland Clinic Foundation; University of Rochester; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Tom Baker Cancer Clinic; University of Calgary; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; Northwestern University; University of Wisconsin System; University of Wisconsin Madison; University of Arizona; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; City of Hope; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Stiff, PJ (corresponding author), Loyola Univ, Med Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA.		Stiff, Patrick/S-2676-2019; Unger, Joseph/O-7457-2019	Winter, Jane/0000-0001-7542-3305	National Cancer Institute, Department of Health and Human Services [CA32102, CA38926, CA11083, CA46282, CA58658, CA13612, CA45377, CA35431, CA76448, CA46441, CA35261, CA20319, CA22433, CA58416, CA46113, CA63844, CA35090, CA63845, CA76447, CA04919, CA35178, CA35281, CA14028, CA46368, CA67575, CA45560, CA58686]; Canadian Cancer Society Research Institute [021039, 015469]; Bristol-Myers Squibb; Hospira; Medicis; Physician Education Resources; Genentech; Celgene; Spectrum; Abbott; Ventana Medical Systems; Abbott Molecular Vysis; Lilly; Trubion; Spectrum Pharmaceuticals; Merck; Micromet; Bio Linx; Boehringer Ingelheim; Roche; Pfizer; Natl Canc Inst, Dept of Hlth and Human Services [CA52654, CA58861, CA35192, CA76132, CA37981, CA12644, CA27057, CA077202, CA047559, CA077658, CA17145, CA21076, CA21115]; NATIONAL CANCER INSTITUTE [U10CA027057, U10CA052654, U10CA014028, U10CA046368, U10CA077202, U10CA063845, U10CA035090, U10CA021115, U10CA058658, U10CA077658, U10CA013612, U10CA037981, U10CA017145, U10CA067575, U10CA022433, U10CA012644, U10CA046441, U10CA020319, U10CA035178, U10CA046282, U10CA011083, U10CA063844, U10CA037403, U10CA032102, U10CA035281, P30CA060553, U10CA035261, U10CA076447, U10CA058861, P30CA016058, U10CA058686, U10CA046113, U10CA035431, P30CA014520, U10CA045377, U10CA047559, U10CA045560, U10CA038926, U10CA035192, U10CA004919, U10CA021076, U10CA058416] Funding Source: NIH RePORTER	National Cancer Institute, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Bristol-Myers Squibb(Bristol-Myers Squibb); Hospira; Medicis; Physician Education Resources; Genentech(Roche HoldingGenentech); Celgene(Bristol-Myers SquibbCelgene Corporation); Spectrum; Abbott(Abbott Laboratories); Ventana Medical Systems; Abbott Molecular Vysis; Lilly(Eli Lilly); Trubion; Spectrum Pharmaceuticals; Merck(Merck & Company); Micromet(Amgen); Bio Linx; Boehringer Ingelheim(Boehringer Ingelheim); Roche(Roche Holding); Pfizer(Pfizer); Natl Canc Inst, Dept of Hlth and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by Public Health Service Cooperative Agreement grants from the National Cancer Institute, Department of Health and Human Services (CA32102, CA38926, CA11083, CA46282, CA58658, CA13612, CA45377, CA35431, CA76448, CA46441, CA35261, CA20319, CA22433, CA58416, CA46113, CA63844, CA35090, CA63845, CA76447, CA04919, CA35178, CA35281, CA14028, CA46368, CA67575, CA45560, CA58686, CA52654, CA58861, CA35192, CA76132, CA37981, CA12644, CA27057, CA077202, CA047559, CA077658, CA17145, CA21076, and CA21115); by grants from the Canadian Cancer Society Research Institute (021039 and 015469); and in part by Bristol-Myers Squibb.; Dr. Porcu reports receiving consulting fees from Hospira and Medicis, lecture fees from Physician Education Resources, honoraria from Easton Associates, ClearView Health Care Partners, and E Squared Communications, and grant support through his institution from Millennium. Dr. Kahl reports receiving payment for board membership from Roche, Seattle Genetics, Millennium, and Cell Therapeutics and consulting fees from Genentech and Celgene. Dr. Miller reports receiving grant support through his institution from Spectrum, Celgene, and Abbott. Dr. Tubbs reports receiving lecture fees from Ventana Medical Systems and grant support through his institution from Ventana Medical Systems and Abbott Molecular Vysis. Dr. Friedberg reports receiving consulting fees from Genentech, Lilly, and Trubion. Dr. LeBlanc reports holding a pending - patent regarding the uses of diffuse large-B-cell lymphoma markers. Dr. Rimsza reports receiving lecture fees from Ventana Medical Systems, and grant support through her institution from Ventana Medical Systems, Spectrum Pharmaceuticals, and Merck. Dr. Fisher reports receiving consulting fees from Micromet, Bio Linx, Boehringer Ingelheim, Roche, and Pfizer. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2001, J CLIN ONCOL, V19, P389; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Betticher DC, 2006, ANN ONCOL, V17, P1546, DOI 10.1093/annonc/mdl153; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Cook JR, 2012, BLOOD S, V120, P543; Cunningham D, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.4_suppl.6; Dilhuydy MS, 2010, BIOL BLOOD MARROW TR, V16, P672, DOI 10.1016/j.bbmt.2009.12.530; Fitoussi O, 2011, HAEMATOL-HEMATOL J, V96, P1136, DOI 10.3324/haematol.2010.038109; FREEDMAN AS, 1993, J CLIN ONCOL, V11, P931, DOI 10.1200/JCO.1993.11.5.931; Gianni AM, 1997, NEW ENGL J MED, V336, P1290, DOI 10.1056/NEJM199705013361804; Gisselbrecht C, 2002, J CLIN ONCOL, V20, P2472, DOI 10.1200/JCO.2002.02.125; Glass B, 2010, ANN ONCOL, V21, P2255, DOI 10.1093/annonc/mdq235; Greb A, 2008, COCHRANE DB SYST REV, V1; Greb A, 2007, CANCER TREAT REV, V33, P338, DOI 10.1016/j.ctrv.2007.02.002; Haioun C, 2000, J CLIN ONCOL, V18, P3025, DOI 10.1200/JCO.2000.18.16.3025; Jerusalem G, 2000, HAEMATOLOGICA, V85, P613; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Kluin-Nelemans HC, 2001, JNCI-J NATL CANCER I, V93, P22, DOI 10.1093/jnci/93.1.22; Linch DC, 2010, BRIT J HAEMATOL, V149, P237, DOI 10.1111/j.1365-2141.2010.08081.x; Martelli M, 2003, J CLIN ONCOL, V21, P1255, DOI 10.1200/JCO.2003.01.117; Milpied N, 2004, NEW ENGL J MED, V350, P1287, DOI 10.1056/NEJMoa031770; Moskowitz CH, 2010, J CLIN ONCOL, V28, P1896, DOI 10.1200/JCO.2009.26.5942; Nademanee A, 1997, BLOOD, V90, P3844, DOI 10.1182/blood.V90.10.3844; Ohmachi K, 2011, ANN ONCOL, V22, P1382, DOI 10.1093/annonc/mdq619; PHILIP T, 1995, NEW ENGL J MED, V333, P1540, DOI 10.1056/NEJM199512073332305; Rimsza LM, 2008, BLOOD, V112, P3425, DOI 10.1182/blood-2008-02-137372; Santini G, 1998, J CLIN ONCOL, V16, P2796, DOI 10.1200/JCO.1998.16.8.2796; Schnitz N, 2011, J CLIN ONCOL S, V29, p504s; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Spaepen K, 2001, J CLIN ONCOL, V19, P414, DOI 10.1200/JCO.2001.19.2.414; Spaepen K, 2002, ANN ONCOL, V13, P1356, DOI 10.1093/annonc/mdf256; Stiff PJ, 1998, J CLIN ONCOL, V16, P48, DOI 10.1200/JCO.1998.16.1.48; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tarella C, 2007, LEUKEMIA, V21, P1802, DOI 10.1038/sj.leu.2404781; Taverna CJ, 2010, BLOOD, V116, P752; VERDONCK LF, 1995, NEW ENGL J MED, V332, P1045, DOI 10.1056/NEJM199504203321601; Vitolo U, 2009, HAEMATOL-HEMATOL J, V94, P1250, DOI 10.3324/haematol.2009.007005; Yang DH, 2011, EUR J CANCER, V47, P1312, DOI 10.1016/j.ejca.2010.12.027; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493	39	230	255	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1681	1690		10.1056/NEJMoa1301077	http://dx.doi.org/10.1056/NEJMoa1301077			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24171516	Green Accepted, Green Published			2022-12-28	WOS:000326311300006
J	Kuchenreuther, JM; Myers, WK; Stich, TA; George, SJ; NejatyJahromy, Y; Swartz, JR; Britt, RD				Kuchenreuther, Jon M.; Myers, William K.; Stich, Troy A.; George, Simon J.; NejatyJahromy, Yaser; Swartz, James R.; Britt, R. David			A Radical Intermediate in Tyrosine Scission to the CO and CN- Ligands of FeFe Hydrogenase	SCIENCE			English	Article							ESCHERICHIA-COLI; ACONITASE; CLUSTER; HYDG; IDENTIFICATION; CYANIDE; OXYGEN	The radical S-adenosylmethionine (SAM) enzyme HydG lyses free L-tyrosine to produce CO and CN- for the assembly of the catalytic H cluster of FeFe hydrogenase. We used electron paramagnetic resonance spectroscopy to detect and characterize HydG reaction intermediates generated with a set of H-2, C-13, and N-15 nuclear spin-labeled tyrosine substrates. We propose a detailed reaction mechanism in which the radical SAM reaction, initiated at an N-terminal 4Fe-4S cluster, generates a tyrosine radical bound to a C-terminal 4Fe-4S cluster. Heterolytic cleavage of this tyrosine radical at the C-alpha-C-beta bond forms a transient 4-oxidobenzyl (4OB(center dot)) radical and a dehydroglycine bound to the C-terminal 4Fe-4S cluster. Electron and proton transfer to this 4OB(center dot) radical forms p-cresol, with the conversion of this dehydroglycine ligand to Fe-bound CO and CN-, a key intermediate in the assembly of the 2Fe subunit of the H cluster.	[Kuchenreuther, Jon M.; Myers, William K.; Stich, Troy A.; George, Simon J.; NejatyJahromy, Yaser; Britt, R. David] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of California System; University of California Davis; Stanford University; Stanford University	Britt, RD (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	rdbritt@ucdavis.edu	NejatyJahromy, Yaser/T-9182-2017	NejatyJahromy, Yaser/0000-0002-3367-7208; Myers, William/0000-0001-5935-9112; George, Simon/0000-0002-4864-5479	Division of Chemical Sciences, Geosciences, and Biosciences [DE-FG02-11ER16282]; Division of Material Sciences and Engineering of the Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-09ER46632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104543] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/D048559/1] Funding Source: researchfish; EPSRC [EP/D048559/1] Funding Source: UKRI	Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); Division of Material Sciences and Engineering of the Office of Basic Energy Sciences of the U.S. Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Division of Chemical Sciences, Geosciences, and Biosciences (R.D.B. award no. DE-FG02-11ER16282) and the Division of Material Sciences and Engineering (J.R.S. award no. DE-FG02-09ER46632) of the Office of Basic Energy Sciences of the U.S. Department of Energy. We thank D. Suess for useful discussions on the proposed HydG mechanism.	BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Berggren G, 2013, NATURE, V499, P66, DOI 10.1038/nature12239; Dole F, 1997, J AM CHEM SOC, V119, P11540, DOI 10.1021/ja9717727; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Esselborn J, 2013, NAT CHEM BIOL, V9, P607, DOI [10.1038/NCHEMBIO.1311, 10.1038/nchembio.1311]; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Fugate CJ, 2012, J AM CHEM SOC, V134, P9042, DOI 10.1021/ja3012963; GEORGE SJ, 1989, BIOCHEM J, V264, P275, DOI 10.1042/bj2640275; GILCHRIST ML, 1995, P NATL ACAD SCI USA, V92, P9545, DOI 10.1073/pnas.92.21.9545; Hulsebosch RJ, 1997, J AM CHEM SOC, V119, P8685, DOI 10.1021/ja9707872; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; KENT TA, 1982, P NATL ACAD SCI-BIOL, V79, P1096, DOI 10.1073/pnas.79.4.1096; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Kuchenreuther JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045850; Kuchenreuther JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020346; MICHAELS R, 1965, ARCH BIOCHEM BIOPHYS, V111, P121, DOI 10.1016/0003-9861(65)90329-2; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Nicolet Y, 2012, J BIOL CHEM, V287, P13532, DOI 10.1074/jbc.R111.310797; Nicolet Y, 2010, FEBS LETT, V584, P4197, DOI 10.1016/j.febslet.2010.09.008; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; RICHARDS AJM, 1990, SPECTROCHIM ACTA A, V46, P987, DOI 10.1016/0584-8539(90)80015-Q; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Tron C, 2011, EUR J INORG CHEM, P1121, DOI 10.1002/ejic.201001101; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u	31	79	79	1	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					472	475		10.1126/science.1241859	http://dx.doi.org/10.1126/science.1241859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159045	Green Submitted			2022-12-28	WOS:000326042600041
J	Udell, JA; Zawi, R; Bhatt, DL; Keshtkar-Jahromi, M; Gaughran, F; Phrommintikul, A; Ciszewski, A; Vakili, H; Hoffman, EB; Farkouh, ME; Cannon, CP				Udell, Jacob A.; Zawi, Rami; Bhatt, Deepak L.; Keshtkar-Jahromi, Maryam; Gaughran, Fiona; Phrommintikul, Arintaya; Ciszewski, Andrzej; Vakili, Hossein; Hoffman, Elaine B.; Farkouh, Michael E.; Cannon, Christopher P.			Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; SECONDARY PREVENTION; REDUCED RISK; FLU VACCINATION; ELDERLY PERSONS; HEART-DISEASE; EFFICACY; PNEUMONIA; EVENTS	IMPORTANCE Among nontraditional cardiovascular risk factors, recent influenzalike infection is associated with fatal and nonfatal atherothrombotic events. OBJECTIVES To determine if influenza vaccination is associated with prevention of cardiovascular events. DATA SOURCES AND STUDY SELECTION A systematic review and meta-analysis of MEDLINE (1946-August 2013), EMBASE (1947-August 2013), and the Cochrane Library Central Register of Controlled Trials (inception-August 2013) for randomized clinical trials (RCTs) comparing influenza vaccine vs placebo or control in patients at high risk of cardiovascular disease, reporting cardiovascular outcomes either as efficacy or safety events. DATA EXTRACTION AND SYNTHESIS Two investigators extracted data independently on trial design, baseline characteristics, outcomes, and safety events from published manuscripts and unpublished supplemental data. High-quality studies were considered those that described an appropriate method of randomization, allocation concealment, blinding, and completeness of follow-up. MAIN OUTCOMES AND MEASURES Random-effects Mantel-Haenszel risk ratios (RRs) and 95% CIs were derived for composite cardiovascular events, cardiovascular mortality, all-cause mortality, and individual cardiovascular events. Analyses were stratified by subgroups of patients with and without a history of acute coronary syndrome (ACS) within 1 year of randomization. RESULTS Five published and 1 unpublished randomized clinical trials of 6735 patients (mean age, 67 years; 51.3% women; 36.2% with a cardiac history; mean follow-up time, 7.9 months) were included. Influenza vaccine was associated with a lower risk of composite cardiovascular events (2.9% vs 4.7%; RR, 0.64 [95% CI, 0.48-0.86], P = .003) in published trials. A treatment interaction was detected between patients with (RR, 0.45 [95% CI, 0.32-0.63]) and without (RR, 0.94 [95% CI, 0.55-1.61]) recent ACS (P for interaction = .02). Results were similar with the addition of unpublished data. CONCLUSIONS AND RELEVANCE In a meta-analysis of RCTs, the use of influenza vaccine was associated with a lower risk of major adverse cardiovascular events. The greatest treatment effect was seen among the highest-risk patients with more active coronary disease. A large, adequately powered, multicenter trial is warranted to address these findings and assess individual cardiovascular end points.	[Udell, Jacob A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON M5S 1B1, Canada; [Udell, Jacob A.] Univ Toronto, Div Cardiovasc, Dept Med, Womens Coll Hosp, Toronto, ON M5S 1B1, Canada; [Zawi, Rami] Med Univ Amer, Nevis, Guyana; [Bhatt, Deepak L.] Harvard Univ, Sch Med, VA Boston Healthcare Syst, Boston, MA USA; [Bhatt, Deepak L.; Hoffman, Elaine B.; Cannon, Christopher P.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA USA; [Keshtkar-Jahromi, Maryam] Shahid Beheshti Univ MC, Clin Res & Dev Ctr, Shahid Modarres Med Ctr, Infect Dis & Trop Med Res Ctr, Tehran, Iran; [Keshtkar-Jahromi, Maryam] Penn State Univ, Div Infect Dis, Dept Med, Sch Med, Hershey, PA USA; [Gaughran, Fiona] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Gaughran, Fiona] South London & Maudsley Natl Hlth Serv Fdn Trust, London, England; [Phrommintikul, Arintaya] Chiang Mai Univ, Dept Internal Med, Fac Med, Chiang Mai 50000, Thailand; [Ciszewski, Andrzej] Inst Cardiol, Warsaw, Poland; [Vakili, Hossein] Shahid Beheshti Univ MC, Cardiovasc Res Ctr, Shahid Modarres Med Ctr, Tehran, Iran; [Farkouh, Michael E.] Univ Toronto, Peter Munk Cardiac Ctr, Univ Hlth Network, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Shahid Beheshti University Medical Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of London; King's College London; South London & Maudsley NHS Trust; Chiang Mai University; Institute of Cardiology - Poland; Shahid Beheshti University Medical Sciences; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto	Udell, JA (corresponding author), Univ Toronto, Womens Coll Res Inst, Womens Coll Hosp, 76 Grenville St, Toronto, ON M5S 1B1, Canada.	jay.udell@utoronto.ca	Gaughran, Fiona/H-5495-2011; Cannon, Christopher P/AAY-7644-2020; Jahromi, Maryam Keshtkar/M-7181-2019; vakili, hossein/P-4016-2018; Phrommintikul, Arintaya/X-1881-2019; Gaughran, Fiona/AAC-7160-2019	Gaughran, Fiona/0000-0001-7414-5569; Cannon, Christopher P/0000-0003-4596-2791; Jahromi, Maryam Keshtkar/0000-0001-8686-1036; Phrommintikul, Arintaya/0000-0003-3986-1951; vakili, hossien/0000-0003-3611-5670; Udell, Jacob/0000-0001-7402-9584	Canadian Institutes for Health Research; Canadian Foundation for Women's Health	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Women's Health	Dr Udell is supported by a Canadian Institutes for Health Research and Canadian Foundation for Women's Health postdoctoral research fellowship award.	Ajani UA, 2005, AM HEART J, V149, P254, DOI 10.1016/j.ahj.2004.07.028; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; BAINTON D, 1978, INT J EPIDEMIOL, V7, P231, DOI 10.1093/ije/7.3.231; Bratincsak A, 2010, J AM COLL CARDIOL, V55, P928, DOI 10.1016/j.jacc.2010.01.004; Bridges CB, 2013, ANN INTERN MED, V158, P191, DOI 10.7326/0003-4819-158-3-201302050-00584; Centers for Disease Control and Prevention, 2013, 2012 2013 INFL SEAS; Centers for Disease Control and Prevention, 2008, MANUAL SURVEILLANCE; Ciszewski A, 2008, EUR HEART J, V29, P1350, DOI 10.1093/eurheartj/ehm581; Ciszewski A, 2010, POSTEP KARDIOL INTER, V6, P6; Corrales-Medina VF, 2013, LANCET, V381, P496, DOI 10.1016/S0140-6736(12)61266-5; COX DR, 1970, BIOMETRIKA, V57, P217, DOI 10.1093/biomet/57.1.217; Davis MM, 2006, J AM COLL CARDIOL, V48, P1498, DOI 10.1016/j.jacc.2006.09.004; de Bruijn IA, 2005, VACCINE, V23, pS39, DOI 10.1016/j.vaccine.2005.04.020; De Villiers PJT, 2009, VACCINE, V28, P228, DOI 10.1016/j.vaccine.2009.09.092; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiazGranados CA, 2013, VACCINE, V31, P861, DOI 10.1016/j.vaccine.2012.12.013; Dolin R., 2012, HARRISONS PRINCIPLES; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; Forrest BD, 2011, VACCINE, V29, P3633, DOI 10.1016/j.vaccine.2011.03.029; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Gaughran F, 2007, J AM GERIATR SOC, V55, P1912, DOI 10.1111/j.1532-5415.2007.01471.x; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Grau AJ, 2005, STROKE, V36, P1501, DOI 10.1161/01.STR.0000170674.45136.80; Gurfinkel EP, 2004, EUR HEART J, V25, P25, DOI 10.1016/j.ehj.2003.10.018; Gurfinkel EP, 2002, CIRCULATION, V105, P2143, DOI 10.1161/01.CIR.0000016182.85461.F4; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Hashim Ahmed B, 2010, J Infect Public Health, V3, P159, DOI 10.1016/j.jiph.2010.09.007; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hung IFN, 2010, CLIN INFECT DIS, V51, P1007, DOI 10.1086/656587; Jackson LA, 1999, VACCINE, V17, P1905, DOI 10.1016/S0264-410X(98)00471-X; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnstone J, 2012, CIRCULATION, V126, P278, DOI 10.1161/CIRCULATIONAHA.111.071100; Keller T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005050.pub2; Keshtkar-Jahromi M, 2009, CLIN MICROBIOL INFEC, V15, P395; Kwong Jeff C, 2007, Health Rep, V18, P9; Lavallee P, 2002, STROKE, V33, P513, DOI 10.1161/hs0202.102328; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Loomba RS, 2012, J CARDIOVASC PHARM T, V17, P277, DOI 10.1177/1074248411429965; Macintyre CR, 2013, HEART; Madjid M, 2004, TEX HEART I J, V31, P4; Madjid M, 2007, EUR HEART J, V28, P1205, DOI 10.1093/eurheartj/ehm035; Madjid M, 2009, TEX HEART I J, V36, P546; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Muhammad S, 2011, STROKE, V42, P783, DOI 10.1161/STROKEAHA.110.596783; Naghavi M, 2000, CIRCULATION, V102, P3039; Natarajan P, 2011, EUR HEART J, V32, P1701, DOI 10.1093/eurheartj/ehr053; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Phrommintikul A, 2011, EUR HEART J, V32, P1730, DOI 10.1093/eurheartj/ehr004; Rubin MA, 2012, HARRISONS PRINCIPLES; Siriwardena AN, 2010, CAN MED ASSOC J, V182, P1617, DOI 10.1503/cmaj.091891; Siscovick DS, 2000, AM J EPIDEMIOL, V152, P674, DOI 10.1093/aje/152.7.674; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Talbot TR, 2013, JAMA-J AM MED ASSOC, V309, P881, DOI 10.1001/jama.2013.453; Ungchusak K, 2012, EMERG INFECT DIS, V18, P1058, DOI 10.3201/eid1807.110976; Warren-Gash C, 2011, J INFECT DIS, V203, P1710, DOI 10.1093/infdis/jir171; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66; World Health Organization, GLOB ATL INF DIS	67	330	341	2	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1711	1720		10.1001/jama.2013.279206	http://dx.doi.org/10.1001/jama.2013.279206			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24150467	Bronze			2022-12-28	WOS:000325948500027
J	Basil, N				Basil, Neil			Stoma care: the market in products lets patients down	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Basil, Neil] Patient Choice, Benfleet SS7 3TN, Essex, England			neil.basil@patientchoicefoundation.org						[Anonymous], 2013, YOU YOURS; Burch J., 2008, STOMA CARE; NHS Business Services Authority, PRESCR COST AN PCA D; Thomas L, 2013, BBC	4	2	2	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2013	347								f6129	10.1136/bmj.f6129	http://dx.doi.org/10.1136/bmj.f6129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WP	24136685				2022-12-28	WOS:000325982700005
J	Levine, DI				Levine, Deborah I.			Corpulence and Correspondence: President William H. Taft and the Medical Management of Obesity	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Providence Coll, Providence, RI 02918 USA	Providence College	Levine, DI (corresponding author), Providence Coll, 1 Cunningham Sq Providence, Providence, RI 02918 USA.	dlevine2@providence.edu						[Anonymous], 1908, NY TIMES, P1; [Anonymous], 1918, NY TIMES; [Anonymous], 1913, NY TIMES, pA1; Banting W., 1864, LETT CORPULENCE ADDR, P5; Lerner B., 2009, ILLNESS GOES PUBLIC; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Schwartz Hillel, 1986, NEVER SATISFIED CULT; Sotos JG, 2003, CHEST, V124, P1133, DOI 10.1378/chest.124.3.1133; Taft W. H., 1905, COMMUNICATION; York-Davies NE, 1907, COMMUNICATION; York-Davies NE, 1905, COMMUNICATION; York-Davies NE, 1906, COMMUNICATION; Yorke-Davies NE, 1894, HLTH CONDITION ACTIV; Yorke-Davies NE, 1889, FOODS FAT TREATISE C, Vvi, P11; Yorke-Davies NE, 1909, WINE HLTH ENJOY BOTH; [No title captured]	16	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					565	+		10.7326/0003-4819-159-8-201310150-00012	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126649				2022-12-28	WOS:000326751200022
J	Goddeeris, MM; Wu, BM; Venzke, D; Yoshida-Moriguchi, T; Saito, F; Matsumura, K; Moore, SA; Campbell, KP				Goddeeris, Matthew M.; Wu, Biming; Venzke, David; Yoshida-Moriguchi, Takako; Saito, Fumiaki; Matsumura, Kiichiro; Moore, Steven A.; Campbell, Kevin P.			LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy	NATURE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; ALPHA-DYSTROGLYCAN; ABNORMAL GLYCOSYLATION; LAMININ-BINDING; DISRUPTION; MUTATIONS; EXPRESSION; MEMBRANE; COMPLEX; CELLS	The dense glycan coat that surrounds every cell is essential for cellular development and physiological function(1), and it is becoming appreciated that its composition is highly dynamic. Post-translational addition of the polysaccharide repeating unit [-3-xylose-alpha 1,3-glucuronic acid-beta 1-](n) by like-acetylglucosaminyltransferase (LARGE) is required for the glycoprotein dystroglycan to function as a receptor for proteins in the extracellular matrix(2,3). Reductions in the amount of [-3-xylose-alpha 1,3-glucuronic acid-beta 1-](n) (hereafter referred to as LARGE-glycan) on dystroglycan result in heterogeneous forms of muscular dystrophy(4). However, neither patient nor mouse studies has revealed a clear correlation between glycosylation status and phenotype(5,6). This disparity can be attributed to our lack of knowledge of the cellular function of the LARGE-glycan repeat. Here we show that coordinated upregulation of Large and dystroglycan in differentiating mouse muscle facilitates rapid extension of LARGE-glycan repeat chains. Using synthesized LARGE-glycan repeats we show a direct correlation between LARGE-glycan extension and its binding capacity for extracellular matrix ligands. Blocking Large upregulation during muscle regeneration results in the synthesis of dystroglycan with minimal LARGE-glycan repeats in association with a less compact basement membrane, immature neuromuscular junctions and dysfunctional muscle predisposed to dystrophy. This was consistent with the finding that patients with increased clinical severity of disease have fewer LARGE-glycan repeats. Our results reveal that the LARGE-glycan of dystroglycan serves as a tunable extracellular matrix protein scaffold, the extension of which is required for normal skeletal muscle function.	[Goddeeris, Matthew M.; Wu, Biming; Venzke, David; Yoshida-Moriguchi, Takako; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Goddeeris, Matthew M.; Wu, Biming; Venzke, David; Yoshida-Moriguchi, Takako; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol, Iowa City, IA 52242 USA; [Saito, Fumiaki; Matsumura, Kiichiro] Teikyo Univ, Sch Med, Dept Neurol & Neurosci, Itabashi Ku, Tokyo 1738605, Japan; [Moore, Steven A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; Teikyo University; University of Iowa; University of Iowa; University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	kevin-campbell@uowa.edu		Venzke, David/0000-0001-8180-9562; Campbell, Kevin/0000-0003-2066-5889; Moore, Steven/0000-0002-6353-7900	NIH/NIAMS Ruth L. Kirschstein National Research Science Award [F32 AR057289-01]; NIH [T32-DK07690-16]; American Reinvestment and Recovery Act Grant [1RC2NS069521-01]; Muscular Dystrophy Association Research Grant [157538]; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant [1U54NS053672]; NCNP (Ministry of Health and Welfare, Japan); MEXT [23591256, 24501357, 25430075]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672, RC2NS069521] Funding Source: NIH RePORTER	NIH/NIAMS Ruth L. Kirschstein National Research Science Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Reinvestment and Recovery Act Grant; Muscular Dystrophy Association Research Grant; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant; NCNP (Ministry of Health and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M. M. G. was supported by a NIH/NIAMS Ruth L. Kirschstein National Research Science Award (F32 AR057289-01) and NIH grant (T32-DK07690-16). The work was supported by American Reinvestment and Recovery Act Grant (1RC2NS069521-01), a Muscular Dystrophy Association Research Grant (157538), and a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant (1U54NS053672). F. S. and K. M. were supported by an Intramural Research Grant (23-5) for Neurological and Psychiatric Disorders of NCNP (Ministry of Health and Welfare, Japan) and a MEXT Grant-in-Aid for Scientific Research (C 23591256, 24501357, 25430075). We thank P. Yurchenco for his gift of alpha 1LG4-5 producing cells; J. Levy for microscopy expertise; M. B. Zimmerman for assisting with statistical analysis; R. Crawford for technical expertise; H. Nguyen for illustrations; J. Hartner for oversight of Large<SUP>KD</SUP> mouse targeting; J. Shao and R. Nessler of the University of Iowa Central Microscopy Core for their contributions to imaging; and J. Sanes, G. Valdez, D. Glass, C. Blaumueller and Campbell laboratory colleagues for discussions. K. P. C. is an Investigator of the Howard Hughes Medical Institute.	Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beedle AM, 2012, J CLIN INVEST, V122, P3330, DOI 10.1172/JCI63004; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Breloy I, 2012, J BIOL CHEM, V287, P18275, DOI 10.1074/jbc.M111.280297; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Brown SC, 2004, AM J PATHOL, V164, P727, DOI 10.1016/S0002-9440(10)63160-4; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Groh S, 2009, J BIOL CHEM, V284, P19178, DOI 10.1074/jbc.C109.010728; GURNETT CA, 1995, J BIOL CHEM, V270, P9035, DOI 10.1074/jbc.270.16.9035; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hsu NY, 2007, RAPID COMMUN MASS SP, V21, P2137, DOI 10.1002/rcm.3072; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; KOSTROMINOVA TY, 1995, J CELL BIOCHEM, V58, P527, DOI 10.1002/jcb.240580416; Leschziner A, 2000, J NEUROCHEM, V74, P70, DOI 10.1046/j.1471-4159.2000.0740070.x; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Masaki T, 2001, ACTA NEUROPATHOL, V101, P174; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Montanaro F, 1998, J NEUROSCI, V18, P1250; Muntoni F, 2011, CURR OPIN NEUROL, V24, P437, DOI 10.1097/WCO.0b013e32834a95e3; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Osawa T, 2003, J ELECTRON MICROSC, V52, P435, DOI 10.1093/jmicro/52.4.435; Pereboev AV, 2001, BBA-GEN SUBJECTS, V1527, P54, DOI 10.1016/S0304-4165(01)00147-7; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	46	74	76	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					136	+		10.1038/nature12605	http://dx.doi.org/10.1038/nature12605			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24132234	Green Accepted			2022-12-28	WOS:000326585600047
J	Naesens, M; Heylen, L; Lerut, E; Claes, K; De Wever, L; Claus, F; Oyen, R; Kuypers, D; Evenepoel, P; Bammens, B; Sprangers, B; Meijers, B; Pirenne, J; Monbaliu, D; de Jonge, H; Metalidis, C; De Vusser, K; Vanrenterghem, Y				Naesens, Maarten; Heylen, Line; Lerut, Evelyne; Claes, Kathleen; De Wever, Liesbeth; Claus, Filip; Oyen, Raymond; Kuypers, Dirk; Evenepoel, Pieter; Bammens, Bert; Sprangers, Ben; Meijers, Bjorn; Pirenne, Jacques; Monbaliu, Diethard; de Jonge, Hylke; Metalidis, Christoph; De Vusser, Katrien; Vanrenterghem, Yves			Intrarenal Resistive Index after Renal Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANCE INDEX; DOPPLER INDEXES; VASCULAR-RESISTANCE; ALLOGRAFT SURVIVAL; DUPLEX SONOGRAPHY; PULSE PRESSURE; RECIPIENTS; REJECTION; DIAGNOSIS; KIDNEYS	BackgroundThe intrarenal resistive index is routinely measured in many renal-transplantation centers for assessment of renal-allograft status, although the value of the resistive index remains unclear. MethodsIn a single-center, prospective study involving 321 renal-allograft recipients, we measured the resistive index at baseline, at the time of protocol-specified renal-allograft biopsies (3, 12, and 24 months after transplantation), and at the time of biopsies performed because of graft dysfunction. A total of 1124 renal-allograft resistive-index measurements were included in the analysis. All patients were followed for at least 4.5 years after transplantation. ResultsAllograft recipients with a resistive index of at least 0.80 had higher mortality than those with a resistive index of less than 0.80 at 3, 12, and 24 months after transplantation (hazard ratio, 5.20 [95% confidence interval {CI}, 2.14 to 12.64; P<0.001]; 3.46 [95% CI, 1.39 to 8.56; P=0.007]; and 4.12 [95% CI, 1.26 to 13.45; P=0.02], respectively). The need for dialysis did not differ significantly between patients with a resistive index of at least 0.80 and those with a resistive index of less than 0.80 at 3, 12, and 24 months after transplantation (hazard ratio, 1.95 [95% CI, 0.39 to 9.82; P=0.42]; 0.44 [95% CI, 0.05 to 3.72; P=0.45]; and 1.34 [95% CI, 0.20 to 8.82; P=0.76], respectively). At protocol-specified biopsy time points, the resistive index was not associated with renal-allograft histologic features. Older recipient age was the strongest determinant of a higher resistive index (P<0.001). At the time of biopsies performed because of graft dysfunction, antibody-mediated rejection or acute tubular necrosis, as compared with normal biopsy results, was associated with a higher resistive index (0.870.12 vs. 0.780.14 [P=0.05], and 0.860.09 vs. 0.780.14 [P=0.007], respectively). Conclusions<p id="p005">The resistive index, routinely measured at predefined time points after transplantation, reflects characteristics of the recipient but not those of the graft. (ClinicalTrials.gov number, NCT01879124.)	[Naesens, Maarten; Heylen, Line; Claes, Kathleen; Kuypers, Dirk; Evenepoel, Pieter; Bammens, Bert; Sprangers, Ben; Meijers, Bjorn; de Jonge, Hylke; Metalidis, Christoph; De Vusser, Katrien; Vanrenterghem, Yves] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Louvain, Belgium; [Lerut, Evelyne] Univ Hosp Leuven, Dept Pathol, Louvain, Belgium; [De Wever, Liesbeth; Claus, Filip; Oyen, Raymond] Univ Hosp Leuven, Dept Radiol, Louvain, Belgium; [Pirenne, Jacques; Monbaliu, Diethard] Univ Hosp Leuven, Dept Abdominal Transplant Surg, Louvain, Belgium; [Naesens, Maarten; Claes, Kathleen; Kuypers, Dirk; Evenepoel, Pieter; Bammens, Bert; Sprangers, Ben; Meijers, Bjorn; Pirenne, Jacques; Monbaliu, Diethard; De Vusser, Katrien; Vanrenterghem, Yves] Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium; [Lerut, Evelyne; De Wever, Liesbeth; Claus, Filip; Oyen, Raymond] Katholieke Univ Leuven, Dept Imaging & Pathol, Louvain, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven	Naesens, M (corresponding author), Katholieke Univ Leuven, Dept Nephrol & Renal Transplantat, Univ Hosp Leuven, Dept Microbiol & Immunol, Herestr 49, B-3000 Louvain, Belgium.	maarten.naesens@uzleuven.be	Monbaliu, Diethard/AAK-8499-2020; De Vusser, Katrien/AAE-2856-2019; Bammens, Bert/D-4659-2018; Mark, Patrick/N-5536-2014; Sprangers, Ben/T-6559-2017; Naesens, Maarten/J-4766-2015; Kuypers, Dirk RJ/D-4393-2018; Meijers, Bjorn/D-6169-2018; PIRENNE, Jacques/I-3728-2018	Monbaliu, Diethard/0000-0002-0506-1609; Bammens, Bert/0000-0002-2477-2633; Mark, Patrick/0000-0003-3387-2123; Sprangers, Ben/0000-0003-1314-9675; Naesens, Maarten/0000-0002-5625-0792; Kuypers, Dirk RJ/0000-0001-5546-9680; De Vusser, Katrien/0000-0002-3096-6207; Meijers, Bjorn/0000-0002-2846-2026; PIRENNE, Jacques/0000-0002-8147-8801; Heylen, Line/0000-0002-4595-0195	Clinical Research Foundation, University Hospitals Leuven, Leuven, Belgium	Clinical Research Foundation, University Hospitals Leuven, Leuven, Belgium	Supported by funding from the Clinical Research Foundation, University Hospitals Leuven, Leuven, Belgium (to Drs. Naesens and Lerut).	BUCKLEY AR, 1987, AM J ROENTGENOL, V149, P521, DOI 10.2214/ajr.149.3.521; Danovitch, 2010, HDB KIDNEY TRANSPLAN; Doxiadis ILN, 2004, TRANSPLANTATION, V77, P615, DOI 10.1097/01.TP.0000103725.72023.D7; Frei U, 2008, AM J TRANSPLANT, V8, P50, DOI 10.1111/j.1600-6143.2007.02014.x; GOTTLIEB RH, 1995, AM J ROENTGENOL, V165, P1441, DOI 10.2214/ajr.165.6.7484582; Hamano K, 2008, DIABETES CARE, V31, P1853, DOI 10.2337/dc08-0168; Hashimoto J, 2011, HYPERTENSION, V58, P839, DOI 10.1161/HYPERTENSIONAHA.111.177469; Hausberg M, 2005, J HYPERTENS, V23, P1795, DOI 10.1097/01.hjh.0000183525.50875.d1; Heine GH, 2005, KIDNEY INT, V68, P878, DOI 10.1111/j.1523-1755.2005.00470.x; Ikee R, 2005, AM J KIDNEY DIS, V46, P603, DOI 10.1053/j.ajkd.2005.06.006; Keogan MT, 1996, RADIOLOGY, V199, P165, DOI 10.1148/radiology.199.1.8633141; Krumme B, 1997, J AM SOC NEPHROL, V8, P813; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Nankivell BJ, 2011, LANCET, V378, P1428, DOI 10.1016/S0140-6736(11)60699-5; Nosadini R, 2006, DIABETES, V55, P234, DOI 10.2337/diabetes.55.1.234; Ohta Y, 2005, J HYPERTENS, V23, P1905, DOI 10.1097/01.hjh.0000181323.44162.01; Okura T, 2010, J NEPHROL, V23, P175; Parolini C, 2009, RADIOLOGY, V252, P888, DOI 10.1148/radiol.2523080351; Petersen LJ, 1997, NEPHROL DIAL TRANSPL, V12, P1376, DOI 10.1093/ndt/12.7.1376; Poggio ED, 2006, AM J TRANSPLANT, V6, P100, DOI 10.1111/j.1600-6143.2005.01140.x; Radermacher J, 2002, HYPERTENSION, V39, P699, DOI 10.1161/hy0202.103782; Radermacher J, 2003, NEW ENGL J MED, V349, P115, DOI 10.1056/NEJMoa022602; RIFKIN MD, 1987, AM J ROENTGENOL, V148, P759, DOI 10.2214/ajr.148.4.759; RIGSBY CM, 1986, RADIOLOGY, V158, P375, DOI 10.1148/radiology.158.2.3510443; Schwenger V, 2006, AM J TRANSPLANT, V6, P2721, DOI 10.1111/j.1600-6143.2006.01524.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; Sugiura T, 2009, NEPHROL DIAL TRANSPL, V24, P2780, DOI 10.1093/ndt/gfp121; Tublin ME, 1999, RADIOLOGY, V213, P258, DOI 10.1148/radiology.213.1.r99oc19258; Vallejos A, 2005, NEPHROL DIAL TRANSPL, V20, P2511, DOI 10.1093/ndt/gfi041; Yilmaz S, 2003, J AM SOC NEPHROL, V14, P773, DOI 10.1097/01.ASN.0000054496.68498.13	32	130	139	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1797	1806		10.1056/NEJMoa1301064	http://dx.doi.org/10.1056/NEJMoa1301064			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24195547				2022-12-28	WOS:000326607800008
J	Lin, JS; O'Connor, E; Rossom, RC; Perdue, LA; Eckstrom, E				Lin, Jennifer S.; O'Connor, Elizabeth; Rossom, Rebecca C.; Perdue, Leslie A.; Eckstrom, Elizabeth			Screening for Cognitive Impairment in Older Adults: A Systematic Review for the U.S. Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							PLACEBO-CONTROLLED TRIAL; MODERATE ALZHEIMER-DISEASE; MENTAL-STATE-EXAMINATION; RANDOMIZED CONTROLLED-TRIAL; CLOCK DRAWING TEST; QUALITY-OF-LIFE; MODIFIED TELEPHONE INTERVIEW; PROBABLE VASCULAR DEMENTIA; PRIMARY-CARE PATIENTS; LONG-TERM EFFICACY	Background: Earlier identification of cognitive impairment may reduce patient and caregiver morbidity. Purpose: To systematically review the diagnostic accuracy of brief cognitive screening instruments and the benefits and harms of pharmacologic and nonpharmacologic interventions for early cognitive impairment. Data Sources: MEDLINE, PsycINFO, and the Cochrane Central Register of Controlled Trials through December 2012; systematic reviews; clinical trial registries; and experts. Study Selection: English-language studies of fair to good quality, primary care feasible screening instruments, and treatments aimed at persons with mild cognitive impairment or mild to moderate dementia. Data Extraction: Dual quality assessment and abstraction of relevant study details. Data Synthesis: The Mini-Mental State Examination (k = 25) is the most thoroughly studied instrument but is not available for use without cost. Publicly available instruments with adequate test performance to detect dementia include the Clock Drawing Test (k = 7), Mini-Cog (k = 4), Memory Impairment Screen (k = 5), Abbreviated Mental Test (k = 4), Short Portable Mental Status Questionnaire (k = 4), Free and Cued Selective Reminding Test (k = 2), 7-Minute Screen (k = 2), and Informant Questionnaire on Cognitive Decline in the Elderly (k = 5). Medications approved by the U.S. Food and Drug Administration for Alzheimer disease (k = 58) and caregiver interventions (k = 59) show a small benefit of uncertain clinical importance for patients and their caregivers. Small benefits are also limited by common adverse effects of acetylcholinesterase inhibitors and limited availability of complex caregiver interventions. Although promising, cognitive stimulation (k = 6) and exercise (k = 10) have limited evidence to support their use in persons with mild to moderate dementia or mild cognitive impairment. Limitation: Limited studies in persons with dementia other than Alzheimer disease and sparse reporting of important, health outcomes. Conclusion: Brief instruments to screen for cognitive impairment can adequately detect dementia, but there is no empirical evidence that screening improves decision making. Whether interventions for patients or their caregivers have a clinically significant effect in persons with earlier detected cognitive impairment is still unclear.	[Lin, Jennifer S.; O'Connor, Elizabeth; Perdue, Leslie A.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR 97227 USA; [Rossom, Rebecca C.] HealthPartners Inst Educ & Res, Minneapolis, MN 55440 USA; [Eckstrom, Elizabeth] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA	Kaiser Permanente; Oregon Health & Science University	Lin, JS (corresponding author), Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR 97227 USA.		Rossom, Rebecca/R-7103-2019	Rossom, Rebecca/0000-0002-9531-914X	Kaiser Permanente Research Affiliates Evidence-based Practice Center under AHRQ, Rockville, Maryland [HHS-290-2007-10057-I]	Kaiser Permanente Research Affiliates Evidence-based Practice Center under AHRQ, Rockville, Maryland	This review was conducted by the Kaiser Permanente Research Affiliates Evidence-based Practice Center under contract to AHRQ, Rockville, Maryland (contract HHS-290-2007-10057-I). AHRQ staff provided oversight for the project and assisted in external review of the companion draft evidence synthesis.	AD2000 Collaborative Grp, 2008, LANCET NEUROL, V7, P41, DOI 10.1016/S1474-4422(07)70293-4; Agid Y, 1998, CURR THER RES CLIN E, V59, P837, DOI 10.1016/S0011-393X(98)85048-0; Aisen PS, 2008, JAMA-J AM MED ASSOC, V300, P1774, DOI 10.1001/jama.300.15.1774; Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Aronson S, 2009, DRUG AGING, V26, P231, DOI 10.2165/00002512-200926030-00004; Auchus AP, 2007, NEUROLOGY, V69, P448, DOI 10.1212/01.wnl.0000266625.31615.f6; Ayalon L, 2011, J GERIATR PSYCH NEUR, V24, P168, DOI 10.1177/0891988711418506; Babai S, 2010, THERAPIE, V65, P255, DOI 10.2515/therapie/2010008; Bakchine S, 2008, J ALZHEIMERS DIS, V13, P97; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Balk Ethan, 2006, Evid Rep Technol Assess (Full Rep), P1; Ball LJ, 2001, J AM GERIATR SOC, V49, P798, DOI 10.1046/j.1532-5415.2001.49159.x; Ballard C, 2008, CURR MED RES OPIN, V24, P2561, DOI 10.1185/03007990802328142 ; Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Bass DM, 2003, GERONTOLOGIST, V43, P73, DOI 10.1093/geront/43.1.73; Beer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028155; Bellantonio S, 2008, J AM GERIATR SOC, V56, P523, DOI 10.1111/j.1532-5415.2007.01591.x; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Bentham P, 2004, LANCET, V363, P2105; Berg AO, 2003, AM J NURS, V103, P87; Black S, 2003, STROKE, V34, P2323, DOI 10.1161/01.STR.0000091396.95360.E1; Boada-Rovira M, 2004, DRUG AGING, V21, P43, DOI 10.2165/00002512-200421010-00004; BORENSTEIN M, 2009, INTRODUCT TO META AN; Borson S, 2006, INT J GERIATR PSYCH, V21, P349, DOI 10.1002/gps.1470; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; BOUSTANI M, 2003, SYSTEMAT EVIDENCE RE; Boustani M, 2006, INT J GERIATR PSYCH, V21, P556, DOI 10.1002/gps.1524; BRADBURN MJ, 1998, META ANAL STATA, P3; BRENNAN PF, 1995, NURS RES, V44, P166; Brodaty H, 2006, AM J GERIAT PSYCHIAT, V14, P391, DOI 10.1097/01.JGP.0000216181.20416.b2; Brodaty H, 2005, DEMENT GERIATR COGN, V20, P120, DOI 10.1159/000086613; BRODATY H, 1989, BMJ-BRIT MED J, V299, P1375, DOI 10.1136/bmj.299.6712.1375; Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x; Bullock R, 2004, DEMENT GERIATR COGN, V17, P29, DOI 10.1159/000074140; Burgener SC, 2008, AM J ALZHEIMERS DIS, V23, P382, DOI 10.1177/1533317508317527; Burgio L, 2003, GERONTOLOGIST, V43, P568, DOI 10.1093/geront/43.4.568; Burns A, 2007, INT J GERIATR PSYCH, V22, P806, DOI 10.1002/gps.1746; Burns A, 1999, DEMENT GERIATR COGN, V10, P237, DOI 10.1159/000017126; Buschert VC, 2011, J ALZHEIMERS DIS, V25, P679, DOI 10.3233/JAD-2011-100999; Buschke H, 1999, NEUROLOGY, V52, P231, DOI 10.1212/WNL.52.2.231; Cahn-Weiner DA, 2003, APPL NEUROPSYCHOL, V10, P215, DOI 10.1207/s15324826an1004_3; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Chang BL, 1999, NURS RES, V48, P173, DOI 10.1097/00006199-199905000-00007; Chapman SB, 2004, J SPEECH LANG HEAR R, V47, P1149, DOI 10.1044/1092-4388(2004/085); Charlesworth G, 2008, BRIT MED J, V336, P1295, DOI 10.1136/bmj.39549.548831.AE; Chien LY, 2011, INT J GERIATR PSYCH, V26, P1089, DOI 10.1002/gps.2660; Chodosh J, 2004, J AM GERIATR SOC, V52, P1051, DOI 10.1111/j.1532-5415.2004.52301.x; Chu H, 2011, J AGING HEALTH, V23, P228, DOI 10.1177/0898264310381522; Chu P., 2000, AM J ALZHEIMERS DIS, V15, P284, DOI [DOI 10.1177/153331750001500506, 10.1177/153331750001500506]; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Clarke R, 2003, J INTERN MED, V254, P67, DOI 10.1046/j.1365-2796.2003.01154.x; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Connell CM, 2009, J APPL GERONTOL, V28, P171, DOI 10.1177/0733464808326951; Connelly PJ, 2008, INT J GERIATR PSYCH, V23, P155, DOI 10.1002/gps.1856; Cook SE, 2009, J GERIATR PSYCH NEUR, V22, P103, DOI 10.1177/0891988708328214; Coon DW, 2003, GERONTOLOGIST, V43, P678, DOI 10.1093/geront/43.5.678; COREYBLOOM J, 1998, INT J GERIATR PSYCHO, V1, P55; Cruz-Orduna I, 2012, FAM PRACT, V29, P401, DOI 10.1093/fampra/cmr114; Cullen B, 2005, INT J GERIATR PSYCH, V20, P371, DOI 10.1002/gps.1291; de Jager CA, 2012, INT J GERIATR PSYCH, V27, P592, DOI 10.1002/gps.2758; de Jong D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001475; de Rotrou J, 2011, INT J GERIATR PSYCH, V26, P833, DOI 10.1002/gps.2611; Del Ser T, 2006, DEMENT GERIATR COGN, V22, P454, DOI 10.1159/000095858; Donnelly K, 2008, AM J ALZHEIMERS DIS, V23, P218, DOI 10.1177/1533317508315932; Doody RS, 2009, NEUROLOGY, V72, P1555, DOI 10.1212/01.wnl.0000344650.95823.03; dos Santos Moraes WA, 2006, SLEEP, V29, P199, DOI 10.1093/sleep/29.2.199; Ducharme FC, 2011, GERONTOLOGIST, V51, P484, DOI 10.1093/geront/gnr014; Dunn NR, 2000, J PSYCHOPHARMACOL, V14, P406, DOI 10.1177/026988110001400410; Ehreke L, 2011, INT PSYCHOGERIATR, V23, P1592, DOI 10.1017/S104161021100144X; Ehreke L, 2009, DEMENT GERIATR COGN, V28, P365, DOI 10.1159/000253484; Eloniemi-Sulkava U, 2001, J AM GERIATR SOC, V49, P1282, DOI 10.1046/j.1532-5415.2001.49255.x; Eloniemi-Sulkava U, 2009, J AM GERIATR SOC, V57, P2200, DOI 10.1111/j.1532-5415.2009.02564.x; Engberg SJ, 2003, AM J NURS, V103, P93, DOI 10.1097/00000446-200307000-00029; ERKINJUNTTI T, 1987, J AM GERIATR SOC, V35, P412, DOI 10.1111/j.1532-5415.1987.tb04662.x; Erkinjuntti T, 2002, LANCET, V359, P1283, DOI 10.1016/S0140-6736(02)08267-3; Feldman H, 2001, NEUROLOGY, V57, P613, DOI 10.1212/WNL.57.4.613; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Feldman HH, 2007, J NEUROL NEUROSUR PS, V78, P1056, DOI 10.1136/jnnp.2006.099424; Ferris S, 2007, INT J GERIATR PSYCH, V22, P448, DOI 10.1002/gps.1711; FILLENBAUM G, 1990, J CLIN EPIDEMIOL, V43, P651, DOI 10.1016/0895-4356(90)90035-N; Finkel S, 2007, AM J GERIAT PSYCHIAT, V15, P443, DOI 10.1097/JGP.0b013e3180437d87; Forstl H, 2011, DEMENT GERIATR COGN, V32, P267, DOI 10.1159/000334991; Fong TG, 2011, ARCH INTERN MED, V171, P432, DOI 10.1001/archinternmed.2010.423; Forbes D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub2; Forette F, 1999, EUR J NEUROL, V6, P423, DOI 10.1046/j.1468-1331.1999.640423.x; Fortinsky RH, 2009, AGING MENT HEALTH, V13, P162, DOI 10.1080/13607860902746160; Fosbol EL, 2012, J AM GERIATR SOC, V60, P2283, DOI 10.1111/j.1532-5415.2012.04241.x; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Froelich L, 2009, CURR MED RES OPIN, V25, P3059, DOI 10.1185/03007990903396626; Fuchs A, 2012, J AM GERIATR SOC, V60, P130, DOI 10.1111/j.1532-5415.2011.03765.x; GAGNON M, 1990, NEUROEPIDEMIOLOGY, V9, P143, DOI 10.1159/000110764; Gallagher-Thompson D, 2003, GERONTOLOGIST, V43, P580, DOI 10.1093/geront/43.4.580; Gallagher-Thompson Dolores, 2008, J Ration Emot Cogn Behav Ther, V26, P286, DOI 10.1007/s10942-008-0087-4; Ganguli M, 2004, J AM GERIATR SOC, V52, P1668, DOI 10.1111/j.1532-5415.2004.52459.x; Gill SS, 2009, ARCH INTERN MED, V169, P867, DOI 10.1001/archinternmed.2009.43; Gitlin LN, 2008, AM J GERIAT PSYCHIAT, V16, P229, DOI 10.1097/JGP.0b013e318160da72; Gitlin LN, 2010, JAMA-J AM MED ASSOC, V304, P983, DOI 10.1001/jama.2010.1253; Gitlin LN, 2010, J AM GERIATR SOC, V58, P1465, DOI 10.1111/j.1532-5415.2010.02971.x; Gitlin LN, 2001, GERONTOLOGIST, V41, P4, DOI 10.1093/geront/41.1.4; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Goldrick BA, 2003, AM J NURS, V103, P89, DOI 10.1097/00000446-200304000-00028; GOY E, 2010, VA EVIDENCE BASED SY; Graff MJL, 2006, BMJ-BRIT MED J, V333, P1196, DOI 10.1136/bmj.39001.688843.BE; Greenaway MC, 2013, INT J GERIATR PSYCH, V28, P402, DOI 10.1002/gps.3838; Grober E, 2008, J INT NEUROPSYCH SOC, V14, P130, DOI 10.1017/S1355617708080156; GRUT M, 1993, ACTA NEUROL SCAND, V87, P312, DOI 10.1111/j.1600-0404.1993.tb05514.x; Hebert R, 2003, J GERONTOL B-PSYCHOL, V58, pS58, DOI 10.1093/geronb/58.1.S58; HEBERT R, 1994, ARCH GERONTOL GERIAT, V18, P1, DOI 10.1016/0167-4943(94)90043-4; Henderson VW, 2000, NEUROLOGY, V54, P295, DOI 10.1212/WNL.54.2.295; Hepburn KW, 2001, J AM GERIATR SOC, V49, P450, DOI 10.1046/j.1532-5415.2001.49090.x; HEPBURN KW, 2005, CLIN GERONTOL, V29, P53, DOI DOI 10.1300/J018V29N1301_1305_1353; Hernandez RK, 2009, J AM GERIATR SOC, V57, P1997, DOI 10.1111/j.1532-5415.2009.02488.x; Heun R, 1998, INT J GERIATR PSYCH, V13, P368, DOI 10.1002/(SICI)1099-1166(199806)13:6<368::AID-GPS775>3.3.CO;2-0; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HINCHLIFFE AC, 1995, INT J GERIATR PSYCH, V10, P839, DOI 10.1002/gps.930101005; Hirano A, 2011, ARCH GERONTOL GERIAT, V53, pE158, DOI 10.1016/j.archger.2010.08.004; Holmes C, 2004, NEUROLOGY, V63, P214, DOI 10.1212/01.WNL.0000129990.32253.7B; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; Holsinger T, 2012, J AM GERIATR SOC, V60, P1027, DOI 10.1111/j.1532-5415.2012.03967.x; HOOIJER C, 1992, INT J GERIATR PSYCH, V7, P559, DOI 10.1002/gps.930070805; Huang HL, 2003, INT J GERIATR PSYCH, V18, P337, DOI 10.1002/gps.835; Inglis T, 2003, AM J NURS, V103, P91, DOI 10.1097/00000446-200301000-00080; Issa AM, 2006, DEMENT GERIATR COGN, V21, P88, DOI 10.1159/000090224; Jansen APD, 2011, INT J NURS STUD, V48, P933, DOI 10.1016/j.ijnurstu.2011.02.004; Jeong SK, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-31; Jia X, 2008, J HUM NUTR DIET, V21, P317, DOI 10.1111/j.1365-277X.2008.00887.x; Joling KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030936; Jorm AF, 1996, INT J GERIATR PSYCH, V11, P131; Kadir A, 2008, NEUROBIOL AGING, V29, P1204, DOI 10.1016/j.neurobiolaging.2007.02.020; Kahle-Wrobleski K, 2007, J AM GERIATR SOC, V55, P284, DOI 10.1111/j.1532-5415.2007.01049.x; Karaman Y, 2005, DEMENT GERIATR COGN, V19, P51, DOI 10.1159/000080972; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kaufer DI, 2008, J AM MED DIR ASSOC, V9, P586, DOI 10.1016/j.jamda.2008.05.006; KAY DWK, 1985, PSYCHOL MED, V15, P771, DOI 10.1017/S0033291700005006; Kemp PM, 2003, J NEUROL NEUROSUR PS, V74, P1567, DOI 10.1136/jnnp.74.11.1567; King AC, 2002, J GERONTOL A-BIOL, V57, pM26, DOI 10.1093/gerona/57.1.M26; Kinsella GJ, 2009, J NEUROL NEUROSUR PS, V80, P730, DOI 10.1136/jnnp.2008.148346; Kirby M, 2001, INT J GERIATR PSYCH, V16, P935, DOI 10.1002/gps.445; Koontz Jennifer, 2005, Am J Alzheimers Dis Other Demen, V20, P295, DOI 10.1177/153331750502000502; Krishnan KRR, 2003, AM J PSYCHIAT, V160, P2003, DOI 10.1176/appi.ajp.160.11.2003; Kurz A, 2012, ALZ DIS ASSOC DIS, V26, P246, DOI 10.1097/WAD.0b013e318231e46e; Kurz A, 2010, INT J GERIATR PSYCH, V25, P861, DOI 10.1002/gps.2428; Kurz AF, 2011, INT PSYCHOGERIATR, V23, P1364, DOI 10.1017/S1041610211001001; Kuslansky G, 2002, J AM GERIATR SOC, V50, P1086, DOI 10.1046/j.1532-5415.2002.50265.x; Kwok T, 2011, CLIN NUTR, V30, P297, DOI 10.1016/j.clnu.2010.12.004; Lam LCW, 2008, NEUROEPIDEMIOLOGY, V30, P6, DOI 10.1159/000113300; Lam LCW, 2011, INT J GERIATR PSYCH, V26, P733, DOI 10.1002/gps.2602; Lam LCW, 2010, INT J GERIATR PSYCH, V25, P395, DOI 10.1002/gps.2352; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lavery LL, 2007, J GEN INTERN MED, V22, P949, DOI 10.1007/s11606-007-0198-0; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee JY, 2008, J GERIATR PSYCH NEUR, V21, P104, DOI 10.1177/0891988708316855; Lee KS, 2008, DEMENT GERIATR COGN, V26, P483, DOI 10.1159/000167879; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Li ML, 2006, DEMENT GERIATR COGN, V21, P392, DOI 10.1159/000092808; LIJMER JG, 1999, JAMA-J AM MED ASSOC, V82, P1061; Lipton RB, 2003, J AM GERIATR SOC, V51, P1382, DOI 10.1046/j.1532-5415.2003.51455.x; LoGiudice D, 1999, INT J GERIATR PSYCH, V14, P626, DOI 10.1002/(SICI)1099-1166(199908)14:8<626::AID-GPS990>3.0.CO;2-5; Losada A, 2011, INT J GERIATR PSYCH, V26, P1119, DOI 10.1002/gps.2648; Lu PH, 2006, ARCH NEUROL-CHICAGO, V63, P177, DOI 10.1001/archneur.63.2.nct50002; Mahoney DF, 2003, GERONTOLOGIST, V43, P556, DOI 10.1093/geront/43.4.556; Malouf R, 2003, Cochrane Database Syst Rev, pCD004393, DOI 10.1002/14651858.CD004393; Malouf R, 2003, COCHRANE DB SYST REV, V2003; Malouf R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004514.pub2; Manly JJ, 2011, ARCH NEUROL-CHICAGO, V68, P607, DOI 10.1001/archneurol.2011.88; Markwick A, 2012, J CLIN EXP NEUROPSYC, V34, P750, DOI 10.1080/13803395.2012.672966; Marriott A, 2000, BRIT J PSYCHIAT, V176, P557, DOI 10.1192/bjp.176.6.557; Martin-Carrasco M, 2009, INT J GERIATR PSYCH, V24, P489, DOI 10.1002/gps.2142; Martin-Cook Kristin, 2005, Am J Alzheimers Dis Other Demen, V20, P204, DOI 10.1177/153331750502000411; Mazza M, 2006, EUR J NEUROL, V13, P981, DOI 10.1111/j.1468-1331.2006.01409.x; McDowell I, 1997, J CLIN EPIDEMIOL, V50, P377, DOI 10.1016/S0895-4356(97)00060-7; McGuinness B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007514.pub2; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; Meeuwsen EJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3086; Menn P, 2012, VALUE HEALTH, V15, P851, DOI 10.1016/j.jval.2012.06.007; Mitchell AJ, 2008, INT J GERIATR PSYCH, V23, P1191, DOI 10.1002/gps.2053; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mittelman MS, 2008, AM J GERIAT PSYCHIAT, V16, P893, DOI 10.1097/JGP.0b013e3181898095; Mohs RC, 2001, NEUROLOGY, V57, P481, DOI 10.1212/WNL.57.3.481; Mok Vincent, 2007, Neuropsychiatr Dis Treat, V3, P943; Morales JM, 1997, INT J GERIATR PSYCH, V12, P808, DOI 10.1002/(SICI)1099-1166(199708)12:8<808::AID-GPS644>3.0.CO;2-5; Mori E, 2012, ANN NEUROL, V72, P41, DOI 10.1002/ana.23557; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; Munoz DG, 2000, CAN MED ASSOC J, V162, P65; Nagamatsu LS, 2012, ARCH INTERN MED, V172, P666, DOI 10.1001/archinternmed.2012.379; *NAT I HLTH CLIN, 2006, GUID MAN; *NAT INST HLTH CLI, 2011, DONEPEZIL GALANTAMIN; Nourhashemi Fati, 2010, BMJ, V340, pc2466, DOI 10.1136/bmj.c2466; Olafsdottir M, 2000, DEMENT GERIATR COGN, V11, P223, DOI 10.1159/000017241; Olazaran J, 2004, NEUROLOGY, V63, P2348, DOI 10.1212/01.WNL.0000147478.03911.28; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Ostwald SK, 1999, GERONTOLOGIST, V39, P299, DOI 10.1093/geront/39.3.299; Ott BR, 2007, J NEUROL, V254, P351, DOI 10.1007/s00415-006-0374-x; Pariente A, 2010, CNS DRUGS, V24, P55, DOI 10.2165/11530300-000000000-00000; Park-Wyllie LY, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000157; Pasqualetti P, 2009, AGING CLIN EXP RES, V21, P102, DOI 10.1007/BF03325217; Peskind ER, 2006, AM J GERIAT PSYCHIAT, V14, P704, DOI 10.1097/01.JGP.0000224350.82719.83; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Pillemer K, 2002, RES AGING, V24, P171, DOI 10.1177/0164027502242001; Pitkala K, 2013, EXP GERONTOL, V48, P85, DOI 10.1016/j.exger.2012.08.008; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Porsteinsson AP, 2008, CURR ALZHEIMER RES, V5, P83, DOI 10.2174/156720508783884576; Potkin SG, 2001, INT J NEUROPSYCHOPH, V4, P223, DOI 10.1017/S1461145701002528; PRINCE M, 2011, WORLD ALZHEIMER REP; Qaseem A, 2008, ANN INTERN MED, V148, P370, DOI 10.7326/0003-4819-148-5-200803040-00008; QUAYHAGEN MP, 1995, NURS RES, V44, P153; Quayhagen MP, 2001, NEUROPSYCHOL REHABIL, V11, P319, DOI 10.1080/09602010042000024; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Rait G, 2000, PSYCHOL MED, V30, P957, DOI 10.1017/S0033291799002305; Rait G, 2000, INT J GERIATR PSYCH, V15, P54, DOI 10.1002/(SICI)1099-1166(200001)15:1<54::AID-GPS77>3.0.CO;2-C; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rapp S, 2002, AGING MENT HEALTH, V6, P5, DOI 10.1080/13607860120101077; Raschetti R, 2005, EUR J CLIN PHARMACOL, V61, P361, DOI 10.1007/s00228-005-0946-1; Raskind MA, 2000, NEUROLOGY, V54, P2261, DOI 10.1212/WNL.54.12.2261; Reijnders J, 2013, AGEING RES REV, V12, P263, DOI 10.1016/j.arr.2012.07.003; Reisberg B., 2003, NEW ENGL J MED, V348, P1333, DOI [10.1056/NEJMoa013128, DOI 10.1056/NEJMOA013128]; Reischies FM, 1997, BRIT J PSYCHIAT, V171, P449, DOI 10.1192/bjp.171.5.449; Relkin NR, 2003, DEMENT GERIATR COGN, V16, P15, DOI 10.1159/000069988; Requena C, 2006, DEMENT GERIATR COGN, V22, P339, DOI 10.1159/000095600; Requena C, 2004, DEMENT GERIATR COGN, V18, P50, DOI 10.1159/000077735; Richard E, 2009, ALZ DIS ASSOC DIS, V23, P198, DOI 10.1097/WAD.0b013e31819783a4; Rideaux T, 2012, J ALZHEIMERS DIS, V31, P371, DOI 10.3233/JAD-2012-112180; Roberts J, 1999, NURS RES, V48, P162, DOI 10.1097/00006199-199905000-00006; Rockwood K, 2006, CAN MED ASSOC J, V174, P1099, DOI 10.1503/cmaj.051432; Rockwood K, 2001, J NEUROL NEUROSUR PS, V71, P589, DOI 10.1136/jnnp.71.5.589; Rockwood K, 2008, INT J GERIATR PSYCH, V23, P207, DOI 10.1002/gps.1864; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Russ TC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009132.pub2; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Salloway S, 2004, NEUROLOGY, V63, P651, DOI 10.1212/01.WNL.0000134664.80320.92; Sano M, 2011, NEUROLOGY, V77, P556, DOI 10.1212/WNL.0b013e318228bf11; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Saxton J, 2012, J ALZHEIMERS DIS, V28, P109, DOI 10.3233/JAD-2011-110947; Saxton J, 2009, POSTGRAD MED, V121, P177, DOI 10.3810/pgm.2009.03.1990; Scharre DW, 2010, ALZ DIS ASSOC DIS, V24, P64, DOI 10.1097/WAD.0b013e3181b03277; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; SCHOENMAKERS B, 2010, INT J FAM MED, P1; Schwenk M, 2010, NEUROLOGY, V74, P1961, DOI 10.1212/WNL.0b013e3181e39696; Seltzer B, 2004, ARCH NEUROL-CHICAGO, V61, P1852, DOI 10.1001/archneur.61.12.1852; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Sinn N, 2012, BRIT J NUTR, V107, P1682, DOI 10.1017/S0007114511004788; Soininen H, 2007, DEMENT GERIATR COGN, V23, P8, DOI 10.1159/000096588; Solomon PR, 2000, INT PSYCHOGERIATR, V12, P483, DOI 10.1017/S1041610200006608; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Spijker A, 2011, AM J GERIAT PSYCHIAT, V19, P521, DOI 10.1097/JGP.0b013e3182110599; Steichen T.J., 2009, METAANALYSIS STATA U, P165; Steinberg M, 2009, INT J GERIATR PSYCH, V24, P680, DOI 10.1002/gps.2175; Stephenson A, 2012, DRUG AGING, V29, P213, DOI 10.2165/11599480-000000000-00000; STERNE JA, 2009, METAANALYSIS STATA U, P109; Sun Y, 2007, CLIN THER, V29, P2204, DOI 10.1016/j.clinthera.2007.10.012; Suzuki T, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-128; Tam-Tham H, 2013, INT J GERIATR PSYCH, V28, P889, DOI 10.1002/gps.3906; Tariot PN, 2000, NEUROLOGY, V54, P2269, DOI 10.1212/WNL.54.12.2269; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Tariot PN, 2001, J AM GERIATR SOC, V49, P1590, DOI 10.1046/j.1532-5415.2001.t01-1-49266.x; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; Teri L, 2008, J NUTR HEALTH AGING, V12, P391, DOI 10.1007/BF02982672; Teri L, 2005, GERONTOLOGIST, V45, P802, DOI 10.1093/geront/45.6.802; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Thomas A, 2001, CLIN NEUROPHARMACOL, V24, P31, DOI 10.1097/00002826-200101000-00007; Tokuhara Keith G, 2006, Hawaii Med J, V65, P72; Troyer AK, 2008, NEUROPSYCHOL REHABIL, V18, P65, DOI 10.1080/09602010701409684; Tsai PF, 2013, J PAIN SYMPTOM MANAG, V45, P660, DOI 10.1016/j.jpainsymman.2012.04.009; Tsolaki M, 2011, NEURODEGENER DIS, V8, P138, DOI 10.1159/000320575; Tune L, 2003, AM J GERIAT PSYCHIAT, V11, P169, DOI 10.1176/appi.ajgp.11.2.169; Ulstein ID, 2007, DEMENT GERIATR COGN, V24, P469, DOI 10.1159/000110740; *US PREV SERV TASK, 2003, AM J NURS, V103, P95; US Preventive Services Task Force, 2008, AHRQ PUBL; Valcour VG, 2000, ARCH INTERN MED, V160, P2964, DOI 10.1001/archinte.160.19.2964; Valen-Sendstad A, 2010, AM J GERIAT PSYCHIAT, V18, P11, DOI 10.1097/JGP.0b013e3181beaaf4; Van Der Putt R, 2006, INT J GERIATR PSYCH, V21, P755, DOI 10.1002/gps.1557; van Uffelen JGZ, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.044735; van Uffelen JGZ, 2008, CLIN J SPORT MED, V18, P486, DOI 10.1097/JSM.0b013e3181845f0b; Venturelli M, 2010, EXP AGING RES, V36, P190, DOI 10.1080/03610731003613771; Vercambre MN, 2010, INT J GERIATR PSYCH, V25, P1142, DOI 10.1002/gps.2447; Vernooij-Dassen M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005318.pub2; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; Vidal JS, 2008, ALZ DIS ASSOC DIS, V22, P125, DOI 10.1097/WAD.0b013e31815a9e10; Voigt-Radloff S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000096; Vreugdenhil A, 2012, SCAND J CARING SCI, V26, P12, DOI 10.1111/j.1471-6712.2011.00895.x; Waite LM, 1998, AGING NEUROPSYCHOL C, V5, P194, DOI 10.1076/anec.5.3.194.614; Waldorff FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4693; Wang PN, 2000, NEUROLOGY, V54, P2061, DOI 10.1212/WNL.54.11.2061; Wells G., 2013, OTTAWA HOSP RES I; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wilcock G, 2002, INT CLIN PSYCHOPHARM, V17, P297, DOI 10.1097/00004850-200211000-00005; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Wilkinson D, 2003, NEUROLOGY, V61, P479, DOI 10.1212/01.WNL.0000078943.50032.FC; Wilkinson D, 2001, INT J GERIATR PSYCH, V16, P852, DOI 10.1002/gps.409; Wilkinson D, 2012, J ALZHEIMERS DIS, V29, P459, DOI 10.3233/JAD-2011-111616; Wilkinson D, 2010, INT J GERIATR PSYCH, V25, P305, DOI 10.1002/gps.2340; Wilkinson DG, 2005, INT J GERIATR PSYCH, V20, P489, DOI 10.1002/gps.1301; Williams PS, 2000, COCHRANE DB SYST REV, pCD001296, DOI 10.1002/14651858.CD001296; Williams VP, 2010, PSYCHOSOM MED, V72, P897, DOI 10.1097/PSY.0b013e3181fc2d09; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489; Winblad B, 2007, INT J GERIATR PSYCH, V22, P456, DOI 10.1002/gps.1788; Winter Laraine, 2006, Am J Alzheimers Dis Other Demen, V21, P391; WOLFKLEIN GP, 1989, J AM GERIATR SOC, V37, P730, DOI 10.1111/j.1532-5415.1989.tb02234.x; Wolfs CAG, 2008, BRIT J PSYCHIAT, V192, P300, DOI 10.1192/bjp.bp.107.035204; Woods B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005562.pub2; Wright L K, 2001, Issues Ment Health Nurs, V22, P231, DOI 10.1080/01612840152053084; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	315	245	255	6	100	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					601	612		10.7326/0003-4819-159-9-201311050-00730	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00730			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249HX	24145578				2022-12-28	WOS:000326769400004
J	Lyne, A; Graham-Smith, F; Weltevrede, P; Jordan, C; Stappers, B; Bassa, C; Kramer, M				Lyne, Andrew; Graham-Smith, Francis; Weltevrede, Patrick; Jordan, Christine; Stappers, Ben; Bassa, Cees; Kramer, Michael			Evolution of the Magnetic Field Structure of the Crab Pulsar	SCIENCE			English	Article							NEUTRON-STARS; EMISSION; PRECESSION; RADIATION; MODEL	Pulsars are highly magnetized rotating neutron stars and are well known for the stability of their signature pulse shapes, allowing high-precision studies of their rotation. However, during the past 22 years, the radio pulse profile of the Crab pulsar has shown a steady increase in the separation of the main pulse and interpulse components at 0.62 degrees +/- 0.03 degrees per century. There are also secular changes in the relative strengths of several components of the profile. The changing component separation indicates that the axis of the dipolar magnetic field, embedded in the neutron star, is moving toward the stellar equator. This evolution of the magnetic field could explain why the pulsar does not spin down as expected from simple braking by a rotating dipolar magnetic field.	[Lyne, Andrew; Graham-Smith, Francis; Weltevrede, Patrick; Jordan, Christine; Stappers, Ben; Bassa, Cees; Kramer, Michael] Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Kramer, Michael] Max Planck Inst Radioastron, D-53121 Bonn, Germany	University of Manchester; Jodrell Bank Centre for Astrophysics; Max Planck Society	Lyne, A (corresponding author), Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England.	andrew.lyne@manchester.ac.uk		Bassa, Cees/0000-0002-1429-9010; Kramer, Michael/0000-0002-4175-2271	U.K. Science and Technology Facilities Council; Science and Technology Facilities Council [ST/J001562/1] Funding Source: researchfish	U.K. Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Pulsar research at Jodrell Bank Centre for Astrophysics is supported by a Consolidated Grant from the U.K. Science and Technology Facilities Council.	Abdo AA, 2010, ASTROPHYS J, V708, P1254, DOI 10.1088/0004-637X/708/2/1254; Beskin VS, 2007, ASTROPHYS SPACE SCI, V308, P569, DOI 10.1007/s10509-007-9307-0; CHENG KS, 1986, ASTROPHYS J, V300, P500, DOI 10.1086/163829; COMELLA JM, 1969, NATURE, V221, P453, DOI 10.1038/221453a0; Du YJ, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/84; Dyks J, 2003, ASTROPHYS J, V598, P1201, DOI 10.1086/379052; GOLD T, 1968, NATURE, V218, P731, DOI 10.1038/218731a0; Harding AK, 2008, ASTROPHYS J, V680, P1378, DOI 10.1086/588037; Link B, 1997, ASTROPHYS J, V478, pL91, DOI 10.1086/310549; Lyne A., 2012, PULSAR ASTRONOMY; Lyne A. G., 2013, JODRELL BANK CRAB PU; LYNE AG, 1988, MON NOT R ASTRON SOC, V233, P667, DOI 10.1093/mnras/233.3.667; LYNE AG, 1993, MON NOT R ASTRON SOC, V265, P1003, DOI 10.1093/mnras/265.4.1003; Lyne A, 2010, SCIENCE, V329, P408, DOI 10.1126/science.1186683; MACY WW, 1974, ASTROPHYS J, V190, P153, DOI 10.1086/152859; Moffett DA, 1996, ASTROPHYS J, V468, P779, DOI 10.1086/177734; MORINI M, 1983, MON NOT R ASTRON SOC, V202, P495, DOI 10.1093/mnras/202.2.495; Muslimov AG, 2004, ASTROPHYS J, V606, P1143, DOI 10.1086/383079; Ng CY, 2008, ASTROPHYS J, V673, P411, DOI 10.1086/523935; Romani RW, 2010, ASTROPHYS J, V714, P810, DOI 10.1088/0004-637X/714/1/810; ROMANI RW, 1995, ASTROPHYS J, V438, P314, DOI 10.1086/175076; Sedrakian A, 1999, ASTROPHYS J, V524, P341, DOI 10.1086/307777; SHAHAM J, 1977, ASTROPHYS J, V214, P251, DOI 10.1086/155249; STAELIN DH, 1968, SCIENCE, V162, P1481, DOI 10.1126/science.162.3861.1481; Watters KP, 2009, ASTROPHYS J, V695, P1289, DOI 10.1088/0004-637X/695/2/1289	27	85	87	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					598	601		10.1126/science.1243254	http://dx.doi.org/10.1126/science.1243254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179221	Green Submitted			2022-12-28	WOS:000326334300042
J	Rosenthal, Y; Linsley, BK; Oppo, DW				Rosenthal, Yair; Linsley, Braddock K.; Oppo, Delia W.			Pacific Ocean Heat Content During the Past 10,000 Years	SCIENCE			English	Article							WESTERN EQUATORIAL PACIFIC; TEMPERATURE; WATER; VARIABILITY; THROUGHFLOW	Observed increases in ocean heat content (OHC) and temperature are robust indicators of global warming during the past several decades. We used high-resolution proxy records from sediment cores to extend these observations in the Pacific 10,000 years beyond the instrumental record. We show that water masses linked to North Pacific and Antarctic intermediate waters were warmer by 2.1 +/- 0.4 degrees C and 1.5 +/- 0.4 degrees C, respectively, during the middle Holocene Thermal Maximum than over the past century. Both water masses were similar to 0.9 degrees C warmer during the Medieval Warm period than during the Little Ice Age and similar to 0.65 degrees warmer than in recent decades. Although documented changes in global surface temperatures during the Holocene and Common era are relatively small, the concomitant changes in OHC are large.	[Rosenthal, Yair] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rosenthal, Yair] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08901 USA; [Linsley, Braddock K.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Oppo, Delia W.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University; Woods Hole Oceanographic Institution	Rosenthal, Y (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	rosentha@imcs.rutgers.edu		Linsley, Braddock/0000-0003-2085-0662	Center of Research and Development for Oceanography (LIPI) of Indonesia; NSF	Center of Research and Development for Oceanography (LIPI) of Indonesia; NSF(National Science Foundation (NSF))	We are indebted to Y. S. Djajadihardja, F. Syamsudin, the captain and crew of our 2003 R/V Baruna Jaya VIII cruise, the Indonesian Agency for Assessment and Application of Technology (BPPT), and the Center of Research and Development for Oceanography (LIPI) of Indonesia for their support of this project. This work was also supported by the NSF. We thank M. Chong, K. Esswein, A. Morely, S. Woodard, and S. Howe for technical assistance; A. L. Gordon for helpful discussions; and the National Ocean Sciences Accelerator Mass Spectrometry and Radio analytical facilities at Woods Hole Oceanographic Institution. Helpful comments from reviewers are highly appreciated.	Bostock HC, 2013, QUATERNARY SCI REV, V74, P35, DOI 10.1016/j.quascirev.2012.07.018; Dang H., 2011, GEOPHYS RES LETT, V39, P1; Easterling DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037810; FINE RA, 1994, J GEOPHYS RES-OCEANS, V99, P25063, DOI 10.1029/94JC02277; Gordon A.L, 2005, OCEANOGRAPHY, V18, P15, DOI [10.5670/oceanog.2005.01, DOI 10.5670/OCEANOG.2005.01]; Hansen J, 2005, SCIENCE, V308, P1431, DOI 10.1126/science.1110252; Leduc G, 2010, QUATERNARY SCI REV, V29, P989, DOI 10.1016/j.quascirev.2010.01.004; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Linsley BK, 2010, NAT GEOSCI, V3, P578, DOI [10.1038/NGEO920, 10.1038/ngeo920]; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Masson V, 2000, QUATERNARY RES, V54, P348, DOI 10.1006/qres.2000.2172; Mauritzen C, 2012, NAT GEOSCI, V5, P905, DOI [10.1038/NGEO1639, 10.1038/ngeo1639]; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Mohtadi M, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002132; Morley A, 2011, EARTH PLANET SC LETT, V308, P161, DOI 10.1016/j.epsl.2011.05.043; Oppo DW, 2009, NATURE, V460, P1113, DOI 10.1038/nature08233; Orsi AJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051260; Rosenthal Y, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003333; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Sprintall J, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005257; Steinke S, 2011, GLOBAL PLANET CHANGE, V78, P170, DOI 10.1016/j.gloplacha.2011.06.006; Talley LD, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002826; Wanner H, 2008, QUATERNARY SCI REV, V27, P1791, DOI 10.1016/j.quascirev.2008.06.013; Wijffels S, 2002, DEEP-SEA RES PT II, V49, P1341, DOI 10.1016/S0967-0645(01)00155-2; Xu J, 2008, EARTH PLANET SC LETT, V273, P152, DOI 10.1016/j.epsl.2008.06.029; Zenk W, 2005, PROG OCEANOGR, V67, P245, DOI 10.1016/j.pocean.2005.05.003	29	59	59	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					617	621		10.1126/science.1240837	http://dx.doi.org/10.1126/science.1240837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179224				2022-12-28	WOS:000326334300048
J	Zatorre, RJ				Zatorre, Robert J.			Predispositions and Plasticity in Music and Speech Learning: Neural Correlates and Implications	SCIENCE			English	Review							HUMAN AUDITORY-CORTEX; VENTRAL LANGUAGE PATHWAY; FUNCTIONAL PLASTICITY; STRUCTURE PREDICTS; BRAIN PLASTICITY; HESCHLS GYRUS; SOUNDS; PERFORMANCE; ACTIVATION; SUCCESS	Speech and music are remarkable aspects of human cognition and sensory-motor processing. Cognitive neuroscience has focused on them to understand how brain function and structure are modified by learning. Recent evidence indicates that individual differences in anatomical and functional properties of the neural architecture also affect learning and performance in these domains. Here, neuroimaging findings are reviewed that reiterate evidence of experience-dependent brain plasticity, but also point to the predictive validity of such data in relation to new learning in speech and music domains. Indices of neural sensitivity to certain stimulus features have been shown to predict individual rates of learning; individual network properties of brain activity are especially relevant in this regard, as they may reflect anatomical connectivity. Similarly, numerous studies have shown that anatomical features of auditory cortex and other structures, and their anatomical connectivity, are predictive of new sensory-motor learning ability. Implications of this growing body of literature are discussed.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Zatorre, RJ (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	robert.zatorre@mcgill.ca			Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Fund for Innovation; Fonds de Recherche Nature et Technologies/Societe et Culture via Centre for Research in Brain, Language and Music	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Fund for Innovation(Canada Foundation for Innovation); Fonds de Recherche Nature et Technologies/Societe et Culture via Centre for Research in Brain, Language and Music	I thank all the authors who shared their materials for figures. I acknowledge support from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, the Canada Fund for Innovation, and the Fonds de Recherche Nature et Technologies/Societe et Culture via its funding of the Centre for Research in Brain, Language and Music.	Alain C, 2007, CEREB CORTEX, V17, P1074, DOI 10.1093/cercor/bhl018; Baldassarre A, 2012, P NATL ACAD SCI USA, V109, P3516, DOI 10.1073/pnas.1113148109; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Callan DE, 2003, NEUROIMAGE, V19, P113, DOI 10.1016/S1053-8119(03)00020-X; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Ellis RJ, 2012, NEUROIMAGE, V60, P1902, DOI 10.1016/j.neuroimage.2012.01.138; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Garrett DD, 2013, CEREB CORTEX, V23, P684, DOI 10.1093/cercor/bhs055; Gaser C, 2003, J NEUROSCI, V23, P9240; Golestani N, 2004, NEUROIMAGE, V21, P494, DOI 10.1016/j.neuroimage.2003.09.071; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Golestani N, 2007, CEREB CORTEX, V17, P929, DOI 10.1093/cercor/bhl003; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; Golestani N, 2011, J NEUROSCI, V31, P4213, DOI 10.1523/JNEUROSCI.3891-10.2011; Golestani N, 2009, BRAIN LANG, V109, P55, DOI 10.1016/j.bandl.2008.01.005; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Jancke L, 2001, COGNITIVE BRAIN RES, V12, P479, DOI 10.1016/S0926-6410(01)00092-1; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Koelsch S, 2005, NEUROIMAGE, V25, P1068, DOI 10.1016/j.neuroimage.2004.12.050; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lopez-Barroso D, 2013, P NATL ACAD SCI USA, V110, P13168, DOI 10.1073/pnas.1301696110; Lopez-Barroso D, 2011, CEREB CORTEX, V21, P2742, DOI 10.1093/cercor/bhr064; Margulis EH, 2009, HUM BRAIN MAPP, V30, P267, DOI 10.1002/hbm.20503; Menning H, 2002, LEARN MEMORY, V9, P253, DOI 10.1101/lm.49402; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Opitz B, 2003, NEUROIMAGE, V19, P1730, DOI 10.1016/S1053-8119(03)00170-8; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Penhune VB, 2011, CORTEX, V47, P1126, DOI 10.1016/j.cortex.2011.05.010; Pruitt JS, 2006, J ACOUST SOC AM, V119, P1684, DOI 10.1121/1.2161427; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Ressel V, 2012, J NEUROSCI, V32, P16597, DOI 10.1523/JNEUROSCI.1996-12.2012; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Shahin A, 2003, J NEUROSCI, V23, P5545; Song JH, 2012, CEREB CORTEX, V22, P1180, DOI 10.1093/cercor/bhr196; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Ventura-Campos N, 2013, J NEUROSCI, V33, P9295, DOI 10.1523/JNEUROSCI.4655-12.2013; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805; Warren JE, 2005, TRENDS NEUROSCI, V28, P636, DOI 10.1016/j.tins.2005.09.010; Wong FCK, 2011, J NEUROSCI, V31, P8780, DOI 10.1523/JNEUROSCI.0999-11.2011; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Wong PCM, 2007, HUM BRAIN MAPP, V28, P995, DOI 10.1002/hbm.20330; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; Zarate JM, 2008, NEUROIMAGE, V40, P1871, DOI 10.1016/j.neuroimage.2008.01.026; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zatorre RJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00544; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	64	99	102	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					585	589		10.1126/science.1238414	http://dx.doi.org/10.1126/science.1238414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179219				2022-12-28	WOS:000326334300038
J	Vincent, JL; De Backer, D				Vincent, Jean-Louis; De Backer, Daniel			Circulatory Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SEPTIC SHOCK; SEVERE SEPSIS; MICROCIRCULATORY ALTERATIONS; NOREPINEPHRINE; DOPAMINE; RESUSCITATION; FLUID; VASOPRESSIN; EPINEPHRINE; DOBUTAMINE	Circulatory shock is present when physical signs and changes in laboratory values suggest tissue hypoperfusion. This article in the Critical Care Medicine series reviews the diagnosis and treatment of various forms of shock. Shock is the clinical expression of circulatory failure that results in inadequate cellular oxygen utilization. Shock is a common condition in critical care, affecting about one third of patients in the intensive care unit (ICU).(1) A diagnosis of shock is based on clinical, hemodynamic, and biochemical signs, which can broadly be summarized into three components. First, systemic arterial hypotension is usually present, but the magnitude of the hypotension may be only moderate, especially in patients with chronic hypertension. Typically, in adults, the systolic arterial pressure is less than 90 mm Hg or the mean arterial pressure is less than 70 ...	[Vincent, Jean-Louis; De Backer, Daniel] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium	Universite Libre de Bruxelles	Vincent, JL (corresponding author), Erasme Univ Hosp, Dept Intens Care, Rte Lennik 808, B-1070 Brussels, Belgium.	jlvincen@ulb.ac.be	De Backer, Daniel/AAF-4177-2020; Rodrigues, Alfredo/C-3426-2013; Soong, John Tshon Yit/I-2008-2018	De Backer, Daniel/0000-0001-9841-5762; Rodrigues, Alfredo/0000-0002-0654-2893; Soong, John Tshon Yit/0000-0003-4235-8505; Vincent, Jean-Louis/0000-0001-6011-6951				Annane D, 2007, LANCET, V370, P676, DOI 10.1016/S0140-6736(07)61344-0; Bellomo R, 2000, LANCET, V356, P2139; Cavallaro F, 2010, INTENS CARE MED, V36, P1475, DOI 10.1007/s00134-010-1929-y; Combes A, 2008, CRIT CARE MED, V36, P1404, DOI 10.1097/CCM.0b013e31816f7cf7; Correa TD, 2012, CRIT CARE MED, V40, P2841, DOI 10.1097/CCM.0b013e31825b916b; Creteur J, 2007, INTENS CARE MED, V33, P1549, DOI 10.1007/s00134-007-0739-3; De Backer D, 2006, CRIT CARE MED, V34, P403, DOI 10.1097/01.CCM.0000198107.61493.5A; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; De Backer D, 2012, CRIT CARE MED, V40, P725, DOI 10.1097/CCM.0b013e31823778ee; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Delaney AP, 2011, CRIT CARE MED, V39, P386, DOI 10.1097/CCM.0b013e3181ffe217; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Gomez H, 2008, INTENS CARE MED, V34, P1600, DOI 10.1007/s00134-008-1145-1; Hochman JS, 2007, JAMA-J AM MED ASSOC, V297, P1657; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Labovitz AJ, 2010, J AM SOC ECHOCARDIOG, V23, P1225, DOI 10.1016/j.echo.2010.10.005; Levy B, 2011, CRIT CARE MED, V39, P450, DOI 10.1097/CCM.0b013e3181ffe0eb; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Marik PE, 2009, CRIT CARE MED, V37, P2642, DOI 10.1097/CCM.0b013e3181a590da; Myburgh JA, 2013, NEW ENGL J MED, V369, P1243, DOI 10.1056/NEJMra1208627; Myburgh JA, 2008, INTENS CARE MED, V34, P2226, DOI 10.1007/s00134-008-1219-0; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2007, CRIT CARE MED, V35, P2016, DOI 10.1097/01.CCM.0000281637.08984.6E; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Russell JA, 2009, CRIT CARE MED, V37, P811, DOI 10.1097/CCM.0b013e3181961ace; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Sakr Y, 2006, CRIT CARE MED, V34, P589, DOI 10.1097/01.CCM.0000201896.45809.E3; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Vincent JL, 2012, CRIT CARE, V16, DOI 10.1186/cc11510; Vincent JL, 2011, CRIT CARE, V15, DOI 10.1186/cc10291; Vincent JL, 2008, CRIT CARE, V12, DOI 10.1186/cc6975; VINCENT JL, 1983, CRIT CARE MED, V11, P449, DOI 10.1097/00003246-198306000-00012; Vincent JL, 2006, CRIT CARE MED, V34, P1333, DOI 10.1097/01.CCM.0000214677.76535.A5; Weil M H, 1971, Adv Exp Med Biol, V23, P13; WEIL MH, 1969, J AMER MED ASSOC, V207, P337, DOI 10.1001/jama.207.2.337	35	639	734	6	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1726	1734		10.1056/NEJMra1208943	http://dx.doi.org/10.1056/NEJMra1208943			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24171518				2022-12-28	WOS:000326311300010
J	Wright, J				Wright, Jessica			SURGERY The eyes of the operation	NATURE			English	Editorial Material							TRACTOGRAPHY											Golby AJ, 2011, NEUROSURGERY, V68, P496, DOI 10.1227/NEU.0b013e3182061ebb; Milot L, 2010, RADIOLOGY, V254, P747, DOI 10.1148/radiol.09090508; Winston GP, 2011, EPILEPSIA, V52, P1430, DOI 10.1111/j.1528-1167.2011.03088.x	3	2	2	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S88	S89		10.1038/502S88a	http://dx.doi.org/10.1038/502S88a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187702	Bronze			2022-12-28	WOS:000326293200005
J	Knapp, M; King, D; Romeo, R; Schehl, B; Barber, J; Griffin, M; Rapaport, P; Livingston, D; Mummery, C; Walker, Z; Hoe, J; Sampson, EL; Cooper, C; Livingston, G				Knapp, Martin; King, Derek; Romeo, Renee; Schehl, Barbara; Barber, Julie; Griffin, Mark; Rapaport, Penny; Livingston, Debbie; Mummery, Cath; Walker, Zuzana; Hoe, Juanita; Sampson, Elizabeth L.; Cooper, Claudia; Livingston, Gill			Cost effectiveness of a manual based coping strategy programme in promoting the mental health of family carers of people with dementia (the START (STrAtegies for RelaTives) study): a pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; CAREGIVERS; DEPRESSION; ANXIETY	Objective To assess whether the START (STrAtegies for RelatTives) intervention added to treatment as usual is cost effective compared with usual treatment alone. Design Cost effectiveness analysis nested within a pragmatic randomised controlled trial. Setting Three mental health and one neurological outpatient dementia service in London and Essex, UK. Participants Family carers of people with dementia. Intervention Eight session, manual based, coping intervention delivered by supervised psychology graduates to family carers of people with dementia added to usual treatment, compared with usual treatment alone. Primary outcome measures Costs measured from a health and social care perspective were analysed alongside the Hospital Anxiety and Depression Scale total score (HADS- T) of affective symptoms and quality adjusted life years (QALYs) in cost effectiveness analyses over eight months from baseline. Results Of the 260 participants recruited to the study, 173 were randomised to the START intervention, and 87 to usual treatment alone. Mean HADS-T scores were lower in the intervention group than the usual treatment group over the 8 month evaluation period (mean difference -1.79 (95% CI -3.32 to -0.33)), indicating better outcomes associated with the START intervention. There was a small improvement in health related quality of life as measured by QALYs (0.03 (-0.01 to 0.08)). Costs were no different between the intervention and usual treatment groups (252 pound (-28 to 565) higher for START group). The cost effectiveness calculations suggested that START had a greater than 99% chance of being cost effective compared with usual treatment alone at a willingness to pay threshold of 30 pound 000 per QALY gained, and a high probability of cost effectiveness on the HADS-T measure. Conclusions The manual based coping intervention START, when added to treatment as usual, was cost effective compared with treatment as usual alone by reference to both outcome measures (affective symptoms for family carers, and carer based QALYs).	[Knapp, Martin; King, Derek] London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London WC2A 2AE, England; [Knapp, Martin; Romeo, Renee] Kings Coll London, Inst Psychiat, Ctr Econ Mental & Phys Hlth, London SE5 8AF, England; [Barber, Julie] UCL, Dept Stat Sci, London WC1E 6BT, England; [Barber, Julie] UCL, PRIMENT Clin Trials Unit, London WC1E 6BT, England; [Griffin, Mark] Royal Free Hosp, Inst Epidemiol & Hlth, London NW3 2PF, England; [Rapaport, Penny] Camden & Islington NHS Fdn Trust, London N19 4PJ, England; [Livingston, Debbie; Mummery, Cath; Walker, Zuzana; Hoe, Juanita; Sampson, Elizabeth L.; Cooper, Claudia; Livingston, Gill] UCL, Mental Hlth Sci Unit, London W1W 7EJ, England	University of London; London School Economics & Political Science; University of London; King's College London; University of London; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London	Knapp, M (corresponding author), London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London WC2A 2AE, England.	m.knapp@lse.ac.uk	Walker, Zuzana/B-8339-2009; Cooper, Claudia A/C-1556-2008; Hoe, Juanita/C-5641-2008; Livingston, G/C-7081-2008; Romeo, Renee/E-3261-2010; Hoe, Juanita/ABA-6310-2020; Sampson, Elizabeth L/B-8647-2009	Walker, Zuzana/0000-0001-7346-8200; Cooper, Claudia A/0000-0002-2777-7616; Hoe, Juanita/0000-0003-4647-8950; Romeo, Renee/0000-0003-3871-9697; Hoe, Juanita/0000-0003-4647-8950; Sampson, Elizabeth L/0000-0001-8929-7362; Livingston, Gill/0000-0001-6741-5516; Barber, Julie/0000-0001-5762-762X; Knapp, Martin/0000-0003-1427-0215; Rapaport, Penny/0000-0003-0479-6950	National Institute of Health Research (NIHR), HTA Programme [08/14/06]; University College London; National Institute for Health Research [08/14/06, 08/14/99] Funding Source: researchfish	National Institute of Health Research (NIHR), HTA Programme; University College London(General Electric); National Institute for Health Research(National Institute for Health Research (NIHR))	The project was funded by the National Institute of Health Research (NIHR), HTA Programme (project No 08/14/06) and will be published in full in Health Technology Assessment (see HTA Programme website for further information). The authors analysed results and prepared this manuscript independently of the funding body. Views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA Programme, NIHR, National Health Service, or the Department of Health. The study was sponsored by University College London. Neither funders nor sponsors had a role in: study design; collection, analysis, and interpretation of data; writing of the article; or the decision to submit it for publication. The researchers were independent from funders and sponsors. All researchers could access all the data.	[Anonymous], 2011, STAT STAT SOFTW REL; Beecham J., 2001, MEASURING MENTAL HLT, P200; Briggs A, 2000, BRIT MED J, V321, P1362, DOI 10.1136/bmj.321.7273.1362; Coen RF, 2002, DEMENT GERIATR COGN, V13, P164, DOI 10.1159/000048648; Comas-Herrera A, 2007, INT J GERIATR PSYCH, V22, P1037, DOI 10.1002/gps.1830; Coon DW, 2003, GERONTOLOGIST, V43, P678, DOI 10.1093/geront/43.5.678; Cooper C, 2008, J NERV MENT DIS, V196, P838, DOI 10.1097/NMD.0b013e31818b504c; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Curtis LA, 2010, UN COSTS HLTH SOC CA; Davies B., 2000, EQUITY EFFICIENCY PO; Department of Health, 2010, NAT HLTH SERV SCHED; Department of Health, 2010, REC VAL SUPP NEXT ST; Department of Health, 2009, CAR CAR NAT STRAT CA; Department of Health, 2009, LIVING WELL DEMENTIA; DOLAN P, 1995, 138 U YORK; Gallagher-Thompson D., 2002, COPING CAREGIVING RE; Gonyea Judith G, 2005, Am J Alzheimers Dis Other Demen, V20, P273, DOI 10.1177/153331750502000505; Knapp M, 2013, INT J GERIATR PSYCH, V28, P551, DOI 10.1002/gps.3864; Livingston G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6276; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; MITTELMAN MS, 1995, GERONTOLOGIST, V35, P792, DOI 10.1093/geront/35.6.792; National Institute for Health and Clinical Excellence, 2008, GUID METH TECHN APPR; National Institute for Health and Clinical Excellence and the Social Care Institute for Excellence, 2006, NICE CLIN GUID; Nichols LO, 2008, J AM GERIATR SOC, V56, P413, DOI 10.1111/j.1532-5415.2007.01569.x; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Thompson SG, 2000, BMJ-BRIT MED J, V320, P7243; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	45	45	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2013	347								f6342	10.1136/bmj.f6342	http://dx.doi.org/10.1136/bmj.f6342			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243CM	24162943	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000326294200008
J	Paerl, HW; Otten, TG				Paerl, Hans W.; Otten, Timothy G.			Blooms Bite the Hand That Feeds Them	SCIENCE			English	Editorial Material							DISSOLVED ORGANIC-CARBON; PATTERNS; SURFACE		[Paerl, Hans W.; Otten, Timothy G.] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA; [Otten, Timothy G.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	University of North Carolina; University of North Carolina Chapel Hill; Oregon State University	Paerl, HW (corresponding author), Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA.	hans_paerl@unc.edu						Bade DL, 2007, BIOGEOCHEMISTRY, V84, P115, DOI 10.1007/s10533-006-9013-y; Bozarth CS, 2010, APPL ENVIRON MICROB, V76, P5207, DOI 10.1128/AEM.00001-10; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; COOPER WJ, 1983, SCIENCE, V220, P711, DOI 10.1126/science.220.4598.711; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Evans CD, 2005, ENVIRON POLLUT, V137, P55, DOI 10.1016/j.envpol.2004.12.031; Hanson PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021884; Horner-Devine MC, 2003, ECOL LETT, V6, P613; Kardinaal WEA, 2007, APPL ENVIRON MICROB, V73, P2939, DOI 10.1128/AEM.02892-06; Lee DY, 1997, J PHYCOL, V33, P991, DOI 10.1111/j.0022-3646.1997.00991.x; Otten TG, 2012, ENVIRON SCI TECHNOL, V46, P3480, DOI 10.1021/es2041288; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	15	141	155	7	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					433	434		10.1126/science.1245276	http://dx.doi.org/10.1126/science.1245276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159037				2022-12-28	WOS:000326042600030
J	Savulescu, J; Creaney, L; Vondy, A				Savulescu, Julian; Creaney, Leon; Vondy, Anna			Should athletes be allowed to use performance enhancing drugs?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE; EXERCISE; ABUSE		[Savulescu, Julian] Univ Oxford, Oxford, England; [Creaney, Leon] Univ Hosp Birmingham, Birmingham, W Midlands, England; [Vondy, Anna] Royal Liverpool Univ Hosp, Emergency Dept, Salisbury, Merseyside, England	University of Oxford; University of Birmingham; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Savulescu, J (corresponding author), Univ Oxford, Oxford, England.	julian.savulescu@philosophy.ox.ac.uk; leon.creaney@uhb.nhs.uk						Bonetti A, 2008, INT J SPORTS MED, V29, P679, DOI 10.1055/s-2007-965808; Bowers LD., WITNESS STATEMENT US; Bronstein AC, 2012, CLIN TOXICOL, V50, P911, DOI 10.3109/15563650.2012.746424; Di Luigi L, 2010, J SEX MED, V7, P2591, DOI 10.1111/j.1743-6109.2009.01694.x; Drepper D, 2013, SPIEGEL INT     0903; Eriksson A, 2005, HISTOCHEM CELL BIOL, V124, P167, DOI 10.1007/s00418-005-0029-5; ERIKSSON A, 2006, STRENGTH TRAINING AN; Garevik N, 2011, J STEROID BIOCHEM, V127, P295, DOI 10.1016/j.jsbmb.2011.08.005; Goodbody J., 1998, TIMES; Hamilton T., 2012, SECRET RACE INSIDE H; Hermann A, 2013, CONVERSATION; Kirk J, 2012, ARCH DIS CHILD, V97, P63, DOI 10.1136/adc.2010.186205; Laure P, 2007, BRIT J SPORT MED, V41, P660, DOI 10.1136/bjsm.2007.035733; Lopez B, 2011, SPORT HIST, V31, P84, DOI 10.1080/17460263.2011.555208; Lucia A, 2001, BRIT J SPORT MED, V35, P424, DOI 10.1136/bjsm.35.6.424; Marijon E, 2013, EUR HEART J; Robson D., 2010, CBC SPORTS      0604; SCOTT WC, 1990, JAMA-J AM MED ASSOC, V264, P1660, DOI 10.1001/jama.1990.03450130030017; Shermer M, 2008, SCI AM, V298, P82, DOI 10.1038/scientificamerican0408-82; SMITH JA, 1995, SPORTS MED, V19, P9, DOI 10.2165/00007256-199519010-00002; Staunton P., 2013, GOAL            0502; World Anti Doping Agency, 2011, QUEST ANSW EPO DET	22	9	9	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6150	10.1136/bmj.f6150	http://dx.doi.org/10.1136/bmj.f6150			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CI	24149520				2022-12-28	WOS:000326293800006
J	Zenner, D; Zumla, A; Gill, P; Cosford, P; Abubakar, I				Zenner, Dominik; Zumla, Alimuddin; Gill, Paramjit; Cosford, Paul; Abubakar, Ibrahim			Reversing the tide of the UK tuberculosis epidemic	LANCET			English	Editorial Material							LATENT TUBERCULOSIS; IMMIGRANTS		[Zenner, Dominik; Abubakar, Ibrahim] Publ Hlth England, TB Sect, Ctr Infect Dis Surveillance & Control, London NW9 5EQ, England; [Zenner, Dominik; Abubakar, Ibrahim] UCL, Res Dept Infect & Populat Hlth, London, England; [Cosford, Paul] Publ Hlth England, Hlth Protect & Med Directorate, London NW9 5EQ, England; [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England; [Gill, Paramjit] Univ Birmingham, Birmingham, W Midlands, England	Public Health England; University of London; University College London; Public Health England; University of London; University College London; University of Birmingham	Zenner, D (corresponding author), Publ Hlth England, TB Sect, Ctr Infect Dis Surveillance & Control, London NW9 5EQ, England.	dominik.zenner@phe.gov.uk	ZUMLA, Alimuddin/ABA-8208-2020; Zenner, Dominik/AAF-5134-2019	ZUMLA, Alimuddin/0000-0002-5111-5735; Abubakar, Ibrahim/0000-0002-0370-1430; Zenner, Dominik/0000-0002-9200-6180	Department of Health [08/68/01] Funding Source: Medline; National Institute for Health Research [08/68/01] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Abubakar I, 2012, LANCET, V379, pE21, DOI 10.1016/S0140-6736(11)61428-1; [Anonymous], 2013, TUB UK 2013 REP; Brewin P, 2006, J PUBLIC HEALTH-UK, V28, P253, DOI 10.1093/pubmed/fdl031; European Centre for Disease Prevention and Control WHO Regional Office for Europe, 2013, TUB SURV MON EUR 201; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; National Institute for Health and Clinical Excellence, 2011, TUB CLIN DIAGN MAN T; Pareek M, 2011, EUR RESPIR J, V37, P1175, DOI 10.1183/09031936.00105810; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Smieja M, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001363; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Zumla A, 2011, LANCET, V377, P10, DOI 10.1016/S0140-6736(10)62176-9	12	16	16	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1311	1312		10.1016/S0140-6736(13)62113-3	http://dx.doi.org/10.1016/S0140-6736(13)62113-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	24139110				2022-12-28	WOS:000325975700004
J	Saliba, F; Camus, C; Durand, F; Mathurin, P; Letierce, A; Delafosse, B; Barange, K; Perrigault, PF; Belnard, M; Ichai, P; Samuel, D				Saliba, Faouzi; Camus, Christophe; Durand, Francois; Mathurin, Philippe; Letierce, Alexia; Delafosse, Bertrand; Barange, Karl; Perrigault, Pierre Francois; Belnard, Magali; Ichai, Philippe; Samuel, Didier			Albumin Dialysis With a Noncell Artificial Liver Support Device in Patients With Acute Liver Failure	ANNALS OF INTERNAL MEDICINE			English	Article							ADSORBENT RECIRCULATING SYSTEM; FULMINANT HEPATIC-FAILURE; BIOARTIFICIAL LIVER; CONTROLLED-TRIAL; TRANSPLANTATION; IMPACT	Background: Albumin dialysis with the Molecular Adsorbent Recirculating System (MARS) (Gambro, Lund, Sweden), a noncell artificial liver support device, may be beneficial in acute liver failure (ALF). Objective: To determine whether MARS improves survival in ALF. Design: Randomized, controlled trial. (ClinicalTrials.gov: NCT00224705) Setting: 16 French liver transplantation centers. Patients: 102 patients with ALF. Intervention: Conventional treatment (n = 49) or MARS with conventional treatment (n = 53), stratified according to whether paracetamol caused ALF. Measurements: 6-month survival and secondary end points, including adverse events. Results: 102 patients (mean age, 40.4 years [SD, 13]) were in the modified intention-to-treat (mITT) population. The per-protocol analysis (49 conventional, 39 MARS) included patients with at least 1 session of MARS of 5 hours or more. Six-month survival was 75.5% (95% CI, 60.8% to 86.2%) with conventional treatment and 84.9% (CI, 71.9% to 92.8%) with MARS (P = 0.28) in the mITT population and 75.5% (CI, 60.8% to 86.2%) with conventional treatment and 82.9% (CI, 65.9% to 91.9%) with MARS (P = 0.50) in the per-protocol population. In patients with paracetamol-related ALF, the 6-month survival rate was 68.4% (CI, 43.5% to 86.4%) with conventional treatment and 85.0% (CI, 61.1% to 96.0%) with MARS (P = 0.46) in the mITT population. Sixty-six of 102 patients had transplantation (41.0% among paracetamol-induced ALF; 79.4% among non-paracetamol-induced ALF) (P < 0.001). Adverse events did not significantly differ between groups. Limitation: The short delay from randomization to liver transplantation (median, 16.2 hours) precludes definitive efficacy or safety evaluations. Conclusion: This randomized trial of MARS in patients with ALF was unable to provide definitive efficacy or safety conclusions because many patients had transplantation before administration of the intervention. Acute liver failure not caused by paracetamol was associated with greater 6-month patient survival.	Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, F-94804 Villejuif, France; Univ Paris 11, Paris, France; Inst Natl Sante & Rech Med 785, Paris, France; Hop Pontchaillou, Ctr Hosp Univ, Rennes, France; Hop Beaujon, AP HP, Clichy, France; Hop Claude Huriez, Ctr Hosp Univ, Lille, France; Hop Bicetre, AP HP, Unite Rech Clin Paris Sud, Le Kremlin Bicetre, France; Hop Edouard Herriot, Ctr Hosp Univ, Lyon, France; Hop Purpan, Ctr Hosp Univ, Toulouse, France; Hop St Eloi, Ctr Hosp Univ, Montpellier, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon; CHU de Toulouse; Universite de Montpellier; CHU de Montpellier	Saliba, F (corresponding author), Hop Paul Brousse, Ctr Hepatobiliaire, 12 Ave Paul Vaillant Couturier, F-94804 Villejuif, France.	faouzi.saliba@pbr.aphp.fr	Mathurin, Philippe/A-9121-2018; SALIBA, Faouzi/T-7456-2018; ICHAI, Philippe/T-7435-2018	Mathurin, Philippe/0000-0003-3447-2025; LETIERCE, Alexia/0000-0001-6679-5772; Durand, Francois/0000-0002-0357-1090	Assistance Publique-Hopitaux de Paris	Assistance Publique-Hopitaux de Paris	By Assistance Publique-Hopitaux de Paris.	Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7; BERNUAU J, 1986, HEPATOLOGY, V6, P648, DOI 10.1002/hep.1840060417; BERNUAU J, 1986, SEMIN LIVER DIS, V6, P97, DOI 10.1055/s-2008-1040593; BISMUTH H, 1987, ANN INTERN MED, V107, P337, DOI 10.7326/0003-4819-107-2-337; Camus C, 2009, THER APHER DIAL, V13, P549, DOI 10.1111/j.1744-9987.2009.00708.x; Demetriou AA, 2004, ANN SURG, V239, P660, DOI 10.1097/01.sla.0000124298.74199.e5; Felldin M, 2003, TRANSPLANT P, V35, P822, DOI 10.1016/S0041-1345(03)00086-1; Katoonizadeh A, 2007, LIVER INT, V27, P329, DOI 10.1111/j.1478-3231.2006.01429.x; Lai WK, 2005, INTENS CARE MED, V31, P1544, DOI 10.1007/s00134-005-2786-y; Millis JM, 2002, TRANSPLANTATION, V74, P1735, DOI 10.1097/01.TP.0000038483.93833.21; Mitzner S, 2006, THER APHER DIAL, V10, P108, DOI 10.1111/j.1744-9987.2006.00351.x; Novelli G, 2009, THER APHER DIAL, V13, P404, DOI 10.1111/j.1744-9987.2009.00759.x; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Polson J, 2005, HEPATOLOGY, V41, P1179, DOI 10.1002/hep.20703; Samuel D, 2003, TRANSPLANTATION, V75, P1769, DOI 10.1097/01.TP.0000065018.51103.0C; Samuel D, 2002, TRANSPLANTATION, V73, P257, DOI 10.1097/00007890-200201270-00019; Schmidt LE, 2003, LIVER TRANSPLANT, V9, P290, DOI 10.1053/jlts.2003.50051; Stange J, 1993, ASAIO J, V39, pM621; Tsai MH, 2005, INT J CLIN PRACT, V59, P1289, DOI 10.1111/j.1742-1241.2005.00604.x	20	143	156	0	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					522	+		10.7326/0003-4819-159-8-201310150-00005	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126646				2022-12-28	WOS:000326751200015
J	Theron, G; Zijenah, L; Chanda, D; Clowes, P; Rachow, A; Lesosky, M; Bara, W; Mungofa, S; Pai, M; Hoelscher, M; Dowdy, D; Pym, A; Mwaba, P; Mason, P; Peter, J; Dheda, K				Theron, Grant; Zijenah, Lynn; Chanda, Duncan; Clowes, Petra; Rachow, Andrea; Lesosky, Maia; Bara, Wilbert; Mungofa, Stanley; Pai, Madhukar; Hoelscher, Michael; Dowdy, David; Pym, Alex; Mwaba, Peter; Mason, Peter; Peter, Jonny; Dheda, Keertan		TB-NEAT Team	Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial	LANCET			English	Article							PULMONARY TUBERCULOSIS; POTENTIAL IMPACT; SOUTH-AFRICA; DIAGNOSIS; RESISTANCE; HIV; IMPLEMENTATION	Background The Xpert MTB/RIF test for tuberculosis is being rolled out in many countries, but evidence is lacking regarding its implementation outside laboratories, ability to inform sameday treatment decisions at the point of care, and clinical effect on tuberculosis-related morbidity. We aimed to assess the feasibility, accuracy, and clinical effect of point of care Xpert MTB/RIF testing at primary care healthcare facilities in southern Africa. Methods In this pragmatic, randomised, parallel-group, multicentre trial, we recruited adults with symptoms suggestive of active tuberculosis from five primary-care healthcare facilities in South Africa, Zimbabwe, Zambia, and Tanzania. Eligible patients were randomly assigned using pregenerated tables to nurse-performed Xpert MTB/RIF at the clinic or sputum smear microscopy. Participants with a negative test result were empirically managed according to local WHO-compliant guidelines. Our primary outcome was tuberculosis-related morbidity (measured with the TBscore and Karnofsky performance score [KPS]) in culture-positive patients who had begun anti-tuberculosis treatment, measured at 2 months and 6 months after randomisation, analysed by intention to treat. This trial is registered with Clinicaltrials.gov, number NCT01554384. Findings Between April 12, 2011, and March 30, 2012, we randomly assigned 758 patients to smear microscopy (182 culture positive) and 744 to Xpert MTB/RIF (185 culture positive). Median TBscore in culture-positive patients did not differ between groups at 2 months (2 [IQR0-3] in the smear microscopy group vs 2 [0.253] in the MTB/RIF group; p=0.85) or 6 months (1 [03] vs 1 [03]; p=0.35), nor did median KPS at 2 months (80 [7090] vs 90 [8090]; p=0.23) or 6 months (100 [90100] vs 100 [90100]; p=0.85). Pointofcare MTB/RIF had higher sensitivity than microscopy (154 [83%] of 185 vs 91 [50%] of 182; p=0.0001) but similar specificity (517 [95%] 544 vs 540 [96%] of 560; p=0.25), and had similar sensitivity to laboratory-based MTB/RIF (292 [83%] of 351; p=0.99) but higher specificity (952 [92%] of 1037; p=0.0173). 34 (5%) of 744 tests with point-of-care MTB/RIF and 82 (6%) of 1411 with laboratory-based MTB/RIF failed (p=0.22). Compared with the microscopy group, more patients in the MTB/RIF group had a sameday diagnosis (178 [24%] of 744 vs 99 [13%] of 758; p<0.0001) and sameday treatment initiation (168 [23%] of 744 vs 115 [15%] of 758; p=0.0002). Although, by end of the study, more culture-positive patients in the MTB/RIF group were on treatment due to reduced dropout (15 [8%] of 185 in the MTB/RIF group did not receive treatment vs 28 [15%] of 182 in the microscopy group; p=0.0302), the proportions of all patients on treatment in each group by day 56 were similar (320 [43%] of 744 in the MTB/RIF group vs 317 [42%] of 758 in the microscopy group; p=0.6408). Interpretation Xpert MTB/RIF can be accurately administered by a nurse in primary-care clinics, resulting in more patients starting sameday treatment, more culture-positive patients starting therapy, and a shorter time to treatment. However, the benefits did not translate into lower tuberculosis-related morbidity, partly because of high levels of empirical-evidence-based treatment in smear-negative patients.	[Theron, Grant; Lesosky, Maia; Peter, Jonny] Dept Med, Div Pulmonol, Lung Infect & Immun Unit, Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Zijenah, Lynn] Univ Zimbabwe, Coll Hlth Sci, Dept Immunol, Harare, Zimbabwe; [Chanda, Duncan; Mwaba, Peter] Univ Teaching Hosp, Lusaka, Zambia; [Clowes, Petra] Natl Inst Med Res, Mbeya Med Res Ctr, Mbeya, Tanzania; [Clowes, Petra; Rachow, Andrea; Hoelscher, Michael] Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany; [Rachow, Andrea; Hoelscher, Michael] German Ctr Infect Res DZIF, Munich, Germany; [Bara, Wilbert; Mungofa, Stanley] City Harare Hlth Serv, Harare, Zimbabwe; [Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Dowdy, David] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Pym, Alex] MRC, Durban, South Africa; [Pym, Alex] KwaZulu Res Inst TB & HIV K RITH, Durban, South Africa; [Mason, Peter] Biomed Res & Training Inst, Harare, Zimbabwe	University of Cape Town; University of Cape Town; University of Zimbabwe; University of Zambia; National Institute of Medical Research; University of Munich; German Center for Infection Research; McGill University; McGill University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Biomedical Research Training Institute	Dheda, K (corresponding author), Groote Schuur Hosp, Main Bldg, ZA-7925 Observaotry, South Africa.	keertan.dheda@uct.ac.za	Mwaba, Peter/V-6017-2019; Trajman, Anete/C-7679-2016; Theron, Grant/ABB-1167-2020; PAL, MRINAL/ABG-9676-2020; Chanda, Duncan/N-1045-2019; Pai, Madhukar/AAX-9901-2021; Lesosky, Maia/AAM-4174-2020; Hoelscher, Michael/D-3436-2012	Trajman, Anete/0000-0002-4000-4984; Theron, Grant/0000-0002-9216-2415; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Lesosky, Maia/0000-0002-2026-958X; Peter, Jonathan/0000-0002-2658-0723; Pym, Alexander/0000-0002-6260-8180				Aderaye G., 2007, IMPROVING DIAGNOSIS; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/SAMJ.5851, 10.7196/samj.5851]; Dean AG, OPENEPI OPEN SOURCE; Development Core Team, 2005, R LANG ENV STAT COMP; Dowdy DW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001063; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleiss JL., 2003, STAT METHODS RATES P, V3rd ed; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hanrahan CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065421; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lin HH, 2012, B WORLD HEALTH ORGAN, V90, P739, DOI 10.2471/BLT.11.101436; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Peter JG, 2013, LANCET RESP MED, V1, P471, DOI 10.1016/S2213-2600(13)70120-6; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Rudolf F, 2013, SCAND J INFECT DIS, V45, P256, DOI 10.3109/00365548.2012.731077; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Theron G, 2013, THORAX, V68, P1043, DOI 10.1136/thoraxjnl-2013-203485; Van Rie A, 2013, INT J TUBERC LUNG D, V17, P368, DOI 10.5588/ijtld.12.0392; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; WHO, 2013, IMPL ROLL OUT XPERT; *WHO, 2008, MON ACH HLTH REL MIL; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31; World Health Oragnization, 2013, DEF TUB CAS TREATM O; World Health Organization, 2011, WHO PUBL; World Health Organization, 2012, WHO PUBL; Yoon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048599; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	40	327	332	2	110	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					424	435		10.1016/S0140-6736(13)62073-5	http://dx.doi.org/10.1016/S0140-6736(13)62073-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303KS	24176144				2022-12-28	WOS:000330673700032
J	Masoudi, A; Raetz, CRH; Zhou, P; Pemble, CW				Masoudi, Ali; Raetz, Christian R. H.; Zhou, Pei; Pemble, Charles W.			Chasing acyl carrier protein through a catalytic cycle of lipid A production	NATURE			English	Article							N-ACYLTRANSFERASE; BINDING; REVEAL; CRYSTALLOGRAPHY; BIOSYNTHESIS; RECOGNITION; MECHANISM; COMPLEX; SYSTEM; SUITE	Acyl carrier protein represents one of the most highly conserved proteins across all domains of life and is nature's way of transporting hydrocarbon chains in vivo. Notably, type II acyl carrier proteins serve as a crucial interaction hub in primary cellular metabolism(1) by communicating transiently between partner enzymes of the numerous biosynthetic pathways(2,3). However, the highly transient nature of such interactions and the inherent conformational mobility of acyl carrier protein(2) have stymied previous attempts to visualize structurally acyl carrier protein tied to an overall catalytic cycle. This is essential to understanding a fundamental aspect of cellular metabolism leading to compounds that are not only useful to the cell, but also of therapeutic value. For example, acyl carrier protein is central to the biosynthesis of the lipid A (endotoxin) component of lipopolysaccharides in Gram-negative microorganisms, which is required for their growth and survival(4,5), and is an activator of the mammalian host's immune system(6,7), thus emerging as an important therapeutic target(8-10). During lipid A synthesis (Raetz pathway), acyl carrier protein shuttles acyl intermediates linked to its prosthetic 4'-phosphopantetheine group(2) among four acyltransferases, including LpxD(11). Here we report the crystal structures of three forms of Escherichia coli acyl carrier protein engaging LpxD, which represent stalled substrate and liberated products along the reaction coordinate. The structures show the intricate interactions at the interface that optimally position acyl carrier protein for acyl delivery and that directly involve the pantetheinyl group. Conformational differences among the stalled acyl carrier proteins provide the molecular basis for the association-dissociation process. An unanticipated conformational shift of 4'-phosphopantetheine groups within the LpxD catalytic chamber shows an unprecedented role of acyl carrier protein in product release.	[Masoudi, Ali; Raetz, Christian R. H.; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Pemble, Charles W.] Duke Univ, Med Ctr, HumanVaccine Inst, Durham, NC 27710 USA; [Pemble, Charles W.] Duke Univ, Med Ctr, Duke Macromol Crystallog Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Pemble, CW (corresponding author), Duke Univ, Med Ctr, HumanVaccine Inst, Durham, NC 27710 USA.	charles.pemble@duke.edu	Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416; Masoudi, Ali/0000-0001-5691-9495	US Department of Energy, Office of Science and the Office of Basic Energy Sciences [W-31-109-Eng-38]; National Institutes of Health [GM-51310, AI-055588]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310] Funding Source: NIH RePORTER	US Department of Energy, Office of Science and the Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge our co-author Christian R. H. Raetz, who shaped the lipid field with his curiosity and efforts, introducing many scientists to the field during his renowned career. We thank R. Brennan and W. Todd Lowther for reviewing the manuscript. Finally, we thank Z. Guan for the help with the mass spectrometry of ACP, H.-S. Chung and other members of Raetz laboratory, as well as J. M. Burg, for discussions. Crystal screening, data collection and data processing were conducted in collaboration with the Duke Macromolecular X-ray Crystallography Shared Resource. Diffraction data were collected remotely at the Southeast Regional Collaborative Access Team 22-BM and 22-ID beamlines at the Advanced Photon Source, Argonne National Laboratory, supported by the US Department of Energy, Office of Science and the Office of Basic Energy Sciences under Contract number W-31-109-Eng-38. This work was supported by National Institutes of Health grants GM-51310 and AI-055588 awarded to C.R.H.R. and P.Z.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal V, 2012, P NATL ACAD SCI USA, V109, P17406, DOI 10.1073/pnas.1207028109; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Babu M, 2010, STRUCTURE, V18, P1450, DOI 10.1016/j.str.2010.08.015; Bartling CM, 2008, BIOCHEMISTRY-US, V47, P5290, DOI 10.1021/bi800240r; Bartling CM, 2009, BIOCHEMISTRY-US, V48, P8672, DOI 10.1021/bi901025v; BELUNIS CJ, 1995, J BIOL CHEM, V270, P27646, DOI 10.1074/jbc.270.46.27646; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buetow L, 2007, P NATL ACAD SCI USA, V104, P4321, DOI 10.1073/pnas.0606356104; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; HOLAK TA, 1988, EUR J BIOCHEM, V175, P9, DOI 10.1111/j.1432-1033.1988.tb14159.x; Jenkins RJ, 2012, ACS CHEM BIOL, V7, P1170, DOI 10.1021/cb300094a; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; KELLY TM, 1993, J BIOL CHEM, V268, P19866; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Ploskon E, 2010, CHEM BIOL, V17, P776, DOI 10.1016/j.chembiol.2010.05.024; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qiu XY, 2004, ACTA CRYSTALLOGR D, V60, P1545, DOI 10.1107/S0907444904015422; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STOKES GB, 1974, ARCH BIOCHEM BIOPHYS, V162, P638, DOI 10.1016/0003-9861(74)90226-4; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Williams AH, 2006, P NATL ACAD SCI USA, V103, P10877, DOI 10.1073/pnas.0604465103; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	56	57	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					422	+		10.1038/nature12679	http://dx.doi.org/10.1038/nature12679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24196711	Green Accepted			2022-12-28	WOS:000329621800047
J	Rivara, FP; Graham, R				Rivara, Frederick P.; Graham, Robert			Sports-Related Concussions in Youth Report From the Institute of Medicine and National Research Council	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rivara, Frederick P.] Univ Washington, Seattle, WA 98104 USA; [Rivara, Frederick P.] Seattle Childrens Hosp, Seattle, WA USA; [Graham, Robert] George Washington Univ, Washington, DC USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; George Washington University	Rivara, FP (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, 325 9th Ave,POB 359960, Seattle, WA 98104 USA.	fpr@uw.edu						Committee on Sports-Related Concussions in Youth Institute of Medicine National Research Council, 2013, SPORTS RELATED CONCU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001	2	39	40	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					239	240		10.1001/jama.2013.282985	http://dx.doi.org/10.1001/jama.2013.282985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24185195				2022-12-28	WOS:000329566400011
J	Neculai, D; Schwake, M; Ravichandran, M; Zunke, F; Collins, RF; Peters, J; Neculai, M; Plumb, J; Loppnau, P; Pizarro, JC; Seitova, A; Trimble, WS; Saftig, P; Grinstein, S; Dhe-Paganon, S				Neculai, Dante; Schwake, Michael; Ravichandran, Mani; Zunke, Friederike; Collins, Richard F.; Peters, Judith; Neculai, Mirela; Plumb, Jonathan; Loppnau, Peter; Pizarro, Juan Carlos; Seitova, Alma; Trimble, William S.; Saftig, Paul; Grinstein, Sergio; Dhe-Paganon, Sirano			Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36	NATURE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; SCAVENGER RECEPTOR; BINDING; IDENTIFICATION; PHOSPHOLIPIDS; INHIBITORS; LIPIDS	Members of the CD36 superfamily of scavenger receptor proteins are important regulators of lipid metabolism and innate immunity. They recognize normal and modified lipoproteins, as well as pathogen-associated molecular patterns. The family consists of three members: SR-BI (which delivers cholesterol to the liver and steroidogenic organs and is a co-receptor for hepatitis C virus), LIMP-2/LGP85 (which mediates lysosomal delivery of beta-glucocerebrosidase and serves as a receptor for enterovirus 71 and coxsackieviruses) and CD36 (a fatty-acid transporter and receptor for phagocytosis of effete cells and Plasmodium-infected erythrocytes). Notably, CD36 is also a receptor for modified lipoproteins and beta-amyloid, and has been implicated in the pathogenesis of atherosclerosis and of Alzheimer's disease(1). Despite their prominent roles in health and disease, understanding the function and abnormalities of the CD36 family members has been hampered by the paucity of information about their structure. Here we determine the crystal structure of LIMP-2 and infer, by homology modelling, the structure of SR-BI and CD36. LIMP-2 shows a helical bundle where beta-glucocerebrosidase binds, and where ligands are most likely to bind to SR-BI and CD36. Remarkably, the crystal structure also shows the existence of a large cavity that traverses the entire length of the molecule. Mutagenesis of SR-BI indicates that the cavity serves as a tunnel through which cholesterol(esters) are delivered from the bound lipoprotein to the outer leaflet of the plasma membrane. We provide evidence supporting a model(2) whereby lipidic constituents of the ligands attached to the receptor surface are handed off to the membrane through the tunnel, accounting for the selective lipid transfer characteristic of SR-BI and CD36.	[Neculai, Dante; Collins, Richard F.; Plumb, Jonathan; Trimble, William S.; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Schwake, Michael; Zunke, Friederike; Peters, Judith; Saftig, Paul] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany; [Schwake, Michael] Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany; [Ravichandran, Mani; Neculai, Mirela; Loppnau, Peter; Pizarro, Juan Carlos; Seitova, Alma; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Pizarro, Juan Carlos] Tulane Univ, Dept Trop Med, New Orleans, LA 70118 USA; [Trimble, William S.; Grinstein, Sergio] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Grinstein, Sergio] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5C 1N8, Canada; [Dhe-Paganon, Sirano] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Kiel; University of Bielefeld; University of Toronto; Structural Genomics Consortium; Tulane University; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Harvard University; Dana-Farber Cancer Institute	Grinstein, S (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sergio.grinstein@sickkids.ca	Schwake, Michael/F-5381-2010; Neculai, Dante/A-9923-2011; Saftig, Paul/A-7966-2010	Neculai, Dante/0000-0001-8887-9168; Schwake, Michael/0000-0002-4173-2166; Zunke, Friederike/0000-0002-0408-6388	Canadian Institutes for Health Research [MOP-102474, MOP-126069]; Deutsche Forschungsgemeinschaft [GRK1459, SFB877]; Bohringer Ingelheim Fonds; Canada Research Chair in Molecular Cell Biology; Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bohringer Ingelheim Fonds; Canada Research Chair in Molecular Cell Biology(Canada Research Chairs); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank W. Temple, D. Cossar, S. Graslund, C. Arrowsmith, R. Stahelin, L. Andresen, J. Groth, M. Langer and J. Scott for assistance and discussions. This study was supported by the Canadian Institutes for Health Research (grants MOP-102474 and MOP-126069) and the Deutsche Forschungsgemeinschaft (grants GRK1459 to M. S. and SFB877). F.Z. is supported through the Bohringer Ingelheim Fonds. W. S. T. is the recipient of a Canada Research Chair in Molecular Cell Biology. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanz J, 2010, HUM MOL GENET, V19, P563, DOI 10.1093/hmg/ddp523; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chadwick AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045660; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jimenez-Dalmaroni MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007411; Kar NS, 2008, J BIOL CHEM, V283, P8765, DOI 10.1074/jbc.M709195200; Liu B, 2002, J BIOL CHEM, V277, P34125, DOI 10.1074/jbc.M204265200; Navazo MDP, 1996, ARTERIOSCL THROM VAS, V16, P1033, DOI 10.1161/01.ATV.16.8.1033; Nieland TJF, 2008, BIOCHEMISTRY-US, V47, P460, DOI 10.1021/bi701277x; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Rasmussen JT, 1998, EUR J BIOCHEM, V257, P488, DOI 10.1046/j.1432-1327.1998.2570488.x; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Ryeom SW, 1996, J BIOL CHEM, V271, P20536, DOI 10.1074/jbc.271.34.20536; Stylianou IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006521; Yu M, 2012, BIOCHEMISTRY-US, V51, P10044, DOI 10.1021/bi301203x; Yu M, 2011, P NATL ACAD SCI USA, V108, P12243, DOI 10.1073/pnas.1109078108; Zachos C, 2012, TRAFFIC, V13, P1113, DOI 10.1111/j.1600-0854.2012.01372.x	21	176	195	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					172	176		10.1038/nature12684	http://dx.doi.org/10.1038/nature12684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24162852				2022-12-28	WOS:000327851700054
J	Gerhart-Hines, Z; Feng, D; Emmett, MJ; Everett, LJ; Loro, E; Briggs, ER; Bugge, A; Hou, C; Ferrara, C; Seale, P; Pryma, DA; Khurana, TS; Lazar, MA				Gerhart-Hines, Zachary; Feng, Dan; Emmett, Matthew J.; Everett, Logan J.; Loro, Emanuele; Briggs, Erika R.; Bugge, Anne; Hou, Catherine; Ferrara, Christine; Seale, Patrick; Pryma, Daniel A.; Khurana, Tejvir S.; Lazar, Mitchell A.			The nuclear receptor Rev-erb alpha controls circadian thermogenic plasticity	NATURE			English	Article							BROWN ADIPOSE-TISSUE; NONSHIVERING THERMOGENESIS; METABOLISM; COLD; BEHAVIOR; RHYTHM; UCP1	Circadian oscillation of body temperature is a basic, evolutionarily conserved feature of mammalian biology(1). In addition, homeostatic pathways allow organisms to protect their core temperatures in response to cold exposure(2). However, the mechanism responsible for coordinating daily body temperature rhythm and adaptability to environmental challenges is unknown. Here we show that the nuclear receptor Rev-erb alpha (also known as Nr1d1), a powerful transcriptional repressor, links circadian and thermogenic networks through the regulation of brown adipose tissue (BAT) function. Mice exposed to cold fare considerably better at 05:00 (Zeitgeber time 22) when Rev-erb alpha is barely expressed than at 17:00 (Zeitgeber time 10) when Rev-erb alpha is abundant. Deletion of Rev-erb alpha markedly improves cold tolerance at 17: 00, indicating that overcoming Rev-erb alpha-dependent repression is a fundamental feature of the thermogenic response to cold. Physiological induction of uncoupling protein 1 (Ucp1) by cold temperatures is preceded by rapid downregulation of Rev-erb alpha in BAT. Rev-erb alpha represses Ucp1 in a brown-adipose-cell-autonomous manner and BAT Ucp1 levels are high in Rev-erb alpha-null mice, even at thermoneutrality. Genetic loss of Rev-erb alpha also abolishes normal rhythms of body temperature and BAT activity. Thus, Rev-erb alpha acts as a thermogenic focal point required for establishing and maintaining body temperature rhythm in a manner that is adaptable to environmental demands.	[Gerhart-Hines, Zachary; Feng, Dan; Emmett, Matthew J.; Everett, Logan J.; Briggs, Erika R.; Bugge, Anne; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA; [Gerhart-Hines, Zachary; Feng, Dan; Emmett, Matthew J.; Everett, Logan J.; Briggs, Erika R.; Bugge, Anne; Seale, Patrick; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Loro, Emanuele; Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Loro, Emanuele; Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Hou, Catherine; Pryma, Daniel A.] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Ferrara, Christine] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Seale, Patrick] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Loro, Emanuele/J-5212-2019; Everett, Logan/AAK-1523-2021; Lazar, Mitchell A/AAF-3738-2019	Loro, Emanuele/0000-0002-0822-4514; Emmett, Matthew/0000-0002-8855-423X; Feng, Dan/0000-0001-5926-8894; Gerhart-Hines, Zachary/0000-0003-2981-4991; Bugge, Anne/0000-0001-5885-4541	NIH [R01 DK45586, F-32 DK095563]; JPB Foundation; Novo Nordisk STAR postdoctoral program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586, F32DK095563, P30DK019525, U19DK062434, F32DK095526] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Novo Nordisk STAR postdoctoral program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Functional Genomics Core (J. Schug) and the Mouse Phenotyping, Physiology, and Metabolism Core (R. Ahima and R. Dhir) of the Penn Diabetes Research Center (NIH P30 DK19525). We also thank the Small Animal Imaging Facility of the Perelman School of Medicine at the University of Pennsylvania (E. Blankemeyer). This work was supported by NIH grants R01 DK45586 (M.A.L.) and F-32 DK095563 (Z.G.-H.) and the JPB Foundation. A.B. was funded by the Novo Nordisk STAR postdoctoral program.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Pearen MA, 2006, ENDOCRINOLOGY, V147, P5217, DOI 10.1210/en.2006-0447; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Saito S, 2008, GENE, V408, P37, DOI 10.1016/j.gene.2007.10.018; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; TALAN MI, 1991, PHYSIOL BEHAV, V50, P613, DOI 10.1016/0031-9384(91)90554-2; van der Veen DR, 2012, OBESITY, V20, P1527, DOI 10.1038/oby.2012.78; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288; Woldt E., 2013, NATURE MED	30	180	187	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					410	+		10.1038/nature12642	http://dx.doi.org/10.1038/nature12642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24162845	Green Accepted			2022-12-28	WOS:000327163200044
J	Hughes, KA; Houde, AE; Price, AC; Rodd, FH				Hughes, Kimberly A.; Houde, Anne E.; Price, Anna C.; Rodd, F. Helen			Mating advantage for rare males in wild guppy populations	NATURE			English	Article							FREQUENCY-DEPENDENT SELECTION; SEXUAL SELECTION; POECILIA-RETICULATA; COLOR POLYMORPHISM; SPERM TRANSFER; EVOLUTION; FAMILIARITY; SUCCESS; TRAITS; CHOICE	To understand the processes that maintain genetic diversity is a long-standing challenge in evolutionary biology, with implications for predicting disease resistance, response to environmental change, and population persistence(1-3). Simple population genetic models are not sufficient to explain the high levels of genetic diversity sometimes observed in ecologically important traits(2). In guppies (Poecilia reticulata), male colour pattern is both diverse and heritable, and is arguably one of the most extreme examples of morphological polymorphism known(4,5). Negative frequency-dependent selection (NFDS), a form of selection in which genotypes are favoured when they are rare(6), can potentially maintain such extensive polymorphism, but few experimental studies have confirmed its operation in nature(7,8). Here we use highly replicated experimental manipulations of natural populations to show that males with rare colour patterns have higher reproductive fitness, demonstrating NFDS mediated by sexual selection. Rare males acquired more mates and sired more offspring compared to common males and, as previously reported, had higher rates of survival(8). Orange colour, implicated in other studies of sexual selection in guppies, did predict male reproductive success, but only in one of three populations. These data support the hypothesis that NFDS maintains diversity in the colour patterns of male guppies through two selective agents, mates and predators. Similar field-based manipulations of genotype frequencies could provide a powerful approach to reveal the underlying ecological and behavioural mechanisms that maintain genetic and phenotypic diversity.	[Hughes, Kimberly A.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Houde, Anne E.] Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA; [Price, Anna C.; Rodd, F. Helen] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3G5, Canada	State University System of Florida; Florida State University; University of Toronto	Hughes, KA (corresponding author), Florida State Univ, Dept Biol Sci, 319 Stadium Dr, Tallahassee, FL 32306 USA.	kahughes@bio.fsu.edu			National Science Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada; Direct For Biological Sciences [0934451] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0743990] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Olendorf for help with field work and genotyping; D. Punzalan, K. Dixon, M. Bryant, T. Pitcher, C. Baril, A. Inman and C. Hurt for field work; C. Gibson, K. McGhee for photographs in Fig. 1 and for animal rearing; J. Koprivnikar for animal rearing; and A. Vanesyan for collecting morphology data. D. Reznick provided advice on field experiments, and D. Punzalan, K. Dixon and M. Fitzpatrick commented on manuscript drafts. In Trinidad, we thank the Sinanan family for accommodation, and I. Ramnarine and the government of Trinidad for permission to collect guppies and to work in the Quare watershed. This work was supported by grants from the National Science Foundation (to K. A. H. and A. E. H.) and the Natural Sciences and Engineering Research Council (NSERC) of Canada (to F.H.R.).	Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Bleay C, 2007, P ROY SOC B-BIOL SCI, V274, P2019, DOI 10.1098/rspb.2007.0361; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; Dijkstra PD, 2005, BEHAV ECOL SOCIOBIOL, V58, P136, DOI 10.1007/s00265-005-0919-5; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Evans JP, 2003, BIOL J LINN SOC, V78, P605, DOI 10.1046/j.0024-4066.2002.00193.x; FARR JA, 1977, EVOLUTION, V31, P162, DOI 10.1111/j.1558-5646.1977.tb00993.x; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Hampton KJ, 2009, ETHOLOGY, V115, P475, DOI 10.1111/j.1439-0310.2009.01634.x; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Hughes KA, 2005, J EVOLUTION BIOL, V18, P35, DOI 10.1111/j.1420-9101.2004.00806.x; Johnson AM, 2010, ETHOLOGY, V116, P448, DOI 10.1111/j.1439-0310.2010.01763.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kokko H, 2007, P ROY SOC B-BIOL SCI, V274, P1317, DOI 10.1098/rspb.2007.0043; Lewontin RC, 1974, GENETIC BASIS EVOLUT; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Matthews IM, 2000, J FISH BIOL, V56, P1381, DOI 10.1111/j.1095-8649.2000.tb02150.x; Maynard Smith J., 1982, pi; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Olendorf R, 2004, MOL ECOL NOTES, V4, P668, DOI 10.1111/j.1471-8286.2004.00777.x; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; Petit C., 1969, EVOLUTIONARY BIOL, V3; Pires MN, 2010, BIOL J LINN SOC, V99, P784, DOI 10.1111/j.1095-8312.2010.01391.x; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; ROSENTHAL HL, 1952, BIOL BULL, V102, P30, DOI 10.2307/1538621; SAS Institute, 2011, SAS STAT 9 3 US GUID; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Takahashi Y, 2010, EVOLUTION, V64, P3620, DOI 10.1111/j.1558-5646.2010.01083.x; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053; Zajitschek SRK, 2008, AM NAT, V172, P843, DOI 10.1086/593001	34	117	120	0	264	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					108	+		10.1038/nature12717	http://dx.doi.org/10.1038/nature12717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24172904				2022-12-28	WOS:000326585600041
J	Vinden, C; Nash, DM; Rangrej, J; Shariff, SZ; Dixon, SN; Jain, AK; Garg, AX				Vinden, Christopher; Nash, Danielle M.; Rangrej, Jagadish; Shariff, Salimah Z.; Dixon, Stephanie N.; Jain, Arsh K.; Garg, Amit X.			Complications of Daytime Elective Laparoscopic Cholecystectomies Performed by Surgeons Who Operated the Night Before	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SLEEP-DEPRIVATION; OUTCOMES	IMPORTANCE The effect of surgeons' disrupted sleep on patient outcomes is not clearly defined. OBJECTIVE To assess if surgeons operating the night before have more complications of elective surgery performed the next day. DESIGN, SETTING, AND PARTICIPANTS Population-based, matched, retrospective cohort study using administrative health care databases in Ontario, Canada (2012 population, 13 505 900). Participants were 2078 patients who underwent elective laparoscopic cholecystectomies performed by surgeons who operated the night before, matched with 4 other elective laparoscopic cholecystectomy recipients (n = 8312). EXPOSURE In total, 94 183 eligible elective laparoscopic cholecystectomies were performed between 2004 and 2011. Of these surgeries, there were 2078 procedures in which 331 different surgeons across 102 community hospitals had operated between midnight and 7 AM the night before. Each "at-risk" surgery was randomly matched with 4 other elective laparoscopic cholecystectomies (n = 8312) performed by the same surgeon, who had no evidence of having operated the night before. MAIN OUTCOMES AND MEASURES The primary outcome was conversion from a laparoscopic cholecystectomy to open cholecystectomy. Secondary outcomes included evidence of iatrogenic injuries or death. Risks were quantified using generalized estimating equations. RESULTS No significant association was found in conversion rates to open operations between surgeons when they operated the night before compared with when they did not operate the previous night (46/2031 [2.2%] vs 157/8124 [1.9%]; adjusted odds ratio [OR], 1.18; 95% CI, 0.85-1.64). There was no association between operating the night before vs not operating the night before, and risk of iatrogenic injuries (14/2031 [0.7%] vs 72/8124 [0.9%]; adjusted OR, 0.77; 95% CI, 0.43-1.37) or death (<= 5/2031 [<= 0.2%] vs 7/8124 [0.1%]). CONCLUSIONS AND RELEVANCE No significant association was found between operating the night before and not operating the previous night for conversion to open cholecystectomy, risk of iatrogenic complications, or death for elective daytime cholecystectomy. These findings do not support safety concerns related to surgeons operating the night before performing elective surgery.	[Vinden, Christopher] Univ Western Ontario, Dept Surg, Div Gen Surg, London, ON N6A 3K7, Canada; [Vinden, Christopher; Nash, Danielle M.; Shariff, Salimah Z.; Dixon, Stephanie N.; Jain, Arsh K.; Garg, Amit X.] Inst Clin Evaluat Sci, London, ON, Canada; [Dixon, Stephanie N.; Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Rangrej, Jagadish] Inst Clin Evaluat Sci, Toronto, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto	Vinden, C (corresponding author), Victoria Hosp, London Hlth Sci Ctr, 800 Commissioners Rd E,Room E2-218, London, ON N6A 5W9, Canada.	chris.vinden@lhsc.on.ca	Jain, Arsh/G-3308-2011; Garg, Amit X/G-3295-2011	Shariff, Salimah/0000-0002-1219-6763	Ontario Ministry of Health and Long-Term Care; Academic Medical Organization of Southwestern Ontario; Lawson Health Research Institute; Schulich School of Medicine and Dentistry; Western University; Division of General Surgery at the London Health Sciences Centre; ICES Western facility	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario; Lawson Health Research Institute; Schulich School of Medicine and Dentistry; Western University; Division of General Surgery at the London Health Sciences Centre; ICES Western facility	The Institute for Clinical Evaluative Sciences (ICES) is a nonprofit research corporation funded by the Ontario Ministry of Health and Long-Term Care. This work was supported by personnel at the ICES Western facility, which receives support from the Academic Medical Organization of Southwestern Ontario, the Lawson Health Research Institute, the Schulich School of Medicine and Dentistry, and multiple departments at Western University. This project was funded by the Division of General Surgery at the London Health Sciences Centre.	ASCH DA, 1988, NEW ENGL J MED, V318, P771, DOI 10.1056/NEJM198803243181209; Chu MWA, 2011, ARCH SURG-CHICAGO, V146, P1080, DOI 10.1001/archsurg.2011.121; Ellman PI, 2004, ANN THORAC SURG, V78, P906, DOI 10.1016/j.athoracsur.2004.04.006; Goel V, 1996, PATTERNS HLTH CARE O; Hallock GG, 2011, ANN PLAS SURG, V66, P323, DOI 10.1097/SAP.0b013e3182118fc0; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Harvey EJ, 2011, CAN J SURG, V54, P4, DOI 10.1503/cjs.001611; KOSLOWSKY M, 1992, CHRONOBIOL INT, V9, P132, DOI 10.3109/07420529209064524; MacDonald NE, 2011, CAN MED ASSOC J, V183, P1689, DOI 10.1503/cmaj.110402; Molnar AO, 2011, J AM SOC NEPHROL, V22, P939, DOI 10.1681/ASN.2010050442; Nurok M, 2010, NEW ENGL J MED, V363, P2577, DOI 10.1056/NEJMp1007901; Payette M, 2009, AM J SURG, V197, P820, DOI 10.1016/j.amjsurg.2008.05.013; Pellegrini CA, 2010, NEW ENGL J MED, V363, P2672, DOI 10.1056/NEJMc1012517; Rothschild JM, 2009, JAMA-J AM MED ASSOC, V302, P1565, DOI 10.1001/jama.2009.1423; Sharpe JP, 2013, J AM COLL SURGEONS, V216, P791, DOI 10.1016/j.jamcollsurg.2012.12.005; Siddiqui NF, 2012, CAN MED ASSOC J, V184, P1237, DOI 10.1503/cmaj.110895; Stavert RR, 2013, NEW ENGL J MED, V368, P8, DOI 10.1056/NEJMp1210501; Sturm L, 2011, ANZ J SURG, V81, P502, DOI 10.1111/j.1445-2197.2010.05642.x; Temple J, TIME TRAINING REV IM; TILLEY AJ, 1982, HUM FACTORS, V24, P629, DOI 10.1177/001872088202400601; Urbach DR, 2005, CAN MED ASSOC J, V172, P1015, DOI 10.1503/cmaj.1041363; WILKINSON RT, 1992, SLEEP, AROUSAL, AND PERFORMANCE, P254	22	33	33	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1837	1841		10.1001/jama.2013.280372	http://dx.doi.org/10.1001/jama.2013.280372			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193081	Bronze			2022-12-28	WOS:000326550900017
J	Brewer, C				Brewer, Colin			Balloon phobia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												brewerismo@gmail.com						Johnston L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028079; Ougrin D, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-200	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2013	347								f6652	10.1136/bmj.f6652	http://dx.doi.org/10.1136/bmj.f6652			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XL	24192971				2022-12-28	WOS:000326890000008
J	Stern, P				Stern, Peter			Connection, Connection, Connection ... INTRODUCTION	SCIENCE			English	Editorial Material																			0	6	10	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					577	577		10.1126/science.342.6158.577	http://dx.doi.org/10.1126/science.342.6158.577			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179217				2022-12-28	WOS:000326334300034
J	Sun, LO; Jiang, Z; Rivlin-Etzion, M; Hand, R; Brady, CM; Matsuoka, RL; Yau, KW; Feller, MB; Kolodkin, AL				Sun, Lu O.; Jiang, Zheng; Rivlin-Etzion, Michal; Hand, Randal; Brady, Colleen M.; Matsuoka, Ryota L.; Yau, King-Wai; Feller, Marla B.; Kolodkin, Alex L.			On and Off Retinal Circuit Assembly by Divergent Molecular Mechanisms	SCIENCE			English	Article							DIRECTION-SELECTIVITY; AMACRINE CELLS; ORGANIZATION; LAMINATION; PLEXIN-A2; DENDRITES	Direction-selective responses to motion can be to the onset (On) or cessation (Off) of illumination. Here, we show that the transmembrane protein semaphorin 6A and its receptor plexin A2 are critical for achieving radially symmetric arborization of On starburst amacrine cell (SAC) dendrites and normal SAC stratification in the mouse retina. Plexin A2 is expressed in both On and Off SACs; however, semaphorin 6A is expressed in On SACs. Specific On-Off bistratified direction- selective ganglion cells in semaphorin 6A(-/-) mutants exhibit decreased tuning of On directional motion responses. These results correlate the elaboration of symmetric SAC dendritic morphology and asymmetric responses to motion, shedding light on the development of visual pathways that use the same cell types for divergent outputs.	[Sun, Lu O.; Jiang, Zheng; Hand, Randal; Brady, Colleen M.; Matsuoka, Ryota L.; Yau, King-Wai; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Sun, Lu O.; Hand, Randal; Brady, Colleen M.; Matsuoka, Ryota L.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Rivlin-Etzion, Michal; Feller, Marla B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rivlin-Etzion, Michal; Feller, Marla B.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu	Matsuoka, Ryota L./K-5439-2019; Jiang, Zheng/A-7674-2015; Sun, Lu O/P-9339-2015	Matsuoka, Ryota L./0000-0001-6214-2889; Sun, Lu O/0000-0002-9293-7241; Rivlin, Michal/0000-0002-1310-3370; Longley, Colleen/0000-0001-8326-6143	Human Frontier Science Program Organization; National Postdoctoral Award Program for Advancing Women in Science; Edmond and Lily Safra (ELSC) Fellowship for postdoctoral training in Brain Science;  [NS35165];  [EY06837];  [EY019498];  [EY013528]; NATIONAL EYE INSTITUTE [F32EY006837, R01EY006837, R37EY006837, R01EY019498, R01EY013528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035165, R37NS035165, P30NS050274, R56NS035165] Funding Source: NIH RePORTER	Human Frontier Science Program Organization(Human Frontier Science Program); National Postdoctoral Award Program for Advancing Women in Science; Edmond and Lily Safra (ELSC) Fellowship for postdoctoral training in Brain Science; ; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Ginty for the ROSA<SUP>LSL-Tdtomato</SUP> mice, J. Nathans for Six3-cre, ChAT::cre, ChAT::cre<SUP>ER</SUP>, and ROSA<SUP>iAP</SUP> mice, and Y. Yoshida for the Sema6B<SUP>-/-</SUP> and Sema6C<SUP>-/-</SUP>;6D<SUP>-/-</SUP> eyes. We also thank S. Hattar, M. Riccomagno, and Q. Wang for comments on the manuscript and all Kolodkin laboratory members for assistance and discussions throughout the course of this project. This work was supported by NS35165 (A. L. K.); EY06837 (K.-W.Y.); EY019498 and EY013528 (M. B. F.); and the Human Frontier Science Program Organization, the National Postdoctoral Award Program for Advancing Women in Science, and the Edmond and Lily Safra (ELSC) Fellowship for postdoctoral training in Brain Science (M. R.-E.). A. L. K. is an investigator of the Howard Hughes Medical Institute.	Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Chalupa LM, 2004, PROG RETIN EYE RES, V23, P31, DOI 10.1016/j.preteyeres.2003.10.001; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Ford KJ, 2012, VISUAL NEUROSCI, V29, P61, DOI 10.1017/S0952523811000216; Haklai-Topper L, 2010, EMBO J, V29, P2635, DOI 10.1038/emboj.2010.147; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Matsuoka RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063207; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Rivlin-Etzion M, 2011, J NEUROSCI, V31, P8760, DOI 10.1523/JNEUROSCI.0564-11.2011; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Wei W, 2011, TRENDS NEUROSCI, V34, P638, DOI 10.1016/j.tins.2011.08.002; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; WONG ROL, 1989, J COMP NEUROL, V287, P164, DOI 10.1002/cne.902870203; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	25	89	89	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					590	+		10.1126/science.1241974	http://dx.doi.org/10.1126/science.1241974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179230	Green Accepted			2022-12-28	WOS:000326334300039
J	Werner, N; Urban, O; Simionescu, A; Allen, SW				Werner, Norbert; Urban, Ondrej; Simionescu, Aurora; Allen, Steven W.			A uniform metal distribution in the intergalactic medium of the Perseus cluster of galaxies	NATURE			English	Article							IRON CONTENT; ABUNDANCES; EVOLUTION; METALLICITY; ENRICHMENT; BARYONS; ORIGIN; GAS	Most of the metals (elements heavier than helium) produced by stars in the member galaxies of clusters currently reside within the hot, X-ray-emitting intra-cluster gas. Observations of X-ray line emission from this intergalactic medium have suggested a relatively small cluster-to-cluster scatter outside the cluster centres(1,2) and enrichment with iron out to large radii(3-5), leading to the idea that the metal enrichment occurred early in the history of the Universe(3). Models with early enrichment predict a uniform metal distribution at large radii in clusters, whereas those with late-time enrichment(6,7) are expected to introduce significant spatial variations of the metallicity. To discriminate clearly between these competing models, it is essential to test for potential inhomogeneities by measuring the abundances out to large radii along multiple directions in clusters, which has not hitherto been done. Here we report a remarkably uniform iron abundance, as a function of radius and azimuth, that is statistically consistent with a constant value of Z(Fe) = 0.306 +/- 0.012 in solar units out to the edge of the nearby Perseus cluster. This homogeneous distribution requires that most of the metal enrichment of the intergalactic medium occurred before the cluster formed, probably more than ten billion years ago, during the period of maximal star formation and black hole activity.	[Werner, Norbert; Urban, Ondrej; Simionescu, Aurora; Allen, Steven W.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Werner, Norbert; Urban, Ondrej; Simionescu, Aurora; Allen, Steven W.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Urban, Ondrej; Allen, Steven W.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Simionescu, Aurora] JAXA, Inst Space & Astronaut Sci ISAS, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Werner, N (corresponding author), Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, 452 Lomita Mall, Stanford, CA 94305 USA.	norbertw@stanford.edu	Werner, Norbert/AAW-2434-2021; Werner, Norbert/G-2832-2019	Werner, Norbert/0000-0003-0392-0120; Werner, Norbert/0000-0003-0392-0120; Simionescu, Aurora/0000-0002-9714-3862; Allen, Steven/0000-0003-0667-5941	Suzaku grants [NNX09AV64G, NNX10AR48G]; NASA ADAP grant [NNX12AE05G]; US Department of Energy [DE-AC02-76SF00515]	Suzaku grants; NASA ADAP grant; US Department of Energy(United States Department of Energy (DOE))	We are grateful for discussions with other members of the Perseus cluster Suzaku Key project collaboration, as well as with Y. Lu, P. Simeon and R. Blandford. This work was supported by the Suzaku grants NNX09AV64G and NNX10AR48G, the NASA ADAP grant NNX12AE05G, and by the US Department of Energy under contract number DE-AC02-76SF00515.	Abraham J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.091101; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Andreon S, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219194; Baldi A, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117836; Balestra I, 2007, ASTRON ASTROPHYS, V462, P429, DOI 10.1051/0004-6361:20065568; Bohringer H, 2004, ASTRON ASTROPHYS, V416, pL21, DOI 10.1051/0004-6361:20040047; Brandt WN, 2005, ANNU REV ASTRON ASTR, V43, P827, DOI 10.1146/annurev.astro.43.051804.102213; Cen RY, 1999, ASTROPHYS J, V514, P1, DOI 10.1086/306949; Dave R, 2001, ASTROPHYS J, V552, P473, DOI 10.1086/320548; De Grandi S, 2004, ASTRON ASTROPHYS, V419, P7, DOI 10.1051/0004-6361:20034228; DEYOUNG DS, 1978, ASTROPHYS J, V223, P47, DOI 10.1086/156234; Domainko W, 2006, ASTRON ASTROPHYS, V452, P795, DOI 10.1051/0004-6361:20053921; Fabjan D, 2010, MON NOT R ASTRON SOC, V401, P1670, DOI 10.1111/j.1365-2966.2009.15794.x; FELDMAN U, 1992, PHYS SCRIPTA, V46, P202, DOI 10.1088/0031-8949/46/3/002; Fujita Y, 2008, PUBL ASTRON SOC JPN, V60, pS343, DOI 10.1093/pasj/60.sp1.S343; Leccardi A, 2008, ASTRON ASTROPHYS, V487, P461, DOI 10.1051/0004-6361:200810113; Madau P, 1996, MON NOT R ASTRON SOC, V283, P1388, DOI 10.1093/mnras/283.4.1388; Mannucci F, 2006, MON NOT R ASTRON SOC, V370, P773, DOI 10.1111/j.1365-2966.2006.10501.x; Maoz D, 2012, MON NOT R ASTRON SOC, V426, P3282, DOI 10.1111/j.1365-2966.2012.21871.x; Matsushita K, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/147; Matsushita K, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/200913432; Maughan BJ, 2008, ASTROPHYS J SUPPL S, V174, P117, DOI 10.1086/521225; NORMAN CA, 1995, ASTROPHYS J, V454, P60, DOI 10.1086/176465; Simionescu A, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/182; Simionescu A, 2011, SCIENCE, V331, P1576, DOI [10.1126/science.1200331, 10.1126/science.1195970]; Urban O, 2011, MON NOT R ASTRON SOC, V414, P2101, DOI 10.1111/j.1365-2966.2011.18526.x; Urban O., 2013, MON NOT R ASTR UNPUB; Voit GM, 2005, MON NOT R ASTRON SOC, V364, P909, DOI 10.1111/j.1365-2966.2005.09621.x	29	96	96	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					656	658		10.1038/nature12646	http://dx.doi.org/10.1038/nature12646			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24172976	Green Submitted			2022-12-28	WOS:000326293200041
J	Attanasio, C; Nord, AS; Zhu, YW; Blow, MJ; Li, ZR; Liberton, DK; Morrison, H; Plajzer-Frick, I; Holt, A; Hosseini, R; Phouanenavong, S; Akiyama, JA; Shoukry, M; Afzal, V; Rubin, EM; FitzPatrick, DR; Ren, B; Hallgrimsson, B; Pennacchio, LA; Visel, A				Attanasio, Catia; Nord, Alex S.; Zhu, Yiwen; Blow, Matthew J.; Li, Zirong; Liberton, Denise K.; Morrison, Harris; Plajzer-Frick, Ingrid; Holt, Amy; Hosseini, Roya; Phouanenavong, Sengthavy; Akiyama, Jennifer A.; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; FitzPatrick, David R.; Ren, Bing; Hallgrimsson, Benedikt; Pennacchio, Len A.; Visel, Axel			Fine Tuning of Craniofacial Morphology by Distant-Acting Enhancers	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; CLEFT-LIP; GENE-EXPRESSION; SONIC HEDGEHOG; CRANIAL BASE; PALATE; REVEALS; HERITABILITY; MUTATIONS; FAMILY	The shape of the human face and skull is largely genetically determined. However, the genomic basis of craniofacial morphology is incompletely understood and hypothesized to involve protein-coding genes, as well as gene regulatory sequences. We used a combination of epigenomic profiling, in vivo characterization of candidate enhancer sequences in transgenic mice, and targeted deletion experiments to examine the role of distant-acting enhancers in craniofacial development. We identified complex regulatory landscapes consisting of enhancers that drive spatially complex developmental expression patterns. Analysis of mouse lines in which individual craniofacial enhancers had been deleted revealed significant alterations of craniofacial shape, demonstrating the functional importance of enhancers in defining face and skull morphology. These results demonstrate that enhancers are involved in craniofacial development and suggest that enhancer sequence variation contributes to the diversity of human facial morphology.	[Attanasio, Catia; Nord, Alex S.; Zhu, Yiwen; Plajzer-Frick, Ingrid; Holt, Amy; Hosseini, Roya; Phouanenavong, Sengthavy; Akiyama, Jennifer A.; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Pennacchio, Len A.; Visel, Axel] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Blow, Matthew J.; Rubin, Edward M.; Pennacchio, Len A.; Visel, Axel] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Li, Zirong; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Li, Zirong; Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Liberton, Denise K.; Hallgrimsson, Benedikt] Univ Calgary, Dept Cell Biol & Anat, McCaig Bone & Joint Inst, Calgary, AB T2N 4N1, Canada; [Morrison, Harris; FitzPatrick, David R.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [FitzPatrick, David R.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Hallgrimsson, Benedikt] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB T2N 4N1, Canada	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Calgary; University of Edinburgh; Alberta Childrens Hospital; University of Calgary	Visel, A (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	avisel@lbl.gov	Visel, Axel/A-9398-2009; Hallgrimsson, Benedikt/A-9616-2008; attanasio, catia/D-5042-2017; wang, edwin/G-5372-2010; Blow, Matthew/G-6369-2012	Visel, Axel/0000-0002-4130-7784; Hallgrimsson, Benedikt/0000-0002-7192-9103; attanasio, catia/0000-0001-8077-5719; Blow, Matthew/0000-0002-8844-9149; Nord, Alexander/0000-0003-4259-7514; Liberton, Denise/0000-0002-2885-8864; Pennacchio, Len/0000-0002-8748-3732; FitzPatrick, David R./0000-0003-4861-969X	NIDCR FaceBase grant [U01DE020060]; National Human Genome Research Institute [R01HG003988, U54HG006997]; Swiss National Science Foundation; F32 NIH/National Institute of General Medical Sciences National Research Service Award [GM105202]; NIH [U54HG006997, 1R01DE021708, 1R01DE01963, 1U01DE020054, R01HG003991]; Natural Sciences and Engineering Research Council of Canada [238992-11]; UK Medical Research Council; Ludwig Institute for Cancer Research; NIH; Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997, R01HG003988, R01HG003991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019638, U01DE020060, U01DE020054, R01DE021708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105202] Funding Source: NIH RePORTER; Medical Research Council [MC_U127561093, MC_PC_U127561093] Funding Source: researchfish; MRC [MC_U127561093, MC_PC_U127561093] Funding Source: UKRI	NIDCR FaceBase grant; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); F32 NIH/National Institute of General Medical Sciences National Research Service Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank J. Harkes and M. Satyanarayanan for development of the OPT viewer; S. Shen and H. Hochheiser for integration of the OPT viewer and data sets into FaceBase; and J. Murray, M. Marazita, J. Manak, B. Schutte, and all FaceBase members for help in the selection of relevant craniofacial intervals and comments on results. A. V. and L. A. P. were supported by NIDCR FaceBase grant U01DE020060 and by National Human Genome Research Institute grants R01HG003988 and U54HG006997. C. A. was supported by a Swiss National Science Foundation advanced researcher fellowship. A. S. N. was supported by a F32 NIH/National Institute of General Medical Sciences National Research Service Award fellowship GM105202. B. H. was supported by NIH 1R01DE021708, NIH 1R01DE01963, NIH 1U01DE020054, and Natural Sciences and Engineering Research Council of Canada #238992-11 grants. D. R. F. and H. M. were supported by a UK Medical Research Council core program grant. B. R. was supported by the Ludwig Institute for Cancer Research and NIH grants U54HG006997 and R01HG003991. B. H. was supported by NIH 1R01DE01963. Research was conducted at the E. O. Lawrence Berkeley National Laboratory and performed under Department of Energy contract DE-AC02-05CH11231, University of California. ChIP-Seq data are available through GEO (accession no. GSE49413) and FaceBase. org. In vivo reporter data are available through the Vista Enhancer Browser (http://enhancer.lbl.gov) and FaceBase. org. OPT data, including raw images and interactive 3D viewing option, is available through http://facebase.org. All enhancer reporter vectors, as well as archived surplus LacZ-stained embryos for selected enhancers, are available from the authors. Craniofacial enhancer knockout lines are available through the Mutant Mouse Regional Resource Centers (Delta hs1431, MMRRC 03895; Delta hs746, MMRRC 03888; and Delta hs586, MMRRCC 03894).	Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Balczerski B, 2012, DEV BIOL, V371, P203, DOI 10.1016/j.ydbio.2012.08.011; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Boehringer S, 2011, EUR J HUM GENET, V19, P1192, DOI 10.1038/ejhg.2011.110; Christensen K, 2004, BRIT MED J, V328, P1405, DOI 10.1136/bmj.38106.559120.7C; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Dixon MJ, 1996, HUM MOL GENET, V5, P1391, DOI 10.1093/hmg/5.Supplement_1.1391; Feng WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008066; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hochheiser H, 2011, DEV BIOL, V355, P175, DOI 10.1016/j.ydbio.2011.02.033; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Johannsdottir B, 2005, AM J ORTHOD DENTOFAC, V127, P200, DOI 10.1016/j.ajodo.2004.07.033; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kayser M, 2009, FORENSIC SCI INT-GEN, V3, P154, DOI 10.1016/j.fsigen.2009.01.012; KOHN LAP, 1991, ANNU REV ANTHROPOL, V20, P261, DOI 10.1146/annurev.an.20.100191.001401; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Koyama E, 1996, DEV DYNAM, V206, P59, DOI 10.1002/(SICI)1097-0177(199605)206:1<59::AID-AJA6>3.0.CO;2-#; Leslie EJ, 2012, BIRTH DEFECTS RES A, V94, P934, DOI 10.1002/bdra.23076; Lieberman DE, 2008, J ANAT, V212, P720, DOI 10.1111/j.1469-7580.2008.00900.x; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; MacKenzie A, 1997, MECH DEVELOP, V62, P29, DOI 10.1016/S0925-4773(96)00646-6; Manfredi C, 1997, AM J ORTHOD DENTOFAC, V111, P44, DOI 10.1016/S0889-5406(97)70301-9; Mangold E, 2011, TRENDS MOL MED, V17, P725, DOI 10.1016/j.molmed.2011.07.007; Mangold E, 2009, AM J MED GENET A, V149A, P2680, DOI 10.1002/ajmg.a.33136; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mitsiadis TA, 2003, DEVELOPMENT, V130, P4451, DOI 10.1242/dev.00631; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nikopensius T, 2009, AM J MED GENET A, V149A, P2551, DOI 10.1002/ajmg.a.33024; Oram KF, 2003, ANAT REC PART A, V271A, P189, DOI 10.1002/ar.a.10027; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Tucker AS, 1999, DEVELOPMENT, V126, P221; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wehby GL, 2010, ORAL DIS, V16, P3, DOI 10.1111/j.1601-0825.2009.01588.x; Yanagisawa H, 2003, DEVELOPMENT, V130, P1069, DOI 10.1242/dev.00337; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011; Young NM, 2010, DEVELOPMENT, V137, P3405, DOI 10.1242/dev.052340; Yuan QP, 2011, AM J MED GENET A, V155A, P1469, DOI 10.1002/ajmg.a.33940; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	60	156	159	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157							1241006	10.1126/science.1241006	http://dx.doi.org/10.1126/science.1241006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159046	Green Accepted			2022-12-28	WOS:000326042600032
J	Cui, MM; Emrick, T; Russell, TP				Cui, Mengmeng; Emrick, Todd; Russell, Thomas P.			Stabilizing Liquid Drops in Nonequilibrium Shapes by the Interfacial Jamming of Nanoparticles	SCIENCE			English	Article							COLLOIDAL PARTICLES; ELECTRIC-FIELD; EMULSIONS; ELECTROHYDRODYNAMICS; COLLOIDOSOMES; DEFORMATION; DYNAMICS; ROUTE; FILMS	Nanoparticles assemble at the interface between two fluids into disordered, liquid-like arrays where the nanoparticles can diffuse laterally at the interface. Using nanoparticles dispersed in water and amine end-capped polymers in oil, nanoparticle surfactants are generated in situ at the interface overcoming the inherent weak forces governing the interfacial adsorption of nanoparticles. When the shape of the liquid domain is deformed by an external field, the surface area increases and more nanoparticles adsorb to the interface. Upon releasing the field, the interfacial area decreases, jamming the nanoparticle surfactants and arresting further shape change. The jammed nanoparticles remain disordered and liquid-like, enabling multiple, consecutive deformation and jamming events. Further stabilization is realized by replacing monofunctional ligands with difunctional versions that cross-link the assemblies. The ability to generate and stabilize liquids with a prescribed shape poses opportunities for reactive liquid systems, packaging, delivery, and storage.	[Cui, Mengmeng; Emrick, Todd; Russell, Thomas P.] Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 01003 USA; [Russell, Thomas P.] Tohoku Univ, WPI Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	University of Massachusetts System; University of Massachusetts Amherst; Tohoku University	Russell, TP (corresponding author), Univ Massachusetts, Polymer Sci & Engn Dept, 120 Governors Dr, Amherst, MA 01003 USA.	russell@mail.pse.umass.edu	Russell, Thomas Paul/ADL-3689-2022	Russell, Thomas Paul/0000-0001-6384-5826; Cui, Mengmeng/0000-0002-5494-6614	U.S. Department of Energy Office of Basic Energy Science [DE-FG02-04ER46126]	U.S. Department of Energy Office of Basic Energy Science(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy Office of Basic Energy Science through contract DE-FG02-04ER46126. There are no conflicts of interest.	Abkarian M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.188301; Binks BP, 2000, LANGMUIR, V16, P8622, DOI 10.1021/la000189s; Binks BP, 2006, COLLOIDAL PARTICLES; Bon SAF, 2007, EUR POLYM J, V43, P4839, DOI 10.1016/j.eurpolymj.2007.09.001; Bramhaiah K, 2013, RSC ADV, V3, P7765, DOI 10.1039/c3ra23324c; Cheng HL, 2009, LANGMUIR, V25, P4412, DOI 10.1021/la803552j; Clegg PS, 2007, LANGMUIR, V23, P5984, DOI 10.1021/la063707t; Clegg PS, 2005, J PHYS-CONDENS MAT, V17, pS3433, DOI 10.1088/0953-8984/17/45/031; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Feng JQ, 1996, J FLUID MECH, V311, P289, DOI 10.1017/S0022112096002601; Ha JW, 2000, J FLUID MECH, V405, P131, DOI 10.1017/S0022112099007223; Herzig EM, 2007, NAT MATER, V6, P966, DOI 10.1038/nmat2055; Hong R, 2006, J AM CHEM SOC, V128, P1078, DOI 10.1021/ja056726i; Lee D, 2008, ADV MATER, V20, P3498, DOI 10.1002/adma.200800918; Li L, 2011, NANO LETT, V11, P1997, DOI 10.1021/nl200366z; Lin Y, 2005, LANGMUIR, V21, P191, DOI 10.1021/la048000q; Lin Y, 2003, SCIENCE, V299, P226, DOI 10.1126/science.1078616; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Orsi D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.105701; Pawar AB, 2011, SOFT MATTER, V7, P7710, DOI 10.1039/c1sm05457k; Rao CNR, 2008, ACCOUNTS CHEM RES, V41, P489, DOI 10.1021/ar700192d; Saville DA, 1997, ANNU REV FLUID MECH, V29, P27, DOI 10.1146/annurev.fluid.29.1.27; Shi YQ, 2013, NEW J CHEM, V37, P236, DOI 10.1039/c2nj40779e; Stone HA, 1999, P ROY SOC A-MATH PHY, V455, P329, DOI 10.1098/rspa.1999.0316; Stratford K, 2005, SCIENCE, V309, P2198, DOI 10.1126/science.1116589; Subramaniam AB, 2005, NATURE, V438, P930, DOI 10.1038/438930a; Tavacoli JW, 2011, ADV FUNCT MATER, V21, P2020, DOI 10.1002/adfm.201002562; TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151; VIZIKA O, 1992, J FLUID MECH, V239, P1, DOI 10.1017/S0022112092004294; Zeng C, 2012, SOFT MATTER, V8, P8582, DOI 10.1039/c2sm25871d	30	255	260	19	462	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					460	463		10.1126/science.1242852	http://dx.doi.org/10.1126/science.1242852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159042				2022-12-28	WOS:000326042600037
J	Apostolou, E; Hochedlinger, K				Apostolou, Effie; Hochedlinger, Konrad			Chromatin dynamics during cellular reprogramming	NATURE			English	Review							PLURIPOTENT STEM-CELLS; MOUSE SOMATIC-CELLS; GROUND-STATE PLURIPOTENCY; PRIMORDIAL GERM-CELLS; DNA DEMETHYLATION; HISTONE VARIANTS; SELF-RENEWAL; C-MYC; TRANSCRIPTION FACTORS; LINEAGE SPECIFIERS	Induced pluripotency is a powerful tool to derive patient-specific stem cells. In addition, it provides a unique assay to study the interplay between transcription factors and chromatin structure. Here, we review the latest insights into chromatin dynamics that are inherent to induced pluripotency. Moreover, we compare and contrast these events with other physiological and pathological processes that involve changes in chromatin and cell state, including germ cell maturation and tumorigenesis. We propose that an integrated view of these seemingly diverse processes could provide mechanistic insights into cell fate transitions in general and might lead to new approaches in regenerative medicine and cancer treatment.	[Apostolou, Effie; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Apostolou, Effie; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Apostolou, Effie; Hochedlinger, Konrad] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Apostolou, Effie; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Apostolou, Effie; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu	Apostolou, Effie/AAG-1559-2020		HHMI; NIH [R01HD058013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank A. Bortvin, D. Egli, V. Pasque, B. Payer, B. Ren, X. Wei, M. Tahiliani and members of the laboratory for helpful suggestions, and B. Lowry, K. Plath and M. Stadtfeld for critical reading of the manuscript. We apologize to those colleagues whose work we could not cite due to space constraints. Support to E. A. was by HHMI and to K. H. by HHMI and NIH (R01HD058013).	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barrero MJ, 2013, CELL REP, V3, P1005, DOI 10.1016/j.celrep.2013.02.029; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Do JT, 2008, STEM CELLS, V26, P2821, DOI 10.1634/stemcells.2008-0482; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Foshay KM, 2012, MOL CELL, V46, P159, DOI 10.1016/j.molcel.2012.02.013; Fragola G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003292; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Hikichi T, 2013, P NATL ACAD SCI USA, V110, P6412, DOI 10.1073/pnas.1220200110; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho R, 2013, CELL REP, V3, P2113, DOI 10.1016/j.celrep.2013.05.015; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Jia JL, 2012, CELL, V151, P576, DOI 10.1016/j.cell.2012.09.023; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Jullien J, 2010, P NATL ACAD SCI USA, V107, P5483, DOI 10.1073/pnas.1000599107; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Lu XW, 2013, SCIENCE, V340, P78, DOI 10.1126/science.1234654; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Magnusdottir E, 2012, CURR OPIN GENET DEV, V22, P466, DOI 10.1016/j.gde.2012.06.002; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nashun B, 2011, EPIGENETICS-US, V6, P1489, DOI 10.4161/epi.6.12.18206; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Pasque V, 2011, EMBO J, V30, P2373, DOI 10.1038/emboj.2011.144; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rapino F, 2013, CELL REP, V3, P1153, DOI 10.1016/j.celrep.2013.03.003; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Skene PJ, 2013, DEVELOPMENT, V140, P2513, DOI 10.1242/dev.091439; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stricker SH, 2013, GENE DEV, V27, P654, DOI 10.1101/gad.212662.112; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026406; Tanabe K, 2013, P NATL ACAD SCI USA, V110, P12172, DOI 10.1073/pnas.1310291110; Tzatsos A, 2013, J CLIN INVEST, V123, P727, DOI 10.1172/JCI64535; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yang SM, 2013, P NATL ACAD SCI USA, V110, P1708, DOI 10.1073/pnas.1213266110; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang H, 2013, CELL STEM CELL, V13, P30, DOI 10.1016/j.stem.2013.05.012; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	125	262	270	0	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					462	471		10.1038/nature12749	http://dx.doi.org/10.1038/nature12749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153299	Green Accepted			2022-12-28	WOS:000325988400040
J	Dajani, R				Dajani, Rana			Universities must inspire students as well as teach	NATURE			English	Editorial Material									[Dajani, Rana] Hashemite Univ, Zarqa, Jordan	Hashemite University	Dajani, R (corresponding author), Hashemite Univ, Zarqa, Jordan.	rdajani@hu.edu.jo	Dajani, Rana/C-3466-2014	Dajani, Rana/0000-0002-4355-9977				2013, NATURE, V499, P381	1	0	0	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					411	411		10.1038/502411a	http://dx.doi.org/10.1038/502411a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	238YN	24153256	Bronze			2022-12-28	WOS:000325988400006
J	Eichler, HG; Petavy, F; Pignatti, F; Rasi, G				Eichler, Hans-Georg; Petavy, Frank; Pignatti, Francesco; Rasi, Guido			Access to Patient-Level Trial Data - A Boon to Drug Developers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The European Medicines Agency aims to make patient-level data from clinical trials publicly accessible while protecting privacy; this would improve drug-development efficiency, cost-effectiveness, and comparative-effectiveness analysis and reduce duplication of effort. The provision of access to clinical trial results that include patient-level data is generating much debate. A growing chorus of transparency advocates is pushing for open access to these data, making a case on the basis of respect for patients' altruism, the need to safeguard public health, and distrust in the integrity and completeness of published trial information.(1) We at the European Medicines Agency (EMA) have been actively engaged in this debate, and the EMA has recently published a draft of a policy that would make patient-level data in its possession publicly accessible. The principle of privacy protection will inform ...	[Eichler, Hans-Georg; Petavy, Frank; Pignatti, Francesco; Rasi, Guido] European Med Agcy, London, England		Eichler, HG (corresponding author), European Med Agcy, London, England.		Rasi, Guido/AAC-8172-2021	Rasi, Guido/0000-0002-2191-1386				[Anonymous], PRINC RESP CLIN TRIA; [Anonymous], 2010, CAT TRANSF HEALTHC I; European Medicines Agency, 2013, PUBL ACC CL IN PRESS; Rabinowitz J., 2011, 24 C EUR COLL NEUR P; Zarin DA, 2013, NEW ENGL J MED, V369, P468, DOI 10.1056/NEJMe1307268	5	50	50	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1577	1579		10.1056/NEJMp1310771	http://dx.doi.org/10.1056/NEJMp1310771			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	24144395	Bronze			2022-12-28	WOS:000326031100003
J	Mello, MM; Francer, JK; Wilenzick, M; Teden, P; Bierer, BE; Barnes, M				Mello, Michelle M.; Francer, Jeffrey K.; Wilenzick, Marc; Teden, Patricia; Bierer, Barbara E.; Barnes, Mark			Preparing for Responsible Sharing of Clinical Trial Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RAW DATA; ACCESS; CLINICALTRIALS.GOV; POLICY; DRUG	The authors review the potential benefits and unintended consequences of the broad sharing of participant-level data from clinical trials. Several options for governance structures that could be implemented to provide expanded access to clinical trial data are discussed. Data from clinical trials, including participant-level data, are being shared by sponsors and investigators more widely than ever before. Some sponsors have voluntarily offered data to researchers,(1),(2) some journals now require authors to agree to share the data underlying the studies they publish,(3) the Office of Science and Technology Policy has directed federal agencies to expand public access to data from federally funded projects,(4) and the European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) have proposed the expansion of access to data submitted in regulatory applications.(5),(6) Sharing participant-level data may bring exciting benefits for scientific ...	[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Bierer, Barbara E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bierer, Barbara E.] Harvard Univ, Sch Med, Boston, MA USA; [Barnes, Mark] Ropes & Gray, Boston, MA USA; [Bierer, Barbara E.; Barnes, Mark] Multireg Clin Trials Ctr Harvard, Cambridge, MA USA; [Barnes, Mark] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Francer, Jeffrey K.] Pharmaceut Res & Manufacturers Amer, Washington, DC USA; [Wilenzick, Marc] Stonington Hts Consulting, Briarcliff Manor, NY USA; [Wilenzick, Marc] Core Risks, Ardmore, PA USA; [Teden, Patricia] Teden Consulting, S Orange, NJ USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Bierer, Barbara/0000-0001-6448-8170				[Anonymous], 2012, NAT BIOTECHNOL, V30, P371, DOI 10.1038/nbt.2237; [Anonymous], 2013, NY TIMES, pA18; [Anonymous], 2010, POL ACC DOC REL MED; [Anonymous], 2013, PUBL ACC CLIN TRIAL; [Anonymous], 2013, MEM HEADS EX DEP AG; [Anonymous], 2012, ETHICAL SCI ISSUES S; Bauchner H, 2013, JAMA-J AM MED ASSOC, V309, P607, DOI 10.1001/jama.2013.58; Bhattacharjee Y, 2012, SCIENCE, V338, P29, DOI 10.1126/science.338.6103.29; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; CEO Life Sciences Consortium, PROJJ DAT SPHER; Chan AW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d80; Copley C., 2013, REUTERS; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; European Federation of Pharmaceutical Industries and Associations, 2013, PRINC RESP CLIN TRIA; Food and Drug Administration (FDA), 2013, AV MASK DEID NONS SA; GlaxoSmithKline, CLIN STUD REG; Godlee F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7888; Godlee F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7304; Godlee F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5641; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Grogan K., 2013, PHARMATIMES ONL 0227; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Harrison C, 2012, NAT REV DRUG DISCOV, V11, P891, DOI 10.1038/nrd3907; Hauser RM, 2013, CONDUCITNG BIOSOCIAL; Idem, 2009, PRINC COND CLIN TRIA; Institute of Medicine, 2006, FUT DRUG SAF PROM PR; Institute of Medicine (US), 2013, SHAR CLIN RES DAT WO; InterMune UK Ltd. v. European Medicines Agency, 2013, NEW ENGL J MED; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1374; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Lemmens T, 2013, J LAW MED ETHICS, V41, P163, DOI 10.1111/jlme.12012; Malin B, 2010, J INVEST MED, V58, P11, DOI 10.2310/JIM.0b013e3181c9b2ea; Miller JD, 2010, JAMA-J AM MED ASSOC, V303, P773, DOI 10.1001/jama.2010.207; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541; Pharmaceutical Research and Manufacturers of America, 2002, PRINC COND CLIN TRIA; Rabesandratana T, 2013, SCIENCE, V339, P1369, DOI 10.1126/science.339.6126.1369; Ross JS, 2013, JAMA-J AM MED ASSOC, V309, P1355, DOI 10.1001/jama.2013.1299; Ross JS, 2012, CIRC-CARDIOVASC QUAL, V5, P238, DOI 10.1161/CIRCOUTCOMES.112.965798; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Spertus JA, 2012, CIRC-CARDIOVASC QUAL, V5, P143, DOI 10.1161/CIRCOUTCOMES.112.965814; Thomas K., 2013, NY TIMES, pBU1; Vickers AJ, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-15; Vickers AJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2323; Yale School of Medicine, RHBMP 2 PROJ; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	47	120	123	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1651	1658		10.1056/NEJMhle1309073	http://dx.doi.org/10.1056/NEJMhle1309073			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239MZ	24144394				2022-12-28	WOS:000326031100016
J	Murdock, DJE; Dong, XP; Repetski, JE; Marone, F; Stampanoni, M; Donoghue, PCJ				Murdock, Duncan J. E.; Dong, Xi-Ping; Repetski, John E.; Marone, Federica; Stampanoni, Marco; Donoghue, Philip C. J.			The origin of conodonts and of vertebrate mineralized skeletons	NATURE			English	Article							TEETH; PHYLOGENY; ANATOMY; JAWS	Conodonts are an extinct group of jawless vertebrates whose toothlike elements are the earliest instance of a mineralized skeleton in the vertebrate lineage(1,2), inspiring the 'inside-out' hypothesis that teeth evolved independently of the vertebrate dermal skeleton and before the origin of jaws(3-6). However, these propositions have been based on evidence from derived euconodonts. Here we test hypotheses of a paraconodont ancestry of euconodonts(7-11) using synchrotron radiation X-ray tomographic microscopy to characterize and compare the microstructure of morphologically similar euconodont and paraconodont elements. Paraconodonts exhibit a range of grades of structural differentiation, including tissues and a pattern of growth common to euconodont basal bodies. The different grades of structural differentiation exhibited by paraconodonts demonstrate the stepwise acquisition of euconodont characters, resolving debate over the relationship between these two groups. By implication, the putative homology of euconodont crown tissue and vertebrate enamel must be rejected as these tissues have evolved independently and convergently. Thus, the precise ontogenetic, structural and topological similarities between conodont elements and vertebrate odontodes appear to be a remarkable instance of convergence. The last common ancestor of conodonts and jawed vertebrates probably lacked mineralized skeletal tissues. The hypothesis that teeth evolved before jaws and the inside-out hypothesis of dental evolution must be rejected; teeth seem to have evolved through the extension of odontogenic competence from the external dermis to internal epithelium soon after the origin of jaws.	[Murdock, Duncan J. E.; Donoghue, Philip C. J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Dong, Xi-Ping] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Dong, Xi-Ping] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China; [Repetski, John E.] US Geol Survey, Natl Ctr, Reston, VA 20192 USA; [Marone, Federica; Stampanoni, Marco] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Univ Zurich, Inst Biomed Engn, CH-8006 Zurich, Switzerland; [Stampanoni, Marco] ETH, CH-8006 Zurich, Switzerland	University of Bristol; Peking University; Chinese Academy of Sciences; United States Department of the Interior; United States Geological Survey; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Donoghue, PCJ (corresponding author), Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	phil.donoghue@bristol.ac.uk	Stampanoni, Marco/J-4099-2013; Dong, Xi-ping/N-5741-2014; Murdock, Duncan/H-3503-2019; Donoghue, Philip/A-3873-2008; Marone, Federica/J-4420-2013; Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/GRR-9695-2022	Stampanoni, Marco/0000-0001-7486-6681; Dong, Xi-ping/0000-0001-5917-7159; Murdock, Duncan/0000-0001-6838-5566; Donoghue, Philip/0000-0003-3116-7463; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681	Swiss Light Source, Paul Scherrer Institut (Villigen, Switzerland); NERC [NE/G016623/1]; Paul Scherrer Institut; NSFC [41372015]; Natural Environment Research Council [NE/G016623/1] Funding Source: researchfish	Swiss Light Source, Paul Scherrer Institut (Villigen, Switzerland); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Paul Scherrer Institut; NSFC(National Natural Science Foundation of China (NSFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The SRXTM experiments were performed on the TOMCAT beamline at the Swiss Light Source, Paul Scherrer Institut (Villigen, Switzerland), funded through a project awarded to P.C.J.D. and S. Bengtson (Stockholm). NERC grant NE/G016623/1 to P.C.J.D., a studentship to DJEM funded by NERC and the Paul Scherrer Institut, and NSFC Project 41372015 to X.-P.D. Thanks to R. Stamm (USGS) for reviewing a draft of this manuscript; and thanks to J. E. Cunningham, D. O. Jones and M. Rucklin for assistance at the beamline. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	ALDRIDGE RJ, 1993, PHILOS T R SOC B, V340, P405, DOI 10.1098/rstb.1993.0082; BENGTSON S, 1976, LETHAIA, V9, P184; Blieck A, 2010, EPISODES, V33, P234, DOI 10.18814/epiiugs/2010/v33i4/002; Donoghue PCJ, 1998, PHILOS T R SOC B, V353, P633, DOI 10.1098/rstb.1998.0231; Donoghue PCJ, 2002, MICROSC RES TECHNIQ, V59, P352, DOI 10.1002/jemt.10217; Donoghue PCJ, 2001, SYST ASSOC SPEC VOL, V61, P85; Donoghue PCJ, 2001, P ROY SOC B-BIOL SCI, V268, P1691, DOI 10.1098/rspb.2001.1728; Donoghue PCJ, 1998, LETHAIA, V31, P211; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; DZIK J, 1976, Acta Palaeontologica Polonica, V21, P395; Dzik J., 1986, PROBLEMATIC FOSSIL T, P240; Fraser GJ, 2010, BIOESSAYS, V32, P808, DOI 10.1002/bies.200900151; Gross W., 1957, Palaeontologische Zeitschrift, V31, P78; Muller K. J, 1971, Mem Fac Sci Kyoto Univ (Geol Mineral), V38, P1; Muller K.J., 1972, International Geol Congr, V24, P20; Patterson C., 1982, PROBLEMS PHYLOGENETI, V29, P21; Pridmore PA, 1996, LETHAIA, V29, P317, DOI 10.1111/j.1502-3931.1996.tb01667.x; Rucklin M, 2012, NATURE, V491, P748, DOI 10.1038/nature11555; Rucklin M, 2011, EVOL DEV, V13, P523, DOI 10.1111/j.1525-142X.2011.00508.x; SANSOM IJ, 1992, SCIENCE, V256, P1308, DOI 10.1126/science.1598573; SANSOM IJ, 1994, NATURE, V368, P591, DOI 10.1038/368591a0; Smith M.M., 2000, P133, DOI 10.1017/CBO9780511542626.010; Smith MA, 1998, INT REV NEUROBIOL, V42, P1, DOI 10.1016/S0074-7742(08)60607-8; Smith MM, 2001, SYST ASSOC SPEC VOL, V61, P223; Stampanoni M, 2006, PROC SPIE, V6318, DOI 10.1117/12.679497; Szaniawski H., 1987, P35; SZANIAWSKI H, 1993, J PALEONTOL, V67, P640, DOI 10.1017/S0022336000024963; SZANIAWSKI H, 1982, J PALEONTOL, V56, P806; Turner S, 2010, GEODIVERSITAS, V32, P545, DOI 10.5252/g2010n4a1	29	57	61	1	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					546	+		10.1038/nature12645	http://dx.doi.org/10.1038/nature12645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24132236				2022-12-28	WOS:000325988400053
J	Mullick, A; Martin, J; Sallnow, L				Mullick, Anjali; Martin, Jonathan; Sallnow, Libby			An introduction to advance care planning in practice	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OF-LIFE CARE; PALLIATIVE CARE; END; DIRECTIVES; DISCUSSIONS; BARRIERS; PEOPLE; DEATH; IMPLEMENTATION; INDIVIDUALS		[Mullick, Anjali; Martin, Jonathan; Sallnow, Libby] St Josephs Hosp, London E8 4SA, England; [Mullick, Anjali] Newham Univ Hosp, London, England; [Martin, Jonathan] Univ Oxford, Harris Manchester Coll, Oxford, England	University of Oxford	Mullick, A (corresponding author), St Josephs Hosp, London E8 4SA, England.	a.mullick@stjh.org.uk	Sallnow, Libby/ABF-2995-2021	Sallnow, Libby/0000-0001-7079-9637				Abel J, 2013, BMJ SUPPORT PALLIAT, V3, P168, DOI 10.1136/bmjspcare-2012-000327; American Medical Association, 2011, OP 2 191 ADV CAR PLA; [Anonymous], 1995, JAMA, V274, P1591; Australian Medical Association, 2006, ROL MED PRACT ADV CA; Barnes K, 2007, PALLIATIVE MED, V21, P23, DOI 10.1177/0269216306073638; Barnes KA, 2011, PALLIAT SUPPORT CARE, V9, P73, DOI 10.1017/S1478951510000568; Billings JA, 2012, J GEN INTERN MED, V27, P595, DOI 10.1007/s11606-011-1976-2; Boddy J, 2013, AUST J PRIM HEALTH, V19, P38, DOI 10.1071/PY11070; Boyd K, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X544032; Callaghan D., HASTINGS CENT REP, V995, pS33; Curtis JR, 2008, J PALLIAT MED, V11, P610, DOI 10.1089/jpm.2007.0209; Dening KH, 2013, PALLIATIVE MED, V27, P409, DOI 10.1177/0269216312464094; Department of Health, 2008, END LIF CAR STRAT PR; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Fried TR, 2008, J GEN INTERN MED, V23, P1602, DOI 10.1007/s11606-008-0748-0; Goodman MD, 1998, CRIT CARE MED, V26, P701, DOI 10.1097/00003246-199804000-00018; Gott M, 2009, PALLIATIVE MED, V23, P642, DOI 10.1177/0269216309106790; Halpern SD, 2012, SEMIN RESP CRIT CARE, V33, P393, DOI 10.1055/s-0032-1322403; Hayhoe B, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588592; Kaldjian LC, 2008, AM J HOSP PALLIAT ME, V25, P501, DOI 10.1177/1049909108328256; Knauft E, 2005, CHEST, V127, P2188, DOI 10.1378/chest.127.6.2188; Levi BH, 2010, AM J HOSP PALLIAT ME, V27, P306, DOI 10.1177/1049909109355280; Lorenz KA, 2008, ANN INTERN MED, V148, P147, DOI 10.7326/0003-4819-148-2-200801150-00010; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Mahon MM, 2011, J PAIN SYMPTOM MANAG, V41, P801, DOI 10.1016/j.jpainsymman.2011.01.002; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; National Institute for Health and Care Excellence, 2006, CG42 NAT I HLTH CAR; NHS National End of Life Care Programme, 2011, CAP CAR PLANN ADV CA; O'Malley AJ, 2011, HEALTH SERV RES, V46, P82, DOI 10.1111/j.1475-6773.2010.01170.x; Pantilat SZ, 2004, JAMA-J AM MED ASSOC, V291, P2476, DOI 10.1001/jama.291.20.2476; Pautex S, 2008, PALLIATIVE MED, V22, P835, DOI 10.1177/0269216308094336; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; Piers RD, 2013, PATIENT EDUC COUNS, V90, P323, DOI 10.1016/j.pec.2011.07.008; Poppe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060412; Prendergast TJ, 2001, CRIT CARE MED, V29, pN34, DOI 10.1097/00003246-200102001-00007; Quill T., 2000, JAMA-J AM MED ASSOC, V284, P2503; Randall F, 2011, BRIT J HOSP MED, V72, P437, DOI 10.12968/hmed.2011.72.8.437; Rhee JJ, 2013, FAM PRACT, V30, P219, DOI 10.1093/fampra/cms063; Rhee JJ, 2012, AUST HEALTH REV, V36, P98, DOI 10.1071/AH11019; Robinson L, 2013, PALLIATIVE MED, V27, P401, DOI 10.1177/0269216312465651; Robinson L, 2012, AGE AGEING, V41, P263, DOI 10.1093/ageing/afr148; Royal College of Physicians National Council for Palliative Care British Society of Rehabilitation Medicine British Geriatrics Society, 2009, CONC GUID GOOD PRACT, V12; Schickedanz AD, 2009, J AM GERIATR SOC, V57, P31, DOI 10.1111/j.1532-5415.2008.02093.x; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Spence A, 2009, PALLIATIVE MED, V23, P126, DOI 10.1177/0269216308098804; Tonelli MR, 1996, CHEST, V110, P816, DOI 10.1378/chest.110.3.816; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	48	125	128	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2013	347								f6064	10.1136/bmj.f6064	http://dx.doi.org/10.1136/bmj.f6064			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243CF	24144870				2022-12-28	WOS:000326293500002
J	Mayes, H; Sheehan, S; Dotan, H				Mayes, Heather; Sheehan, Stafford; Dotan, Hen			ENERGY Fuelling the future	NATURE			English	Editorial Material									[Mayes, Heather] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Sheehan, Stafford] Yale Univ, Phys Chem PhD Programme, New Haven, CT USA; [Dotan, Hen] Technion Israel Inst Technol, Dept Mat Sci & Engn, Haifa, Israel	Northwestern University; Yale University; Technion Israel Institute of Technology	Mayes, H (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.		Sheehan, Stafford/L-3963-2013; Mayes, Heather/D-8755-2016	Sheehan, Stafford/0000-0003-0432-9260; Mayes, Heather/0000-0001-9373-0106				Aden A, 2009, CELLULOSE, V16, P535, DOI 10.1007/s10570-009-9327-8; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Dotan H, 2013, NAT MATER, V12, P158, DOI [10.1038/NMAT3477, 10.1038/nmat3477]; Humbird D., 2011, TECHNICAL REPORT NRE, DOI DOI 10.2172/1107470; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; Lin YJ, 2011, ENERG ENVIRON SCI, V4, P4862, DOI 10.1039/c1ee01850g; Michel H, 2012, ANGEW CHEM INT EDIT, V51, P2516, DOI 10.1002/anie.201200218; Van Noorden R., 2012, NATURE, DOI [10.1038/nature.2012.10703, DOI 10.1038/NATURE.2012.10703]	8	0	0	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					S60	S61		10.1038/502S60a	http://dx.doi.org/10.1038/502S60a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132337	Bronze			2022-12-28	WOS:000325706300008
J	McShane, LM; Cavenagh, MM; Lively, TG; Eberhard, DA; Bigbee, WL; Williams, PM; Mesirov, JP; Polley, MYC; Kim, KY; Tricoli, JV; Taylor, JMG; Shuman, DJ; Simon, RM; Doroshow, JH; Conley, BA				McShane, Lisa M.; Cavenagh, Margaret M.; Lively, Tracy G.; Eberhard, David A.; Bigbee, William L.; Williams, P. Mickey; Mesirov, Jill P.; Polley, Mei-Yin C.; Kim, Kelly Y.; Tricoli, James V.; Taylor, Jeremy M. G.; Shuman, Deborah J.; Simon, Richard M.; Doroshow, James H.; Conley, Barbara A.			Criteria for the use of omics-based predictors in clinical trials	NATURE			English	Article							MICROARRAY; BIOMARKERS	The US National Cancer Institute (NCI), in collaboration with scientists representing multiple areas of expertise relevant to 'omics'-based test development, has developed a checklist of criteria that can be used to determine the readiness of omics-based tests for guiding patient care in clinical trials. The checklist criteria cover issues relating to specimens, assays, mathematical modelling, clinical trial design, and ethical, legal and regulatory aspects. Funding bodies and journals are encouraged to consider the checklist, which they may find useful for assessing study quality and evidence strength. The checklist will be used to evaluate proposals for NCI-sponsored clinical trials in which omics tests will be used to guide therapy.	[McShane, Lisa M.; Cavenagh, Margaret M.; Lively, Tracy G.; Polley, Mei-Yin C.; Kim, Kelly Y.; Tricoli, James V.; Shuman, Deborah J.; Simon, Richard M.; Doroshow, James H.; Conley, Barbara A.] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Eberhard, David A.] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [Eberhard, David A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bigbee, William L.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Bigbee, William L.] Univ Pittsburgh, Sch Med, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Williams, P. Mickey] NCI, Frederick Natl Lab Canc Res, NIH, Frederick, MD 21702 USA; [Mesirov, Jill P.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Mesirov, Jill P.] Harvard Univ, Cambridge, MA 02142 USA; [Taylor, Jeremy M. G.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Michigan System; University of Michigan	McShane, LM (corresponding author), NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA.	mcshanel@ctep.nci.nih.gov	McShane, Lisa/GXM-8870-2022; Mesirov, Jill/AGF-7626-2022		NATIONAL CANCER INSTITUTE [P30CA046592, ZIABC011078, R01CA129102] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NCI NIH HHS [R01 CA129102, P30 CA046592] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], INV NEW DRUG IND APP; Centers for Medicare & Medicaid Services, CLIN LAB IMPR AM CLI; Dobbin KK, 2005, CLIN CANCER RES, V11, P565; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Freidlin B, 2010, J NATL CANCER I, V102, P152, DOI 10.1093/jnci/djp477; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; McShane LM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-220; Micheel C., 2012, EVOLUTION TRANSLATIO; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Moore HM, 2011, CANCER CYTOPATHOL, V119, P92, DOI 10.1002/cncy.20147; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; US Department of Health and Human Services, SACHRP LETT SECR FAQ; US FDA, 2007, GUID IND COMP SYST U; US Food and Drug Administration, GUID IND FD IN PRESS; US Food and Drug Administration, DEV ADV COMPR REG AS	18	151	156	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					317	320		10.1038/nature12564	http://dx.doi.org/10.1038/nature12564			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132288	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000325706300042
J	Spence, D				Spence, Des			General practice 8 till 8	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2013, NHS DIR ANN REP 2012; Iacobucci G, 2013, BMJ-BRIT MED J, V347, pf5949; Royal College of General Practitioners, 2013, MOR DET NEED HLTH SE	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2013	347								F6162	10.1136/bmj.f6162	http://dx.doi.org/10.1136/bmj.f6162			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WM	24133126				2022-12-28	WOS:000325982400003
J	Gill, ON; Spencer, Y; Richard-Loendt, A; Kelly, C; Dabaghian, R; Boyes, L; Linehan, J; Simmons, M; Webb, P; Bellerby, P; Andrews, N; Hilton, DA; Ironside, JW; Beck, J; Poulter, M; Mead, S; Brandner, S				Gill, O. Noel; Spencer, Yvonne; Richard-Loendt, Angela; Kelly, Carole; Dabaghian, Reza; Boyes, Lynnette; Linehan, Jacqueline; Simmons, Marion; Webb, Paul; Bellerby, Peter; Andrews, Nick; Hilton, David A.; Ironside, James W.; Beck, Jon; Poulter, Mark; Mead, Simon; Brandner, Sebastian			Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CREUTZFELDT-JAKOB-DISEASE; VARIANT CJD; TISSUE SAMPLES; BLOOD-TRANSFUSION; TONSIL SPECIMENS; ACCUMULATION; SCRAPIE; SHEEP; BSE; TRANSMISSION	Objectives To carry out a further survey of archived appendix samples to understand better the differences between existing estimates of the prevalence of subclinical infection with prions after the bovine spongiform encephalopathy epizootic and to see whether a broader birth cohort was affected, and to understand better the implications for the management of blood and blood products and for the handling of surgical instruments. Design Irreversibly unlinked and anonymised large scale survey of archived appendix samples. Setting Archived appendix samples from the pathology departments of 41 UK hospitals participating in the earlier survey, and additional hospitals in regions with lower levels of participation in that survey. Sample 32 441 archived appendix samples fixed in formalin and embedded in paraffin and tested for the presence of abnormal prion protein (PrP). Results Of the 32 441 appendix samples 16 were positive for abnormal PrP, indicating an overall prevalence of 493 per million population (95% confidence interval 282 to 801 per million). The prevalence in those born in 1941-60 (733 per million, 269 to 1596 per million) did not differ significantly from those born between 1961 and 1985 (412 per million, 198 to 758 per million) and was similar in both sexes and across the three broad geographical areas sampled. Genetic testing of the positive specimens for the genotype at PRNP codon 129 revealed a high proportion that were valine homozygous compared with the frequency in the normal population, and in stark contrast with confirmed clinical cases of vCJD, all of which were methionine homozygous at PRNP codon 129. Conclusions This study corroborates previous studies and suggests a high prevalence of infection with abnormal PrP, indicating vCJD carrier status in the population compared with the 177 vCJD cases to date. These findings have important implications for the management of blood and blood products and for the handling of surgical instruments.	[Gill, O. Noel; Kelly, Carole; Andrews, Nick] Publ Hlth England, Natl Ctr Infect Dis Surveillance & Control, HIV & STI Dept, London, England; [Gill, O. Noel; Kelly, Carole; Andrews, Nick] Publ Hlth England, Natl Ctr Infect Dis Surveillance & Control, CJD Sect, London, England; [Gill, O. Noel; Kelly, Carole; Andrews, Nick] Publ Hlth England, Natl Ctr Infect Dis Surveillance & Control, CJD Sect, London, England; [Spencer, Yvonne; Webb, Paul; Bellerby, Peter] Anim Hlth & Vet Labs Agcy, Sci Directorate, Pathol Unit, Addlestone, Surrey, England; [Simmons, Marion] Anim Hlth & Vet Labs Agcy, Sci Directorate, Pathol Unit, EU Reference Lab, Addlestone, Surrey, England; [Richard-Loendt, Angela; Brandner, Sebastian] UCL Inst Neurol, Div Neuropathol, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Richard-Loendt, Angela; Boyes, Lynnette; Beck, Jon; Poulter, Mark; Mead, Simon; Brandner, Sebastian] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Dabaghian, Reza; Mead, Simon] Publ Hlth England, Virus Reference Dept, London, England; [Beck, Jon; Poulter, Mark] UCL Inst Neurol, MRC Prion Unit, London, England; [Hilton, David A.] Derriford Hosp, Dept Cellular & Anat Pathol, Plymouth PL6 8DH, Devon, England; [Ironside, James W.] Univ Edinburgh, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis Res & Surveillance Uni, Edinburgh, Midlothian, Scotland	Public Health England; Public Health England; Public Health England; Veterinary Laboratories Agency; Veterinary Laboratories Agency; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Public Health England; University of London; University College London; Derriford Hospital; University of Edinburgh	Brandner, S (corresponding author), UCL Inst Neurol, Div Neuropathol, Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	s.brandner@ucl.ac.uk	Bellerby, Peter/F-1182-2011; Brandner, Sebastian/J-4562-2014; Simmons, Marion/C-2586-2011; Webb, Paul/C-3285-2011; Spencer, Yvonne I/C-6549-2011; Beck, Jon/GRX-8457-2022	Brandner, Sebastian/0000-0002-9821-0342; Mead, Simon/0000-0002-4326-1468; Ironside, James/0000-0001-5869-2108	Policy Research Programme of the UK Department of Health; MRC [G0600953, MC_U123160651, G0900580] Funding Source: UKRI; Medical Research Council [G0900580, G0600953, MC_U123160651] Funding Source: researchfish	Policy Research Programme of the UK Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This was an independent scientific survey commissioned and funded by the Policy Research Programme of the UK Department of Health. The views expressed are those of the authors and not necessarily those of the UK Department of Health.	Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Bell JE, 1997, NEUROPATH APPL NEURO, V23, P26, DOI 10.1111/j.1365-2990.1997.tb01182.x; Bennett P, 2011, BLOOD BORNE TRANSMIS; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; de Marco MF, 2010, J PATHOL, V222, P380, DOI 10.1002/path.2767; Frosh A, 2004, LANCET, V364, P1260, DOI 10.1016/S0140-6736(04)17143-2; Garske T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015626; Georgsson G, 2008, ARCH VIROL, V153, P637, DOI 10.1007/s00705-008-0035-8; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hilton DA, 2002, BRIT MED J, V325, P633, DOI 10.1136/bmj.325.7365.633; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Mead S, 2012, HUM MOL GENET, V21, P1897, DOI 10.1093/hmg/ddr607; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Ryder SJ, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-9; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; TSUNODA R, 1990, VIRCHOWS ARCH B, V59, P95, DOI 10.1007/BF02899393; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wadsworth JDF, 2011, J PATHOL, V223, P511, DOI 10.1002/path.2821; Zeidler M, 1997, LANCET, V350, P668, DOI 10.1016/S0140-6736(05)63366-1; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831	35	184	188	1	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2013	347								f5675	10.1136/bmj.f5675	http://dx.doi.org/10.1136/bmj.f5675			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WK	24129059	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000325982200004
J	Fournie, G; Pfeiffer, DU				Fournie, Guillaume; Pfeiffer, Dirk U.			Can closure of live poultry markets halt the spread of H7N9?	LANCET			English	Editorial Material							AVIAN INFLUENZA		[Fournie, Guillaume; Pfeiffer, Dirk U.] Royal Vet Coll, Prod & Populat Hlth Dept, Vet Epidemiol Econ & Publ Hlth Grp, Hatfield AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Fournie, G (corresponding author), Royal Vet Coll, Prod & Populat Hlth Dept, Vet Epidemiol Econ & Publ Hlth Grp, Hatfield AL9 7TA, Herts, England.	gfournie@rvc.ac.uk	Pfeiffer, Dirk U/C-5002-2009	Pfeiffer, Dirk U/0000-0001-7000-0530; Fournie, Guillaume/0000-0002-6998-1201				[Anonymous], HIGHLY PATHOGENIC AV; Biswas PK, 2009, EMERG INFECT DIS, V15, P1931, DOI 10.3201/eid1512.090643; *CHATH HOUS, 2010, SHIFT EM RESP PREV P; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Figuie M, 2008, RISK ANAL, V28, P441, DOI 10.1111/j.1539-6924.2008.01039.x; Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510; Fournie G, 2013, P NATL ACAD SCI USA, V110, P9177, DOI 10.1073/pnas.1220815110; Murhekar M, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.008, 10.5365/WPSAR.2013.4.2.008]; Naysmith S, 2014, ECOHEALTH, V11, P50, DOI 10.1007/s10393-013-0858-y; *PROMED MAIL, 2013, AV INFL 43 CHIN ZOON; *PROMED MAIL, 2013, AV INFL HUM 104; *REUT, 2013, REUTERS         0416; YU H, 2013, LANCET, DOI DOI 10.1016/S0140-6736(13)61754-7; Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014	14	26	26	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					496	497		10.1016/S0140-6736(13)62109-1	http://dx.doi.org/10.1016/S0140-6736(13)62109-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA5KH	24183055	Green Submitted			2022-12-28	WOS:000331136400009
J	Ronco, G; Dillner, J; Elfstrom, KM; Tunesi, S; Snijders, PJF; Arbyn, M; Kitchener, H; Segnan, N; Gilham, C; Giorgi-Rossi, P; Berkhof, J; Peto, J; Meijer, CJLM				Ronco, Guglielmo; Dillner, Joakim; Elfstrom, K. Miriam; Tunesi, Sara; Snijders, Peter J. F.; Arbyn, Marc; Kitchener, Henry; Segnan, Nereo; Gilham, Clare; Giorgi-Rossi, Paolo; Berkhof, Johannes; Peto, Julian; Meijer, Chris J. L. M.		Int HPV Screening Working Grp	Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials	LANCET			English	Article							HUMAN-PAPILLOMAVIRUS DNA; LIQUID-BASED CYTOLOGY; INTRAEPITHELIAL NEOPLASIA; HIGH-RISK; RECRUITMENT; IMPLEMENTATION; POBASCAM; TESTS	Background In four randomised trials, human papillomavirus (HPV)-based screening for cervical cancer was compared with cytology-based cervical screening, and precursors of cancer were the endpoint in every trial. However, direct estimates are missing of the relative efficacy of HPV-based versus cytology-based screening for prevention of invasive cancer in women who undergo regular screening, of modifiers (eg, age) of this relative efficacy, and of the duration of protection. We did a follow-up study of the four randomised trials to investigate these outcomes. Methods 176 464 women aged 20-64 years were randomly assigned to HPV-based (experimental arm) or cytologybased (control arm) screening in Sweden (Swedescreen), the Netherlands (POBASCAM), England (ARTISTIC), and Italy (NTCC). We followed up these women for a median of 6.5 years (1 214 415 person-years) and identified 107 invasive cervical carcinomas by linkage with screening, pathology, and cancer registries, by masked review of histological specimens, or from reports. Cumulative and study-adjusted rate ratios (experimental vs control) were calculated for incidence of invasive cervical carcinoma. Findings The rate ratio for invasive cervical carcinoma among all women from recruitment to end of follow-up was 0.60 (95% CI 0.40-0.89), with no heterogeneity between studies (p= 0.52). Detection of invasive cervical carcinoma was similar between screening methods during the first 2.5 years of follow-up (0.79, 0.46-1.36) but was significantly lower in the experimental arm thereafter (0.45, 0.25-0.81). In women with a negative screening test at entry, the rate ratio was 0.30 (0.15-0.60). The cumulative incidence of invasive cervical carcinoma in women with negative entry tests was 4.6 per 10(5) (1.1-12.1) and 8.7 per 10(5) (3.3-18.6) at 3.5 and 5.5 years, respectively, in the experimental arm, and 15.4 per 10(5) (7.9-27.0) and 36.0 per 10(5) (23.2-53.5), respectively, in the control arm. Rate ratios did not diff er by cancer stage, but were lower for adenocarcinoma (0.31, 0.14-0.69) than for squamous-cell carcinoma (0.78, 0.49-1.25). The rate ratio was lowest in women aged 30-34 years (0.36, 0.14-0.94).	[Ronco, Guglielmo; Tunesi, Sara; Segnan, Nereo] AO City Hlth & Sci, Ctr Canc Epidemiol & Prevent, I-10123 Turin, Italy; [Segnan, Nereo] Int Agcy Res Canc, F-69372 Lyon, France; [Dillner, Joakim; Elfstrom, K. Miriam] Karolinska Inst, Stockholm, Sweden; [Snijders, Peter J. F.; Berkhof, Johannes; Meijer, Chris J. L. M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Arbyn, Marc] Sci Inst Publ Hlth, Brussels, Belgium; [Kitchener, Henry] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England; [Giorgi-Rossi, Paolo] Azienda Sanit Locale, Reggio Emilia, Italy; [Gilham, Clare; Peto, Julian] London Sch Hyg & Trop Med, London WC1, England	A.O.U. Citta della Salute e della Scienza di Torino; World Health Organization; International Agency for Research on Cancer (IARC); Karolinska Institutet; Vrije Universiteit Amsterdam; University of Manchester; University of London; London School of Hygiene & Tropical Medicine	Ronco, G (corresponding author), AO City Hlth & Sci, Ctr Canc Epidemiol & Prevent CPO, Canc Epidemiol Unit, I-10123 Turin, Italy.	guglielmo.ronco@cpo.it	Rossi, Paolo Giorgi/K-6367-2016; Zorzi, Manuel/J-7029-2016; zappa, marco/AAB-3294-2019; Carozzi, Francesca/AAB-4985-2019; Almonte, Maribel/O-3286-2016; Tunesi, Sara/I-3746-2013; Carozzi, Francesca Maria/K-4739-2016; SANI, CRISTINA/J-8722-2016	Rossi, Paolo Giorgi/0000-0001-9703-2460; Zorzi, Manuel/0000-0001-6025-5214; zappa, marco/0000-0002-6606-9786; Carozzi, Francesca/0000-0002-6980-8011; Tunesi, Sara/0000-0002-8576-942X; Carozzi, Francesca Maria/0000-0002-7162-8781; Confortini, Massimo/0000-0002-9978-8592; Gillio-Tos, Anna/0000-0001-6553-5362; Segnan, Nereo/0000-0002-4730-5384; SANI, CRISTINA/0000-0001-8955-8913	European Union (PREDHICT) [242061]; Belgian Foundation Against Cancer; KCE-Centre d'Expertise (Brussels, Belgium); IARC (Lyon, France); Netherlands Organisation for Health Research and Development (The Hague); Italian Ministry of Health; National Institute for Health Research [98/04/64, 98/04/501] Funding Source: researchfish	European Union (PREDHICT); Belgian Foundation Against Cancer; KCE-Centre d'Expertise (Brussels, Belgium); IARC (Lyon, France); Netherlands Organisation for Health Research and Development (The Hague)(Netherlands Organization for Health Research and Development); Italian Ministry of Health(Ministry of Health, Italy); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the European Union (PREDHICT project, FP7 grant agreement no 242061), Belgian Foundation Against Cancer, KCE-Centre d'Expertise (Brussels, Belgium), IARC (Lyon, France), The Netherlands Organisation for Health Research and Development (The Hague), and the Italian Ministry of Health. We thank all the staff for assistance in running the four randomised trials and the women who participated.	Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Breslow NE., 1987, STAT METHODS CANC RE, P81; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Elfgren K, 2005, AM J OBSTET GYNECOL, V193, P650, DOI 10.1016/j.ajog.2005.01.056; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Leinonen MK, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7789; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Ogilvie GS, 2012, BRIT J CANCER, V107, P1917, DOI 10.1038/bjc.2012.489; Palma PD, 2009, AM J CLIN PATHOL, V132, P125, DOI 10.1309/AJCPBRK7D1YIUWFP; Parkin DM., 1998, 31 IARC; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2008, J NATL CANCER I, V100, P492, DOI 10.1093/jnci/djn065; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; ROTHMAN KJ, 1978, J CHRON DIS, V31, P557, DOI 10.1016/0021-9681(78)90043-7; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Zappa M, 2000, EVALUATION MONITORIN, P99	28	1001	1055	10	130	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					524	532		10.1016/S0140-6736(13)62218-7	http://dx.doi.org/10.1016/S0140-6736(13)62218-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24192252				2022-12-28	WOS:000331136400028
J	Yu, HJ; Wu, JT; Cowling, BJ; Liao, QH; Fang, VJ; Zhou, S; Wu, P; Zhou, H; Lau, EHY; Guo, DH; Ni, MY; Peng, ZB; Feng, LZ; Jiang, H; Luo, HM; Li, Q; Feng, ZJ; Wang, Y; Yang, WZ; Leung, GM				Yu, Hongjie; Wu, Joseph T.; Cowling, Benjamin J.; Liao, Qiaohong; Fang, Vicky J.; Zhou, Sheng; Wu, Peng; Zhou, Hang; Lau, Eric H. Y.; Guo, Danhuai; Ni, Michael Y.; Peng, Zhibin; Feng, Luzhao; Jiang, Hui; Luo, Huiming; Li, Qun; Feng, Zijian; Wang, Yu; Yang, Weizhong; Leung, Gabriel M.			Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study	LANCET			English	Article							HUMAN INFECTIONS; HONG-KONG; RISK-FACTORS; RESPIRATORY DROPLET; CHINA; FERRETS; OUTBREAK; EXPOSURE; DISEASE; HEALTH	Background Transmission of the novel avian influenza A H7N9 virus seems to be predominantly between poultry and people. In the major Chinese cities of Shanghai, Hangzhou, Huzhou, and Nanjing-where most human cases of infection have occurred-live poultry markets (LPMs) were closed in April, 2013, soon after the initial outbreak, as a precautionary public health measure. Our objective was to quantify the effect of LPM closure in these cities on poultry-to-person transmission of avian influenza A H7N9 virus. Methods We obtained information about every laboratory-confirmed human case of avian influenza A H7N9 virus infection reported in the four cities by June 7, 2013, from a database built by the Chinese Center for Disease Control and Prevention. We used data for age, sex, location, residence type (rural or urban area), and dates of illness onset. We obtained information about LPMs from official sources. We constructed a statistical model to explain the patterns in incidence of cases reported in each city on the basis of the assumption of a constant force of infection before LPM closure, and a different constant force of infection after closure. We fitted the model with Markov chain Monte Carlo methods. Findings 85 human cases of avian influenza A H7N9 virus infection were reported in Shanghai, Hangzhou, Huzhou, and Nanjing by June 7, 2013, of which 60 were included in our main analysis. Closure of LPMs reduced the mean daily number of infections by 99% (95% credibility interval 93-100%) in Shanghai, by 99% (92-100%) in Hangzhou, by 97% (68-100%) in Huzhou, and by 97% (81-100%) in Nanjing. Because LPMs were the predominant source of exposure to avian influenza A H7N9 virus for confirmed cases in these cities, we estimated that the mean incubation period was 3.3 days (1.4-5.7). Interpretation LPM closures were effective in the control of human risk of avian influenza A H7N9 virus infection in the spring of 2013. In the short term, LPM closure should be rapidly implemented in areas where the virus is identified in live poultry or people. In the long term, evidence-based discussions and deliberations about the role of market rest days and central slaughtering of all live poultry should be renewed.	[Yu, Hongjie; Liao, Qiaohong; Zhou, Sheng; Zhou, Hang; Peng, Zhibin; Feng, Luzhao; Jiang, Hui] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Luo, Huiming] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China; [Li, Qun; Feng, Zijian] Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing, Peoples R China; [Wang, Yu; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Off Director, Beijing, Peoples R China; [Wu, Joseph T.; Cowling, Benjamin J.; Fang, Vicky J.; Wu, Peng; Lau, Eric H. Y.; Ni, Michael Y.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China; [Guo, Danhuai] Chinese Acad Sci, Comp Network Informat Ctr, Sci Data Ctr, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; University of Hong Kong; Chinese Academy of Sciences; Computer Network Information Center, CAS	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk; yangwz@chinacdc.cn	Cowling, Benjamin John/C-4263-2009; Wu, Joseph/ABD-5880-2021; Guo, Danhuai/AAE-9112-2020; Guo, Dan/S-8823-2019; Yu, Hongjie/GZK-5351-2022; Lau, Eric/AAJ-6588-2021	Cowling, Benjamin John/0000-0002-6297-7154; Lau, Eric/0000-0002-6688-9637; Ni, Michael/0000-0002-1217-5858; Yang, Weizhong/0000-0002-6599-825X; Leung, Gabriel/0000-0002-2503-6283; Wu, Peng/0000-0003-1157-9401	Ministry of Science and Technology, China; Research Fund for the Control of Infectious Disease; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; US National Institutes of Health; Hong Kong University Grants Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Research Fund for the Control of Infectious Disease; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong University Grants Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Ministry of Science and Technology, China; Research Fund for the Control of Infectious Disease; Hong Kong University Grants Committee; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; and the US National Institutes of Health.	Ai J, 2013, EUROSURVEILLANCE, V18, P4, DOI 10.2807/1560-7917.ES2013.18.26.20510; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Arima Y, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.005, 10.5365/WPSAR.2013.4.2.005]; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Centre for Health Protection Hong Kong Special Administrative Region, 2013, NOT ADD HUM CAS AV I; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, EUROSURVEILLANCE, V18, P2; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Food and Agriculture Organization World Organisation for Animal Health World Health Organization United Nations Children's Fund World Bank UN System Influenza Coordinator, 2008, CONTR ON WORLD ON HL; Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gebski V, 2012, EPIDEMIOL INFECT, V140, P2131, DOI 10.1017/S0950268812000179; Gelman A, 1996, STAT SINICA, V6, P733; Han J, 2013, EUROSURVEILLANCE, V18, P6; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Horby P, 2013, NATURE, V496, P399, DOI 10.1038/496399a; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jonges M, 2013, EUROSURVEILLANCE, V18, P2; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Lau EHY, 2007, EMERG INFECT DIS, V13, P1340, DOI 10.3201/eid1309.061549; Leung YHC, 2012, EMERG INFECT DIS, V18, P1339, DOI 10.3201/eid1808.111879; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Martin V, 2011, PREV VET MED, V102, P196, DOI 10.1016/j.prevetmed.2011.07.007; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Mullaney R, 2003, AVIAN DIS, V47, P1096, DOI 10.1637/0005-2086-47.s3.1096; Murhekar M, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.008, 10.5365/WPSAR.2013.4.2.008]; Oladokun AT, 2012, PAN AFR MED J, V13; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Shortridge KF, 1999, VACCINE, V17, pS26, DOI 10.1016/S0264-410X(99)00102-4; The Central People's Government of the People's Republic of China, CONTR PREV INFL H7N9; The Central People's Government of the People's Republic of China, 1 BATCH LIV POULTR R; The Central People's Government of the People's Republic of China, AGR DEP FUJ PROV TAK; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; WHO, 2003, CUM NUMB CONF HUM CA; Wu Y, 2013, SCI CHINA LIFE SCI, V56, P493, DOI 10.1007/s11427-013-4496-y; Xu JG, 2013, LANCET, V381, P1815, DOI 10.1016/S0140-6736(13)60950-2; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	43	208	232	4	122	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					541	548		10.1016/S0140-6736(13)61904-2	http://dx.doi.org/10.1016/S0140-6736(13)61904-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24183056	Green Accepted			2022-12-28	WOS:000331136400030
J	Williams, CL; Bunch, KJ; Stiller, CA; Murphy, MFG; Botting, BJ; Wallace, WH; Davies, M; Sutcliffe, AG				Williams, Carrie L.; Bunch, Kathryn J.; Stiller, Charles A.; Murphy, Michael F. G.; Botting, Beverley J.; Wallace, W. Hamish; Davies, Melanie; Sutcliffe, Alastair G.			Cancer Risk among Children Born after Assisted Conception	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; IN-VITRO FERTILIZATION; CHILDHOOD-CANCER; DNA METHYLATION; REPRODUCTIVE TECHNOLOGIES; EPIGENETIC ALTERATIONS; TWINS; IVF; SINGLETONS; DISORDERS	BackgroundAccurate population-based data are needed on the incidence of cancer in children born after assisted conception. MethodsWe linked data on all children born in Britain between 1992 and 2008 after assisted conception without donor involvement with data from the United Kingdom National Registry of Childhood Tumours to determine the number of children in whom cancer developed before 15 years of age. Cohort cancer rates were compared with population-based rates in Britain over the same period, with stratification for potential mediating and moderating factors, including sex, age at diagnosis, birth weight, singleton versus multiple birth, parity, parental age, type of assisted conception, and cause of parental infertility. ResultsThe cohort consisted of 106,013 children born after assisted conception (700,705 person-years of observation). The average duration of follow-up was 6.6 years. Overall, 108 cancers were identified, as compared with 109.7 expected cancers (standardized incidence ratio, 0.98; 95% confidence interval [CI], 0.81 to 1.19; P=0.87). Assisted conception was not associated with an increased risk of leukemia, neuroblastoma, retinoblastoma, central nervous system tumors, or renal or germ-cell tumors. It was associated with an increased risk of hepatoblastoma (standardized incidence ratio, 3.64; 95% CI, 1.34 to 7.93; P=0.02; absolute excess risk, 6.21 cases per 1 million person-years) and rhabdomyosarcoma (standardized incidence ratio, 2.62; 95% CI, 1.26 to 4.82; P=0.02; absolute excess risk, 8.82 cases per 1 million person-years), with hepatoblastoma developing in 6 children and rhabdomyosarcoma in 10 children. The excess risk of hepatoblastoma was associated with low birth weight. ConclusionsThere was no increase in the overall risk of cancer among British children born after assisted conception during the 17-year study period. Increased risks of hepatoblastoma and rhabdomyosarcoma were detected, but the absolute risks were small. (Funded by Cancer Research UK and others.)	[Williams, Carrie L.; Botting, Beverley J.; Sutcliffe, Alastair G.] UCL, Inst Child Hlth, London WC1N 1EH, England; [Davies, Melanie] Univ Coll London Hosp, Reprod Med Unit, London, England; [Bunch, Kathryn J.; Stiller, Charles A.; Murphy, Michael F. G.] Univ Oxford, Childhood Canc Res Grp, Dept Paediat, Oxford, England; [Wallace, W. Hamish] Univ Edinburgh, Royal Hosp Sick Children, Dept Paediat Oncol, Edinburgh, Midlothian, Scotland	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Oxford; University of Edinburgh	Sutcliffe, AG (corresponding author), UCL, Inst Child Hlth, Gen & Adolescent Paediat Unit, 30 Guilford St, London WC1N 1EH, England.	a.sutcliffe@ucl.ac.uk		Davies, Melanie/0000-0001-6907-5527; wallace, william, hamish/0000-0001-8080-5674; Sutcliffe, Alastair/0000-0001-8542-6155; Stiller, Charles/0000-0002-3006-7869	Cancer Research UK; Cancer Research UK [16874, 11704] Funding Source: researchfish; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [DRF-2011-04-148] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Cancer Research UK and others	Adamson GD, 2012, HUM REPROD S2, V27, pii38; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Bruinsma F, 2000, HUM REPROD, V15, P604, DOI 10.1093/humrep/15.3.604; Chen SL, 2010, FERTIL STERIL, V94, P2356, DOI 10.1016/j.fertnstert.2010.01.120; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; Halliday J, 2004, AM J HUM GENET, V75, P526, DOI 10.1086/423902; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Hiura H, 2012, HUM REPROD, V27, P2541, DOI 10.1093/humrep/des197; Kallen B, 2010, PEDIATRICS, V126, pE270, DOI 10.1542/peds.2009-3225; Katagiri Y, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/437528; Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319; Klip H, 2003, HUM REPROD, V18, P1951, DOI 10.1093/humrep/deg358; Kroll ME, 2011, BRIT J CANCER, V104, P1227, DOI 10.1038/bjc.2011.70; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; Maher ER, 2003, HUM REPROD, V18, P2508, DOI 10.1093/humrep/deg486; McDonald SD, 2010, EUR J OBSTET GYN R B, V148, P105, DOI 10.1016/j.ejogrb.2009.09.019; McLaughlin CC, 2006, AM J EPIDEMIOL, V163, P818, DOI 10.1093/aje/kwj104; Murphy MFG, 2008, PEDIATR BLOOD CANCER, V51, P62, DOI 10.1002/pbc.21479; Office for National Statistics, 2011, INT LIF TABL UK 1980; Pinborg A, 2004, HUM REPROD, V19, P435, DOI 10.1093/humrep/deh063; Puumala SE, 2012, HUM REPROD, V27, P1649, DOI 10.1093/humrep/des109; Puumala SE, 2009, CANCER EPIDEM BIOMAR, V18, P162, DOI 10.1158/1055-9965.EPI-08-0660; Raimondi S, 2005, BRIT J CANCER, V93, P1053, DOI 10.1038/sj.bjc.6602838; Santos F, 2010, HUM REPROD, V25, P2387, DOI 10.1093/humrep/deq151; Schieve LA, 2004, OBSTET GYNECOL, V103, P1154, DOI 10.1097/01.AOG.0000124571.04890.67; Spector LG, 2008, BRIT J CANCER, V98, P1570, DOI 10.1038/sj.bjc.6604335; Spector LG, 2009, PEDIATRICS, V124, P96, DOI 10.1542/peds.2008-3069; StataCorp, 2021, STATA STAT SOFTWARE; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Sutcliffe AG, 1995, HUM REPROD, V10, P3332, DOI 10.1093/oxfordjournals.humrep.a135915; Sutcliffe AG, 2007, LANCET, V370, P351, DOI 10.1016/S0140-6736(07)60456-5; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Williams C, 2011, ARCH DIS CHILD S, V96, pA6; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343	38	71	74	4	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1819	1827		10.1056/NEJMoa1301675	http://dx.doi.org/10.1056/NEJMoa1301675			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24195549				2022-12-28	WOS:000326607800010
J	Meinert, CL				Meinert, Curtis L.			PERSONAL VIEW The US requirement to deposit trial data within a year is unworkable	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXPRESSION		Johns Hopkins Univ, Baltimore, MD 21205 USA	Johns Hopkins University	Meinert, CL (corresponding author), Johns Hopkins Univ, Baltimore, MD 21205 USA.	cmeinert@jhsph.edu						Bombardier C, 2006, NEW ENGL J MED, V354, P1196; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Goldacre B., 2013, NY TIMES; Meinert CL, 2012, CLIN TRIALS DESIGN C; Pittman G., 2013, REUTERS HLTH    0306; Ross JS, 2013, JAMA INTERN MED, V173, P825, DOI 10.1001/jamainternmed.2013.136; University Group Diabetes Program Research Group, 1970, DIABETES, V19, P785	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2013	347								f6449	10.1136/bmj.f6449	http://dx.doi.org/10.1136/bmj.f6449			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247FD	24185131				2022-12-28	WOS:000326600400009
J	Rey, G; Reddy, AB				Rey, Guillaume; Reddy, Akhilesh B.			Rhythmic Respiration	SCIENCE			English	Editorial Material							CIRCADIAN CLOCKS; CYCLE		[Rey, Guillaume; Reddy, Akhilesh B.] Univ Cambridge, Addenbrookes Hosp, Wellcome MRC Inst Metab Sci,Metab Res Labs, NIHR Biomed Res Ctr,Dept Clin Neurosci, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rey, G (corresponding author), Univ Cambridge, Addenbrookes Hosp, Wellcome MRC Inst Metab Sci,Metab Res Labs, NIHR Biomed Res Ctr,Dept Clin Neurosci, Cambridge CB2 0QQ, England.	areddy@cantab.net	Rey, Guillaume/F-5303-2012	Rey, Guillaume/0000-0001-7664-7052	Medical Research Council [G0600717B, MC_UU_12012/5/B] Funding Source: researchfish; MRC [G0600717] Funding Source: UKRI; Medical Research Council [G0600717] Funding Source: Medline; Wellcome Trust [100333, 100574] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Masri S, 2013, P NATL ACAD SCI USA, V110, P3339, DOI 10.1073/pnas.1217632110; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Rey G, 2013, TRENDS CELL BIOL, V23, P234, DOI 10.1016/j.tcb.2013.01.003; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Stangherlin A, 2013, J BIOL CHEM, V288, P26505, DOI 10.1074/jbc.R113.457564; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499	15	4	4	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					570	571		10.1126/science.1246658	http://dx.doi.org/10.1126/science.1246658			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179212	Green Accepted			2022-12-28	WOS:000326334300029
J	Chung, HS; Eaton, WA				Chung, Hoi Sung; Eaton, William A.			Single-molecule fluorescence probes dynamics of barrier crossing	NATURE			English	Article							SOLVENT VISCOSITY; INTERNAL-FRICTION; FOLDING RATES; PROTEIN; DEPENDENCE; KINETICS; STATES; FORCE; MODEL	Kramers developed the theory on how chemical reaction rates are influenced by the viscosity of the medium(1,2). At the viscosity of water, the kinetics of unimolecular reactions are described by diffusion of a Brownian particle over a free-energy barrier separating reactants and products. For reactions in solution this famous theory extended Eyring's transition state theory, and is widely applied in physics, chemistry and biology, including to reactions as complex as protein folding(3,4). Because the diffusion coefficient of Kramers' theory is determined by the dynamics in the sparsely populated region of the barrier top, its properties have not been directly measured for any molecular system. Here we show that the Kramers diffusion coefficient and free-energy barrier can be characterized by measuring the temperature- and viscosity-dependence of the transition path time for protein folding. The transition path is the small fraction of an equilibrium trajectory for a single molecule when the free-energy barrier separating two states is actually crossed. Its duration, the transition path time, can now be determined from photon trajectories for single protein molecules undergoing folding/unfolding transitions(5). Our finding of a long transition path time with an unusually small solvent viscosity dependence suggests that internal friction as well as solvent friction determine the Kramers diffusion coefficient for alpha-helical proteins, as opposed to a breakdown of his theory, which occurs for many small-molecule reactions(2). It is noteworthy that the new and fundamental information concerning Kramers' theory and the dynamics of barrier crossings obtained here come from experiments on a protein rather than a much simpler chemical or physical system.	[Chung, Hoi Sung; Eaton, William A.] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chung, HS (corresponding author), NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.	chunghoi@niddk.nih.gov; eaton@helix.nih.gov	Chung, Hoi Sung/C-2624-2009	Chung, Hoi Sung/0000-0001-6897-4969	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029055] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are particularly indebted to J. M. Louis for the preparation, dye labelling and purification of the protein used in this work, with technical assistance from A. Aniana. We also thank R. Best, G. Hummer and A. Szabo for discussions and comments on the manuscript, and D. E. Shaw Research for providing access to their molecular dynamics trajectories for the calculations by R. Best. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Benninger RKP, 2006, ANAL CHEM, V78, P2272, DOI 10.1021/ac051990f; Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; Chung HS, 2013, CHEM PHYS, V422, P229, DOI 10.1016/j.chemphys.2012.08.005; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Chung HS, 2011, J PHYS CHEM A, V115, P3642, DOI 10.1021/jp1009669; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Eaton W. A., P NATL ACAD IN PRESS; Godoy-Ruiz R, 2008, J PHYS CHEM B, V112, P5938, DOI 10.1021/jp0757715; Gopich IV, 2009, J PHYS CHEM B, V113, P10965, DOI 10.1021/jp903671p; Hagen SJ, 2010, CURR PROTEIN PEPT SC, V11, P385; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hummer G, 2005, ACCOUNTS CHEM RES, V38, P504, DOI 10.1021/ar040148d; Hummer G, 2004, J CHEM PHYS, V120, P516, DOI 10.1063/1.1630572; Jas GS, 2001, J PHYS CHEM B, V105, P261, DOI 10.1021/jp0022048; Klimov DK, 1997, PHYS REV LETT, V79, P317, DOI 10.1103/PhysRevLett.79.317; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2008, P NATL ACAD SCI USA, V105, P18655, DOI 10.1073/pnas.0808600105; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Liu F, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3077008; Makarov DE, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4773283; Merchant KA, 2007, P NATL ACAD SCI USA, V104, P1528, DOI 10.1073/pnas.0607097104; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Portman JJ, 2001, J CHEM PHYS, V114, P5082, DOI 10.1063/1.1334663; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Schulz JCF, 2012, J AM CHEM SOC, V134, P6273, DOI 10.1021/ja211494h; Socci ND, 1996, J CHEM PHYS, V104, P5860, DOI 10.1063/1.471317; Soranno A, 2012, P NATL ACAD SCI USA, V109, P17800, DOI 10.1073/pnas.1117368109; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609; Zagrovic B, 2003, J COMPUT CHEM, V24, P1432, DOI 10.1002/jcc.10297; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P15486, DOI 10.1073/pnas.2136623100	38	169	169	2	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					685	+		10.1038/nature12649	http://dx.doi.org/10.1038/nature12649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153185	Green Accepted			2022-12-28	WOS:000326293200048
J	Walker, I; Chappell, LC; Williamson, C				Walker, Ian; Chappell, Lucy C.; Williamson, Catherine			RATIONAL TESTING Abnormal liver function tests in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREECLAMPSIA; HEMOLYSIS; OUTCOMES; ENZYMES; WOMEN		[Walker, Ian] Wexham Pk Hosp, Dept Biochem, Slough SL2 4HL, Berks, England; [Chappell, Lucy C.; Williamson, Catherine] Kings Coll London & Kings Hlth Partners, Womens Hlth Acad Ctr, London SE1 1UL, England	University of London; King's College London	Williamson, C (corresponding author), Kings Coll London & Kings Hlth Partners, Womens Hlth Acad Ctr, London SE1 1UL, England.	catherine.williamson@kcl.ac.uk		Williamson, Catherine/0000-0002-6226-7611				Bailey DJ, 2005, AUST NZ J OBSTET GYN, V45, P144, DOI 10.1111/j.1479-828X.2005.00382.x; Barton JR, 2004, CLIN PERINATOL, V31, P807, DOI 10.1016/j.clp.2004.06.008; Ch'ng CL, 2002, GUT, V51, P876, DOI 10.1136/gut.51.6.876; Geenes V, 2014, HEPATOLOGY, V59, P1482, DOI 10.1002/hep.26617; Girling JC, 1997, BRIT J OBSTET GYNAEC, V104, P246, DOI 10.1111/j.1471-0528.1997.tb11054.x; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Haddad B, 2000, AM J OBSTET GYNECOL, V183, P444, DOI 10.1067/mob.2000.105915; Knight M, 2008, GUT, V57, P951, DOI 10.1136/gut.2008.148676; National Institute for Health and Clinical Excellence: Guidance, 2010, HYP PREGN MAN HYP DI; Nelson-Piercy C, 2010, HDB OBSTET MED; Pak Eddy, 2004, Prog Transplant, V14, P91; Royal College of Obstetricians and Gynaecologists, 2011, OBST CHOL GREEN TOP; Thangaratinam S, 2011, ACTA OBSTET GYN SCAN, V90, P574, DOI 10.1111/j.1600-0412.2011.01112.x; Verberg MFG, 2005, HUM REPROD UPDATE, V11, P527, DOI 10.1093/humupd/dmi021; Walker IAL, 2002, ANN CLIN BIOCHEM, V39, P105, DOI 10.1258/0004563021901856	15	29	31	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2013	347								f6055	10.1136/bmj.f6055	http://dx.doi.org/10.1136/bmj.f6055			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CM	24162941				2022-12-28	WOS:000326294200004
J	Moore, W				Moore, Wendy			PAST CARING The saviour of Hunter's collection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2013	347								f6450	10.1136/bmj.f6450	http://dx.doi.org/10.1136/bmj.f6450			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CK	24157640				2022-12-28	WOS:000326294000008
J	Spence, D				Spence, Des			Which is the best medical school?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2012, GUARDIAN; Department for Education, IMP TEACH SCH WHIT P; McManus IC, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-5; Russell Group, 2010, MOR STUD POOR AR ENT; Wallop Harry, 2013, TELEGRAPH	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6352	10.1136/bmj.f6352	http://dx.doi.org/10.1136/bmj.f6352			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CI	24149822				2022-12-28	WOS:000326293800025
J	Srivastava, R				Srivastava, Ranjana			Privacy and All That	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia.			Srivastava, Rakesh/0000-0002-0065-4069; Srivastava, Rakesh/0000-0003-3112-4252					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1488	1489		10.1056/NEJMp1307152	http://dx.doi.org/10.1056/NEJMp1307152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	267MJ	24131177				2022-12-28	WOS:000328101700005
J	Frieden, R				Frieden, Rick			In adults with acute ICH, intensive BP management did not reduce death or major disability	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Lakeland Reg Hlth Syst, St Joseph, MI 49085 USA		Frieden, R (corresponding author), Lakeland Reg Hlth Syst, St Joseph, MI 49085 USA.			Anderson, Craig/0000-0002-7248-4863					0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC6	10.7326/0003-4819-159-8-201310150-02006	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126667				2022-12-28	WOS:000326751200005
J	Harper, DM				Harper, Diane M.			Review: Yoga reduces low back pain and back-specific disability	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Louisville, Sch Med, Louisville, KY 40292 USA	University of Louisville	Harper, DM (corresponding author), Univ Louisville, Sch Med, Louisville, KY 40292 USA.		Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X; Cramer, Holger/0000-0002-3640-8046				Cruser D, 2012, J MAN MANIP THER, V20, P5, DOI 10.1179/2042618611Y.0000000016; Licciardone JC, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-43; Monticone M, 2013, CLIN J PAIN; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805	4	1	1	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC13	10.7326/0003-4819-159-8-201310150-02013	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126662				2022-12-28	WOS:000326751200012
J	Kowdley, KV; Burman, BE				Kowdley, Kris V.; Burman, Blaire E.			Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kowdley, Kris V.] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Burman, Blaire E.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Virginia Mason Medical Center; University of California System; University of California San Francisco	Kowdley, KV (corresponding author), Virginia Mason Med Ctr, Seattle, WA 98101 USA.		Kowdley, Kris/AAF-5202-2019					Als-Nielsen B, 2004, BMJ-BRIT MED J, V328, P1046, DOI 10.1136/bmj.38048.506134.EE; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Stepanova M, 2012, CLIN GASTROENTEROL H, V10, P1034, DOI 10.1016/j.cgh.2012.05.016	3	3	3	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC8	10.7326/0003-4819-159-8-201310150-02008	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126669				2022-12-28	WOS:000326751200007
J	Wan, J; Wang, SW; Haynes, K; Denburg, MR; Shin, DB; Gelfand, JM				Wan, Joy; Wang, Shuwei; Haynes, Kevin; Denburg, Michelle R.; Shin, Daniel B.; Gelfand, Joel M.			Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPROVEMENT NETWORK THIN; IGA NEPHROPATHY; MYOCARDIAL-INFARCTION; RENAL IMPAIRMENT; PREVALENCE; INVOLVEMENT; VALIDATION; MORTALITY; CONSENSUS; VALIDITY	Objective To determine the risk of chronic kidney disease in patients with psoriasis. Design Population based cohort study and nested cross sectional study. Setting Electronic medical records database based in United Kingdom. Participants Cohort study: patients with psoriasis aged 18-90 each matched to up to five patients without psoriasis based on age, practice, and time of visit. Nested study: patients with psoriasis aged 25-64 with confirmed data on psoriasis severity, each matched to up to 10 patients without psoriasis based on age and practice. Main outcome measures Cohort study: incident moderate to advanced (stage 3 through 5) chronic kidney disease. Nested study: baseline prevalence of chronic kidney disease. Results 136 529 patients with mild psoriasis and 7354 patients with severe psoriasis based on treatment patterns were matched to 689 702 unaffected patients. The adjusted hazard ratios (95% confidence intervals) for incident chronic kidney disease were 1.05 (1.02 to 1.07), 0.99 (0.97 to 1.02), and 1.93 (1.79 to 2.08) in the overall, mild, and severe psoriasis groups, respectively. Age was a significant effect modifier in the severe psoriasis group, with age specific adjusted hazard ratios (95% confidence intervals) of 3.82 (3.15 to 4.64) and 2.00 (1.86 to 2.17) for patients aged 30 and 60, respectively. In the nested analysis of 8731 patients with psoriasis with measurements of affected body surface area matched to 87 310 patients without psoriasis, the adjusted odds ratios (95% confidence intervals) for chronic kidney disease were 0.89 (0.72 to 1.10), 1.36 (1.06 to 1.74), and 1.58 (1.07 to 2.34) in the mild, moderate, and severe psoriasis groups, respectively. Conclusions Moderate to severe psoriasis is associated with an increased risk of chronic kidney disease independent of traditional risk factors.	[Wan, Joy; Wang, Shuwei; Shin, Daniel B.; Gelfand, Joel M.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Haynes, Kevin; Shin, Daniel B.; Gelfand, Joel M.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Denburg, Michelle R.] Childrens Hosp Philadelphia, Dept Nephrol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Gelfand, JM (corresponding author), Univ Penn, Dept Dermatol, 1471 Penn Tower,1 Convent Ave, Philadelphia, PA 19104 USA.	joel.gelfand@uphs.upenn.edu		Gelfand, Joel/0000-0003-3480-2661	National Institute of Arthritis and Musculoskeletal and Skin Diseases [K24AR064310, T32-AR07465]; National Heart, Lung, and Blood Institute [R01-HL089744]; National Institute of Diabetes and Digestive and Kidney Diseases [K23-DK093556, T35-DK060441, UL1TR000003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR064310, T32AR007465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK093556, T35DK060441] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases K24AR064310 (JMG) and training grant T32-AR07465 (SW), the National Heart, Lung, and Blood Institute R01-HL089744 (JMG), and the National Institute of Diabetes and Digestive and Kidney Diseases K23-DK093556 (MRD) and training grant T35-DK060441 (JW) and UL1TR000003 (KH). Funding sources had no role in the study, and researchers were independent from funders.	Abuabara K, 2010, BRIT J DERMATOL, V163, P586, DOI 10.1111/j.1365-2133.2010.09941.x; Ahuja TS, 1998, AM J NEPHROL, V18, P425, DOI 10.1159/000013388; [Anonymous], 2006, PSOR PSOR ARTHR POCK; Archibald G, 2007, NEPHROL DIAL TRANSPL, V22, P2455, DOI 10.1093/ndt/gfm268; Azfar RS, 2012, ARCH DERMATOL, V148, P995, DOI 10.1001/archdermatol.2012.1401; Booth N, 1994, Health Libr Rev, V11, P177; Brauchli YB, 2009, BRIT J DERMATOL, V160, P1048, DOI 10.1111/j.1365-2133.2008.09020.x; Bruce IN, 2000, JCR-J CLIN RHEUMATOL, V6, P6, DOI 10.1097/00124743-200002000-00001; Cassano N, 2011, EUR J DERMATOL, V21, P264, DOI 10.1684/ejd.2011.1274; CECCHI R, 1992, DERMATOLOGY, V185, P93, DOI 10.1159/000247420; Denburg MR, 2010, PHARMACOEPIDEM DR S, V19, pS105; Dervisoglu E, 2012, INT UROL NEPHROL, V44, P509, DOI 10.1007/s11255-011-9966-1; Dommasch ED, 2010, BRIT J DERMATOL, V162, P835, DOI 10.1111/j.1365-2133.2009.09589.x; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; IMAI H, 1995, CLIN NEPHROL, V44, P64; Kaftan O, 1996, DERMATOLOGY, V192, P189, DOI 10.1159/000246358; KAJI T, 1994, CLIN NEPHROL, V42, P63; Kim MK, 1998, CLIN EXP DERMATOL, V23, P295; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Kurd SK, 2009, J AM ACAD DERMATOL, V60, P218, DOI 10.1016/j.jaad.2008.09.022; Langan SM, 2012, J INVEST DERMATOL, V132, P556, DOI 10.1038/jid.2011.365; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; MADEDDU P, 1988, NEPHRON, V48, P222, DOI 10.1159/000184916; Mehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Office for National Statistics, 2011, OFF NAT STAT STAT B; Pearce DJ, 2005, J DERMATOL TREAT, V16, P319, DOI 10.1080/09546630500335977; Perazella MA, 2010, SEMIN NEPHROL, V30, P570, DOI 10.1016/j.semnephrol.2010.09.005; Seminara NM, 2011, BRIT J DERMATOL, V164, P602, DOI 10.1111/j.1365-2133.2010.10134.x; Singh NP, 2005, RENAL FAILURE, V27, P123, DOI 10.1081/JDI-200042811; Sirolli V, 2000, NEPHRON, V86, P89, DOI 10.1159/000045718; Smith CH, 2005, BRIT J DERMATOL, V153, P486, DOI 10.1111/j.1365-2133.2005.06893.x; Szepietowski JC, 2000, J EUR ACAD DERMATOL, V14, P513, DOI 10.1046/j.1468-3083.2000.00119.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Widemann BC, 2006, ONCOLOGIST, V11, P694, DOI 10.1634/theoncologist.11-6-694; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Yang YW, 2011, BRIT J DERMATOL, V165, P1037, DOI 10.1111/j.1365-2133.2011.10494.x; Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015; Zadrazil J, 2006, J NEPHROL, V19, P382	42	117	119	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2013	347								f5961	10.1136/bmj.f5961	http://dx.doi.org/10.1136/bmj.f5961			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WK	24129480	hybrid, Green Published			2022-12-28	WOS:000325982200009
J	Heinz, S; Romanoski, CE; Benner, C; Allison, KA; Kaikkonen, MU; Orozco, LD; Glass, CK				Heinz, S.; Romanoski, C. E.; Benner, C.; Allison, K. A.; Kaikkonen, M. U.; Orozco, L. D.; Glass, C. K.			Effect of natural genetic variation on enhancer selection and function	NATURE			English	Article							REGULATORY ELEMENTS; OPEN CHROMATIN; TRANSCRIPTION; BINDING; MACROPHAGE; RESPONSES; ALIGNMENT; SNPS; MAP	The mechanisms by which genetic variation affects transcription regulation and phenotypes at the nucleotide level are incompletely understood. Here we use natural genetic variation as an in vivo mutagenesis screen to assess the genome-wide effects of sequence variation on lineage-determining and signal-specific transcription factor binding, epigenomics and transcriptional outcomes in primary macrophages from different mouse strains. We find substantial genetic evidence to support the concept that lineage-determining transcription factors define epigenetic and transcriptomic states by selecting enhancer-like regions in the genome in a collaborative fashion and facilitating binding of signal-dependent factors. This hierarchical model of transcription factor function suggests that limited sets of genomic data for lineage-determining transcription factors and informative histone modifications can be used for the prioritization of disease-associated regulatory variants.	[Heinz, S.; Romanoski, C. E.; Benner, C.; Allison, K. A.; Kaikkonen, M. U.; Glass, C. K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Benner, C.] Salk Inst Biol Studies, Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA; [Benner, C.; Glass, C. K.] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Kaikkonen, M. U.] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio 70211, Finland; [Orozco, L. D.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Glass, C. K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; University of Eastern Finland; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr,Mail Code 0651, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Kaikkonen, Minna U/AAK-3612-2020; Glass, Christopher/AAI-3933-2021	Kaikkonen, Minna U/0000-0001-6294-0979; Glass, Christopher/0000-0003-4344-3592; Romanoski, Casey/0000-0002-0149-225X; Benner, Christopher/0000-0002-4618-0719; Heinz, Sven/0000-0002-4665-1007	National Institutes of Health (NIH) [DK091183, CA17390, DK063491]; Foundation Leducq; Academy of Finland; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; American Heart Association Western States Affiliates [12POST11760017]; NIH [5T32DK007494]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA173903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR059033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091183, P01DK074868, T32DK007494, P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq(Leducq Foundation); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); American Heart Association Western States Affiliates(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. J. Lusis for providing access to eQTL data (http://systems.genetics.ucla.edu/) and for productive conversations. We thank D. Pollard for discussions and suggestions, and L. Bautista for assistance with figure preparation. These studies were supported by National Institutes of Health (NIH) grants DK091183, CA17390 and DK063491 (C.K.G.). M.U.K. was supported by the Foundation Leducq Career Development award and grants from Academy of Finland, Finnish Foundation for Cardiovascular Research and Finnish Cultural Foundation, North Savo Regional fund. C.E.R. was supported by the American Heart Association Western States Affiliates (12POST11760017) and the NIH (5T32DK007494).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Smale ST, 2012, CURR OPIN IMMUNOL, V24, P51, DOI 10.1016/j.coi.2011.12.008; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Pham TH, 2013, NUCLEIC ACIDS RES, V41, P6391, DOI 10.1093/nar/gkt355; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70	39	228	229	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					487	+		10.1038/nature12615	http://dx.doi.org/10.1038/nature12615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24121437	Green Accepted, Green Submitted			2022-12-28	WOS:000327464200035
J	Leaning, J; Guha-Sapir, D				Leaning, Jennifer; Guha-Sapir, Debarati			Natural Disasters, Armed Conflict, and Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							EPIDEMIOLOGIC APPROACH; MORTALITY; EARTHQUAKE; MORBIDITY; INJURIES; MEDICINE; LESSONS; FAMINE	Global disasters, both natural and man-made, affect health in many ways, as reviewed in this article in the Global Health series. Natural disasters and armed conflict have marked human existence throughout history and have always caused peaks in mortality and morbidity. But in recent times, the scale and scope of these events have increased markedly. Since 1990, natural disasters have affected about 217 million people every year,(1) and about 300 million people now live amidst violent insecurity around the world.(2) The immediate and longer-term effects of these disruptions on large populations constitute humanitarian crises. In recent decades, public health interventions in the humanitarian response have made gains in the equity and quality of emergency assistance. Natural disasters are broadly classified as ...	[Leaning, Jennifer] Harvard Univ, Sch Publ Hlth, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA; [Guha-Sapir, Debarati] Univ Louvain, Inst Hlth & Soc, World Hlth Org Collaborating Ctr Res Epidemiol Di, Brussels, Belgium	Harvard University; Harvard T.H. Chan School of Public Health; Universite Catholique Louvain; World Health Organization	Leaning, J (corresponding author), Harvard Univ, Sch Publ Hlth, Francois Xavier Bagnoud Ctr Hlth & Human Rights, 651 Huntington Ave,7th Flr, Boston, MA 02115 USA.	jleaning@hsph.harvard.edu						[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2010, PUBL HLTH EQ REF OTH; [Anonymous], 1949, 4 GEN CONV 1949; [Anonymous], 2011, SPHER HDB HUM CHART, P311; Batniji R, 2006, SOC SCI MED, V62, P1853, DOI 10.1016/j.socscimed.2005.08.050; BOSS LP, 1994, JAMA-J AM MED ASSOC, V272, P371, DOI 10.1001/jama.272.5.371; BROWN RE, 1969, TROP GEOGR MED, V21, P348; Bruderlein C, 1999, BRIT MED J, V319, P430, DOI 10.1136/bmj.319.7207.430; Byass P, 2001, SCAND J PUBLIC HEALT, V29, P84, DOI 10.1080/14034940152393336; Checchi F, 2005, HUMANITARIAN PRACTIC, V52; COUPLAND RM, 1994, BRIT MED J, V308, P1693, DOI 10.1136/bmj.308.6945.1693; de Ville de Goyet C, 2011, HLTH RESPONSE EARTHQ, P112; DEBRUYCKER M, 1985, INT J EPIDEMIOL, V14, P113, DOI 10.1093/ije/14.1.113; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; Deitchler M, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-6; Feikin DR, 2010, B WORLD HEALTH ORGAN, V88, P601, DOI 10.2471/BLT.09.069732; Ferris E., 2013, YEAR RECURRING DISAS; Ford Nathan, 2009, Confl Health, V3, P7, DOI 10.1186/1752-1505-3-7; Gerdin M, 2013, EMERG MED J, V30, DOI 10.1136/emermed-2011-200717; GLASS RI, 1977, SCIENCE, V197, P638, DOI 10.1126/science.197.4304.638; GLASS RI, 1980, LANCET, V1, P868; Guha-Sapir D, 2005, EPIDEMIOL REV, V27, P67, DOI 10.1093/epirev/mxi010; Guha-Sapir D, 2004, DISASTERS, V28, P418, DOI 10.1111/j.0361-3666.2004.00267.x; Guha-Sapir D., 2012, ANN DISASTER STAT RE; Guha-Sapir D., 2011, WORLD DEV REPORT 201; Inter-Agency Standing Committee (IASC), 2000, IN RAP ASS IRA GUID, P3; Iserson KV, 2007, ANN EMERG MED, V49, P275, DOI 10.1016/j.annemergmed.2006.05.019; KATZ J, 1995, AM J CLIN NUTR, V61, P155, DOI 10.1093/ajcn/61.1.155; Leaning J., 1999, HUMANITARIAN CRISES; Leaning J, 2007, PREHOSPITAL DISASTER, V22, P418, DOI 10.1017/S1049023X00005148; LECHAT MF, 1976, P ROY SOC MED, V69, P421, DOI 10.1177/003591577606900612; LIBARIDIAN GJ, 1989, SOCIETY, V26, P59, DOI 10.1007/BF02699249; Macedo D., 2011, FOX NEWS NETWOR 0322; Management of dead bodies in disaster situations, 2004, DIS MAN GUID SER, V5, P85; Noji EK, 1997, DISASTERS, V21, P366, DOI 10.1111/1467-7717.00068; Reed HE, 2001, FORCED MIGRATION MOR; RIVERS JPW, 1976, ANN SOC BELG MED TR, V56, P345; ROCES MC, 1992, B WORLD HEALTH ORGAN, V70, P509; Rodriguez-Llanes JM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000109; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; SOMMER A, 1972, LANCET, V1, P1029; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; Thompson Ginger, 2010, NY TIMES; Thurer D., 2007, INT REV RED CROSS, V89, P47; Waldman RJ, 2011, ROUTLEDGE HANDBOOK OF GLOBAL PUBLIC HEALTH, P229; Weissman F., 1997, MED SANS FRONTIERES, P100; Western KA, 1972, THESIS U LONDON LOND	47	240	241	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1836	1842		10.1056/NEJMra1109877	http://dx.doi.org/10.1056/NEJMra1109877			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247HF	24195550				2022-12-28	WOS:000326607800012
J	Wei, F; Wang, J				Wei, Fei; Wang, Jie			Sydenham's Chorea, or St. Vitus's Dance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A previously healthy 11-year-old boy presented with rapid, irregular, aimless, involuntary movements of the limbs, neck, and trunk. These uncontrollable movements began 1 month earlier, initially affecting only his left limbs but later extending to other parts of his body. A previously healthy 11-year-old boy presented with rapid, irregular, aimless, involuntary movements of the limbs, neck, and trunk that resembled continuous restlessness (Panel A, and Video 1). These uncontrollable movements had begun 1 month earlier, initially affecting only his left limbs but later extending to other parts of his body. The movements were absent during sleep and were exacerbated with stress. He had no previous movement disorders. The patient reported having a sore throat 4 months before presentation. Neither his schoolmates nor members of his family were affected. Physical examination revealed the presence of uncoordinated jerking movements, emotional lability, hypotonic ...	[Wei, Fei; Wang, Jie] Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University	Wei, F (corresponding author), Xinqiao Hosp, Chongqing, Peoples R China.								0	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					E25	E25		10.1056/NEJMicm1303705	http://dx.doi.org/10.1056/NEJMicm1303705			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24195571				2022-12-28	WOS:000326607800001
J	Machta, BB; Chachra, R; Transtrum, MK; Sethna, JP				Machta, Benjamin B.; Chachra, Ricky; Transtrum, Mark K.; Sethna, James P.			Parameter Space Compression Underlies Emergent Theories and Predictive Models	SCIENCE			English	Article							PROBABILITY-DISTRIBUTIONS; STATISTICAL-MECHANICS; EXPERIMENTAL-DESIGN; GEOMETRY; SIMPLICITY; BIOLOGY	The microscopically complicated real world exhibits behavior that often yields to simple yet quantitatively accurate descriptions. Predictions are possible despite large uncertainties in microscopic parameters, both in physics and in multiparameter models in other areas of science. We connect the two by analyzing parameter sensitivities in a prototypical continuum theory (diffusion) and at a self-similar critical point (the Ising model). We trace the emergence of an effective theory for long-scale observables to a compression of the parameter space quantified by the eigenvalues of the Fisher Information Matrix. A similar compression appears ubiquitously in models taken from diverse areas of science, suggesting that the parameter space structure underlying effective continuum and universal theories in physics also permits predictive modeling more generally.	[Machta, Benjamin B.; Chachra, Ricky; Transtrum, Mark K.; Sethna, James P.] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Machta, Benjamin B.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08854 USA; [Transtrum, Mark K.] Brigham Young Univ, Dept Phys & Astron, Provo, UT 84602 USA	Cornell University; Princeton University; Brigham Young University	Sethna, JP (corresponding author), Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.	sethna@lassp.cornell.edu	Transtrum, Mark/K-5323-2019; Transtrum, Mark/B-6379-2018	Transtrum, Mark/0000-0001-9529-9399	NSF [DMR 1005479, DMR 1312160]; Lewis-Sigler Fellowhip; Direct For Mathematical & Physical Scien [1312160] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Lewis-Sigler Fellowhip; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank S. Kuehn and S. Papanikolaou for helpful comments and discussions. This work was supported by NSF grants DMR 1005479 and DMR 1312160 and a Lewis-Sigler Fellowhip (B.B.M.). Raw data and analysis code are available on request from the authors or via the Internet: www.lassp.cornell.edu/sethna/Sloppy/EmergentParameterCompression.	Alon U, 2007, NATURE, V446, P497, DOI 10.1038/446497a; Amari S. I., 2000, METHODS INFORM GEOME; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; [Anonymous], 2007, PRINCIPLES CONDENSED; Apgar JF, 2010, MOL BIOSYST, V6, P1890, DOI 10.1039/b918098b; Balasubramanian V, 1997, NEURAL COMPUT, V9, P349, DOI 10.1162/neco.1997.9.2.349; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Cardy J., 1996, SCALING RENORMALIZAT; Casey FP, 2007, IET SYST BIOL, V1, P190, DOI 10.1049/iet-syb:20060065; Corson F, 2012, P NATL ACAD SCI USA, V109, P5568, DOI 10.1073/pnas.1201505109; Crooks GE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.100602; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Mora T, 2011, J STAT PHYS, V144, P268, DOI 10.1007/s10955-011-0229-4; Myung IJ, 2000, P NATL ACAD SCI USA, V97, P11170, DOI 10.1073/pnas.170283897; Ron D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.275701; RUPPEINER G, 1995, REV MOD PHYS, V67, P605, DOI 10.1103/RevModPhys.67.605; Sanger TD, 2000, J NEUROSCI, V20, P1066, DOI 10.1523/JNEUROSCI.20-03-01066.2000; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stephens GJ, 2011, P NATL ACAD SCI USA, V108, P15565, DOI 10.1073/pnas.1010868108; Transtrum MK, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036701; Transtrum MK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.060201; Veatch SL, 2007, P NATL ACAD SCI USA, V104, P17650, DOI 10.1073/pnas.0703513104; Waterfall JJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.150601; WIGNER EP, 1960, COMMUN PUR APPL MATH, V13, P1, DOI 10.1002/cpa.3160130102	25	146	147	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					604	607		10.1126/science.1238723	http://dx.doi.org/10.1126/science.1238723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179222	Green Submitted			2022-12-28	WOS:000326334300044
J	Macosko, EZ; McCarroll, SA				Macosko, Evan Z.; McCarroll, Steven A.			Our Fallen Genomes	SCIENCE			English	Editorial Material							DETECTABLE CLONAL MOSAICISM; ANEUPLOIDY; MUTATIONS		[Macosko, Evan Z.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Macosko, Evan Z.; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02141 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Macosko, EZ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mccarroll@genetics.med.harvard.edu	Macosko, Evan/X-4664-2019	McCarroll, Steven/0000-0002-6954-8184	NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER; NIMH NIH HHS [R25 MH094612] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Koren A, 2014, GENOME RES, V24, P64, DOI 10.1101/gr.161828.113; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558	14	5	5	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					564	565		10.1126/science.1246942	http://dx.doi.org/10.1126/science.1246942			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179207				2022-12-28	WOS:000326334300024
J	Avraham, KB				Avraham, Karen B.			Rescue from Hearing Loss in Usher's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEAFNESS	A mouse model of a particular genetic form of Usher's syndrome, which involves hearing loss and difficulties with balance, showed that hearing at the low and middle frequencies and balance can be rescued. Attempts to restore or prevent genetically based hearing loss by means of biologic intervention have been largely unsuccessful because of the limitations inherent in both regenerating lost mechanosensory cells and salvaging the remaining function of partially damaged cells. Although the current treatment for hearing loss relies primarily on the use of cochlear implants (the Lasker-DeBakey Clinical Medical Research Award of 2013 was bestowed on the pioneers of this technology), the implants are still far from ideal. Elucidation of the genetic basis of many forms of hearing loss and advances in gene delivery may change this picture. Earlier this year, Lentz ...	[Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Avraham, Karen B.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Avraham, KB (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.			Avraham, Karen B/0000-0002-4913-251X				Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Gregory FD, 2013, J PHYSIOL-LONDON, V591, P3253, DOI 10.1113/jphysiol.2013.254367; Lentz J, 2007, MUTAT RES-FUND MOL M, V616, P139, DOI 10.1016/j.mrfmmm.2006.11.006; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Southwell AL, 2012, TRENDS MOL MED, V18, P634, DOI 10.1016/j.molmed.2012.09.001	5	6	6	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1758	1760		10.1056/NEJMcibr1311048	http://dx.doi.org/10.1056/NEJMcibr1311048			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24171523				2022-12-28	WOS:000326311300015
J	Ma, DL; Vano-Galvan, S				Ma, Dong-Lai; Vano-Galvan, Sergio			Trichomycosis Axillaris	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 40-year-old man presented with axillary odor and reported having had dirty axillary hair for 4 years. The condition worsened in the summer, staining his clothing. A 40-year-old man presented with axillary odor and reported having had dirty axillary hair for 4 years. The condition worsened in the summer, staining his clothing. His medical history was notable only for obesity. On examination, creamy yellow concretions were observed along several hair shafts (Panels A and B). The concretions took on a soft fluorescence when examined under a Woods lamp, but the skin of the axilla showed no coral red fluorescence, ruling out erythrasma. Microscopical examination after topical administration of potassium hydroxide showed an opaque material surrounding the involved hair, without invasion of the hair cortex (Panel C). ...	[Ma, Dong-Lai] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Vano-Galvan, Sergio] Hosp Ramon & Cajal, E-28034 Madrid, Spain	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Hospital Universitario Ramon y Cajal	Ma, DL (corresponding author), Beijing Union Med Coll Hosp, Beijing, Peoples R China.	mdonglai@sohu.com		Vano-Galvan, Sergio/0000-0003-2773-7494					0	11	11	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1735	1735		10.1056/NEJMicm1300241	http://dx.doi.org/10.1056/NEJMicm1300241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24171519				2022-12-28	WOS:000326311300011
J	Von Hoff, DD; Ervin, T; Arena, FP; Chiorean, EG; Infante, J; Moore, M; Seay, T; Tjulandin, SA; Ma, WW; Saleh, MN; Harris, M; Reni, M; Dowden, S; Laheru, D; Bahary, N; Ramanathan, RK; Tabernero, J; Hidalgo, M; Goldstein, D; Van Cutsem, E; Wei, XY; Iglesias, J; Renschler, MF				Von Hoff, Daniel D.; Ervin, Thomas; Arena, Francis P.; Chiorean, E. Gabriela; Infante, Jeffrey; Moore, Malcolm; Seay, Thomas; Tjulandin, Sergei A.; Ma, Wen Wee; Saleh, Mansoor N.; Harris, Marion; Reni, Michele; Dowden, Scot; Laheru, Daniel; Bahary, Nathan; Ramanathan, Ramesh K.; Tabernero, Josep; Hidalgo, Manuel; Goldstein, David; Van Cutsem, Eric; Wei, Xinyu; Iglesias, Jose; Renschler, Markus F.			Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; ONCOLOGY-GROUP; ADENOCARCINOMA; MONOTHERAPY; PLACEBO	BackgroundIn a phase 1-2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clinical activity was noted in patients with advanced pancreatic cancer. We conducted a phase 3 study of the efficacy and safety of the combination versus gemcitabine monotherapy in patients with metastatic pancreatic cancer. MethodsWe randomly assigned patients with a Karnofsky performance-status score of 70 or more (on a scale from 0 to 100, with higher scores indicating better performance status) to nab-paclitaxel (125 mg per square meter of body-surface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 weeks or gemcitabine monotherapy (1000 mg per square meter) weekly for 7 of 8 weeks (cycle 1) and then on days 1, 8, and 15 every 4 weeks (cycle 2 and subsequent cycles). Patients received the study treatment until disease progression. The primary end point was overall survival; secondary end points were progression-free survival and overall response rate. ResultsA total of 861 patients were randomly assigned to nab-paclitaxel plus gemcitabine (431 patients) or gemcitabine (430). The median overall survival was 8.5 months in the nab-paclitaxel-gemcitabine group as compared with 6.7 months in the gemcitabine group (hazard ratio for death, 0.72; 95% confidence interval [CI], 0.62 to 0.83; P<0.001). The survival rate was 35% in the nab-paclitaxel-gemcitabine group versus 22% in the gemcitabine group at 1 year, and 9% versus 4% at 2 years. The median progression-free survival was 5.5 months in the nab-paclitaxel-gemcitabine group, as compared with 3.7 months in the gemcitabine group (hazard ratio for disease progression or death, 0.69; 95% CI, 0.58 to 0.82; P<0.001); the response rate according to independent review was 23% versus 7% in the two groups (P<0.001). The most common adverse events of grade 3 or higher were neutropenia (38% in the nab-paclitaxel-gemcitabine group vs. 27% in the gemcitabine group), fatigue (17% vs. 7%), and neuropathy (17% vs. 1%). Febrile neutropenia occurred in 3% versus 1% of the patients in the two groups. In the nab-paclitaxel-gemcitabine group, neuropathy of grade 3 or higher improved to grade 1 or lower in a median of 29 days. ConclusionsIn patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but rates of peripheral neuropathy and myelosuppression were increased. (Funded by Celgene; ClinicalTrials.gov number, NCT00844649.) In this report, the addition of nab-paclitaxel to standard gemcitabine increased the response rate, progression-free survival, and overall survival among patients with metastatic pancreatic adenocarcinoma. Pancreatic cancer is the fourth leading cause of cancer-related death in Europe and the United States.(1),(2) Since 1997, gemcitabine therapy has been the standard first-line treatment for patients with unresectable locally advanced or metastatic pancreatic cancer.(3) Among patients with metastatic disease, the 5-year survival rate is only 2%,(1) and 1-year survival rates of 17 to 23% have been reported with gemcitabine.(3)-(5) Numerous phase 2 studies involving patients with advanced pancreatic cancer have shown promising results; however, most subsequent large phase 3 studies have not shown significantly improved survival,(6)-(16) with the exception of a study involving patients who ...	[Von Hoff, Daniel D.; Ramanathan, Ramesh K.] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Von Hoff, Daniel D.; Ramanathan, Ramesh K.] Virginia G Piper Canc Ctr, Scottsdale, AZ USA; [Ervin, Thomas] Canc Specialists, Ft Myers, FL USA; [Arena, Francis P.] Arena Oncol Associates, Lake Success, NY USA; [Ma, Wen Wee] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Chiorean, E. Gabriela] Univ Washington, Seattle, WA 98195 USA; [Infante, Jeffrey] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA; [Moore, Malcolm] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Seay, Thomas] Atlanta Canc Care, Atlanta, GA USA; [Saleh, Mansoor N.] Georgia Canc Specialists, Atlanta, GA USA; [Tjulandin, Sergei A.] Blokhin Canc Res Ctr, Moscow, Russia; [Harris, Marion] Southern Hlth, East Bentleigh, Vic, Australia; [Goldstein, David] Prince Wales Hosp, Sydney, NSW, Australia; [Iglesias, Jose] Bionomics, Thebarton, SA, Australia; [Reni, Michele] Ist Sci San Raffaele, I-20132 Milan, Italy; [Dowden, Scot] Tom Baker Canc Clin, Calgary, AB, Canada; [Laheru, Daniel] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA; [Bahary, Nathan] Univ Pittsburgh Med Ctr, Pittsburgh, PA USA; [Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, E-08193 Barcelona, Spain; [Harris, Marion] Ctr Integral Oncol Clara Campal, Madrid, Spain; [Van Cutsem, Eric] Katholieke Univ Leuven Hosp, Louvain, Belgium; [Van Cutsem, Eric] Katholieke Univ Leuven, Louvain, Belgium; [Wei, Xinyu; Renschler, Markus F.] Celgene, Summit, NJ USA	Translational Genomics Research Institute; Florida Cancer Specialists; Roswell Park Cancer Institute; University of Washington; University of Washington Seattle; Sarah Cannon Research Institute; Tennessee Oncology; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; N.N. Blokhin Russian Cancer Research Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Tom Baker Cancer Clinic; University of Calgary; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; Bristol-Myers Squibb; Celgene Corporation	Von Hoff, DD (corresponding author), Translat Genom Res Inst, 445 N 5th St,Ste 600, Phoenix, AZ 85004 USA.	dvh@tgen.org	Tjulandin, Sergei/Y-5069-2018; HIDALGO, MANUEL/I-4995-2015; Van+Cutsem, Eric/ABE-1762-2021; Reni, Michele/J-8296-2016; goldstein, david/J-6711-2012; Tabernero, Josep/AAG-5026-2019	HIDALGO, MANUEL/0000-0002-3765-3318; Reni, Michele/0000-0002-6463-0293; Tabernero, Josep/0000-0002-2495-8139	Celgene; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Celgene(Bristol-Myers SquibbCelgene Corporation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Celgene.	Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4441, DOI 10.1200/JCO.2006.07.0201; American Cancer Society, 2013, CANC FACTS FIG 2013; [Anonymous], 2008, J ONCOL PRACT, V4, P233; Buccheri G, 1996, EUR J CANCER, V32A, P1135, DOI 10.1016/0959-8049(95)00664-8; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chauffert B, 2008, ANN ONCOL, V19, P1592, DOI 10.1093/annonc/mdn281; Colucci G, 2010, J CLIN ONCOL, V28, P1645, DOI 10.1200/JCO.2009.25.4433; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Frese KK, 2012, CANCER DISCOV, V2, P260, DOI 10.1158/2159-8290.CD-11-0242; Goncalves A, 2012, ANN ONCOL, V23, P2799, DOI 10.1093/annonc/mds135; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Lima CMR, 2004, J CLIN ONCOL, V22, P3776, DOI 10.1200/JCO.2004.12.082; Malvezzi M, 2013, ANN ONCOL, V24, P792, DOI 10.1093/annonc/mdt010; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Oettle H, 2006, ANN ONCOL, V17, P535, DOI 10.1093/annonc/mdl032; Oettle H, 2005, ANN ONCOL, V16, P1639, DOI 10.1093/annonc/mdi309; Philip PA, 2010, J CLIN ONCOL, V28, P3605, DOI 10.1200/JCO.2009.25.7550; Poplin E, 2009, J CLIN ONCOL, V27, P3778, DOI 10.1200/JCO.2008.20.9007; Reni M, 2009, CANCER-AM CANCER SOC, V115, P2630, DOI 10.1002/cncr.24302; Stathopoulos GP, 2006, BRIT J CANCER, V95, P587, DOI 10.1038/sj.bjc.6603301; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742	24	3896	3961	16	300	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1691	1703		10.1056/NEJMoa1304369	http://dx.doi.org/10.1056/NEJMoa1304369			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24131140	Bronze, Green Accepted			2022-12-28	WOS:000326311300007
J	Olson, P				Olson, Peter			The New Core Paradox	SCIENCE			English	Editorial Material							EARTHS CORE; ELECTRICAL-RESISTIVITY; THERMAL-CONDUCTIVITY; HIGH-PRESSURE; MANTLE; IRON; EVOLUTION		Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Olson, P (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	olson@jhu.edu						Anzellini S, 2013, SCIENCE, V340, P464, DOI 10.1126/science.1233514; de Koker N, 2012, P NATL ACAD SCI USA, V109, P4070, DOI 10.1073/pnas.1111841109; Deng LW, 2013, GEOPHYS RES LETT, V40, P33, DOI 10.1029/2012GL054347; Gomi H., 2013, PHYS EARTH PLANET IN; KENNEDY GC, 1973, J GEOPHYS RES, V78, P900, DOI 10.1029/JB078i005p00900; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Nakagawa T, 2013, GEOPHYS RES LETT, V40, P2652, DOI 10.1002/grl.50574; Olson P, 2013, PHYS EARTH PLANET IN, V214, P87, DOI 10.1016/j.pepi.2012.10.003; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Seagle C. T., 2012, SAND20128321 SAND NA; Stacey FD, 2007, PHYS EARTH PLANET IN, V161, P13, DOI 10.1016/j.pepi.2006.12.001; Tarduno JA, 2010, SCIENCE, V327, P1238, DOI 10.1126/science.1183445; van der Hilst RD, 2007, SCIENCE, V315, P1813, DOI 10.1126/science.1137867; Wu B., 2011, J GEOPHYS RES SOLID, V116, P1978	14	59	60	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					431	432		10.1126/science.1243477	http://dx.doi.org/10.1126/science.1243477			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159035				2022-12-28	WOS:000326042600028
J	Rowe, AH; Xiao, YC; Rowe, MP; Cummins, TR; Zakon, HH				Rowe, Ashlee H.; Xiao, Yucheng; Rowe, Matthew P.; Cummins, Theodore R.; Zakon, Harold H.			Voltage-Gated Sodium Channel in Grasshopper Mice Defends Against Bark Scorpion Toxin	SCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; FORMALIN TEST; NA+ CHANNEL; SENSORY NEURONS; ONYCHOMYS SPP.; ALPHA-SUBUNIT; PAIN; NA(V)1.8; BINDING; RESISTANCE	Painful venoms are used to deter predators. Pain itself, however, can signal damage and thus serves an important adaptive function. Evolution to reduce general pain responses, although valuable for preying on venomous species, is rare, likely because it comes with the risk of reduced response to tissue damage. Bark scorpions capitalize on the protective pain pathway of predators by inflicting intensely painful stings. However, grasshopper mice regularly attack and consume bark scorpions, grooming only briefly when stung. Bark scorpion venom induces pain in many mammals (house mice, rats, humans) by activating the voltage-gated Na+ channel Nav1.7, but has no effect on Nav1.8. Grasshopper mice Nav1.8 has amino acid variants that bind bark scorpion toxins and inhibit Na+ currents, blocking action potential propagation and inducing analgesia. Thus, grasshopper mice have solved the predator-pain problem by using a toxin bound to a nontarget channel to block transmission of the pain signals the venom itself is initiating.	[Rowe, Ashlee H.; Zakon, Harold H.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Rowe, Matthew P.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77341 USA; [Zakon, Harold H.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA	University of Texas System; University of Texas Austin; Indiana University System; Indiana University Bloomington; Texas State University System; Sam Houston State University; Marine Biological Laboratory - Woods Hole	Rowe, AH (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.	roweashl@msu.edu			NSF IOS Award [1122115]; Department of the Army from Army Research Office Life Sciences Division [W911NF-06-1-0213, W911NF-09-1-0355]; NIH from National Institute of Neurological Disorders and Stroke [NS 053422]; Office of Research and Sponsored Projects, Sam Houston State University; Division Of Integrative Organismal Systems [1448393] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422, R56NS053422] Funding Source: NIH RePORTER	NSF IOS Award; Department of the Army from Army Research Office Life Sciences Division; NIH from National Institute of Neurological Disorders and Stroke; Office of Research and Sponsored Projects, Sam Houston State University; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Heitlinger, the Santa Rita Experimental Range (Univ. of Arizona), and the Arizona Game and Fish Department for assistance with animal collections. We also thank Y. Lu and M. Wu for technical assistance with Nav1.8 sequencing and construct assembly. This work was supported, in part or in whole, by NSF IOS Award 1122115 (to A. H. R., M. P. R., and H.H.Z.), Department of the Army grants W911NF-06-1-0213 and W911NF-09-1-0355 from the Army Research Office Life Sciences Division (to A. H. R. and H.H.Z.), NIH grant NS 053422 from the National Institute of Neurological Disorders and Stroke (to T. R. C. and Y. X.), and a Faculty Research Grant from the Office of Research and Sponsored Projects, Sam Houston State University (to M. P. R.). The Department of Biological Sciences at Sam Houston State University provided logistical support for fieldwork. We declare no conflict of interest. The data are included in the main article and in the supplementary materials. The gene (Scn10a) encoding O. torridus Nav1.8 has been deposited in NCBI's GenBank gene database. Information about the GenBank accession numbers can be found in the supplementary materials.	Blair NT, 2002, J NEUROSCI, V22, P10277; Boyer LV, 2009, NEW ENGL J MED, V360, P2090, DOI 10.1056/NEJMoa0808455; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Choi JS, 2011, J NEUROPHYSIOL, V106, P3173, DOI 10.1152/jn.00100.2011; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; CURRY SC, 1984, J TOXICOL-CLIN TOXIC, V21, P417; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Fet V., 2000, CATALOG SCORPIONS WO, V1, P54; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Gilchrist J, 2012, TOXINS, V4, P620, DOI 10.3390/toxins4080620; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; Kaneko Y, 1997, BIOCHEM BIOPH RES CO, V240, P651, DOI 10.1006/bbrc.1997.7696; KREIENKAMP HJ, 1994, J BIOL CHEM, V269, P8108; Leo S, 2010, BEHAV BRAIN RES, V208, P149, DOI 10.1016/j.bbr.2009.11.023; Lolignier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023083; LoVecchio F, 2003, J TOXICOL-CLIN TOXIC, V41, P937, DOI 10.1081/CLT-120026514; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Moraes ER, 2011, NEUROTOX RES, V19, P102, DOI 10.1007/s12640-009-9144-8; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rowe AH, 2006, ANIM BEHAV, V71, P725, DOI 10.1016/j.anbehav.2005.08.003; Rowe AH, 2008, TOXICON, V52, P597, DOI 10.1016/j.toxicon.2008.07.004; Rowe AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023520; Saab CY, 2002, NEUROSCI LETT, V331, P79, DOI 10.1016/S0304-3940(02)00860-1; Schmidt J.O., 1990, INSECT DEFENSES ADAP, P383; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; Simard J.M., 1992, NAT TOXINS, V1, P236; Skolnik AB, 2013, PEDIATR EMERG CARE, V29, P98, DOI 10.1097/PEC.0b013e31827b5733; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; Sufka KJ, 1998, EUR J PAIN-LONDON, V2, P351, DOI 10.1016/S1090-3801(98)90033-7; Takacs Z, 2001, MOL BIOL EVOL, V18, P1800, DOI 10.1093/oxfordjournals.molbev.a003967; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Venkatesh B, 2005, CURR BIOL, V15, P2069, DOI 10.1016/j.cub.2005.10.068; Yotsu-Yamashita M, 2000, BIOCHEM BIOPH RES CO, V267, P403, DOI 10.1006/bbrc.1999.1974; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742	43	90	96	17	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					441	446		10.1126/science.1236451	http://dx.doi.org/10.1126/science.1236451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159039	Green Submitted, Green Accepted			2022-12-28	WOS:000326042600033
J	Jager, N; Schlesner, M; Jones, DTW; Raffel, S; Mallm, JP; Junge, KM; Weichenhan, D; Bauer, T; Ishaque, N; Kool, M; Northcott, PA; Korshunov, A; Drews, RM; Koster, J; Versteeg, R; Richter, J; Hummel, M; Mack, SC; Taylor, MD; Witt, H; Swartman, B; Schulte-Bockholt, D; Sultan, M; Yaspo, ML; Lehrach, H; Hutter, B; Brors, B; Wolf, S; Plass, C; Siebert, R; Trumpp, A; Rippe, K; Lehmann, I; Lichter, P; Pfister, SM; Eils, R				Jaeger, Natalie; Schlesner, Matthias; Jones, David T. W.; Raffel, Simon; Mallm, Jan-Philipp; Junge, Kristin M.; Weichenhan, Dieter; Bauer, Tobias; Ishaque, Naveed; Kool, Marcel; Northcott, Paul A.; Korshunov, Andrey; Drews, Ruben M.; Koster, Jan; Versteeg, Rogier; Richter, Julia; Hummel, Michael; Mack, Stephen C.; Taylor, Michael D.; Witt, Hendrik; Swartman, Benedict; Schulte-Bockholt, Dietrich; Sultan, Marc; Yaspo, Marie-Laure; Lehrach, Hans; Hutter, Barbara; Brors, Benedikt; Wolf, Stephan; Plass, Christoph; Siebert, Reiner; Trumpp, Andreas; Rippe, Karsten; Lehmann, Irina; Lichter, Peter; Pfister, Stefan M.; Eils, Roland			Hypermutation of the Inactive X Chromosome Is a Frequent Event in Cancer	CELL			English	Article							MUTATION-RATE; GENOME; GENE; ORGANIZATION; INSTABILITY; CHROMATIN; PATTERNS; LEUKEMIA; DEFECTS; ORIGIN	Mutation is a fundamental process in tumorigenesis. However, the degree to which the rate of somatic mutation varies across the human genome and the mechanistic basis underlying this variation remain to be fully elucidated. Here, we performed a cross-cancer comparison of 402 whole genomes comprising a diverse set of childhood and adult tumors, including both solid and hematopoietic malignancies. Surprisingly, we found that the inactive X chromosome of many female cancer genomes accumulates on average twice and up to four times as many somatic mutations per megabase, as compared to the individual autosomes. Whole-genome sequencing of clonally expanded hematopoietic stem/progenitor cells (HSPCs) from healthy individuals and a premalignant myelodysplastic syndrome (MDS) sample revealed no X chromosome hypermutation. Our data suggest that hypermutation of the inactive X chromosome is an early and frequent feature of tumorigenesis resulting from DNA replication stress in aberrantly proliferating cells.	[Jaeger, Natalie; Schlesner, Matthias; Bauer, Tobias; Ishaque, Naveed; Drews, Ruben M.; Hutter, Barbara; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Jones, David T. W.; Kool, Marcel; Northcott, Paul A.; Witt, Hendrik; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Raffel, Simon; Trumpp, Andreas] German Canc Res Ctr, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Raffel, Simon; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Mallm, Jan-Philipp; Rippe, Karsten] DKFZ, Res Grp Genome Org & Funct, D-69120 Heidelberg, Germany; [Mallm, Jan-Philipp; Rippe, Karsten] BioQuant, D-69120 Heidelberg, Germany; [Junge, Kristin M.; Lehmann, Irina] Helmholtz Ctr Environm Res Leipzig, UFZ, Dept Environm Immunol, D-04318 Leipzig, Germany; [Weichenhan, Dieter; Plass, Christoph] DKFZ, Div Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Korshunov, Andrey] DKFZ, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Richter, Julia; Siebert, Reiner] Univ Kiel, Inst Human Genet, D-24105 Kiel, Germany; [Hummel, Michael] Charite, Inst Pathol, D-10117 Berlin, Germany; [Mack, Stephen C.; Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Mack, Stephen C.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Witt, Hendrik; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Swartman, Benedict; Schulte-Bockholt, Dietrich] BG Trauma Ctr, Dept Trauma & Orthopaed Surg, D-67071 Ludwigshafen, Germany; [Sultan, Marc; Yaspo, Marie-Laure; Lehrach, Hans] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Wolf, Stephan] DKFZ, Genom & Prote Core Facil, D-69120 Heidelberg, Germany; [Trumpp, Andreas; Lichter, Peter; Pfister, Stefan M.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Lichter, Peter] DKFZ, Div Mol Genet, D-69120 Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Bioquant Ctr, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; [Ishaque, Naveed; Lichter, Peter; Eils, Roland] DKFZ, DKFZ HIPO, Heidelberg Ctr Personalized Oncol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Kiel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ruprecht Karls University Heidelberg; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	r.eils@dkfz-heidelberg.de	Jones, David T. W./Z-1963-2019; Pfister, Stefan M/F-6860-2013; Plass, Christoph/H-7192-2014; Schlesner, Matthias/I-4030-2013; Junge, Kristin M/L-2630-2019; Versteeg, Rogier/AAQ-1765-2020; Ishaque, Naveed/AAF-3454-2020; Witt, Hendrik/L-7810-2015; Siebert, Reiner/A-8049-2010; Kool, Marcel/H-2541-2013; Brors, Benedikt/E-5620-2013; Rippe, Karsten/A-3562-2012; Koster, Jan/C-5934-2008; Northcott, Paul A/N-4022-2018; Trumpp, Andreas/Z-2141-2019; Jones, David TW/G-9588-2013; Eils, Roland/B-6121-2009	Pfister, Stefan M/0000-0002-5447-5322; Schlesner, Matthias/0000-0002-5896-4086; Ishaque, Naveed/0000-0002-8426-901X; Brors, Benedikt/0000-0001-5940-3101; Rippe, Karsten/0000-0001-9951-9395; Koster, Jan/0000-0002-0890-7585; Northcott, Paul A/0000-0002-1220-5252; Trumpp, Andreas/0000-0002-6212-3466; Jones, David TW/0000-0002-2036-5141; Eils, Roland/0000-0002-0034-4036; Hutter, Barbara/0000-0002-9034-0329; Junge, Kristin/0000-0001-5016-110X; Taylor, Michael/0000-0001-7009-3466; Mallm, Jan-Philipp/0000-0002-7059-4030; Mack, Stephen C./0000-0001-9620-4742; Hummel, Michael/0000-0001-6717-605X; Raffel, Simon/0000-0003-4671-1097; Bauer, Tobias/0000-0002-4961-3639; Jaeger, Natalie/0000-0002-9589-7580; Versteeg, Rogier/0000-0001-7172-0388; Drews, Ruben/0000-0001-7360-4970; Lehmann, Irina/0000-0001-8875-5587	PedBrain Tumor Project; MMMLSeq Project; German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, MedSys 0315416C, 01KU1002A, 01KU1002B, 01KU1002C, 01KU1002D, 01KU1002E, 01KU1002F, 01KU1002G, 01KU1002H, 01KU1002I, 01KU1002J]; German Cancer Research Center Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Max Planck Society; Genome Canada; Canadian Institute for Health Research (CIHR); Genome BC; Genome Quebec; CIHR-ICR (Institute for Cancer Research); Dietmar Hopp Foundation	PedBrain Tumor Project; MMMLSeq Project; German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Max Planck Society(Max Planck Society); Genome Canada(Genome Canada); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome BC; Genome Quebec; CIHR-ICR (Institute for Cancer Research)(Canadian Institutes of Health Research (CIHR)); Dietmar Hopp Foundation	We would like to acknowledge the members of the PedBrain Tumor and MMML-Seq Project contributing to the ICGC. For technical support and expertise, we thank the DKFZ Genomics and Proteomics Core Facility, specifically Sabine Schmidt and Sasithorn Chotewutmontri. We acknowledge assistance provided by Hans-Jorg Warnatz for RNA sequencing and analysis at the Max Planck Institute for Molecular Genetics. We especially express our gratitude to Edith Heard for very helpful comments on our manuscript. This work was principally supported by the PedBrain Tumor Project and the MMMLSeq Project contributing to the ICGC, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants 01KU1201A, MedSys 0315416C and 01KU1002A to 01KU1002J). Additional support came from the German Cancer Research Center Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the Max Planck Society, Genome Canada, and the Canadian Institute for Health Research (CIHR) with cofunding from Genome BC, Genome Quebec, CIHR-ICR (Institute for Cancer Research), and the Dietmar Hopp Foundation.	Barakat TS, 2012, DEVELOPMENT, V139, P2085, DOI 10.1242/dev.069328; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Ellegren H, 2003, CURR OPIN GENET DEV, V13, P562, DOI 10.1016/j.gde.2003.10.008; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hansen RS, 1996, HUM MOL GENET, V5, P1345, DOI 10.1093/hmg/5.9.1345; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2502; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Malcom CM, 2003, MOL BIOL EVOL, V20, P1633, DOI 10.1093/molbev/msg178; Mietton F, 2009, MOL CELL BIOL, V29, P150, DOI 10.1128/MCB.00997-08; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; MORISHIMA A, 1962, P NATL ACAD SCI USA, V48, P756, DOI 10.1073/pnas.48.5.756; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Weisse K, 2012, CLIN EXP ALLERGY, V42, P1337, DOI 10.1111/j.1365-2222.2012.04024.x; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	34	48	48	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					567	581		10.1016/j.cell.2013.09.042	http://dx.doi.org/10.1016/j.cell.2013.09.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24139898	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000326571800012
J	McColl, K				McColl, Karen			PUBLIC HEALTH POLICY IN NEWYORK CITY What's next for public health in a post-Bloomberg NYC?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												karenmccoll@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2013	347								f6272	10.1136/bmj.f6272	http://dx.doi.org/10.1136/bmj.f6272			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WQ	24141605				2022-12-28	WOS:000325982800003
J	Kole, AK; Roy, R				Kole, Alakes K.; Roy, Rammohan			Respiratory Diphtheria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kole, Alakes K.; Roy, Rammohan] Infect Dis Hosp, Kolkata, W Bengal, India		Kole, AK (corresponding author), Infect Dis Hosp, Kolkata, W Bengal, India.	dralakeskole@yahoo.co.in							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1544	1544		10.1056/NEJMicm1309222	http://dx.doi.org/10.1056/NEJMicm1309222			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24131179				2022-12-28	WOS:000328101700012
J	Thomas, KH; Martin, RM; Davies, NM; Metcalfe, C; Windmeijer, F; Gunnell, D				Thomas, Kyla H.; Martin, Richard M.; Davies, Neil M.; Metcalfe, Chris; Windmeijer, Frank; Gunnell, David			Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; GENERAL-PRACTICE; VARENICLINE; INSTRUMENTS; VALIDATION; NICOTINE; EVENTS; SAFETY	Objective To compare the risk of suicide, self harm, and depression in patients prescribed varenicline or bupropion with those prescribed nicotine replacement therapy. Design Prospective cohort study within the Clinical Practice Research Datalink. Setting 349 general practices in England. Participants 119 546 men and women aged 18 years and over who used a smoking cessation product between 1 September 2006 and 31 October 2011. There were 81 545 users of nicotine replacement products (68.2% of all users of smoking cessation medicines), 6741 bupropion (5.6%), and 31 260 varenicline (26.2%) users. Main outcome measures Outcomes were treated depression and fatal and non-fatal self harm within three months of the first smoking cessation prescription, determined from linkage with mortality data from the Office for National Statistics (for suicide) and Hospital Episode Statistics data (for hospital admissions relating to non-fatal self harm). Hazard ratios or risk differences were estimated using Cox multivariable regression models, propensity score matching, and instrumental variable analysis using physicians' prescribing preferences as an instrument. Sensitivity analyses were performed for outcomes at six and nine months. Results We detected 92 cases of fatal and non-fatal self harm (326.5 events per 100 000 person years) and 1094 primary care records of treated depression (6963.3 per 100 000 person years). Cox regression analyses showed no evidence that patients prescribed varenicline had higher risks of fatal or non-fatal self harm (hazard ratio 0.88, 95% confidence interval 0.52 to 1.49) or treated depression (0.75, 0.65 to 0.87) compared with those prescribed nicotine replacement therapy. There was no evidence that patients prescribed bupropion had a higher risk of fatal or non-fatal self harm (0.83, 0.30 to 2.31) or of treated depression (0.63, 0.46 to 0.87) compared with patients prescribed nicotine replacement therapy. Similar findings were obtained using propensity score methods and instrumental variable analyses. Conclusions There is no evidence of an increased risk of suicidal behaviour in patients prescribed varenicline or bupropion compared with those prescribed nicotine replacement therapy. These findings should be reassuring for users and prescribers of smoking cessation medicines.	[Thomas, Kyla H.; Martin, Richard M.; Metcalfe, Chris; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Martin, Richard M.; Davies, Neil M.] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol BS8 2PS, Avon, England; [Windmeijer, Frank] Univ Bristol, Dept Econ, CMPO, Bristol BS8 2PS, Avon, England	University of Bristol; University of Bristol; University of Bristol	Thomas, KH (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England.	kyla.thomas@bristol.ac.uk	Gunnell, David/ABE-6653-2020; Windmeijer, Frank/AAL-5695-2020	Gunnell, David/0000-0002-0829-6470; Metcalfe, Chris/0000-0001-8318-8907; Davies, Neil/0000-0002-2460-0508; Thomas, Kyla/0000-0001-5418-4034; Martin, Richard/0000-0002-7992-7719; Windmeijer, Frank/0000-0002-4232-2783	ESRC [ES/H005331/1] Funding Source: UKRI; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: Medline; Department of Health [DRF-2010-03-138] Funding Source: Medline; Economic and Social Research Council [ES/H005331/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068, DRF-2010-03-138] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Baum C.F., 2002, IVREG2 STATA MODULE; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P268, DOI 10.1097/01.ede.0000193606.58671.c5; Cahill K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub6; Cahill K, 2009, DRUG SAFETY, V32, P119, DOI 10.2165/00002018-200932020-00005; Campbell AR, 2010, AM J HEALTH-SYST PH, V67, P1832, DOI 10.2146/ajhp100196; Clarke PS, 2012, J AM STAT ASSOC, V107, P1638, DOI 10.1080/01621459.2012.734171; Davies NM, 2013, EPIDEMIOLOGY, V24, P352, DOI 10.1097/EDE.0b013e318289e024; Davies NM, 2013, EPIDEMIOLOGY, V24, P363, DOI 10.1097/EDE.0b013e31828abafb; Dhillon S, 2008, DRUGS, V68, P653, DOI 10.2165/00003495-200868050-00011; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Faulk K., 2013, BIRMINGHAM NEWS 0301; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Gunnell D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3805; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Harrison-Woolrych M, 2011, DRUG SAFETY, V34, P763, DOI 10.2165/11594450-000000000-00000; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; Kasliwal R, 2009, DRUG SAFETY, V32, P499, DOI 10.2165/00002018-200932060-00006; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Leuven Edwin, 2003, PSMATCH2 STATA MODUL; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Martens EP, 2006, EPIDEMIOLOGY, V17, P260, DOI 10.1097/01.ede.0000215160.88317.cb; Martin RM, 2006, BRIT J CLIN PHARMACO, V61, P224, DOI 10.1111/j.1365-2125.2005.02527.x; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Medicines and Healthcare Products Regulatory Agency, 2008, DRUG SAFETY UPDATE, V2, P2; Meyer TE, 2013, ADDICTION, V108, P203, DOI 10.1111/j.1360-0443.2012.04024.x; Miller M, 2000, AM J PUBLIC HEALTH, V90, P768, DOI 10.2105/AJPH.90.5.768; Miller M, 2000, AM J EPIDEMIOL, V151, P1060, DOI 10.1093/oxfordjournals.aje.a010148; Mills EJ, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-25; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Moore TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027016; National Institute for Health and Clinical Excellence, 2010, NICE IMPL UPT REP SM; National Institute for Health and Clinical Excellence, 2008, NICE PUBL HLTH GUID; Office for National Statistics, 2011, STAT B, P1; Rassen JA, 2009, J CLIN EPIDEMIOL, V62, P1233, DOI 10.1016/j.jclinepi.2008.12.006; Rassen JA, 2009, J CLIN EPIDEMIOL, V62, P1226, DOI 10.1016/j.jclinepi.2008.12.005; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Setakis E, 2010, PHARMACOEPIDEM DR S, V19, pS310; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Thomas KH, 2013, BRIT J CLIN PHARMACO, V76, P145, DOI 10.1111/bcp.12059; Twigg L, 2004, SMOKING EPIDEMIC ENG; US Food and Drug Administration, 2009, FDA DRUG SAFETY NEWS; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; World Health Organization, 2019, WHO REPORT GLOBAL TO	46	77	78	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2013	347								f5704	10.1136/bmj.f5704	http://dx.doi.org/10.1136/bmj.f5704			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OP	24124105	hybrid, Green Published			2022-12-28	WOS:000325729300001
J	Koslow, JA; Couture, J				Koslow, J. Anthony; Couture, Jennifer			Follow the fish	NATURE			English	Editorial Material							OXYGEN; CLIMATE		[Koslow, J. Anthony; Couture, Jennifer] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Koslow, JA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	jkoslow@ucsd.edu						Alverson K, 2008, J OCEAN TECHNOL, P19; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; Kaartvedt S, 2012, MAR ECOL PROG SER, V456, P1, DOI 10.3354/meps09785; Koslow JA, 2011, MAR ECOL PROG SER, V436, P207, DOI 10.3354/meps09270; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Ohman M. D., 2003, OCEANOGRAPHY, V16, P76, DOI DOI 10.5670/OCEANOG.2003.34; Roberts C, 2012, OCEAN LIFE FATE MAN; Shaffer G, 2009, NAT GEOSCI, V2, P105, DOI 10.1038/NGEO420; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847	10	25	25	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					163	164		10.1038/502163a	http://dx.doi.org/10.1038/502163a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24137750	Bronze			2022-12-28	WOS:000325436100021
J	Bulik, CM				Bulik, Cynthia M.			The challenges of treating anorexia nervosa	LANCET			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Bulik, CM (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	cbulik@med.unc.edu		Bulik, Cynthia/0000-0001-7772-3264				Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Bulik CM, 2007, INT J EAT DISORDER, V40, P310, DOI 10.1002/eat.20367; Fairburn CG, 2005, INT J EAT DISORDER, V37, pS26, DOI 10.1002/eat.20112; Halmi KA, 2005, ARCH GEN PSYCHIAT, V62, P776, DOI 10.1001/archpsyc.62.7.776; Hay P., 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003909; McIntosh VVW, 2005, AM J PSYCHIAT, V162, P741, DOI 10.1176/appi.ajp.162.4.741; Watson HJ, 2013, PSYCHOL MED, V43, P2477, DOI 10.1017/S0033291712002620; Zipfel S, 2013, LANCET IN PRESS	8	28	28	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					105	106		10.1016/S0140-6736(13)61940-6	http://dx.doi.org/10.1016/S0140-6736(13)61940-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	287YX	24131860				2022-12-28	WOS:000329579600007
J	Jones, W; Klin, A				Jones, Warren; Klin, Ami			Attention to eyes is present but in decline in 2-6-month-old infants later diagnosed with autism	NATURE			English	Article							SPECTRUM DISORDERS; CHILDREN	Deficits in eye contact have been a hallmark of autism(1,2) since the condition's initial description(3). They are cited widely as a diagnostic feature(4) and figure prominently in clinical instruments(5); however, the early onset of these deficits has not been known. Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASDs) exhibit mean decline in eye fixation from 2 to 6 months of age, a pattern not observed in infants who do not develop ASD. These observations mark the earliest known indicators of social disability in infancy, but also falsify a prior hypothesis: in the first months of life, this basic mechanism of social adaptive action-eye looking-is not immediately diminished in infants later diagnosed with ASD; instead, eye looking appears to begin at normative levels prior to decline. The timing of decline highlights a narrow developmental window and reveals the early derailment of processes that would otherwise have a key role in canalizing typical social development. Finally, the observation of this decline in eye fixation-rather than outright absence-offers a promising opportunity for early intervention that could build on the apparent preservation of mechanisms subserving reflexive initial orientation towards the eyes.	[Jones, Warren; Klin, Ami] Childrens Healthcare Atlanta, Marcus Autism Ctr, Atlanta, GA 30329 USA; [Jones, Warren; Klin, Ami] Emory Univ, Sch Med, Dept Pediat, Div Autism & Related Disabil, Atlanta, GA 30022 USA; [Jones, Warren; Klin, Ami] Emory Univ, Ctr Translat Social Neurosci, Atlanta, GA 30022 USA	Children's Healthcare of Atlanta (CHOA); Emory University; Emory University	Jones, W (corresponding author), Childrens Healthcare Atlanta, Marcus Autism Ctr, Atlanta, GA 30329 USA.	warren.jones@emory.edu; ami.klin@emory.edu			Simons Foundation; National Institute of Mental Health [R01 MH083727]; Marcus Foundation; Whitehead Foundation; Georgia Research Alliance; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100029, R01MH083727] Funding Source: NIH RePORTER	Simons Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Marcus Foundation; Whitehead Foundation; Georgia Research Alliance; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Simons Foundation and the National Institute of Mental Health (R01 MH083727). Additional support was provided by the Marcus Foundation, the Whitehead Foundation, and the Georgia Research Alliance. We wish to thank the families and children for their time and participation. We also wish to thank S. Habayeb, S. Glazer, M. Ly, T. Tsang, J. Jones, A. Trubanova, J. Borjon, J. Moriuchi, K. Rice, J. Northrup, L. Edwards, J. Xu, S. Shultz, A. Krasno, C. Zampella, K. Knoch, D. Lin, K. Carr and A. Blank for their assistance in data collection and processing; P. Lewis, J. Paredes, P. Gorrindo and M. Ackerman for assistance in designing and building laboratory hardware and software; G. Ramsay and C. McCracken for discussions of data analysis and statistics; I. Zilber, A. Margolis, D. Blum, M. Dye, D. Simeone, A. Smith and K. O'Loughlin for project supervision, coordination, and data collection; T. Babitz for administrative support; and K. Chawarska, C. Saulnier, K. Bearss, S. Macari, R. Paul, A. Carney, T. Goldsmith, A. Steiner, G. Gengoux, D. Goudreau, E. Loring, J. McGrath and A. Gupta for their contributions to the clinical characterization of the samples.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; [Anonymous], 2006, MONOGR SOC RES CHILD, V71, P65; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Chawarska K, 2007, J CHILD PSYCHOL PSYC, V48, P128, DOI 10.1111/j.1469-7610.2006.01685.x; Constantino JN, 2013, MOL PSYCHIATR, V18, P137, DOI 10.1038/mp.2012.9; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Grice SJ, 2005, CORTEX, V41, P342, DOI 10.1016/S0010-9452(08)70271-5; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Hall P, 2009, ANN STAT, V37, P3307, DOI 10.1214/09-AOS686; Horn G, 2001, P NATL ACAD SCI USA, V98, P5282, DOI 10.1073/pnas.091094798; Johnson M. H., 2004, THEORIES INFANT DEV, P121, DOI DOI 10.1002/9780470752180.CH5; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Jones W, 2009, J AM ACAD CHILD PSY, V48, P471, DOI 10.1097/CHI.0b013e31819f6c0d; Kanner L, 1943, NERV CHILD, V2, P217; Klin A, 2003, PHILOS T R SOC B, V358, P345, DOI 10.1098/rstb.2002.1202; Klin A, 2007, J AUTISM DEV DISORD, V37, P748, DOI 10.1007/s10803-006-0229-4; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Liu BT, 2009, J AM STAT ASSOC, V104, P704, DOI 10.1198/jasa.2009.0115; Lord C., 2008, AUTISM DIAGNOSTIC OB, V2nd; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; Oyama S., 2000, ONTOGENY INFORM, V2nd; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; Salva OR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018802; Shultz S, 2011, P NATL ACAD SCI USA, V108, P21270, DOI 10.1073/pnas.1109304108; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Singer J.D., 2003, APPL LONGITUDINAL DA; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Steer CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012633; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Tang R, 2008, BIOMETRIKA, V95, P875, DOI 10.1093/biomet/asn047; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; Zee DS., 1999, NEUROLOGY EYE MOVEME	37	667	696	18	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					427	+		10.1038/nature12715	http://dx.doi.org/10.1038/nature12715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24196715	Green Accepted			2022-12-28	WOS:000328575300050
J	Kawwass, JF; Monsour, M; Crawford, S; Kissin, DM; Session, DR; Kulkarni, AD; Jamieson, DJ				Kawwass, Jennifer F.; Monsour, Michael; Crawford, Sara; Kissin, Dmitry M.; Session, Donna R.; Kulkarni, Aniket D.; Jamieson, Denise J.		Natl ART Surveillance Syst NASS Gr	Trends and Outcomes for Donor Oocyte Cycles in the United States, 2000-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SINGLE-EMBRYO-TRANSFER; PERINATAL OUTCOMES; MATERNAL AGE; PREGNANCY; WOMEN; RISK	IMPORTANCE The prevalence of oocyte donation for in vitro fertilization (IVF) has increased in the United States, but little information is available regarding maternal or infant outcomes to improve counseling and clinical decision making. OBJECTIVES To quantify trends in donor oocyte cycles in the United States and to determine predictors of a good perinatal outcome among IVF cycles using fresh (noncryopreserved) embryos derived from donor oocytes. DESIGN, SETTING, AND PARTICIPANTS Analysis of data from the Centers for Disease Control and Prevention's National ART Surveillance System, to which fertility centers are mandated to report and which includes data on more than 95% of all IVF cycles performed in the United States. Data from 2000 to 2010 described trends. Data from 2010 determined predictors. MAIN OUTCOMES AND MEASURES Good perinatal outcome, defined as a singleton live-born infant delivered at 37 weeks or later and weighing 2500 g or more. RESULTS From 2000 to 2010, data from 443 clinics (93% of all US fertility centers) were included. The annual number of donor oocyte cycles significantly increased, from 10 801 to 18 306. Among all donor oocyte cycles, an increasing trend was observed from 2000 to 2010 in the proportion of cycles using frozen (vs fresh) embryos (26.7%[95% CI, 25.8%-27.5%] to 40.3%[95% CI, 39.6%-41.1%]) and elective single-embryo transfers (vs transfer of multiple embryos) (0.8%[95% CI, 0.7%-1.0%] to 14.5%[95% CI, 14.0%-15.1%]). Good perinatal outcomes increased from 18.5%(95% CI, 17.7%-19.3%) to 24.4%(95% CI, 23.8%-25.1%) (P < .001 for all listed trends). Mean donor and recipient ages remained stable at 28 (SD, 2.8) years and 41 (SD, 5.3) years, respectively. In 2010, 396 clinics contributed data. For donor oocyte cycles using fresh embryos (n = 9865), 27.5%(95% CI, 26.6%-28.4%) resulted in good perinatal outcome. Transfer of an embryo at day 5 (adjusted odds ratio [OR], 1.17 [95% CI, 1.04-1.32]) and elective single-embryo transfers (adjusted OR, 2.32 [95% CI, 1.92-2.80]) were positively associated with good perinatal outcome; tubal (adjusted OR, 0.72 [95% CI, 0.60-0.86]) or uterine (adjusted OR, 0.74 [95% CI, 0.58-0.94]) factor infertility and non-Hispanic black recipient race/ethnicity (adjusted OR, 0.48 [95% CI, 0.35-0.67]) were associated with decreased odds of good outcome. Recipient age was not associated with likelihood of good perinatal outcome. CONCLUSIONS AND RELEVANCE In the United States from 2000 to 2010, there was an increase in number of donor oocyte cycles, accompanied by an increase in good outcomes. Further studies are needed to understand the mechanisms underlying the factors associated with less successful outcomes.	[Kawwass, Jennifer F.; Kissin, Dmitry M.; Session, Donna R.; Jamieson, Denise J.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Endocrinol & Infertil, Atlanta, GA 30308 USA; [Kawwass, Jennifer F.; Monsour, Michael; Crawford, Sara; Kissin, Dmitry M.; Kulkarni, Aniket D.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Kawwass, JF (corresponding author), Emory Univ, Sch Med, Dept Gynecol & Obstet, 550 Peachtree St,Ste 1800, Atlanta, GA 30308 USA.	jennifer.kawwass@emory.edu		Jamieson, Denise/0000-0003-2597-1201; Kawwass, Jennifer/0000-0001-7345-735X	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Adashi EY, 2011, JAMA-J AM MED ASSOC, V306, P1135, DOI 10.1001/jama.2011.1249; Amato P, 2013, FERTIL STERIL, V100, P337, DOI 10.1016/j.fertnstert.2013.02.030; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P44, DOI 10.1016/j.fertnstert.2012.09.038; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Joseph KS, 2005, OBSTET GYNECOL, V105, P1410, DOI 10.1097/01.AOG.0000163256.83313.36; Joshi N, 2012, OBSTET GYNECOL, V120, P843, DOI 10.1097/AOG.0b013e318269c0e9; Kawwass JF, 2013, OBSTET GYNECOL, V121, P1263, DOI 10.1097/AOG.0b013e31829006d9; Kort DH, 2012, AM J PERINAT, V29, P245, DOI 10.1055/s-0031-1285101; Laskov I, 2012, J MATERN-FETAL NEO M, V25, P2190, DOI 10.3109/14767058.2012.684108; Matthews T J, 2009, NCHS Data Brief, P1; McDonald SD, 2009, EUR J OBSTET GYN R B, V146, P138, DOI 10.1016/j.ejogrb.2009.05.035; OECD, 2018, OECD FAM DAT; Paulson RJ, 2002, JAMA-J AM MED ASSOC, V288, P2320, DOI 10.1001/jama.288.18.2320; Pfeifer S, 2012, FERTIL STERIL, V97, P835, DOI 10.1016/j.fertnstert.2011.11.050; Shrim A, 2010, J PERINAT MED, V38, P645, DOI [10.1515/JPM.2010.084, 10.1515/jpm.2010.084]; Steinberg ML, 2013, FERTIL STERIL, V99, P1937, DOI 10.1016/j.fertnstert.2013.01.134; Stillman RJ, 2013, HUM REPROD, V28, P2599, DOI 10.1093/humrep/det317; Stoop D, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-42; Sunderam Saswati, 2012, Morbidity and Mortality Weekly Report, V61, P1; Tranquilli AL, 2013, J MATERN-FETAL NEO M, V26, P1263, DOI 10.3109/14767058.2013.777422; Vincent-Rohfritsch A, 2012, J GYNECOL OBST BIO R, V41, P468, DOI 10.1016/j.jgyn.2012.04.013; Ziadeh S., 2001, Archives of Gynecology and Obstetrics, V265, P30, DOI 10.1007/s004040000122	23	82	88	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2426	2434		10.1001/jama.2013.280924	http://dx.doi.org/10.1001/jama.2013.280924			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24135860	Green Accepted, Bronze			2022-12-28	WOS:000328030900023
J	Sergienko, OV; Hindmarsh, RCA				Sergienko, Olga V.; Hindmarsh, Richard C. A.			Regular Patterns in Frictional Resistance of Ice-Stream Beds Seen by Surface Data Inversion	SCIENCE			English	Article							FLOW; SEDIMENT; TILL	Fast-flowing glaciers and ice streams are pathways for ice discharge from the interior of the Antarctic Ice Sheet to ice shelves, at rates controlled by conditions at the ice-bed interface. Using recently compiled high-resolution data sets and a standard inverse method, we computed basal shear stress distributions beneath Pine Island and Thwaites Glaciers, which are currently losing mass at an accelerating rate. The inversions reveal the presence of riblike patterns of very high basal shear stress embedded within much larger areas with zero basal shear stress. Their colocation with highs in the gradient of hydraulic potential suggests that subglacial water may control the evolution of these high-shear-stress ribs, potentially causing migration of the grounding line by changes in basal resistance in its vicinity.	[Sergienko, Olga V.] Princeton Univ, Program Atmospher & Ocean Sci, Princeton, NJ 08540 USA; [Hindmarsh, Richard C. A.] British Antarctic Survey, Cambridge CB3 0ET, England	National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Sergienko, OV (corresponding author), Princeton Univ, Program Atmospher & Ocean Sci, 201 Forrestal Road, Princeton, NJ 08540 USA.	osergien@princeton.edu	Hindmarsh, Richard C A/C-1405-2012; Sergienko, Olga/HII-8500-2022; Hindmarsh, Richard/N-1195-2019	Hindmarsh, Richard C A/0000-0003-1633-2416; Sergienko, Olga/0000-0002-5764-8815; Hindmarsh, Richard/0000-0003-1633-2416	NSF [CMG-0934534]; British Antarctic Survey Polar Science for Planet Earth program; NERC [NE/J008087/1] Funding Source: UKRI; Office of Polar Programs (OPP) [0934534] Funding Source: National Science Foundation; Natural Environment Research Council [bas0100027, NE/J008087/1] Funding Source: researchfish	NSF(National Science Foundation (NSF)); British Antarctic Survey Polar Science for Planet Earth program; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research is supported by NSF grant CMG-0934534 and the British Antarctic Survey Polar Science for Planet Earth program. We thank anonymous referees for their valuable comments and suggestions.	Bamber J. L., 2009, ANTARCTIC 1 KM DIGIT; Bingham RG, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031483; Dunlop P, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000954; Engelhardt H, 1997, J GLACIOL, V43, P207, DOI 10.3189/S0022143000003166; ENGELHARDT H, 1990, SCIENCE, V248, P57, DOI 10.1126/science.248.4951.57; Fowler A. C., 2009, P ROY SOC LOND A MAT, V465, P681; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Gray L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021387; Greenwood SL, 2010, QUATERNARY SCI REV, V29, P1894, DOI 10.1016/j.quascirev.2010.04.010; Hindmarsh RCA, 1998, J GLACIOL, V44, P589, DOI 10.3189/S0022143000002100; Hindmarsh RCA, 1998, J GLACIOL, V44, P285, DOI 10.3189/S0022143000002628; Joughin I, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002960; MACAYEAL DR, 1989, J GEOPHYS RES-SOLID, V94, P4071, DOI 10.1029/JB094iB04p04071; MACAYEAL DR, 1993, J GLACIOL, V39, P91, DOI 10.3189/S0022143000015744; Morlighem M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043853; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Schoof C., 2007, J GEOPHYS RES, V112, P227; Schoof C, 2007, J FLUID MECH, V570, P227, DOI 10.1017/S0022112006002874; Sergienko OV, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF001004; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Shreve R.L., 1972, J GLACIOL, V11, P205, DOI [DOI 10.3189/S002214300002219X, 10.3189/S002214300002219X]; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]	24	57	57	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1086	1089		10.1126/science.1243903	http://dx.doi.org/10.1126/science.1243903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24200815				2022-12-28	WOS:000327518600055
J	Field, AE; Camargo, CA; Ogino, S				Field, Alison E.; Camargo, Carlos A., Jr.; Ogino, Shuji			The Merits of Subtyping Obesity One Size Does Not Fit All	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BODY-MASS INDEX; ASSOCIATION; PREVALENCE; TRENDS		[Field, Alison E.; Camargo, Carlos A., Jr.] Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Dept Epidemiol,Dept Med, Boston, MA 02115 USA; [Field, Alison E.; Camargo, Carlos A., Jr.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Field, Alison E.] Boston Childrens Hosp, Dept Med, Div Adolescent Med, Boston, MA USA; [Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Dept Epidemiol,Dept Pathol, Boston, MA 02115 USA; [Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Field, AE (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Adolescent Med, 300 Longwood Ave,AU 506, Boston, MA 02115 USA.	alison.field@childrens.harvard.edu	Camargo, Carlos A./C-2145-2008; Field, Alison/AAA-4508-2021	Camargo, Carlos A./0000-0002-5071-7654; Ogino, Shuji/0000-0002-3909-2323				Chaput JP, 2008, AM J CLIN NUTR, V87, P303, DOI 10.1093/ajcn/87.2.303; Epstein LH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-13; Ferriday D, 2011, INT J OBESITY, V35, P142, DOI 10.1038/ijo.2010.117; Field AE, 2012, PEDIATRICS, V130, pE289, DOI 10.1542/peds.2011-3663; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ogino S, 2014, ONCOGENE, V33, P2949, DOI 10.1038/onc.2013.244; Roemmich JN, 2008, PHYSIOL BEHAV, V93, P1011, DOI 10.1016/j.physbeh.2008.01.010; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174	10	73	76	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2147	2148		10.1001/jama.2013.281501	http://dx.doi.org/10.1001/jama.2013.281501			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24189835				2022-12-28	WOS:000327404400020
J	Chung, CY; Khurana, V; Auluck, PK; Tardiff, DF; Mazzulli, JR; Soldner, F; Baru, V; Lou, YL; Freyzon, Y; Cho, S; Mungenast, AE; Muffat, J; Mitalipova, M; Pluth, MD; Jui, NT; Schule, B; Lippard, SJ; Tsai, LH; Krainc, D; Buchwald, SL; Jaenisch, R; Lindquist, S				Chung, Chee Yeun; Khurana, Vikram; Auluck, Pavan K.; Tardiff, Daniel F.; Mazzulli, Joseph R.; Soldner, Frank; Baru, Valeriya; Lou, Yali; Freyzon, Yelena; Cho, Sukhee; Mungenast, Alison E.; Muffat, Julien; Mitalipova, Maisam; Pluth, Michael D.; Jui, Nathan T.; Schuele, Birgitt; Lippard, Stephen J.; Tsai, Li-Huei; Krainc, Dimitri; Buchwald, Stephen L.; Jaenisch, Rudolf; Lindquist, Susan			Identification and Rescue of alpha-Synuclein Toxicity in Parkinson Patient-Derived Neurons	SCIENCE			English	Article							NEURODEGENERATION; NITRATION; NETWORK; STRESS; RISK	The induced pluripotent stem (iPS) cell field holds promise for in vitro disease modeling. However, identifying innate cellular pathologies, particularly for age-related neurodegenerative diseases, has been challenging. Here, we exploited mutation correction of iPS cells and conserved proteotoxic mechanisms from yeast to humans to discover and reverse phenotypic responses to alpha-synuclein (alpha syn), a key protein involved in Parkinson's disease (PD). We generated cortical neurons from iPS cells of patients harboring alpha syn mutations, who are at high risk of developing PD dementia. Genetic modifiers from unbiased screens in a yeast model of alpha syn toxicity led to identification of early pathogenic phenotypes in patient neurons. These included nitrosative stress, accumulation of endoplasmic reticulum (ER)-associated degradation substrates, and ER stress. A small molecule identified in a yeast screen (NAB2), and the ubiquitin ligase Nedd4 it affects, reversed pathologic phenotypes in these neurons.	[Chung, Chee Yeun; Khurana, Vikram; Auluck, Pavan K.; Tardiff, Daniel F.; Soldner, Frank; Baru, Valeriya; Lou, Yali; Freyzon, Yelena; Muffat, Julien; Mitalipova, Maisam; Jaenisch, Rudolf; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Khurana, Vikram; Mazzulli, Joseph R.; Krainc, Dimitri] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Khurana, Vikram; Auluck, Pavan K.; Mazzulli, Joseph R.; Krainc, Dimitri] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Auluck, Pavan K.] Massachusetts Gen Hosp, Dept Pathol Neuropathol, Boston, MA 02114 USA; [Baru, Valeriya; Lou, Yali; Tsai, Li-Huei; Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Cho, Sukhee; Mungenast, Alison E.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Pluth, Michael D.; Jui, Nathan T.; Lippard, Stephen J.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Schuele, Birgitt] Parkinsons Inst, Sunnyvale, CA 94085 USA; [Jaenisch, Rudolf; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Muffat, Julien/P-2298-2014; Mazzulli, joseph/AAS-4480-2020; Pluth, Michael/A-7222-2012	Muffat, Julien/0000-0003-1889-7023; Khurana, Vikram/0000-0002-4018-5527; Schuele, Birgitt/0000-0002-9952-5776; Mungenast, Alison/0000-0003-1020-0471; Pluth, Michael/0000-0003-3604-653X	Howard Hughes Medical Institute; JPB Foundation; NIH/National Institute on Aging [K01 AG038546]; American Brain Foundation; Parkinson's Disease Foundation; NIH [5 R01CA084198]; NSF; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, K01AG038546] Funding Source: NIH RePORTER; Division Of Chemistry [0907905] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation; NIH/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Brain Foundation; Parkinson's Disease Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank D. Dickson, L. Golbe, and J. Trojanowki for postmorterm tissue or data; D. Pincus for the UPR reporter; I. Cheeseman, J. Kim, J. Pruszak, P. Wisniewski, and W. Salmon for important technical advice; R. Alagappan, T. Lungiangwa, and P. Xu for superb technical assistance; and S. Santagata, L. Whitesell, M. Feany, D. Landgraf, and L. Clayton for fruitful discussion and critical comments on the manuscript. Grant support was provided by a Howard Hughes Medical Institute Collaborative Innovation Award (S.L.), JPB Foundation grants (S.L.), NIH/National Institute on Aging grant K01 AG038546 (C.Y.C.), an American Brain Foundation and Parkinson's Disease Foundation Clinician-Scientist Development Award (V.K.), NIH grant 5 R01CA084198 (R.J.), and the NSF (S.J.L.). Whitehead Institute for Biomedical Research has filed a patent application, on which authors V.K., C.Y.C., and S.L. are inventors, relating to the use of yeast- and iPS cell-based models of synucleinopathies and associated phenotypes for identifying compounds. In addition, author S.L. is an inventor on patents and patent applications filed by The University of Chicago relating to methods of screening for compounds that decrease alpha-synuclein-associated toxicity using yeast that expresses alpha-synuclein. All the yeast plasmids and strains and NAB2 are available under a Uniform Biological Material Transfer Agreement from the Whitehead Institute. Author contributions: C.Y.C., V.K., and S.L. conceptualized the study, designed the experiments, and wrote the paper. V.K. developed the human iPS cell-derived cortical synucleinopathy model, assisted by Y.L. Pluripotent cell lines, advice on experimental design, and technical expertise were provided by F.S., J.R.M., J.M., M.M., and R.J. F.S. reprogrammed the WIBR-IPS-SYN<SUP>TRPL</SUP> line from fibroblasts provided by B.S. C.Y.C. developed the rat cortical synucleinopathy model, assisted by V.B. The mKate2-tagged constructs were generated by Y.F. C.Y.C. and V.K. performed all experiments except Fig. 1, D and E, Fig. 2E, and fig. S5, A and B (P.K.A.); Fig. 4A (D.F.T.); Fig. 4C and fig. S6C (J.R.M./D.K.); fig. S2, H and I (A.E.M./S.C./L.-H.T.); and fig. S1 (Y.F./Y.L.). The small molecule NAB2 was synthesized by N.T.J. and S.L.B., based on a yeast screen performed by D.F.T. FL2 dye synthesis and technical advice were provided by M.D.P. and S.J.L.	Alcalay RN, 2012, NEUROLOGY, V78, P1434, DOI 10.1212/WNL.0b013e318253d54b; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Castello PR, 2008, P NATL ACAD SCI USA, V105, P8203, DOI 10.1073/pnas.0709461105; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Donovan P, 2013, INT J BIOCHEM CELL B, V45, P706, DOI 10.1016/j.biocel.2012.12.006; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gomez-Tortosa E, 2002, ACTA NEUROPATHOL, V103, P495, DOI 10.1007/s00401-001-0495-3; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Markopoulou K, 2008, ACTA NEUROPATHOL, V116, P25, DOI 10.1007/s00401-008-0372-4; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pluth MD, 2011, ANNU REV BIOCHEM, V80, P333, DOI 10.1146/annurev-biochem-061009-091643; Saito T, 2011, CEREB CORTEX, V21, P588, DOI 10.1093/cercor/bhq125; Sarver A, 2005, MOL BIOL CELL, V16, P4781, DOI 10.1091/mbc.E05-05-0436; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210	28	343	361	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					983	987		10.1126/science.1245296	http://dx.doi.org/10.1126/science.1245296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24158904	Green Submitted, Green Accepted			2022-12-28	WOS:000327223500044
J	Kim, J; Park, H; Hannon, JB; Bedell, SW; Fogel, K; Sadana, DK; Dimitrakopoulos, C				Kim, Jeehwan; Park, Hongsik; Hannon, James B.; Bedell, Stephen W.; Fogel, Keith; Sadana, Devendra K.; Dimitrakopoulos, Christos			Layer-Resolved Graphene Transfer via Engineered Strain Layers	SCIENCE			English	Article							EPITAXIAL GRAPHENE; WAFER; ENERGY; FILMS	The performance of optimized graphene devices is ultimately determined by the quality of the graphene itself. Graphene grown on copper foils is often wrinkled, and the orientation of the graphene cannot be controlled. Graphene grown on SiC(0001) via the decomposition of the surface has a single orientation, but its thickness cannot be easily limited to one layer. We describe a method in which a graphene film of one or two monolayers grown on SiC is exfoliated via the stress induced with a Ni film and transferred to another substrate. The excess graphene is selectively removed with a second exfoliation process with a Au film, resulting in a monolayer graphene film that is continuous and single-oriented.	[Kim, Jeehwan; Park, Hongsik; Hannon, James B.; Bedell, Stephen W.; Fogel, Keith; Sadana, Devendra K.; Dimitrakopoulos, Christos] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Kim, J (corresponding author), IBM TJ Watson Res Ctr, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA.	jeehwkim@us.ibm.com; hpark@us.ibm.com; dimitrak@umass.edu		Dimitrakopoulos, Christos/0000-0003-1059-3498	Defense Advanced Research Projects Agency [HR0011-12-C-0038]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The authors thank J. Bacchignano and S. Dawes for technical assistance with electron-beam lithography; E. Kim for assistance with figure illustration; and F. M. Ross, B. Shin, S. J. Chey, and S.-J. Han for helpful discussions. C. D. was partially supported for this work by Defense Advanced Research Projects Agency contract HR0011-12-C-0038.	Avouris P, 2012, MATER TODAY, V15, P86, DOI 10.1016/S1369-7021(12)70044-5; BAUER E, 1994, REP PROG PHYS, V57, P895, DOI 10.1088/0034-4885/57/9/002; Caldwell JD, 2010, ACS NANO, V4, P1108, DOI 10.1021/nn901585p; Dimitrakopoulos C, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3595945; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]; Franklin AD, 2011, IEEE ELECTR DEVICE L, V32, P1035, DOI 10.1109/LED.2011.2158058; Hamada I, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.153412; Hannon JB, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.241404; Ji SH, 2012, NAT MATER, V11, P114, DOI [10.1038/NMAT3170, 10.1038/nmat3170]; Kim J, 2010, J APPL PHYS, V107, DOI 10.1063/1.3369254; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Knox KR, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.201408; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Lin YM, 2011, IEEE ELECTR DEVICE L, V32, P1343, DOI 10.1109/LED.2011.2162934; Lin YM, 2011, SCIENCE, V332, P1294, DOI 10.1126/science.1204428; Liu M, 2011, NATURE, V474, P64, DOI 10.1038/nature10067; NIX WD, 1989, METALL TRANS A, V20, P2217, DOI 10.1007/BF02666659; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Podeszwa R, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3300064; Riedl C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2960341; Srivastava N., 2010, J VAC SCI TECHNOL B, V28, pC5C1; Tanaka S., 2009, PHYS REV B, V80; Unarunotai S, 2010, ACS NANO, V4, P5591, DOI 10.1021/nn101896a; Xia FN, 2011, NAT NANOTECHNOL, V6, P179, DOI [10.1038/nnano.2011.6, 10.1038/NNANO.2011.6]; Xia FN, 2009, NAT NANOTECHNOL, V4, P839, DOI [10.1038/nnano.2009.292, 10.1038/NNANO.2009.292]; Zacharia R, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.155406	28	152	166	11	331	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					833	836		10.1126/science.1242988	http://dx.doi.org/10.1126/science.1242988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24179157				2022-12-28	WOS:000326923000031
J	Leek, PJ				Leek, Peter J.			Storing Quantum Information in Schrodinger's Cats	SCIENCE			English	Editorial Material							PHOTON; STATES		Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Leek, PJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	peter.leek@physics.ox.ac.uk	Leek, Peter/C-7252-2016	Leek, Peter/0000-0002-1410-5642	EPSRC [EP/J001821/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J001821/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		[Anonymous], 2013, SCIENCE, V339, P1163; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Gleyzes S, 2007, NATURE, V446, P297, DOI 10.1038/nature05589; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Leghtas Z, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.042315; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Ourjoumtsev A, 2007, NATURE, V448, P784, DOI 10.1038/nature06054; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Reagor M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807015; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Zurek WH, 2001, NATURE, V412, P712, DOI 10.1038/35089017	14	3	3	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					568	569		10.1126/science.1245510	http://dx.doi.org/10.1126/science.1245510			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179210				2022-12-28	WOS:000326334300027
J	Moynihan, R				Moynihan, Ray			Act now to fight chronic procrastination disorder Procrastination awareness week will happen next week-or the week after that	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Frances A. J., 2013, HUFFINGTON POST	1	0	0	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2013	347								f6119	10.1136/bmj.f6119	http://dx.doi.org/10.1136/bmj.f6119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247ES	24167202				2022-12-28	WOS:000326599200003
J	Wang, YH; Steinberg, H; Jarillo-Herrero, P; Gedik, N				Wang, Y. H.; Steinberg, H.; Jarillo-Herrero, P.; Gedik, N.			Observation of Floquet-Bloch States on the Surface of a Topological Insulator	SCIENCE			English	Article							SEMICONDUCTOR; FIELD	The unique electronic properties of the surface electrons in a topological insulator are protected by time-reversal symmetry. Circularly polarized light naturally breaks time-reversal symmetry, which may lead to an exotic surface quantum Hall state. Using time-and angle-resolved photoemission spectroscopy, we show that an intense ultrashort midinfrared pulse with energy below the bulk band gap hybridizes with the surface Dirac fermions of a topological insulator to form Floquet-Bloch bands. These photon-dressed surface bands exhibit polarization-dependent band gaps at avoided crossings. Circularly polarized photons induce an additional gap at the Dirac point, which is a signature of broken time-reversal symmetry on the surface. These observations establish the Floquet-Bloch bands in solids and pave the way for optical manipulation of topological quantum states of matter.	[Wang, Y. H.; Steinberg, H.; Jarillo-Herrero, P.; Gedik, N.] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gedik, N (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	gedik@mit.edu	Steinberg, Hadar/Q-7504-2019; Wang, Yihua/I-5407-2013; Steinberg, Hadar/R-7417-2018; Jarillo-Herrero, Pablo/E-3755-2013	Steinberg, Hadar/0000-0002-7409-5087; Wang, Yihua/0000-0002-5590-5881; Steinberg, Hadar/0000-0002-7409-5087; Jarillo-Herrero, Pablo/0000-0001-8217-8213	U.S. Department of Energy (DOE) [DE-FG02-08ER46521, DE-SC0006423]; Army Research Office (ARO-DURIP) [W911NF-09-1-0170]; DOE, Basic Energy Sciences Office, Division of Materials Sciences and Engineering [DE-SC0006418]; NSF [DMR-0819762]	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Army Research Office (ARO-DURIP); DOE, Basic Energy Sciences Office, Division of Materials Sciences and Engineering; NSF(National Science Foundation (NSF))	This work is supported by U.S. Department of Energy (DOE) award numbers DE-FG02-08ER46521 and DE-SC0006423 (data acquisition and analysis) and Army Research Office (ARO-DURIP) grant W911NF-09-1-0170 (electron spectrometer). H. S. and P.J.-H. have been supported by the DOE, Basic Energy Sciences Office, Division of Materials Sciences and Engineering, under award DE-SC0006418 (materials growth). This work made use of the Materials Research Science and Engineering Center Shared Experimental Facilities supported by NSF under award DMR-0819762. We are grateful for the stimulating discussions with L. Fu, T. Kitagawa, T. Oka, B. Fregoso, and V. Galitski.	Beidenkopf H, 2011, NAT PHYS, V7, P939, DOI [10.1038/nphys2108, 10.1038/NPHYS2108]; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Chen YL, 2010, SCIENCE, V329, P659, DOI 10.1126/science.1189924; Cohen-Tannoudji C., 1998, ATOM PHOTON INTERACT; Faisal FHM, 1997, PHYS REV A, V56, P748, DOI 10.1103/PhysRevA.56.748; GALITSKII VM, 1970, SOV PHYS JETP-USSR, V30, P117; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; Hajlaoui M, 2012, NANO LETT, V12, P3532, DOI 10.1021/nl301035x; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Inoue J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.017401; Kitagawa T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235108; Kittel C., 2004, INTRO SOLID STATE PH; LaForge AD, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125120; Lindner NH, 2011, NAT PHYS, V7, P490, DOI 10.1038/NPHYS1926; Miaja-Avila L, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.030901; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Oka T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.081406; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Saathoff G, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022903; SAMBE H, 1973, PHYS REV A, V7, P2203, DOI 10.1103/PhysRevA.7.2203; Schultze M, 2013, NATURE, V493, P75, DOI 10.1038/nature11720; Sobota JA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.117403; Syzranov SV, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045407; Vu QT, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.217403; Wang YH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.127401; Wang YH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.207602; Xu SY, 2012, NAT PHYS, V8, P616, DOI [10.1038/nphys2351, 10.1038/NPHYS2351]; Yazyev OV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266806; Zhou Y, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245436	33	710	716	11	302	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					453	457		10.1126/science.1239834	http://dx.doi.org/10.1126/science.1239834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159040	Green Submitted			2022-12-28	WOS:000326042600035
J	Roehr, B				Roehr, Bob			ENERGY DRINKS Energy drinks: cause for concern or scaremongering?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Bronstein AC, CAFFEINE ENERGY DRIN; Higgins JP, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.12.023; Liu J., 2013, THESIS TEXAS MED CTR; Martin-lof A, 2013, AM J TRANSPLANT; Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965; Sullum J., 2011, REASON 2011	6	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2013	347								f6343	10.1136/bmj.f6343	http://dx.doi.org/10.1136/bmj.f6343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CK	24157499				2022-12-28	WOS:000326294000003
J	Lajoie, MJ; Kosuri, S; Mosberg, JA; Gregg, CJ; Zhang, D; Church, GM				Lajoie, M. J.; Kosuri, S.; Mosberg, J. A.; Gregg, C. J.; Zhang, D.; Church, G. M.			Probing the Limits of Genetic Recoding in Essential Genes	SCIENCE			English	Article							SYNONYMOUS CODON USAGE; ESCHERICHIA-COLI; IN-VIVO; TRANSLATION; GENOME; REVEALS; CELL; EXPRESSION; EFFICIENCY; SELECTION	Engineering radically altered genetic codes will allow for genomically recoded organisms that have expanded chemical capabilities and are isolated from nature. We have previously reassigned the translation function of the UAG stop codon; however, reassigning sense codons poses a greater challenge because such codons are more prevalent, and their usage regulates gene expression in ways that are difficult to predict. To assess the feasibility of radically altering the genetic code, we selected a panel of 42 highly expressed essential genes for modification. Across 80 Escherichia coli strains, we removed all instances of 13 rare codons from these genes and attempted to shuffle all remaining codons. Our results suggest that the genome-wide removal of 13 codons is feasible; however, several genome design constraints were apparent, underscoring the importance of a strategy that rapidly prototypes and tests many designs in small pieces.	[Lajoie, M. J.; Mosberg, J. A.; Gregg, C. J.; Church, G. M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lajoie, M. J.; Mosberg, J. A.] Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA; [Kosuri, S.; Zhang, D.; Church, G. M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu	Zhang, Di/AAN-3312-2021	Zhang, Di/0000-0002-9007-4665; church, george/0000-0001-6232-9969; Kosuri, Sriram/0000-0002-4661-0600	U.S. Department of Energy [DE-FG02-02ER63445]; NSF [SA5283-11210]; Defense Advanced Research Projects Agency [N66001-12-C-4040]; U.S. Office of Naval Research [N000141010144]; Agilent Technologies; Wyss Institute; Department of Defense National Defense Science and Engineering Graduate Fellowship	U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Office of Naval Research(Office of Naval Research); Agilent Technologies; Wyss Institute; Department of Defense National Defense Science and Engineering Graduate Fellowship(United States Department of Defense)	We thank S. Vassallo and J. Ho for technical assistance and U. Laserson, D. Goodman, N. Eroshenko, D. Mandell, D. Soll, L. Ling, and F. Isaacs for helpful comments. Funding was from the U.S. Department of Energy (DE-FG02-02ER63445), NSF (SA5283-11210), the Defense Advanced Research Projects Agency (N66001-12-C-4040), the U.S. Office of Naval Research (N000141010144), Agilent Technologies, Wyss Institute, and Department of Defense National Defense Science and Engineering Graduate Fellowship (M.J.L.).	AKASHI H, 1994, GENETICS, V136, P927; Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332; BULMER M, 1991, GENETICS, V129, P897; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Schafer MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025736; Shinhara A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-428; Sorensen MA, 2005, J MOL BIOL, V354, P16, DOI 10.1016/j.jmb.2005.08.076; Sykes MT, 2010, ANAL CHEM, V82, P5038, DOI 10.1021/ac9028664; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Yamazaki Yukiko, 2008, V416, P385, DOI 10.1007/978-1-59745-321-9_26; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; ZELL R, 1987, EMBO J, V6, P1809, DOI 10.1002/j.1460-2075.1987.tb02435.x	30	92	103	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					361	363		10.1126/science.1241460	http://dx.doi.org/10.1126/science.1241460			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136967				2022-12-28	WOS:000325755100045
J	Percy, AK				Percy, Alan K.			Path to Treat Rett Syndrome	SCIENCE			English	Editorial Material							MOUSE MODEL; MECP2; REVERSAL; AUTISM		Univ Alabama Birmingham, Civitan Int Res Ctr, Dept Pediat Neurol Neurobiol Genet & Psychol, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham	Percy, AK (corresponding author), Univ Alabama Birmingham, Civitan Int Res Ctr, Dept Pediat Neurol Neurobiol Genet & Psychol, Birmingham, AL 35233 USA.	apercy@uab.edu			NICHD NIH HHS [HD38985, HD061222, U54 HD061222] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061222, P30HD038985] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Glaze DG, 2010, NEUROLOGY, V74, P909, DOI 10.1212/WNL.0b013e3181d6b852; Glaze DG, 2002, MENT RETARD DEV D R, V8, P66, DOI 10.1002/mrdd.10024; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Lane JB, 2011, NEUROLOGY, V77, P1812, DOI 10.1212/WNL.0b013e3182377dd2; Li WJ, 2012, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2012-97; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Percy AK, 2010, PEDIATR RES, V67, P435, DOI 10.1203/PDR.0b013e3181d0187f; Rett A., 1966, WIEN MED WOCHENSCHR, V116; Tarquinio DC, 2012, NEUROLOGY, V79, P1653, DOI 10.1212/WNL.0b013e31826e9a70; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106	16	4	4	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					318	320		10.1126/science.1245657	http://dx.doi.org/10.1126/science.1245657			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136956				2022-12-28	WOS:000325755100030
J	Derdeyn, CP; Chimowitz, MI; Lynn, MJ; Fiorella, D; Turan, TN; Janis, LS; Montgomery, J; Nizam, A; Lane, BF; Lutsep, HL; Barnwell, SL; Waters, MF; Hoh, BL; Hourihane, JM; Levy, EI; Alexandrov, AV; Harrigan, MR; Chiu, D; Klucznik, RP; Clark, JM; McDougall, CG; Johnson, MD; Pride, GL; Lynch, JR; Zaidat, OO; Rumboldt, Z; Cloft, HJ				Derdeyn, Colin P.; Chimowitz, Marc I.; Lynn, Michael J.; Fiorella, David; Turan, Tanya N.; Janis, L. Scott; Montgomery, Jean; Nizam, Azhar; Lane, Bethany F.; Lutsep, Helmi L.; Barnwell, Stanley L.; Waters, Michael F.; Hoh, Brian L.; Hourihane, J. Maurice; Levy, Elad I.; Alexandrov, Andrei V.; Harrigan, Mark R.; Chiu, David; Klucznik, Richard P.; Clark, Joni M.; McDougall, Cameron G.; Johnson, Mark D.; Pride, G. Lee, Jr.; Lynch, John R.; Zaidat, Osama O.; Rumboldt, Zoran; Cloft, Harry J.		Stenting Aggressive Med Management	Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial	LANCET			English	Article							PREVENTING RECURRENT STROKE; ISCHEMIC-STROKE; MANAGEMENT; ANGIOPLASTY; MECHANISMS; DISEASE; ASPIRIN; DESIGN; FUTURE	Background Early results of the Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis trial showed that, by 30 days, 33 (14.7%) of 224 patients in the stenting group and 13 (5.8%) of 227 patients in the medical group had died or had a stroke (percentages are product limit estimates), but provided insufficient data to establish whether stenting offered any longer-term benefit. Here we report the long-term outcome of patients in this trial. Methods We randomly assigned (1:1, stratified by centre with randomly permuted block sizes) 451 patients with recent transient ischaemic attack or stroke related to 70-99% stenosis of a major intracranial artery to aggressive medical management (antiplatelet therapy, intensive management of vascular risk factors, and a lifestyle-modification programme) or aggressive medical management plus stenting with the Wingspan stent. The primary endpoint was any of the following:stroke or death within 30 days after enrolment, ischaemic stroke in the territory of the qualifying artery beyond 30 days of enrolment, or stroke or death within 30 days after a revascularisation procedure of the qualifying lesion during follow-up. Primary endpoint analysis of between-group differences with log-rank test was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT 00576693. Findings During a median follow-up of 32.4 months, 34 (15%) of 227 patients in the medical group and 52 (23%) of 224 patients in the stenting group had a primary endpoint event. The cumulative probability of the primary endpoints was smaller in the medical group versus the percutaneous transluminal angioplasty and stenting (PTAS) group (p=0.0252). Beyond 30 days, 21 (10%) of 210 patients in the medical group and 19 (10%) of 191 patients in the stenting group had a primary endpoint. The absolute differences in the primary endpoint rates between the two groups were 7.1% at year 1 (95% CI 0.2 to 13.8%; p=0.0428), 6.5% at year 2 (-0.5 to 13.5%; p=0.07) and 9.0% at year 3 (1.5 to 16.5%; p=0.0193). The occurrence of the following adverse events was higher in the PTAS group than in the medical group:any stroke (59 [26%] of 224 patients vs 42 [19%] of 227 patients; p=0.0468) and major haemorrhage (29 [13%] of 224 patients vs 10 [4%] of 227 patients; p=0.0009). Interpretation The early benefit of aggressive medical management over stenting with the Wingspan stent for high-risk patients with intracranial stenosis persists over extended follow-up. Our findings lend support to the use of aggressive medical management rather than PTAS with the Wingspan system in high-risk patients with atherosclerotic intracranial arterial stenosis.	[Derdeyn, Colin P.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Derdeyn, Colin P.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Derdeyn, Colin P.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA; [Chimowitz, Marc I.; Turan, Tanya N.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Lynn, Michael J.; Montgomery, Jean; Nizam, Azhar; Lane, Bethany F.] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ, Atlanta, GA 30322 USA; [Fiorella, David] SUNY Stony Brook, Dept Neurosurg, Stony Brook, NY 11794 USA; [Janis, L. Scott] NINDS, NIH, Bethesda, MD 20892 USA; [Lutsep, Helmi L.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Barnwell, Stanley L.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR USA; [Barnwell, Stanley L.] Oregon Hlth & Sci Univ, Dotter Intervent Inst, Portland, OR USA; [Waters, Michael F.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Waters, Michael F.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Hoh, Brian L.] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Levy, Elad I.] SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA; [Hourihane, J. Maurice] Dent Neurol Inst, Buffalo, NY USA; [Alexandrov, Andrei V.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Harrigan, Mark R.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA; [Chiu, David] Houston Methodist Hosp, Dept Neurol, Houston, TX USA; [Klucznik, Richard P.] Houston Methodist Hosp, Dept Radiol, Houston, TX USA; [Clark, Joni M.] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [McDougall, Cameron G.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Johnson, Mark D.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Pride, G. Lee, Jr.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Pride, G. Lee, Jr.] Univ Texas SW Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA; [Lynch, John R.; Zaidat, Osama O.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Rumboldt, Zoran] Med Univ S Carolina, Dept Radiol, Charleston, SC 29425 USA; [Cloft, Harry J.] Mayo Clin, Dept Radiol, Rochester, MN USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Medical University of South Carolina; Emory University; Rollins School Public Health; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Barrow Neurological Institute; Barrow Neurological Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical University of South Carolina; Mayo Clinic	Derdeyn, CP (corresponding author), Washington Univ, Sch Med, Barnes Jewish Hosp, 510 South Kingshighway Blvd, St Louis, MO 63110 USA.	derdeync@wustl.edu	Rumboldt, Zoran/AAA-9893-2019	Rumboldt, Zoran/0000-0001-6833-9762; Papamitsakis, Nikolaos/0000-0001-9003-3399; Turan, Tanya/0000-0001-5399-8845; Fisher, III, Winfield/0000-0001-5078-8439; Alexandrov, Andrei V/0000-0001-8871-1023; Gutmann, Laurie/0000-0003-3926-4209; Hsia, Amie/0000-0002-0214-9736; Derdeyn, Colin/0000-0002-5932-2683; Provencio, Jose Javier/0000-0003-1298-1806; Nizam, Azhar/0000-0001-9995-5920	National Institute of Neurological Disorders and Stroke (NINDS); US Public Health Service National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS058728]; National Institutes of Health; Medical University of South Carolina [UL1RR029882]; University of Florida [UL1RR029889]; University of Cincinnati [UL1RR029890]; University of California, San Francisco [UL1RR024131]; Stryker Neurovascular; AstraZeneca; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131, UL1RR029890, UL1RR029882, TL1RR029889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058728, K23NS069668] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US Public Health Service National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina; University of Florida(University of Florida); University of Cincinnati; University of California, San Francisco(University of California System); Stryker Neurovascular; AstraZeneca(AstraZeneca); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by a research grant (U01 NS058728) from the US Public Health Service National Institute of Neurological Disorders and Stroke (NINDS). Additionally, the following Clinical and Translational Science Awards, funded by the National Institutes of Health, provided local support for the assessment of patients in the trial: Medical University of South Carolina (UL1RR029882), University of Florida (UL1RR029889), University of Cincinnati (UL1RR029890), and University of California, San Francisco (UL1RR024131). Stryker Neurovascular (formerly Boston Scientific Neurovascular) provided study devices and supplemental funding for third party device distribution, site monitoring, and study auditing. This research was also supported by the Investigator-Sponsored Study Program of AstraZeneca, which donated rosuvastatin (Crestor) to study patients. INTERVENT provided the lifestyle modification programme to the study at a discounted rate. The Regulatory and Clinical Research Institute (RCRI; Minneapolis, MN, USA) provided assistance in designing the site monitoring processes and did the site monitoring visits. The VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center (Albuquerque, NM, USA) handled the procurement, labelling, distribution, and inventory management of the study devices and rosuvastatin. Walgreens pharmacies provided study drugs other than rosuvastatin to patients at a discounted price (paid for by the study). The PACE self-assessment forms for physical activity and smoking cessation were provided by the San Diego Center for Health Interventions, LLC. We thank the patients for participating in this study; Oscar Benavente, Carole White, Robert Hart, Pablo Pergola, and Ana Roldan of the Secondary Prevention of Small Subcortical Strokes trial (SPS3, NCT00059306) for assisting with the development and implementation of the SAMMPRIS blood pressure management protocol; George Howard and Thomas Brott for providing advice on study design and other issues based on their experience with the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST, NCT00004732); and Rie Calcaterra who helped with the SAMMPRIS grant application and with the launching of the trial.	Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2; Bose A, 2007, STROKE, V38, P1531, DOI 10.1161/STROKEAHA.106.477711; Chaturvedi S, 2007, NEUROLOGY, V69, P2063, DOI 10.1212/01.wnl.0000279338.18776.26; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2011, J STROKE CEREBROVASC, V20, P357, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.001; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Derdeyn CP, 2007, NEUROIMAG CLIN N AM, V17, P303, DOI 10.1016/j.nic.2007.03.001; Derdeyn CP, 2013, J NEUROINTERV SURG, V5, P528, DOI 10.1136/neurintsurg-2012-010504; Derdeyn CP, 2013, NEUROSURGERY, V72, P777, DOI 10.1227/NEU.0b013e318286fdc8; Dumont TM, 2012, NEUROSURGERY, V71, P1103, DOI 10.1227/NEU.0b013e318271bcb8; Fiorella D, 2012, STROKE, V43, P2682, DOI 10.1161/STROKEAHA.112.661173; Fleg JL, 2012, JACC-CARDIOVASC IMAG, V5, P941, DOI 10.1016/j.jcmg.2012.07.007; Gordon NF, 2004, AM J CARDIOL, V94, P1558, DOI 10.1016/j.amjcard.2004.08.039; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Lee DK, 2005, STROKE, V36, P2583, DOI 10.1161/01.STR.0000189999.19948.14; Liebeskind DS, 2011, ANN NEUROL, V69, P963, DOI 10.1002/ana.22354; Marks MP, 2012, STROKE, V43, P580, DOI 10.1161/STROKEAHA.111.645507; Marks MP, 2006, STROKE, V37, P1016, DOI 10.1161/01.STR.0000206142.03677.c2; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Turan TN, 2012, CIRC-CARDIOVASC QUAL, V5, pE51, DOI 10.1161/CIRCOUTCOMES.112.966911; US Food and Drug Administration, SUMM SAF PROB BEN; US Food and Drug Administration, FDA SAF COMM NARR IN; Wang X, 2013, INT J STROKE, V8, P663, DOI 10.1111/j.1747-4949.2012.00828.x; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong KS, 2002, ANN NEUROL, V52, P74, DOI 10.1002/ana.10250; Zaidat OO, 2008, NEUROLOGY, V70, P1518, DOI 10.1212/01.wnl.0000306308.08229.a3	30	436	488	1	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					333	341		10.1016/S0140-6736(13)62038-3	http://dx.doi.org/10.1016/S0140-6736(13)62038-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296VD	24168957	Green Accepted			2022-12-28	WOS:000330212600032
J	Zipfel, S; Wild, B; Gross, G; Friederich, HC; Teufel, M; Schellberg, D; Giel, KE; de Zwaan, M; Dinkel, A; Herpertz, S; Burgmer, M; Lowe, B; Tagay, S; von Wietersheim, J; Zeeck, A; Schade-Brittinger, C; Schauenburg, H; Herzog, W				Zipfel, Stephan; Wild, Beate; Gross, Gaby; Friederich, Hans-Christoph; Teufel, Martin; Schellberg, Dieter; Giel, Katrin E.; de Zwaan, Martina; Dinkel, Andreas; Herpertz, Stephan; Burgmer, Markus; Loewe, Bernd; Tagay, Sefik; von Wietersheim, Joern; Zeeck, Almut; Schade-Brittinger, Carmen; Schauenburg, Henning; Herzog, Wolfgang		ANTOP Study Grp	Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial	LANCET			English	Article							EATING-DISORDERS; PSYCHOLOGICAL THERAPIES; ADULTS; PREDICTORS; RECOVERY	Background Psychotherapy is the treatment of choice for patients with anorexia nervosa, although evidence of efficacy is weak. The Anorexia Nervosa Treatment of OutPatients (ANTOP) study aimed to assess the efficacy and safety of two manual-based outpatient treatments for anorexia nervosa-focal psychodynamic therapy and enhanced cognitive behaviour therapy-versus optimised treatment as usual. Methods The ANTOP study is a multicentre, randomised controlled efficacy trial in adults with anorexia nervosa. We recruited patients from ten university hospitals in Germany. Participants were randomly allocated to 10 months of treatment with either focal psychodynamic therapy, enhanced cognitive behaviour therapy, or optimised treatment as usual (including outpatient psychotherapy and structured care from a family doctor). The primary outcome was weight gain, measured as increased body-mass index (BMI) at the end of treatment. A key secondary outcome was rate of recovery (based on a combination of weight gain and eating disorder-specific psycho pathology). Analysis was by intention to treat. This trial is registered at http://isrctn.org, number ISRCTN72809357. Findings Of 727 adults screened for inclusion, 242 underwent randomisation: 80 to focal psychodynamic therapy, 80 to enhanced cognitive behaviour therapy, and 82 to optimised treatment as usual. At the end of treatment, 54 patients (22%) were lost to follow-up, and at 12-month follow-up a total of 73 (30%) had dropped out. At the end of treatment, BMI had increased in all study groups (focal psychodynamic therapy 0.73 kg/m(2), enhanced cognitive behaviour therapy 0.93 kg/m(2), optimised treatment as usual 0.69 kg/m(2)); no differences were noted between groups (mean difference between focal psychodynamic therapy and enhanced cognitive behaviour therapy -0.45, 95% CI -0.96 to 0.07; focal psychodynamic therapy vs optimised treatment as usual -0.14, -0.68 to 0.39; enhanced cognitive behaviour therapy vs optimised treatment as usual -0.30, -0.22 to 0.83). At 12-month follow-up, the mean gain in BMI had risen further (1.64 kg/m(2), 1.30 kg/m(2), and 1.22 kg/m(2), respectively), but no differences between groups were recorded (0.10, -0.56 to 0.76; 0.25, -0.45 to 0.95; 0.15, -0.54 to 0.83, respectively). No serious adverse events attributable to weight loss or trial participation were recorded. Interpretation Optimised treatment as usual, combining psychotherapy and structured care from a family doctor, should be regarded as solid baseline treatment for adult outpatients with anorexia nervosa. Focal psychodynamic therapy proved advantageous in terms of recovery at 12-month follow-up, and enhanced cognitive behaviour therapy was more effective with respect to speed of weight gain and improvements in eating disorder psychopathology. Long-term outcome data will be helpful to further adapt and improve these novel manual-based treatment approaches.	[Zipfel, Stephan; Gross, Gaby; Teufel, Martin; Giel, Katrin E.] Univ Tubingen Hosp, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany; [Wild, Beate; Friederich, Hans-Christoph; Schellberg, Dieter; Schauenburg, Henning; Herzog, Wolfgang] Univ Heidelberg Hosp, Dept Gen Internal Med & Psychosomat, Ctr Psychosocial Med, Heidelberg, Germany; [de Zwaan, Martina] Univ Hosp Erlangen, Dept Psychosomat Med & Psychotherapy, Erlangen, Germany; [Dinkel, Andreas] Univ Technol Munich, Clin Psychosomat Med & Psychotherapy, Munich, Germany; [Herpertz, Stephan] Ruhr Univ Bochum, Clin Psychosomat Med & Psychotherapy, LWL Univ Hosp Ruhr, Bochum, Germany; [Burgmer, Markus] Univ Hosp Munster, Clin Psychosomat Med & Psychotherapy, Munster, Germany; [Loewe, Bernd] Univ Hosp Hamburg Eppendorf, Inst & Outpatient Clin Psychosomat Med & Psychoth, Hamburg, Germany; [Tagay, Sefik] Univ Duisburg Essen, Clin Psychosomat Med & Psychotherapy, LVR Hosp Essen, Essen, Germany; [von Wietersheim, Joern] Univ Hosp Ulm, Dept Psychosomat Med & Psychotherapy, Ulm, Germany; [Zeeck, Almut] Univ Hosp Freiburg, Dept Psychosomat Med & Psychotherapy, Freiburg, Germany; [Schade-Brittinger, Carmen] Coordinat Ctr Clin Trials KKS, Marburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Technical University of Munich; Ruhr University Bochum; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen; Ulm University; University of Freiburg	Zipfel, S (corresponding author), Univ Tubingen Hosp, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany.	stephan.zipfel@med.uni-tuebingen.de	Tagay, Sefik/AAQ-3350-2021; Löwe, Bernd/AAG-4038-2020; Dinkel, Andreas/AAP-4681-2021	Dinkel, Andreas/0000-0001-6587-1550; Zipfel, Stephan/0000-0003-1659-4440; Lowe, Bernd/0000-0003-4220-3378	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF); German Eating Disorders Diagnostic and Treatment Network (EDNET)	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); German Eating Disorders Diagnostic and Treatment Network (EDNET)	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF), German Eating Disorders Diagnostic and Treatment Network (EDNET).	Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Carter FA, 2011, INT J EAT DISORDER, V44, P647, DOI 10.1002/eat.20879; Dare C, 2001, BRIT J PSYCHIAT, V178, P216, DOI 10.1192/bjp.178.3.216; DeJong H, 2012, INT J EAT DISORDER, V45, P635, DOI 10.1002/eat.20956; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; FAIRBURN CG, 1995, ARCH GEN PSYCHIAT, V52, P304; Fairburn CG, 2008, COGNITIVE BEHAV THER; Fairburn CG, 2013, BEHAV RES THER, V51, pR2, DOI 10.1016/j.brat.2012.09.010; Flament MF, 2012, INT J NEUROPSYCHOPH, V15, P189, DOI 10.1017/S1461145711000381; Halmi KA, 2005, ARCH GEN PSYCHIAT, V62, P776, DOI 10.1001/archpsyc.62.7.776; Hay P., 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003909; Herpertz S, 2011, DTSCH ARZTEBL INT, V108, P678, DOI 10.3238/arztebl.2011.0678; Herzog W, 1997, PSYCHOL MED, V27, P269, DOI 10.1017/S0033291796004394; Herzog W, 1997, J CONSULT CLIN PSYCH, V65, P169, DOI 10.1037/0022-006X.65.1.169; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Klump KL, 2009, INT J EAT DISORDER, V42, P97, DOI 10.1002/eat.20589; Lipsman N, 2013, LANCET, V381, P1361, DOI 10.1016/S0140-6736(12)62188-6; Lock J, 2010, ARCH GEN PSYCHIAT, V67, P1025, DOI 10.1001/archgenpsychiatry.2010.128; Malik ML, 2003, J CONSULT CLIN PSYCH, V71, P150, DOI 10.1037//0022-006X.71.1.150; Mallinckrodt CH, 2004, PHARM STAT, V3, P161, DOI 10.1002/pst.124; McIntosh VVW, 2005, AM J PSYCHIAT, V162, P741, DOI 10.1176/appi.ajp.162.4.741; NICE, 2004, EAT DIS COR INT TREA; NORDLE O, 1977, CLIN PHARMACOL THER, V22, P825; Pike KM, 2003, AM J PSYCHIAT, V160, P2046, DOI 10.1176/appi.ajp.160.11.2046; Rosenberg WF, 2002, RANDOMIZATION CLIN T; Schauenburg H, 2009, PSYCHOTHERAPEUT, V54, P270, DOI 10.1007/s00278-009-0668-4; Schmidt U, 2012, BRIT J PSYCHIAT, V201, P392, DOI 10.1192/bjp.bp.112.112078; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Strober M, 2012, INT J EAT DISORDER, V45, P155, DOI 10.1002/eat.22005; Stuhldreher N, 2012, INT J EAT DISORDER, V45, P476, DOI 10.1002/eat.20977; Touyz S, 2013, PSYCHOL MED, V43, P2501, DOI 10.1017/S0033291713000949; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Walsh BT, 2013, AM J PSYCHIAT, V170, P477, DOI 10.1176/appi.ajp.2012.12081074; Watson HJ, 2013, PSYCHOL MED, V43, P2477, DOI 10.1017/S0033291712002620; Wild B, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-23; Zerwas S, 2013, J PSYCHIATR RES, V47, P972, DOI 10.1016/j.jpsychires.2013.02.011; Zipfel S, 2000, LANCET, V355, P721, DOI 10.1016/S0140-6736(99)05363-5	37	251	252	1	136	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					127	137		10.1016/S0140-6736(13)61746-8	http://dx.doi.org/10.1016/S0140-6736(13)61746-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	287YX	24131861				2022-12-28	WOS:000329579600028
J	Courcoulas, AP; Christian, NJ; Belle, SH; Berk, PD; Flum, DR; Garcia, L; Horlick, M; Kalarchian, MA; King, WC; Mitchell, JE; Patterson, EJ; Pender, JR; Pomp, A; Pories, WJ; Thirlby, RC; Yanovski, SZ; Wolfe, BM				Courcoulas, Anita P.; Christian, Nicholas J.; Belle, Steven H.; Berk, Paul D.; Flum, David R.; Garcia, Luis; Horlick, Mary; Kalarchian, Melissa A.; King, Wendy C.; Mitchell, James E.; Patterson, Emma J.; Pender, John R.; Pomp, Alfons; Pories, Walter J.; Thirlby, Richard C.; Yanovski, Susan Z.; Wolfe, Bruce M.		Labs Consortium	Weight Change and Health Outcomes at 3 Years After Bariatric Surgery Among Individuals With Severe Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ROUX-EN-Y; GASTRIC BYPASS; LONGITUDINAL ASSESSMENT; REPORTING WEIGHT; MEDICAL THERAPY; BLOOD-PRESSURE; HYPERTENSION; SAFETY; LIFE	IMPORTANCE Severe obesity (body mass index [BMI] >= 35) is associated with a broad range of health risks. Bariatric surgery induces weight loss and short-term health improvements, but little is known about long-term outcomes of these operations. OBJECTIVE To report 3-year change in weight and select health parameters after common bariatric surgical procedures. DESIGN AND SETTING The Longitudinal Assessment of Bariatric Surgery (LABS) Consortium is a multicenter observational cohort study at 10 US hospitals in 6 geographically diverse clinical centers. PARTICIPANTS AND EXPOSURE Adults undergoing first-time bariatric surgical procedures as part of routine clinical care by participating surgeons were recruited between 2006 and 2009 and followed up until September 2012. Participants completed research assessments prior to surgery and 6 months, 12 months, and then annually after surgery. MAIN OUTCOMES AND MEASURES Three years after Roux-en-Y gastric bypass (RYGB) or laparoscopic adjustable gastric banding (LAGB), we assessed percent weight change from baseline and the percentage of participants with diabetes achieving hemoglobin A(1c) levels less than 6.5% or fasting plasma glucose values less than 126 mg/dL without pharmacologic therapy. Dyslipidemia and hypertension resolution at 3 years was also assessed. RESULTS At baseline, participants (N = 2458) were 18 to 78 years old, 79% were women, median BMI was 45.9 (IQR, 41.7-51.5), and median weight was 129 kg (IQR, 115-147). For their first bariatric surgical procedure, 1738 participants underwent RYGB, 610 LAGB, and 110 other procedures. At baseline, 774 (33%) had diabetes, 1252 (63%) dyslipidemia, and 1601 (68%) hypertension. Three years after surgery, median actual weight loss for RYGB participants was 41 kg (IQR, 31-52), corresponding to a percentage of baseline weight lost of 31.5% (IQR, 24.6%-38.4%). For LAGB participants, actual weight loss was 20 kg (IQR, 10-29), corresponding to 15.9% (IQR, 7.9%-23.0%). The majority of weight loss was evident 1 year after surgery for both procedures. Five distinct weight change trajectory groups were identified for each procedure. Among participants who had diabetes at baseline, 216 RYGB participants (67.5%) and 28 LAGB participants (28.6%) experienced partial remission at 3 years. The incidence of diabetes was 0.9% after RYGB and 3.2% after LAGB. Dyslipidemia resolved in 237 RYGB participants (61.9%) and 39 LAGB participants (27.1%); remission of hypertension occurred in 269 RYGB participants (38.2%) and 43 LAGB participants (17.4%). CONCLUSIONS AND RELEVANCE Among participants with severe obesity, there was substantial weight loss 3 years after bariatric surgery, with the majority experiencing maximum weight change during the first year. However, there was variability in the amount and trajectories of weight loss and in diabetes, blood pressure, and lipid outcomes.	[Courcoulas, Anita P.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15213 USA; [Christian, Nicholas J.; Belle, Steven H.; King, Wendy C.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Berk, Paul D.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Flum, David R.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Garcia, Luis] Univ N Dakota, Sch Hlth Sci, Dept Surg, Grand Forks, ND 58201 USA; [Horlick, Mary; Yanovski, Susan Z.] NIDDK, Div Digest Dis & Nutr, Bethesda, MD 20892 USA; [Kalarchian, Melissa A.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Mitchell, James E.] Univ N Dakota, Sch Med & Hlth Sci, Dept Neurosci, Neuropsychiatr Res Inst, Grand Forks, ND 58201 USA; [Patterson, Emma J.] Legacy Good Samaritan Med Ctr, Dept Surg, Portland, OR USA; [Pender, John R.; Pories, Walter J.] E Carolina Univ, Brody Sch Med, Dept Surg, Greenville, NC USA; [Pomp, Alfons] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Thirlby, Richard C.] Virginia Mason Med Ctr, Dept Surg, Seattle, WA 98101 USA; [Wolfe, Bruce M.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; University of Washington; University of Washington Seattle; University of North Dakota Grand Forks; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Neuropsychiatric Research Institute; University of North Dakota Grand Forks; University of North Carolina; East Carolina University; Cornell University; Virginia Mason Medical Center; Oregon Health & Science University	Courcoulas, AP (corresponding author), Univ Pittsburgh, Med Ctr, Dept Surg, 3380 Blvd Allies,Ste 390, Pittsburgh, PA 15213 USA.	courcoulasap@upmc.edu	King, Wendy C/AAC-5122-2022; Flum, David/GPX-7976-2022	King, Wendy C/0000-0002-0740-0029; Kalarchian, Melissa/0000-0003-2099-9299	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01 DK066557, U01-DK66667, UL1-RR024996, U01-DK66568, M01RR-00037, U01-DK66471, U01-DK66526, U01-DK66585, UL1-RR024153, U01-DK66555]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037, UL1RR024153, UL1RR024996, UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066526, U01DK066585, U01DK066471, U01DK066557, U01DK066568, U01DK066667, U01DK066555] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	LABS-2 was a cooperative agreement funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) with grants for the data coordinating center (U01 DK066557), Columbia University Medical Center (U01-DK66667) (in collaboration with Cornell University Medical Center Clinical and Translational Research Center [CTRC], grant UL1-RR024996), University of Washington (U01-DK66568) (in collaboration with CTRC, grant M01RR-00037), Neuropsychiatric Research Institute (U01-DK66471), East Carolina University (U01-DK66526), University of Pittsburgh Medical Center (U01-DK66585) (in collaboration with CTRC, grant UL1-RR024153), and Oregon Health and Science University (U01-DK66555).	Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Alhamdani A, 2012, OBES SURG, V22, P1029, DOI 10.1007/s11695-012-0645-9; Belle SH, 2007, SURG OBES RELAT DIS, V3, P116, DOI 10.1016/j.soard.2007.01.006; Belle SH, 2013, SURG OBES RELAT DIS, V9, P926, DOI 10.1016/j.soard.2013.01.023; Belle SH, 2013, SURG OBES RELAT DIS, V9, P782, DOI 10.1016/j.soard.2012.11.006; Benaiges D, 2012, OBES SURG, V22, P1268, DOI 10.1007/s11695-012-0662-8; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Christian NJ, 2013, JAMA-J AM MED ASSOC, V310, P2454, DOI 10.1001/jama.2013.281043; DANNENBERG AL, 1987, JAMA-J AM MED ASSOC, V257, P1477, DOI 10.1001/jama.257.11.1477; Dixon JB, 2002, DIABETES CARE, V25, P358, DOI 10.2337/diacare.25.2.358; Dixon JB, 2002, AM J SURG, V184, p51S, DOI 10.1016/S0002-9610(02)01181-9; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Espeland M, 2007, DIABETES CARE, V30, P1374; Favretti F, 2007, OBES SURG, V17, P168, DOI 10.1007/s11695-007-9043-0; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Garb J, 2009, OBES SURG, V19, P1447, DOI 10.1007/s11695-009-9927-2; Gourash WF, 2013, SURG OBES RELAT DIS, V9, P514, DOI 10.1016/j.soard.2013.02.012; Hatoum IJ, 2013, OBESITY, V21, P1519, DOI 10.1002/oby.20186; Higa K, 2011, SURG OBES RELAT DIS, V7, P516, DOI 10.1016/j.soard.2010.10.019; Kenward MG, 2007, MISSING DATA IN CLIN; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; O'Brien PE, 2006, OBES SURG, V16, P1032, DOI 10.1381/096089206778026316; O'Brien PE, 2013, ANN SURG, V257, P87, DOI 10.1097/SLA.0b013e31827b6c02; Ponce J, 2004, OBES SURG, V14, P1335, DOI 10.1381/0960892042583932; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom CD, 2001, OBES RES, V9, P188, DOI 10.1038/oby.2001.20; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sugerman HJ, 2003, ANN SURG, V237, P751, DOI 10.1097/00000658-200306000-00002; Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230; Wang J, 2019, STRUCTURAL EQUATION, DOI [DOI 10.1002/9781118356258, DOI 10.1002/]; Wittgrove AC, 2000, OBES SURG, V10, P233, DOI 10.1381/096089200321643511	36	557	564	4	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2416	2425		10.1001/jama.2013.280928	http://dx.doi.org/10.1001/jama.2013.280928			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24189773	Green Accepted, Bronze			2022-12-28	WOS:000328030900022
J	Dougan, SK; Ashour, J; Karssemeijer, RA; Popp, MW; Avalos, AM; Barisa, M; Altenburg, AF; Ingram, JR; Cragnolini, JJ; Guo, CG; Alt, FW; Jaenisch, R; Ploegh, HL				Dougan, Stephanie K.; Ashour, Joseph; Karssemeijer, Roos A.; Popp, Maximilian W.; Avalos, Ana M.; Barisa, Marta; Altenburg, Arwen F.; Ingram, Jessica R.; Cragnolini, Juan Jose; Guo, Chunguang; Alt, Frederick W.; Jaenisch, Rudolf; Ploegh, Hidde L.			Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus	NATURE			English	Article							TRANSNUCLEAR MICE; T-CELLS; IN-VIVO; MEMORY; LUNG; STRAINS; ENTRY	Influenza A virus-specific B lymphocytes and the antibodies they produce protect against infection(1). However, the outcome of interactions between an influenza haemagglutinin-specific B cell via its receptor (BCR) and virus is unclear. Through somatic cell nuclear transfer we generated mice that harbour B cells with a BCR specific for the haemagglutinin of influenza A/WSN/33 virus (FluBI mice). Their B cells secrete an immunoglobulin gamma 2b that neutralizes infectious virus. Whereas B cells from FluBI and control mice bind equivalent amounts of virus through interaction of haemagglutinin with surface-disposed sialic acids, the A/WSN/33 virus infects only the haemagglutinin-specific B cells. Mere binding of virus is not sufficient for infection of B cells: this requires interactions of the BCR with haemagglutinin, causing both disruption of antibody secretion and FluBI B-cell death within 18 h. In mice infected with A/WSN/33, lung-resident FluBI B cells are infected by the virus, thus delaying the onset of protective antibody release into the lungs, whereas FluBI cells in the draining lymph node are not infected and proliferate. We propose that influenza targets and kills influenza-specific B cells in the lung, thus allowing the virus to gain purchase before the initiation of an effective adaptive response.	[Dougan, Stephanie K.; Ashour, Joseph; Karssemeijer, Roos A.; Popp, Maximilian W.; Avalos, Ana M.; Barisa, Marta; Altenburg, Arwen F.; Ingram, Jessica R.; Cragnolini, Juan Jose; Jaenisch, Rudolf; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Popp, Maximilian W.; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Guo, Chunguang; Alt, Frederick W.] Boston Childrens Hosp, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Altenburg, Arwen/N-4302-2018	Altenburg, Arwen/0000-0002-5361-4909; Ashour, Joseph/0000-0003-3809-2783; Barisa, Marta/0000-0001-7846-6810	Cancer Research Institute; Human Frontiers Science Program; National Institutes of Health; American Association for Cancer Research-Pancreatic Cancer Action Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033456, R01AI087879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106409, R01GM100518] Funding Source: NIH RePORTER	Cancer Research Institute; Human Frontiers Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research-Pancreatic Cancer Action Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.K.D. and C.G. were funded by the Cancer Research Institute. J.J.C. was funded by the Human Frontiers Science Program. F.W.A., R.J. and H.L.P. are funded by grants from the National Institutes of Health. F.W.A. is a Howard Hughes Medical Institute investigator. S.K.D. and H.L.P. are funded by the American Association for Cancer Research-Pancreatic Cancer Action Network. We are grateful to P. Wisniewski for cell sorting, to J. Jackson for mouse husbandry, to G. Bell for statistical analysis, to N. Watson for electron microscopy and to M. Witte for sortase nucleophiles.	Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; DELIMA MCP, 1995, BBA-BIOMEMBRANES, V1236, P323; Dougan SK, 2013, CANCER IMMUNOL RES, V1, P99, DOI 10.1158/2326-6066.CIR-13-0047; Dougan SK, 2012, P NATL ACAD SCI USA, V109, P13739, DOI 10.1073/pnas.1210273109; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Huang RTC, 1996, FEBS LETT, V392, P59, DOI 10.1016/0014-5793(96)00783-1; JONES PD, 1987, VACCINE, V5, P244, DOI 10.1016/0264-410X(87)90109-5; Joo HM, 2008, P NATL ACAD SCI USA, V105, P3485, DOI 10.1073/pnas.0800003105; Kirak Oktay, 2010, J Vis Exp, DOI 10.3791/2168; Kirak O, 2010, SCIENCE, V328, P243, DOI 10.1126/science.1178590; Kishigami S, 2006, NAT PROTOC, V1, P125, DOI 10.1038/nprot.2006.21; Londrigan SL, 2011, J VIROL, V85, P2990, DOI 10.1128/JVI.01705-10; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; MORGAN DJ, 1993, VIRUS RES, V29, P179, DOI 10.1016/0168-1702(93)90058-U; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Popp M.W.-L., 2009, CURR PROTOC PROTEIN; Popp MWL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002604; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Sehrawat S, 2012, CELL REPORTS, V1, P461, DOI 10.1016/j.celrep.2012.03.009; SIMONS K, 1978, P NATL ACAD SCI USA, V75, P5306, DOI 10.1073/pnas.75.11.5306; Stray SJ, 2000, GLYCOBIOLOGY, V10, P649, DOI 10.1093/glycob/10.7.649; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Witte MD, 2012, P NATL ACAD SCI USA, V109, P11993, DOI 10.1073/pnas.1205427109	30	50	52	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					406	+		10.1038/nature12637	http://dx.doi.org/10.1038/nature12637			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24141948	Green Accepted, Green Submitted			2022-12-28	WOS:000327163200043
J	Davoli, T; Xu, AW; Mengwasser, KE; Sack, LM; Yoon, JC; Park, PJ; Elledge, SJ				Davoli, Teresa; Xu, Andrew Wei; Mengwasser, Kristen E.; Sack, Laura M.; Yoon, John C.; Park, Peter J.; Elledge, Stephen J.			Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome	CELL			English	Article							REVEALS; MUTATIONS; RESOURCE	Aneuploidy has been recognized as a hallmark of cancer for more than 100 years, yet no general theory to explain the recurring patterns of aneuploidy in cancer has emerged. Here, we develop Tumor Suppressor and Oncogene (TUSON) Explorer, a computational method that analyzes the patterns of mutational signatures in tumors and predicts the likelihood that any individual gene functions as a tumor suppressor (TSG) or oncogene (OG). By analyzing >8,200 tumor-normal pairs, we provide statistical evidence suggesting that many more genes possess cancer driver properties than anticipated, forming a continuum of oncogenic potential. Integrating our driver predictions with information on somatic copy number alterations, we find that the distribution and potency of TSGs (STOP genes), OGs, and essential genes (GO genes) on chromosomes can predict the complex patterns of aneuploidy and copy number variation characteristic of cancer genomes. We propose that the cancer genome is shaped through a process of cumulative haploinsufficiency and triplosensitivity.	[Davoli, Teresa; Mengwasser, Kristen E.; Sack, Laura M.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Davoli, Teresa; Xu, Andrew Wei; Mengwasser, Kristen E.; Sack, Laura M.; Yoon, John C.; Park, Peter J.; Elledge, Stephen J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Yoon, John C.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Xu, Andrew Wei; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	wang, edwin/G-5372-2010	Sack, Laura/0000-0003-1186-1335; Davoli, Teresa/0000-0003-4116-9745; Park, Peter/0000-0001-9378-960X	DOD Breast Cancer Innovator Award; NIH [U54LM008748, K08DK081612]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM044664] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	DOD Breast Cancer Innovator Award(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Simon Forbes and Michael Stratton (Wellcome Trust Sanger Institute, UK) for the data from the Cosmic dataset (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/), Eric Wooten for help on data extraction, and Chad Creighton and Kim Rathmell for allowing access to their unpublished data on KICH SCNAs. We also thank Andrew Futreal, Semin Lee, David Livingston, David Page, Mary-Claire King, Jim Lupski, Rameen Beroukhim, Matt Meyerson, Atanas Kamburov, and Paul Edwards for helpful advice and Bert Vogelstein, Judith Glaven, and members of the Elledge lab for helpful comments on the manuscript. This work was funded by a DOD Breast Cancer Innovator Award and NIH grant to S.J.E., U54LM008748 to P.J.P., and K08DK081612 to J.C.Y. S.J.E. is an investigator with the Howard Hughes Medical Institute. We apologize to our colleagues whose papers we could not cite due to space limitations.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bianchi NO, 2009, MUTAT RES-REV MUTAT, V682, P21, DOI 10.1016/j.mrrev.2009.02.001; Boveri T, 1929, ORIGIN MALIGNANT TUM; Conti P, 2007, AUTOIMMUN REV, V6, P131, DOI 10.1016/j.autrev.2006.08.015; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kowalski J, 2007, CANCER GENET CYTOGEN, V178, P26, DOI 10.1016/j.cancergencyto.2007.06.004; Lai K, 2009, DEV DYNAM, V238, P76, DOI 10.1002/dvdy.21815; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mosig MO, 2001, GENETICS, V157, P1683; Ozery-Flato M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r61; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Shannon C. E., 1949, MATH THEORY COMMUNIC; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Willig TN, 2000, CURR OPIN HEMATOL, V7, P85, DOI 10.1097/00062752-200003000-00003; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	37	472	480	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					948	962		10.1016/j.cell.2013.10.011	http://dx.doi.org/10.1016/j.cell.2013.10.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24183448	Green Accepted, Bronze			2022-12-28	WOS:000326934300022
J	Groarke, JD; Cheng, S; Moslehi, J				Groarke, John D.; Cheng, Susan; Moslehi, Javid			Cancer-Drug Discovery and Cardiovascular Surveillance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The story of impressive evolution in treatment for chronic myeloid leukemia has taken an unexpected turn, as serious adverse cardiovascular events have occurred in patients treated with the tyrosine kinase inhibitors ponatinib and nilotinib. Targeted BCR-ABL protein kinase inhibitors have revolutionized the treatment of chronic myeloid leukemia (CML) and have established tyrosine kinase inhibition as a model for cancer-drug discovery and therapy in general. In 2001, imatinib became the first such tyrosine kinase inhibitor therapy to be approved by the Food and Drug Administration (FDA). Initially developed as part of a series of compounds that inhibit the platelet-derived growth factor receptor, imatinib was also shown to have potency against ABL and KIT kinases. Despite imatinib's breakthrough success, more than 20% of patients are resistant to the drug. Therefore, second- and third-generation inhibitors dasatinib, ...	[Groarke, John D.; Moslehi, Javid] Dana Farber Canc Inst, Cardiooncol Program, Boston, MA 02115 USA; [Groarke, John D.; Cheng, Susan; Moslehi, Javid] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Groarke, John D.; Cheng, Susan; Moslehi, Javid] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Groarke, JD (corresponding author), Dana Farber Canc Inst, Cardiooncol Program, Boston, MA 02115 USA.			Cheng, Susan/0000-0002-4977-036X				Food and Drug Administration, FDA DRUG SAF COMM FD; Herndon TM, 2013, CLIN CANCER RES, V19, P4559, DOI 10.1158/1078-0432.CCR-13-0755; Sawyers CL, 2010, NEW ENGL J MED, V362, P2314, DOI 10.1056/NEJMe1004430; Tefferi A, 2013, LEUKEMIA, V27, P1939, DOI 10.1038/leu.2013.112	4	54	56	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1779	1781		10.1056/NEJMp1313140	http://dx.doi.org/10.1056/NEJMp1313140			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24180496				2022-12-28	WOS:000326607800005
J	Wiysonge, CS; Opie, LH				Wiysonge, Charles S.; Opie, Lionel H.			beta-Blockers as Initial Therapy for Hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wiysonge, Charles S.] Univ Stellenbosch, Ctr Evidence Based Hlth Care, ZA-7505 Cape Town, South Africa; [Opie, Lionel H.] Univ Cape Town, Sch Med, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa	Stellenbosch University; University of Cape Town	Wiysonge, CS (corresponding author), Univ Stellenbosch, Ctr Evidence Based Hlth Care, Tygerberg Campus,POB 19063, ZA-7505 Cape Town, South Africa.	charlesw@sun.ac.za	Wiysonge, Charles Shey U/A-3843-2008	Wiysonge, Charles Shey U/0000-0002-1273-4779	National Research Foundation of South Africa	National Research Foundation of South Africa(National Research Foundation - South Africa)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Wiysonge reports receiving grant funding from the National Research Foundation of South Africa. Dr Opie reports receiving grant funding from the National Research Foundation of South Africa.	Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Lewin A, 2013, CLIN THER, V35, P142, DOI 10.1016/j.clinthera.2012.12.015; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Opie LH, 2013, DRUGS HEART, P1; Vanhoutte PM, 2013, CURR OPIN PHARMACOL, V13, P265, DOI 10.1016/j.coph.2012.12.002; Wiysonge CS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002003.pub4	6	20	25	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1851	1852		10.1001/jama.2013.277510	http://dx.doi.org/10.1001/jama.2013.277510			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193083				2022-12-28	WOS:000326550900019
J	Brody, H				Brody, Herb			MEDICAL IMAGING	NATURE			English	Editorial Material																			0	22	25	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S81	S81		10.1038/502S81a	http://dx.doi.org/10.1038/502S81a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187698	Bronze			2022-12-28	WOS:000326293200001
J	Rashid, MA				Rashid, Mohammed Ahmed			Select the right medical students to be the next generation of generalists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge CB1 8RN, England	University of Cambridge	Rashid, MA (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge CB1 8RN, England.	mar74@medschl.cam.ac.uk						Centre for Workforce Intelligence, 2011, SHAP MED WORKF INF M; O'Dowd A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4332; Witzburg RA, 2013, NEW ENGL J MED, V368, P1565, DOI 10.1056/NEJMp1300411	3	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2013	347								f6453	10.1136/bmj.f6453	http://dx.doi.org/10.1136/bmj.f6453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EX	24179034				2022-12-28	WOS:000326599700005
J	Chakraborty, S; Yanchulova, P; Thiemens, MH				Chakraborty, Subrata; Yanchulova, Petia; Thiemens, Mark H.			Mass-Independent Oxygen Isotopic Partitioning During Gas-Phase SiO2 Formation	SCIENCE			English	Article							FRACTIONATION; OZONE; ANOMALIES; SYMMETRY; DYNAMICS; STRANGE; O+CO; O-17; CO	Meteorites contain a wide range of oxygen isotopic compositions that are interpreted as heterogeneity in solar nebula. The anomalous oxygen isotopic compositions of refractory mineral phases may reflect a chemical fractionation process in the nebula, but there are no experiments to demonstrate this isotope effect during particle formation through gas-phase reactions. We report experimental results of gas-to-particle conversion during oxidation of silicon monoxide that define a mass-independent line (slope one) in oxygen three-isotope space of O-18/O-16 versus O-17/O-16. This mass-independent chemical reaction is a potentially initiating step in nebular meteorite formation, which would be capable of producing silicate reservoirs with anomalous oxygen isotopic compositions.	[Chakraborty, Subrata; Yanchulova, Petia; Thiemens, Mark H.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Chakraborty, S (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	subrata@ucsd.edu			NASA [NNX09AG93G, NNX11AB39G]	NASA(National Aeronautics & Space Administration (NASA))	The authors thank the three anonymous reviewers for their helpful critical comments, which helped improve the manuscript. S. C. and M. H. T. acknowledge funding support from NASA Cosmochemistry (NNX09AG93G) and Origins in Solar System (NNX11AB39G) programs. We acknowledge G. Dominguez for helping to develop the kinetic model and helpful discussion with members of the Thiemens research group. Data described in this paper are presented in supplementary materials.	ALAGIA M, 1993, J CHEM PHYS, V98, P8341, DOI 10.1063/1.464540; BALLY J, 1982, ASTROPHYS J, V257, P612, DOI 10.1086/160017; BHATTACHARYA SK, 1989, Z NATURFORSCH A, V44, P435; BOUISSET E, 1991, J PHYS B-AT MOL OPT, V24, P1609, DOI 10.1088/0953-4075/24/7/015; Brouard M, 1998, J PHYS CHEM A, V102, P9559, DOI 10.1021/jp982148z; BUJARRABAL V, 1992, ASTRON ASTROPHYS, V257, P701; Cho SH, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/129; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Clayton RN, 2007, ANN REV EARTH PLANET, V35, P1, DOI DOI 10.1146/ANNUREV.EARTH.35.092006.145059; Gao YQ, 2002, J CHEM PHYS, V116, P137, DOI 10.1063/1.1415448; Gao YQ, 2001, SCIENCE, V293, P259, DOI 10.1126/science.1058528; HEIDENREICH JE, 1986, J CHEM PHYS, V84, P2129, DOI 10.1063/1.450373; Huff AK, 1998, GEOPHYS RES LETT, V25, P3509, DOI 10.1029/98GL02603; Ivanov MV, 2013, P NATL ACAD SCI USA, V110, P17708, DOI 10.1073/pnas.1215464110; Li J, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3680256; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; MacPherson GJ, 2011, P NATL ACAD SCI USA, V108, P19152, DOI 10.1073/pnas.1110051108; McKeegan KD, 2011, SCIENCE, V332, P1528, DOI 10.1126/science.1204636; Miller MF, 2002, GEOCHIM COSMOCHIM AC, V66, P1881, DOI 10.1016/S0016-7037(02)00832-3; Pandey A, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206584; Rockmann T, 1998, SCIENCE, V281, P544, DOI 10.1126/science.281.5376.544; Savarino J, 1999, J PHYS CHEM A, V103, P9221, DOI 10.1021/jp991221y; Song X., 2006, J CHEM PHYS, V125, P6; Thiemens MH, 2006, ANNU REV EARTH PL SC, V34, P217, DOI 10.1146/annurev.earth.34.031405.125026; Thiemens MH, 2012, ANNU REV PHYS CHEM, V63, P155, DOI 10.1146/annurev-physchem-032511-143657; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; Walsh C, 2010, ASTROPHYS J, V722, P1607, DOI 10.1088/0004-637X/722/2/1607	31	29	29	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					463	466		10.1126/science.1242237	http://dx.doi.org/10.1126/science.1242237			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159043				2022-12-28	WOS:000326042600038
J	Kohli, RM; Zhang, Y				Kohli, Rahul M.; Zhang, Yi			TET enzymes, TDG and the dynamics of DNA demethylation	NATURE			English	Review							HEMATOPOIETIC STEM-CELLS; THYMINE DNA; ACTIVE-DEMETHYLATION; CXXC DOMAIN; 5-METHYLCYTOSINE OXIDATION; PATERNAL GENOME; SELF-RENEWAL; METHYLATION; MOUSE; 5-HYDROXYMETHYLCYTOSINE	DNA methylation has a profound impact on genome stability, transcription and development. Although enzymes that catalyse DNA methylation have been well characterized, those that are involved in methyl group removal have remained elusive, until recently. The transformative discovery that ten-eleven translocation (TET) family enzymes can oxidize 5-methylcytosine has greatly advanced our understanding of DNA demethylation. 5-Hydroxymethylcytosine is a key nexus in demethylation that can either be passively depleted through DNA replication or actively reverted to cytosine through iterative oxidation and thymine DNA glycosylase (TDG)-mediated base excision repair. Methylation, oxidation and repair now offer a model for a complete cycle of dynamic cytosine modification, with mounting evidence for its significance in the biological processes known to involve active demethylation.	[Kohli, Rahul M.] Univ Penn, Dept Med, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA; [Kohli, Rahul M.] Univ Penn, Dept Biochem & Biophys, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhang, Yi] Howard Hughes Med Inst, Boston, MA 02115 USA; [Zhang, Yi] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Zhang, Yi] Boston Childrens Hosp, Div Hematol Oncol, Dept Pediat, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; [Zhang, Yi] Harvard Stem Cell Inst, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Kohli, RM (corresponding author), Univ Penn, Dept Med, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA.	rkohli@upenn.edu; yzhang@genetics.med.harvard.edu	Erlitzki, Noa/AHC-5346-2022	Kohli, Rahul/0000-0002-7689-5678; Zhang, Yi/0000-0002-2789-0811	NIH [U01DK089565, GM068804, K08-AI089242]; Rita Allen Foundation; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank S. Yamaguchi for preparing Figure 3; D. Crawford, A. Inoue, C. Nabel, E. Schutsky and S. Yamaguchi for their helpful comments. We apologize to the people whose work cannot be cited due to space limitations. Our DNA methylation-related work is supported by the NIH (U01DK089565 and GM068804 to Y.Z., and K08-AI089242 to R. M. K.), the Rita Allen Foundation (R. M. K.) and HHMI (Y.Z.). Y.Z. is an investigator of the HHMI.	Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Freudenberg JM, 2012, NUCLEIC ACIDS RES, V40, P3364, DOI 10.1093/nar/gkr1253; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hashimoto H, 2013, J MOL BIOL, V425, P971, DOI 10.1016/j.jmb.2013.01.013; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenkins Timothy G., 2012, Frontiers in Genetics, V3, P143, DOI 10.3389/fgene.2012.00143; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kumar R, 2013, NATURE, V500, P89, DOI 10.1038/nature12299; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; LIU CK, 1973, ARCH BIOCHEM BIOPHYS, V159, P180, DOI 10.1016/0003-9861(73)90443-8; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nabel CS, 2012, ACS CHEM BIOL, V7, P20, DOI 10.1021/cb2002895; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Ono R, 2002, CANCER RES, V62, P4075; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Quintas-Cardama A, 2010, NAT REV CLIN ONCOL, V7, P433, DOI 10.1038/nrclinonc.2010.87; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rangam G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043279; Schiesser S, 2012, ANGEW CHEM INT EDIT, V51, P6516, DOI 10.1002/anie.201202583; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Smiley JA, 2005, BBA-GEN SUBJECTS, V1723, P256, DOI 10.1016/j.bbagen.2005.02.001; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2012, NAT BIOTECHNOL, V30, P1107, DOI 10.1038/nbt.2398; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Surani MA, 2010, COLD SH Q B, V75, P211, DOI 10.1101/sqb.2010.75.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Williams RT, 2012, BIOCHEMISTRY-US, V51, P6458, DOI 10.1021/bi300797q; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	104	978	1013	14	333	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					472	479		10.1038/nature12750	http://dx.doi.org/10.1038/nature12750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153300	Green Accepted			2022-12-28	WOS:000325988400041
J	Abramson, JD; Rosenberg, HG; Jewell, N; Wright, JM				Abramson, John D.; Rosenberg, Harriet G.; Jewell, Nicholas; Wright, James M.			Should people at low risk of cardiovascular disease take a statin?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							END-POINTS; TRIALS; OUTCOMES; WOMEN		[Abramson, John D.] Harvard Univ, Dept Hlth Care Policy, Sch Med, Ipswich, MA 01938 USA; [Rosenberg, Harriet G.] York Univ, Dept Social Sci, Toronto, ON M3J 2R7, Canada; [Jewell, Nicholas] Univ Calif Berkeley, Sch Publ Hlth, Dept Stat, Div Biostat, Berkeley, CA 94720 USA; [Wright, James M.] Univ British Columbia, Dept Anesthesiol, Therapeut Initiat, Vancouver, BC V5Z 1M9, Canada; [Wright, James M.] Univ British Columbia, Dept Pharmacol & Therapeut, Therapeut Initiat, Vancouver, BC V6T 1W5, Canada; [Wright, James M.] Univ British Columbia, Dept Med, Therapeut Initiat, Vancouver, BC, Canada	Harvard University; York University - Canada; University of California System; University of California Berkeley; University of British Columbia; University of British Columbia; University of British Columbia	Abramson, JD (corresponding author), Harvard Univ, Dept Hlth Care Policy, Sch Med, 39 Spring St, Ipswich, MA 01938 USA.	john_abramson@hms.harvard.edu						Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Donnelly LA, 2008, DIABETIC MED, V25, P850, DOI 10.1111/j.1464-5491.2008.02476.x; Ebrahim S, 2012, LANCET, V380, P545, DOI 10.1016/S0140-6736(12)60694-1; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Golomb BA, 2012, ARCH INTERN MED, V172, P1180, DOI 10.1001/archinternmed.2012.2171; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1437; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Maningat P, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0291-7; Mansi I, 2013, JAMA INTERN MED, V173, P1318, DOI 10.1001/jamainternmed.2013.6184; Mansi I, 2013, EXPERT OPIN DRUG SAF, V12, P327, DOI 10.1517/14740338.2013.779667; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Mora S, 2010, CIRCULATION, V121, P1069, DOI 10.1161/CIRCULATIONAHA.109.906479; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Naci H., 2013, BMJ-BRIT MED J, V347, P15577; NICE, 2008, STAT PREV CARD EV TE, V94; Nissen SE, 2009, J AM COLL CARDIOL, V54, P2363, DOI 10.1016/j.jacc.2009.09.021; Pharmacy Checker, ZOC PRIC ORD COMP; Tatley M, 2007, DRUG SAFETY, V30, P195, DOI 10.2165/00002018-200730030-00003; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	26	154	158	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6123	10.1136/bmj.f6123	http://dx.doi.org/10.1136/bmj.f6123			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CI	24149819	Green Published			2022-12-28	WOS:000326293800004
J	Shannon, RM; Ravi, V; Coles, WA; Hobbs, G; Keith, MJ; Manchester, RN; Wyithe, JSB; Bailes, M; Bhat, NDR; Burke-Spolaor, S; Khoo, J; Levin, Y; Oslowski, S; Sarkissian, JM; van Straten, W; Verbiest, JPW; Wang, JB				Shannon, R. M.; Ravi, V.; Coles, W. A.; Hobbs, G.; Keith, M. J.; Manchester, R. N.; Wyithe, J. S. B.; Bailes, M.; Bhat, N. D. R.; Burke-Spolaor, S.; Khoo, J.; Levin, Y.; Oslowski, S.; Sarkissian, J. M.; van Straten, W.; Verbiest, J. P. W.; Wang, J. -B.			Gravitational-Wave Limits from Pulsar Timing Constrain Supermassive Black Hole Evolution	SCIENCE			English	Article							ACTIVE GALACTIC NUCLEI; BINARY EVOLUTION; GALAXIES; ARRAY; SIMULATION; COSMOLOGY; PACKAGE; TEMPO2; BAND	The formation and growth processes of supermassive black holes (SMBHs) are not well constrained. SMBH population models, however, provide specific predictions for the properties of the gravitational-wave background (GWB) from binary SMBHs in merging galaxies throughout the universe. Using observations from the Parkes Pulsar Timing Array, we constrain the fractional GWB energy density (Omega(GW)) with 95% confidence to be Omega(GW)(H-0/73 kilometers per second per megaparsec)(2) < 1.3 x 10(-9) (where H-0 is the Hubble constant) at a frequency of 2.8 nanohertz, which is approximately a factor of 6 more stringent than previous limits. We compare our limit to models of the SMBH population and find inconsistencies at confidence levels between 46 and 91%. For example, the standard galaxy formation model implemented in the Millennium Simulation Project is inconsistent with our limit with 50% probability.	[Shannon, R. M.; Ravi, V.; Hobbs, G.; Keith, M. J.; Manchester, R. N.; Khoo, J.; Wang, J. -B.] Commonwealth Sci & Ind Res Org CSIRO Astron & Spa, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Ravi, V.; Wyithe, J. S. B.] Univ Melbourne, Sch Phys, Parkville, Vic 3010, Australia; [Coles, W. A.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Bailes, M.; Bhat, N. D. R.; Oslowski, S.; van Straten, W.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Bhat, N. D. R.] Curtin Univ, Int Ctr Radio Astron Res, Bentley, WA 6102, Australia; [Burke-Spolaor, S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Khoo, J.] CSIRO Adv Sci Comp Informat Management & Technol, Clayton, Vic 3169, Australia; [Levin, Y.] Monash Univ, Sch Phys, Clayton, Vic 3800, Australia; [Sarkissian, J. M.] CSIRO Astron & Space Sci, Parkes Observ, Parkes, NSW 2870, Australia; [Verbiest, J. P. W.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Wang, J. -B.] Chinese Acad Sci, Xinjiang Astron Observ, Urumqi 830011, Xinjiang, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne; University of California System; University of California San Diego; Swinburne University of Technology; Curtin University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; Chinese Academy of Sciences; Xinjiang Astronomy Observatory, NACO, CAS	Shannon, RM (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Astron & Spa, Australia Telescope Natl Facil, POB 76, Epping, NSW 1710, Australia.	ryan.shannon@csiro.au; v.ravi@pgrad.unimelb.edu.au	Shannon, Ryan/AAW-8522-2020; Verbiest, Joris PW/X-4941-2019; Bulik, Tomasz/AAJ-6742-2020; Shannon, Ryan/ABD-6796-2021; Keith, Michael/AAH-2606-2019; Oslowski, Stefan/AAI-7959-2021; Hobbs, George/AAS-5025-2020	Shannon, Ryan/0000-0002-7285-6348; Verbiest, Joris PW/0000-0002-4088-896X; Shannon, Ryan/0000-0002-7285-6348; Keith, Michael/0000-0001-5567-5492; Oslowski, Stefan/0000-0003-0289-0732; Bailes, Matthew/0000-0003-3294-3081; Wyithe, Stuart/0000-0001-7956-9758; Spolaor, Sarah/0000-0003-4052-7838; Manchester, Richard/0000-0001-9445-5732; Hobbs, George/0000-0003-1502-100X; van Straten, Willem/0000-0003-2519-7375; Bhat, Ramesh/0000-0002-8383-5059	Commonwealth of Australia for operation; R.N.M.'s Australian Research Council (ARC) Federation Fellowship [FF0348478]; CSIRO; ARC [DP0985272]; John Stocker Postgraduate Scholarship from the Science and Industry Endowment Fund; ARC QEII Fellowship [DP0878388]; Australian Research Council Laureate Fellowship; NASA; European Research Council (ERC) for the ERC Starting Grant Beacon [279202]	Commonwealth of Australia for operation; R.N.M.'s Australian Research Council (ARC) Federation Fellowship(Australian Research Council); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); ARC(Australian Research Council); John Stocker Postgraduate Scholarship from the Science and Industry Endowment Fund; ARC QEII Fellowship(Australian Research Council); Australian Research Council Laureate Fellowship(Australian Research Council); NASA(National Aeronautics & Space Administration (NASA)); European Research Council (ERC) for the ERC Starting Grant Beacon(European Research Council (ERC))	We thank all of the observers, engineers, and Parkes observatory staff members who have assisted with the observations reported in this paper. We thank N. McConnell for providing and confirming some dynamical SMBH and bulge mass measurements, S. Mutch for discussions on the Millennium-based model, and X.-J. Zhu for comments on the manuscript. The Parkes radio telescope is part of the Australia Telescope National Facility, which is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. The Millennium and Millennium-II Simulation databases used in this paper and the Web application providing online access to these databases were constructed as part of the activities of the German Astrophysical Virtual Observatory. The PPTA project was initiated with support from R.N.M.'s Australian Research Council (ARC) Federation Fellowship (no. FF0348478) and from the CSIRO under that fellowship program. The PPTA project has also received support from ARC Discovery Project grant no. DP0985272. V. R. is a recipient of a John Stocker Postgraduate Scholarship from the Science and Industry Endowment Fund, G. H. is the recipient of an ARC QEII Fellowship (no. DP0878388), and J.S.B.W. acknowledges an Australian Research Council Laureate Fellowship. Part of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. J.P.W.V. acknowledges the financial support by the European Research Council (ERC) for the ERC Starting Grant Beacon under contract no. 279202. The authors declare no conflicts of interest. Data used in this analysis can be accessed via the Australia National Data Service (www.ands.org.au).	[Anonymous], 2013, ASTROPHYS SPACE SCI, DOI [DOI 10.1007/978-3-642-32362-1_6, DOI 10.1007/978-3-642-32362-1.6]; BEGELMAN MC, 1980, NATURE, V287, P307, DOI 10.1038/287307a0; Boylan-Kolchin M, 2009, MON NOT R ASTRON SOC, V398, P1150, DOI 10.1111/j.1365-2966.2009.15191.x; Coles W, 2011, MON NOT R ASTRON SOC, V418, P561, DOI 10.1111/j.1365-2966.2011.19505.x; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Demorest PB, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/94; Edwards RT, 2006, MON NOT R ASTRON SOC, V372, P1549, DOI 10.1111/j.1365-2966.2006.10870.x; Enoki M, 2007, PROG THEOR PHYS, V117, P241, DOI 10.1143/PTP.117.241; FOSTER RS, 1990, ASTROPHYS J, V361, P300, DOI 10.1086/169195; Guo Q, 2011, MON NOT R ASTRON SOC, V413, P101, DOI 10.1111/j.1365-2966.2010.18114.x; Hobbs G, 2009, MON NOT R ASTRON SOC, V394, P1945, DOI 10.1111/j.1365-2966.2009.14391.x; KASPI VM, 1994, ASTROPHYS J, V428, P713, DOI 10.1086/174280; Khan FM, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/100; Khan FM, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/147; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Manchester RN, 2013, PUBL ASTRON SOC AUST, V30, DOI 10.1017/pasa.2012.017; McConnell NJ, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/184; Ravi V, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/84; Roedig C, 2012, J PHYS CONF SER, V363, DOI 10.1088/1742-6596/363/1/012035; Sathyaprakash BS, 2009, LIVING REV RELATIV, V12, DOI 10.12942/lrr-2009-2; Sesana A, 2008, MON NOT R ASTRON SOC, V390, P192, DOI 10.1111/j.1365-2966.2008.13682.x; Sesana A, 2013, MON NOT R ASTRON SOC, V433, pL1, DOI 10.1093/mnrasl/slt034; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; van Haasteren R, 2011, MON NOT R ASTRON SOC, V414, P3117, DOI 10.1111/j.1365-2966.2011.18613.x; Verbiest JPW, 2009, MON NOT R ASTRON SOC, V400, P951, DOI 10.1111/j.1365-2966.2009.15508.x; Volonteri M, 2003, ASTROPHYS J, V582, P559, DOI 10.1086/344675; Yardley DRB, 2011, MON NOT R ASTRON SOC, V414, P1777, DOI 10.1111/j.1365-2966.2011.18517.x	27	121	124	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					334	337		10.1126/science.1238012	http://dx.doi.org/10.1126/science.1238012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136962	Green Published, Green Submitted			2022-12-28	WOS:000325755100037
J	Ideguchi, T; Holzner, S; Bernhardt, B; Guelachvili, G; Picque, N; Hansch, TW				Ideguchi, Takuro; Holzner, Simon; Bernhardt, Birgitta; Guelachvili, Guy; Picque, Nathalie; Haensch, Theodor W.			Coherent Raman spectro-imaging with laser frequency combs	NATURE			English	Article							SCATTERING MICROSCOPY; IN-VIVO; TISSUE	Advances in optical spectroscopy and microscopy have had a profound impact throughout the physical, chemical and biological sciences. One example is coherent Raman spectroscopy, a versatile technique interrogating vibrational transitions in molecules. It offers high spatial resolution and three-dimensional sectioning capabilities that make it a label-free tool(1,2) for the non-destructive and chemically selective probing of complex systems. Indeed, single-colour Raman bands have been imaged in biological tissue at video rates(3,4) by using ultra-short-pulse lasers. However, identifying multiple, and possibly unknown, molecules requires broad spectral bandwidth and high resolution. Moderate spectral spans combined with high-speed acquisition are now within reach using multichannel detection(5) or frequency-swept laser beams(6-9). Laser frequency combs(10) are finding increasing use for broadband molecular linear absorption spectroscopy(11-15). Here we show, by exploring their potential for nonlinear spectroscopy(16), that they can be harnessed for coherent anti-Stokes Raman spectroscopy and spectro-imaging. The method uses two combs and can simultaneously measure, on the microsecond timescale, all spectral elements over a wide bandwidth and with high resolution on a single photodetector. Although the overall measurement time in our proof-of-principle experiments is limited by the waiting times between successive spectral acquisitions, this limitation can be overcome with further system development. We therefore expect that our approach of using laser frequency combs will not only enable new applications for nonlinear microscopy but also benefit other nonlinear spectroscopic techniques.	[Ideguchi, Takuro; Holzner, Simon; Bernhardt, Birgitta; Picque, Nathalie; Haensch, Theodor W.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Guelachvili, Guy; Picque, Nathalie] Univ Paris 11, CNRS, Inst Sci Mol Orsay, F-91405 Orsay, France; [Bernhardt, Birgitta; Picque, Nathalie; Haensch, Theodor W.] Univ Munich, Fak Phys, D-80799 Munich, Germany	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Munich	Picque, N (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	nathalie.picque@mpq.mpg.de	Ideguchi, Takuro/AAE-6357-2021; Ideguchi, Takuro/O-2542-2014; Picqué, Nathalie/AFQ-1629-2022; Bernhardt, Birgitta/L-9424-2015	Ideguchi, Takuro/0000-0002-7233-2528; Picqué, Nathalie/0000-0002-8540-7218; Bernhardt, Birgitta/0000-0001-7537-4689	Max Planck Foundation; Munich Center for Advanced Photonics; Eurostars; European Research Council [267854]	Max Planck Foundation(Foundation CELLEX); Munich Center for Advanced Photonics; Eurostars; European Research Council(European Research Council (ERC)European Commission)	We thank P. Hommelhoff, M. Schultze and W. Schweinberger for the loan of optical components, and A. Hipke for experimental support. Research was conducted in the scope of the European Laboratory for Frequency Comb Spectroscopy. We acknowledge support from the Max Planck Foundation, the Munich Center for Advanced Photonics, Eurostars and the European Research Council (Advanced Investigator grant no. 267854).	Bartels A, 2009, SCIENCE, V326, P681, DOI 10.1126/science.1179112; Bernhardt B, 2010, NAT PHOTONICS, V4, P55, DOI 10.1038/NPHOTON.2009.217; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Cheng J-X, 2012, COHERENT RAMAN SCATT; Cleff C, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.023825; Coddington I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013902; Diddams SA, 2007, NATURE, V445, P627, DOI 10.1038/nature05524; Dudovich N, 2002, NATURE, V418, P512, DOI 10.1038/nature00933; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Frontiera RR, 2011, J PHYS CHEM LETT, V2, P1199, DOI 10.1021/jz200498z; Fu D, 2013, J PHYS CHEM B, V117, P4634, DOI 10.1021/jp308938t; Hansch TW, 2006, REV MOD PHYS, V78, P1297, DOI 10.1103/RevModPhys.78.1297; Hiramatsu K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.083901; Ichimura T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220801; Ideguchi T, 2012, OPT LETT, V37, P4498, DOI 10.1364/OL.37.004498; Kippenberg TJ, 2011, SCIENCE, V332, P555, DOI 10.1126/science.1193968; Knutsen KP, 2006, J PHYS CHEM B, V110, P5854, DOI 10.1021/jp052416a; Kong LJ, 2013, OPT LETT, V38, P145, DOI 10.1364/OL.38.000145; Mukamel S., 1995, PRINCIPLES NONLINEAR, V1st; Nafie LA, 2012, J RAMAN SPECTROSC, V43, P1845, DOI 10.1002/jrs.4221; Ogilvie JP, 2006, OPT LETT, V31, P480, DOI 10.1364/OL.31.000480; Ozeki Y, 2012, NAT PHOTONICS, V6, P844, DOI [10.1038/nphoton.2012.263, 10.1038/NPHOTON.2012.263]; Pegoraro AF, 2009, OPT EXPRESS, V17, P2984, DOI 10.1364/OE.17.002984; Saar BG, 2010, SCIENCE, V330, P1368, DOI 10.1126/science.1197236; Schliesser A, 2012, NAT PHOTONICS, V6, P440, DOI [10.1038/nphoton.2012.142, 10.1038/NPHOTON.2012.142]; Steuwe C, 2011, NANO LETT, V11, P5339, DOI 10.1021/nl202875w; Thorpe MJ, 2006, SCIENCE, V311, P1595, DOI 10.1126/science.1123921; Volkmer A, 2002, APPL PHYS LETT, V80, P1505, DOI 10.1063/1.1456262; WEINER AM, 1991, J OPT SOC AM B, V8, P1264, DOI 10.1364/JOSAB.8.001264; YAN YX, 1985, J CHEM PHYS, V83, P5391, DOI 10.1063/1.449708	30	288	298	24	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					355	+		10.1038/nature12607	http://dx.doi.org/10.1038/nature12607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132293	Green Submitted			2022-12-28	WOS:000325706300049
J	Tanaka, G; Hou, XG; Ma, XY; Edgecombe, GD; Strausfeld, NJ				Tanaka, Gengo; Hou, Xianguang; Ma, Xiaoya; Edgecombe, Gregory D.; Strausfeld, Nicholas J.			Chelicerate neural ground pattern in a Cambrian great appendage arthropod	NATURE			English	Article							BURGESS SHALE; BRITISH-COLUMBIA; VISUAL-SYSTEMS; LEANCHOILIA; BRAIN; EYES; MORPHOLOGY; EVOLUTION; ORIGIN; SPIDER	Preservation of neural tissue in early Cambrian arthropods has recently been demonstrated(1), to a degree that segmental structures of the head can be associated with individual brain neuromeres. This association provides novel data for addressing long-standing controversies about the segmental identities of specialized head appendages in fossil taxa(2,3). Here we document neuroanatomy in the head and trunk of a 'great appendage' arthropod, Alalcomenaeus sp., from the Chengjiang biota, southwest China, providing the most complete neuroanatomical profile known from a Cambrian animal. Micro-computed tomography reveals a configuration of one optic neuropil separate from a protocerebrum contiguous with four head ganglia, succeeded by eight contiguous ganglia in an eleven-segment trunk. Arrangements of optic neuropils, the brain and ganglia correspond most closely to the nervous system of Chelicerata of all extant arthropods, supporting the assignment of 'great appendage' arthropods to the chelicerate total group(4,5). The position of the deutocerebral neuromere aligns with the insertion of the great appendage, indicating its deutocerebral innervation and corroborating a homology between the 'great appendage' and chelicera indicated by morphological similarities(4,6,7). Alalcomenaeus and Fuxianhuia protensa(1) demonstrate that the two main configurations of the brain observed in modern arthropods, those of Chelicerata and Mandibulata, respectively(8), had evolved by the early Cambrian.	[Tanaka, Gengo] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Hou, Xianguang; Ma, Xiaoya] Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China; [Ma, Xiaoya; Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Strausfeld, Nicholas J.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Strausfeld, Nicholas J.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Yunnan University; Natural History Museum London; University of Arizona; University of Arizona	Hou, XG (corresponding author), Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China.	xghou@ynu.edu.cn; flybrain@email.arizona.edu	Strausfeld, Nicholas James/AAF-4566-2021	Strausfeld, Nicholas James/0000-0002-1115-1774; Edgecombe, Gregory/0000-0002-9591-8011	Natural Science Foundation of China [40730211]; Research in Education and Science from the Government of Japan [21740370]; Leverhulme Trust [F/00 696/T]; Center for Insect Science, University of Arizona; Air Force Research Laboratories [FA8651-10-1-0001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research in Education and Science from the Government of Japan; Leverhulme Trust(Leverhulme Trust); Center for Insect Science, University of Arizona; Air Force Research Laboratories(United States Department of DefenseUS Air Force Research Laboratory)	We thank N. Shimobayashi, H. Maeda, and T. Kogiso for arranging and performing EDXRF analyses, and D. Andrew for advice on cladistics. This work was supported by grants from the Natural Science Foundation of China (no. 40730211), Research in Education and Science from the Government of Japan (no. 21740370), a Leverhulme Trust Research Project Grant (F/00 696/T), by the Center for Insect Science, University of Arizona, and a grant from the Air Force Research Laboratories (FA8651-10-1-0001) to N.J.S.	Brenneis G, 2010, J MORPHOL, V271, P169, DOI 10.1002/jmor.10789; Briggs DEG, 1999, PALAEONTOLOGY, V42, P953, DOI 10.1111/1475-4983.00104; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Edgecombe GD, 2011, ACTA PALAEONTOL POL, V56, P385, DOI 10.4202/app.2010.0080; Eriksson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042582; Eriksson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035625; Garcia-Bellido DC, 2007, PALAEONTOLOGY, V50, P693, DOI 10.1111/j.1475-4983.2007.00649.x; Harzsch S, 2006, DEV DYNAM, V235, P2641, DOI 10.1002/dvdy.20866; Haug JT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-162; Haug JT, 2012, PALAEONTOLOGY, V55, P369, DOI 10.1111/j.1475-4983.2011.01124.x; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Legg DA, 2012, P ROY SOC B-BIOL SCI, V279, P4699, DOI 10.1098/rspb.2012.1958; Lehmann T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030474; Lin C, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-7; Liu Y, 2007, GFF, V129, P263, DOI 10.1080/11035890701293263; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Richter Stefan, 2013, P223; Schoenemann B, 2012, LETHAIA, V45, P524, DOI 10.1111/j.1502-3931.2012.00313.x; Stein M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-99; Strausfeld N.J., 2012, ARTHROPOD BRAINS EVO; Strausfeld NJ, 2011, ARTHROPOD STRUCT DEV, V40, P276, DOI 10.1016/j.asd.2011.02.002; STRAUSFELD NJ, 1993, J COMP NEUROL, V328, P63, DOI 10.1002/cne.903280105; Yang J, 2013, NATURE, V494, P468, DOI 10.1038/nature11874; ZEIL J, 1983, CELL TISSUE RES, V229, P591	29	104	107	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					364	+		10.1038/nature12520	http://dx.doi.org/10.1038/nature12520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132294				2022-12-28	WOS:000325706300051
J	Ubel, PA; Abernethy, AP; Zafar, SY				Ubel, Peter A.; Abernethy, Amy P.; Zafar, S. Yousuf			Full Disclosure - Out-of-Pocket Costs as Side Effects	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Ubel, Peter A.; Abernethy, Amy P.; Zafar, S. Yousuf] Duke Univ, Med Ctr, Durham, NC USA; [Abernethy, Amy P.; Zafar, S. Yousuf] Duke Clin Res Inst, Duke Ctr Learning Hlth Care, Durham, NC USA; [Abernethy, Amy P.; Zafar, S. Yousuf] Duke Canc Inst, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Ubel, PA (corresponding author), Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA.			Zafar, S. Yousuf/0000-0002-9039-5258				Alexander GC, 2003, JAMA-J AM MED ASSOC, V290, P953, DOI 10.1001/jama.290.7.953; Center for American Progress Action Fund, 2009, COV IT COUNTS MUCH P; Centers for Medicare Medicaid Services, 2013, 2013 ASP DRUG PRIC F; National Center for Health Statistics, 2012, FIN BURD MED CAR EAR; Zafar SY, 2013, ONCOLOGIST, V18, P381, DOI 10.1634/theoncologist.2012-0279	5	199	199	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1484	1486		10.1056/NEJMp1306826	http://dx.doi.org/10.1056/NEJMp1306826			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	267MJ	24131175				2022-12-28	WOS:000328101700003
J	Wolfe, SM				Wolfe, Sidney M.			Selling amphetamine emblazoned athletic shirts v overselling amphetamines: a tale of two entrepreneurs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Citizen, Hlth Res Grp, Washington, DC USA		Wolfe, SM (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC USA.	Swolfe@citizen.org						Mintzes B, 2009, FUTURE MED CHEM, V1, P1555, DOI [10.4155/fmc.09.136, 10.4155/FMC.09.136]; Taylor V., 2013, NEW YORK DAILY NEWS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2013	347								F6215	10.1136/bmj.f6215	http://dx.doi.org/10.1136/bmj.f6215			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WP	24136796				2022-12-28	WOS:000325982700008
J	Costantini, M; Romoli, V; Di Leo, S; Beccaro, M; Bono, L; Pilastri, P; Miccinesi, G; Valenti, D; Peruselli, C; Bulli, F; Franceschini, C; Grubich, S; Brunelli, C; Martini, C; Pellegrini, F; Higginson, IJ				Costantini, Massimo; Romoli, Vittoria; Di Leo, Silvia; Beccaro, Monica; Bono, Laura; Pilastri, Paola; Miccinesi, Guido; Valenti, Danila; Peruselli, Carlo; Bulli, Francesco; Franceschini, Catia; Grubich, Sergio; Brunelli, Cinzia; Martini, Cinzia; Pellegrini, Fabio; Higginson, Irene J.		Liverpool Care Pathway Italian Clu	Liverpool Care Pathway for patients with cancer in hospital: a cluster randomised trial	LANCET			English	Article							END-OF-LIFE; ITALIAN SURVEY; DYING PATIENT; IMPROVING END; LAST HOURS; PLACE; DEATH; IMPLEMENTATION; INTERVENTIONS; POPULATION	Background The quality of care provided to patients with cancer who are dying in hospital and their families is suboptimum. The UK Liverpool Care Pathway (LCP) for patients who are dying was developed with the aim of transferring the best practice of hospices to hospitals. We therefore assessed the effectiveness of LCP in the Italian context (LCP-I) in improving the quality of end-of-life care for patients with cancer in hospitals and for their family. Methods In this pragmatic cluster randomised trial, 16 Italian general medicine hospital wards were randomly assigned to implement the LCP-I programme or standard health-care practice. For each ward, we identified all patients who died from cancer in the 3 months before randomisation (preintervention) and in the 6 months after the completion of the LCP-I training programme. The primary endpoint was the overall quality of care toolkit scale. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT01081899. Findings During the postintervention assessment, data were gathered for 308 patients who died from cancer (147 in LCP-I programme wards and 161 in control wards). 232 (75%) of 308 family members were interviewed, 119 (81%) of 147 with relatives cared for in the LCP-I wards (mean cluster size 14.9 [range eight to 22]) and 113 (70%) of 161 in the control wards (14.1 [eight to 22]). After implementation of the LCP-I programme, no significant difference was noted in the distribution of the overall quality of care toolkit scores between the wards in which the LCP-I programme was implemented and the control wards (score 70.5 of 100 vs 63.0 of 100; cluster-adjusted mean difference 7.6 [95% CI -3.6 to 18.7]; p=0.186). Interpretation The effect of the LCP-I programme in our study is less than the effects noted in earlier phase 2 trials. However, if the programme is implemented well it has the potential to reduce the gap in quality of care between hospices and hospitals. Further research is needed to ascertain what components of the LCP-I programme might be effective and to develop and assess a wider range of approaches to quality improvement in hospital care for people at the end of their lives and for their families.	[Costantini, Massimo] Ist Ricovero & Cura Carattere Sci IRCCS Arcispeda, Palliat Care Unit, Reggio Emilia, Italy; [Romoli, Vittoria; Di Leo, Silvia; Beccaro, Monica; Bono, Laura] IRCCS Azienda Osped Univ San Martino, Ist Nazl Ric Canc, Reg Palliat Care Network, Genoa, Italy; [Pilastri, Paola] IRCCS Azienda Osped Univ San Martino, Ist Nazl Ric Canc, Hosp Maria Chighine, Genoa, Italy; [Miccinesi, Guido; Bulli, Francesco] Ist Studio & Prevenz Oncol, Clin & Descript Epidemiol Unit, Florence, Italy; [Valenti, Danila] Azienda Unita Sanit Locale Bologna, Palliat Care Network, Bologna, Italy; [Peruselli, Carlo; Grubich, Sergio] Biella Hosp, Palliat Care Unit, Biella, Italy; [Franceschini, Catia] Fdn Hosp Maria Teresa Chiantore Seragnoli, Bologna, Italy; [Brunelli, Cinzia; Martini, Cinzia] Fdn IRCCS Ist Nazl Tumori, Palliat Care Pain Therapy & Rehabil Unit, Milan, Italy; [Brunelli, Cinzia] Norwegian Univ Sci & Technol, Fac Med, European Palliat Care Res Ctr, N-7034 Trondheim, Norway; [Pellegrini, Fabio] Mario Negri Sud Consortium, Mario Negri Sud Inst, Chieti, Italy; [Higginson, Irene J.] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; Fondazione IRCCS Istituto Nazionale Tumori Milan; Norwegian University of Science & Technology (NTNU); Consorzio Mario Negri Sud; University of London; King's College London	Costantini, M (corresponding author), IRCCS Arcispedale S Maria Nuova, Palliat Care Unit, Viale Umberto 1,50, I-42123 Reggio Emilia, Italy.	costantini.massimo@asmn.re.it	costantini, massimo/AAK-5388-2021; Di Leo, Silvia/AAA-3180-2021; Harding, Richard/G-9729-2012; miccinesi, guido/AAB-5476-2022; Brunelli, Cinzia/B-9361-2017; Higginson, Irene Julie/C-7309-2012	costantini, massimo/0000-0002-5293-7079; Di Leo, Silvia/0000-0003-1673-2786; miccinesi, guido/0000-0002-7452-9594; Brunelli, Cinzia/0000-0003-3905-1289; Higginson, Irene Julie/0000-0002-3687-1313	Italian Ministry of Health; Maruzza Lefebvre D'Ovidio Foundation-Onlus; National Institute for Health Research [NF-SI-0611-10209] Funding Source: researchfish	Italian Ministry of Health(Ministry of Health, Italy); Maruzza Lefebvre D'Ovidio Foundation-Onlus; National Institute for Health Research(National Institute for Health Research (NIHR))	Italian Ministry of Health and Maruzza Lefebvre D'Ovidio Foundation-Onlus.	[Anonymous], 2012, LANCET, V379, P1171, DOI 10.1016/S0140-6736(12)60490-5; [Anonymous], 2011, NAR CAR DYING AUD HO; Bailey FA, 2005, ARCH INTERN MED, V165, P1722, DOI 10.1001/archinte.165.15.1722; Beccaro M, 2006, J EPIDEMIOL COMMUN H, V60, P412, DOI 10.1136/jech.2005.043646; Beccaro M, 2010, J PAIN SYMPTOM MANAG, V39, P1003, DOI 10.1016/j.jpainsymman.2009.11.317; Bookbinder M, 2005, J PAIN SYMPTOM MANAG, V29, P529, DOI 10.1016/j.jpainsymman.2004.05.011; Bowden J, 2013, J ROY COLL PHYS EDIN, V43, P24, DOI 10.4997/JRCPE.2013.105; Chan R, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008006.pub2, 10.1002/14651858.CD008006.pub4]; ClinicalTrials.gov, IMPR QUAL CAR DYING; Cohen J, 2008, PALLIATIVE MED, V22, P702, DOI 10.1177/0269216308092285; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Conry MC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-275; Costantini M, 2006, ANN ONCOL, V17, P853, DOI 10.1093/annonc/mdl028; Costantini M, 2005, PALLIATIVE MED, V19, P628, DOI 10.1191/0269216305pm1086oa; Costantini M, 2014, PALLIATIVE MED, V28, P10, DOI 10.1177/0269216313487569; Costantini M, 2011, PALLIATIVE MED, V25, P766, DOI 10.1177/0269216311418870; Costantini M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-13; Costantini M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-127; Department of Health, 2008, END LIF CAR STRAT PR; Department of Health, 2013, MAR CAR LESS PATHW R; Di Leo S, 2011, PALLIATIVE MED, V25, P293, DOI 10.1177/0269216310392436; Ellershaw J, 2003, BRIT MED J, V326, P30, DOI 10.1136/bmj.326.7379.30; Farquhar Morag C, 2009, BMC Palliat Care, V8, P9, DOI 10.1186/1472-684X-8-9; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Gibbins J, 2011, MED EDUC, V45, P389, DOI 10.1111/j.1365-2923.2010.03873.x; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gysels MH, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-123; Gysels MH, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-15; Hall S, 2011, PALL CAR OLD PEOPL B; Higginson IJ, 2008, EUR J CANCER, V44, P1414, DOI 10.1016/j.ejca.2008.02.024; Higginson IJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-111; Jack Barbara A, 2003, Int J Palliat Nurs, V9, P375; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Luhrs CA, 2005, J PAIN SYMPTOM MANAG, V29, P544, DOI 10.1016/j.jpainsymman.2005.02.010; McConnell T, 2013, WORLDV EVID-BASED NU, V10, P218, DOI 10.1111/wvn.12003; National Health System (NHS), 2010, NAT END LIF CAR PROG; NHS Medical Directorate, 2012, END LIF CAR 1 NAT VO; Phillips JL, 2011, J PAIN SYMPTOM MANAG, V41, P940, DOI 10.1016/j.jpainsymman.2010.07.020; Raijmakers NJH, 2013, SUPPORT CARE CANCER, V21, P1003, DOI 10.1007/s00520-012-1619-0; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; SILVERMAN HJ, 1995, ARCH INTERN MED, V155, P502, DOI 10.1001/archinte.155.5.502; Simon ST, 2012, PUBLIC HEALTH, V126, P937, DOI 10.1016/j.puhe.2012.06.014; Singer Peter A, 2002, BMC Palliat Care, V1, P4, DOI 10.1186/1472-684X-1-4; Snijders T.A., 1999, INTRO BASIC ADV MULT; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P752, DOI 10.1016/S0885-3924(01)00331-1; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P738, DOI 10.1016/S0885-3924(01)00335-9; Teno JM, 2001, TOOLKIT INSTRUMENTS; Veerbeek L, 2008, AM J HOSP PALLIAT ME, V25, P207, DOI 10.1177/1049909108315515; Veerbeek L, 2008, PALLIATIVE MED, V22, P145, DOI 10.1177/0269216307087164	50	56	56	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					226	237		10.1016/S0140-6736(13)61725-0	http://dx.doi.org/10.1016/S0140-6736(13)61725-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294FC	24139708				2022-12-28	WOS:000330027500031
J	Corbett-Detig, RB; Zhou, J; Clark, AG; Hartl, DL; Ayroles, JF				Corbett-Detig, Russell B.; Zhou, Jun; Clark, Andrew G.; Hartl, Daniel L.; Ayroles, Julien F.			Genetic incompatibilities are widespread within species	NATURE			English	Article							HYBRID MALE-STERILITY; DOBZHANSKY-MULLER INCOMPATIBILITIES; SYNTHETIC POPULATION RESOURCE; DROSOPHILA-MELANOGASTER; COMPLEX TRAIT; EPISTASIS; EVOLUTION; GENOME; DISSECTION; DISCOVERY	The importance of epistasis-non-additive interactions between alleles-in shaping population fitness has long been a controversial topic, hampered in part by lack of empirical evidence(1-4). Traditionally, epistasis is inferred on the basis of non-independence of genotypic values between loci for a given trait. However, epistasis for fitness should also have a genomic footprint(5-7). To capture this signal, we have developed a simple approach that relies on detecting genotype ratio distortion as a sign of epistasis, and we apply this method to a large panel of Drosophila melanogaster recombinant inbred lines(8,9). Here we confirm experimentally that instances of genotype ratio distortion represent loci with epistatic fitness effects; we conservatively estimate that any two haploid genomes in this study are expected to harbour 1.15 pairs of epistatically interacting alleles. This observation has important implications for speciation genetics, as it indicates that the raw material to drive reproductive isolation is segregating contemporaneously within species and does not necessarily require, as proposed by the Dobzhansky-Muller model, the emergence of incompatible mutations independently derived and fixed in allopatry. The relevance of our result extends beyond speciation, as it demonstrates that epistasis is widespread but that it may often go undetected owing to lack of statistical power or lack of genome-wide scope of the experiments.	[Corbett-Detig, Russell B.; Zhou, Jun; Hartl, Daniel L.; Ayroles, Julien F.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Clark, Andrew G.; Ayroles, Julien F.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Ayroles, Julien F.] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA	Harvard University; Cornell University; Cornell University; Harvard University	Ayroles, JF (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	ayroles@fas.harvard.edu	Corbett-Detig, Russ/Y-9659-2019	Clark, Andrew/0000-0001-7159-8511	NIH [GM065169, GM084236, HD059060]; Harvard Society; Harvard Milton Funds; Harvard Prize Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084236, R01GM065169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Society; Harvard Milton Funds; Harvard Prize Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to T. Long, S. Macdonald and E. King for creating the DSPR and sharing the RILs and founder strains with us. We thank C. Jones, B. de Bivort, T. Sackton, S. D. Kocher, J. Grenier and N.E. Soltis for comments and discussions. We thank X. Shi for technical assistance. This work was supported by grants: NIH GM065169 and GM084236 to D. L. H., HD059060 to A. G. C., and Harvard Society of Fellows Fellowship and Harvard Milton Funds to J. F. A. R.B.C.-D. was supported by a Harvard Prize Fellowship.	Ackermann M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002463; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; CHEVERUD JM, 1995, GENETICS, V139, P1455; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coyne J.A., 2004, SPECIATION; Cutter AD, 2012, TRENDS ECOL EVOL, V27, P209, DOI 10.1016/j.tree.2011.11.004; Demuth JP, 2005, AM NAT, V165, P524, DOI 10.1086/429276; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobzhansky T., 1937; Dockendorff TC, 2000, MOL GEN GENET, V263, P137, DOI 10.1007/s004380050040; Fitzpatrick BM, 2008, AM NAT, V171, P491, DOI 10.1086/528991; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Kasai S, 2003, BIOCHEM BIOPH RES CO, V300, P894, DOI 10.1016/S0006-291X(02)02950-9; King EG, 2012, GENOME RES, V22, P1558, DOI 10.1101/gr.134031.111; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; Orr HA, 2001, EVOLUTION, V55, P1085; PALOPOLI MF, 1994, GENETICS, V138, P329; Payseur BA, 2005, GENETICS, V171, P1905, DOI 10.1534/genetics.105.046193; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Reed LK, 2004, P NATL ACAD SCI USA, V101, P9009, DOI 10.1073/pnas.0403106101; Tao Y, 2003, GENETICS, V164, P1383; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	37	126	128	0	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					135	+		10.1038/nature12678	http://dx.doi.org/10.1038/nature12678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24196712	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000327851700046
J	Ge, XY; Li, JL; Yang, XL; Chmura, AA; Zhu, GJ; Epstein, JH; Mazet, JK; Hu, B; Zhang, W; Peng, C; Zhang, YJ; Luo, CM; Tan, B; Wang, N; Zhu, Y; Crameri, G; Zhang, SY; Wang, LF; Daszak, P; Shi, ZL				Ge, Xing-Yi; Li, Jia-Lu; Yang, Xing-Lou; Chmura, Aleksei A.; Zhu, Guangjian; Epstein, Jonathan H.; Mazet, Jonna K.; Hu, Ben; Zhang, Wei; Peng, Cheng; Zhang, Yu-Ji; Luo, Chu-Ming; Tan, Bing; Wang, Ning; Zhu, Yan; Crameri, Gary; Zhang, Shu-Yi; Wang, Lin-Fa; Daszak, Peter; Shi, Zheng-Li			Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor	NATURE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; FUNCTIONAL RECEPTOR; ADAPTATION; DIVERSITY; ORIGIN	The 2002-3 pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV) was one of the most significant public health events in recent history(1). An ongoing outbreak of Middle East respiratory syndrome coronavirus(2) suggests that this group of viruses remains a key threat and that their distribution is wider than previously recognized. Although bats have been suggested to be the natural reservoirs of both viruses(3-5), attempts to isolate the progenitor virus of SARS-CoV from bats have been unsuccessful. Diverse SARS-like coronaviruses (SL-CoVs) have now been reported from bats in China, Europe and Africa(5-8), but none is considered a direct progenitor of SARS-CoV because of their phylogenetic disparity from this virus and the inability of their spike proteins to use the SARS-CoV cellular receptor molecule, the human angiotensin converting enzyme II (ACE2)(9,10). Here we report whole-genome sequences of two novel bat coronaviruses from Chinese horseshoe bats (family: Rhinolophidae) in Yunnan, China: RsSHC014 and Rs3367. These viruses are far more closely related to SARS-CoV than any previously identified bat coronaviruses, particularly in the receptor binding domain of the spike protein. Most importantly, we report the first recorded isolation of a live SL-CoV (bat SL-CoV-WIV1) from bat faecal samples in Vero E6 cells, which has typical coronavirus morphology, 99.9% sequence identity to Rs3367 and uses ACE2 from humans, civets and Chinese horseshoe bats for cell entry. Preliminary in vitro testing indicates that WIV1 also has a broad species tropism. Our results provide the strongest evidence to date that Chinese horseshoe bats are natural reservoirs of SARS-CoV, and that intermediate hosts may not be necessary for direct human infection by some bat SL-CoVs. They also highlight the importance of pathogen-discovery programs targeting high-risk wildlife groups in emerging disease hotspots as a strategy for pandemic preparedness.	[Ge, Xing-Yi; Li, Jia-Lu; Yang, Xing-Lou; Hu, Ben; Zhang, Wei; Peng, Cheng; Zhang, Yu-Ji; Luo, Chu-Ming; Tan, Bing; Wang, Ning; Zhu, Yan; Shi, Zheng-Li] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Ctr Emerging Infect Dis, Wuhan 430071, Peoples R China; [Chmura, Aleksei A.; Zhu, Guangjian; Epstein, Jonathan H.; Daszak, Peter] EcoHlth Alliance, New York, NY 10001 USA; [Mazet, Jonna K.] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA; [Crameri, Gary; Wang, Lin-Fa] CSIRO Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [Zhang, Shu-Yi] E China Normal Univ, Coll Life Sci, Shanghai 200062, Peoples R China; [Wang, Lin-Fa] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore 169857, Singapore	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; EcoHealth Alliance; University of California System; University of California Davis; Commonwealth Scientific & Industrial Research Organisation (CSIRO); East China Normal University; National University of Singapore	Daszak, P (corresponding author), EcoHlth Alliance, New York, NY 10001 USA.	daszak@ecohealthalliance.org; zlshi@wh.iov.cn	yang, xinglou/AAW-6969-2020; wang, lin/GSE-3040-2022; daszak, peter/U-4588-2017; Crameri, Gary/H-8441-2013; Chmura, Aleksei/K-9971-2018; Shi, Zhengli/A-1013-2013	daszak, peter/0000-0002-2046-5695; Chmura, Aleksei/0000-0001-5544-0431; Shi, Zhengli/0000-0001-8089-163X; Li, Jialu/0000-0002-6411-6876; Wang, Lin-Fa/0000-0003-2752-0535; Yang, Xing-Lou/0000-0002-5317-8983; Li, Jialu/0000-0001-9772-3886	State Key Program for Basic Research [2011CB504701, 2010CB530100]; National Natural Science Foundation of China [81290341, 31321001]; Scientific and technological basis special project [2013FY113500]; CSIRO OCE Science Leaders Award; National Institute of Allergy and Infectious Diseases (NIAID) [R01AI079231]; National Institutes of Health (NIH)/National Science Foundation (NSF) 'Ecology and Evolution of Infectious Diseases' award from the NIH Fogarty International Center [R01TW005869]; NIH Fogarty International Center; Office of the Secretary of the Department of Health and Human Services [R56TW009502]; United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT; FOGARTY INTERNATIONAL CENTER [R56TW009502, R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110964, R01AI079231] Funding Source: NIH RePORTER	State Key Program for Basic Research(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and technological basis special project; CSIRO OCE Science Leaders Award; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)/National Science Foundation (NSF) 'Ecology and Evolution of Infectious Diseases' award from the NIH Fogarty International Center(National Science Foundation (NSF)); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of the Secretary of the Department of Health and Human Services; United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT(United States Agency for International Development (USAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge financial support from the State Key Program for Basic Research (2011CB504701 and 2010CB530100), National Natural Science Foundation of China (81290341 and 31321001), Scientific and technological basis special project (2013FY113500), CSIRO OCE Science Leaders Award, National Institute of Allergy and Infectious Diseases (NIAID) award number R01AI079231, a National Institutes of Health (NIH)/National Science Foundation (NSF) 'Ecology and Evolution of Infectious Diseases' award from the NIH Fogarty International Center (R01TW005869), an award from the NIH Fogarty International Center supported by International Influenza Funds from the Office of the Secretary of the Department of Health and Human Services (R56TW009502), and United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT. The contents are the responsibility of the authors and do not necessarily reflect the views of NIAID, NIH, NSF, USAID or the United States Government. We thank X. Che from Zhujiang Hospital, Southern Medical University, for providing human SARS patient sera.	Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0; Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Cui J, 2007, EMERG INFECT DIS, V13, P1526, DOI 10.3201/eid1310.070448; Luna LKD, 2007, J CLIN MICROBIOL, V45, P1049, DOI 10.1128/JCM.02426-06; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Hon CC, 2008, J VIROL, V82, P1819, DOI 10.1128/JVI.01926-07; Hou YX, 2010, ARCH VIROL, V155, P1563, DOI 10.1007/s00705-010-0729-6; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2010, J VIROL, V84, P11385, DOI 10.1128/JVI.01121-10; Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Li Y, 2010, J VIROL, V84, P3889, DOI 10.1128/JVI.02497-09; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Ren W, 2006, J GEN VIROL, V87, P3355, DOI 10.1099/vir.0.82220-0; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Wu KL, 2012, J BIOL CHEM, V287, P8904, DOI 10.1074/jbc.M111.325803; Yuan JF, 2010, J GEN VIROL, V91, P1058, DOI 10.1099/vir.0.016378-0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	29	996	1060	11	289	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					535	+		10.1038/nature12711	http://dx.doi.org/10.1038/nature12711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24172901	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000327464200045
J	Marchetto, MCN; Narvaiza, I; Denli, AM; Benner, C; Lazzarini, TA; Nathanson, JL; Paquola, ACM; Desai, KN; Herai, RH; Weitzman, MD; Yeo, GW; Muotri, AR; Gage, FH				Marchetto, Maria C. N.; Narvaiza, Inigo; Denli, Ahmet M.; Benner, Christopher; Lazzarini, Thomas A.; Nathanson, Jason L.; Paquola, Apua C. M.; Desai, Keval N.; Herai, Roberto H.; Weitzman, Matthew D.; Yeo, Gene W.; Muotri, Alysson R.; Gage, Fred H.			Differential L1 regulation in pluripotent stem cells of humans and apes	NATURE			English	Article							LINE-1 RETROTRANSPOSITION; MOBILE ELEMENTS; CHIMPANZEE; AMPLIFICATION; APOBEC3A; DATABASE; UPDATE; MILI	Identifying cellular and molecular differences between human and non-human primates (NHPs) is essential to the basic understanding of the evolution and diversity of our own species. Until now, preserved tissues have been the main source for most comparative studies between humans, chimpanzees (Pan troglodytes) and bonobos (Pan paniscus)(1,2). However, these tissue samples do not fairly represent the distinctive traits of live cell behaviour and are not amenable to genetic manipulation. We propose that induced pluripotent stem (iPS) cells could be a unique biological resource to determine relevant phenotypical differences between human and NHPs, and that those differences could have potential adaptation and speciation value. Here we describe the generation and initial characterization of iPS cells from chimpanzees and bonobos as new tools to explore factors that may have contributed to great ape evolution. Comparative gene expression analysis of human and NHP iPS cells revealed differences in the regulation of long interspersed element-1 (L1, also known as LINE-1) transposons. A force of change in mammalian evolution, L1 elements are retrotransposons that have remained active during primate evolution(3-5). Decreased levels of L1-restricting factors APOBEC3B (also known as A3B)(6) and PIWIL2 (ref. 7) in NHP iPS cells correlated with increased L1 mobility and endogenous L1 messenger RNA levels. Moreover, results from the manipulation of A3B and PIWIL2 levels in iPS cells supported a causal inverse relationship between levels of these proteins and L1 retrotransposition. Finally, we found increased copy numbers of species-specific L1 elements in the genome of chimpanzees compared to humans, supporting the idea that increased L1 mobility in NHPs is not limited to iPS cells in culture and may have also occurred in the germ line or embryonic cells developmentally upstream to germline specification during primate evolution. We propose that differences in L1 mobility may have differentially shaped the genomes of humans and NHPs and could have continuing adaptive significance.	[Marchetto, Maria C. N.; Narvaiza, Inigo; Denli, Ahmet M.; Benner, Christopher; Lazzarini, Thomas A.; Paquola, Apua C. M.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Nathanson, Jason L.; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, Stem Cell Program, Inst Genom Med,Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Desai, Keval N.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Herai, Roberto H.; Muotri, Alysson R.] Univ Calif San Diego, Rady Childrens Hosp San Diego, Dept Cellular & Mol Med,Dept Pediat, Stem Cell Program,Sanford Consortium,Sch Med, La Jolla, CA 92093 USA; [Weitzman, Matthew D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Weitzman, Matthew D.] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Muotri, Alysson R.; Gage, Fred H.] CARTA, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Yeo, Gene/AAE-7676-2019; Herai, Roberto/HII-2648-2022	Yeo, Gene/0000-0002-0799-6037; Herai, Roberto/0000-0001-9885-2735; Lipton, Stuart/0000-0002-3490-1259; Benner, Christopher/0000-0002-4618-0719; Lazzarini, Thomas/0000-0003-1855-2957	National Institutes of Health (NIH) [TR01: MH095741, Eureka: MH08848, MH094753, AI074967, NS075449, HG004659, GM084317]; Mathers Foundation; Helmsley Foundation; Alfred P. Sloan Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094753, R01MH088485, R01MH095741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Helmsley Foundation; Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by funds from the National Institutes of Health (NIH) (TR01: MH095741 and Eureka: MH08848 to F.H.G.), the Mathers Foundation and the Helmsley Foundation. This work was also partially supported by funds from the NIH to A.R.M. (MH094753), M.D.W. (AI074967) and G.W.Y. (NS075449, HG004659 and GM084317). G.W.Y. is a recipient of the Alfred P. Sloan Research Fellowship. We thank J. V. Moran and W. An for reagents. We would like to thank A. Varki, P. Gagneux, L. Fourgeaud and I. Guimont for discussions, N. Varki for help with teratoma analysis, R. Keithley, I. Gallina and Y. Nunez for technical assistance, and M. L. Gage for editorial comments.	Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bowden R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002504; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee J, 2007, GENE, V390, P18, DOI 10.1016/j.gene.2006.08.029; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mathews LM, 2003, AM J HUM GENET, V72, P739, DOI 10.1086/368275; Mills RE, 2006, AM J HUM GENET, V78, P671, DOI 10.1086/501028; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; Muotri AR, 2005, P NATL ACAD SCI USA, V102, P18644, DOI 10.1073/pnas.0509315102; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Wissing S, 2011, J BIOL CHEM, V286, P36427, DOI 10.1074/jbc.M111.251058; Xie Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1076; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	51	154	165	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					525	+		10.1038/nature12686	http://dx.doi.org/10.1038/nature12686			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24153179	Green Accepted, Green Submitted			2022-12-28	WOS:000327464200043
J	Teufel, R; Miyanaga, A; Michaudel, Q; Stull, F; Louie, G; Noel, JP; Baran, PS; Palfey, B; Moore, BS				Teufel, Robin; Miyanaga, Akimasa; Michaudel, Quentin; Stull, Frederick; Louie, Gordon; Noel, Joseph P.; Baran, Phil S.; Palfey, Bruce; Moore, Bradley S.			Flavin-mediated dual oxidation controls an enzymatic Favorskii-type rearrangement	NATURE			English	Article							DEPENDENT MONOOXYGENASE; CRYSTAL-STRUCTURE; SWISS-MODEL; ENTEROCIN; PROTEIN; OXYGEN; HYDROXYLATION; ENVIRONMENT; MECHANISM; SYNTHASE	Flavoproteins catalyse a diversity of fundamental redox reactions and are one of the most studied enzyme families(1,2). As monooxygenases, they are universally thought to control oxygenation by means of a peroxyflavin species that transfers a single atom of molecular oxygen to an organic substrate(1,3,4). Here we report that the bacterial flavoenzyme EncM(5,6) catalyses the peroxyflavin-independent oxygenation-dehydrogenation dual oxidation of a highly reactive poly(beta-carbonyl). The crystal structure of EncM with bound substrate mimics and isotope labelling studies reveal previously unknown flavin redox biochemistry. We show that EncM maintains an unexpected stable flavin-oxygenating species, proposed to be a flavin-N5-oxide, to promote substrate oxidation and trigger a rare Favorskii-type rearrangement that is central to the biosynthesis of the antibiotic enterocin. This work provides new insight into the fine-tuning of the flavin cofactor in offsetting the innate reactivity of a polyketide substrate to direct its efficient electrocyclization.	[Teufel, Robin; Miyanaga, Akimasa; Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Michaudel, Quentin; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Stull, Frederick; Palfey, Bruce] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Louie, Gordon; Noel, Joseph P.] Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Palfey, Bruce] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Scripps Research Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Salk Institute; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Moore, BS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.	bsmoore@ucsd.edu	Noel, Joseph P/A-9459-2009; Michaudel, Quentin/AAE-8261-2020; Miyanaga, Akimasa/C-1472-2015; Michaudel, Quentin/F-1678-2018	Michaudel, Quentin/0000-0002-1791-9174; Miyanaga, Akimasa/0000-0003-2219-6051; Michaudel, Quentin/0000-0002-1791-9174; Teufel, Robin/0000-0001-5863-7248; Stull, Frederick/0000-0002-2969-4224; Moore, Bradley/0000-0002-4652-1253; Palfey, Bruce/0000-0001-5098-259X	US National Institutes of Health [R01AI47818]; National Science Foundation (NSF) [EEC-0813570, MCB-0645794, CHE-1213620]; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft [TE 931/1-1]; Japan Society for the Promotion of Science [21-644]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047818] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Bowman for technical assistance; Y. Su for mass spectrometric measurements; D.-H. Huang and L. Pasternack for NMR spectroscopic assistance; A. Rheingold for X-ray crystallographic analysis; and C. Hertweck for establishing the synthesis of 26. This research was supported by US National Institutes of Health grant R01AI47818 to B.S.M., National Science Foundation (NSF) awards EEC-0813570 and MCB-0645794 and the Howard Hughes Medical Institute for grants to J.P.N., NSF grant CHE-1213620 to B.P., and fellowships to R.T. from the Deutsche Forschungsgemeinschaft (TE 931/1-1) and to A.M. from the Japan Society for the Promotion of Science (21-644).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baumann K, 2004, TETRAHEDRON LETT, V45, P549, DOI 10.1016/j.tetlet.2003.10.199; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Cheng Q, 2007, NAT CHEM BIOL, V3, P557, DOI 10.1038/nchembio.2007.22; Crosby J, 2012, NAT PROD REP, V29, P1111, DOI 10.1039/c2np20062g; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENTSCH B, 1989, BIOCHIM BIOPHYS ACTA, V999, P313, DOI 10.1016/0167-4838(89)90014-9; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; Garman EF, 2006, ACTA CRYSTALLOGR D, V62, P32, DOI 10.1107/S0907444905034207; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han L, 1998, J BACTERIOL, V180, P4481, DOI 10.1128/JB.180.17.4481-4486.1998; Hertweck C, 2004, CHEM BIOL, V11, P461, DOI 10.1016/j.chembiol.2004.03.018; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Izumikawa W, 2006, J AM CHEM SOC, V128, P1428, DOI 10.1021/ja0559707; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kalaitzis JA, 2003, J AM CHEM SOC, V125, P9290, DOI 10.1021/ja035973o; Koetter JWA, 2005, J MOL BIOL, V352, P418, DOI 10.1016/j.jmb.2005.07.041; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ORF HW, 1974, P NATL ACAD SCI USA, V71, P2646, DOI 10.1073/pnas.71.7.2646; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Piel J, 2000, CHEM BIOL, V7, P943, DOI 10.1016/S1074-5521(00)00044-2; RASTETTER WH, 1979, J AM CHEM SOC, V101, P2228, DOI 10.1021/ja00502a063; SETO H, 1976, TETRAHEDRON LETT, P4367; Takikawa H, 2008, ANGEW CHEM INT EDIT, V47, P7446, DOI 10.1002/anie.200801586; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; WALSH C, 1978, BIOCHEMISTRY-US, V17, P1942, DOI 10.1021/bi00603a022; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Xiang L, 2004, P NATL ACAD SCI USA, V101, P15609, DOI 10.1073/pnas.0405508101	40	102	102	6	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					552	+		10.1038/nature12643	http://dx.doi.org/10.1038/nature12643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24162851	Green Accepted			2022-12-28	WOS:000327464200049
J	Stieglitz, B; Rana, RR; Koliopoulos, MG; Morris-Davies, AC; Schaeffer, V; Christodoulou, E; Howell, S; Brown, NR; Dikic, I; Rittinger, K				Stieglitz, Benjamin; Rana, Rohini R.; Koliopoulos, Marios G.; Morris-Davies, Aylin C.; Schaeffer, Veronique; Christodoulou, Evangelos; Howell, Steven; Brown, Nicholas R.; Dikic, Ivan; Rittinger, Katrin			Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP	NATURE			English	Article							RING DOMAIN; E3 LIGASE; REVEALS; PARKIN; MECHANISM; PROTEIN; INSIGHTS; SHARPIN; FAMILY; HHARI	Linear ubiquitin chains are important regulators of cellular signalling pathways that control innate immunity and inflammation through nuclear factor (NF)-kappa B activation and protection against tumour necrosis factor-alpha-induced apoptosis(1-5). They are synthesized by HOIP, which belongs to the RBR (RING-between-RING) family of E3 ligases and is the catalytic component of LUBAC (linear ubiquitin chain assembly complex), a multisubunit E3 ligase(6). RBR family members act as RING/HECT hybrids, employing RING1 to recognize ubiquitin-loaded E2 while a conserved cysteine in RING2 subsequently forms a thioester intermediate with the transferred or 'donor' ubiquitin(7). Here we report the crystal structure of the catalytic core of HOIP in its apo form and in complex with ubiquitin. The carboxy-terminal portion of HOIP adopts a novel fold that, together with a zinc-finger, forms a ubiquitin-binding platform that orients the acceptor ubiquitin and positions its alpha-amino group for nucleophilic attack on the E3 similar to ubiquitin thioester. The C-terminal tail of a second ubiquitin molecule is located in close proximity to the catalytic cysteine, providing a unique snapshot of the ubiquitin transfer complex containing both donor and acceptor ubiquitin. These interactions are required for activation of the NF-kappa B pathway in vivo, and they explain the determinants of linear ubiquitin chain specificity by LUBAC.	[Stieglitz, Benjamin; Rana, Rohini R.; Koliopoulos, Marios G.; Morris-Davies, Aylin C.; Christodoulou, Evangelos; Howell, Steven; Brown, Nicholas R.; Rittinger, Katrin] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Schaeffer, Veronique; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Main, Germany	MRC National Institute for Medical Research; Goethe University Frankfurt	Rittinger, K (corresponding author), Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England.	katrin.rittinger@nimr.mrc.ac.uk	Rittinger, Katrin/D-2586-2014; Rittinger, Katrin/N-3344-2019; Stieglitz, Benjamin/AAY-4140-2020; Dikic, Ivan/O-4650-2015	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435; Stieglitz, Benjamin/0000-0003-3634-6997; Dikic, Ivan/0000-0001-8156-9511; Schaeffer, Veronique/0000-0002-2564-9012; Koliopoulos, Marios/0000-0002-9535-1529; Christodoulou, Evangelos/0000-0001-8464-1558	Medical Research Council [U117565398]; Wellcome Foundation [094112/Z/10/Z]; European Research Council (ERC) under the European Union; ERC [250241-LineUb]; Medical Research Council [MC_U117565398] Funding Source: researchfish; MRC [MC_U117565398] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Foundation; European Research Council (ERC) under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Strekopytov for inductively coupled plasma mass spectrometry experiments, I. Taylor for help with analytical ultracentrifugation, L. Haire for help with crystallization, S. Martin for circular dichroism spectroscopy, S. Caswell for help with cloning, C. Bayart for technical assistance, P. Walker for data collection, S. Smerdon for discussions and advice, and the Diamond Light Source for synchrotron access. This work was supported by the Medical Research Council (grant U117565398) and the Wellcome Foundation (grant 094112/Z/10/Z) to K.R., and the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) and ERC grant agreement 250241-LineUb to I.D.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Raasi Shahri, 2005, V301, P47; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	37	137	141	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					422	+		10.1038/nature12638	http://dx.doi.org/10.1038/nature12638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24141947	Green Accepted, Green Submitted			2022-12-28	WOS:000327163200047
J	Kasowski, M; Kyriazopoulou-Panagiotopoulou, S; Grubert, F; Zaugg, JB; Kundaje, A; Liu, YL; Boyle, AP; Zhang, QC; Zakharia, F; Spacek, DV; Li, JJ; Xie, D; Olarerin-George, A; Steinmetz, LM; Hogenesch, JB; Kellis, M; Batzoglou, S; Snyder, M				Kasowski, Maya; Kyriazopoulou-Panagiotopoulou, Sofia; Grubert, Fabian; Zaugg, Judith B.; Kundaje, Anshul; Liu, Yuling; Boyle, Alan P.; Zhang, Qiangfeng Cliff; Zakharia, Fouad; Spacek, Damek V.; Li, Jingjing; Xie, Dan; Olarerin-George, Anthony; Steinmetz, Lars M.; Hogenesch, John B.; Kellis, Manolis; Batzoglou, Serafim; Snyder, Michael			Extensive Variation in Chromatin States Across Humans	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTOR-BINDING; HUMAN GENE-EXPRESSION; DISEASES; TRAITS; YEAST	The majority of disease-associated variants lie outside protein-coding regions, suggesting a link between variation in regulatory regions and disease predisposition. We studied differences in chromatin states using five histone modifications, cohesin, and CTCF in lymphoblastoid lines from 19 individuals of diverse ancestry. We found extensive signal variation in regulatory regions, which often switch between active and repressed states across individuals. Enhancer activity is particularly diverse among individuals, whereas gene expression remains relatively stable. Chromatin variability shows genetic inheritance in trios, correlates with genetic variation and population divergence, and is associated with disruptions of transcription factor binding motifs. Overall, our results provide insights into chromatin variation among humans.	[Kasowski, Maya; Grubert, Fabian; Zaugg, Judith B.; Kundaje, Anshul; Boyle, Alan P.; Zhang, Qiangfeng Cliff; Zakharia, Fouad; Spacek, Damek V.; Li, Jingjing; Xie, Dan; Steinmetz, Lars M.; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Kasowski, Maya] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Kyriazopoulou-Panagiotopoulou, Sofia; Kundaje, Anshul; Batzoglou, Serafim] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Kundaje, Anshul; Kellis, Manolis] MIT, Dept Comp Sci, Cambridge, MA 02139 USA; [Kundaje, Anshul; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Olarerin-George, Anthony; Hogenesch, John B.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Liu, Yuling] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Yale University; Stanford University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Pennsylvania; European Molecular Biology Laboratory (EMBL); Stanford University	Snyder, M (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Kundaje, Anshul/Y-2739-2019; Kellis, Manolis/ABE-7385-2020; Zhang, Qiangfeng/C-2902-2011; Li, Jingjing/B-5136-2016; Kundaje, Anshul/Y-2598-2019; Boyle, Alan/I-1848-2014	Kundaje, Anshul/0000-0003-3084-2287; Kellis, Manolis/0000-0001-7113-9630; Li, Jingjing/0000-0001-6025-9522; Kundaje, Anshul/0000-0003-3084-2287; Boyle, Alan/0000-0002-2081-1105; Snyder, Michael/0000-0003-0784-7987; Olarerin-George, Anthony/0000-0002-6109-3824; Steinmetz, Lars/0000-0002-3962-2865; Zaugg, Judith B./0000-0001-8324-4040	NIH; Genetics Department, Stanford University; Vera Moulton Wall Center for Pulmonary Vascular Disease; NIH MSTP TG [T32GM07205]; Siebel Scholars Foundation; KAUST-Stanford Academic Excellence Alliance program; Swiss National Foundation; Janggen-Poehn Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, R01HG004037, K99HG007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; Direct For Biological Sciences [0644282] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics Department, Stanford University; Vera Moulton Wall Center for Pulmonary Vascular Disease; NIH MSTP TG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siebel Scholars Foundation; KAUST-Stanford Academic Excellence Alliance program; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Janggen-Poehn Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by grants from the NIH and Genetics Department, Stanford University, Vera Moulton Wall Center for Pulmonary Vascular Disease and NIH MSTP TG T32GM07205 (M. K.), the Siebel Scholars Foundation (S.-K.P.), the KAUST-Stanford Academic Excellence Alliance program (S.-K.P. and S. B.), the Swiss National Foundation, and the Janggen-Poehn Foundation (J.B.Z.). Data sets are available at the Gene Expression Omnibus (GEO) database with accession no. GSE50893. We thank S. Montgomery, W. Huber, C. Bustamante, H. Tang, S. Anders, G. Euskirchen, B. Altshuler, M. Eaton, and L. Ward. M. S. is a founder and member of the science advisory board for Personalis and a science advisory board member for Genapsys and AxioMx. S. B. is a founder and advisor for DNAnexus and serves on the advisory boards of 23andMe and Eve Biomedical. Genotype calls and BAM files with mapped sequencing reads for the San individuals are available through a data access agreement for transfer of genetic data by contacting M.S.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duan SW, 2008, BIOINFORMATION, V3, P139, DOI 10.6026/97320630003139; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	20	251	254	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					750	752		10.1126/science.1242510	http://dx.doi.org/10.1126/science.1242510			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24136358	Green Accepted, Green Submitted			2022-12-28	WOS:000326647600047
J	Bird, ST; Delaney, JAC; Brophy, JM; Etminan, M; Skeldon, SC; Hartzema, AG				Bird, Steven T.; Delaney, Joseph A. C.; Brophy, James M.; Etminan, Mahyar; Skeldon, Sean C.; Hartzema, Abraham G.			Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED CASE SERIES; URINARY-TRACT SYMPTOMS; BLOCKERS; SAFETY	Objective To characterize risk of hypotension requiring admission to hospital in middle aged and older men treated with tamsulosin for benign prostatic hyperplasia. Design Population based retrospective cohort study (between patient methodology) and self controlled case series (within patient methodology). Setting Healthcare claims data from the IMS Lifelink database in the United States. Participants Men aged 40-85 years with private US healthcare insurance entering the cohort at their first dispensing for tamsulosin or for a 5a reductase inhibitor (5ARI) between January 2001 and June 2011 after a minimum of six months' enrolment. Main outcomes measures Hypotension requiring admission to hospital. Cox proportional hazards models estimated rate ratios at time varying intervals during follow-up: weeks 1-4, 5-8, and 9-12 after tamsulosin initiation; weeks 1-4, 5-8, and 9-12 after restarting tamsulosin (after a four week gap); and maintenance tamsulosin treatment (remaining exposed person time). Covariates included age, calendar year, demographics, antihypertensive use, healthcare use, and a Charlson comorbidity score. A self controlled case series, having implicit control for time invariant covariates, was additionally conducted. Results Among 383 567 new users of study drugs (tamsulosin 297 596; 5ARI 85 971), 2562 admissions to hospital for severe hypotension were identified. The incidence for hypotension was higher for tamsulosin (42.4 events per 10 000 person years) than for 5ARIs (31.3 events per 10 000 person years) or all accrued person time (29.1 events per 10 000 person years). After tamsulosin initiation, the cohort analysis identified an increased rate of hypotension during weeks 1-4 (rate ratio 2.12 (95% confidence interval 1.29 to 3.04)) and 5-8 (1.51 (1.04 to 2.18)), and no significant increase at weeks 9-12. The rate ratio for hypotension also increased at weeks 1-4 (1.84 (1.46 to 2.33)) and 5-8 (1.85 (1.45 to 2.36)) after restarting tamsulosin, as did maintenance tamsulosin treatment (1.19 (1.07 to 1.32)). The self controlled case series gave similar results as the cohort analysis. Conclusions We observed a temporal association between tamsulosin use for benign prostatic hyperplasia and severe hypotension during the first eight weeks after initiating treatment and the first eight weeks after restarting treatment. This association suggests that physicians should focus on improving counseling strategies to warn patients regarding the "first dose phenomenon" with tamsulosin.	[Bird, Steven T.] US FDA, Ctr Drug Evaluat & Res, Off Surveillance & Epidemiol, Dept Epidemiol, Silver Spring, MD USA; [Bird, Steven T.; Hartzema, Abraham G.] Univ Florida, Coll Pharm & Epidemiol Pharmaceut Outcomes & Poli, Gainesville, FL USA; [Delaney, Joseph A. C.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Brophy, James M.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Etminan, Mahyar] Univ British Columbia, Fac Med, Therapeut Evaluat Unit, Prov Hlth Serv Author, Vancouver, BC V5Z 1M9, Canada; [Skeldon, Sean C.] Univ Toronto, Dept Surg, Div Urol, Toronto, ON, Canada; [Skeldon, Sean C.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	US Food & Drug Administration (FDA); State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; McGill University; Royal Victoria Hospital; University of British Columbia; University of Toronto; University of British Columbia	Etminan, M (corresponding author), Univ British Columbia, Fac Med, Therapeut Evaluat Unit, Prov Hlth Serv Author, Vancouver, BC V5Z 1M9, Canada.	metminan@popi.ubc.ca	Delaney, Joseph A/J-8204-2019; brophy, james/H-6673-2019	Delaney, Joseph A/0000-0003-1771-1776; brophy, james/0000-0001-8049-6875	McGill University Health Center; Fonds de la Recherche en Sante du Quebec; Ministere de la Sante et des Services Sociaux	McGill University Health Center; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Ministere de la Sante et des Services Sociaux	This work was funded in part by the McGill University Health Center, Fonds de la Recherche en Sante du Quebec, and the Ministere de la Sante et des Services Sociaux. The authors had full autonomy in the study design; the collection, analysis, and interpretation of data; the writing of the article; and the decision to submit it for publication. The authors have no other conflicts or competing interests to declare. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure. pdf and declare: support from the McGill University Health Center, Fonds de la Recherche en Sante du Quebec, and the Ministere de la Sante et des Services Sociaux for the submitted work; JMB has received peer review financial support from le Fonds de la Recherche en Sante du Quebec, JACD has a research grant from the Agency for Healthcare Research and Quality, AGH is a principal investigator for the Observational Medical Outcomes Partnership, a private-public partnership designed to help improve drug safety monitoring, and STB is employed by the US Food and Drug Administration; no other relationships or activities that could appear to have influenced the submitted work.	American Urological Association, 2010, MAN BEN PROST HYP BP; [Anonymous], 1997, 20579 NDA FOOD DRUG; BENDALL MJ, 1975, BRIT MED J, V2, P727, DOI 10.1136/bmj.2.5973.727-a; Bird ST, 2013, CAN MED ASSOC J, V185, pE475, DOI 10.1503/cmaj.121730; Black L, 2006, AM J MANAG CARE, V12, pS99; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Douglas IJ, 2013, BMJ-BRIT MED J, V346, P1936; Farrington CP, 2006, J R STAT SOC C-APPL, V55, P553, DOI 10.1111/j.1467-9876.2006.00554.x; Farrington CP, 2011, J AM STAT ASSOC, V106, P417, DOI 10.1198/jasa.2011.ap10108; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; FORRAY C, 1994, MOL PHARMACOL, V45, P703; IMS Health, 2010, LIFELINK HLTH PLAN C; Jacobsen SJ, 2008, JAMA-J AM MED ASSOC, V300, P1660, DOI 10.1001/jama.300.14.1660; Jick SS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2151; Maclure M, 2012, PHARMACOEPIDEM DR S, V21, P50, DOI 10.1002/pds.2330; NASH DT, 1990, CLIN CARDIOL, V13, P764, DOI 10.1002/clc.4960131104; Parsons JK, 2009, BJU INT, V104, P63, DOI 10.1111/j.1464-410X.2008.08317.x; Pfizer Pharmaceuticals, 2010, CARD PACK INS; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Provider Synergies, 2010, BEN PROST HYP BPH TR; Stafford RS, 2004, JAMA-J AM MED ASSOC, V291, P54, DOI 10.1001/jama.291.1.54; Whitaker HJ, 2007, ENVIRONMETRICS, V18, P157, DOI 10.1002/env.809; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; Wilt T, 2002, COCHRANE DB SYST REV, V4; Winterstein AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4627; Wright AJ, 2011, CAN MED ASSOC J, V183, P303, DOI 10.1503/cmaj.100702; Yoshimura K, 2013, INT J MED SCI, V10, P864, DOI 10.7150/ijms.5892	29	48	50	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2013	347								f6320	10.1136/bmj.f6320	http://dx.doi.org/10.1136/bmj.f6320			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XL	24192967	hybrid, Green Published			2022-12-28	WOS:000326890000002
J	MacAuley, Y; O'Donnell, P; Duncan, HF				MacAuley, Yvonne; O'Donnell, Patrick; Duncan, Henry F.			Dental pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[MacAuley, Yvonne] Dublin Dent Univ Hosp, Dublin 2, Ireland; [O'Donnell, Patrick] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Duncan, Henry F.] Univ Dublin Trinity Coll, Dublin Dent Univ Hosp, Div Restorat Dent & Periodontol, Dublin 2, Ireland	Trinity College Dublin; University of Limerick; Trinity College Dublin	MacAuley, Y (corresponding author), Dublin Dent Univ Hosp, Lincoln Pl, Dublin 2, Ireland.	yvonne.macauley@hotmail.com	Duncan, Henry/ABD-7085-2021; Vieyra, Jorge JPV Paredes/B-8945-2014	Duncan, Henry/0000-0001-8690-2379; Vieyra, Jorge JPV Paredes/0000-0003-2168-3405; O'Donnell, Patrick/0000-0001-7710-7832				Ellison SJ, 2011, BRIT DENT J, V211, P591, DOI 10.1038/sj.bdj.2011.1051; Joint Formulary Committee: British Medical Association Royal Pharmaceutical Society of Great Britain, 2012, BRIT NATL FORMULARY; Martin MV, 2010, FAC DENT J, V1, P15; Matthews Debora C, 2003, J Can Dent Assoc, V69, P660; National Institute for Health and Care Excellence, 2012, CLIN KNOWL SUMM DENT; Robertson D, 2009, J MED MICROBIOL, V58, P155, DOI 10.1099/jmm.0.003517-0	6	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2013	347								f6539	10.1136/bmj.f6539	http://dx.doi.org/10.1136/bmj.f6539			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XL	24192969				2022-12-28	WOS:000326890000004
J	Samieri, C; Sun, Q; Townsend, MK; Chiuve, SE; Okereke, OI; Willett, WC; Stampfer, M; Grodstein, F				Samieri, Cecilia; Sun, Qi; Townsend, Mary K.; Chiuve, Stephanie E.; Okereke, Olivia I.; Willett, Walter C.; Stampfer, Meir; Grodstein, Francine			The Association Between Dietary Patterns at Midlife and Health in Aging. An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							GUIDELINES-FOR-AMERICANS; EATING INDEX-2005 SCORES; CORONARY-HEART-DISEASE; MAJOR CHRONIC DISEASE; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; TOBACCO-SMOKE; OLDER PERSONS; AGE 70	Background: Maintaining health and well-being in aging populations is critical. Objective: To examine the association between dietary patterns in midlife and prevalence of healthy aging. Design: Cross-sectional observational study. Setting: Nurses' Health Study. Participants: 10 670 women with dietary data and no major chronic diseases between 1984 and 1986, when they were in their late 505 and early 60s (median age, 59 years). Women provided information on health an average of 15 years later. Measurements: Diet quality in midlife was ascertained using the Alternative Healthy Eating Index-2010 (AHEI-2010) and Alternate Mediterranean diet scores, averaged from 2 food-frequency questionnaires (1984 to 1986). "Healthy" aging was defined as survival to 70 years or older with maintenance of 4 health domains: no major chronic diseases or major impairments in cognitive or physical function or mental health. Results: After multivariable adjustment, greater adherence to the AHEI-2010 (upper vs. lower quintiles) in midlife was related to 34% (95% CI, 9% to 66%; P for trend < 0.001) greater odds of healthy versus usual aging. Greater adherence to Alternate Mediterranean diet was related to 46% (CI, 17% to 83%; P for trend = 0.002) greater odds of healthy aging. When the 4 components of healthy aging were analyzed separately, the AHEI-2010 and Alternate Mediterranean diet were significantly associated with greater likelihood of no major limitations in physical function and mental health. Limitations:. Residual confounding was possible, although many confounding factors were considered. Bias due to complex patterns of measurement error within diet scores cannot be excluded. Conclusion: Better diet quality at midlife seems to be strongly linked to greater health and well-being in persons surviving to older ages.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; INSERM, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; Univ Bordeaux, Bordeaux, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Samieri, C (corresponding author), Univ Bordeaux Segalen, Inst Sante Publ & Dev, Case 11,146 Rue Leo Saignat, F-33076 Bordeaux, France.	cecilia.samieri@channing.harvard.edu	Okereke, Olivia I/R-9934-2016; Okereke, Olivia/AAF-7031-2021; Samieri, Cecilia/T-3267-2019; Samieri, Cécilia/E-3334-2014	Samieri, Cecilia/0000-0001-9809-7506; Samieri, Cécilia/0000-0001-9809-7506	National Cancer Institute [P01 CA87969]; PRES Universite de Bordeaux; National Institutes of Health [K08 AG 029813]; National Heart, Lung, and Blood Institute [R00HL098459]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, K08AG029813] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PRES Universite de Bordeaux; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Cancer Institute (P01 CA87969). Dr. Samieri was supported by a Fulbrighi Research Scholar award and a grant from the PRES Universite de Bordeaux. Dr. Okereke was supported by the National Institutes of Health (K08 AG 029813). Dr. Sun was supported by the National Heart, Lung, and Blood Institute (R00HL098459).	Akbaraly TN, 2011, AM J CLIN NUTR, V94, P247, DOI 10.3945/ajcn.111.013128; Al-Delaimy WK, 2002, CANCER EPIDEM BIOMAR, V11, P1400; Alonso A, 2008, ACTA NEUROL SCAND, V117, P15, DOI 10.1111/j.1600-0404.2007.00898.x; Barr RG, 2002, AM J EPIDEMIOL, V155, P965, DOI 10.1093/aje/155.10.965; Belin RJ, 2011, AM J CLIN NUTR, V94, P49, DOI 10.3945/ajcn.110.011221; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Brandt J., 1988, NEUROPSY NEUROPSY BE, V1, P111; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P101; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Feart C, 2011, EUR J EPIDEMIOL, V26, P747, DOI 10.1007/s10654-011-9611-4; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Fogli-Cawley JJ, 2007, AM J CLIN NUTR, V86, P1193, DOI 10.1093/ajcn/86.4.1193; Fogli-Cawley JJ, 2007, DIABETES CARE, V30, P817, DOI 10.2337/dc06-1927; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford ES, 2012, PREV MED, V55, P23, DOI 10.1016/j.ypmed.2012.04.016; Friedman B, 2005, J AM GERIATR SOC, V53, P1978, DOI 10.1111/j.1532-5415.2005.00469.x; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Fung TT, 2010, AM J CLIN NUTR, V92, P1429, DOI 10.3945/ajcn.2010.29242; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Guenther PM, 2008, J AM DIET ASSOC, V108, P1896, DOI 10.1016/j.jada.2008.08.016; Imamura F, 2009, AM J CLIN NUTR, V90, P193, DOI 10.3945/ajcn.2009.27576; Kuczmarski MF, 2010, J AM DIET ASSOC, V110, P383, DOI 10.1016/j.jada.2009.11.025; McCullough ML, 2000, AM J CLIN NUTR, V72, P1223; McCullough ML, 2000, AM J CLIN NUTR, V72, P1214; Milaneschi Y, 2011, EXP GERONTOL, V46, P303, DOI 10.1016/j.exger.2010.11.030; Panagiotakos D, 2009, NUTR METAB CARDIOVAS, V19, P253, DOI 10.1016/j.numecd.2008.06.005; Psaltopoulou T, 2013, ANN NEUROL; Rathod AD, 2012, ARCH INTERN MED, V172, P275, DOI 10.1001/archinternmed.2011.1031; RIBOLI E, 1995, EUR RESPIR J, V8, P285, DOI 10.1183/09031936.95.08020285; Russell J, 2012, BR J NUTR, P1; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Shahar DR, 2012, J AM GERIATR SOC, V60, P1881, DOI 10.1111/j.1532-5415.2012.04167.x; Skov T, 1998, INT J EPIDEMIOL, V27, P91, DOI 10.1093/ije/27.1.91; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Stampfer MJ, 2005, NEW ENGL J MED, V352, P245, DOI 10.1056/NEJMoa041152; Sun Q, 2007, CIRCULATION, V115, P1858, DOI 10.1161/CIRCULATIONAHA.106.679985; Sun Q, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001090; Sun Q, 2010, ARCH INTERN MED, V170, P194, DOI 10.1001/archinternmed.2009.503; Sun Q, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3796; Tangney CC, 2011, AM J CLIN NUTR, V93, P601, DOI 10.3945/ajcn.110.007369; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Ware JE, 1993, SF36 HLTH SURVEY MAN; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Willett W, 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Xu BB, 2012, AGE AGEING, V41, P365, DOI 10.1093/ageing/afr158; Xu BB, 2012, J GERONTOL A-BIOL, V67, P93, DOI 10.1093/gerona/glr159	50	86	88	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					584	591		10.7326/0003-4819-159-9-201311050-00004	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249HX	24189593	Green Accepted			2022-12-28	WOS:000326769400002
J	Mayer, KH				Mayer, Kenneth H.			Thinking about an AIDS end game	LANCET			English	Editorial Material							HIV-1 INFECTION; PREVENTION; MEN		Fenway Hlth, Fenway Inst, Boston, MA 02118 USA	Fenway Health	Mayer, KH (corresponding author), Fenway Hlth, Fenway Inst, Boston, MA 02118 USA.	khmayer@gmail.com						Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dubin C, 2013, TRANSFUSION, V53, P2359, DOI 10.1111/trf.12374; Ghoshal N., 2013, HUMAN RIGHTS WATCH; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; GROOPMAN JE, 1985, ANN INTERN MED, V102, P334, DOI 10.7326/0003-4819-102-3-334; Henrich T, 2013, 7TH IAS CONFERENCE O; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Persaud D., 2013, SATELLITE OF THE INT; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Sullivan, 1996, NEW YORK TIMES MAGAZ; UNAIDS, 2013, DATA AND ANALYSIS	13	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1462	1464		10.1016/S0140-6736(13)62029-2	http://dx.doi.org/10.1016/S0140-6736(13)62029-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	24182528				2022-12-28	WOS:000326622500005
J	Gut, P; Verdin, E				Gut, Philipp; Verdin, Eric			The nexus of chromatin regulation and intermediary metabolism	NATURE			English	Review							BETA-N-ACETYLGLUCOSAMINE; FATTY-ACID OXIDATION; GENE-EXPRESSION; HISTONE ACETYLATION; CALORIE RESTRICTION; PROTEIN ACYLATION; LIFE-SPAN; O-GLCNAC; EPIGENETICS; SIRT1	Living organisms and individual cells continuously adapt to changes in their environment. Those changes are particularly sensitive to fluctuations in the availability of energy substrates. The cellular transcriptional machinery and its chromatin-associated proteins integrate environmental inputs to mediate homeostatic responses through gene regulation. Numerous connections between products of intermediary metabolism and chromatin proteins have recently been identified. Chromatin modifications that occur in response to metabolic signals are dynamic or stable and might even be inherited transgenerationally. These emerging concepts have biological relevance to tissue homeostasis, disease and ageing.	[Gut, Philipp; Verdin, Eric] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94941 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Verdin, E (corresponding author), Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94941 USA.	everdin@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Gut, Philipp/0000-0002-0689-9518; Verdin, Eric/0000-0003-3703-3183	Gladstone Institutes	Gladstone Institutes(University of California System)	We thank J. Carroll for graphics, G. Howard and A.-L. Lucido for editorial assistance, V. Fonseca and P. Cruz for administrative assistance. The authors are supported by funds from the Gladstone Institutes.	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Barres R, 2013, CELL REP, V3, P1020, DOI 10.1016/j.celrep.2013.03.018; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; BIRD AP, 1993, COLD SPRING HARB SYM, V58, P281, DOI 10.1101/SQB.1993.058.01.033; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Comalada M, 2006, J CANCER RES CLIN, V132, P487, DOI 10.1007/s00432-006-0092-x; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Osta A, 2012, CURR OPIN LIPIDOL, V23, P24, DOI 10.1097/MOL.0b013e32834f319d; Ellis JM, 2012, CHEM BIOL, V19, P1333, DOI 10.1016/j.chembiol.2012.08.018; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Gut P, 2013, CELL METAB, V17, P635, DOI 10.1016/j.cmet.2013.04.016; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim YS, 2007, J NUTR, V137, p2576S, DOI 10.1093/jn/137.11.2576S; Kirchner H, 2013, TRENDS CELL BIOL, V23, P203, DOI 10.1016/j.tcb.2012.11.008; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Ladurner AG, 2006, MOL CELL, V24, P1, DOI 10.1016/j.molcel.2006.09.002; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Patti ME, 2013, CELL MOL LIFE SCI, V70, P1597, DOI 10.1007/s00018-013-1298-0; Pirola L, 2011, GENOME RES, V21, P1601, DOI 10.1101/gr.116095.110; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Sassone-Corsi P, 2012, ENDOCRINOLOGY, V153, P1, DOI 10.1210/en.2011-1535; Shi YJ, 2004, TRENDS GENET, V20, P445, DOI 10.1016/j.tig.2004.07.004; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Stein AD, 2007, AM J CLIN NUTR, V85, P869, DOI 10.1093/ajcn/85.3.869; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Zhang QH, 2002, SCIENCE, V295, P1895	116	268	274	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					489	498		10.1038/nature12752	http://dx.doi.org/10.1038/nature12752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153302				2022-12-28	WOS:000325988400043
J	Wu, HY; Huang, JW; Lin, HJ; Liao, WC; Peng, YS; Hung, KY; Wu, KD; Tu, YK; Chien, KL				Wu, Hon-Yen; Huang, Jenq-Wen; Lin, Hung-Ju; Liao, Wei-Chih; Peng, Yu-Sen; Hung, Kuan-Yu; Wu, Kwan-Dun; Tu, Yu-Kang; Chien, Kuo-Liong			Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR OUTCOMES; RECEPTOR BLOCKERS; RENAL OUTCOMES; CONTROLLED-TRIAL; INCREASE RISK; BETA-BLOCKERS; DOUBLE-BLIND; HYPERTENSION; COMBINATION; PLACEBO	Objective To assess the effects of different classes of antihypertensive treatments, including monotherapy and combination therapy, on survival and major renal outcomes in patients with diabetes. Design Systematic review and bayesian network meta-analysis of randomised clinical trials. Data sources Electronic literature search of PubMed, Medline, Scopus, and the Cochrane Library for studies published up to December 2011. Study selection Randomised clinical trials of antihypertensive therapy (angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), a blockers, beta blockers, calcium channel blockers, diuretics, and their combinations) in patients with diabetes with a follow-up of at least 12 months, reporting all cause mortality, requirement for dialysis, or doubling of serum creatinine levels. Data extraction Bayesian network meta-analysis combined direct and indirect evidence to estimate the relative effects between treatments as well as the probabilities of ranking for treatments based on their protective effects. Results 63 trials with 36 917 participants were identified, including 2400 deaths, 766 patients who required dialysis, and 1099 patients whose serum creatinine level had doubled. Compared with placebo, only ACE inhibitors significantly reduced the doubling of serum creatinine levels (odds ratio 0.58, 95% credible interval 0.32 to 0.90), and only beta blockers showed a significant difference in mortality (odds ratio 7.13, 95% credible interval 1.37 to 41.39). Comparisons among all treatments showed no statistical significance in the outcome of dialysis. Although the beneficial effects of ACE inhibitors compared with ARBs did not reach statistical significance, ACE inhibitors consistently showed higher probabilities of being in the superior ranking positions among all three outcomes. Although the protective effect of an ACE inhibitor plus calcium channel blocker compared with placebo was not statistically significant, the treatment ranking identified this combination therapy to have the greatest probability (73.9%) for being the best treatment on reducing mortality, followed by ACE inhibitor plus diuretic (12.5%), ACE inhibitors (2.0%), calcium channel blockers (1.2%), and ARBs (0.4%). Conclusions Our analyses show the renoprotective effects and superiority of using ACE inhibitors in patients with diabetes, and available evidence is not able to show a better effect for ARBs compared with ACE inhibitors. Considering the cost of drugs, our findings support the use of ACE inhibitors as the first line antihypertensive agent in patients with diabetes. Calcium channel blockers might be the preferred treatment in combination with ACE inhibitors if adequate blood pressure control cannot be achieved by ACE inhibitors alone.	[Wu, Hon-Yen; Peng, Yu-Sen] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Wu, Hon-Yen; Huang, Jenq-Wen; Lin, Hung-Ju; Liao, Wei-Chih; Peng, Yu-Sen; Hung, Kuan-Yu; Wu, Kwan-Dun; Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wu, Hon-Yen; Huang, Jenq-Wen; Lin, Hung-Ju; Liao, Wei-Chih; Peng, Yu-Sen; Hung, Kuan-Yu; Wu, Kwan-Dun; Chien, Kuo-Liong] Coll Med, Taipei, Taiwan; [Wu, Hon-Yen; Lin, Hung-Ju; Liao, Wei-Chih; Tu, Yu-Kang; Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Tu, YK (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	yukangtu@ntu.edu.tw; klchien@ntu.edu.tw	peng, yu/GXW-2071-2022	HUNG, KUAN-YU/0000-0003-3472-5512; CHIEN, KUO-LIONG/0000-0003-4979-8351; WU, KWAN-DUN/0000-0002-3339-1509; LIAO, WEI-CHIH/0000-0001-5362-6953; Tu, Yu-Kang/0000-0002-2461-474X; HUANG, JENQ-WEN/0000-0001-8011-2317				Abbate M, 1999, J AM SOC NEPHROL, V10, P804; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 2008, TYP 2 DIAB NAT CLIN; [Anonymous], 2000, LANCET, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7; Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Balamuthusamy S, 2009, AM J THER, V16, P133, DOI 10.1097/MJT.0b013e31817fd87e; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berl T, 2003, ANN INTERN MED, V138, P542, DOI 10.7326/0003-4819-138-7-200304010-00010; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Carlberg B, 2004, LANCET, V364, P1684, DOI 10.1016/S0140-6736(04)17355-8; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cutler JA, 2008, CIRCULATION, V117, P2691, DOI 10.1161/CIRCULATIONAHA.107.709931; de Galan BE, 2009, J AM SOC NEPHROL, V20, P883, DOI 10.1681/ASN.2008070667; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Fogari R, 2002, AM J HYPERTENS, V15, P1042, DOI 10.1016/S0895-7061(02)03017-0; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hartling L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1714; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Imai E, 2011, DIABETOLOGIA, V54, P2978, DOI 10.1007/s00125-011-2325-z; Jamerson KA, 2004, AM J HYPERTENS, V17, P793, DOI 10.1016/j.amjhyper.2004.05.004; Katayama K, 2006, KIDNEY INT, V70, P151, DOI 10.1038/sj.ki.5000349; Klingbeil AU, 2003, AM J MED, V115, P41, DOI 10.1016/S0002-9343(03)00158-X; Kohlmann O, 2009, ADV THER, V26, P313, DOI 10.1007/s12325-009-0015-8; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Levy BI, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000096609.73772.C5; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; LOUTZENHISER R, 1985, AM J PHYSIOL, V249, pF619, DOI 10.1152/ajprenal.1985.249.5.F619; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Lv Y, 2010, BLOOD PRESS MONIT, V15, P195, DOI 10.1097/MBP.0b013e32833a23d4; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; National Clinical Guideline Centre (UK), 2011, HYP CLIN MAN PRIM HY; National Vascular Disease Prevention Alliance (NVDPA), 2012, GUIDELINES MANAGEMEN; Orth SR, 1996, KIDNEY INT, V49, P868, DOI 10.1038/ki.1996.120; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Ram CVS, 2011, VASC HEALTH RISK MAN, V7, P315, DOI 10.2147/VHRM.S15787; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Sarafidis PA, 2008, AM J HYPERTENS, V21, P922, DOI 10.1038/ajh.2008.206; Sciarretta S, 2011, ARCH INTERN MED, V171, P384, DOI 10.1001/archinternmed.2010.427; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Strauss MH, 2006, CIRCULATION, V114, P838, DOI 10.1161/CIRCULATIONAHA.105.594986; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006254; Strippoli GFM, 2005, J AM SOC NEPHROL, V16, P3081, DOI 10.1681/ASN.2004080634; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Tsuyuki RT, 2006, CIRCULATION, V114, P855, DOI 10.1161/CIRCULATIONAHA.105.594978; Tu YK, 2012, J CLIN PERIODONTOL, V39, P303, DOI 10.1111/j.1600-051X.2011.01844.x; van der Valk R, 2009, J CLIN EPIDEMIOL, V62, P1279, DOI 10.1016/j.jclinepi.2008.04.012; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Weber MA, 2010, J AM COLL CARDIOL, V56, P77, DOI 10.1016/j.jacc.2010.02.046; Wiysonge CS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002003.pub2; WRIGHT JM, 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001841.PUB2	62	164	170	1	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2013	347								f6008	10.1136/bmj.f6008	http://dx.doi.org/10.1136/bmj.f6008			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CK	24157497	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000326294000001
J	Pouw, ME; Peelen, LM; Moons, KGM; Kalkman, CJ; Lingsma, HF				Pouw, Maurice E.; Peelen, L. M.; Moons, K. G. M.; Kalkman, C. J.; Lingsma, H. F.			Including post-discharge mortality in calculation of hospital standardised mortality ratios: retrospective analysis of hospital episode statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DATABASE; CARE	Objectives To assess the consequences of applying different mortality timeframes on standardised mortality ratios of individual hospitals and, secondarily, to evaluate the association between in-hospital standardised mortality ratios and early post-discharge mortality rate, length of hospital stay, and transfer rate. Design Retrospective analysis of routinely collected hospital data to compare observed deaths in 50 diagnostic categories with deaths predicted by a case mix adjustment method. Setting 60 Dutch hospitals. Participants 1 228 815 patients discharged in the period 2008 to 2010. Main outcome measures In-hospital standardised mortality ratio, 30 days post-admission standardised mortality ratio, and 30 days post-discharge standardised mortality ratio. Results Compared with the in-hospital standardised mortality ratio, 33% of the hospitals were categorised differently with the 30 days post-admission standardised mortality ratio and 22% were categorised differently with the 30 days post-discharge standardised mortality ratio. A positive association was found between in-hospital standardised mortality ratio and length of hospital stay (Pearson correlation coefficient 0.33; P=0.01), and an inverse association was found between in-hospital standardised mortality ratio and early post-discharge mortality (Pearson correlation coefficient -0.37; P=0.004). Conclusions Applying different mortality timeframes resulted in differences in standardised mortality ratios and differences in judgment regarding the performance of individual hospitals. Furthermore, associations between in-hospital standardised mortality rates, length of stay, and early post-discharge mortality rates were found. Combining these findings suggests that standardised mortality ratios based on in-hospital mortality are subject to so-called "discharge bias." Hence, early post-discharge mortality should be included in the calculation of standardised mortality ratios.	[Pouw, Maurice E.; Kalkman, C. J.] Univ Med Ctr Utrecht, Dept Anesthesiol, NL-3508 GA Utrecht, Netherlands; [Peelen, L. M.; Moons, K. G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Lingsma, H. F.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	Pouw, ME (corresponding author), Univ Med Ctr Utrecht, Dept Anesthesiol, 100,POB 85500, NL-3508 GA Utrecht, Netherlands.	M.Pouw@umcutrecht.nl	Kalkman, Cor/O-3215-2019	Kalkman, Cor/0000-0002-8372-6960				Ben-Tovim D, 2009, MEASURING REPORTING; Borghans I, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-220; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Campbell MJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1001; Canadian Institute for Health Information, 2012, HSMR TECHN NOT; desBruin A., 2004, STAT J UN EC COMM EU, V21, P23; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A., 1993, AHCPR PUBLICATION; Israels A, HSMR 2010 METHODOLOG; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Jarman B, 2010, QUAL SAF HEALTH CARE, V19, P9, DOI 10.1136/qshc.2009.032953; LAWLESS JF, 1978, BIOMETRICS, V34, P318, DOI 10.2307/2530022; Metersky ML, 2012, CHEST, V142, P476, DOI 10.1378/chest.11-2393; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; Pitches DW, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-91; Pouw ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059160; Powell H, 2001, J CLIN EPIDEMIOL, V54, P687, DOI 10.1016/S0895-4356(00)00364-4; Roques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2; Rosenthal GE, 2000, HEALTH SERV RES, V34, P7; Shahian DM, 2010, NEW ENGL J MED, V363, P2530, DOI 10.1056/NEJMsa1006396; Slobbe LCJ, 2008, BMC HEALTH SERV RES, V4, P52; Tu YK, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-185; van den Bosch WF, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-57; van Gestel YRBM, 2012, MED CARE, V50, P662, DOI 10.1097/MLR.0b013e31824ebd9f; Vasilevskis EE, 2009, MED CARE, V47, P803, DOI 10.1097/MLR.0b013e3181a39454; Yu P, 2011, J SURG RES, V170, pE217, DOI 10.1016/j.jss.2011.05.040	26	44	44	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2013	347								f5913	10.1136/bmj.f5913	http://dx.doi.org/10.1136/bmj.f5913			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CF	24144869	Green Published, hybrid			2022-12-28	WOS:000326293500001
J	Brunet, T; Leng, J; Mondain-Monval, O				Brunet, Thomas; Leng, Jacques; Mondain-Monval, Olivier			Soft Acoustic Metamaterials	SCIENCE			English	Editorial Material							SOUND		[Brunet, Thomas] Univ Bordeaux, CNRS, UMR 5295, APy I2M, F-33405 Talence, France; [Leng, Jacques] Univ Bordeaux, CNRS, UMR 5258, Solvay,LOF, F-33608 Pessac, France; [Mondain-Monval, Olivier] Univ Bordeaux, CNRS, UPR 8641, CRPP, F-33600 Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Solvay SA; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Brunet, T (corresponding author), Univ Bordeaux, CNRS, UMR 5295, APy I2M, F-33405 Talence, France.	mondain@crpp-bordeaux.cnrs.fr	Leng, Jacques/E-9726-2011; Brunet, Thomas/O-3658-2015	Brunet, Thomas/0000-0003-1967-3371				[Anonymous], 1831, PHILOS MAG, V9, P384; Brunet T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733615; Ding YQ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093904; Fang N, 2006, NAT MATER, V5, P452, DOI 10.1038/nmat1644; Gokmen MT, 2009, MACROMOLECULES, V42, P9289, DOI 10.1021/ma9018679; GROSS J, 1992, J ACOUST SOC AM, V91, P2004, DOI 10.1121/1.403684; Knowne C. M., 2007, PHYS NEGATIVE REFRAC; Li J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.055602; Liu F, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3593490; Liu ZY, 2000, SCIENCE, V289, P1734, DOI 10.1126/science.289.5485.1734; Lukyanova L, 2013, J APPL POLYM SCI, V128, P3512, DOI 10.1002/app.38411; Mei J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1758; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164; Zhang S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.194301	15	91	93	8	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					323	324		10.1126/science.1241727	http://dx.doi.org/10.1126/science.1241727			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136959				2022-12-28	WOS:000325755100033
J	Chessman, AW				Chessman, Alexander W.			Review: Approved and some off-label preventive drugs reduce migraine frequency in episodic migraine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Chessman, AW (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.								0	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC11	10.7326/0003-4819-159-8-201310150-02011	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126660				2022-12-28	WOS:000326751200010
J	Wejse, C				Wejse, Christian			Point-of-care diagnostics for tuberculosis elimination?	LANCET			English	Editorial Material							XPERT(R) MTB/RIF		[Wejse, Christian] Aarhus Univ, Dept Publ Hlth, Ctr Global Hlth, GloHAU, DK-8000 Aarhus C, Denmark; [Wejse, Christian] INDEPTH Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Wejse, Christian] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Wejse, C (corresponding author), Aarhus Univ, Dept Publ Hlth, Ctr Global Hlth, GloHAU, DK-8000 Aarhus C, Denmark.	wejse@dadlnet.dk	Wejse, Christian/C-8468-2014	Wejse, Christian/0000-0002-2534-2942				[Anonymous], 2011, AUT REAL TIM NUCL AC; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Botha E, 2008, INT J TUBERC LUNG D, V12, P936; Choi HW, 2013, INT J TUBERC LUNG D, V17, P1328, DOI 10.5588/ijtld.13.0095; Hanrahan CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065421; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Rudolf F, 2013, SCAND J INFECT DIS, V45, P256, DOI 10.3109/00365548.2012.731077; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392	12	9	9	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					388	390		10.1016/S0140-6736(13)62003-6	http://dx.doi.org/10.1016/S0140-6736(13)62003-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24176145				2022-12-28	WOS:000330673700007
J	Norris, SL				Norris, Susan L.			My Best Work	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA	Oregon Health & Science University	Norris, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA.	norriss@ohsu.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1801	1802		10.1001/jama.2013.280213	http://dx.doi.org/10.1001/jama.2013.280213			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193076				2022-12-28	WOS:000326550900010
J	Heath, I				Heath, Iona			ESSAY Overdiagnosis: when good intentions meet vested interests-an essay by Iona Heath	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH					iona.heath22@yahoo.co.uk						Allmark P, 2006, J MED ETHICS, V32, P3, DOI 10.1136/jme.2005.011999; Campbell D, 2013, GUARDIAN; Dyer Geoff, 1994, MISSING SOMME; Ebrahim S., 2011, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD001561.PUB3; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Ghosh Amitav, 1996, CALCUTTA CHROMOSOME; Howick J, 2013, THEOR MED BIOETH, V34, P275, DOI 10.1007/s11017-013-9266-0; James William, 1912, WILL BELIEVE OTHER E; Kierkegaard S, 1843, JOURNALS A, VIV A, P164; Lindqvist S, 1997, EXPT ALL BRUTES; Marcuse H., 1964, ONE DIMENSIONAL MAN; MCCORMICK J, 1994, LANCET, V344, P390; METCALFE D, 1986, J ROY COLL GEN PRACT, V36, P349; Popper K.R., 2002, CONJECTURES REFUTATI; Trilling L, 1949, 20 CENTURY INTERPRET; World Health Organization (WHO), GLOB HLTH EXP ATL	16	48	48	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2013	347								f6361	10.1136/bmj.f6361	http://dx.doi.org/10.1136/bmj.f6361			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CM	24162944				2022-12-28	WOS:000326294200009
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN "First do no harm" revisited	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London WC2R 2LS, England	University of London; King's College London	Sokol, DK (corresponding author), Kings Coll London, London WC2R 2LS, England.	daniel.sokol@talk21.com						[Anonymous], 1860, FDN NEW THEORY PRACT; Daniel Michelle, 2012, J Clin Ethics, V23, P331; Gillon R, 1985, PHILOS MED ETHICS; Holmes Oliver Wendell, 1865, CURRENTS COUNTER CUR	4	37	38	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2013	347								f6426	10.1136/bmj.f6426	http://dx.doi.org/10.1136/bmj.f6426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CM	24163087				2022-12-28	WOS:000326294200010
J	de Laat, W; Duboule, D				de Laat, Wouter; Duboule, Denis			Topology of mammalian developmental enhancers and their regulatory landscapes	NATURE			English	Review							GLOBIN LOCUS REQUIRES; GENE-EXPRESSION; CONTROL REGION; SPATIAL-ORGANIZATION; HYPERSENSITIVE SITES; STRUCTURAL VARIATION; TRANSCRIPTION; ELEMENTS; GENOME; LIMB	How a complex animal can arise from a fertilized egg is one of the oldest and most fascinating questions of biology, the answer to which is encoded in the genome. Body shape and organ development, and their integration into a functional organism all depend on the precise expression of genes in space and time. The orchestration of transcription relies mostly on surrounding control sequences such as enhancers, millions of which form complex regulatory landscapes in the non-coding genome. Recent research shows that high-order chromosome structures make an important contribution to enhancer functionality by triggering their physical interactions with target genes.	[de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Duboule, Denis] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	de Laat, W (corresponding author), Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	w.delaat@hubrecht.eu; denis.duboule@epfl.ch		duboule, denis/0000-0001-9961-2960; de Laat, Wouter/0000-0002-6393-595X	Dutch Scientific Organization (NWO) [714012002, 724012003]; EU [2010-259743]; KWF Dutch Cancer Foundation [2009-4459]; NanoNextNL grant; Ecole Polytechnique Federale de Lausanne; University of Geneva; Swiss National Research Foundation; ERC; FP7 program IDEAL	Dutch Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); KWF Dutch Cancer Foundation(KWF Kankerbestrijding); NanoNextNL grant; Ecole Polytechnique Federale de Lausanne; University of Geneva; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission); FP7 program IDEAL	The authors thank Y. Oz for preparing the figures, and G. Geeven, M. Janssen, G. Andrey, L. Beccari, T. Montavon and M. Leleu for their help. The authors' laboratories are supported by funds from the Dutch Scientific Organization (NWO) (714012002 and 724012003 (VICI)), EU grant 2010-259743 (MODHEP), a KWF Dutch Cancer Foundation grant (2009-4459) and a NanoNextNL grant (to W.dL) and the Ecole Polytechnique Federale de Lausanne, the University of Geneva, the Swiss National Research Foundation, the ERC grant SystemsHox.ch and the FP7 program IDEAL (to D.D.).	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bender MA, 2006, BLOOD, V108, P1395, DOI 10.1182/blood-2006-04-014431; Bender MA, 2001, BLOOD, V98, P2022, DOI 10.1182/blood.V98.7.2022; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cajiao I, 2004, EMBO J, V23, P3854, DOI 10.1038/sj.emboj.7600365; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Duboule D, 1998, TRENDS GENET, V14, P54, DOI 10.1016/S0168-9525(97)01358-9; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eijkelenboom A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.74; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Gaetz J, 2012, CELL RES, V22, P848, DOI 10.1038/cr.2011.190; Gorkin DU, 2012, GENOME RES, V22, P2290, DOI 10.1101/gr.139360.112; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kleinjan Dirk-Jan, 2009, Briefings in Functional Genomics & Proteomics, V8, P317, DOI 10.1093/bfgp/elp022; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2012, DEV CELL, V22, P459, DOI 10.1016/j.devcel.2011.12.010; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lower KM, 2009, P NATL ACAD SCI USA, V106, P21771, DOI 10.1073/pnas.0909331106; Maeda RK, 2011, CURR OPIN GENET DEV, V21, P187, DOI 10.1016/j.gde.2011.01.021; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Montavon T, 2012, TRENDS CELL BIOL, V22, P347, DOI 10.1016/j.tcb.2012.04.003; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Noordermeer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000016; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Nora E. P., 2013, BIOESSAYS, V5; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ohno S., 1970, EVOLUTION GENE DUPLI; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stamatoyannopoulos JA, 2012, GENOME RES, V22, P1602, DOI 10.1101/gr.146506.112; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tschopp P, 2011, P NATL ACAD SCI USA, V108, P10632, DOI 10.1073/pnas.1102985108; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	76	331	339	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					499	506		10.1038/nature12753	http://dx.doi.org/10.1038/nature12753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153303				2022-12-28	WOS:000325988400044
J	Marouf, F; Giallourakis, CC; Baer, L; Hanau, MS; Holbert, BC				Marouf, Feyza; Giallourakis, Cosmas C.; Baer, Lee; Hanau, Michael S.; Holbert, Barbara C.			Case 33-2013: A 40-Year-Old Woman with Abdominal Pain, Weight Loss, and Anxiety about Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; COGNITIVE-BEHAVIOR THERAPY; DOUBLE-BLIND; HYPOCHONDRIASIS; COMPRESSION; FLUOXETINE; SYMPTOMS; PATIENT; ADULTS; ADHD		[Marouf, Feyza; Baer, Lee; Hanau, Michael S.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA USA; [Giallourakis, Cosmas C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Marouf, Feyza; Baer, Lee; Hanau, Michael S.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Giallourakis, Cosmas C.; Holbert, Barbara C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Marouf, F (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA USA.		Meghea, Aurelia/C-2573-2011		Arbour Health System	Arbour Health System	Dr. Hanau reports receiving lecture fees from Arbour Health System and honoraria from Quadrant HealthCom. No other potential conflict of interest relevant to this article was reported.	Abramowitz JS, 2006, PSYCHIAT CLIN N AM, V29, P503, DOI 10.1016/j.psc.2006.02.008; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; American Psychiatric Association, ATT DEF HYP DIS FACT; Baer Lee, 2012, GETTING CONTROL OVER; Barkley RA, 2008, CNS SPECTRUMS, V13, P977, DOI 10.1017/S1092852900014036; Barsky AJ, 2004, JAMA-J AM MED ASSOC, V291, P1464, DOI 10.1001/jama.291.12.1464; Barsky AJ, 2001, NEW ENGL J MED, V345, P1395, DOI 10.1056/NEJMcp002896; BARSKY AJ, 1994, ARCH GEN PSYCHIAT, V51, P918; Bech FR, 1997, SURG CLIN N AM, V77, P409, DOI 10.1016/S0039-6109(05)70558-2; Bystritsky A, 2004, J CLIN PSYCHIAT, V65, P565; Denys D, 2004, J CLIN PSYCHIAT, V65, P1040; Dimsdale JE, 2007, PSYCHOSOM MED, V69, P850, DOI 10.1097/PSY.0b013e31815b00e7; Duffy AJ, 2009, ANN VASC SURG, V23, P778, DOI 10.1016/j.avsg.2008.11.005; DUNBAR JD, 1965, AMER J ROENTGENOL RA, V95, P731, DOI 10.2214/ajr.95.3.731; Evans S, 2008, J ANXIETY DISORD, V22, P716, DOI 10.1016/j.janxdis.2007.07.005; FALLON BA, 1993, J CLIN PSYCHOPHARM, V13, P438; FALLON BA, 1991, J CLIN PSYCHIAT, V52, P457; Fallon BA, 2001, HYPOCHONDRIASIS MODE, P329; Greeven A, 2007, AM J PSYCHIAT, V164, P91, DOI 10.1176/appi.ajp.164.1.91; Hanau M, 2012, CURR PSYCHIAT, V11, P43; HARJOLA P T, 1963, Ann Chir Gynaecol Fenn, V52, P547; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Klassen LJ, 2010, J AFFECT DISORDERS, V124, P1, DOI 10.1016/j.jad.2009.06.036; Lai L, 2004, AM J GASTROENTEROL, V99, P40, DOI 10.1046/j.1572-0241.2003.04020.x; Lovas DA, 2010, J ANXIETY DISORD, V24, P931, DOI 10.1016/j.janxdis.2010.06.019; McDonald IG, 1996, BRIT MED J, V313, P329, DOI 10.1136/bmj.313.7053.329; McDougle CJ, 2000, ARCH GEN PSYCHIAT, V57, P794, DOI 10.1001/archpsyc.57.8.794; Merideth C, 2008, EUR NEUROPSYCHOPHARM, V18, pS499, DOI 10.1016/S0924-977X(08)70749-1; Olatunji BO, 2009, BRIT J PSYCHIAT, V194, P481, DOI 10.1192/bjp.bp.108.061085; Page LA, 2003, J ROY SOC MED, V96, P223, DOI 10.1258/jrsm.96.5.223; PATTEN RM, 1991, AM J ROENTGENOL, V156, P1101, DOI 10.2214/ajr.156.5.2017934; Pollack MH, 2006, BIOL PSYCHIAT, V59, P211, DOI 10.1016/j.biopsych.2005.07.005; Ramos-Quiroga JA, 2013, CURR MED RES OPIN; REILLY LM, 1985, J VASC SURG, V2, P79, DOI 10.1067/mva.1985.avs0020079; REUTER SR, 1973, SURGERY, V73, P381; Safren SA, 2010, JAMA-J AM MED ASSOC, V304, P875, DOI 10.1001/jama.2010.1192; Thomson AB, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006520.pub2; WESNER RB, 1991, J AFFECT DISORDERS, V22, P43, DOI 10.1016/0165-0327(91)90082-4	39	0	0	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1639	1647		10.1056/NEJMcpc1215968	http://dx.doi.org/10.1056/NEJMcpc1215968			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	24152264				2022-12-28	WOS:000326031100014
J	Mitchell, JM				Mitchell, Jean M.			Urologists' Use of Intensity-Modulated Radiation Therapy for Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; SPECIALTY HOSPITALS; SURGERY; IMPACT	BackgroundSome urology groups have integrated intensity-modulated radiation therapy (IMRT), a radiation treatment with a high reimbursement rate, into their practice. This is permitted by the exception for in-office ancillary services in the federal prohibition against self-referral. I examined the association between ownership of IMRT services and use of IMRT to treat prostate cancer. MethodsUsing Medicare claims from 2005 through 2010, I constructed two samples: one comprising 35 self-referring urology groups in private practice and a matched control group comprising 35 non-self-referring urology groups in private practice, and the other comprising non-self-referring urologists employed at 11 National Comprehensive Cancer Network centers matched with 11 self-referring urology groups in private practice. I compared the use of IMRT in the periods before and during ownership and used a difference-in-differences analysis to evaluate changes in IMRT use according to self-referral status. ResultsThe rate of IMRT use by self-referring urologists in private practice increased from 13.1 to 32.3%, an increase of 19.2 percentage points (P<0.001). Among non-self-referring urologists, the rate of IMRT use increased from 14.3 to 15.6%, an increase of 1.3 percentage points (P=0.05). The unadjusted difference-in-differences effect was 17.9 percentage points (P<0.001). The regression-adjusted increase in IMRT use associated with self-referral was 16.4 percentage points (P<0.001). The rate of IMRT use by urologists working at National Comprehensive Cancer Network centers remained stable at 8.0% but increased by 33.0 percentage points among the 11 matched self-referring urology groups. The regression-adjusted difference-in-differences effect was 29.3 percentage points (P<0.001). ConclusionsUrologists who acquired ownership of IMRT services increased their use of IMRT substantially more than urologists who did not own such services. Allowing urologists to self-refer for IMRT may contribute to increased use of this expensive therapy. (Funded by the American Society for Radiation Oncology.)	Georgetown Univ, Washington, DC 20057 USA	Georgetown University	Mitchell, JM (corresponding author), Georgetown Univ, Old North 314,37th & O Sts NW, Washington, DC 20057 USA.	mitchejm@georgetown.edu			American Society for Radiation Oncology; Georgetown University	American Society for Radiation Oncology; Georgetown University	Supported by an unrestricted educational research contract between the American Society for Radiation Oncology and Georgetown University.	Addressing the growth of ancillary services in physicians' offices, 2010, REP C AG INC MED PRO, P213; American Cancer Society, PROST CANC OV; [Anonymous], 2008, COMP EFF THER CLIN L; Baker LC, 2010, HEALTH AFFAIR, V29, P2252, DOI 10.1377/hlthaff.2009.1099; Bishop TF, 2010, J GEN INTERN MED, V25, P1057, DOI 10.1007/s11606-010-1409-7; Carreyrou J, 2010, WALL STREET J, pA1; DRANOVE D, 1988, ECON INQ, V26, P281, DOI 10.1111/j.1465-7295.1988.tb01494.x; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gazelle GS, 2007, RADIOLOGY, V245, P517, DOI 10.1148/radiol.2452070193; HILLMAN BJ, 1992, JAMA-J AM MED ASSOC, V268, P2050, DOI 10.1001/jama.268.15.2050; Hillman BJ, 2010, HEALTH AFFAIR, V29, P2231, DOI 10.1377/hlthaff.2010.1019; Hughes DR, 2010, HEALTH AFFAIR, V29, P2244, DOI 10.1377/hlthaff.2010.0413; Jacobs BL, 2012, HLTH AFF MILLWOOD, V1, P750; Kerr RR, 2011, UROLOGY TIMES   1201, P1; Litwin MS, 2007, CANCER, V109, P2239, DOI 10.1002/cncr.22676; Management options for low-risk prostate cancer, 2010, MAN OPT LOW RISK PRO; Medicare Payment Advisory Commission, 2009, REP C IMPR INC MED P, P81; Mitchell JM, 2008, MED CARE, V46, P732, DOI 10.1097/MLR.0b013e31817892a7; Mitchell JM, 2007, MED CARE RES REV, V64, P395, DOI 10.1177/1077558707301953; Mitchell JM, 2007, HEALTH AFFAIR, V26, pW415, DOI 10.1377/hlthaff.26.3.w415; Mitchell JM, 2012, HEALTH AFFAIR, V31, P741, DOI 10.1377/hlthaff.2011.1372; Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962; Newhouse JP, 2013, NEW ENGL J MED, V368, P1465, DOI 10.1056/NEJMp1302981; Nguyen PL, 2011, J CLIN ONCOL, V29, P1517, DOI 10.1200/JCO.2010.31.1217; Pauly MV, 1980, DOCTORS THEIR WORKSH, P1; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Shahinian VB, 2010, NEW ENGL J MED, V363, P1822, DOI 10.1056/NEJMsa0910784; Shreibati JB, 2011, HEALTH SERV RES, V46, P1362, DOI 10.1111/j.1475-6773.2011.01265.x; Sunshine J, 2010, HEALTH AFFAIR, V29, P2237, DOI 10.1377/hlthaff.2009.1081; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	31	107	108	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1629	1637		10.1056/NEJMsa1201141	http://dx.doi.org/10.1056/NEJMsa1201141			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239MZ	24152262				2022-12-28	WOS:000326031100012
J	Basu, S; Babiarz, KS; Ebrahim, S; Vellakkal, S; Stuckler, D; Goldhaber-Fiebert, JD				Basu, Sanjay; Babiarz, Kim S.; Ebrahim, Shah; Vellakkal, Sukumar; Stuckler, David; Goldhaber-Fiebert, Jeremy D.			Palm oil taxes and cardiovascular disease mortality in India: economic-epidemiologic model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; TOTAL CHOLESTEROL; FATTY-ACIDS; RISK; HEALTH; COUNTRIES; PREVALENCE; GLUCOSE; DIET	Objective To examine the potential effect of a tax on palm oil on hyperlipidemia and on mortality due to cardiovascular disease in India. Design Economic-epidemiologic model. Modeling methods A microsimulation model of mortality due to myocardial infarction and stroke among Indian populations was constructed, incorporating nationally representative data on systolic blood pressure, total cholesterol, tobacco smoking, diabetes, and cardiovascular event history, and stratified by age, sex, and urban/rural residence. Household expenditure data were used to estimate the change in consumption of palm oil following changes in oil price and the potential substitution of alternative oils that might occur after imposition of a tax. A 20% excise tax on palm oil purchases was simulated over the period 2014-23. Main outcome measures The model was used to project future mortality due to myocardial infarction and stroke, as well as the potential effect of a tax on food insecurity, accounting for the effect of increased food prices. Results A 20% tax on palm oil purchases would be expected to avert approximately 363 000 (95% confidence interval 247 000 to 479 000) deaths from myocardial infarctions and strokes over the period 2014-23 in India (1.3% reduction in cardiovascular deaths) if people do not substitute other oils for reduced palm oil consumption. Given estimates of substitution of palm oil with other oils following a 20% price increase for palm oil, the beneficial effects of increased polyunsaturated fat consumption would be expected to enhance the projected reduction in deaths to as much as 421 000 (256 000 to 586 000). The tax would be expected to benefit men more than women and urban populations more than rural populations, given differential consumption and cardiovascular risk. In a scenario incorporating the effect of taxation on overall food expenditures, the tax may increase food insecurity by <1%, resulting in 16 000 (95% confidence interval 12 000 to 22 000) deaths. Conclusions Curtailing palm oil intake through taxation may modestly reduce hyperlipidemia and cardiovascular mortality, but with potential distributional consequences differentially benefiting male and urban populations, as well as affecting food security.	[Basu, Sanjay] Stanford Univ, Prevent Res Ctr, Stanford, CA 94305 USA; [Basu, Sanjay] Stanford Univ, Ctr Poverty & Inequal, Stanford, CA 94305 USA; [Basu, Sanjay; Babiarz, Kim S.; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Basu, Sanjay; Babiarz, Kim S.; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Primary Care, Stanford, CA 94305 USA; [Basu, Sanjay; Babiarz, Kim S.; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Outcomes Res, Stanford, CA 94305 USA; [Basu, Sanjay; Ebrahim, Shah; Stuckler, David] London Sch Hyg & Trop Med, London WC1, England; [Ebrahim, Shah; Vellakkal, Sukumar] Publ Hlth Fdn India, South Asia Network Chron Dis, Delhi, India; [Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Oxford	Basu, S (corresponding author), Stanford Univ, Sch Med, Med Sch Off Bldg X322,1265 Welch Rd,Mail Code 541, Stanford, CA 94305 USA.	basus@stanford.edu	Vellakkal, Sukumar/AAD-4893-2020	Vellakkal, Sukumar/0000-0002-0594-1454; Vellakkal, Sukumar/0000-0003-2635-1944; Stuckler, David/0000-0002-1288-8401; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	National Institute on Aging [K01 AG037593-02, P30 AG017253]; Stanford Woods Institute for the Environment; International Development Research Centre of Canada; Economic and Social Research Council [ES/K013130/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [K01AG037593, P30AG017253] Funding Source: NIH RePORTER; ESRC [ES/K013130/1] Funding Source: UKRI	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Stanford Woods Institute for the Environment; International Development Research Centre of Canada(CGIAR); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by the National Institute on Aging (K01 AG037593-02, JGF; P30 AG017253, SB), the Stanford Woods Institute for the Environment (JDG-F), and the International Development Research Centre of Canada (SB, DS, SE, SV). The funders had no role in the study design, analysis, interpretation, or decision to submit for publication.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 2011, GLOB AD TOB SURV GAT; Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001480; Basu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044037; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Chen BK, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-45; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Dohlman EN, 2003, INDIAS EDIBLE OIL SE; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; FAO, 2013, FAOSTAT DAT; Fletcher JM, 2011, J POLICY ANAL MANAG, V30, P655, DOI 10.1002/pam.20582; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Institute of Medicine, 2010, PROM CARD HLTH DEV W; KEYS A, 1965, METABOLIS, V14, P776, DOI 10.1016/0026-0495(65)90004-1; Kuntz KM., 2001, EC EVALUATION HLTH C; Lemar L.E., 2011, USDA NATL NUTR DATAB; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Narasinga Rao BS., 1989, NUTR VALUE INDIAN FO; National Sample Survey Organization (NSSO), 2012, NAT SAMPL SURV 2012; Pan SuWen, 2008, Journal of Agricultural and Applied Economics, V40, P821; Patel G., 2011, CONSUMER TRENDS INDI; Pearson TA, 1999, CARDIOVASC DRUG THER, V13, P95, DOI 10.1023/A:1007727924276; Praduman Kumar, 2011, Agricultural Economics Research Review, V24, P1; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P301, DOI 10.1016/j.diabres.2004.04.008; Shah B, 2010, ASSESSMENT BURDEN NO; Sovio U, 2013, EUR J PREV CARDIOL, V20, P844, DOI 10.1177/2047487312446136; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Sturm R, 2010, HEALTH AFFAIR, V29, P1052, DOI 10.1377/hlthaff.2009.0061; Sullivan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024898; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; USDA, 2013, PROD SUPPL DISTR PSD; Uusitalo U, 1996, BRIT MED J, V313, P1044, DOI 10.1136/bmj.313.7064.1044; Vega-Lopez S, 2006, AM J CLIN NUTR, V84, P54, DOI 10.1093/ajcn/84.1.54; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Wang YC, 2012, HEALTH AFFAIR, V31, P199, DOI 10.1377/hlthaff.2011.0410; World Health Organization, 2008, DIS INJ COUNTR EST; World Health Organization, 2011, STUD GLOB AGEING AD; World Health Organization, 2012, WHO GLOB INFOBASE; Young H., 2009, REV NUTR MORTALITY I, P78; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187	49	43	44	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6048	10.1136/bmj.f6048	http://dx.doi.org/10.1136/bmj.f6048			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243CI	24149818	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000326293800003
J	Flight, MH				Flight, Monica Hoyos			DRUG DISCOVERY Structure-led design	NATURE			English	Editorial Material							RECEPTOR							Hoyos Flight, Monica/0000-0002-3181-0933				Chen X, 2012, J MED CHEM, V55, P7141, DOI 10.1021/jm300603y; Davie BJ, 2013, ACS CHEM NEUROSCI, V4, P1026, DOI 10.1021/cn400086m; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167	7	5	6	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					S50	S52		10.1038/502S50a	http://dx.doi.org/10.1038/502S50a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132331	Bronze			2022-12-28	WOS:000325706300002
J	Armstrong, PW; Califf, RM				Armstrong, Paul W.; Califf, Robert M.			Data and Safety Monitoring Boards Academic Credit Where Credit Is Due?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-TRIALS		[Armstrong, Paul W.] Univ Alberta, Dept Med, Div Cardiol, Canadian VIGOUR Ctr, Edmonton, AB T6G 2E1, Canada; [Califf, Robert M.] Duke Univ, Duke Translat Med Inst, Durham, NC USA; [Califf, Robert M.] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA	University of Alberta; Duke University; Duke University	Armstrong, PW (corresponding author), Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat 2 132, Edmonton, AB T6G 2E1, Canada.	parmstro@ualberta.ca		Armstrong, Paul/0000-0002-0460-3445				ARMSTRONG PW, 1995, CIRCULATION, V91, P901, DOI 10.1161/01.CIR.91.3.901; Borer JS, 2008, JAMA-J AM MED ASSOC, V299, P1710, DOI 10.1001/jama.299.14.1710; Bueno H, 2011, EUR HEART J, V32, P1583, DOI 10.1093/eurheartj/ehq388; Chow SC, 2012, J BIOPHARM STAT, V22, P853, DOI 10.1080/10543406.2012.676536; Dixon DO, 2011, CLIN TRIALS, V8, P727, DOI 10.1177/1740774511425181; Drazen JM, 2010, NEW ENGL J MED, V363, P477, DOI 10.1056/NEJMe1007445; Eapen ZJ, 2013, AM HEART J, V165, P837, DOI 10.1016/j.ahj.2013.02.003; Ellenberg S, 2012, PEDIATRICS, V129, pS132, DOI 10.1542/peds.2012-0055F; Grant AM, 2005, LANCET, V365, P711; Slutsky AS, 2004, NEW ENGL J MED, V350, P1143, DOI 10.1056/NEJMsb033476	10	11	11	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1563	1564		10.1001/jama.2013.280383	http://dx.doi.org/10.1001/jama.2013.280383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129461				2022-12-28	WOS:000325624800016
J	Byrne, RA; Kastrati, A				Byrne, Robert A.; Kastrati, Adnan			Drug-eluting stent trials: too much non-inferiority, too little progress?	LANCET			English	Editorial Material									[Byrne, Robert A.] Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany; Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Byrne, RA (corresponding author), Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany.	byrne@dhm.mhn.de	, Kastrati/Y-2389-2019; Byrne, Robert/C-3902-2016	Byrne, Robert/0000-0001-5224-6393				Byrne RA, 2009, DRUG SAFETY, V32, P749, DOI 10.2165/11316500-000000000-00000; Hanratty CG, 2011, EUROINTERVENTION, V7, P872, DOI 10.4244/EIJV7I7A135; Joner M, 2010, EUROINTERVENTION, V6, P19, DOI 10.4244/; Kereiakes DJ, 2012, EUROINTERVENTION, V8, P187, DOI 10.4244/EIJV8I2A32; Kim H., 2013, AM COLL CARD SCI SES; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; von Birgelen C, 2014, LANCET, V383, P413, DOI 10.1016/S0140-6736(13)62037-1	8	12	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					386	388		10.1016/S0140-6736(13)62240-0	http://dx.doi.org/10.1016/S0140-6736(13)62240-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303KS	24183565				2022-12-28	WOS:000330673700006
J	Julien, JP; Cupo, A; Sok, D; Stanfield, RL; Lyumkis, D; Deller, MC; Klasse, PJ; Burton, DR; Sanders, RW; Moore, JP; Ward, AB; Wilson, IA				Julien, Jean-Philippe; Cupo, Albert; Sok, Devin; Stanfield, Robyn L.; Lyumkis, Dmitry; Deller, Marc C.; Klasse, Per-Johan; Burton, Dennis R.; Sanders, Rogier W.; Moore, John P.; Ward, Andrew B.; Wilson, Ian A.			Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer	SCIENCE			English	Article							N-GLYCAN RECOGNITION; MOLECULAR ARCHITECTURE; POTENT NEUTRALIZATION; GLYCOPROTEIN COMPLEX; V3 LOOP; GP120; VIRUS; ANTIBODY; BROAD; REGION	HIV-1 entry into CD4(+) target cells is mediated by cleaved envelope glycoprotein (Env) trimers that have been challenging to characterize structurally. Here, we describe the crystal structure at 4.7 angstroms of a soluble, cleaved Env trimer that is stabilized and antigenically near-native (termed the BG505 SOSIP. 664 gp140 trimer) in complex with a potent broadly neutralizing antibody, PGT122. The structure shows a prefusion state of gp41, the interaction between the component gp120 and gp41 subunits, and how a close association between the gp120 V1/V2/V3 loops stabilizes the trimer apex around the threefold axis. The complete epitope of PGT122 on the trimer involves gp120 V1, V3, and several surrounding glycans. This trimer structure advances our understanding of how Env functions and is presented to the immune system, and provides a blueprint for structure-based vaccine design.	[Julien, Jean-Philippe; Stanfield, Robyn L.; Lyumkis, Dmitry; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Julien, Jean-Philippe; Sok, Devin; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Julien, Jean-Philippe; Sok, Devin; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Cupo, Albert; Klasse, Per-Johan; Sanders, Rogier W.; Moore, John P.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Sok, Devin; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Lyumkis, Dmitry] Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Deller, Marc C.; Wilson, Ian A.] Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02129 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Cornell University; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Amsterdam; Academic Medical Center Amsterdam; Scripps Research Institute	Moore, JP (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10021 USA.	jpm2003@med.cornell.edu; abward@scripps.edu; wilson@scripps.edu	Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014; Stanfield, Robyn/AAH-3190-2019; Klasse, P.J./AEX-0142-2022; Ibrahim, Essam Hassan/G-1960-2018	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Klasse, P.J./0000-0001-8222-278X; Ibrahim, Essam Hassan/0000-0003-0130-2257; Julien, Jean-Philippe/0000-0001-7602-3995; Deller, Marc/0000-0001-8070-6502	NIH [P01 AI82362, R01 AI084817, R37 AI36082, R01 AI33292]; International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center; CHAVI-ID [UM1 AI100663]; Netherlands Organization for Scientific Research; European Research Council; Canadian Institutes of Health Research fellowship; Ragon Institute; U.S. NIH National Institute of General Medical Sciences (NIGMS) Biomedical Technology Research Center program [GM103310]; NIH NIGMS via a Protein Structure Initiative [U54 GM094586]; U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Cancer Institute (NCI) [Y1-CO-1020]; NIGMS [Y1-GM-1104]; DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NIGMS; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, R37AI036082, R01AI033292, R01AI084817, P01AI082362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, P41GM103310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center; CHAVI-ID; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); Ragon Institute; U.S. NIH National Institute of General Medical Sciences (NIGMS) Biomedical Technology Research Center program; NIH NIGMS via a Protein Structure Initiative; U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Hua, L. Kong, P. S. Lee, X. Zhu, R. Pejchal, H. Tien, T. Clayton, K. Saye, and J. Korzun, for technical assistance, previous contributions to the Env trimer project, and insightful discussions and C. R. King and W. Koff for support and encouragement. This work was supported by NIH grant P01 AI82362 (J. P. M., I. A. W.), as well as the International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center (D. R. B., I. A. W., J. P. M., A. B. W.), CHAVI-ID UM1 AI100663 (D. R. B., I. A. W., AB. W.), NIH grant R01 AI084817 (I. A. W.), NIH grant R37 AI36082 (J. P. M.), NIH grant R01 AI33292 (D. R. B.), a Vidi grant from the Netherlands Organization for Scientific Research (R. W. S.), a Starting Investigator Grant from the European Research Council (R. W. S.), Canadian Institutes of Health Research fellowship (J.-P.J.), and the Ragon Institute. D. L. is supported by the U.S. NIH National Institute of General Medical Sciences (NIGMS) Biomedical Technology Research Center program (grant GM103310). The Joint Center of Structural Genomics is supported by NIH NIGMS via a Protein Structure Initiative grant U54 GM094586 (I. A. W.). Use of the Advanced Photon Source for data collection was supported by the U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. GM/CA CAT has been funded in whole or in part with federal funds from the National Cancer Institute (NCI) (grant Y1-CO-1020) and NIGMS (grant Y1-GM-1104). Extensive crystal screening was also carried out at the Stanford Synchrotron Radiation Lightsource (SSRL) and at the Canadian Light Source (CLS). SSRL, a Directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility, is operated for the U.S. DOE Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program (P41RR001209); and the NIGMS. CLS is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. The content is the responsibility of the authors and does not necessarily reflect the official views of the NIGMS, NCI, or NIH. Coordinates and structure factors have been deposited with the Protein Data Bank under accession code 4NCO. The International AIDS Vaccine Initiative has previously filed a patent relating to the BG505 SOSIP. 664 trimer: U.S. Provisional Application no. 61/772,739, titled "HIV-1 envelope glycoprotein," with inventors M. Caulfield, A. C., H. Dean, S. Hoffenberg, C. R. King, P. J. K., A. Marozsan, J. P. M., R. S., A. B. W., I. A. W., J.-P. J., but no patents have been filed on any work described here. Materials and information will be provided under a Materials Transfer Agreement. This is manuscript 25054 from The Scripps Research Institute.	[Anonymous], THE PYMOL MOLECULAR; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cohen J, 2013, SCIENCE, V341, P443, DOI 10.1126/science.341.6145.443; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Henderson R, 2013, P NATL ACAD SCI USA, V110, P18037, DOI 10.1073/pnas.1314449110; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Kolchinsky P, 2001, J VIROL, V75, P3435, DOI 10.1128/JVI.75.7.3435-3443.2001; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mao YD, 2013, P NATL ACAD SCI USA, V110, pE4178, DOI 10.1073/pnas.1316666110; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Sadjadpour R, 2013, J VIROL, V87, P8798, DOI 10.1128/JVI.00878-13; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Stanfield RL, 1999, STRUCTURE, V7, P131, DOI 10.1016/S0969-2126(99)80020-3; Subramaniam S, 2013, P NATL ACAD SCI USA, V110, pE4172, DOI 10.1073/pnas.1313802110; SULLIVAN N, 1993, J VIROL, V67, P3674, DOI 10.1128/JVI.67.6.3674-3679.1993; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; van Heel M, 2013, P NATL ACAD SCI USA, V110, pE4175, DOI 10.1073/pnas.1314353110; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xiang SH, 2010, J VIROL, V84, P3147, DOI 10.1128/JVI.02587-09; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	56	645	671	3	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1477	1483		10.1126/science.1245625	http://dx.doi.org/10.1126/science.1245625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24179159	Green Accepted			2022-12-28	WOS:000328644300050
J	Berenson, RA; Kaye, DR				Berenson, Robert A.; Kaye, Deborah R.			Grading a Physician's Value - The Misapplication of Performance Measurement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								By 2017, the value-based payment modifier will be used to reward or penalize all Medicare physicians on the basis of the relative calculated value of the care they provide. But a physician's overall value cannot be assessed with current or foreseeable measures. Perhaps the only health policy issue on which Republicans and Democrats agree is the need to move from volume-based to value-based payment for health care providers. Rather than paying for activity, the aspirational goal is to pay for outcomes that take into account quality and costs. In keeping with this notion of paying for value rather than volume, the Affordable Care Act (ACA) created the value-based payment modifier, or value modifier, a pay-for-performance approach for physicians who actively participate in Medicare. By 2017, physicians will be rewarded or penalized on the basis of the relative calculated value of the care ...	[Berenson, Robert A.] Urban Inst, Washington, DC 20037 USA; [Kaye, Deborah R.] Johns Hopkins Med Inst, Brady Urol Inst, Baltimore, MD 21205 USA	Urban Institute; Johns Hopkins University; Johns Hopkins Medicine	Berenson, RA (corresponding author), Urban Inst, Washington, DC 20037 USA.							Bendapudi NM, 2006, MAYO CLIN PROC, V81, P338, DOI 10.4065/81.3.338; Berenson Robert A, 2013, TIMELY ANAL IMMED HL; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P2595, DOI 10.1001/jama.2012.6382; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Halladay JR, 2009, ANN FAM MED, V7, P495, DOI 10.1370/afm.1050	5	42	42	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2079	2081		10.1056/NEJMp1312287	http://dx.doi.org/10.1056/NEJMp1312287			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	258OB	24195500				2022-12-28	WOS:000327467500005
J	Carter, ME; Soden, ME; Zweifel, LS; Palmiter, RD				Carter, Matthew E.; Soden, Marta E.; Zweifel, Larry S.; Palmiter, Richard D.			Genetic identification of a neural circuit that suppresses appetite	NATURE			English	Article							CANINE ADENOVIRUS VECTORS; FOS-LIKE IMMUNOREACTIVITY; PARABRACHIAL NUCLEUS; THERMOSENSORY PATHWAY; RAT-BRAIN; NEURONS; EXPRESSION; IMMUNE; AMYGDALA; PEPTIDE	Appetite suppression occurs after a meal and in conditions when it is unfavourable to eat, such as during illness or exposure to toxins. A brain region proposed to play a role in appetite suppression is the parabrachial nucleus(1-3), a heterogeneous population of neurons surrounding the superior cerebellar peduncle in the brainstem. The parabrachial nucleus is thought to mediate the suppression of appetite induced by the anorectic hormones amylin and cholecystokinin(2), as well as by lithium chloride and lipopolysaccharide, compounds that mimic the effects of toxic foods and bacterial infections, respectively(4-6). Hyperactivity of the parabrachial nucleus is also thought to cause starvation after ablation of orexigenic agouti-related peptide neurons in adult mice(1,7). However, the identities of neurons in the parabrachial nucleus that regulate feeding are unknown, as are the functionally relevant downstream projections. Here we identify calcitonin gene-related peptide-expressing neurons in the outer external lateral subdivision of the parabrachial nucleus that project to the laterocapsular division of the central nucleus of the amygdala as forming a functionally important circuit for suppressing appetite. Using genetically encoded anatomical, optogenetic(8) and pharmacogenetic(9) tools, we demonstrate that activation of these neurons projecting to the central nucleus of the amygdala suppresses appetite. In contrast, inhibition of these neurons increases food intake in circumstances when mice do not normally eat and prevents starvation in adult mice whose agouti-related peptide neurons are ablated. Taken together, our data demonstrate that this neural circuit from the parabrachial nucleus to the central nucleus of the amygdala mediates appetite suppression in conditions when it is unfavourable to eat. This neural circuit may provide targets for therapeutic intervention to overcome or promote appetite.	[Carter, Matthew E.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Carter, Matthew E.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Soden, Marta E.; Zweifel, Larry S.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Soden, Marta E.; Zweifel, Larry S.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@uw.edu	Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331; Carter, Matthew/0000-0003-1802-090X; Soden, Marta/0000-0002-0695-8653	Hilda and Preston Davis Foundation; National Institutes of Health [R01MH094536, R01DA024908]; Klarman Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024908] Funding Source: NIH RePORTER	Hilda and Preston Davis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Roth for hM<INF>3</INF>Dq-mCherry and hM<INF>4</INF>Di-mCherry constructs, and K. Deisseroth for mCherry and ChR2-mCherry constructs. E. Allen, J. Resnick, M. Soleiman and S. Padilla assisted with histology, E. Allen and A. Rainwater assisted with animal husbandry, and J. Shulkin provided suggestions and advice. We thank members of the Palmiter and Zweifel laboratories for feedback on the manuscript. M. E. C. is financed by a fellowship from the Hilda and Preston Davis Foundation. L.S.Z. is financed by a grant from the National Institutes of Health (R01MH094536). R. D. P is supported in part by grants from the National Institutes of Health (R01DA024908) and the Klarman Family Foundation.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Becskei C, 2007, BRAIN RES, V1162, P76, DOI 10.1016/j.brainres.2007.06.016; CHAMBERLIN NL, 1994, J NEUROSCI, V14, P6500; D'Hanis W, 2007, J COMP NEUROL, V505, P268, DOI 10.1002/cne.21495; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Geerling JC, 2007, J COMP NEUROL, V504, P379, DOI 10.1002/cne.21452; Geerling JC, 2011, BRAIN RES, V1375, P19, DOI 10.1016/j.brainres.2010.11.028; Hermanson O, 1996, J COMP NEUROL, V368, P45, DOI 10.1002/(SICI)1096-9861(19960422)368:1<45::AID-CNE4>3.0.CO;2-K; JACOBS JW, 1981, SCIENCE, V213, P457, DOI 10.1126/science.6264603; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Lenth RV, 2001, AM STAT, V55, P187, DOI 10.1198/000313001317098149; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; Nakamura K, 2010, P NATL ACAD SCI USA, V107, P8848, DOI 10.1073/pnas.0913358107; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Paues J, 2006, NEUROSCIENCE, V141, P287, DOI 10.1016/j.neuroscience.2006.03.041; Paues J, 2001, NEUROREPORT, V12, P2399, DOI 10.1097/00001756-200108080-00023; Paxinos G, 2013, MOUSE BRAIN STEREOTA; Richard S, 2005, J COMP NEUROL, V481, P210, DOI 10.1002/cne.20384; Rosen AM, 2011, J NEUROPHYSIOL, V105, P1889, DOI 10.1152/jn.00836.2010; SCHWABER JS, 1988, J COMP NEUROL, V270, P416, DOI 10.1002/cne.902700310; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Tokita K, 2012, J NEUROPHYSIOL, V108, P2179, DOI 10.1152/jn.00465.2012; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; YAMAMOTO T, 1992, NEUROREPORT, V3, P1049, DOI 10.1097/00001756-199212000-00004; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	34	370	379	8	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					111	+		10.1038/nature12596	http://dx.doi.org/10.1038/nature12596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24121436	Green Accepted			2022-12-28	WOS:000326585600042
J	Fauci, AS; Marston, HD				Fauci, Anthony S.; Marston, Hilary D.			Achieving an AIDS-free World: Science and Implementation	CELL			English	Editorial Material							HIV-1 INFECTION; PREVENTION; ANTIBODIES; VACCINE		[Fauci, Anthony S.; Marston, Hilary D.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						[Anonymous], 2013, WHO GLOB UPD HIV TRE; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Granich R, 2013, CURR OPIN HIV AIDS, V8, P41, DOI 10.1097/COH.0b013e32835b80dd; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; US Department of State, 2013, REC 10 ANN US PRES P	12	1	1	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					733	734		10.1016/j.cell.2013.10.016	http://dx.doi.org/10.1016/j.cell.2013.10.016			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24157218	Bronze			2022-12-28	WOS:000326934300001
J	Naruse, G; Shimada, K				Naruse, Genki; Shimada, Kota			Cutaneous and Gastrointestinal Purpura	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 38-year-old previously healthy man presented with progressive rash, abdominal pain, arthralgia, and low-grade fever of 2-weeks' duration despite treatment with oral prednisolone. Physical examination showed diffuse abdominal tenderness and palpable purpura distal to the knees. A 38-year-old previously healthy man presented with progressive rash, abdominal pain, arthralgia, and low-grade fever that had lasted for 2 weeks despite treatment with oral prednisolone at a dose of 30 mg per day. Physical examination showed diffuse abdominal tenderness and palpable purpura distal to the knees (Panel A). The white-cell count and C-reactive protein level were elevated (13,600 cells per cubic millimeter [normal range, 3900 to 9000] and 6.5 mg per liter [normal value, <3.0], respectively), but other laboratory tests, including platelet count and urinalysis, were normal. Computed tomography revealed thickening of the duodenal and jejunal walls. Upper gastrointestinal ...	[Naruse, Genki; Shimada, Kota] Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan		Naruse, G (corresponding author), Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan.	kouta_shimada@tmhp.jp							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1843	1843		10.1056/NEJMicm1302936	http://dx.doi.org/10.1056/NEJMicm1302936			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24195551				2022-12-28	WOS:000326607800013
J	Jencks, SF; Brock, JE				Jencks, Stephen F.; Brock, Jane E.			Hospital Accountability and Population Health: Lessons From Measuring Readmission Rates	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							REHOSPITALIZATIONS; PROGRAM		CFMC, Englewood, CO USA		Jencks, SF (corresponding author), 8 Midvale Rd, Baltimore, MD 21210 USA.	steve.jencks@comcast.net			Integrating Care for Populations & Communities National Coordinating Center at CFMC; Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services	Integrating Care for Populations & Communities National Coordinating Center at CFMC; Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services	Dr. Brock was partially supported by the Integrating Care for Populations & Communities National Coordinating Center at CFMC with the Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services.	Berenson RA, 2012, NEW ENGL J MED, V366, P1364, DOI 10.1056/NEJMp1201268; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Department of Health and Human Services Centers for Medicare & Medicaid Services, 2012, FED REGISTER, V77, P27870; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Medicare.gov, 2013, FREQ ASK QUEST CMS P; U. S. Department of Health and Human Services, 2011, C NAT STRAT QUAL IMP	9	17	17	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					629	630		10.7326/0003-4819-159-9-201311050-00010	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249HX	24189596				2022-12-28	WOS:000326769400008
J	Frisch, S				Frisch, Suzy			The primary care physician shortage	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												suzyfrisch@yahoo.com						Chen C, 2013, ACAD MED, V88, P1267, DOI 10.1097/ACM.0b013e31829a3ce9; Medscape, PHYS COMP REP 2013; West CP, 2012, JAMA-J AM MED ASSOC, V308, P2241, DOI 10.1001/jama.2012.47535; Wyman O, 2013, TRACKING GROWTH ACCO	4	7	7	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2013	347								f6559	10.1136/bmj.f6559	http://dx.doi.org/10.1136/bmj.f6559			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XI	24188903				2022-12-28	WOS:000326889700007
J	Delgado-Baquerizo, M; Maestre, FT; Gallardol, A; Bowker, MA; Wallenstein, MD; Quero, JL; Ochoa, V; Gozalo, B; Garcia-Gomez, M; Soliveres, S; Garcia-Palacios, P; Berdugo, M; Valencia, E; Escolar, C; Arredondol, T; Barraza-Zepeda, C; Bran, D; Carreiral, JA; Chaiebll, M; Conceicao, AA; Derak, M; Eldridge, DL; Escudero, A; Espinosa, CI; Gaitan, J; Gatica, MG; Gomez-Gonzalez, S; Guzman, E; Gutierrez, JR; Florentino, A; Hepper, E; Hernandez, RM; Huber-Sannwald, E; Jankju, M; Liu, JS; Mau, RL; Miriti, M; Monerris, J; Naseri, K; Noumi, Z; Polo, V; Prina, A; Pucheta, E; Ramirez, E; Ramirez-Collantes, DA; Romao, R; Tighe, M; Torres, D; Torres-Diaz, C; Ungar, ED; Val, J; Wamiti, W; Wang, DL; Zaady, E				Delgado-Baquerizo, Manuel; Maestre, Fernando T.; Gallardol, Antonio; Bowker, Matthew A.; Wallenstein, Matthew D.; Luis Quero, Jose; Ochoa, Victoria; Gozalo, Beatriz; Garcia-Gomez, Miguel; Soliveres, Santiago; Garcia-Palacios, Pablo; Berdugo, Miguel; Valencia, Enrique; Escolar, Cristina; Arredondo, Turin; Barraza-Zepeda, Claudia; Bran, Donald; Antonio Carreiral, Jose; Chaieb, Mohamed; Conceicao, Abel A.; Derak, Mchich; Eldridge, David J.; Escudero, Adrian; Espinosa, Carlos I.; Gaitan, Juan; Gatica, M. Gabriel; Gomez-Gonzalez, Susana; Guzman, Elizabeth; Gutierrez, Julio R.; Florentino, Adriana; Hepper, Estela; Hernandez, Rosa M.; Huber-Sannwald, Elisabeth; Jankju, Mohammad; Liu, Jushan; Mau, Rebecca L.; Miriti, Maria; Monerris, Jorge; Naseri, Kamal; Noumi, Zouhaier; Polo, Vicente; Prina, Anibal; Pucheta, Eduardo; Ramirez, Elizabeth; Ramirez-Collantes, David A.; Romao, Roberto; Tighe, Matthew; Torres, Duiio; Torres-Diaz, Cristian; Ungar, Eugene D.; Val, James; Wamiti, Wanyoike; Wang, Deli; Zaady, Eli			Decoupling of soil nutrient cycles as a function of aridity in global drylands	NATURE			English	Article							DISSOLVED ORGANIC NITROGEN; BIOGEOCHEMICAL CYCLES; PHOSPHORUS; CARBON; MATTER; TRANSFORMATIONS; SHRUBLANDS; RETENTION; FEEDBACKS; RESPONSES	The biogeochemical cycles of carbon (C), nitrogen (N) and phosphorus (P) are interlinked by primary production, respiration and decomposition in terrestrial ecosystems(1). It has been suggested that the C, N and P cycles could become uncoupled under rapid climate change because of the different degrees of control exerted on the supply of these elements by biological and geochemical processes(1-5). Climatic controls on biogeochemical cycles are particularly relevant in arid, semi-arid and dry sub-humid ecosystems (drylands) because their biological activity is mainly driven by water availability(6-8). The increase in aridity predicted for the twenty-first century in many drylands worldwide(9-11) may therefore threaten the balance between these cycles, differentially affecting the availability of essential nutrients(12-14). Here we evaluate how aridity affects the balance between C, N and P in soils collected from 224 dryland sites from all continents except Antarctica. We find a negative effect of aridity on the concentration of soil organic C and total N, but a positive effect on the concentration of inorganic P. Aridity is negatively related to plant cover, which may favour the dominance of physical processes such as rock weathering, a major source of P to ecosystems, over biological processes that provide more C and N, such as litter decomposition(12-14). Our findings suggest that any predicted increase in aridity with climate change will probably reduce the concentrations of N and C in global drylands, but increase that of P. These changes would uncouple the C, N and P cycles in drylands and could negatively affect the provision of key services provided by these ecosystems.	[Delgado-Baquerizo, Manuel; Gallardol, Antonio] Univ Pablo Olavide, Dept Sistemas Fis Quim & Nat, Seville 41013, Spain; [Delgado-Baquerizo, Manuel; Maestre, Fernando T.; Luis Quero, Jose; Ochoa, Victoria; Gozalo, Beatriz; Garcia-Gomez, Miguel; Soliveres, Santiago; Berdugo, Miguel; Valencia, Enrique; Escolar, Cristina; Escudero, Adrian; Polo, Vicente] Univ Rey Juan Carlos, Dept Biol & Geol, Area Biodiversidad & Conservac, Escuela Super Ciencias Expt & Tecnol, Mostoles 28933, Spain; [Bowker, Matthew A.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Wallenstein, Matthew D.; Garcia-Palacios, Pablo] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Luis Quero, Jose] Univ Cordoba, Dept Ingn Forestal, E-14071 Cordoba, Spain; [Garcia-Palacios, Pablo] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Arredondo, Turin; Huber-Sannwald, Elisabeth] Inst Potosino Invest Cient Tecnol, Div Ciencias Ambientales, San Luis Potosi 78210, Mexico; [Barraza-Zepeda, Claudia; Gutierrez, Julio R.] Univ La Serena, Dept Biol, Coquimbo Region 1700000, Chile; [Bran, Donald; Gaitan, Juan] Inst Nacl Tecnol Agropecuaria, Estn Expt San Carlos Bariloche 277, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Antonio Carreiral, Jose] Univ Jaen, Dept Biol Anim Biol Vegetal & Ecol, Jaen 23071, Spain; [Chaieb, Mohamed; Noumi, Zouhaier] Univ Sfax, Fac Sci, Unite Rech Plant Divers & Ecosyst Arid Environm, Sfax 3018, Tunisia; [Conceicao, Abel A.; Romao, Roberto] Univ Estadual Feira de Santana, Dept Ciencias Biol, Bairro Novo Horizonte 44036, Feira De Santan, Brazil; [Derak, Mchich] Direct Reg Eaux & Forets & Lutte Desertificat Rif, Tetouan 93000, Morocco; [Eldridge, David J.] Univ New S Wales, Sch Biol Earth Environm Sci, Sydney, NSW 2052, Australia; [Espinosa, Carlos I.; Guzman, Elizabeth] Univ Tecn Particular Loja, Inst Ecol, Marcelino Champagnat, Loja, Ecuador; [Gatica, M. Gabriel; Pucheta, Eduardo] Univ Nacl San Juan, Dept Biol, Fac Ciencias Exactas Fis & Nat, Rivadavia, San Juan, Argentina; [Gomez-Gonzalez, Susana; Torres-Diaz, Cristian] Univ Bio Bio 447, Dept Ciencias Basicas, Lab Genom & Biodiversidad, Chillan 3780000, Chile; [Florentino, Adriana] Cent Univ Venezuela, Fac Agron, Inst Edafol, Caracas 1051, Venezuela; [Hepper, Estela; Prina, Anibal] Univ Nacl La Pampa, Fac Agron, RA-6300 Santa Rosa, La Pampa, Argentina; [Hernandez, Rosa M.; Ramirez, Elizabeth] Univ Expt Simon Rodriguez, Ctr Agroecol Trop, Lab Biogeoquim, Caracas 47925, Venezuela; [Jankju, Mohammad; Naseri, Kamal] Ferdowsi Univ Mashhad, Dept Range & Watershed Management, Fac Nat Resources & Environm, Mashhad 917751363, Iran; [Liu, Jushan; Wang, Deli] NE Normal Univ, Inst Grassland Sci, Changchun 130024, Jilin Province, Peoples R China; [Liu, Jushan; Wang, Deli] Minist Educ, Key Lab Vegetat Ecol, Changchun 130024, Jilin Province, Peoples R China; [Mau, Rebecca L.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 36011 USA; [Miriti, Maria] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Monerris, Jorge] Univ Quebec, Dept Sci Biol, Montreal, PQ H2X 3Y5, Canada; [Ramirez-Collantes, David A.] Int Potato Ctr, Prod Syst & Environm Sub Program, Lima, Peru; [Tighe, Matthew] Univ New England, Sch Environm & Rural Sci, Dept Agron & Soil Sci, Armidale, NSW 2351, Australia; [Torres, Duiio] Univ Centroccidental Lisandro Alvarado, Dept Quim & Suelos, Barquisimeto 3001, Venezuela; [Ungar, Eugene D.] Agr Res Org, Volcani Ctr, Inst Plant Sci, Dept Agron & Nat Resources, IL-50250 Bet Dagan, Israel; [Val, James] Off Environm & Heritage, Buronga, NSW 2739, Australia; [Wamiti, Wanyoike] Natl Museums Kenya, Dept Zool, Nairobi 7842000500, Kenya; [Zaady, Eli] Agr Res Org, Dept Nat Resources & Agron, Minist Agr, IL-85280 Negev, Israel	Universidad Pablo de Olavide; Universidad Rey Juan Carlos; Northern Arizona University; Colorado State University; Universidad de Cordoba; Colorado State University; Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad de La Serena; Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidad de Jaen; Universite de Sfax; Faculty of Sciences Sfax; Universidade Estadual de Feira de Santana; University of New South Wales Sydney; Universidad Tecnica Particular de Loja; Universidad Nacional de San Juan; University of Central Venezuela; Ferdowsi University Mashhad; Northeast Normal University - China; Northern Arizona University; University System of Ohio; Ohio State University; University of Quebec; University of Quebec Montreal; CGIAR; International Potato Center (CIP); University of New England; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Office of Environment & Heritage - New South Wales	Delgado-Baquerizo, M (corresponding author), Univ Pablo Olavide, Dept Sistemas Fis Quim & Nat, Carretera Utrera,Kilometro 1, Seville 41013, Spain.	mdelbaq@upo.es	Pérez, Jose Luis Quero/M-1074-2013; Huber-Sannwald, Elisabeth/D-2507-2009; Valencia, Enrique/AAR-1438-2021; Bowker, Matthew/B-6258-2014; Farzam, Mohammad/AAU-7275-2020; Delgado-Baquerizo, Manuel/L-3653-2017; Wallenstein, Matthew D/S-3512-2016; Escudero, Adrián/H-5046-2015; Gallardo, Antonio/L-3941-2017; GOMEZ-GONZALEZ, SUSANA/J-7637-2018; Barraza Zepeda, Claudia Elizabeth/P-7311-2015; DE LA FUENTE, JOSÉ ANTONIO CARREIRA/A-7484-2011; DELGADO-BAQUERIZO, MANUEL/GLS-0346-2022; Gómez-González, Susana/AAL-2631-2021; Maestre, Fernando T./A-6825-2008; Wallenstein, Matthew/C-6441-2008; Espinosa, Carlos Ivan/AAI-1305-2019; García-Palacios, Pablo/K-7567-2014; Tighe, Matt/AAC-5369-2019; Conceição, Abel Augusto/A-7544-2012; Codina, Santiago Soliveres/A-2291-2016; Hernández, Rosa/GRF-5998-2022; Gutierrez, Julio R/A-8367-2011; Ramirez, David/Q-5522-2017; Alvarez, Sergio/H-9727-2015; Arredondo Moreno, Jose Tulio/A-9972-2015	Pérez, Jose Luis Quero/0000-0001-5553-506X; Bowker, Matthew/0000-0002-5891-0264; Farzam, Mohammad/0000-0003-1947-0187; Delgado-Baquerizo, Manuel/0000-0002-6499-576X; Wallenstein, Matthew D/0000-0002-6219-1442; Escudero, Adrián/0000-0002-1427-5465; Gallardo, Antonio/0000-0002-2674-4265; GOMEZ-GONZALEZ, SUSANA/0000-0002-3779-8701; DE LA FUENTE, JOSÉ ANTONIO CARREIRA/0000-0002-5995-076X; DELGADO-BAQUERIZO, MANUEL/0000-0002-6499-576X; Gómez-González, Susana/0000-0002-3779-8701; Maestre, Fernando T./0000-0002-7434-4856; Wallenstein, Matthew/0000-0002-6219-1442; Espinosa, Carlos Ivan/0000-0002-5330-4505; García-Palacios, Pablo/0000-0002-6367-4761; Tighe, Matt/0000-0003-1027-0082; Conceição, Abel Augusto/0000-0001-7461-0133; Codina, Santiago Soliveres/0000-0001-9661-7192; Valencia, Enrique/0000-0003-3359-0759; Wamiti, Wanyoike/0000-0001-7300-2101; Ramirez, David/0000-0003-4546-9745; Berdugo, Miguel/0000-0003-1053-8907; gaitan, juan/0000-0003-2889-1418; Gatica, Gabriel/0000-0003-2883-2565; bran, donaldo/0000-0001-7749-2726; Prina, Anibal/0000-0003-3522-9342; Gutierrez, Julio/0000-0002-1099-1341; Hernandez Hernandez, Rosa Mary/0000-0003-0689-8862; Vicente, Polo/0000-0002-0994-5372; Huber- Sannwald, Elisabeth/0000-0002-8321-1270; Alvarez, Sergio/0000-0001-7204-502X; Barraza Zepeda, Claudia Elizabeth/0000-0002-8766-0700; Arredondo Moreno, Jose Tulio/0000-0003-1969-9942	European Research Council (ERC) under the European Community [242658]; Ministry of Science and Innovation of the Spanish Government [CGL2010-21381]; CYTED [Accion 407AC0323]; Pablo de Olavide University	European Research Council (ERC) under the European Community(European Research Council (ERC)); Ministry of Science and Innovation of the Spanish Government(Spanish Government); CYTED; Pablo de Olavide University	We thank M. Scheffer, N. J. Gotelli and R. Bardgett for comments on previous versions of the manuscript, and all the technicians and colleagues who helped with the field surveys and laboratory analyses. This research is supported by the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 242658 (BIOCOM), and by the Ministry of Science and Innovation of the Spanish Government, grant no. CGL2010-21381. CYTED funded networking activities (EPES, Accion 407AC0323). M.D.-B. was supported by a PhD fellowship from the Pablo de Olavide University.	Anderson J. M., 1993, TROPICAL SOIL BIOL F; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Blanco H., 2010, PRINCIPLES SOIL CONS; BOWMAN RA, 1978, SOIL SCI, V125, P49, DOI 10.1097/00010694-197801000-00008; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Carreira JA, 1997, BIOGEOCHEMISTRY, V39, P87, DOI 10.1023/A:1005871404474; Cerda A, 1997, J ARID ENVIRON, V36, P37, DOI 10.1006/jare.1995.0198; Chantigny M. H, 2006, SOIL SAMPLING METHOD; Cornelis W. S., 2006, DRYLAND ECOHYDROLOGY; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Cross AF, 2001, BIOGEOCHEMISTRY, V52, P155, DOI 10.1023/A:1006437504494; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Delgado-Baquerizo M, 2011, PEDOSPHERE, V21, P309, DOI 10.1016/S1002-0160(11)60131-8; Eldridge DJ, 2010, ECOSYSTEMS, V13, P499, DOI 10.1007/s10021-010-9335-4; Evans SE, 2013, ECOSYSTEMS, V16, P20, DOI 10.1007/s10021-012-9593-4; Feng S, 2013, ATMOS CHEM PHYS, V13, P10081, DOI 10.5194/acp-13-10081-2013; Finzi AC, 2011, FRONT ECOL ENVIRON, V9, P61, DOI 10.1890/100001; Food and Agriculture Organization (FAO), 1989, AR ZON FOR GUID FIEL; Gao XJ, 2008, GLOBAL PLANET CHANGE, V62, P195, DOI 10.1016/j.gloplacha.2008.02.002; Grace J.B., 2006, STRUCT EQ MOD NAT; Helmut G., 2005, CAUSES PROGR DESERTI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Johnson P.M., 2006, GOVERNING GLOBAL DES; Kandeler E., 2007, SOIL MICROBIOLOGY EC, V3rd ed., P53; LAJTHA K, 1988, SOIL SCI, V146, P160, DOI 10.1097/00010694-198809000-00003; Li J, 2007, BIOGEOCHEMISTRY, V85, P317, DOI 10.1007/s10533-007-9142-y; Liebig J., 1842, CHEM ITS APPL AGR PH; Maestre FT, 2012, PHILOS T R SOC B, V367, P3062, DOI 10.1098/rstb.2011.0323; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Maestre FT, 2003, ECOLOGY, V84, P3186, DOI 10.1890/02-0635; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; MARSHALL KC, 1975, ANNU REV PHYTOPATHOL, V13, P357, DOI 10.1146/annurev.py.13.090175.002041; MCGILL WB, 1981, GEODERMA, V26, P267, DOI 10.1016/0016-7061(81)90024-0; Michael B., 2003, HUMAN IMPACT ENV SUS; Morford SL, 2011, NATURE, V477, P78, DOI 10.1038/nature10415; Nannipieri P, 2011, SOIL BIOL, V26, P215, DOI 10.1007/978-3-642-15271-9_9; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; OADES JM, 1988, BIOGEOCHEMISTRY, V5, P35, DOI 10.1007/BF02180317; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Reynolds JF, 1999, ECOL MONOGR, V69, P69, DOI 10.1890/0012-9615(1999)069[0069:IODODS]2.0.CO;2; ROBERTS TL, 1985, CAN J SOIL SCI, V65, P651, DOI 10.4141/cjss85-071; Robertson GP, 2015, SOIL MICROBIOLOGY EC, V4th, P421, DOI [10.1016/B978-0-08-047514-1.50017-2, 10.1016/b978-0-12-415955-6.00014-1, DOI 10.1016/B978-0-12-415955-6.00014-1]; Rovira P, 2002, GEODERMA, V107, P109, DOI 10.1016/S0016-7061(01)00143-4; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23, DOI [10.13287/j.1001-9332.202201.010, DOI 10.1002/0470010940]; Schimel DS, 2010, SCIENCE, V327, P418, DOI 10.1126/science.1184946; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schlesinger W.M., 1996, BIOGEOCHEMISTRY ANAL; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; SCHOENAU JJ, 1989, BIOGEOCHEMISTRY, V8, P223, DOI 10.1007/BF00002890; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; SHIPLEY B, 2001, CAUSE CORRELATION BI; Sinsabaugh R. L., 2002, ENZYMES ENV; Stotzky G, 1972, CRC Crit Rev Microbiol, V2, P59, DOI 10.3109/10408417209108383; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Tiessen H., 1993, SOIL SAMPL METHODS A, V7, P5; Tietjen T, 2003, AQUAT ECOL, V37, P331, DOI 10.1023/B:AECO.0000007044.52801.6b; Vicente-Serrano SM, 2012, ECOL MONOGR, V82, P407, DOI 10.1890/11-2164.1; Vitousek, 2004, NUTR CYCLING LIMITAT; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Whitford W., 2002, ECOLOGY DESERT SYSTE; Yerima P. K., 2005, INTRO SOIL SCI SOILS; Zomer R., 2006, CARBON LAND WATER GL	72	530	581	74	1061	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					672	+		10.1038/nature12670	http://dx.doi.org/10.1038/nature12670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24172979				2022-12-28	WOS:000326293200045
J	Fernandez-Tornero, C; Moreno-Morcillo, M; Rashid, UJ; Taylor, NMI; Ruiz, FM; Gruene, T; Legrand, P; Steuerwald, U; Muller, CW				Fernandez-Tornero, Carlos; Moreno-Morcillo, Maria; Rashid, Umar J.; Taylor, Nicholas M. I.; Ruiz, Federico M.; Gruene, Tim; Legrand, Pierre; Steuerwald, Ulrich; Mueller, Christoph W.			Crystal structure of the 14-subunit RNA polymerase I	NATURE			English	Article							CONFORMATIONAL FLEXIBILITY; TRANSCRIPTION INITIATION; ELECTRON-MICROSCOPY; ELONGATION COMPLEX; PHASE INFORMATION; CROSS-LINKING; ARCHITECTURE; SUBUNITS; MODEL; TFIIF	Protein biosynthesis depends on the availability of ribosomes, which in turn relies on ribosomal RNA production. In eukaryotes, this process is carried out by RNA polymerase I (Pol I), a 14-subunit enzyme, the activity of which is a major determinant of cell growth. Here we present the crystal structure of Pol I from Saccharomyces cerevisiae at 3.0 angstrom resolution. The Pol I structure shows a compact core with a wide DNA-binding cleft and a tightly anchored stalk. An extended loop mimics the DNA backbone in the cleft and may be involved in regulating Pol I transcription. Subunit A12.2 extends from the A190 jaw to the active site and inserts a transcription elongation factor TFIIS-like zinc ribbon into the nucleotide triphosphate entry pore, providing insight into the role of A12.2 in RNA cleavage and Pol I insensitivity to alpha-amanitin. The A49-A34.5 heterodimer embraces subunit A135 through extended arms, thereby contacting and potentially regulating subunit A12.2.	[Fernandez-Tornero, Carlos; Taylor, Nicholas M. I.; Ruiz, Federico M.] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Moreno-Morcillo, Maria; Rashid, Umar J.; Steuerwald, Ulrich; Mueller, Christoph W.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Gruene, Tim] Univ Gottingen, Dept Struct Chem, D-37077 Gottingen, Germany; [Legrand, Pierre] SOLEIL Synchrotron, F-91192 Gif Sur Yvette, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); European Molecular Biology Laboratory (EMBL); University of Gottingen; SOLEIL Synchrotron	Fernandez-Tornero, C (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	cftornero@cib.csic.es; cmueller@embl.de	Fernandez-Tornero, Carlos/AAV-8028-2021; Ruiz, Federico M./AAO-9600-2021; Taylor, Nicholas/O-6477-2016; Müller, Christoph W/I-7420-2012; LEGRAND, Pierre/G-7709-2011; Fernandez-Tornero, Carlos/I-6888-2015	Fernandez-Tornero, Carlos/0000-0001-5097-731X; Ruiz, Federico M./0000-0002-0385-7777; Taylor, Nicholas/0000-0003-0761-4921; Müller, Christoph W/0000-0003-2176-8337; LEGRAND, Pierre/0000-0003-2431-2255; Fernandez-Tornero, Carlos/0000-0001-5097-731X; Moreno Morcillo, Maria/0000-0001-7928-3338; Moreno Morcillo, Maria/0000-0003-4603-2529	EMBL Heidelberg Protein Expression and Purification, Proteomics Core Facilities and Crystallization Platform; 'Fermentation et culture de microorganisms' (CNRS) [IFR88]; EMBO Long-Term fellowships; Marie-Curie fellowship [FP7-PEOPLE-2011-IEF 301002]; Fundacion Futuro fellowship; ESF/CSIC; Volkswagen Stiftung; Spanish Ministry of Science [BFU2010-16336]	EMBL Heidelberg Protein Expression and Purification, Proteomics Core Facilities and Crystallization Platform; 'Fermentation et culture de microorganisms' (CNRS); EMBO Long-Term fellowships; Marie-Curie fellowship(European Commission); Fundacion Futuro fellowship; ESF/CSIC; Volkswagen Stiftung(Volkswagen); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank H. Grotsch for preparing the loop deletion yeast strain, and G. von Scheven and A. Scholz for technical assistance. We are also grateful to C. Vonrhein, G. Bricogne, S. Glatt and A. Romero for advice and discussions. We thank staff from the European synchrotrons SOLEIL, DESY, ESRF and SLS, where data were collected during different stages of the project. In particular, we thank A. Thompson for access and support at beamline Proxima 1 (Soleil) and T. Schneider and G. Bourenkov at beamline P14 (PETRA III). We also acknowledge support by the EMBL Heidelberg Protein Expression and Purification, Proteomics Core Facilities and Crystallization Platform, and the 'Fermentation et culture de microorganisms' (IFR88, CNRS). We are grateful to M. Bauzan, E. Poilpre and J. Scheurich for yeast fermentation. M.M.-M. and U. J. R. were supported by EMBO Long-Term fellowships, M.M.-M. by the Marie-Curie fellowship (FP7-PEOPLE-2011-IEF 301002), N.M.I.T. by a Fundacion Futuro fellowship, F. M. R. by an ESF/CSIC funded JAE-DOC contract and T. G. by the Volkswagen Stiftung via the Niedersachsenprofessur of Prof. G. M. Sheldrick. This work was also partly funded by grant BFU2010-16336 of the Spanish Ministry of Science.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Bischler N, 2002, EMBO J, V21, P4136, DOI 10.1093/emboj/cdf392; Blattner C, 2011, GENE DEV, V25, P2093, DOI 10.1101/gad.17363311; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Carter R, 2010, MOL BIOL EVOL, V27, P1035, DOI 10.1093/molbev/msp316; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; De Carlo S, 2003, J MOL BIOL, V329, P891, DOI 10.1016/S0022-2836(03)00510-2; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; HUET J, 1975, P NATL ACAD SCI USA, V72, P3034, DOI 10.1073/pnas.72.8.3034; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Jovanovic M, 2011, J BIOL CHEM, V286, P14469, DOI 10.1074/jbc.M110.212902; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; SCHULTZ P, 1993, EMBO J, V12, P2601, DOI 10.1002/j.1460-2075.1993.tb05920.x; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Tan Lin, 2008, J Biol, V7, P40, DOI 10.1186/jbiol98; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P1790, DOI 10.1073/pnas.71.5.1790; Weinzierl ROJ, 2011, ARCHAEA, V2011, DOI 10.1155/2011/608385; WITTEKIND M, 1988, MOL CELL BIOL, V8, P3997, DOI 10.1128/MCB.8.10.3997; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	55	124	128	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					644	+		10.1038/nature12636	http://dx.doi.org/10.1038/nature12636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153184				2022-12-28	WOS:000326293200039
J	ter Steege, H; Nigel, CA; Sabatier, D; Baraloto, C; Salomao, RP; Guevara, JE; Phillips, OL; Castilho, CV; Magnusson, WE; Molino, JF; Monteagudo, A; Vargas, PN; Montero, JC; Feldpausch, TR; Coronado, ENH; Killeen, TJ; Mostacedo, B; Vasquez, R; Assis, RL; Terborgh, J; Wittmann, F; Andrade, A; Laurance, WF; Laurance, SGW; Marimon, BS; Marimon, BH; Vieira, ICG; Amaral, IL; Brienen, R; Castellanos, H; Lopez, DC; Duivenvoorden, JF; Mogollon, HF; Matos, FDD; Davila, N; Garcia-Villacorta, R; Diaz, PRS; Costa, F; Emilio, T; Levis, C; Schietti, J; Souza, P; Alonso, A; Dallmeier, F; Montoya, AJD; Piedade, MTF; Araujo-Murakami, A; Arroyo, L; Gribel, R; Fine, PVA; Peres, CA; Toledo, M; Gerardo, AAC; Baker, TR; Ceron, C; Engel, J; Henkel, TW; Maas, P; Petronelli, P; Stropp, J; Zartman, CE; Daly, D; Neill, D; Silveira, M; Paredes, MR; Chave, J; Lima, DD; Jorgensen, PM; Fuentes, A; Schongart, J; Valverde, FC; Di Fiore, A; Jimenez, EM; Mora, MCP; Phillips, JF; Rivas, G; van Andel, TR; von Hildebrand, P; Hoffman, B; Zent, EL; Malhi, Y; Prieto, A; Rudas, A; Ruschell, AR; Silva, N; Vos, V; Zent, S; Oliveira, AA; Schutz, AC; Gonzales, T; Nascimento, MT; Ramirez-Angulo, H; Sierra, R; Tirado, M; Medina, MNU; van der Heijden, G; Vela, CIA; Torre, EV; Vriesendorp, C; Wang, O; Young, KR; Baider, C; Balslev, H; Ferreira, C; Mesones, I; Torres-Lezama, A; Giraldo, LEU; Zagt, R; Alexiades, MN; Hernandez, L; Huamantupa-Chuquimaco, I; Milliken, W; Cuenca, WP; Pauletto, D; Sandoval, EV; Gamarra, LV; Dexter, KG; Feeley, K; Lopez-Gonzalez, G; Silman, MR				ter Steege, Hans; Pitman, Nigel C. A.; Sabatier, Daniel; Baraloto, Christopher; Salomao, Rafael P.; Guevara, Juan Ernesto; Phillips, Oliver L.; Castilho, Carolina V.; Magnusson, William E.; Molino, Jean-Franois; Monteagudo, Abel; Nunez Vargas, Percy; Carlos Montero, Juan; Feldpausch, Ted R.; Coronado, Euridice N. Honorio; Killeen, Tim J.; Mostacedo, Bonifacio; Vasquez, Rodolfo; Assis, Rafael L.; Terborgh, John; Wittmann, Florian; Andrade, Ana; Laurance, William F.; Laurance, Susan G. W.; Marimon, Beatriz S.; Marimon, Ben-Hur, Jr.; Guimaraes Vieira, Ima Celia; Amaral, Ieda Leao; Brienen, Roel; Castellanos, Hernan; Cardenas Lopez, Dairon; Duivenvoorden, Joost F.; Mogollon, Hugo F.; de Almeida Matos, Francisca Dionizia; Davila, Nallarett; Garcia-Villacorta, Roosevelt; Stevenson Diaz, Pablo Roberto; Costa, Flavia; Emilio, Thaise; Levis, Carolina; Schietti, Juliana; Souza, Priscila; Alonso, Alfonso; Dallmeier, Francisco; Duque Montoya, Alvaro Javier; Fernandez Piedade, Maria Teresa; Araujo-Murakami, Alejandro; Arroyo, Luzmila; Gribel, Rogerio; Fine, Paul V. A.; Peres, Carlos A.; Toledo, Marisol; Gerardo, A. Aymard C.; Baker, Tim R.; Ceron, Carlos; Engel, Julien; Henkel, Terry W.; Maas, Paul; Petronelli, Pascal; Stropp, Juliana; Eugene Zartman, Charles; Daly, Doug; Neill, David; Silveira, Marcos; Rios Paredes, Marcos; Chave, Jerome; de Andrade Lima, Diogenes; Jorgensen, Peter Moller; Fuentes, Alfredo; Schoengart, Jochen; Cornejo Valverde, Fernando; Di Fiore, Anthony; Jimenez, Eliana M.; Penuela Mora, Maria Cristina; Fernando Phillips, Juan; Rivas, Gonzalo; van Andel, Tinde R.; von Hildebrand, Patricio; Hoffman, Bruce; Zent, Eglee L.; Malhi, Yadvinder; Prieto, Adriana; Rudas, Agustin; Ruschell, Ademir R.; Silva, Natalino; Vos, Vincent; Zent, Stanford; Oliveira, Alexandre A.; Cano Schutz, Angela; Gonzales, Therany; Nascimento, Marcelo Trindade; Ramirez-Angulo, Hirma; Sierra, Rodrigo; Tirado, Milton; Umana Medina, Maria Natalia; van der Heijden, Geertje; Vela, Cesar I. A.; Vilanova Torre, Emilio; Vriesendorp, Corine; Wang, Ophelia; Young, Kenneth R.; Baider, Claudia; Balslev, Henrik; Ferreira, Cid; Mesones, Italo; Torres-Lezama, Armando; Urrego Giraldo, Ligia Estela; Zagt, Roderick; Alexiades, Miguel N.; Hernandez, Lionel; Huamantupa-Chuquimaco, Isau; Milliken, William; Palacios Cuenca, Walter; Pauletto, Daniela; Valderrama Sandoval, Elvis; Valenzuela Gamarra, Luis; Dexter, Kyle G.; Feeley, Ken; Lopez-Gonzalez, Gabriela; Silman, Miles R.			Hyperdominance in the Amazonian Tree Flora	SCIENCE			English	Article							SPECIES ABUNDANCE; RAIN-FOREST; PATTERNS; DIVERSIFICATION; DISTRIBUTIONS; DIVERSITY; RARITY; GENUS; SIZE	The vast extent of the Amazon Basin has historically restricted the study of its tree communities to the local and regional scales. Here, we provide empirical data on the commonness, rarity, and richness of lowland tree species across the entire Amazon Basin and Guiana Shield (Amazonia), collected in 1170 tree plots in all major forest types. Extrapolations suggest that Amazonia harbors roughly 16,000 tree species, of which just 227 (1.4%) account for half of all trees. Most of these are habitat specialists and only dominant in one or two regions of the basin. We discuss some implications of the finding that a small group of species-less diverse than the North American tree flora-accounts for half of the world's most diverse tree community.	[ter Steege, Hans; Maas, Paul; van Andel, Tinde R.; Hoffman, Bruce] Naturalis Biodivers Ctr, Leiden, Netherlands; [ter Steege, Hans] Univ Utrecht, Ecol & Biodivers Grp, NL-3508 TC Utrecht, Netherlands; [Pitman, Nigel C. A.; Terborgh, John] Duke Univ, Ctr Trop Conservat, Nicholas Sch Environm, Durham, NC 27708 USA; [Pitman, Nigel C. A.; Vriesendorp, Corine] Field Museum, Chicago, IL 60605 USA; [Sabatier, Daniel; Molino, Jean-Franois] Inst Dev Res, UMR Architecture Fonctionnement & Evolut Plantes, Montpellier, France; [Salomao, Rafael P.] Museu Paraense Emilio Goeldi Cordenadoria Bot, Minist Ciencia Tecnol & Inovacao, Belem, Para, Brazil; [Guevara, Juan Ernesto; Fine, Paul V. A.; Mesones, Italo] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Phillips, Oliver L.; Feldpausch, Ted R.; Coronado, Euridice N. Honorio; Brienen, Roel; Baker, Tim R.; Lopez-Gonzalez, Gabriela] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Castilho, Carolina V.] Embrapa Roraima, Boa Vista, RR, Brazil; [Magnusson, William E.; Carlos Montero, Juan; Assis, Rafael L.; de Almeida Matos, Francisca Dionizia; Costa, Flavia; Emilio, Thaise; Levis, Carolina; Schietti, Juliana; Souza, Priscila; Fernandez Piedade, Maria Teresa; Eugene Zartman, Charles; de Andrade Lima, Diogenes; Ferreira, Cid] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Monteagudo, Abel; Vasquez, Rodolfo; Valenzuela Gamarra, Luis] Jardin Bot Missouri, Oxapampa, Peru; [Nunez Vargas, Percy] Univ Nacl San Antonio Abad del Cusco, Cuzco, Peru; [Carlos Montero, Juan] BOLFOR Bolivia Sustainable Forest Management Proj, Casilla 6204, Santa Cruz, Bolivia; [Feldpausch, Ted R.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4RJ, Devon, England; [Coronado, Euridice N. Honorio] Inst Invest Amazonia Peruana, Iquitos, Peru; [Killeen, Tim J.] WWF, Washington, DC 20037 USA; [Mostacedo, Bonifacio] Univ Autonoma Gabriel Rene Moreno, Fac Ciencias Agr, Santa Cruz, Bolivia; [Assis, Rafael L.] Norwegian Univ Life Sci UMB, Dept Ecol & Nat Resource Management, As, Norway; [Wittmann, Florian; Schoengart, Jochen] Max Planck Inst Chem, D-55128 Mainz, Germany; [Andrade, Ana] Inst Nacl de Pesquisas da Amazonia, Projeto Dinam Biol Fragmentos Florestais, Manaus, Amazonas, Brazil; [Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld, Australia; [Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Laurance, Susan G. W.; Marimon, Beatriz S.; Marimon, Ben-Hur, Jr.] Univ Estado Mato Grosso, Nova Xavantina, MT, Brazil; [Guimaraes Vieira, Ima Celia] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [Amaral, Ieda Leao] INPA, Projeto TEAM Trop Ecol Assessment & Monitoring Ma, Manaus, Amazonas, Brazil; [Castellanos, Hernan; Hernandez, Lionel] Univ Nacl Expt Guayana, Puerto Ordaz, Bolivar, Venezuela; [Cardenas Lopez, Dairon] SINCHI Inst Amazon Invest Cient, Bogota, Colombia; [Duivenvoorden, Joost F.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Mogollon, Hugo F.] Endangered Species Coalit, Silver Spring, MD 20901 USA; [Davila, Nallarett] Univ Estadual Campinas, Campinas, SP, Brazil; [Garcia-Villacorta, Roosevelt] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Garcia-Villacorta, Roosevelt] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland; [Stevenson Diaz, Pablo Roberto; Cano Schutz, Angela; Umana Medina, Maria Natalia] Univ Los Andes, Lab Ecol Bosques Trop & Primatol, Bogota, DF, Colombia; [Alonso, Alfonso; Dallmeier, Francisco] Smithsonian Conservat Biol Inst, Washington, DC 20013 USA; [Duque Montoya, Alvaro Javier; Urrego Giraldo, Ligia Estela] Univ Nacl Colombia, Dept Ciencias Forest, Sede Medellin, Colombia; [Araujo-Murakami, Alejandro; Arroyo, Luzmila] Museo Hist Nat Noel Kempff Mercado, Santa Cruz, Bolivia; [Gribel, Rogerio] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Toledo, Marisol] Univ Autonoma Gabriel Rene Moreno, Inst Boliviano Invest Forestal, Santa Cruz, Bolivia; [Ceron, Carlos] Univ Cent Ecuador, Herbario Alfredo Paredes QAP, Quito, Ecuador; [Henkel, Terry W.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Petronelli, Pascal] La Rech Agron Dev CIRAD, UMR Ecofog, Kourou, French Guiana; [Stropp, Juliana] Commiss European Communities, Land Resource & Management Unit, Joint Res Ctr, I-21027 Ispra, VA, Italy; [Daly, Doug] New York Bot Garden, Bronx, NY 10458 USA; [Neill, David] Univ Estatal Amaz, Puyo, Ecuador; [Silveira, Marcos] Univ Fed Acre, Museu Univ, Rio Branco, AC, Brazil; [Rios Paredes, Marcos] Serv Biodiversidad EIRL, Iquitos, Peru; [Chave, Jerome] CNRS, F-31000 Toulouse, France; [Chave, Jerome] Univ Toulouse 3, UMR EDB 5174, F-31000 Toulouse, France; [Jorgensen, Peter Moller; Fuentes, Alfredo] Missouri Bot Garden, St Louis, MO 63166 USA; [Fuentes, Alfredo] Herbario Nacl Bolivia, La Paz, Bolivia; [Cornejo Valverde, Fernando] Andes Amazon Biodivers Program, Madre De Dios, Peru; [Di Fiore, Anthony] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Jimenez, Eliana M.; Penuela Mora, Maria Cristina] Univ Nacl Colombia Sede Amazonia, Grp Ecol Ecosistemas Terrestres Trop, Leticia, Amazonas, Brazil; [Fernando Phillips, Juan; von Hildebrand, Patricio] Fdn Puerto Rastrojo, Bogota, Colombia; [Rivas, Gonzalo] Univ Florida, Gainesville, FL 32611 USA; [Zent, Eglee L.; Zent, Stanford] Inst Venezolano Invest Cient, Lab Human Ecol, Caracas 1020A, Venezuela; [Malhi, Yadvinder] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford, England; [Prieto, Adriana; Rudas, Agustin] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Colombia; [Ruschell, Ademir R.] Embrapa Amazonia Oriental, Belem, Para, Brazil; [Silva, Natalino] Univ Fed Rural Amazonia, Belem, Para, Brazil; [Vos, Vincent] Univ Autonoma Beni, Riberalta, Bolivia; [Oliveira, Alexandre A.; Baider, Claudia] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Gonzales, Therany] Amazon Ctr Environm Educ & Res Fdn, Madre De Dios, Peru; [Nascimento, Marcelo Trindade] Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, BR-28013620 Campos Dos Goyatacazes, RJ, Brazil; [Ramirez-Angulo, Hirma; Vilanova Torre, Emilio] Univ Los Andes, INDEFOR Res Inst Forestry Dev, Merida, Venezuela; [Sierra, Rodrigo; Tirado, Milton] Geoinformat & Sistemas Cia Ltda GeoIS, Quito, Ecuador; [van der Heijden, Geertje] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53202 USA; [van der Heijden, Geertje] Smithsonian Trop Res Inst, Panama City 084303092, Panama; [Vela, Cesar I. A.] Univ Nacl San Antonio Abad del Cusco, Fac Ciencias Forest & Medio Ambiente, Puerto Maldonado, Madre De Dios, Peru; [Wang, Ophelia] No Arizona Univ, Flagstaff, AZ 86011 USA; [Young, Kenneth R.] Univ Texas Austin, Austin, TX 78712 USA; [Baider, Claudia] Minist Agro Ind & Food Secur, Mauritius Herbarium Agr Serv, Reduit, Mauritius; [Balslev, Henrik] Univ Aarhus, Aarhus, Denmark; [Torres-Lezama, Armando] Univ Los Andes, Merida, Venezuela; [Zagt, Roderick] Tropenbos Int, Wageningen, Netherlands; [Alexiades, Miguel N.] Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England; [Huamantupa-Chuquimaco, Isau] Univ Nacl San Antonio Abad del Cusco, Herbario CUZ, Cuzco, Peru; [Milliken, William] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Palacios Cuenca, Walter] Univ Tecn Norte Herbario Nacl Euador, Quito, Ecuador; [Pauletto, Daniela] Serv Florestal Brasileiro, Santarem, PA, Brazil; [Valderrama Sandoval, Elvis] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Valderrama Sandoval, Elvis] Univ Nacl Amazonia Peruana, Fac Biol, Iquitos, Peru; [Dexter, Kyle G.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JN, Midlothian, Scotland; [Feeley, Ken] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Feeley, Ken] Fairchild Trop Bot Garden, Coral Gables, FL 33156 USA; [Silman, Miles R.] Wake Forest Univ, Biol Dept, Winston Salem, NC 27106 USA; [Silman, Miles R.] Wake Forest Univ, Ctr Energy Environm & Sustainabil, Winston Salem, NC 27106 USA	Naturalis Biodiversity Center; Utrecht University; Duke University; Field Museum of Natural History (Chicago); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Museu Paraense Emilio Goeldi; University of California System; University of California Berkeley; University of Leeds; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Institute Nacional de Pesquisas da Amazonia; Universidad Nacional de San Antonio Abad del Cusco; University of Exeter; World Wildlife Fund; Norwegian University of Life Sciences; Max Planck Society; Institute Nacional de Pesquisas da Amazonia; James Cook University; James Cook University; Universidade do Estado de Mato Grosso; Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia; University of Amsterdam; Universidade Estadual de Campinas; University of Edinburgh; Universidad de los Andes (Colombia); Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Universidad Nacional de Colombia; Jardim Botanico do Rio de Janeiro; University of East Anglia; Universidad Central del Ecuador; California State University System; California State Polytechnic University, Humboldt; CIRAD; European Commission Joint Research Centre; EC JRC ISPRA Site; New York Botanical Garden; Universidade Federal do Acre (UFAC); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Missouri Botanical Gardens; University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; Venezuelan Institute Science Research; University of Oxford; Universidad Nacional de Colombia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal Rural da Amazonia (UFRA); Universidade de Sao Paulo; Universidade Estadual do Norte Fluminense; University of Los Andes Venezuela; University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Nacional de San Antonio Abad del Cusco; Northern Arizona University; University of Texas System; University of Texas Austin; Aarhus University; University of Los Andes Venezuela; University of Kent; Universidad Nacional de San Antonio Abad del Cusco; Royal Botanic Gardens, Kew; University of Missouri System; University of Missouri Saint Louis; Universidad Nacional de la Amazonia Peruana; University of Edinburgh; State University System of Florida; Florida International University; Wake Forest University; Wake Forest University	ter Steege, H (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.	hans.tersteege@naturalis.nl	Dexter, Kyle G/D-5589-2018; van der Heijden, Geertje/AAB-4102-2019; de Castilho, Carolina Volkmer/I-6618-2019; Aymard, Gerardo/ABE-9203-2020; Gribel, Rogerio/C-5392-2013; Junior, Ben Hur Marimon/E-7330-2013; Vos, Vincent Antoine/I-7209-2019; de Oliveira, Alexandre Adalardo/G-8830-2012; Balslev, Hendrik/AAE-4071-2020; Baider, Claudia/C-2570-2009; Stropp, Juliana/AAF-7946-2020; Oliveira, Alexandre/ABH-1255-2020; Laurance, William F/B-2709-2012; Emilio, Thaise/A-6221-2013; Coronado, Eurídice Nora Honorio/K-3412-2015; Marimon, Beatriz/J-6389-2012; Peres, Carlos A./ABE-8361-2020; Fuentes, Alfredo F./FNZ-7942-2022; Cano, Ángela/N-9392-2017; Peres, Carlos A./B-1276-2013; Schongart, Jochen/I-2659-2016; Costa, Flavia/K-4386-2014; Pauletto, Daniela/AAX-4777-2020; Feldpausch, Ted/ABH-3123-2020; Vilanova, Emilio/AAG-9543-2020; Baraloto, Christopher/ABG-2500-2020; Peres, Carlos Augusto/N-8275-2019; SALOMÃO, RAFAEL/AAU-1306-2020; Pitman, Nigel C A/A-7681-2008; Feeley, Kenneth James/A-7631-2009; Brienen, Roel/AAU-9959-2020; Nascimento, Marcelo T/D-2824-2013; Vos, Vincent/ABA-1492-2020; Laurance, Susan/G-6021-2011; Phillips, Oliver/A-1523-2011; Magnusson, William E/J-9408-2014; Schietti, Juliana/B-8226-2015; Piedade, Maria Teresa/C-5372-2013; Feldpausch, Ted/D-3436-2009; Ruschel, ademir/AAL-8382-2021; Silveira, Marcos/H-7906-2013; Steege, Hans ter/B-5866-2011; Schietti, Juliana/AAV-7451-2020; Vieira, Ima C.G./H-6897-2012; Balslev, Henrik/J-9191-2013; Junior, Ben Hur Marimon/AAT-9354-2020; Molino, Jean-François/C-5011-2009; Zent, Eglee/O-7640-2014	Dexter, Kyle G/0000-0001-9232-5221; van der Heijden, Geertje/0000-0002-2110-5173; de Castilho, Carolina Volkmer/0000-0002-1064-2758; Aymard, Gerardo/0000-0001-9405-0508; Gribel, Rogerio/0000-0002-0850-5578; Vos, Vincent Antoine/0000-0002-0388-8530; de Oliveira, Alexandre Adalardo/0000-0001-5526-8109; Baider, Claudia/0000-0002-2203-2076; Stropp, Juliana/0000-0002-2831-4066; Oliveira, Alexandre/0000-0001-5526-8109; Laurance, William F/0000-0003-4430-9408; Emilio, Thaise/0000-0001-5415-1822; Coronado, Eurídice Nora Honorio/0000-0003-2314-590X; Marimon, Beatriz/0000-0003-3105-2914; Peres, Carlos A./0000-0002-1588-8765; Cano, Ángela/0000-0002-5090-7730; Peres, Carlos A./0000-0002-1588-8765; Costa, Flavia/0000-0002-9600-4625; Pauletto, Daniela/0000-0003-1855-6077; Feldpausch, Ted/0000-0002-6631-7962; Vilanova, Emilio/0000-0001-6289-5127; Baraloto, Christopher/0000-0001-7322-8581; SALOMÃO, RAFAEL/0000-0003-0947-0132; Pitman, Nigel C A/0000-0002-9211-2880; Feeley, Kenneth James/0000-0002-3618-1144; Brienen, Roel/0000-0002-5397-5755; Nascimento, Marcelo T/0000-0003-4492-3344; Vos, Vincent/0000-0002-0388-8530; Laurance, Susan/0000-0002-2831-2933; Phillips, Oliver/0000-0002-8993-6168; Magnusson, William E/0000-0003-1988-3950; Schietti, Juliana/0000-0002-1687-4373; Piedade, Maria Teresa/0000-0002-7320-0498; Feldpausch, Ted/0000-0002-6631-7962; Ruschel, ademir/0000-0002-0352-5238; Silveira, Marcos/0000-0003-0485-7872; Steege, Hans ter/0000-0002-8738-2659; Schietti, Juliana/0000-0002-1687-4373; Vieira, Ima C.G./0000-0003-1233-318X; Balslev, Henrik/0000-0002-7101-7120; Molino, Jean-François/0000-0001-8853-7133; Fine, Paul/0000-0002-0550-5628; Jimenez, Eliana M./0000-0002-8610-1771; Sabatier, Daniel/0000-0003-0883-1530; Mostacedo, Bonifacio/0000-0003-3806-2445; Lopez-Gonzalez, Gabriela/0000-0002-0814-8830; Milliken, William/0000-0002-3926-6661; Neill, David Alan/0000-0002-5143-9430; Hernandez, Lionel/0000-0002-7279-1003; Zent, Eglee/0000-0002-7475-7335; Engel, Julien/0000-0002-8078-9309; Fuentes, Alfredo/0000-0003-4848-4182; Young, Kenneth R./0000-0003-0866-1260; Sierra, Rodrigo/0000-0002-1146-2943; Valenzuela Gamarra, Luis/0000-0002-6191-0580; Schongart, Jochen/0000-0002-7696-9657; Penuela Mora, Maria Cristina/0000-0002-9611-1359	Alberta Mennega Stichting; ALCOA Suriname; Banco de la Republica; Center for Agricultural Research in Suriname; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Plano Nacional de Pos-Graduacao); Conselho Nacional de Desenvovimento Cientifico e Tecnologico of Brazil (CNPq) projects Programa de Pesquisas Ecologicas de Longa Duracao (PELD) [558069/2009-6]; Programa de Apoio a Nucleos de Excelencia da Fundacao de Amparo a Pesquisa do Estado do Amazonas (PRONEX-FAPEAM) [1600/2006]; Areas Umidas; MAUA; PELD [403792/2012-6]; PPBio; CENBAM; Universal [479599/2008-4, 307807-2009-6]; Fundacao de Amparo A Pesquisa Do Estado Do Amazonas (APEAM) projects [DCR/2006]; Hidroveg; FAPESP; PRONEX; CNPq; Colciencias; Duke University; Ecopetrol; FEPIM [044/2003]; Field Museum; Conservation International/DC (TEAM/INPA Manuas), Gordon; Betty Moore Foundation; Guyana Forestry Commission; Investissement d'Avenir grant of the French Agence Nationale de la Recherche (ANR) (Centre d'Etude de la Biodiversite Amazonienne) [ANR-10-LABX-0025]; Margaret Mee Amazon Trust; Miquel fonds; National Geographic Society [7754-04, 8047-06]; Netherlands Foundation for the Advancement of Tropical Research WOTRO grants [WB85- 335, W84-581]; Primate Conservation Incorporated; French Ministry of Ecology and Sustainable Development; Shell Prospecting and Development Peru; Smithsonian Institution's Biological Diversity of the Guiana Shield Program; Stichting het van Eeden-fonds; the Body Shop; Ministry of the Environment of Ecuador; TROBIT; Tropenbos International; NSF [NSF-0743457, NSF-0101775]; USAID; Variety Woods Guyana; WWF-Brazil; WWF-Guianas; XIIeme Contrat de Plan Etat Region-Guyane (French Government and European Union); European Union; UK Natural Environment Research Council; Gordon and Betty Moore Foundation; U.S. National Geographic Society; European Research Council Advanced Grant; Royal Society Wolfson Research Merit Award; NERC [NE/I027797/1, NE/I021160/1] Funding Source: UKRI; Natural Environment Research Council [NE/I021160/1, NE/B504630/1, NE/B503384/1, NE/I027797/1] Funding Source: researchfish; Division Of Environmental Biology [0918591] Funding Source: National Science Foundation	Alberta Mennega Stichting; ALCOA Suriname; Banco de la Republica; Center for Agricultural Research in Suriname; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Plano Nacional de Pos-Graduacao); Conselho Nacional de Desenvovimento Cientifico e Tecnologico of Brazil (CNPq) projects Programa de Pesquisas Ecologicas de Longa Duracao (PELD)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio a Nucleos de Excelencia da Fundacao de Amparo a Pesquisa do Estado do Amazonas (PRONEX-FAPEAM); Areas Umidas; MAUA; PELD; PPBio; CENBAM; Universal; Fundacao de Amparo A Pesquisa Do Estado Do Amazonas (APEAM) projects; Hidroveg; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PRONEX; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Duke University; Ecopetrol; FEPIM; Field Museum; Conservation International/DC (TEAM/INPA Manuas), Gordon; Betty Moore Foundation(Gordon and Betty Moore Foundation); Guyana Forestry Commission; Investissement d'Avenir grant of the French Agence Nationale de la Recherche (ANR) (Centre d'Etude de la Biodiversite Amazonienne)(French National Research Agency (ANR)); Margaret Mee Amazon Trust; Miquel fonds; National Geographic Society(National Geographic Society); Netherlands Foundation for the Advancement of Tropical Research WOTRO grants; Primate Conservation Incorporated; French Ministry of Ecology and Sustainable Development; Shell Prospecting and Development Peru; Smithsonian Institution's Biological Diversity of the Guiana Shield Program(Smithsonian InstitutionSmithsonian National Museum of Natural History); Stichting het van Eeden-fonds; the Body Shop; Ministry of the Environment of Ecuador; TROBIT; Tropenbos International; NSF(National Science Foundation (NSF)); USAID(United States Agency for International Development (USAID)); Variety Woods Guyana; WWF-Brazil; WWF-Guianas; XIIeme Contrat de Plan Etat Region-Guyane (French Government and European Union); European Union(European Commission); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. National Geographic Society(National Geographic Society); European Research Council Advanced Grant(European Research Council (ERC)); Royal Society Wolfson Research Merit Award(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This paper is the result of the work of hundreds of different scientists and research institutions in the Amazon over the past 80 years. Without their hard work this analysis would have been impossible. This work was supported by Alberta Mennega Stichting; ALCOA Suriname; Banco de la Republica; Center for Agricultural Research in Suriname; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Plano Nacional de Pos-Graduacao); Conselho Nacional de Desenvovimento Cientifico e Tecnologico of Brazil (CNPq) projects Programa de Pesquisas Ecologicas de Longa Duracao (PELD) (558069/2009-6), Programa de Apoio a Nucleos de Excelencia da Fundacao de Amparo a Pesquisa do Estado do Amazonas (PRONEX-FAPEAM) (1600/2006), Areas Umidas, and MAUA; PELD (403792/2012-6), PPBio, CENBAM, Universal (479599/2008-4), and Universal 307807-2009-6; Fundacao de Amparo A Pesquisa Do Estado Do Amazonas (APEAM) projects DCR/2006, Hidroveg with FAPESP, and PRONEX with CNPq; FAPESP; Colciencias; Duke University; Ecopetrol; FEPIM 044/2003; the Field Museum; Conservation International/DC (TEAM/INPA Manuas), Gordon and Betty Moore Foundation; Guyana Forestry Commission; Investissement d'Avenir grant of the French Agence Nationale de la Recherche (ANR) (Centre d'Etude de la Biodiversite Amazonienne ANR-10-LABX-0025); Margaret Mee Amazon Trust; Miquel fonds; National Geographic Society (7754-04, 8047-06 to P.M.J.); Netherlands Foundation for the Advancement of Tropical Research WOTRO grants WB85- 335 and W84-581; Primate Conservation Incorporated; Programme Ecosystemes Tropicaux (French Ministry of Ecology and Sustainable Development; Shell Prospecting and Development Peru; Smithsonian Institution's Biological Diversity of the Guiana Shield Program; Stichting het van Eeden-fonds; the Body Shop; the Ministry of the Environment of Ecuador; TROBIT; Tropenbos International; NSF (NSF-0743457 and NSF-0101775 to P.M.J.); USAID; Variety Woods Guyana; WWF-Brazil; WWF-Guianas; XIIeme Contrat de Plan Etat Region-Guyane (French Government and European Union); and grants to RAINFOR from the European Union, UK Natural Environment Research Council, the Gordon and Betty Moore Foundation, and U.S. National Geographic Society. O.L.P. is supported by a European Research Council Advanced Grant and a Royal Society Wolfson Research Merit Award. A summary of the data is given in appendix 1. Plot metadata are given in appendix 4.	Adeney J. M., 2009, THESIS DUKE U DURHAM; BALEE W, 1990, BIOTROPICA, V22, P36, DOI 10.2307/2388717; Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; BLACK GA, 1950, BOT GAZ, V111, P413, DOI 10.1086/335612; Cavers S, 2013, J BIOGEOGR, V40, P615, DOI 10.1111/jbi.12097; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Couvreur TLP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-44; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Erickson CL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P157, DOI 10.1007/978-0-387-74907-5_11; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Feeley KJ, 2009, P NATL ACAD SCI USA, V106, P12382, DOI 10.1073/pnas.0900698106; Fine PVA, 2005, EVOLUTION, V59, P1464; Gomez-Navarro C, 2009, AM J BOT, V96, P1300, DOI 10.3732/ajb.0800378; Haripersaud P, 2010, TAXON, V59, P592, DOI 10.1002/tax.592024; Hopkins MJG, 2007, J BIOGEOGR, V34, P1400, DOI 10.1111/j.1365-2699.2007.01737.x; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; iPlant Collaborative, TAX NAM RES SERV VER; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Levis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048559; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Lozano FD, 2005, BIOL CONSERV, V126, P146, DOI 10.1016/j.biocon.2005.04.024; Maas PJM, 2011, NORD J BOT, V29, P257, DOI 10.1111/j.1756-1051.2011.01092.x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McMichael CH, 2012, SCIENCE, V336, P1429, DOI 10.1126/science.1219982; Montoya E, 2011, QUATERNARY RES, V76, P335, DOI 10.1016/j.yqres.2011.06.014; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; NASA, VIS EARTH; PETERS CM, 2000, IMPERFECT BALANCE LA, P203; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PIRES JM, 1953, BOT GAZ, V114, P467, DOI 10.1086/335790; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; PITMAN NCA, 2000, THESIS DUKE U DURHAM; Pitman NCA, 2013, ECOGRAPHY, V36, P114, DOI 10.1111/j.1600-0587.2012.00083.x; Posey D. A., 1985, Agroforestry Systems, V3, P139, DOI 10.1007/BF00122640; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; R Development Core Team, 2012, R LANG ENV STAT COMP; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Rollet B., 1993, BOIS FORTS TROPIQUES, V236, P43; Schwartz MW, 2001, ECOL LETT, V4, P464, DOI 10.1046/j.1461-0248.2001.00241.x; ter Steege H., AMAZON TREE DIVERSIT; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Ter Steege H, 2011, AM J BOT, V98, P31, DOI 10.3732/ajb.1000215; Warren RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017342	46	740	773	9	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					325	+		10.1126/science.1243092	http://dx.doi.org/10.1126/science.1243092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136971	Green Submitted			2022-12-28	WOS:000325755100034
J	Schmolzer, GM; Kumar, M; Pichler, G; Aziz, K; O'Reilly, M; Cheung, PY				Schmoelzer, Georg M.; Kumar, Manoj; Pichler, Gerhard; Aziz, Khalid; O'Reilly, Megan; Cheung, Po-Yin			Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC LUNG-DISEASE; BRONCHOPULMONARY DYSPLASIA; NASAL CPAP; OXYGEN; RESUSCITATION; INTUBATION; RATES	Objective To assess the role of nasal continuous positive airway pressure (CPAP) initiated at birth for prevention of death and bronchopulmonary dysplasia in very preterm infants. Design Systematic review. Data sources PubMed, Embase, the Cochrane Central Register of Controlled Trials, and online Pediatric Academic Society abstracts from the year of inception to June 2013. Eligibility criteria for selecting studies Randomised controlled trials evaluating the effect of nasal CPAP compared with intubation in preterm infants born at less than 32 weeks' gestation and presenting the outcomes of either death or bronchopulmonary dysplasia, or both (defined as the need for oxygen support or mechanical ventilation at 36 weeks corrected gestation), during hospital stay. Results Four randomised controlled trials (2782 participants) met the inclusion criteria, with 1296 infants in the nasal CPAP group and 1486 in the intubation group. All the trials reported bronchopulmonary dysplasia independently at 36 weeks corrected gestation, with borderline significance in favour of the nasal CPAP group (relative risk 0.91, 95% confidence interval 0.82 to 1.01, risk difference -0.03, 95% confidence interval -0.07 to 0.01). No difference in death was observed (relative risk 0.88, 0.68 to 1.14, risk difference -0.02, -0.04 to 0.01, respectively). Pooled analysis showed a significant benefit for the combined outcome of death or bronchopulmonary dysplasia, or both, at 36 weeks corrected gestation for babies treated with nasal CPAP (relative risk 0.91, 0.84 to 0.99, risk difference -0.04, -0.07 to 0.00), number needed to treat of 25). Conclusion One additional infant could survive to 36 weeks without bronchopulmonary dysplasia for every 25 babies treated with nasal CPAP in the delivery room rather than being intubated.	[Schmoelzer, Georg M.; Kumar, Manoj; Pichler, Gerhard; Aziz, Khalid; O'Reilly, Megan; Cheung, Po-Yin] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Schmoelzer, Georg M.; Kumar, Manoj; Pichler, Gerhard; Aziz, Khalid; O'Reilly, Megan; Cheung, Po-Yin] Royal Alexandra Hosp, Neonatal Res Unit, Edmonton, AB, Canada; [Schmoelzer, Georg M.; Pichler, Gerhard] Med Univ, Div Neonatol, Dept Pediat, Graz, Austria	University of Alberta; Royal Alexandra Hospital; Medical University of Graz	Schmolzer, GM (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	georg.schmoelzer@me.com	Cheung, Po-Yin/C-2804-2013; Schmölzer, Georg M/E-7883-2010	Cheung, Po-Yin/0000-0002-7141-1523; Schmölzer, Georg M/0000-0001-9798-2415; Pichler, Gerhard/0000-0003-2405-7143; Kumar, Manoj/0000-0001-7879-7724				Ammari A, 2005, J PEDIATR-US, V147, P341, DOI 10.1016/j.jpeds.2005.04.062; AVERY ME, 1987, PEDIATRICS, V79, P26; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; Dawson JA, 2012, J PEDIATR-US, V160, P158, DOI 10.1016/j.jpeds.2011.07.045; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; Doyle LW, 2009, SEMIN FETAL NEONAT M, V14, P391, DOI 10.1016/j.siny.2009.08.004; Dunn MS, 2011, PEDIATRICS, V128, pE1069, DOI 10.1542/peds.2010-3848; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Gagliardi L, 2011, ARCH DIS CHILD-FETAL, V96, pF30, DOI 10.1136/adc.2010.183905; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kinsella JP, 2006, LANCET, V367, P1421, DOI 10.1016/S0140-6736(06)68615-7; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Rabi Y, 2006, J PEDIATR-US, V148, P590, DOI 10.1016/j.jpeds.2005.12.047; Sandri F, 2010, PEDIATRICS, V125, pE1402, DOI 10.1542/peds.2009-2131; Schmolzer GM, 2008, J PEDIATR-US, V153, P741, DOI 10.1016/j.jpeds.2008.08.016; Van Marter LJ, 2000, PEDIATRICS, V105, P1194, DOI 10.1542/peds.105.6.1194; Vaucher YE, 2012, NEW ENGL J MED, V367, P2495, DOI 10.1056/NEJMoa1208506; Vento M, 2009, NEONATOLOGY, V95, P286, DOI 10.1159/000178770	24	298	316	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2013	347								f5980	10.1136/bmj.f5980	http://dx.doi.org/10.1136/bmj.f5980			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WP	24136633	Green Published, hybrid			2022-12-28	WOS:000325982700003
J	Cohen, D				Cohen, Deborah			Devices and desires: industry fights toughening of medical device regulation in Europe	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com						[Anonymous], 2013, HEALIO          1004; Bowis J., 2013, MED DEVICES DIRECTIV; Cohen D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7090; Davis S, 2011, EU MED DEVICE APPROV; Eucomed, FACTSH FIN IMP REV E; Farr C., CNBC; German National Associations of Statutory Health Insurance Funds, 2013, MED DEV MYTHS TRUTH; Health First Europe, TRANSP GOV; Hirschler B, 2013, REUTERS; McCulloch P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7126; MDD, 2013, MEDTECH EUROPE, V4; Van Brabandt H, 2012, BRIT MED J, V345, P4710	12	5	5	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2013	347								f6204	10.1136/bmj.f6204	http://dx.doi.org/10.1136/bmj.f6204			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WM	24133129				2022-12-28	WOS:000325982400007
J	Cole, TB				Cole, Thomas B.			Racer's Pillow Salvatore Scarpitta	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1540	1541		10.1001/jama.2013.5366	http://dx.doi.org/10.1001/jama.2013.5366			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129446				2022-12-28	WOS:000325624800001
J	Ohno, H; Shinoda, K; Ohyama, K; Sharp, LZ; Kajimura, S				Ohno, Haruya; Shinoda, Kosaku; Ohyama, Kana; Sharp, Louis Z.; Kajimura, Shingo			EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex	NATURE			English	Article							TRANSCRIPTIONAL CONTROL; NONSHIVERING THERMOGENESIS; HISTONE METHYLTRANSFERASES; TISSUE; METHYLATION; DELETION; OBESITY; UCP1; 9Q34	Brown adipose tissue (BAT) dissipates chemical energy in the form of heat as a defence against hypothermia and obesity. Current evidence indicates that brown adipocytes arise from Myf5(+) dermotomal precursors through the action of PR domain containing protein 16 (PRDM16) transcriptional complex(1,2). However, the enzymatic component of the molecular switch that determines lineage specification of brown adipocytes remains unknown. Here we show that euchromatic histone-lysine N-methyltransferase 1 (EHMT1) is an essential BAT-enriched lysine methyltransferase in the PRDM16 transcriptional complex and controls brown adipose cell fate. Loss of EHMT1 in brown adipocytes causes a severe loss of brown fat characteristics and induces muscle differentiation in vivo through demethylation of histone 3 lysine 9 (H3K9me2 and 3) of the muscle-selective gene promoters. Conversely, EHMT1 expression positively regulates the BAT-selective thermogenic program by stabilizing the PRDM16 protein. Notably, adipose-specific deletion of EHMT1 leads to a marked reduction of BAT-mediated adaptive thermogenesis, obesity and systemic insulin resistance. These data indicate that EHMT1 is an essential enzymatic switch that controls brown adipose cell fate and energy homeostasis.	[Ohno, Haruya; Shinoda, Kosaku; Ohyama, Kana; Sharp, Louis Z.; Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, UCSF Diabet Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kajimura, S (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, UCSF Diabet Ctr, 35 Med Ctr Way, San Francisco, CA 94143 USA.	skajimura@diabetes.ucsf.edu	Kajimura, Shingo/AAC-5090-2019; Shinoda, Kosaku/V-1698-2019	Kajimura, Shingo/0000-0003-0672-5910; Shinoda, Kosaku/0000-0002-1928-0749; Ohno, Haruya/0000-0001-5400-1162	National Institutes of Health [DK087853, DK97441]; DERC center [DK63720]; University of California, San Francisco Program for Breakthrough Biomedical Research program; Pew Charitable Trust; PRESTO from the Japan Science and Technology Agency; Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK087853, R01DK097441, P30DK063720, K99DK087853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DERC center; University of California, San Francisco Program for Breakthrough Biomedical Research program; Pew Charitable Trust; PRESTO from the Japan Science and Technology Agency; Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to A. Tarakhovsky, E. D. Rosen, Y. Shinkai and E. Hara for providing mice and plasmids. We thank our colleagues in the University of California, San Francisco, including Y. Qiu, A. Chawla, C. Paillart, S. Koliwad, M. Robblee, D. Scheel, S. Ohata, L. Mera, D. Lowe, S. Sonne, S. Keylin, I. Luijten, H. Hong and E. Tomoda for their assistance. This work was supported by grants from the National Institutes of Health (DK087853 and DK97441) to S. K. We acknowledge supports from the DERC center grant (DK63720), University of California, San Francisco Program for Breakthrough Biomedical Research program, the Pew Charitable Trust, and PRESTO from the Japan Science and Technology Agency to S. K. H.O. is supported by the Manpei Suzuki Diabetes Foundation. K. S. is supported by a fellowship from the Japan Society for the Promotion of Science.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cormier-Daire V, 2003, J MED GENET, V40, P300, DOI 10.1136/jmg.40.4.300; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kleefstra T, 2005, J MED GENET, V42, P299, DOI 10.1136/jmg.2004.028464; Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Willemsen MH, 2011, MOL SYNDROMOL, V2, P202, DOI 10.1159/000335648; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Yoneshiro T, 2013, INT J OBESITY, V37, P993, DOI 10.1038/ijo.2012.161	36	223	229	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					163	+		10.1038/nature12652	http://dx.doi.org/10.1038/nature12652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24196706	Green Submitted, Green Accepted			2022-12-28	WOS:000327851700052
J	Pepe, F; Cameron, AC; Latham, DW; Molinari, E; Udry, S; Bonomo, AS; Buchhave, LA; Charbonneau, D; Cosentino, R; Dressing, CD; Dumusque, X; Figueira, P; Fiorenzano, AFM; Gettel, S; Harutyunyan, A; Haywood, RD; Horne, K; Lopez-Morales, M; Lovis, C; Malavolta, L; Mayor, M; Micela, G; Motalebi, F; Nascimbeni, V; Phillips, D; Piotto, G; Pollacco, D; Queloz, D; Rice, K; Sasselov, D; Segransan, D; Sozzetti, A; Szentgyorgyi, A; Watson, CA				Pepe, Francesco; Cameron, Andrew Collier; Latham, David W.; Molinari, Emilio; Udry, Stephane; Bonomo, Aldo S.; Buchhave, Lars A.; Charbonneau, David; Cosentino, Rosario; Dressing, Courtney D.; Dumusque, Xavier; Figueira, Pedro; Fiorenzano, Aldo F. M.; Gettel, Sara; Harutyunyan, Avet; Haywood, Raphaelle D.; Horne, Keith; Lopez-Morales, Mercedes; Lovis, Christophe; Malavolta, Luca; Mayor, Michel; Micela, Giusi; Motalebi, Fatemeh; Nascimbeni, Valerio; Phillips, David; Piotto, Giampaolo; Pollacco, Don; Queloz, Didier; Rice, Ken; Sasselov, Dimitar; Segransan, Damien; Sozzetti, Alessandro; Szentgyorgyi, Andrew; Watson, Christopher A.			An Earth-sized planet with an Earth-like density	NATURE			English	Article							KEPLER	Recent analyses(1-4) of data from the NASA Kepler spacecraft(5) have established that planets with radii within 25 per cent of the Earth's (R-circle plus) are commonplace throughout the Galaxy, orbiting at least 16.5 per cent of Sun-like stars(1). Because these studies were sensitive to the sizes of the planets but not their masses, the question remains whether these Earth-sized planets are indeed similar to the Earth in bulk composition. The smallest planets for which masses have been accurately determined(6,7) are Kepler-10b (1.42R(circle plus)) and Kepler-36b (1.49R(circle plus)), which are both significantly larger than the Earth. Recently, the planet Kepler-78b was discovered(8) and found to have a radius of only 1.16R(circle plus). Here we report that the mass of this planet is 1.86 Earth masses. The resulting mean density of the planet is 5.57 g cm(-3), which is similar to that of the Earth and implies a composition of iron and rock.	[Pepe, Francesco; Udry, Stephane; Lovis, Christophe; Mayor, Michel; Motalebi, Fatemeh; Queloz, Didier; Segransan, Damien] Univ Geneva, Astron Observ, CH-1290 Versoix, Switzerland; [Cameron, Andrew Collier; Haywood, Raphaelle D.; Horne, Keith] Univ St Andrews, Sch Phys & Astron, Scottish Univ Phys Alliance, St Andrews KY16 9SS, Fife, Scotland; [Latham, David W.; Buchhave, Lars A.; Charbonneau, David; Dressing, Courtney D.; Dumusque, Xavier; Gettel, Sara; Lopez-Morales, Mercedes; Phillips, David; Sasselov, Dimitar; Szentgyorgyi, Andrew] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Molinari, Emilio; Cosentino, Rosario; Fiorenzano, Aldo F. M.; Harutyunyan, Avet] INAF Fdn Galileo Galilei, Brena Baja 38712, Spain; [Molinari, Emilio] INAF IASF Milano, I-20133 Milan, Italy; [Bonomo, Aldo S.; Sozzetti, Alessandro] INAF Osservatorio Astron Torino, I-10025 Pino Torinese, Italy; [Buchhave, Lars A.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Cosentino, Rosario] INAF Osservatorio Astrofis Catania, I-95125 Catania, Italy; [Figueira, Pedro] Univ Porto, Ctr Astrofis, P-4150762 Oporto, Portugal; [Malavolta, Luca; Piotto, Giampaolo] Univ Padua, Dipartimento Fis & Astron Galileo Galilei, I-35122 Padua, Italy; [Malavolta, Luca; Nascimbeni, Valerio; Piotto, Giampaolo] INAF Osservatorio Astron Padova, I-35122 Padua, Italy; [Micela, Giusi] INAF Osservatorio Astron Palermo, I-90124 Palermo, Italy; [Pollacco, Don] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Queloz, Didier] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Rice, Ken] Univ Edinburgh, Royal Observ, Inst Astron, Scottish Univ Phys Alliance, Edinburgh EH9 3HJ, Midlothian, Scotland; [Watson, Christopher A.] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland	University of Geneva; University of St Andrews; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Copenhagen; Istituto Nazionale Astrofisica (INAF); Universidade do Porto; University of Padua; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Warwick; University of Cambridge; University of Edinburgh; Queens University Belfast	Pepe, F (corresponding author), Univ Geneva, Astron Observ, 51 Chemin Maillettes, CH-1290 Versoix, Switzerland.	francesco.pepe@unige.ch	Malavolta, Luca/AHD-3055-2022; Molinari, Emilio/GYR-1322-2022; Buchhave, Lars A./ABF-2000-2020; Rice, Ken/H-5084-2011; Figueira, Pedro/J-4916-2013; Sozzetti, Alessandro/F-2943-2018	Malavolta, Luca/0000-0002-6492-2085; Molinari, Emilio/0000-0002-1742-7735; Buchhave, Lars A./0000-0003-1605-5666; Rice, Ken/0000-0002-6379-9185; Figueira, Pedro/0000-0001-8504-283X; Sozzetti, Alessandro/0000-0002-7504-365X; Haywood, Raphaelle/0000-0001-9140-3574; Latham, David/0000-0001-9911-7388; udry, Stephane/0000-0001-7576-6236; Queloz, Didier/0000-0002-3012-0316; Watson, Christopher/0000-0002-9718-3266; Cameron, Andrew/0000-0002-8863-7828; Cosentino, Rosario/0000-0003-1784-1431; Piotto, Giampaolo/0000-0002-9937-6387; Micela, Giuseppina/0000-0002-9900-4751; Nascimbeni, Valerio/0000-0001-9770-1214; Phillips, David/0000-0001-5132-1339; Pepe, Francesco/0000-0002-9815-773X; Bonomo, Aldo Stefano/0000-0002-6177-198X	Prodex Program of the Swiss Space Office; Harvard University Origins of Life Initiative; Scottish Universities Physics Alliance; University of Geneva; Smithsonian Astrophysical Observatory; Italian National Astrophysical Institute; University of St Andrews; Queen's University Belfast; University of Edinburgh; European Research Council/European Community through the European Union [239953]; Fundacao para a Ciencia e a Tecnologia [PTDC/CTE-AST/098528/2008, PTDC/CTE-AST/098604/2008]; European Union [313014]; STFC [ST/J00152X/1, ST/I001719/1, ST/I001123/1, ST/K006126/1, ST/J001651/1, ST/G001987/1, ST/J500744/1, ST/K001620/1, ST/J004626/1, PP/F000065/1] Funding Source: UKRI; Science and Technology Facilities Council [1105238, ST/K001620/1, ST/J001651/1, ST/J004626/1, ST/J00152X/1, ST/I001123/1, PP/F000065/1, ST/J500744/1, ST/K006126/1, ST/I001719/1, ST/G001987/1] Funding Source: researchfish	Prodex Program of the Swiss Space Office; Harvard University Origins of Life Initiative; Scottish Universities Physics Alliance; University of Geneva; Smithsonian Astrophysical Observatory; Italian National Astrophysical Institute; University of St Andrews; Queen's University Belfast; University of Edinburgh; European Research Council/European Community through the European Union; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union(European Commission); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This Letter was submitted simultaneously with the paper by Howard et al.<SUP>17</SUP>. Both papers are the result of a coordinated effort to carry out independent radial-velocity observations and studies of Kepler-78. Our team greatly appreciates the spirit of this collaboration, and we sincerely thank A. Howard and his team for the collegial work. We wish to thank the technical personnel of the Geneva Observatory, the Astronomical Technology Centre, the Smithsonian Astrophysical Observatory and the Telescopio Nazionale Galileo for their enthusiasm and competence, which made the HARPS-N project possible. The HARPS-N project was funded by the Prodex Program of the Swiss Space Office, the Harvard University Origins of Life Initiative, the Scottish Universities Physics Alliance, the University of Geneva, the Smithsonian Astrophysical Observatory, the Italian National Astrophysical Institute, the University of St Andrews, Queen's University Belfast and the University of Edinburgh. P.F. acknowledges support from the European Research Council/European Community through the European Union Seventh Framework Programme, Starting Grant agreement number 239953, and from the Fundacao para a Ciencia e a Tecnologia through grants PTDC/CTE-AST/098528/2008 and PTDC/CTE-AST/098604/2008. The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 313014 (ETAEARTH).	Baranne A, 1996, ASTRON ASTROPHYS SUP, V119, P373, DOI 10.1051/aas:1996251; Batalha N. M., 2011, ASTROPHYS J SUPPL, V204, P24; Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Buchhave LA, 2012, NATURE, V486, P375, DOI 10.1038/nature11121; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Charbonneau D, 2009, NATURE, V462, P891, DOI 10.1038/nature08679; Cosentino R., 2012, P SPIE, V8446, p84461V; Dressing CD, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/95; Fressin F, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/81; Hatzes AP, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201014795; Howard A. W, RESEARCH; Leger A, 2009, ASTRON ASTROPHYS, V506, P287, DOI 10.1051/0004-6361/200911933; Liddle AR, 2007, MON NOT R ASTRON SOC, V377, pL74, DOI 10.1111/j.1745-3933.2007.00306.x; Lissauer JJ, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/131; Lovis C., 2011, PREPRINT; Mayor M., 2003, MESSENGER, V114, P20; Petigura EA, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/69; Rogers L. A., 2011, B AM ASTRON SOC, V43; Sanchis-Ojeda R, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/54; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith JC, 2012, PUBL ASTRON SOC PAC, V124, P1000, DOI 10.1086/667697; Stumpe MC, 2012, PUBL ASTRON SOC PAC, V124, P985, DOI 10.1086/667698; Swift JJ, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/105; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795; Zechmeister M, 2009, ASTRON ASTROPHYS, V496, P577, DOI 10.1051/0004-6361:200811296; Zeng L, 2013, PUBL ASTRON SOC PAC, V125, P227, DOI 10.1086/669163	28	144	145	28	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					377	+		10.1038/nature12768	http://dx.doi.org/10.1038/nature12768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24172902	Green Accepted, Green Submitted			2022-12-28	WOS:000327163200036
J	Crouch, T				Crouch, Tom			Harold Melvin Agnew (1921-2013) OBITUARY	NATURE			English	Biographical-Item									Smithsonian Inst, Natl Air & Space Museum, Washington, DC 20560 USA	Smithsonian Institution	Crouch, T (corresponding author), Smithsonian Inst, Natl Air & Space Museum, Washington, DC 20560 USA.	croucht@si.edu							0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					40	40		10.1038/503040a	http://dx.doi.org/10.1038/503040a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201273	Bronze			2022-12-28	WOS:000326585600024
J	Smith, SL; Smith, IT; Branco, T; Hausser, M				Smith, Spencer L.; Smith, Ikuko T.; Branco, Tiago; Haeusser, Michael			Dendritic spikes enhance stimulus selectivity in cortical neurons in vivo	NATURE			English	Article							MOUSE VISUAL-CORTEX; PYRAMIDAL NEURONS; BARREL CORTEX; SYNAPTIC INTEGRATION; RECEPTIVE-FIELDS; BASAL DENDRITES; STRIATE CORTEX; INPUT; ORGANIZATION; POTENTIALS	Neuronal dendrites are electrically excitable: they can generate regenerative events such as dendritic spikes in response to sufficiently strong synaptic input(1-3). Although such events have been observed in many neuronal types(4-9), it is not well understood how active dendrites contribute to the tuning of neuronal output in vivo. Here we show that dendritic spikes increase the selectivity of neuronal responses to the orientation of a visual stimulus (orientation tuning). We performed direct patch-clamp recordings from the dendrites of pyramidal neurons in the primary visual cortex of lightly anaesthetized and awake mice, during sensory processing. Visual stimulation triggered regenerative local dendritic spikes that were distinct from back-propagating action potentials. These events were orientation tuned and were suppressed by either hyperpolarization of membrane potential or intracellular blockade of NMDA(N-methyl-D-aspartate) receptors. Both of these manipulations also decreased the selectivity of subthreshold orientation tuning measured at the soma, thus linking dendritic regenerative events to somatic orientation tuning. Together, our results suggest that dendritic spikes that are triggered by visual input contribute to a fundamental cortical computation: enhancing orientation selectivity in the visual cortex. Thus, dendritic excitability is an essential component of behaviourally relevant computations in neurons.	[Smith, Spencer L.; Smith, Ikuko T.; Branco, Tiago; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Smith, Spencer L.; Smith, Ikuko T.; Branco, Tiago; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Smith, Spencer L.; Smith, Ikuko T.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Smith, Spencer L.; Smith, Ikuko T.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Branco, Tiago] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	University of London; University College London; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; MRC Laboratory Molecular Biology	Smith, SL (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	slab@unc.edu; m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957	Long-Term Fellowship; Career Development Award from the Human Frontier Science Program; Klingenstein Fellowship; Helen Lyng White Fellowship; Wellcome Trust; Royal Society; MRC; ERC; Gatsby Charitable Foundation; MRC [MC_UP_1201/1] Funding Source: UKRI; Medical Research Council [MC_UP_1201/1] Funding Source: researchfish	Long-Term Fellowship; Career Development Award from the Human Frontier Science Program; Klingenstein Fellowship(Klingenstein Philanthropies); Helen Lyng White Fellowship; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); Gatsby Charitable Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to B. Clark, P. Latham, M. London, D. Ringach, A. Roth, C. Schmidt-Hieber and C. Wilms for discussions and comments on the manuscript. This work was supported by the following: a Long-Term Fellowship and a Career Development Award from the Human Frontier Science Program and a Klingenstein Fellowship (S. L. S.); a Helen Lyng White Fellowship (I. T. S.); a Wellcome Trust and Royal Society Fellowship and MRC Programme Leader Track (T. B.); and by grants from the Wellcome Trust, ERC and Gatsby Charitable Foundation (M.H.).	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; FASANO G, 1987, MON NOT R ASTRON SOC, V225, P155, DOI 10.1093/mnras/225.1.155; FERSTER D, 1992, J NEUROSCI, V12, P1262; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; LLINAS R, 1968, SCIENCE, V160, P1132, DOI 10.1126/science.160.3832.1132; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; VOLGUSHEV M, 1992, NEUROREPORT, V3, P679, DOI 10.1097/00001756-199208000-00006; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	38	231	237	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					115	+		10.1038/nature12600	http://dx.doi.org/10.1038/nature12600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24162850	Green Accepted, Green Published			2022-12-28	WOS:000326585600043
J	Dwivedi, RC; Masterson, L; Alam, M; Jani, P				Dwivedi, Raghav C.; Masterson, Liam; Alam, Mostayn; Jani, Piyush			An adult with a neck lump	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								A 40 year old man presents with a 1 cm tender soft swelling in the lateral neck region. This developed seven days after the onset of a tonsillitis episode that has now resolved. He has a 20 pack-year smoking history and consumes minimal alcohol. Examination is otherwise normal.	[Dwivedi, Raghav C.; Masterson, Liam; Jani, Piyush] Cambridge Univ Hosp NHS Trust, Dept Otolaryngol & Head & Neck Surg, Cambridge CB2 0QQ, England; [Alam, Mostayn] Nuffield Rd Med Ctr, Cambridge CB2 0QQ, England		Masterson, L (corresponding author), Cambridge Univ Hosp NHS Trust, Dept Otolaryngol & Head & Neck Surg, Cambridge CB2 0QQ, England.	raghav.rmh@gmail.com; lmm398@doctors.org.uk	masterson, liam/GQQ-9472-2022	Masterson, Liam/0000-0001-7214-030X					0	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2013	347								f5473	10.1136/bmj.f5473	http://dx.doi.org/10.1136/bmj.f5473			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247ES	24167200				2022-12-28	WOS:000326599200001
J	Finkelstein, SL; Papovich, C; Dickinson, M; Song, M; Tilvi, V; Koekemoer, AM; Finkelstein, KD; Mobasher, B; Ferguson, HC; Giavalisco, M; Reddy, N; Ashby, MLN; Dekel, A; Fazio, GG; Fontana, A; Grogin, NA; Huang, JS; Kocevski, D; Rafelski, M; Weiner, BJ; Willner, SP				Finkelstein, S. L.; Papovich, C.; Dickinson, M.; Song, M.; Tilvi, V.; Koekemoer, A. M.; Finkelstein, K. D.; Mobasher, B.; Ferguson, H. C.; Giavalisco, M.; Reddy, N.; Ashby, M. L. N.; Dekel, A.; Fazio, G. G.; Fontana, A.; Grogin, N. A.; Huang, J. -S.; Kocevski, D.; Rafelski, M.; Weiner, B. J.; Willner, S. P.			A galaxy rapidly forming stars 700 million years after the Big Bang at redshift 7.51	NATURE			English	Article							LYMAN BREAK GALAXIES; EXTRAGALACTIC LEGACY SURVEY; LY-ALPHA EMITTERS; ULTRA-DEEP-FIELD; SPECTROSCOPIC CONFIRMATION; KECK SPECTROSCOPY; REIONIZATION; CANDELS; EVOLUTION; EMISSION	Of several dozen galaxies observed spectroscopically that are candidates for having a redshift (z) in excess of seven, only five have had their redshifts confirmed via Lyman alpha emission, at z = 7.008, 7.045, 7.109, 7.213 and 7.215 (refs 1-4). The small fraction of confirmed galaxies may indicate that the neutral fraction in the intergalactic medium rises quickly at z > 6.5, given that Lyman alpha is resonantly scattered by neutral gas(3,5-8). The small samples and limited depth of previous observations, however, makes these conclusions tentative. Here we report a deep near-infrared spectroscopic survey of 43 photometrically-selected galaxies with z > 6.5. We detect a near-infrared emission line from only a single galaxy, confirming that some process is making Lyman alpha difficult to detect. The detected emission line at a wavelength of 1.0343 micrometres is likely to be Lyman alpha emission, placing this galaxy at a redshift z = 7.51, an epoch 700 million years after the Big Bang. This galaxy's colours are consistent with significant metal content, implying that galaxies become enriched rapidly. We calculate a surprisingly high star-formation rate of about 330 solar masses per year, which is more than a factor of 100 greater than that seen in the Milky Way. Such a galaxy is unexpected in a survey of our size(9), suggesting that the early Universe may harbour a larger number of intense sites of star formation than expected.	[Finkelstein, S. L.; Song, M.; Finkelstein, K. D.] Univ Texas Austin, Austin, TX 78712 USA; [Papovich, C.; Tilvi, V.] Texas A&M Univ, George P & Cynthia Woods Mitchell Inst Fundamenta, College Stn, TX 78743 USA; [Dickinson, M.] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Koekemoer, A. M.; Ferguson, H. C.; Grogin, N. A.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Mobasher, B.; Reddy, N.] Univ Calif Riverside, Riverside, CA 92521 USA; [Giavalisco, M.] Univ Massachusetts, Amherst, MA 01003 USA; [Ashby, M. L. N.; Fazio, G. G.; Huang, J. -S.; Willner, S. P.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Dekel, A.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Fontana, A.] INAF Osservatorio Roma, I-00040 Monte Porzio Catone, Italy; [Kocevski, D.] Univ Kentucky, Lexington, KY 40506 USA; [Rafelski, M.] CALTECH, Ctr Infrared Proc & Anal, Pasadena, CA 91125 USA; [Weiner, B. J.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA	University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station; National Optical Astronomy Observatory; Space Telescope Science Institute; University of California System; University of California Riverside; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Hebrew University of Jerusalem; Istituto Nazionale Astrofisica (INAF); University of Kentucky; California Institute of Technology; University of Arizona	Finkelstein, SL (corresponding author), Univ Texas Austin, 2515 Speedway,Stop C1400, Austin, TX 78712 USA.	stevenf@astro.as.utexas.edu	Koekemoer, Anton M./F-8400-2014; Dekel, Avishai/ABF-9516-2021	Koekemoer, Anton M./0000-0002-6610-2048; Dekel, Avishai/0000-0003-4174-0374; Weiner, Benjamin/0000-0001-6065-7483; fontana, adriano/0000-0003-3820-2823	W. M. Keck Foundation; NASA [NAS 5-26555]; Spitzer Space Telescope	W. M. Keck Foundation(W.M. Keck Foundation); NASA(National Aeronautics & Space Administration (NASA)); Spitzer Space Telescope(National Aeronautics & Space Administration (NASA))	We thank M. Dijkstra, J. Rhoads and S. Malhotra for conversations, as well as N. Konidaris and C. Steidel for assistance with the MOSFIRE data reduction pipeline. Wealso thank our KeckSupport Astronomer G. Wirth for assistance duringour observing run. S. L. F. acknowledges support from the University of Texas at Austin, the McDonald Observatory and NASA through a NASA Keck PI Data Award, administered by the NASA Exoplanet Science Institute. Data presented here were obtained at the W. M. Keck Observatory from telescope time allocated to NASA through the agency's scientific partnership with the California Institute of Technology and the University of California. The Observatory was made possible by the financial support of the W. M. Keck Foundation. Werecognize and acknowledge the cultural role and reverence that the summit of Mauna Kea has within the indigenous Hawaiian community. This work is also based in part on observations made with the NASA/ESA Hubble Space Telescope, obtained at the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS 5-26555, as well as the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA.	Dekel A, 2013, MON NOT R ASTRON SOC, V435, P999, DOI 10.1093/mnras/stt1338; Fan XH, 2006, ASTRON J, V132, P117, DOI 10.1086/504836; Finkelstein SL, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/93; Finkelstein SL, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/164; Finkelstein SL, 2010, ASTROPHYS J, V719, P1250, DOI 10.1088/0004-637X/719/2/1250; Grogin NA, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/35; Iye M, 2006, NATURE, V443, P186, DOI 10.1038/nature05104; Kashikawa N, 2006, ASTROPHYS J, V648, P7, DOI 10.1086/504966; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Koekemoer AM, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/36; Krumholz MR, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/16; McLean I. S., 2012, P SOC PHOTO-OPT INS, V8446; McLure RJ, 2013, MON NOT R ASTRON SOC, V432, P2696, DOI 10.1093/mnras/stt627; Ono Y, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/83; Ouchi M, 2010, ASTROPHYS J, V723, P869, DOI 10.1088/0004-637X/723/1/869; Pentericci L, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/132; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Schenker MA, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/179; Shibuya T, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/114; Smit R, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/14; Stark DP, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/129; Stark DP, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/1/L2; Vanzella E, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L35	26	190	190	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					524	527		10.1038/nature12657	http://dx.doi.org/10.1038/nature12657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153304	Green Submitted			2022-12-28	WOS:000325988400048
J	Jarenwattananon, NN; Gloggler, S; Otto, T; Melkonian, A; Morris, W; Burt, SR; Yaghi, OM; Bouchard, LS				Jarenwattananon, Nanette N.; Gloeggler, Stefan; Otto, Trenton; Melkonian, Arek; Morris, William; Burt, Scott R.; Yaghi, Omar M.; Bouchard, Louis-S.			Thermal maps of gases in heterogeneous reactions	NATURE			English	Article							PARA-HYDROGEN; PARAHYDROGEN; POLARIZATION; CATALYST	More than 85 per cent of all chemical industry products are made using catalysts(1,2), the overwhelming majority of which are heterogeneous catalysts(2) that function at the gas-solid interface(3). Consequently, much effort is invested in optimizing the design of catalytic reactors, usually by modelling(4) the coupling between heat transfer, fluid dynamics and surface reactionkinetics. The complexity involved requires a calibration of model approximations against experimental observations(5,6), with temperature maps being particularly valuable because temperature control is often essential for optimal operation and because temperature gradients contain information about the energetics of a reaction. However, it is challenging to probe the behaviour of a gas inside a reactor without disturbing its flow, particularly when trying also to map the physical parameters and gradients that dictate heat and mass flow and catalytic efficiency(1-9). Although optical techniques(10-12) and sensors(13,14) have been used for that purpose, the former perform poorly in opaque media and the latter perturb the flow. NMR thermometry can measure temperature non-invasively, but traditional approaches applied to gases produce signals that depend only weakly on temperature(15,16) are rapidly attenuated by diffusion(16,17) or require contrast agents(18) that may interfere with reactions. Here we present a new NMR thermometry technique that circumvents these problems by exploiting the inverse relationship between NMR line-widths and temperature caused by motional averaging in a weak magnetic field gradient. We demonstrate the concept by non-invasively mapping gas temperatures during the hydrogenation of propylene in reactors packed with metal nanoparticles and metal-organic framework catalysts, with measurement errors of less than four per cent of the absolute temperature. These results establish our technique as a non-invasive tool for locating hot and cold spots in catalyst-packed gas-solid reactors, with unprecedented capabilities for testing the approximations used in reactor modelling.	[Jarenwattananon, Nanette N.; Gloeggler, Stefan; Otto, Trenton; Melkonian, Arek; Morris, William; Yaghi, Omar M.; Bouchard, Louis-S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Burt, Scott R.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Yaghi, Omar M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Yaghi, Omar M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Yaghi, Omar M.] NanoCentury KAIST Inst, Taejon 305701, South Korea; [Yaghi, Omar M.] World Class Univ, Grad Sch Energy Environm Water & Sustainabil, Taejon 305701, South Korea; [Bouchard, Louis-S.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Bouchard, Louis-S.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Brigham Young University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bouchard, LS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	bouchard@chem.ucla.edu	Yaghi, Omar M/C-6749-2013	Yaghi, Omar/0000-0002-5611-3325	Dreyfus New Faculty Award; Beckman Young Investigator Award; US NSF [CHE-1153159]; BASF, Germany (synthesis); US DOE	Dreyfus New Faculty Award; Beckman Young Investigator Award; US NSF(National Science Foundation (NSF)); BASF, Germany (synthesis); US DOE(United States Department of Energy (DOE))	We thank J. Reimer, C. T. Campbell, W. S. Warren, I. Oppenheim and R. Bruinsma for discussions; N. K. Garg, C. T. Campbell, W. Gelbart and C. Knobler for reading the manuscript; M. T. Yeung for technical help with MATLAB; and J. Brown and R. Sharma for assistance with chemical synthesis. This work was funded by a Dreyfus New Faculty Award (L.-S.B.); a Beckman Young Investigator Award (L.-S.B.); US NSF CHE-1153159 (L.-S.B., O.M.Y.); BASF, Germany (synthesis); and the US DOE (O.M.Y.; porosity measurements).	Adams RW, 2009, SCIENCE, V323, P1708, DOI 10.1126/science.1168877; Beckmann PA, 2000, J MAGN RESON, V146, P379, DOI 10.1006/jmre.2000.2171; Bouchard LS, 2008, SCIENCE, V319, P442, DOI 10.1126/science.1151787; BOWERS CR, 1987, J AM CHEM SOC, V109, P5541, DOI 10.1021/ja00252a049; Burt S. R., 2008, THESIS U CALIF, p[37, 69]; Buurmans ILC, 2011, NAT CHEM, V3, P862, DOI [10.1038/NCHEM.1148, 10.1038/nchem.1148]; Callaghan P. T., 1994, PRINCIPLES NUCL MAGN, p[59, 328]; Chorkendorff I., 2007, CONCEPTS MODERN CATA, P11; Cussler E. L, 1997, DIFFUSION MASS TRANS, P13; de Smit E, 2008, NATURE, V456, P222, DOI 10.1038/nature07516; Deng HX, 2010, SCIENCE, V327, P846, DOI 10.1126/science.1181761; Dietrich T. R., 2009, TOP APPL PHYS, V10, P199; Doonan CJ, 2009, J AM CHEM SOC, V131, P9492, DOI 10.1021/ja903251e; Duckett SB, 2008, COORDIN CHEM REV, V252, P2278, DOI 10.1016/j.ccr.2008.01.028; EISENSCHMID TC, 1987, J AM CHEM SOC, V109, P8089, DOI 10.1021/ja00260a026; Ferstl W, 2007, CHEM ENG TECHNOL, V30, P370, DOI 10.1002/ceat.200600404; Galiana G, 2008, SCIENCE, V322, P421, DOI 10.1126/science.1163242; Gladden LF, 1999, TOP CATAL, V8, P87, DOI 10.1023/A:1019180220757; Hagen J., 2006, IND CATALYSIS PRACTI, P2; Horn R, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3428727; JENSEN KF, 1997, MICROREACTION TECHNO, P2; Korup O, 2011, CHEM ENG PROCESS, V50, P998, DOI 10.1016/j.cep.2011.05.024; Kovtunov KV, 2008, ANGEW CHEM INT EDIT, V47, P1492, DOI 10.1002/anie.200704881; Lysova AA, 2010, CHEM SOC REV, V39, P4585, DOI 10.1039/b919540h; Rothenberg G, 2008, CATALYSIS CONCEPTS G, P129; Schwiedernoch R, 2002, P COMBUST INST, V29, P1005, DOI 10.1016/S1540-7489(02)80127-4; Sharma R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00277; Taylor SJ, 1998, SCIENCE, V280, P267, DOI 10.1126/science.280.5361.267; Urakawa A, 2009, TOP CATAL, V52, P1312, DOI 10.1007/s11244-009-9312-3; Webb A., 2002, ANN REP NMR SPECTR, V45, P1, DOI DOI 10.1016/S0066-4103(02)45009-0	30	42	43	7	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					537	+		10.1038/nature12568	http://dx.doi.org/10.1038/nature12568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153305	Green Submitted			2022-12-28	WOS:000325988400051
J	Azari, AA; Barney, NP				Azari, Amir A.; Barney, Neal P.			Conjunctivitis A Systematic Review of Diagnosis and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE BACTERIAL CONJUNCTIVITIS; OPHTHALMIC SUSPENSION 0.6-PERCENT; SEASONAL ALLERGIC CONJUNCTIVITIS; TOPICAL LOMEFLOXACIN 0.3-PERCENT; RESISTANT STAPHYLOCOCCUS-AUREUS; 1.5-PERCENT EYE DROPS; CLINICAL-TRIAL; PHASE-III; OLOPATADINE HYDROCHLORIDE; CHALLENGE MODEL	IMPORTANCE Conjunctivitis is a common problem. OBJECTIVE To examine the diagnosis, management, and treatment of conjunctivitis, including various antibiotics and alternatives to antibiotic use in infectious conjunctivitis and use of antihistamines and mast cell stabilizers in allergic conjunctivitis. EVIDENCE REVIEW A search of the literature published through March 2013, using PubMed, the ISI Web of Knowledge database, and the Cochrane Library was performed. Eligible articles were selected after review of titles, abstracts, and references. FINDINGS Viral conjunctivitis is the most common overall cause of infectious conjunctivitis and usually does not require treatment; the signs and symptoms at presentation are variable. Bacterial conjunctivitis is the second most common cause of infectious conjunctivitis, with most uncomplicated cases resolving in 1 to 2 weeks. Mattering and adherence of the eyelids on waking, lack of itching, and absence of a history of conjunctivitis are the strongest factors associated with bacterial conjunctivitis. Topical antibiotics decrease the duration of bacterial conjunctivitis and allow earlier return to school or work. Conjunctivitis secondary to sexually transmitted diseases such as chlamydia and gonorrhea requires systemic treatment in addition to topical antibiotic therapy. Allergic conjunctivitis is encountered in up to 40% of the population, but only a small proportion of these individuals seek medical help; itching is the most consistent sign in allergic conjunctivitis, and treatment consists of topical antihistamines and mast cell inhibitors. CONCLUSIONS AND RELEVANCE The majority of cases in bacterial conjunctivitis are self-limiting and no treatment is necessary in uncomplicated cases. However, conjunctivitis caused by gonorrhea or chlamydia and conjunctivitis in contact lens wearers should be treated with antibiotics. Treatment for viral conjunctivitis is supportive. Treatment with antihistamines and mast cell stabilizers alleviates the symptoms of allergic conjunctivitis.	[Azari, Amir A.; Barney, Neal P.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Azari, AA (corresponding author), Univ Wisconsin, Dept Ophthalmol, Room F4-349,600 Highland Ave, Madison, WI 53792 USA.	amirazarimd@gmail.com		Azari, Amir/0000-0003-2013-3284	National Institutes of Health (NIH) [P30-EY016665]; Research to Prevent Blindness; Clinical and Translational Science Award program through the NIH National Center for Advancing Translational Sciences [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Clinical and Translational Science Award program through the NIH National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grant P30-EY016665 (Core Grant for Vision Research) and an unrestricted department award from Research to Prevent Blindness. The project was also supported by the Clinical and Translational Science Award program through the NIH National Center for Advancing Translational Sciences, grant UL1TR000427.	Abelson MB, 2008, AM J OPHTHALMOL, V145, P959, DOI 10.1016/j.ajo.2008.01.019; Alves MRKJ, 1993, REV BRA OFTALMOL, V52, P371; American Academy of Ophthalmology Cornea/External Disease Panel, 2011, PREF PRACT PATT GUID; Avery RK, 2008, ALBERT JAKOBIECS PRI, P4791; Azar MJ, 1996, AM J OPHTHALMOL, V121, P711, DOI 10.1016/S0002-9394(14)70640-3; Baudouin C, 2005, CURR OPIN ALLERGY CL, V5, P459, DOI 10.1097/01.all.0000183112.86181.9e; Bielory BP, 2012, ACTA OPHTHALMOL, V90, P399, DOI 10.1111/j.1755-3768.2011.02272.x; Bielory L, 2012, ALLERGY ASTHMA PROC, V33, P129, DOI 10.2500/aap.2012.33.3525; Bremond-Gignac D, 2010, PEDIATR INFECT DIS J, V29, P222, DOI 10.1097/INF.0b013e3181b99fa2; Butrus S, 2000, CLIN THER, V22, P1462, DOI 10.1016/S0149-2918(00)83044-1; Cochereau I, 2007, BRIT J OPHTHALMOL, V91, P465, DOI 10.1136/bjo.2006.103556; Cronau H, 2010, AM FAM PHYSICIAN, V81, P137; Denis F, 2008, EUR J OPHTHALMOL, V18, P858, DOI 10.1177/112067210801800602; Deschenes J, 1999, ACTA OPHTHALMOL SCAN, V77, P47, DOI 10.1111/j.1600-0420.1999.tb01174.x; Donshik PC, 2000, ADV THER, V17, P94, DOI 10.1007/BF02854842; Epling J., 2010, CLIN EVID, V2010; Epling John, 2005, Clin Evid, P756; FITCH CP, 1989, OPHTHALMOLOGY, V96, P1215; Freidlin J, 2007, AM J OPHTHALMOL, V144, P313, DOI 10.1016/j.ajo.2007.03.032; Gallenga PE, 1999, OPHTHALMOLOGICA, V213, P250, DOI 10.1159/000027430; Gibbons RJ, 2003, CIRCULATION, V107, P2979, DOI 10.1161/01.CIR.0000063682.20730.A5; GIBSON JR, 1989, J ANTIMICROB CHEMOTH, V23, P261; Gong Lan, 2010, Zhonghua Yan Ke Za Zhi, V46, P525; Granet DB, 2008, J PEDIAT OPHTH STRAB, V45, P340, DOI 10.3928/01913913-20081101-07; Gregory DG, 2008, OCUL SURF, V6, P87, DOI 10.1016/S1542-0124(12)70273-2; Greiner JV, 2005, CLIN THER, V27, P568, DOI 10.1016/j.clinthera.2005.04.011; Greiner JV, 2003, CLIN THER, V25, P1988, DOI 10.1016/S0149-2918(03)80200-X; Greiner JV, 2002, ADV THER, V19, P185, DOI 10.1007/BF02848694; Gross RD, 1997, CLIN PEDIATR, V36, P435, DOI 10.1177/000992289703600801; Gross RD, 2003, TODAYS THER TRENDS, V21, P227; HALLETT JW, 1957, AM J OPHTHALMOL, V44, P519, DOI 10.1016/0002-9394(57)90152-6; HARDING SP, 1987, EYE, V1, P512, DOI 10.1038/eye.1987.77; HORVEN I, 1993, ACTA OPHTHALMOL, V71, P165; Hovding G, 2008, ACTA OPHTHALMOL, V86, P5, DOI 10.1111/j.1600-0420.2007.01006.x; HUERVA V, 1991, Ciencia Pharmaceutica, V1, P221; Hwang DG, 2003, BRIT J OPHTHALMOL, V87, P1004, DOI 10.1136/bjo.87.8.1004; Jackson WB, 2002, CAN J OPHTHALMOL, V37, P228, DOI 10.1016/S0008-4182(02)80114-4; Karpecki P, 2009, CLIN THER, V31, P514, DOI 10.1016/j.clinthera.2009.03.010; Katusic D, 2003, AM J OPHTHALMOL, V135, P447, DOI 10.1016/S0002-9394(02)02094-9; Kaufman HE, 2011, CURR OPIN OPHTHALMOL, V22, P290, DOI 10.1097/ICU.0b013e3283477cb5; Kumaresan JA, 2003, AM J TROP MED HYG, V69, P24, DOI 10.4269/ajtmh.2003.69.24; LEIBOWITZ H M, 1991, American Journal of Ophthalmology, V112, p29S; Leibowitz HM, 2000, NEW ENGL J MED, V343, P345, DOI 10.1056/NEJM200008033430507; LOHR JA, 1988, PEDIATR INFECT DIS J, V7, P626, DOI 10.1097/00006454-198809000-00005; Mahmood AR, 2008, EMERG MED CLIN N AM, V26, P35, DOI 10.1016/j.emc.2007.10.002; Mannis MJ, 2006, DUANES OPHTHALMOLOGY; McDonald MB, 2009, OPHTHALMOLOGY, V116, P1615, DOI 10.1016/j.ophtha.2009.05.014; Miller NR, 2007, NEUROSURG FOCUS, V23, P13; MONTERO J, 1998, J CLIN RES, V1, P29; Morrow GL, 1998, AM FAM PHYSICIAN, V57, P735; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; O'Brien TP, 2009, CURR MED RES OPIN, V25, P1953, DOI 10.1185/03007990903038269; Ohnsman CM, 2007, J PEDIAT OPHTH STRAB, V44, P101, DOI 10.3928/01913913-20070301-03; Owen CG, 2004, BRIT J GEN PRACT, V54, P451; Papa V, 2002, CORNEA, V21, P43, DOI 10.1097/00003226-200201000-00010; Postema EJ, 1996, GENITOURIN MED, V72, P203; Puri LR, 2011, NEPAL J OPHTHALMOL, V3, P165, DOI http://dx.doi.org/10.3126/nepjoph.v3i2.5271; Rietveld RP, 2004, BRIT MED J, V329, P206, DOI 10.1136/bmj.38128.631319.AE; Rietveld RP, 2003, BRIT MED J, V327, P789, DOI 10.1136/bmj.327.7418.789; RONNERSTAM R, 1985, BRIT J OPHTHALMOL, V69, P385, DOI 10.1136/bjo.69.5.385; Rosario N, 2011, CURR OPIN ALLERGY CL, V11, P471, DOI 10.1097/ACI.0b013e32834a9676; Sambursky R, 2006, OPHTHALMOLOGY, V113, P1758, DOI 10.1016/j.ophtha.2006.06.029; SATTAR SA, 1988, J MED VIROL, V25, P289, DOI 10.1002/jmv.1890250306; Schwab IR, 2003, OPHTHALMOLOGY, V110, P457, DOI 10.1016/S0161-6420(02)01894-8; Shanmuganathan VA, 2005, EYE, V19, P284, DOI 10.1038/sj.eye.6701465; Sheikh A, 2005, BRIT J GEN PRACT, V55, P962; Sheikh A., 2012, COCHRANE DB SYST REV, V9; Shields T, 1991, Fam Med, V23, P544; Silverstein BE, 2011, CLIN THER, V33, P13, DOI 10.1016/j.clinthera.2010.12.004; Skevaki CL, 2011, DRUGS, V71, P331, DOI 10.2165/11585330-000000000-00000; Smith AF, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-13; STENSON S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1275; Sy A, 2012, CORNEA, V31, P786, DOI 10.1097/ICO.0b013e31823cbe6a; Szaflik J, 2009, EUR J OPHTHALMOL, V19, P1; Tabbara KF, 1999, EUR J OPHTHALMOL, V9, P269, DOI 10.1177/112067219900900403; Tarabishy AB, 2008, CLEV CLIN J MED, V75, P507, DOI 10.3949/ccjm.75.7.507; Tepedino ME, 2009, CURR MED RES OPIN, V25, P1159, DOI [10.1185/03007990902837919, 10.1185/03007990902837919 ]; Uchio E, 2000, BRIT J OPHTHALMOL, V84, P968, DOI 10.1136/bjo.84.9.968; Udeh BL, 2008, AM J MED SCI, V336, P254, DOI 10.1097/MAJ.0b013e3181637417; WARREN D, 1989, J INFECT DIS, V160, P938, DOI 10.1093/infdis/160.6.938; WILHELMUS KR, 1987, CORNEA, V6, P286, DOI 10.1097/00003226-198706040-00011; WOODLAND RM, 1992, T ROY SOC TROP MED H, V86, P317, DOI 10.1016/0035-9203(92)90328-A; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yannof J., 2004, OPHTHALMOLOGY, V2nd ed, P397; Yaylali V, 2003, ACTA OPHTHALMOL SCAN, V81, P378, DOI 10.1034/j.1600-0420.2003.00079.x; Zhang M, 2000, Yan Ke Xue Bao, V16, P146	86	242	256	1	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1721	1729		10.1001/jama.2013.280318	http://dx.doi.org/10.1001/jama.2013.280318			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24150468	Green Accepted			2022-12-28	WOS:000325948500028
J	Appleby, J				Appleby, John			What are we spending on the English NHS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Deaner B, 2013, R83 I FISC STUD; Department of Health, 2013, ANN REP ACC 2012 13; Health and Social Care Information Centre, PERS SOC SERV EXP UN; HM Treasury, 2013, CM8663; HM Treasury, CMD8639; King's Fund, 2013, JOIN CAR SUMS STOR; Morgan D, 2013, OECD HLTH WORKING PA, V60; NHS England, 2013, 180712 NHSE; West D., 2013, HLTH SERVICE J	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6287	10.1136/bmj.f6287	http://dx.doi.org/10.1136/bmj.f6287			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CI	24149821				2022-12-28	WOS:000326293800014
J	Xie, LL; Kang, HY; Xu, QW; Chen, MJ; Liao, YH; Thiyagarajan, M; O'Donnell, J; Christensen, DJ; Nicholson, C; Iliff, JJ; Takano, T; Deane, R; Nedergaard, M				Xie, Lulu; Kang, Hongyi; Xu, Qiwu; Chen, Michael J.; Liao, Yonghong; Thiyagarajan, Meenakshisundaram; O'Donnell, John; Christensen, Daniel J.; Nicholson, Charles; Iliff, Jeffrey J.; Takano, Takahiro; Deane, Rashid; Nedergaard, Maiken			Sleep Drives Metabolite Clearance from the Adult Brain	SCIENCE			English	Article							EXTRACELLULAR-SPACE; ALZHEIMERS-DISEASE; IN-VIVO; TRANSGENIC MICE; DIFFUSION; DEPRIVATION; DISRUPTION; MECHANISMS; TORTUOSITY; NETWORKS	The conservation of sleep across all animal species suggests that sleep serves a vital function. We here report that sleep has a critical function in ensuring metabolic homeostasis. Using real-time assessments of tetramethylammonium diffusion and two-photon imaging in live mice, we show that natural sleep or anesthesia are associated with a 60% increase in the interstitial space, resulting in a striking increase in convective exchange of cerebrospinal fluid with interstitial fluid. In turn, convective fluxes of interstitial fluid increased the rate of beta-amyloid clearance during sleep. Thus, the restorative function of sleep may be a consequence of the enhanced removal of potentially neurotoxic waste products that accumulate in the awake central nervous system.	[Xie, Lulu; Kang, Hongyi; Xu, Qiwu; Chen, Michael J.; Liao, Yonghong; Thiyagarajan, Meenakshisundaram; O'Donnell, John; Christensen, Daniel J.; Iliff, Jeffrey J.; Takano, Takahiro; Deane, Rashid; Nedergaard, Maiken] Univ Rochester, Med Ctr, Dept Neurosurg, Div Glial Dis & Therapeut,Ctr Translat Neuromed, Rochester, NY 14642 USA; [Nicholson, Charles] NYU, Langone Med Ctr, Dept Neurosci & Physiol, New York, NY 10016 USA	University of Rochester; New York University; NYU Langone Medical Center	Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, Div Glial Dis & Therapeut,Ctr Translat Neuromed, Rochester, NY 14642 USA.	nedergaard@urmc.rochester.edu	Xie, Lulu/N-7359-2014; Ebben, Matthew R/I-4561-2012	Xie, Lulu/0000-0002-3340-6483; Ebben, Matthew R/0000-0002-4399-7010; O'Donnell, John/0000-0002-0774-9028; Takano, Takahiro/0000-0002-6235-6673; Nicholson, Charles/0000-0002-7346-0484	NIH/National Institute of Neurological Disorders and Stroke [NS078167, NS078304, NS028642]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078167, R01NS028642, R01NS075177, R01NS078304] Funding Source: NIH RePORTER	NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH/National Institute of Neurological Disorders and Stroke (NS078167 and NS078304 to M.N. and NS028642 to C.N.). We thank S. Veasey for comments on the manuscript.	AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Barbera J, 2008, SLEEP MED, V9, P906, DOI 10.1016/j.sleep.2007.10.010; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; BORBELY AA, 1985, BRAIN MECH SLEEP, P35; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Hobson JA, 2005, NATURE, V437, P1254, DOI 10.1038/nature04283; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kinney JP, 2013, J COMP NEUROL, V521, P448, DOI 10.1002/cne.23181; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Malow Beth A, 2004, Epilepsy Curr, V4, P193, DOI 10.1111/j.1535-7597.2004.04509.x; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; MCBAIN CJ, 1990, SCIENCE, V249, P674, DOI 10.1126/science.2382142; Montagna P, 2003, LANCET NEUROL, V2, P167, DOI 10.1016/S1474-4422(03)00323-5; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; NICHOLSON C, 1993, J NEUROSCI METH, V48, P199, DOI 10.1016/0165-0270(93)90092-6; O'Donnell J, 2012, NEUROCHEM RES, V37, P2496, DOI 10.1007/s11064-012-0818-x; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stickgold R, 2006, NATURE, V444, P559, DOI 10.1038/nature05309; Sykova E, 2005, P NATL ACAD SCI USA, V102, P479, DOI 10.1073/pnas.0408235102; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008	34	2256	2350	34	761	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					373	377		10.1126/science.1241224	http://dx.doi.org/10.1126/science.1241224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136970	Green Accepted			2022-12-28	WOS:000325755100049
J	Li, MH; Chen, SW; Li, YD; Chen, YC; Cheng, YS; Hu, DJ; Tan, HQ; Wu, Q; Wang, W; Sun, ZK; Wei, XE; Zhang, JY; Qiao, RH; Zong, WH; Zhang, Y; Lou, W; Chen, ZY; Zhu, Y; Peng, DR; Ding, SX; Xu, XF; Hou, XH; Jia, WP				Li, Ming-Hua; Chen, Shi-Wen; Li, Yong-Dong; Chen, Yuan-Chang; Cheng, Ying-Sheng; Hu, Ding-Jun; Tan, Hua-Qiao; Wu, Qian; Wang, Wu; Sun, Zhen-Kui; Wei, Xiao-Er; Zhang, Jia-Yin; Qiao, Rui-Hua; Zong, Wen-Hong; Zhang, Yin; Lou, Wei; Chen, Zhi-Yuan; Zhu, Yu; Peng, De-Rong; Ding, Sui-Xin; Xu, Xue-Fan; Hou, Xu-Hong; Jia, Wei-Ping			Prevalence of Unruptured Cerebral Aneurysms in Chinese Adults Aged 35 to 75 Years	ANNALS OF INTERNAL MEDICINE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; CT ANGIOGRAPHY; MR-ANGIOGRAPHY; SUBARACHNOID HEMORRHAGE; DIAGNOSTIC-ACCURACY; DIGITAL-SUBTRACTION; NATURAL COURSE; RISK; MANAGEMENT	Background: The reported prevalence of unruptured cerebral aneurysms (UCAs) varies widely. Objective: To measure the prevalence of UCAs by using 3-dimensional time-of-flight magnetic resonance angiography in adults aged 35 to 75 years. Design: Cross-sectional study done between June 2007 and June 2011. Setting: Two communities chosen at random from 2 districts (1 urban and 1 suburban) in Shanghai, China. Participants: 4813 adults aged 35 to 75 years. Measurements: Three-dimensional time-of-flight magnetic resonance angiography, interpreted by 3 observers blinded to the participants' information, was used to identify the location and size of UCAs and to estimate the overall, age-specific, and sex-specific prevalence. Results: 369 UCAs were found in 336 participants (130 men and 206 women); 4477 participants had no evidence of UCAs. The prevalence was 7.0% overall (95% CI, 6.3% to 7.7%), with 5.5% for men (CI, 4.6% to 6.4%) and 8.4% for women (CI, 7.3% to 9.5%). The overall prevalence of UCAs was higher in women than in men (P < 0.001) and peaked at ages 55 to 64 years in men and women. The UCAs were mostly located in the internal carotid artery (81%), and 90.2% had a maximum diameter less than 5 mm. Mean diameter was larger in women than in men (3.7 mm vs. 3.2 mm; P < 0.009). Limitation: Participants were from 2 communities selected from 2 districts in Shanghai, and adults older than 75 years were not studied. Conclusion: The overall prevalence of UCAs was 7.0% in Chinese adults aged 35 to 75 years, and most lesions had a diameter less than 5 mm.	Shanghai Jiao Tong Univ, Peoples Hosp 6, Inst Diagnost & Intervent Radiol, Shanghai 200233, Peoples R China; Linfen Community Hlth Care Ctr, Shanghai, Peoples R China; Huayan Community Hlth Care Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Li, YD (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	shliminghua@163.com; dr_liyongdong@sina.com.cn; wpjia@sjtu.edu.cn			National Natural Science Foundation of China [81171440, 30970793]; Twelfth Five-Year National Science and Technology Support Program of China [2011BAI08B14, 2011BAI08B06]; Shanghai Important Subject Fund of Medicine [05III023, 074119505]; Program for Shanghai Outstanding Medical Academic Leader [06016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Twelfth Five-Year National Science and Technology Support Program of China; Shanghai Important Subject Fund of Medicine; Program for Shanghai Outstanding Medical Academic Leader	By National Natural Science Foundation of China (grants 81171440 and 30970793), Twelfth Five-Year National Science and Technology Support Program of China (grants 2011BAI08B14 and 2011BAI08B06), Shanghai Important Subject Fund of Medicine (grants 05III023 and 074119505), and Program for Shanghai Outstanding Medical Academic Leader (grant LJ 06016).	Atlas SW, 1997, RADIOLOGY, V203, P807, DOI 10.1148/radiology.203.3.9169709; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bouthillier A, 1996, NEUROSURGERY, V38, P425, DOI 10.1097/00006123-199603000-00001; Bowen BC, 2007, RADIOLOGY, V245, P357, DOI 10.1148/radiol.2452061706; Brisman JL, 2006, NEW ENGL J MED, V355, P928, DOI 10.1056/NEJMra052760; Broderick JP, 2009, STROKE, V40, P1952, DOI 10.1161/STROKEAHA.108.542571; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Harrod CG, 2006, MED HYPOTHESES, V66, P736, DOI 10.1016/j.mehy.2005.09.051; Horikoshi T, 2002, NEUROL MED-CHIR, V42, P105, DOI 10.2176/nmc.42.105; Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674; Iwamoto H, 1999, STROKE, V30, P1390, DOI 10.1161/01.STR.30.7.1390; Jayaraman MV, 2004, RADIOLOGY, V230, P510, DOI 10.1148/radiol.2302021465; Kojima M, 1998, NEUROSURGERY, V43, P776, DOI 10.1097/00006123-199810000-00026; Korogi Y, 1996, RADIOLOGY, V199, P199, DOI 10.1148/radiology.199.1.8633146; Li MH, 2011, NEUROLOGY, V77, P667, DOI 10.1212/WNL.0b013e3182299f5a; Li MH, 2009, STROKE, V40, P3127, DOI 10.1161/STROKEAHA.109.553800; Li Q, 2009, RADIOLOGY, V252, P808, DOI 10.1148/radiol.2523081911; McKinney AM, 2008, AM J NEURORADIOL, V29, P594, DOI 10.3174/ajnr.A0848; Metens T, 2000, RADIOLOGY, V216, P39, DOI 10.1148/radiology.216.1.r00jl1139; Meyers PM, 2009, STROKE, V40, pE366, DOI 10.1161/STROKEAHA.108.527572; Mhurchu CN, 2001, STROKE, V32, P606, DOI 10.1161/01.STR.32.3.606; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Morita A, 2010, NEUROL MED-CHIR, V50, P777, DOI 10.2176/nmc.50.777; Nieuwkamp DJ, 2011, STROKE, V42, P902, DOI 10.1161/STROKEAHA.110.602722; Okahara M, 2002, STROKE, V33, P1803, DOI 10.1161/01.STR.0000019510.32145.A9; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Romijn M, 2008, AM J NEURORADIOL, V29, P134, DOI 10.3174/ajnr.A0741; Schwab KE, 2008, NEUROSURGERY, V63, P29, DOI 10.1227/01.NEU.0000335068.53190.46; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wardlaw JM, 2000, BRAIN, V123, P205, DOI 10.1093/brain/123.2.205; White PM, 2001, RADIOLOGY, V219, P739, DOI 10.1148/radiology.219.3.r01ma16739; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Winn HR, 2002, J NEUROSURG, V96, P43, DOI 10.3171/jns.2002.96.1.0043; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	36	128	166	1	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					514	+		10.7326/0003-4819-159-8-201310150-00004	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126645				2022-12-28	WOS:000326751200014
J	Dufour, HD; Carroll, SB				Dufour, Heloise D.; Carroll, Sean B.			Great myths die hard	NATURE			English	Editorial Material									[Dufour, Heloise D.; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Dufour, HD (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu		Dufour, Heloise/0000-0001-7934-7549				Allchin D, 2003, SCI EDUC, V87, P329, DOI 10.1002/sce.10055; [Anonymous], 1940, J DEBATS POLITIQUES, V152, P2; [Anonymous], 1940, VET MED, V35, P5538; Carroll S., 2013, BRAVE GENIUS SCI PHI; Deville Patrick, 2012, PESTE CHOLERA; Dubos RJ., 1950, L PASTEUR FREE LANCE; Faunce T. A., 2004, PILGRIMS MED CONSCIE; FitzGerald James, 2010, WHAT DISTURBS OUR BL; Gapp M., 2001, CHEM HERITAGE, V19, P18; Magill F. N., 1993, MASTERPLOTS; Perrot A., PROPOS SUICIDE J MEI; Waller J., 2004, FABULOUS SCI FACT FI	12	3	4	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					32	33		10.1038/502032a	http://dx.doi.org/10.1038/502032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227IM	24137644	Bronze			2022-12-28	WOS:000325106000014
J	Feres, F; Costa, RA; Abizaid, A; Leon, MB; Marin-Neto, JA; Botelho, RV; King, SB; Negoita, M; Liu, ML; de Paula, JET; Mangione, JA; Meireles, GX; Castello, HJ; Nicolela, EL; Perin, MA; Devito, FS; Labrunie, A; Salvadori, D; Gusmao, M; Staico, R; Costa, JR; de Castro, JP; Abizaid, AS; Bhatt, DL				Feres, Fausto; Costa, Ricardo A.; Abizaid, Alexandre; Leon, Martin B.; Marin-Neto, J. Antonio; Botelho, Roberto V.; King, Spencer B., III; Negoita, Manuela; Liu, Minglei; de Paula, J. Eduardo T.; Mangione, Jose A.; Meireles, George X.; Castello, Helio J., Jr.; Nicolela, Eduardo L., Jr.; Perin, Marco A.; Devito, Fernando S.; Labrunie, Andre; Salvadori, Decio, Jr.; Gusmao, Marcos; Staico, Rodolfo; Costa, J. Ribamar; de Castro, Juliana P.; Abizaid, Andrea S.; Bhatt, Deepak L.		OPTIMIZE Trial Investigators	Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents The OPTIMIZE Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; OPTICAL COHERENCE TOMOGRAPHY; TERM CLINICAL-OUTCOMES; BARE-METAL STENT; CLOPIDOGREL THERAPY; NONCARDIAC SURGERY; DOUBLE-BLIND; FOLLOW-UP; DRUG; IMPLANTATION	IMPORTANCE The current recommendation is for at least 12 months of dual antiplatelet therapy after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet therapy with specific types of drug-eluting stents remains unknown. OBJECTIVE To assess the clinical noninferiority of 3 months (short-term) vs 12 months (long-term) of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (PCI) with zotarolimus-eluting stents. DESIGN, SETTING, AND PATIENTS The OPTIMIZE trial was an open-label, active-controlled, 1:1 randomized noninferiority study including 3119 patients in 33 sites in Brazil between April 2010 and March 2012. Clinical follow-up was performed at 1, 3, 6, and 12 months. Eligible patients were those with stable coronary artery disease or history of low-risk acute coronary syndrome (ACS) undergoing PCI with zotarolimus-eluting stents. INTERVENTIONS After PCI with zotarolimus-eluting stents, patients were prescribed aspirin (100-200 mg daily) and clopidogrel (75 mg daily) for 3 months (n = 1563) or 12 months (n = 1556), unless contraindicated because of occurrence of an end point. MAIN OUTCOMES AND MEASURES The primary end point was net adverse clinical and cerebral events (NACCE; a composite of all-cause death, myocardial infarction [MI], stroke, or major bleeding); the expected event rate at 1 year was 9%, with a noninferiority margin of 2.7%. Secondary end points were major adverse cardiac events (MACE; a composite of all-cause death, MI, emergent coronary artery bypass graft surgery, or target lesion revascularization) and Academic Research Consortium definite or probable stent thrombosis. RESULTS NACCE occurred in 93 patients receiving short-term and 90 patients receiving long-term therapy (6.0% vs 5.8%, respectively; risk difference, 0.17 [95% CI, -1.52 to 1.86]; P = .002 for noninferiority). Kaplan-Meier estimates demonstrated MACE rates at 1 year of 8.3%(128) in the short-term group and 7.4%(114) in the long-term group (HR, 1.12 [95% CI, 0.87-1.45]). Between 91 and 360 days, no statistically significant association was observed for NACCE (39 [2.6%] vs 38 [2.6%] for the short-and long-term groups, respectively; HR, 1.03 [95% CI, 0.66-1.60]), MACE (78 [5.3%] vs 64 [4.3%]; HR, 1.22 [95% CI, 0.88-1.70]), or stent thrombosis (4 [0.3%] vs 1 [0.1%]; HR, 3.97 [95% CI, 0.44-35.49]). CONCLUSIONS AND RELEVANCE In patients with stable coronary artery disease or low-risk ACS treated with zotarolimus-eluting stents, 3 months of dual antiplatelet therapy was noninferior to 12 months for NACCE, without significantly increasing the risk of stent thrombosis.	[Feres, Fausto; Costa, Ricardo A.; Abizaid, Alexandre; Staico, Rodolfo; Costa, J. Ribamar] Inst Dante Pazzanese Cardiol, BR-04012180 Sao Paulo, Brazil; [Leon, Martin B.] Columbia Univ, Med Ctr, New York Presbyterian Med Ctr, New York, NY USA; [Leon, Martin B.] Cardiovasc Res Fdn, New York, NY USA; [Marin-Neto, J. Antonio] Univ Sao Paulo, Sao Paulo, Brazil; [Botelho, Roberto V.] Inst Coracao Triangulo Mineiro, Uberlandia, MG, Brazil; [King, Spencer B., III] St Josephs Med Grp, Atlanta, GA USA; [Negoita, Manuela; Liu, Minglei] Medtron CardioVasc, Santa Rosa, CA USA; [de Paula, J. Eduardo T.] Unicor Linhares, Linhares, Espirito Santo, Brazil; [Mangione, Jose A.; Salvadori, Decio, Jr.] Hosp Beneficencia Portuguesa Sao Paulo, Sao Paulo, Brazil; [Meireles, George X.] Hosp Publ Estadual Sao Paulo, Sao Paulo, Brazil; [Castello, Helio J., Jr.] Hosp Bandeirantes, Sao Paulo, Brazil; [Nicolela, Eduardo L., Jr.] Emcor Emergencias Coracao, Sao Paulo, Brazil; [Perin, Marco A.] Hosp Santa Marcelina, Sao Paulo, Brazil; [Devito, Fernando S.] Hosp Padre Albino FIPA, Sao Paulo, Brazil; [Labrunie, Andre] Santa Casa Misericordia Marilia, Sao Paulo, Brazil; [Gusmao, Marcos] Hosp Agamenon Magalhaes, Recife, PE, Brazil; [de Castro, Juliana P.; Abizaid, Andrea S.] Cardiovasc Res Ctr, Sao Paulo, Brazil; [Bhatt, Deepak L.] Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA USA	Instituto Dante Pazzanese de Cardiologia; Columbia University; Cardiovascular Research Foundation (CRF); Universidade de Sao Paulo; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School	Feres, F (corresponding author), Inst Dante Pazzanese Cardiol, Ave Dante Pazzanense 500, BR-04012180 Sao Paulo, Brazil.	fferes@lee.dante.br	Perin, Marco A/O-2309-2014; Abizaid, Alexandre Antônio Cunha/H-6955-2012; Janella, Bruno L/N-3148-2014; Costa Junior, José de Ribamar/B-8215-2013; Marin-Neto, Jose Antonio/F-6099-2012; MEIRELES, GEORGE CX/H-7350-2012	Janella, Bruno L/0000-0003-1230-4653; Costa Junior, José de Ribamar/0000-0001-6286-3109; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Gomes Sarmento Leite, Rogerio Eduardo/0000-0002-9674-8528	independent clinical research organization-Cardiovascular Research Center, SA, Sao Paulo, Sao Paulo, Brazil; Medtronic Comercial Ltda, Sao Paulo, Sao Paulo, Brazil; Medtronic Comercial Ltda	independent clinical research organization-Cardiovascular Research Center, SA, Sao Paulo, Sao Paulo, Brazil; Medtronic Comercial Ltda, Sao Paulo, Sao Paulo, Brazil(Medtronic); Medtronic Comercial Ltda	The OPTIMIZE trial was a physician-initiated trial cosponsored by an independent clinical research organization-Cardiovascular Research Center, SA, Sao Paulo, Sao Paulo, Brazil, and Medtronic Comercial Ltda, Sao Paulo, Sao Paulo, Brazil. The study was funded by Medtronic Comercial Ltda.	Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Banerjee S, 2012, ATHEROSCLEROSIS, V225, P91, DOI 10.1016/j.atherosclerosis.2012.08.025; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Ben-Dor I, 2010, AM HEART J, V159, P871, DOI 10.1016/j.ahj.2010.01.016; Berger PB, 2010, JACC-CARDIOVASC INTE, V3, P920, DOI 10.1016/j.jcin.2010.03.021; Bhatt DL, 2012, LANCET, V380, P1453, DOI 10.1016/S0140-6736(12)61021-6; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Byrne RA, 2009, AM HEART J, V157, P620, DOI 10.1016/j.ahj.2008.12.019; Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Feit F, 2007, AM J CARDIOL, V100, P1364, DOI 10.1016/j.amjcard.2007.06.026; Feres F, 2012, AM HEART J, V164, P810, DOI 10.1016/j.ahj.2012.09.009; Frobert O, N ENGL J MED; Guagliumi G, 2010, JACC-CARDIOVASC INTE, V3, P531, DOI 10.1016/j.jcin.2010.02.008; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hawn MT, 2013, JAMA-J AM MED ASSOC, V310, P1462, DOI 10.1001/jama.2013.278787; Kandzari DE, 2009, JACC-CARDIOVASC INTE, V2, P1279, DOI 10.1016/j.jcin.2009.09.012; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Kim JS, 2009, JACC-CARDIOVASC INTE, V2, P1240, DOI 10.1016/j.jcin.2009.10.006; Kirtane AJ, 2013, JACC-CARDIOVASC INTE, V6, P325, DOI 10.1016/j.jcin.2012.12.123; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Levine, 2012, CIRCULATION, V125, pE412, DOI 10.1161/CIR.0b013e31824da922; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Lotan C, 2009, JACC-CARDIOVASC INTE, V2, P1227, DOI 10.1016/j.jcin.2009.10.001; Mauri L, 2010, JACC-CARDIOVASC INTE, V3, P1240, DOI 10.1016/j.jcin.2010.08.021; Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Roy P, 2009, AM J CARDIOL, V103, P801, DOI 10.1016/j.amjcard.2008.11.038; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; TOPOL EJ, 1992, J AM COLL CARDIOL, V19, P1123, DOI 10.1016/0735-1097(92)90312-B; Valgimigli M, 2013, EUR HEART J, V34, P909, DOI 10.1093/eurheartj/ehs460; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889	44	524	547	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2510	2522		10.1001/jama.2013.282183	http://dx.doi.org/10.1001/jama.2013.282183			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24177257				2022-12-28	WOS:000328503600021
J	Hashem, Y; des Georges, A; Dhote, V; Langlois, R; Liao, HY; Grassucci, RA; Pestova, TV; Hellen, CUT; Frank, J				Hashem, Yaser; des Georges, Amedee; Dhote, Vidya; Langlois, Robert; Liao, Hstau Y.; Grassucci, Robert A.; Pestova, Tatyana V.; Hellen, Christopher U. T.; Frank, Joachim			Hepatitis-C-virus-like internal ribosome entry sites displace eIF3 to gain access to the 40S subunit	NATURE			English	Article							EUKARYOTIC TRANSLATION INITIATION; SWINE-FEVER VIRUS; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; DOMAIN-II; MACROMOLECULAR COMPLEXES; CRYSTAL-STRUCTURE; 80S RIBOSOME; RNA; IRES	Hepatitis C virus (HCV) and classical swine fever virus (CSFV) messenger RNAs contain related (HCV-like) internal ribosome entry sites (IRESs) that promote 5'-end independent initiation of translation, requiring only a subset of the eukaryotic initiation factors (eIFs) needed for canonical initiation on cellular mRNAs(1). Initiation on HCV-like IRESs relies on their specific interaction with the 40S subunit(2-8), which places the initiation codon into the P site, where it directly base-pairs with eIF2-bound initiator methionyl transfer RNA to form a 48S initiation complex. However, all HCV-like IRESs also specifically interact with eIF3 (refs 2, 5-7, 9-12), but the role of this interaction in IRES-mediated initiation has remained unknown. During canonical initiation, eIF3 binds to the 40S subunit as a component of the 43S pre-initiation complex, and comparison of the ribosomal positions of eIF3(13) and the HCV IRES8 revealed that they overlap, so that their rearrangement would be required for formation of ribosomal complexes containing both components(13). Here we present a cryo-electron microscopy reconstruction of a 40S ribosomal complex containing eIF3 and the CSFV IRES. Remarkably, although the position and interactions of the CSFV IRES with the 40S subunit in this complex are similar to those of the HCV IRES in the 40S-IRES binary complex(8), eIF3 is completely displaced from its ribosomal position in the 43S complex, and instead interacts through its ribosome-binding surface exclusively with the apical region of domain III of the IRES. Our results suggest a role for the specific interaction of HCV-like IRESs with eIF3 in preventing ribosomal association of eIF3, which could serve two purposes: relieving the competition between the IRES and eIF3 for a common binding site on the 40S subunit, and reducing formation of 43S complexes, thereby favouring translation of viral mRNAs.	[Hashem, Yaser; des Georges, Amedee; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; [Hashem, Yaser; des Georges, Amedee; Langlois, Robert; Liao, Hstau Y.; Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Dhote, Vidya; Pestova, Tatyana V.; Hellen, Christopher U. T.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University	Hellen, CUT (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	christopher.hellen@downstate.edu; jf2192@columbia.edu	Georges, Amédée des/C-3588-2014	Georges, Amédée des/0000-0002-9704-3781	HHMI; National Institutes of Health (NIH) [R01 GM29169, R01 AI51340, R01 GM59660]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051340, R56AI051340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029169, R01GM059660] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Thomas for assistance in the preparation of figures and A. Jobe for critical reading of the manuscript. This work was supported by the HHMI and National Institutes of Health (NIH) grants R01GM29169 (to J.F.), NIH R01 AI51340 (to C.U.T.H.) and NIH R01 GM59660 (to T.V.P.).	Abaeva IS, 2011, EMBO J, V30, P115, DOI 10.1038/emboj.2010.302; Babaylova E, 2009, NUCLEIC ACIDS RES, V37, P1141, DOI 10.1093/nar/gkn1026; Berry KE, 2011, STRUCTURE, V19, P1456, DOI 10.1016/j.str.2011.08.002; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buratti E, 1998, NUCLEIC ACIDS RES, V26, P3179, DOI 10.1093/nar/26.13.3179; De Breyne S, 2008, RNA, V14, P367, DOI 10.1261/rna.696508; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Fletcher SP, 2002, J VIROL, V76, P5024, DOI 10.1128/JVI.76.10.5024-5033.2002; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Friis MB, 2012, J VIROL, V86, P8681, DOI 10.1128/JVI.00346-12; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hellen CUT, 2007, J VIROL, V81, P5850, DOI 10.1128/JVI.02403-06; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Ji H, 2004, P NATL ACAD SCI USA, V101, P16990, DOI 10.1073/pnas.0407402101; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kolupaeva VG, 2000, J VIROL, V74, P6242, DOI 10.1128/JVI.74.14.6242-6250.2000; Kolupaeva VG, 2000, RNA, V6, P1791, DOI 10.1017/S1355838200000662; Liao HY, 2010, I S BIOMED IMAGING, P169, DOI 10.1109/ISBI.2010.5490386; Locker N, 2007, EMBO J, V26, P795, DOI 10.1038/sj.emboj.7601549; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Lukavsky PJ, 2000, NAT STRUCT BIOL, V7, P1105; MacKerell AD., 1998, ENCY COMPUTATIONAL C, V1, P271; Malygin AA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P53, DOI 10.1134/S0006297913010069; Melcher SE, 2003, RNA, V9, P809, DOI 10.1261/rna.5130703; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 2001, RNA, V7, P1496, DOI 10.1017/S135583820101038X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Pisarev AV, 2004, J VIROL, V78, P4487, DOI 10.1128/JVI.78.9.4487-4497.2004; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; RIJNBRAND R, 1995, FEBS LETT, V365, P115, DOI 10.1016/0014-5793(95)00458-L; Rijnbrand R, 1997, J VIROL, V71, P451, DOI 10.1128/JVI.71.1.451-457.1997; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; WAGENKNECHT T, 1988, J MOL BIOL, V203, P753, DOI 10.1016/0022-2836(88)90207-0; Zhang W, 2008, STRUCTURE, V16, P1770, DOI 10.1016/j.str.2008.10.011	55	131	134	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					539	+		10.1038/nature12658	http://dx.doi.org/10.1038/nature12658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24185006	Green Accepted			2022-12-28	WOS:000327464200046
J	Le, TBK; Imakaev, MV; Mirny, LA; Laub, MT				Le, Tung B. K.; Imakaev, Maxim V.; Mirny, Leonid A.; Laub, Michael T.			High-Resolution Mapping of the Spatial Organization of a Bacterial Chromosome	SCIENCE			English	Article							ESCHERICHIA-COLI CHROMOSOME; DROSOPHILA GENOME; DNA; PROTEINS; ARCHITECTURE; PRINCIPLES; DYNAMICS; DOMAINS; COMPLEX	Chromosomes must be highly compacted and organized within cells, but how this is achieved in vivo remains poorly understood. We report the use of chromosome conformation capture coupled with deep sequencing (Hi-C) to map the structure of bacterial chromosomes. Analysis of Hi-C data and polymer modeling indicates that the Caulobacter crescentus chromosome consists of multiple, largely independent spatial domains that are probably composed of supercoiled plectonemes arrayed into a bottle brush-like fiber. These domains are stable throughout the cell cycle and are reestablished concomitantly with DNA replication. We provide evidence that domain boundaries are established by highly expressed genes and the formation of plectoneme-free regions, whereas the histone-like protein HU and SMC (structural maintenance of chromosomes) promote short-range compaction and the colinearity of chromosomal arms, respectively. Collectively, our results reveal general principles for the organization and structure of chromosomes in vivo.	[Le, Tung B. K.; Laub, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Imakaev, Maxim V.; Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Mirny, Leonid A.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Laub, Michael T.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Mirny, LA (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	leonid@mit.edu; laub@mit.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410; Imakaev, Maxim/0000-0002-5320-2728; Le, Tung BK/0000-0003-4764-8851; Laub, Michael/0000-0002-8288-7607	NIH [R01GM082899, U54CA143874]; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082899] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Hi-C data were deposited in the Gene Expression Omnibus (accession no. GSE45966). We thank M. Umbarger for help in optimizing Hi-C and G. Fudenberg, A. Goloborodko, M. Hu, and T. Maxwell for discussions. M. T. L. is an Early Career Scientist of the Howard Hughes Medical Institute. T. B. K. L is a Gordon and Betty Moore Foundation postdoctoral fellow of the Life Sciences Research Foundation. This work was supported by NIH grants to M. T. L. (R01GM082899) and L. A. M. (U54CA143874).	Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Booker BM, 2010, MOL MICROBIOL, V78, P1348, DOI 10.1111/j.1365-2958.2010.07394.x; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Graumann PL, 2009, CHROMOSOME RES, V17, P265, DOI 10.1007/s10577-008-9014-x; Guo FS, 2007, P NATL ACAD SCI USA, V104, P4309, DOI 10.1073/pnas.0611686104; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Niki H, 2000, GENE DEV, V14, P212; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Schwartz MA, 2011, MOL MICROBIOL, V82, P1359, DOI 10.1111/j.1365-2958.2011.07836.x; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Valens M, 2004, EMBO J, V23, P4330, DOI 10.1038/sj.emboj.7600434; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Volkov A, 2003, MOL CELL BIOL, V23, P5638, DOI 10.1128/MCB.23.16.5638-5650.2003	22	359	362	1	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					731	734		10.1126/science.1242059	http://dx.doi.org/10.1126/science.1242059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24158908	Green Submitted, Green Accepted			2022-12-28	WOS:000326647600041
J	McVicker, G; van de Geijn, B; Degner, JF; Cain, CE; Banovich, NE; Raj, A; Lewellen, N; Myrthil, M; Gilad, Y; Pritchard, JK				McVicker, Graham; van de Geijn, Bryce; Degner, Jacob F.; Cain, Carolyn E.; Banovich, Nicholas E.; Raj, Anil; Lewellen, Noah; Myrthil, Marsha; Gilad, Yoav; Pritchard, Jonathan K.			Identification of Genetic Variants That Affect Histone Modifications in Human Cells	SCIENCE			English	Article							HUMAN GENOME; METHYLTRANSFERASE ACTIVITY; EXPRESSION VARIATION; CHROMATIN-STRUCTURE; DYNAMICS; LINEAGE; STATE	Histone modifications are important markers of function and chromatin state, yet the DNA sequence elements that direct them to specific genomic locations are poorly understood. Here, we identify hundreds of quantitative trait loci, genome-wide, that affect histone modification or RNA polymerase II (Pol II) occupancy in Yoruba lymphoblastoid cell lines (LCLs). In many cases, the same variant is associated with quantitative changes in multiple histone marks and Pol II, as well as in deoxyribonuclease I sensitivity and nucleosome positioning. Transcription factor binding site polymorphisms are correlated overall with differences in local histone modification, and we identify specific transcription factors whose binding leads to histone modification in LCLs. Furthermore, variants that affect chromatin at distal regulatory sites frequently also direct changes in chromatin and gene expression at associated promoters.	[McVicker, Graham; van de Geijn, Bryce; Degner, Jacob F.; Cain, Carolyn E.; Banovich, Nicholas E.; Raj, Anil; Gilad, Yoav; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [McVicker, Graham; Lewellen, Noah; Myrthil, Marsha; Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [van de Geijn, Bryce; Degner, Jacob F.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Raj, Anil; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Chicago; Howard Hughes Medical Institute; Stanford University; University of Chicago; Stanford University; Stanford University	Gilad, Y (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	gilad@uchicago.edu; pritch@stanford.edu		Banovich, Nicholas/0000-0003-2604-3247; Raj, Anil/0000-0003-4412-0883; McVicker, Graham/0000-0003-0991-0951	NIH [HG007036, HG006123, GM007197, MH084703]; NSF [DGE-0638477]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007036, R01HG006123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084703] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Ruthenberg, B. Howie, and members of the Pritchard, Przeworski, Stephens, and Gilad laboratories for discussions and three anonymous reviewers for comments. This work was supported by grants from the NIH (HG007036, HG006123, GM007197 and MH084703), by an NSF predoctoral award (DGE-0638477 to B.v.d.G.), and by the Howard Hughes Medical Institute. ChIP-seq data have been deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession GSE47991. RNA-seq, DNase-seq, and MNase-seq data were previously deposited with accessions GSE19480, GSE31388, and GSE36979. J.K.P. is on the scientific advisory boards for 23andMe and DNANexus with stock options.	Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/nmeth.1937, 10.1038/NMETH.1937]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035	23	297	299	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					747	749		10.1126/science.1242429	http://dx.doi.org/10.1126/science.1242429			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24136359	Green Accepted			2022-12-28	WOS:000326647600046
J	Omuro, A; DeAngelis, LM				Omuro, Antonio; DeAngelis, Lisa M.			Glioblastoma and Other Malignant Gliomas A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PHASE-II TRIAL; GENOME-WIDE ASSOCIATION; BRAIN-TUMORS; HEPATITIS-B; TEMOZOLOMIDE; RECURRENT; RADIOTHERAPY; CHEMOTHERAPY; EXPOSURE; RISK	IMPORTANCE Glioblastomas and malignant gliomas are the most common primary malignant brain tumors, with an annual incidence of 5.26 per 100 000 population or 17 000 new diagnoses per year. These tumors are typically associated with a dismal prognosis and poor quality of life. OBJECTIVE To review the clinical management of malignant gliomas, including genetic and environmental risk factors such as cell phones, diagnostic pitfalls, symptom management, specific antitumor therapy, and common complications. EVIDENCE REVIEW Search of PubMed references from January 2000 to May 2013 using the terms glioblastoma, glioma, malignant glioma, anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligoastrocytoma, and brain neoplasm. Articles were also identified through searches of the authors' own files. Evidence was graded using the American Heart Association classification system. FINDINGS Only radiation exposure and certain genetic syndromes are well-defined risk factors for malignant glioma. The treatment of newly diagnosed glioblastoma is based on radiotherapy combined with temozolomide. This approach doubles the 2-year survival rate to 27%, but overall prognosis remains poor. Bevacizumab is an emerging treatment alternative that deserves further study. Grade III tumors have been less well studied, and clinical trials to establish standards of care are ongoing. Patients with malignant gliomas experience frequent clinical complications, including thromboembolic events, seizures, fluctuations in neurologic symptoms, and adverse effects from corticosteroids and chemotherapies that require proper management and prophylaxis. CONCLUSIONS AND RELEVANCE Glioblastoma remains a difficult cancer to treat, although therapeutic options have been improving. Optimal management requires a multidisciplinary approach and knowledge of potential complications from both the disease and its treatment.	[Omuro, Antonio; DeAngelis, Lisa M.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Omuro, A (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10065 USA.	omuroa@mskcc.org		DeAngelis, Lisa/0000-0002-6290-7818; Omuro, Antonio/0000-0003-4299-3664	Clinical and Translational Science Center	Clinical and Translational Science Center	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Omuro reported having served on advisory boards for Roche La Hoffman, Novocure, and Schering-Plough/Merck. Dr DeAngelis reported having served as a consultant to the NFL Players Association, received grants from the Clinical and Translational Science Center, received royalties from Oxford, and received travel reimbursements as a board member for the American Academy of Neurology.	Abrey LE, 2007, NEURO-ONCOLOGY, V9, P314, DOI 10.1215/15228517-2007-002; Batchelor TT, 2013, J CLIN ONCOL, V31, P3212, DOI 10.1200/JCO.2012.47.2464; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; BRADLEY WG, 1984, RADIOLOGY, V152, P695, DOI 10.1148/radiology.152.3.6463251; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Buhring U, 2001, NEUROLOGY, V57, P393, DOI 10.1212/WNL.57.3.393; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Corle C, 2012, J NEURO-ONCOL, V106, P1, DOI 10.1007/s11060-011-0663-9; de Wit MCY, 2004, NEUROLOGY, V63, P535, DOI 10.1212/01.WNL.0000133398.11870.9A; Delios AM, 2012, J CLIN ONCOL, V30; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; FORSYTH PA, 1993, NEUROLOGY, V43, P1678, DOI 10.1212/WNL.43.9.1678; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Gibbons RJ, 2003, CIRCULATION, V107, P2979, DOI 10.1161/01.CIR.0000063682.20730.A5; Gilbert MR, 2013, J CLIN ONCOL SUPPL, V31, P1; Glantz MJ, 2000, NEUROLOGY, V54, P1886, DOI 10.1212/WNL.54.10.1886; Grewal J, 2007, NEW ENGL J MED, V356, P1591, DOI 10.1056/NEJMc063696; Gu J, 2009, NEUROTHERAPEUTICS, V6, P427, DOI 10.1016/j.nurt.2009.05.001; Hardell Lennart, 2013, Pathophysiology, V20, P85, DOI 10.1016/j.pathophys.2012.11.001; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Holdhoff M, 2013, J NEURO-ONCOL, V113, P343, DOI 10.1007/s11060-013-1113-7; Hottinger AF, 2007, CURR NEUROL NEUROSCI, V7, P200, DOI 10.1007/s11910-007-0031-5; Huber R, 2005, EUR J NEUROSCI, V21, P1000, DOI 10.1111/j.1460-9568.2005.03929.x; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Kalva SP, 2008, J VASC INTERV RADIOL, V19, P1041, DOI 10.1016/j.jvir.2008.03.026; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Kwon S, 2013, AM J MED SCI, V345, P274, DOI 10.1097/MAJ.0b013e31828a6a01; Link TW, 2012, J CLIN NEUROSCI, V19, P996, DOI 10.1016/j.jocn.2011.09.031; Linos E, 2007, JNCI-J NATL CANCER I, V99, P1544, DOI 10.1093/jnci/djm170; Louis DN., 2007, WHO CLASSIFICATION T, V4; Mahindra AK, 2003, J NEURO-ONCOL, V63, P263, DOI 10.1023/A:1024217527650; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; Maschio M, 2011, J NEURO-ONCOL, V104, P205, DOI 10.1007/s11060-010-0460-x; Omuro A, 2013, NEURO-ONCOLOGY, V15, P242, DOI 10.1093/neuonc/nos295; Omuro AMP, 2007, MOL CANCER THER, V6, P1909, DOI 10.1158/1535-7163.MCT-07-0047; Omuro AMP, 2006, LANCET NEUROL, V5, P937, DOI 10.1016/S1474-4422(06)70597-X; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Perry JR, 2012, NEURO-ONCOLOGY, V14, P73, DOI 10.1093/neuonc/nos197; Perry JR, 2010, J CLIN ONCOL, V28, P2051, DOI 10.1200/JCO.2009.26.5520; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Rajaraman P, 2012, HUM GENET, V131, P1877, DOI 10.1007/s00439-012-1212-0; Seystahl K, 2013, EUR NEUROL, V69, P95, DOI 10.1159/000343811; Sherman JH, 2011, CURR NEUROL NEUROSCI, V11, P313, DOI 10.1007/s11910-011-0188-9; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Theeler BJ, 2012, NEUROLOGY, V79, P1917, DOI 10.1212/WNL.0b013e318271f7cb; Tsao MN, 2005, INT J RADIAT ONCOL, V63, P47, DOI 10.1016/j.ijrobp.2005.05.024; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P808, DOI 10.1001/jama.2011.186; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; Wick A, 2007, J CLIN ONCOL, V25, P3357, DOI 10.1200/JCO.2007.10.7722; Wick W, 2013, ASCO M S, V31, P2002; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Yadav AK, 2009, JAMA-J AM MED ASSOC, V302, P276, DOI 10.1001/jama.2009.1022; Young RJ, 2013, CLIN IMAG, V37, P41, DOI 10.1016/j.clinimag.2012.02.016; Yung WKA, 1999, J CLIN ONCOL, V17, P2762, DOI 10.1200/JCO.1999.17.9.2762	62	1423	1488	31	420	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1842	1850		10.1001/jama.2013.280319	http://dx.doi.org/10.1001/jama.2013.280319			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193082				2022-12-28	WOS:000326550900018
J	McLellan, JS; Chen, M; Joyce, MG; Sastry, M; Stewart-Jones, GBE; Yang, YP; Zhang, BS; Chen, L; Srivatsan, S; Zheng, AQ; Zhou, TQ; Graepel, KW; Kumar, A; Moin, S; Boyington, JC; Chuang, GY; Soto, C; Baxa, U; Bakker, AQ; Spits, H; Beaumont, T; Zheng, ZZ; Xia, NS; Ko, SY; Todd, JP; Rao, S; Graham, BS; Kwong, PD				McLellan, Jason S.; Chen, Man; Joyce, M. Gordon; Sastry, Mallika; Stewart-Jones, Guillaume B. E.; Yang, Yongping; Zhang, Baoshan; Chen, Lei; Srivatsan, Sanjay; Zheng, Anqi; Zhou, Tongqing; Graepel, Kevin W.; Kumar, Azad; Moin, Syed; Boyington, Jeffrey C.; Chuang, Gwo-Yu; Soto, Cinque; Baxa, Ulrich; Bakker, Arjen Q.; Spits, Hergen; Beaumont, Tim; Zheng, Zizheng; Xia, Ningshao; Ko, Sung-Youl; Todd, John-Paul; Rao, Srinivas; Graham, Barney S.; Kwong, Peter D.			Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus	SCIENCE			English	Article							NEUTRALIZATION; ANTIBODIES; PROTEIN; EPITOPE	Respiratory syncytial virus (RSV) is the leading cause of hospitalization for children under 5 years of age. We sought to engineer a viral antigen that provides greater protection than currently available vaccines and focused on antigenic site empty set, a metastable site specific to the prefusion state of the RSV fusion (F) glycoprotein, as this site is targeted by extremely potent RSV-neutralizing antibodies. Structure-based design yielded stabilized versions of RSV F that maintained antigenic site empty set when exposed to extremes of pH, osmolality, and temperature. Six RSV F crystal structures provided atomic-level data on how introduced cysteine residues and filled hydrophobic cavities improved stability. Immunization with site empty set-stabilized variants of RSV F in mice and macaques elicited levels of RSV-specific neutralizing activity many times the protective threshold.	[McLellan, Jason S.; Chen, Man; Joyce, M. Gordon; Sastry, Mallika; Stewart-Jones, Guillaume B. E.; Yang, Yongping; Zhang, Baoshan; Chen, Lei; Srivatsan, Sanjay; Zheng, Anqi; Zhou, Tongqing; Graepel, Kevin W.; Kumar, Azad; Moin, Syed; Boyington, Jeffrey C.; Chuang, Gwo-Yu; Soto, Cinque; Ko, Sung-Youl; Todd, John-Paul; Rao, Srinivas; Graham, Barney S.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Baxa, Ulrich] SAIC Frederick Inc, Electron Microscope Lab, Adv Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Bakker, Arjen Q.; Spits, Hergen; Beaumont, Tim] AIMM Therapeut, Acad Med Ctr, NL-1105 BA Amsterdam, Netherlands; [Zheng, Zizheng; Xia, Ningshao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen 361005, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Amsterdam; Academic Medical Center Amsterdam; Xiamen University	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov; pdkwong@nih.gov	Spits, Hergen/N-2581-2019; Graham, Barney S./AAC-5898-2019; Kumar, Azad/AAD-2093-2020; Zhou, Tongqing/A-6880-2010	Spits, Hergen/0000-0003-3269-8338; Graham, Barney S./0000-0001-8112-0853; Zhou, Tongqing/0000-0002-3935-4637; Xia, Ningshao/0000-0003-0179-5266; Baxa, Ulrich/0000-0002-7263-5078; McLellan, Jason/0000-0003-3991-542X; Moin, Syed/0000-0001-8789-9167	National Institute of Allergy and Infectious Diseases; National Natural Science Foundation of China [81161120419, 812111615]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005061] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. M. Salazar for poly-ICLC; J. Stuckey for assistance with figures; I. S. Georgiev and M. Pancera for assistance with immunogen design; G. J. Nabel, R. A. Seder, L. Shapiro, and members of the Structural Biology Section; Structural Bioinformatics Core Section; and Viral Pathogenesis Laboratory at the Vaccine Research Center for helpful comments; and J. Chrzas, J. Gonczy, U. Chinte, and staff at SER-CAT (Southeast Regional Collaborative Access Team) for help with x-ray diffraction data collection. The data presented in this manuscript are tabulated in the main paper and supplementary materials. Atomic coordinates and structure factors of the reported crystal structures have been deposited in the Protein Data Bank under accession codes 4MMQ to 4MMV. Support for this work was provided by the Intramural Research Program (National Institute of Allergy and Infectious Diseases) and the National Natural Science Foundation of China (81161120419 and 812111615). Use of insertion device 22 (SER-CAT) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. H. S. and T. B. are inventors on an international patent application describing the technology used to isolate D25 and AM22 (Means and methods for influencing the stability of antibody producing cells, WO2007067046A1). A. Q. B. and T. B. are inventors on international patent applications for antibody D25 (RSV-specific binding molecules and means for producing them, WO2008147196A2) and antibody AM22 (RSV-specific binding molecule, WO2011043643A1). J. S. M., M. G. J., B.Z., B. S. G., and P. D. K. are inventors on U. S. patent applications describing the use of prefusion-stabilized RSV F glycoproteins as vaccine antigens (Prefusion RSV F proteins and their use, 61/798,389 and 61/863,909). J. S. M., M. C., Z.Z., N.X., and B. S. G. are inventors on a Chinese patent application for antibody 5C4 and its epitope (Anti-RSV high neutralization antibody and the peptide can be used for prevention of RSV infection and related disease, 201310082338.1). Reagents from the NIH are subject to nonrestrictive materials transfer agreements.	Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Beaumont T., 2012, Patent Application, Patent No. [12/898,325, 12898325]; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Delany I, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012476; Dormitzer PR, 2012, NAT REV MICROBIOL, V10, P807, DOI 10.1038/nrmicro2893; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; EFIMOV VP, 1994, J MOL BIOL, V242, P470, DOI 10.1006/jmbi.1994.1595; GARTEN W, 1983, J GEN VIROL, V64, P2127, DOI 10.1099/0022-1317-64-10-2127; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Liljeroos L, 2013, P NATL ACAD SCI USA, V110, P11133, DOI 10.1073/pnas.1309070110; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2011, J MOL BIOL, V409, P853, DOI 10.1016/j.jmb.2011.04.044; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Miroshnikov KA, 1998, PROTEIN ENG, V11, P329, DOI 10.1093/protein/11.4.329; Mora M, 2006, CURR OPIN MICROBIOL, V9, P532, DOI 10.1016/j.mib.2006.07.003; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Nabel GJ, 2009, SCIENCE, V326, P53, DOI 10.1126/science.1177637; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pancera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055701; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Spits H., 2010, Patent Application, Patent No. [12/600,950, 12600950]; Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	33	549	624	6	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					592	598		10.1126/science.1243283	http://dx.doi.org/10.1126/science.1243283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179220	Green Accepted			2022-12-28	WOS:000326334300041
J	Gwynne, P				Gwynne, Peter			NEXT-GENERATION SCANS Seeing into the future	NATURE			English	Editorial Material																		Balog J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005623; Walker-Samuel S, 2013, NAT MED, V19, P1067, DOI 10.1038/nm.3252	2	1	1	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S96	S97		10.1038/502S96a	http://dx.doi.org/10.1038/502S96a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187706	Bronze			2022-12-28	WOS:000326293200009
J	Arie, S				Arie, Sophie			BRIEFING Are migrant patients really a drain on European health systems?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophiearie@fmail.co.uk		Curtis, Hilary/0000-0002-1440-1812				Centre for Research and Analysis of Migration, 2009, ASS FISC COSTS BEN A; Creative Research, 2013, QUAL ASS VIS MIGR US; Department of Health, 2013, SUST SERV ENS FAIRN; European Commission, 2013, IMP MOB EU CIT NAT S; Rada AG, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5716; Graupner H, 2009, DTSCH WELLE     0226; Hanefield J, 2001, PLOS ONE, V201; Iacobucci G., 2013, BMJ-BRIT MED J, V347, pf6408; International Organization for Migration, 2013, INT MIGR HLTH HUM RI; Medecins du Monde, 2013, ACC HEALTHC EUR TIM; NHS Choices, SEEK MED TREATM EUR; OECD, INT MIGR OUTL 2013	12	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2013	347								f6444	10.1136/bmj.f6444	http://dx.doi.org/10.1136/bmj.f6444			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EV	24169570				2022-12-28	WOS:000326599500016
J	Jones, CW; Handler, L; Crowell, KE; Keil, LG; Weaver, MA; Platts-Mills, TF				Jones, Christopher W.; Handler, Lara; Crowell, Karen E.; Keil, Lukas G.; Weaver, Mark A.; Platts-Mills, Timothy F.			Non-publication of large randomized clinical trials: cross sectional analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REPORTING BIAS; REGISTRATION; CLINICALTRIALS.GOV; QUALITY; DISCREPANCIES; METAANALYSES	Objective To estimate the frequency with which results of large randomized clinical trials registered with ClinicalTrials.gov are not available to the public. Design Cross sectional analysis Setting Trials with at least 500 participants that were prospectively registered with ClinicalTrials.gov and completed prior to January 2009. Data sources PubMed, Google Scholar, and Embase were searched to identify published manuscripts containing trial results. The final literature search occurred in November 2012. Registry entries for unpublished trials were reviewed to determine whether results for these studies were available in the ClinicalTrials.gov results database. Main outcome measures The frequency of non-publication of trial results and, among unpublished studies, the frequency with which results are unavailable in the ClinicalTrials.gov database. Results Of 585 registered trials, 171 (29%) remained unpublished. These 171 unpublished trials had an estimated total enrollment of 299 763 study participants. The median time between study completion and the final literature search was 60 months for unpublished trials. Non-publication was more common among trials that received industry funding (150/468, 32%) than those that did not (21/117, 18%), P=0.003. Of the 171 unpublished trials, 133 (78%) had no results available in ClinicalTrials.gov. Conclusions Among this group of large clinical trials, non-publication of results was common and the availability of results in the ClinicalTrials.gov database was limited. A substantial number of study participants were exposed to the risks of trial participation without the societal benefits that accompany the dissemination of trial results.	[Jones, Christopher W.] Rowan Univ, Dept Emergency Med, Cooper Med Sch, Camden, NJ 08103 USA; [Handler, Lara; Crowell, Karen E.] Univ N Carolina, Sch Med, Hlth Sci Lib, Chapel Hill, NC USA; [Keil, Lukas G.; Platts-Mills, Timothy F.] Univ N Carolina, Dept Emergency Med, Chapel Hill, NC USA; [Weaver, Mark A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	Rowan University; Cooper Medical School of Rowan University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jones, CW (corresponding author), Rowan Univ, Dept Emergency Med, Cooper Med Sch, 1 Cooper Plaza, Camden, NJ 08103 USA.	cjones.unc@gmail.com		Handler, Lara/0000-0002-9791-8947	National Center for Research Resources; National Center for Advancing Translational Sciences [UL1TR000083]; National Center for Research Resources [KL2 TR00084]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000084, UL1TR000083] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	MAW is supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences through Grant UL1TR000083. TPM is supported by the National Center for Research Resources through Grant KL2 TR00084. These sponsors had no role in the study design, data collection, data analysis, data interpretation, or manuscript preparation. The corresponding author had full access to all the study data and had final responsibility for the decision to submit the manuscript for publication.	Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Clinicaltrials.gov, RES DAT; ClinicalTrials.gov, GLOSS COMM SIT TERMS; ClinicalTrials. gov, FDAAA 801 REQ; Cobo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000332; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Dekkers OM, 2011, J CLIN EPIDEMIOL, V64, P1034, DOI 10.1016/j.jclinepi.2010.12.008; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Gibson LM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-43; Gillen JE, 2004, STUD HEALTH TECHNOL, V107, P1466; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Jones CW, 2012, ANN EMERG MED, V60, P458, DOI 10.1016/j.annemergmed.2012.02.005; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Levin LA, 2007, ARCH INTERN MED, V167, P1576, DOI 10.1001/archinte.167.15.1576; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; McGee RG, 2011, TRANSPLANTATION, V92, P1094, DOI 10.1097/TP.0b013e318232baf2; Moher D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c869; Moreno J, 1998, JAMA-J AM MED ASSOC, V280, P1951, DOI 10.1001/jama.280.22.1951; MUNRO AJ, 1993, BRIT MED J, V307, P1340, DOI 10.1136/bmj.307.6915.1340; Nieminen Pentti, 2006, BMC Med Res Methodol, V6, P42, DOI 10.1186/1471-2288-6-42; PEARN J, 1995, BRIT MED J, V310, P1313, DOI 10.1136/bmj.310.6990.1313; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; ROSS JS, 2011, BMJ-BRIT MED J, V344, pD7292, DOI DOI 10.1136/BMJ.D7292; Sekeres M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001610; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Strech D, 2012, J CLIN EPIDEMIOL, V65, P276, DOI 10.1016/j.jclinepi.2011.07.002; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Turner EH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001189; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; World Medical Association, DECL HELS ETH PRINC, P1; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	50	203	205	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2013	347								f6104	10.1136/bmj.f6104	http://dx.doi.org/10.1136/bmj.f6104			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EV	24169943	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000326599500004
J	Hoffmann, DE; Fraser, CM; Palumbo, FB; Ravel, J; Rothenberg, K; Rowthorn, V; Schwartz, J				Hoffmann, D. E.; Fraser, C. M.; Palumbo, F. B.; Ravel, J.; Rothenberg, K.; Rowthorn, V.; Schwartz, J.			Probiotics: Finding the Right Regulatory Balance	SCIENCE			English	Editorial Material									[Hoffmann, D. E.; Rothenberg, K.; Rowthorn, V.; Schwartz, J.] Univ Maryland, Sch Law, Baltimore, MD 21201 USA; [Fraser, C. M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Palumbo, F. B.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Hoffmann, DE (corresponding author), Univ Maryland, Sch Law, Baltimore, MD 21201 USA.	dhoffman@law.umaryland.edu	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233; Fraser, Claire/0000-0003-1462-2428	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005171] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG005171, R01-HG005171] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		FDA, 2010, GUID IND EARL CLIN T; Floch MH, 2011, J CLIN GASTROENTEROL, V45, pS168, DOI 10.1097/MCG.0b013e318230928b; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Grzeskowiak L, 2011, BRIT J NUTR, V105, P887, DOI 10.1017/S0007114510004496; Health Canada, 2012, PROB; Hoffmann D., 2013, FEDERAL REGULA UNPUB; *JOINT FAO UN WHO, 2001, HLTH NUTR PROP PROB; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Olle B, 2013, NAT BIOTECHNOL, V31, P309, DOI 10.1038/nbt.2548; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Sanders ME, 2011, GUT MICROBES, V2, P127, DOI 10.4161/gmic.2.3.16174; Satine LA, 2008, FOOD DRUG LAW J, V63, P537; Schardt D., 2006, NUTR ACTION HEALTHLE; Slashinski MJ, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-28; Vaillancourt J, 2006, ENDING WAR METAPHOR, P229	15	38	42	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					314	315		10.1126/science.1244656	http://dx.doi.org/10.1126/science.1244656			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136953	Green Submitted, Green Accepted			2022-12-28	WOS:000325755100027
J	Kandoth, C; McLellan, MD; Vandin, F; Ye, K; Niu, BF; Lu, C; Xie, MC; Zhang, QY; McMichael, JF; Wyczalkowski, MA; Leiserson, MDM; Miller, CA; Welch, JS; Walter, MJ; Wendl, MC; Ley, TJ; Wilson, RK; Raphael, BJ; Ding, L				Kandoth, Cyriac; McLellan, Michael D.; Vandin, Fabio; Ye, Kai; Niu, Beifang; Lu, Charles; Xie, Mingchao; Zhang, Qunyuan; McMichael, Joshua F.; Wyczalkowski, Matthew A.; Leiserson, Mark D. M.; Miller, Christopher A.; Welch, John S.; Walter, Matthew J.; Wendl, Michael C.; Ley, Timothy J.; Wilson, Richard K.; Raphael, Benjamin J.; Ding, Li			Mutational landscape and significance across 12 major cancer types	NATURE			English	Article							SOMATIC POINT MUTATIONS; BRCA2 MUTATIONS; HUMAN BREAST; SURVIVAL; PATHWAYS; ASSOCIATION; DISCOVERY; EVOLUTION; PBRM1	The Cancer Genome Atlas (TCGA) has used the latest sequencing and analysis methods to identify somatic variants across thousands of tumours. Here we present data and analytical results for point mutations and small insertions/deletions from 3,281 tumours across 12 tumour types as part of the TCGA Pan-Cancer effort. We illustrate the distributions of mutation frequencies, types and contexts across tumour types, and establish their links to tissues of origin, environmental/carcinogen influences, and DNA repair defects. Using the integrated data sets, we identified 127 significantly mutated genes from well-known(for example, mitogen-activated protein kinase, phosphatidylinositol-3-OH kinase, Wnt/beta-catenin and receptor tyrosine kinase signalling pathways, and cell cycle control) and emerging (for example, histone, histone modification, splicing, metabolism and proteolysis) cellular processes in cancer. The average number of mutations in these significantly mutated genes varies across tumour types; most tumours have two to six, indicating that the number of driver mutations required during oncogenesis is relatively small. Mutations in transcriptional factors/regulators show tissue specificity, whereas histone modifiers are often mutated across several cancer types. Clinical association analysis identifies genes having a significant effect on survival, and investigations of mutations with respect to clonal/subclonal architecture delineate their temporal orders during tumorigenesis. Taken together, these results lay the groundwork for developing new diagnostics and individualizing cancer treatment.	[Kandoth, Cyriac; McLellan, Michael D.; Ye, Kai; Niu, Beifang; Lu, Charles; Xie, Mingchao; Zhang, Qunyuan; McMichael, Joshua F.; Wyczalkowski, Matthew A.; Miller, Christopher A.; Wendl, Michael C.; Ley, Timothy J.; Wilson, Richard K.; Ding, Li] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Vandin, Fabio; Leiserson, Mark D. M.; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Ye, Kai; Zhang, Qunyuan; Wendl, Michael C.; Ley, Timothy J.; Wilson, Richard K.; Ding, Li] Washington Univ, Dept Genet, St Louis, MO 63108 USA; [Welch, John S.; Walter, Matthew J.; Ley, Timothy J.; Ding, Li] Washington Univ, Dept Med, St Louis, MO 63108 USA; [Welch, John S.; Walter, Matthew J.; Ley, Timothy J.; Wilson, Richard K.; Ding, Li] Washington Univ, Siteman Canc Ctr, St Louis, MO 63108 USA; [Wendl, Michael C.] Washington Univ, Dept Math, St Louis, MO 63108 USA	Washington University (WUSTL); Brown University; Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Ding, L (corresponding author), Washington Univ, Genome Inst, St Louis, MO 63108 USA.	lding@genome.wustl.edu	Ye, Kai/B-3640-2012; Ye, Kai/GSD-9856-2022; Wilson, Richard K./AAF-4139-2019; wang, edwin/G-5372-2010; Walter, Matthew J/S-7758-2018; Miller, Christopher A./A-1060-2009	Ye, Kai/0000-0002-2851-6741; Wilson, Richard K./0000-0002-1992-1358; Miller, Christopher A./0000-0003-4266-6700; Wyczalkowski, Matthew/0000-0003-4197-551X; Kandoth, Cyriac/0000-0002-1345-3573; MCLELLAN, MICHAEL/0000-0002-2703-8784	National Cancer Institute [R01CA180006, PO1CA101937]; National Human Genome Research Institute [R01HG005690, U54HG003079, U01HG006517]; National Science Foundation [IIS-1016648]; NATIONAL CANCER INSTITUTE [R01CA180006, P01CA101937] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, R01HG005690, U01HG006517] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Cancer Institute grants R01CA180006 to L. D. and PO1CA101937 to T.J.L., and National Human Genome Research Institute grants R01HG005690 to B.J.R., U54HG003079 to R. K. W., and U01HG006517 to L. D., and National Science Foundation grant IIS-1016648 to B.J.R. We gratefully acknowledge the contributions from TCGA Research Network and its TCGA Pan-Cancer Analysis Working Group. We also thank M. Bharadwaj for technical assistance.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bolton KL, 2012, JAMA-J AM MED ASSOC, V307, P382, DOI 10.1001/jama.2012.20; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Ma ZY, 2011, IEEE T PATTERN ANAL, V33, P2160, DOI 10.1109/TPAMI.2011.63; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Myung JK, 2012, ONCOL REP, V28, P1639, DOI 10.3892/or.2012.1994; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tao MH, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12431; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456	38	2797	2888	9	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					333	+		10.1038/nature12634	http://dx.doi.org/10.1038/nature12634			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132290	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000325706300045
J	Rafelson, W				Rafelson, William			The Warmth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Brown Univ, Rhode Isl Hosp, Dept Med, Warren Alpert Med Sch, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Rafelson, W (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Med, Warren Alpert Med Sch, Providence, RI 02903 USA.	wrafelson@lifespan.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1565	1566		10.1001/jama.2013.277425	http://dx.doi.org/10.1001/jama.2013.277425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129462				2022-12-28	WOS:000325624800017
J	Landers, S				Landers, Steven			The Future of the Medicare Home Health Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Landers, Steven] Visiting Nurse Assoc Hlth Grp, Red Bank, NJ 07701 USA; [Landers, Steven] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Landers, S (corresponding author), Visiting Nurse Assoc Hlth Grp, 176 Riverside Ave, Red Bank, NJ 07701 USA.	steven.landers@vnahg.org						[Centers for Medicare & Medicaid Services. U. S. Department of Health and Human Services], 2012, REP C POST CAR PAYM; Centers for Medicare & Medicaid Services, 2013, HOM HLTH PROSP PAYM; Department of Health and Human Services Office of Inspector General, 2012, IN QUEST BILL MED HO; Dobson A., 2012, CLIN APPROPRIATE COS; Farber N., 2011, AGING PLACE STATE SU; Hackbarth GM, REPORT C MEDICARE PA	6	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1443	1444		10.1001/jama.2013.278062	http://dx.doi.org/10.1001/jama.2013.278062			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24137758				2022-12-28	WOS:000325354100015
J	Basner, M; Babisch, W; Davis, A; Brink, M; Clark, C; Janssen, S; Stansfeld, S				Basner, Mathias; Babisch, Wolfgang; Davis, Adrian; Brink, Mark; Clark, Charlotte; Janssen, Sabine; Stansfeld, Stephen			Auditory and non-auditory effects of noise on health	LANCET			English	Review							ROAD TRAFFIC NOISE; INTENSIVE CORONARY-CARE; INDUCED HEARING-LOSS; AIRCRAFT NOISE; COMMUNITY NOISE; BLOOD-PRESSURE; AIR-POLLUTION; EXPOSURE; SLEEP; DISEASE	Noise is pervasive in everyday life and can cause both auditory and non-auditory health effects. Noise-induced hearing loss remains highly prevalent in occupational settings, and is increasingly caused by social noise exposure (eg, through personal music players). Our understanding of molecular mechanisms involved in noise-induced hair-cell and nerve damage has substantially increased, and preventive and therapeutic drugs will probably become available within 10 years. Evidence of the non-auditory effects of environmental noise exposure on public health is growing. Observational and experimental studies have shown that noise exposure leads to annoyance, disturbs sleep and causes daytime sleepiness, affects patient outcomes and staff performance in hospitals, increases the occurrence of hypertension and cardiovascular disease, and impairs cognitive performance in schoolchildren. In this Review, we stress the importance of adequate noise prevention and mitigation strategies for public health.	[Basner, Mathias] Univ Penn, Perelman Sch Med, Unit Expt Psychiat, Div Sleep & Chronobiol,Dept Psychiat, Philadelphia, PA 19104 USA; [Babisch, Wolfgang] Fed Environm Agcy, Dept Environm Hyg, Berlin, Germany; [Davis, Adrian] Publ Hlth England, London, England; [Davis, Adrian] UCL, Ear Inst, London, England; [Brink, Mark] ETH, D MTEC Publ & Org Hlth, Zurich, Switzerland; [Clark, Charlotte; Stansfeld, Stephen] Queen Mary Univ London, Ctr Psychiat, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England; [Janssen, Sabine] TNO Netherlands Org Appl Sci Res, Dept Urban Environm & Safety, Delft, Netherlands	University of Pennsylvania; Pennsylvania Medicine; Public Health England; University of London; University College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of London; Queen Mary University London; Netherlands Organization Applied Science Research	Basner, M (corresponding author), Univ Penn, Perelman Sch Med, Unit Expt Psychiat, Div Sleep & Chronobiol,Dept Psychiat, Philadelphia, PA 19104 USA.	basner@upenn.edu	Davis, Adrian C/E-6022-2015	Davis, Adrian C/0000-0001-7134-7528; Clark, Charlotte/0000-0003-3031-4986; Stansfeld, Stephen/0000-0001-8716-3897	National Institutes of Health [NR004281]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR004281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	We thank Dietmar Wurzel for designing and providing figure 1. MBA is partly funded by National Institutes of Health grant NR004281. CC is a member of the Airports Commission's External Advisory Panel in the UK. SS is a member of the Acoustics Review Group for ARUP High Speed Two (HS2).	Adrian D., 2000, TINNITUS HDB, P1; [Anonymous], 2009, NIGHT NOIS GUID EUR; Babisch W., 2012, EXPOSURE ENV NOISE R; Babisch W, 2009, NOISE HEALTH, V11, P161, DOI 10.4103/1463-1741.53363; Babisch W, 2011, NOISE HEALTH, V13, P201, DOI 10.4103/1463-1741.80148; Babisch W, 2008, NOISE HEALTH, V10, P27, DOI 10.4103/1463-1741.39005; Basner M., 2008, SOMNOLOGIE SCHLAFFOR, V12, P110; Basner M, 2006, J ACOUST SOC AM, V119, P2772, DOI 10.1121/1.2184247; Basner M, 2011, SLEEP, V34, P11, DOI 10.1093/sleep/34.1.11; Basner M, 2010, APPL ACOUST, V71, P518, DOI 10.1016/j.apacoust.2010.01.002; Berglund B., 1999, GUIDELINES COMMUNITY; Blomkvist V, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.017632; Brink M., 2009, SOMNOL SCHLAFFORSCHU, V31, P236, DOI [10.1007/s11818-009-0437-1, DOI 10.1007/S11818-009-0437-1]; Bronzaft AL, 1981, J ENVIRON PSYCHOL, V1, P215, DOI DOI 10.1016/S0272-4944(81)80040-0; Busch-Vishniac IJ, 2005, J ACOUST SOC AM, V118, P3629, DOI 10.1121/1.2118327; Buxton OM, 2012, ANN INTERN MED, V157, P170, DOI [10.7326/0003-4819-156-12-201208070-00472, 10.7326/0003-4819-157-3-201208070-00472]; Campbell KCM, 2011, 10 INT C NOIS PUBL H; Campo P., 2009, COMBINED EXPOSURE NO; Campo P, 2011, HEARING RES, V280, P122, DOI 10.1016/j.heares.2011.04.016; Cassel W, 2008, SOMNOLOGIE, V12, P158; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Clark C, 2006, AM J EPIDEMIOL, V163, P27, DOI 10.1093/aje/kwj001; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; Davies H, 2012, NOISE HEALTH, V14, P287, DOI 10.4103/1463-1741.104895; Davis A, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11420; Ecob R, 2011, LONGITUD LIFE COURSE, V2, P242; Elmenhorst EM, 2010, INT ARCH OCC ENV HEA, V83, P743, DOI 10.1007/s00420-010-0515-5; Evans Gary W., 2007, NOISE ITS EFFECTS, P549; Evans GW, 2006, ANNU REV PSYCHOL, V57, P423, DOI 10.1146/annurev.psych.57.102904.190057; Fidell S, 2011, J ACOUST SOC AM, V130, P791, DOI 10.1121/1.3605673; Fields JM, 2001, J SOUND VIB, V242, P641, DOI 10.1006/jsvi.2000.3384; Fuente A, 2011, INT J AUDIOL, V50, pS3, DOI 10.3109/14992027.2010.540584; Gan WQ, 2012, AM J EPIDEMIOL, V175, P898, DOI 10.1093/aje/kwr424; Hagerman I, 2005, INT J CARDIOL, V98, P267, DOI 10.1016/j.ijcard.2003.11.006; Hughes R W, 2003, Noise Health, V6, P63; Huss A, 2010, EPIDEMIOLOGY, V21, P829, DOI 10.1097/EDE.0b013e3181f4e634; Hygge S, 2002, PSYCHOL SCI, V13, P469, DOI 10.1111/1467-9280.00483; Jansen EJM, 2009, INT ARCH OCC ENV HEA, V82, P153, DOI 10.1007/s00420-008-0317-1; Janssen SA, 2011, J ACOUST SOC AM, V130, P3746, DOI 10.1121/1.3653984; Jarup L, 2008, ENVIRON HEALTH PERSP, V116, P329, DOI 10.1289/ehp.10775; Johnson A-C, 2010, NORDIC EXPERT GROUP; Karpa MJ, 2010, ANN EPIDEMIOL, V20, P452, DOI 10.1016/j.annepidem.2010.03.011; Kephalopoulos, 2011, BURDEN DIS ENV NOISE; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Le Prell CG, 2011, 10 INT C NOIS PUBL H; Le Prell CG, 2011, TRANSL RES, V158, P54, DOI 10.1016/j.trsl.2011.02.003; Lercher P, 2003, ENVIRON BEHAV, V35, P725, DOI 10.1177/0013916503256260; Liang MJ, 2012, J ACOUST SOC AM, V131, P4526, DOI 10.1121/1.4707457; Lusk SL, 2004, ARCH ENVIRON HEALTH, V59, P392, DOI 10.3200/AEOH.59.8.392-399; Lutman M.E., 2008, EPIDEMIOLOGICAL EVID; Lutman MH, 2000, NOVEL METHODS EARLY; Messingher G., 2012, J ACOUST SOC AM, V132, P203, DOI [10.1121/1.4755468, DOI 10.1121/1.4755468]; Miedema HME, 2001, ENVIRON HEALTH PERSP, V109, P409, DOI 10.2307/3454901; Miller JAL, 2006, J ACOUST SOC AM, V120, P280, DOI 10.1121/1.2204437; Muhr P, 2011, NOISE HEALTH, V13, P320, DOI 10.4103/1463-1741.82965; Muzet A, 2007, SLEEP MED REV, V11, P135, DOI 10.1016/j.smrv.2006.09.001; National In stitute for Occupational Safety and Health (NIOSH): noise and hearing loss prevention, 2013, NOIS HEAR LOSS PREV; Ohrstrom E, 2006, J SOUND VIB, V295, P40, DOI 10.1016/j.jsv.2005.11.034; Oishi N, 2011, EXPERT OPIN EMERG DR, V16, P235, DOI 10.1517/14728214.2011.552427; Parthasarathy S, 2004, INTENS CARE MED, V30, P197, DOI 10.1007/s00134-003-2030-6; Richardson A, 2009, J CLIN NURS, V18, P3316, DOI 10.1111/j.1365-2702.2009.02897.x; Ryherd EE, 2008, J ACOUST SOC AM, V123, P747, DOI 10.1121/1.2822661; Schmidt JH, 2011, ANN OCCUP HYG, V55, P893, DOI 10.1093/annhyg/mer055; Scientific Committee on Emerging and Newly Identifi ed Health Risks (SCENIHR) of the European Commission, 2008, POT HLTH RISKS EXP N; Sliwinska-Kowalska M, 2011, P 10 INT C NOIS PUBL; Smith Pauline A., 2000, Noise Health, V2, P41; Sorensen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039283; Sorensen M, 2011, EUR HEART J, V32, P737, DOI 10.1093/eurheartj/ehq466; Stansfeld S, 2000, Rev Environ Health, V15, P43; Stansfeld SA, 2005, LANCET, V365, P1942, DOI 10.1016/S0140-6736(05)66660-3; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; The Stationery Office, 2005, CONTR NOIS WORK REG; Tomei G, 2010, SCI TOTAL ENVIRON, V408, P681, DOI 10.1016/j.scitotenv.2009.10.071; Twardella D, 2011, BUNDESGESUNDHEITSBLA, V54, P965, DOI 10.1007/s00103-011-1321-2; van Kempen EEMM, 2002, ENVIRON HEALTH PERSP, V110, P307, DOI 10.1289/ehp.02110307; van Kempen E, 2012, J HYPERTENS, V30, P1075, DOI 10.1097/HJH.0b013e328352ac54; Verbeek JH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006396.pub3; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Xie H, 2009, CRIT CARE, V13, DOI 10.1186/cc7154; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016	80	954	995	46	588	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1325	1332		10.1016/S0140-6736(13)61613-X	http://dx.doi.org/10.1016/S0140-6736(13)61613-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LQ	24183105	Green Accepted			2022-12-28	WOS:000334104900031
J	Smolen, JS; Emery, P; Fleischmann, R; van Vollenhoven, RF; Pavelka, K; Durez, P; Guerette, B; Kupper, H; Redden, L; Arora, V; Kavanaugh, A				Smolen, Josef S.; Emery, Paul; Fleischmann, Roy; van Vollenhoven, Ronald F.; Pavelka, Karel; Durez, Patrick; Guerette, Benoit; Kupper, Hartmut; Redden, Laura; Arora, Vipin; Kavanaugh, Arthur			Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial	LANCET			English	Article							RECEIVING CONCOMITANT METHOTREXATE; MODIFYING ANTIRHEUMATIC DRUGS; TREATMENT STRATEGIES; COMBINATION THERAPY; AMERICAN-COLLEGE; RADIOGRAPHIC PROGRESSION; MONOCLONAL-ANTIBODY; CLINICAL-TRIALS; TIGHT CONTROL; DOUBLE-BLIND	Background Biological agents off er good control of rheumatoid arthritis, but the long-term benefits of achieving low disease activity with a biological agent plus methotrexate or methotrexate alone are unclear. The OPTIMA trial assessed different treatment adjustment strategies in patients with early rheumatoid arthritis attaining (or not) stable low disease activity with adalimumab plus methotrexate or methotrexate monotherapy. Methods This trial was done at 161 sites worldwide. Patients with early (<1 year duration) rheumatoid arthritis naive to methotrexate were randomly allocated (by interactive voice response system, in a 1: 1 ratio, block size four) to adalimumab (40 mg every other week) plus methotrexate (initiated at 7.5 mg/week, increased by 2.5 mg every 1-2 weeks to a maximum weekly dose of 20 mg by week 8) or placebo plus methotrexate for 26 weeks (period 1). Patients in the adalimumab plus methotrexate group who completed period 1 and achieved the stable low disease activity target (28-joint disease activity score with C-reactive protein [DAS28]<3.2 at weeks 22 and 26) were randomised to adalimumab-continuation or adalimumab-withdrawal for an additional 52 weeks (period 2). Patients achieving the target with initial methotrexate continued methotrexate-monotherapy. Inadequate responders were offered adalimumab plus methotrexate. All patients and investigators were masked to treatment allocation in period 1. During period 2, treatment reallocation of patients who achieved the target was masked to patients and investigators; patients who did not achieve the target remained masked to original randomisation, but were aware of the subsequent assignment. The primary endpoint was a composite measure of DAS28 of less than 3.2 at week 78 and radiographic non-progression from baseline to week 78, compared between adalimumab-continuation and methotrexate-monotherapy. Adverse events were monitored throughout period 2. This trial is registered with ClinicalTrials.gov, number NCT00420927. Findings The study was done between Dec 28, 2006, and Aug 3, 2010. 1636 patients were assessed and 1032 were randomised in period 1 (515 to adalimumab plus methotrexate; 517 to placebo plus methotrexate). 466 patients in the adalimumab plus methotrexate group completed period 1; 207 achieved the stable low disease activity target, of whom 105 were rerandomised to adalimumab-continuation. 460 patients in the placebo plus methotrexate group completed period 1; 112 achieved the stable low disease activity target and continued methotrexate-monotherapy. 73 of 105 (70%) patients in the adalimumab-continuation group and 61 of 112 (54%) patients in the methotrexate-monotherapy group achieved the primary endpoint at week 78 (mean difference 15% [95% CI 2-28%], p=0.0225). Patients achieving the stable low disease activity target on adalimumab plus methotrexate who withdrew adalimumab mostly maintained their good responses. Overall, 706 of 926 patients in period 2 had an adverse event, of which 82 were deemed serious; however, distribution of adverse events did not differ between groups. Interpretation Treatment to a stable low disease activity target resulted in improved clinical, functional, and structural outcomes, with both adalimumab-continuation and methotrexate-monotherapy. However, a higher proportion of patients treated with initial adalimumab plus methotrexate achieved the low disease activity target compared with those initially treated with methotrexate alone. Outcomes were much the same whether adalimumab was continued or withdrawn in patients who initially responded to adalimumab plus methotrexate.	[Smolen, Josef S.] Med Univ Vienna, Dept Med 3, Div Rheumatol, A-1090 Vienna, Austria; [Smolen, Josef S.] Hietzing Hosp, Dept Med 2, Vienna, Austria; [Emery, Paul] Univ Leeds, Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Emery, Paul] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Fleischmann, Roy] Univ Texas SW Med Ctr Dallas, Div Rheumatol, Dallas, TX 75390 USA; [van Vollenhoven, Ronald F.] Karolinska Univ Hosp, Stockholm, Sweden; [Pavelka, Karel] Charles Univ Prague, Med Fac 1, Inst & Clin Rheumatol, Prague, Czech Republic; [Durez, Patrick] Catholic Univ Louvain, Serv & Pole Rhumatol, Clin Univ St Luc, Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Guerette, Benoit; Redden, Laura; Arora, Vipin] AbbVie, N Chicago, IL USA; [Kupper, Hartmut] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany; [Kavanaugh, Arthur] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA	Medical University of Vienna; Hietzing Hospital; Chapel Allerton Hospital; University of Leeds; Leeds Biomedical Research Centre; University of Leeds; University of Texas System; University of Texas Southwestern Medical Center Dallas; Karolinska Institutet; Karolinska University Hospital; Charles University Prague; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; AbbVie; AbbVie; University of California System; University of California San Diego	Smolen, JS (corresponding author), Med Univ Vienna, Dept Med 3, Div Rheumatol, A-1090 Vienna, Austria.	josef.smolen@meduniwien.ac.at	emery, paul/B-3560-2013; Pavelka, Karel/E-6578-2017; van Vollenhoven, Ronald/ABE-1244-2021	Pavelka, Karel/0000-0003-1952-8422; durez, patrick/0000-0002-7156-2356	AbbVie; AbbVie (North Chicago, IL, US); National Institute for Health Research [NF-SI-0508-10299] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish	AbbVie(AbbVie); AbbVie (North Chicago, IL, US)(AbbVie); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	The design, study conduct, and financial support for the clinical trial was provided by AbbVie (North Chicago, IL, US). Medical writing support, funded by AbbVie, was provided by Theresa J Peterson, a former employee of AbbVie, and Elaine Smith, and Benjamin Wolfe, of AbbVie. We thank all the study investigators and staff and patients who participated in this trial, Stefan Florentinus, of AbbVie, for helpful discussions during manuscript development, and Suchitrita Rathmann and Mahinda Karunaratne, both of AbbVie, for statistical support.	Aletaha D, 2006, RHEUM DIS CLIN N AM, V32, P9, DOI 10.1016/j.rdc.2005.09.005; Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bakker MF, 2012, ANN INTERN MED, V156, P329, DOI 10.7326/0003-4819-156-5-201203060-00004; Baron G, 2008, ARTHRIT RHEUM-ARTHR, V59, P25, DOI 10.1002/art.23253; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Calguneri M, 1999, CLIN EXP RHEUMATOL, V17, P699; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Goekoop-Ruiterman YPM, 2007, ANN INTERN MED, V146, P406, DOI 10.7326/0003-4819-146-6-200703200-00005; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P64, DOI 10.1136/annrheumdis-2011-201247; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P1039, DOI 10.1136/ard.2010.141234; Lard LR, 2001, AM J MED, V111, P446, DOI 10.1016/S0002-9343(01)00872-5; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Nell VPK, 2004, RHEUMATOLOGY, V43, P906, DOI 10.1093/rheumatology/keh199; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Saleem B, 2010, ANN RHEUM DIS, V69, P1636, DOI 10.1136/ard.2009.117341; Sangha O, 2000, RHEUMATOLOGY, V39, P3, DOI 10.1093/rheumatology/39.suppl_2.3; Schiff MH, 2006, ANN RHEUM DIS, V65, P889, DOI 10.1136/ard.2005.043166; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2013, LANCET, V381, P918, DOI 10.1016/S0140-6736(12)61811-X; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Tanaka Y, 2010, ANN RHEUM DIS, V69, P1286, DOI 10.1136/ard.2009.121491; Tanaka Y, 2013, ANN RHEUM DIS, V72, P124, DOI 10.1136/annrheumdis-2012-202350; van der Heijde D, 2002, ARTHRIT RHEUM-ARTHR, V47, P215, DOI 10.1002/art.10181; van der Heijde D, 2010, J RHEUMATOL, V37, P2237, DOI 10.3899/jrheum.100208; Wiles NJ, 2001, ARTHRITIS RHEUM-US, V44, P1033, DOI 10.1002/1529-0131(200105)44:5<1033::AID-ANR182>3.3.CO;2-7	40	190	204	3	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					321	332		10.1016/S0140-6736(13)61751-1	http://dx.doi.org/10.1016/S0140-6736(13)61751-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296VD	24168956				2022-12-28	WOS:000330212600031
J	Hao, YF; Bharathi, MS; Wang, L; Liu, YY; Chen, H; Nie, S; Wang, XH; Chou, H; Tan, C; Fallahazad, B; Ramanarayan, H; Magnuson, CW; Tutuc, E; Yakobson, BI; McCarty, KF; Zhang, YW; Kim, P; Hone, J; Colombo, L; Ruoff, RS				Hao, Yufeng; Bharathi, M. S.; Wang, Lei; Liu, Yuanyue; Chen, Hua; Nie, Shu; Wang, Xiaohan; Chou, Harry; Tan, Cheng; Fallahazad, Babak; Ramanarayan, H.; Magnuson, Carl W.; Tutuc, Emanuel; Yakobson, Boris I.; McCarty, Kevin F.; Zhang, Yong-Wei; Kim, Philip; Hone, James; Colombo, Luigi; Ruoff, Rodney S.			The Role of Surface Oxygen in the Growth of Large Single-Crystal Graphene on Copper	SCIENCE			English	Article							CHEMICAL-VAPOR-DEPOSITION; GRAIN-BOUNDARIES; METAL-SURFACES; HIGH-QUALITY; ACTIVATION; NUCLEATION; FOILS; FILMS; EDGE; CU	The growth of high-quality single crystals of graphene by chemical vapor deposition on copper (Cu) has not always achieved control over domain size and morphology, and the results vary from lab to lab under presumably similar growth conditions. We discovered that oxygen (O) on the Cu surface substantially decreased the graphene nucleation density by passivating Cu surface active sites. Control of surface O enabled repeatable growth of centimeter-scale single-crystal graphene domains. Oxygen also accelerated graphene domain growth and shifted the growth kinetics from edge-attachment-limited to diffusion-limited. Correspondingly, the compact graphene domain shapes became dendritic. The electrical quality of the graphene films was equivalent to that of mechanically exfoliated graphene, in spite of being grown in the presence of O.	[Hao, Yufeng; Wang, Xiaohan; Chou, Harry; Tan, Cheng; Magnuson, Carl W.; Ruoff, Rodney S.] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA; [Hao, Yufeng; Wang, Xiaohan; Chou, Harry; Tan, Cheng; Magnuson, Carl W.; Ruoff, Rodney S.] Univ Texas Austin, Mat Sci & Engn Program, Austin, TX 78712 USA; [Bharathi, M. S.; Ramanarayan, H.; Zhang, Yong-Wei] ASTAR, Inst High Performance Comp, Singapore 138632, Singapore; [Wang, Lei; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Liu, Yuanyue; Yakobson, Boris I.] Rice Univ, Dept Mech Engn & Mat Sci, Houston, TX 77005 USA; [Liu, Yuanyue; Yakobson, Boris I.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Chen, Hua] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Nie, Shu; McCarty, Kevin F.] Sandia Natl Labs, Livermore, CA 94550 USA; [Fallahazad, Babak; Tutuc, Emanuel] Univ Texas Austin, Microelect Res Ctr, Austin, TX 78758 USA; [Kim, Philip] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Colombo, Luigi] Texas Instruments Inc, Dallas, TX 75243 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Columbia University; Rice University; Rice University; University of Texas System; University of Texas Austin; United States Department of Energy (DOE); Sandia National Laboratories; University of Texas System; University of Texas Austin; Columbia University; Texas Instruments	Colombo, L (corresponding author), Texas Instruments Inc, Dallas, TX 75243 USA.	colombo@ti.com; r.ruoff@mail.utexas.edu	Liu, Yuanyue/C-5763-2008; Ruoff, Rodney/ABE-6532-2020; Ruoff, Rodney S/B-7605-2009; hao, yufeng/B-9178-2013; Hone, James C/E-1879-2011; Kim, Philip/N-1886-2013; Zhang, Yong-Wei/D-5191-2012; Yakobson, Boris/ABA-3897-2020; Chen, Hua/H-3092-2013; Wang, Lei/K-1160-2012; Colombo, Luigi/T-4677-2018	Liu, Yuanyue/0000-0002-5880-8649; Ruoff, Rodney/0000-0002-6599-6764; Ruoff, Rodney S/0000-0002-6599-6764; Hone, James C/0000-0002-8084-3301; Kim, Philip/0000-0002-8255-0086; Zhang, Yong-Wei/0000-0001-7255-1678; Yakobson, Boris/0000-0001-8369-3567; Chen, Hua/0000-0003-0676-3079; Wang, Lei/0000-0002-1919-9107; Colombo, Luigi/0000-0002-9048-3565; Wang, Xiaohan/0000-0003-2608-0718; Hariharaputran, Ramanarayan/0000-0002-8882-3727; Srinivasan, Bharathi Madurai/0000-0002-4342-3172	W. M. Keck Foundation; Office of Naval Research (ONR); South West Academy of Nanolectronics of the Nanoelectronics Research Initiative; Center for Re-Defining Photovoltaic Efficiency through Molecular-Scale Control, an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-SC0001085]; National Science Foundation (NSF) [DMR-1124894]; ONR [N000141310662]; Agency for Science, Technology And Research (A*STAR), Singapore; Office of Basic Energy Sciences, Division of Materials and Engineering Sciences, U.S. DOE [DE-AC04-94AL85000]; NSF's Chemical, Bioengineering, Environmental, and Transport Systems Division; NSF [OCI-1053575, OCI-0959097, DMR-1122603]; DOE [DE-AC02-05CH11231]	W. M. Keck Foundation(W.M. Keck Foundation); Office of Naval Research (ONR)(Office of Naval Research); South West Academy of Nanolectronics of the Nanoelectronics Research Initiative; Center for Re-Defining Photovoltaic Efficiency through Molecular-Scale Control, an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); ONR(Office of Naval Research); Agency for Science, Technology And Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Office of Basic Energy Sciences, Division of Materials and Engineering Sciences, U.S. DOE(United States Department of Energy (DOE)); NSF's Chemical, Bioengineering, Environmental, and Transport Systems Division; NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	We thank V. B. Shenoy (University of Pennsylvania), Zhenyu Zhang [University of Science and Technology of China (USTC)], Zhenyu Li (USTC), N. C. Bartelt (Sandia Laboratories), P. Sutter (Brookhaven Laboratory), Gui-Chang Wang (Nankai University), Cheng Gong (University of Texas-Dallas), Zhen Yan (Texas A&M University), and C. R. Dean (City College of New York) for valuable discussions. We thank K. Watanabe and T. Taniguchi for providing h-BN substrates. This work acknowledges support from the W. M. Keck Foundation, the Office of Naval Research (ONR), and the South West Academy of Nanolectronics of the Nanoelectronics Research Initiative. Work at Columbia University was supported by the Center for Re-Defining Photovoltaic Efficiency through Molecular-Scale Control, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under award DE-SC0001085, National Science Foundation (NSF) grant DMR-1124894, and ONR grant N000141310662. Work at the Institute of High Performance Computing was supported by the Agency for Science, Technology And Research (A*STAR), Singapore. Work at Sandia was supported by the Office of Basic Energy Sciences, Division of Materials and Engineering Sciences, U.S. DOE, under contract no. DE-AC04-94AL85000. Work at Rice University was supported by the ONR and NSF's Chemical, Bioengineering, Environmental, and Transport Systems Division. The first-principles computations were performed on Kraken at the National Institute for Computational Sciences (NSF grant OCI-1053575), Hopper at the National Energy Research Scientific Computing Center (DOE grant DE-AC02-05CH11231), and DaVinCI at Rice University (NSF grant OCI-0959097). H. C. acknowledges support from NSF grant DMR-1122603. A relevant patent application is in process.	Ajayan PM, 2011, NAT MATER, V10, P415, DOI 10.1038/nmat3027; ALSTRUP I, 1992, SURF SCI, V264, P95, DOI 10.1016/0039-6028(92)90168-6; Artyukhov VI, 2012, P NATL ACAD SCI USA, V109, P15136, DOI 10.1073/pnas.1207519109; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Bartelt NC, 2012, MRS BULL, V37, P1158, DOI 10.1557/mrs.2012.237; Bhaviripudi S, 2010, NANO LETT, V10, P4128, DOI 10.1021/nl102355e; Chen H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.186101; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Gao JF, 2011, J AM CHEM SOC, V133, P5009, DOI 10.1021/ja110927p; Hammer B, 2000, ADV CATAL, V45, P71; Han GH, 2011, NANO LETT, V11, P4144, DOI 10.1021/nl201980p; Hwang EH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.186806; Kim H, 2012, ACS NANO, V6, P3614, DOI 10.1021/nn3008965; Li XS, 2009, NANO LETT, V9, P4268, DOI 10.1021/nl902515k; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Murdock AT, 2013, ACS NANO, V7, P1351, DOI 10.1021/nn3049297; Nie S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.155425; Petrone N, 2012, NANO LETT, V12, P2751, DOI 10.1021/nl204481s; Starodub E, 2010, J PHYS CHEM C, V114, P5134, DOI 10.1021/jp912139e; Tsen AW, 2012, SCIENCE, V336, P1143, DOI 10.1126/science.1218948; van Santen RA, 2010, CHEM REV, V110, P2005, DOI 10.1021/cr9001808; Vlassiouk I, 2011, ACS NANO, V5, P6069, DOI 10.1021/nn201978y; Wang H, 2012, J AM CHEM SOC, V134, P3627, DOI 10.1021/ja2105976; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; Wu B, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2012.68; Xing B, 2011, J CATAL, V282, P74, DOI 10.1016/j.jcat.2011.05.027; Yan Z, 2012, ACS NANO, V6, P9110, DOI 10.1021/nn303352k; Yu QK, 2011, NAT MATER, V10, P443, DOI [10.1038/NMAT3010, 10.1038/nmat3010]; Zhang WH, 2011, J PHYS CHEM C, V115, P17782, DOI 10.1021/jp2006827; Zhang ZY, 1997, SCIENCE, V276, P377, DOI 10.1126/science.276.5311.377	30	862	894	34	1382	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					720	723		10.1126/science.1243879	http://dx.doi.org/10.1126/science.1243879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24158906				2022-12-28	WOS:000326647600038
J	Khan, KN; Ali, M; Poulter, JA; McKibbin, M; Inglehearn, CF				Khan, Kamron N.; Ali, Manir; Poulter, James A.; McKibbin, Martin; Inglehearn, Chris F.			Patterns of inheritance, not always easily visible	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MUTATIONS; DISEASE		[Khan, Kamron N.; Ali, Manir; Poulter, James A.; McKibbin, Martin; Inglehearn, Chris F.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Khan, KN (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England.	medknk@leeds.ac.uk	Ali, Manir/ABE-5251-2020; Poulter, James A/A-8190-2013; Inglehearn, Chris/GYD-9783-2022	Ali, Manir/0000-0003-3204-3788; Poulter, James A/0000-0003-2048-5693; 				Teng YH, 2009, HEAD NECK-J SCI SPEC, V31, P1282, DOI 10.1002/hed.21094; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201	4	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2013	347								f6610	10.1136/bmj.f6610	http://dx.doi.org/10.1136/bmj.f6610			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XO	24196503				2022-12-28	WOS:000326890300006
J	Binswanger, IA; Blatchford, PJ; Mueller, SR; Stern, MF				Binswanger, Ingrid A.; Blatchford, Patrick J.; Mueller, Shane R.; Stern, Marc F.			Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG-RELATED DEATH; SUICIDE; COHORT; ADDICTION; SCOTLAND; DATABASE; INMATES; LINKAGE; HEALTH; MODEL	Background: Among former prisoners, a high rate of death has been documented in the early postrelease period, particularly from drug-related causes. Little is known about risk factors and trends in postrelease mortality in the past decade, especially given general population increases in overdose deaths from pharmaceutical opioids. Objective: To determine postrelease mortality between 1999 and 2009; cause-specific mortality rates; and whether sex, calendar year, and custody factors were risk factors for all-cause, overdose, and opioid-related deaths. Design: Cohort study. Setting: Prison system of the Washington State Department of Corrections. Participants: 76 208 persons released from prison. Measurements: Identities were linked probabilistically to the National Death Index to identify deaths and causes of death, and mortality rates were calculated. Cox proportional hazards regression estimated the effect of age, sex, race or ethnicity, whether the incarceration resulted from a violation of terms of the person's community supervision, length of incarceration, release type, and calendar year on the hazard ratio (HR) for death. Results: The all-cause mortality rate was 737 per 100 000 person-years (95% CI, 708 to 766) (n = 2462 deaths). Opioids were involved in 14.8% of all deaths. Overdose was the leading cause of death (167 per 100 000 person-years [CI, 153 to 181]), and overdose deaths in former prisoners accounted for 8.3% of the overdose deaths among persons aged 15 to 84 years in Washington from 2000 to 2009. Women were at increased risk for overdose (HR, 1.38 [CI, 1.12 to 1.69]) and opioid-related deaths (HR, 1.39 [CI, 1.09 to 179]). Limitation: The study was done in only 1 state. Conclusion: Innovation is needed to reduce the risk for overdose among former prisoners.	Univ Colorado, Sch Med, Aurora, CO 80045 USA; Colorado Sch Publ Hlth, Aurora, CO USA; Denver Hlth Med Ctr, Denver, CO USA; Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; Denver Health Medical Center; University of Washington; University of Washington Seattle	Binswanger, IA (corresponding author), Univ Colorado, Sch Med, Div Gen Internal Med, Dept Med, Mailstop B180,12631 East 17th Ave, Aurora, CO 80045 USA.	ingrid.binswanger@ucdenver.edu; Patrick.Blatchford@ucdenver.edu	Binswanger, Ingrid/X-4496-2019	Binswanger, Ingrid/0000-0001-8862-8078	National Institute on Drug Abuse of the National Institutes of Health [R21DA031041]; Robert Wood Johnson Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031041] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By the National Institute on Drug Abuse of the National Institutes of Health (R21DA031041) and the Robert Wood Johnson Foundation.	Bilgrad R, 1999, NDIPLUS CODED CAUSES; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Binswanger IA, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-3; Binswanger IA, 2011, DRUG ALCOHOL DEPEN, V117, P1, DOI 10.1016/j.drugalcdep.2010.11.029; Binswanger IA, 2010, AM J PUBLIC HEALTH, V100, P476, DOI 10.2105/AJPH.2008.149591; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; Bureau of Justice Statistics, 2010, WHAT IS DIFF JAILS P; Calcaterra S, 2013, DRUG ALCOHOL DEPEN, V131, P263, DOI 10.1016/j.drugalcdep.2012.11.018; Campbell CI, 2010, AM J PUBLIC HEALTH, V100, P2541, DOI 10.2105/AJPH.2009.180646; Carson EA, 2012, PRISONERS 2011; Centers for Disease Control and Prevention, 2012, WIDE RANG ONL DAT EP; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1487; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; Huerino PM, 2011, NDIPLUS CODED CAUSES; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Kariminia A, 2007, EUR J EPIDEMIOL, V22, P417, DOI 10.1007/s10654-007-9134-1; Krinsky CS, 2009, AM J FOREN MED PATH, V30, P6, DOI 10.1097/PAF.0b013e3181873784; Lim S, 2012, AM J EPIDEMIOL, V175, P519, DOI 10.1093/aje/kwr327; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; McAuley A, 2012, DRUG-EDUC PREV POLIC, V19, P309, DOI 10.3109/09687637.2012.682232; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Merralll ELC, 2013, ADDICTION, V108, P377, DOI 10.1111/j.1360-0443.2012.04066.x; Nunn A, 2010, ADDICTION, V105, P1312, DOI 10.1111/j.1360-0443.2010.03000.x; Pratt D, 2006, LANCET, V368, P119, DOI 10.1016/S0140-6736(06)69002-8; Rosen DL, 2008, AM J PUBLIC HEALTH, V98, P2278, DOI 10.2105/AJPH.2007.121855; Seaman SR, 1998, BRIT MED J, V316, P426, DOI 10.1136/bmj.316.7129.426; Spaulding AC, 2011, AM J EPIDEMIOL, V173, P479, DOI 10.1093/aje/kwq422; Stewart LM, 2004, AUST NZ J PUBL HEAL, V28, P32, DOI 10.1111/j.1467-842X.2004.tb00629.x; Strang J, 2003, BMJ-BRIT MED J, V326, P959, DOI 10.1136/bmj.326.7396.959; Substance Abuse and Mental Health Services Administration and Center for Behavioral Health Statistics and Quality, 2013, NSDUH REP STAT EST N; Warner M, 2011, DRUG POISONING DEATH; World Health Organisation, 2010, PREV AC DRUG REL MOR, P33; Zlodre Jakov, 2012, Am J Public Health, V102, pe67, DOI 10.2105/AJPH.2012.300764	36	305	308	2	35	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					592	600		10.7326/0003-4819-159-9-201311050-00005	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	249HX	24189594	Green Accepted			2022-12-28	WOS:000326769400003
J	Cohen, MS; Smith, MK; Muessig, KE; Hallett, TB; Powers, KA; Kashuba, AD				Cohen, Myron S.; Smith, M. Kumi; Muessig, Kathryn E.; Hallett, Timothy B.; Powers, Kimberly A.; Kashuba, Angela D.			Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?	LANCET			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUAL RISK BEHAVIOR; T-CELL-ACTIVATION; MATHEMATICAL-MODELS; MALE CIRCUMCISION; INFECTED PATIENTS; UNITED-STATES; VIRAL LOAD; FOLLOW-UP; BASE-LINE	Antiretroviral drugs that inhibit viral replication were expected to reduce transmission of HIV by lowering the concentration of HIV in the genital tract. In 11 of 13 observational studies, antiretroviral therapy (ART) provided to an HIV-infected index case led to greatly reduced transmission of HIV to a sexual partner. In the HPTN 052 randomised controlled trial, ART used in combination with condoms and counselling reduced HIV transmission by 96.4%. Evidence is growing that wider, earlier initiation of ART could reduce population-level incidence of HIV. However, the full benefits of this strategy will probably need universal access to very early ART and excellent adherence to treatment. Challenges to this approach are substantial. First, not all HIV-infected individuals can be located, especially people with acute and early infection who are most contagious. Second, the ability of ART to prevent HIV transmission in men who have sex with men (MSM) and people who use intravenous drugs has not been shown. Indeed, the stable or increased incidence of HIV in MSM in some communities where widespread use of ART has been established emphasises the concern that not enough is known about treatment as prevention for this crucial population. Third, although US guidelines call for immediate use of ART, such guidelines have not been embraced worldwide. Some experts do not believe that immediate or early ART is justified by present evidence, or that health-care infrastructure for this approach is sufficient. These concerns are very difficult to resolve. Ongoing community-based prospective trials of early ART are likely to help to establish the population-level benefit of ART, and-if successful-to galvanise treatment as prevention.	[Cohen, Myron S.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.; Smith, M. Kumi; Powers, Kimberly A.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Muessig, Kathryn E.] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27599 USA; [Kashuba, Angela D.] Univ N Carolina, Dept Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Imperial College London	Cohen, MS (corresponding author), Univ N Carolina, 130 Mason Farm Rd,Suite 2115,CB 7030, Chapel Hill, NC 27599 USA.	mscohen@med.unc.edu	Muessig, Kate/P-1242-2018	Hallett, Timothy/0000-0002-9681-0424; Smith, M. Kumi/0000-0001-5861-8100	University of North Carolina Center for AIDS Research; National Institute of Diabetes and Digestive and Kidney Diseases [DK R37 49381]; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, T32AI007001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049381] Funding Source: NIH RePORTER	University of North Carolina Center for AIDS Research; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Joseph Eron and Ward Cates for review of this manuscript, and Christophe Fraser, Andrew Phillips, and Joel Gallant for helpful comments. This work was supported by University of North Carolina Center for AIDS Research and National Institute of Diabetes and Digestive and Kidney Diseases (grant DK R37 49381).	Adakun SA, 2013, JAIDS-J ACQ IMM DEF, V62, P317, DOI 10.1097/QAI.0b013e3182800daf; Alam SJ, 2013, EPIDEMICS-NETH, V5, P44, DOI 10.1016/j.epidem.2012.11.003; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Anglemyer A, 2013, JAMA-J AM MED ASSOC, V310, P1619, DOI [10.1001/jama.2013.278328, 10.1002/14651858.CD009153.pub3]; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P1; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 19 INT AIDS C WASH D; [Anonymous], PAN ANT GUID AD AD 2; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], MOD WHO 2013 GUID US; [Anonymous], 19 INT AIDS C WASH D; [Anonymous], PEPFAR BLUEPR CREAT; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Boily MC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001250; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Celum C, 2012, ANTIVIR THER, V17, P1483, DOI 10.3851/IMP2492; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Cu-Uvin S, 2011, AIDS, V25, P880, DOI 10.1097/QAD.0b013e328344ccf8; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; El-Sadr WM, 2011, AIDS, V25, P2295, DOI 10.1097/QAD.0b013e32834c4c22; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Fallon SJ, 2012, AIDS BEHAV, V16, P1739, DOI 10.1007/s10461-012-0258-2; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Funk MJ, 2011, ARCH INTERN MED, V171, P1560, DOI 10.1001/archinternmed.2011.401; Gallant JE, 2013, CLIN INFECT DIS, V57, P884, DOI 10.1093/cid/cit382; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gay Cynthia L, 2008, Curr Infect Dis Rep, V10, P323, DOI 10.1007/s11908-008-0052-5; Geng EH, 2013, JAIDS-J ACQ IMM DEF, V63, pE64, DOI 10.1097/QAI.0b013e31828af5a6; Granich R, 2013, CURR OPIN HIV AIDS, V8, P41, DOI 10.1097/COH.0b013e32835b80dd; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Grulich AE, 2010, LANCET, V376, P1824, DOI 10.1016/S0140-6736(10)62162-9; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hankins CA, 2013, CURR OPIN HIV AIDS, V8, P50, DOI 10.1097/COH.0b013e32835b809d; Hendrix CW, 2012, CURR OPIN HIV AIDS, V7, P498, DOI 10.1097/COH.0b013e32835847ae; HIV Modelling Consortium Treatment, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001259; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Imrie A, 1997, J INFECT DIS, V175, P1502, DOI 10.1086/516487; Iwuji CC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-230; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Koff WC, 2013, VACCINE, V31, pB204, DOI 10.1016/j.vaccine.2012.10.115; Krakower Douglas, 2011, Curr HIV/AIDS Rep, V8, P241, DOI 10.1007/s11904-011-0094-4; Kuhar DT, 2013, INFECT CONT HOSP EP, V34, P875, DOI 10.1086/672271; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Lundgren JD, 2013, CLIN INFECT DIS, V57, P888, DOI 10.1093/cid/cit381; Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08; MARMOR M, 1987, AIDS, V1, P39; Mayer KH, 1999, CLIN INFECT DIS, V28, P1252, DOI 10.1086/514775; McNairy ML, 2013, CURR HIV-AIDS REP, V10, P152, DOI 10.1007/s11904-013-0152-1; Meyer-Rath G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001247; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Morris BJ, 2012, INT J STD AIDS, V23, P153, DOI 10.1258/ijsa.2011.011228; Muessig KE, 2012, AIDS, V26, P2267, DOI 10.1097/QAD.0b013e328355713d; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Newstein M, 2005, JAIDS-J ACQ IMM DEF, V38, P364; Novitsky V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010148; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Pati R, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18490; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Ping LH, 2013, J VIROL, V87, P7218, DOI 10.1128/JVI.03577-12; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Sabin CA, 2013, AIDS, V27, P1839, DOI 10.1097/QAD.0b013e328360d546; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shaw GM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006965; Smith DM, 2007, J INFECT DIS, V196, P356, DOI 10.1086/519164; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Smith K, 2011, CURR OPIN HIV AIDS, V6, P315, DOI 10.1097/COH.0b013e32834788e7; Smith MK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001260; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Taiwo B, 2013, J ANTIMICROB CHEMOTH, V68, P1857, DOI 10.1093/jac/dkt120; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Thompson CG, 2013, JAIDS-J ACQ IMM DEF, V63, pS240, DOI 10.1097/QAI.0b013e3182986ff8; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; UNAIDS, 2012, UNAIDS REP GLOB AIDS; van Sighem A, 2012, AIDS, V26, P1840, DOI 10.1097/QAD.0b013e3283574df9; Vernazza P, 2008, B MED SUISSES, V89, P165; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212; Wand H, 2010, HIV MED, V11, P395, DOI 10.1111/j.1468-1293.2009.00804.x; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Wilson DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001231; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2012, GUID OR PREEXP PROPH; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zuckerman RA, 2004, J INFECT DIS, V190, P156, DOI 10.1086/421246	114	162	164	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1515	1524		10.1016/S0140-6736(13)61998-4	http://dx.doi.org/10.1016/S0140-6736(13)61998-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	24152938	Green Accepted, Green Submitted			2022-12-28	WOS:000326622500030
J	Cohn, A				Cohn, Anthony			Restore the prominence of the medical ward round	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TIME		Watford Dist Gen Hosp, Dept Paediat, Watford WD18 0HB, Herts, England	Watford General Hospital	Cohn, A (corresponding author), Watford Dist Gen Hosp, Dept Paediat, Watford WD18 0HB, Herts, England.	anthony.cohn@whht.nhs.uk						Herring R, 2011, CLIN GOV, V16, P129; Iacobucci G, 2013, PULSE           1024; Ogden J, 2004, FAM PRACT, V21, P479, DOI 10.1093/fampra/cmh502; Pollock K, 2002, BRIT MED J, V325, P687, DOI 10.1136/bmj.325.7366.687; Royal College of Physicians, 2012, WARD ROUNDS MED PRIN	5	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2013	347								f6451	10.1136/bmj.f6451	http://dx.doi.org/10.1136/bmj.f6451			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EX	24179033				2022-12-28	WOS:000326599700004
J	Raina, JB; Tapiolas, DM; Foret, S; Lutz, A; Abrego, D; Ceh, J; Seneca, FO; Clode, PL; Bourne, DG; Willis, BL; Motti, CA				Raina, Jean-Baptiste; Tapiolas, Dianne M.; Foret, Sylvain; Lutz, Adrian; Abrego, David; Ceh, Janja; Seneca, Francois O.; Clode, Peta L.; Bourne, David G.; Willis, Bette L.; Motti, Cherie A.			DMSP biosynthesis by an animal and its role in coral thermal stress response	NATURE			English	Article							PARTICULATE DIMETHYLSULFONIOPROPIONATE DMSP; GREAT-BARRIER-REEF; DIMETHYL SULFIDE; SULFUR-COMPOUNDS; SOLAR-RADIATION; ACROPORA; BACTERIA; PRIMERS; CLIMATE; QUANTIFICATION	Globally, reef-building corals are the most prolific producers of dimethylsulphoniopropionate (DMSP)(1,2), a central molecule in the marine sulphur cycle and precursor of the climate-active gas dimethylsulphide(3,4). At present, DMSP production by corals is attributed entirely to their algal endosymbiont, Symbiodinium(2). Combining chemical, genomic and molecular approaches, we show that coral juveniles produce DMSP in the absence of algal symbionts. DMSP levels increased up to 54% over time in newly settled coral juveniles lacking algal endosymbionts, and further increases, up to 76%, were recorded when juveniles were subjected to thermal stress. We uncovered coral orthologues of two algal genes recently identified in DMSP biosynthesis, strongly indicating that corals possess the enzymatic machinery necessary for DMSP production. Our results overturn the paradigm that photosynthetic organisms are the sole biological source of DMSP, and highlight the double jeopardy represented by worldwide declining coral cover, as the potential to alleviate thermal stress through coral-produced DMSP declines correspondingly.	[Raina, Jean-Baptiste; Lutz, Adrian; Seneca, Francois O.; Willis, Bette L.] James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia; [Raina, Jean-Baptiste; Seneca, Francois O.; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Raina, Jean-Baptiste; Tapiolas, Dianne M.; Lutz, Adrian; Abrego, David; Seneca, Francois O.; Bourne, David G.; Motti, Cherie A.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Raina, Jean-Baptiste; Foret, Sylvain; Lutz, Adrian; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Foret, Sylvain] Australian Natl Univ, Canberra, ACT 2601, Australia; [Lutz, Adrian] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; [Ceh, Janja] Murdoch Univ, Sch Biol Sci & Biotechnol, Perth, WA 6050, Australia; [Clode, Peta L.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, WA 6009, Australia; [Clode, Peta L.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia	James Cook University; James Cook University; Australian Institute of Marine Science; James Cook University; Australian National University; James Cook University; Murdoch University; University of Western Australia; University of Western Australia	Raina, JB (corresponding author), James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia.	j.raina@aims.gov.au	Clode, Peta L/C-4482-2011; FORET, Sylvain/B-9207-2012; Abrego, David/AAT-8120-2020; Bourne, David G/B-5073-2008; Motti, Cherie/A-2588-2012; Lutz, Adrian/O-9805-2016; Seneca, Francois/F-9040-2010	Abrego, David/0000-0003-3311-2730; Bourne, David G/0000-0002-1492-8710; Lutz, Adrian/0000-0002-8392-3921; Clode, Peta/0000-0002-5188-4737; Seneca, Francois/0000-0002-8908-1227; Motti, Cherie/0000-0002-3292-2785; Raina, Jean-Baptiste/0000-0002-7508-0004	AMMRF Centre for Microscopy, Characterisation and Analysis (UWA); ARC Centre of Excellence for Coral Reef Studies; AIMS	AMMRF Centre for Microscopy, Characterisation and Analysis (UWA); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); AIMS	The authors would like to thank D. Yellowlees, R. Stocker, M. Garren, A. Johnston, W. Dunlap, H. Harrison, P. Warner and E. Botte for valuable comments on the manuscript. We specially thank K. Ritchie for her advice and encouragement. We also thank J. Hicks, P. Barron (Bruker Biospin), A. Negri, T. Harder, J. Tebben, M. Logan and J. Pollock for their assistance. This work was supported by the AMMRF Centre for Microscopy, Characterisation and Analysis (UWA), the ARC Centre of Excellence for Coral Reef Studies and AIMS.	AYERS GP, 1991, NATURE, V353, P834, DOI 10.1038/353834a0; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; BIGG EK, 1978, ATMOS ENVIRON, V12, P1643, DOI 10.1016/0004-6981(78)90313-X; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Broadbent AD, 2004, MAR FRESHWATER RES, V55, P849, DOI 10.1071/MF04114; Broadbent AD, 2002, ESTUAR COAST SHELF S, V55, P547, DOI 10.1006/ecss.2002.1021; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Fischer E, 2012, BIOGEOCHEMISTRY, V110, P31, DOI 10.1007/s10533-012-9719-y; Gage DA, 1997, NATURE, V387, P891, DOI 10.1038/43160; Gomez-Consarnau L, 2012, ENVIRON MICROBIOL, V14, P2361, DOI 10.1111/j.1462-2920.2012.02804.x; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Ito T, 2011, J PHYCOL, V47, P517, DOI 10.1111/j.1529-8817.2011.00977.x; Leahy SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070400; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Lyon BR, 2011, PLANT PHYSIOL, V157, P1926, DOI 10.1104/pp.111.185025; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; McLenon AL, 2012, BIOGEOCHEMISTRY, V110, P17, DOI 10.1007/s10533-012-9733-0; Modini RL, 2009, ATMOS CHEM PHYS, V9, P7607, DOI 10.5194/acp-9-7607-2009; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Schafer H, 2007, APPL ENVIRON MICROB, V73, P2580, DOI 10.1128/AEM.02074-06; Sherwood AR, 2008, MOL ECOL RESOUR, V8, P1011, DOI 10.1111/j.1755-0998.2008.02138.x; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Sievert SM, 2007, OCEANOGRAPHY, V20, P117, DOI 10.5670/oceanog.2007.55; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Strychar KB, 2004, PHYCOLOGIA, V43, P768, DOI 10.2216/i0031-8884-43-6-768.1; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Suzuki G, 2008, MAR ECOL PROG SER, V355, P149, DOI 10.3354/meps07253; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tapiolas DM, 2013, J EXP MAR BIOL ECOL, V443, P85, DOI 10.1016/j.jembe.2013.02.037; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; Van Alstyne K, 2009, CORAL REEFS, V28, P167, DOI 10.1007/s00338-008-0443-y; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Veal CJ, 2010, LIMNOL OCEANOGR-METH, V8, P241, DOI 10.4319/lom.2010.8.241; Veron J. E., 2000, CORALS WORLD, V1; Vogt C, 1998, MICROBIOL RES, V153, P219; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Yost DM, 2012, CORAL REEFS, V31, P561, DOI 10.1007/s00338-011-0870-z; Yost DM, 2010, J EXP MAR BIOL ECOL, V395, P72, DOI 10.1016/j.jembe.2010.08.016	51	183	191	19	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					677	+		10.1038/nature12677	http://dx.doi.org/10.1038/nature12677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153189				2022-12-28	WOS:000326293200046
J	Caldwell, PHY; Deshpande, AV; Von Gontard, A				Caldwell, Patrina H. Y.; Deshpande, Aniruddh V.; Von Gontard, Alexander			Management of nocturnal enuresis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BLADDER CAPACITY; CHILDREN; URINARY; ADOLESCENTS; SLEEP; CONSTIPATION; OXYBUTYNIN; ATTITUDE; AROUSAL		[Caldwell, Patrina H. Y.; Deshpande, Aniruddh V.] Childrens Hosp Westmead, Ctr Kidney Res, Westmead, NSW 2145, Australia; [Caldwell, Patrina H. Y.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Deshpande, Aniruddh V.] John Hunter Childrens Hosp, Newcastle, NSW, Australia; [Von Gontard, Alexander] Saarland Univ Hosp, Dept Child & Adolescent Psychiat, Homburg, Saar, Germany	University of Sydney; University of Sydney; Universitatsklinikum des Saarlandes	Caldwell, PHY (corresponding author), Childrens Hosp Westmead, Discipline Paediat & Child Hlth, Westmead, NSW 2145, Australia.	patrina.caldwell@health.nsw.gov.au						Abrams P, 2007, BJU INT, V100, P987, DOI 10.1111/j.1464-410X.2007.07205.x; Aloni MN, 2012, ACTA PAEDIATR, V101, pE475, DOI 10.1111/j.1651-2227.2012.02791.x; Austin PFB, STANDARDIZA IN PRESS; BANERJEE S, 1993, AM J CLIN HYPN, V36, P113, DOI 10.1080/00029157.1993.10403053; Bower WF, 2010, AUTON NEUROSCI-BASIC, V157, P63, DOI 10.1016/j.autneu.2010.07.003; Bower WF, 1996, BRIT J UROL, V78, P602, DOI 10.1046/j.1464-410X.1996.13618.x; Butler R, 2008, CHILD CARE HLTH DEV, V34, P65, DOI 10.1111/j.1365-2214.2007.00781.x; Butler RJ, 2008, SCAND J UROL NEPHROL, V42, P257, DOI 10.1080/00365590701748054; Butler RJ, 2005, CHILD CARE HLTH DEV, V31, P659, DOI 10.1111/j.1365-2214.2005.00556.x; Butler RJ, 2004, SCAND J UROL NEPHROL, V38, P117, DOI 10.1080/00365590410025371; Butler RJ, 2005, BJU INT, V96, P404, DOI 10.1111/j.1464-410X.2005.05640.x; Butler RJ, 2002, SCAND J UROL NEPHROL, V36, P268, DOI 10.1080/003655902320248227; Caldwell PHY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003637.pub3; Can G, 2004, PEDIATR INT, V46, P64, DOI 10.1111/j.1442-200X.2004.01829.x; Deshpande AV, 2011, J UROLOGY, V186, P1048, DOI 10.1016/j.juro.2011.04.104; Deshpande AV, 2012, COCHRANE DB SYST REV, V12; Fava GA, 1981, ITALIAN J PSYCHOL, V8, P149; Franco I, 2013, J PEDIATR UROL, V9, P234, DOI 10.1016/j.jpurol.2012.10.026; Glazener C. M. A., 2005, COCHRANE DB SYST REV, V2; Glazener CM, 2004, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858, DOI 10.1002/14651858]; Glazener CM, 2003, COCHRANE DB SYST REV, V3; Glazener CM, 2002, COCHRANE DB SYST REV; Guven A, 2007, J UROLOGY, V178, P1458, DOI 10.1016/j.juro.2007.05.165; Huang T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005230.pub2; Jeyakumar A, 2012, LARYNGOSCOPE, V122, P1873, DOI 10.1002/lary.23323; Kawauchi A, 2003, UROLOGY, V61, P1016, DOI 10.1016/S0090-4295(02)02515-3; Kawauchi A, 1998, BRIT J UROL, V81, P72, DOI 10.1046/j.1464-410x.1998.00012.x; Kilic N, 2006, INT J UROL, V13, P105, DOI 10.1111/j.1442-2042.2006.01240.x; Koff SA, 1996, PEDIATR NEPHROL, V10, P667, DOI 10.1007/s004670050186; Landgraf JM, 2004, PEDIATRICS, V113, P334, DOI 10.1542/peds.113.2.334; Lei D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031023; Lei D, 2012, NEUROUROL URODYNAM, V31, P99, DOI 10.1002/nau.21205; LoeningBaucke V, 1997, PEDIATRICS, V100, P228, DOI 10.1542/peds.100.2.228; Madersbacher H, 2009, BJU INT, V103, P776, DOI 10.1111/j.1464-410X.2008.08093.x; McGrath KH, 2008, J PAEDIATR CHILD H, V44, P19, DOI 10.1111/j.1440-1754.2007.01207.x; National Institute for Health and Care Excellence, 2010, NOCT EN MAN BEDW CHI; Neveus T, 1999, PEDIATRICS, V103, P1193, DOI 10.1542/peds.103.6.1193; Redsell SA, 2001, CHILD CARE HLTH DEV, V27, P149, DOI 10.1046/j.1365-2214.2001.00195.x; RITTIG S, 1989, AM J PHYSIOL, V256, pF664, DOI 10.1152/ajprenal.1989.256.4.F664; Robson WLM, 2005, PEDIATRICS, V115, P956, DOI 10.1542/peds.2004-1402; Ronen T., 1995, J COGN PSYCHOTHER, V9, P249; Sapi MC, 2009, J PEDIAT-BRAZIL, V85, P433, DOI [10.2223/JPED.1935, 10.1590/S0021-75572009000500011]; Senbanjo IO, 2011, AFR HEALTH SCI, V11, P244; TAYLOR PD, 1975, BEHAV RES THER, V13, P281, DOI 10.1016/0005-7967(75)90033-9; Van de Walle J, 2010, DRUG SAFETY, V33, P261, DOI 10.2165/11319110-000000000-00000; van Dommelen P, 2009, J PEDIATR-US, V154, P662, DOI 10.1016/j.jpeds.2008.12.001; VANLONDEN A, 1993, BEHAV RES THER, V31, P613, DOI 10.1016/0005-7967(93)90113-9; von Gontard A, 2011, J UROLOGY, V185, P2303, DOI 10.1016/j.juro.2011.02.040; von Gontard A, 2011, J UROLOGY, V185, P1432, DOI 10.1016/j.juro.2010.11.051; WAGNER WG, 1986, CHILD STUDY J, V16, P13; Weintraub Y, 2013, INT J OBESITY, V37, P75, DOI 10.1038/ijo.2012.108; WENNERGREN HM, 1991, SCAND J UROL NEPHROL, V25, P205, DOI 10.3109/00365599109107948; Yeung CK, 2008, NEW ENGL J MED, V358, P2414, DOI 10.1056/NEJMc0706528; Yeung CK, 2006, BJU INT, V97, P1069, DOI 10.1111/j.1464-410x.2006.06074.x; Yeung CK, 2002, BJU INT, V90, P302, DOI 10.1046/j.1464-410X.2002.02884.x; YOUNG GC, 1972, BEHAV RES THER, V10, P419, DOI 10.1016/0005-7967(72)90068-X	56	36	38	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2013	347								f6259	10.1136/bmj.f6259	http://dx.doi.org/10.1136/bmj.f6259			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EV	24170156				2022-12-28	WOS:000326599500008
J	Kane, M; Yadav, SS; Bitzegeio, J; Kutluay, SB; Zang, T; Wilson, SJ; Schoggins, JW; Rice, CM; Yamashita, M; Hatziioannou, T; Bieniasz, PD				Kane, Melissa; Yadav, Shalini S.; Bitzegeio, Julia; Kutluay, Sebla B.; Zang, Trinity; Wilson, Sam J.; Schoggins, John W.; Rice, Charles M.; Yamashita, Masahiro; Hatziioannou, Theodora; Bieniasz, Paul D.			MX2 is an interferon-induced inhibitor of HIV-1 infection	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS; NUCLEAR IMPORT; NONDIVIDING CELLS; LENTIVIRAL VECTOR; GENE; REPLICATION; DETERMINANTS; RESTRICTION; MACROPHAGES; PROTEIN	HIV-1 replication can be inhibited by type I interferon (IFN), and the expression of a number of gene products with anti-HIV-1 activity is induced by type I IFN1,2. However, none of the known antiretroviral proteins can account for the ability of type I IFN to inhibit early, preintegration phases of the HIV-1 replication cycle in human cells(3,4). Here, by comparing gene expression profiles in cell lines that differ in their ability to support the inhibitory action of IFN-alpha at early steps of the HIV-1 replication cycle, we identify myxovirus resistance 2 (MX2) as an interferon-induced inhibitor of HIV-1 infection. Expression of MX2 reduces permissiveness to a variety of lentiviruses, whereas depletion of MX2 using RNA interference reduces the anti-HIV-1 potency of IFN-alpha. HIV-1 reverse transcription proceeds normally in MX2-expressing cells, but 2-long terminal repeat circular forms of HIV-1 DNA are less abundant, suggesting that MX2 inhibits HIV-1 nuclear import, or destabilizes nuclear HIV-1 DNA. Consistent with this notion, mutations in the HIV-1 capsid protein that are known, or suspected, to alter the nuclear import pathways used by HIV-1 confer resistance to MX2, whereas preventing cell division increases MX2 potency. Overall, these findings indicate that MX2 is an effector of the anti-HIV-1 activity of type-I IFN, and suggest that MX2 inhibits HIV-1 infection by inhibiting capsid-dependent nuclear import of subviral complexes.	[Kane, Melissa; Yadav, Shalini S.; Bitzegeio, Julia; Kutluay, Sebla B.; Zang, Trinity; Wilson, Sam J.; Yamashita, Masahiro; Hatziioannou, Theodora; Bieniasz, Paul D.] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Kane, Melissa; Yadav, Shalini S.; Bitzegeio, Julia; Kutluay, Sebla B.; Zang, Trinity; Wilson, Sam J.; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10065 USA; [Yadav, Shalini S.; Zang, Trinity; Wilson, Sam J.; Bieniasz, Paul D.] Howard Hughes Med Inst, New York, NY 10016 USA; [Schoggins, John W.; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Bieniasz, PD (corresponding author), Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.	pbienias@adarc.org		Wilson, Sam/0000-0002-6065-0895; Kane, Melissa/0000-0002-4580-1210	National Institutes of Health [R37AI64003, R01AI078788, R01AI100720, AI091707, AI057158, DK095031]; Greenberg Medical Research Institute; Starr Foundation; Howard Hughes Medical Institute; MRC [G0801822, MR/K024752/1] Funding Source: UKRI; Medical Research Council [G0801822, MR/K024752/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100720, R01AI078788, R01AI091707, U54AI057158, R37AI064003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenberg Medical Research Institute; Starr Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of The Rockefeller University Genomics Resource Center for assistance with the microarray experiments and members of the Bieniasz laboratory for discussion and advice. This work was supported by grants from the National Institutes of Health; R37AI64003 (to P.D.B.), R01AI078788 (to T.H.) R01AI100720 (to M.Y.), AI091707 to C.M.R., AI057158 (to I. Lipkin, Northeast Biodefense Center, subcontracted to C.M.R.) and DK095031 to J.W.S., the Greenberg Medical Research Institute and the Starr Foundation (C.M.R.) and by the Howard Hughes Medical Institute.	Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Bitzegeio J, 2013, J VIROL, V87, P3549, DOI 10.1128/JVI.03219-12; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Goujon C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-23; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hatziioannou T, 2004, J VIROL, V78, P6005, DOI 10.1128/JVI.78.11.6005-6012.2004; Hatziioannou T, 2003, EMBO J, V22, P385, DOI 10.1093/emboj/cdg042; HO DD, 1985, LANCET, V1, P602; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Kemler I, 2002, J VIROL, V76, P11889, DOI 10.1128/JVI.76.23.11889-11903.2002; King MC, 2004, P NATL ACAD SCI USA, V101, P8957, DOI 10.1073/pnas.0403167101; Koh Y, 2013, J VIROL, V87, P648, DOI 10.1128/JVI.01148-12; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Melen K, 1996, J BIOL CHEM, V271, P23478, DOI 10.1074/jbc.271.38.23478; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; Stoye JP, 1998, REV SCI TECH OIE, V17, P269, DOI 10.20506/rst.17.1.1080; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09	30	357	366	6	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					563	+		10.1038/nature12653	http://dx.doi.org/10.1038/nature12653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24121441	Green Accepted			2022-12-28	WOS:000325988400057
J	Lee, CH; Orloff, ND; Birol, T; Zhu, Y; Goian, V; Rocas, E; Haislmaier, R; Vlahos, E; Mundy, JA; Kourkoutis, LF; Nie, YF; Biegalski, MD; Zhang, JS; Bernhagen, M; Benedek, NA; Kim, Y; Brock, JD; Uecker, R; Xi, XX; Gopalan, V; Nuzhnyy, D; Kamba, S; Muller, DA; Takeuchi, I; Booth, JC; Fennie, CJ; Schlom, DG				Lee, Che-Hui; Orloff, Nathan D.; Birol, Turan; Zhu, Ye; Goian, Veronica; Rocas, Eduard; Haislmaier, Ryan; Vlahos, Eftihia; Mundy, Julia A.; Kourkoutis, Lena F.; Nie, Yuefeng; Biegalski, Michael D.; Zhang, Jingshu; Bernhagen, Margitta; Benedek, Nicole A.; Kim, Yongsam; Brock, Joel D.; Uecker, Reinhard; Xi, X. X.; Gopalan, Venkatraman; Nuzhnyy, Dmitry; Kamba, Stanislav; Muller, David A.; Takeuchi, Ichiro; Booth, James C.; Fennie, Craig J.; Schlom, Darrell G.			Exploiting dimensionality and defect mitigation to create tunable microwave dielectrics	NATURE			English	Article							THIN-FILMS; DEPENDENCE; FERROELECTRICITY; DISPERSION; OXIDES	The miniaturization and integration of frequency-agile microwave circuits-relevant to electronically tunable filters, antennas, resonators and phase shifters-with microelectronics offers tantalizing device possibilities, yet requires thin films whose dielectric constant at gigahertz frequencies can be tuned by applying a quasi-static electric field(1). Appropriate systems such as BaxSr1-xTiO3 have a paraelectric-ferroelectric transition just below ambient temperature, providing high tunability(1-3). Unfortunately, such films suffer significant losses arising from defects. Recognizing that progress is stymied by dielectric loss, we start with a system with exceptionally low loss-Srn+1TinO3n+1 phases(4,5)-in which (SrO)(2) crystallographic shear(6,7) planes provide an alternative to the formation of point defects for accommodating non-stoichiometry(8,9). Here we report the experimental realization of a highly tunable ground state arising from the emergence of a local ferroelectric instability(10) in biaxially strained Srn+1TinO3n+1 phases with n >= 3 at frequencies up to 125 GHz. In contrast to traditional methods of modifying ferroelectrics-doping(1-3,11,12) or strain(13-16)-in this unique system an increase in the separation between the (SrO)(2) planes, which can be achieved by changing n, bolsters the local ferroelectric instability. This new control parameter, n, can be exploited to achieve a figure of merit at room temperature that rivals all known tunable microwave dielectrics(3).	[Lee, Che-Hui; Nie, Yuefeng; Zhang, Jingshu; Schlom, Darrell G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Lee, Che-Hui; Haislmaier, Ryan; Vlahos, Eftihia; Gopalan, Venkatraman] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Orloff, Nathan D.; Booth, James C.] NIST, Boulder, CO 80305 USA; [Orloff, Nathan D.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Birol, Turan; Zhu, Ye; Mundy, Julia A.; Kourkoutis, Lena F.; Kim, Yongsam; Brock, Joel D.; Muller, David A.; Fennie, Craig J.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Goian, Veronica; Nuzhnyy, Dmitry; Kamba, Stanislav] Inst Phys ASCR, Prague 18221 8, Czech Republic; [Rocas, Eduard] Univ Politecn Cataluna, Dept Signal Theory & Commun, ES-08034 Barcelona, Spain; [Kourkoutis, Lena F.; Muller, David A.; Schlom, Darrell G.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Biegalski, Michael D.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Bernhagen, Margitta; Uecker, Reinhard] Leibniz Inst Crystal Growth, D-12489 Berlin, Germany; [Benedek, Nicole A.] Univ Texas Austin, Mat Sci & Engn Program, Austin, TX 78712 USA; [Xi, X. X.] Temple Univ, Dept Phys, Philadelphia, PA 19122 USA; [Takeuchi, Ichiro] Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; Cornell University; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Universitat Politecnica de Catalunya; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; Leibniz Institut fur Kristallzuchtung (IKZ); University of Texas System; University of Texas Austin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Maryland; University of Maryland College Park	Schlom, DG (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	schlom@cornell.edu	Benedek, Nicole/AAG-5388-2021; Goian, Veronica/G-6154-2014; Zhu, Ye/U-3836-2019; Nuzhnyy, Dmitry/G-6661-2014; Zhu, Ye/A-1844-2011; Brock, Joel/AAZ-3439-2020; Benedek, Nicole/T-4041-2017; Muller, David/A-7745-2010; Xi, Xiaoxing/D-8498-2011; Nie, Yuefeng/L-8071-2013; Nie, Yuefeng/A-1595-2013; Schlom, Darrell G/J-2412-2013; Birol, Turan/D-1948-2012; Kamba, Stanislav/G-5332-2014; Kourkoutis, Lena/B-4229-2010	Benedek, Nicole/0000-0001-5026-5574; Goian, Veronica/0000-0002-7971-2224; Zhu, Ye/0000-0002-5217-493X; Nuzhnyy, Dmitry/0000-0001-7591-8295; Zhu, Ye/0000-0002-5217-493X; Benedek, Nicole/0000-0001-5026-5574; Muller, David/0000-0003-4129-0473; Nie, Yuefeng/0000-0002-3449-5393; Nie, Yuefeng/0000-0002-3449-5393; Schlom, Darrell G/0000-0003-2493-6113; Birol, Turan/0000-0001-5174-3320; Kamba, Stanislav/0000-0003-4699-869X; Kourkoutis, Lena/0000-0002-1303-1362; Xi, Xiaoxing/0000-0002-3808-1358; Orloff, Nathan/0000-0001-5391-4699; Barnes, Eftihia/0000-0002-6075-6278	Army Research Office (ARO) [W911NF-09-1-0415, W911NF-12-1-0437, W911NF-10-1-0345]; National Science Foundation (NSF) through Materials Research Science and Engineering Centers (MRSEC) [DMR-0820404, DMR-1120296]; Czech Science Foundation [P204/12/1163]; Czech Ministry of Education, Youth and Sports [LD12026]; Spanish Government; European Union [EUI-ENIAC-2011-4349, EUI-ENIAC 2010-04252]; NSF [DMR-0820404]; National Defense Science & Engineering Graduate Fellowship; Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, US Department of Energy; National Science Foundation [ECCS-0335765]; NSF MRSEC programme [DMR 1120296, NSF IMR-0417392]	Army Research Office (ARO); National Science Foundation (NSF) through Materials Research Science and Engineering Centers (MRSEC)(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Spanish Government(Spanish GovernmentEuropean Commission); European Union(European Commission); NSF(National Science Foundation (NSF)); National Defense Science & Engineering Graduate Fellowship; Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NSF MRSEC programme(National Science Foundation (NSF))	We acknowledge discussions with S. Trolier-McKinstry and C. A. Randall. Research was supported by Army Research Office (ARO) grants W911NF-09-1-0415 (for C.-H. L., Y. Z., J. A. M. and D. A. M.), W911NF-12-1-0437 (for Y. N., J. Z. and D. G. S.) and W911NF-10-1-0345 (for T. B., N. A. B. and C. J. F.); by the National Science Foundation (NSF) through Materials Research Science and Engineering Centers (MRSEC) grants DMR-0820404 (for R. H., E. V., X. X. X. and V. G.) and DMR-1120296 (for Y. K., J. D. B. and L. F. K.); by the Czech Science Foundation Project no. P204/12/1163 and the Czech Ministry of Education, Youth and Sports project LD12026 (for V. G., D. N. and S. K.); and by the Spanish Government and the European Union through grants EUI-ENIAC-2011-4349 and EUI-ENIAC 2010-04252 (for E. R.). C.-H. L. acknowledges stipend support from NSF grant DMR-0820404. J. A. M. acknowledges financial support from a National Defense Science & Engineering Graduate Fellowship. The dielectric and ferroelectric measurements in Fig. 3c were conducted at the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, US Department of Energy. This work was performed in part at the Cornell NanoScale Factory, a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation (grant ECCS-0335765). This work made use of the electron microscopy facility of the Cornell Center for Materials Research (CCMR) with support fromthe NSF MRSEC programme (DMR 1120296) and NSF IMR-0417392.	ANDERSON JS, 1973, NATURE, V243, P81, DOI 10.1038/243081a0; ANDERSSON S, 1966, NATURE, V211, P581, DOI 10.1038/211581a0; Antons A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.024102; BABBITT RW, 1992, MICROWAVE J, V35, P63; Bao P, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/6/063001; Birol T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.257602; Booth JC, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2033139; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Cole MW, 2003, J APPL PHYS, V93, P9218, DOI 10.1063/1.1569392; Cole MW, 2001, J APPL PHYS, V89, P6336, DOI 10.1063/1.1366656; Folkman CM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2396920; Gevorgian S, 1998, INTEGR FERROELECTR, V22, P765; Ghosez P, 1998, FERROELECTRICS, V206, P205, DOI 10.1080/00150199808009159; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Haeni JH, 2004, NATURE, V430, P758, DOI 10.1038/nature02773; Haeni JH, 2000, J ELECTROCERAM, V4, P385, DOI 10.1023/A:1009947517710; Houzet G, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2969469; Kadlec C, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/11/115902; Kamba S, 2003, J EUR CERAM SOC, V23, P2639, DOI 10.1016/S0955-2219(03)00150-X; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; KUNC K, 1983, PHYSICA B & C, V117, P511, DOI 10.1016/0378-4363(83)90573-9; Lee CH, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4798241; Lee J, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.180104; Li YL, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.184112; LU ZG, 1995, PHYS REV B, V51, P2694, DOI 10.1103/PhysRevB.51.2694; MARKS RB, 1991, IEEE T MICROW THEORY, V39, P1205, DOI 10.1109/22.85388; Nakamura T, 1997, FERROELECTRICS, V196, P525; Neaton JB, 2003, APPL PHYS LETT, V82, P1586, DOI 10.1063/1.1559651; Noujni D, 2004, INTEGR FERROELECTR, V62, P199, DOI 10.1080/10584580490457820; Orloff N, 2007, IEEE MTT S INT MICR, P1174; Orloff ND, 2011, IEEE T MICROW THEORY, V59, P188, DOI 10.1109/TMTT.2010.2091200; Perez-Mato JM, 2010, ACTA CRYSTALLOGR A, V66, P558, DOI 10.1107/S0108767310016247; Pertsev NA, 2000, PHYS REV B, V61, pR825, DOI 10.1103/PhysRevB.61.R825; RUDDLESDEN SN, 1958, ACTA CRYSTALLOGR, V11, P54, DOI 10.1107/S0365110X58000128; RUDDLESDEN SN, 1957, ACTA CRYSTALLOGR, V10, P538, DOI 10.1107/S0365110X57001929; Theis CD, 1996, J VAC SCI TECHNOL A, V14, P2677, DOI 10.1116/1.580185; TILLEY RJD, 1977, NATURE, V269, P229, DOI 10.1038/269229a0; TILLEY RJD, 1977, J SOLID STATE CHEM, V21, P293, DOI 10.1016/0022-4596(77)90128-1; UDAYAKUMAR KR, 1989, J PHYS CHEM SOLIDS, V50, P55, DOI 10.1016/0022-3697(89)90473-3; UDAYAKUMAR KR, 1988, J AM CERAM SOC, V71, pC469, DOI 10.1111/j.1151-2916.1988.tb07552.x; Uecker R, 2008, J CRYST GROWTH, V310, P2649, DOI 10.1016/j.jcrysgro.2008.01.019; Velickov B, 2007, Z KRISTALLOGR, V222, P466, DOI 10.1524/zkri.2007.222.9.466; Weiss CV, 2009, J MATER SCI, V44, P5364, DOI 10.1007/s10853-009-3514-8; Williams DF, 2003, IEEE T MICROW THEORY, V51, P2391, DOI 10.1109/TMTT.2003.819211; Wise PL, 2001, J EUR CERAM SOC, V21, P1723, DOI 10.1016/S0955-2219(01)00102-9; Xi XX, 2000, J ELECTROCERAM, V4, P393, DOI 10.1023/A:1009903802688; Xu GY, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064112	47	180	181	10	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					532	+		10.1038/nature12582	http://dx.doi.org/10.1038/nature12582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24132232				2022-12-28	WOS:000325988400050
J	Litvak, E; Fineberg, HV				Litvak, Eugene; Fineberg, Harvey V.			Smoothing the Way to High Quality, Safety, and Economy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Artificial peaks and valleys in hospital demand, driven by planned surgeries, foster health care delivery that endangers patients, reduces access to care, puts pressure on clinicians at some times, and results in underutilization of health care resources at others. In recent years, health care institutions have awakened to the need to provide safe, high-quality care at lower cost. The Centers for Medicare and Medicaid Services is implementing multiple incentives and penalties intended to help realize this goal. For example, innovations designed to reduce the rate of infections associated with ventilators or central venous catheters have had demonstrated success. We believe that greater attention to a frequently overlooked parameter in health service design patient load and flow would accelerate progress toward reliable, safe, efficient care. A reliable health system is one that functions properly in difficult and unanticipated ...	[Litvak, Eugene] Inst Healthcare Optimizat, Newton, MA USA; [Fineberg, Harvey V.] Natl Acad, Inst Med, Washington, DC USA	National Academies of Sciences, Engineering & Medicine	Litvak, E (corresponding author), Inst Healthcare Optimizat, Newton, MA USA.							[Anonymous], 2013, STUD EFF PAT FLOW VA; Litvak E., 2010, MANAGING PATIENT FLO; Litvak E, 2011, HEALTH AFFAIR, V30, P76, DOI 10.1377/hlthaff.2010.1114; Ryckman FC, 2010, MANAGING PATIENT FLO, P97; Smith CD, 2013, J AM COLL SURGEONS, V216, P1230, DOI 10.1016/j.jamcollsurg.2013.04.001; Smith CD, 2013, J AM COLL SURGEONS, V216, P559, DOI 10.1016/j.jamcollsurg.2012.12.046	6	19	19	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1581	1583		10.1056/NEJMp1307699	http://dx.doi.org/10.1056/NEJMp1307699			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239MZ	24152258				2022-12-28	WOS:000326031100005
J	Wood, E; Samet, JH; Volkow, ND				Wood, Evan; Samet, Jeffrey H.; Volkow, Nora D.			Physician Education in Addiction Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEPENDENCE; HEALTH; BURDEN; CARE		[Wood, Evan] Univ British Columbia, Dept Med, Vancouver, BC V6Z 1Y6, Canada; [Samet, Jeffrey H.] Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA; [Volkow, Nora D.] US Natl Inst Drug Abuse, Bethesda, MD USA	University of British Columbia; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Wood, E (corresponding author), Univ British Columbia, Div Aids, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	uhri-ew@cfenet.ubc.ca		Samet, Jeffrey/0000-0002-0897-3400	Intramural NIH HHS [Z99 DA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Chamorro AJ, 2012, ADDICT BIOL, V17, P505, DOI 10.1111/j.1369-1600.2012.00442.x; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Mayo-Smith M., 2009, PRINCIPLES ADDICTION, P559; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; National Center on Addiction and Substance Abuse at Columbia Uni- versity, ADD MED CLOS GAP SCI; National Center on Addiction and Substance Abuse at Columbia University, MISS OPP NAT SURV PR; Volkow ND, 2012, ANNU REV PHARMACOL, V52, P321, DOI 10.1146/annurev-pharmtox-010611-134625; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X	9	71	73	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1673	1674		10.1001/jama.2013.280377	http://dx.doi.org/10.1001/jama.2013.280377			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24150462	Green Accepted			2022-12-28	WOS:000325948500019
J	Cooper, A; Stringer, CB				Cooper, A.; Stringer, C. B.			Did the Denisovans Cross Wallace's Line?	SCIENCE			English	Editorial Material							HUMAN-EVOLUTION; HOMININ; GENOME; CAVE; ADMIXTURE; SEQUENCE; SIBERIA		[Cooper, A.] Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Stringer, C. B.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	University of Adelaide; Natural History Museum London	Cooper, A (corresponding author), Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia.	cooper@adelaide.edu.au; c.stringer@nhm.ac.uk	Cooper, Alan/E-8171-2012	Cooper, Alan/0000-0002-7738-7851				Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Balme J, 2009, QUATERN INT, V202, P59, DOI 10.1016/j.quaint.2008.10.002; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gibbons A, 2011, SCIENCE, V333, P1084, DOI 10.1126/science.333.6046.1084; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Huxley TH, 1868, P ZOOL SOC LOND, P296; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Morwood MJ, 2009, J HUM EVOL, V57, P640, DOI 10.1016/j.jhevol.2009.08.003; OConnell J.F., 2010, GLOBAL ORIGINS DEV S, P57; Paabo S., 2013, BIOL GENOMES; Pennisi E, 2013, SCIENCE, V340, P799, DOI 10.1126/science.340.6134.799; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311	18	37	40	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					321	323		10.1126/science.1244869	http://dx.doi.org/10.1126/science.1244869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136958				2022-12-28	WOS:000325755100032
J	Herculano-Houzel, S				Herculano-Houzel, Suzana			Sleep It Out	SCIENCE			English	Editorial Material							MAMMALIAN SLEEP; RESTRICTION; WAKEFULNESS		Univ Fed Rio de Janeiro, Lab Comparat Neuroanat, Inst Biomed Sci, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Herculano-Houzel, S (corresponding author), Univ Fed Rio de Janeiro, Lab Comparat Neuroanat, Inst Biomed Sci, BR-21941 Rio De Janeiro, Brazil.	suzanahh@gmail.com						Capellini I, 2008, EVOLUTION, V62, P1764, DOI 10.1111/j.1558-5646.2008.00392.x; HOFMAN MA, 1988, BRAIN BEHAV EVOLUT, V32, P17, DOI 10.1159/000116529; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; O'Donnell J, 2012, NEUROCHEM RES, V37, P2496, DOI 10.1007/s11064-012-0818-x; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Porkka-Heiskanen T, 2011, SLEEP MED REV, V15, P123, DOI 10.1016/j.smrv.2010.06.005; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; ZEPELIN H, 1974, BRAIN BEHAV EVOLUT, V10, P425, DOI 10.1159/000124330; Zimmerman JE, 2008, TRENDS NEUROSCI, V31, P371, DOI 10.1016/j.tins.2008.05.001	12	10	10	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					316	317		10.1126/science.1245798	http://dx.doi.org/10.1126/science.1245798			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136954				2022-12-28	WOS:000325755100028
J	Darcy, P; Moughty, AM				Darcy, Philip; Moughty, Adrian M.			Pronator Drift	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Darcy, Philip; Moughty, Adrian M.] Mater Misericordiae Univ Hosp, Dublin, Ireland	Mater Misericordiae University Hospital; University College Dublin	Darcy, P (corresponding author), Mater Misericordiae Univ Hosp, Dublin, Ireland.	amoughty@hotmail.com							0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					E20	E20		10.1056/NEJMicm1213343	http://dx.doi.org/10.1056/NEJMicm1213343			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24131195				2022-12-28	WOS:000328101700001
J	Shah, NR; Chokshi, DA				Shah, Nirav R.; Chokshi, Dave A.			Should Health Care Systems Become Insurers?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ORGANIZATIONS		[Shah, Nirav R.] New York State Dept Hlth, Albany, NY USA; [Chokshi, Dave A.] US Dept Vet Affairs, Washington, DC USA	State University of New York (SUNY) System; US Department of Veterans Affairs	Chokshi, DA (corresponding author), Dept Vet Affairs, 810 Vermont Ave NW, Washington, DC 20006 USA.	dave.chokshi@alumni.duke.edu	Shah, Nirav R./B-6622-2008	Shah, Nirav R./0000-0003-2044-7865; Chokshi, Dave/0000-0001-7467-4591				Advisory Board Co, 2013 ACCOUNTABLE PAY; Burke G., MOVING TOWARD ACCOUN; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P2263, DOI 10.1001/jama.2012.4313; Lesser CS, 2000, HEALTH AFFAIR, V19, P206, DOI 10.1377/hlthaff.19.6.206; Scheffler RM, 2012, JAMA-J AM MED ASSOC, V307, P1493, DOI 10.1001/jama.2012.451; UnitedHealth Group Inc, UNITEDHEALTHCARE EXP	6	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1561	1562		10.1001/jama.2013.280015	http://dx.doi.org/10.1001/jama.2013.280015			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129460				2022-12-28	WOS:000325624800015
J	Montori, VM; Brito, JP; Murad, MH				Montori, Victor M.; Brito, Juan Pablo; Murad, M. Hassan			The Optimal Practice of Evidence-Based Medicine Incorporating Patient Preferences in Practice Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Montori, Victor M.; Brito, Juan Pablo; Murad, M. Hassan] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [Montori, Victor M.; Brito, Juan Pablo; Murad, M. Hassan] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Montori, Victor M.; Brito, Juan Pablo; Murad, M. Hassan] Mayo Clin, Ctr Sci Healthcare Delivery, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Montori, VM (corresponding author), Mayo Clin, 200 1st St SW,Plummer 3-35, Rochester, MN 55905 USA.	montori.victor@mayo.edu	Murad, M. Hassan/AAW-4367-2020	Montori, Victor/0000-0003-0595-2898; Murad, Mohammad Hassan/0000-0001-5502-5975				Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], USERS GUIDES MED LIT; Boivin A, 2009, MED CARE, V47, P908, DOI 10.1097/MLR.0b013e3181a81158; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; MacLean S, 2012, CHEST, V141, pE1S, DOI 10.1378/chest.11-2290; Murad MH, 2011, J CLIN EPIDEMIOL, V64, P743, DOI 10.1016/j.jclinepi.2010.08.005; Shippee ND, 2015, HEALTH EXPECT, V18, P1151, DOI 10.1111/hex.12090; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076	8	173	177	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2503	2504		10.1001/jama.2013.281422	http://dx.doi.org/10.1001/jama.2013.281422			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24165826				2022-12-28	WOS:000328503600017
J	Imayoshi, I; Isomura, A; Harima, Y; Kawaguchi, K; Kori, H; Miyachi, H; Fujiwara, T; Ishidate, F; Kageyama, R				Imayoshi, Itaru; Isomura, Akihiro; Harima, Yukiko; Kawaguchi, Kyogo; Kori, Hiroshi; Miyachi, Hitoshi; Fujiwara, Takahiro; Ishidate, Fumiyoshi; Kageyama, Ryoichiro			Oscillatory Control of Factors Determining Multipotency and Fate in Mouse Neural Progenitors	SCIENCE			English	Article							STEM-CELLS; ACHAETE-SCUTE; FACTOR OLIG2; HES1; EXPRESSION; GENES; ROLES; OLIGODENDROCYTES; DIFFERENTIATION; TRANSCRIPTION	The basic helix-loop-helix transcription factors Ascl1/Mash1, Hes1, and Olig2 regulate fate choice of neurons, astrocytes, and oligodendrocytes, respectively. These same factors are coexpressed by neural progenitor cells. Here, we found by time-lapse imaging that these factors are expressed in an oscillatory manner by mouse neural progenitor cells. In each differentiation lineage, one of the factors becomes dominant. We used optogenetics to control expression of Ascl1 and found that, although sustained Ascl1 expression promotes neuronal fate determination, oscillatory Ascl1 expression maintains proliferating neural progenitor cells. Thus, the multipotent state correlates with oscillatory expression of several fate-determination factors, whereas the differentiated state correlates with sustained expression of a single factor.	[Imayoshi, Itaru; Isomura, Akihiro; Harima, Yukiko; Miyachi, Hitoshi; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Imayoshi, Itaru] Kyoto Univ, Hakubi Ctr, Kyoto 6068302, Japan; [Imayoshi, Itaru; Fujiwara, Takahiro; Ishidate, Fumiyoshi; Kageyama, Ryoichiro] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, World Premier Int Res Initiat, Kyoto 6068501, Japan; [Imayoshi, Itaru] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Isomura, Akihiro; Harima, Yukiko; Kori, Hiroshi; Kageyama, Ryoichiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan; [Kawaguchi, Kyogo] Univ Tokyo, Grad Sch Sci, Dept Phys, Tokyo 1130033, Japan; [Kori, Hiroshi] Ochanomizu Univ, Dept Informat Sci, Tokyo 1128610, Japan	Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; Ochanomizu University	Imayoshi, I (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan.	iimayosh@virus.kyoto-u.ac.jp; rkageyam@virus.kyoto-u.ac.jp	Kori, Hiroshi/AAD-3700-2019; Kawaguchi, Kyogo/AAF-5133-2021; Fujiwara, Takahiro/G-2755-2012	Fujiwara, Takahiro/0000-0001-5576-759X; Kageyama, Ryoichiro/0000-0002-5985-1120; Kawaguchi, Kyogo/0000-0001-9395-9875	Core Research for Evolutional Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology [22123002]; Japan Society for Promotion of Science (JSPS) [24240049]; Takeda Foundation;  [JSPS 24680035]; Grants-in-Aid for Scientific Research [12J08031] Funding Source: KAKEN	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Foundation(Takeda Science Foundation (TSF)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to F. Guillemot, J. Johnson, H. Takebayashi, K. Ikenaka, D. Melton, A. Miyawaki, A. Sakaue-Sawano, Q. Lu, and Y. Yang for reagents and S. Kitano, M. Sakamoto, H. Shimojo, and Center for Meso-Bio Single-Molecule Imaging (CeMI), WPI-iCeMS, Kyoto University for technical help. This work was supported by Core Research for Evolutional Science and Technology (R. K. and H. K.), Grant-in-Aid for Scientific Research on Innovative Areas (Ministry of Education, Culture, Sports, Science, and Technology 22123002) (R. K.), Scientific Research (A) [Japan Society for Promotion of Science (JSPS) 24240049] (R. K.) and Young Scientists (A) (JSPS 24680035) (I. I.), and Takeda Foundation (R. K.). I. I. and R. K. designed the project and wrote the manuscript. A. I. developed the light-induced gene expression system. I. I., A. I., Y. H., and H. M. performed experiments, and T. F. and F. I. conducted fluorescent imaging analyses. K. K. and H. K. performed computer simulation. A national (Japanese) patent application, "Optogenetic control of proliferation and differentiation of stem cells" (2013-193582), has been filed by Kyoto University.	Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Fukuda S, 2004, CELL DEATH DIFFER, V11, P196, DOI 10.1038/sj.cdd.4401332; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; Hindley C, 2012, DEVELOPMENT, V139, P1718, DOI 10.1242/dev.077552; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Marshall CAG, 2002, J NEUROSCI, V22, P9821; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Parras CM, 2007, J NEUROSCI, V27, P4233, DOI 10.1523/JNEUROSCI.0126-07.2007; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Wu YY, 2003, DEV DYNAM, V226, P675, DOI 10.1002/dvdy.10278; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	37	331	337	6	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1203	1208		10.1126/science.1242366	http://dx.doi.org/10.1126/science.1242366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24179156	Green Published			2022-12-28	WOS:000327857900039
J	Johannessen, CM; Johnson, LA; Piccioni, F; Townes, A; Frederick, DT; Donahue, MK; Narayan, R; Flaherty, KT; Wargo, JA; Root, DE; Garraway, LA				Johannessen, Cory M.; Johnson, Laura A.; Piccioni, Federica; Townes, Aisha; Frederick, Dennie T.; Donahue, Melanie K.; Narayan, Rajiv; Flaherty, Keith T.; Wargo, Jennifer A.; Root, David E.; Garraway, Levi A.			A melanocyte lineage program confers resistance to MAP kinase pathway inhibition	NATURE			English	Article							IMPROVED SURVIVAL; MEK INHIBITION; BRAF; EXPRESSION; MICROPHTHALMIA; TRANSCRIPTION; MUTATIONS; ONCOGENE; REVEALS; RAF-1	Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth(1). RAF and MEK inhibitors show remarkable clinical efficacy in BRAF(V600E) melanoma(2,3); however, resistance to these agents remains a formidable challenge(2,4). Global characterization of resistance mechanisms may inform the development of more effective therapeutic combinations. Here we carried out systematic gain-of-function resistance studies by expressing more than 15,500 genes individually in a BRAF(V600E) melanoma cell line treated with RAF, MEK, ERK or combined RAF-MEK inhibitors. These studies revealed a cyclic-AMP-dependent melanocytic signalling network not previously associated with drug resistance, including G-protein-coupled receptors, adenyl cyclase, protein kinase A and cAMP response element binding protein(CREB). Preliminary analysis of biopsies from BRAF (V600E) melanoma patients revealed that phosphorylated (active) CREB was suppressed by RAF-MEK inhibition but restored in relapsing tumours. Expression of transcription factors activated downstream of MAP kinase and cAMP pathways also conferred resistance, including c-FOS, NR4A1, NR4A2 and MITF. Combined treatment with MAPK-pathway and histone-deacetylase inhibitors suppressed MITF expression and cAMP-mediated resistance. Collectively, these data suggest that oncogenic dysregulation of a melanocyte lineage dependency can cause resistance to RAF-MEK-ERK inhibition, which may be overcome by combining signalling-and chromatin-directed therapeutics.	[Johannessen, Cory M.; Johnson, Laura A.; Piccioni, Federica; Townes, Aisha; Donahue, Melanie K.; Narayan, Rajiv; Root, David E.; Garraway, Levi A.] Broad Inst Harvard Univ & Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Johannessen, Cory M.; Johnson, Laura A.; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Johannessen, Cory M.; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Frederick, Dennie T.; Flaherty, Keith T.; Wargo, Jennifer A.] Massachusetts Gen Hosp, Dept Surg Oncol Med Oncol & Dermatol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Garraway, LA (corresponding author), Broad Inst Harvard Univ & Massachusetts Inst Tech, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	Levi_Garraway@dfci.harvard.edu			National Institutes of Health (NIH) [DP2 OD002750]; Melanoma Research Alliance; Starr Cancer Consortium; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NCI Skin Cancer SPORE [P50CA93683]; LINCS Program [U54 HG006093]; NATIONAL CANCER INSTITUTE [P01CA163222, P50CA093683, R33CA155554] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006093, U01HG006492] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Starr Cancer Consortium; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NCI Skin Cancer SPORE; LINCS Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) Director's New Innovator Award (DP2 OD002750, L. A. G.), Melanoma Research Alliance (L. A. G.), Starr Cancer Consortium (L. A. G.), Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (L. A. G.), the NCI Skin Cancer SPORE (P50CA93683, L. A. G.) and the LINCS Program (U54 HG006093).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Aronov AM, 2009, J MED CHEM, V52, P6362, DOI 10.1021/jm900630q; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; Hayward NK, 2003, ONCOGENE, V22, P3053, DOI 10.1038/sj.onc.1206445; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Jane-Valbuena J, 2010, CANCER RES, V70, P2075, DOI 10.1158/0008-5472.CAN-09-3092; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PHAM CD, 1995, ONCOGENE, V10, P1683; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Smith MP, 2013, JNCI-J NATL CANCER I, V105, P33, DOI 10.1093/jnci/djs471; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Wood KC, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002612; Wu M, 2000, GENE DEV, V14, P301; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yokoyama S, 2008, PIGM CELL MELANOMA R, V21, P457, DOI 10.1111/j.1755-148X.2008.00480.x	26	326	333	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					138	+		10.1038/nature12688	http://dx.doi.org/10.1038/nature12688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24185007	Green Submitted, Green Accepted			2022-12-28	WOS:000327851700047
J	Brown, PG; Assink, JD; Astiz, L; Blaauw, R; Boslough, MB; Borovicka, J; Brachet, N; Brown, D; Campbell-Brown, M; Ceranna, L; Cooke, W; de Groot-Hedlin, C; Drob, DP; Edwards, W; Evers, LG; Garces, M; Gill, J; Hedlin, M; Kingery, A; Laske, G; Le Pichon, A; Mialle, P; Moser, DE; Saffer, A; Silber, E; Smets, P; Spalding, RE; Spurny, P; Tagliaferri, E; Uren, D; Weryk, RJ; Whitaker, R; Krzeminski, Z				Brown, P. G.; Assink, J. D.; Astiz, L.; Blaauw, R.; Boslough, M. B.; Borovicka, J.; Brachet, N.; Brown, D.; Campbell-Brown, M.; Ceranna, L.; Cooke, W.; de Groot-Hedlin, C.; Drob, D. P.; Edwards, W.; Evers, L. G.; Garces, M.; Gill, J.; Hedlin, M.; Kingery, A.; Laske, G.; Le Pichon, A.; Mialle, P.; Moser, D. E.; Saffer, A.; Silber, E.; Smets, P.; Spalding, R. E.; Spurny, P.; Tagliaferri, E.; Uren, D.; Weryk, R. J.; Whitaker, R.; Krzeminski, Z.			A 500-kiloton airburst over Chelyabinsk and an enhanced hazard from small impactors	NATURE			English	Article							EARTH; ASTEROIDS; EXPLOSION	Most large (over a kilometre in diameter) near-Earth asteroids are now known, but recognition that airbursts (or fireballs resulting from nuclear-weapon-sized detonations of meteoroids in the atmosphere) have the potential to do greater damage(1) than previously thought has shifted an increasing portion of the residual impact risk (the risk of impact from an unknown object) to smaller objects(2). Above the threshold size of impactor at which the atmosphere absorbs sufficient energy to prevent a ground impact, most of the damage is thought to be caused by the airburst shock wave(3), but owing to lack of observations this is uncertain(4,5). Here we report an analysis of the damage from the airburst of an asteroid about 19 metres (17 to 20 metres) in diameter southeast of Chelyabinsk, Russia, on 15 February 2013, estimated to have an energy equivalent of approximately 500 (+/- 100) kilotons of trinitrotoluene (TNT, where 1 kiloton of TNT = 4.185x10(12) joules). We show that a widely referenced technique(4-6) of estimating airburst damage does not reproduce the observations, and that the mathematical relations(7) based on the effects of nuclear weapons-almost always used with this technique-overestimate blast damage. This suggests that earlier damage estimates(5,6) near the threshold impactor size are too high. We performed a global survey of airbursts of a kiloton or more (including Chelyabinsk), and find that the number of impactors with diameters of tens of metres may be an order of magnitude higher than estimates based on other techniques(8,9). This suggests a non-equilibrium(if the population were in a long-term collisional steady state the size-frequency distribution would either follow a single power law or there must be a size-dependent bias in other surveys) in the near-Earth asteroid population for objects 10 to 50 metres in diameter, and shifts more of the residual impact risk to these sizes.	[Brown, P. G.; Campbell-Brown, M.; Gill, J.; Silber, E.; Uren, D.; Weryk, R. J.; Krzeminski, Z.] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; [Brown, P. G.] Univ Western Ontario, Ctr Planetary Sci & Explorat, London, ON N6A 5B7, Canada; [Assink, J. D.; Brachet, N.; Le Pichon, A.] Commissariat Energie Atom, Dept Anal Surveillance Environm CEA DAM DIF, F-91297 Bruyeres Le Chatel, Arpajon, France; [Astiz, L.; de Groot-Hedlin, C.; Hedlin, M.; Laske, G.] Univ Calif San Diego, Inst Geophys & Planetary Phys, Lab Atmospher Acoust, La Jolla, CA 92093 USA; [Blaauw, R.; Moser, D. E.] NASA, Marshall Informat Technol Serv MITS, Dynet Tech Serv, Marshall Space Flight Ctr, Huntsville, CA 35812 USA; [Boslough, M. B.; Spalding, R. E.] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Borovicka, J.; Spurny, P.] Acad Sci Czech Republ, Astron Inst, CZ-25165 Ondrejov, Czech Republic; [Brown, D.; Mialle, P.] Comprehens Test Ban Treaty Org, Provis Tech Secretariat, Int Data Ctr, A-1400 Vienna, Austria; [Ceranna, L.] Bundesanstalt Geowissensch & Rohstoffe, D-30655 Hannover, Germany; [Cooke, W.; Saffer, A.] Marshall Space Flight Ctr, Meteoroid Environm Off, Space Environm Team, Huntsville, AL 35812 USA; [Drob, D. P.] Naval Res Lab, Space Sci Div, Washington, DC 20375 USA; [Edwards, W.] Nat Resources Canada, Canadian Hazard Informat Serv, Ottawa, ON K1A 0Y3, Canada; [Evers, L. G.; Smets, P.] Royal Netherlands Meteorol Inst, Seismol Div, NL-3732 GK De Bilt, Netherlands; [Evers, L. G.; Smets, P.] Delft Univ Technol, Fac Civil Engn & Geosci, Dept Geosci & Engn, NL-2628 CN Delft, Netherlands; [Garces, M.] Univ Hawaii, Infrasound Lab, Honolulu, HI 96740 USA; [Kingery, A.] NASA, ERC Inc Jacobs ESSSA Grp, Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Tagliaferri, E.] ET Space Syst, Camarillo, CA 93012 USA; [Whitaker, R.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of California System; University of California San Diego; National Aeronautics & Space Administration (NASA); United States Department of Energy (DOE); Sandia National Laboratories; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; United States Department of Defense; United States Navy; Naval Research Laboratory; Natural Resources Canada; Royal Netherlands Meteorological Institute; Delft University of Technology; University of Hawaii System; National Aeronautics & Space Administration (NASA); United States Department of Energy (DOE); Los Alamos National Laboratory	Brown, PG (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada.	pbrown@uwo.ca	Borovicka, Jiri/F-4257-2014; Spurny, Pavel/G-9044-2014; Drob, Douglas P/G-4061-2014; Spurný, Pavel/X-9268-2019; Evers, Läslo/E-5707-2011; Brown, Peter/C-8763-2018	Borovicka, Jiri/0000-0002-5569-8982; Drob, Douglas P/0000-0002-2045-7740; Spurný, Pavel/0000-0001-5944-3090; Evers, Läslo/0000-0003-2825-6211; Brown, Peter/0000-0001-6130-7039; Assink, Jelle/0000-0002-4990-6845; Le Pichon, Alexis/0000-0001-6531-069X; Campbell-Brown, Margaret/0000-0001-6010-1784; Smets, Pieter/0000-0003-0394-0973; Silber, Elizabeth A./0000-0003-4778-1409	NASA [NNX11AB76A]; Office of Naval Research;  [67985815]; Directorate For Geosciences [1147962] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); Office of Naval Research(Office of Naval Research); ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by the NASA co-operative agreement NNX11AB76A and the Czech institutional project RVO:67985815. D. P. D. acknowledges support from the Office of Naval Research. We appreciate discussions with F. Gilbert (of UCSD), J. Stevens (of SAIC), P. Earle and J. Bellini (of USGS). D. Dearborn provided assistance with video reductions.	BENMENAHEM A, 1975, PHYS EARTH PLANET IN, V11, P1, DOI 10.1016/0031-9201(75)90072-2; Bland PA, 2006, METEORIT PLANET SCI, V41, P607, DOI 10.1111/j.1945-5100.2006.tb00485.x; Borovicka J., 2013, METEORIT PLANET SCI; Boslough MBE, 2008, INT J IMPACT ENG, V35, P1441, DOI 10.1016/j.ijimpeng.2008.07.053; Boslough MBE, 1997, ANN NY ACAD SCI, V822, P236, DOI 10.1111/j.1749-6632.1997.tb48345.x; Brachet N, 2010, INFRASOUND MONITORING FOR ATMOSPHERIC STUDIES, P77, DOI 10.1007/978-1-4020-9508-5_3; Brown P, 2011, METEORIT PLANET SCI, V46, P339, DOI 10.1111/j.1945-5100.2010.01167.x; Brown P, 2002, NATURE, V420, P294, DOI 10.1038/nature01238; Brown P, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003105; CEPLECHA Z, 1992, ASTRON ASTROPHYS, V263, P361; CHAPMAN CR, 1994, NATURE, V367, P33, DOI 10.1038/367033a0; Collins GS, 2005, METEORIT PLANET SCI, V40, P817, DOI 10.1111/j.1945-5100.2005.tb00157.x; Ens TA, 2012, J ATMOS SOL-TERR PHY, V80, P208, DOI 10.1016/j.jastp.2012.01.018; Glasstone S., 1977, EFFECTS NUCL WEAPONS, P100; Harris A., 2013, PLAN DEF C IAA; Harris A, 2008, NATURE, V453, P1178, DOI 10.1038/4531178a; HILLS JG, 1993, ASTRON J, V105, P1114, DOI 10.1086/116499; Rabinowitz D, 2000, NATURE, V403, P165, DOI 10.1038/35003128; ReVelle D. O., 2007, P INT ASTRON UNION S, P95; REVELLE DO, 1976, J GEOPHYS RES-SPACE, V81, P1217, DOI 10.1029/JA081i007p01217; Silber EA, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003334; Tagliaferri E., 1998, HAZARDS DUE COMETS A, P199; Toon OB, 1997, REV GEOPHYS, V35, P41, DOI 10.1029/96RG03038; Ward SN, 2000, ICARUS, V145, P64, DOI 10.1006/icar.1999.6336; Werner SC, 2002, ICARUS, V156, P287, DOI 10.1006/icar.2001.6789	26	273	283	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					238	241		10.1038/nature12741	http://dx.doi.org/10.1038/nature12741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24196713	Green Submitted			2022-12-28	WOS:000326894200046
J	Groschel, AH; Walther, A; Lobling, TI; Schacher, FH; Schmalz, H; Muller, AHE				Groeschel, Andre H.; Walther, Andreas; Loebling, Tina I.; Schacher, Felix H.; Schmalz, Holger; Mueller, Axel H. E.			Guided hierarchical co-assembly of soft patchy nanoparticles	NATURE			English	Article							MULTICOMPARTMENT MICELLES; BLOCK; JANUS; COPOLYMERS; ARCHITECTURES; OBJECTS; COMPLEX; LENGTH	The concept of hierarchical bottom-up structuring commonly encountered in naturalmaterials provides inspiration for the design of complex artificial materials with advanced functionalities(1,2). Natural processes have achieved the orchestration of multicomponent systems across many length scales with very high precision(3,4), but man-made self-assemblies still face obstacles in realizing well-defined hierarchical structures(5-11). In particle-based self-assembly, the challenge is to program symmetries and periodicities of superstructures by providing monodisperse building blocks with suitable shape anisotropy or anisotropic interaction patterns ('patches'). Irregularities in particle architecture are intolerable because they generate defects that amplify throughout the hierarchical levels. For patchy microscopic hard colloids, this challenge has been approached by using top-down methods (such as metal shading or microcontact printing), enabling molecule-like directionality during aggregation(12-16). However, both top-down procedures and particulate systems based on molecular assembly struggle to fabricate patchy particles controllably in the desired size regime (10-100 nm). Here we introduce the co-assembly of dynamic patchy nanoparticles-that is, soft patchy nanoparticles that are intrinsically self-assembled and monodisperse-as a modular approach for producing well-ordered binary and ternary supracolloidal hierarchical assemblies. We bridge up to three hierarchical levels by guiding triblock terpolymers (length scale 10 nm) to form soft patchy nanoparticles (20-50 nm) of different symmetries that, in combination, co-assemble into substructured, compartmentalized materials (>10 mu m) with predictable and tunable nanoscale periodicities. We establish how molecular control over polymer composition programs the building block symmetries and regulates particle positioning, offering a route to well-ordered mixed mesostructures of high complexity.	[Groeschel, Andre H.; Loebling, Tina I.; Schmalz, Holger; Mueller, Axel H. E.] Univ Bayreuth, D-95440 Bayreuth, Germany; [Walther, Andreas] Rhein Westfal TH Aachen, DWI, Inst Interact Mat Res, D-52056 Aachen, Germany; [Schacher, Felix H.] Univ Jena, Inst Organ Chem & Makromol Chem, D-07743 Jena, Germany; [Schacher, Felix H.] Univ Jena, Jena Ctr Soft Matter, D-07743 Jena, Germany	University of Bayreuth; RWTH Aachen University; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Muller, AHE (corresponding author), Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55099 Mainz, Germany.	andre.groschel@aalto.fi; axel.mueller@uni-mainz.de	Walther, Andreas/GYA-4224-2022; Schacher, Felix H/C-9248-2009; Walther, Andreas/D-4139-2009; Gröschel, Andre/G-1280-2011; Löbling, Tina/B-7075-2017; Schmalz, Holger/D-6362-2015; Mueller, Axel/B-7591-2009	Walther, Andreas/0000-0003-4516-1783; Schacher, Felix H/0000-0003-4685-6608; Walther, Andreas/0000-0002-3662-5606; Gröschel, Andre/0000-0002-2576-394X; Schmalz, Holger/0000-0002-4876-0450; Mueller, Axel/0000-0001-9423-9829	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 840]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank O. Ikkala and E. Kumacheva for discussions and comments on the manuscript, and A. Majewski for providing maghemite nanoparticles. This work was supported by Deutsche Forschungsgemeinschaft within Sonderforschungsbereich 840 (TP A1 and A2).	AUSCHRA C, 1993, POLYM BULL, V30, P257, DOI 10.1007/BF00343058; Bates FS, 2012, SCIENCE, V336, P434, DOI 10.1126/science.1215368; Bowden N, 1997, SCIENCE, V276, P233, DOI 10.1126/science.276.5310.233; Chen Q, 2012, LANGMUIR, V28, P13555, DOI 10.1021/la302226w; Chen Q, 2012, J AM CHEM SOC, V134, P11080, DOI 10.1021/ja303434d; Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Fang B, 2009, ANGEW CHEM INT EDIT, V48, P2877, DOI 10.1002/anie.200806051; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Gadt T, 2009, NAT MATER, V8, P144, DOI [10.1038/NMAT2356, 10.1038/nmat2356]; Giebeler E, 1997, MACROMOL CHEM PHYSIC, V198, P3815, DOI 10.1002/macp.1997.021981204; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Groschel AH, 2012, J AM CHEM SOC, V134, P13850, DOI 10.1021/ja305903u; Groschel AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1707; Grzelczak M, 2010, ACS NANO, V4, P3591, DOI 10.1021/nn100869j; Kaufmann T, 2011, ADV MATER, V23, P79, DOI 10.1002/adma.201003564; Kubowicz S, 2005, ANGEW CHEM INT EDIT, V44, P5262, DOI 10.1002/anie.200500584; Li ZB, 2006, MACROMOLECULES, V39, P765, DOI 10.1021/ma052199b; Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350; Liu K, 2010, SCIENCE, V329, P197, DOI 10.1126/science.1189457; Majewski AP, 2012, BIOMACROMOLECULES, V13, P857, DOI 10.1021/bm2017756; Mann S, 2009, NAT MATER, V8, P781, DOI [10.1038/NMAT2496, 10.1038/nmat2496]; Nie ZH, 2007, NAT MATER, V6, P609, DOI 10.1038/nmat1954; Quan ZW, 2010, NANO TODAY, V5, P390, DOI 10.1016/j.nantod.2010.08.011; Ruckdaschel H, 2006, POLYMER, V47, P2772, DOI 10.1016/j.polymer.2006.02.064; Rupar PA, 2012, SCIENCE, V337, P559, DOI 10.1126/science.1221206; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Schacher F, 2010, POLYMER, V51, P2021, DOI 10.1016/j.polymer.2010.02.046; Schmelz J, 2012, J AM CHEM SOC, V134, P14217, DOI 10.1021/ja306264d; Studart AR, 2012, ADV MATER, V24, P5024, DOI 10.1002/adma.201201471; Walther A, 2007, J AM CHEM SOC, V129, P6187, DOI 10.1021/ja068153v; Wang T, 2012, SCIENCE, V338, P358, DOI 10.1126/science.1224221; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821	36	477	480	42	1086	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					247	+		10.1038/nature12610	http://dx.doi.org/10.1038/nature12610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24185010				2022-12-28	WOS:000326894200048
J	Stillman, M; Tailor, M				Stillman, Michael; Tailor, Monalisa			Dead Man Walking	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-INSURANCE; MORTALITY		[Stillman, Michael; Tailor, Monalisa] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40292 USA	University of Louisville	Stillman, M (corresponding author), Univ Louisville, Sch Med, Dept Med, Louisville, KY 40292 USA.							Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Huddle TS, 2011, ANN INTERN MED, V155, P633, DOI 10.7326/0003-4819-155-9-201111010-00013; Institute of Medicine Committee on Health Insurance Status and Its Consequences, 2009, AM UN CRIS CONS HLTH; Ng DK, 2012, J GEN INTERN MED, V27, P1368, DOI 10.1007/s11606-012-2147-9; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685	5	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1880	1881		10.1056/NEJMp1312793	http://dx.doi.org/10.1056/NEJMp1312793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300MP	24152232				2022-12-28	WOS:000330468300006
J	Persaud, D; Gay, H; Ziemniak, C; Chen, YH; Piatak, M; Chun, TW; Strain, M; Richman, D; Luzuriaga, K				Persaud, Deborah; Gay, Hannah; Ziemniak, Carrie; Chen, Ya Hui; Piatak, Michael, Jr.; Chun, Tae-Wook; Strain, Matthew; Richman, Douglas; Luzuriaga, Katherine			Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; EFFECTIVE ANTIRETROVIRAL THERAPY; INFECTED INFANTS; DYNAMICS; CHILDREN; TRANSMISSION; REPLICATION; CLEARANCE; TIME; RESERVOIRS	An infant born to a woman with human immunodeficiency virus type 1 (HIV-1) infection began receiving antiretroviral therapy (ART) 30 hours after birth owing to high-risk exposure. ART was continued when detection of HIV-1 DNA and RNA on repeat testing met the standard diagnostic criteria for infection. After therapy was discontinued (when the child was 18 months of age), levels of plasma HIV-1 RNA, proviral DNA in peripheral-blood mononuclear cells, and HIV-1 antibodies, as assessed by means of clinical assays, remained undetectable in the child through 30 months of age. This case suggests that very early ART in infants may alter the establishment and long-term persistence of HIV-1 infection.	[Persaud, Deborah; Ziemniak, Carrie; Chen, Ya Hui] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; [Piatak, Michael, Jr.] Leidos Biomed Res, Frederick Natl Lab Canc Res, Frederick, MD USA; [Chun, Tae-Wook] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Gay, Hannah] Univ Mississippi, Dept Pediat, Med Ctr, Jackson, MS USA; [Strain, Matthew; Richman, Douglas] Univ Calif San Diego, La Jolla, CA 92093 USA; [Strain, Matthew; Richman, Douglas] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Luzuriaga, Katherine] Univ Massachusetts, Sch Med, Dept Pediat, Program Mol Med, Worcester, MA USA; [Luzuriaga, Katherine] Univ Massachusetts, Sch Med, Ctr Clin & Translat Sci, Worcester, MA USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Mississippi; University of Mississippi Medical Center; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Persaud, D (corresponding author), Johns Hopkins Univ, Sch Med, 720 Rutland Ave,Ross Bldg,Rm 1170, Baltimore, MD 21287 USA.	dpers@jhmi.edu	Chun, Tae-Wook/AAC-3101-2020; Chun, Tae-Wook/W-9187-2019	Chun, Tae-Wook/0000-0001-5153-7340	NIH [AI93701, HD0577849]; American Foundation for AIDS Research; International Maternal Pediatric Adolescent AIDS Clinical Trials Network [U01-AI-068632, UM1-AI-068632]; University of Massachusetts Center for Clinical and Translational Science [UL1TR000161]; Collaboratory of AIDS Researchers for Eradication [AI080193, AI69432, AI047745, AI74621, AI306214, AI096113]; Department of Veterans Affairs; Johns Hopkins University Center for AIDS Research (CFAR) [P30-AI094189]; University of Massachusetts Medical School CFAR [P30-AI042845]; NIAID; National Cancer Institute [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000851] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for AIDS Research; International Maternal Pediatric Adolescent AIDS Clinical Trials Network; University of Massachusetts Center for Clinical and Translational Science; Collaboratory of AIDS Researchers for Eradication; Department of Veterans Affairs(US Department of Veterans Affairs); Johns Hopkins University Center for AIDS Research (CFAR); University of Massachusetts Medical School CFAR; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the NIH (AI93701 and HD0577849, to Dr. Persaud), by funding from the American Foundation for AIDS Research (to Drs. Persaud and Luzuriaga); by grants from the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (U01-AI-068632 and UM1-AI-068632, to Drs. Persaud and Luzuriaga), the University of Massachusetts Center for Clinical and Translational Science (UL1TR000161, to Dr. Luzuriaga), and the Collaboratory of AIDS Researchers for Eradication (AI080193, AI69432, AI047745, AI74621, AI306214, and AI096113); and by funding from the Department of Veterans Affairs (to Drs. Strain and Richman). The research was also supported in part by grants from the Johns Hopkins University Center for AIDS Research (CFAR) (P30-AI094189) and the University of Massachusetts Medical School CFAR (P30-AI042845) and by the NIAID Intramural Research Program. Specific specialty viral-load testing was funded by a contract from the National Cancer Institute (HHSN261200800001E).	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; BAKSHI SS, 1995, PEDIATR INFECT DIS J, V14, P658, DOI 10.1097/00006454-199508000-00002; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; BRYSON YJ, 1995, NEW ENGL J MED, V332, P833, DOI 10.1056/NEJM199503303321301; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Dickover RE, 1998, J INFECT DIS, V178, P375, DOI 10.1086/515637; FDA Drug Safety Communication, 2011, SERIOUS HEALTH PROBL; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Frenkel LM, 1998, SCIENCE, V280, P1073, DOI 10.1126/science.280.5366.1073; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Lee TH, 2010, JAIDS-J ACQ IMM DEF, V55, P143, DOI 10.1097/QAI.0b013e3181eb301e; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Luzuriaga K, 2004, NEW ENGL J MED, V350, P2471, DOI 10.1056/NEJMoa032706; Luzuriaga K, 1999, J VIROL, V73, P362, DOI 10.1128/JVI.73.1.362-367.1999; Newell ML, 1996, LANCET, V347, P213, DOI 10.1016/S0140-6736(96)90401-8; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palumbo P, 2007, J INFECT DIS, V196, P23, DOI 10.1086/518508; Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, 2012, GUIDELINES FOR THE U; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Persaud D, 2007, AIDS RES HUM RETROV, V23, P381, DOI 10.1089/aid.2006.0175; Persaud D, 2012, AIDS, V26, P1483, DOI 10.1097/QAD.0b013e3283553638; Petz LD, 2013, BIOL BLOOD MARROW TR, V19, P393, DOI 10.1016/j.bbmt.2012.10.017; ROQUES PA, 1995, AIDS, V9, pF19; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347	32	407	425	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1828	1835		10.1056/NEJMoa1302976	http://dx.doi.org/10.1056/NEJMoa1302976			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24152233	Green Published, Green Accepted			2022-12-28	WOS:000326607800011
J	Shen, B; Zhao, XJ; O'Brien, KA; Stojanovic-Terpo, A; Delaney, MK; Kim, K; Cho, J; Lam, SCT; Du, XP				Shen, Bo; Zhao, Xiaojuan; O'Brien, Kelly A.; Stojanovic-Terpo, Aleksandra; Delaney, M. Keegan; Kim, Kyungho; Cho, Jaehyung; Lam, Stephen C. -T.; Du, Xiaoping			A directional switch of integrin signalling and a new anti-thrombotic strategy	NATURE			English	Article							OUTSIDE-IN; INSIDE-OUT; STRUCTURAL BASIS; TALIN-BINDING; ACTIVATION; FIBRINOGEN; ADHESION; DOMAIN; ROLES	Integrins have a critical role in thrombosis and haemostasis(1). Antagonists of the platelet integrin alpha(IIb)beta(3) are potent anti-thrombotic drugs, but also have the life-threatening adverse effect of causing bleeding(2,3). It is therefore desirable to develop new antagonists that do not cause bleeding. Integrins transmit signals bidirectionally(4,5). Inside-out signalling activates integrins through a talin-dependent mechanism(6,7). Integrin ligation mediates thrombus formation and outside-in signalling(8,9), which requires G alpha(13) and greatly expands thrombi. Here we show that G alpha(13) and talin bind to mutually exclusive but distinct sites within the integrin beta(3) cytoplasmic domain in opposing waves. The first talin-binding wave mediates inside-out signalling and also ligand-induced integrin activation, but is not required for outside-in signalling. Integrin ligation induces transient talin dissociation and G alpha(13) binding to an EXE motif (in which X denotes any residue), which selectively mediates outside-in signalling and platelet spreading. The second talin-binding wave is associated with clot retraction. An EXE-motif-based inhibitor of G alpha(13)-integrin interaction selectively abolishes outside-in signalling without affecting integrin ligation, and suppresses occlusive arterial thrombosis without affecting bleeding time. Thus, we have discovered a new mechanism for the directional switch of integrin signalling and, on the basis of this mechanism, designed a potent new anti-thrombotic drug that does not cause bleeding.	[Shen, Bo; Zhao, Xiaojuan; O'Brien, Kelly A.; Stojanovic-Terpo, Aleksandra; Delaney, M. Keegan; Kim, Kyungho; Cho, Jaehyung; Lam, Stephen C. -T.; Du, Xiaoping] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Du, XP (corresponding author), Univ Illinois, Dept Pharmacol, 835 South Wolcott Ave, Chicago, IL 60612 USA.	xdu@uic.edu	Shen, Bo/G-2012-2014	Shen, Bo/0000-0002-5237-6144; Cho, Jaehyung/0000-0003-2404-3446	National Heart, Lung, and Blood Institute [HL080264, HL062350, HL109439]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062350, R01HL080264, R01HL109439, T32HL007829] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Kozasa, B. Kreutz and C. Chow for providing purified recombinant G alpha<INF>13</INF> protein; and B. Petrich and D. Critchley for providing talin<SUP>-/-</SUP> mice. We acknowledge that H. Gong performed experiments for this project. This work is supported by grants from National Heart, Lung, and Blood Institute (HL080264, HL062350 (X. D.) and HL109439 (J.C.)).	Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Cho J, 2012, BLOOD, V120, P647, DOI 10.1182/blood-2011-08-372532; COLLER BS, 1980, BLOOD, V55, P169; Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427; Delaney MK, 2012, ARTERIOSCL THROM VAS, V32, P2761, DOI 10.1161/ATVBAHA.112.254920; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Haling JR, 2011, BLOOD, V117, P1719, DOI 10.1182/blood-2010-09-305433; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Krishnadas A, 2003, PHARMACEUT RES, V20, P297, DOI 10.1023/A:1022243709003; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Marjanovic JA, 2005, J BIOL CHEM, V280, P37430, DOI 10.1074/jbc.M506518200; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; NIMURA N, 1988, ANAL CHEM, V60, P2067, DOI 10.1021/ac00170a017; O'Brien KA, 2012, ARTERIOSCL THROM VAS, V32, P2232, DOI 10.1161/ATVBAHA.112.254680; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Serebruany VL, 2004, AM J HEMATOL, V75, P40, DOI 10.1002/ajh.10451; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; UGAROVA TP, 1993, J BIOL CHEM, V268, P21080; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Ye F, 2011, J THROMB HAEMOST, V9, P20, DOI 10.1111/j.1538-7836.2011.04355.x	30	117	125	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					131	+		10.1038/nature12613	http://dx.doi.org/10.1038/nature12613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24162846	Green Accepted			2022-12-28	WOS:000326585600046
J	Fine, AM; Nizet, V; Mandl, KD				Fine, Andrew M.; Nizet, Victor; Mandl, Kenneth D.			Participatory Medicine: A Home Score for Streptococcal Pharyngitis Enabled by Real-Time Biosurveillance. A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PREDICTION RULES; QUALITY-OF-CARE; RETAIL CLINICS; ANTIBIOTIC USE; SURVEILLANCE; VALIDATION; GUIDELINES; MANAGEMENT; CHILDREN	Background: Consensus guidelines recommend against testing or treating adults at low risk for group A streptococcal (GAS) pharyngitis. Objective: To help patients decide when to visit a clinician for the evaluation of sore throat. Design: Retrospective cohort study. Setting: A national chain of retail health clinics. Patients: 71 776 patients aged 15 years or older with pharyngitis who visited a clinic from September 2006 to December 2008. Measurements: The authors created a score using information from patient-reported clinical variables plus the incidence of local disease and compared it with the Centor score and other traditional scores that require clinician-elicited signs. Results: If patients aged 15 years or older with sore throat did not visit a clinician when the new score estimated the likelihood of GAS pharyngitis to be less than 10% instead of having clinicians manage their symptoms following guidelines that use the Centor score, 230 000 visits would be avoided in the United States each year and 8500 patients with GAS pharyngitis who would have received antibiotics would not be treated with them. Limitation: Real-time information about the local incidence of GAS pharyngitis, which is necessary to calculate the new score, is not currently available. Conclusion: A patient-driven approach to pharyngitis diagnosis that uses this new score could save hundreds of thousands of visits annually by identifying patients at home who are unlikely to require testing or treatment.	Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston Childrens Hosp, Boston, MA USA; Ctr Biomed Informat, Boston, MA USA; Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Diego	Fine, AM (corresponding author), Boston Childrens Hosp, Div Emergency Med Main 1, 300 Longwood Ave, Boston, MA 02115 USA.	andrew.fine@childrens.harvard.edu	Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	Public Health Research Scientist Development [KO1HK000055]; Public Health Informatics Center of Excellence [PO1HK000088]; Centers for Disease Control and Prevention [1G08LM009778, RO1 LM007677]; National Library of Medicine, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007677, G08LM009778] Funding Source: NIH RePORTER	Public Health Research Scientist Development; Public Health Informatics Center of Excellence; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	By the Mentored Public Health Research Scientist Development Award KO1HK000055 and Public Health Informatics Center of Excellence Award PO1HK000088 from the Centers for Disease Control and Prevention and by 1G08LM009778 and RO1 LM007677 from the National Library of Medicine, National Institutes of Health.	Basch E, 2010, NEW ENGL J MED, V362, P865, DOI 10.1056/NEJMp0911494; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Centor RM, 2012, ARCH INTERN MED, V172, P852, DOI 10.1001/archinternmed.2012.1741; Chapin KC, 2002, J CLIN MICROBIOL, V40, P4207, DOI 10.1128/JCM.40.11.4207-4210.2002; Costello D, 2008, HEALTH AFFAIR, V27, P1299, DOI 10.1377/hlthaff.27.5.1299; Fine AM, 2007, J AM MED INFORM ASSN, V14, P206, DOI 10.1197/jamia.M2253; Fine AM, 2012, ARCH INTERN MED, V172, P847, DOI 10.1001/archinternmed.2012.950; Fine AM, 2011, ANN INTERN MED, V155, P345, DOI 10.7326/0003-4819-155-6-201109200-00002; Fine AM, 2011, ARCH PEDIAT ADOL MED, V165, P61, DOI 10.1001/archpediatrics.2010.250; Fine AM, 2010, J AM MED INFORM ASSN, V17, P85, DOI 10.1197/jamia.M3061; Kaye J, 2012, NAT REV GENET, V13, P371, DOI 10.1038/nrg3218; Kellermann AL, 2010, ANN EMERG MED, V56, P288; Klepser DG, 2012, AM J MANAG CARE, V18, pE145; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; Nakhoul GN, 2013, J GEN INTERN MED, V28, P830, DOI 10.1007/s11606-012-2245-8; Pollack CE, 2009, ARCH INTERN MED, V169, P945, DOI 10.1001/archinternmed.2009.69; Price RA, 2013, JAMA PEDIATR, V167, P112, DOI 10.1001/jamapediatrics.2013.1573; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Rudavsky R, 2009, ANN INTERN MED, V151, P315, DOI 10.7326/0003-4819-151-5-200909010-00005; Shulman ST, 2012, CLIN INFECT DIS, V55, P1279, DOI 10.1093/cid/cis847; Snellman L, 2013, HLTH CARE GUIDELINE; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Wasson JH, 1996, JAMA-J AM MED ASSOC, V275, P641, DOI 10.1001/jama.275.8.641; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Weitzman ER, 2013, JAMA INTERN MED, V173, P345, DOI 10.1001/jamainternmed.2013.2512; Wessels MR, 2011, NEW ENGL J MED, V364, P648, DOI 10.1056/NEJMcp1009126; Woodburn JA, 2007, AM J MED QUAL, V22, P457, DOI 10.1177/1062860607309626	31	12	12	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					577	583		10.7326/0003-4819-159-9-201311050-00003	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249HX	24189592	Green Accepted			2022-12-28	WOS:000326769400001
J	Fauci, AS; Marston, HD				Fauci, Anthony S.; Marston, Hilary D.			Achieving an AIDS-free world: science and implementation	LANCET			English	Editorial Material							HIV-1 INFECTION; ANTIBODIES; PREVENTION; VACCINE		[Fauci, Anthony S.; Marston, Hilary D.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Granich R, 2013, CURR OPIN HIV AIDS, V8, P41, DOI 10.1097/COH.0b013e32835b80dd; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; US Department of State, 2013, RECOGNIZING THE 10TH; World Health Organization, 2013, GLOBAL UPDATE ON HIV	12	12	12	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1461	1462		10.1016/S0140-6736(13)62042-5	http://dx.doi.org/10.1016/S0140-6736(13)62042-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	24152937				2022-12-28	WOS:000326622500004
J	Lamb, RC; Porter, M				Lamb, R. C.; Porter, M.			Sudden onset hair loss and colour change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALOPECIA-AREATA		[Lamb, R. C.; Porter, M.] Univ Glasgow, Western Infirm, Alan Lyell Ctr Dermatol, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	Lamb, RC (corresponding author), Univ Glasgow, Western Infirm, Alan Lyell Ctr Dermatol, Glasgow G11 6NT, Lanark, Scotland.	rlamb@nhs.net						Gilhar A, 2012, NEW ENGL J MED, V366, P1515, DOI 10.1056/NEJMra1103442; Lew BL, 2009, J AM ACAD DERMATOL, V60, P85, DOI 10.1016/j.jaad.2008.08.045; Madani S, 2000, J AM ACAD DERMATOL, V42, P549, DOI 10.1016/S0190-9622(00)90164-6; Messenger AG, 2012, BRIT J DERMATOL, V166, P916, DOI 10.1111/j.1365-2133.2012.10955.x; Miteva M, 2012, J AM ACAD DERMATOL, V67, P1040, DOI 10.1016/j.jaad.2012.02.013; Navarini Alexander A, 2009, Arch Dermatol, V145, P656, DOI 10.1001/archdermatol.2009.51; PAUS R, 1993, YALE J BIOL MED, V66, P541; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Rokhsar CK, 1998, J AM ACAD DERMATOL, V39, P751, DOI 10.1016/S0190-9622(98)70048-9; SAFAVI K, 1992, ARCH DERMATOL, V128, P702, DOI 10.1001/archderm.1992.01680150136027; Sperling LC, 2003, DERMATOLOGICAL SIGNS, P315; Tobin DJ, 2001, EXP GERONTOL, V36, P29, DOI 10.1016/S0531-5565(00)00210-2; Werner B, 2012, AN BRAS DERMATOL, V87, P742, DOI 10.1590/S0365-05962012000500012	13	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2013	347								f6112	10.1136/bmj.f6112	http://dx.doi.org/10.1136/bmj.f6112			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EX	24179085				2022-12-28	WOS:000326599700002
J	Shatz, CJ				Shatz, Carla J.			David Hunter Hubel (1926-2013) OBITUARY	NATURE			English	Biographical-Item									[Shatz, Carla J.] Stanford Univ, Stanford, CA 94305 USA; [Shatz, Carla J.] Harvard Univ, Sch Med, Boston, MA USA	Stanford University; Harvard University; Harvard Medical School		cshatz@stanford.edu						HUBEL DH, PUBLICATION LIST	1	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					625	625		10.1038/502625a	http://dx.doi.org/10.1038/502625a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24172972	Bronze			2022-12-28	WOS:000326293200031
J	Spence, D				Spence, Des			FROM THE FRONTLINE Why I worry about large international studies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Borrell B., 2009, SCI AM; Kim AS, 2011, CIRCULATION, V124, P314, DOI 10.1161/CIRCULATIONAHA.111.018820; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Kumar S., 2003, BMJ, V326, P104; Parry J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4541; Stafford N., 2013, BMJ-BRIT MED J, V346, pf2194; Turone F, 2004, BRIT MED J, V328, P1333, DOI 10.1136/bmj.328.7452.1333	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2013	347								F6510	10.1136/bmj.f6510	http://dx.doi.org/10.1136/bmj.f6510			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EV	24170179				2022-12-28	WOS:000326599500032
J	Page, L				Page, Leigh			The rise and further rise of concierge medicine Leigh Page finds that as US healthcare expands, direct pay or "concierge" practices are gaining a foothold by meeting a few basic desires both of US physicians and patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												leighpage@comcast.net						American Medical Association, STAT LAWS MAND MIN L; [Anonymous], 2012, SURV AM PHYS PRACT P; Concierge Medicine Research Collective, 2013, SAL 2013 NEW DAT CON; Tetreault M., 2013, CONCIERGE MED T 0823	4	4	4	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2013	347								f6465	10.1136/bmj.f6465	http://dx.doi.org/10.1136/bmj.f6465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247ES	24167204				2022-12-28	WOS:000326599200005
J	Belkaid, Y; Grainger, J				Belkaid, Yasmine; Grainger, John			Mucus Coat, a Dress Code for Tolerance	SCIENCE			English	Editorial Material							CD103(+) DENDRITIC CELLS; EPITHELIUM; MICROBIOTA; INFECTION		[Belkaid, Yasmine; Grainger, John] NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Parasit Dis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Parasit Dis Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov		Grainger, John/0000-0002-4052-5923; Belkaid, Yasmine/0000-0001-9962-3571	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001132, ZIAAI001133] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Larsson JMH, 2011, INFLAMM BOWEL DIS, V17, P2299, DOI 10.1002/ibd.21625; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Muller AJ, 2012, CELL HOST MICROBE, V11, P19, DOI 10.1016/j.chom.2011.11.013; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572	14	5	6	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					432	433		10.1126/science.1246252	http://dx.doi.org/10.1126/science.1246252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159036				2022-12-28	WOS:000326042600029
J	Chiller, TM; Roy, M; Nguyen, D; Guh, A; Malani, AN; Latham, R; Peglow, S; Kerkering, T; Kaufman, D; McFadden, J; Collins, J; Kainer, M; Duwve, J; Trump, D; Blackmore, C; Tan, C; Cleveland, AA; MacCannell, T; Muehlenbachs, A; Zaki, SR; Brandt, ME; Jernigan, JA				Chiller, Tom M.; Roy, Monika; Duc Nguyen; Guh, Alice; Malani, Anurag N.; Latham, Robert; Peglow, Sheree; Kerkering, Tom; Kaufman, David; McFadden, Jevon; Collins, Jim; Kainer, Marion; Duwve, Joan; Trump, David; Blackmore, Carina; Tan, Christina; Cleveland, Angela A.; MacCannell, Tara; Muehlenbachs, Atis; Zaki, Sherif R.; Brandt, Mary E.; Jernigan, John A.		Multistate Fungal Infection	Clinical Findings for Fungal Infections Caused by Methylprednisolone Injections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTAMINATED METHYLPREDNISOLONE; EXSEROHILUM; MENINGITIS; TISSUES; STROKE; DNA	Background Since September 18, 2012, public health officials have been investigating a large outbreak of fungal meningitis and other infections in patients who received epidural, paraspinal, or joint injections with contaminated lots of methylprednisolone acetate. Little is known about infections caused by Exserohilum rostratum, the predominant outbreak-associated pathogen. We describe the early clinical course of outbreak-associated infections. Methods We reviewed medical records for outbreak cases reported to the Centers for Disease Control and Prevention before November 19, 2012, from the six states with the most reported cases (Florida, Indiana, Michigan, New Jersey, Tennessee, and Virginia). Polymerase-chain-reaction assays and immunohistochemical testing were performed on clinical isolates and tissue specimens for pathogen identification. Results Of 328 patients without peripheral-joint infection who were included in this investigation, 265 (81%) had central nervous system (CNS) infection and 63 (19%) had non-CNS infections only. Laboratory evidence of E. rostratum was found in 96 of 268 patients (36%) for whom samples were available. Among patients with CNS infections, strokes were associated with an increased severity of abnormalities in cerebrospinal fluid (P<0.001). Non-CNS infections were more frequent later in the course of the outbreak (median interval from last injection to diagnosis, 39 days for epidural abscess and 21 days for stroke; P<0.001), and such infections developed in patients with and in those without meningitis. Conclusions The initial clinical findings from this outbreak suggest that fungal infections caused by epidural and paraspinal injection of a contaminated glucocorticoid product can result in a broad spectrum of clinical disease, reflecting possible variations in the pathogenic mechanism and in host and exposure risk factors. (Funded by the Centers for Disease Control and Prevention.)	[Chiller, Tom M.; Roy, Monika; Cleveland, Angela A.; Brandt, Mary E.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA; [Duc Nguyen; Guh, Alice; MacCannell, Tara; Jernigan, John A.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Duc Nguyen] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [McFadden, Jevon] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Career Epidemiol Field Officer Program, Off Sci & Publ Hlth Practice,Off Publ Hlth Prepar, Atlanta, GA 30333 USA; [Muehlenbachs, Atis; Zaki, Sherif R.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [Malani, Anurag N.] St Joseph Mercy Hlth Syst, Ann Arbor, MI USA; [Latham, Robert] St Thomas Hosp, Nashville, TN USA; [Kainer, Marion] Tennessee Dept Hlth, Nashville, TN USA; [Peglow, Sheree] Elkhart Gen Hosp, Elkhart, IN USA; [Kerkering, Tom] Virginia Tech Carilion Sch Med, Roanoke, NJ USA; [Kaufman, David] Cumberland Internal Med, Vineland, NJ USA; [McFadden, Jevon; Collins, Jim] Michigan Dept Community Hlth, Lansing, MI USA; [Duwve, Joan] Indiana State Dept Hlth, Indianapolis, IN 46202 USA; [Trump, David] Virginia Dept Hlth, Richmond, VA USA; [Blackmore, Carina] Florida Dept Hlth, Tallahassee, FL USA; [Tan, Christina] New Jersey Dept Hlth, Trenton, NJ USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Saint Joseph Mercy Health System (SJMHS); Saint Thomas Hospital; Tennessee Department Health; MDHHS - Michigan Department of Health & Human Services; Florida Department of Health; New Jersey Department of Health & Senior Services	Jernigan, JA (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,MS A-31, Atlanta, GA 30333 USA.	jqj9@cdc.gov	Cleveland, Angela Ahlquist/Q-2778-2019	Cleveland, Angela Ahlquist/0000-0003-1375-8964; Jernigan, John/0000-0001-8163-925X; Kainer, Marion/0000-0001-7678-8744	CDC	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the CDC.	Adler A, 2006, EUR J CLIN MICROBIOL, V25, P247, DOI 10.1007/s10096-006-0093-3; Bromage PR, 1978, EPIDURAL ANALGESIA, V1st; Centers for Disease Control and Prevention, 2013, MULT FUNG MEN OUTBR; Clinical and Laboratory Standards Institute , 2008, INT CRIT ID BACT FUN, V28; DALAL PM, 1989, HDB CLIN NEUROLOGY 3, V55, P411; Finks J, 2013, MMWR-MORBID MORTAL W, V62, P377; Gade L, 2013, EUKARYOT CELL, V12, P677, DOI 10.1128/EC.00046-13; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; Kerkering TM, 2013, ANN INTERN MED, V158, P504, DOI 10.7326/0003-4819-158-6-201303190-00024; Kerkering TM, 2013, ANN INTERN MED, V158, P154, DOI 10.7326/0003-4819-158-3-201302050-00568; LEFKOVITS J, 1992, AUST NZ J MED, V22, P30, DOI 10.1111/j.1445-5994.1992.tb01705.x; MCGINNIS MR, 1986, J CLIN MICROBIOL, V24, P250, DOI 10.1128/JCM.24.2.250-259.1986; Misra UK, 2011, J NEUROL SCI, V303, P22, DOI 10.1016/j.jns.2010.12.015; Munoz-Cadavid C, 2010, J CLIN MICROBIOL, V48, P2147, DOI 10.1128/JCM.00459-10; Ritter JM, 2013, AM J PATHOL, V183, P881, DOI 10.1016/j.ajpath.2013.05.007; Smith RM, 2013, NEW ENGL J MED, V369, P1598, DOI 10.1056/NEJMoa1213978; Windsor Robert E, 2003, Pain Physician, V6, P473	17	49	51	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1610	1619		10.1056/NEJMoa1304879	http://dx.doi.org/10.1056/NEJMoa1304879			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	24152260				2022-12-28	WOS:000326031100010
J	Rajab, TK; Weaver, MJ; Havens, JM				Rajab, Taufiek K.; Weaver, Michael J.; Havens, Joaquim M.			Technique for Temporary Pelvic Stabilization after Trauma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLUNT TRAUMA; FRACTURES	Early temporary pelvic stabilization can reduce hemorrhage from pelvic-ring fractures. This video demonstrates the use of pelvic sheeting to provide mechanical stabilization of pelvic-ring fracture.	[Rajab, Taufiek K.; Havens, Joaquim M.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Weaver, Michael J.] Brigham & Womens Hosp, Orthoped Trauma Serv, Boston, MA 02115 USA; [Havens, Joaquim M.] Brigham & Womens Hosp, Div Trauma Burns & Surg Crit Care, Boston, MA 02115 USA; [Rajab, Taufiek K.; Weaver, Michael J.; Havens, Joaquim M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Rajab, TK (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.	trajab@rics.bwh.harvard.edu			AO Foundation; Synthes	AO Foundation; Synthes	Dr. Weaver reports receiving personal fees from the AO Foundation for teaching a course for which continuing medical education credits were available and from Synthes for teaching an anatomy course for resident physicians. No other potential conflict of interest relevant to this article was reported.	BURGESS AR, 1990, J TRAUMA, V30, P848, DOI 10.1097/00005373-199007000-00015; Gonzalez RP, 2002, J AM COLL SURGEONS, V194, P121, DOI 10.1016/S1072-7515(01)01153-X; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Routt MLC, 2002, J ORTHOP TRAUMA, V16, P45; Schulman JE, 2010, J TRAUMA, V68, P930, DOI 10.1097/TA.0b013e3181cb49d1; Spanjersberg WR, 2009, INJURY, V40, P1031, DOI 10.1016/j.injury.2009.06.164	6	5	6	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					E22	E22		10.1056/NEJMvcm1200383	http://dx.doi.org/10.1056/NEJMvcm1200383			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	24152281				2022-12-28	WOS:000326031100002
J	Metsch, LR; Feaster, DJ; Gooden, L; Schackman, BR; Matheson, T; Das, M; Golden, MR; Huffaker, S; Haynes, LF; Tross, S; Malotte, CK; Douaihy, A; Korthuis, PT; Duffus, WA; Henn, S; Bolan, R; Philip, SS; Castro, JG; Castellon, PC; McLaughlin, G; Mandler, RN; Branson, B; Colfax, GN				Metsch, Lisa R.; Feaster, Daniel J.; Gooden, Lauren; Schackman, Bruce R.; Matheson, Tim; Das, Moupali; Golden, Matthew R.; Huffaker, Shannon; Haynes, Louise F.; Tross, Susan; Malotte, C. Kevin; Douaihy, Antoine; Korthuis, P. Todd; Duffus, Wayne A.; Henn, Sarah; Bolan, Robert; Philip, Susan S.; Castro, Jose G.; Castellon, Pedro C.; McLaughlin, Gayle; Mandler, Raul N.; Branson, Bernard; Colfax, Grant N.			Effect of Risk-Reduction Counseling With Rapid HIV Testing on Risk of Acquiring Sexually Transmitted Infections The AWARE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEX; MEN; EFFICACY; ADOLESCENTS; BEHAVIORS; COHORT; ADULTS; VIRUS	IMPORTANCE To increase human immunodeficiency virus (HIV) testing rates, many institutions and jurisdictions have revised policies to make the testing process rapid, simple, and routine. A major issue for testing scale-up efforts is the effectiveness of HIV risk-reduction counseling, which has historically been an integral part of the HIV testing process. OBJECTIVE To assess the effect of brief patient-centered risk-reduction counseling at the time of a rapid HIV test on the subsequent acquisition of sexually transmitted infections (STIs). DESIGN, SETTING, AND PARTICIPANTS From April to December 2010, Project AWARE randomized 5012 patients from 9 sexually transmitted disease (STD) clinics in the United States to receive either brief patient-centered HIV risk-reduction counseling with a rapid HIV test or the rapid HIV test with information only. Participants were assessed for multiple STIs at both baseline and 6-month follow-up. INTERVENTIONS Participants randomized to counseling received individual patient-centered risk-reduction counseling based on an evidence-based model. The core elements included a focus on the patient's specific HIV/STI risk behavior and negotiation of realistic and achievable risk-reduction steps. All participants received a rapid HIV test. MAIN OUTCOMES AND MEASURES The prespecified outcome was a composite end point of cumulative incidence of any of the measured STIs over 6 months. All participants were tested for Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum (syphilis), herpes simplex virus 2, and HIV. Women were also tested for Trichomonas vaginalis. RESULTS There was no significant difference in 6-month composite STI incidence by study group (adjusted risk ratio, 1.12; 95% CI, 0.94-1.33). There were 250 of 2039 incident cases (12.3%) in the counseling group and 226 of 2032 (11.1%) in the information-only group. CONCLUSION AND RELEVANCE Risk-reduction counseling in conjunction with a rapid HIV test did not significantly affect STI acquisition among STD clinic patients, suggesting no added benefit from brief patient-centered risk-reduction counseling.	[Metsch, Lisa R.; Gooden, Lauren; Castellon, Pedro C.] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Metsch, Lisa R.; Feaster, Daniel J.; Gooden, Lauren; Castellon, Pedro C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Schackman, Bruce R.] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA; [Matheson, Tim; Das, Moupali; Huffaker, Shannon; Colfax, Grant N.] San Francisco Dept Publ Hlth, HIV Prevent Sect, San Francisco, CA USA; [Das, Moupali; Colfax, Grant N.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Golden, Matthew R.] Univ Washington, Ctr AIDS & STD, Seattle, WA 98195 USA; [Golden, Matthew R.] Publ Hlth Seattle & King Cty, Seattle, WA USA; [Haynes, Louise F.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA; [Tross, Susan] Columbia Univ, HIV Ctr Clin & Behav Studies, Dept Psychiat, New York, NY 10032 USA; [Tross, Susan] Columbia Univ, Subst Use Res Ctr, Dept Psychiat, New York, NY 10032 USA; [Malotte, C. Kevin] Calif State Univ Long Beach, Dept Hlth Sci, Long Beach, CA 90840 USA; [Douaihy, Antoine] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Korthuis, P. Todd] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Korthuis, P. Todd] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Duffus, Wayne A.] Univ S Carolina, Div Infect Dis, Dept Med, Sch Med, Columbia, SC 29208 USA; [Henn, Sarah] Whitman Walker Hlth, Elizabeth Taylor Med Ctr, Washington, DC USA; [Bolan, Robert] Los Angeles Gay & Lesbian Ctr, Jeffrey Goodman Special Care Clin, Los Angeles, CA USA; [Philip, Susan S.] San Francisco Dept Publ Hlth, STD Prevent & Control, San Francisco, CA USA; [Castro, Jose G.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [McLaughlin, Gayle] Duval Cty Hlth Dept, Jacksonville, FL USA; [Mandler, Raul N.] NIDA, NIH, Bethesda, MD 20892 USA; [Branson, Bernard] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA	Columbia University; University of Miami; Cornell University; San Francisco Department of Public Health; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Medical University of South Carolina; Columbia University; Columbia University; California State University System; California State University Long Beach; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University; Oregon Health & Science University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; San Francisco Department of Public Health; University of Miami; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Centers for Disease Control & Prevention - USA	Metsch, LR (corresponding author), Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, 722 W 168th St, New York, NY 10032 USA.	lm2892@cumc.columbia.edu	Bolan, Robert/AAD-4716-2020; King, Carina/C-8883-2016; Schackman, Bruce R./J-8208-2019; Golden, Matthew/AAE-4314-2020	Schackman, Bruce R./0000-0002-1132-2932; Korthuis, Philip/0000-0001-5556-3597	National Institute on Drug Abuse [RC2DA028973]; University of Miami Center for AIDS Research (CFAR) [P30 AI073961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U10DA013720, K23DA019809, RC2DA028973] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); University of Miami Center for AIDS Research (CFAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study and analysis was provided by the National Institute on Drug Abuse (RC2DA028973). The infrastructure of the National Drug Abuse Treatment Clinical Trials Network was used as a platform in conducting this trial (U10-DA13720). Support from the University of Miami Center for AIDS Research (CFAR) is also acknowledged (P30 AI073961).	[Anonymous], HIV SURVEILLANCE SUP, V17; [Anonymous], 2011, UPDATE ON IMPLEMENTA; [Anonymous], NATIONAL HIV AIDS ST; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Bernaards CA, 2007, STAT MED, V26, P1368, DOI 10.1002/sim.2619; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Cassels S, 2009, AIDS, V23, P2497, DOI 10.1097/QAD.0b013e328330ed8a; Centers for Disease Control and Prevention, HIV SURVEILLANCE SUP; Colfax G, 2004, AM J EPIDEMIOL, V159, P1002, DOI 10.1093/aje/kwh135; Dilley JW, 2007, JAIDS-J ACQ IMM DEF, V44, P569, DOI 10.1097/QAI.0b013e318033ffbd; Eaton Lisa A, 2012, Am J Public Health, V102, pe34, DOI 10.2105/AJPH.2012.300968; Enders CK., 2010, APPL MISSING DATA AN, P265; Farnham PG, 2008, PUBLIC HEALTH REP, V123, P51, DOI 10.1177/00333549081230S307; Farnham PG, 2012, MED DECIS MAKING, V32, P459, DOI 10.1177/0272989X11431609; Fishbein M, 2000, SEX TRANSM DIS, V27, P452, DOI 10.1097/00007435-200009000-00005; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Koblin BA, 2011, JAIDS-J ACQ IMM DEF, V58, P319, DOI 10.1097/QAI.0b013e31822b76d2; Lin JS, 2008, ANN INTERN MED, V149, P497, DOI 10.7326/0003-4819-149-7-200810070-00011; Mansergh G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000329; Metcalf CA, 2005, SEX TRANSM DIS, V32, P130, DOI 10.1097/01.olq.0000151421.97004.c0; Metsch LR, 2012, AM J PUBLIC HEALTH, V102, P1160, DOI 10.2105/AJPH.2011.300460; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Peterman TA, 2000, SEX TRANSM DIS, V27, P446, DOI 10.1097/00007435-200009000-00004; Pinkerton SD, 2002, JAIDS-J ACQ IMM DEF, V31, P71, DOI 10.1097/00126334-200209010-00010; Polsky D, 2009, PHARMACOECONOMICS, V27, P179, DOI 10.2165/00019053-200927030-00001; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Ratitch B, COMBINING ANALYSIS R; United States Bureau of Labor Statistics, OCCUPATIONAL EMPLOYM; Wilson DP, 2010, SEX TRANSM DIS, V37, P13, DOI 10.1097/OLQ.0b013e3181b35549	32	93	94	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1701	1710		10.1001/jama.2013.280034	http://dx.doi.org/10.1001/jama.2013.280034			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	238LR	24150466	Green Accepted, Bronze			2022-12-28	WOS:000325948500026
J	Dyer, C				Dyer, Clare			GMC and vulnerable doctors: too blunt an instrument?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COURT QUASHES SUSPENSION; GP		BMJ, London, England		Dyer, C (corresponding author), BMJ, London, England.	claredyer4@gmail.com						Dyer C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8701; Dyer C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8400; Dyer C, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8130; Dyer C, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7455; Dyer C, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6964; Dyer C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3377; Dyer C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1745; General Medical Council, 2012, FITN PRACT ANN STAT; White C., 2013, BMJ	9	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6230	10.1136/bmj.f6230	http://dx.doi.org/10.1136/bmj.f6230			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CI	24149820				2022-12-28	WOS:000326293800010
J	Turner, EH				Turner, Erick H.			How to access and process FDA drug approval packages for use in research	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRIALS; PUBLICATION; INFORMATION		[Turner, Erick H.] Portland VA Med Ctr, Behav Hlth & Neurosci Div, Portland, OR USA; [Turner, Erick H.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Turner, Erick H.] Oregon Hlth & Sci Univ, Dept Pharmacol, Portland, OR 97201 USA; [Turner, Erick H.] Oregon Hlth & Sci Univ, Ctr Eth Hlth Care, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Turner, EH (corresponding author), Portland VA Med Ctr, Behav Hlth & Neurosci Div, Portland, OR USA.	turnere@ohsu.edu	Turner, Erick/A-4848-2008	Turner, Erick/0000-0002-3522-3357				[Anonymous], 2013, PLOS MED, V10; Bennett DA, 2003, LANCET, V361, P1402, DOI 10.1016/S0140-6736(03)13147-9; Chan AW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8013; Cook GE, 2013, J MANAGE CARE PHARM, V19, P72, DOI 10.18553/jmcp.2013.19.1.72; Doshi P, 2013, JAMA INTERN MED, V173, P380, DOI 10.1001/jamainternmed.2013.3838; Food and drug administration, 2000, EX SUMM FOOD DRUG AD; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Lurie P, 2006, LAW CONTEMP PROBL, V68, P85; MacLean CH, 2003, J CLIN EPIDEMIOL, V56, P44, DOI 10.1016/S0895-4356(02)00520-6; Marchand HC, 2012, J MANAGE CARE PHARM, V18, P713, DOI 10.18553/jmcp.2012.18.9.713; McDonagh MS, 2013, J CLIN EPIDEMIOL; Navarro RP, 2012, J MANAGE CARE PHARM, V18, P719, DOI 10.18553/jmcp.2012.18.9.719; O'Connor AB, 2009, JAMA-J AM MED ASSOC, V302, P191, DOI 10.1001/jama.2009.973; Ohmer J, 2007, ANN PHARMACOTHER, V41, P2071, DOI 10.1345/aph.1K268; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Schroll JB, 2013, BMJ-BRIT MED J, V346, pf2231; Schroll J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4219; Schwartz LM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1086; Schwartz LM, 2009, NEW ENGL J MED, V361, P1717, DOI 10.1056/NEJMp0907708; Steinbrook R, 2012, ARCH INTERN MED, P1; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Turner EH, 2007, JAMA-J AM MED ASSOC, V298, P863, DOI 10.1001/jama.298.8.863; Turner EH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001189; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	25	32	32	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2013	347								f5992	10.1136/bmj.f5992	http://dx.doi.org/10.1136/bmj.f5992			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238VR	24126858	Bronze			2022-12-28	WOS:000325980100001
J	von Birgelen, C; Sen, H; Lam, MK; Danse, PW; Jessurun, GAJ; Hautvast, RWM; van Houwelingen, GK; Schramm, AR; Gin, RMTJ; Louwerenburg, JW; de Man, FHAF; Stoel, MG; Lowik, MM; Linssen, GCM; Said, SAM; Nienhuis, MB; Verhorst, PMJ; Basalus, MWZ; Doggen, CJM; Tandjung, K				von Birgelen, Clemens; Sen, Hanim; Lam, Ming Kai; Danse, Peter W.; Jessurun, Gillian A. J.; Hautvast, Raymond W. M.; van Houwelingen, Gert K.; Schramm, Alexander R.; Gin, R. Melvyn Tjon Joe; Louwerenburg, Johannes W.; de Man, Frits H. A. F.; Stoel, Martin G.; Lowik, Marije M.; Linssen, Gerard C. M.; Said, Salah A. M.; Nienhuis, Mark B.; Verhorst, Patrick M. J.; Basalus, Mounir W. Z.; Doggen, Carine J. M.; Tandjung, Kenneth			Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial	LANCET			English	Article							REAL-WORLD PATIENTS; XIENCE V STENTS; DURABLE POLYMER; BIODEGRADABLE POLYMER; PROMUS ELEMENT; DEFORMATION; RESOLUTE; OUTCOMES; EXPERIENCE; INSIGHTS	Background Third-generation, permanent-polymer-based drug-eluting stents with novel, flexible designs might be more easily delivered than previous generations of stents in complex coronary lesions, but might be less longitudinally stable. We aimed to assess the safety and efficacy in all-comer patients of two third-generation stents that are often used clinically, but that have not yet been compared, and one of which has not previously been assessed in a randomised trial. Methods In this investigator-initiated, single-blind, multicentre, randomised, two-arm, non-inferiority trial, patients aged 18 years and older who required a percutaneous coronary intervention with implantation of a drug-eluting stent were recruited from four study sites in the Netherlands. We randomly assigned patients by independently managed computer-generated allocation sequences in a 1: 1 ratio to receive either cobalt-chromium-based zotarolimus-eluting stents (Resolute Integrity, Medtronic, Santa Rosa, CA, USA) or platinum-chromium-based everolimus-eluting stents (Promus Element, Boston Scientifi c, Natick, MA, USA). Patients and analysts were masked to the allocated stent, but treating clinicians were not. The primary endpoint of target-vessel failure was a composite of safety (cardiac death or target-vessel-related myocardial infarction) and efficacy (target-vessel revascularisation) at 12 months, analysed by intention to treat (with a non-inferiority margin of 3.6%). This trial is registered with ClinicalTrials.gov, number NCT01331707. Findings Between Nov 25, 2010, and May 24, 2012, 1811 eligible all-comer patients, with 2371 target lesions, were enrolled in the study. 370 (20%) patients presented with ST-elevation myocardial infarction and 447 (25%) with non-ST-elevation myocardial infarction. 906 patients were assigned to receive zotarolimus-eluting stents and 905 to receive everolimus-eluting stents. Ease of stent delivery was shown by very low numbers of patients requiring treatment other than their assigned study treatment (six [1%] in the zotarolimus-eluting stent group vs five [1%] in the everolimuseluting stent group; p=0.22). 12-month follow-up results were available for 1810 patients (one patient in the zotarolimus-eluting stent group withdrew consent). The primary endpoint was met by 55 (6%) of 905 patients in the zotarolimus-eluting stent group and 47 (5%) of 905 in the everolimus-eluting stent group. The zotarolimus-eluting stent was non-inferior to the everolimus-eluting stent (absolute risk difference 0.88%, 95% CI -1.24% to 3.01%; upper limit of one-sided 95% CI 2.69%; non-inferiority p=0.006). We noted no significant between-group differences in individual components of the primary endpoint. Definite stent thrombosis occurred in three (0.3%) patients in the zotarolimus-eluting stent group and six (0.7%) patients in the everolimus-eluting stent group (p=0.34). Longitudinal stent deformation was seen only in the everolimus-eluting stent group (nine [1.0%] of 905 vs 0 of 906, p=0.002; nine of 1591 [0.6%] everolimus-eluting stents implanted became deformed), but was not associated with any adverse events. Interpretation Both stents were similarly efficacious and safe, and provided excellent clinical outcomes, especially in view of the large number of patients who presented with acute myocardial infarctions.	[von Birgelen, Clemens; Sen, Hanim; Lam, Ming Kai; van Houwelingen, Gert K.; Louwerenburg, Johannes W.; de Man, Frits H. A. F.; Stoel, Martin G.; Lowik, Marije M.; Verhorst, Patrick M. J.; Basalus, Mounir W. Z.; Tandjung, Kenneth] Med Spectrum Twente, Thoraxctr Twente, Dept Cardiol, Enschede, Netherlands; [von Birgelen, Clemens; Doggen, Carine J. M.] Univ Twente, Dept Hlth Technol & Serv Res, NL-7500 AE Enschede, Netherlands; [Danse, Peter W.; Gin, R. Melvyn Tjon Joe] Rijnstate Hosp, Dept Cardiol, Arnhem, Netherlands; [Jessurun, Gillian A. J.; Schramm, Alexander R.] Scheper Hosp, Dept Cardiol, Emmen, Netherlands; [Hautvast, Raymond W. M.] Med Ctr Alkmaar, Dept Cardiol, Alkmaar, Netherlands; [Linssen, Gerard C. M.; Said, Salah A. M.] Hosp Grp Twente, Dept Cardiol, Almelo, Netherlands; [Linssen, Gerard C. M.; Said, Salah A. M.] Hosp Grp Twente, Dept Cardiol, Hengelo, Netherlands; [Nienhuis, Mark B.] Queen Beatrix Hosp, Dept Cardiol, Winterswijk, Netherlands	Medical Spectrum Twente; University of Twente; Rijnstate Hospital; Medical Center Of Alkmaar	von Birgelen, C (corresponding author), Thoraxctr Twente, Dept Cardiol, NL-7513 ER Enschede, Netherlands.	c.vonbirgelen@mst.nl	Said, Salah Ali Mohamed/I-6656-2019		Boston Scientific and Medtronic	Boston Scientific and Medtronic(MedtronicBoston Scientific)	Boston Scientific and Medtronic supported this study equally. We thank Job van der Palen (Medisch Spectrum Twente and University of Twente, Enschede, Netherlands) for providing statistical advice and Liefke van der Heijden (Medisch Spectrum Twente, Enschede, Netherlands) for data retrieval and verification. We are grateful for the invaluable support of the cardiologists and other staff of the research departments, catheterisation laboratories, wards, and administrative departments of the study centres and referring hospitals, and of the various general physicians and pharmacists involved in the treatment of our patients.	Abdel-Wahab M, 2012, J INTERV CARDIOL, V25, P576, DOI 10.1111/j.1540-8183.2012.00765.x; Basalus MWZ, 2009, EUROINTERVENTION, V5, P157, DOI 10.4244/EIJV5I1A24; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Hernandez JMD, 2013, J INVASIVE CARDIOL, V25, P182; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kereiakes DJ, 2012, EUROINTERVENTION, V8, P187, DOI 10.4244/EIJV8I2A32; Kim HS, 2013, AM COLL CARD SCI SES, P2667; Lee SWL, 2011, CATHETER CARDIO INTE, V78, P898, DOI 10.1002/ccd.23267; Mamas MA, 2012, EUROINTERVENTION, V8, P196, DOI 10.4244/EIJV8I2A33; Meredith IT, 2011, EUROINTERVENTION, V7, P84, DOI 10.4244/EIJV7I1A15; Ormiston JA, 2011, JACC-CARDIOVASC INTE, V4, P1310, DOI 10.1016/j.jcin.2011.11.002; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Senn S, 2013, STAT MED, V32, P1439, DOI 10.1002/sim.5713; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stone GW, 2011, J AM COLL CARDIOL, V57, P1700, DOI 10.1016/j.jacc.2011.02.016; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Tandjung K, 2013, J AM COLL CARDIOL, V61, P2406, DOI 10.1016/j.jacc.2013.04.005; Tandjung K, 2012, AM HEART J, V163, P557, DOI 10.1016/j.ahj.2012.02.001; Turco MA, 2011, EXPERT REV MED DEVIC, V8, P303, DOI [10.1586/erd.11.2, 10.1586/ERD.11.2]; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Williams PD, 2012, EUROINTERVENTION, V8, P267, DOI 10.4244/EIJV8I2A41; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Yeung AC, 2011, J AM COLL CARDIOL, V57, P1778, DOI 10.1016/j.jacc.2011.03.005	32	140	141	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					413	423		10.1016/S0140-6736(13)62037-1	http://dx.doi.org/10.1016/S0140-6736(13)62037-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303KS	24183564				2022-12-28	WOS:000330673700031
J	Wong, CA; Davis, JC; Asch, DA; Shugerman, RP				Wong, Charlene A.; Davis, Jeremiah C.; Asch, David A.; Shugerman, Richard P.			Political Tug-of-War and Pediatric Residency Funding	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GRADUATE MEDICAL-EDUCATION	The recent government shutdown led to effective defunding of the Children's Hospitals Graduate Medical Education (CHGME) Payment Program. The funding lapse highlights the danger of subjecting GME funding to a politicized process. On October 1, 2013, without a continuing resolution in place to support its budget, the U.S. federal government partially closed. One of many effects of the government shutdown was the defunding of the Children's Hospitals Graduate Medical Education (CHGME) Payment Program. Fifty-five freestanding children's hospitals currently receive CHGME funds. These hospitals train almost 30% of the general pediatricians, 44% of the pediatric medical and surgical subspecialists, and the majority of the pediatric physician-researchers in the United States.(1),(2) Capable of providing highly specialized care for pediatric patients with complex and acute conditions, freestanding children's hospitals are at the apex of ...	[Wong, Charlene A.; Asch, David A.] Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Davis, Jeremiah C.; Shugerman, Richard P.] Seattle Childrens Hosp, Pediat Residency Program, Seattle, WA USA; [Davis, Jeremiah C.; Shugerman, Richard P.] Univ Washington, Sch Med, Seattle, WA USA	Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Wong, CA (corresponding author), Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA.			Asch, David/0000-0002-7970-286X				[Anonymous], C CHILDR HOSP GRAD M; Children's Hospital Association, CHILDR HOSP GRAD MED; Fieldston ES, 2013, JAMA PEDIATR, V167, P190, DOI 10.1001/2013.jamapediatrics.126; Newhouse JP, 2001, HEALTH AFFAIR, V20, P136, DOI 10.1377/hlthaff.20.2.136; Pletcher B, 2008, PEDIATRICS, V121, P855, DOI 10.1542/peds.2008-0279	5	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2372	2374		10.1056/NEJMp1312898	http://dx.doi.org/10.1056/NEJMp1312898			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	274DQ	24171507				2022-12-28	WOS:000328586000004
J	Okada-Iwabu, M; Yamauchi, T; Iwabu, M; Honma, T; Hamagami, K; Matsuda, K; Yamaguchi, M; Tanabe, H; Kimura-Someya, T; Shirouzu, M; Ogata, H; Tokuyama, K; Ueki, K; Nagano, T; Tanaka, A; Yokoyama, S; Kadowaki, T				Okada-Iwabu, Miki; Yamauchi, Toshimasa; Iwabu, Masato; Honma, Teruki; Hamagami, Ken-ichi; Matsuda, Koichi; Yamaguchi, Mamiko; Tanabe, Hiroaki; Kimura-Someya, Tomomi; Shirouzu, Mikako; Ogata, Hitomi; Tokuyama, Kumpei; Ueki, Kohjiro; Nagano, Tetsuo; Tanaka, Akiko; Yokoyama, Shigeyuki; Kadowaki, Takashi			A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ADIPONECTIN LEVELS; SKELETAL-MUSCLE; CRUCIAL ROLE; DISEASE; INFLAMMATION; MECHANISMS; EXPRESSION	Adiponectin secreted from adipocytes binds to adiponectin receptors AdipoR1 and AdipoR2, and exerts antidiabetic effects via activation of AMPK and PPAR-alpha pathways, respectively. Levels of adiponectin in plasma are reduced in obesity, which causes insulin resistance and type 2 diabetes. Thus, orally active small molecules that bind to and activate AdipoR1 and AdipoR2 could ameliorate obesity-related diseases such as type 2 diabetes. Here we report the identification of orally active synthetic small-molecule AdipoR agonists. One of these compounds, AdipoR agonist (AdipoRon), bound to both AdipoR1 and AdipoR2 in vitro. AdipoRon showed very similar effects to adiponectin in muscle and liver, such as activation of AMPK and PPAR-alpha pathways, and ameliorated insulin resistance and glucose intolerance in mice fed a high-fat diet, which was completely obliterated in AdipoR1 and AdipoR2 double-knockout mice. Moreover, AdipoRon ameliorated diabetes of genetically obese rodent model db/db mice, and prolonged the shortened lifespan of db/db mice on a high-fat diet. Thus, orally active AdipoR agonists such as AdipoRon are a promising therapeutic approach for the treatment of obesity-related diseases such as type 2 diabetes.	[Okada-Iwabu, Miki; Yamauchi, Toshimasa; Iwabu, Masato; Hamagami, Ken-ichi; Matsuda, Koichi; Yamaguchi, Mamiko; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1130033, Japan; [Okada-Iwabu, Miki; Yamauchi, Toshimasa; Iwabu, Masato; Kadowaki, Takashi] Univ Tokyo, Dept Integrated Mol Sci Metab Dis, 22nd Century Med & Res Ctr, Tokyo 1130033, Japan; [Okada-Iwabu, Miki; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Dept Mol Med Sci Metab Regulat, 22nd Century Med & Res Ctr, Tokyo 1130033, Japan; [Honma, Teruki; Tanabe, Hiroaki; Kimura-Someya, Tomomi; Shirouzu, Mikako; Tanaka, Akiko; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Ogata, Hitomi; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Nagano, Tetsuo; Tanaka, Akiko] Univ Tokyo, Open Innovat Ctr Drug Discovery, Bunkyo Ku, Tokyo 1130033, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo; RIKEN; University of Tsukuba; University of Tokyo; University of Tokyo	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1130033, Japan.	tyamau-tky@umin.net; kadowaki-3im@h.u-tokyo.ac.jp	Kimura-Someya, Tomomi/C-4169-2017; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016	Kimura-Someya, Tomomi/0000-0003-2232-1801; Yokoyama, Shigeyuki/0000-0003-3133-7338; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [20229008, 25221307, 23689048]; Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Translational Research Network Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Cabinet Office, Government of Japan; Grants-in-Aid for Scientific Research [24790908] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Translational Research Network Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Cabinet Office, Government of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Kubota, K. Hara, I. Takamoto, Y. Hada, T. Kobori, H. Umematsu, S. Odawara, T. Aoyama, Y. Jing, S. Wei, K. Soeda and H. Waki for technical help and support; and K. Miyata, Y. Nishibaba, M. Yuasa and A. Hayashi for technical assistance and support. This work was supported by a Grant-in-aid for Scientific Research (S) (20229008, 25221307) (to T.K.), Grant-in-aid for Young Scientists (A) (23689048) (to M.I.), Targeted Proteins Research Program (to T.K.), the Global COE Research Program (to T.K.), Translational Systems Biology and Medicine Initiative (to T.K.) and Translational Research Network Program (to M.O.-I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Funding Program for Next Generation World-Leading Researchers (NEXT Program) (to T.Y.) from Cabinet Office, Government of Japan.	Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; LeRoith D, 2008, NAT CLIN PRACT ENDOC, V4, P164, DOI 10.1038/ncpendmet0729; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osler ME, 2008, ENDOCRINOLOGY, V149, P935, DOI 10.1210/en.2007-1441; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746	42	431	459	8	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					493	+		10.1038/nature12656	http://dx.doi.org/10.1038/nature12656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24172895				2022-12-28	WOS:000327464200036
J	Heyman, J; Cools, T; Vandenbussche, F; Heyndrickx, KS; Van Leene, J; Vercauteren, I; Vanderauwera, S; Vandepoele, K; De Jaeger, G; Van Der Straeten, D; De Veylder, L				Heyman, Jefri; Cools, Toon; Vandenbussche, Filip; Heyndrickx, Ken S.; Van Leene, Jelle; Vercauteren, Ilse; Vanderauwera, Sandy; Vandepoele, Klaas; De Jaeger, Geert; Van Der Straeten, Dominique; De Veylder, Lieven			ERF115 Controls Root Quiescent Center Cell Division and Stem Cell Replenishment	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; PHYTOSULFOKINE; MERISTEM; GROWTH; PROLIFERATION; MAINTENANCE; COMPLEX; FATE	The quiescent center (QC) plays an essential role during root development by creating a microenvironment that preserves the stem cell fate of its surrounding cells. Despite being surrounded by highly mitotic active cells, QC cells self-renew at a low proliferation rate. Here, we identified the ERF115 transcription factor as a rate-limiting factor of QC cell division, acting as a transcriptional activator of the phytosulfokine PSK5 peptide hormone. ERF115 marks QC cell division but is restrained through proteolysis by the APC/C-CCS52A2 ubiquitin ligase, whereas QC proliferation is driven by brassinosteroid-dependent ERF115 expression. Together, these two antagonistic mechanisms delimit ERF115 activity, which is called upon when surrounding stem cells are damaged, revealing a cell cycle regulatory mechanism accounting for stem cell niche longevity.	[Heyman, Jefri; Cools, Toon; Heyndrickx, Ken S.; Van Leene, Jelle; Vercauteren, Ilse; Vanderauwera, Sandy; Vandepoele, Klaas; De Jaeger, Geert; De Veylder, Lieven] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Heyman, Jefri; Cools, Toon; Heyndrickx, Ken S.; Van Leene, Jelle; Vercauteren, Ilse; Vanderauwera, Sandy; Vandepoele, Klaas; De Jaeger, Geert; De Veylder, Lieven] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Vandenbussche, Filip; Van Der Straeten, Dominique] Univ Ghent, Dept Physiol, Lab Funct Plant Biol, Fac Sci, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University	De Veylder, L (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	lieven.deveylder@psb.vib-ugent.be	de veylder, lieven/AAM-9909-2020; Vandepoele, Klaas/E-7514-2010; Van Der Straeten, Dominique/E-7385-2016; Van Leene, Jelle/ABE-6697-2020	de veylder, lieven/0000-0003-1150-4426; Vandepoele, Klaas/0000-0003-4790-2725; Van Der Straeten, Dominique/0000-0002-7755-1420; Van Leene, Jelle/0000-0002-4932-8192; De Jaeger, Geert/0000-0001-6558-5669	Ghent University; Interuniversity Attraction Poles Programme [IUAP P7/29]; Belgian Science Policy Office; Ghent University-Bijzonder Onderzoeksfonds; Research Foundation-Flanders [G.029809, G.022.10N]; Agency for Innovation by Science and Technology	Ghent University(Ghent University); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); Ghent University-Bijzonder Onderzoeksfonds; Research Foundation-Flanders(FWO); Agency for Innovation by Science and Technology	The authors thank M. Sauter for sharing the pskr1-3 mutant and A. Bleys and M. De Cock for help in preparing the manuscript. This work was supported by Ghent University (Multidisciplinary Research Partnership Bioinformatics: From nucleotides to networks); theInteruniversity Attraction Poles Programme (IUAP P7/29 MARS), initiated by the Belgian Science Policy Office; Ghent University-Bijzonder Onderzoeksfonds (to D. V. D. S.); and Research Foundation-Flanders (grants G.029809 and G.022.10N to D. V. D. S. and L. D. V., respectively). K. S. H. is indebted to the Agency for Innovation by Science and Technology for a predoctoral fellowship. T. C., F. V., and J.V.L. are Postdoctoral Fellows of the Research Foundation-Flanders. Microarray and sequencing data have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo under accession nos. GSE48836 and GSE48793, respectively. J.H. and L. D. V. are inventors on a patent application filed by Ghent University and Vlaams Instituut voor Biotechnologie that covers the use of ERF115 to modulate plant growth through phytosulfokine gene expression.	Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Bergonie J, 1906, CR HEBD ACAD SCI, V143, P983; Boudolf V, 2009, PLANT PHYSIOL, V150, P1482, DOI 10.1104/pp.109.140269; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; CLOWES F. A. L., 1959, ANN BOT [LONDON], V23, P205; CLOWES FA, 1961, EXP CELL RES, V25, P529, DOI 10.1016/0014-4827(61)90188-4; FUJIE M, 1993, J EXP BOT, V44, P689, DOI 10.1093/jxb/44.4.689; Fulcher N, 2009, P NATL ACAD SCI USA, V106, P20984, DOI 10.1073/pnas.0909218106; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Hartmann J, 2013, PLANT J, V73, P579, DOI 10.1111/tpj.12056; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; Kutschmar A, 2009, NEW PHYTOL, V181, P820, DOI 10.1111/j.1469-8137.2008.02710.x; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Matsubayashi Y, 2004, PLANT CELL REP, V23, P155, DOI 10.1007/s00299-004-0816-9; Ortega-Martinez O, 2007, SCIENCE, V317, P507, DOI 10.1126/science.1143409; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Stuhrwohldt N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021054; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Vanstraelen M, 2009, P NATL ACAD SCI USA, V106, P11806, DOI 10.1073/pnas.0901193106; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Yang HP, 2001, PLANT PHYSIOL, V127, P842, DOI 10.1104/pp.010452	25	186	195	10	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					860	863		10.1126/science.1240667	http://dx.doi.org/10.1126/science.1240667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24158907	Bronze			2022-12-28	WOS:000326923000039
J	Tata, PR; Mou, HM; Pardo-Saganta, A; Zhao, R; Prabhu, M; Law, BM; Vinarsky, V; Cho, JL; Breton, S; Sahay, A; Medoff, BD; Rajagopal, J				Tata, Purushothama Rao; Mou, Hongmei; Pardo-Saganta, Ana; Zhao, Rui; Prabhu, Mythili; Law, Brandon M.; Vinarsky, Vladimir; Cho, Josalyn L.; Breton, Sylvie; Sahay, Amar; Medoff, Benjamin D.; Rajagopal, Jayaraj			Dedifferentiation of committed epithelial cells into stem cells in vivo	NATURE			English	Article							PROGENITOR CELLS; LUNG DEVELOPMENT; REGENERATION; ORIGIN; AIRWAY; EXPRESSION; TRANSDIFFERENTIATION; MAINTENANCE; REVERT; REPAIR	Cellular plasticity contributes to the regenerative capacity of plants, invertebrates, teleost fishes and amphibians. In vertebrates, differentiated cells are known to revert into replicating progenitors, but these cells do not persist as stable stem cells. Here we present evidence that differentiated airway epithelial cells can revert into stable and functional stem cells in vivo. After the ablation of airway stem cells, we observed a surprising increase in the proliferation of committed secretory cells. Subsequent lineage tracing demonstrated that the luminal secretory cells had dedifferentiated into basal stem cells. Dedifferentiated cells were morphologically indistinguishable from stem cells and they functioned as well as their endogenous counterparts in repairing epithelial injury. Single secretory cells clonally dedifferentiated into multipotent stem cells when they were cultured ex vivo without basal stem cells. By contrast, direct contact with a single basal stem cell was sufficient to prevent secretory cell dedifferentiation. In analogy to classical descriptions of amphibian nuclear reprogramming, the propensity of committed cells to dedifferentiate is inversely correlated to their state of maturity. This capacity of committed cells to dedifferentiate into stem cells may have a more general role in the regeneration of many tissues and in multiple disease states, notably cancer.	[Tata, Purushothama Rao; Mou, Hongmei; Pardo-Saganta, Ana; Zhao, Rui; Prabhu, Mythili; Law, Brandon M.; Vinarsky, Vladimir; Sahay, Amar; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Tata, Purushothama Rao; Mou, Hongmei; Pardo-Saganta, Ana; Zhao, Rui; Prabhu, Mythili; Law, Brandon M.; Vinarsky, Vladimir; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Tata, Purushothama Rao; Mou, Hongmei; Pardo-Saganta, Ana; Zhao, Rui; Prabhu, Mythili; Law, Brandon M.; Vinarsky, Vladimir; Cho, Josalyn L.; Medoff, Benjamin D.; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Dept Internal Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Tata, Purushothama Rao; Mou, Hongmei; Pardo-Saganta, Ana; Zhao, Rui; Prabhu, Mythili; Law, Brandon M.; Vinarsky, Vladimir; Sahay, Amar; Rajagopal, Jayaraj] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Cho, Josalyn L.; Medoff, Benjamin D.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Breton, Sylvie] Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02214 USA; [Breton, Sylvie] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02214 USA; [Breton, Sylvie] Harvard Univ, Sch Med, Boston, MA 02214 USA; [Sahay, Amar] Harvard Univ, Dept Psychiat, Sch Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Rajagopal, J (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	jrajagopal@partners.org	Zhao, Rui/J-7110-2014; Cho, Josalyn/ABF-8931-2021; Sahay, Amar/J-3696-2014	Cho, Josalyn/0000-0002-0367-4495; Tata, Purushothama Rao/0000-0003-4837-0337; Medoff, Benjamin/0000-0002-2558-0449; Pardo-Saganta, Ana/0000-0002-5926-6255	Harvard Stem Cell Institute Seed Grant; National Institutes of Health-National Heart, Lung, and Blood Institute Early Career Research New Faculty [5P30HL101287-02]; Harvard Stem Cell Institute (HSCI) Junior Investigator Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101287, R01HL118185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH086615] Funding Source: NIH RePORTER	Harvard Stem Cell Institute Seed Grant; National Institutes of Health-National Heart, Lung, and Blood Institute Early Career Research New Faculty; Harvard Stem Cell Institute (HSCI) Junior Investigator Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work in this manuscript was supported by a Harvard Stem Cell Institute Seed Grant and a National Institutes of Health-National Heart, Lung, and Blood Institute Early Career Research New Faculty (P30) award (5P30HL101287-02) and a Harvard Stem Cell Institute (HSCI) Junior Investigator Grant to J.R. J.R. is a New York Stem Cell Foundation-Robertson Investigator. We wish to extend our thanks to W. Anderson, Y. Dor, Q. Zhou, A. Brack, J. Galloway and all members of the Rajagopal laboratory for their constructive criticism. We thank the members of the HSCI flow cytometry core facility for help with cell sorting.	Blanpain C, 2013, NAT CELL BIOL, V15, P126, DOI 10.1038/ncb2657; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Cho JL, 2012, J IMMUNOL, V189, P2879, DOI 10.4049/jimmunol.1102483; Dabeva MD, 1998, CANCER RES, V58, P5825; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kim JK, 2012, AM J RESP CELL MOL, V47, P864, DOI 10.1165/rcmb.2012-0164OC; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Sugimoto K, 2011, TRENDS CELL BIOL, V21, P212, DOI 10.1016/j.tcb.2010.12.004; Tata P. R., 2013, AM J RESPIR CELL MOL; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Weber T, 2011, GLIA, V59, P615, DOI 10.1002/glia.21129; Wolff G., 1895, REGEN URODELENLINSE, V1, P380	35	422	427	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					218	+		10.1038/nature12777	http://dx.doi.org/10.1038/nature12777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24196716	Green Accepted, Green Submitted			2022-12-28	WOS:000326894200042
J	Tian, YJ; Xu, B; Yu, DL; Ma, YM; Wang, YB; Jiang, YB; Hu, WT; Tang, CC; Gao, YF; Luo, K; Zhao, ZS; Wang, LM; Wen, B; He, JL; Liu, ZY				Tian, Yongjun; Xu, Bo; Yu, Dongli; Ma, Yanming; Wang, Yanbin; Jiang, Yingbing; Hu, Wentao; Tang, Chengchun; Gao, Yufei; Luo, Kun; Zhao, Zhisheng; Wang, Li-Min; Wen, Bin; He, Julong; Liu, Zhongyuan			Controversy about ultrahard nanotwinned cBN reply	NATURE			English	Letter							DIAMOND; HARDER		[Tian, Yongjun; Xu, Bo; Yu, Dongli; Hu, Wentao; Gao, Yufei; Luo, Kun; Zhao, Zhisheng; Wang, Li-Min; Wen, Bin; He, Julong; Liu, Zhongyuan] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China; [Ma, Yanming] Jilin Univ, State Key Lab Superhard Mat, Changchun 130012, Peoples R China; [Wang, Yanbin] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60439 USA; [Jiang, Yingbing] Univ New Mexico, TEM Lab, Albuquerque, NM 87131 USA; [Tang, Chengchun] Hebei Univ Technol, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China	Yanshan University; Jilin University; University of Chicago; University of New Mexico; Hebei University of Technology	Tian, YJ (corresponding author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.	fhcl@ysu.edu.cn	Xu, Bo/C-6925-2008; Wen, Bin/G-8404-2012; Luo, Kun/AAV-6532-2021; Tian, Yongjun/A-1693-2010; Zhao, Zhisheng/G-8199-2015; Ma, Yanming/ABE-8450-2020; Gao, Yu/HGE-1937-2022; Ma, Yanming/A-7297-2008; Zhao, Zhisheng/AAA-7969-2021	Xu, Bo/0000-0002-9804-1614; Wen, Bin/0000-0001-9846-5452; Luo, Kun/0000-0002-5826-1612; Tian, Yongjun/0000-0002-4594-4879; Zhao, Zhisheng/0000-0001-8492-0151; Ma, Yanming/0000-0003-3711-0011; Zhao, Zhisheng/0000-0001-8492-0151; Wang, Yanbin/0000-0001-5716-3183; Yu, Dongli/0000-0002-0914-6837				Brazhkin V, 2004, NAT MATER, V3, P576, DOI 10.1038/nmat1196; Chaudhri MM, 2005, NAT MATER, V4, P4, DOI 10.1038/nmat1288; CORRIGAN FR, 1975, J CHEM PHYS, V63, P3812, DOI 10.1063/1.431874; Dubrovinskaia N, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711277; Dubrovinskaia N, 2013, NATURE, V502, pE1, DOI 10.1038/nature12620; Horiuchi S., 1997, J SURF ANAL, V3, P197; Luo XG, 2010, J PHYS CHEM C, V114, P17851, DOI 10.1021/jp102037j; Nix WD, 1998, J MECH PHYS SOLIDS, V46, P411, DOI 10.1016/S0022-5096(97)00086-0; Pan ZC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.055503; Roundy D, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.212103; Tian YJ, 2013, NATURE, V493, P385, DOI 10.1038/nature11728; Yan CS, 2004, PHYS STATUS SOLIDI A, V201, pR25, DOI 10.1002/pssa.200409033	12	8	10	7	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					E2	E3		10.1038/nature12621	http://dx.doi.org/10.1038/nature12621			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153312				2022-12-28	WOS:000325988400002
J	Hoy, WE				Hoy, Wendy E.			PERSONAL VIEW Chronic disease care in remote Aboriginal Australia has been transformed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE; TREATMENT PROGRAM; HEALTH; GAP		Univ Queensland, Sch Med, Ctr Chron Dis, Brisbane, Qld, Australia	University of Queensland	Hoy, WE (corresponding author), Univ Queensland, Sch Med, Ctr Chron Dis, Brisbane, Qld, Australia.	w.hoy@uq.edu.au	Hoy, Wendy E/A-7325-2010	Hoy, Wendy E/0000-0002-8405-1539				Andreasyan K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-483; Australia and New Zealand Dialysis and Transplant Registry, 2010, END STAG KIDN DIS IN; Australian Government Department for Health, HLTH LIF PROGR AB TO; Australian Government National Health and Medical Research Council (NHMRC), IND HLTH; Australian Government Pharmacy Guild of Australia, 2012, QUAL US MED MAX AB T; Baker PR, 2005, ADV CHRONIC KIDNEY D, V12, P22, DOI 10.1053/j.ackd.2004.10.001; Central Australian Rural Practitioners Association Inc (CARPA), 2012, CARPA REF MAN; Eades SJ, 2010, MED J AUSTRALIA, V193, P521, DOI 10.5694/j.1326-5377.2010.tb04036.x; Hoy WE, 2003, J AM SOC NEPHROL, V14, pS178, DOI 10.1097/01.ASN.0000070033.86955.48; Hoy WE, 2006, ETHNIC DIS, V16; Hoy WE, 2013, NEPHROLOGY, V18, pS1; Hoy WE, 2012, LANCET, V379, P1101, DOI 10.1016/S0140-6736(12)60458-9; Hoy WE, 2010, AUST NZ J PUBL HEAL, V34, P11, DOI 10.1111/j.1753-6405.2010.00467.x; Hoy WE, 2010, MED J AUSTRALIA, V192, P14, DOI 10.5694/j.1326-5377.2010.tb03394.x; Hoy WE, 2009, MED J AUSTRALIA, V190, P542, DOI 10.5694/j.1326-5377.2009.tb02555.x; National Aboriginal Community Controlled Health Organisation (NACCHO), 2012, AD PREV HTLH LIF CYC; National Aboriginal Community Controlled Health Organisation (NACCHO), NACCHO ABORIGINAL HL; Passey ME, 2013, MED J AUSTRALIA, V199, P39, DOI 10.5694/mja12.11848	18	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2013	347								F6127	10.1136/bmj.f6127	http://dx.doi.org/10.1136/bmj.f6127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WQ	24141604				2022-12-28	WOS:000325982800001
J	Corey, KE; Gupta, NK; Agarwal, S; Xiao, HD				Corey, Kathleen E.; Gupta, Nitin K.; Agarwal, Sheela; Xiao, Hong D.			Case 32-2013: A 55-Year-Old Woman with Autoimmune Hepatitis, Cirrhosis, Anorexia, and Abdominal Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INVASIVE GASTRIC MUCORMYCOSIS; GASTROINTESTINAL-TRACT; EARLY DIAGNOSIS; INFECTION; PATIENT; TUBERCULOSIS; ZYGOMYCOSIS; COLITIS; DISEASE; FUNGAL		[Corey, Kathleen E.; Gupta, Nitin K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Agarwal, Sheela] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Xiao, Hong D.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Corey, Kathleen E.; Gupta, Nitin K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Agarwal, Sheela] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Xiao, Hong D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Corey, KE (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Gupta, Nitin/A-1076-2016	Gupta, Nitin/0000-0002-4471-2363				AGHA FP, 1985, AM J ROENTGENOL, V145, P739, DOI 10.2214/ajr.145.4.739; BUCKNER FS, 1993, CLIN INFECT DIS, V17, P644, DOI 10.1093/clinids/17.4.644; Bureau C, 2004, GASTROENTEROLOGY, V126, P469, DOI 10.1053/j.gastro.2003.11.016; Chayakulkeeree M, 2006, EUR J CLIN MICROBIOL, V25, P215, DOI 10.1007/s10096-006-0107-1; Cherney CL, 1999, AM J GASTROENTEROL, V94, P252, DOI 10.1111/j.1572-0241.1999.00809.x; Choi SH, 2010, GUT LIVER, V4, P274, DOI 10.5009/gnl.2010.4.2.274; Corley DA, 1997, GASTROINTEST ENDOSC, V46, P452, DOI 10.1016/S0016-5107(97)70041-5; DEFRANCHIS R, 1988, NEW ENGL J MED, V319, P983; Hopper A Neil, 2006, Gastric Cancer, V9, P217, DOI 10.1007/s10120-006-0385-4; Hosseini M, 1998, AM J GASTROENTEROL, V93, P1360, DOI 10.1111/j.1572-0241.1998.00417.x; Ishii N, 2011, INTERNAL MED, V50, P439, DOI 10.2169/internalmedicine.50.4634; Kahi CJ, 2005, AM J GASTROENTEROL, V100, P220, DOI 10.1111/j.1572-0241.2005.40823.x; Lavery Eric A, 2008, Curr Gastroenterol Rep, V10, P417, DOI 10.1007/s11894-008-0078-8; Leung J, 2008, AM J GASTROENTEROL, V103, P2960, DOI 10.1111/j.1572-0241.2008.02094_22.x; Maravi-Poma E, 2004, INTENS CARE MED, V30, P724, DOI 10.1007/s00134-003-2132-1; MARSHALL JB, 1993, AM J GASTROENTEROL, V88, P989; Martinez EJ, 1997, SOUTH MED J, V90, P341, DOI 10.1097/00007611-199703000-00017; Negreanu L, 2006, ENDOSCOPY, V38, pE91, DOI 10.1055/s-2007-966089; Rivasi F, 2006, ARCH PATHOL LAB MED, V130, P1792; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Virk Satpal Singh, 2004, Indian J Gastroenterol, V23, P146; Xiao SY, 2001, AM J GASTROENTEROL, V96, P223, DOI 10.1111/j.1572-0241.2001.03480.x; Zwolinska-Wcislo M, 2001, MED SCI MONITOR, V7, P266	24	6	6	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1545	1553		10.1056/NEJMcpc1208153	http://dx.doi.org/10.1056/NEJMcpc1208153			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24131180				2022-12-28	WOS:000328101700013
J	Nicholl, M; Smartt, SJ; Jerkstrand, A; Inserra, C; McCrum, M; Kotak, R; Fraser, M; Wright, D; Chen, TW; Smith, K; Young, DR; Sim, SA; Valenti, S; Howell, DA; Bresolin, F; Kudritzki, RP; Tonry, JL; Huber, ME; Rest, A; Pastorello, A; Tomasella, L; Cappellaro, E; Benetti, S; Mattila, S; Kankare, E; Kangas, T; Leloudas, G; Sollerman, J; Taddia, F; Berger, E; Chornock, R; Narayan, G; Stubbs, CW; Foley, RJ; Lunnan, R; Soderberg, A; Sanders, N; Milisavljevic, D; Margutti, R; Kirshner, RP; Elias-Rosa, N; Morales-Garoffolo, A; Taubenberger, S; Botticella, MT; Gezari, S; Urata, Y; Rodney, S; Riess, AG; Scolnic, D; Wood-Vasey, WM; Burgett, WS; Chambers, K; Flewelling, HA; Magnier, EA; Kaiser, N; Metcalfe, N; Morgan, J; Price, PA; Sweeney, W; Waters, C				Nicholl, M.; Smartt, S. J.; Jerkstrand, A.; Inserra, C.; McCrum, M.; Kotak, R.; Fraser, M.; Wright, D.; Chen, T-W; Smith, K.; Young, D. R.; Sim, S. A.; Valenti, S.; Howell, D. A.; Bresolin, F.; Kudritzki, R. P.; Tonry, J. L.; Huber, M. E.; Rest, A.; Pastorello, A.; Tomasella, L.; Cappellaro, E.; Benetti, S.; Mattila, S.; Kankare, E.; Kangas, T.; Leloudas, G.; Sollerman, J.; Taddia, F.; Berger, E.; Chornock, R.; Narayan, G.; Stubbs, C. W.; Foley, R. J.; Lunnan, R.; Soderberg, A.; Sanders, N.; Milisavljevic, D.; Margutti, R.; Kirshner, R. P.; Elias-Rosa, N.; Morales-Garoffolo, A.; Taubenberger, S.; Botticella, M. T.; Gezari, S.; Urata, Y.; Rodney, S.; Riess, A. G.; Scolnic, D.; Wood-Vasey, W. M.; Burgett, W. S.; Chambers, K.; Flewelling, H. A.; Magnier, E. A.; Kaiser, N.; Metcalfe, N.; Morgan, J.; Price, P. A.; Sweeney, W.; Waters, C.			Slowly fading super-luminous supernovae that are not pair-instability explosions	NATURE			English	Article							CORE-COLLAPSE SUPERNOVAE; ULTRALUMINOUS SUPERNOVAE; SUPERLUMINOUS SUPERNOVAE; LOW-METALLICITY; IC SUPERNOVAE; LIGHT CURVES; MAGNETAR; 2007BI; NI-56	Super-luminous supernovae(1-4) that radiate more than 1044 ergs per second at their peak luminosity have recently been discovered in faint galaxies at redshifts of 0.1-4. Some evolve slowly, resembling models of 'pair-instability' supernovae(5,6). Such models involve stars with original masses 140-260 times that of the Sun that now have carbon-oxygen cores of 65-130 solar masses. In these stars, the photons that prevent gravitational collapse are converted to electron-positron pairs, causing rapid contraction and thermonuclear explosions. Many solar masses of Ni-56 are synthesized; this isotope decays to Fe-56 via Co-56, powering bright light curves(7,8). Such massive progenitors are expected to have formed from metal-poor gas in the early Universe(9). Recently, supernova 2007bi in a galaxy at redshift 0.127 (about 12 billion years after the Big Bang) with a metallicity one-third that of the Sun was observed to look like a fading pair-instability supernova(1,10). Here we report observations of two slow-to-fade super-luminous supernovae that show relatively fast rise times and blue colours, which are incompatible with pair-instability models. Their late-time light-curve and spectral similarities to supernova 2007bi call the nature of that event into question. Our early spectra closely resemble typical fast-declining super-luminous supernovae(2,11,12), which are not powered by radio-activity. Modelling our observations with 10-16 solar masses of magnetar-energized(13,14) ejecta demonstrates the possibility of a common explosion mechanism. The lack of unambiguous nearby pair-instability events suggests that their local rate of occurrence is less than 6 x 10(-6) times that of the core-collapse rate.	[Nicholl, M.; Smartt, S. J.; Jerkstrand, A.; Inserra, C.; McCrum, M.; Kotak, R.; Fraser, M.; Wright, D.; Chen, T-W; Smith, K.; Young, D. R.; Sim, S. A.] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Valenti, S.; Howell, D. A.] Global Telescope Network, Las Cumbres Observ, Goleta, CA 93117 USA; [Valenti, S.; Howell, D. A.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Bresolin, F.; Kudritzki, R. P.; Tonry, J. L.; Huber, M. E.; Burgett, W. S.; Chambers, K.; Flewelling, H. A.; Magnier, E. A.; Kaiser, N.; Morgan, J.; Sweeney, W.; Waters, C.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Rest, A.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Pastorello, A.; Tomasella, L.; Cappellaro, E.; Benetti, S.] Osserv Astron Padova, INAF, I-35122 Padua, Italy; [Mattila, S.; Kankare, E.] Univ Turku, Finnish Ctr Astron ESO FINCA, FI-21500 Piikkio, Finland; [Mattila, S.; Kankare, E.; Kangas, T.] Univ Turku, Tuorla Observ, Dept Phys & Astron, FI-21500 Piikkio, Finland; [Leloudas, G.] Stockholm Univ, Oskar Klein Ctr, Dept Phys, S-10691 Stockholm, Sweden; [Leloudas, G.] Univ Copenhagen, Dark Cosmol Ctr, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Sollerman, J.; Taddia, F.] Stockholm Univ, Oskar Klein Ctr, Dept Astron, S-10691 Stockholm, Sweden; [Berger, E.; Chornock, R.; Narayan, G.; Stubbs, C. W.; Foley, R. J.; Lunnan, R.; Soderberg, A.; Sanders, N.; Milisavljevic, D.; Margutti, R.; Kirshner, R. P.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Kirshner, R. P.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Elias-Rosa, N.; Morales-Garoffolo, A.] Inst Ciencies Espai IEEC CSIC, Fac Ciencies, Bellaterra 08193, Spain; [Taubenberger, S.] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Botticella, M. T.] Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; [Gezari, S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Urata, Y.] Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; [Rodney, S.; Riess, A. G.; Scolnic, D.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Wood-Vasey, W. M.] Univ Pittsburgh, Pittsburgh Particle Phys Astrophys & Cosmol Ctr, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Metcalfe, N.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Price, P. A.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Queens University Belfast; University of California System; University of California Santa Barbara; University of Hawaii System; Space Telescope Science Institute; Istituto Nazionale Astrofisica (INAF); University of Padua; University of Turku; University of Turku; Oskar Klein Centre; Stockholm University; University of Copenhagen; Niels Bohr Institute; Oskar Klein Centre; Stockholm University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Santa Barbara; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Max Planck Society; Istituto Nazionale Astrofisica (INAF); University System of Maryland; University of Maryland College Park; National Central University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Durham University; Princeton University	Nicholl, M (corresponding author), Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland.	mnicholl03@qub.ac.uk	Stubbs, Christopher W/C-2829-2012; Elias-Rosa, Nancy/D-3759-2014; Botticella, Maria Teresa/AAJ-9694-2020; Morgan, James/GRO-2905-2022; Jerkstrand, Anders/AAJ-7018-2021; Morales-Garoffolo, Antonia/AAE-9810-2022; Valenti, Stefano/M-5924-2017; Morales-Garoffolo, Antonia/CAA-3480-2022; Jerkstrand, Anders R/K-9648-2015; Kotak, Rubina/F-3325-2011; Morgan, James/N-8104-2018; Rest, Armin/ABE-6469-2020; Riess, Adam/ABF-2480-2020; Nicholl, Matt/GLS-0681-2022; Leloudas, Giorgos/E-4470-2015	Stubbs, Christopher W/0000-0003-0347-1724; Elias-Rosa, Nancy/0000-0002-1381-9125; Botticella, Maria Teresa/0000-0002-3938-692X; Morgan, James/0000-0002-8920-1065; Morales-Garoffolo, Antonia/0000-0001-8830-7063; Valenti, Stefano/0000-0001-8818-0795; Morales-Garoffolo, Antonia/0000-0001-8830-7063; Jerkstrand, Anders R/0000-0001-8005-4030; Kotak, Rubina/0000-0001-5455-3653; Nicholl, Matt/0000-0002-2555-3192; Chen, Ting-Wan/0000-0002-1066-6098; Taddia, Francesco/0000-0002-2387-6801; Sim, Stuart/0000-0002-9774-1192; Rodney, Steven/0000-0003-1947-687X; Chambers, Kenneth/0000-0001-6965-7789; Metcalfe, Nigel/0000-0001-9034-4402; Inserra, Cosimo/0000-0002-3968-4409; Foley, Ryan/0000-0002-2445-5275; Sollerman, Jesper/0000-0003-1546-6615; Kankare, Erkki/0000-0001-8257-3512; Tomasella, Lina/0000-0002-3697-2616; Young, David/0000-0002-1229-2499; Fraser, Morgan/0000-0003-2191-1674; Benetti, Stefano/0000-0002-3256-0016; Lunnan, Ragnhild/0000-0001-9454-4639; Bresolin, Fabio/0000-0002-5068-9833; Leloudas, Giorgos/0000-0002-8597-0756; Chornock, Ryan/0000-0002-7706-5668; Cappellaro, Enrico/0000-0001-5008-8619; Magnier, Eugene/0000-0002-7965-2815; Mattila, Seppo/0000-0001-7497-2994; Tonry, John/0000-0003-2858-9657; Narayan, Gautham/0000-0001-6022-0484	NASA through the Planetary Science Division of the NASA Science Mission Directorate [NNX08AR22G]; National Science Foundation [AST-1238877]; University of Maryland; NSF [AST-1009749, AST-121196]; Swedish Research Council [623-2011-7117];  [291222]; STFC [ST/I001123/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I001123/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1238877, 1009749, 1211196] Funding Source: National Science Foundation	NASA through the Planetary Science Division of the NASA Science Mission Directorate; National Science Foundation(National Science Foundation (NSF)); University of Maryland; NSF(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); ; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank D. Kasen and L. Dessart for sending us their model data. The Pan-STARRS1 Surveys (PS1) have been made possible through contributions of the Institute for Astronomy, the University of Hawaii, the Pan-STARRS Project Office, the Max Planck Society (and its participating institutes, the Max Planck Institute for Astronomy, Heidelberg, and the Max Planck Institute for Extraterrestrial Physics, Garching), The Johns Hopkins University, Durham University, the University of Edinburgh, Queen's University Belfast, the Harvard-Smithsonian Center for Astrophysics, the Las Cumbres Observatory Global Telescope Network Incorporated, the National Central University of Taiwan, the Space Telescope Science Institute, NASA grant no. NNX08AR22G issued through the Planetary Science Division of the NASA Science Mission Directorate, National Science Foundation grant no. AST-1238877, and the University of Maryland. S.J.S. acknowledges FP7/2007-2013/ERC Grant agreement no. 291222; J.L.T. and R. P. Kirshner acknowledge NSF grants AST-1009749, AST-121196; G. L. acknowledges Swedish Research Council grant no. 623-2011-7117; A. P., L. T., E. C., S. B. and M. T. B. acknowledge PRIN-INAF 2011. Work is based on observations made with the following telescopes: the William Herschel Telescope, Gran Telescopio Canarias, the Nordic Optical Telescope, Telescopio Nazionale Galileo, the Liverpool Telescope, the Gemini Observatory, the Faulkes North Telescope, the Asiago Copernico Telescope and the United Kingdom Infrared Telescope.	ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; BARKAT Z, 1967, PHYS REV LETT, V18, P379, DOI 10.1103/PhysRevLett.18.379; Berger E, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L29; Chomiuk L, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/114; Cooke J, 2012, NATURE, V491, P228, DOI 10.1038/nature11521; Dahlen T, 2004, ASTROPHYS J, V613, P189, DOI 10.1086/422899; Dessart L, 2013, MON NOT R ASTRON SOC, V428, P3227, DOI 10.1093/mnras/sts269; Dessart L, 2012, MON NOT R ASTRON SOC, V426, pL76, DOI 10.1111/j.1745-3933.2012.01329.x; Drout MR, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/97; Gal-Yam A, 2009, NATURE, V462, P624, DOI 10.1038/nature08579; Gal-Yam A, 2012, SCIENCE, V337, P927, DOI 10.1126/science.1203601; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Inserra C, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/128; Jerkstrand A, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201015937; Kasen D, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/102; Kasen D, 2010, ASTROPHYS J, V717, P245, DOI 10.1088/0004-637X/717/1/245; Kobayashi C, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L14; Mazzali PA, 2006, ASTROPHYS J, V645, P1323, DOI 10.1086/504415; McCrum M., MON NOT R ASTR UNPUB; Moriya T, 2010, ASTROPHYS J LETT, V717, pL83, DOI 10.1088/2041-8205/717/2/L83; Pastorello A, 2010, ASTROPHYS J LETT, V724, pL16, DOI 10.1088/2041-8205/724/1/L16; Quimby RM, 2011, NATURE, V474, P487, DOI 10.1038/nature10095; Quimby R. M., 2012, ASTRON TEL, V4121; RAKAVY G, 1967, ASTROPHYS J, V148, P803, DOI 10.1086/149204; Thompson TA, 2004, ASTROPHYS J, V611, P380, DOI 10.1086/421969; Tonry JL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/42; Umeda H, 2008, ASTROPHYS J, V673, P1014, DOI 10.1086/524767; Valenti S, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/2/L28; Woosley SE, 2010, ASTROPHYS J LETT, V719, pL204, DOI 10.1088/2041-8205/719/2/L204; Young DR, 2008, ASTRON ASTROPHYS, V489, P359, DOI 10.1051/0004-6361:20078662; Young DR, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913004	31	197	198	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					346	+		10.1038/nature12569	http://dx.doi.org/10.1038/nature12569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132291	Green Submitted, Green Accepted			2022-12-28	WOS:000325706300047
J	Riste, D; Dukalski, M; Watson, CA; de Lange, G; Tiggelman, MJ; Blanter, YM; Lehnert, KW; Schouten, RN; DiCarlo, L				Riste, D.; Dukalski, M.; Watson, C. A.; de Lange, G.; Tiggelman, M. J.; Blanter, Ya. M.; Lehnert, K. W.; Schouten, R. N.; DiCarlo, L.			Deterministic entanglement of superconducting qubits by parity measurement and feedback	NATURE			English	Article							QUANTUM TELEPORTATION	The stochastic evolution of quantum systems during measurement is arguably the most enigmatic feature of quantum mechanics. Measuring a quantum system typically steers it towards a classical state, destroying the coherence of an initial quantum superposition and the entanglement with other quantum systems. Remarkably, the measurement of a shared property between non-interacting quantum systems can generate entanglement, starting from an uncorrelated state. Of special interest in quantum computing is the parity measurement(1), which projects the state of multiple qubits (quantum bits) to a state with an even or odd number of excited qubits. A parity meter must discern the two qubit-excitation parities with high fidelity while preserving coherence between same-parity states. Despite numerous proposals for atomic(2), semiconducting(1,3-7) and superconducting qubits(8,9), realizing a parity meter that creates entanglement for both even and odd measurement results has remained an outstanding challenge. Here we perform a time-resolved, continuous parity measurement of two superconducting qubits using the cavity in a three-dimensional circuit quantum electrodynamics(10,11) architecture and phase-sensitive parametric amplification(12). Using postselection, we produce entanglement by parity measurement reaching 88 per cent fidelity to the closest Bell state. Incorporating the parity meter in a feedback-control loop, we transform the entanglement generation from probabilistic to fully deterministic, achieving 66 per cent fidelity to a target Bell state on demand. These realizations of a parity meter and a feedback-enabled deterministic measurement protocol provide key ingredients for active quantum error correction in the solid state(13-15).	[Riste, D.; Dukalski, M.; Watson, C. A.; de Lange, G.; Tiggelman, M. J.; Blanter, Ya. M.; Schouten, R. N.; DiCarlo, L.] Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Lehnert, K. W.] Univ Colorado, JILA, NIST, Boulder, CO 80309 USA; [Lehnert, K. W.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	Delft University of Technology; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	DiCarlo, L (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands.	l.dicarlo@tudelft.nl	de Lange, Gijs/D-6868-2012; Lehnert, Konrad/B-7577-2009; Ristè, Diego/G-9215-2012; DiCarlo, Leonardo/F-8714-2010; Lehnert, Konrad W/O-7555-2019	de Lange, Gijs/0000-0002-9437-0816; Lehnert, Konrad/0000-0002-0750-9649; Ristè, Diego/0000-0003-1458-2585; Lehnert, Konrad W/0000-0002-0750-9649	Dutch Organization for Fundamental Research on Matter (FOM); Netherlands Organization for Scientific Research (NWO); EU; DARPA QuEST programme	Dutch Organization for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); DARPA QuEST programme	We thank C. C. Bultink and H.-S. Ku for experimental assistance, and G. Haack, R. Hanson, G. Johansson, A. F. Kockum and L. Tornberg for discussions. We acknowledge funding from the Dutch Organization for Fundamental Research on Matter (FOM), the Netherlands Organization for Scientific Research (NWO, VIDI scheme), the EU FP7 integrated projects SOLID and SCALEQIT, and partial support from the DARPA QuEST programme.	Ahn C, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.042301; Beenakker CWJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.020501; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Engel HA, 2005, SCIENCE, V309, P586, DOI 10.1126/science.1113203; Filipp S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.200402; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Gambetta J, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042318; Gambetta J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.012112; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Haack G, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155303; Hatridge M, 2013, SCIENCE, V339, P178, DOI 10.1126/science.1226897; Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865; Houck AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.080502; Hutchison CL, 2009, CAN J PHYS, V87, P225, DOI 10.1139/P08-140; Ionicioiu R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032339; Kerckhoff J, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.024305; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Kockum AF, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.052318; Lalumiere K, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.040301; Motzoi F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.110501; Murch K. W., 2013, PREPRINT; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Pfaff W, 2013, NAT PHYS, V9, P29, DOI [10.1038/nphys2444, 10.1038/NPHYS2444]; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.240502; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.050507; Ruskov R, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.241305; Sarovar M, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.062327; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Tornberg L, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.012329; Trauzettel B, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235331; Williams NS, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.062322	36	222	225	5	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					350	+		10.1038/nature12513	http://dx.doi.org/10.1038/nature12513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132292	Green Submitted			2022-12-28	WOS:000325706300048
J	Lader, E				Lader, Ellis			Review: NSAIDs increase GI and CV events; coxibs increase mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS		NYU, Sch Med, Kingston, NY 10012 USA	New York University	Lader, E (corresponding author), NYU, Sch Med, Kingston, NY 10012 USA.							Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Dubois RW, 2004, JCR-J CLIN RHEUMATOL, V10, P178, DOI 10.1097/01.rhu.0000128851.12010.46	2	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC12	10.7326/0003-4819-159-8-201310150-02012	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126661				2022-12-28	WOS:000326751200011
J	Borovicka, J; Spurny, P; Brown, P; Wiegert, P; Kalenda, P; Clark, D; Shrbeny, L				Borovicka, Jiri; Spurny, Pavel; Brown, Peter; Wiegert, Paul; Kalenda, Pavel; Clark, David; Shrbeny, Lukas			The trajectory, structure and origin of the Chelyabinsk asteroidal impactor	NATURE			English	Article							NEAR-EARTH OBJECTS; METEORITE FALL; METEOROIDS; DYNAMICS; FRAGMENTATION; ATMOSPHERE; SPACE; ORBIT	Earth is continuously colliding with fragments of asteroids and comets of various sizes. The largest encounter in historical times occurred over the Tunguska river in Siberia in 1908, producing(1,2) an airburst of energy equivalent to 5-15 megatons of trinitrotoluene (1 kiloton of trinitrotoluene represents an energy of 4.185 x 10(12) joules). Until recently, the next most energetic airburst events occurred over Indonesia(3) in 2009 and near the Marshall Islands(4) in 1994, both with energies of several tens of kilotons. Here we report an analysis of selected video records of the Chelyabinsk superbolide(5) of 15 February 2013, with energy equivalent to 500 kilotons of trinitrotoluene, and details of its atmospheric passage. We found that its orbit was similar to the orbit of the two-kilometre-diameter asteroid 86039 (1999 NC43), to a degree of statistical significance sufficient to suggest that the two were once part of the same object. The bulk strength-the ability to resist breakage-of the Chelyabinsk asteroid, of about one megapascal, was similar to that of smaller meteoroids(6) and corresponds to a heavily fractured single stone. The asteroid broke into small pieces between the altitudes of 45 and 30 kilometres, preventing more-serious damage on the ground. The total mass of surviving fragments larger than 100 grams was lower than expected(7).	[Borovicka, Jiri; Spurny, Pavel; Shrbeny, Lukas] Acad Sci Czech Republ, Astron Inst, CZ-25165 Ondrejov, Czech Republic; [Brown, Peter; Wiegert, Paul; Clark, David] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; [Brown, Peter; Wiegert, Paul; Clark, David] Univ Western Ontario, Ctr Planetary Sci & Explorat, London, ON N6A 5B7, Canada; [Kalenda, Pavel] Acad Sci Czech Republ, Inst Rock Struct & Mech, CZ-18209 Prague 8, Czech Republic	Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; Western University (University of Western Ontario); Western University (University of Western Ontario); Czech Academy of Sciences; Institute of Rock Structure & Mechanics of the Czech Academy of Sciences	Borovicka, J (corresponding author), Acad Sci Czech Republ, Astron Inst, CZ-25165 Ondrejov, Czech Republic.	jiri.borovicka@asu.cas.cz	Spurny, Pavel/G-9044-2014; Shrbeny, Lukas/G-9040-2014; Spurný, Pavel/X-9268-2019; Borovicka, Jiri/F-4257-2014; Brown, Peter/C-8763-2018	Shrbeny, Lukas/0000-0002-3930-770X; Spurný, Pavel/0000-0001-5944-3090; Borovicka, Jiri/0000-0002-5569-8982; Brown, Peter/0000-0001-6130-7039	GACR [P209/11/1382]; Praemium Academiae; Natural Sciences and Engineering Research Council of Canada; NASA's Meteoroid Environment Office;  [67985815]	GACR(Grant Agency of the Czech Republic); Praemium Academiae(Czech Academy of Sciences); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NASA's Meteoroid Environment Office; 	We thank D. Castek and O. Popova and her team (V. Emelyanenko, A. Kartashova, D. Glazachev and E. Biryukov) for providing the nocturnal in situ calibration images. We are obliged to all the videographers who posted videos of the Chelyabinsk superbolide on the internet. The work of J.B., P. S. and L. S. was supported by grant no. P209/11/1382 from GACR and Praemium Academiae. The Czech institutional project was RVO:67985815. The work of P. B., P. W. and D. C. was supported in part by the Natural Sciences and Engineering Research Council of Canada and NASA's Meteoroid Environment Office.	Artemieva NA, 2001, J GEOPHYS RES-PLANET, V106, P3297, DOI 10.1029/2000JE001264; Binzel RP, 2004, ICARUS, V170, P259, DOI 10.1016/j.icarus.2004.04.004; Bland PA, 2003, NATURE, V424, P288, DOI 10.1038/nature01757; Borovicka J, 2008, ASTRON ASTROPHYS, V485, pL1, DOI 10.1051/0004-6361:200809905; Borovicka J, 2003, METEORIT PLANET SCI, V38, P1023, DOI 10.1111/j.1945-5100.2003.tb00296.x; Borovicka J, 1998, ASTRON ASTROPHYS, V334, P713; BOROVICKA J, 1990, B ASTRON I CZECH, V41, P391; Borovicka J., 2013, METEORIT PLANET SCI; Boslough MBE, 2008, INT J IMPACT ENG, V35, P1441, DOI 10.1016/j.ijimpeng.2008.07.053; Bottke WF, 2002, ICARUS, V156, P399, DOI 10.1006/icar.2001.6788; Brown P, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003105; CEPLECHA Z, 1987, B ASTRON I CZECH, V38, P222; Clark DL, 2011, METEORIT PLANET SCI, V46, P1217, DOI 10.1111/j.1945-5100.2011.01226.x; Daubar IJ, 2013, ICARUS, V225, P506, DOI 10.1016/j.icarus.2013.04.009; Delbo M, 2003, ICARUS, V166, P116, DOI 10.1016/j.icarus.2003.07.002; DRUMMOND JD, 1981, ICARUS, V45, P545, DOI 10.1016/0019-1035(81)90020-8; Everhart E., 1985, DYNAMICS COMETS THEI, P185; Jenniskens P, 2012, SCIENCE, V338, P1583, DOI 10.1126/science.1227163; Kelley MC, 2013, J GEOPHYS RES-SPACE, V118, P3622, DOI 10.1002/jgra.50339; Mainzer A, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/156; MCCORD TB, 1995, J GEOPHYS RES-PLANET, V100, P3245, DOI 10.1029/94JE02802; Nazarov M. A., 2013, METEORIT B, V102; Park C, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/6/184; Popova O, 2011, METEORIT PLANET SCI, V46, P1525, DOI 10.1111/j.1945-5100.2011.01247.x; Sanchez P., 2013, PREPRINT; Silber EA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047633; Southworth R.B., 1963, SMITHSONIAN CONTRIB, V7, P261; Spurny P, 2012, METEORIT PLANET SCI, V47, P163, DOI 10.1111/j.1945-5100.2011.01321.x; Vasilyev NV, 1998, PLANET SPACE SCI, V46, P129, DOI 10.1016/S0032-0633(97)00145-1	29	150	157	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					235	+		10.1038/nature12671	http://dx.doi.org/10.1038/nature12671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24196708				2022-12-28	WOS:000326894200045
J	Fica, SM; Tuttle, N; Novak, T; Li, NS; Lu, J; Koodathingal, P; Dai, Q; Staley, JP; Piccirilli, JA				Fica, Sebastian M.; Tuttle, Nicole; Novak, Thaddeus; Li, Nan-Sheng; Lu, Jun; Koodathingal, Prakash; Dai, Qing; Staley, Jonathan P.; Piccirilli, Joseph A.			RNA catalyses nuclear pre-mRNA splicing	NATURE			English	Article							METAL-ION COORDINATION; TETRAHYMENA RIBOZYME; CRYSTAL-STRUCTURE; EXON-LIGATION; ACTIVE-SITE; AGC TRIAD; SPLICEOSOME; MECHANISM; PROTEIN; STEPS	In nuclear pre-messenger RNA splicing, introns are excised by the spliceosome, a dynamic machine composed of both proteins and small nuclear RNAs (snRNAs). Over thirty years ago, after the discovery of self-splicing group II intron RNAs, the snRNAs were proposed to catalyse splicing. However, no definitive evidence for a role of either RNA or protein in catalysis by the spliceosome has been reported so far. By using metal rescue strategies in spliceosomes from budding yeast, here we show that the U6 snRNA catalyses both of the two splicing reactions by positioning divalent metals that stabilize the leaving groups during each reaction. Notably, all of the U6 catalytic metal ligands we identified correspond to the ligands observed to position catalytic, divalent metals in crystal structures of a group II intron RNA. These findings indicate that group II introns and the spliceosome share common catalytic mechanisms and probably common evolutionary origins. Our results demonstrate that RNA mediates catalysis within the spliceosome.	[Fica, Sebastian M.] Univ Chicago, Grad Program Cell & Mol Biol, Chicago, IL 60637 USA; [Fica, Sebastian M.; Koodathingal, Prakash; Staley, Jonathan P.] Univ Chicago, Cummings Life Sci Ctr, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Tuttle, Nicole; Lu, Jun; Dai, Qing; Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Novak, Thaddeus; Li, Nan-Sheng; Piccirilli, Joseph A.] Univ Chicago, Gordon Ctr Integrat Sci, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Piccirilli, JA (corresponding author), Univ Chicago, Dept Chem, 929 East 57th St, Chicago, IL 60637 USA.	jstaley@uchicago.edu; jpicciri@uchicago.edu	Dai, Qing/ABD-8444-2021; Lu, Jun/G-2224-2012	Lu, Jun/0000-0003-0858-8577	NSF; CBI Training Grant [5T32GM008720]; Chicago Biomedical Consortium; The Searle Funds at the Chicago Community Trust; National Institutes of Health [R01GM088656]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008720, R01GM088656] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); CBI Training Grant; Chicago Biomedical Consortium; The Searle Funds at the Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Guthrie for plasmids; S. -C. Cheng for anti-Cwc25p serum; D. Semlow for strains; J. Olvera for reagents and experimental assistance; R. -J. Lin for sharing unpublished data; members of the Staley and Piccirilli laboratories for discussions; and D. Herschlag, A. Macmillan and T. Nilsen for comments on the manuscript. N.T. was supported by an NSF Graduate Research Fellowship and by a CBI Training Grant (5T32GM008720). This work was funded by a grant from the Chicago Biomedical Consortium, with support from The Searle Funds at the Chicago Community Trust, to J. P. S, A. S. Mankin and E. J. Sontheimer, and by a grant from the National Institutes of Health (R01GM088656) to J. P. S. and J.A.P.	Abelson J, 2010, METHOD ENZYMOL, V472, P31, DOI [10.1016/S0076-6879(10)72017_6, 10.1016/S0076-6879(10)72017-6]; Anokhina M, 2013, EMBO J, V32, P2804, DOI 10.1038/emboj.2013.198; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; Bonnal S, 2013, EMBO J, V32, P2785, DOI 10.1038/emboj.2013.213; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; Burke JE, 2012, RNA, V18, P673, DOI 10.1261/rna.031138.111; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; CECH TR, 1987, SCIENCE, V236, P1532, DOI 10.1126/science.2438771; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; CHANFREAU G, 1994, SCIENCE, V266, P1383, DOI 10.1126/science.7973729; Chiu YF, 2009, MOL CELL BIOL, V29, P5671, DOI 10.1128/MCB.00773-09; Dery Kenneth J., 2008, V488, P41, DOI 10.1007/978-1-60327-475-3_4; FABRIZIO P, 1989, GENE DEV, V3, P2137, DOI 10.1101/gad.3.12b.2137; FABRIZIO P, 1992, NUCLEIC ACIDS RES, V20, P3659, DOI 10.1093/nar/20.14.3659; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; Forconi M, 2008, BIOCHEMISTRY-US, V47, P6883, DOI 10.1021/bi800519a; Frederiksen JK, 2009, METHOD ENZYMOL, V468, P289, DOI 10.1016/S0076-6879(09)68014-9; Frederiksen JK, 2009, METHODS, V49, P148, DOI 10.1016/j.ymeth.2009.07.005; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Hilliker AK, 2004, RNA, V10, P921, DOI 10.1261/rna.7310704; Jaladat Y, 2011, RNA BIOL, V8, P372, DOI 10.4161/rna.8.3.15386; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; Loverix S, 2000, CHEM BIOL, V7, P651, DOI 10.1016/S1074-5521(00)00005-3; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Mefford MA, 2009, RNA, V15, P1386, DOI 10.1261/rna.1582609; MOORE MJ, 1993, NATURE, V365, P364, DOI 10.1038/365364a0; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; PECORARO VL, 1984, BIOCHEMISTRY-US, V23, P5262, DOI 10.1021/bi00317a026; Schellenberg MJ, 2013, NAT STRUCT MOL BIOL, V20, P728, DOI 10.1038/nsmb.2556; Schurer H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf055; Semlow DR, 2012, TRENDS BIOCHEM SCI, V37, P263, DOI 10.1016/j.tibs.2012.04.001; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Shukla GC, 2002, MOL CELL, V9, P1145, DOI 10.1016/S1097-2765(02)00505-1; Sigel RKO, 1997, J AM CHEM SOC, V119, P744, DOI 10.1021/ja962970l; Smith DJ, 2009, RNA, V15, P1, DOI 10.1261/rna.1322709; Sontheimer EJ, 1999, GENE DEV, V13, P1729, DOI 10.1101/gad.13.13.1729; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; Tagwerker C, 2006, YEAST, V23, P623, DOI 10.1002/yea.1380; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; UMEN JG, 1995, GENE DEV, V9, P855, DOI 10.1101/gad.9.7.855; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Valadkhan S, 2009, RNA, V15, P4, DOI 10.1261/rna.1425809; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Yoshida A, 1999, NAT STRUCT BIOL, V6, P318; YU YT, 1995, RNA, V1, P46	61	223	234	0	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					229	+		10.1038/nature12734	http://dx.doi.org/10.1038/nature12734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24196718	Green Accepted			2022-12-28	WOS:000326894200044
J	Jin, FL; Li, Y; Dixon, JR; Selvaraj, S; Ye, Z; Lee, AY; Yen, CA; Schmitt, AD; Espinoza, CA; Ren, B				Jin, Fulai; Li, Yan; Dixon, Jesse R.; Selvaraj, Siddarth; Ye, Zhen; Lee, Ah Young; Yen, Chia-An; Schmitt, Anthony D.; Espinoza, Celso A.; Ren, Bing			A high-resolution map of the three-dimensional chromatin interactome in human cells	NATURE			English	Article							GENE-EXPRESSION; ORGANIZATION; GENOMES; PRINCIPLES; LANDSCAPE; ENHANCERS; INSIGHTS	A large number of cis-regulatory sequences have been annotated in the human genome(1,2), but defining their target genes remains a challenge(3). One strategy is to identify the long-range looping interactions at these elements with the use of chromosome conformation capture (3C)-based techniques(4). However, previous studies lack either the resolution or coverage to permit a whole-genome, unbiased view of chromatin interactions. Here we report a comprehensive chromatin interaction map generated in human fibroblasts using a genome-wide 3C analysis method (Hi-C)(5). We determined over one million long-range chromatin interactions at 5-10-kb resolution, and uncovered general principles of chromatin organization at different types of genomic features. We also characterized the dynamics of promoter-enhancer contacts after TNF-alpha signalling in these cells. Unexpectedly, we found that TNF-alpha-responsive enhancers are already in contact with their target promoters before signalling. Such pre-existing chromatin looping, which also exists in other cell types with different extracellular signalling, is a strong predictor of gene induction. Our observations suggest that the three-dimensional chromatin landscape, once established in a particular cell type, is relatively stable and could influence the selection or activation of target genes by a ubiquitous transcription activator in a cell-specific manner.	[Jin, Fulai; Li, Yan; Dixon, Jesse R.; Selvaraj, Siddarth; Ye, Zhen; Lee, Ah Young; Yen, Chia-An; Schmitt, Anthony D.; Espinoza, Celso A.; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, UCSD Med Scientist Training Program, Sch Med, La Jolla, CA 92093 USA; [Selvaraj, Siddarth] Univ Calif San Diego, UCSD Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Schmitt, Anthony D.] Univ Calif San Diego, UCSD Biomed Sci Grad Program, Sch Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Moores Canc Ctr, Dept Cellular & Mol Med,Inst Genome Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Dixon, Jesse/AAT-2914-2020	Dixon, Jesse/0000-0002-6273-2181; Jin, Fulai/0000-0003-0025-4337	Ludwig Institute for Cancer Research; California Institute of Regenerative Medicine [RN2-00905]; US National Institutes of Health [P50 GM085764-03, U01 ES017166]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, T32GM008666, T32GM007198] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. K. Glass for sharing the GRO-seq protocol, and S. Kuan and L. Edsall for assistance with high-throughput DNA sequencing and the initial processing. This work is supported by funds from the Ludwig Institute for Cancer Research, the California Institute of Regenerative Medicine (RN2-00905) and US National Institutes of Health (P50 GM085764-03 and U01 ES017166).	Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jin FL, 2011, TRANSCR-AUSTIN, V2, P226, DOI 10.4161/trns.2.5.17712; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mercer TR, 2013, NAT GENET, V45, P852, DOI 10.1038/ng.2677; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	30	864	882	1	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					290	294		10.1038/nature12644	http://dx.doi.org/10.1038/nature12644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24141950	Green Accepted			2022-12-28	WOS:000326894200057
J	Cortes, JE; Kim, DW; Pinilla-Ibarz, J; le Coutre, P; Paquette, R; Chuah, C; Nicolini, FE; Apperley, JF; Khoury, HJ; Talpaz, M; DiPersio, J; DeAngelo, DJ; Abruzzese, E; Rea, D; Baccarani, M; Muller, MC; Gambacorti-Passerini, C; Wong, S; Lustgarten, S; Rivera, VM; Clackson, T; Turner, CD; Haluska, FG; Guilhot, F; Deininger, MW; Hochhaus, A; Hughes, T; Goldman, JM; Shah, NP; Kantarjian, H				Cortes, J. E.; Kim, D. -W.; Pinilla-Ibarz, J.; le Coutre, P.; Paquette, R.; Chuah, C.; Nicolini, F. E.; Apperley, J. F.; Khoury, H. J.; Talpaz, M.; DiPersio, J.; DeAngelo, D. J.; Abruzzese, E.; Rea, D.; Baccarani, M.; Mueller, M. C.; Gambacorti-Passerini, C.; Wong, S.; Lustgarten, S.; Rivera, V. M.; Clackson, T.; Turner, C. D.; Haluska, F. G.; Guilhot, F.; Deininger, M. W.; Hochhaus, A.; Hughes, T.; Goldman, J. M.; Shah, N. P.; Kantarjian, H.		PACE Investigators	A Phase 2 Trial of Ponatinib in Philadelphia Chromosome-Positive Leukemias	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITOR; CHRONIC MYELOGENOUS LEUKEMIA; DIAGNOSED CHRONIC-PHASE; BCR-ABL INHIBITOR; DOMAIN MUTATIONS; FOLLOW-UP; IMATINIB RESISTANCE; OCCLUSIVE DISEASE; NILOTINIB	BackgroundPonatinib is a potent oral tyrosine kinase inhibitor of unmutated and mutated BCR-ABL, including BCR-ABL with the tyrosine kinase inhibitor-refractory threonine-to-isoleucine mutation at position 315 (T315I). We conducted a phase 2 trial of ponatinib in patients with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL). MethodsWe enrolled 449 heavily pretreated patients who had CML or Ph-positive ALL with resistance to or unacceptable side effects from dasatinib or nilotinib or who had the BCR-ABL T315I mutation. Ponatinib was administered at an initial dose of 45 mg once daily. The median follow-up was 15 months. ResultsAmong 267 patients with chronic-phase CML, 56% had a major cytogenetic response (51% of patients with resistance to or unacceptable side effects from dasatinib or nilotinib and 70% of patients with the T315I mutation), 46% had a complete cytogenetic response (40% and 66% in the two subgroups, respectively), and 34% had a major molecular response (27% and 56% in the two subgroups, respectively). Responses were observed regardless of the baseline BCR-ABL kinase domain mutation status and were durable; the estimated rate of a sustained major cytogenetic response of at least 12 months was 91%. No single BCR-ABL mutation conferring resistance to ponatinib was detected. Among 83 patients with accelerated-phase CML, 55% had a major hematologic response and 39% had a major cytogenetic response. Among 62 patients with blast-phase CML, 31% had a major hematologic response and 23% had a major cytogenetic response. Among 32 patients with Ph-positive ALL, 41% had a major hematologic response and 47% had a major cytogenetic response. Common adverse events were thrombocytopenia (in 37% of patients), rash (in 34%), dry skin (in 32%), and abdominal pain (in 22%). Serious arterial thrombotic events were observed in 9% of patients; these events were considered to be treatment-related in 3%. A total of 12% of patients discontinued treatment because of an adverse event. ConclusionsPonatinib had significant antileukemic activity across categories of disease stage and mutation status. (Funded by Ariad Pharmaceuticals and others; PACE ClinicalTrials.gov number, NCT01207440.)	[Cortes, J. E.; Kantarjian, H.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Kim, D. -W.] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea; [Pinilla-Ibarz, J.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [le Coutre, P.] Charite, D-13353 Berlin, Germany; [Mueller, M. C.] Univ Med Mannheim, Med Klin 3, Mannheim, Germany; [Hochhaus, A.] Univ Klinikum Jena, Abt Hamatol & Onkol, Jena, Germany; [Paquette, R.] Univ Calif Los Angeles, Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA; [Chuah, C.] Singapore Gen Hosp, Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore; [Nicolini, F. E.] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France; [Rea, D.] Hop St Louis, Serv Malad Sang, Paris, France; [Rea, D.] Hop St Louis, CIC, Paris, France; [Guilhot, F.] Ctr Hosp Univ Poitiers, INSERM CIC, Poitiers, France; [Apperley, J. F.; Goldman, J. M.] Univ London Imperial Coll Sci Technol & Med, Ctr Haematol, London, England; [Khoury, H. J.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Talpaz, M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [DiPersio, J.] Washington Univ, Sch Med, St Louis, MO USA; [DeAngelo, D. J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Abruzzese, E.] Univ Roma Tor Vergata, S Eugenio Hosp, Rome, Italy; [Baccarani, M.] S Orsola Malpighi Univ Hosp, Dept Hematol & Oncol L&A Seragnoli, Bologna, Italy; [Gambacorti-Passerini, C.] Univ Milano Bicocca, Azienda Osped San Gerardo, Unita Ric Clin Ematol, Monza, Italy; [Wong, S.] MolecularMD, Portland, OR USA; [Lustgarten, S.; Rivera, V. M.; Clackson, T.; Turner, C. D.; Haluska, F. G.] Ariad Pharmaceut, Cambridge, MA USA; [Deininger, M. W.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Hughes, T.] Inst Med & Vet Sci, Adelaide, SA 5000, Australia; [Shah, N. P.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Texas System; UTMD Anderson Cancer Center; Catholic University of Korea; Seoul St. Mary's Hospital; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Friedrich Schiller University of Jena; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; Singapore General Hospital; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Imperial College London; Emory University; University of Michigan System; University of Michigan; Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; Sant'Eugenio Hospital; University of Rome Tor Vergata; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Milano-Bicocca; Takeda Pharmaceutical Company Ltd; Takeda Oncology; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Institute Medical & Veterinary Science Australia; University of California System; University of California San Francisco	Cortes, JE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	jcortes@mdanderson.org	Seymour, John/K-7326-2019; Hughes, Tim/AAO-9975-2021; von Bubnoff, Nikolas/F-2351-2017; Abruzzese, Elisabetta/D-4408-2019; Ottmann, Oliver/D-5007-2016; holyoake, tessa/M-3668-2015	Seymour, John/0000-0003-2188-6835; von Bubnoff, Nikolas/0000-0001-9593-8947; Abruzzese, Elisabetta/0000-0001-5228-6491; Rea, Delphine/0000-0001-5379-7461; Ottmann, Oliver/0000-0001-9559-1330; Sanchez-Guijo, Fermin/0000-0002-7076-7739; Rivera, Victor/0000-0002-7258-3001; Guilhot, Francois/0000-0001-7222-487X; holyoake, tessa/0000-0002-0608-6066; Talpaz, Moshe/0000-0003-3361-3981; Hughes, Timothy/0000-0002-0910-3730; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Cortes, Jorge/0000-0002-8636-1071; Hochhaus, Andreas/0000-0003-0626-0834	Ariad Pharmaceuticals; NATIONAL CANCER INSTITUTE [P01CA049639, P30CA016672, P50CA171963] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0611-10275] Funding Source: researchfish	Ariad Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Ariad Pharmaceuticals and others; PACE ClinicalTrials.gov number, NCT01207440.)	[Anonymous], 2011, TAS NIL CAPS PRESCR; [Anonymous], 2011, SPRYC DAS TABL OR US; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Bauer RC, 2013, CLIN CANCER RES, V19, P2962, DOI 10.1158/1078-0432.CCR-13-0052; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Cortes JE, 2012, J CLIN ONCOL, V30, P3486, DOI 10.1200/JCO.2011.38.7522; Cortes JE, 2011, BLOOD, V118, P4567, DOI 10.1182/blood-2011-05-355594; Deininger M, 2009, BLOOD S, V114; Garg RJ, 2009, BLOOD, V114, P4361, DOI 10.1182/blood-2009-05-221531; Giles FJ, 2013, LEUKEMIA, V27, P1310, DOI 10.1038/leu.2013.69; Giles FJ, 2010, LEUKEMIA, V24, P1299, DOI 10.1038/leu.2010.110; Hochhaus A, 2010, LEUKEMIA, V24, P1102, DOI 10.1038/leu.2010.71; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Ibrahim AR, 2010, BLOOD, V116, P5497, DOI 10.1182/blood-2010-06-291922; Jabbour E, 2011, BLOOD, V117, P1822, DOI 10.1182/blood-2010-07-293977; Jabbour E, 2008, BLOOD, V112, P4839, DOI 10.1182/blood-2008-04-149948; Johansson B, 2002, ACTA HAEMATOL-BASEL, V107, P76, DOI 10.1159/000046636; Jootar S., 2012, BLOOD, V120, P695; Kantariian H, 2007, CANCER-AM CANCER SOC, V109, P1556, DOI 10.1002/cncr.22569; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Kantarjian HM, 2011, LANCET ONCOL, V12, P841, DOI 10.1016/S1470-2045(11)70201-7; Kantarjian HM, 2011, BLOOD, V117, P1141, DOI 10.1182/blood-2010-03-277152; Khorashad JS, 2013, BLOOD, V121, P489, DOI 10.1182/blood-2012-05-431379; Khoury HJ, 2012, BLOOD, V119, P3403, DOI 10.1182/blood-2011-11-390120; Kim TD, 2013, LEUKEMIA, V27, P1316, DOI 10.1038/leu.2013.70; Mauro MJ, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.3747.3747; Nakamae H, 2012, J CLIN ONCOL S, V30; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Neelakantan P, 2012, HAEMATOL-HEMATOL J, V97, P1444, DOI 10.3324/haematol.2012.064618; Nicolini FE, 2006, LEUKEMIA, V20, P1061, DOI 10.1038/sj.leu.2404236; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Shah NP, 2008, J CLIN ONCOL, V26, P3204, DOI 10.1200/JCO.2007.14.9260; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; Shah NP, 2010, J CLIN ONCOL S, V28; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Soverini S, 2013, BLOOD, V122, P1634, DOI 10.1182/blood-2013-03-487728; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Xu ZS, 2009, HEMATOL REP, V1, P17, DOI 10.4081/hr.2009.e4	42	701	717	3	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1783	1796		10.1056/NEJMoa1306494	http://dx.doi.org/10.1056/NEJMoa1306494			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24180494	Green Accepted			2022-12-28	WOS:000326607800007
J	Spence, D				Spence, Des			FROM THE FRONTLINE Do we need GPs?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2013	347								f6589	10.1136/bmj.f6589	http://dx.doi.org/10.1136/bmj.f6589			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247FD	24185132				2022-12-28	WOS:000326600400011
J	Butt, N; Beyer, HL; Bennett, JR; Biggs, D; Maggini, R; Mills, M; Renwick, AR; Seabrook, LM; Possingham, HP				Butt, N.; Beyer, H. L.; Bennett, J. R.; Biggs, D.; Maggini, R.; Mills, M.; Renwick, A. R.; Seabrook, L. M.; Possingham, H. P.			Biodiversity Risks from Fossil Fuel Extraction	SCIENCE			English	Editorial Material							OIL; IMPACTS		[Butt, N.; Beyer, H. L.; Bennett, J. R.; Biggs, D.; Maggini, R.; Renwick, A. R.; Seabrook, L. M.; Possingham, H. P.] Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Environm Decis, St Lucia, Qld 4072, Australia; [Mills, M.] Univ Queensland, Global Change Inst, St Lucia, Qld 4072, Australia; [Seabrook, L. M.] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland	Butt, N (corresponding author), Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Environm Decis, St Lucia, Qld 4072, Australia.	n.butt@uq.edu.au	Beyer, Hawthorne/F-8050-2013; Seabrook, Leonie M K/D-2992-2009; Butt, Nathalie/B-3558-2014; Mills, Morena/C-6546-2013; Biggs, Duan/F-9445-2011; Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Mills, Morena/AAD-8916-2019	Beyer, Hawthorne/0000-0002-5430-0784; Seabrook, Leonie M K/0000-0001-5602-5168; Butt, Nathalie/0000-0003-1517-6191; Mills, Morena/0000-0001-9865-0770; Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Maggini, Ramona/0000-0001-7031-0096; Biggs, Duan/0000-0003-3177-4677; Bennett, Joseph/0000-0002-3901-9513				BELL F.G., 2006, MINING ITS IMPACT EN; BP, 2013, STAT REV WORLD EN; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cristescu RH, 2012, BIOL CONSERV, V149, P60, DOI 10.1016/j.biocon.2012.02.003; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Fredriksson PG, 2003, J PUBLIC ECON, V87, P1383, DOI 10.1016/S0047-2727(02)00036-1; GUZMAN HM, 1994, MAR ECOL PROG SER, V105, P231, DOI 10.3354/meps105231; Institute for Energy Research, EN INF ASS FOR; IUCN ICMM, 2004, INT MIN BIOD CONS CA; Kingston PF, 2002, SPILL SCI TECHNOL B, V7, P53, DOI 10.1016/S1353-2561(02)00051-8; Lewis M, 2011, ENVIRON POLLUT, V159, P2328, DOI 10.1016/j.envpol.2011.04.027; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; O'Rourke D, 2003, ANNU REV ENV RESOUR, V28, P587, DOI 10.1146/annurev.energy.28.050302.105617; Pedroni PM, 2013, J APPL ECOL, V50, P539, DOI 10.1111/1365-2664.12088; Quintero JD, 2011, CONSERV BIOL, V25, P1121, DOI 10.1111/j.1523-1739.2011.01769.x; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x	16	76	78	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					425	426		10.1126/science.1237261	http://dx.doi.org/10.1126/science.1237261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159031				2022-12-28	WOS:000326042600024
J	Zhu, L; Ploessl, K; Kung, HF				Zhu, Lin; Ploessl, Karl; Kung, Hank F.			Expanding the Scope of Fluorine Tags for PET Imaging	SCIENCE			English	Editorial Material							TRIFLUOROMETHYLATION; METABOLISM		[Zhu, Lin] Beijing Normal Univ, Minist Educ, Key Lab Radiopharmaceut, Beijing 100875, Peoples R China; [Zhu, Lin; Ploessl, Karl; Kung, Hank F.] Univ Penn, Dept Radiol, Philadelphia, PA 19014 USA; [Zhu, Lin] Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China; [Kung, Hank F.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19014 USA	Beijing Normal University; University of Pennsylvania; Capital Medical University; University of Pennsylvania	Zhu, L (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Radiopharmaceut, Beijing 100875, Peoples R China.	kunghf@mail.med.upenn.edu		Ploessl, Karl/0000-0001-7896-5900	NCI NIH HHS [CA-164490] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA164490] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Huiban M, 2013, NAT CHEM, V5, P941, DOI [10.1038/NCHEM.1756, 10.1038/nchem.1756]; MACNEIL JG, 1991, J FLUORINE CHEM, V55, P225, DOI 10.1016/S0022-1139(00)80126-8; Plathow C, 2008, J NUCL MED, V49, p43S, DOI 10.2967/jnumed.107.045930; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293	8	18	20	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					429	430		10.1126/science.1245011	http://dx.doi.org/10.1126/science.1245011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159034				2022-12-28	WOS:000326042600027
J	Hahn, R				Hahn, Robert			Ronald Harry Coase (1910-2013) OBITUARY	NATURE			English	Biographical-Item									Univ Oxford, Smith Sch Enterprise & Environm, Oxford OX1 2JD, England	University of Oxford	Hahn, R (corresponding author), Univ Oxford, Smith Sch Enterprise & Environm, Oxford OX1 2JD, England.	robert.hahn@smithschool.ox.ac.uk							0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					449	449		10.1038/502449a	http://dx.doi.org/10.1038/502449a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153291	Bronze			2022-12-28	WOS:000325988400031
J	Lapinaite, A; Simon, B; Skjaerven, L; Rakwalska-Bange, M; Gabel, F; Carlomagno, T				Lapinaite, Audrone; Simon, Bernd; Skjaerven, Lars; Rakwalska-Bange, Magdalena; Gabel, Frank; Carlomagno, Teresa			The structure of the box C/D enzyme reveals regulation of RNA methylation	NATURE			English	Article							X-RAY; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; RIBOSE METHYLATION; SITE; RESONANCE; FIBRILLARIN; RESOLUTION; PROTEINS; SYSTEM	Post-transcriptional modifications are essential to the cell life cycle, as they affect both pre-ribosomal RNA processing and ribosome assembly. The box C/D ribonucleoprotein enzyme that methylates ribosomal RNA at the 2'-O-ribose uses a multitude of guide RNAs as templates for the recognition of rRNA target sites. Two methylation guide sequences are combined on each guide RNA, the significance of which has remained unclear. Here we use a powerful combination of NMR spectroscopy and small-angle neutron scattering to solve the structure of the 390 kDa archaeal RNP enzyme bound to substrate RNA. We show that the two methylation guide sequences are located in different environments in the complex and that the methylation of physiological substrates targeted by the same guide RNA occurs sequentially. This structure provides a means for differential control of methylation levels at the two sites and at the same time offers an unexpected regulatory mechanism for rRNA folding.	[Lapinaite, Audrone; Simon, Bernd; Skjaerven, Lars; Rakwalska-Bange, Magdalena; Carlomagno, Teresa] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Gabel, Frank] Univ Grenoble Alpes, Inst Biol Struct, F-38027 Grenoble, France; [Gabel, Frank] Commisariat Energie Atom, Direct Sci Vivant, Inst Biol Struct, F-38027 Grenoble, France; [Gabel, Frank] Ctr Natl Rech Sci, Inst Biol Struct, F-38027 Grenoble, France; [Gabel, Frank] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut Laue-Langevin (ILL)	Carlomagno, T (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	teresa.carlomagno@embl.de	Skjærven, Lars/C-1919-2017	Skjærven, Lars/0000-0002-8176-4891; Carlomagno, Teresa/0000-0002-2437-2760; Gabel, Frank/0000-0003-3446-2601; Simon, Bernd/0000-0003-0164-5516	DFG [CA294/3-1]; EU FP7 ITN project RNPnet [289007]; EMBL	DFG(German Research Foundation (DFG)); EU FP7 ITN project RNPnet; EMBL	This work was supported by DFG grant CA294/3-1, by EU FP7 ITN project RNPnet (contract number 289007) and by the EMBL. For the SAXS and SANS experiments we thank the ESRF and ILL, BAG MX1219 and the D22 BAG system for beam-time as well as A. Martel and P. Pernot for help with the setup of the instruments. We thank J. Wohnert for the gift of <SUP>13</SUP>C-labelled SAM and C. Kreutz for the gift of [<SUP>13</SUP>C]2'OCH<INF>3</INF> substrate RNA. We thank John Kirkpatrick for the assignment of the L7Ae resonances.	Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; AMBER, 2012, AMBER 12; [Anonymous], PYMOL MOL GRAPH SYST; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BAX A, 1983, J MAGN RESON, V55, P301, DOI 10.1016/0022-2364(83)90241-X; Bleichert F, 2009, SCIENCE, V325, P1384, DOI 10.1126/science.1176099; Bower-Phipps KR, 2012, RNA, V18, P1527, DOI 10.1261/rna.033134.112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ghalei H, 2010, RNA, V16, P2341, DOI 10.1261/rna.2380410; Gosh R. E., 2006, ILL06GH05T; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8312, DOI 10.1021/bi00083a035; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAWAI G, 1992, BIOCHEMISTRY-US, V31, P1040, DOI 10.1021/bi00119a012; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Lin JZ, 2011, NATURE, V469, P559, DOI 10.1038/nature09688; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Nolivos S, 2005, NUCLEIC ACIDS RES, V33, P6507, DOI 10.1093/nar/gki962; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; Simon B, 2010, ANGEW CHEM INT EDIT, V49, P1967, DOI 10.1002/anie.200906147; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; TOLLERVEY D, 1991, EMBO J, V10, P573, DOI 10.1002/j.1460-2075.1991.tb07984.x; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Williams DJ, 2001, RNA, V7, P44, DOI 10.1017/S1355838201001558; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xue S, 2010, MOL CELL, V39, P939, DOI 10.1016/j.molcel.2010.08.022	49	120	124	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					519	+		10.1038/nature12581	http://dx.doi.org/10.1038/nature12581			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24121435				2022-12-28	WOS:000325988400047
J	Stonington, SD				Stonington, Scott D.			The Debt of Life - Thai Lessons on a Process-Oriented Ethical Logic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								In Thailand, families of dying patients often advocate for aggressive ICU care in order to pay their debt of life. Their reasoning is based on process, not outcome. Many Americans may similarly see the process of providing care as in some ways more important than cure. We love him so much, said Ms. M., standing over her father as he lay on life support in a Boston ICU where I was an intern. We want to do everything or at least I want to, she said tearfully, acknowledging the disagreement among her siblings about how to proceed. Later that morning, I presented her father's case on rounds: after a failed bone marrow transplant, he'd had a myocardial infarction, which had led to heart failure, then renal failure, then pneumonia and sepsis. He was receiving maximal doses of pressors and couldn't be weaned from the ventilator. ...	[Stonington, Scott D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Stonington, Scott D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Stonington, SD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.			Stonington, Scott/0000-0002-0472-3885				Quill TE, 2009, ANN INTERN MED, V151, P345, DOI 10.7326/0003-4819-151-5-200909010-00010; Stonington SD, 2012, SOC SCI MED, V75, P836, DOI 10.1016/j.socscimed.2012.03.045	2	11	11	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1583	1585		10.1056/NEJMp1308613	http://dx.doi.org/10.1056/NEJMp1308613			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239MZ	24152259				2022-12-28	WOS:000326031100006
J	Colautti, RI; Barrett, SCH				Colautti, Robert I.; Barrett, Spencer C. H.			Rapid Adaptation to Climate Facilitates Range Expansion of an Invasive Plant	SCIENCE			English	Article							LOOSESTRIFE LYTHRUM-SALICARIA; PURPLE LOOSESTRIFE; NORTH-AMERICA; EVOLUTION; POPULATIONS; CONSTRAINTS; HYPOTHESIS; LYTHRACEAE; PHENOLOGY; HERBIVORY	Adaptation to climate, evolving over contemporary time scales, could facilitate rapid range expansion across environmental gradients. Here, we examine local adaptation along a climatic gradient in the North American invasive plant Lythrum salicaria. We show that the evolution of earlier flowering is adaptive at the northern invasion front where it increases fitness as much as, or more than, the effects of enemy release and the evolution of increased competitive ability. However, early flowering decreases investment in vegetative growth, which reduces fitness by a factor of 3 in southern environments where the North American invasion commenced. Our results demonstrate that local adaptation can evolve quickly during range expansion, overcoming environmental constraints on propagule production.	[Colautti, Robert I.; Barrett, Spencer C. H.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada	University of Toronto	Colautti, RI (corresponding author), Univ British Columbia, Dept Bot, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	rob.colautti@botany.ubc.ca	Colautti, Robert/AAT-1270-2021; Barrett, Spencer CH/M-3751-2013; Barrett, Spencer C.H./S-5782-2019	Colautti, Robert/0000-0003-4213-0711; Barrett, Spencer C.H./0000-0002-7762-3455	Ontario Government; University of Toronto; Canada Research Chair's program; Ontario Premier's Discovery Award; Natural Sciences and Engineering Research Council of Canada	Ontario Government; University of Toronto(University of Toronto); Canada Research Chair's program(Canada Research Chairs); Ontario Premier's Discovery Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank D. Carr and A. Weis for assistance at BEF and KSR, respectively, and K. Pols (Millson Forestry Service) and G. Paquette for assistance in Timmins. We also thank S. Yakimowski, M. Johnson, J. Alexander, J. Stinchcombe, K. Rice, K. Dlugosch, and L. Rieseberg for helpful comments. This work was supported by Ontario Government and University of Toronto graduate scholarships (to R. I. C.), the Canada Research Chair's program and an Ontario Premier's Discovery Award for funding (to S. C. H. B.), and the Natural Sciences and Engineering Research Council of Canada for graduate and postdoctoral funding to R. I. C. and Discovery Grants to S. C. H. B. The Original data and analysis are available from the Dryad Data Repository (DOI: 10.5061/dryad.878m3).	Alexander JM, 2009, ECOLOGY, V90, P612, DOI 10.1890/08-0453.1; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Chun YJ, 2009, MOL ECOL, V18, P3020, DOI 10.1111/j.1365-294X.2009.04254.x; Clewley GD, 2012, J APPL ECOL, V49, P1287, DOI 10.1111/j.1365-2664.2012.02209.x; Colautti RI, 2011, EVOLUTION, V65, P2514, DOI 10.1111/j.1558-5646.2011.01313.x; Colautti RI, 2010, INT J PLANT SCI, V171, P960, DOI 10.1086/656444; Colautti RI, 2010, P ROY SOC B-BIOL SCI, V277, P1799, DOI 10.1098/rspb.2009.2231; Colautti RI, 2009, EVOL APPL, V2, P187, DOI 10.1111/j.1752-4571.2008.00053.x; De Poorter M., 2004, 100 ESPECIES EXOTICA, P1; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Houghton-Thompson J, 2005, ANN BOT-LONDON, V96, P877, DOI 10.1093/aob/mci240; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Hunt-Joshi TR, 2004, ECOL APPL, V14, P1574, DOI 10.1890/03-5181; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Montague JL, 2008, J EVOLUTION BIOL, V21, P234, DOI 10.1111/j.1420-9101.2007.01456.x; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Schat M, 2005, ENVIRON ENTOMOL, V34, P906, DOI 10.1603/0046-225X-34.4.906; Thompson DW., 1987, SPREAD IMPACT CONTRO; Willis AJ, 1999, BIOCONTROL SCI TECHN, V9, P567, DOI 10.1080/09583159929523	21	291	295	7	423	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					364	366		10.1126/science.1242121	http://dx.doi.org/10.1126/science.1242121			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136968				2022-12-28	WOS:000325755100046
J	Ramtani, S				Ramtani, Salah			How to Be Both Strong and Thermally Stable	SCIENCE			English	Editorial Material							NANOSTRUCTURED METALS; STRENGTH		Univ Paris 13, LSPM UPR CNRS 3407, Inst Galilee, F-93430 Villetaneuse, France	Universite Paris 13	Ramtani, S (corresponding author), Univ Paris 13, LSPM UPR CNRS 3407, Inst Galilee, 99 Ave Jean Baptiste Clement, F-93430 Villetaneuse, France.	ramtani@univ-paris13.fr	RAMTANI, Salah/AAM-2408-2020					Abdul-Latif A, 2009, INT J MECH SCI, V51, P797, DOI 10.1016/j.ijmecsci.2009.09.005; Alexandrov IV, 2001, SCRIPTA MATER, V44, P1605, DOI 10.1016/S1359-6462(01)00783-7; Azizi-Alizamini H, 2007, SCRIPTA MATER, V57, P1065, DOI 10.1016/j.scriptamat.2007.08.035; Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2; Gurtin ME, 2008, J MECH PHYS SOLIDS, V56, P184, DOI 10.1016/j.jmps.2007.09.001; Hall E. O., 1951, P PHYS SOC LOND B, V64, P787; Jia D, 2001, APPL PHYS LETT, V79, P611, DOI 10.1063/1.1384000; Jiang B, 2004, J MECH PHYS SOLIDS, V52, P1125, DOI 10.1016/j.jmps.2003.09.002; Koch CC, 2005, ADV ENG MATER, V7, P787, DOI 10.1002/adem.200500094; Liu XC, 2013, SCIENCE, V342, P337, DOI 10.1126/science.1242578; Ma E, 2004, APPL PHYS LETT, V85, P4932, DOI 10.1063/1.1814431; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Ramtani S, 2010, MECH MATER, V42, P522, DOI 10.1016/j.mechmat.2010.02.001	13	1	1	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					320	321		10.1126/science.1245794	http://dx.doi.org/10.1126/science.1245794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136957				2022-12-28	WOS:000325755100031
J	Abdallah, MS; Wang, KJ; Magnuson, EA; Spertus, JA; Farkouh, ME; Fuster, V; Cohen, DJ				Abdallah, Mouin S.; Wang, Kaijun; Magnuson, Elizabeth A.; Spertus, John A.; Farkouh, Michael E.; Fuster, Valentin; Cohen, David J.		FREEDOM Trial Investigators	Quality of Life After PCI vs CABG Among Patients With Diabetes and Multivessel Coronary Artery Disease A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG-ELUTING STENTS; BYPASS-SURGERY; HEALTH-STATUS; BALLOON ANGIOPLASTY; REVASCULARIZATION; INTERVENTION; MELLITUS; OUTCOMES; PREFERENCES; RECOVERY	IMPORTANCE The FREEDOM trial demonstrated that among patients with diabetes mellitus and multivessel coronary artery disease, coronary artery bypass graft (CABG) surgery resulted in lower rates of death and myocardial infarction but a higher risk of stroke when compared with percutaneous coronary intervention (PCI) using drug-eluting stents. Whether there are treatment differences in health status, as assessed from the patient's perspective, is unknown. OBJECTIVES To compare the relative effects of CABG vs PCI using drug-eluting stents on health status among patients with diabetes mellitus and multivessel coronary artery disease. DESIGN, SETTING, AND PARTICIPANTS Between 2005 and 2010, 1900 patients from 18 countries with diabetes mellitus and multivessel coronary artery disease were randomized to undergo either CABG surgery (n = 947) or PCI (n = 953) as an initial treatment strategy. Of these, a total of 1880 patients had baseline health status assessed (935 CABG, 945 PCI) and comprised the primary analytic sample. INTERVENTIONS Initial revascularization with CABG surgery or PCI. MAIN OUTCOMES AND MEASURES Health status was assessed using the angina frequency, physical limitations, and quality-of-life domains of the Seattle Angina Questionnaire at baseline, at 1, 6, and 12 months, and annually thereafter. For each scale, scores range from 0 to 100 with higher scores representing better health. The effect of CABG surgery vs PCI was evaluated using longitudinal mixed-effect models. RESULTS At baseline, mean (SD) scores for the angina frequency, physical limitations, and quality-of-life subscales of the Seattle Angina Questionnaire were 70.9 (25.1), 67.3 (24.4), and 47.8 (25.0) for the CABG group and 71.4 (24.7), 69.9 (23.2), and 49.2 (25.7) for the PCI group, respectively. At 2-year follow-up, mean (SD) scores were 96.0 (11.9), 87.8 (18.7), and 82.2 (18.9) after CABG and 94.7 (14.3), 86.0 (19.3), and 80.4 (19.6) after PCI, with significantly greater benefit of CABG on each domain (mean treatment benefit, 1.3 [95% CI, 0.3-2.2], 4.4 [95% CI, 2.7-6.1], and 2.2 [95% CI, 0.7-3.8] points, respectively; P < .01 for each comparison). Beyond 2 years, the 2 revascularization strategies provided generally similar patient-reported outcomes. CONCLUSIONS AND RELEVANCE For patients with diabetes and multivessel CAD, CABG surgery provided slightly better intermediate-term health status and quality of life than PCI using drug-eluting stents. The magnitude of benefit was small, without consistent differences beyond 2 years, in part due to the higher rate of repeat revascularization with PCI.	[Abdallah, Mouin S.; Wang, Kaijun; Magnuson, Elizabeth A.; Spertus, John A.; Cohen, David J.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Abdallah, Mouin S.; Magnuson, Elizabeth A.; Spertus, John A.; Cohen, David J.] Univ Missouri, Sch Med, Kansas City, MO 64111 USA; [Farkouh, Michael E.; Fuster, Valentin] Mt Sinai Sch Med, New York, NY USA; [Farkouh, Michael E.] Univ Toronto, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Farkouh, Michael E.] Univ Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada	Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Icahn School of Medicine at Mount Sinai; University of Toronto; Peter Munk Cardiac Centre; University of Toronto; Li Ka Shing Knowledge Institute	Cohen, DJ (corresponding author), Univ Missouri, Sch Med, St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA.	dcohen@saint-lukes.org	Cohen, David/AAF-1648-2019; Fuster, Valentin/H-4319-2015; Spertus, John/ABD-3075-2021; Abdallah, Mouin/AAO-5143-2021	Fuster, Valentin/0000-0002-9043-9986; Felix, Ana Cristina Goncalves/0000-0002-3690-1156	National Heart, Lung, and Blood Institute (NHLBI) [U01 01HL071988, 01HL092989]; Eli Lilly; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092989, U01HL071988, P50HL077113] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eli Lilly(Eli Lilly); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants (U01 01HL071988 and 01HL092989) from the National Heart, Lung, and Blood Institute (NHLBI). Cordis and Boston Scientific provided the stents; Eli Lilly provided abciximab and an unrestricted research grant; and sanofi-aventis and Bristol-Myers Squibb provided clopidogrel.	Alderman EL, 1996, NEW ENGL J MED, V335, P217; Arnold SV, 2012, CIRC-CARDIOVASC QUAL, V5, P267, DOI 10.1161/CIRCOUTCOMES.111.964585; Arnold SV, 2009, AM HEART J, V157, P1042, DOI 10.1016/j.ahj.2009.03.021; Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Borkon AM, 2002, ANN THORAC SURG, V74, P1526, DOI 10.1016/S0003-4975(02)04063-8; Brooks MM, 2010, CIRCULATION, V122, P1690, DOI 10.1161/CIRCULATIONAHA.109.912642; Brophy JM, 2003, ANN INTERN MED, V138, P777, DOI 10.7326/0003-4819-138-10-200305200-00005; Cardiovascular Outcomes Inc, SEATTLE ANGINA QUEST; CLEARY PD, 1991, MED CARE, V29, P939, DOI 10.1097/00005650-199110000-00001; Cohen DJ, 2011, NEW ENGL J MED, V364, P1016, DOI 10.1056/NEJMoa1001508; Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; Hlatky MA, 2012, NEW ENGL J MED, V367, P2437, DOI 10.1056/NEJMe1212278; Hofer S, 2003, QUAL LIFE RES, V12, P199, DOI 10.1023/A:1022272620947; Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8; JENKINS CD, 1994, PSYCHOSOM MED, V56, P203, DOI 10.1097/00006842-199405000-00005; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Lewis EF, 2001, J HEART LUNG TRANSPL, V20, P1016, DOI 10.1016/S1053-2498(01)00298-4; Magnuson EA, 2013, CIRCULATION, V127, P820, DOI 10.1161/CIRCULATIONAHA.112.147488; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rose JH, 2004, J CLIN ONCOL, V22, P4907, DOI 10.1200/JCO.2004.06.050; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Sianos Georgios, 2005, EuroIntervention, V1, P219; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Zhang ZF, 2003, CIRCULATION, V108, P1694, DOI 10.1161/01.CIR.0000087600.83707.FD	37	105	110	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1581	1590		10.1001/jama.2013.279208	http://dx.doi.org/10.1001/jama.2013.279208			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129463	Green Accepted, Bronze			2022-12-28	WOS:000325624800021
J	Maki, DG				Maki, Dennis G.			Review: Antibiotic prophylaxis on removal of urinary catheters reduces symptomatic urinary tract infections	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.							Foon R, 2012, COCHRANE DATABASE SY, P10; Johnson JR, 2006, ANN INTERN MED, V144, P116, DOI 10.7326/0003-4819-144-2-200601170-00009; Lusardi G, 2013, COCHRANE DB SYST REV, V7; Nicolle LE, 2012, INFECT DIS CLIN N AM, V26, P13, DOI 10.1016/j.idc.2011.09.009	4	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC9	10.7326/0003-4819-159-8-201310150-02009	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126670				2022-12-28	WOS:000326751200008
J	Ndebele, P				Ndebele, Paul			The Declaration of Helsinki, 50 Years Later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-TRIALS		Med Res Council Zimbabwe, Harare, Zimbabwe		Ndebele, P (corresponding author), Med Res Council Zimbabwe, Cnr J Tongogara Mazowe St,POB CY573, Harare, Zimbabwe.	pndexas@yahoo.com		Ndebele, Paul/0000-0001-9669-1544				Bhattacharjee Y, 2013, SCIENCE, V341, P327, DOI 10.1126/science.341.6144.327; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; Mamotte N, 2013, J EMPIR RES HUM RES, V8, P45, DOI 10.1525/jer.2013.8.1.45; Mandava A, 2012, J MED ETHICS, V38, P356, DOI 10.1136/medethics-2011-100178; Plomer A, 2012, S AFR J BIOETH LAW, V5, P83, DOI 10.7196/SAJBL.232; SHERWIN S, 1994, WOMEN HLTH RES ETHIC; WHO, 2011, STAND OP GUID ETH RE	7	29	31	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2145	2146		10.1001/jama.2013.281316	http://dx.doi.org/10.1001/jama.2013.281316			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24141794	Bronze			2022-12-28	WOS:000327404400019
J	Dror, RO; Green, HF; Valant, C; Borhani, DW; Valcourt, JR; Pan, AC; Arlow, DH; Canals, M; Lane, JR; Rahmani, R; Baell, JB; Sexton, PM; Christopoulos, A; Shaw, DE				Dror, Ron O.; Green, Hillary F.; Valant, Celine; Borhani, David W.; Valcourt, James R.; Pan, Albert C.; Arlow, Daniel H.; Canals, Meritxell; Lane, J. Robert; Rahmani, Raphael; Baell, Jonathan B.; Sexton, Patrick M.; Christopoulos, Arthur; Shaw, David E.			Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs	NATURE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; FORCE-FIELD; SUBTYPE SELECTIVITY; AMINO-ACIDS; SITE; DYNAMICS; BINDING; IDENTIFICATION; LIGANDS; TRANSMEMBRANE	The design of G-protein-coupled receptor (GPCR) allosteric modulators, an active area of modern pharmaceutical research, has proved challenging because neither the binding modes nor the molecular mechanisms of such drugs are known(1,2). Here we determine binding sites, bound conformations and specific drug-receptor interactions for several allosteric modulators of the M2 muscarinic acetylcholine receptor (M2 receptor), a prototypical family A GPCR, using atomic-level simulations in which the modulators spontaneously associate with the receptor. Despite substantial structural diversity, all modulators form cation-p interactions with clusters of aromatic residues in the receptor extracellular vestibule, approximately 15 angstrom from the classical, 'orthosteric' ligand-binding site. We validate the observed modulator binding modes through radioligand binding experiments on receptor mutants designed, on the basis of our simulations, either to increase or to decrease modulator affinity. Simulations also revealed mechanisms that contribute to positive and negative allosteric modulation of classical ligand binding, including coupled conformational changes of the two binding sites and electrostatic interactions between ligands in these sites. These observations enabled the design of chemical modifications that substantially alter a modulator's allosteric effects. Our findings thus provide a structural basis for the rational design of allosteric modulators targeting muscarinic and possibly other GPCRs.	[Dror, Ron O.; Green, Hillary F.; Borhani, David W.; Valcourt, James R.; Pan, Albert C.; Arlow, Daniel H.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Valant, Celine; Canals, Meritxell; Lane, J. Robert; Rahmani, Raphael; Baell, Jonathan B.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Valant, Celine; Canals, Meritxell; Lane, J. Robert; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; Monash University; Monash University; Columbia University	Dror, RO (corresponding author), DE Shaw Res, 120 West 45th St,39th Floor, New York, NY 10036 USA.	Ron.Dror@DEShawResearch.com; Arthur.Christopoulos@Monash.edu; David.Shaw@DEShawResearch.com	Borhani, David/O-2692-2019; Sexton, Patrick M/B-1319-2008; Baell, Jonathan/E-5844-2017; rahmani, raphael/D-1185-2012; Christopoulos, Arthur/B-6207-2013	Borhani, David/0000-0002-8486-8792; Sexton, Patrick M/0000-0001-8902-2473; Baell, Jonathan/0000-0003-2114-8242; rahmani, raphael/0000-0002-2946-2562; Christopoulos, Arthur/0000-0003-4442-3294; Dror, Ron/0000-0002-6418-2793; Lane, J. Robert/0000-0002-7361-7875; Canals, Meritxell/0000-0002-7942-5006; Valant, Celine/0000-0002-2509-7465; Valcourt, James/0000-0001-6861-6088	National Health and Medical Research Council (NHMRC) of Australia [519461]; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank T. Mildorf, A. Kruse and B. Kobilka for comments; J. Klepeis, B. Gregersen, J.-L. Li, K. Palmo, A. Donchev and particularly A. Taube for advice and support related to force fields and quantum mechanical calculations; Z. Fan for assistance with statistical analysis; A. Lerer and T. O'Donnell for assistance with simulation and analysis software; A. Philippsen for creating the video; A. Stewart for assistance with mutagenesis and cell line generation; K. Ban and J. Harjani for assistance with chemical synthesis; J. Swarbrick for recording and analysing the two-dimensional NMR data; B. Sleebs and S. Marcuccio for provision of synthetic reagents; J. Dang for advice on analytical chemistry; and M. Kirk and R. Kastleman for editorial assistance. Portions of this work were financed by Program Grant no. 519461 from the National Health and Medical Research Council (NHMRC) of Australia, with synthetic chemistry infrastructure support from the Australian Federal Education Investment Fund Super Science Initiative and Victoria's Science Agenda Investment Fund. A. C. and P. M. S. are Principal Research Fellows of the NHMRC; J. B. B. is a Senior Research Fellow of the NHMRC; J. R. L. is a Career Development Awardee of the NHMRC.	Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; BOURNE PE, 1985, J CRYST SPECTROSC, V15, P453, DOI 10.1007/BF01171049; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; CALDWELL JW, 1995, J AM CHEM SOC, V117, P4177, DOI 10.1021/ja00119a037; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Daiss JO, 2002, ORGANOMETALLICS, V21, P803, DOI 10.1021/om010847j; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dror RO, 2009, P C HIGH PERF COMP N; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; EVERETT AJ, 1957, J CHEM SOC, P1120, DOI 10.1039/jr9570001120; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; Gao ZG, 2003, MOL PHARMACOL, V63, P1021, DOI 10.1124/mol.63.5.1021; Gnagey AL, 1999, MOL PHARMACOL, V56, P1245, DOI 10.1124/mol.56.6.1245; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakubik J, 2010, PHARMACEUTICALS, V3, P2838, DOI 10.3390/ph3092838; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Lazareno S, 2002, MOL PHARMACOL, V62, P1492, DOI 10.1124/mol.62.6.1492; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schneider H., 1991, J AM CHEM SOC, V20, P7698; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Silvano E, 2010, MOL PHARMACOL, V78, P925, DOI 10.1124/mol.110.065755; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Trankle C, 2003, MOL PHARMACOL, V64, P180, DOI 10.1124/mol.64.1.180; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Yanamala N, 2010, PHARMACEUTICALS-BASE, V3, P3324, DOI 10.3390/ph3103324	52	303	305	7	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					295	+		10.1038/nature12595	http://dx.doi.org/10.1038/nature12595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24121438				2022-12-28	WOS:000326894200058
J	Lee, TH				Lee, Thomas H.			The Word That Shall Not Be Spoken	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Physicians and health care organizations know that pain, anxiety, uncertainty, and confusion are common among patients, and we work hard to reduce these problems. So why do we avoid the word suffering, which captures so completely what patients endure? During the years when I worked in an academic integrated delivery system, my colleagues and I would frequently discuss patients' experiences and ways to improve our management of their pain and reduce their confusion as they navigated our complex organization. We knew that anxiety is inevitable for patients facing health issues, but we also knew that there is anxiety, and there is unnecessary anxiety caused, for example, by the uncertainty that weighs on patients and their families while they await a consultation for a potentially serious diagnosis, or the confusion induced when clinicians give conflicting information. We worked hard ...	Press Ganey, Wakefield, MA USA		Lee, TH (corresponding author), Press Ganey, Wakefield, MA USA.								0	19	21	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1777	1779		10.1056/NEJMp1309660	http://dx.doi.org/10.1056/NEJMp1309660			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247HF	24195546				2022-12-28	WOS:000326607800004
J	Liao, JM; Stewart, GC; Padera, RF; Miller, AL; Loscalzo, J				Liao, Joshua M.; Stewart, Garrick C.; Padera, Robert F.; Miller, Amy Leigh; Loscalzo, Joseph			A Curious Case of Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GIANT-CELL MYOCARDITIS; ENDOMYOCARDIAL BIOPSY; HEART-FAILURE; DISEASE	A 67-year-old man presented to the emergency department with chest pain that had begun earlier that day and had progressed over a period of several hours. The pain was substernal and nonradiating, and it did not change with position or food intake. ForewordIn this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors' commentary follows.StageA 67-year-old man presented to the emergency department with chest pain, reporting that he had felt well until 10 days before presentation, when nausea, nonbloody emesis, bloating, and epigastric pain developed. At that time, he was evaluated at another hospital, where the results of computed tomography (CT) of the abdomen and pelvis, performed after the administration of intravenous contrast material, and laboratory tests were normal except for an elevated platelet count (491,000 per cubic millimeter). A presumptive diagnosis of gastroesophageal reflux was made, and omeprazole was prescribed but provided no relief of symptoms. Over the course of several hours ...	[Liao, Joshua M.; Stewart, Garrick C.; Miller, Amy Leigh; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Padera, Robert F.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021	Padera, Robert/0000-0002-4571-5494				Cooper LT, 2012, HERZ, V37, P632, DOI 10.1007/s00059-012-3658-1; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Cooper LT, 2006, HERZ, V31, P767, DOI 10.1007/s00059-006-2917-4; Cooper LT, 2008, AM J CARDIOL, V102, P1535, DOI 10.1016/j.amjcard.2008.07.041; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; DAVIES MJ, 1975, BRIT HEART J, V37, P192; DESJARDINS V, 1992, CAN J CARDIOL, V8, P788; GRIES W, 1992, J HEART LUNG TRANSPL, V11, P370; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; Okada R, 1985, Heart Vessels Suppl, V1, P23, DOI 10.1007/BF02072354; Shields RC, 2002, J CARD FAIL, V8, P74, DOI 10.1054/jcaf.2002.32196; Vaideeswar P, 2013, CARDIOVASC PATHOL, V22, P70, DOI 10.1016/j.carpath.2012.06.003; WHITEHEAD R, 1965, BRIT HEART J, V27, P220	13	0	1	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1844	1850		10.1056/NEJMcps1301819	http://dx.doi.org/10.1056/NEJMcps1301819			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24195552				2022-12-28	WOS:000326607800014
J	Walmsley, SL; Antela, A; Clumeck, N; Duiculescu, D; Eberhard, A; Gutierrez, F; Hocqueloux, L; Maggiolo, F; Sandkovsky, U; Granier, C; Pappa, K; Wynne, B; Min, S; Nichols, G				Walmsley, Sharon L.; Antela, Antonio; Clumeck, Nathan; Duiculescu, Dan; Eberhard, Andrea; Gutierrez, Felix; Hocqueloux, Laurent; Maggiolo, Franco; Sandkovsky, Uriel; Granier, Catherine; Pappa, Keith; Wynne, Brian; Min, Sherene; Nichols, Garrett		SINGLE Investigators	Dolutegravir plus Abacavir-Lamivudine for the Treatment of HIV-1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIRETROVIRAL-NAIVE ADULTS; ONCE-DAILY DOLUTEGRAVIR; NON-INFERIORITY TRIAL; CO-FORMULATED ELVITEGRAVIR; DOUBLE-BLIND; INITIAL TREATMENT; RALTEGRAVIR; PHASE-3; EMTRICITABINE; EFAVIRENZ	BackgroundDolutegravir (S/GSK1349572), a once-daily, unboosted integrase inhibitor, was recently approved in the United States for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in combination with other antiretroviral agents. Dolutegravir, in combination with abacavir-lamivudine, may provide a simplified regimen. MethodsWe conducted a randomized, double-blind, phase 3 study involving adult participants who had not received previous therapy for HIV-1 infection and who had an HIV-1 RNA level of 1000 copies per milliliter or more. Participants were randomly assigned to dolutegravir at a dose of 50 mg plus abacavir-lamivudine once daily (DTG-ABC-3TC group) or combination therapy with efavirenz-tenofovir disoproxil fumarate (DF)-emtricitabine once daily (EFV-TDF-FTC group). The primary end point was the proportion of participants with an HIV-1 RNA level of less than 50 copies per milliliter at week 48. Secondary end points included the time to viral suppression, the change from baseline in CD4+ T-cell count, safety, and viral resistance. ResultsA total of 833 participants received at least one dose of study drug. At week 48, the proportion of participants with an HIV-1 RNA level of less than 50 copies per milliliter was significantly higher in the DTG-ABC-3TC group than in the EFV-TDF-FTC group (88% vs. 81%, P=0.003), thus meeting the criterion for superiority. The DTG-ABC-3TC group had a shorter median time to viral suppression than did the EFV-TDF-FTC group (28 vs. 84 days, P<0.001), as well as greater increases in CD4+ T-cell count (267 vs. 208 per cubic millimeter, P<0.001). The proportion of participants who discontinued therapy owing to adverse events was lower in the DTG-ABC-3TC group than in the EFV-TDF-FTC group (2% vs. 10%); rash and neuropsychiatric events (including abnormal dreams, anxiety, dizziness, and somnolence) were significantly more common in the EFV-TDF-FTC group, whereas insomnia was reported more frequently in the DTG-ABC-3TC group. No participants in the DTG-ABC-3TC group had detectable antiviral resistance; one tenofovir DF-associated mutation and four efavirenz-associated mutations were detected in participants with virologic failure in the EFV-TDF-FTC group. ConclusionsDolutegravir plus abacavir-lamivudine had a better safety profile and was more effective through 48 weeks than the regimen with efavirenz-tenofovir DF-emtricitabine. (Funded by ViiV Healthcare; SINGLE ClinicalTrials.gov number, NCT01263015.)	[Walmsley, Sharon L.] Univ Hlth Network, Toronto, ON, Canada; [Antela, Antonio] Hosp Clin Univ, Santiago De Compostela, Spain; [Gutierrez, Felix] Hosp Gen Elche, Alicante, Spain; [Gutierrez, Felix] Univ Miguel Hernandez, Alicante, Spain; [Clumeck, Nathan] Ctr Hosp Univ St Pierre, Brussels, Belgium; [Duiculescu, Dan] Dr Victor Babes Infect & Trop Dis Hosp, Bucharest, Romania; [Eberhard, Andrea] HIV Res & Clini Care Ctr, Med Versorgungszentrum Karlspl, Munich, Germany; [Hocqueloux, Laurent] Ctr Hosp Reg Orleans, Orleans, France; [Maggiolo, Franco] Osped Riuniti Bergamo, Antiviral Therapy Unit, I-24100 Bergamo, Italy; [Sandkovsky, Uriel] Univ Nebraska Med Ctr, Omaha, NE USA; [Granier, Catherine] GlaxoSmithKline, Stockley Pk, England; [Pappa, Keith; Wynne, Brian; Min, Sherene; Nichols, Garrett] GlaxoSmithKline, Res Triangle Pk, NC USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Complexo Hospitalario Universitario de Santiago de Compostela; Universidad Miguel Hernandez de Elche; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centre Hospitalier Regional d'Orleans; Ospedali Riuniti di Bergamo; University of Nebraska System; University of Nebraska Medical Center; GlaxoSmithKline; GlaxoSmithKline	Walmsley, SL (corresponding author), Toronto Gen Hosp, Eaton N Wing,13th Fl,Rm 214,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	sharon.walmsley@uhn.ca	Vandekerckhove, Linos/J-6420-2013; Soriano, Vicente/O-5730-2018; Streinu-Cercel, Adrian/M-5835-2017; Berenguer, Juan/A-1347-2009; Portilla, Joaquín/O-7609-2018; Rodero, Félix Gutiérrez/Q-7880-2018; Arribas, Jose R/A-1595-2015; Oteo, Jose A./AAB-3134-2020; Rugina, Sorin/U-5168-2019	Vandekerckhove, Linos/0000-0002-8600-1631; Soriano, Vicente/0000-0002-4624-5199; Streinu-Cercel, Adrian/0000-0001-6382-5067; Berenguer, Juan/0000-0001-8541-8200; Portilla, Joaquín/0000-0002-3676-9511; Rodero, Félix Gutiérrez/0000-0002-9485-6867; Oteo, Jose A./0000-0001-7080-6542; fox, Julie/0000-0002-0583-8019; Estrada, Vicente/0000-0002-7795-5986; Taylor, stephen/0000-0001-5496-6482; Marquez, Manuel/0000-0002-7901-6966; Walmsley, Sharon/0000-0002-3959-5692; OCAMPO HERMIDA, ANTONIO/0000-0002-3176-9758; Pasquau, Juan/0000-0001-9409-9205; Ribera, Esteban/0000-0002-3752-8808	ViiV Healthcare	ViiV Healthcare	Funded by ViiV Healthcare; SINGLE ClinicalTrials.gov number, NCT01263015.	Andreev E, 1999, J INTERN MED, V246, P247, DOI 10.1046/j.1365-2796.1999.00515.x; [Anonymous], 2012, ATR; [Anonymous], 2013, EUR AIDS CLIN SOC GU; [Anonymous], GUIDELINES USE ANTIR; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Division of AIDS, 2009, DIV AIDS TABL GRAD S; Dmitrienko A, 2008, BIOMETRICAL J, V50, P667, DOI 10.1002/bimj.200710464; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Hightower KE, 2011, ANTIMICROB AGENTS CH, V55, P4552, DOI 10.1128/AAC.00157-11; Hill A, 2008, AIDS, V22, P913, DOI 10.1097/QAD.0b013e3282f5556d; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Katlama C, 2003, HIV Med, V4, P79, DOI 10.1046/j.1468-1293.2003.00139.x; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Koteff J, 2013, BRIT J CLIN PHARMACO, V75, P990, DOI 10.1111/j.1365-2125.2012.04440.x; Lennox JL, 2009, LANCET, V374, P786; Lepist E, 2011, 51 INT C ANT AG CHEM; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Marc LG, 2012, AIDS CARE, V24, P1432, DOI 10.1080/09540121.2012.656567; Min S, 2010, ANTIMICROB AGENTS CH, V54, P254, DOI 10.1128/AAC.00842-09; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Nichols G, 2013, 7 INT AIDS SOC C HIV; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Rozenbaum W, 2001, ANTIVIR THER, V6, P135; Sato T., 1989, BIOMETRICS, V42, P311; Sax PE, 2012, LANCET, V380, P730; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Scourfield A, 2012, AIDS, V26, P1399, DOI 10.1097/QAD.0b013e328353b047; Smith F, 2011, DRUG INF J, V45, P291, DOI 10.1177/009286151104500309; Stellbrink HJ, 2013, AIDS, V27, P1771, DOI 10.1097/QAD.0b013e3283612419; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Wiens BL, 2005, J BIOPHARM STAT, V15, P929, DOI 10.1080/10543400500265660; World Medical Association, 2008, DECL HELS ETH PRINC	36	556	586	1	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1807	1818		10.1056/NEJMoa1215541	http://dx.doi.org/10.1056/NEJMoa1215541			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24195548	Green Published			2022-12-28	WOS:000326607800009
J	Wang, H; Goehring, A; Wang, KH; Penmatsa, A; Ressler, R; Gouaux, E				Wang, Hui; Goehring, April; Wang, Kevin H.; Penmatsa, Aravind; Ressler, Ryan; Gouaux, Eric			Structural basis for action by diverse antidepressants on biogenic amine transporters	NATURE			English	Article							HUMAN SEROTONIN TRANSPORTER; HIGH-AFFINITY RECOGNITION; BINDING-SITE; SELECTIVE RECOGNITION; BACTERIAL HOMOLOG; LEUT; NEUROTRANSMITTER; MECHANISM; CHLORIDE; DETERMINANTS	The biogenic amine transporters (BATs) regulate endogenous neurotransmitter concentrations and are targets for a broad range of therapeutic agents including selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs)(1,2). Because eukaryotic BATs are recalcitrant to crystallographic analysis, our understanding of the mechanism of these inhibitors and antidepressants is limited. LeuT is a bacterial homologue of BATs and has proven to be a valuable paradigm for understanding relationships between their structure and function(3). However, because only approximately 25% of the amino acid sequence of LeuT is in common with that of BATs, and as LeuT is a promiscuous amino acid transporter(4), it does not recapitulate the pharmacological properties of BATs. Indeed, SSRIs and TCAs bind in the extracellular vestibule of LeuT(5-7) and act as non-competitive inhibitors of transport(5). By contrast, multiple studies demonstrate that both TCAs and SSRIs are competitive inhibitors for eukaryotic BATs and bind to the primary binding pocket(8-16). Here we engineered LeuT to harbour human BAT-like pharmacology by mutating key residues around the primary binding pocket. The final LeuBAT mutant binds the SSRI sertraline with a binding constant of 18 nM and displays high-affinity binding to a range of SSRIs, SNRIs and a TCA. We determined 12 crystal structures of LeuBAT in complex with four classes of antidepressants. The chemically diverse inhibitors have a remarkably similar mode of binding in which they straddle transmembrane helix (TM) 3, wedge between TM3/TM8 and TM1/TM6, and lock the transporter in a sodium-and chloride-bound outward-facing open conformation. Together, these studies define common and simple principles for the action of SSRIs, SNRIs and TCAs on BATs.	[Wang, Hui; Goehring, April; Wang, Kevin H.; Penmatsa, Aravind; Ressler, Ryan; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Penmatsa, Aravind/AAQ-2688-2020; Gouaux, Eric/Y-4370-2019; Wang, Hui/C-4051-2012	Gouaux, Eric/0000-0002-8549-2360; Penmatsa, Aravind/0000-0001-9519-5055	National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Michel for help in binding experiments, D. Claxton for comments and L. Vaskalis for assistance with illustrations. We also thank the beamline staff at the Advanced Light Source (beamlines 8.2.1 and 5.0.2) and Advanced Photon Source (Argonne National Laboratory, beamlines 24-ID-C and 24-ID-E). H. W. also thanks the presenters at 2012 CCP4/APS summer school for useful lectures and tutorials. This work was supported by the National Institutes of Health. E. G. is an Investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen J, 2011, P NATL ACAD SCI USA, V108, P12137, DOI 10.1073/pnas.1103060108; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P815, DOI 10.1002/cmdc.200600242; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penmatsa A., 2013, NATURE          0915; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sorensen L, 2012, J BIOL CHEM, V287, P43694, DOI 10.1074/jbc.M112.342212; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Wang H, 2012, EMBO REP, V13, P861, DOI 10.1038/embor.2012.110; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	39	102	104	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					141	+		10.1038/nature12648	http://dx.doi.org/10.1038/nature12648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24121440	Green Accepted			2022-12-28	WOS:000326585600048
J	Livingston, G; Barber, J; Rapaport, P; Knapp, M; Griffin, M; King, D; Livingston, D; Mummery, C; Walker, Z; Hoe, J; Sampson, EL; Cooper, C				Livingston, Gill; Barber, Julie; Rapaport, Penny; Knapp, Martin; Griffin, Mark; King, Derek; Livingston, Debbie; Mummery, Cath; Walker, Zuzana; Hoe, Juanita; Sampson, Elizabeth L.; Cooper, Claudia			Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NURSING-HOME PLACEMENT; ALZHEIMERS-DISEASE; DEPRESSION SCALE; HOSPITAL ANXIETY; PSYCHOSOCIAL INTERVENTION; BRIEF COPE; LASER-AD; CAREGIVERS; PEOPLE; VALIDITY	Objective To assess whether a manual based coping strategy compared with treatment as usual reduces depression and anxiety symptoms in carers of family members with dementia. Design Randomised, parallel group, superiority trial. Setting Three mental health community services and one neurological outpatient dementia service in London and Essex, UK. Participants 260 carers of family members with dementia. Intervention A manual based coping intervention comprising eight sessions and delivered by supervised psychology graduates to carers of family members with dementia. The programme consisted of psychoeducation about dementia, carers' stress, and where to get emotional support; understanding behaviours of the family member being cared for, and behavioural management techniques; changing unhelpful thoughts; promoting acceptance; assertive communication; relaxation; planning for the future; increasing pleasant activities; and maintaining skills learnt. Carers practised these techniques at home, using the manual and relaxation CDs. Main outcome measures Affective symptoms (hospital anxiety and depression total score) at four and eight months. Secondary outcomes were depression and anxiety caseness on the hospital anxiety and depression scale; quality of life of both the carer (health status questionnaire, mental health) and the recipient of care (quality of life-Alzheimer's disease); and potentially abusive behaviour by the carer towards the recipient of care (modified conflict tactics scale). Results 260 carers were recruited; 173 were randomised to the intervention and 87 to treatment as usual. Mean total scores on the hospital anxiety and depression scale were lower in the intervention group than in the treatment as usual group over the eight month evaluation period: adjusted difference in means -1.80 points (95% confidence interval -3.29 to -0.31; P=0.02) and absolute difference in means -2.0 points. Carers in the intervention group were less likely to have case level depression (odds ratio 0.24, 95% confidence interval 0.07 to 0.76) and there was a non-significant trend towards reduced case level anxiety (0.30, 0.08 to 1.05). Carers' quality of life was higher in the intervention group (difference in means 4.09, 95% confidence interval 0.34 to 7.83) but not for the recipient of care (difference in means 0.59, -0.72 to 1.89). Carers in the intervention group reported less abusive behaviour towards the recipient of care compared with those in the treatment as usual group (odds ratio 0.47, 95% confidence interval 0.18 to 1.23), although this was not significant. Conclusions A manual based coping strategy was effective in reducing affective symptoms and case level depression in carers of family members with dementia. The carers' quality of life also improved.	[Livingston, Gill; Livingston, Debbie; Walker, Zuzana; Hoe, Juanita; Sampson, Elizabeth L.; Cooper, Claudia] UCL, London W1W 7EJ, England; [Barber, Julie; Griffin, Mark] UCL, Stat Sci & PRIMENT Clin Trials Unit, London W1W 7EJ, England; [Rapaport, Penny] Camden & Islington NHS Fdn Trust, London, England; [Knapp, Martin] London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London, England; [King, Derek] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Mummery, Cath] UCL, Dementia Res Unit, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; London School Economics & Political Science; University of London; King's College London; University of London; University College London	Livingston, G (corresponding author), UCL, London W1W 7EJ, England.	g.livingston@ucl.ac.uk	Cooper, Claudia A/C-1556-2008; Hoe, Juanita/C-5641-2008; Livingston, G/C-7081-2008; Sampson, Elizabeth L/B-8647-2009; Hoe, Juanita/ABA-6310-2020; Walker, Zuzana/B-8339-2009	Cooper, Claudia A/0000-0002-2777-7616; Hoe, Juanita/0000-0003-4647-8950; Sampson, Elizabeth L/0000-0001-8929-7362; Hoe, Juanita/0000-0003-4647-8950; Walker, Zuzana/0000-0001-7346-8200; Rapaport, Penny/0000-0003-0479-6950; Livingston, Gill/0000-0001-6741-5516; Knapp, Martin/0000-0003-1427-0215; Barber, Julie/0000-0001-5762-762X	National Institute for Health Research Health Technology Assessment (HTA) programme [08/14/06]; University College London; National Institute for Health Research [08/14/06, 08/14/99] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment (HTA) programme; University College London(General Electric); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research Health Technology Assessment (HTA) programme (project No 08/14/06) and will be published in full in Health Technology Assessment. Further information on the project is available at www.nets.nihr.ac.uk/projects/hta/081406. The authors analysed results and prepared this manuscript independently of the funding body. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, National Institute for Health Research, National Health Service, or the Department of Health. The study was sponsored by University College London. Neither funders nor sponsors had a role in the study design and the collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication. The researchers were independent from funders and sponsors. All researchers could access all the data.	Andren S, 2008, INT PSYCHOGERIATR, V20, P1177, DOI 10.1017/S1041610208007503; [Anonymous], 2006, DEPR REP NEW DEAL DE; Barry TL, 2007, J NURS MEAS, V15, P24, DOI 10.1891/106137407780851778; Beach SR, 2005, J AM GERIATR SOC, V53, P255, DOI 10.1111/j.1532-5415.2005.53111.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BRODATY H, 1989, BMJ-BRIT MED J, V299, P1375, DOI 10.1136/bmj.299.6712.1375; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Charlesworth G, 2007, BMJ-BRIT MED J, V336, P1295; Coon DW, 2003, GERONTOLOGIST, V43, P678, DOI 10.1093/geront/43.5.678; Cooper C, 2010, J AFFECT DISORDERS, V121, P136, DOI 10.1016/j.jad.2009.05.001; Cooper C, 2008, INT J GERIATR PSYCH, V23, P929, DOI 10.1002/gps.2007; Cooper C, 2007, INT J GERIATR PSYCH, V22, P181, DOI 10.1002/gps.1656; Cooper C, 2007, INT PSYCHOGERIATR, V19, P175, DOI 10.1017/S1041610206004297; Cooper C, 2010, BRIT J PSYCHIAT, V196, P480, DOI 10.1192/bjp.bp.109.071811; Cooper C, 2008, J NERV MENT DIS, V196, P838, DOI 10.1097/NMD.0b013e31818b504c; Cooper C, 2009, AM J GERIAT PSYCHIAT, V17, P826, DOI 10.1097/JGP.0b013e3181b0fa2e; Cooper C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b155; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Gallagher-Thompson D., 2002, COPING CAREGIVING RE; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Knapp M., 2007, DEMENTIA UK REPORT A; Knapp M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6342; Knapp M, 2013, INT J GERIATR PSYCH, V28, P551, DOI 10.1002/gps.3864; Livingston G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4184; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; National Institute for Health and Care Excellence, 2006, DEM GUID CG42; Nichols LO, 2008, J AM GERIATR SOC, V56, P413, DOI 10.1111/j.1532-5415.2007.01569.x; Pettit T, 2001, INT J GERIATR PSYCH, V16, P1061, DOI 10.1002/gps.479; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Selwood A, 2007, J AFFECT DISORDERS, V101, P75, DOI 10.1016/j.jad.2006.10.025; Spijker A, 2008, J AM GERIATR SOC, V56, P1116, DOI 10.1111/j.1532-5415.2008.01705.x; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Waldorff FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4693; Walwyn R, 2010, STAT METHODS MED RES, V19, P291, DOI 10.1177/0962280209105017; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	124	128	0	58	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2013	347								F6276	10.1136/bmj.f6276	http://dx.doi.org/10.1136/bmj.f6276			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243CM	24162942	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000326294200005
J	Malhotra, A				Malhotra, Aseem			Saturated fat is not the major issue	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE; LOW-CHOLESTEROL; HEART-DISEASE; RISK; METAANALYSIS; POTASSIUM; CALORIE; STROKE		Croydon Univ Hosp, London, England	Croydon University Hospital	Malhotra, A (corresponding author), Croydon Univ Hosp, London, England.	aseem_malhotra@hotmail.com						Alonso A, 2010, HYPERTENSION, V55, P776, DOI 10.1161/HYPERTENSIONAHA.109.143461; Bae JM, 2012, J KOREAN MED SCI, V27, P58, DOI 10.3346/jkms.2012.27.1.58; British Heart Foundation, 2011, TRENDS COR HEART DIS; Champeau R., 2009, UCLA NEWSROOM; Committee on Medical Aspects of Food Policy, 1984, DIET CARD DIS REP PA; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Feinman RD, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-9; Geleijnse JM, 2003, J HUM HYPERTENS, V17, P471, DOI 10.1038/sj.jhh.1001575; KEKWICK A, 1956, LANCET, V271, P155; KEYS A, 1970, CIRCULATION, V41, pI1; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Musunuru K, 2010, LIPIDS, V45, P907, DOI 10.1007/s11745-010-3408-1; Nago N, 2011, J EPIDEMIOL, V21, P67, DOI 10.2188/jea.JE20100065; Newman D., STATINS GIVEN 5 YEAR; Sacks FM, 1998, HYPERTENSION, V31, P131, DOI 10.1161/01.HYP.31.1.131; SIMES RJ, 1994, AUST NZ J MED, V24, P113, DOI 10.1111/j.1445-5994.1994.tb04446.x; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Wallace SK, 2009, CURR ATHEROSCLER REP, V11, P423, DOI 10.1007/s11883-009-0064-0; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	22	86	88	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6340	10.1136/bmj.f6340	http://dx.doi.org/10.1136/bmj.f6340			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CI	24149521	Green Published			2022-12-28	WOS:000326293800023
J	Bettigole, C				Bettigole, Cheryl			The Thousand-Dollar Pap Smear	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bettigole, Cheryl] CompleteCare Hlth Network, Bridgeton, NJ USA; [Bettigole, Cheryl] Natl Phys Alliance, Washington, DC USA		Bettigole, C (corresponding author), CompleteCare Hlth Network, Bridgeton, NJ USA.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1486	1487		10.1056/NEJMp1307295	http://dx.doi.org/10.1056/NEJMp1307295			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	267MJ	24131176				2022-12-28	WOS:000328101700004
J	Beckman, JA				Beckman, Joshua A.			Management of Asymptomatic Internal Carotid Artery Stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; CARDIOVASCULAR-DISEASE; STROKE-ASSOCIATION; RANDOMIZED-TRIAL; BLOOD-PRESSURE; ENDARTERECTOMY; SURGERY; RISK	Optimal management of patients with asymptomatic carotid artery stenosis remains unclear. Although 2 high-quality randomized clinical trials demonstrated reductions in ispsilateral stroke rates in patients without symptoms after carotid endarterectomy, medical therapy of asymptomatic carotid artery stenosis has reduced rates of stroke to approximately 1% per year, raising questions about the generalizability of these previous trials to current medical practice. However, reductions in adverse events after revascularization can make revascularization more attractive. The emergence of percutaneous revascularization for carotid artery stenosis has raised further questions about optimal management of asymptomatic carotid artery stenosis. This Grand Rounds summarizes the factors to consider when counseling patients and making clinical decisions regarding medical therapy and revascularization for patients with asymptomatic carotid artery stenosis. This information should provide clinicians with the knowledge base to counsel patients about the risks and benefits of treatment options.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Beckman, JA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	jbeckman@partners.org	Beckman, Joshua/A-7537-2016	Beckman, Joshua/0000-0001-8332-8439	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Beckman is a Board Member of Vascular Interventional Advances, receives grant funding from Bristol-Myers Squibb, and consults for Novartis, Ferring, Merck, Boston Scientific, and AstraZeneca.	Abbott AL, 2012, EUR J VASC ENDOVASC, V43, P247, DOI 10.1016/j.ejvs.2011.12.006; Abbott AL, 2009, STROKE, V40, pE573, DOI 10.1161/STROKEAHA.109.556068; [Anonymous], 1989, GUIDE CLIN PREVENTIV; Bakhai A, 2004, PHARMACOECONOMICS, V22, P11, DOI 10.2165/00019053-200422004-00004; Bosch J, 2002, BMJ-BRIT MED J, V324, P699, DOI 10.1136/bmj.324.7339.699; Brott A, 2011, AM J MENS HEALTH, V5, P528, DOI 10.1177/1557988311421214; Brott TG, 2011, CIRCULATION, V124, pE54, DOI [10.1161/CIR.0b013e31820d8c98, 10.1161/CIR.0b0113e31820d8c98]; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Brown MM, 2001, LANCET, V357, P1729; CHAMBERS BR, 1986, NEW ENGL J MED, V315, P860, DOI 10.1056/NEJM198610023151404; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2004, LANCET, V363, P757; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; COTE R, 1995, ANN INTERN MED, V123, P649, DOI 10.7326/0003-4819-123-9-199511010-00002; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Diethrich EB, 1996, J ENDOVASC SURG, V3, P42, DOI 10.1583/1074-6218(1996)003<0042:SITCAI>2.0.CO;2; FINEEDELSTEIN JS, 1994, NEUROLOGY, V44, P1046, DOI 10.1212/WNL.44.6.1046; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Goldstein LB, 2006, CIRCULATION, V113, pE873, DOI 10.1161/01.STR.0000223048.70103.F1; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Gray WA, 2011, JACC-CARDIOVASC INTE, V4, P235, DOI 10.1016/j.jcin.2010.10.009; Halliday A, 2004, LANCET, V363, P1491; Hsia DC, 1998, STROKE, V29, P346, DOI 10.1161/01.STR.29.2.346; Lal BK, 2012, LANCET NEUROL, V11, P755, DOI 10.1016/S1474-4422(12)70159-X; Liapis CD, 2001, STROKE, V32, P2782, DOI 10.1161/hs1201.099797; Longmore RB, 2011, CIRC-CARDIOVASC INTE, V4, P88, DOI 10.1161/CIRCINTERVENTIONS.110.958843; Marquardt L, 2010, STROKE, V41, pE11, DOI 10.1161/STROKEAHA.109.561837; Myerson M, 2009, CIRCULATION, V119, P503, DOI 10.1161/CIRCULATIONAHA.107.693879; Naylor AR, 2009, EUR J VASC ENDOVASC, V37, P625, DOI 10.1016/j.ejvs.2009.01.026; Neal B, 2000, LANCET, V356, P1955; NORRIS JW, 1990, J NEUROL NEUROSUR PS, V53, P235, DOI 10.1136/jnnp.53.3.235; OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752; Palm F, 2013, EUR J EPIDEMIOL, V28, P373, DOI 10.1007/s10654-013-9772-4; Pickett CA, 2008, LANCET, V371, P1587, DOI 10.1016/S0140-6736(08)60691-1; Raman G, 2013, ANN INTERN MED, V158, P676, DOI 10.7326/0003-4819-158-9-201305070-00007; Ricotta JJ, 2011, J VASC SURG, V54, P832, DOI 10.1016/j.jvs.2011.07.004; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rockman CB, 2013, J VASC SURG, V57, P327, DOI 10.1016/j.jvs.2012.08.118; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Rothwell PM, 2004, STROKE, V35, P2425, DOI 10.1161/01.STR.0000141706.50170.a7; Rudarakanchana N, 2009, EUR J VASC ENDOVASC, V38, P239, DOI 10.1016/j.ejvs.2009.05.010; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212; Skerritt MR, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-17; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wennberg DE, 1998, JAMA-J AM MED ASSOC, V279, P1278, DOI 10.1001/jama.279.16.1278; White RA, 2005, J VASC SURG, V42, P213, DOI 10.1016/j.jvs.2005.04.023; WIEBERS DO, 1992, MAYO CLIN PROC, V67, P513; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Yadav JS, 1997, CIRCULATION, V95, P376, DOI 10.1161/01.cir.95.2.376; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	52	13	15	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1612	1618		10.1001/jama.2013.280039	http://dx.doi.org/10.1001/jama.2013.280039			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129465				2022-12-28	WOS:000325624800024
J	Raftery, J				Raftery, James			Value based pricing: can it work?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCHEME		Univ Southampton, Southampton SO16 7NS, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Chilworth Sci Pk, Southampton SO16 7NS, Hants, England.	raftery@soton.ac.uk						[Anonymous], 2007, PHARM PRIC REG SCHEM; Collins M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1363; Department of Health, 2010, NEW VAL BAS APPR PRI; Department of Health, 2015, NHS CONST; Department of Health, 1996, PPRS 1 REP PARL; Department of Health, 2013, HEALTH; Health and Sport Committee, 2013, 8 HLTH SPORT COMM; HM Government, 2010, COAL GOV OUR PROGR G; Illman J, 2013, HLTH SERVICE J; National Institute for Health and Care Excellence (NICE), GUID METH TECHN APPR; National institute for Health and Clinical Excellence-NICE, 2013, LIST TECHN APPR PAT; NHS Information Centre, PRESCR DISP COMM ENG; NICE, NICE CANC DRUGS FACT; OECD, 2012, BREAKD GROSS DOM PRO; Porter M.E., 2006, REDEFINING HLTH CARE; Raftery J., 2012, QALYS VALUE BASED PR; Raftery J., 2013, VALUE BASED PRICING; Raftery J., 2013, MOVING VALUE BASED P; Raftery J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1672; Sussex J, 2013, PHARMACOECONOMICS, V31, P1, DOI 10.1007/s40273-012-0001-x	20	16	17	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2013	347								f5941	10.1136/bmj.f5941	http://dx.doi.org/10.1136/bmj.f5941			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OP	24124158				2022-12-28	WOS:000325729300002
J	Isidean, SD; Franco, EL				Isidean, Sandra D.; Franco, Eduardo L.			Embracing a new era in cervical cancer screening	LANCET			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; TRIAL		[Franco, Eduardo L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada	McGill University; McGill University	Franco, EL (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada.	eduardo.franco@mcgill.ca	Franco, Eduardo/C-6445-2014	Franco, Eduardo/0000-0002-4409-8084				Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Dickinson J, 2013, CAN MED ASSOC J, V185, P35, DOI 10.1503/cmaj.121505; Franco EL, 2009, ARCH MED RES, V40, P478, DOI 10.1016/j.arcmed.2009.06.003; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516	11	13	14	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					493	494		10.1016/S0140-6736(13)62028-0	http://dx.doi.org/10.1016/S0140-6736(13)62028-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA5KH	24192251				2022-12-28	WOS:000331136400007
J	Prasad, VK				Prasad, Vinod K.			Stem-cell transplantation for chronic granulomatous disease	LANCET			English	Editorial Material							CORD BLOOD TRANSPLANTATION; EXCELLENT SURVIVAL; CHILDREN		Duke Univ, Med Ctr, Durham, NC 27705 USA	Duke University	Prasad, VK (corresponding author), Duke Univ, Med Ctr, Durham, NC 27705 USA.	vinod.prasad@duke.edu						Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; Bhatia S, 2011, EXPERT REV HEMATOL, V4, P437, DOI [10.1586/EHM.11.39, 10.1586/ehm.11.39]; Bradley MB, 2007, BONE MARROW TRANSPL, V40, P621, DOI 10.1038/sj.bmt.1705785; Confer D, 2008, BONE MARROW TRANSPL, V42, pS3, DOI 10.1038/bmt.2008.102; Gungor T, 2014, LANCET, V383, P436, DOI [10.1016/s0140-6736(13)62069-3, 10.1016/S0140-6736(13)62069-3]; Horwitz ME, 2001, NEW ENGL J MED, V344, P881, DOI 10.1056/NEJM200103223441203; Iannone R, 2003, BIOL BLOOD MARROW TR, V9, P519, DOI 10.1016/S1083-8791(03)00192-7; Kamani NR, 2012, BIOL BLOOD MARROW TR, V18, P1265, DOI 10.1016/j.bbmt.2012.01.019; Martinez CA, 2012, J ALLERGY CLIN IMMUN, V129, P176, DOI 10.1016/j.jaci.2011.10.005; Tewari P, 2012, BIOL BLOOD MARROW TR, V18, P1368, DOI 10.1016/j.bbmt.2012.02.002; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003	11	3	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					390	392		10.1016/S0140-6736(13)62144-3	http://dx.doi.org/10.1016/S0140-6736(13)62144-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303KS	24161823				2022-12-28	WOS:000330673700008
J	Gafni, O; Weinberger, L; Mansour, AA; Manor, YS; Chomsky, E; Ben-Yosef, D; Kalma, Y; Viukov, S; Maza, I; Zviran, A; Rais, Y; Shipony, Z; Mukamel, Z; Krupalnik, V; Zerbib, M; Geula, S; Caspi, I; Schneir, D; Shwartz, T; Gilad, S; Amann-Zalcenstein, D; Benjamin, S; Amit, I; Tanay, A; Massarwa, R; Novershtern, N; Hanna, JH				Gafni, Ohad; Weinberger, Leehee; Mansour, Abed AlFatah; Manor, Yair S.; Chomsky, Elad; Ben-Yosef, Dalit; Kalma, Yael; Viukov, Sergey; Maza, Itay; Zviran, Asaf; Rais, Yoach; Shipony, Zohar; Mukamel, Zohar; Krupalnik, Vladislav; Zerbib, Mirie; Geula, Shay; Caspi, Inbal; Schneir, Dan; Shwartz, Tamar; Gilad, Shlomit; Amann-Zalcenstein, Daniela; Benjamin, Sima; Amit, Ido; Tanay, Amos; Massarwa, Rada; Novershtern, Noa; Hanna, Jacob H.			Derivation of novel human ground state naive pluripotent stem cells	NATURE			English	Article							DEMETHYLATION; INACTIVATION; INHIBITION	Mouse embryonic stem (ES) cells are isolated from the inner cell mass of blastocysts, and can be preserved in vitro in a naive inner-cell-mass-like configuration by providing exogenous stimulation with leukaemia inhibitory factor (LIF) and small molecule inhibition of ERK1/ERK2 and GSK3 beta signalling (termed 2i/LIF conditions)(1,2). Hallmarks of naive pluripotency include driving Oct4 (also known as Pou5f1) transcription by its distal enhancer, retaining a pre-inactivation Xchromosome state, and global reduction in DNA methylation and in H3K27me3 repressive chromatin mark deposition on developmental regulatory gene promoters(3). Upon withdrawal of 2i/LIF, naive mouse ES cells can drift towards a primed pluripotent state resembling that of the post-implantation epiblast(4). Although human ES cells share several molecular features with naive mouse ES cells(5), they also share a variety of epigenetic properties with primed murine epiblast stemcells (EpiSCs)(6,7). These include predominant use of the proximal enhancer element to maintain OCT4 expression, pronounced tendency for X chromosome inactivation in most female human ES cells, increase in DNA methylation and prominent deposition of H3K27me3 and bivalent domain acquisition on lineage regulatory genes(7). The feasibility of establishing human ground state naive pluripotency in vitro with equivalent molecular and functional features to those characterized in mouse ES cells remains to be defined(1). Here we establish defined conditions that facilitate the derivation of genetically unmodified human naive pluripotent stem cells from already established primed human ES cells, from somatic cells through induced pluripotent stem(iPS) cell reprogramming or directly from blastocysts. The novel naive pluripotent cells validated herein retain molecular characteristics and functional properties that are highly similar to mouse naive ES cells, and distinct from conventional primed human pluripotent cells. This includes competence in the generation of cross-species chimaeric mouse embryos that underwent organogenesis following microinjection of human naive iPS cells into mouse morulas. Collectively, our findings establish new avenues for regenerative medicine, patient-specific iPS cell disease modelling and the study of early human development in vitro and in vivo.	[Gafni, Ohad; Weinberger, Leehee; Mansour, Abed AlFatah; Manor, Yair S.; Chomsky, Elad; Viukov, Sergey; Maza, Itay; Zviran, Asaf; Rais, Yoach; Krupalnik, Vladislav; Zerbib, Mirie; Geula, Shay; Caspi, Inbal; Schneir, Dan; Massarwa, Rada; Novershtern, Noa; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Chomsky, Elad; Shipony, Zohar; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Chomsky, Elad; Shipony, Zohar; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Ben-Yosef, Dalit; Kalma, Yael; Shwartz, Tamar] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Lis Matern Hosp, Wolfe PGD Stem Cell Lab,Racine IVF Unit, IL-69978 Tel Aviv, Israel; [Ben-Yosef, Dalit] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Gilad, Shlomit; Amann-Zalcenstein, Daniela; Benjamin, Sima] Weizmann Inst Sci, INCPM, IL-76100 Rehovot, Israel; [Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Weizmann Institute of Science	Hanna, JH (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	rada.massarwa@weizmann.ac.il; noa.novershtern@weizmann.ac.il; jacob.hanna@weizmann.ac.il	Hanna, Jacob/K-1339-2012; Geula, Shay Yosef/Z-3789-2019	Hanna, Jacob/0000-0003-2042-9974; Geula, Shay Yosef/0000-0001-8111-4410; Novershtern, Noa/0000-0002-2244-6877; Mansour, Abed AlFatah/0000-0001-9025-6998	Ilana and Pascal Mantoux; European Research Council [StG-2011-281906]; Leona M. and Harry B. Helmsley Charitable Trust; BIRAX (Britain Israel Research and Academic Exchange Partnership); Sir Charles Clore Research Prize; Israel Science Foundation (Bikura, ICORE (Israeli Centre of Research Excellence) and Regular research program); Israel Cancer Research Foundation; ERANET E-Rare disease program; Benoziyo Endowment fund; Fritz Thyssen Stiftung; EMBO; Alon Foundation scholar award; ICRF; Weizmann Dean fellowship award	Ilana and Pascal Mantoux; European Research Council(European Research Council (ERC)European Commission); Leona M. and Harry B. Helmsley Charitable Trust; BIRAX (Britain Israel Research and Academic Exchange Partnership); Sir Charles Clore Research Prize; Israel Science Foundation (Bikura, ICORE (Israeli Centre of Research Excellence) and Regular research program); Israel Cancer Research Foundation; ERANET E-Rare disease program; Benoziyo Endowment fund; Fritz Thyssen Stiftung; EMBO(European Molecular Biology Organization (EMBO)); Alon Foundation scholar award; ICRF; Weizmann Dean fellowship award	J.H.H. is supported by a gift from Ilana and Pascal Mantoux, and research grants from the European Research Council starting investigator grant (StG-2011-281906, for funding iPS cell experiments only), the Leona M. and Harry B. Helmsley Charitable Trust, the BIRAX (Britain Israel Research and Academic Exchange Partnership), The Sir Charles Clore Research Prize, the Israel Science Foundation (Bikura, ICORE (Israeli Centre of Research Excellence) and Regular research program), the Israel Cancer Research Foundation, the ERANET E-Rare disease program, the Benoziyo Endowment fund, Fritz Thyssen Stiftung (used for human iPS cell experiments only), EMBO young investigator program, the Alon Foundation scholar award, a grant from E.A. and R. Drake, postdoctoral fellowships from ICRF and the Weizmann Dean fellowship award for A. A. M. We thank the embryologists of the Racine In Vitro Fertilization Laboratory at the Lis Maternity Hospital (A. Carmon, T. Cohen and N. M. Raz) for their skilful assistance. We thank the Weizmann Institute management for providing financial and infrastructural support.	Ben-Yosef D, 2012, STEM CELLS DEV, V21, P363, DOI 10.1089/scd.2011.0102; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chappell J, 2013, GENE DEV, V27, P725, DOI 10.1101/gad.211300.112; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Massarwa R, 2013, DEVELOPMENT, V140, P226, DOI 10.1242/dev.085001; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Pietrobono R, 2002, NUCLEIC ACIDS RES, V30, P3278, DOI 10.1093/nar/gkf434; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rajendran G, 2013, J BIOL CHEM, V288, P24351, DOI 10.1074/jbc.M113.455725; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	29	708	755	6	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					282	+		10.1038/nature12745	http://dx.doi.org/10.1038/nature12745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24172903				2022-12-28	WOS:000328121500037
J	Naumova, N; Imakaev, M; Fudenberg, G; Zhan, Y; Lajoie, BR; Mirny, LA; Dekker, J				Naumova, Natalia; Imakaev, Maxim; Fudenberg, Geoffrey; Zhan, Ye; Lajoie, Bryan R.; Mirny, Leonid A.; Dekker, Job			Organization of the Mitotic Chromosome	SCIENCE			English	Article							METAPHASE CHROMOSOMES; NUCLEAR-ORGANIZATION; CHROMATIN-STRUCTURE; TOPOISOMERASE-II; GENE-REGULATION; MOUSE GENOME; MODEL; CONDENSATION; CONFORMATION; LANDSCAPE	Mitotic chromosomes are among the most recognizable structures in the cell, yet for over a century their internal organization remains largely unsolved. We applied chromosome conformation capture methods, 5C and Hi-C, across the cell cycle and revealed two distinct three-dimensional folding states of the human genome. We show that the highly compartmentalized and cell type-specific organization described previously for nonsynchronous cells is restricted to interphase. In metaphase, we identified a homogenous folding state that is locus-independent, common to all chromosomes, and consistent among cell types, suggesting a general principle of metaphase chromosome organization. Using polymer simulations, we found that metaphase Hi-C data are inconsistent with classic hierarchical models and are instead best described by a linearly organized longitudinally compressed array of consecutive chromatin loops.	[Naumova, Natalia; Zhan, Ye; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, Worcester, MA 01605 USA; [Imakaev, Maxim; Fudenberg, Geoffrey; Mirny, Leonid A.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Imakaev, Maxim; Fudenberg, Geoffrey; Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Fudenberg, Geoffrey] Harvard Univ, Program Biophys, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Mirny, LA (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leonid@mit.edu; job.dekker@umassmed.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410; Imakaev, Maxim/0000-0002-5320-2728; Fudenberg, Geoffrey/0000-0001-5905-6517	National Cancer Institute (Physical Sciences-Oncology Center at MIT) [U54CA143874]; National Human Genome Research Institute [HG003143]; Human Frontier Science Program; W. M. Keck Foundation; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Cancer Institute (Physical Sciences-Oncology Center at MIT); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Human Frontier Science Program(Human Frontier Science Program); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	All data will be made publicly available through the Gene Expression Omnibus. This work was supported by grants from the National Cancer Institute (Physical Sciences-Oncology Center at MIT U54CA143874 to L.A.M.) and the National Human Genome Research Institute (HG003143 to J.D.), the Human Frontier Science Program (to J.D.), and a W. M. Keck Foundation distinguished young scholar in medical research grant (to J.D.). We thank J. A. Stamatoyannopoulos and R. Humbert for designing part of the 5C primers; C. Smith and A. Hawkins for technical help; J. Benanti for providing HFF1 cell stock and discussion; M. Walhout, Dekker lab, and Mirny lab members for discussions; and the UMMS deep sequencing core for sequencing 5C and Hi-C libraries. The data are available at ArrayExpress database www.ebi.ac.uk/arrayexpress, accession no. E-MTAB-1948. Information about Gene Expression Omnibus accession nos. can be found in the supplementary materials. Data visualizations can also be found at http://hic.umassmed.edu and http://mirnylab.mit.edu.	ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; BAK AL, 1977, P NATL ACAD SCI USA, V74, P1595, DOI 10.1073/pnas.74.4.1595; BELMONT AS, 1987, J CELL BIOL, V105, P77, DOI 10.1083/jcb.105.1.77; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Deng WL, 2010, CURR OPIN GENET DEV, V20, P548, DOI 10.1016/j.gde.2010.06.007; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; DUPRAW EJ, 1966, NATURE, V209, P577, DOI 10.1038/209577a0; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; Flemming W, 1878, SCHRIFTEN NATURWISSE, V3, P23; Follmer NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003135; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; Fussner E, 2012, EMBO REP, V13, P992, DOI 10.1038/embor.2012.139; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; JACKSON DA, 1990, EMBO J, V9, P567, DOI 10.1002/j.1460-2075.1990.tb08144.x; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Konig P, 2007, CHROMOSOMA, V116, P349, DOI 10.1007/s00412-007-0101-0; Li G, 1998, J CELL BIOL, V140, P975, DOI 10.1083/jcb.140.5.975; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lua R, 2004, POLYMER, V45, P717, DOI 10.1016/j.polymer.2003.10.073; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maeshima K, 2010, COLD SH Q B, V75, P439, DOI 10.1101/sqb.2010.75.034; Maeshima K, 2008, J BIOCHEM, V143, P145, DOI 10.1093/jb/mvm214; Markaki Y, 2010, COLD SH Q B, V75, P475, DOI 10.1101/sqb.2010.75.042; Marko JF, 1997, MOL BIOL CELL, V8, P2217, DOI 10.1091/mbc.8.11.2217; Marko JF, 2008, CHROMOSOME RES, V16, P469, DOI 10.1007/s10577-008-1233-7; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Rosa A, 2010, BIOPHYS J, V98, P2410, DOI 10.1016/j.bpj.2010.01.054; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; SEDAT J, 1977, COLD SPRING HARB SYM, V42, P331, DOI 10.1101/SQB.1978.042.01.035; SIKORAV JL, 1994, BIOPHYS J, V66, P827, DOI 10.1016/S0006-3495(94)80859-8; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Strukov YG, 2003, J CELL BIOL, V162, P23, DOI 10.1083/jcb.200303098; Strukov YG, 2009, BIOPHYS J, V96, P1617, DOI 10.1016/j.bpj.2008.10.051; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029225; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	50	578	588	4	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					948	953		10.1126/science.1236083	http://dx.doi.org/10.1126/science.1236083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24200812	Green Accepted, Green Published			2022-12-28	WOS:000327223500035
J	Asch, DA; Nicholson, S; Vujicic, M				Asch, David A.; Nicholson, Sean; Vujicic, Marko			Are We in a Medical Education Bubble Market?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Debt-to-income ratios for new physicians reveal the connection between what physicians can charge patients and what medical schools can charge students. If we aim to reduce the costs of health care, we need to reduce the costs of medical education. In November 1636, the prices of tulip bulbs in the Dutch market rose rapidly from their normal level to the point where a single bulb might sell for 10 times the annual earnings of a typical worker. Just as quickly, in May 1637, tulip-bulb prices returned to their previous values. The causes of this dramatic rise and fall remain in dispute. The event occurred during the Dutch Golden Age, when stock exchanges, central banking, and many of the fundamental structures that govern contemporary capital markets and the approaches deployed by MBAs today were developed. One modern economic analysis suggests that ...	[Asch, David A.] Univ Penn, Ctr Hlth Equ Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Asch, David A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Asch, David A.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Nicholson, Sean] Cornell Univ, Ithaca, NY USA; [Nicholson, Sean] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Vujicic, Marko] Amer Dent Assoc, Chicago, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; Cornell University; National Bureau of Economic Research	Asch, DA (corresponding author), Univ Penn, Ctr Hlth Equ Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.			Asch, David/0000-0002-7970-286X				Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P1143, DOI 10.1001/jama.2012.292; Isherwood Charles, 2013, NEW YORK TIMES; Seabury SA, 2012, JAMA-J AM MED ASSOC, V308, P2083, DOI 10.1001/jama.2012.14552; Thompson EA, 2007, PUBLIC CHOICE, V130, P99, DOI 10.1007/s11127-006-9074-4; Vujicic M, 2012, J AM DENT ASSOC, V143, P452, DOI 10.14219/jada.archive.2012.0204	5	46	46	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					1973	1975		10.1056/NEJMp1310778	http://dx.doi.org/10.1056/NEJMp1310778			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254KE	24171508				2022-12-28	WOS:000327163000002
J	Newey, PJ; Gorvin, CM; Cleland, SJ; Willberg, CB; Bridge, M; Azharuddin, M; Drummond, RS; van der Merwe, PA; Klenerman, P; Bountra, C; Thakker, RV				Newey, Paul J.; Gorvin, Caroline M.; Cleland, Stephen J.; Willberg, Christian B.; Bridge, Marcus; Azharuddin, Mohammed; Drummond, Russell S.; van der Merwe, P. Anton; Klenerman, Paul; Bountra, Chas; Thakker, Rajesh V.			Mutant Prolactin Receptor and Familial Hyperprolactinemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MECHANISMS; MUTATION; WOMEN; MICE	Hyperprolactinemia that is not associated with gestation or the puerperium is usually due to tumors in the anterior pituitary gland and occurs occasionally in hereditary multiple endocrine neoplasia syndromes. Here, we report data from three sisters with hyperprolactinemia, two of whom presented with oligomenorrhea and one with infertility. These symptoms were not associated with pituitary tumors or multiple endocrine neoplasia but were due to a heterozygous mutation in the prolactin receptor gene, PRLR, resulting in an amino acid change from histidine to arginine at codon 188 (His188Arg). This substitution disrupted the high-affinity ligand-binding interface of the prolactin receptor, resulting in a loss of downstream signaling by Janus kinase 2 (JAK2) and signal transducer and activator of transcription 5 (STAT5). Thus, the familial hyperprolactinemia appears to be due to a germline, loss-of-function mutation in PRLR, resulting in prolactin insensitivity.	[Newey, Paul J.; Gorvin, Caroline M.; Thakker, Rajesh V.] Univ Oxford, Acad Endocrine Unit, Radcliffe Dept Med, Oxford OX3 7LJ, England; [Willberg, Christian B.; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Oxford OX3 7LJ, England; [Bridge, Marcus; van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, Oxford OX3 7LJ, England; [Bountra, Chas] Univ Oxford, Struct Genom Consortium, Oxford OX3 7LJ, England; [Cleland, Stephen J.; Azharuddin, Mohammed; Drummond, Russell S.] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Glasgow	Thakker, RV (corresponding author), Univ Oxford, Churchill Hosp, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England.	rajesh.thakker@ndm.ox.ac.uk	Gorvin, Caroline/T-2406-2019	Gorvin, Caroline/0000-0002-1361-9174; klenerman, paul/0000-0003-4307-9161; Willberg, Christian/0000-0001-5299-9344; Thakker, Rajesh/0000-0002-1438-3220	United Kingdom Medical Research Council [G1000467/2010]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; NIHR; Wellcome Trust [WT091663MA]; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; MRC [G1000467, G9825289, G19/31] Funding Source: UKRI; Medical Research Council [G1000467, G9825289, G19/31] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10204, CL-2010-13-004] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102924, UC2HL103010, RC2HL103010, UC2HL102926, UC2HL102925, RC2HL102926, UC2HL102924, RC2HL102923, RC2HL102925, UC2HL102923] Funding Source: NIH RePORTER	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Lung GO Sequencing Project; Women's Health Initiative Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a grant (G1000467/2010, to Drs. Newey, Gorvin, and Thakker) from the United Kingdom Medical Research Council, funding from the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (to Drs. Newey, Willberg, Klenerman, and Thakker), an NIHR Senior Investigator Award (to Dr. Klenerman), and a grant (WT091663MA, to Dr. Klenerman) from the Wellcome Trust. The GO Exome Sequencing Project of the National Heart, Lung, and Blood Institute and its ongoing studies produced and provided exome variant calls for comparison (the Lung GO Sequencing Project [HL-102923], the Women's Health Initiative Sequencing Project [HL-102924], the Broad GO Sequencing Project [HL-102925], the Seattle GO Sequencing Project [HL-102926], and the Heart GO Sequencing Project [HL-103010]).	Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Binart N, 2010, TRENDS ENDOCRIN MET, V21, P362, DOI 10.1016/j.tem.2010.01.008; Bogorad RL, 2008, P NATL ACAD SCI USA, V105, P14533, DOI 10.1073/pnas.0800685105; Bouchard B, 1999, J IMMUNOL, V163, P576; Brooks CL, 2012, ENDOCR REV, V33, P504, DOI 10.1210/er.2011-1040; Broutin I, 2010, J BIOL CHEM, V285, P8422, DOI 10.1074/jbc.M109.089128; Dagil R, 2012, STRUCTURE, V20, P270, DOI 10.1016/j.str.2011.12.010; David A, 2011, ENDOCR REV, V32, P472, DOI 10.1210/er.2010-0023; Famini P, 2011, J CLIN ENDOCR METAB, V96, P1633, DOI 10.1210/jc.2011-0168; Fang F, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-11; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Jakobovitz-Picard O, 2000, Hum Mutat, V16, P269; Klibanski A, 2010, NEW ENGL J MED, V362, P1219, DOI 10.1056/NEJMcp0912025; Kulkarni MV, 2010, J BIOL CHEM, V285, P38524, DOI 10.1074/jbc.M110.172072; Levine MA, 1999, J BONE MINER RES, V14, P1255, DOI 10.1359/jbmr.1999.14.8.1255; Li W, 2013, J OBSTET GYNAECOL, V33, P285, DOI 10.3109/01443615.2012.759916; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Rao GV, 2011, BIOCHEMISTRY-US, V50, P1347, DOI 10.1021/bi101838s; Schuff KG, 2002, J CLIN INVEST, V110, P973, DOI 10.1172/JCI200215912; Souter I, 2010, FERTIL STERIL, V94, P1159, DOI 10.1016/j.fertnstert.2009.12.017; Thakker RV, 2012, J CLIN ENDOCR METAB, V97, P2990, DOI 10.1210/jc.2012-1230; van Agthoven J, 2010, J MOL BIOL, V404, P112, DOI 10.1016/j.jmb.2010.09.036	25	59	62	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					2012	2020		10.1056/NEJMoa1307557	http://dx.doi.org/10.1056/NEJMoa1307557			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24195502	Green Published, Green Accepted			2022-12-28	WOS:000327163000009
J	Barouch, DH; Whitney, JB; Moldt, B; Klein, F; Oliveira, TY; Liu, JY; Stephenson, KE; Chang, HW; Shekhar, K; Gupta, S; Nkolola, JP; Seaman, MS; Smith, KM; Borducchi, EN; Cabral, C; Smith, JY; Blackmore, S; Sanisetty, S; Perry, JR; Beck, M; Lewis, MG; Rinaldi, W; Chakraborty, AK; Poignard, P; Nussenzweig, MC; Burton, DR				Barouch, Dan H.; Whitney, James B.; Moldt, Brian; Klein, Florian; Oliveira, Thiago Y.; Liu, Jinyan; Stephenson, Kathryn E.; Chang, Hui-Wen; Shekhar, Karthik; Gupta, Sanjana; Nkolola, Joseph P.; Seaman, Michael S.; Smith, Kaitlin M.; Borducchi, Erica N.; Cabral, Crystal; Smith, Jeffrey Y.; Blackmore, Stephen; Sanisetty, Srisowmya; Perry, James R.; Beck, Matthew; Lewis, Mark G.; Rinaldi, William; Chakraborty, Arup K.; Poignard, Pascal; Nussenzweig, Michel C.; Burton, Dennis R.			Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys	NATURE			English	Article							RECOMBINANT ADENOVIRUS VECTORS; ANTIRETROVIRAL THERAPY; HIV-1; BROAD; VACCINE; CHALLENGES; RESPONSES; MEMORY	Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with extraordinary potency and breadth have recently been described. In humanized mice, combinations of monoclonal antibodies have been shown to suppress viraemia, but the therapeutic potential of these monoclonal antibodies has not yet been evaluated in primates with an intact immune system. Here we show that administration of a cocktail of HIV-1-specific monoclonal antibodies, as well as the single glycan-dependent monoclonal antibody PGT121, resulted in a rapid and precipitous decline of plasma viraemia to undetectable levels in rhesus monkeys chronically infected with the pathogenic simian-human immunodeficiency virus SHIV-SF162P3. A single monoclonal antibody infusion afforded up to a 3.1 log decline of plasma viral RNA in 7 days and also reduced proviral DNA in peripheral blood, gastrointestinal mucosa and lymph nodes without the development of viral resistance. Moreover, after monoclonal antibody administration, host Gag-specific T-lymphocyte responses showed improved functionality. Virus rebounded in most animals after a median of 56 days when serum monoclonal antibody titres had declined to undetectable levels, although, notably, a subset of animals maintained long-term virological control in the absence of further monoclonal antibody infusions. These data demonstrate a profound therapeutic effect of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys as well as an impact on host immune responses. Our findings strongly encourage the investigation of monoclonal antibody therapy for HIV-1 in humans.	[Barouch, Dan H.; Whitney, James B.; Liu, Jinyan; Stephenson, Kathryn E.; Chang, Hui-Wen; Nkolola, Joseph P.; Seaman, Michael S.; Smith, Kaitlin M.; Borducchi, Erica N.; Cabral, Crystal; Smith, Jeffrey Y.; Blackmore, Stephen; Sanisetty, Srisowmya; Perry, James R.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.; Chakraborty, Arup K.; Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Moldt, Brian; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, La Jolla, CA 92037 USA; [Klein, Florian; Oliveira, Thiago Y.; Nussenzweig, Michel C.] Rockefeller Univ, New York, NY 10065 USA; [Shekhar, Karthik; Gupta, Sanjana; Chakraborty, Arup K.] MIT, Cambridge, MA 02139 USA; [Beck, Matthew] New England Primate Res Ctr, Southborough, MA 01776 USA; [Lewis, Mark G.] Bioqual Inc, Rockville, MD 20852 USA; [Rinaldi, William] Alpha Genesis Inc, Yemassee, SC 29945 USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10065 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Scripps Research Institute; Rockefeller University; Massachusetts Institute of Technology (MIT); BIOQUAL Inc.; Howard Hughes Medical Institute	Barouch, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019; Gupta, Sanjana/L-1014-2019; Oliveira, Thiago Y/HGA-3848-2022; poignard, pascal/AAB-4613-2020; poignard, pascal/N-6678-2013; Oliveira, Thiago Y/ABF-5186-2020; Nussenzweig, Michel/AAE-7292-2019; Chang, Hui-Wen/C-9058-2017	Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Chang, Hui-Wen/0000-0001-8877-1886; Stephenson, Kathryn/0000-0002-3440-4105; Poignard, Pascal/0000-0002-0021-7192	National Institutes of Health [AI055332, AI060354, AI078526, AI084794, AI095985, AI096040, AI10063, AI100148, AI100663]; Bill and Melinda Gates Foundation [OPP1033091, OPP1033115, OPP1040741, OPP1040753]; Ragon Institute of MGH, MIT, and Harvard; Lundbeck Foundation; Stavros Niarchos Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI055332, U19AI078526, UM1AI100663, R01AI055332, T32AI007387, R56AI091514, P01AI100148, U19AI066305, U19AI095985, P30AI060354, R01AI084794, U19AI096040] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD012217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ragon Institute of MGH, MIT, and Harvard; Lundbeck Foundation(Lundbeckfonden); Stavros Niarchos Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Brinkman, M. Ferguson, C. Gittens, R. Geleziunas, R. Hamel, K. Kelly, J. Kramer, A. McNally, D. Montefiori, L. Nogueira, L. Parenteau, M. Pensiero, L. Peter, M. Shetty, D. Sok, K. Stanley, F. Stephens, W. Wagner, B. Walker, A. West and J. Yalley-Ogunro for advice, assistance and reagents. The SIVmac239 Gag peptide pool was obtained from the NIH AIDS Research and Reference Reagent Program. We acknowledge support from the National Institutes of Health (AI055332, AI060354, AI078526, AI084794, AI095985, AI096040, AI10063, AI100148, AI100663); the Bill and Melinda Gates Foundation (OPP1033091, OPP1033115, OPP1040741, OPP1040753); the Ragon Institute of MGH, MIT, and Harvard; the Lundbeck Foundation; and the Stavros Niarchos Foundation. M.C.N. is a Howard Hughes Medical Institute investigator. M.C.N. and D. R. B. are co-inventors on patents covering the monoclonal antibodies used in the present study.	Andrade A, 2013, J INFECT DIS, V208, P884, DOI 10.1093/infdis/jit272; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cornall A, 2010, J VIROL METHODS, V165, P90, DOI 10.1016/j.jviromet.2010.01.010; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Gautam R, 2012, J VIROL, V86, P8516, DOI 10.1128/JVI.00644-12; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jaworski JP, 2013, J VIROL, V87, P10447, DOI 10.1128/JVI.00049-13; Jayaraman P, 2007, J VIROL, V81, P822, DOI 10.1128/JVI.01759-06; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kraft Z, 2007, J VIROL, V81, P6402, DOI 10.1128/JVI.00424-07; Li HL, 2011, J VIROL, V85, P11007, DOI 10.1128/JVI.05346-11; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; MONTEFIORI D, 2004, EVALUATING NEUTRALIZ; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Nishimura Y, 2010, J VIROL, V84, P4769, DOI 10.1128/JVI.02279-09; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; Whitney JB, 2009, J VIROL, V83, P10840, DOI 10.1128/JVI.01202-09; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	39	484	526	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					224	+		10.1038/nature12744	http://dx.doi.org/10.1038/nature12744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24172905	Green Submitted, Green Accepted			2022-12-28	WOS:000326894200043
J	Dang, I; Gorelik, R; Sousa-Blin, C; Derivery, E; Guerin, C; Linkner, J; Nemethova, M; Dumortier, JG; Giger, FA; Chipysheva, TA; Ermilova, VD; Vacher, S; Campanacci, V; Herrada, I; Planson, AG; Fetics, S; Henriot, V; David, V; Oguievetskaia, K; Lakisic, G; Pierre, F; Steffen, A; Boyreau, A; Peyrieras, N; Rottner, K; Zinn-Justin, S; Cherfils, J; Bieche, I; Alexandrova, AY; David, NB; Small, JV; Faix, J; Blanchoin, L; Gautreau, A				Dang, Irene; Gorelik, Roman; Sousa-Blin, Carla; Derivery, Emmanuel; Guerin, Christophe; Linkner, Joern; Nemethova, Maria; Dumortier, Julien G.; Giger, Florence A.; Chipysheva, Tamara A.; Ermilova, Valeria D.; Vacher, Sophie; Campanacci, Valerie; Herrada, Isaline; Planson, Anne-Gaelle; Fetics, Susan; Henriot, Veronique; David, Violaine; Oguievetskaia, Ksenia; Lakisic, Goran; Pierre, Fabienne; Steffen, Anika; Boyreau, Adeline; Peyrieras, Nadine; Rottner, Klemens; Zinn-Justin, Sophie; Cherfils, Jacqueline; Bieche, Ivan; Alexandrova, Antonina Y.; David, Nicolas B.; Small, J. Victor; Faix, Jan; Blanchoin, Laurent; Gautreau, Alexis			Inhibitory signalling to the Arp2/3 complex steers cell migration	NATURE			English	Article							ACTIN POLYMERIZATION; MOTILITY; NETWORKS; DYNAMICS; PROTEIN; LAMELLIPODIA; NUCLEATION; PREDICTION; VERTEBRATE; ALIGNMENT	Cell migration requires the generation of branched actin networks that power the protrusion of the plasma membrane inlamellipodia(1,2). The actin-related proteins 2 and 3 (Arp2/3) complex is the molecular machine that nucleates these branched actin networks(3). This machine is activated at the leading edge of migrating cells by Wiskott-Aldrich syndrome protein (WASP)-family verprolin-homologous protein (WAVE, also known as SCAR). The WAVE complex is itself directly activated by the small GTPase Rac, which induces lamellipodia(4-6). However, how cells regulate the directionality of migration is poorly understood. Here we identify a new protein, Arpin, that inhibits the Arp2/3 complex in vitro, and show that Rac signalling recruits and activates Arpin at the lamellipodial tip, like WAVE. Consistently, after depletion of the inhibitory Arpin, lamellipodia protrude faster and cells migrate faster. A major role of this inhibitory circuit, however, is to control directional persistence of migration. Indeed, Arpin depletion in both mammalian cells and Dictyostelium discoideum amoeba resulted in straighter trajectories, whereas Arpin microinjection in fish keratocytes, one of the most persistent systems of cell migration, induced these cells to turn. The coexistence of the Rac-Arpin-Arp2/3 inhibitory circuit with the Rac-WAVE-Arp2/3 activatory circuit can account for this conserved role of Arpin in steering cell migration.	[Dang, Irene; Gorelik, Roman; Sousa-Blin, Carla; Derivery, Emmanuel; Henriot, Veronique; David, Violaine; Oguievetskaia, Ksenia; Lakisic, Goran; Pierre, Fabienne; Gautreau, Alexis] CNRS, Grp Cytoskeleton Cell Morphogenesis, Lab Enzymol & Biochim Struct, UPR3082, F-91190 Gif Sur Yvette, France; [Guerin, Christophe; Blanchoin, Laurent] CNRS CEA INRA UJF, Lab Physiol Cellulaire & Vegetale, Inst Rech Technol & Sci Vivant IRTSV, F-38054 Grenoble, France; [Linkner, Joern; Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Nemethova, Maria; Small, J. Victor] Inst Mol Biotechnol, A-1030 Vienna, Austria; [Dumortier, Julien G.; Giger, Florence A.; David, Nicolas B.] Inst Biol ENS, ENS, CNRS UMR8197, INSERM U1024, F-75005 Paris, France; [Chipysheva, Tamara A.; Ermilova, Valeria D.; Alexandrova, Antonina Y.] Russian Acad Med Sci, NN Blokhin Canc Res Ctr, Inst Carcinogenesis, Moscow 115478, Russia; [Vacher, Sophie; Bieche, Ivan] Hop Rene Huguenin, Inst Curie, Oncogenet Lab, F-92210 St Cloud, France; [Campanacci, Valerie; Planson, Anne-Gaelle; Fetics, Susan; Cherfils, Jacqueline] CNRS, Grp Small Prot G, Lab Enzymol & Biochim Struct, UPR3082, F-91190 Gif Sur Yvette, France; [Herrada, Isaline; Zinn-Justin, Sophie] CEA Saclay, CNRS URA2096, Lab Biol Struct & Radiobiol IBiTec S, F-91190 Gif Sur Yvette, France; [Steffen, Anika; Rottner, Klemens] Univ Bonn, Inst Genet, D-53115 Bonn, Germany; [Boyreau, Adeline; Peyrieras, Nadine] CNRS, Inst Neurobiol Alfred Fessard, Inst Syst Complexes & NeD, UPR3294, F-91190 Gif Sur Yvette, France; [Rottner, Klemens] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Hannover Medical School; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Bonn; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Helmholtz-Center for Infection Research	Gautreau, A (corresponding author), CNRS, Grp Cytoskeleton Cell Morphogenesis, Lab Enzymol & Biochim Struct, UPR3082, F-91190 Gif Sur Yvette, France.	alexis.gautreau@lebs.cnrs-gif.fr	Alexandrova, Antonina/R-7449-2019; Bièche, Ivan/O-7399-2017; David, Violaine/E-3892-2019; Dumortier, Julien/M-7469-2013; Gautreau, Alexis/AAT-2751-2020; David, Nicolas/A-1699-2008; Planson, Anne-Gaëlle/AAK-9595-2021; Rottner, Klemens/AAE-5030-2020	Bièche, Ivan/0000-0002-2430-5429; David, Violaine/0000-0003-0127-1200; Dumortier, Julien/0000-0002-1483-4028; Gautreau, Alexis/0000-0002-2369-4362; David, Nicolas/0000-0003-1166-6732; Steffen, Anika/0000-0002-2933-0543; Campanacci, Valerie/0000-0001-6407-6395; Peyrieras, Nadine/0000-0002-4905-6414; LAKISIC, Goran/0000-0002-0079-5072; VACHER, Sophie/0000-0002-0042-6023; Dang, Irene/0000-0003-2467-0191; Rottner, Klemens/0000-0003-4244-4198; Giger, Florence/0000-0002-9408-4959; Planson, Anne-Gaelle/0000-0003-4343-3386	Agence Nationale pour la Recherche [ANR-08-BLAN-0012-CSD 8, ANR-08-PCVI-0010-03, ANR-11-BSV8-0010-02]; Association pour la Recherche sur le Cancer [SFI20101201512, PDF20111204331, SFI20111203770]; Bio-Emergences IBISA facility; Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/46451/2008]; Austrian Science Fund [FWF P21292-B09]; Deutsche Forschungsgemeinschaft [FA 330/5-1]; Russian Ministry of Education and Science [8066, 2012-1.1-12-000-1002-064]; Austrian Science Fund (FWF) [I 516] Funding Source: researchfish	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Bio-Emergences IBISA facility; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	A.G. acknowledges his PhD supervisor M. Arpin, the name of the here identified protein is a tribute to her mentoring. We thank G. Romet-Lemonne, E. Portnoy and F. Marletaz for suggestions. We acknowledge support from Agence Nationale pour la Recherche (ANR-08-BLAN-0012-CSD 8 to A. G. and L. B., ANR-08-PCVI-0010-03 to A. G., ANR-11-BSV8-0010-02 to A. G., J.C. and S.Z.-J.), Association pour la Recherche sur le Cancer (SFI20101201512 to A. G., PDF20111204331 to R. G., SFI20111203770 to N.B.D.), the Bio-Emergences IBISA facility and Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/46451/2008 to C.S.-B.), the Austrian Science Fund (FWF P21292-B09 to J.V.S.), the Deutsche Forschungsgemeinschaft (FA 330/5-1 to J.F.) and grant number 8066, code 2012-1.1-12-000-1002-064 from the Russian Ministry of Education and Science to A.Y.A.	Allard J, 2013, CURR OPIN CELL BIOL, V25, P107, DOI 10.1016/j.ceb.2012.08.012; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Castro-Castro A, 2011, EMBO J, V30, P3913, DOI 10.1038/emboj.2011.310; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Derivery E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002462; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Dumontier M, 2000, J CELL SCI, V113, P2253; Dumortier JG, 2012, P NATL ACAD SCI USA, V109, P16945, DOI 10.1073/pnas.1205870109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Li A, 2011, DEV CELL, V21, P722, DOI 10.1016/j.devcel.2011.07.008; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Maritzen T, 2012, P NATL ACAD SCI USA, V109, P10382, DOI 10.1073/pnas.1206468109; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Millard TH, 2003, CELL MOTIL CYTOSKEL, V54, P81, DOI 10.1002/cm.10087; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Steffen A., 2013, J CELL SCI; Suetsugu S, 2012, TRENDS CELL BIOL, V22, P141, DOI 10.1016/j.tcb.2012.01.001; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034	46	145	156	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					281	+		10.1038/nature12611	http://dx.doi.org/10.1038/nature12611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24132237	Green Submitted			2022-12-28	WOS:000326894200055
J	Shcheglovitov, A; Shcheglovitova, O; Yazawa, M; Portmann, T; Shu, R; Sebastiano, V; Krawisz, A; Froehlich, W; Bernstein, JA; Hallmayer, JF; Dolmetsch, RE				Shcheglovitov, Aleksandr; Shcheglovitova, Olesya; Yazawa, Masayuki; Portmann, Thomas; Shu, Rui; Sebastiano, Vittorio; Krawisz, Anna; Froehlich, Wendy; Bernstein, Jonathan A.; Hallmayer, Joachim F.; Dolmetsch, Ricardo E.			SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients	NATURE			English	Article							SCAFFOLDING PROTEIN SHANK3; CORTICAL-NEURONS; HUMAN FIBROBLASTS; MUTATIONS; HAPLOINSUFFICIENCY; GENERATION; CONVERSION; BEHAVIORS; FAMILY; CELLS	Phelan-McDermid syndrome (PMDS) is a complex neurodevelopmental disorder characterized by global developmental delay, severely impaired speech, intellectual disability, and an increased risk of autism spectrum disorders (ASDs)(1). PMDS is caused by heterozygous deletions of chromosome 22q13.3. Among the genes in the deleted region is SHANK3, which encodes a protein in the postsynaptic density (PSD)(2,3). Rare mutations in SHANK3 have been associated with idiopathic ASDs(4-7), non-syndromic intellectual disability(8), and schizophrenia(9). Although SHANK3 is considered to be the most likely candidate gene for the neurological abnormalities in PMDS patients(10), the cellular and molecular phenotypes associated with this syndrome in human neurons are unknown. We generated induced pluripotent stem (iPS) cells from individuals with PMDS and autism and used them to produce functional neurons. We show that PMDS neurons have reduced SHANK3 expression and major defects in excitatory, but not inhibitory, synaptic transmission. Excitatory synaptic transmission in PMDS neurons can be corrected by restoring SHANK3 expression or by treating neurons with insulin-like growth factor 1 (IGF1). IGF1 treatment promotes formation of mature excitatory synapses that lack SHANK3 but contain PSD95 and N-methyl-D-aspartate (NMDA) receptors with fast deactivation kinetics. Our findings provide direct evidence for a disruption in the ratio of cellular excitation and inhibition in PMDS neurons, and point to a molecular pathway that can be recruited to restore it.	[Shcheglovitov, Aleksandr; Shcheglovitova, Olesya; Yazawa, Masayuki; Portmann, Thomas; Shu, Rui; Krawisz, Anna] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Sebastiano, Vittorio] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Sebastiano, Vittorio] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Froehlich, Wendy; Bernstein, Jonathan A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Froehlich, Wendy; Hallmayer, Joachim F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Dolmetsch, Ricardo E.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Novartis	Dolmetsch, RE (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	Ricardo.dolmetsch@novartis.com		Krawisz, Anna/0000-0002-1462-3773	National Institutes of Health (NIH) [NS069375]; California Institute for Regenerative Medicine CIRM; Autism Science Foundation; Phelan-McDermid Syndrome Foundation; Swiss National Science Foundation; Japan Society for the Promotion of Research Abroad; American Heart Association; National Institute of Mental Health (NIMH) [R33MH087898]; NIH [5DP1OD3889]; CIRM [RT2-01906]; Simons Foundation; JDH; Flora foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine CIRM(California Institute for Regenerative Medicine); Autism Science Foundation; Phelan-McDermid Syndrome Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japan Society for the Promotion of Research Abroad; American Heart Association(American Heart Association); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Simons Foundation; JDH; Flora foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to participants and their families for their support; M. Adam for assistance with recruitment; to X. Jia, A. Cherry, C. Bangs, P. Jones, and J. Williams for assistance with tissue culture; P. Liao for help with multiplex ligation-dependent probe amplification (MLPA); M. Fabian for astrocyte preparations; H.N. Nguyen for consultations on the neural differentiation protocol and spectral karyotyping (SKY); V. Vu and G. Lin for help with data analysis; T. Sudhof, T. Boeckers, A. Grabruker, C. Garner and C. Sala for antibodies; R. Xavier for SHANK3 complementary DNA; R. Reijo-Pera and members of the Dolmetsch laboratory for commenting on the manuscript; E. Nigh for editing the manuscript. We also thank the Stanford Neuroscience Microscopy Service (supported by National Institutes of Health (NIH) NS069375). Support for this study came from the California Institute for Regenerative Medicine CIRM, the Autism Science Foundation and the Phelan-McDermid Syndrome Foundation (to A. S.), the Swiss National Science Foundation (to T. P.), the Japan Society for the Promotion of Research Abroad and American Heart Association (to M.Y.), the National Institute of Mental Health (NIMH) grant R33MH087898 (to J. F. H.); NIH Pioneer Award (5DP1OD3889), CIRM (grant RT2-01906) and Simons Foundation (to R. E. D.). We are also grateful for funding from the JDH research fund, N. Juaw, B. and F. Horowitz, M. McCafferey, B. and J. Packard, P. Kwan and K. Wang, and the Flora foundation.	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Boccuto L, 2013, EUR J HUM GENET, V21, P310, DOI 10.1038/ejhg.2012.175; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Phelan K, 2011, MOL SYNDROMOL, V2, P186, DOI 10.1159/000334260; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Sheng M, 2000, J CELL SCI, V113, P1851; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323	32	315	334	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					267	+		10.1038/nature12618	http://dx.doi.org/10.1038/nature12618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24132240	Green Accepted			2022-12-28	WOS:000326894200052
J	Shenker, D				Shenker, Don			Employers should help prevent misuse of alcohol by employees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Alcohol Hlth Network, London SW1P 1JH, England		Shenker, D (corresponding author), Alcohol Hlth Network, London SW1P 1JH, England.	donshenker@alcoholhealthnetwork.org.uk						Home Office, 2012, IMP ASS MIN UN PRIC; Institute of Alcohol Studies, 2009, ALC WORKPL FACTSH; Johansson E, 2009, EUR J PUBLIC HEALTH, V19, P19, DOI 10.1093/eurpub/ckn116; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; NICE (National Institute of Clinical Excellence), 2010, ALCOHOL USE DISORDER; Quanbeck Andrew, 2010, WMJ, V109, P9; Raistrick D, 2006, REV EFFECTIVENESS TR; Roche AM, 2008, ADDICTION, V103, P738, DOI 10.1111/j.1360-0443.2008.02154.x	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2013	347								f6590	10.1136/bmj.f6590	http://dx.doi.org/10.1136/bmj.f6590			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	250XQ	24201166				2022-12-28	WOS:000326890500006
J	Thomas, R; Mitchell, GK; Batstra, L				Thomas, Rae; Mitchell, Geoffrey K.; Batstra, Laura			Attention-deficit/hyperactivity disorder: are we helping or harming?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEFICIT HYPERACTIVITY DISORDER; STIMULANT MEDICATION; FOLLOW-UP; ADHD; CHILDREN; PREVALENCE; CHILDHOOD; DIAGNOSIS; OUTCOMES; CRITERIA		[Thomas, Rae] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia; [Mitchell, Geoffrey K.] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia; [Batstra, Laura] Univ Groningen, Dept Special Needs Educ & Youth Care, NL-9700 AB Groningen, Netherlands	Bond University; University of Queensland; University of Groningen	Thomas, R (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia.	rthomas@bond.edu.au	Thomas, Rae/A-6397-2014; Mitchell, Geoffrey/F-1489-2010	Thomas, Rae/0000-0002-2165-5917; Mitchell, Geoffrey/0000-0001-7817-6821				Alloway T, 2010, J ATTEN DISORD, V14, P52, DOI 10.1177/1087054709356197; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; AUGUST GJ, 1992, AM J ORTHOPSYCHIAT, V62, P387, DOI 10.1037/h0079354; Barkley RA, 2002, J CLIN PSYCHIAT, V63, P10; Batstra L, 2012, PSYCHOTHER PSYCHOSOM, V81, P5, DOI 10.1159/000331565; Biederman J, 2002, AM J PSYCHIAT, V159, P36, DOI 10.1176/appi.ajp.159.1.36; Bruchmuller K, 2012, J CONSULT CLIN PSYCH, V80, P128, DOI 10.1037/a0026582; CHADD, 2008, CHADDS INC EXP 2008; Charach A., 2011, ATTENTION DEFICIT HY; Correll CU, 2009, JAMA-J AM MED ASSOC, V302, P1765, DOI 10.1001/jama.2009.1549; Cosgrove L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001190; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P825, DOI 10.1111/j.1467-7687.2009.00918.x; Dalsgaard Soren, 2013, Crim Behav Ment Health, V23, P86, DOI 10.1002/cbm.1860; de Graaf R, 2008, OCCUP ENVIRON MED, V65, P835, DOI 10.1136/oem.2007.038448; Dopfner M, 2008, EUR CHILD ADOLES PSY, V17, P59, DOI 10.1007/s00787-008-1007-y; Elder TE, 2010, J HEALTH ECON, V29, P641, DOI 10.1016/j.jhealeco.2010.06.003; Evans WN, 2010, J HEALTH ECON, V29, P657, DOI 10.1016/j.jhealeco.2010.07.005; Everyday Health, 2013, COULD YOU HAV ADHD; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Fischer ER, 2005, MULTIDISCIPLINAIRE R; Foggo D, 2005, TELEGRAPH; Garfield CF, 2012, ACAD PEDIATR, V12, P110, DOI 10.1016/j.acap.2012.01.003; Gilbody S, 2005, QUAL SAF HEALTH CARE, V14, P246, DOI 10.1136/qshc.2004.012781; Gordon Michael, 2006, J Atten Disord, V9, P465, DOI 10.1177/1087054705283881; Hodgkins P, 2011, CLIN THER, V33, P188, DOI 10.1016/j.clinthera.2011.03.001; Hoza B, 2007, J PEDIATR PSYCHOL, V32, P655, DOI 10.1093/jpepsy/jsm024; Jerome L, 2006, J CAN ACAD CHILD ADO, V15, P105; Kang JH, 2013, ACTA PAEDIATR, V102, P640, DOI 10.1111/apa.12213; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Lynch F, 2006, J ADOLESCENCE, V29, P555, DOI 10.1016/j.adolescence.2005.08.011; McCarthy S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-78; McGee R, 2002, J CHILD PSYCHOL PSYC, V43, P1004, DOI 10.1111/1469-7610.00228; Mintzes B, 2003, CAN MED ASSOC J, V169, P405; Mitchell J, 2012, CLIN CHILD PSYCHOL P, V17, P121, DOI 10.1177/1359104510396432; Molina B, J LEARNING DISABIL, V202, P333; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Morrow RL, 2012, CAN MED ASSOC J, V184, P755, DOI 10.1503/cmaj.111619; National Health and Medical Research Council, 2012, CLIN PRACT POINTS DI; National Institute for Health and Clinical Excellence, 2013, NICE CLIN GUID; Parker J, 2013, PSYCHOL RES BEHAV MA, V6, P87, DOI 10.2147/PRBM.S49114; Pelham WE, 2008, ATTENTION DEFICIT HY, P301; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Poulton AS, 2013, MED J AUSTRALIA, V198, P29, DOI 10.5694/mja12.10931; Robison LM, 2002, CNS DRUGS, V16, P129, DOI 10.2165/00023210-200216020-00005; Ruggiero S, 2012, J CHILD ADOL PSYCHOP, V22, P415, DOI 10.1089/cap.2012.0003; Sayal K, 2010, ARCH PEDIAT ADOL MED, V164, P462, DOI 10.1001/archpediatrics.2010.40; Scheffler RM, 2007, HEALTH AFFAIR, V26, P450, DOI 10.1377/hlthaff.26.2.450; Singh I, 2008, NAT REV NEUROSCI, V9, P957, DOI 10.1038/nrn2514; Sonnby K, 2011, NORD J PSYCHIAT, V65, P315, DOI 10.3109/08039488.2010.545894; Stephenson CP, 2013, AUST NZ J PSYCHIAT, V47, P74, DOI 10.1177/0004867412466595; Swanson J, 2008, J ATTEN DISORD, V12, P4, DOI 10.1177/1087054708319345; Thomas R, 2013, PREV OV C 10 12 SEPT; Visser S. N., 2010, Morbidity and Mortality Weekly Report, V59, P1439; Walker JS, 2008, J AM ACAD CHILD PSY, V47, P912, DOI 10.1097/CHI.0b013e318179961a; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Wolraich ML, 2012, J ATTEN DIS     0905; Zima BT, 2010, J AM ACAD CHILD PSY, V49, P1225, DOI 10.1016/j.jaac.2010.08.012; Zuvekas SH, 2012, AM J PSYCHIAT, V169, P160, DOI 10.1176/appi.ajp.2011.11030387; Zwi M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003018.pub3	60	65	65	0	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2013	347								f6172	10.1136/bmj.f6172	http://dx.doi.org/10.1136/bmj.f6172			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	250XL	24192646	Green Published			2022-12-28	WOS:000326890000001
J	Thrumurthy, SG; Chaudry, MA; Hochhauser, D; Mughal, M				Thrumurthy, Sri G.; Chaudry, M. Asif; Hochhauser, Daniel; Mughal, Muntzer			The diagnosis and management of gastric cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HELICOBACTER-PYLORI; HOSPITAL VOLUME; TOTAL GASTRECTOMY; ALCOHOL-DRINKING; RISK; POPULATION; MORTALITY; SURVIVAL; SURGERY; CHEMOTHERAPY		[Thrumurthy, Sri G.; Mughal, Muntzer] Univ Coll London Hosp, Dept Upper Gastrointestinal Surg, London NW1 2BU, England; [Chaudry, M. Asif] St Thomas Hosp, Dept Upper Gastrointestinal Surg, London, England; [Hochhauser, Daniel] UCL, UCL Canc Inst, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London	Mughal, M (corresponding author), Univ Coll London Hosp, Dept Upper Gastrointestinal Surg, London NW1 2BU, England.	muntzer.mughal@uclh.nhs.uk		Hochhauser, Daniel/0000-0001-5522-9281				Ahn HS, 2011, BRIT J SURG, V98, P255, DOI 10.1002/bjs.7310; Allison JA, 2005, GASTROENTEROLOGY, V129, P1756, DOI 10.1053/j.gastro.2005.09.020; Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Anderson WF, 2010, JAMA-J AM MED ASSOC, V303, P1723, DOI 10.1001/jama.2010.496; [Anonymous], 2012, NEUTR SEPS PREV MAN, P1; Bang YJ, 2010, LANCET, V376, P1302; Bennett C, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004276.PUB3; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Bozzetti F, 1999, ANN SURG, V230, P170, DOI 10.1097/00000658-199908000-00006; Capelle LG, 2010, GASTROENTEROLOGY, V138, P487, DOI 10.1053/j.gastro.2009.10.051; Cavaleiro-Pinto M, 2011, CANCER CAUSE CONTROL, V22, P375, DOI 10.1007/s10552-010-9707-2; Coupland VH, 2013, GUT, V62, P961, DOI 10.1136/gutjnl-2012-303008; Coupland VH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-11; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; de Graaf GW, 2007, EJSO-EUR J SURG ONC, V33, P988, DOI 10.1016/j.ejso.2007.01.007; Dikken JL, 2012, EUR J CANCER, V48, P1004, DOI 10.1016/j.ejca.2012.02.064; Duell EJ, 2011, AM J CLIN NUTR, V94, P1266, DOI 10.3945/ajcn.111.012351; Enzinger PC, 2007, ANN SURG, V245, P426, DOI 10.1097/01.sla.0000245469.35088.42; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fitzgerald RC, 2010, J MED GENET, V47, P436, DOI 10.1136/jmg.2009.074237; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; GOUZI JL, 1989, ANN SURG, V209, P162, DOI 10.1097/00000658-198902000-00005; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; International Agency for Research on Cancer, 2000, PATHOLOGY GENETICS T; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Kato M, 2012, JPN J CLIN ONCOL, V42, P987, DOI 10.1093/jjco/hys151; Kim HH, 2010, ANN SURG, V251, P417, DOI 10.1097/SLA.0b013e3181cc8f6b; Kim J, 2010, AM J CLIN NUTR, V91, P1289, DOI 10.3945/ajcn.2009.28732; La Torre G, 2009, TUMORI, V95, P13; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; Lagergren J, 2000, JAMA-J AM MED ASSOC, V284, P961, DOI 10.1001/jama.284.8.961; Larsson SC, 2006, CANCER EPIDEM BIOMAR, V15, P1998, DOI 10.1158/1055-9965.EPI-06-0402; Lepage C, 2010, BRIT J SURG, V97, P235, DOI 10.1002/bjs.6865; Lynch HT, 2005, J SURG ONCOL, V90, P114, DOI 10.1002/jso.20214; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mocellin S, 2011, GASTROINTEST ENDOSC, V73, P1122, DOI 10.1016/j.gie.2011.01.030; National Comprehensive Cancer Network, 2013, GASTR CANC VERS 2; National Institute for Health and Care Excellence, 2010, TRAST TREATM HER2 PO; Office for National Statistics, 2010, SERIES MB1, V39; Ohtani H, 2010, J GASTROINTEST SURG, V14, P958, DOI 10.1007/s11605-010-1195-x; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Park B, 2011, CANCER CAUSE CONTROL, V22, P1497, DOI 10.1007/s10552-011-9823-7; Pharoah PDP, 2001, GASTROENTEROLOGY, V121, P1348, DOI 10.1053/gast.2001.29611; Rugge M, 2007, GUT, V56, P1646, DOI 10.1136/gut.2007.133926; Rupnow MFT, 2009, J INFECT DIS, V200, P1311, DOI 10.1086/605845; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Shikata K, 2006, INT J CANCER, V119, P196, DOI 10.1002/ijc.21822; Sjodahl K, 2007, INT J CANCER, V120, P128, DOI 10.1002/ijc.22157; Smyth EC, 2012, ANN SURG ONCOL, V19, P2088, DOI 10.1245/s10434-012-2230-9; Smyth E, 2012, CANCER-AM CANCER SOC, V118, P5481, DOI 10.1002/cncr.27550; Song KY, 2008, AM J SURG, V196, P19, DOI 10.1016/j.amjsurg.2007.05.056; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029; Van Cutsem E, 2012, J CLIN ONCOL, V30, P2119, DOI 10.1200/JCO.2011.39.9824; Vannella L, 2013, ALIMENT PHARM THER, V37, P375, DOI 10.1111/apt.12177; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Woo Y, 2011, ARCH SURG-CHICAGO, V146, P1086, DOI 10.1001/archsurg.2011.114; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Xu ZQ, 2013, BRIT J CANCER, V108, P941, DOI 10.1038/bjc.2013.44; Zhang JZ, 2011, AM J SURG, V202, P91, DOI 10.1016/j.amjsurg.2010.05.014	68	93	103	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2013	347								f6367	10.1136/bmj.f6367	http://dx.doi.org/10.1136/bmj.f6367			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XI	24191271				2022-12-28	WOS:000326889700004
J	Nilsson, O				Nilsson, Ove			A Pathway to Flowering-Why Staying Cool Matters	SCIENCE			English	Editorial Material							TEMPERATURE; ARABIDOPSIS; TIME; SVP		Swedish Univ Agr Sci, Umea Plant Sci Ctr, S-90183 Umea, Sweden	Swedish University of Agricultural Sciences; Umea University	Nilsson, O (corresponding author), Swedish Univ Agr Sci, Umea Plant Sci Ctr, S-90183 Umea, Sweden.	ove.nilsson@slu.se						Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Intergovernmental Panel on Climate Change, 2013, WORK GROUP 1 CONTR I; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee JH, 2013, SCIENCE, V342, P628, DOI 10.1126/science.1241097; Mendez-Vigo B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003289; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; Ratcliffe OJ, 2001, PLANT PHYSIOL, V126, P122, DOI 10.1104/pp.126.1.122; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102	11	5	6	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					566	567		10.1126/science.1245861	http://dx.doi.org/10.1126/science.1245861			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179209				2022-12-28	WOS:000326334300026
J	Scholes, MC; Scholes, RJ				Scholes, Mary C.; Scholes, Robert J.			Dust Unto Dust	SCIENCE			English	Editorial Material							SOILS		[Scholes, Mary C.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2000 Johannesburg, South Africa; [Scholes, Robert J.] CSIR, ZA-0001 Pretoria, South Africa	University of Witwatersrand; Council for Scientific & Industrial Research (CSIR) - South Africa	Scholes, MC (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2000 Johannesburg, South Africa.	mary.scholes@wits.ac.za; bscholes@csir.co.za		Scholes, Robert/0000-0001-5537-6935				Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Connor DJ, 2008, FIELD CROP RES, V106, P187, DOI 10.1016/j.fcr.2007.11.010; Dery P., 2007, ENERGY BULL; Diamond J., 2011, COLLAPSE SOC CHOOSE, V4th ed; Egan Timothy, 2006, THE WORST HARD TIME; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Food and Agriculture Organization of the United Nations, THE STATE OF FOOD AN; Giller KE, 1997, APPL SOIL ECOL, V6, P3, DOI 10.1016/S0929-1393(96)00149-7; LAL R, 1995, SOIL SCI SOC AM J, V59, P661, DOI 10.2136/sssaj1995.03615995005900030004x; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Smil V., 2004, ENRICHING THE EARTH; Smith P, 2013, GLOBAL CHANGE BIOL, V19, P2285, DOI 10.1111/gcb.12160	13	30	31	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					565	566		10.1126/science.1244579	http://dx.doi.org/10.1126/science.1244579			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179208				2022-12-28	WOS:000326334300025
J	Owens, B				Owens, Brian			ENHANCED MEDICAL VISION	NATURE			English	Editorial Material																			0	2	2	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S82	S83		10.1038/502S82a	http://dx.doi.org/10.1038/502S82a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187699	Bronze			2022-12-28	WOS:000326293200002
J	Walensky, RP; Ross, EL; Kumarasamy, N; Wood, R; Noubary, F; Paltiel, AD; Nakamura, YM; Godbole, SV; Panchia, R; Sanne, I; Weinstein, MC; Losina, E; Mayer, KH; Chen, YQ; Wang, L; McCauley, M; Gamble, T; Seage, GR; Cohen, MS; Freedberg, KA				Walensky, Rochelle P.; Ross, Eric L.; Kumarasamy, Nagalingeswaran; Wood, Robin; Noubary, Farzad; Paltiel, A. David; Nakamura, Yoriko M.; Godbole, Sheela V.; Panchia, Ravindre; Sanne, Ian; Weinstein, Milton C.; Losina, Elena; Mayer, Kenneth H.; Chen, Ying Q.; Wang, Lei; McCauley, Marybeth; Gamble, Theresa; Seage, George R., III; Cohen, Myron S.; Freedberg, Kenneth A.			Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIRETROVIRAL TREATMENT PROGRAMS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; COTE-DIVOIRE; FOLLOW-UP; THERAPY; TRANSMISSION; INFECTION; METAANALYSIS; PROPHYLAXIS	BackgroundThe cost-effectiveness of early antiretroviral therapy (ART) in persons infected with human immunodeficiency virus (HIV) in serodiscordant couples is not known. Using a computer simulation of the progression of HIV infection and data from the HIV Prevention Trials Network 052 study, we projected the cost-effectiveness of early ART for such persons. MethodsFor HIV-infected partners in serodiscordant couples in South Africa and India, we compared the early initiation of ART with delayed ART. Five-year and lifetime outcomes included cumulative HIV transmissions, life-years, costs, and cost-effectiveness. We classified early ART as very cost-effective if its incremental cost-effectiveness ratio was less than the annual per capita gross domestic product (GDP; $8,100 in South Africa and $1,500 in India), as cost-effective if the ratio was less than three times the GDP, and as cost-saving if it resulted in a decrease in total costs and an increase in life-years, as compared with delayed ART. ResultsIn South Africa, early ART prevented opportunistic diseases and was cost-saving over a 5-year period; over a lifetime, it was very cost-effective ($590 per life-year saved). In India, early ART was cost-effective ($1,800 per life-year saved) over a 5-year period and very cost-effective ($530 per life-year saved) over a lifetime. In both countries, early ART prevented HIV transmission over short periods, but longer survival attenuated this effect; the main driver of life-years saved was a clinical benefit for treated patients. Early ART remained very cost-effective over a lifetime under most modeled assumptions in the two countries. ConclusionsIn South Africa, early ART was cost-saving over a 5-year period. In both South Africa and India, early ART was projected to be very cost-effective over a lifetime. With individual, public health, and economic benefits, there is a compelling case for early ART for serodiscordant couples in resource-limited settings. (Funded by the National Institute of Allergy and Infectious Diseases and others.) In this study, early initiation of antiretroviral therapy (ART) was shown to be more cost-effective than late initiation of ART in preventing disease transmission among HIV-serodiscordant couples in South Africa and India. In the Human Immunodeficiency Virus (HIV) Prevention Trials Network (HPTN) 052 study,(1) early antiretroviral therapy (ART), as compared with delayed ART, was associated with a 96% relative reduction in the rate of linked transmission among serodiscordant couples during 24 months of follow-up. (Early ART was defined as therapy initiated when the CD4+ T-cell count ranged from 350 to 550 per cubic millimeter, and delayed ART as therapy initiated when the CD4+ count was <250 per cubic millimeter.) The trial also showed clear clinical benefits for patients with HIV infection in the early-ART group, as compared with those in the delayed-ART ...	[Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.; Ross, Eric L.; Noubary, Farzad; Nakamura, Yoriko M.; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.; Ross, Eric L.; Noubary, Farzad; Nakamura, Yoriko M.; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Dept Med, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Walensky, Rochelle P.; Losina, Elena; Mayer, Kenneth H.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Harvard Univ Ctr AIDS Res, Boston, MA USA; [Weinstein, Milton C.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Seage, George R., III] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Mayer, Kenneth H.] Fenway Hlth, Boston, MA USA; [Kumarasamy, Nagalingeswaran] YR Gaitonde Ctr AIDS Res & Educ, Chennai, Tamil Nadu, India; [Godbole, Sheela V.] Natl AIDS Res Inst, Pune, Maharashtra, India; [Wood, Robin] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Wood, Robin] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Paltiel, A. David] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Panchia, Ravindre] Univ Witwatersrand, Perinatal HIV Res Unit, Dept Med, Fac Hlth Sci, Johannesburg, South Africa; [Sanne, Ian] Univ Witwatersrand, Clin HIV Res Unit, Dept Med, Fac Hlth Sci, Johannesburg, South Africa; [Chen, Ying Q.; Wang, Lei] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [McCauley, Marybeth] FHI 360, Washington, DC USA; [Gamble, Theresa] FHI 360, Durham, NC USA; [Cohen, Myron S.] Univ N Carolina, Sch Med, Chapel Hill, NC USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Fenway Health; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); University of Cape Town; University of Cape Town; Yale University; University of Witwatersrand; University of Witwatersrand; Fred Hutchinson Cancer Center; FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Div Infect Dis, 50 Staniford St,9th Flr, Boston, MA 02114 USA.	rwalensky@partners.org	Kumarasasmy, Nagalingeswaran/AAB-7348-2021; Godbole, Sheela/ABG-4942-2020; Godbole, Sheela/K-4177-2017; Sanne, Ian/ABH-2231-2020	Godbole, Sheela/0000-0001-6537-9064; Walensky, Rochelle P./0000-0002-8795-379X; Ross, Eric/0000-0002-6025-2010; Chen, Ying Qing/0000-0002-2726-3391; Paltiel, A. David/0000-0002-4861-3290; Losina, ELENA/0000-0002-3424-0892	National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI058736, R01 AI093269, UM1 AI068636]; National Institute of Mental Health [R01 MH087328]; HIV Prevention Trials Network (HPTN); NIAID [UM1-AI068619, U01-AI068619, UM1-AI068613, U01-AI068613, UM1-AI068617, U01-AI068617]; AIDS Clinical Trials Group [UM1 AI068636]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068617, UM1AI068617, UM1AI068636, R01AI058736, UM1AI068619, R01AI093269, U01AI068619, U01AI068613, UM1AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294, R01MH087328] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HIV Prevention Trials Network (HPTN); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS Clinical Trials Group; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID) (R01 AI058736, R01 AI093269, and UM1 AI068636) and the National Institute of Mental Health (R01 MH087328) (all to the CEPAC International Group), by the HIV Prevention Trials Network (HPTN), and by grants from NIAID (UM1-AI068619, U01-AI068619, UM1-AI068613, and U01-AI068613, to the HPTN Network Laboratory; and UM1-AI068617 and U01-AI068617, to the HPTN Statistical and Data Management Center) and by a grant from the AIDS Clinical Trials Group (UM1 AI068636). Study drugs for the HPTN 052 trial were donated by Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, and Merck.	Ademi Z, 2013, BRIT J CLIN PHARMACO, V75, P944, DOI 10.1111/j.1365-2125.2012.04421.x; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2011, ANN INTERN MED, V154, P509; [Anonymous], 2012, YRG CARE TREATM COST; [Anonymous], HIST EXCH RAT; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Cecelia AJ, 2006, NATL MED J INDIA, V19, P14; Chopra M, 2009, JAIDS-J ACQ IMM DEF, V51, P72, DOI 10.1097/QAI.0b013e31819907de; ClinicalTrials.gov, 2012, PREV SEX TRANSM HIV; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Funk MJ, 2011, ARCH INTERN MED, V171, P1560, DOI 10.1001/archinternmed.2011.401; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Grinsztejn B, 2012, P 19 INT AIDS C WASH; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Medicins Sans Frontieres and Health Systems Trust, 2004, COST EFF ANT TREATM; Mugglin C, 2012, 19 C RETR OPP INF SE; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; NACO, 2007, GUIDELINES PREVENTIO; National Department of Health, 2010, CLIN GUID MAN HIV AI; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Thirumurthy H, 2012, HEALTH AFFAIR, V31, P1470, DOI 10.1377/hlthaff.2012.0217; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; World Health Organization, GLOB PRIC REP MECH H; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6	40	96	97	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1715	1725		10.1056/NEJMsa1214720	http://dx.doi.org/10.1056/NEJMsa1214720			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24171517	Green Published, Green Accepted			2022-12-28	WOS:000326311300009
J	Labrador, S; Gonzalez-Gay, MA				Labrador, Salvador; Gonzalez-Gay, Miguel A.			Cold Hands Associated with Scleroderma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 45-year-old woman living in a rural area of northern Spain presented to our clinic with cold hands. These symptoms had developed over a period of 6 years. Raynaud's phenomenon was seen after her hands were exposed to cold. A 45-year-old woman living in a rural area of northern Spain presented to our clinic with cold hands. These symptoms had developed over a period of 6 years. Raynaud's phenomenon was seen after her hands were exposed to cold. The antinuclear antibody titer was greater than 1:1280, with an anticentromere antibody pattern. This pattern may be present in 40 to 80% of patients with limited scleroderma, and secondary Raynaud's phenomenon may be seen in 80 to 90% of such patients. In 30% of patients with secondary Raynaud's phenomenon, it may be an early presentation of scleroderma. The patient's blood pressure ...	[Labrador, Salvador] Clin Trasmiera, Cantabria, Spain; [Gonzalez-Gay, Miguel A.] Hosp Marques de Valdecilla, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV)	Labrador, S (corresponding author), Clin Trasmiera, Cantabria, Spain.	salvadorlabrador@hotmail.com	González-Gay, Miguel A./B-2306-2008; DESCALZO, SALVADOR LABRADOR/E-5990-2015	González-Gay, Miguel A./0000-0002-7924-7406; DESCALZO, SALVADOR LABRADOR/0000-0001-6455-5804					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1638	1638		10.1056/NEJMicm1304702	http://dx.doi.org/10.1056/NEJMicm1304702			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	24152263				2022-12-28	WOS:000326031100013
J	Torjesen, I				Torjesen, Ingrid			Alliance Boots accused of avoiding over 1bn pound in UK tax	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2012, BBC NEWS; Champion G, 2010, BBC NEWS; Change to Win Unite the Union War on Want, 2013, ALL BOOTS TAX GAP CA	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2013	347								f6236	10.1136/bmj.f6236	http://dx.doi.org/10.1136/bmj.f6236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WK	24129382				2022-12-28	WOS:000325982200024
J	Weed, HG				Weed, Harrison G.			Review: Probiotics prevent C-difficile-associated diarrhea in patients using antibiotics	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Ohio State Univ, Coll Med, Columbus, OH 43210 USA	Ohio State University	Weed, HG (corresponding author), Ohio State Univ, Coll Med, Columbus, OH 43210 USA.							Allen SJ, 2013, LANCET; Dubberke E, 2012, J HOSP MED, V7, pS14, DOI 10.1002/jhm.1908	2	1	1	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC7	10.7326/0003-4819-159-8-201310150-02007	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126668				2022-12-28	WOS:000326751200006
J	Hawkins, M; Malla, S; Blythe, MJ; Nieduszynski, CA; Allers, T				Hawkins, Michelle; Malla, Sunir; Blythe, Martin J.; Nieduszynski, Conrad A.; Allers, Thorsten			Accelerated growth in the absence of DNA replication origins	NATURE			English	Article							ARCHAEON HALOFERAX-VOLCANII; SEQUENCE; INITIATION; RECOMBINATION; POLYPLOIDY; PROTEINS; DYNAMICS; ELEMENTS; BINDING	DNA replication initiates at defined sites called origins, which serve as binding sites for initiator proteins that recruit the replicative machinery. Origins differ in number and structure across the three domains of life(1) and their properties determine the dynamics of chromosome replication. Bacteria and some archaea replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple origins. Initiation mechanisms that rely on homologous recombination operate in some viruses. Here we show that such mechanisms also operate in archaea. We use deep sequencing to study replication in Haloferax volcanii and identify four chromosomal origins of differing activity. Deletion of individual origins results in perturbed replication dynamics and reduced growth. However, a strain lacking all origins has no apparent defects and grows significantly faster than wild type. Origin-less cells initiate replication at dispersed sites rather than at discrete origins and have an absolute requirement for the recombinase RadA, unlike strains lacking individual origins. Our results demonstrate that homologous recombination alone can efficiently initiate the replication of an entire cellular genome. This raises the question of what purpose replication origins serve and why they have evolved.	[Hawkins, Michelle; Nieduszynski, Conrad A.; Allers, Thorsten] Univ Nottingham, Queens Med Ctr, Sch Biol, Nottingham NG7 2UH, England; [Malla, Sunir; Blythe, Martin J.] Univ Nottingham, Queens Med Ctr, Deep Seq, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Allers, T (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Biol, Nottingham NG7 2UH, England.	conrad.nieduszynski@nottingham.ac.uk; thorsten.allers@nottingham.ac.uk	Nieduszynski, Conrad/B-2170-2010	Nieduszynski, Conrad/0000-0003-2001-076X; Allers, Thorsten/0000-0002-7308-3332; Hawkins, Michelle/0000-0001-9393-8206	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E023754/1, BB/G001596/1]; Royal Society; Biotechnology and Biological Sciences Research Council [BB/E023754/1, BB/C501641/1, BB/G001596/1] Funding Source: researchfish; BBSRC [BB/G001596/1, BB/E023754/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported through the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/E023754/1, BB/G001596/1). We thank the BBSRC for a David Phillips Fellowship awarded to C.A.N. and the Royal Society for a University Research Fellowship awarded to T.A., R. Wilson for preparing libraries for sequencing, A. de Moura and I. Duggin for sharing unpublished data, and numerous colleagues for discussions.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45; de Moura APS, 2010, NUCLEIC ACIDS RES, V38, P5623, DOI 10.1093/nar/gkq343; Delmas S, 2013, MOL MICROBIOL, V87, P168, DOI 10.1111/mmi.12091; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Dershowitz A, 2007, MOL CELL BIOL, V27, P4652, DOI 10.1128/MCB.01246-06; Duggin IG, 2008, P NATL ACAD SCI USA, V105, P16737, DOI 10.1073/pnas.0806414105; Duggin IG, 2011, EMBO J, V30, P145, DOI 10.1038/emboj.2010.301; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Leigh JA, 2011, FEMS MICROBIOL REV, V35, P577, DOI 10.1111/j.1574-6976.2011.00265.x; Lestini R, 2010, DNA REPAIR, V9, P994, DOI 10.1016/j.dnarep.2010.06.012; Lindas AC, 2013, NAT REV MICROBIOL, V11, P627, DOI 10.1038/nrmicro3077; Matsunaga F, 2007, NUCLEIC ACIDS RES, V35, P3214, DOI 10.1093/nar/gkm212; McCready Shirley, 2005, Saline Syst, V1, P3, DOI 10.1186/1746-1448-1-3; McGeoch AT, 2008, NAT REV MOL CELL BIO, V9, P569, DOI 10.1038/nrm2426; McGlynn P, 2012, MOL MICROBIOL, V85, P12, DOI 10.1111/j.1365-2958.2012.08102.x; Muller CA, 2012, GENOME RES, V22, P1953, DOI 10.1101/gr.139477.112; MULLAKHANBHAI MF, 1975, ARCH MICROBIOL, V104, P207, DOI 10.1007/BF00447326; Newman TJ, 2013, NUCLEIC ACIDS RES, V41, P9705, DOI 10.1093/nar/gkt728; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; OGAWA T, 1984, P NATL ACAD SCI-BIOL, V81, P1040, DOI 10.1073/pnas.81.4.1040; Pelve E. A., 2013, MOL MICROBIOL; Retkute R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.068103; Robinson NP, 2005, FEBS J, V272, P3757, DOI 10.1111/j.1742-4658.2005.04768.x; ROSENSHINE I, 1989, SCIENCE, V245, P1387, DOI 10.1126/science.2818746; Sernova NV, 2008, BRIEF BIOINFORM, V9, P376, DOI 10.1093/bib/bbn031; Skovgaard O, 2011, GENOME RES, V21, P1388, DOI 10.1101/gr.117416.110; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vujcic M, 1999, MOL CELL BIOL, V19, P6098; Wendoloski D, 2001, MICROBIOL-SGM, V147, P959, DOI 10.1099/00221287-147-4-959; Woods WG, 1997, MOL MICROBIOL, V23, P791, DOI 10.1046/j.1365-2958.1997.2651626.x	38	94	94	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					544	+		10.1038/nature12650	http://dx.doi.org/10.1038/nature12650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24185008	Green Accepted, Green Submitted			2022-12-28	WOS:000327464200047
J	Blomberg, R; Kries, H; Pinkas, DM; Mittl, PRE; Grutter, MG; Privett, HK; Mayo, SL; Hilvert, D				Blomberg, Rebecca; Kries, Hajo; Pinkas, Daniel M.; Mittl, Peer R. E.; Gruetter, Markus G.; Privett, Heidi K.; Mayo, Stephen L.; Hilvert, Donald			Precision is essential for efficient catalysis in an evolved Kemp eliminase	NATURE			English	Article							TRIOSEPHOSPHATE ISOMERASE; ENZYME CATALYSIS; TRANSITION-STATE; BASE CATALYSIS; ANTIBODY; DESIGN; ORIENTATION; SPECIFICITY; MUTAGENESIS; EVOLUTION	Linus Pauling established the conceptual framework for understanding and mimicking enzymes more than six decades ago(1). The notion that enzymes selectively stabilize the rate-limiting transition state of the catalysed reaction relative to the bound ground state reduces the problem of design to one of molecular recognition. Nevertheless, past attempts to capitalize on this idea, for example by using transition state analogues to elicit antibodies with catalytic activities(2), have generally failed to deliver true enzymatic rates. The advent of computational design approaches, combined with directed evolution, has provided an opportunity to revisit this problem. Starting from a computationally designed catalyst for the Kemp elimination(3)-a well-studied model system for proton transfer from carbon-we show that an artificial enzyme can be evolved that accelerates an elementary chemical reaction 6 x 10(8)-fold, approaching the exceptional efficiency of highly optimized natural enzymes such as triosephosphate isomerase. A 1.09 angstrom resolution crystal structure of the evolved enzyme indicates that familiar catalytic strategies such as shape complementarity and precisely placed catalytic groups can be successfully harnessed to afford such high rate accelerations, making us optimistic about the prospects of designing more sophisticated catalysts.	[Blomberg, Rebecca; Kries, Hajo; Pinkas, Daniel M.; Hilvert, Donald] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland; [Mittl, Peer R. E.; Gruetter, Markus G.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Privett, Heidi K.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Mayo, Stephen L.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; California Institute of Technology; California Institute of Technology	Hilvert, D (corresponding author), ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch	Pinkas, Daniel/AAE-3210-2020; Mittl, Peer/E-5352-2017	Kries, Hajo/0000-0002-4919-2811; Pinkas, Daniel/0000-0002-4740-6695	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF; ETH Zurich; Defense Advanced Research Projects Agency (DARPA); Fonds des Verbandes der chemischen Industrie; Stipendienfonds der Schweizer Chemischen Industrie; Studienstiftung des deutschen Volkes; National Security Science and Engineering Faculty Fellowship	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF; ETH Zurich(ETH Zurich); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Fonds des Verbandes der chemischen Industrie; Stipendienfonds der Schweizer Chemischen Industrie; Studienstiftung des deutschen Volkes; National Security Science and Engineering Faculty Fellowship	The authors are grateful to A. Aires-Trapote and C. Mayer for experimental assistance. We also thank C. Stutz and B. Blattmann for help in protein crystallization, and the beamline staff at the Swiss Light Source for support during data collection. This work was supported by the Swiss National Science Foundation (SNSF), the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF, the ETH Zurich, and the Defense Advanced Research Projects Agency (DARPA). Fellowships from the Fonds des Verbandes der chemischen Industrie (to R.B.), the Stipendienfonds der Schweizer Chemischen Industrie (to H.K.), the Studienstiftung des deutschen Volkes (to R.B. and H.K.), and the National Security Science and Engineering Faculty Fellowship (to S.L.M.) are gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Allen BD, 2010, P NATL ACAD SCI USA, V107, P19838, DOI 10.1073/pnas.1012985107; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743; CASEY ML, 1973, J ORG CHEM, V38, P2294, DOI 10.1021/jo00953a006; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Debler EW, 2005, P NATL ACAD SCI USA, V102, P4984, DOI 10.1073/pnas.0409207102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frushicheva MP, 2010, P NATL ACAD SCI USA, V107, P16869, DOI 10.1073/pnas.1010381107; Gamper M, 2000, BIOCHEMISTRY-US, V39, P14087, DOI 10.1021/bi0016570; GANDOUR RD, 1981, BIOORG CHEM, V10, P169, DOI 10.1016/0045-2068(81)90020-1; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Hu YF, 2004, J AM CHEM SOC, V126, P8197, DOI 10.1021/ja0490727; Iranpoor N, 2006, TETRAHEDRON LETT, V47, P8247, DOI 10.1016/j.tetlet.2006.09.120; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khersonsky O, 2012, P NATL ACAD SCI USA, V109, P10358, DOI 10.1073/pnas.1121063109; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kikuchi K, 2006, BIOORGAN MED CHEM, V14, P6189, DOI 10.1016/j.bmc.2006.05.071; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Korendovych IV, 2011, P NATL ACAD SCI USA, V108, P6823, DOI 10.1073/pnas.1018191108; Kries H, 2013, CURR OPIN CHEM BIOL, V17, P221, DOI 10.1016/j.cbpa.2013.02.012; Lassila JK, 2006, P NATL ACAD SCI USA, V103, P16710, DOI 10.1073/pnas.0607691103; Leung DW, 1989, TECHNIQUE, V1, P11; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; Na J, 1996, J AM CHEM SOC, V118, P6462, DOI 10.1021/ja953550j; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; PUTMAN SJ, 1972, BIOCHEM J, V129, P301, DOI 10.1042/bj1290301; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Richard JP, 2012, BIOCHEMISTRY-US, V51, P2652, DOI 10.1021/bi300195b; RICHARD JP, 1984, J AM CHEM SOC, V106, P4926, DOI 10.1021/ja00329a050; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; THORN SN, 1995, NATURE, V373, P228, DOI 10.1038/373228a0; Voigt CA, 2000, J MOL BIOL, V299, P789, DOI 10.1006/jmbi.2000.3758; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Wierenga RK, 2010, CELL MOL LIFE SCI, V67, P3961, DOI 10.1007/s00018-010-0473-9; WOLFENDEN R, 1974, MOL CELL BIOCHEM, V3, P207, DOI 10.1007/BF01686645	47	206	212	3	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					418	+		10.1038/nature12623	http://dx.doi.org/10.1038/nature12623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24132235				2022-12-28	WOS:000327163200046
J	Huckman, RS; Kelley, MA				Huckman, Robert S.; Kelley, Mark A.			Public Reporting, Consumerism, and Patient Empowerment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Huckman, Robert S.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Huckman, Robert S.] Harvard Univ, Natl Bur Econ Res, Cambridge, MA 02138 USA; [Kelley, Mark A.] Harvard Univ, Adv Leadership Initiat, Cambridge, MA 02138 USA	Harvard University; Harvard University; National Bureau of Economic Research; Harvard University	Huckman, RS (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							[Anonymous], 2012, HLTH AFFAIRS    0308; Cutler DM, 2013, HEALTH AFFAIR, V32, P841, DOI 10.1377/hlthaff.2012.0289; Kerr EA, 2013, JAMA-J AM MED ASSOC, V310, P137, DOI 10.1001/jama.2013.6828; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Reinhardt UE, 2006, HEALTH AFFAIR, V25, P57, DOI 10.1377/hlthaff.25.1.57	5	30	30	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1875	1877		10.1056/NEJMp1310419	http://dx.doi.org/10.1056/NEJMp1310419			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300MP	24131139				2022-12-28	WOS:000330468300004
J	Talbot, TR; Bratzler, DW; Carrico, RM; Diekema, DJ; Hayden, MK; Huang, SS; Yokoe, DS; Fishman, NO				Talbot, Thomas R.; Bratzler, Dale W.; Carrico, Ruth M.; Diekema, Daniel J.; Hayden, Mary K.; Huang, Susan S.; Yokoe, Deborah S.; Fishman, Neil O.		Healthcare Infection Control	Public Reporting of Health Care-Associated Surveillance Data: Recommendations From the Healthcare Infection Control Practices Advisory Committee	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-STREAM INFECTIONS; VENTILATOR-ASSOCIATED PNEUMONIA; DEFINITIONS; VALIDATION; RATES; ZERO	Health care-associated infection (HAI) rates are used as measures of a health care facility's quality of patient care. Recently, these outcomes have been used to publicly rank quality efforts and determine facility reimbursement. The value of comparing HAI rates among health care facilities is limited by many factors inherent. to HAI surveillance, and incentives that reward low HAI rates can lead to unintended consequences that can compromise medical care surveillance efforts, such as the use of clinical adjudication panels to veto events that meet HAI surveillance definitions. The Healthcare Infection Control Practices Advisory Committee, a federal advisory committee that provides advice and guidance to the Centers for Disease Control and Prevention (CDC) and the Secretary of the Department of Health and Human Services about strategies for surveillance, prevention, and control of HAIs, assessed the challenges associated with using HAI surveillance data for external quality reporting, including the unintended consequences of clinician veto and clinical adjudication panels. Discussions with stakeholder liaisons and committee members were then used to formulate recommended standards for the use of HAI surveillance data for external facility assessment to ensure valid comparisons and to provide as level a playing field as possible. The final recommendations advocate for consistent, objective, and independent application of CDC HAI definitions with concomitant validation of HAIs and surveillance processes. The use of clinician veto and adjudication is discouraged.	Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Univ Louisville, Sch Med, Louisville, KY 40292 USA; Univ Iowa, Carver Coll Med, Iowa City, IA USA; Rush Univ, Med Ctr, Chicago, IL 60612 USA; Univ Calif Irvine, Sch Med, Orange, CA 92668 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Penn Hlth Syst, Philadelphia, PA USA	Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Louisville; University of Iowa; Rush University; University of California System; University of California Irvine; Harvard University; Brigham & Women's Hospital; University of Pennsylvania	Talbot, TR (corresponding author), Vanderbilt Univ, Med Ctr, A2200 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA.	tom.talbot@vanderbilt.edu		Bratzler, Dale/0000-0002-8033-7521; Diekema, Daniel/0000-0003-1273-0724; Talbot, Thomas/0000-0002-6139-212X; Hayden, Mary/0000-0002-4603-8501				[Anonymous], 2010, INFECT CONT HOSP EP, V31, P1101, DOI 10.1086/656912; Association for Professionals in Infection Control and Epidemiology, 2013, LEG MAPS; Backman LA, 2010, AM J INFECT CONTROL, V38, P832, DOI 10.1016/j.ajic.2010.05.016; Beekmann SE, 2012, INFECT CONT HOSP EP, V33, P875, DOI 10.1086/667379; CAPER P, 1987, AM J PUBLIC HEALTH, V77, P669, DOI 10.2105/AJPH.77.6.669; Centers for Medicare & Medicaid Services, 2011, HOSP INP PROSP PAYM; Haley VB, 2012, INFECT CONT HOSP EP, V33, P565, DOI 10.1086/665710; HUGHES JM, 1987, INFECT CONT HOSP EP, V8, P450, DOI 10.1017/S0195941700069769; Julian KG, 2006, INFECT CONT HOSP EP, V27, P926, DOI 10.1086/507281; Klompas M, 2012, CURR OPIN INFECT DIS, V25, P176, DOI 10.1097/QCO.0b013e3283502437; Klompas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018062; Klompas M, 2010, AM J INFECT CONTROL, V38, P237, DOI 10.1016/j.ajic.2009.10.003; Klompas M, 2009, THORAX, V64, P463, DOI 10.1136/thx.2009.114165; Lin MY, 2010, JAMA-J AM MED ASSOC, V304, P2035, DOI 10.1001/jama.2010.1637; Magill SS, 2012, CLIN INFECT DIS, V54, P378, DOI 10.1093/cid/cir833; MARTONE WJ, 1991, INFECT CONT HOSP EP, V12, P609; Mayer J, 2012, CLIN INFECT DIS, V55, P364, DOI 10.1093/cid/cis410; McKibben L, 2005, AM J INFECT CONTROL, V33, P217, DOI 10.1016/j.ajic.2005.04.001; National Healthcare Safety Network (NHSN), 2022, PNEUM VENT NAV NONV; Oh JY, 2012, INFECT CONT HOSP EP, V33, P439, DOI 10.1086/665317; Sexton DJ, 2010, INFECT CONT HOSP EP, V31, P1286, DOI 10.1086/657583; Stenhem M, 2009, EUROSURVEILLANCE, V14, P18; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912	23	35	35	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					631	635		10.7326/0003-4819-159-9-201311050-00011	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249HX	24189597	Green Submitted			2022-12-28	WOS:000326769400009
J	Das, P				Das, Pamela			Kenneth Mayer: global leader in HIV prevention	LANCET			English	Biographical-Item																		MAYER KU, PUBLICATION LIST	1	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1479	1479		10.1016/S0140-6736(13)62278-3	http://dx.doi.org/10.1016/S0140-6736(13)62278-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	24182533	Bronze			2022-12-28	WOS:000326622500015
J	McConnell, MJ; Lindberg, MR; Brennand, KJ; Piper, JC; Voet, T; Cowing-Zitron, C; Shumilina, S; Lasken, RS; Vermeesch, JR; Hall, IM; Gage, FH				McConnell, Michael J.; Lindberg, Michael R.; Brennand, Kristen J.; Piper, Julia C.; Voet, Thierry; Cowing-Zitron, Chris; Shumilina, Svetlana; Lasken, Roger S.; Vermeesch, Joris R.; Hall, Ira M.; Gage, Fred H.			Mosaic Copy Number Variation in Human Neurons	SCIENCE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; PLURIPOTENT STEM-CELLS; L1 RETROTRANSPOSITION; HUMAN BRAIN; SOMATIC MOSAICISM; HUMAN TISSUES; DNA; ANEUPLOIDY; INSTABILITY; DELETION	We used single-cell genomic approaches to map DNA copy number variation (CNV) in neurons obtained from human induced pluripotent stem cell (hiPSC) lines and postmortem human brains. We identified aneuploid neurons, as well as numerous subchromosomal CNVs in euploid neurons. Neurotypic hiPSC-derived neurons had larger CNVs than fibroblasts, and several large deletions were found in hiPSC-derived neurons but not in matched neural progenitor cells. Single-cell sequencing of endogenous human frontal cortex neurons revealed that 13 to 41% of neurons have at least one megabase-scale de novo CNV, that deletions are twice as common as duplications, and that a subset of neurons have highly aberrant genomes marked by multiple alterations. Our results show that mosaic CNV is abundant in human neurons.	[McConnell, Michael J.; Brennand, Kristen J.; Piper, Julia C.; Cowing-Zitron, Chris; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [McConnell, Michael J.; Piper, Julia C.] Salk Inst Biol Studies, Crick Jacobs Ctr Theoret & Computat Biol, La Jolla, CA 92037 USA; [Voet, Thierry; Vermeesch, Joris R.] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Voet, Thierry] Wellcome Trust Sanger Inst, Single Cell Genom Ctr, Cambridge CB10 1SA, England; [Lasken, Roger S.] J Craig Venter Inst, San Diego, CA 92121 USA; [Lasken, Roger S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [McConnell, Michael J.; Lindberg, Michael R.; Shumilina, Svetlana; Hall, Ira M.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [McConnell, Michael J.] Univ Virginia, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA; [McConnell, Michael J.; Hall, Ira M.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	Salk Institute; Salk Institute; KU Leuven; Wellcome Trust Sanger Institute; J. Craig Venter Institute; University of California System; University of California San Diego; University of Virginia; University of Virginia; University of Virginia	Hall, IM (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	irahall@virginia.edu; gage@salk.edu	Voet, Thierry/E-8877-2017; Brennand, Kristen J/J-8704-2012; Brennand, Kristen J/U-5470-2019	Voet, Thierry/0000-0003-1204-9963; Brennand, Kristen J/0000-0003-0993-5956; Vermeesch, Joris/0000-0002-3071-1191; Lindberg, Michael/0000-0002-7393-8214	Center for Academic Research and Training in Anthropogeny (CARTA); Crick-Jacobs Junior Fellowship; University of Leuven (KU Leuven) SymBioSys grant [PFV/10/016]; Mather's Family Foundation; NIH [R01 MH095741, DP20D006493-01]; J.P.B. Foundation; Annette Merle-Smith; Helmsley Foundation; Burroughs Wellcome Fund; National Institute for Child Health and Human Development (NIH) Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD [HHSN2752009000011C, N01-HD-9-011]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095741] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006493] Funding Source: NIH RePORTER	Center for Academic Research and Training in Anthropogeny (CARTA); Crick-Jacobs Junior Fellowship; University of Leuven (KU Leuven) SymBioSys grant; Mather's Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.P.B. Foundation; Annette Merle-Smith; Helmsley Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute for Child Health and Human Development (NIH) Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Husband (Salk), L. Moore (Salk), S. Jackmaert (KU Leuven), R. Layer (University of Virginia) and R. Clark (University of Virginia) for technical assistance; A. Prorock and Y. Bao (UVA Sequencing Core) for DNA sequencing; and all members of the Gage laboratory for critical feedback on the project. We thank M. L. Gage for editorial comments. F. H. G. thanks the Center for Academic Research and Training in Anthropogeny (CARTA) for support and perspective. This work was supported by a Crick-Jacobs Junior Fellowship to M.J.M.; a University of Leuven (KU Leuven) SymBioSys grant (PFV/10/016) to J.R.V. and T. V.; a Mather's Family Foundation grant, a NIH TR01 (R01 MH095741), the J.P.B. Foundation, Annette Merle-Smith, and a Helmsley Foundation grant to F. H. G.; and an NIH New Innovator Award (DP20D006493-01) and Burroughs Wellcome Fund Career Award to I. M. H. Human tissue was obtained from the National Institute for Child Health and Human Development (NIH) Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD, contract HHSN2752009000011C, ref. no. N01-HD-9-011. The hiPSC lines used in this study are available from the Coriell Cell Repository. Microarray data have been deposited in the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GSE51538), and DNA sequence data have been deposited in the NCBI Short-Read Archive (SRP030642).	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Bushman DM, 2013, SEMIN CELL DEV BIOL, V24, P357, DOI 10.1016/j.semcdb.2013.02.003; Callinan PA, 2005, J MOL BIOL, V348, P791, DOI 10.1016/j.jmb.2005.02.043; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lasken RS, 2009, BIOCHEM SOC T, V37, P450, DOI 10.1042/BST0370450; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Maeda T, 2004, BIOCHEM BIOPH RES CO, V319, P1117, DOI 10.1016/j.bbrc.2004.05.093; Martin SL, 2009, NATURE, V460, P1087, DOI 10.1038/4601087a; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ostertag EM, 2005, NATURE, V435, P890, DOI 10.1038/435890a; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Shibata Y, 2012, SCIENCE, V336, P82, DOI 10.1126/science.1213307; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558	33	380	388	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					632	637		10.1126/science.1243472	http://dx.doi.org/10.1126/science.1243472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179226	Green Accepted			2022-12-28	WOS:000326334300052
J	Ravi, B; Croxford, R; Austin, PC; Lipscombe, L; Bierman, AS; Harvey, PJ; Hawker, GA				Ravi, Bheeshma; Croxford, Ruth; Austin, Peter C.; Lipscombe, Lorraine; Bierman, Arlene S.; Harvey, Paula J.; Hawker, Gillian A.			The relation between total joint arthroplasty and risk for serious cardiovascular events in patients with moderate-severe osteoarthritis: propensity score matched landmark analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; CLINICAL CARDIOLOGY SUBCOMMITTEE; TOTAL HIP-ARTHROPLASTY; MIDDLE-AGED MEN; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; KNEE ARTHROPLASTY; MYOCARDIAL-INFARCTION; NATIONAL-HEALTH	Objective To examine whether total joint arthroplasty of the hip and knee reduces the risk for serious cardiovascular events in patients with moderate-severe osteoarthritis. Design Propensity score matched landmark analysis. Setting Ontario, Canada. Participants 2200 adults with hip or knee osteoarthritis aged 55 or more at recruitment (1996-98) and followed prospectively until death or 2011. Main outcome measure Rates of serious cardiovascular events for those who received a primary total joint arthroplasty compared with those did not within an exposure period of three years after baseline assessment. Results The propensity score matched cohort consisted of 153 matched pairs of participants with moderate-severe arthritis. Over a median follow-up period of seven years after the landmark date (start of the study), matched participants who underwent a total joint arthroplasty during the exposure period were significantly less likely than those who did not to experience a cardiovascular event (hazards ratio 0.56, 95% confidence interval 0.43 to 0.74, P<0.001). Within seven years of the exposure period the absolute risk reduction was 12.4% (95% confidence interval 1.7% to 23.1%) and number needed to treat was 8 (95% confidence interval 4 to 57 patients). Conclusions Using a propensity matched landmark analysis in a population cohort with advanced hip or knee osteoarthritis, this study found a cardioprotective benefit of primary elective total joint arthroplasty.	[Ravi, Bheeshma] Univ Toronto, Dept Surg, Div Orthopaed Surg, Toronto, ON M5S 1B2, Canada; [Ravi, Bheeshma; Austin, Peter C.; Lipscombe, Lorraine; Bierman, Arlene S.; Hawker, Gillian A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5S 1B2, Canada; [Ravi, Bheeshma; Lipscombe, Lorraine; Harvey, Paula J.; Hawker, Gillian A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Croxford, Ruth; Austin, Peter C.; Bierman, Arlene S.; Hawker, Gillian A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Lipscombe, Lorraine; Bierman, Arlene S.; Harvey, Paula J.; Hawker, Gillian A.] Univ Toronto, Dept Med, Toronto, ON M5S 1B2, Canada; [Bierman, Arlene S.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON M5S 1B2, Canada; [Hawker, Gillian A.] Womens Coll Hosp, Dept Med, Div Rheumatol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Ravi, B (corresponding author), Univ Toronto, Womens Coll Hosp, 76 Grenville St,6th Floor,Room 6327, Toronto, ON M5S 1B2, Canada.	bheeshma.ravi@mail.utoronto.ca		Austin, Peter/0000-0003-3337-233X; Lipscombe, Lorraine/0000-0001-7412-7993	Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Heart and Stroke Foundation; FM Hill chair in academic women's medicine; Canadian Institutes of Health Research [MOP-15468]; Ministry of Health and Long-Term Care	Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); FM Hill chair in academic women's medicine; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This study was supported by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by the Institute for Clinical Evaluative Sciences or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. BR is supported in part by a doctoral award from the Canadian Institutes of Health Research. PCA is supported in part by a career investigator award from the Heart and Stroke Foundation. GAH is supported in part by the FM Hill chair in academic women's medicine, and Canadian Institutes of Health Research grant No MOP-15468. ICES received support from the Ministry of Health and Long-Term Care.	Adamson J, 2004, AGE AGEING, V33, P293, DOI 10.1093/ageing/afh090; Agency for Healthcare Research and Quality, 2002, PHYS ACT OLD AM BEN; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Anderson JR, 2008, J CLIN ONCOL, V26, P3913, DOI 10.1200/JCO.2008.16.1000; [Anonymous], 2011, GLOB ATL CARD DIS PR; Austin PC, 2011, STAT MED, V30, P1292, DOI 10.1002/sim.4200; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1146; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Bauman S, 2007, CLIN J SPORT MED, V17, P104, DOI 10.1097/JSM.0b013e3180379b6a; Bavry AA, 2011, AM J MED, V124, P614, DOI 10.1016/j.amjmed.2011.02.025; Beyersmann J, 2008, J CLIN EPIDEMIOL, V61, P1216, DOI 10.1016/j.jclinepi.2008.02.008; Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Bunker SJ, 2003, MED J AUSTRALIA, V178, P272, DOI 10.5694/j.1326-5377.2003.tb05193.x; Canadian Institute for Health Information, 2003, INT STAT CLASS DIS R; Chun BY, 1997, DIABETES CARE, V20, P704, DOI 10.2337/diacare.20.5.704; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Creamer P, 1999, ARTHRIT CARE RES, V12, P3, DOI 10.1002/1529-0131(199902)12:1<3::AID-ART2>3.0.CO;2-K; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Davis MC, 2001, ANN BEHAV MED, V23, P215, DOI 10.1207/S15324796ABM2303_9; Engstrom G, 2009, OSTEOARTHR CARTILAGE, V17, P168, DOI 10.1016/j.joca.2008.07.003; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Friedman B, 2005, J AM GERIATR SOC, V53, P1978, DOI 10.1111/j.1532-5415.2005.00469.x; Graham DJ, 2006, JAMA-J AM MED ASSOC, V296, P1653, DOI 10.1001/jama.296.13.jed60058; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Haapanen N, 1997, INT J EPIDEMIOL, V26, P739, DOI 10.1093/ije/26.4.739; Han CD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-603; Hawker GA, 2000, NEW ENGL J MED, V342, P1016, DOI 10.1056/NEJM200004063421405; Hawker GA, 2004, ARTHRIT RHEUM-ARTHR, V51, P635, DOI 10.1002/art.20524; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Hawker GA, 2010, PROJECT ONTARIO WOME, V2; Hawker GA, 2006, ARTHRITIS RHEUM, V54, P3212, DOI 10.1002/art.22146; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Ho JE, 2003, STROKE, V34, P2812, DOI 10.1161/01.STR.0000102901.41780.5C; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Inoue R, 2011, J ORTHOP SCI, V16, P704, DOI 10.1007/s00776-011-0157-9; Jandric S, 2009, AM J PHYS MED REHAB, V88, P328, DOI 10.1097/PHM.0b013e318194fa24; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; Jones CA, 2007, RHEUM DIS CLIN N AM, V33, P71, DOI 10.1016/j.rdc.2006.12.008; Jones CA, 2000, J RHEUMATOL, V27, P1745; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kritharides L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000147; Lamb SE, 2003, J ARTHROPLASTY, V18, P575, DOI 10.1016/S0883-5403(03)00110-4; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Mahon JL, 2002, CAN MED ASSOC J, V167, P1115; Mariconda M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-222; McCarron P, 2001, PUBLIC HEALTH, V115, P12, DOI 10.1038/sj.ph.1900724; Memel DS, 2000, BRIT J GEN PRACT, V50, P645; Montin L, 2008, J CLIN NURS, V17, P40, DOI 10.1111/j.1365-2702.2007.01944.x; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; NELSON L, 1986, LANCET, V2, P473, DOI 10.1016/S0140-6736(86)90354-5; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Ockene IS, 1997, CIRCULATION, V96, P3243, DOI 10.1161/01.CIR.96.9.3243; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Pereira MA, 1999, PREV MED, V28, P304, DOI 10.1006/pmed.1998.0431; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Prior JA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-295; Quintana JM, 2006, ARCH INTERN MED, V166, P220, DOI 10.1001/archinte.166.2.220; Quintana JM, 2008, ARCH INTERN MED, V168, P1576, DOI 10.1001/archinte.168.14.1576; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Scopaz KA, 2009, ARCH PHYS MED REHAB, V90, P1866, DOI 10.1016/j.apmr.2009.06.012; Sicard-Rosenbaum L, 2002, J GERONTOL A-BIOL, V57, pM47, DOI 10.1093/gerona/57.1.M47; Singh G, 2002, AM J MANAG CARE, V8, pS383; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stevens M, 2012, CLIN GERIATR MED, V28, P509, DOI 10.1016/j.cger.2012.05.003; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Tu K, 2008, CAN MED ASSOC J, V178, P1429, DOI 10.1503/cmaj.071283; Udell JA, 2012, ARCH INTERN MED, V172, P1086, DOI 10.1001/archinternmed.2012.2782; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEINBERGER M, 1990, SOC SCI MED, V30, P503, DOI 10.1016/0277-9536(90)90353-T; White WB, 2007, CURR PAIN HEADACHE R, V11, P428; Woolf V J, 1994, J Arthroplasty, V9, P389, DOI 10.1016/0883-5403(94)90049-3; World Health Organization, 2008, The global burden of disease: 2004 update; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zautra AJ, 2001, PSYCHOSOM MED, V63, P687, DOI 10.1097/00006842-200107000-00022	89	47	47	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2013	347								f6187	10.1136/bmj.f6187	http://dx.doi.org/10.1136/bmj.f6187			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EW	24174640	Green Published, hybrid			2022-12-28	WOS:000326599600006
J	Appleby, J				Appleby, John			DATA BRIEFING Migrants' healthcare: who pays?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Creative Research, 2013, QUAL ASS VIS MIGR US; *DEP HLTH, 2012, REV OV VIS CHARG POL; Department of Health, 2013, QUANT ASS VIS MIGR U; Department of Health, 2013, SUST SERV ENS FAIRN; Department of Health, 2013, NEW REP SHOWS NHS CO; NHS Choices, EHIC EUR HLTH INS CA	6	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2013	347								f6483	10.1136/bmj.f6483	http://dx.doi.org/10.1136/bmj.f6483			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EV	24169257				2022-12-28	WOS:000326599500027
J	Dubrovinskaia, N; Dubrovinsky, L				Dubrovinskaia, Natalia; Dubrovinsky, Leonid			Controversy about ultrahard nanotwinned cBN	NATURE			English	Letter							HIGH-PRESSURE; DIAMOND		[Dubrovinskaia, Natalia] Univ Bayreuth, Crystallog Lab, D-95440 Bayreuth, Germany; [Dubrovinsky, Leonid] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	University of Bayreuth; University of Bayreuth	Dubrovinskaia, N (corresponding author), Univ Bayreuth, Crystallog Lab, POB 101251, D-95440 Bayreuth, Germany.	natalia.dubrovinskaia@uni-bayreuth.de	Dubrovinskaia, Natalia/A-8013-2015	Dubrovinskaia, Natalia/0000-0002-8256-5675; Dubrovinsky, Leonid/0000-0002-3717-7585				Bersani D, 1998, APPL PHYS LETT, V72, P73, DOI 10.1063/1.120648; Brazhkin V, 2004, NAT MATER, V3, P576, DOI 10.1038/nmat1196; CORRIGAN FR, 1975, J CHEM PHYS, V63, P3812, DOI 10.1063/1.431874; Dubrovinskaia N, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711277; Dubrovinskaia N, 2010, NATO SCI PEACE SEC B, P419, DOI 10.1007/978-90-481-9258-8_34; Dubrovinsky L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2160; Eremets MI, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2061853; Horiuchi S., 1997, J SURF ANAL, V3, P197; Rao WF, 2010, PHILOS MAG, V90, P197, DOI 10.1080/14786430903147106; Solozhenko VL, 2012, ADV MATER, V24, P1540, DOI 10.1002/adma.201104361; Sumiya H, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1850654; Sumiya H, 2004, DIAM RELAT MATER, V13, P1771, DOI 10.1016/j.diamond.2004.03.002; Tian YJ, 2013, NATURE, V493, P385, DOI 10.1038/nature11728; Wells A.F., 1975, STRUCTURAL INORGANIC, V4th	14	17	17	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					E1	E2		10.1038/nature12620	http://dx.doi.org/10.1038/nature12620			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153311				2022-12-28	WOS:000325988400001
J	Cole, TB				Cole, Thomas B.			Untitled	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1652	1653		10.1001/jama.2013.5379	http://dx.doi.org/10.1001/jama.2013.5379			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24150444				2022-12-28	WOS:000325948500001
J	Gloy, VL; Briel, M; Bhatt, DL; Kashyap, SR; Schauer, PR; Mingrone, G; Bucher, HC; Nordmann, AJ				Gloy, Viktoria L.; Briel, Matthias; Bhatt, Deepak L.; Kashyap, Sangeeta R.; Schauer, Philip R.; Mingrone, Geltrude; Bucher, Heiner C.; Nordmann, Alain J.			Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR RISK-FACTORS; GASTRIC BYPASS-SURGERY; WEIGHT-LOSS; MEDICAL THERAPY; HETEROGENEITY; HYPERTENSION; OUTCOMES; HEALTH; BIAS	Objective To quantify the overall effects of bariatric surgery compared with non-surgical treatment for obesity. Design Systematic review and meta-analysis based on a random effects model. Data sources Searches of Medline, Embase, and the Cochrane Library from their inception to December 2012 regardless of language or publication status. Eligibility criteria Eligible studies were randomised controlled trials with >= 6 months of follow-up that included individuals with a body mass index >= 30, compared current bariatric surgery techniques with non-surgical treatment, and reported on body weight, cardiovascular risk factors, quality of life, or adverse events. Results The meta-analysis included 11 studies with 796 individuals (range of mean body mass index at baseline 30-52). Individuals allocated to bariatric surgery lost more body weight (mean difference -26 kg (95% confidence interval -31 to -21)) compared with non-surgical treatment, had a higher remission rate of type 2 diabetes (relative risk 22.1 (3.2 to 154.3) in a complete case analysis; 5.3 (1.8 to 15.8) in a conservative analysis assuming diabetes remission in all non-surgically treated individuals with missing data) and metabolic syndrome (relative risk 2.4 (1.6 to 3.6) in complete case analysis; 1.5 (0.9 to 2.3) in conservative analysis), greater improvements in quality of life and reductions in medicine use (no pooled data). Plasma triglyceride concentrations decreased more (mean difference -0.7 mmol/L (-1.0 to -0.4) and high density lipoprotein cholesterol concentrations increased more (mean difference 0.21 mmol/L (0.1 to 0.3)). Changes in blood pressure and total or low density lipoprotein cholesterol concentrations were not significantly different. There were no cardiovascular events or deaths reported after bariatric surgery. The most common adverse events after bariatric surgery were iron deficiency anaemia (15% of individuals undergoing malabsorptive bariatric surgery) and reoperations (8%). Conclusions Compared with non-surgical treatment of obesity, bariatric surgery leads to greater body weight loss and higher remission rates of type 2 diabetes and metabolic syndrome. However, results are limited to two years of follow-up and based on a small number of studies and individuals.	[Gloy, Viktoria L.; Briel, Matthias; Bucher, Heiner C.; Nordmann, Alain J.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Briel, Matthias] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Bhatt, Deepak L.] Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Kashyap, Sangeeta R.] Cleveland Clin, Inst Endocrinol, Cleveland, OH 44106 USA; [Schauer, Philip R.] Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44106 USA; [Mingrone, Geltrude] Univ Cattolica S Cuore, Dept Internal Med, Rome, Italy	University of Basel; McMaster University; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Gloy, VL (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Hebelstr 10, CH-4031 Basel, Switzerland.	Viktoria.Gloy@usb.ch	Briel, Matthias/AAT-9284-2021; Mingrone, Geltrude/AAB-9681-2019	Kashyap, Sangeeta/0000-0002-7489-6650; Mingrone, Geltrude/0000-0003-2021-528X; Schauer, Philip/0000-0002-4029-7537; Briel, Matthias/0000-0002-2070-5230	Santeuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	Santeuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	No specific funding, the Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, is funded by an unrestricted grant from Santeuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation.	Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Allender S, 2007, OBES REV, V8, P467, DOI 10.1111/j.1467-789X.2007.00394.x; [Anonymous], 1998, CLIN GUID ID EV TREA; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Chakravarty PD, 2012, SURG-J R COLL SURG E, V10, P172, DOI 10.1016/j.surge.2012.02.001; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Dixon J, 2012, OBES RES CLIN PRACT, V6, P29; Dixon JB, 2008, OBSTET GYNECOL SURV, V63, P372; Dixon JB, 2007, OBESITY, V15, P1187, DOI 10.1038/oby.2007.639; Dixon JB, 2012, JAMA-J AM MED ASSOC, V308, P1142, DOI 10.1001/2012.jama.11580; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Hage Mirella P, 2012, ISRN Endocrinol, V2012, P504756, DOI 10.5402/2012/504756; Heindorff H, 1997, OBES SURG, V7, P300; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Ioannidis JPA, 2008, J EVAL CLIN PRACT, V14, P951, DOI 10.1111/j.1365-2753.2008.00986.x; Liang ZW, 2013, DIABETES RES CLIN PR, V101, P50, DOI 10.1016/j.diabres.2013.04.005; Lobstein T, TACKLING OBESITIES F; Maggard-Gibbons M, 2013, JAMA-J AM MED ASSOC, V309, P2250, DOI 10.1001/jama.2013.4851; Mingrone G, 2002, ATHEROSCLEROSIS, V161, P455, DOI 10.1016/S0021-9150(01)00667-0; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; O'Brien PE, 2010, JAMA-J AM MED ASSOC, V303, P519, DOI 10.1001/jama.2010.81; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; Padwal R, 2011, OBES REV, V12, P602, DOI 10.1111/j.1467-789X.2011.00866.x; Papamargaritis DK, 2010, OPEN ACCESS SURG, V3, P123, DOI 10.2147/OAS.S7195; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Poirier P, 2011, CIRCULATION, V123, P1683, DOI 10.1161/CIR.0b013e3182149099; Pontiroli AE, 2011, ANN SURG, V253, P484, DOI 10.1097/SLA.0b013e31820d98cb; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Pournaras DJ, 2012, BRIT J SURG, V99, P100, DOI 10.1002/bjs.7704; Reis LO, 2010, INT J ANDROL, V33, P736, DOI 10.1111/j.1365-2605.2009.01017.x; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schauer PR, 2000, ANN SURG, V232, P515, DOI 10.1097/00000658-200010000-00007; Sinha S, 2009, J AM COLL SURGEONS, V209, P565, DOI 10.1016/j.jamcollsurg.2009.07.019; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Tice JA, 2008, AM J MED, V121, P885, DOI 10.1016/j.amjmed.2008.05.036; Wiebe N, 2006, J CLIN EPIDEMIOL, V59, P342, DOI 10.1016/j.jclinepi.2005.08.017; World Healths Organization, WHO GLOB DAT BOD MAS	44	763	782	3	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f5934	10.1136/bmj.f5934	http://dx.doi.org/10.1136/bmj.f5934			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CI	24149519	hybrid, Green Published			2022-12-28	WOS:000326293800002
J	[Anonymous]				[Anonymous]			I was sexually harassed as a junior by senior doctors: it still goes on, and it needs to stop	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Fried JM, 2012, ACAD MED, V87, P1191, DOI 10.1097/ACM.0b013e3182625408; General Medical Council, 2012, NAT TRAIN SURV 2012; Nagata-Kobayashi S, 2009, MED EDUC, V43, P628, DOI 10.1111/j.1365-2923.2009.03388.x; Rautio Arja, 2005, BMC Med Educ, V5, P36, DOI 10.1186/1472-6920-5-36; Rees CE, 2013, MED EDUC, V47, P80, DOI 10.1111/j.1365-2923.2012.04302.x; Witte FM, 2006, ACAD MED, V81, P648, DOI 10.1097/01.ACM.0000232421.04170.d2	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2013	347								f6302	10.1136/bmj.f6302	http://dx.doi.org/10.1136/bmj.f6302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CF	24144872				2022-12-28	WOS:000326293500005
J	[Anonymous]				[Anonymous]			Integrity in research collaborations: The Montreal Statement	LANCET			English	Editorial Material																			0	4	4	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1310	1310						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	24139108				2022-12-28	WOS:000325975700002
J	Xing, GC; Mathews, N; Sun, SY; Lim, SS; Lam, YM; Gratzel, M; Mhaisalkar, S; Sum, TC				Xing, Guichuan; Mathews, Nripan; Sun, Shuangyong; Lim, Swee Sien; Lam, Yeng Ming; Graetzel, Michael; Mhaisalkar, Subodh; Sum, Tze Chien			Long-Range Balanced Electron- and Hole-Transport Lengths in Organic-Inorganic CH3NH3PbI3	SCIENCE			English	Article							EXCITON DIFFUSION LENGTH; HYBRID SOLAR-CELLS; DEVICE PHYSICS; EFFICIENCY; POLYTHIOPHENE; DISSOCIATION; PERFORMANCE; DYNAMICS; BLENDS	Low-temperature solution-processed photovoltaics suffer from low efficiencies because of poor exciton or electron-hole diffusion lengths (typically about 10 nanometers). Recent reports of highly efficient CH3NH3PbI3-based solar cells in a broad range of configurations raise a compelling case for understanding the fundamental photophysical mechanisms in these materials. By applying femtosecond transient optical spectroscopy to bilayers that interface this perovskite with either selective-electron or selective-hole extraction materials, we have uncovered concrete evidence of balanced long-range electron-hole diffusion lengths of at least 100 nanometers in solution-processed CH3NH3PbI3. The high photoconversion efficiencies of these systems stem from the comparable optical absorption length and charge-carrier diffusion lengths, transcending the traditional constraints of solution-processed semiconductors.	[Xing, Guichuan; Lim, Swee Sien; Sum, Tze Chien] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore 637371, Singapore; [Mathews, Nripan; Sun, Shuangyong; Lam, Yeng Ming; Mhaisalkar, Subodh] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Mathews, Nripan; Graetzel, Michael; Mhaisalkar, Subodh] Energy Res Inst NTU ERI N, Singapore 637553, Singapore; [Mathews, Nripan] Singapore Berkeley Res Initiat Sustainable Energy, Singapore 138602, Singapore; [Lam, Yeng Ming] Rhein Westfal TH Aachen, Inst Mat Elect Engn 2, D-52074 Aachen, Germany; [Graetzel, Michael] Swiss Fed Inst Technol, Dept Chem & Chem Engn, Lab Photon & Interfaces, Stn 6, CH-1015 Lausanne, Switzerland	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; RWTH Aachen University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Mathews, N (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Nanyang Ave, Singapore 639798, Singapore.	nripan@ntu.edu.sg; tzechien@ntu.edu.sg	Mhaisalkar, Subodh/K-5278-2019; Xing, Guichuan/X-2429-2018; Mhaisalkar, Subodh/K-5814-2019; Nazeeruddin, Mohammad K/B-1323-2008; Mathews, Nripan/C-8438-2011; Sum, Tze-Chien/B-3438-2008; Mhaisalkar, Subodh G/A-2231-2011; Lam, Yeng Ming/A-2230-2011	Xing, Guichuan/0000-0003-2769-8659; Mhaisalkar, Subodh/0000-0002-9895-2426; Nazeeruddin, Mohammad K/0000-0001-5955-4786; Mathews, Nripan/0000-0001-5234-0822; Sum, Tze-Chien/0000-0003-4049-2719; Mhaisalkar, Subodh G/0000-0002-9895-2426; Lam, Yeng Ming/0000-0001-9390-8074; Lim, Swee Sien/0000-0003-4930-3718	NTU [M4080514]; School of Physical and Mathematical Sciences [M4080536]; Singapore National Research Foundation [NRF-CRP4-2008-03]; Singapore-Berkeley Research Initiative for Sustainable Energy (SinBeRISE) program; European Research Council "Mesolight" [ARG 247404]	NTU(Nanyang Technological University); School of Physical and Mathematical Sciences; Singapore National Research Foundation(National Research Foundation, Singapore); Singapore-Berkeley Research Initiative for Sustainable Energy (SinBeRISE) program; European Research Council "Mesolight"(European Research Council (ERC))	The authors thank M. Duchamp and C. Boothroyd from Ernst Ruska-Centrum, Forschungszentrum Julich, Germany, for the FIB and transmission electron microscopy work carried out. Financial support from NTU startup grant M4080514, School of Physical and Mathematical Sciences collaborative research award M4080536, Singapore National Research Foundation through the Competitive Research Program (NRF-CRP4-2008-03), and the Singapore-Berkeley Research Initiative for Sustainable Energy (SinBeRISE) program is gratefully acknowledged. M. G. thanks the European Research Council for financial support under the Advanced Research Grant (ARG 247404) "Mesolight."	Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Baikie T, 2013, J MATER CHEM A, V1, P5628, DOI 10.1039/c3ta10518k; Bakulin AA, 2010, ADV FUNCT MATER, V20, P1653, DOI 10.1002/adfm.200902099; Ball JM, 2013, ENERG ENVIRON SCI, V6, P1739, DOI 10.1039/c3ee40810h; Beaujuge PM, 2011, J AM CHEM SOC, V133, P20009, DOI 10.1021/ja2073643; Beek WJE, 2006, ADV FUNCT MATER, V16, P1112, DOI 10.1002/adfm.200500573; Blom PWM, 2007, ADV MATER, V19, P1551, DOI 10.1002/adma.200601093; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Etgar L, 2012, J AM CHEM SOC, V134, P17396, DOI 10.1021/ja307789s; Facchetti A, 2011, CHEM MATER, V23, P733, DOI 10.1021/cm102419z; Grancini G, 2013, NAT MATER, V12, P29, DOI [10.1038/NMAT3502, 10.1038/nmat3502]; Grancini G, 2012, J PHYS CHEM LETT, V3, P517, DOI 10.1021/jz3000382; Haugeneder A, 1999, PHYS REV B, V59, P15346, DOI 10.1103/PhysRevB.59.15346; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI [10.1038/NPHOTON.2013.80, 10.1038/nphoton.2013.80]; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; Jailaubekov AE, 2013, NAT MATER, V12, P66, DOI [10.1038/NMAT3500, 10.1038/nmat3500]; Kagan CR, 1999, SCIENCE, V286, P945, DOI 10.1126/science.286.5441.945; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Kim Y, 2007, J PHYS CHEM C, V111, P8137, DOI 10.1021/jp072306z; Kim Y, 2005, J MATER SCI, V40, P1371, DOI 10.1007/s10853-005-0568-0; Klimov VI, 2007, ANNU REV PHYS CHEM, V58, P635, DOI 10.1146/annurev.physchem.58.032806.104537; Kroeze JE, 2003, J PHYS CHEM B, V107, P7696, DOI 10.1021/jp0217738; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Lunt RR, 2010, ADV MATER, V22, P1233, DOI 10.1002/adma.200902827; MITZI DB, 1995, SCIENCE, V267, P1473, DOI 10.1126/science.267.5203.1473; Mueller ML, 2011, NANO LETT, V11, P56, DOI 10.1021/nl102712x; Najafov H, 2010, NAT MATER, V9, P938, DOI 10.1038/nmat2872; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Ostojic GN, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.097401; Peumans P, 2003, J APPL PHYS, V93, P3693, DOI 10.1063/1.1534621; Piris J, 2009, J PHYS CHEM C, V113, P14500, DOI 10.1021/jp904229q; Selinsky RS, 2013, CHEM SOC REV, V42, P2963, DOI 10.1039/c2cs35374a; Shaw PE, 2008, ADV MATER, V20, P3516, DOI 10.1002/adma.200800982; Sirringhaus H, 2005, ADV MATER, V17, P2411, DOI 10.1002/adma.200501152; van Duren JKJ, 2004, ADV FUNCT MATER, V14, P425, DOI 10.1002/adfm.200305049; Wu B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3004; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Zhang W, 2013, NANO LETT, V13, P4505, DOI 10.1021/nl4024287; Zhitomirsky D, 2013, ACS NANO, V7, P5282, DOI 10.1021/nn402197a	39	5332	5433	140	3888	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					344	347		10.1126/science.1243167	http://dx.doi.org/10.1126/science.1243167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136965	Green Accepted			2022-12-28	WOS:000325755100040
J	Cooper, C				Cooper, Cyrus			David Barker (1938-2013) OBITUARY	NATURE			English	Biographical-Item									[Cooper, Cyrus] Univ Southampton, Lifecourse Epidemiol Unit, MRC, Southampton SO9 5NH, Hants, England	University of Southampton	Cooper, C (corresponding author), Univ Southampton, Lifecourse Epidemiol Unit, MRC, Southampton SO9 5NH, Hants, England.	cc@mrc.soton.ac.uk		Cooper, Cyrus/0000-0003-3510-0709	Medical Research Council [MC_UU_12011/1, MC_UP_A620_1014] Funding Source: Medline; Medical Research Council [U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))			0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					304	304		10.1038/502304a	http://dx.doi.org/10.1038/502304a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132283	Bronze			2022-12-28	WOS:000325706300034
J	Duella, CS				Duella, Chitra Subramaniam			Communication is a determinant of public health: a media campaign for tobacco control in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									CSDconsulting, Gland, Switzerland		Duella, CS (corresponding author), CSDconsulting, Chemin Dole 1, Gland, Switzerland.	chitras@csdconsulting.net						[Anonymous], 2013, EC TIMES; Campaign for Tobacco-Free Kids, 2013, P CHAT MUMB HON LEAD; Das M, 2013, SUPREME COURT ACCUSE; Duella CS, 2013, UNITED BREAKS GUITAR; Duella CS, 2013, NEWS LAUNDRY; Federal Trade Commission, 2013, FED TRAD COMM CIG RE; Ilona Kickbusch I., 2013, HLTH LITERACY SOLID; Mishra GA, 2012, INDIAN J MED PAEDIAT, V33, P139, DOI 10.4103/0971-5851.103139; National Institute for Health and Welfare Finland, 2013, PIKK PUSK BIOGR; News Laundry, 2013, NEWS LAUNDRY; Sharma A, 2013, EC TIMES; World Health Organization, 2011, NCD COUNTR PROF IND; World Health Organization, 2010, STAT REP NONC DIS	13	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2013	347								f6275	10.1136/bmj.f6275	http://dx.doi.org/10.1136/bmj.f6275			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WP	24136636				2022-12-28	WOS:000325982700009
J	Miller, L; Arakaki, L; Ramautar, A; Bodach, S; Braunstein, SL; Kennedy, J; Steiner-Sichel, L; Ngai, S; Shepard, C; Weiss, D				Miller, Laura; Arakaki, Lola; Ramautar, Arianne; Bodach, Sara; Braunstein, Sarah L.; Kennedy, Joseph; Steiner-Sichel, Linda; Ngai, Stephanie; Shepard, Colin; Weiss, Don			Elevated Risk for Invasive Meningococcal Disease Among Persons With HIV	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CONJUGATE VACCINE; UNITED-STATES; ADULTS; INFECTION; NAIROBI; IMMUNOGENICITY; SAFETY; AIDS	Background: An association between HIV and invasive meningococcal disease (IMD) has been suggested by several previous studies but has not been fully described in the era of highly active antiretroviral therapy in the United States. Objective: To estimate the risk for IMD and death in people living with HIV/AIDS (PLWHA) in New York City (NYC) and the contribution of CD4(+) cell count and viral load (VL) to IMD risk. Design: Comparison of the incidence rate of IMD among PLWHA with that among HIV-uninfected persons. Surveillance data on IMD for patients aged 15 to 64 years from 2000 to 2011 were matched to death and HIV registries to calculate IMD risk and case-fatality ratios. A subset of PLWHA who had a CD4(+) cell count and VL measurement near the time of their IMD infection was included in age-matched case-control analyses to assess HIV markers and IMD risk. Setting: Retrospective cohort from communicable disease surveillance. Patients: 265 persons aged 15 to 64 years with IMD during 2000 to 2011. Measurements: Meningococcal and HIV data abstracted from surveillance and registry databases, including CD4(+) cell counts and VL. Results: The average annual incidence rate of IMD was 0.39 cases per 100 000 persons. The relative risk for IMD among PLWHA in NYC during 2000 to 2011 was 10.0 (95% CI, 7.2 to 14.1). Among PLWHA, patients with IMD were 5.3 times (CI, 1.4 to 20.4 times) as likely as age-matched control patients to have CD4(+) counts less than 0.200 x 10(9) cells/L. Limitation: Missing data on smoking status and comorbidity. Conclusion: People living with HIV/AIDS in NYC are at increased risk for IMD. Cost-effectiveness and vaccine efficacy studies are needed to evaluate the value of a national recommendation for routine meningococcal vaccination of PLWHA.	[Miller, Laura; Arakaki, Lola; Ramautar, Arianne; Bodach, Sara; Braunstein, Sarah L.; Kennedy, Joseph; Steiner-Sichel, Linda; Ngai, Stephanie; Shepard, Colin; Weiss, Don] New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Weiss, D (corresponding author), New York City Dept Hlth & Mental Hyg, Gotham Ctr, CN 22a,42-09 28th St,6th Floor, Queens, NY 11101 USA.	dweiss@health.nyc.gov		Arakaki, Lola/0000-0002-5281-7405	New York City Tax Levy; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U62PS003993] Funding Source: NIH RePORTER	New York City Tax Levy; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	New York City Tax Levy.	Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P72; Bilukha Oleg O., 2005, Morbidity and Mortality Weekly Report, V54, P1; Bobula SM, 2012, WORLD J AIDS, V2, P237; BRINDLE R, 1991, T ROY SOC TROP MED H, V85, P651, DOI 10.1016/0035-9203(91)90380-H; Bruce MG, 2001, JAMA-J AM MED ASSOC, V286, P688, DOI 10.1001/jama.286.6.688; Cartter ML, 2005, REVISION NATL SURVEI; Cohen C, 2010, AIDS, V24, P1351, DOI 10.1097/QAD.0b013e32833a2520; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Cookson ST, 1998, J INFECT DIS, V178, P266, DOI 10.1086/517450; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Drobnik A, 2013, J PUBLIC HL IN PRESS; Eavey JJ, 2010, 19 INT AIDS C WASH D; Epiquery: NYC Interactive Health Data System, 2010, EP NYC INT HLTH DAT; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Hart CA, 2000, J MED MICROBIOL, V49, P947, DOI 10.1099/0022-1317-49-11-947; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Huang L, 2009, RESPIROLOGY, V14, P474, DOI 10.1111/j.1440-1843.2009.01534.x; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; KIPP W, 1992, AIDS, V6, P1557, DOI 10.1097/00002030-199212000-00031; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Lujan-Zilbermann J, 2012, J PEDIATR-US, V161, P676, DOI 10.1016/j.jpeds.2012.04.005; PINNER RW, 1992, J INFECT DIS, V166, P359, DOI 10.1093/infdis/166.2.359; Rodriguez-Barradas MC, 2008, CLIN INFECT DIS, V46, P1093, DOI 10.1086/529201; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Siberry GK, 2010, PEDIATR INFECT DIS J, V29, P391, DOI 10.1097/INF.0b013e3181c38f3b; Simon MS, 2013, ANN INTERN MED, V159, P300, DOI 10.7326/0003-4819-159-4-201308200-00674; STEPHENS DS, 1995, ANN INTERN MED, V123, P937, DOI 10.7326/0003-4819-123-12-199512150-00007; Weiss D, 2013, MMWR-MORBID MORTAL W, V61, P1048	30	45	50	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					30	+		10.7326/0003-4819-160-1-201401070-00731	http://dx.doi.org/10.7326/0003-4819-160-1-201401070-00731			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297IS	24166695				2022-12-28	WOS:000330249700004
J	Christian, NJ; King, WC; Yanovski, SZ; Courcoulas, AP; Belle, SH				Christian, Nicholas J.; King, Wendy C.; Yanovski, Susan Z.; Courcoulas, Anita P.; Belle, Steven H.			Validity of Self-reported Weights Following Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BODY-MASS INDEX; HEIGHT		[Christian, Nicholas J.; King, Wendy C.; Belle, Steven H.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Yanovski, Susan Z.] NIDDKD, Bethesda, MD USA; [Courcoulas, Anita P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Christian, NJ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, 130 DeSoto St,127 Parran Hall, Pittsburgh, PA 15261 USA.	christiann@edc.pitt.edu	King, Wendy C/AAC-5122-2022	King, Wendy C/0000-0002-0740-0029	NCATS NIH HHS [UL1 TR000005, UL1 TR000457] Funding Source: Medline; NCRR NIH HHS [UL1 RR024153, M01RR-00037, UL1 RR024996, M01 RR000037, UL1-RR024996, UL1-RR024153] Funding Source: Medline; NIDDK NIH HHS [U01 DK066557, U01-DK66555, U01-DK66585, U01 DK066471, U01-DK66568, U01 DK066667, U01 DK066555, U01-DK66667, U01-DK66471, U01 DK066526, U01 DK066585, U01-DK66526, U01 DK066568] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037, UL1RR024996, UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066568, U01DK066667, U01DK066555, U01DK066585, U01DK066526, U01DK066557, U01DK066471] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Belle SH, 2013, SURG OBES RELAT DIS, V9, P926, DOI 10.1016/j.soard.2013.01.023; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Merrill RM, 2009, PREV CHRONIC DIS, V6; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; White MA, 2007, OBESITY, V15, P2761, DOI 10.1038/oby.2007.328	6	67	67	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2454	2456		10.1001/jama.2013.281043	http://dx.doi.org/10.1001/jama.2013.281043			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24189698	Bronze, Green Accepted			2022-12-28	WOS:000328030900027
J	Lindeboom, JJ; Nakamura, M; Hibbel, A; Shundyak, K; Gutierrez, R; Ketelaar, T; Emons, AMC; Mulder, BM; Kirik, V; Ehrhardt, DW				Lindeboom, Jelmer J.; Nakamura, Masayoshi; Hibbel, Anneke; Shundyak, Kostya; Gutierrez, Ryan; Ketelaar, Tijs; Emons, Anne Mie C.; Mulder, Bela M.; Kirik, Viktor; Ehrhardt, David W.			A Mechanism for Reorientation of Cortical Microtubule Arrays Driven by Microtubule Severing	SCIENCE			English	Article							OUTER EPIDERMAL WALL; MAIZE COLEOPTILES; PLASMA-MEMBRANE; GAMMA-TUBULIN; GROWTH-RATE; KATANIN; LIGHT; ORGANIZATION; NUCLEATION; DYNAMICS	Environmental and hormonal signals cause reorganization of microtubule arrays in higher plants, but the mechanisms driving these transitions have remained elusive. The organization of these arrays is required to direct morphogenesis. We discovered that microtubule severing by the protein katanin plays a crucial and unexpected role in the reorientation of cortical arrays, as triggered by blue light. Imaging and genetic experiments revealed that phototropin photoreceptors stimulate katanin-mediated severing specifically at microtubule intersections, leading to the generation of new microtubules at these locations. We show how this activity serves as the basis for a mechanism that amplifies microtubules orthogonal to the initial array, thereby driving array reorientation. Our observations show how severing is used constructively to build a new microtubule array.	[Lindeboom, Jelmer J.; Nakamura, Masayoshi; Gutierrez, Ryan; Kirik, Viktor; Ehrhardt, David W.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Lindeboom, Jelmer J.; Hibbel, Anneke; Ketelaar, Tijs; Emons, Anne Mie C.; Mulder, Bela M.] Wageningen Univ, Cell Biol Lab, NL-6708 PB Wageningen, Netherlands; [Hibbel, Anneke] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Shundyak, Kostya; Mulder, Bela M.] Fundamenteel Onderzoek Materie FOM Inst Atom & Mo, NL-1098 XG Amsterdam, Netherlands; [Gutierrez, Ryan; Ehrhardt, David W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kirik, Viktor] Illinois State Univ, Sch Biol Sci, Normal, IL 61790 USA	Carnegie Institution for Science; Wageningen University & Research; Max Planck Society; Stanford University; Illinois State University	Ehrhardt, DW (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	ehrhardt@stanford.edu	Nakamura, Masayoshi/D-1979-2017; Mulder, Bela/C-1070-2012	Nakamura, Masayoshi/0000-0002-7107-4942; Lindeboom, Jelmer J/0000-0003-4294-4838; Hibbel, Anneke/0000-0003-4074-2343; Mulder, Bela/0000-0002-8620-5749	NSF [1158372]; Carnegie Institution for Science; research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); European Union NEST program CASPIC award [28974]; TOYOBO BIOFOUNDATION; Human Frontier Science Program; Direct For Biological Sciences [1158372] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102839] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Carnegie Institution for Science; research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union NEST program CASPIC award; TOYOBO BIOFOUNDATION; Human Frontier Science Program(Human Frontier Science Program); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.W.E., J.J.L., M.N., and V. K. designed experimental strategy. J.J.L., M.N., A. H., and V. K. carried out experiments. J.J.L., M.N., A. H., and D. W. E. analyzed data. K. S., R. G., J.J.L., B. M. M., and D. W. E. designed and created image-analysis tools. D. W. E., J.J.L., and M.N. wrote the manuscript. B. M. M., A. H., R. G., V. K., T. K., and A. M. C. E. edited the manuscript. We thank W. Briggs, A. Murphy, R. Hangarter, E. Spalding, T. Hashimoto, M. Janson, and S. Shaw for advice and discussions. This work was supported by NSF award 1158372 (D. W. E.); the Carnegie Institution for Science (D. W. E.); the research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (B. M. M.); the European Union NEST program CASPIC award 28974 (J.J.L. and K. S.); TOYOBO BIOFOUNDATION (M.N.); and the Human Frontier Science Program (M.N.).	Allard JF, 2010, BIOPHYS J, V99, P1082, DOI 10.1016/j.bpj.2010.05.037; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Burk DH, 2007, J INTEGR PLANT BIOL, V49, P1174, DOI 10.1111/j.1672-9072.2007.00544.x; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; Dixit R, 2004, PLANT CELL, V16, P3274, DOI 10.1105/tpc.104.026930; Eren EC, 2010, MOL BIOL CELL, V21, P2674, DOI 10.1091/mbc.E10-02-0136; GALLAGHER S, 1988, P NATL ACAD SCI USA, V85, P8003, DOI 10.1073/pnas.85.21.8003; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Hamant O, 2013, CURR BIOL, V23, pR206, DOI 10.1016/j.cub.2013.01.031; Hawkins RJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011911; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kirik A, 2012, PLANT CELL, V24, P1158, DOI 10.1105/tpc.111.094367; LASKOWSKI MJ, 1990, PLANTA, V181, P44, DOI 10.1007/BF00202323; Lin DS, 2013, CURR BIOL, V23, P290, DOI 10.1016/j.cub.2013.01.022; Lindeboom JJ, 2013, PLANT PHYSIOL, V161, P1189, DOI 10.1104/pp.112.204057; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nakamura M, 2004, PLANT CELL PHYSIOL, V45, P1330, DOI 10.1093/pcp/pch300; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; Nakamura M, 2009, J CELL SCI, V122, P2208, DOI 10.1242/jcs.044131; NICK P, 1990, PLANTA, V181, P162, DOI 10.1007/BF02411533; Oda Y, 2012, SCIENCE, V337, P1333, DOI 10.1126/science.1222597; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Rasband W. S., 2012, LIBRARY; Rasi MQ, 2009, MOL BIOL CELL, V20, P379, DOI 10.1091/mbc.E07-10-1007; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Sambade A, 2012, PLANT CELL, V24, P192, DOI 10.1105/tpc.111.093849; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Shi XQ, 2010, P NATL ACAD SCI USA, V107, P11709, DOI 10.1073/pnas.1007138107; SHIBAOKA H, 1994, ANNU REV PLANT PHYS, V45, P527, DOI 10.1146/annurev.pp.45.060194.002523; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Stoppin-Mellet V, 2002, BIOCHEM J, V365, P337, DOI 10.1042/BJ20020689; Tindemans SH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031910; Tindemans SH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058103; Tran PT, 1997, J CELL BIOL, V138, P105, DOI 10.1083/jcb.138.1.105; Ueda K, 2000, PROTOPLASMA, V213, P28, DOI 10.1007/BF01280502; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Vineyard L, 2013, PLANT CELL, V25, P662, DOI 10.1105/tpc.112.107326; WALKER RA, 1989, J CELL BIOL, V108, P931, DOI 10.1083/jcb.108.3.931; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x; ZANDOMENI K, 1993, PROTOPLASMA, V173, P103, DOI 10.1007/BF01378999	52	172	180	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1202	+	1245533	10.1126/science.1245533	http://dx.doi.org/10.1126/science.1245533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24200811				2022-12-28	WOS:000327857900038
J	Yin, P; Li, QX; Yan, CY; Liu, Y; Liu, JJ; Yu, F; Wang, Z; Long, JF; He, JH; Wang, HW; Wang, JW; Zhu, JK; Shi, YG; Yan, NE				Yin, Ping; Li, Quanxiu; Yan, Chuangye; Liu, Ying; Liu, Junjie; Yu, Feng; Wang, Zheng; Long, Jiafu; He, Jianhua; Wang, Hong-Wei; Wang, Jiawei; Zhu, Jian-Kang; Shi, Yigong; Yan, Nieng			Structural basis for the modular recognition of single-stranded RNA by PPR proteins	NATURE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; CYTOPLASMIC MALE-STERILITY; RESTORES FERTILITY; BINDING; IDENTIFICATION; MECHANISM; REVEALS; INSIGHT; TERMINI; RICE	Pentatricopeptide repeat (PPR) proteins represent a large family of sequence-specific RNA-binding proteins that are involved in multiple aspects of RNA metabolism. PPR proteins, which are found in exceptionally large numbers in the mitochondria and chloroplasts of terrestrial plants(1-5), recognize single-stranded RNA (ssRNA) in a modular fashion(6-8). The maize chloroplast protein PPR10 binds to two similar RNA sequences from the ATPI-ATPH and PSAJ-RPL33 intergenic regions, referred to as ATPH and PSAJ, respectively(9,10). By protecting the target RNA elements from 5' or 3' exonucleases, PPR10 defines the corresponding 5' and 3' messenger RNA termini(9-11). Despite rigorous functional characterizations, the structural basis of sequence-specific ssRNA recognition by PPR proteins remains to be elucidated. Here we report the crystal structures of PPR10 in RNA-free and RNA-bound states at resolutions of 2.85 and 2.45 angstrom, respectively. In the absence of RNA binding, the nineteen repeats of PPR10 are assembled into a right-handed superhelical spiral. PPR10 forms an antiparallel, intertwined homodimer and exhibits considerable conformational changes upon binding to its target ssRNA, an 18-nucleotide PSAJ element. Six nucleotides of PSAJ are specifically recognized by six corresponding PPR10 repeats following the predicted code. The molecular basis for the specific and modular recognition of RNA bases A, G and U is revealed. The structural elucidation of RNA recognition by PPR proteins provides an important framework for potential biotechnological applications of PPR proteins in RNA-related research areas.	[Yin, Ping; Li, Quanxiu; Liu, Ying; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Yin, Ping; Li, Quanxiu; Yan, Chuangye; Liu, Ying; Liu, Junjie; Wang, Hong-Wei; Wang, Jiawei; Shi, Yigong; Yan, Nieng] Tsinghua Univ, Ctr Struct Biol, Sch Life Sci, Beijing 100084, Peoples R China; [Yin, Ping; Li, Quanxiu; Yan, Chuangye; Liu, Ying; Liu, Junjie; Wang, Hong-Wei; Wang, Jiawei; Shi, Yigong; Yan, Nieng] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Yan, Chuangye; Liu, Junjie; Wang, Hong-Wei; Shi, Yigong] Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China; [Yu, Feng; He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China; [Wang, Zheng; Long, Jiafu] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Wang, Zheng; Long, Jiafu] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol, Shanghai 200032, Peoples R China; [Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Nankai University; Nankai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Yan, NE (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Long, Jiafu/B-7420-2012; Zhu, Jian-Kang/F-7658-2011; Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021	Long, Jiafu/0000-0002-6625-0147; Zhu, Jian-Kang/0000-0001-5134-731X; Wang, Jiawei/0000-0001-9893-8539; Liu, Jun-Jie/0000-0002-8982-107X; Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2011CB910501]; National Natural Science Foundation of China [91017011, 31070644, 31021002, 31200567]; Howard Hughes Medical Institute	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank X. Yu and Y. Chen at the Institute of Biophysics, Chinese Academy of Sciences, for technical support. We thank K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU for on-site assistance. This work was supported by funds from the Ministry of Science and Technology (grant number 2011CB910501 for N.Y.), and Projects 91017011 (N.Y.), 31070644 (N.Y.), 31021002 (Y. S., N.Y., J.W.) and 31200567 (P. Y.) of the National Natural Science Foundation of China. The research of N.Y. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; DeLano W.L, PYMOL MOL GRAPHICS S; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Desloire S, 2003, EMBO REP, V4, P588, DOI 10.1038/sj.embor.embor848; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipovska A, 2012, MOL BIOSYST, V8, P699, DOI 10.1039/c2mb05392f; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Hu J, 2012, PLANT CELL, V24, P109, DOI 10.1105/tpc.111.093211; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P2712, DOI 10.1093/nar/gkr1084; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Nakamura T, 2012, PLANT CELL PHYSIOL, V53, P1171, DOI 10.1093/pcp/pcs069; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Yagi Y, 2013, RNA BIOL, V10, P1419, DOI 10.4161/rna.24908; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	37	238	252	6	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					168	+		10.1038/nature12651	http://dx.doi.org/10.1038/nature12651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24162847				2022-12-28	WOS:000327851700053
J	Millum, J; Wendler, D; Emanuel, EJ				Millum, Joseph; Wendler, David; Emanuel, Ezekiel J.			The 50th Anniversary of the Declaration of Helsinki Progress but Many Remaining Challenges	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Millum, Joseph; Wendler, David] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Millum, Joseph] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Emanuel, Ezekiel J.] Univ Penn, Off Provost, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Emanuel, EJ (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, 122 Coll Hall, Philadelphia, PA 19104 USA.	vp-global@upenn.edu			Intramural NIH HHS [Z99 CL999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Emanuel EJ, 2004, HASTINGS CENT REP, V34, P5, DOI 10.2307/3528166; Emanuel EJ, 2013, LANCET, V381, P1532, DOI 10.1016/S0140-6736(13)60970-8; Hurst SA, 2008, BIOETHICS, V22, P191, DOI 10.1111/j.1467-8519.2008.00631.x; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Millum J, 2012, J MED ETHICS, V38, P219, DOI 10.1136/medethics-2011-100118; Presidential Commission for the Study of Bioethical Issues, MOR SCI PROT PART HU; Wendler D, 2004, AM J PUBLIC HEALTH, V94, P923, DOI 10.2105/AJPH.94.6.923	7	61	71	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2143	2144		10.1001/jama.2013.281632	http://dx.doi.org/10.1001/jama.2013.281632			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24141885	Bronze, Green Accepted			2022-12-28	WOS:000327404400018
J	Rasaiyaah, J; Tan, CP; Fletcher, AJ; Price, AJ; Blondeau, C; Hilditch, L; Jacques, DA; Selwood, DL; James, LC; Noursadeghi, M; Towers, GJ				Rasaiyaah, Jane; Tan, Choon Ping; Fletcher, Adam J.; Price, Amanda J.; Blondeau, Caroline; Hilditch, Laura; Jacques, David A.; Selwood, David L.; James, Leo C.; Noursadeghi, Mahdad; Towers, Greg J.			HIV-1 evades innate immune recognition through specific cofactor recruitment	NATURE			English	Article							GMP-AMP SYNTHASE; CYCLOSPORINE-A; GENE DELIVERY; RNA-BINDING; CLEAVAGE; CYCLOPHILIN; SENSOR; POLYADENYLATION; INFECTION; CELLS	Human immunodeficiency virus (HIV)-1 is able to replicate in primary human macrophages without stimulating innate immunity despite reverse transcription of genomic RNA into double-stranded DNA, an activity that might be expected to trigger innate pattern recognition receptors. We reasoned that if correctly orchestrated HIV-1 uncoating and nuclear entry is important for evasion of innate sensors then manipulation of specific interactions between HIV-1 capsid and host factors that putatively regulate these processes should trigger pattern recognition receptors and stimulate type 1 interferon (IFN) secretion. Here we show that HIV-1 capsid mutants N74D and P90A, which are impaired for interaction with cofactors cleavage and polyadenylation specificity factor subunit 6 (CPSF6) and cyclophilins (Nup358 and CypA), respectively(1,2), cannot replicate in primary human monocyte-derived macrophages because they trigger innate sensors leading to nuclear translocation of NF-kappa B and IRF3, the production of soluble type 1 IFN and induction of an antiviral state. Depletion of CPSF6 with short hairpin RNA expression allows wild-type virus to trigger innate sensors and IFN production. In each case, suppressed replication is rescued by IFN-receptor blockade, demonstrating a role for IFN in restriction. IFN production is dependent on viral reverse transcription but not integration, indicating that a viral reverse transcription product comprises the HIV-1 pathogen-associated molecular pattern. Finally, we show that we can pharmacologically induce wild-type HIV-1 infection to stimulate IFN secretion and an antiviral state using a non-immunosuppressive cyclosporine analogue. We conclude that HIV-1 has evolved to use CPSF6 and cyclophilins to cloak its replication, allowing evasion of innate immune sensors and induction of a cell-autonomous innate immune response in primary human macrophages.	[Rasaiyaah, Jane; Tan, Choon Ping; Fletcher, Adam J.; Blondeau, Caroline; Hilditch, Laura; Noursadeghi, Mahdad; Towers, Greg J.] UCL, MRC, Ctr Med Mol Virol, Div Infect & Immun, London WC1E 6BT, England; [Price, Amanda J.; Jacques, David A.; James, Leo C.] MRC, Mol Biol Lab, Prot & Nucle Acid Chem Div, Cambridge CB2 0QH, England; [Selwood, David L.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London	Towers, GJ (corresponding author), UCL, MRC, Ctr Med Mol Virol, Div Infect & Immun, 90 Gower St, London WC1E 6BT, England.	m.noursadeghi@ucl.ac.uk; g.towers@ucl.ac.uk	Blondeau, Caroline/D-4269-2017	Selwood, David/0000-0002-6817-5064; Noursadeghi, Mahdad/0000-0002-4774-0853; Fletcher, Adam/0000-0003-1742-6588; Jacques, David/0000-0002-6426-4510; Towers, Gregory/0000-0002-7707-0264	Wellcome Trust [090940]; Medical Research Council; MRC Confidence in Concept Award; National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre; MRC [MC_U105181010, MC_PC_12024, G9721629, G0501446, G0900950, G0801172] Funding Source: UKRI; Medical Research Council [G0900950B, G0501446, G9721629B, G0900950, MC_U105181010, MC_PC_12024, G0801172, G9721629] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Confidence in Concept Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to J. W. Chin, S. Goodbourn, K. Lee, O. Perisic and V. KewalRamani for reagents and advice. This work was funded by Wellcome Trust Senior Fellowship 090940 to G.J.T., the Medical Research Council, an MRC Confidence in Concept Award to G.J.T. and D.S. and the National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Ambrose Z, 2012, J VIROL, V86, P4708, DOI 10.1128/JVI.05887-11; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Dube H, 2012, BIOCHEM J, V441, P901, DOI 10.1042/BJ20111301; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Hori T, 2013, J VIROL, V87, P7726, DOI 10.1128/JVI.00124-13; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iyer SR, 2009, J VIROL, V83, P8662, DOI 10.1128/JVI.00874-09; Lee K, 2012, J VIROL, V86, P3851, DOI 10.1128/JVI.06607-11; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Liu JP, 2011, TRANSPL INFECT DIS, V13, P24, DOI 10.1111/j.1399-3062.2010.00556.x; Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Morner A, 1999, J VIROL, V73, P2343; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Ruepp MD, 2011, WIRES RNA, V2, P79, DOI 10.1002/wrna.35; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tsang J, 2009, AIDS, V23, P2255, DOI 10.1097/QAD.0b013e328331a4ce; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang Q, 2011, RNA BIOL, V8, P748, DOI 10.4161/rna.8.5.16040; Zhang FW, 2006, VIROLOGY, V353, P396, DOI 10.1016/j.virol.2006.05.035; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	32	313	323	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					402	+		10.1038/nature12769	http://dx.doi.org/10.1038/nature12769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24196705	Green Accepted, Green Published			2022-12-28	WOS:000327163200042
J	Han, K; Holder, JL; Schaaf, CP; Lu, H; Chen, HM; Kang, H; Tang, JR; Wu, ZY; Hao, S; Cheung, SW; Yu, P; Sun, H; Breman, AM; Patel, A; Lu, HC; Zoghbi, HY				Han, Kihoon; Holder, J. Lloyd, Jr.; Schaaf, Christian P.; Lu, Hui; Chen, Hongmei; Kang, Hyojin; Tang, Jianrong; Wu, Zhenyu; Hao, Shuang; Cheung, Sau Wai; Yu, Peng; Sun, Hao; Breman, Amy M.; Patel, Ankita; Lu, Hui-Chen; Zoghbi, Huda Y.			SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties	NATURE			English	Article							AUTISM SPECTRUM DISORDER; SCAFFOLDING PROTEIN SHANK3; 22Q13.3 DELETION SYNDROME; BIPOLAR DISORDER; PSYCHIATRIC-DISORDERS; POSTSYNAPTIC DENSITY; GENE; MUTATIONS; DYSFUNCTION; PROFILIN	Mutations in SHANK3 and large duplications of the region spanning SHANK3 both cause a spectrum of neuropsychiatric disorders, indicating that proper SHANK3 dosage is critical for normal brain function. However, SHANK3 overexpression per se has not been established as a cause of human disorders because 22q13 duplications involve several genes. Here we report that Shank3 transgenic mice modelling a human SHANK3 duplication exhibit manic-like behaviour and seizures consistent with synaptic excitatory/inhibitory imbalance. We also identified two patients with hyperkinetic disorders carrying the smallest SHANK3-spanning duplications reported so far. These findings indicate that SHANK3 overexpression causes a hyperkinetic neuropsychiatric disorder. To probe the mechanism underlying the phenotype, we generated a Shank3 in vivo interactome and found that Shank3 directly interacts with the Arp2/3 complex to increase F-actin levels in Shank3 transgenic mice. The mood-stabilizing drug valproate, but not lithium, rescues the manic-like behaviour of Shank3 transgenic mice raising the possibility that this hyperkinetic disorder has a unique pharmacogenetic profile.	[Han, Kihoon; Schaaf, Christian P.; Lu, Hui; Kang, Hyojin; Cheung, Sau Wai; Yu, Peng; Breman, Amy M.; Patel, Ankita; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Han, Kihoon; Lu, Hui; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Han, Kihoon; Holder, J. Lloyd, Jr.; Schaaf, Christian P.; Lu, Hui; Chen, Hongmei; Kang, Hyojin; Tang, Jianrong; Wu, Zhenyu; Hao, Shuang; Yu, Peng; Sun, Hao; Lu, Hui-Chen; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Holder, J. Lloyd, Jr.; Chen, Hongmei; Tang, Jianrong; Wu, Zhenyu; Hao, Shuang; Sun, Hao; Lu, Hui-Chen; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Holder, J. Lloyd, Jr.] Baylor Coll Med, Div Neurol & Dev Neurosci, Houston, TX 77030 USA; [Chen, Hongmei; Sun, Hao; Lu, Hui-Chen] Texas Childrens Hosp, Cain Fdn Labs, Houston, TX 77030 USA; [Cheung, Sau Wai; Breman, Amy M.; Patel, Ankita] Baylor Coll Med, Med Genet Labs, Houston, TX 77030 USA; [Lu, Hui-Chen; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Lu, Hui-Chen; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu	Holder, J. Lloyd/AFT-0389-2022; Han, Kihoon/AAE-8919-2019; Schaaf, Christian P/AAJ-7318-2021	Han, Kihoon/0000-0002-5925-2152; Schaaf, Christian P/0000-0002-2148-7490; Sun, Hao/0000-0002-3670-2886; Breman, Amy/0000-0003-0299-0100; Zoghbi, Huda/0000-0002-0700-3349; Holder, Jimmy/0000-0001-5595-0458	Howard Hughes Medical Institute; National Institutes of Health (NIH) ARRA grant [1R01NS070302]; Baylor Intellectual and Developmental Disabilities Research Center [P30HD024064]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110784]; Thrasher Research Fund; NIH [2T32NS043124]; Ting Tsung and Wei Fong Chao Foundation; Joan and Stanford Alexander family; Doris Duke Clinical Scientist Development Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R01NS070302, R01NS048884] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH) ARRA grant; Baylor Intellectual and Developmental Disabilities Research Center; Cancer Prevention and Research Institute of Texas (CPRIT); Thrasher Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ting Tsung and Wei Fong Chao Foundation; Joan and Stanford Alexander family; Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to the patients and families who participated in this study; to J. W. Belmont and N. Miller for contributing patients to this study; G. Feng for sharing Shank3B mice; G. Schuster for injection of Shank3 BAC; and C. Spencer for behavioural assays training. This project was supported by The Howard Hughes Medical Institute (H.Y.Z.), National Institutes of Health (NIH) ARRA grant (1R01NS070302) (H.Y.Z.), the Baylor Intellectual and Developmental Disabilities Research Center (P30HD024064) confocal, electrophysiology and mouse neurobehavioral cores, and the Cancer Prevention and Research Institute of Texas (CPRIT) RP110784. J. L. H. was supported by an Early Career Award from the Thrasher Research Fund, NIH 2T32NS043124 and the Ting Tsung and Wei Fong Chao Foundation; C. P. S. was supported by the Joan and Stanford Alexander family, the Ting Tsung and Wei Fong Chao Foundation and the Doris Duke Clinical Scientist Development Award.	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUNNER DL, 1974, ARCH GEN PSYCHIAT, V30, P229; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Failla P, 2007, CLIN GENET, V71, P599, DOI 10.1111/j.1399-0004.2007.00819.x; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Giesemann T, 2003, J NEUROSCI, V23, P8330; Gitlin M, 2006, MOL PSYCHIATR, V11, P227, DOI 10.1038/sj.mp.4001793; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Grabrucker AM, 2011, TRENDS CELL BIOL, V21, P594, DOI 10.1016/j.tcb.2011.07.003; Han K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000187; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jope RS, 1999, MOL PSYCHIATR, V4, P117, DOI 10.1038/sj.mp.4000494; Leibenluft E, 2008, ANNU REV CLIN PSYCHO, V4, P163, DOI 10.1146/annurev.clinpsy.4.022007.141216; Lu H, 2009, J NEUROSCI, V29, P12664, DOI 10.1523/JNEUROSCI.1984-09.2009; Magloczky Z, 2005, TRENDS NEUROSCI, V28, P334, DOI 10.1016/j.tins.2005.04.002; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Martinowich K, 2009, J CLIN INVEST, V119, P726, DOI 10.1172/JCI37703; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Neuhoff H, 2005, EUR J NEUROSCI, V21, P15, DOI 10.1111/j.1460-9568.2004.03814.x; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sato D, 2012, AM J HUM GENET, V90, P879, DOI 10.1016/j.ajhg.2012.03.017; Schloesser RJ, 2012, TRENDS NEUROSCI, V35, P36, DOI 10.1016/j.tins.2011.11.009; Shaltiel G, 2008, MOL PSYCHIATR, V13, P858, DOI 10.1038/mp.2008.20; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2011, COLD SPRING HARB PER; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	55	249	267	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					72	+		10.1038/nature12630	http://dx.doi.org/10.1038/nature12630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24153177	Green Accepted			2022-12-28	WOS:000326585600034
J	MacGregor, EA				MacGregor, E. Anne			Migraine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material														MacGregor, E Anne/0000-0002-4116-9828				Adeney KL, 2005, J MATERN-FETAL NEO M, V18, P167, DOI 10.1080/14767050500260566; [Anonymous], 2004, OBSTET GYNECOL, V104, P647; Colman I, 2005, ANN EMERG MED, V45, P393, DOI 10.1016/j.annemergmed.2004.07.430; Colman I, 2004, BMJ-BRIT MED J, V329, P1369, DOI 10.1136/bmj.38281.595718.7C; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Duong S, 2010, CAN FAM PHYSICIAN, V56, P537; EGGER J, 1983, LANCET, V2, P865; Facchinetti F, 2009, CEPHALALGIA, V29, P286, DOI 10.1111/j.1468-2982.2008.01704.x; Ferrari MD, 2001, LANCET, V358, P1668, DOI 10.1016/S0140-6736(01)06711-3; Friedman BW, 2011, ANN EMERG MED, V57, P475, DOI 10.1016/j.annemergmed.2010.11.023; Friedman BW, 2005, NEUROLOGY, V64, P463, DOI 10.1212/01.WNL.0000150904.28131.DD; FRISHBERG BM, 1994, NEUROLOGY, V44, P1191, DOI 10.1212/WNL.44.7.1191; Frishberg BM, 2000, US HEADACHE CONSORTI; GALLAGHER RM, 1986, HEADACHE, V26, P74, DOI 10.1111/j.1526-4610.1986.hed2602074.x; Gillman PK, 2010, HEADACHE, V50, P264, DOI 10.1111/j.1526-4610.2009.01575.x; Goldstein J, 1999, CEPHALALGIA, V19, P684, DOI 10.1046/j.1468-2982.1999.019007684.x; GRANELLA F, 1993, HEADACHE, V33, P385, DOI 10.1111/j.1526-4610.1993.hed3307385.x; GRONSETH GS, 1995, NEUROLOGY, V45, P1263, DOI 10.1212/WNL.45.7.1263; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; HOLROYD KA, 1990, PAIN, V42, P1, DOI 10.1016/0304-3959(90)91085-W; HOLROYD KA, 1989, HEADACHE, V29, P148, DOI 10.1111/j.1526-4610.1989.hed2903148.x; Hoodin F, 2000, HEADACHE, V40, P377, DOI 10.1046/j.1526-4610.2000.00057.x; HUSTON KA, 1978, ANN INTERN MED, V88, P162, DOI 10.7326/0003-4819-88-2-162; Kelly AM, 2009, HEADACHE, V49, P1324, DOI 10.1111/j.1526-4610.2009.01465.x; Kirthi V., 2010, COCHRANE DB SYST REV, V4; Lipton RB, 2000, JAMA-J AM MED ASSOC, V284, P2599, DOI 10.1001/jama.284.20.2599; Lipton RB, 2000, ARCH INTERN MED, V160, P3486, DOI 10.1001/archinte.160.22.3486; MANSFIELD LE, 1985, ANN ALLERGY, V55, P126; MICHEL P, 1993, NEUROEPIDEMIOLOGY, V12, P51, DOI 10.1159/000110299; Morey SS, 2000, AM FAM PHYSICIAN, V62, P2359; Oldman AD, 2002, PAIN, V97, P247, DOI 10.1016/S0304-3959(02)00024-6; Olesen C, 2000, HEADACHE, V40, P20, DOI 10.1046/j.1526-4610.2000.00003.x; PEATFIELD RC, 1995, HEADACHE, V35, P355, DOI 10.1111/j.1526-4610.1995.hed3506355.x; Rabbie R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008039.pub2; RodriguezValverde V, 1997, AM J MED, V102, P331, DOI 10.1016/S0002-9343(97)00117-4; Saper JR, 1999, HEADACHE, V39, P249, DOI 10.1046/j.1526-4610.1999.3904249.x; Scharff L, 1996, HEADACHE, V36, P285, DOI 10.1046/j.1526-4610.1996.3605285.x; Silberstein SD, 2013, NEUROLOGY, V80, P871, DOI 10.1212/WNL.0b013e318287dc4e; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Silberstein SD, 2004, NEUROLOGY, V63, P261, DOI 10.1212/01.WNL.0000134620.30129.D6; Tfelt-Hansen P, 1998, CEPHALALGIA, V18, P532, DOI 10.1046/j.1468-2982.1998.1808532.x; Tfelt-Hansen P, 2000, BRAIN, V123, P9, DOI 10.1093/brain/123.1.9; TFELTHANSEN P, 1995, LANCET, V346, P923, DOI 10.1016/S0140-6736(95)91554-0; VANDENBERGH V, 1987, HEADACHE, V27, P191; Winner P, 1996, ARCH NEUROL-CHICAGO, V53, P180, DOI 10.1001/archneur.1996.00550020092020	46	6	6	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					ITC51	ITC516		10.7326/0003-4819-159-9-201311050-01005	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-01005			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NT	24189604				2022-12-28	WOS:000209756400001
J	Khan, AA; Kelly, RJ; Carrim, ZI				Khan, Ashraf A.; Kelly, Ross J.; Carrim, Zia I.			Flashes, floaters, and a field defect	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Khan, Ashraf A.] Princess Alexandra Eye Pavil, Edinburgh, Midlothian, Scotland; [Kelly, Ross J.] St Pauls Med Ctr, Carlisle, England; [Carrim, Zia I.] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Carrim, ZI (corresponding author), St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	zia.carrim@doctors.org.uk						Hollands H, 2009, JAMA-J AM MED ASSOC, V302, P2243, DOI 10.1001/jama.2009.1714	1	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2013	347								F6496					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XI	24191272				2022-12-28	WOS:000326889700006
J	Wurtz, RH				Wurtz, Robert H.			David H. Hubel (1926-2013)	SCIENCE			English	Biographical-Item									NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Wurtz, RH (corresponding author), NEI, Sensorimotor Res Lab, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	bob@lsr.nei.nih.gov			NATIONAL EYE INSTITUTE [ZIAEY000109] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					572	572		10.1126/science.1247113	http://dx.doi.org/10.1126/science.1247113			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179213				2022-12-28	WOS:000326334300030
J	Laghari, JR				Laghari, Javaid R.			Melting glaciers bring energy uncertainty	NATURE			English	Editorial Material												jlaghari@hec.gov.pk						Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Teng HY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051723; United Nations Educational Scientific and Cultural Organization, 2009, WAT CHANG WORLD; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/nclimate1580, 10.1038/NCLIMATE1580]	5	39	39	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					617	618		10.1038/502617a	http://dx.doi.org/10.1038/502617a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24180016	Bronze			2022-12-28	WOS:000326293200022
J	Power, S; Delage, F; Chung, C; Kociuba, G; Keay, K				Power, Scott; Delage, Francois; Chung, Christine; Kociuba, Greg; Keay, Kevin			Robust twenty-first-century projections of El Nino and related precipitation variability	NATURE			English	Article							CLIMATE; OCEAN; ENSO	The El Nino-Southern Oscillation (ENSO) drives substantial variability in rainfall(1-3), severe weather(4,5), agricultural production(3,6), ecosystems(7) and disease(8) in many parts of the world. Given that further human-forced changes in the Earth's climate system seem inevitable(9,10), the possibility exists that the character of ENSO and its impacts might change over the coming century. Although this issue has been investigated many times during the past 20 years, there is very little consensus on future changes in ENSO, apart from an expectation that ENSO will continue to be a dominant source of year-to-year variability(9,11,12). Here we show that there are in fact robust projected changes in the spatial patterns of year-to-year ENSO-driven variability in both surface temperature and precipitation. These changes are evident in the two most recent generations of climate models(13,14), using four different scenarios for CO2 and other radiatively active gases(14-17). By the mid- to late twenty-first century, the projections include an intensification of both El-Nino-driven drying in the western Pacific Ocean and rainfall increases in the central and eastern equatorial Pacific. Experiments with an Atmospheric General Circulation Model reveal that robust projected changes in precipitation anomalies during El Nino years are primarily determined by a nonlinear response to surface global warming. Uncertain projected changes in the amplitude of ENSO-driven surface temperature variability have only a secondary role. Projected changes in key characteristics of ENSO are consequently much clearer than previously realized.	[Power, Scott; Delage, Francois; Chung, Christine; Kociuba, Greg; Keay, Kevin] Bur Meteorol, Ctr Australian Weather & Climate Res, Melbourne, Vic 3008, Australia	Bureau of Meteorology - Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Power, S (corresponding author), Bur Meteorol, Ctr Australian Weather & Climate Res, Melbourne, Vic 3008, Australia.	s.power@bom.gov.au	Power, Scott Brendan/AAF-3370-2019	Power, Scott Brendan/0000-0002-9596-4368	Australian Climate Change Science Program (ACCSP); Pacific-Australia Climate Change Science and Adaptation planning Program (PACCSAP); AusAID; Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education	Australian Climate Change Science Program (ACCSP); Pacific-Australia Climate Change Science and Adaptation planning Program (PACCSAP); AusAID(Australian Aid (AusAID)); Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education	We thank L. Hanson, H. Ye and A. Moise for making the CMIP data available to us, and R. Colman, A. Handasyde and H. G. Power for comments on an earlier draft. This work is supported by the Australian Climate Change Science Program (ACCSP) and the Pacific-Australia Climate Change Science and Adaptation planning Program (PACCSAP). PACCSAP is supported by AusAID, in collaboration with the Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups for producing and making available their model output. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Callaghan J, 2011, CLIM DYNAM, V37, P647, DOI 10.1007/s00382-010-0883-2; Cambers, 2011, CLIMATE CHANGE PACIF; Chung C. T. Y., 2013, CLIM DYN; Coelho CAS, 2009, J CLIMATE, V22, P6456, DOI 10.1175/2009JCLI3185.1; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Donnelly JP, 2007, NATURE, V447, P465, DOI 10.1038/nature05834; Guilyardi E, 2009, B AM METEOROL SOC, V90, P325, DOI 10.1175/2008BAMS2387.1; Hammer GL, 2001, AGR SYST, V70, P515, DOI 10.1016/S0308-521X(01)00058-0; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Kug JS, 2010, THEOR APPL CLIMATOL, V100, P275, DOI 10.1007/s00704-009-0183-0; Lorenz E.N., 1956, 1 MIT; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Meehl GA, 2007, CLIM DYNAM, V29, P779, DOI 10.1007/s00382-007-0268-3; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Power S., 1999, CLIM DYNAM, V15, P234; Power SB, 2012, J CLIMATE, V25, P3792, DOI 10.1175/JCLI-D-11-00354.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Ropelewski C. F., 2007, J CLIMATOL, V2, P268; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Vecchi GA, 2010, WIRES CLIM CHANGE, V1, P260, DOI 10.1002/wcc.33; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316	30	288	297	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					541	+		10.1038/nature12580	http://dx.doi.org/10.1038/nature12580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24121439				2022-12-28	WOS:000325988400052
J	Kessner, S; Sprenger, C; Wrobel, N; Wiech, K; Bingel, U				Kessner, Simon; Sprenger, Christian; Wrobel, Nathalie; Wiech, Katja; Bingel, Ulrike			Effect of Oxytocin on Placebo Analgesia: A Randomized Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kessner, Simon; Wrobel, Nathalie] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Sprenger, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Wiech, Katja] Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England; [Bingel, Ulrike] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, D-45147 Essen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bath; University of Duisburg Essen	Bingel, U (corresponding author), Univ Duisburg Essen, Dept Neurol, Hufelandstr 55, D-45147 Essen, Germany.	ulrike.bingel@uk-essen.de		Kessner, Simon Stephan/0000-0002-2051-8531				BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steyer R., 1997, MULTIDIMENSIONAL MOO	6	74	77	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1733	1735		10.1001/jama.2013.277446	http://dx.doi.org/10.1001/jama.2013.277446			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24150470	Bronze			2022-12-28	WOS:000325948500030
J	Lordkipanidze, D; de Leon, MSP; Margvelashvili, A; Rak, Y; Rightmire, GP; Vekua, A; Zollikofer, CPE				Lordkipanidze, David; de Leon, Marcia S. Ponce; Margvelashvili, Ann; Rak, Yoel; Rightmire, G. Philip; Vekua, Abesalom; Zollikofer, Christoph P. E.			A Complete Skull from Dmanisi, Georgia, and the Evolutionary Biology of Early Homo	SCIENCE			English	Article							CRANIAL MORPHOLOGY; ERECTUS; HOMINID; FOSSILS; REMAINS; DIVERSITY; SHAPE; SIZE	The site of Dmanisi, Georgia, has yielded an impressive sample of hominid cranial and postcranial remains, documenting the presence of Homo outside Africa around 1.8 million years ago. Here we report on a new cranium from Dmanisi (D4500) that, together with its mandible (D2600), represents the world's first completely preserved adult hominid skull from the early Pleistocene. D4500/D2600 combines a small braincase (546 cubic centimeters) with a large prognathic face and exhibits close morphological affinities with the earliest known Homo fossils from Africa. The Dmanisi sample, which now comprises five crania, provides direct evidence for wide morphological variation within and among early Homo paleodemes. This implies the existence of a single evolving lineage of early Homo, with phylogeographic continuity across continents.	[Lordkipanidze, David; Margvelashvili, Ann; Vekua, Abesalom] Georgian Natl Museum, GE-0105 Tbilisi, Georgia; [de Leon, Marcia S. Ponce; Margvelashvili, Ann; Zollikofer, Christoph P. E.] Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Rak, Yoel] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Rightmire, G. Philip] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	Tel Aviv University; Sackler Faculty of Medicine; Harvard University	Lordkipanidze, D (corresponding author), Georgian Natl Museum, 3 Purtseladze St, GE-0105 Tbilisi, Georgia.	dlordkipanidze@museum.ge; zolli@aim.uzh.ch	Lordkipanidze, David/AAH-6472-2020; Margvelashvili, Ann/AAJ-8955-2020		Rustaveli Georgian National Science Foundation; Swiss National Science Foundation; U.S. National Science Foundation; National Geographic Society; L.S.B. Leakey Foundation; American Philosophical Society; American School for Prehistoric Research; Rolex Award for Enterprise; BP Georgia; Fundacion Duques de Soria; A.H. Schultz Foundation; Foundation for Scientific Research (University of Zurich)	Rustaveli Georgian National Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); L.S.B. Leakey Foundation; American Philosophical Society; American School for Prehistoric Research; Rolex Award for Enterprise; BP Georgia; Fundacion Duques de Soria; A.H. Schultz Foundation; Foundation for Scientific Research (University of Zurich)	This research was supported by the Rustaveli Georgian National Science Foundation, the Swiss National Science Foundation, the U.S. National Science Foundation, the National Geographic Society, the L.S.B. Leakey Foundation, the American Philosophical Society, the American School for Prehistoric Research, a Rolex Award for Enterprise, BP Georgia, the Fundacion Duques de Soria, the A.H. Schultz Foundation, and the Foundation for Scientific Research (University of Zurich). We thank the Dmanisi excavation team for excellent work; special thanks go to G. Kiladze. G. Nioradze was the first H. sapiens to encounter D4500. We gratefully acknowledge the work of the late G. Bumbiashvili, who photographed skull 5 and the other Dmanisi hominids. We thank G. Nemsadze (N. Kipshidze Central Clinical Hospital of Tbilisi State Medical University) and I. Tatishvili (A. Gvamichava Oncology National Center, Tbilisi) for CT data acquisition. We also thank the reviewers for their valuable comments, which helped to improve the manuscript. Dmanisi skull 5 is deposited at the Georgian National Museum, Tbilisi, Georgia.	Agusti J, 2011, QUATERNARY SCI REV, V30, P1338, DOI 10.1016/j.quascirev.2010.04.012; Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Baab KL, 2008, J HUM EVOL, V54, P827, DOI 10.1016/j.jhevol.2007.11.003; Behrensmeyer AK, 2008, GEOL SOC AM SPEC PAP, V446, P203, DOI 10.1130/2008.2446(09); Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Bromage TG, 2008, J CLIN PEDIATR DENT, V33, P43, DOI 10.17796/jcpd.33.1.8168115j12103nut; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Darwin Charles., 1869, ORIGIN SPECIES MEANS, V5th; Ferring R, 2011, P NATL ACAD SCI USA, V108, P10432, DOI 10.1073/pnas.1106638108; Gabounia L, 2002, CR PALEVOL, V1, P243, DOI 10.1016/S1631-0683(02)00032-5; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gabunia L, 2002, ARCHAEOL ETHNOL ANTH, V4, P145; Gilbert WH, 2003, J HUM EVOL, V45, P255, DOI 10.1016/j.jhevol.2003.08.007; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Hastings A, 1996, BIOL CONSERV, V78, P143, DOI 10.1016/0006-3207(96)00023-7; HILL A, 1992, NATURE, V355, P719, DOI 10.1038/355719a0; Holliday TW, 2012, CURR ANTHROPOL, V53, pS330, DOI 10.1086/667360; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3; Howell FC, 1999, J ANTHROPOL RES, V55, P191, DOI 10.1086/jar.55.2.3631209; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P497, DOI 10.1002/ajpa.10427; Kaifu Y, 2008, J HUM EVOL, V55, P551, DOI 10.1016/j.jhevol.2008.05.002; Kaifu Y, 2010, VERTEBR PALEOBIOL PA, P143, DOI 10.1007/978-90-481-9094-2_11; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 2013, NATURE, V497, P573, DOI 10.1038/497573a; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lordkipanidze D, 2006, ANAT REC PART A, V288A, P1146, DOI 10.1002/ar.a.20379; Lozano M, 2008, J HUM EVOL, V55, P713, DOI 10.1016/j.jhevol.2008.04.007; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Marques-Bonet T, 2009, ANNU REV GENOM HUM G, V10, P355, DOI 10.1146/annurev.genom.9.081307.164420; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; Rightmire GP, 2010, VERTEBR PALEOBIOL PA, P225, DOI 10.1007/978-90-481-9036-2_14; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Rightmire GP, 2004, AM J PHYS ANTHROPOL, V124, P109, DOI 10.1002/ajpa.10346; Sherwood RJ, 2002, J HUM EVOL, V42, P153, DOI 10.1006/jhev.2000.0409; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Suwa G, 2007, ANTHROPOL SCI, V115, P133, DOI 10.1537/ase.061203; Terhune CE, 2007, J HUM EVOL, V53, P41, DOI 10.1016/j.jhevol.2007.01.006; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; Walker A., 1993, NARIOKOTOME HOMO ERE; White T.D., 1989, P97; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1991, KOOBI FORA RES PROJE, V4	48	270	286	5	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					326	331		10.1126/science.1238484	http://dx.doi.org/10.1126/science.1238484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136960				2022-12-28	WOS:000325755100035
J	Hahnel, M				Hahnel, Mark			The reuse factor	NATURE			English	Editorial Material												mark@figshare.com		Hahnel, Mark/0000-0003-4741-0309				Altman Micah, 2007, D LIB MAGAZINE; Cowley MJ, 2013, NAT CHEM, V5, P876, DOI [10.1038/NCHEM.1751, 10.1038/nchem.1751]; Heffernan O, 2009, NATURE, V460, P787, DOI 10.1038/460787a	3	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					298	298		10.1038/502298a	http://dx.doi.org/10.1038/502298a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24137833	Bronze			2022-12-28	WOS:000325706300025
J	Miyazaki, T; Sueyoshi, K; Hiraga, T				Miyazaki, Tomonori; Sueyoshi, Kenta; Hiraga, Takehiko			Olivine crystals align during diffusion creep of Earth's upper mantle	NATURE			English	Article							GRAIN-BOUNDARIES; SEISMIC ANISOTROPY; FORSTERITE; TEMPERATURE; GROWTH; SIZE; FLOW; DEFORMATION; SEGREGATION; TRANSITIONS	The crystallographic preferred orientation (CPO) of olivine produced during dislocation creep is considered to be the primary cause of elastic anisotropy in Earth's upper mantle and is often used to determine the direction of mantle flow. A fundamental question remains, however, as to whether the alignment of olivine crystals is uniquely produced by dislocation creep. Here we report the development of CPO in iron-free olivine (that is, forsterite) during diffusion creep; the intensity and pattern of CPO depend on temperature and the presence of melt, which control the appearance of crystallographic planes on grain boundaries. Grain boundary sliding on these crystallography-controlled boundaries accommodated by diffusion contributes to grain rotation, resulting in a CPO. We show that strong radial anisotropy is anticipated at temperatures corresponding to depths where melting initiates to depths where strongly anisotropic and low seismic velocities are detected. Conversely, weak anisotropy is anticipated at temperatures corresponding to depths where almost isotropic mantle is found. We propose diffusion creep to be the primary means of mantle flow.	[Miyazaki, Tomonori; Sueyoshi, Kenta; Hiraga, Takehiko] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Hiraga, T (corresponding author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	hiraga@eri.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; JSPS [23684043, 22000003, 21109005]; Earthquake Research Institute's cooperative research programme; Grants-in-Aid for Scientific Research [21109005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Earthquake Research Institute's cooperative research programme; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Discussions with H. Yoshida, K. Morita, M. E. Zimmerman, Y. Takei, S. Michibayashi, B. K. Holtzman, K. Baba, T. Isse and H. Kawakatsu were very helpful. We thank Ube Material Industries, S. Ohtsuka, K. Ibe, M. Uchida and A. Yasuda for technical assistance. A portion of this work was conducted at the Center for Nano Lithography and Analysis of the University of Tokyo, supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This study was supported by the JSPS through Grants-in-Aid for Scientific Research 23684043, 22000003 and 21109005, and through the Earthquake Research Institute's cooperative research programme (T.H.).	ASHBY MF, 1973, ACTA METALL MATER, V21, P149, DOI 10.1016/0001-6160(73)90057-6; Barreiro JG, 2007, EARTH PLANET SC LETT, V264, P188, DOI 10.1016/j.epsl.2007.09.018; BEERE W, 1978, PHILOS T R SOC A, V288, P177, DOI 10.1098/rsta.1978.0012; Behn MD, 2009, EARTH PLANET SC LETT, V282, P178, DOI 10.1016/j.epsl.2009.03.014; CARTER NL, 1970, GEOL SOC AM BULL, V81, P2181, DOI 10.1130/0016-7606(1970)81[2181:HTFODA]2.0.CO;2; Couvy H, 2004, EUR J MINERAL, V16, P877, DOI 10.1127/0935-1221/2004/0016-0877; Deer W. A., 1982, ROCK FORMING MINER A, V1A, P194; Evans RL, 2005, NATURE, V437, P249, DOI 10.1038/nature04014; Faul UH, 2006, CONTRIB MINERAL PETR, V151, P101, DOI 10.1007/s00410-005-0048-1; Faul UH, 2005, EARTH PLANET SC LETT, V234, P119, DOI 10.1016/j.epsl.2005.02.008; GORDON RB, 1965, J GEOPHYS RES, V70, P2413, DOI 10.1029/JZ070i010p02413; Hiraga T, 2004, NATURE, V427, P699, DOI 10.1038/nature02259; Hiraga T, 2002, CONTRIB MINERAL PETR, V144, P163, DOI 10.1007/s00410-002-0394-1; Hiraga T, 1999, PHYS CHEM MINER, V26, P617, DOI 10.1007/s002690050226; Hiraga T, 2007, GEOCHIM COSMOCHIM AC, V71, P1281, DOI 10.1016/j.gca.2006.11.020; Hiraga T, 2013, GEOLOGY, V41, P959, DOI 10.1130/G34407.1; Hiraga T, 2010, NATURE, V468, P1091, DOI 10.1038/nature09685; Hiraga T, 2010, EARTH PLANET SC LETT, V291, P10, DOI 10.1016/j.epsl.2009.12.026; Holtzman BK, 2003, SCIENCE, V301, P1227, DOI 10.1126/science.1087132; Jung H, 2001, SCIENCE, V293, P1460, DOI 10.1126/science.1062235; KARATO S, 1992, GEOPHYS RES LETT, V19, P2255, DOI 10.1029/92GL02603; Karato S.-I., 2003, GEOPHYS MONOGR SER A, V138, P135, DOI [10.1029/138GM08, DOI 10.1029/138GM08]; Karato SI, 2010, TECTONOPHYSICS, V481, P82, DOI 10.1016/j.tecto.2009.04.011; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; Koizumi S, 2010, PHYS CHEM MINER, V37, P505, DOI 10.1007/s00269-009-0350-y; Mainprice D, 2005, NATURE, V433, P731, DOI 10.1038/nature03266; Mainprice D., 2000, EARTHS DEEP INTERIOR, P237, DOI [10.1029/GM117p0237, DOI 10.1029/GM117P0237]; Mehl L, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002233; MERCIER JCC, 1980, J GEOPHYS RES, V85, P6293, DOI 10.1029/JB085iB11p06293; Morales LFG, 2011, TECTONOPHYSICS, V507, P1, DOI 10.1016/j.tecto.2011.04.014; Nabarro F.R.N., 1948, REP C STRENGTH SOL, P75; Nettles M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004819; Nicolas A., 1987, FORMATION ANISOTROPY, DOI DOI 10.1029/GD016P0111; Nieh T. G., 1997, SUPERPLASTICITY META, P32; Ohuchi T, 2007, PHYS EARTH PLANET IN, V161, P281, DOI 10.1016/j.pepi.2007.02.009; Ohuchi T, 2011, EARTH PLANET SC LETT, V304, P55, DOI 10.1016/j.epsl.2011.01.015; Raterron P, 2007, AM MINERAL, V92, P1436, DOI 10.2138/am.2007.2474; Straumal B, 2004, INTERFACE SCI, V12, P147, DOI 10.1023/B:INTS.0000028645.30358.f5; Sundberg M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005618; TANIMOTO T, 1984, GEOPHYS RES LETT, V11, P287, DOI 10.1029/GL011i004p00287; Tasaka M., 2013, J GEOPHYS RES, V118; Yoshizawa Y, 2001, J AM CERAM SOC, V84, P1392, DOI 10.1111/j.1151-2916.2001.tb00848.x	43	108	112	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					321	+		10.1038/nature12570	http://dx.doi.org/10.1038/nature12570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132289				2022-12-28	WOS:000325706300043
J	Shotton, D				Shotton, David			Open citations	NATURE			English	Editorial Material									[Shotton, David] Univ Oxford, Oxford E Res Ctr, Oxford OX1 2JD, England	University of Oxford		david.shotton@oerc.ox.ac.uk		Shotton, David/0000-0001-5506-523X				Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a; Aghaei Chadegani A., 2013, ASIAN SOCIAL SCI, V9, P18, DOI [10.5539/ass.v9n5p18, DOI 10.5539/ASS.V9N5P18]; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; Peroni S, 2012, J WEB SEMANT, V17, P33, DOI 10.1016/j.websem.2012.08.001; Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a; Piwowar HA, 2013, PEERJ, V1, DOI 10.7717/peerj.175; Priem J, 2013, NATURE, V495, P437, DOI 10.1038/495437a; Shotton D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000361; SHOTTON DM, 1971, COLD SPRING HARB SYM, V36, P91	9	26	26	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					295	297		10.1038/502295a	http://dx.doi.org/10.1038/502295a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	235GY	24137832	hybrid			2022-12-28	WOS:000325706300024
J	Ferner, R				Ferner, Robin			Raising more antibodies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MONOCLONAL-ANTIBODIES; SEPTIC SHOCK; DOUBLE-BLIND; TRIAL; BITE		Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				BARTHOLOMEW C, 1970, BMJ-BRIT MED J, V1, P666, DOI 10.1136/bmj.1.5697.666; Chan K, 2008, CAN MED ASSOC J, V179, P158, DOI 10.1503/cmaj.071844; De Genst E, 2006, DEV COMP IMMUNOL, V30, P187, DOI 10.1016/j.dci.2005.06.010; European Medicines Agency, 2013, WITHDR APPL CHANG MA; Healthy Canadians, 2013, RIT RIT HEP B VIR HB; HINDS CJ, 1992, BRIT MED J, V304, P132, DOI 10.1136/bmj.304.6820.132; Isbister GK, 2005, MED J AUSTRALIA, V182, P407, DOI 10.5694/j.1326-5377.2005.tb06760.x; Karnad DR, 1998, HEART, V79, P485, DOI 10.1136/hrt.79.5.485; MCCLOSKEY RV, 1994, ANN INTERN MED, V121, P1, DOI 10.7326/0003-4819-121-1-199407010-00001; MCGREGOR AM, 1981, BRIT MED J, V283, P1143, DOI 10.1136/bmj.283.6300.1143; Pucca MB, 2013, J IMMUNOTOXICOL; Smalligan R, 2004, BMJ-BRIT MED J, V329, P1129, DOI 10.1136/bmj.329.7475.1129; Von Behring E., 1890, DEUT MED WOCHENSCHR, V16, P1145; World Health Organization, 2011, INT NONPR NAM INN BI, P8; Younes A, 2011, NAT REV CLIN ONCOL, V8, P85, DOI 10.1038/nrclinonc.2010.189	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2013	347								f5969	10.1136/bmj.f5969	http://dx.doi.org/10.1136/bmj.f5969			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WM	24133143				2022-12-28	WOS:000325982400001
J	Pasternak, B; Svanstrom, H; Molgaard-Nielsen, D; Melbye, M; Hviid, A				Pasternak, Bjorn; Svanstrom, Henrik; Molgaard-Nielsen, Ditte; Melbye, Mads; Hviid, Anders			Metoclopramide in Pregnancy and Risk of Major Congenital Malformations and Fetal Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NAUSEA; REGISTRATION; MEDICATIONS; COHORT	IMPORTANCE Metoclopramide, a drug frequently used for nausea and vomiting in pregnancy, is thought to be safe, but information on the risk of specific malformations and fetal death is lacking. OBJECTIVE To investigate the safety of metoclopramide use in pregnancy. DESIGN, SETTING, AND PARTICIPANTS Register-based cohort study in Denmark, 1997-2011. From a cohort of 1 222 503 pregnancies, metoclopramide-exposed and unexposed women were matched (1: 4 ratio) on the basis of age, calendar year, and propensity scores. MAIN OUTCOMES AND MEASURES Primary outcomes were major congenital malformations overall, 20 individual malformation categories (selected according to power criteria), spontaneous abortion, and stillbirth. In matched analyses, logistic regression was used to estimate prevalence odds ratios of malformations and Cox regression to estimate hazard ratios (HRs) of spontaneous abortion. RESULTS Among 28 486 women exposed to metoclopramide in the first trimester, 721 had an infant with a major congenital malformation (25.3 [95% CI, 23.5-27.1] cases per 1000 births), compared with 3024 among 113 698 unexposed women (26.6 [95% CI, 25.7-27.5] per 1000 births). There were no significant associations between metoclopramide use and malformations overall (prevalence odds ratio, 0.93 [95% CI, 0.86-1.02]) or any of the 20 individual malformation categories, eg, neural tube defects, transposition of great vessels, ventricular septal defect, atrial septal defect, tetralogy of Fallot, coarctation of the aorta, cleft lip, cleft palate, anorectal atresia/stenosis, and limb reduction (upper limit of 95% CI below 2.0 for 17 of 20 categories). Metoclopramide was not associated with increased risk of spontaneous abortion (757 cases [20.0 {95% CI, 18.5-21.4} per 1000] among 37 946 metoclopramide-exposed women and 9414 cases [62.1 {95% CI, 60.9-63.3} per 1000] among 151 661 unexposed women; HR, 0.35 [95% CI, 0.33-0.38]) and stillbirth (142 cases [3.5 {95% CI, 2.9-4.1} per 1000] among 40 306 metoclopramide-exposed women and 634 cases [3.9 {95% CI, 3.6-4.2} per 1000] among 161 098 unexposed women; HR, 0.90 [95% CI, 0.74-1.08]). CONCLUSIONS AND RELEVANCE Metoclopramide use in pregnancy was not associated with increased risk of major congenital malformations overall, any of the 20 individual malformation categories assessed, spontaneous abortion, or stillbirth. These safety data may help inform decision making when treatment with metoclopramide is considered in pregnancy.	[Pasternak, Bjorn; Svanstrom, Henrik; Molgaard-Nielsen, Ditte; Melbye, Mads; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466; melbye, mads/0000-0001-8264-6785	Danish Medical Research Council [11-115854]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Danish Medical Research Council grant 11-115854 (Dr Pasternak).	Agergaard Peter, 2011, Clin Epidemiol, V3, P61, DOI 10.2147/CLEP.S15627; Anderka M, 2012, BIRTH DEFECTS RES A, V94, P22, DOI 10.1002/bdra.22865; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; [Anonymous], EUROCAT PREV TABL DE; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Berkovitch M, 2000, NEW ENGL J MED, V343, P445, DOI 10.1056/NEJM200008103430616; Berkovitch M, 2002, AM J PERINAT, V19, P311, DOI 10.1055/s-2002-34469; Briggs GG., 2008, DRUGS PREGNANCY LACT, P1197; Buhimschi CS, 2009, OBSTET GYNECOL, V113, P166, DOI 10.1097/AOG.0b013e31818d6788; Chan RL, 2010, HUM REPROD, V25, P2907, DOI 10.1093/humrep/deq260; EUROCAT, EUR GUID 1 3 REF DOC; Harrell FE., 2001, REGRESSION MODELING, P41; Jarvis S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3606; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lacroix R, 2000, AM J OBSTET GYNECOL, V182, P931, DOI 10.1016/S0002-9378(00)70349-8; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Matok I, 2009, NEW ENGL J MED, V360, P2528, DOI 10.1056/NEJMoa0807154; Mitchell AA, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P501; Niebyl JR, 2010, NEW ENGL J MED, V363, P1544, DOI 10.1056/NEJMcp1003896; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Sorensen HT, 2000, BRIT J CLIN PHARMACO, V49, P264, DOI 10.1046/j.1365-2125.2000.00127.x; WEIGEL RM, 1989, BRIT J OBSTET GYNAEC, V96, P1312, DOI 10.1111/j.1471-0528.1989.tb03229.x	26	53	54	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1601	1611		10.1001/jama.2013.278343	http://dx.doi.org/10.1001/jama.2013.278343			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129464	Bronze			2022-12-28	WOS:000325624800023
J	DeLoughery, T				DeLoughery, Thomas			Apixaban was noninferior to enoxaparin plus warfarin in patients with acute venous thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ORAL RIVAROXABAN		Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	DeLoughery, T (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							[Anonymous], 2009, N ENGL J MED, V361, P2342; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102	4	1	1	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC2	10.7326/0003-4819-159-8-201310150-02002	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126663				2022-12-28	WOS:000326751200001
J	Allen, R				Allen, Richard			Seconds count	NATURE			English	Editorial Material							DISPLACEMENT; SLIP		[Allen, Richard] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Allen, Richard] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Allen, R (corresponding author), Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA.	rallen@berkeley.edu	Allen, Richard/H-8493-2016	Allen, Richard/0000-0003-4293-9772				Allen R, 2011, SCI AM, V304, P74, DOI 10.1038/scientificamerican0411-74; Allen RM, 2012, SCIENCE, V335, P297, DOI 10.1126/science.1214650; Bose M., 2013, EARLY WARNING GEOLOG, P49, DOI DOI 10.1007/978-3-642-12233-0_3; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Jones N, 2011, NATURE, V479, P16, DOI 10.1038/479016a; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Noda H, 2013, NATURE, V493, P518, DOI 10.1038/nature11703; Ozawa S, 2011, NATURE, V475, P373, DOI 10.1038/nature10227; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401	10	12	12	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					29	31		10.1038/502029a	http://dx.doi.org/10.1038/502029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227IM	24137643	Bronze			2022-12-28	WOS:000325106000013
J	Gunter, G; Schempp, H; Robert-de-Saint-Vincent, M; Gavryusev, V; Helmrich, S; Hofmann, CS; Whitlock, S; Weidemuller, M				Guenter, G.; Schempp, H.; Robert-de-Saint-Vincent, M.; Gavryusev, V.; Helmrich, S.; Hofmann, C. S.; Whitlock, S.; Weidemueller, M.			Observing the Dynamics of Dipole-Mediated Energy Transport by Interaction-Enhanced Imaging	SCIENCE			English	Article							FROZEN RYDBERG GAS; QUANTUM SIMULATOR; ATOMS; COMPLEXES; PHOTONS; OPTICS	Electronically highly excited (Rydberg) atoms experience quantum state-changing interactions similar to Forster processes found in complex molecules, offering a model system to study the nature of dipole-mediated energy transport under the influence of a controlled environment. We demonstrate a nondestructive imaging method to monitor the migration of electronic excitations with high time and spatial resolution, using electromagnetically induced transparency on a background gas acting as an amplifier. The continuous spatial projection of the electronic quantum state under observation determines the many-body dynamics of the energy transport.	[Guenter, G.; Schempp, H.; Robert-de-Saint-Vincent, M.; Gavryusev, V.; Helmrich, S.; Hofmann, C. S.; Whitlock, S.; Weidemueller, M.] Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; [Weidemueller, M.] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China	Ruprecht Karls University Heidelberg; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Whitlock, S (corresponding author), Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany.	whitlock@physi.uni-heidelberg.de; weidemueller@uni-heidelberg.de	Gavryusev, Vladislav/HHZ-6446-2022; Hofmann, Christoph/F-3903-2015; Gavryusev, Vladislav/I-4859-2019; Weidemüller, Matthias/N-2232-2014; Whitlock, Shannon/B-3312-2010	Gavryusev, Vladislav/0000-0001-7734-7828; Gavryusev, Vladislav/0000-0001-7734-7828; Weidemüller, Matthias/0000-0001-5639-5126; Robert-de-Saint-Vincent, Martin/0000-0002-8991-1366; Whitlock, Shannon/0000-0002-6955-9326	Studienstiftung des deutschen Volkes; Landesgraduierten Akademie; EU [FP7-PEOPLE-2011-IEF-300870, PERG08-GA-2010-277017, FP7-PEOPLE-2010-ITN-265031]; Heidelberg Center for Quantum Dynamics; Deutsche Forschungsgemeinschaft [WE2661/10.2]	Studienstiftung des deutschen Volkes; Landesgraduierten Akademie; EU(European Commission); Heidelberg Center for Quantum Dynamics; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank S. Wuster, T. Pohl, I. Bloch, M. Honing, and M. Fleischhauer for fruitful discussions. Supported by Studienstiftung des deutschen Volkes (G.G. and C.S.H.), Landesgraduierten Akademie (H.S.), EU Marie-Curie program grants FP7-PEOPLE-2011-IEF-300870 (M.R.d.S.V.) and PERG08-GA-2010-277017 (S.W.), EU Marie-Curie program ITN COHERENCE grant FP7-PEOPLE-2010-ITN-265031 (V.G.), the Heidelberg Center for Quantum Dynamics, and Deutsche Forschungsgemeinschaft grant WE2661/10.2.	Anderson WR, 1998, PHYS REV LETT, V80, P249, DOI 10.1103/PhysRevLett.80.249; Anderson WR, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.063404; Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Cirac JI, 2012, NAT PHYS, V8, P264, DOI 10.1038/nphys2275; Collini E, 2013, CHEM SOC REV, V42, P4932, DOI 10.1039/c3cs35444j; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Gunter G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.013002; Hofmann CS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203601; Karski M, 2009, SCIENCE, V325, P174, DOI 10.1126/science.1174436; McQuillen P, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013407; Mourachko I, 1998, PHYS REV LETT, V80, P253, DOI 10.1103/PhysRevLett.80.253; Mulken O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.090601; Najafov H, 2010, NAT MATER, V9, P938, DOI 10.1038/nmat2872; Nipper J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.113001; Olmos B, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.041607; Peruzzo A, 2010, SCIENCE, V329, P1500, DOI 10.1126/science.1193515; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Pritchard JD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.193603; Sarovar M, 2010, NAT PHYS, V6, P462, DOI [10.1038/NPHYS1652, 10.1038/nphys1652]; Schauss P, 2012, NATURE, V491, P87, DOI 10.1038/nature11596; Schwarzkopf A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.103001; van Ditzhuijzen CSE, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.243201; van Oijen AM, 1999, SCIENCE, V285, P400, DOI 10.1126/science.285.5426.400; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Westermann S, 2006, EUR PHYS J D, V40, P37, DOI 10.1140/epjd/e2006-00130-3	29	173	173	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					954	956		10.1126/science.1244843	http://dx.doi.org/10.1126/science.1244843			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24200814				2022-12-28	WOS:000327223500036
J	Nel, A; Roques, P; Nel, P; Prokin, AA; Bourgoin, T; Prokop, J; Szwedo, J; Azar, D; Desutter-Grandcolas, L; Wappler, T; Garrouste, R; Coty, D; Huang, DY; Engel, MS; Kirejtshuk, AG				Nel, Andre; Roques, Patrick; Nel, Patricia; Prokin, Alexander A.; Bourgoin, Thierry; Prokop, Jakub; Szwedo, Jacek; Azar, Dany; Desutter-Grandcolas, Laure; Wappler, Torsten; Garrouste, Romain; Coty, David; Huang, Diying; Engel, Michael S.; Kirejtshuk, Alexander G.			The earliest known holometabolous insects	NATURE			English	Article							EVOLUTION; DIVERSIFICATION; INSIGHTS; FOSSILS; LAND; SIZE	The Eumetabola (Endopterygota (alsoknown as Holometabola) plus Paraneoptera)(1) have the highest number of species of any clade, and greatly contribute to animal species biodiversity(2,3). The palaeoeco-logical circumstances that favoured their emergence and success remain an intriguing question(3-6). Recent molecular phylogenetic analyses have suggested a wide range of dates for the initial appearance of the Holometabola, from the Middle Devonian epoch (391 million years (Myr) ago) to the Late Pennsylvanian epoch (311 Myr ago(7-12)), and Hemiptera (310 Myr ago(13)). Palaeoenvironments greatly changed over these periods, with global cooling and increasing complexity of green forests(14). The Pennsylvanian-period crown-eumetabolan fossil record remains notably incomplete(15-1)9, particularly as several fossils have been erroneously considered to be stemHolometabola(1,15,20,21) (Supplementary Information); the earliest definitive beetles are from the start of the Permian period(21,22). The emergence of the hymenopterids, sister group to other Holometabola, is dated between 350 and 309 Myr ago(8,9,12), incongruent with their current earliest record(Middle Triassic epoch)(1,20). Here we describe five fossils-aGzhelian-age stem coleopterid, a holometabolous larva of uncertain ordinal affinity, a stem hymenopterid, and early Hemiptera and Psocodea, all from the Moscovian age-and reveal a notable penecontemporaneous breadth of early eumetabolan insects. These discoveries are more congruent with current hypotheses of clade divergence. Eumetabola experienced episodes of diversification during the Bashkirian-Moscovian and the Kasimovian-Gzhelian ages. This cladogenetic activity is perhaps related to notable episodes of drying resulting from glaciations, leading to the eventual demise in Euramerica of coal-swamp ecosystems, evidenced by floral turnover during this interval(23,24). These ancient species were of very small size, living in the shadow of Palaeozoic-era 'giant' insects. Although these discoveries reveal unexpected Pennsylvanian eumetabolan diversity, the lineage radiated more successfully only after the mass extinctions at the end of the Permian period, giving rise to the familiar crown groups of their respective clades.	[Nel, Andre; Roques, Patrick; Nel, Patricia; Bourgoin, Thierry; Azar, Dany; Desutter-Grandcolas, Laure; Garrouste, Romain; Coty, David; Kirejtshuk, Alexander G.] Museum Natl Hist Nat, CNRS, UMR 7205, F-75231 Paris, France; [Nel, Patricia] AgroParisTech, Dept Sci Vie & Sante, F-75231 Paris 05, France; [Prokin, Alexander A.] Russian Acad Sci, Papanin Inst Biol Inland Waters, Borok 152742, Yaroslavl Oblas, Russia; [Prokop, Jakub] Charles Univ Prague, Fac Sci, Dept Zool, CZ-12844 Prague 2, Czech Republic; [Szwedo, Jacek] Polish Acad Sci, Museum & Inst Zool, Dept Palaeozool, PL-00679 Warsaw, Poland; [Azar, Dany] Lebanese Univ, Fac Sci 2, Dept Nat Sci, Fanar, Fanar Matn, Lebanon; [Wappler, Torsten] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Huang, Diying] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China; [Engel, Michael S.] Univ Kansas, Div Entomol, Nat Hist Museum, Lawrence, KS 66045 USA; [Engel, Michael S.] Univ Kansas, Dept Ecol Evolutionary Biol, Lawrence, KS 66045 USA; [Kirejtshuk, Alexander G.] Russian Acad Sci, Zool Inst, St Petersburg, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences; Charles University Prague; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Lebanese University; University of Bonn; Chinese Academy of Sciences; University of Kansas; University of Kansas; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Nel, A (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7205, CP 50,45 Rue Buffon, F-75231 Paris, France.	anel@mnhn.fr	Engel, Michael S/C-5461-2012; Szwedo, Jacek/O-1442-2019; Bourgoin, Thierry/L-5146-2019; Azar, Dany/AAF-7387-2020; Prokop, Jakub/B-1432-2008; GARROUSTE, Romain/AAK-3692-2021; Prokin, Alexander A/Q-6136-2016; Wappler, Torsten/D-4287-2011; Wappler, Torsten/P-6831-2019; Szwedo, Jacek/B-4774-2013	Engel, Michael S/0000-0003-3067-077X; Szwedo, Jacek/0000-0002-2796-9538; Bourgoin, Thierry/0000-0001-9277-2478; Azar, Dany/0000-0002-4485-197X; Prokop, Jakub/0000-0001-6996-7832; GARROUSTE, Romain/0000-0002-0880-5781; Prokin, Alexander A/0000-0002-9345-5607; Wappler, Torsten/0000-0003-1592-0988; Wappler, Torsten/0000-0003-1592-0988; Szwedo, Jacek/0000-0002-2796-9538; Nel, Patricia/0000-0002-7530-5138	Grant Agency of the Czech Republic [P210/10/0633]; German Science Foundation [WA 1492/6-1]; Russian Foundation of Basic Research [12-04-00663-a]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); German Science Foundation(German Research Foundation (DFG)); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	We thank C. C. Labandeira for comments on the first version of the manuscript that helped to improve the paper. We are grateful to A. P. Rasnitsyn, S. I. Golovach and B. R. Striganova, M. Fikacek, A. A. Przhiboro, R. Beutel, T. Hornschemeyer and V. Krassilov for early discussions. C. Garrouste and P. A. Kirejtshuk assisted in the preparation of illustrations for this publication. Financial support was provided by the Grant Agency of the Czech Republic no. P210/10/0633 (to J. P.) and the German Science Foundation WA 1492/6-1 (to T. W.). The study was supported by the program for visiting researchers and professors of the Smithsonian Institution National Museum of Natural History (NMNH) and partly carried out within the framework of the program of the Presidium of the Russian Academy of Sciences Problems of the origin of life and formation of the biosphere'. A. A. P. and A. G. K. were supported by the Russian Foundation of Basic Research (grant 12-04-00663-a). This paper is a participation to the team project Biodiversity: Origin, Structure, Evolution and Geology' allotted to D. A. by the Lebanese University.	Beckemeyer RJ, 2007, AFR INVERTEBR, V48, P23; BERNAYS EA, 1986, PHYSIOL ENTOMOL, V11, P377, DOI 10.1111/j.1365-3032.1986.tb00428.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clapham ME, 2012, P NATL ACAD SCI USA, V109, P10927, DOI 10.1073/pnas.1204026109; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Garrouste R, 2012, NATURE, V488, P82, DOI 10.1038/nature11281; Grimaldi D, 2005, EVOLUTION OF THE INS; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; Ilger JM, 2011, ZOOKEYS, P91, DOI 10.3897/zookeys.130.1422; Kirejtshuk A. G., J SYST PALAEONTOLOGY; Kukalova-Peck J, 2004, EUR J ENTOMOL, V101, P95, DOI 10.14411/eje.2004.018; Kukalova-Peck J, 2012, EUR J ENTOMOL, V109, P633, DOI 10.14411/eje.2012.075; Labandeir CC, 2011, ENTOMOL AM-NY, V117, P9, DOI 10.1664/10-RA-011.1; Mayhew PJ, 2007, BIOL REV, V82, P425, DOI 10.1111/j.1469-185X.2007.00018.x; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Nel A, 2007, ANN SOC ENTOMOL FR, V43, P349, DOI 10.1080/00379271.2007.10697531; Nel A, 2012, J MORPHOL, V273, P480, DOI 10.1002/jmor.11036; Nel P, 2012, J SYST PALAEONTOL, V10, P385, DOI 10.1080/14772019.2011.598578; Ogg J., 2012, THE GEOLOGIC TIME SC, P603; PHILLIPS TL, 1984, INT J COAL GEOL, V3, P205, DOI 10.1016/0166-5162(84)90019-3; Rasnitsyn A.P., 2002, HIST INSECTS; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Song N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058400; Warnock RCM, 2012, BIOL LETTERS, V8, P156, DOI 10.1098/rsbl.2011.0710; Wheat CW, 2013, SYST BIOL, V62, P93, DOI 10.1093/sysbio/sys074; Wiegmann Brian M., 2009, P260; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Yang AS, 2001, EVOL DEV, V3, P59, DOI 10.1046/j.1525-142x.2001.003002059.x; Yeates DK, 2012, AUST J ENTOMOL, V51, P79, DOI 10.1111/j.1440-6055.2012.00857.x	30	135	139	1	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					257	+		10.1038/nature12629	http://dx.doi.org/10.1038/nature12629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24132233				2022-12-28	WOS:000326894200050
J	Rachman, S				Rachman, Stanley			Cleaning damned spots from the obsessive mind	NATURE			English	Editorial Material									[Rachman, Stanley] Inst Psychiat, London, England; [Rachman, Stanley] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of London; King's College London; University of British Columbia	Rachman, S (corresponding author), Inst Psychiat, London, England.	rachman@mail.ubc.ca						Coughtrey AE, 2013, COGN BEHAV PRACT, V20, P221, DOI 10.1016/j.cbpra.2012.07.002	1	2	2	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					7	7		10.1038/503007a	http://dx.doi.org/10.1038/503007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201246	Bronze			2022-12-28	WOS:000326585600004
J	Gammon, K				Gammon, Katharine			INFLAMMATION A complex problem	NATURE			English	Editorial Material																		Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639	4	8	8	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S86	S87		10.1038/502S86a	http://dx.doi.org/10.1038/502S86a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187701				2022-12-28	WOS:000326293200004
J	Haydon, MJ; Mielczarek, O; Robertson, FC; Hubbard, KE; Webb, AAR				Haydon, Michael J.; Mielczarek, Olga; Robertson, Fiona C.; Hubbard, Katharine E.; Webb, Alex A. R.			Photosynthetic entrainment of the Arabidopsis thaliana circadian clock	NATURE			English	Article							PSEUDO-RESPONSE REGULATORS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PHYTOCHROME-A; PROTEIN; ENCODES; LIGHT; TRANSCRIPTION; OSCILLATORS; HOMEOSTASIS	Circadian clocks provide a competitive advantage in an environment that is heavily influenced by the rotation of the Earth(1,2), by driving daily rhythms in behaviour, physiology and metabolism in bacteria, fungi, plants and animals(3,4). Circadian clocks comprise transcription-translation feedback loops, which are entrained by environmental signals such as light and temperature to adjust the phase of rhythms to match the local environment(3). The production of sugars by photosynthesis is a key metabolic output of the circadian clock in plants(2,5). Here we show that these rhythmic, endogenous sugar signals can entrain circadian rhythms in Arabidopsis thaliana by regulating the gene expression of circadian clock components early in the photoperiod, thus defining a 'metabolic dawn'. By inhibiting photosynthesis, we demonstrate that endogenous oscillations in sugar levels provide metabolic feedback to the circadian oscillator through the morning-expressed gene PSEUDO-RESPONSE REGULATOR 7 (PRR7), and we identify that prr7 mutants are insensitive to the effects of sucrose on the circadian period. Thus, photosynthesis has a marked effect on the entrainment and maintenance of robust circadian rhythms in A. thaliana, demonstrating that metabolism has a crucial role in regulation of the circadian clock.	[Haydon, Michael J.; Mielczarek, Olga; Robertson, Fiona C.; Hubbard, Katharine E.; Webb, Alex A. R.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Webb, AAR (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	aarw2@cam.ac.uk	Hubbard, Katharine/ABF-1833-2021; Haydon, Michael/B-9326-2014	Hubbard, Katharine/0000-0002-4862-0466; Haydon, Michael/0000-0003-2486-9387; Webb, Alex/0000-0003-0261-4375	BBSRC [BB/H006826/1]; Biotechnology and Biological Sciences Research Council [BB/D017904/1, BB/H006826/1] Funding Source: researchfish; BBSRC [BB/D017904/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC grant BB/H006826/1. We thank J. O'Neill, J. Davies and J. Hibberd for comments on the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Cho YH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001263; Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Fukushima A, 2009, P NATL ACAD SCI USA, V106, P7251, DOI 10.1073/pnas.0900952106; Gibson SI, 2001, BIOCHEM BIOPH RES CO, V280, P196, DOI 10.1006/bbrc.2000.4062; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Gould PD, 2009, PLANT J, V58, P893, DOI 10.1111/j.1365-313X.2009.03819.x; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; James AB, 2008, SCIENCE, V322, P1832, DOI 10.1126/science.1161403; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Johnson Carl Hirschie, 1992, P209; JOHNSON CH, 1991, PLANT PHYSIOL, V97, P1122, DOI 10.1104/pp.97.3.1122; Kato T, 2007, BIOSCI BIOTECH BIOCH, V71, P834, DOI 10.1271/bbb.60642; Knight H, 2008, PLANT PHYSIOL, V148, P293, DOI 10.1104/pp.108.123901; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; Lehman A, 1996, CELL, V85, P183, DOI 10.1016/S0092-8674(00)81095-8; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Michael TP, 2003, P NATL ACAD SCI USA, V100, P6878, DOI 10.1073/pnas.1131995100; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Nakamichi N, 2012, P NATL ACAD SCI USA, V109, P17123, DOI 10.1073/pnas.1205156109; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Noordally ZB, 2013, SCIENCE, V339, P1316, DOI 10.1126/science.1230397; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063	45	252	258	13	253	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					689	+		10.1038/nature12603	http://dx.doi.org/10.1038/nature12603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153186	Green Accepted			2022-12-28	WOS:000326293200049
J	Wickert, AD; Mitrovica, JX; Williams, C; Anderson, RS				Wickert, Andrew D.; Mitrovica, Jerry X.; Williams, Carlie; Anderson, Robert S.			Gradual demise of a thin southern Laurentide ice sheet recorded by Mississippi drainage	NATURE			English	Article							GULF-OF-MEXICO; POSTGLACIAL SEA-LEVEL; LAST GLACIAL MAXIMUM; HYPERPYCNAL FLOWS; TRANSPORT MODEL; LAKE AGASSIZ; DEGLACIATION; MELTWATER; WATER; SEDIMENT	At the Last Glacial Maximum (LGM), about 21,000 years before present, land-based ice sheets held enough water to reduce global mean sea level by 130 metres(1). Yet after decades of study, major uncertainties remain as to the distribution of that ice(2). Here we test four reconstructions of North American deglacial ice-sheet history(3-6) by quantitatively connecting them to high-resolution oxygen isotope (delta O-18) records from the Gulf of Mexico(7-11) using a water mixing model(12). For each reconstruction, we route meltwater(3-6) and seasonal runoff(13-16) through the time-evolving Mississippi drainage basin, which co-evolves with ice geometry(3-6) and changing topography as ice loads deform the solid Earth and produce spatially variable sea level in a process known as glacial isostatic adjustment(17). The delta O-18 records show that the Mississippi-drained southern Laurentide ice sheet contributed only 5.4 +/- 2.1 metres to global sea level rise, of which 0.66 +/- 0.07 metres were released during the meltwater pulse 1A event 14,650-14,310 years before present(18), far less water than previously thought(5,12,19). In contrast, the three reconstructions based on glacial isostatic adjustment(3-5) overpredict the delta O-18-based post-LGM meltwater volume by a factor of 1.6 to 3.6. The fourth reconstruction(6), which is based on ice physics, has a low enough Mississippi-routed meltwater discharge to be consistent with delta O-18 constraints, but also contains the largest LGM North American ice volume. This suggests that modelling based on ice physics may be the best way of matching isotopic records while also sequestering enough water in the North American ice sheets to match the observed LGM sea level fall(1).	[Wickert, Andrew D.; Anderson, Robert S.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80303 USA; [Wickert, Andrew D.; Anderson, Robert S.] Univ Colorado, Dept Geol Sci, Boulder, CO 80303 USA; [Mitrovica, Jerry X.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Williams, Carlie] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Harvard University; State University System of Florida; University of South Florida	Wickert, AD (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, 1560 30th St, Boulder, CO 80303 USA.	wickert@colorado.edu	Wickert, Andrew/C-2021-2014	Wickert, Andrew/0000-0002-9545-3365; Anderson, Robert/0000-0003-2759-4833	US Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program; US National Science Foundation Graduate Research Fellowship [DGE 1144083]; Canadian Institute for Advanced Research; Harvard University	US Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program; US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Harvard University	We thank F. He, B. Otto-Bliesner and Z. Liu for supplying their TraCE-21K general circulation model outputs. The Climate Prediction Center Merged Analysis of Precipitation (CMAP) precipitation data were provided by the NOAA/OAR/ESRL PSD from their website at http://www.esrl.noaa.gov/psd/. A. D. W. was supported by the US Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program, and by the US National Science Foundation Graduate Research Fellowship under grant number DGE 1144083. J.X.M. acknowledges support from the Canadian Institute for Advanced Research and Harvard University.	Aharon P, 2006, EARTH PLANET SC LETT, V241, P260, DOI 10.1016/j.epsl.2005.10.034; Aharon P, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000840; Austermann J, 2013, NAT GEOSCI, V6, P553, DOI 10.1038/NGEO1859; Bassett S. E., 2005, QUAT SCI REV, V309; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; Carlson AE, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000371; Carlson AE, 2009, QUATERNARY SCI REV, V28, P1625, DOI 10.1016/j.quascirev.2009.02.011; Clark PU, 2002, SCIENCE, V295, P2438; Deschamps P, 2012, NATURE, V483, P559, DOI 10.1038/nature10902; EMILIANI C, 1978, EARTH PLANET SC LETT, V41, P159, DOI 10.1016/0012-821X(78)90005-5; Flower BP, 2004, GEOLOGY, V32, P597, DOI 10.1130/G20604.1; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gregoire LJ, 2012, NATURE, V487, P219, DOI 10.1038/nature11257; He F., 2010, THESIS U WISCONSIN; HOOKE RL, 1982, GEOL SOC AM BULL, V93, P784, DOI 10.1130/0016-7606(1982)93<784:WAHOVB>2.0.CO;2; Kammerer J. C., 1990, LARGEST RIVERS US; Kendall RA, 2005, GEOPHYS J INT, V161, P679, DOI 10.1111/j.1365-246X.2005.02553.x; Kettner AJ, 2008, COMPUT GEOSCI-UK, V34, P1170, DOI 10.1016/j.cageo.2008.02.008; Knox JC., 2007, LARGE RIVERS GEOMORP, P145, DOI DOI 10.1002/9780470723722.CH9; Lamb MP, 2009, GEOLOGY, V37, P1067, DOI 10.1130/G30286A.1; Lambeck K, 2002, QUATERNARY SCI REV, V21, P343, DOI 10.1016/S0277-3791(01)00071-3; Lemieux JM, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000838; LEVENTER A, 1982, EARTH PLANET SC LETT, V59, P11, DOI 10.1016/0012-821X(82)90112-1; Licciardi JM, 1999, GEOPH MONOG SERIES, V112, P177; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; LoDico JM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001243; MARCHITTO TM, 1995, GEOLOGY, V23, P779, DOI 10.1130/0091-7613(1995)023<0779:HOLMFT>2.3.CO;2; Meckler AN, 2008, EARTH PLANET SC LETT, V272, P251, DOI 10.1016/j.epsl.2008.04.046; Metz M, 2011, HYDROL EARTH SYST SC, V15, P667, DOI 10.5194/hess-15-667-2011; Mitrovica JX, 2003, GEOPHYS J INT, V154, P253, DOI 10.1046/j.1365-246X.2003.01942.x; Mitrovica JX, 1996, J GEOPHYS RES-SOL EA, V101, P555, DOI 10.1029/95JB03208; Mu Q, 2007, REMOTE SENS ENVIRON, V111, P519, DOI 10.1016/j.rse.2007.04.015; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Mulder T, 2003, MAR PETROL GEOL, V20, P861, DOI 10.1016/j.marpetgeo.2003.01.003; MULDER T, 1995, J GEOL, V103, P285, DOI 10.1086/629747; Neteler M, 2012, ENVIRON MODELL SOFTW, V31, P124, DOI 10.1016/j.envsoft.2011.11.014; Parsons JD, 2001, SEDIMENTOLOGY, V48, P465, DOI 10.1046/j.1365-3091.2001.00384.x; Peltier WR, 2007, GEOLOGY, V35, P1147, DOI 10.1130/focus122007.1; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; REMENDA VH, 1994, SCIENCE, V266, P1975, DOI 10.1126/science.266.5193.1975; Richey JN, 2007, GEOLOGY, V35, P423, DOI 10.1130/G23507A.1; Ross M, 2009, BOREAS, V38, P421, DOI 10.1111/j.1502-3885.2009.00082.x; Syvitski JPM, 2007, CONT SHELF RES, V27, P296, DOI 10.1016/j.csr.2005.08.029; Tarasov L, 2006, QUATERNARY SCI REV, V25, P659, DOI 10.1016/j.quascirev.2005.12.006; Tarasov L, 2005, NATURE, V435, P662, DOI 10.1038/nature03617; Tarasov L, 2012, EARTH PLANET SC LETT, V315, P30, DOI 10.1016/j.epsl.2011.09.010; Teller JT, 2004, GEOL SOC AM BULL, V116, P729, DOI 10.1130/B25316.1; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wagner AJ, 2011, B MAR SCI, V87, P1, DOI 10.5343/bms.2010.1004; Whitehouse PL, 2012, QUATERNARY SCI REV, V32, P1, DOI 10.1016/j.quascirev.2011.11.016; Wilcock PR, 2003, J HYDRAUL ENG, V129, P120, DOI 10.1061/(ASCE)0733-9429(2003)129:2(120); Williams C, 2012, GEOLOGY, V40, P955, DOI 10.1130/G33279.1; Williams C, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001928; WOLMAN MG, 1960, J GEOL, V68, P54, DOI 10.1086/626637; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Yeager SG, 2006, J CLIMATE, V19, P2545, DOI 10.1175/JCLI3744.1	58	41	41	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					668	+		10.1038/nature12609	http://dx.doi.org/10.1038/nature12609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24172978				2022-12-28	WOS:000326293200044
J	Taha, H; Das, S				Taha, H.; Das, S.			PICTURE QUIZ Cerebral mass in HIV infection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEUROCYSTICERCOSIS		[Taha, H.; Das, S.] Coventry & Warwickshire Partnership NHS Trust, Coventry CV1 4FS, W Midlands, England		Taha, H (corresponding author), Coventry & Warwickshire Partnership NHS Trust, Coventry CV1 4FS, W Midlands, England.	Huda.taha@covwarkpt.nhs.uk						Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; Del Brutto OH, 2001, NEUROLOGY, V57, P177, DOI 10.1212/WNL.57.2.177; Garcia HH, 2002, CLIN MICROBIOL REV, V15, P747, DOI 10.1128/CMR.15.4.747-756.2002; Nash TE, 2006, NEUROLOGY, V67, P1120, DOI 10.1212/01.wnl.0000238514.51747.3a; Pandit S, 2001, J COMPUT ASSIST TOMO, V25, P950, DOI 10.1097/00004728-200111000-00019; Prasad S, 2006, CLIN INFECT DIS, V42, pE30, DOI 10.1086/499359; Rockwood N, 2011, HIV MED, V12, P1, DOI 10.1111/j.1468-1293.2011.00944_1.x; VAZQUEZ V, 1992, NEW ENGL J MED, V327, P696, DOI 10.1056/NEJM199209033271005	8	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2013	347								f6314	10.1136/bmj.f6314	http://dx.doi.org/10.1136/bmj.f6314			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CK	24157498				2022-12-28	WOS:000326294000002
J	Blumberg, JM				Blumberg, Jeremy M.			Shepard's Prayer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Blumberg, Jeremy M.] Harbor UCLA Med Ctr, Div Urol, Los Angeles, CA USA; [Blumberg, Jeremy M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Blumberg, JM (corresponding author), Harbor UCLA Med Ctr, Div Urol, Los Angeles, CA USA.	jblumberg@mednet.ucla.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1675	1676		10.1001/jama.2013.279192	http://dx.doi.org/10.1001/jama.2013.279192			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24150463				2022-12-28	WOS:000325948500020
J	Meddings, JA; Reichert, H; Hofer, T; McMahon, LF				Meddings, Jennifer A.; Reichert, Heidi; Hofer, Tim; McMahon, Laurence F., Jr.			Hospital Report Cards for Hospital-Acquired Pressure Ulcers: How Good Are the Grades?	ANNALS OF INTERNAL MEDICINE			English	Article							URINARY-TRACT-INFECTION; MEDICARE; QUALITY	Background: Value-based purchasing programs use administrative data to compare hospitals by rates of hospital-acquired pressure ulcers (HAPUs) for public reporting and financial penalties. However, validation of these data is lacking. Objective: To assess the validity of the administrative data used to generate HAPU rates by comparing the rates generated from these data with those generated from surveillance data. Design: Retrospective analysis of 2 million all-payer administrative records from 448 California hospitals and quarterly hospitalwide surveillance data from 213 hospitals from the Collaborative Alliance for Nursing Outcomes (as publicly reported on the CalHospital-Compare Web site). Setting: 196 acute care hospitals with at least 6 months of available administrative and surveillance data. Patients: Nonobstetric adults discharged in 2009. Measurements: Hospital-specific HAPU rates were computed as the percentage of discharged adults (from administrative data) or examined adults (from surveillance data) with at least 1 stage II or greater HAPU (HAPU2+). Categorization of hospital performance based on administrative data was compared with the grade assigned when surveillance data were used. Results: When administrative data were used, the mean hospital-specific HAPU2+ rate was 0.15% (95% CI, 0.13% to 0.17%); when surveillance data were used, the rate was 2.0% (CI, 1.8% to 2.2%). Among the 49 hospitals with HAPU2+ rates in the highest (worst) quartile from administrative data, use of the surveillance data set resulted in performance grades of "superior" for 3 of these hospitals, "above average" for 14, "average" for 15, and "below average" for 17. Limitation: Data are from 1 state and 1 year. Conclusion: Hospital performance scores generated from HAPU2+ rates varied considerably according to whether administrative or surveillance data were used, suggesting that administrative data may not be appropriate for comparing hospitals.	Univ Michigan, Sch Publ Hlth, Sch Med, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Meddings, JA (corresponding author), Univ Michigan, Div Gen Med, Dept Internal Med, Sch Med, 2800 Plymouth Rd,Bldg 16,Room 430W, Ann Arbor, MI 48109 USA.	meddings@umich.edu	Hofer, Timothy Philip/AAC-9238-2022	Meddings, Jennifer/0000-0001-9503-0293; Hofer, Timothy/0000-0003-0434-8787	Agency for Healthcare Research and Quality [1K08-HS019767-01]; National Institutes of Health Clinical Loan Repayment Program [1R01-0HS018344-01A1]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS019767] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health Clinical Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By grant 1K08-HS019767-01 from the Agency for Healthcare Research and Quality to Dr. Meddings. The authors were also supported by award 1R01-0HS018344-01A1 to Dr. McMahon. Dr. Meddings is a recipient of the National Institutes of Health Clinical Loan Repayment Program for 2009 to 2013.	Agency for Healthcare Research and Quality, 2012, AHRQ QUAL IND PAT SA; American Hospital Association, DAT COLL METH; [Anonymous], 2013, FED REG, V78, P27486; [Anonymous], 2012, MED PAT SAF MON SYST; Aydin C., 2008, ADV PATIENT SAFETY N, V1; Aydin CE, 2004, J NURS SCHOLARSHIP, V36, P371, DOI 10.1111/j.1547-5069.2004.04066.x; Beckrich K, 1999, NURS ECON, V17, P263; Berlowitz D, 2011, AHRQ PUBLICATION; Berlowitz DR, 1999, J AM GERIATR SOC, V47, P692, DOI 10.1111/j.1532-5415.1999.tb01591.x; Black JM, 2011, OSTOMY WOUND MANAG, V57, P24; Brem H, 2010, AM J SURG, V200, P473, DOI 10.1016/j.amjsurg.2009.12.021; California HealthCare Foundation, 2013, DAT RAT; California HealthCare Foundation, CAL HOSP ASS REP TRA; Centers for Medicare and Medicaid Services (CMS) HHS, 2007, FED REG, V72, P47129; Centers for Medicare and Medicaid Services (CMS) HHS, 2008, FED REG, V73, P48433; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, FED REG, V76, P32816; Centers for Medicare & Medicaid Services, 2013, READM COMPL DEATHS; Centers for Medicare & Medicaid Services National Center for Health Statistics, 2013, ICD 9 CM OFF GUID CO; Collaborative Alliance for Nursing Outcomes, 2010, COD 2, P23; Collaborative Alliance for Nursing Outcomes (CALNOC), FREQ ASK QUEST; Collaborative Alliance for Nursing Outcomes ( CALNOC), PRESS ULC THEIR ASS; Healthcare Cost and Utilization Project, 2008, HCUP QUAL CONTR PROC; Healthcare Cost and Utilization Project, 2013, OV STAT INP DAT SID; Jenkins ML, 2010, ADV SKIN WOUND CARE, V23, P556, DOI 10.1097/01.ASW.0000391184.43845.c1; Lyder CH, 2001, ARCH INTERN MED, V161, P1549, DOI 10.1001/archinte.161.12.1549; Lyder CH, 2012, J AM GERIATR SOC, V60, P1603, DOI 10.1111/j.1532-5415.2012.04106.x; Meddings J, 2010, INFECT CONT HOSP EP, V31, P627, DOI 10.1086/652523; Meddings JA, 2012, ANN INTERN MED, V157, P305, DOI 10.7326/0003-4819-157-5-201209040-00003; Pieper B, 2009, OSTOMY WOUND MANAG, V55, P16; Pressure ulcers in America, 2001, ADV SKIN WOUND CARE, V14, P208; Snow CL, 2012, ACCURACY CODING HOSP; Stausberg Jurgen, 2005, Adv Skin Wound Care, V18, P140, DOI 10.1097/00129334-200504000-00011; Stotts NA, 2013, ADV SKIN WOUND CARE, V26, P13, DOI 10.1097/01.ASW.0000425935.94874.41; Suess E. A., 2010, INTRO PROBABILITY SI; VanGilder C, 2009, OSTOMY WOUND MANAG, V55, P39; Whittington Kathy T, 2004, Adv Skin Wound Care, V17, P490, DOI 10.1097/00129334-200411000-00016	36	37	37	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					505	+		10.7326/0003-4819-159-8-201310150-00003	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126644	Green Accepted			2022-12-28	WOS:000326751200013
J	Schellenberg, ES; Dryden, DM; Vandermeer, B; Ha, C; Korownyk, C				Schellenberg, Elizabeth Sumamo; Dryden, Donna M.; Vandermeer, Ben; Ha, Christine; Korownyk, Christina			Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							IMPAIRED GLUCOSE-TOLERANCE; METABOLIC SYNDROME; CARDIOVASCULAR RISK; MULTIFACTORIAL INTERVENTION; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; MELLITUS; PREVENTION; MANAGEMENT; MORTALITY	Background: The effect of multifaceted lifestyle interventions on clinically oriented outcomes across a spectrum of metabolic risk factors and abnormal glucose is unclear. Purpose: To systematically review the effectiveness of lifestyle interventions on minimizing progression to diabetes in high-risk patients or progression to clinical outcomes (such as cardiovascular disease and death) in patients with type 2 diabetes. Data Sources: 5 electronic databases (1980 to June 2013), reference lists, and gray literature. Study Selection: Two reviewers independently identified randomized, controlled trials of lifestyle interventions (>= 3 months' duration) that included exercise, diet, and at least 1 other component; the comparator was standard care. Data Extraction: One reviewer extracted and a second verified data. Two reviewers independently assessed methodological quality. Data Synthesis: Nine randomized, controlled trials with patients who were at risk for diabetes and 11 with patients who had diabetes were included. Seven studies reported that lifestyle interventions decreased the risk for diabetes from the end of intervention up to 10 years after it. In patients with diabetes, 2 randomized, controlled trials (which included pharmacotherapy) reported no improvement in all-cause mortality (risk ratio, 0.75 [95% CI, 0.53 to 1.06]). Composite outcomes for cardiovascular disease were too heterogeneous to pool. One trial reported improvement in microvascular outcomes at 13-year follow-up. Limitation: Most trials focused on surrogate measures (such as weight change, blood pressure, and lipids) for which clinical relevance was unclear. Conclusion: Comprehensive lifestyle interventions effectively decrease the incidence of type 2 diabetes in high-risk patients. In patients who already have type 2 diabetes, there is no evidence of reduced all-cause mortality and insufficient evidence to suggest benefit on cardiovascular and microvascular outcomes.	Univ Alberta, Evidence Based Practice Ctr, Edmonton, AB T6G 2C8, Canada; Univ Alberta, Alberta Res Ctr Hlth Evidence, Edmonton, AB T6G 2C8, Canada	University of Alberta; University of Alberta	Korownyk, C (corresponding author), Univ Alberta, Dept Family Med, 1706 Coll Plaza,8215 112 St, Edmonton, AB T6G 2C8, Canada.	cpoag@ualberta.ca		Korownyk, Christina/0000-0003-4953-9392	Agency for Healthcare Research and Quality [290-2007-10021-I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (contract 290-2007-10021-I).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bo S, 2007, J GEN INTERN MED, V22, P1695, DOI 10.1007/s11606-007-0399-6; Bo S, 2009, AM J CLIN NUTR, V90, P1502, DOI 10.3945/ajcn.2009.28379; Borenstein M., 2009, INTRO METAANALYSIS; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Centers for Disease Control and Prevention, 2011, DIAB SUCC OPP POP BA; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Christian JG, 2008, ARCH INTERN MED, V168, P141, DOI 10.1001/archinternmed.2007.13; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; FRANZ MJ, 1995, J AM DIET ASSOC, V95, P1009, DOI 10.1016/S0002-8223(95)00276-6; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; GUARE JC, 1995, OBES RES, V3, P329, DOI 10.1002/j.1550-8528.1995.tb00158.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hopper I, 2011, EUR J CARDIOV PREV R, V18, P813, DOI 10.1177/1741826711421687; Horton ES, 2009, OBESITY, V17, pS43, DOI 10.1038/oby.2009.388; Keyserling TC, 2002, DIABETES CARE, V25, P1576, DOI 10.2337/diacare.25.9.1576; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3564; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414; Lu YH, 2011, ADV THER, V28, P511, DOI 10.1007/s12325-011-0022-4; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mayer-Davis EJ, 2004, AM J PUBLIC HEALTH, V94, P1736, DOI 10.2105/AJPH.94.10.1736; Menard Julie, 2005, CMAJ, V173, P1457, DOI 10.1503/cmaj.050054; Mensink M, 2003, INT J OBESITY, V27, P377, DOI 10.1038/sj.ijo.0802249; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; Oh EG, 2010, METABOLISM, V59, P1035, DOI 10.1016/j.metabol.2009.10.027; Oldroyd JC, 2006, DIABETES RES CLIN PR, V72, P117, DOI 10.1016/j.diabres.2005.09.018; Oldroyd JC, 2001, DIABETES RES CLIN PR, V52, P29, DOI 10.1016/S0168-8227(00)00244-8; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pinkston M M, 2006, Eat Weight Disord, V11, pe35; Ratner RE, 2011, MED CLIN N AM, V95, P385, DOI 10.1016/j.mcna.2010.11.007; Samuel-Hodge CD, 2009, DIABETES EDUCATOR, V35, P439, DOI 10.1177/0145721709333270; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Siebenhofer A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007654.pub3; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Stratton IM, 2006, DIABETOLOGIA, V49, P1761, DOI 10.1007/s00125-006-0297-1; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Toobert DJ, 2011, ANN BEHAV MED, V41, P310, DOI 10.1007/s12160-010-9256-7; Toobert DJ, 2003, DIABETES CARE, V26, P2288, DOI 10.2337/diacare.26.8.2288; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; van Vark LC, 2012, EUR HEART J, V33, P2088, DOI 10.1093/eurheartj/ehs075; VANNINEN E, 1992, DIABETOLOGIA, V35, P340, DOI 10.1007/BF00401201; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780; Yoon U, 2013, METABOLISM, V62, P303, DOI 10.1016/j.metabol.2012.07.009	64	299	303	5	69	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					543	+		10.7326/0003-4819-159-8-201310150-00007	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00007			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126648				2022-12-28	WOS:000326751200017
J	Raftery, J; Powell, J				Raftery, James; Powell, John			Health Technology Assessment in the UK	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIALS; ENDOVASCULAR REPAIR; ECONOMIC-EVALUATION; MANAGEMENT; CHILDREN; THERAPY; IMPACT	In this Review, we discuss the UK's Health Technology Assessment programme, which is 20 years old in 2013. We situate the programme in the context of the UK landscape for evidence-based medicine, including in relation to the National Institute for Health and Care Excellence and as guidance to the National Health Service. We identify features that might be of value to other health systems as they confront the challenges of rapid innovation and rising costs. We use examples of recent studies to show the strengths and weaknesses of the programme.	[Raftery, James] Univ Southampton, Wessex Inst, Southampton SO16 7NS, Hants, England; [Powell, John] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England	University of Southampton; University of Oxford	Raftery, J (corresponding author), Univ Southampton, Alpha House, Southampton SO16 7NS, Hants, England.	j.p.raftery@soton.ac.uk		Powell, John/0000-0002-1456-4857	HTA programme	HTA programme	Until January, 2012, JR was chair of the National Institute for Health Research Evaluation Studies and Trials Coordinating Centre, which manages four programmes, including the HTA programme for the National Institute for Health Research. Since January, 2012, he has continued to work part time for the National Institute for Health Research Evaluation Studies and Trials Coordinating Centre. JR is a member of the Editorial Board for the HTA journal. JR has also received research funding from the HTA programme, usually as a coapplicant, and he provides input on health economics to trials. He was the main investigator in a project funded by the HTA programme in 2009, to develop a metadata database of all randomised trials funded by the HTA programme. JP worked full time for the HTA programme, 2003-05, as a senior fellow. JP is a consultant clinical adviser for the NICE Interventional Procedures Programme. He is a member of the Editorial Board of the HTA journal.	Austoker J, PROSTATE CANC RISK M; Buxton M, 1998, J ROY SOC MED, V91, P2, DOI 10.1177/014107689809135S02; Buxton M, 2004, B WORLD HEALTH ORGAN, V82, P733; Campbell MK, 2007, HEALTH TECHNOL ASSES, V11, P1; Cartwright N, 2011, LANCET, V377, P1400, DOI 10.1016/S0140-6736(11)60563-1; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Chalkidou K, 2012, CLIN TRIALS, V9, P436, DOI 10.1177/1740774512450097; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chamberlain J, 1997, HEALTH TECHNOL ASSES, V1, P1; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Cochrane T, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI DOI 10.3310/HTA9310; Commons Select Committee, CLIN TRIALS; Cook JA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-9; Cooksey D., 2006, REV UK HLTH RES FUND; Dent L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-109; Department of Health, 1989, 3 DEP HLTH HOUS LORD; Department of Health, 1993, RES HLTH; Department of Health. Advisory Group on Health Technology Assessment, 1992, ASS EFF HLTH TECHN P; Donovan J, 2003, Health Technol Assess, V7, P1; Drury D, 2005, BRIT J SURG, V92, P937, DOI 10.1002/bjs.5123; Dumville JC, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13550; Epps H, 2005, HEALTH TECHNOL ASSES, V9, pIII; Food and Drug Administration, 2010, GUID IND AD IN PRESS; Godlee F, 2012, BMJ-BRIT MED J, V344, pe3162; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1872, DOI 10.1056/NEJMoa0911056; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Hamdy FC, EXPERIENCES PROTECT; Hanney S, 2007, HEALTH TECHNOL ASSES, V11, P1; Hawkes N, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5161; Henry DA, 2001, COCHRANE DB SYST REV, V1; Hooper L, 2010, HEALTH TECHNOL ASSES, V14, P1193; House of Lords Select Committee on Science and Technology, 1988, PRIOR MED RES; HTA programme, HTA PROGR; HTA programme, HTA PROGR; Krebs I, 2013, BRIT J OPHTHALMOL, V97, P266, DOI 10.1136/bjophthalmol-2012-302391; Laine C, 2007, LANCET, V369, P1909, DOI 10.1016/S0140-6736(07)60894-0; Lederle FA, 2007, ANN INTERN MED, V146, P735, DOI 10.7326/0003-4819-146-10-200705150-00007; Lewis S, 2006, HLTH TECHNOLOGY ASSE, V10, P1, DOI DOI 10.3310/hta10170; Michaels J A, 2006, Health Technol Assess, V10, P1; MOWATT G, 1997, HEALTH TECHNOL ASSES, V1, P1; National Institute for Health and Clinical Excellence (NICE), VAR VEINS LEGS DIAGN; NICE, 2009, TA167 NICE; NICE, 2013, RAP REV TECHN APPR G; Oliver S, 2001, Health Expect, V4, P18, DOI 10.1046/j.1369-6513.2001.00113.x; Peek GJ, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14350; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Peveler R, 2005, Health Technol Assess, V9, P1; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Selley S., 1997, HLTH TECHNOLOGY ASSE, V1, P1, DOI DOI 10.3310/HTA1020; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shilling V, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15150; Thomas KS, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15080; Turner S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002521; Walley T, 2010, LANCET, V375, P1063, DOI 10.1016/S0140-6736(10)60068-2; WAYMONT B, 1993, BRIT J UROL, V71, P577, DOI 10.1111/j.1464-410X.1993.tb16028.x; Wiles N, 2013, LANCET, V381, P375, DOI 10.1016/S0140-6736(12)61552-9; Winyard G., 1997, POPULATION SCREENING; ZON-MW and the Netherlands Organization for Health Research and Development, COMP BEV AV RAN LUC	59	26	29	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1278	1285		10.1016/S0140-6736(13)61724-9	http://dx.doi.org/10.1016/S0140-6736(13)61724-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	24120204				2022-12-28	WOS:000325756400031
J	Cummings, J; Isaacson, S; Mills, R; Williams, H; Chi-Burris, K; Corbett, A; Dhall, R; Ballard, C				Cummings, Jeffrey; Isaacson, Stuart; Mills, Roger; Williams, Hilde; Chi-Burris, Kathy; Corbett, Anne; Dhall, Rohit; Ballard, Clive			Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial	LANCET			English	Article							DRUG-INDUCED PSYCHOSIS; DOUBLE-BLIND; VISUAL HALLUCINATIONS; QUETIAPINE; CLOZAPINE; DEMENTIA; SYMPTOMS; RECEPTOR; AGITATION; SLEEP	Background Parkinson's disease psychosis, which includes hallucinations and delusions, is frequent and debilitating in people with Parkinson's disease. We aimed to assess safety and efficacy of pimavanserin, a selective serotonin 5-HT2A inverse agonist, in this population. Methods In our 6 week, randomised, double-blind, placebo-controlled study, we enrolled adults (aged >= 40 years) with Parkinson's disease psychosis. Antipsychotic treatments were not permitted during the study, but controlled antiparkinsonian medication or deep brain stimulation was allowed. Eligible participants entered a 2 week nonpharmacological lead-in phase to limit the placebo response, after which they were randomly allocated (1:1) to receive pimavanserin 40 mg per day or matched placebo. The primary outcome was antipsychotic benefit as assessed by central, independent raters with the Parkinson's disease-adapted scale for assessment of positive symptoms (SAPS-PD) in all patients who received at least one dose of study drug and had a SAPS assessment at baseline and at least one follow-up. We assessed safety and tolerability in all patients who received at least one dose of study drug. Findings Between Aug 11, 2010, and Aug 29, 2012, we randomly allocated 199 patients to treatment groups. For 90 recipients of placebo and 95 recipients of pimavanserin included in the primary analysis, pimavanserin was associated with a -5.79 decrease in SAPS-PD scores compared with -2.73 for placebo (difference -3.06, 95% CI-4.91 to -1.20; p = 0.001; Cohen's d 0.50). Ten patients in the pimavanserin group discontinued because of an adverse event (four due to psychotic disorder or hallucination within 10 days of start of the study drug) compared with two in the placebo group. Overall, pimavanserin was well tolerated with no significant safety concerns or worsening of motor function. Interpretation Pimavanserin may benefit patients with Parkinson's disease psychosis for whom few other treatment options exist. The trial design used in this study to manage placebo response could have applicability to other studies in neuropsychiatric disease.	[Cummings, Jeffrey] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Isaacson, Stuart] Parkinsons Dis & Movement Disorders Ctr Boca Rato, Boca Raton, FL USA; [Mills, Roger; Williams, Hilde; Chi-Burris, Kathy] ACADIA Pharmaceut, San Diego, CA USA; [Corbett, Anne; Ballard, Clive] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England; [Dhall, Rohit] Barrow Neurol Inst, Phoenix, AZ 85013 USA	Cleveland Clinic Foundation; University of London; King's College London; Barrow Neurological Institute	Ballard, C (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Guys Campus, London SE1 1UL, England.	clive.ballard@kcl.ac.uk	Corbett, Anne/B-3223-2014; Cummings, Jeffrey/AAC-5947-2019	Corbett, Anne/0000-0003-2015-0316; Cummings, Jeffrey/0000-0001-8944-4158; Dhall, Rohit/0000-0001-9436-1920; Ballard, Clive/0000-0003-0022-5632	ACADIA Pharmaceuticals	ACADIA Pharmaceuticals	ACADIA Pharmaceuticals	Aarsland D, 2001, INT J GERIATR PSYCH, V16, P528, DOI 10.1002/gps.389; Ancoli-Israel S, 2011, SLEEP MED, V12, P134, DOI 10.1016/j.sleep.2010.10.004; Andreason NC, 1984, SCALE ASSESSMENT POS; Ballanger B, 2010, ARCH NEUROL-CHICAGO, V67, P416, DOI 10.1001/archneurol.2010.35; Ballard C, 2009, AM J GERIAT PSYCHIAT, V17, P726, DOI 10.1097/JGP.0b013e3181b0f8c0; Creese B, 2014, AM J GERIAT PSYCHIAT, V22, P580, DOI 10.1016/j.jagp.2012.11.001; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dombrovski AY, 2010, INT CLIN PSYCHOPHARM, V25, P37, DOI 10.1097/YIC.0b013e328333ee10; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fernandez HH, 2009, INT J NEUROSCI, V119, P2196, DOI 10.3109/00207450903222758; Friedman J, 1999, NEW ENGL J MED, V340, P757; Friedman JH, 2010, NEUROLOGY, V77; Guy W., 1976, DHEW PUBL, P218; Harvey L, 2003, PHARMACOGENETICS, V13, P107, DOI 10.1097/00008571-200302000-00007; Howard R, 2011, INT J GERIATR PSYCH, V26, P812, DOI 10.1002/gps.2607; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kurlan R, 2007, NEUROLOGY, V68, P1356, DOI 10.1212/01.wnl.0000260060.60870.89; Marinus J, 2003, SLEEP, V26, P1049, DOI 10.1093/sleep/26.8.1049; Meltzer HY, 2010, NEUROPSYCHOPHARMACOL, V35, P881, DOI 10.1038/npp.2009.176; Ondo WG, 2005, MOVEMENT DISORD, V20, P958, DOI 10.1002/mds.20474; Parkinson's Disease Foundation, STAT PARK; Pollak P, 2004, J NEUROL NEUROSUR PS, V75, P689, DOI 10.1136/jnnp.2003.029868; Pollak P, 1999, LANCET, V353, P2041; Proitsi P, 2012, NEUROBIOL AGING, V33, P791, DOI 10.1016/j.neurobiolaging.2010.06.011; Rabey JM, 2007, MOVEMENT DISORD, V22, P313, DOI 10.1002/mds.21116; Ravina B, 2007, MOVEMENT DISORD, V22, P1061, DOI 10.1002/mds.21382; Reynolds GP, 2005, PROG NEURO-PSYCHOPH, V29, P1021, DOI 10.1016/j.pnpbp.2005.03.019; Shotbolt P, 2009, NEUROPSYCH DIS TREAT, V5, P327; Starkstein SE, 2012, CURR OPIN PSYCHIATR, V25, P468, DOI 10.1097/YCO.0b013e3283577ed1; Vanover KE, 2006, J PHARMACOL EXP THER, V317, P910, DOI 10.1124/jpet.105.097006; Voss T, 2013, PARKINSONISM RELAT D, V19, P295, DOI 10.1016/j.parkreldis.2012.10.022	31	391	406	2	64	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					533	540		10.1016/S0140-6736(13)62106-6	http://dx.doi.org/10.1016/S0140-6736(13)62106-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24183563				2022-12-28	WOS:000331136400029
J	Rothwell, PM; Markus, HS				Rothwell, Peter M.; Markus, Hugh S.			Improved medical treatment in secondary prevention of stroke	LANCET			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK; INTRACRANIAL ARTERIAL-STENOSIS; SYMPTOMATIC CAROTID STENOSIS; SAMMPRIS TRIAL; RECURRENT STROKE; THERAPY; ANGIOPLASTY		[Rothwell, Peter M.] Univ Oxford, Dept Clin Neurol, Oxford OX3 9DU, England; [Markus, Hugh S.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	University of Oxford; University of Cambridge	Rothwell, PM (corresponding author), Univ Oxford, Dept Clin Neurol, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	Wellcome Trust [095626] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191, DOI 10.1056/nejm198511073131904; Chaturvedi S, 2013, STROKE, V44, P2957, DOI 10.1161/STROKEAHA.113.000918; Chimowitz MI, 2012, STROKE, V43, P2806, DOI 10.1161/STROKEAHA.112.661041; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Derdeyn CP, 2013, J NEUROINTERV SURG, V5, P528, DOI 10.1136/neurintsurg-2012-010504; Derdeyn CP, 2013, NEUROSURGERY, V72, P777, DOI 10.1227/NEU.0b013e318286fdc8; Derdeyn CP, 2013, LANCET; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Markus HS, 2013, LANCET NEUROL, V12, P989, DOI 10.1016/S1474-4422(13)70211-4; Marquardt L, 2010, STROKE, V41, pE11, DOI 10.1161/STROKEAHA.109.561837; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Wong KSL, 2013, CIRCULATION, V128, P1656, DOI 10.1161/CIRCULATIONAHA.113.003187	14	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					290	291		10.1016/S0140-6736(13)62191-1	http://dx.doi.org/10.1016/S0140-6736(13)62191-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24168958				2022-12-28	WOS:000330212600010
J	Florian, MC; Nattamai, KJ; Dorr, K; Marka, G; Uberle, B; Vas, V; Eckl, C; Andra, I; Schiemann, M; Oostendorp, RAJ; Scharffetter-Kochanek, K; Kestler, HA; Zheng, Y; Geiger, H				Florian, Maria Carolina; Nattamai, Kalpana J.; Doerr, Karin; Marka, Gina; Ueberle, Bettina; Vas, Virag; Eckl, Christina; Andrae, Immanuel; Schiemann, Matthias; Oostendorp, Robert A. J.; Scharffetter-Kochanek, Karin; Kestler, Hans Armin; Zheng, Yi; Geiger, Hartmut			A canonical to non-canonical Wnt signalling switch in haematopoietic stem-cell ageing	NATURE			English	Article							PROGENITOR CELLS; TUMOR-SUPPRESSOR; PATHWAYS; CDC42; PROLIFERATION; REJUVENATION; COOPERATE; MUSCLE; NOTCH; FATE	Many organs with a high cell turnover (for example, skin, intestine and blood) are composed of short-lived cells that require continuous replenishment by somatic stem cells(1,2). Ageing results in the inability of these tissues to maintain homeostasis and it is believed that somatic stem-cell ageing is one underlying cause of tissue attrition with age or age-related diseases. Ageing of haematopoietic stem cells (HSCs) is associated with impaired haematopoiesis in the elderly(3-6). Despite a large amount of data describing the decline of HSC function on ageing, the molecular mechanisms of this process remain largely unknown, which precludes rational approaches to attenuate stem-cell ageing. Here we report an unexpected shift from canonical to non-canonical Wnt signalling in mice due to elevated expression of Wnt5a in aged HSCs, which causes stem-cell ageing. Wnt5a treatment of young HSCs induces ageing-associated stem-cell apolarity, reduction of regenerative capacity and an ageing-like myeloid-lymphoid differentiation skewing via activation of the small Rho GTPase Cdc42. Conversely, Wnt5a haploinsufficiency attenuates HSC ageing, whereas stem-cell-intrinsic reduction of Wnt5a expression results in functionally rejuvenated aged HSCs. Our data demonstrate a critical role for stem-cell-intrinsic non-canonical Wnt5a signalling in HSC ageing.	[Florian, Maria Carolina; Doerr, Karin; Marka, Gina; Ueberle, Bettina; Vas, Virag; Scharffetter-Kochanek, Karin; Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, D-89091 Ulm, Germany; [Nattamai, Kalpana J.; Zheng, Yi; Geiger, Hartmut] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Nattamai, Kalpana J.; Zheng, Yi; Geiger, Hartmut] Univ Cincinnati, Cincinnati, OH 45229 USA; [Eckl, Christina; Oostendorp, Robert A. J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 3, D-81675 Munich, Germany; [Andrae, Immanuel; Schiemann, Matthias] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Kestler, Hans Armin] Univ Ulm, Dept Bioinformat & Syst Biol, Inst Neuroinformat, D-89091 Ulm, Germany	Ulm University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Technical University of Munich; University of Munich; Technical University of Munich; Ulm University	Geiger, H (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, D-89091 Ulm, Germany.	hartmut.geiger@uni-ulm.de	Zheng, Yi/J-7235-2015; Florian, M. Carolina/AAH-5309-2019; Vas, Virag/B-8067-2016; Virag, Vas/AAD-3532-2022; Kestler, Hans A./D-5799-2012; Oostendorp, Robert A. J./K-9841-2018	Zheng, Yi/0000-0001-7089-6074; Florian, M. Carolina/0000-0002-5791-1310; Vas, Virag/0000-0001-7249-6816; Virag, Vas/0000-0001-7249-6816; Kestler, Hans A./0000-0002-4759-5254; Oostendorp, Robert A. J./0000-0002-4947-0412; Vas, Virag/0000-0002-9722-8188; Andra, Immanuel/0000-0003-1543-9158; Scharffetter-Kochanek, Karin/0000-0002-9655-685X	Deutsche Forschungsgemeinschaft [KFO 142, GE2063/1, SFB 1074]; German Federal Ministry of Education and Research; Excellence program of the Baden-Wurttemberg Foundation; National Institute of Health [HL076604, DK077762, AG040118]; Edward P. Evans foundation; European Commission (FP7 Marie Curie Initial Training Network MARRIAGE); Department of Medicine of Ulm University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040118] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Excellence program of the Baden-Wurttemberg Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans foundation; European Commission (FP7 Marie Curie Initial Training Network MARRIAGE); Department of Medicine of Ulm University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Van Zant and J. A. Cancelas for advice and critical reading of the manuscript. We thank F. Kirchhoff and D. van der Merwe for cell sorting support, A. Ruck and the Institut fur Lasertechnologien in der Medizin und Messtechnik of Ulm University for support with confocal microscopy, and the Mouse and Cancer Core in Cincinnati and the Tierforschungszentrum of the University of Ulm for supporting our animal work. The work in the laboratory of H.G. is supported by grants from the Deutsche Forschungsgemeinschaft KFO 142, GE2063/1 and SFB 1074, the German Federal Ministry of Education and Research within its joint research project SyStaR (also to H.A.K. and K.S.-K.), the Excellence program of the Baden-Wurttemberg Foundation, the National Institute of Health, HL076604, DK077762 and AG040118, the Edward P. Evans foundation and the European Commission (FP7 Marie Curie Initial Training Network MARRIAGE). M.C.F. is supported by a 'Bausteinprogramm' of the Department of Medicine of Ulm University.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Daria D, 2008, BLOOD, V111, P1894, DOI 10.1182/blood-2007-02-071746; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Li JS, 2010, CANCER BIOL THER, V10, P617, DOI 10.4161/cbt.10.6.12609; Li ZX, 2003, EXP HEMATOL, V31, P1206, DOI 10.1016/j.exphem.2003.08.008; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2010, BLOOD, V116, P496, DOI 10.1182/blood-2010-04-282624; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Peterson JR, 2006, CHEM BIOL, V13, P443, DOI 10.1016/j.chembiol.2006.02.009; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Staal FJT, 2010, J CELL BIOCHEM, V109, P844, DOI 10.1002/jcb.22467; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Yang L, 2007, BLOOD, V110, P3853, DOI 10.1182/blood-2007-03-079582; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	31	201	206	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					392	+		10.1038/nature12631	http://dx.doi.org/10.1038/nature12631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24141946	Green Accepted			2022-12-28	WOS:000327163200040
J	Hurria, A; Naylor, M; Cohen, HJ				Hurria, Arti; Naylor, Mary; Cohen, Harvey Jay			Improving the Quality of Cancer Care in an Aging Population Recommendations From an IOM Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hurria, Arti] City Hope Natl Med Ctr, Ctr Comprehens Canc, Duarte, CA USA; [Naylor, Mary] Univ Penn, Sch Nursing, New Cortland Ctr Transit & Hlth, Philadelphia, PA 19104 USA; [Cohen, Harvey Jay] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27705 USA; [Cohen, Harvey Jay] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27705 USA	City of Hope; University of Pennsylvania; Duke University; Duke University	Cohen, HJ (corresponding author), Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, POB 3003, Durham, NC 27705 USA.	harvey.cohen@duke.edu						Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; IOM, 2013, DELIVERING HIGH QUAL; National Vital Statistics System (NVSS), 2012, DEATHS LEADING CAUSE; NCI: National Cancer Institute, 2013, SEER STAT FACT SHEET; Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983; Talarico L, 2004, J CLIN ONCOL, V22, P4626, DOI 10.1200/JCO.2004.02.175	6	85	86	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1795	1796		10.1001/jama.2013.280416	http://dx.doi.org/10.1001/jama.2013.280416			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193075				2022-12-28	WOS:000326550900007
J	Deeks, SG; Lewin, SR; Havlir, DV				Deeks, Steven G.; Lewin, Sharon R.; Havlir, Diane V.			The end of AIDS: HIV infection as a chronic disease	LANCET			English	Review							T-CELL-ACTIVATION; IMMUNODEFICIENCY-VIRUS CARE; IMMUNE ACTIVATION; ANTIRETROVIRAL THERAPY; OLDER-ADULTS; LIFE EXPECTANCY; RNA LEVELS; INFLAMMATION; FRAILTY; HEALTH	The success of antiretroviral therapy has led some people to now ask whether the end of AIDS is possible. For patients who are motivated to take therapy and who have access to lifelong treatment, AIDS-related illnesses are no longer the primary threat, but a new set of HIV-associated complications have emerged, resulting in a novel chronic disease that for many will span several decades of life. Treatment does not fully restore immune health; as a result, several inflammation-associated or immunodeficiency complications such as cardiovascular disease and cancer are increasing in importance. Cumulative toxic effects from exposure to antiretroviral drugs for decades can cause clinically-relevant metabolic disturbances and end-organ damage. Concerns are growing that the multimorbidity associated with HIV disease could affect healthy ageing and overwhelm some health-care systems, particularly those in resource-limited regions that have yet to develop a chronic care model fully. In view of the problems inherent in the treatment and care for patients with a chronic disease that might persist for several decades, a global effort to identify a cure is now underway.	[Deeks, Steven G.; Havlir, Diane V.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lewin, Sharon R.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Alfred Hosp, Melbourne, Vic, Australia; [Lewin, Sharon R.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia	University of California System; University of California San Francisco; Monash University; Florey Institute of Neuroscience & Mental Health; Burnet Institute	Deeks, SG (corresponding author), San Francisco Gen Hosp, 995 Potrero Ave, San Francisco, CA 94110 USA.	sdeeks@php.ucsf.edu	Lewin, Sharon/Z-3297-2019	Lewin, Sharon Ruth/0000-0002-0330-8241	National Institute of Allergy and Infectious Diseases (NIAID) [K24 AI069994]; DARE: Delaney AIDS Research Enterprise [U19AI096109]; University of California, San Francisco (UCSF)/Gladstone Center for AIDS Research (CFAR) [P30 AI027763]; NIAID [1R56AI095073-01A1, A151982]; Burnet Institute; UCSF/Gladstone CFAR [A1027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K24AI069994, K24AI051982, U19AI096109, R56AI095073] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DARE: Delaney AIDS Research Enterprise; University of California, San Francisco (UCSF)/Gladstone Center for AIDS Research (CFAR)(University of California System); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burnet Institute; UCSF/Gladstone CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SGD was supported by the National Institute of Allergy and Infectious Diseases (NIAID; K24 AI069994), the DARE: Delaney AIDS Research Enterprise (U19AI096109), and the University of California, San Francisco (UCSF)/Gladstone Center for AIDS Research (CFAR; P30 AI027763). SRL is a National Health and Medical Research Council (NHMRC) of Australia Practitioner Fellow and is supported by DARE: Delaney AIDS Research Enterprise (U19AI096109) and NIAID (1R56AI095073-01A1). SRL gratefully acknowledges the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. DVH was supported by NIAID (A151982) and the UCSF/Gladstone CFAR (A1027763). We acknowledge the support of John Carroll and Warner Greene of the Gladstone Institute of Virology and Immunology for assistance with the figures.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Baker JV, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000264; Baker JV, 2013, 20TH CONFERENCE ON R, p66LB; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Barzilay JI, 2007, ARCH INTERN MED, V167, P635, DOI 10.1001/archinte.167.7.635; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Bendavid Eran, 2012, AIDS, V26 Suppl 1, pS85; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown TT, 2012, NAT REV ENDOCRINOL, V8, P11, DOI 10.1038/nrendo.2011.151; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Byakwaga H, 2011, J INFECT DIS, V204, P1532, DOI 10.1093/infdis/jir559; Cahn P, 2013, CLIN INFECT DIS, V57, P139, DOI 10.1093/cid/cit171; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Duncombe C, 2013, CURR OPIN HIV AIDS, V8, P4, DOI 10.1097/COH.0b013e32835ba7ff; Erlandson KM, 2013, J INFECT DIS, V208, P249, DOI 10.1093/infdis/jit147; Fauci AS, 2012, JAMA-J AM MED ASSOC, V308, P343, DOI 10.1001/jama.2012.8142; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Ford N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001060; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Fried LP, 2009, J GERONTOL A-BIOL, V64, P1049, DOI 10.1093/gerona/glp076; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Geneau Robert, 2012, AIDS, V26 Suppl 1, pS7; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Gori A, 2011, MUCOSAL IMMUNOL, V4, P554, DOI 10.1038/mi.2011.15; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055824; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hatano H, 2013, J INFECT DIS, V208, P1436, DOI 10.1093/infdis/jit453; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Heidari S, 2011, JAIDS-J ACQ IMM DEF, V57, P290, DOI 10.1097/QAI.0b013e318221c56a; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Hirschhorn Lisa R, 2012, AIDS, V26 Suppl 1, pS65; Hontelez JAC, 2011, AIDS, V25, P1665, DOI 10.1097/QAD.0b013e32834982ea; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Leeansyah E, 2013, J INFECT DIS, V207, P1157, DOI 10.1093/infdis/jit006; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Mills EJ, 2012, AIDS, V26, P1171, DOI 10.1097/QAD.0b013e32834f3319; Moore RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021843; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Pandrea I, 2012, BLOOD, V120, P1357, DOI 10.1182/blood-2012-03-414706; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Persaud D, 2013, 20TH CONFERENCE ON R, p48LB; Piggott DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054910; Piot P, 2013, NEW ENGL J MED, V368, P2210, DOI 10.1056/NEJMra1201533; Rabkin M, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/137460; Rabkin M, 2011, JAIDS-J ACQ IMM DEF, V57, pS87, DOI 10.1097/QAI.0b013e31821db92a; Rajasuriar R, 2013, AIDS, V27, P1199, DOI 10.1097/QAD.0b013e32835ecb8b; Roberts T, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17324; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Sambo Luis G, 2011, Int Arch Med, V4, P39, DOI 10.1186/1755-7682-4-39; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Shah K, 2012, J AM GERIATR SOC, V60, P545, DOI 10.1111/j.1532-5415.2011.03819.x; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Srinivasula S, 2011, BLOOD, V118, P262, DOI 10.1182/blood-2011-02-335174; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; Tinetti ME, 2011, J AM GERIATR SOC, V59, P1686, DOI 10.1111/j.1532-5415.2011.03573.x; van Olmen J, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/349312; Virga PH, 2012, INT J MED INFORM, V81, pE39, DOI 10.1016/j.ijmedinf.2012.06.006; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Wester CW, 2011, AIDS, V25, P1471, DOI 10.1097/QAD.0b013e328347f9d4; WHO, 2012, WHO POLICY ON COLLAB; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	98	1108	1125	10	236	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1525	1533		10.1016/S0140-6736(13)61809-7	http://dx.doi.org/10.1016/S0140-6736(13)61809-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	24152939	Green Accepted			2022-12-28	WOS:000326622500031
J	Bourzac, K				Bourzac, Katherine			SOFTWARE The computer will see you now	NATURE			English	Editorial Material							WIDE-FIELD											Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Greenbaum A, 2012, NAT METHODS, V9, P889, DOI 10.1038/nmeth.2114; Hipp Jason D, 2011, J Pathol Inform, V2, P13, DOI 10.4103/2153-3539.77175; Mavandadi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037245; Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330; Zheng GA, 2013, NAT PHOTONICS, V7, P739, DOI [10.1038/NPHOTON.2013.187, 10.1038/nphoton.2013.187]	6	10	15	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S92	S94		10.1038/502S92a	http://dx.doi.org/10.1038/502S92a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187704	Bronze			2022-12-28	WOS:000326293200007
J	Dubois, J; Jullien, T; Portier, F; Roche, P; Cavanna, A; Jin, Y; Wegscheider, W; Roulleau, P; Glattli, DC				Dubois, J.; Jullien, T.; Portier, F.; Roche, P.; Cavanna, A.; Jin, Y.; Wegscheider, W.; Roulleau, P.; Glattli, D. C.			Minimal-excitation states for electron quantum optics using levitons	NATURE			English	Article							COHERENT STATES; HANBURY-BROWN; INTERFERENCE; NOISE	The on-demand generation of pure quantum excitations is important for the operation of quantum systems, but it is particularly difficult for a system of fermions. This is because any perturbation affects all states below the Fermi energy, resulting in a complex superposition of particle and hole excitations. However, it was predicted nearly 20 years ago(1-3) that a Lorentzian time-dependent potential with quantized flux generates a minimal excitation with only one particle and no hole. Here we report that such quasiparticles (hereafter termed levitons) can be generated on demand in a conductor by applying voltage pulses to a contact. Partitioning the excitations with an electronic beam splitter generates a current noise that we use to measure their number. Minimal-excitation states are observed for Lorentzian pulses, whereas for other pulse shapes there are significant contributions from holes. Further identification of levitons is provided in the energy domain with shot-noise spectroscopy, and in the time domain with electronic Hong-Ou-Mandel noise correlations(4-8). The latter, obtained by colliding synchronized levitons on a beam splitter, exemplifies the potential use of levitons for quantum information: using linear electron quantum optics(9) in ballistic conductors, it is possible to imagine flying-qubit(10,11) operation in which the Fermi statistics are exploited(12-14) to entangle synchronized electrons emitted by distinct sources(15-18). Compared with electron sources based on quantum dots(19-21), the generation of levitons does not require delicate nanolithography, considerably simplifying the circuitry for scalability. Levitons are not limited to carrying a single charge, and so in a broader context n-particle levitons could find application in the study of full electron counting statistics(22-25). But they can also carry a fraction of charge if they are implemented in Luttinger liquids(3) or in fractional quantum Hall edge channels(26); this allows the study of Abelian and non-Abelian quasiparticles in the time domain. Finally, the generation technique could be applied to cold atomic gases(27,28), leading to the possibility of atomic levitons.	[Dubois, J.; Jullien, T.; Portier, F.; Roche, P.; Roulleau, P.; Glattli, D. C.] CEA Saclay, Serv Phys Etat Condense, Nanoelect Grp, IRAMIS,DSM,CNRS,URA 2464, F-91191 Gif Sur Yvette, France; [Cavanna, A.; Jin, Y.] Univ Paris Diderot, CNRS, Lab Photon & Nanostruct LPN, Sorbonne Paris Cite, F-91460 Marcoussis, France; [Wegscheider, W.] ETH, Lab Solid State Phys, CH-8093 Zurich, Switzerland	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; ETH Zurich	Glattli, DC (corresponding author), CEA Saclay, Serv Phys Etat Condense, Nanoelect Grp, IRAMIS,DSM,CNRS,URA 2464, F-91191 Gif Sur Yvette, France.	christian.glattli@cea.fr	Jullien, Thibaut/D-2305-2014; GLATTLI, D. Christian/A-3748-2019; roulleau, preden/F-1606-2019; Portier, Fabien/N-5131-2014	Jullien, Thibaut/0000-0002-1449-0106; GLATTLI, D. Christian/0000-0002-1457-0915; Roche, Patrice/0000-0001-6089-4083; roulleau, preden/0000-0002-8397-5019	ERC [228273 MeQuaNo]	ERC(European Research Council (ERC)European Commission)	The ERC Advanced Grant 228273 MeQuaNo is acknowledged. We thank P. Jacques for technical help and P. Pari and P. Forget for support with cryogenics.	ANDERSON PW, 1967, PHYS REV LETT, V18, P1049, DOI 10.1103/PhysRevLett.18.1049; Beenakker CWJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.147901; Bertoni A, 2000, PHYS REV LETT, V84, P5912, DOI 10.1103/PhysRevLett.84.5912; Bocquillon E, 2013, SCIENCE, V339, P1054, DOI 10.1126/science.1232572; Brantut JP, 2012, SCIENCE, V337, P1069, DOI 10.1126/science.1223175; Burkard G, 2000, PHYS REV B, V61, P16303, DOI 10.1103/PhysRevB.61.R16303; Dubois J, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.085301; Feve G, 2007, SCIENCE, V316, P1169, DOI 10.1126/science.1141243; Haack G, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.081303; Hassler F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.076804; Henny M, 1999, SCIENCE, V284, P296, DOI 10.1126/science.284.5412.296; Hermelin S, 2011, NATURE, V477, P435, DOI 10.1038/nature10416; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Ivanov DA, 1997, PHYS REV B, V56, P6839, DOI 10.1103/PhysRevB.56.6839; Ji Y, 2003, NATURE, V422, P415, DOI 10.1038/nature01503; Jonckheere T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205321; Keeling J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116403; Lee H. W., 1993, ORTHOGONALITY CATAST; Levitov LS, 1996, J MATH PHYS, V37, P4845, DOI 10.1063/1.531672; LEVITOV LS, 1993, JETP LETT+, V58, P230; Liu RC, 1998, NATURE, V391, P263, DOI 10.1038/34611; McNeil RPG, 2011, NATURE, V477, P439, DOI 10.1038/nature10444; Ol'khovskaya S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.166802; Oliver WD, 1999, SCIENCE, V284, P299, DOI 10.1126/science.284.5412.299; Samuelsson P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.026805; Sherkunov Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.081108; Sherkunov YB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.196601; Splettstoesser J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.076804; Thywissen JH, 1999, PHYS REV LETT, V83, P3762, DOI 10.1103/PhysRevLett.83.3762; Vanevic M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.076601; Yamamoto M, 2012, NAT NANOTECHNOL, V7, P247, DOI [10.1038/nnano.2012.28, 10.1038/NNANO.2012.28]	31	241	244	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					659	663		10.1038/nature12713	http://dx.doi.org/10.1038/nature12713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153178	Green Submitted			2022-12-28	WOS:000326293200042
J	Helin, K; Dhanak, D				Helin, Kristian; Dhanak, Dashyant			Chromatin proteins and modifications as drug targets	NATURE			English	Review							HISTONE METHYLTRANSFERASE EZH2; SMALL-MOLECULE INHIBITOR; THERAPEUTIC STRATEGY; SOMATIC MUTATIONS; CHEMICAL PROBE; SELECTIVE-INHIBITION; DEMETHYLASE GENE; HDAC INHIBITORS; CANCER-CELLS; LYSINE 27	A plethora of groundbreaking studies have demonstrated the importance of chromatin-associated proteins and post-translational modifications of histones, proteins and DNA (so-called epigenetic modifications) for transcriptional control and normal development. Disruption of epigenetic control is a frequent event in disease, and the first epigenetic-based therapies for cancer treatment have been approved. A generation of new classes of potent and specific inhibitors for several chromatin-associated proteins have shown promise in preclinical trials. Although the biology of epigenetic regulation is complex, new inhibitors such as these will hopefully be of clinical use in the coming years.	[Helin, Kristian] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr, DK-2200 Copenhagen, Denmark; [Dhanak, Dashyant] Janssen Res & Dev, Spring House, PA 19477 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; Johnson & Johnson; Janssen Pharmaceuticals	Helin, K (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	kristian.helin@bric.ku.dk; ddhanak8@ITS.JNJ.com	Helin, Kristian/HDM-8306-2022; Helin, Kristian/K-2526-2019	Helin, Kristian/0000-0003-1975-6097; 	Danish National Research Foundation; Danish Cancer Society; Novo Nordisk Foundation; Lundbeck Foundation; European Union; European Research Council; Excellence Programme of the University of Copenhagen	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Excellence Programme of the University of Copenhagen	Work in the Helin laboratory is supported by the Danish National Research Foundation, the Danish Cancer Society, the Novo Nordisk Foundation, the Lundbeck Foundation, the European Union, The European Research Council and the Excellence Programme of the University of Copenhagen.	Allan M, 2009, BIOORG MED CHEM LETT, V19, P1218, DOI 10.1016/j.bmcl.2008.12.075; Amatangelo MD, 2013, CELL CYCLE, V12, P2113, DOI 10.4161/cc.25163; Anglin JL, 2012, J MED CHEM, V55, P8066, DOI 10.1021/jm300917h; [Anonymous], 2009, [No title captured], Patent No. [2009084693, WO2009084693]; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Copeland R. A., 2012, PCT Int. Appl. Pat., Patent No. [WO 2012034132, 2012034132]; Daigle S. R., 2013, BLOOD; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; Guibourt N., 2010, [No title captured], Patent No. [WO2010084160, 2010084160, WO 2010084160 A1]; Gyuris A, 2009, BBA-GENE REGUL MECH, V1789, P413, DOI 10.1016/j.bbagrm.2009.03.005; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kauffman EC, 2011, MOL CARCINOGEN, V50, P931, DOI 10.1002/mc.20758; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Liu F, 2013, J MED CHEM, V56, P2110, DOI 10.1021/jm3018332; Liu F, 2010, J MED CHEM, V53, P5844, DOI 10.1021/jm100478y; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Lynch JT, 2012, EXPERT OPIN THER TAR, V16, P1239, DOI 10.1517/14728222.2012.722206; Maes T, 2013, J CLIN ONCOL, V31; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Ryan RJH, 2012, SCIENCE, V336, P1513, DOI 10.1126/science.1223730; Ryan RJH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028585; Sack JS, 2011, BIOCHEM J, V436, P331, DOI 10.1042/BJ20102161; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Seal J, 2012, BIOORG MED CHEM LETT, V22, P2968, DOI 10.1016/j.bmcl.2012.02.041; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Structural Genomics Consortium, 2013, CHEM PROB; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Valente S, 2012, BIOCHIMIE, V94, P2308, DOI 10.1016/j.biochi.2012.06.003; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wagener N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-524; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wan HH, 2009, BIOORG MED CHEM LETT, V19, P5063, DOI 10.1016/j.bmcl.2009.07.040; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wu SC, 2009, MOL ENDOCRINOL, V23, P1323, DOI 10.1210/me.2009-0131; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Yang ZQ, 2000, CANCER RES, V60, P4735; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Yu WY, 2013, BIOORGAN MED CHEM, V21, P1787, DOI 10.1016/j.bmc.2013.01.049; Yu WY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2304; Yuan Y, 2012, ACS CHEM BIOL, V7, P1152, DOI 10.1021/cb300139y; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	103	331	344	2	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					480	488		10.1038/nature12751	http://dx.doi.org/10.1038/nature12751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153301	Green Submitted			2022-12-28	WOS:000325988400042
J	Liu, SH; Brown, JD; Stanya, KJ; Homan, E; Leidl, M; Inouye, K; Bhargava, P; Gangl, MR; Dai, LL; Hatano, B; Hotamisligil, GS; Saghatelian, A; Plutzky, J; Lee, CH				Liu, Sihao; Brown, Jonathan D.; Stanya, Kristopher J.; Homan, Edwin; Leidl, Mathias; Inouye, Karen; Bhargava, Prerna; Gangl, Matthew R.; Dai, Lingling; Hatano, Ben; Hotamisligil, Goekhan S.; Saghatelian, Alan; Plutzky, Jorge; Lee, Chih-Hao			A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use	NATURE			English	Article							CIRCADIAN BEHAVIOR; ADIPOSE-TISSUE; METABOLISM; IDENTIFICATION; MASS; ALPHA; GLUCOSE; MICE	Food intake increases the activity of hepatic de novo lipogenesis, which mediates the conversion of glucose to fats for storage or use. In mice, this program follows a circadian rhythm that peaks with nocturnal feeding(1,2) and is repressed by Rev-erb alpha/beta and an HDAC3-containing complex(3-5) during the day. The transcriptional activators controlling rhythmic lipid synthesis in the dark cycle remain poorly defined. Disturbances in hepatic lipogenesis are also associated with systemic metabolic phenotypes(6-8), suggesting that lipogenesis in the liver communicates with peripheral tissues to control energy substrate homeostasis. Here we identify a PPAR delta-dependent de novo lipogenic pathway in the liver that modulates fat use by muscle via a circulating lipid. The nuclear receptor PPAR delta controls diurnal expression of lipogenic genes in the dark/feeding cycle. Liver-specific PPAR delta activation increases, whereas hepatocyte-Ppard deletion reduces, muscle fatty acid uptake. Unbiased metabolite profiling identifies phosphatidylcholine 18:0/18:1 (PC(18:0/18:1) as a serum lipid regulated by diurnal hepatic PPAR delta activity. PC(18:0/18:1) reduces postprandial lipid levels and increases fatty acid use through muscle PPAR alpha. High-fat feeding diminishes rhythmic production of PC(18:0/18:1), whereas PC(18:0/18:1) administration in db/db mice (also known as Lepr(-/-)) improves metabolic homeostasis. These findings reveal an integrated regulatory circuit coupling lipid synthesis in the liver to energy use in muscle by coordinating the activity of two closely related nuclear receptors. These data implicate alterations in diurnal hepatic PPAR delta-PC(18:0/18:1) signalling in metabolic disorders, including obesity.	[Liu, Sihao; Stanya, Kristopher J.; Inouye, Karen; Bhargava, Prerna; Gangl, Matthew R.; Dai, Lingling; Hatano, Ben; Hotamisligil, Goekhan S.; Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Div Biol Sci, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Brown, Jonathan D.; Plutzky, Jorge] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Dept Med, Boston, MA 02115 USA; [Homan, Edwin; Leidl, Mathias; Saghatelian, Alan] Harvard Univ, Dept Chem, Cambridge, MA 02138 USA; [Dai, Lingling] Cent South Univ, XiangYa Hosp, Good Clin Practice Off, Changsha 410000, Hunan, Peoples R China; [Dai, Lingling] Cent South Univ, Inst Clin Pharmacol, Changsha 410000, Hunan, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Central South University; Central South University	Lee, CH (corresponding author), Harvard Univ, Sch Publ Hlth, Div Biol Sci, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	clee@hsph.harvard.edu	liu, sihao/A-8823-2015; Plutzky, Jorge/V-3410-2019	liu, sihao/0000-0002-4188-3693; Stanya, Kristopher/0000-0002-5369-729X	American Heart Association; American Diabetes Association; National Institutes of Health [R01DK075046, R01HL048743, K08HL105678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, K08HL105678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. Newgard for providing shACC1 and shScramble adenovirus, U. Unluturk, X. Li and A. N. White for technical help and D. E. Cohen, S. Watkins and D. Jacobi for comments. This work is supported by the American Heart Association and the American Diabetes Association (C.-H.L.) and National Institutes of Health grants R01DK075046 (C.-H.L.), R01HL048743 (J.P.) and K08HL105678 (J.D.B.).	AGREN JJ, 1992, J LIPID RES, V33, P1871; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Brown JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021209; Brown M, 2011, BIOINFORMATICS, V27, P1108, DOI 10.1093/bioinformatics/btr079; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Homan EA, 2011, J AM CHEM SOC, V133, P5178, DOI 10.1021/ja111173c; Hsu FF, 1998, J AM SOC MASS SPECTR, V9, P516, DOI 10.1016/S1044-0305(98)00012-9; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kotronen A, 2010, OBESITY, V18, P937, DOI 10.1038/oby.2009.326; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Liu SH, 2011, J BIOL CHEM, V286, P1237, DOI 10.1074/jbc.M110.138115; Lobo S, 2009, J BIOL CHEM, V284, P18347, DOI 10.1074/jbc.M109.017244; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007; Ronnebaum SM, 2008, J BIOL CHEM, V283, P14248, DOI 10.1074/jbc.M800119200; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shearer J, 2005, AM J PHYSIOL-ENDOC M, V288, pE292, DOI 10.1152/ajpendo.00287.2004; Shearer J, 2008, LIPIDS, V43, P703, DOI 10.1007/s11745-008-3183-4; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tautenhahn R, 2011, ANAL CHEM, V83, P696, DOI 10.1021/ac102980g; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319	40	156	157	3	89	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					550	+		10.1038/nature12710	http://dx.doi.org/10.1038/nature12710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153306	Green Accepted, Green Submitted			2022-12-28	WOS:000325988400054
J	Reiter, N; Reiter, M; Altrichter, S; Becker, S; Kristensen, T; Broesby-Olsen, S; Church, MK; Metz, M; Maurer, M; Siebenhaar, F				Reiter, Nadine; Reiter, Marielies; Altrichter, Sabine; Becker, Stefanie; Kristensen, Thomas; Broesby-Olsen, Sigurd; Church, Martin K.; Metz, Martin; Maurer, Marcus; Siebenhaar, Frank			Anaphylaxis caused by mosquito allergy in systemic mastocytosis	LANCET			English	Editorial Material									[Reiter, Nadine; Reiter, Marielies; Altrichter, Sabine; Church, Martin K.; Metz, Martin; Maurer, Marcus; Siebenhaar, Frank] Charite, Dept Dermatol & Allergy, Interdisciplinary Mastocytosis Ctr Charite, D-10117 Berlin, Germany; [Kristensen, Thomas; Broesby-Olsen, Sigurd] Odense Univ Hosp, Dept Pathol, Mastocytosis Ctr, DK-5000 Odense, Denmark; [Kristensen, Thomas; Broesby-Olsen, Sigurd] Odense Univ Hosp, Dept Dermatol, DK-5000 Odense, Denmark; [Kristensen, Thomas; Broesby-Olsen, Sigurd] Odense Univ Hosp, Allergy Ctr, DK-5000 Odense, Denmark; [Becker, Stefanie] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Bernhard Nocht Institut fur Tropenmedizin	Siebenhaar, F (corresponding author), Charite, Allergie Ctr Charite ECARF, Dept Dermatol & Allergy, Charitepl 1, D-10117 Berlin, Germany.	frank.siebenhaar@charite.de	Maurer, Marcus/ABG-2174-2020; Becker, Stefanie/AEM-2050-2022; Metz, Martin/B-8799-2009; Metz, Martin/M-5237-2013	Maurer, Marcus/0000-0002-4121-481X; Metz, Martin/0000-0002-4070-9976; Metz, Martin/0000-0002-4070-9976; Siebenhaar, Frank/0000-0003-4532-1644; Altrichter, Sabine/0000-0001-9955-385X				Bonadonna P, 2009, J ALLERGY CLIN IMMUN, V123, P680, DOI 10.1016/j.jaci.2008.11.018; Galindo P A, 1998, Allergol Immunopathol (Madr), V26, P251; Hassoun S, 1999, Allerg Immunol (Paris), V31, P285; Kontou-Fili K, 2010, ANN ALLERG ASTHMA IM, V104, P537, DOI 10.1016/j.anai.2010.04.011; Kristensen T, 2011, J MOL DIAGN, V13, P180, DOI 10.1016/j.jmoldx.2010.10.004; Lieberman P, 2010, J ALLERGY CLIN IMMUN, V126, P477, DOI 10.1016/j.jaci.2010.06.022; MCCORMACK DR, 1995, ANN ALLERG ASTHMA IM, V74, P39; Peng ZK, 2007, CURR OPIN ALLERGY CL, V7, P350, DOI 10.1097/ACI.0b013e328259c313	8	25	26	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1380	1380		10.1016/S0140-6736(13)61605-0	http://dx.doi.org/10.1016/S0140-6736(13)61605-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	24139121				2022-12-28	WOS:000325975700028
J	Gonfiotti, A; Jaus, MO; Barale, D; Baiguera, S; Comin, C; Lavorini, F; Fontana, G; Sibila, O; Rombola, G; Jungebluth, P; Macchiarini, P				Gonfiotti, Alessandro; Jaus, Massimo O.; Barale, Daniel; Baiguera, Silvia; Comin, Camilla; Lavorini, Federico; Fontana, Giovanni; Sibila, Oriol; Rombola, Giovanni; Jungebluth, Philipp; Macchiarini, Paolo			The first tissue-engineered airway transplantation: 5-year follow-up results	LANCET			English	Article							TRACHEAL ALLOTRANSPLANTATION; HLA ANTIBODIES; REPLACEMENTS; COUGH	Background In 2008, the first transplantation of a tissue-engineered trachea in a human being was done to replace an end-staged left main bronchus with malacia in a 30-year-old woman. We report 5 year follow-up results. Methods The patient was followed up approximately every 3 months with multidetector CT scan and bronchoscopic assessment. We obtained mucosal biopsy samples every 6 months for histological, immunohistochemical, and electron microscopy assessment. We also assessed quality of life, respiratory function, cough reflex test, and production and specificity of recipient antibodies against donor human leucocyte antigen. Findings By 12 months after transplantation, a progressive cicatricial stenosis had developed in the native trachea close to the tissue-engineered trachea anastomosis, which needed repeated endoluminal stenting. However, the tissue-engineered trachea itself remained open over its entire length, well vascularised, completely re-cellularised with respiratory epithelium, and had normal ciliary function and mucus clearance. Lung function and cough reflex were normal. No stem-cell-related teratoma formed and no anti-donor antibodies developed. Aside from intermittent bronchoscopic interventions, the patient had a normal social and working life. Interpretation These clinical results provide evidence that a tissue-engineering strategy including decellularisation of a human trachea, autologous epithelial and stem-cell culture and differentiation, and cell-scaffold seeding with a bioreactor is safe and promising.	[Gonfiotti, Alessandro; Jaus, Massimo O.; Barale, Daniel] Univ Hosp Careggi, Dept Gen Thorac & Regenerat Surg, Florence, Italy; [Rombola, Giovanni] Univ Hosp Careggi, Dept Biomed, Florence, Italy; [Baiguera, Silvia; Jungebluth, Philipp; Macchiarini, Paolo] Karolinska Inst, Div Ear Nose & Throat, Adv Ctr Translat Regenerat Med, SE-14186 Stockholm, Sweden; [Comin, Camilla] Univ Florence, Dept Crit Care Med & Surg, Div Anat Pathol, Florence, Italy; [Lavorini, Federico; Fontana, Giovanni] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Sibila, Oriol] Univ Autonoma Barcelona, Inst Invest Biomed St Pau, Hosp Santa Creu & St Pau, Dept Resp Med, E-08193 Barcelona, Spain	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; Karolinska Institutet; University of Florence; University of Florence; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau	Macchiarini, P (corresponding author), Karolinska Inst, Div Ear Nose & Throat, Adv Ctr Translat Regenerat Med, Alfred Nobels Alle 8, SE-14186 Stockholm, Sweden.	paolo.macchiarini@ki.se	Baiguera, Silvia/AAC-4738-2022; Sibila, Oriol/T-4366-2017; Lavorini, Federico/AFQ-2334-2022; Macchiarini, Paolo/E-6878-2013; Gonfiotti, Alessandro/AAP-1479-2020	Baiguera, Silvia/0000-0002-6669-7061; Sibila, Oriol/0000-0002-4833-6713; Lavorini, Federico/0000-0002-3293-2123; GONFIOTTI, Alessandro/0000-0003-2724-9474	European Commission; Knut and Alice Wallenberg Foundation; Swedish Research Council; ALF Medicine	European Commission(European CommissionEuropean Commission Joint Research Centre); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF Medicine	European Commission, Knut and Alice Wallenberg Foundation, Swedish Research Council, ALF Medicine.	Baiguera S, 2012, BIOMATERIALS, V33, P3662, DOI 10.1016/j.biomaterials.2012.01.064; Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005; Delaere P, 2010, NEW ENGL J MED, V362, P138, DOI 10.1056/NEJMoa0810653; Doss AE, 2007, ASAIO J, V53, P631, DOI 10.1097/MAT.0b013e318145ba13; EJNELL H, 1984, EUR J RESPIR DIS, V65, P600; Fontana GA, 1997, EUR RESPIR J, V10, P983, DOI 10.1183/09031936.97.10050983; Fontana GA, 1998, AM J RESP CRIT CARE, V158, P458, DOI 10.1164/ajrccm.158.2.9705094; Freitag L, 2007, EUR RESPIR J, V30, P7, DOI 10.1183/09031936.00132804; Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6; Jandial R, 2009, NAT MED, V15, P999, DOI 10.1038/nm0909-999; Kucera KA, 2007, ASAIO J, V53, P497, DOI 10.1097/MAT.0b013e3180616b5d; Lavorini F, 2007, AM J RESP CRIT CARE, V176, P825, DOI 10.1164/rccm.200612-1870OC; Macchiarini P, 2004, J THORAC CARDIOV SUR, V128, P638, DOI 10.1016/j.jtcvs.2004.02.042; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Myer C M 3rd, 1995, Ear Nose Throat J, V74, P560; Pei R, 1998, HUM IMMUNOL, V59, P313, DOI 10.1016/S0198-8859(98)00020-2; ROSE KG, 1979, LANCET, V1, P433; ROTMAN HH, 1975, CHEST, V68, P796, DOI 10.1378/chest.68.6.796; Steger V, 2008, EXPERT REV MED DEVIC, V5, P605, DOI 10.1586/17434440.5.5.605; Tait BD, 2013, TRANSPLANTATION, V95, P19, DOI 10.1097/TP.0b013e31827a19cc; TAKAO M, 1995, J THORAC CARDIOV SUR, V109, P815, DOI 10.1016/S0022-5223(95)70374-8; Terasaki PI, 2004, AM J TRANSPLANT, V4, P438, DOI 10.1111/j.1600-6143.2004.00360.x; Vondrys D, 2011, ANN THORAC SURG, V92, P1870, DOI 10.1016/j.athoracsur.2011.07.042	23	196	216	1	115	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					238	244		10.1016/S0140-6736(13)62033-4	http://dx.doi.org/10.1016/S0140-6736(13)62033-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294FC	24161821				2022-12-28	WOS:000330027500032
J	Williams, C; House, A				Williams, Chris; House, Allan			Cognitive behaviour therapy for health anxiety	LANCET			English	Editorial Material							PREVALENCE		[Williams, Chris] Univ Glasgow, Inst Hlth & Wellbeing, Gartnavel Royal Hosp, Glasgow G12 0XH, Lanark, Scotland; [House, Allan] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England	Gartnavel Royal Hospital; University of Glasgow; University of Leeds	Williams, C (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Gartnavel Royal Hosp, Adm Bldg, Glasgow G12 0XH, Lanark, Scotland.	chris.williams@glasgow.ac.uk		House, Allan/0000-0001-8721-8026				National Institute for Clinical Health and Excellence, NICE DEPR TREATM MAN; Ruddy R, 2005, BRIT J PSYCHIAT, V187, P109, DOI 10.1192/bjp.187.2.109; Shapiro DA, 2003, BEHAV COGN PSYCHOTH, V31, P185, DOI 10.1017/S1352465803002066; Sunderland M, 2013, BRIT J PSYCHIAT, V202, P56, DOI 10.1192/bjp.bp.111.103960; Thomson AB, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006520.pub2; Tyrer P, 2013, LANCET; Tyrer P, 2011, J PSYCHOSOM RES, V71, P392, DOI 10.1016/j.jpsychores.2011.07.004	7	3	3	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					190	191		10.1016/S0140-6736(13)62107-8	http://dx.doi.org/10.1016/S0140-6736(13)62107-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294FC	24139976	Green Accepted			2022-12-28	WOS:000330027500005
J	Warner, M; Din, S; Tupitsyn, IS; Morley, GW; Stoneham, AM; Gardener, JA; Wu, ZL; Fisher, AJ; Heutz, S; Kay, CWM; Aeppli, G				Warner, Marc; Din, Salahud; Tupitsyn, Igor S.; Morley, Gavin W.; Stoneham, A. Marshall; Gardener, Jules A.; Wu, Zhenlin; Fisher, Andrew J.; Heutz, Sandrine; Kay, Christopher W. M.; Aeppli, Gabriel			Potential for spin-based information processing in a thin-film molecular semiconductor	NATURE			English	Article							COPPER PHTHALOCYANINE; RELAXATION; TRANSPORT; CRYSTAL; EPR; TEMPERATURE; COHERENCE; MAGNETS; SILICON; ECHO	Organic semiconductors are studied intensively for applications in electronics and optics(1), and even spin-based information technology, or spintronics(2). Fundamental quantities in spintronics are the population relaxation time (T-1) and the phase memory time (T-2): T-1 measures the lifetime of a classical bit, in this case embodied by a spin oriented either parallel or antiparallel to an external magnetic field, and T-2 measures the corresponding lifetime of a quantum bit, encoded in the phase of the quantum state. Here we establish that these times are surprisingly long for a common, low-cost and chemically modifiable organic semiconductor, the blue pigment copper phthalocyanine(3), in easily processed thin-film form of the type used for device fabrication. At 5 K, a temperature reachable using inexpensive closed-cycle refrigerators, T-1 and T-2 are respectively 59 ms and 2.6 mu s, and at 80 K, which is just above the boiling point of liquid nitrogen, they are respectively 10 ms and 1 ms, demonstrating that the performance of thin-film copper phthalocyanine is superior to that of single-molecule magnets over the same temperature range(4). T-2 is more than two orders of magnitude greater than the duration of the spin manipulation pulses, which suggests that copper phthalocyanine holds promise for quantum information processing, and the long T-1 indicates possibilities for medium-term storage of classical bits in all-organic devices on plastic substrates.	[Warner, Marc; Morley, Gavin W.; Stoneham, A. Marshall; Gardener, Jules A.; Fisher, Andrew J.; Aeppli, Gabriel] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Warner, Marc; Morley, Gavin W.; Stoneham, A. Marshall; Gardener, Jules A.; Fisher, Andrew J.; Aeppli, Gabriel] UCL, Dept Phys & Astron, London WC1H 0AH, England; [Din, Salahud; Wu, Zhenlin; Heutz, Sandrine] Univ London Imperial Coll Sci Technol & Med, London Ctr Nanotechnol, London SW7 2AZ, England; [Din, Salahud; Wu, Zhenlin; Heutz, Sandrine] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England; [Tupitsyn, Igor S.] Univ British Columbia, Pacific Inst Theoret Phys, Vancouver, BC V6T 1Z1, Canada; [Kay, Christopher W. M.] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England; [Kay, Christopher W. M.] UCL, London Ctr Nanotechnol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; Imperial College London; University of London; University College London; Imperial College London; University of British Columbia; University of London; Birkbeck University London; University College London; University of London; University College London	Warner, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	marc.warner@ucl.ac.uk; gabriel.aeppli@ucl.ac.uk	Kay, Christopher William Michael/C-2467-2008; Morley, Gavin W/C-1658-2008; Fisher, Andrew J/A-4723-2012	Kay, Christopher William Michael/0000-0002-5200-6004; Morley, Gavin W/0000-0002-8760-6907; Fisher, Andrew J/0000-0001-6411-1840; Din, Salahud/0000-0002-1767-8120	EPSRC [EP/F039948/1, EP/F041349/1, EP/F04139X/1]; Royal Society; IARPA; NSERC [CNXP 22R81695]; PITP; EPSRC [EP/H002022/1, EP/H026622/1, EP/K032526/1, EP/H002367/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H002367/1, EP/H026622/1, EP/F04139X/1, EP/K032526/1, EP/H002022/1, EP/F039948/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); IARPA; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); PITP; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	S.H. and Z.W. thank EPSRC (EP/F039948/1) for the award of a First Grant. S.H. and S.D. thank Kurt J. Lesker and EPSRC for a CASE award. Work at UCL and Imperial College was supported by the EPSRC Basic Technologies grant Molecular Spintronics (EP/F041349/1 and EP/F04139X/1). G.W.M. is supported by the Royal Society. I.S.T. thanks IARPA, NSERC (grant CNXP 22R81695) and PITP for support.	Abragam A., 1970, ELECT PARAMAGNETIC R; Ardavan A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057201; ASSOUR JM, 1964, J PHYS CHEM-US, V68, P872, DOI 10.1021/j100786a029; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Bao Z, 1996, APPL PHYS LETT, V69, P3066, DOI 10.1063/1.116841; Barbon A, 1999, PHYS CHEM CHEM PHYS, V1, P4015, DOI 10.1039/a903380g; Bertaina S, 2008, NATURE, V453, P203, DOI 10.1038/nature06962; Cinchetti M, 2009, NAT MATER, V8, P115, DOI 10.1038/NMAT2334; Dediu VA, 2009, NAT MATER, V8, P707, DOI [10.1038/NMAT2510, 10.1038/nmat2510]; Finazzo C, 2006, PHYS CHEM CHEM PHYS, V8, P1942, DOI 10.1039/b516184c; Heutz S, 2000, APPL PHYS LETT, V77, P3938, DOI 10.1063/1.1332820; Heutz S, 2007, ADV MATER, V19, P3618, DOI 10.1002/adma.200701458; Hill S, 2003, SCIENCE, V302, P1015, DOI 10.1126/science.1090082; Hoshino A, 2003, ACTA CRYSTALLOGR B, V59, P393, DOI 10.1107/S010876810300942X; Ishikawa N, 2007, POLYHEDRON, V26, P2147, DOI 10.1016/j.poly.2006.10.022; Koehl WF, 2011, NATURE, V479, P84, DOI 10.1038/nature10562; L?bbert, 2000, ULLMANNS ENCY IND CH; Morello A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.207206; Morley GW, 2010, NAT MATER, V9, P725, DOI [10.1038/nmat2828, 10.1038/NMAT2828]; Morton JJL, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2147262; Opitz A, 2009, PHYS STATUS SOLIDI A, V206, P2683, DOI 10.1002/pssa.200925238; Romanelli M, 1997, CONCEPT MAGNETIC RES, V9, P403, DOI 10.1002/(SICI)1099-0534(1997)9:6<403::AID-CMR3>3.3.CO;2-H; Schweiger A., 2001, PRINCIPLES PULSE ELE; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Stamp PCE, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014401; Stamp PCE, 2004, CHEM PHYS, V296, P281, DOI 10.1016/j.chemphys.2003.10.033; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STONEHAM AM, 1965, P PHYS SOC LOND, V85, P107, DOI 10.1088/0370-1328/85/1/314; Szybowicz M, 2004, J MOL STRUCT, V704, P107, DOI 10.1016/j.molstruc.2004.01.053; Takahashi S, 2011, NATURE, V476, P76, DOI 10.1038/nature10314; Takahashi S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047601; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; VANVLECK JH, 1948, PHYS REV, V74, P1168, DOI 10.1103/PhysRev.74.1168; Wang H, 2010, ACS NANO, V4, P3921, DOI 10.1021/nn100782w; Wedge CJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.107204	35	203	202	17	420	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					504	+		10.1038/nature12597	http://dx.doi.org/10.1038/nature12597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24162849				2022-12-28	WOS:000327464200038
J	Howard, AW; Sanchis-Ojeda, R; Marcy, GW; Johnson, JA; Winn, JN; Isaacson, H; Fischer, DA; Fulton, BJ; Sinukoff, E; Fortney, JJ				Howard, Andrew W.; Sanchis-Ojeda, Roberto; Marcy, Geoffrey W.; Johnson, John Asher; Winn, Joshua N.; Isaacson, Howard; Fischer, Debra A.; Fulton, Benjamin J.; Sinukoff, Evan; Fortney, Jonathan J.			A rocky composition for an Earth-sized exoplanet	NATURE			English	Article							SOLAR-TYPE STARS; PLANET-SEARCH; MASS; EVOLUTION; ROTATION; KEPLER; SPECTROMETER; PRECISION; DENSITY; RADII	Planets with sizes between that of Earth (with radius R-circle plus) and Neptune (about 4R(circle plus)) are now known to be common around Sun-like stars(1-3). Most such planets have been discovered through the transit technique, by which the planet's size can be determined from the fraction of starlight blocked by the planet as it passes in front of its star. Measuring the planet's mass-and hence its density, which is a clue to its composition-is more difficult. Planets of size 2-4R(circle plus) have proved to have a wide range of densities, implying a diversity of compositions(4,5), but these measurements did not extend to planets as small as Earth. Here we report Doppler spectroscopic measurements of the mass of the Earth-sized planet Kepler-78b, which orbits its host star every 8.5 hours (ref. 6). Given a radius of 1.20 +/- 0.09R(circle plus) and a mass of 1.69 +/- 0.41M(circle plus), the planet's mean density of 5.3 +/- 1.8 g cm(-3) is similar to Earth's, suggesting a composition of rock and iron.	[Howard, Andrew W.; Fulton, Benjamin J.; Sinukoff, Evan] Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA; [Sanchis-Ojeda, Roberto; Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Sanchis-Ojeda, Roberto; Winn, Joshua N.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Marcy, Geoffrey W.; Isaacson, Howard] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Johnson, John Asher] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Fischer, Debra A.] Yale Univ, Dept Astron, New Haven, CT 06510 USA; [Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA	University of Hawaii System; University of Hawaii Manoa; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Yale University; University of California System; University of California Santa Cruz	Howard, AW (corresponding author), Univ Hawaii Manoa, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	howard@ifa.hawaii.edu; rsanchis86@gmail.com	Fischer, Debra A/C-1639-2014; Marcy, Geoff/AAC-6050-2019; Fortney, Jonathan/F-8813-2014	Fischer, Debra A/0000-0003-2221-0861; Fulton, Benjamin/0000-0003-3504-5316; Fortney, Jonathan/0000-0002-9843-4354	NASA's Science Mission Directorate; Kepler Participating Scientist programme; NASA [NNX12AJ23G]	NASA's Science Mission Directorate; Kepler Participating Scientist programme; NASA(National Aeronautics & Space Administration (NASA))	This Letter and another<SUP>10</SUP> were submitted simultaneously and are the result of coordinated, independent radial-velocity observations and analyses of Kepler-78. We thank the HARPS-N team for their collegiality. We also thank E. Chiang, I. Crossfield, R. Kolbl, E. Petigura, and D. Huber for discussions, S. Howard for support, C. Dressing for a convenient packaging of stellar models, and A. Hatzes for a thorough review. This work was based on observations at the W.M. Keck Observatory granted by the University of Hawaii, the University of California, and the California Institute of Technology. We thank the observers who contributed to the measurements reported here and acknowledge the efforts of the Keck Observatory staff. We thank those of Hawaiian ancestry on whose sacred mountain of Mauna Kea we are guests. Kepler was competitively selected as the tenth Discovery mission with funding provided by NASA's Science Mission Directorate. J.N.W. and R.S.-O. acknowledge support from the Kepler Participating Scientist programme. A.W.H. acknowledges funding from NASA grant NNX12AJ23G.	Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Bouchy F, 2005, ASTRON ASTROPHYS, V444, pL15, DOI 10.1051/0004-6361:200500201; Boyajian TS, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/112; Butler RP, 1996, PUBL ASTRON SOC PAC, V108, P500, DOI 10.1086/133755; Chubak C., 2012, ASTROPHYS J UNPUB; Dotter A, 2008, ASTROPHYS J SUPPL S, V178, P89, DOI 10.1086/589654; Dumusque X, 2012, NATURE, V491, P207, DOI 10.1038/nature11572; Fortney JJ, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/80; Fressin F, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/81; Hatzes AP, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/75; Hauck SA, 2013, J GEOPHYS RES-PLANET, V118, P1204, DOI 10.1002/jgre.20091; Henry GW, 2008, ASTRON J, V135, P68, DOI 10.1088/0004-6256/135/1/68; Howard AW, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/15; Isaacson H, 2010, ASTROPHYS J, V725, P875, DOI 10.1088/0004-637X/725/1/875; Jackson B., 2013, ASTROPHYS J UNPUB; Johnson JA, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/26; Jones BF, 1997, ASTRON J, V114, P352, DOI 10.1086/118479; Lissauer JJ, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/131; Lopez ED, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/59; Mamajek EE, 2008, ASTROPHYS J, V687, P1264, DOI 10.1086/591785; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; MARCY GW, 1992, PUBL ASTRON SOC PAC, V104, P270, DOI 10.1086/132989; Muirhead PS, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/144; Ofir A, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201219877; Pecaut MJ, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/154; Pepe F, 2013, NATURE, V503, P377, DOI 10.1038/nature12768; Perez-Becker D, 2013, MON NOT R ASTRON SOC, V433, P2294, DOI 10.1093/mnras/stt895; Petigura EA, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/69; Rappaport S, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/1; Rappaport S, 2013, ASTROPHYS J LETT, V773, DOI 10.1088/2041-8205/773/1/L15; Sanchis-Ojeda R, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/54; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; Torres G, 2010, ASTRON ASTROPHYS REV, V18, P67, DOI 10.1007/s00159-009-0025-1; Torres G., 2012, ASTROPHYS J, V667, P1324; Valencia D, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/10; Valenti JA, 2005, ASTROPHYS J SUPPL S, V159, P141, DOI 10.1086/430500; VALENTI JA, 1995, PUBL ASTRON SOC PAC, V107, P966, DOI 10.1086/133645; Valenti JA, 1996, ASTRON ASTROPHYS SUP, V118, P595, DOI 10.1051/aas:1996222; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; Wright JT, 2011, PUBL ASTRON SOC PAC, V123, P412, DOI 10.1086/659427	43	122	123	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					381	+		10.1038/nature12767	http://dx.doi.org/10.1038/nature12767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24172898	Green Submitted, Green Accepted			2022-12-28	WOS:000327163200037
J	Angulo, I; Vadas, O; Garcon, F; Banham-Hall, E; Plagnol, V; Leahy, TR; Baxendale, H; Coulter, T; Curtis, J; Wu, CX; Blake-Palmer, K; Perisic, O; Smyth, D; Maes, M; Fiddler, C; Juss, J; Cilliers, D; Markelj, G; Chandra, A; Farmer, G; Kielkowska, A; Clark, J; Kracker, S; Debre, M; Picard, C; Pellier, I; Jabado, N; Morris, JA; Barcenas-Morales, G; Fischer, A; Stephens, L; Hawkins, P; Barrett, JC; Abinun, M; Clatworthy, M; Durandy, A; Doffinger, R; Chilvers, ER; Cant, AJ; Kumararatne, D; Okkenhaug, K; Williams, RL; Condliffe, A; Nejentsev, S				Angulo, Ivan; Vadas, Oscar; Garcon, Fabien; Banham-Hall, Edward; Plagnol, Vincent; Leahy, Timothy R.; Baxendale, Helen; Coulter, Tanya; Curtis, James; Wu, Changxin; Blake-Palmer, Katherine; Perisic, Olga; Smyth, Deborah; Maes, Mailis; Fiddler, Christine; Juss, Jatinder; Cilliers, Deirdre; Markelj, Gasper; Chandra, Anita; Farmer, George; Kielkowska, Anna; Clark, Jonathan; Kracker, Sven; Debre, Marianne; Picard, Capucine; Pellier, Isabelle; Jabado, Nada; Morris, James A.; Barcenas-Morales, Gabriela; Fischer, Alain; Stephens, Len; Hawkins, Phillip; Barrett, Jeffrey C.; Abinun, Mario; Clatworthy, Menna; Durandy, Anne; Doffinger, Rainer; Chilvers, Edwin R.; Cant, Andrew J.; Kumararatne, Dinakantha; Okkenhaug, Klaus; Williams, Roger L.; Condliffe, Alison; Nejentsev, Sergey			Phosphoinositide 3-Kinase delta Gene Mutation Predisposes to Respiratory Infection and Airway Damage	SCIENCE			English	Article							PTEN; ACTIVATION; PI3K; IMMUNODEFICIENCY	Genetic mutations cause primary immunodeficiencies (PIDs) that predispose to infections. Here, we describe activated PI3K-delta syndrome (APDS), a PID associated with a dominant gain-of-function mutation in which lysine replaced glutamic acid at residue 1021 (E1021K) in the p110 delta protein, the catalytic subunit of phosphoinositide 3-kinase delta (PI3K delta), encoded by the PIK3CD gene. We found E1021K in 17 patients from seven unrelated families, but not among 3346 healthy subjects. APDS was characterized by recurrent respiratory infections, progressive airway damage, lymphopenia, increased circulating transitional B cells, increased immunoglobulin M, and reduced immunoglobulin G2 levels in serum and impaired vaccine responses. The E1021K mutation enhanced membrane association and kinase activity of p110 delta. Patient-derived lymphocytes had increased levels of phosphatidylinositol 3,4,5-trisphosphate and phosphorylated AKT protein and were prone to activation-induced cell death. Selective p110 delta inhibitors IC87114 and GS-1101 reduced the activity of the mutant enzyme in vitro, which suggested a therapeutic approach for patients with APDS.	[Angulo, Ivan; Curtis, James; Wu, Changxin; Blake-Palmer, Katherine; Maes, Mailis; Fiddler, Christine; Juss, Jatinder; Clatworthy, Menna; Chilvers, Edwin R.; Condliffe, Alison; Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Vadas, Oscar; Perisic, Olga; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Garcon, Fabien; Banham-Hall, Edward; Stephens, Len; Hawkins, Phillip; Okkenhaug, Klaus] Babraham Inst, Cambridge, England; [Plagnol, Vincent] UCL, Univ Coll London Genet Inst, London, England; [Leahy, Timothy R.; Abinun, Mario; Cant, Andrew J.] Newcastle Univ, Inst Cellular Med, Primary Immunodeficiency Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Leahy, Timothy R.; Coulter, Tanya] Our Ladys Childrens Hosp, Dublin, Ireland; [Baxendale, Helen; Chandra, Anita; Doffinger, Rainer; Kumararatne, Dinakantha] Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge, England; [Coulter, Tanya] Trinity Coll Dublin, Sch Med, Dept Immunol, Dublin, Ireland; [Smyth, Deborah] Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Dept Med Genet,Cambridge Inst Med Res, Cambridge, England; [Cilliers, Deirdre] Oxford Univ Hosp, Dept Clin Genet, Oxford, England; [Markelj, Gasper] Univ Med Ctr, Univ Childrens Hosp, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia; [Farmer, George] Raigmore Hosp, Inverness, Scotland; [Kielkowska, Anna; Clark, Jonathan] Babraham Biosci Technol Ltd, Cambridge, England; [Kracker, Sven; Fischer, Alain; Durandy, Anne] Necker Childrens Hosp, INSERM, U768, Natl Inst Hlth & Med Res, Paris, France; [Kracker, Sven; Picard, Capucine; Fischer, Alain; Durandy, Anne] Descartes Sorbonne Paris Cite Univ Paris, Imagine Inst, Paris, France; [Debre, Marianne; Picard, Capucine; Fischer, Alain; Durandy, Anne] Necker Childrens Hosp, AP HP, Dept Immunol & Hematol, Paris, France; [Picard, Capucine; Durandy, Anne] Necker Childrens Hosp, AP HP, Ctr Primary Immunodeficiencies CEDI, Paris, France; [Pellier, Isabelle] CHU Angers, Dept Pediat, Angers, France; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Jabado, Nada] McGill Univ Hlth Ctr, Montreal, PQ, Canada; [Morris, James A.; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Hinxton, England; [Barcenas-Morales, Gabriela] Lab Inmunol, Fes Cuautitlan, Mexico	University of Cambridge; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of London; University College London; Newcastle University - UK; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Trinity College Dublin; University of Cambridge; University Medical Centre Ljubljana; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; McGill University; McGill University; Wellcome Trust Sanger Institute	Nejentsev, S (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	sn262@cam.ac.uk	Leahy, Ronan/AAL-5008-2021; Jabado, Nada/AAN-4026-2020; Durandy, Anne/H-7475-2017; Picard, Capucine/H-3914-2017; isabelle, pellier/L-5683-2015; Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019; Kracker, Sven/H-3681-2017	Leahy, Ronan/0000-0001-6419-9328; Durandy, Anne/0000-0001-7706-8466; Picard, Capucine/0000-0001-8788-5056; Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Kracker, Sven/0000-0003-4543-8236; Banham-Hall, Edward/0000-0002-9121-4690; Doffinger, R/0000-0002-9841-3617; Maes, Mailis/0000-0002-0266-6557; stephens, len/0000-0002-2771-3487; Barcenas Morales, Gabriela/0000-0003-0063-8795; Perisic, Olga/0000-0002-3842-2896; Plagnol, Vincent/0000-0002-5597-9215; Markelj, Gasper/0000-0002-7453-0173; Barrett, Jeffrey/0000-0002-1152-370X; Williams, Roger/0000-0001-7754-4207; Chilvers, Edwin/0000-0002-4230-9677; condliffe, alison/0000-0002-6697-8648; smyth, deborah/0000-0002-6330-2669; Hawkins, Phillip/0000-0002-6979-0464	European Research Council (ERC) [260477]; European Union (EU) [261441]; National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; Swiss National Science Foundation [PA00P3_134202]; European Commission [275880]; Medical Research Council [U105184308]; National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland; Wellcome Trust; Medical Research Council UK; British Lung Foundation; Biotechnology and Biological Sciences Research Council [BB/J004456/1]; Institut National de la Sante et de la Recherche Medicale; EU FP7 EUROPAD [201549]; Association Contre Le Cancer; Agence Nationale de la Recherche [2010-CSRD]; EU FP7 ERC PIDIMMUNE [249816]; PASPA-DGAPA-UNAM; GlaxoSmithKline; Roche; Novartis; Karus Therapeutics Ltd; BBSRC [BBS/E/B/0000H260, BBS/E/B/0000H329, BBS/E/B/000C0411] Funding Source: UKRI; MRC [MC_U105184308] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H260, BBS/E/B/0000H329, BBS/E/B/000C0411] Funding Source: researchfish; Medical Research Council [MC_U105184308] Funding Source: researchfish	European Research Council (ERC)(European Research Council (ERC)European Commission); European Union (EU)(CGIAREuropean Commission); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland; Wellcome Trust(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); EU FP7 EUROPAD; Association Contre Le Cancer; Agence Nationale de la Recherche(French National Research Agency (ANR)); EU FP7 ERC PIDIMMUNE; PASPA-DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); Novartis(Novartis); Karus Therapeutics Ltd; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S.N. is a Wellcome Trust Senior Research Fellow in Basic Biomedical Science (095198/Z/10/Z). S.N. is also supported by the European Research Council (ERC) Starting grant 260477 and the European Union (EU) FP7 collaborative grant 261441 (PEVNET project). S.N., A. C., D. K., and R. D. are supported by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. O.V. was supported by a Swiss National Science Foundation fellowship (grant PA00P3_134202) and a European Commission fellowship (FP7-PEOPLE-2010-IEF, no. 275880). R. L. W. was supported by the Medical Research Council (file reference U105184308). T. C. is supported by the National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland. E. B.-H. is supported by a Wellcome Trust Translational Medicine and Therapeutics award. A. C. is supported by the Medical Research Council UK and the British Lung Foundation. K.O. is supported by a strategic grant from the Biotechnology and Biological Sciences Research Council and a New Investigator Award from the Wellcome Trust. P. H. and L. S. are funded by an Institute Programme grant from the Biotechnology and Biological Sciences Research Council (BB/J004456/1). S. K. is a Centre National de la Recherche Scientifique (CNRS) researcher. A. D., A. F., and S. K. are funded by Institut National de la Sante et de la Recherche Medicale; A. D. is supported by the EU FP7 EUROPAD contract 201549, Association Contre Le Cancer, and Agence Nationale de la Recherche (grant 2010-CSRD). A. F. is supported by the EU FP7 ERC PIDIMMUNE grant 249816. G. B.-M. was supported by a sabbatical grant from PASPA-DGAPA-UNAM. E. C. is a paid consultant for GlaxoSmithKline, Roche, and Novartis; A. C. is a paid consultant for GlaxoSmithKline; P. H. and L. S are paid consultants for GlaxoSmithKline and Karus Therapeutics Ltd; K.O. is a paid consultant for GlaxoSmithKline. Requests for DNA of individual patients will require informed consent from the patients and samples will be available under a material transfer agreement. The p110 delta knockout mice are available from the Babraham Institute under a material transfer agreement. The mutation has been submitted to the ClinVar database; accession no. SCV000083058.	Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Burke JE, 2011, STRUCTURE, V19, P1127, DOI 10.1016/j.str.2011.06.003; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Durandy A, 2013, NAT REV IMMUNOL, V13, P519, DOI 10.1038/nri3466; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Janas ML, 2008, J IMMUNOL, V180, P739, DOI 10.4049/jimmunol.180.2.739; Jou ST, 2006, INT J IMMUNOGENET, V33, P361, DOI 10.1111/j.1744-313X.2006.00627.x; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Knight ZA, 2007, NAT PROTOC, V2, P2459, DOI 10.1038/nprot.2007.361; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165	25	385	409	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					866	871		10.1126/science.1243292	http://dx.doi.org/10.1126/science.1243292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24136356	Green Accepted			2022-12-28	WOS:000326923000041
J	Vigen, R; O'Donnell, CI; Baron, AE; Grunwald, GK; Maddox, TM; Bradley, SM; Barqawi, A; Woning, G; Wierman, ME; Plomondon, ME; Rumsfeld, JS; Ho, PM				Vigen, Rebecca; O'Donnell, Colin I.; Baron, Anna E.; Grunwald, Gary K.; Maddox, Thomas M.; Bradley, Steven M.; Barqawi, Al; Woning, Glenn; Wierman, Margaret E.; Plomondon, Mary E.; Rumsfeld, John S.; Ho, P. Michael			Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE SLEEP-APNEA; BODY-COMPOSITION; HYPOGONADAL MEN; SEXUAL FUNCTION; REPLACEMENT; METAANALYSIS; EXPRESSION; THRESHOLD; ADHESION; BENEFITS	IMPORTANCE Rates of testosterone therapy are increasing and the effects of testosterone therapy on cardiovascular outcomes and mortality are unknown. A recent randomized clinical trial of testosterone therapy in men with a high prevalence of cardiovascular diseases was stopped prematurely due to adverse cardiovascular events raising concerns about testosterone therapy safety. OBJECTIVES To assess the association between testosterone therapy and all-cause mortality, myocardial infarction (MI), or stroke among male veterans and to determine whether this association is modified by underlying coronary artery disease. DESIGN, SETTING, AND PATIENTS A retrospective national cohort study of men with low testosterone levels (<300 ng/dL) who underwent coronary angiography in the Veterans Affairs (VA) system between 2005 and 2011. MAIN OUTCOMES AND MEASURES Primary outcome was a composite of all-cause mortality, MI, and ischemic stroke. RESULTS Of the 8709 men with a total testosterone level lower than 300 ng/dL, 1223 patients started testosterone therapy after a median of 531 days following coronary angiography. Of the 1710 outcome events, 748 men died, 443 had MIs, and 519 had strokes. Of 7486 patients not receiving testosterone therapy, 681 died, 420 had MIs, and 486 had strokes. Among 1223 patients receiving testosterone therapy, 67 died, 23 had MIs, and 33 had strokes. The absolute rate of events were 19.9% in the no testosterone therapy group vs 25.7% in the testosterone therapy group, with an absolute risk difference of 5.8% (95% CI, -1.4% to 13.1%) at 3 years after coronary angiography. In Cox proportional hazards models adjusting for the presence of coronary artery disease, testosterone therapy use as a time-varying covariate was associated with increased risk of adverse outcomes (hazard ratio, 1.29; 95% CI, 1.04 to 1.58). There was no significant difference in the effect size of testosterone therapy among those with and without coronary artery disease (test for interaction, P = .41). CONCLUSIONS AND RELEVANCE Among a cohort of men in the VA health care system who underwent coronary angiography and had a low serum testosterone level, the use of testosterone therapy was associated with increased risk of adverse outcomes. These findings may inform the discussion about the potential risks of testosterone therapy.	[Vigen, Rebecca] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [O'Donnell, Colin I.; Baron, Anna E.; Grunwald, Gary K.; Maddox, Thomas M.; Bradley, Steven M.; Wierman, Margaret E.; Plomondon, Mary E.; Rumsfeld, John S.; Ho, P. Michael] VA Eastern Colorado Hlth Care Syst, Denver, CO 80220 USA; [O'Donnell, Colin I.; Baron, Anna E.; Grunwald, Gary K.; Maddox, Thomas M.; Bradley, Steven M.; Barqawi, Al; Woning, Glenn; Wierman, Margaret E.; Plomondon, Mary E.; Rumsfeld, John S.; Ho, P. Michael] Univ Colorado Denver, Aurora, CO USA; [Maddox, Thomas M.; Bradley, Steven M.; Plomondon, Mary E.; Rumsfeld, John S.; Ho, P. Michael] Colorado Cardiovasc Outcomes Res CCOR Consortium, Denver, CO USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Ho, PM (corresponding author), VA Eastern Colorado Hlth Care Syst, Res A151, 1055 Clermont St, Denver, CO 80220 USA.	Michael.Ho@va.gov	Bradley, Steven/AID-7839-2022		Cardiovascular Outcomes Research Fellowship through a Department of Veterans Affairs Graduate Medical Education Enhancement Grant; Department of Veterans Affairs Health Services Research and Development Service Career Development Awards	Cardiovascular Outcomes Research Fellowship through a Department of Veterans Affairs Graduate Medical Education Enhancement Grant; Department of Veterans Affairs Health Services Research and Development Service Career Development Awards	Dr Vigen was supported by a Cardiovascular Outcomes Research Fellowship through a Department of Veterans Affairs Graduate Medical Education Enhancement Grant. Drs Maddox and Bradley were supported by a Department of Veterans Affairs Health Services Research and Development Service Career Development Awards.	Abbate R, 2012, THROMB RES, V129, P235, DOI 10.1016/j.thromres.2011.12.026; AJAYI AAL, 1995, CIRCULATION, V91, P2742, DOI 10.1161/01.CIR.91.11.2742; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Bolona ER, 2007, MAYO CLIN PROC, V82, P20, DOI 10.4065/82.1.20; Box TL, 2010, J GEN INTERN MED, V25, P72, DOI 10.1007/s11606-009-1130-6; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; Byrd JB, 2013, AM HEART J, V165, P434, DOI 10.1016/j.ahj.2012.12.009; Calof OM, 2005, J GERONTOL A-BIOL, V60, P1451, DOI 10.1093/gerona/60.11.1451; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Death AK, 2004, ENDOCRINOLOGY, V145, P1889, DOI 10.1210/en.2003-0789; Drager LF, 2011, CHEST, V140, P534, DOI 10.1378/chest.10-2223; Haddad RM, 2007, MAYO CLIN PROC, V82, P29; Hoyos CM, 2012, CLIN ENDOCRINOL, V77, P599, DOI 10.1111/j.1365-2265.2012.04413.x; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Jones TH, 2011, DIABETES CARE, V34, P828, DOI 10.2337/dc10-1233; Jones TH, 2009, ATHEROSCLEROSIS, V207, P318, DOI 10.1016/j.atherosclerosis.2009.04.016; Malkin CJ, 2004, HEART, V90, P871, DOI 10.1136/hrt.2003.021121; Mathur A, 2009, EUR J ENDOCRINOL, V161, P443, DOI 10.1530/EJE-09-0092; McCrohon JA, 1999, CIRCULATION, V99, P2317, DOI 10.1161/01.CIR.99.17.2317; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Niesner K, 2013, EPIDEMIOLOGY, V24, P334, DOI 10.1097/EDE.0b013e3182821e75; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Reker DM, 2001, J REHABIL RES DEV, V38, P281; Rosmond R, 1996, OBES RES, V4, P245, DOI 10.1002/j.1550-8528.1996.tb00542.x; Shores MM, 2012, J CLIN ENDOCR METAB, V97, P2050, DOI 10.1210/jc.2011-2591; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Spitzer M, 2013, NAT REV ENDOCRINOL, V9, DOI [10.1038/nrendo.2013.73-c2, 10.1038/nrendo.2013.73]; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; US Securities and Exchange Commission, ANNUAL REPORT OF AUX; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; WILSON RF, 1987, CIRCULATION, V75, P723, DOI 10.1161/01.CIR.75.4.723; Xu S, 2012, VALUE HEALTH, V15, P167, DOI 10.1016/j.jval.2011.07.010	39	648	661	2	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1829	1836		10.1001/jama.2013.280386	http://dx.doi.org/10.1001/jama.2013.280386			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193080				2022-12-28	WOS:000326550900016
J	Kumar, V; Santhanakrishnan, K				Kumar, Vaibhav; Santhanakrishnan, Karthik			Obstructing broncholith	LANCET			English	Editorial Material									[Kumar, Vaibhav; Santhanakrishnan, Karthik] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England	University of Manchester	Kumar, V (corresponding author), Manchester Royal Infirm, Oxford Rd, Manchester M13 9WL, Lancs, England.	vaibhav.kumar94@gmail.com	Kumar, Vaibhav/ABG-5515-2020	Kumar, Vaibhav/0000-0002-5594-9497; santhanakrishnan, karthik/0000-0002-4499-847X				Craig K, 2002, J EMERG MED, V23, P359, DOI 10.1016/S0736-4679(02)00568-1; Nollet AS, 1998, RESP MED, V92, P963, DOI 10.1016/S0954-6111(98)90197-4; Olson EJ, 1999, AM J RESP CRIT CARE, V160, P766, DOI 10.1164/ajrccm.160.3.9810021; Seo JB, 2002, RADIOGRAPHICS, V22, pS199, DOI 10.1148/radiographics.22.suppl_1.g02oc07s199	4	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1534	1534		10.1016/S0140-6736(13)61743-2	http://dx.doi.org/10.1016/S0140-6736(13)61743-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	24182542				2022-12-28	WOS:000326622500032
J	Yartsev, MM				Yartsev, Michael M.			Space Bats: Multidimensional Spatial Representation in the Bat	SCIENCE			English	Editorial Material							GRID CELLS; OSCILLATIONS; HIPPOCAMPUS; MAP		Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA	Princeton University	Yartsev, MM (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA.	myartsev@gmail.com		Yartsev, Michael/0000-0003-0952-2801				Andersen P., 2007, HIPPOCAMPUS BOOK; Buzsaki G, 2012, PROG NEUROBIOL, V98, P241, DOI 10.1016/j.pneurobio.2012.02.004; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Yartsev MM, 2013, SCIENCE, V340, P367, DOI 10.1126/science.1235338; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	14	2	2	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					573	574		10.1126/science.1245809	http://dx.doi.org/10.1126/science.1245809			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179214				2022-12-28	WOS:000326334300031
J	Davies, P				Davies, Peter			PROFILE Simon Stevens: new NHS leader who's "not just Mr Insurance USA"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												petergdavies@ntlworld.com						Stevens S, 2010, FINANCIAL TIMES; Stevens S, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4136	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2013	347								f6512	10.1136/bmj.f6512	http://dx.doi.org/10.1136/bmj.f6512			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EV	24169606				2022-12-28	WOS:000326599500033
J	Wenz, AN; Zurn, G; Murmann, S; Brouzos, I; Lompe, T; Jochim, S				Wenz, A. N.; Zuern, G.; Murmann, S.; Brouzos, I.; Lompe, T.; Jochim, S.			From Few to Many: Observing the Formation of a Fermi Sea One Atom at a Time	SCIENCE			English	Article							SUPERFLUIDITY; DIMENSION; POLARONS; PHASE; GAS	Knowing when a physical system has reached sufficient size for its macroscopic properties to be well described by many-body theory is difficult. We investigated the crossover from few-to many-body physics by studying quasi-one-dimensional systems of ultracold atoms consisting of a single impurity interacting with an increasing number of identical fermions. We measured the interaction energy of such a system as a function of the number of majority atoms for different strengths of the interparticle interaction. As we increased the number of majority atoms one by one, we observed fast convergence of the normalized interaction energy toward a many-body limit calculated for a single impurity immersed in a Fermi sea of majority particles.	[Wenz, A. N.; Zuern, G.; Murmann, S.; Lompe, T.; Jochim, S.] Heidelberg Univ, Inst Phys, D-69210 Heidelberg, Germany; [Wenz, A. N.; Zuern, G.; Murmann, S.; Lompe, T.; Jochim, S.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Brouzos, I.] Univ Ulm, Inst Quanten Informat Verarbeitung, D-89069 Ulm, Germany; [Lompe, T.; Jochim, S.] GSI Helmholtzzentrum Schwerionenforsch, Extreme Matter Inst EMMI, D-64291 Darmstadt, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ulm University; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research	Wenz, AN (corresponding author), Heidelberg Univ, Inst Phys, D-69210 Heidelberg, Germany.	wenz@physi.uni-heidelberg.de	Jochim, Selim/G-1287-2011	Jochim, Selim/0000-0001-6049-2658; Lompe, Thomas/0000-0002-7880-1639	International Max Planck Research School for Quantum Dynamics; European Commission; European Research Council [279697]; Helmholtz Alliance [HA216-EMMI]; Heidelberg Center for Quantum Dynamics	International Max Planck Research School for Quantum Dynamics; European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Helmholtz Alliance; Heidelberg Center for Quantum Dynamics	We thank D. Blume and S. E. Gharashi for inspiring discussions and for providing the results of their numerical calculations, and R. Schmidt, X. Guan, and J. McGuire for very helpful discussions. I. B. thanks G. E. Astrakharchik for helpful discussions. Supported by the International Max Planck Research School for Quantum Dynamics (A.N.W. and G.Z.), the European Commission-funded Future and Emerging Technologies project Quantum Interferometry with Bose-Einstein Condensates (I. B.), European Research Council starting grant 279697, the Helmholtz Alliance (HA216-EMMI), and the Heidelberg Center for Quantum Dynamics.	Astrakharchik GE, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.021602; Bergeman T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.163201; Brouzos I, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.023605; Bugnion PO, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.060502; Busch T., 1998, FOUND PHYS, V28, P549; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Gharashi SE, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.045302; Gharashi SE, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.042702; GIRARDEAU M, 1960, J MATH PHYS, V1, P516, DOI 10.1063/1.1703687; Girardeau MD, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.011607; Giraud S, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.043615; Grebenev S, 1998, SCIENCE, V279, P2083, DOI 10.1126/science.279.5359.2083; Haller E, 2009, SCIENCE, V325, P1224, DOI [10.1126/science.11758510, 10.1126/science.1175850]; Idziaszek Z, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.050701; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; Kohstall C, 2012, NATURE, V485, P615, DOI 10.1038/nature11065; Koschorreck M, 2012, NATURE, V485, P619, DOI 10.1038/nature11151; MCGUIRE JB, 1965, J MATH PHYS, V6, P432, DOI 10.1063/1.1704291; MIGDAL AB, 1959, NUCL PHYS, V13, P655, DOI 10.1016/0029-5582(59)90264-0; Ospelkaus C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.120402; Prokof'ev NV, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125101; Prokof'ev N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.020408; Schirotzek A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230402; Serwane F, 2011, SCIENCE, V332, P336, DOI 10.1126/science.1201351; Will S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.115305; Zurn G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135301; Zurn G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.075303; Zurn G, 2012, THESIS RUPRECHT KARL	30	232	232	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					457	460		10.1126/science.1240516	http://dx.doi.org/10.1126/science.1240516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159041	Green Submitted			2022-12-28	WOS:000326042600036
J	Fox, SH				Fox, Susan H.			Pimavanserin as treatment for Parkinson's disease psychosis	LANCET			English	Editorial Material							VISUAL HALLUCINATIONS; RECEPTORS; SYMPTOMS		Univ Hlth Network, Toronto Western Hosp, Movement Disorder Clin, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Fox, SH (corresponding author), Univ Hlth Network, Toronto Western Hosp, Movement Disorder Clin, Toronto, ON M5T 2S8, Canada.	sfox@uhnresearch.ca						Ballanger B, 2010, ARCH NEUROL-CHICAGO, V67, P416, DOI 10.1001/archneurol.2010.35; Cummings J, 2014, LANCET, V383, P533, DOI 10.1016/S0140-6736(13)62106-6; Fenelon G, 2010, MOVEMENT DISORD, V25, P763, DOI 10.1002/mds.22839; Fernandez HH, 2008, MOVEMENT DISORD, V23, P484, DOI 10.1002/mds.21875; Goetz CG, 2008, MOVEMENT DISORD, V23, P1541, DOI 10.1002/mds.22132; Huot P, 2010, MOVEMENT DISORD, V25, P1399, DOI 10.1002/mds.23083; Meltzer HY, 2011, CURR OPIN PHARMACOL, V11, P59, DOI 10.1016/j.coph.2011.02.007; Mills RG, 2013, 17 INT C PARK DIS MO; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Vanover KE, 2006, J PHARMACOL EXP THER, V317, P910, DOI 10.1124/jpet.105.097006; Voss T, 2013, PARKINSONISM RELAT D, V19, P295, DOI 10.1016/j.parkreldis.2012.10.022; Weiner DM, 2001, J PHARMACOL EXP THER, V299, P268; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P899, DOI 10.1001/archneurol.2011.139	13	12	15	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					494	496		10.1016/S0140-6736(13)62157-1	http://dx.doi.org/10.1016/S0140-6736(13)62157-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24183566				2022-12-28	WOS:000331136400008
J	Matsui, A; Tran, M; Yoshida, AC; Kikuchi, SS; Mami, U; Ogawa, M; Shimogori, T				Matsui, Asuka; Tran, May; Yoshida, Aya C.; Kikuchi, Satomi S.; Mami, U.; Ogawa, Masaharu; Shimogori, Tomomi			BTBD3 Controls Dendrite Orientation Toward Active Axons in Mammalian Neocortex	SCIENCE			English	Article							VISUAL-CORTEX; RECEPTOR; GROWTH; MECHANISMS; EXPRESSION; DROSOPHILA	Experience-dependent structural changes in the developing brain are fundamental for proper neural circuit formation. Here, we show that during the development of the sensory cortex, dendritic field orientation is controlled by the BTB/POZ domain-containing 3 (BTBD3). In developing mouse somatosensory cortex, endogenous Btbd3 translocated to the cell nucleus in response to neuronal activity and oriented primary dendrites toward active axons in the barrel hollow. Btbd3 also directed dendrites toward active axon terminals when ectopically expressed in mouse visual cortex or normally expressed in ferret visual cortex. BTBD3 regulation of dendrite orientation is conserved across species and cortical areas and shows how high-acuity sensory function may be achieved by the tuning of subcellular polarity to sources of high sensory activity.	[Matsui, Asuka; Tran, May; Yoshida, Aya C.; Kikuchi, Satomi S.; Mami, U.; Ogawa, Masaharu; Shimogori, Tomomi] RIKEN Brain Sci Inst, Lab Mol Mech Thalamus Dev, Wako, Saitama 3510198, Japan	RIKEN	Shimogori, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Mech Thalamus Dev, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tshimogori@brain.riken.jp	Shimogori, Tomomi/L-2893-2013	Shimogori, Tomomi/0000-0002-6931-5401; Tran, May/0000-0001-9370-2682	RIKEN Brain Science Institute; MEXT Strategic Research Program for Brain Science (SRPBS); Center of Novel Science Initiative Brain Science Project; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST); Human Frontier Science Program (HFSP); Japan-U.S. Educational Commission (Fulbright Japan)	RIKEN Brain Science Institute; MEXT Strategic Research Program for Brain Science (SRPBS); Center of Novel Science Initiative Brain Science Project; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Japan-U.S. Educational Commission (Fulbright Japan)	We thank C. Yokoyama, A. Kania, T. Young, and A. Terashima for critical reading. We also thank Y. Takahashi, S. Tonegawa, S. Blackshaw, and S. Itohara for providing plasmids and mouse line, and F. Matsuzaki, D. Konno, T. Suetsugu, H. Mashiko, and Y. Maeda for technical assistance. This work was supported by the RIKEN Brain Science Institute, MEXT Strategic Research Program for Brain Science (SRPBS), Center of Novel Science Initiative Brain Science Project, Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), and the Human Frontier Science Program (HFSP). M.T. is funded by the Japan-U.S. Educational Commission (Fulbright Japan).	Bathellier B, 2009, J NEUROSCI, V29, P12641, DOI 10.1523/JNEUROSCI.1124-09.2009; Callaway EM, 2011, J NEUROSCI, V31, P7456, DOI 10.1523/JNEUROSCI.5222-10.2011; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kawasaki H, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-24; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Lebrand C, 1998, J COMP NEUROL, V401, P506; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; Lee SU, 2012, IMMUNOL REV, V247, P107, DOI 10.1111/j.1600-065X.2012.01116.x; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Mashiko H, 2012, J NEUROSCI, V32, P5039, DOI 10.1523/JNEUROSCI.4788-11.2012; Nakagami Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00043; Narboux-Neme N, 2012, J NEUROSCI, V32, P6183, DOI 10.1523/JNEUROSCI.0343-12.2012; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Siggs OM, 2012, CELL CYCLE, V11, P3358, DOI 10.4161/cc.21277; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931	26	60	64	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1114	1118		10.1126/science.1244505	http://dx.doi.org/10.1126/science.1244505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24179155				2022-12-28	WOS:000327518600063
J	Fernandez, IS; Bai, XC; Hussain, T; Kelley, AC; Lorsch, JR; Ramakrishnan, V; Scheres, SHW				Fernandez, Israel S.; Bai, Xiao-Chen; Hussain, Tanweer; Kelley, Ann C.; Lorsch, Jon R.; Ramakrishnan, V.; Scheres, Sjors H. W.			Molecular Architecture of a Eukaryotic Translational Initiation Complex	SCIENCE			English	Article							CRYO-EM STRUCTURE; RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; TRANSFER-RNA; MECHANISMS	The last step in eukaryotic translational initiation involves the joining of the large and small subunits of the ribosome, with initiator transfer RNA (Met-tRNA(i)(Met)) positioned over the start codon of messenger RNA in the P site. This step is catalyzed by initiation factor eIF5B. We used recent advances in cryo-electron microscopy (cryo-EM) to determine a structure of the eIF5B initiation complex to 6.6 angstrom resolution from <3% of the population, comprising just 5143 particles. The structure reveals conformational changes in eIF5B, initiator tRNA, and the ribosome that provide insights into the role of eIF5B in translational initiation. The relatively high resolution obtained from such a small fraction of a heterogeneous sample suggests a general approach for characterizing the structure of other dynamic or transient biological complexes.	[Fernandez, Israel S.; Bai, Xiao-Chen; Hussain, Tanweer; Kelley, Ann C.; Ramakrishnan, V.; Scheres, Sjors H. W.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	MRC Laboratory Molecular Biology; Johns Hopkins University	Lorsch, JR (corresponding author), Eunice K Shriver Inst Child Hlth & Human Dev, Lab Mech & Regulat Prot Synth, Bethesda, MD 20892 USA.	jon.lorsch@nih.gov; ramak@mrc-lmb.cam.ac.uk; scheres@mrc-lmb.cam.ac.uk	Bai, Xiao-chen/HGV-1244-2022; Scheres, Sjors H.W./AAY-2265-2021	Bai, Xiao-chen/0000-0002-4234-5686; Scheres, Sjors H.W./0000-0002-0462-6540; Ramakrishnan, V/0000-0002-4699-2194; Lorsch, Jon/0000-0002-4521-4999; Hussain, Tanweer/0000-0003-4735-2380; Fernandez, Israel/0000-0001-7218-1603	EU FP7 Marie Curie postdoctoral fellowship; UK Medical Research Council [MC_U105184332, MC_UP_A025_1013]; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; Human Frontiers Science Program [RGP 28/2009]; MRC [MC_UP_A025_1013, MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1013, MC_U105184332] Funding Source: researchfish	EU FP7 Marie Curie postdoctoral fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; Human Frontiers Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Chen for technical support with cryo-EM, G. McMullan for help in movie data acquisition, T. Darling and J. Grimmett for help with computing, D. Tourigny for discussions, and one of the reviewers for suggestions on properly modeling the P/I tRNA. X.-C. B. is supported by a EU FP7 Marie Curie postdoctoral fellowship. Supported by grants from the UK Medical Research Council (MC_U105184332 to V. R. and MC_UP_A025_1013 to S. H. W. S.); a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation (V. R.); and the Human Frontiers Science Program (grant RGP 28/2009 to V. R. and J. R. L.). The cryo-EM density maps have been deposited in the Electron Microscopy Data Bank with accession numbers EMD-2421 (for the large class with P/E tRNA) and EMD-2422 (for the small class with P/I tRNA). Fitted atomic coordinates have been deposited in the Protein Data Bank, with entry codes 4byl, 4byn, 4byo, 4byp, 4byq, 4byr, and 4bys for the large class and entry codes 4byt, 4byu, 4byv, 4byw, and 4byx for the small class.	Acker MG, 2006, J BIOL CHEM, V281, P8469, DOI 10.1074/jbc.M600210200; Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Acker MG, 2009, J MOL BIOL, V385, P491, DOI 10.1016/j.jmb.2008.10.029; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kapp LD, 2004, J MOL BIOL, V335, P923, DOI 10.1016/j.jmb.2003.11.025; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Roll-Mecak A, 2001, TRENDS BIOCHEM SCI, V26, P705, DOI 10.1016/S0968-0004(01)02024-2; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; Shin BS, 2009, MOL CELL BIOL, V29, P808, DOI 10.1128/MCB.00896-08; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Trabuco LG, 2011, J STRUCT BIOL, V173, P420, DOI 10.1016/j.jsb.2010.09.024; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577	39	97	105	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					824	+	1240585	10.1126/science.1240585	http://dx.doi.org/10.1126/science.1240585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24200810	Green Accepted			2022-12-28	WOS:000326923000028
J	Kravitz, RL; Franks, P; Feldman, MD; Tancredi, DJ; Slee, CA; Epstein, RM; Duberstein, PR; Bell, RA; Jackson-Triche, M; Paterniti, DA; Cipri, C; Iosif, AM; Olson, S; Kelly-Reif, S; Hudnut, A; Dvorak, S; Turner, C; Jerant, A				Kravitz, Richard L.; Franks, Peter; Feldman, Mitchell D.; Tancredi, Daniel J.; Slee, Christina A.; Epstein, Ronald M.; Duberstein, Paul R.; Bell, Robert A.; Jackson-Triche, Maga; Paterniti, Debora A.; Cipri, Camille; Iosif, Ana-Maria; Olson, Sarah; Kelly-Reif, Steven; Hudnut, Andrew; Dvorak, Simon; Turner, Charles; Jerant, Anthony			Patient Engagement Programs for Recognition and Initial Treatment of Depression in Primary Care A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TO-CONSUMER TELEVISION; PREFERENCES; DIAGNOSIS; PHYSICIAN; SEVERITY; MESSAGE; QUALITY; STIGMA; PHQ-9; COST	IMPORTANCE Encouraging primary care patients to address depression symptoms and care with clinicians could improve outcomes but may also result in unnecessary treatment. OBJECTIVE To determine whether a depression engagement video (DEV) or a tailored interactive multimedia computer program (IMCP) improves initial depression care compared with a control without increasing unnecessary antidepressant prescribing. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial comparing DEV, IMCP, and control among 925 adult patients treated by 135 primary care clinicians (603 patients with depression and 322 patients without depression, defined by Patient Health Questionnaire-9 [PHQ-9] score) conducted from June 2010 through March 2012 at 7 primary care clinical sites in California. INTERVENTIONS DEV targeted to sex and income, an IMCP tailored to individual patient characteristics, and a sleep hygiene video (control). MAIN OUTCOMES AND MEASURES Among depressed patients, superiority assessment of the composite measure of patient-reported antidepressant drug recommendation, mental health referral, or both (primary outcome); depression at 12-week follow-up, measured by the PHQ-8 (secondary outcome). Among nondepressed patients, noninferiority assessment of clinician-and patient-reported antidepressant drug recommendation (primary outcomes) with a noninferiority margin of 3.5%. Analyses were cluster adjusted. RESULTS Of the 925 eligible patients, 867 were included in the primary analysis (depressed, 559; nondepressed, 308). Among depressed patients, rates of achieving the primary outcome were 17.5% for DEV, 26% for IMCP, and 16.3% for control (DEV vs control, 1.1 [95% CI, -6.7 to 8.9], P = .79; IMCP vs control, 9.9 [95% CI, 1.6 to 18.2], P = .02). There were no effects on PHQ-8 measured depression score at the 12-week follow-up: DEV vs control, -0.2 (95% CI, -1.2 to 0.8); IMCP vs control, 0.9 (95% CI, -0.1 to 1.9). Among nondepressed patients, clinician-reported antidepressant prescribing in the DEV and IMCP groups was noninferior to control (mean percentage point difference [PPD]: DEV vs control, -2.2 [90% CI, -8.0 to 3.49], P = .0499 for noninferiority; IMCP vs control, -3.3 [90% CI, -9.1 to 2.4], P = .02 for noninferiority); patient-reported antidepressant recommendation did not achieve noninferiority (mean PPD: DEV vs control, 0.9 [90% CI, -4.9 to 6.7], P = .23 for noninferiority; IMCP vs control, 0.3 [90% CI, -5.1 to 5.7], P = .16 for noninferiority). CONCLUSIONS AND RELEVANCE A tailored IMCP increased clinician recommendations for antidepressant drugs, a mental health referral, or both among depressed patients but had no effect on mental health at the 12-week follow-up. The possibility that the IMCP and DEV increased patient-reported clinician recommendations for an antidepressant drug among nondepressed patients could not be excluded.	[Kravitz, Richard L.] Univ Calif Davis, Div Gen Med, Sacramento, CA 95817 USA; [Kravitz, Richard L.; Franks, Peter; Tancredi, Daniel J.; Bell, Robert A.; Paterniti, Debora A.; Cipri, Camille; Jerant, Anthony] Univ Calif Davis, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA; [Franks, Peter; Jerant, Anthony] Univ Calif Davis, Dept Family & Community Med, Sacramento, CA 95817 USA; [Feldman, Mitchell D.; Olson, Sarah] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Tancredi, Daniel J.] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA; [Slee, Christina A.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Epstein, Ronald M.; Duberstein, Paul R.] Univ Rochester, Dept Family Med, Rochester, NY USA; [Epstein, Ronald M.; Duberstein, Paul R.] Univ Rochester, Dept Psychiat, Rochester, NY USA; [Epstein, Ronald M.] Univ Rochester, Dept Oncol, Rochester, NY USA; [Bell, Robert A.] Univ Calif Davis, Dept Commun & Publ Hlth Sci, Davis, CA 95616 USA; [Jackson-Triche, Maga] Univ Calif Davis, VA Northern Calif Hlth Care Syst, Sacramento, CA 95817 USA; [Paterniti, Debora A.] Univ Calif Davis, Dept Internal Med & Sociol, Sacramento, CA 95817 USA; [Iosif, Ana-Maria] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Kelly-Reif, Steven] Permanente Med Grp Inc, Sacramento, CA USA; [Hudnut, Andrew] Sutter Med Fdn, Sacramento, CA USA; [Dvorak, Simon; Turner, Charles] Univ Calif Davis, Acad Technol Serv, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Davis; University of Rochester; University of Rochester; University of Rochester; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Permanente Medical Groups; University of California System; University of California Davis	Kravitz, RL (corresponding author), Univ Calif Davis, Div Gen Med, 4150 V St,Ste 2400 PSSB, Sacramento, CA 95817 USA.	rlkravitz@ucdavis.edu	Tancredi, Daniel J/O-3381-2013; Kravitz, Richard/AAF-7425-2021; Duberstein, Paul Raphael/AAO-5302-2020	Tancredi, Daniel J/0000-0002-3884-7907; Duberstein, Paul Raphael/0000-0001-6882-0898; Iosif, Ana-Maria/0000-0001-7283-2015; Kravitz, Richard/0000-0001-5575-529X	National Institute of Mental Health [1R01MH079387, K24MH072756, K24 K24MH072712]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH072756, R01MH079387, K24MH072712] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants 1R01MH079387 (Kravitz), K24MH072756 (Kravitz), and K24 K24MH072712 (Duberstein) from the National Institute of Mental Health.	Avery RJ, 2012, J HEALTH ECON, V31, P705, DOI 10.1016/j.jhealeco.2012.05.002; Bell RA, 2011, ANN FAM MED, V9, P439, DOI 10.1370/afm.1277; Bell RA, 2010, PATIENT EDUC COUNS, V78, P198, DOI 10.1016/j.pec.2009.07.007; Berardi D, 2005, PSYCHOTHER PSYCHOSOM, V74, P225, DOI 10.1159/000085146; Block AE, 2007, PHARMACOECONOMICS, V25, P511, DOI 10.2165/00019053-200725060-00006; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cooper AE, 2003, J NERV MENT DIS, V191, P339, DOI 10.1097/00005053-200305000-00010; CooperPatrick L, 1997, J GEN INTERN MED, V12, P431, DOI 10.1046/j.1525-1497.1997.00075.x; DECI EL, 1987, J PERS SOC PSYCHOL, V53, P1024, DOI 10.1037/0022-3514.53.6.1024; DeSouza CM, 2009, J BIOPHARM STAT, V19, P1055, DOI 10.1080/10543400903242795; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Duffy SA, 2006, CANCER EPIDEM BIOMAR, V15, P2203, DOI 10.1158/1055-9965.EPI-05-0880; Dwight-Johnson M, 2001, MED CARE, V39, P934, DOI 10.1097/00005650-200109000-00004; Dwight-Johnson M, 2000, J GEN INTERN MED, V15, P527, DOI 10.1046/j.1525-1497.2000.08035.x; Epstein A., 2011, COMMON SLEEPING PROB; Epstein RM, 2010, J GEN INTERN MED, V25, P954, DOI 10.1007/s11606-010-1367-0; Fleishman JA, 2010, QUAL LIFE RES, V19, P231, DOI 10.1007/s11136-009-9582-z; Hauck WW, 1998, CONTROL CLIN TRIALS, V19, P249, DOI 10.1016/S0197-2456(97)00147-5; Jerant A, 2011, PATIENT EDUC COUNS, V85, P323, DOI 10.1016/j.pec.2010.11.012; Kanter JW, 2008, J NERV MENT DIS, V196, P663, DOI 10.1097/NMD.0b013e318183f8af; Karasz A, 2003, J GEN INTERN MED, V18, P475, DOI 10.1046/j.1525-1497.2003.20636.x; Katon W, 2010, GEN HOSP PSYCHIAT, V32, P456, DOI 10.1016/j.genhosppsych.2010.04.001; Kravitz RL, 2008, J GEN INTERN MED, V23, P1722, DOI 10.1007/s11606-008-0763-1; Kravitz RL, 2013, PATIENT EDUC COUNS, V90, P411, DOI 10.1016/j.pec.2011.07.003; Kravitz RL, 2011, PATIENT EDUC COUNS, V82, P207, DOI 10.1016/j.pec.2010.05.007; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; KREUTER M, 2000, TAILORING HLTH MESSA; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lotfi L, 2010, NORD J PSYCHIAT, V64, P421, DOI 10.3109/08039481003786378; MacArthur Foundation, IN DEPR PRIM CAR; Maly RC, 1998, J AM GERIATR SOC, V46, P889, DOI 10.1111/j.1532-5415.1998.tb02725.x; Mintzes B, 2003, CAN MED ASSOC J, V169, P405; Niederdeppe J, 2013, J GEN INTERN MED, V28, P886, DOI 10.1007/s11606-013-2379-3; Nutting PA, 2000, ARCH FAM MED, V9, P1059, DOI 10.1001/archfami.9.10.1059; Petty R.E., 1986, COMMUN PERSUATION, P1; Ryan GL, 2001, HEALTH EDUC RES, V16, P555, DOI 10.1093/her/16.5.555; Schmid KL, 2008, MARK HEALTH SERV, V28, P32; Simon GE, 2004, AM J PSYCHIAT, V161, P1626, DOI 10.1176/appi.ajp.161.9.1626; Stata Corp, 2011, STAT STAT SOFTW COMP; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Tancredi DJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-141; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wells KB, 1997, J CLIN PSYCHIAT, V58, P24; Wells TS, 2013, J AFFECT DISORDERS, V148, P77, DOI 10.1016/j.jad.2012.11.052	47	29	29	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1818	1828		10.1001/jama.2013.280038	http://dx.doi.org/10.1001/jama.2013.280038			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	246PH	24193079	Green Accepted, Bronze			2022-12-28	WOS:000326550900015
J	Steinbrook, R				Steinbrook, Robert			The Peer Review Congresses Improving Peer Review and Biomedical Publication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,1-456 SHM,POB 208008, New Haven, CT 06520 USA.	robert.steinbrook@yale.edu						[Anonymous], THE SEVENTH INTERNAT; BURNHAM JC, 1990, JAMA-J AM MED ASSOC, V263, P1323, DOI 10.1001/jama.263.10.1323; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; KRONICK DA, 1990, JAMA-J AM MED ASSOC, V263, P1321, DOI 10.1001/jama.263.10.1321; Steinbrook R., 1989, LOS ANGELES TIM 0115, P113; Steinbrook R, 2012, JAMA-J AM MED ASSOC, V308, P1437, DOI 10.1001/jama.2012.12829; Steinbrook R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5391	7	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1799	1800		10.1001/jama.2013.280834	http://dx.doi.org/10.1001/jama.2013.280834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24126455				2022-12-28	WOS:000326550900009
J	Mendenhall, GS				Mendenhall, G. Stuart			Emphasis and Priority	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Mendenhall, G. Stuart] Univ Pittsburgh, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mendenhall, GS (corresponding author), Univ Pittsburgh, Dept Cardiac Electrophysiol, B-535 Scaife Hall,200 Lothrop St, Pittsburgh, PA 15213 USA.	gsmenden@post.hanrard.edu						Bibbins-Domingo K, 2007, ANN INTERN MED, V146, P52, DOI 10.7326/0003-4819-146-1-200701020-00009; Buchanan AV, 2006, INT J EPIDEMIOL, V35, P562, DOI 10.1093/ije/dyl001; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					627	628		10.7326/0003-4819-159-9-201311050-00009	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249HX	24189595				2022-12-28	WOS:000326769400007
J	Markov, NT; Ercsey-Ravasz, M; Van Essen, DC; Knoblauch, K; Toroczkai, Z; Kennedy, H				Markov, Nikola T.; Ercsey-Ravasz, Maria; Van Essen, David C.; Knoblauch, Kenneth; Toroczkai, Zoltan; Kennedy, Henry			Cortical High-Density Counterstream Architectures	SCIENCE			English	Review							VISUAL-CORTEX; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; SQUIRREL-MONKEY; MACAQUE MONKEY; LAMINAR DISTRIBUTION; AREAS V1; ORGANIZATION; BRAIN; NEURONS	Small-world networks provide an appealing description of cortical architecture owing to their capacity for integration and segregation combined with an economy of connectivity. Previous reports of low-density interareal graphs and apparent small-world properties are challenged by data that reveal high-density cortical graphs in which economy of connections is achieved by weight heterogeneity and distance-weight correlations. These properties define a model that predicts many binary and weighted features of the cortical network including a core-periphery, a typical feature of self-organizing information processing systems. Feedback and feedforward pathways between areas exhibit a dual counterstream organization, and their integration into local circuits constrains cortical computation. Here, we propose a bow-tie representation of interareal architecture derived from the hierarchical laminar weights of pathways between the high-efficiency dense core and periphery.	[Markov, Nikola T.; Knoblauch, Kenneth; Kennedy, Henry] INSERM, U846, Stem Cell & Brain Res Inst, F-69500 Bron, France; [Markov, Nikola T.; Knoblauch, Kenneth; Kennedy, Henry] Univ Lyon 1, F-69003 Lyon, France; [Markov, Nikola T.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; [Ercsey-Ravasz, Maria] Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania; [Van Essen, David C.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Toroczkai, Zoltan] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Toroczkai, Zoltan] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA; [Toroczkai, Zoltan] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Yale University; Babes Bolyai University from Cluj; Washington University (WUSTL); University of Notre Dame; University of Notre Dame; Max Planck Society	Toroczkai, Z (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	toro@nd.edu; henry.kennedy@inserm.fr	Ravasz, Maria Ercsey/E-2098-2017; Knoblauch, Kenneth/H-8156-2014; Kennedy, Henry/B-9636-2013; Van Essen, David/ABA-8888-2020; Markov, Nikola T./AFO-2802-2022; Toroczkai, Zoltan/AAC-8446-2019; Markov, Nikola/AAI-9680-2020	Ravasz, Maria Ercsey/0000-0003-4428-9953; Knoblauch, Kenneth/0000-0002-4681-4638; Kennedy, Henry/0000-0002-2796-7663; Markov, Nikola T./0000-0003-1417-1161; Toroczkai, Zoltan/0000-0002-6602-2849; 	LabEx CORTEX [ANR-11-LABX-0042]; National Institute of Mental Health [R01 MH60974]; Notre Dame's Interdisciplinary Center for Network Science and Applications (iCeNSA); U.S. Air Force Office of Scientific Research and Defense Advanced Research Projects Agency [FA9550-12-1-0405];  [FP6-2005 IST-1583];  [FP7-2007 ICT-216593];  [ANR-11-BSV4-501];  [PN-II-RU-TE-2011-3-0121];  [FP7-PEOPLE-2011-IIF-299915]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060974] Funding Source: NIH RePORTER	LabEx CORTEX; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Notre Dame's Interdisciplinary Center for Network Science and Applications (iCeNSA); U.S. Air Force Office of Scientific Research and Defense Advanced Research Projects Agency; ; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge C. Lamy and P. Misery for histology and M. A. Gariel for data analysis. This work was supported by FP6-2005 IST-1583 (H. K.); FP7-2007 ICT-216593 (H. K.); ANR-11-BSV4-501 (H. K.); LabEx CORTEX (ANR-11-LABX-0042) (H. K.); PN-II-RU-TE-2011-3-0121, FP7-PEOPLE-2011-IIF-299915 (M.E.-R.); National Institute of Mental Health grant R01 MH60974 (D. C. V. E.); Notre Dame's Interdisciplinary Center for Network Science and Applications (iCeNSA) funds; and, in part, by grant FA9550-12-1-0405 from the U.S. Air Force Office of Scientific Research and Defense Advanced Research Projects Agency (Z.T.).	Adams RA, 2013, BRAIN STRUCT FUNCT, V218, P611, DOI 10.1007/s00429-012-0475-5; Anderson JC, 1998, J NEUROSCI, V18, P10525; Anderson JC, 2011, J NEUROSCI, V31, P10872, DOI 10.1523/JNEUROSCI.0622-11.2011; BARBAS H, 1986, J COMP NEUROL, V252, P415, DOI 10.1002/cne.902520310; Barbas H, 1997, CEREB CORTEX, V7, P635, DOI 10.1093/cercor/7.7.635; Barone P, 2000, J NEUROSCI, V20, P3263, DOI 10.1523/JNEUROSCI.20-09-03263.2000; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Bressler SL, 2004, NEUROINFORMATICS, V2, P227, DOI 10.1385/NI:2:2:227; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Chen CM, 2007, CEREB CORTEX, V17, P1561, DOI 10.1093/cercor/bhl067; Cherniak C, 1999, PHYS REV E, V59, P6001, DOI 10.1103/PhysRevE.59.6001; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Cherniak C, 2004, P NATL ACAD SCI USA, V101, P1081, DOI 10.1073/pnas.0305212101; Cherniak C, 2012, PROG BRAIN RES, V195, P361, DOI 10.1016/B978-0-444-53860-4.00017-9; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Collins CE, 2011, BRAIN BEHAV EVOLUT, V78, P37, DOI 10.1159/000327319; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; de Reus MA, 2013, J NEUROSCI, V33, P12929, DOI 10.1523/JNEUROSCI.1448-13.2013; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 1989, NEURAL COMPUT, V1, P480, DOI 10.1162/neco.1989.1.4.480; Douglas RJ, 2012, CURR BIOL, V22, pR1033, DOI 10.1016/j.cub.2012.11.017; Doyle JC, 2011, P NATL ACAD SCI USA, V108, P15624, DOI 10.1073/pnas.1103557108; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Ercsey-Ravasz M, 2013, NEURON, V80, P184, DOI 10.1016/j.neuron.2013.07.036; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Herculano-Houzel S, 2010, P NATL ACAD SCI USA, V107, P19008, DOI 10.1073/pnas.1012590107; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hilgetag CC, 1996, SCIENCE, V271, P776, DOI 10.1126/science.271.5250.776; HOF PR, 1995, J COMP NEUROL, V352, P161, DOI 10.1002/cne.903520202; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Jehee JFM, 2007, BRAIN RES, V1157, P167, DOI 10.1016/j.brainres.2007.03.090; Jouve B, 1998, CEREB CORTEX, V8, P28, DOI 10.1093/cercor/8.1.28; KAAS JH, 1977, VISION RES, V17, P739, DOI 10.1016/S0042-6989(77)80013-8; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P500, DOI 10.1016/S0959-4388(99)80075-0; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; KENNEDY H, 1985, J NEUROSCI, V5, P2815; Kennedy H, 2013, NEUROIMAGE, V80, P37, DOI 10.1016/j.neuroimage.2013.04.031; Kennedy H, 2012, PROG BRAIN RES, V195, P341, DOI 10.1016/B978-0-444-53860-4.00016-7; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Klyachko VA, 2003, P NATL ACAD SCI USA, V100, P7937, DOI 10.1073/pnas.0932745100; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; Krumnack Antje, 2010, Front Neuroinform, V4, P7, DOI 10.3389/fninf.2010.00007; Lanciego JL, 2011, J CHEM NEUROANAT, V42, P157, DOI 10.1016/j.jchemneu.2011.07.001; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Man K, 2013, J COMP NEUROL, V521, P4097, DOI 10.1002/cne.23408; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Markov NT, 2014, J COMP NEUROL, V522, P225, DOI 10.1002/cne.23458; Markov NT, 2013, CURR OPIN NEUROBIOL, V23, P187, DOI 10.1016/j.conb.2012.12.008; Markova NT, 2013, P NATL ACAD SCI USA, V110, P5187, DOI 10.1073/pnas.1218972110; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; O'Reilly RC, 2010, CURR OPIN NEUROBIOL, V20, P257, DOI 10.1016/j.conb.2010.01.008; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Polouliakh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004189; Potjans TC, 2014, CEREB CORTEX, V24, P785, DOI 10.1093/cercor/bhs358; Raj A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014832; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Reid AT, 2009, NEUROIMAGE, V47, P611, DOI 10.1016/j.neuroimage.2009.04.061; Rivera-Alba M, 2011, CURR BIOL, V21, P2000, DOI 10.1016/j.cub.2011.10.022; Rockland KS, 1997, CEREBR CORT, V12, P243; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Rosa MGP, 2005, PHILOS T R SOC B, V360, P665, DOI 10.1098/rstb.2005.1626; Salazar RF, 2012, SCIENCE, V338, P1097, DOI 10.1126/science.1224000; Scholte HS, 2008, J COGNITIVE NEUROSCI, V20, P2097, DOI 10.1162/jocn.2008.20142; Schuaz A., 2002, CORTICAL AREAS UNITY, P377, DOI DOI 10.1201/9780203299296.CH16; Self MW, 2012, P NATL ACAD SCI USA, V109, P11031, DOI 10.1073/pnas.1119527109; Shipp S, 2005, PHILOS T R SOC B, V360, P797, DOI 10.1098/rstb.2005.1630; Siganos G, 2006, J COMMUN NETW-S KOR, V8, P339, DOI 10.1109/JCN.2006.6182774; Singla A., 2011, 3 USENIX WORKSH HOT; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; Striedter G. F., 2005, PRINCIPLES BRAIN EVO; Super H, 2007, CEREB CORTEX, V17, P1468, DOI 10.1093/cercor/bhl058; Tauro SL, 2001, GLOB TELECOMM CONF, P1667, DOI 10.1109/GLOCOM.2001.965863; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; TIGGES J, 1973, J COMP NEUROL, V148, P481, DOI 10.1002/cne.901480406; TIGGES J, 1981, J COMP NEUROL, V202, P539, DOI 10.1002/cne.902020407; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Ullman S., 2000, HIGH LEVEL VISION; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; Van Essen DC, 2012, CEREB CORTEX, V22, P2227, DOI 10.1093/cercor/bhr290; van Hemmen J. L., 2006, 23 PROBLEMS SYSTEMS, P103; VANESSEN DC, 1978, J PHYSIOL-LONDON, V277, P193; Vezoli J, 2004, NEUROSCIENTIST, V10, P476, DOI 10.1177/1073858404268478; Vragovic I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036122; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Wang W, 2005, BIOL CYBERN, V92, P38, DOI 10.1007/s00422-004-0527-x; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen Q, 2009, P NATL ACAD SCI USA, V106, P12536, DOI 10.1073/pnas.0901530106; WONGRILEY M, 1978, BRAIN RES, V147, P159, DOI 10.1016/0006-8993(78)90781-3; Xing DJ, 2012, P NATL ACAD SCI USA, V109, P13871, DOI 10.1073/pnas.1201478109; Yamamori T, 2011, PROG NEUROBIOL, V94, P201, DOI 10.1016/j.pneurobio.2011.04.008; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; YOUNG MP, 1993, P ROY SOC B-BIOL SCI, V252, P13, DOI 10.1098/rspb.1993.0040; Zador AM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001411; Zeki S, 2005, PHILOS T R SOC B, V360, P1145, DOI 10.1098/rstb.2005.1666	136	290	290	5	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					578	+		10.1126/science.1238406	http://dx.doi.org/10.1126/science.1238406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179228	Green Accepted			2022-12-28	WOS:000326334300035
J	Maskus, KE; Mobarak, AM; Stuen, ET				Maskus, Keith E.; Mobarak, A. Mushfiq; Stuen, Eric T.			Doctoral Students and US Immigration Policy	SCIENCE			English	Editorial Material							TEAMS		[Maskus, Keith E.] Univ Colorado, Boulder, CO 80309 USA; [Mobarak, A. Mushfiq] Yale Univ, Sch Management, New Haven, CT 06520 USA; [Stuen, Eric T.] Univ Idaho, Moscow, ID 83844 USA	University of Colorado System; University of Colorado Boulder; Yale University; Idaho; University of Idaho	Mobarak, AM (corresponding author), Yale Univ, Sch Management, New Haven, CT 06520 USA.	ahmed.mobarak@yale.edu	Stuen, Eric/AAD-8332-2020					Adams JD, 2005, RES POLICY, V34, P259, DOI 10.1016/j.respol.2005.01.014; [Anonymous], 2012, ICEF MONITOR    0507; [Anonymous], 2008, SCI ENG STAT DAT SYS; Azoulay P, 2010, Q J ECON, V125, P549, DOI 10.1162/qjec.2010.125.2.549; Borjas, 2009, SCI ENG CAREERS US A, P131; Borjas GJ, 2012, Q J ECON, V127, P1143, DOI 10.1093/qje/qjs015; Bouw B., 2013, GLOBE MAIL; Brumfiel G, 2004, NATURE, V431, P231, DOI 10.1038/431231a; Ehrenberg, 2007, SCI U, P134; Finn M., 2012, OAK RIDGE I SCI ED P; Fischer K., 2013, CHRONICLE HIGHER ED; Grimes C., 2004, FINANCIAL TIMES; Hunt J, 2010, AM ECON J-MACROECON, V2, P31, DOI 10.1257/mac.2.2.31; I. G. M, HIGH SKILL IMM; Kerr WR, 2010, J LABOR ECON, V28, P473, DOI 10.1086/651934; National Academy of Sciences, 2005, POL IMPL INT GRAD ST; Nelson L. A., 2013, INSIDE HIGHER E 0130; Ottaviano GIP, 2012, J EUR ECON ASSOC, V10, P152, DOI 10.1111/j.1542-4774.2011.01052.x; Peri G., 2013, WALL STREET J; Peri G., 2013, 2013009 U COLL LOND; Shen H, 2013, NATURE, V499, P17, DOI 10.1038/499017a; Stuen ET, 2012, ECON J, V122, P1143, DOI 10.1111/j.1468-0297.2012.02543.x; *TASK FORC FUT AM, 2005, KNOWL EC IS US LOS I; Waldinger F, 2012, REV ECON STUD, V79, P838, DOI 10.1093/restud/rdr029; Waldinger F, 2010, J POLIT ECON, V118, P787, DOI 10.1086/655976; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	26	5	5	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					562	563		10.1126/science.1239572	http://dx.doi.org/10.1126/science.1239572			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179206				2022-12-28	WOS:000326334300023
J	Sothmann, B; Flindt, C				Sothmann, Bjoern; Flindt, Christian			Quantized Electronic Heat Flow	SCIENCE			English	Editorial Material							THERMAL CONDUCTANCE; QUANTUM; NOISE		[Sothmann, Bjoern; Flindt, Christian] Univ Geneva, Dept Phys Theor, CH-1211 Geneva 4, Switzerland	University of Geneva	Sothmann, B (corresponding author), Univ Geneva, Dept Phys Theor, 24 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	bjorn.sothmann@unige.ch	Sothmann, Björn/F-4865-2010; Flindt, Christian/H-4883-2011	Sothmann, Björn/0000-0001-9696-9446; Flindt, Christian/0000-0002-7223-8400				Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; BUTTIKER M, 1988, PHYS REV B, V38, P9375, DOI 10.1103/PhysRevB.38.9375; BUTTIKER M, 1990, PHYS REV LETT, V65, P2901, DOI 10.1103/PhysRevLett.65.2901; BUTTIKER M, 1990, PHYS REV B, V41, P7906, DOI 10.1103/PhysRevB.41.7906; Jezouin S, 2013, SCIENCE, V342, P601, DOI 10.1126/science.1241912; Jordan AN, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.075312; Meschke M, 2006, NATURE, V444, P187, DOI 10.1038/nature05276; PENDRY JB, 1983, J PHYS A-MATH GEN, V16, P2161, DOI 10.1088/0305-4470/16/10/012; Prance JR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146602; Rego LGC, 1998, PHYS REV LETT, V81, P232, DOI 10.1103/PhysRevLett.81.232; Schwab K, 2000, NATURE, V404, P974, DOI 10.1038/35010065; Timofeev AV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.200801; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002; Yung CS, 2002, APPL PHYS LETT, V81, P31, DOI 10.1063/1.1491300	15	2	2	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					569	570		10.1126/science.1246105	http://dx.doi.org/10.1126/science.1246105			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179211				2022-12-28	WOS:000326334300028
J	Moody, A				Moody, Alan			The big picture	NATURE			English	Editorial Material									[Moody, Alan] Univ Toronto, Dept Med Imaging, Toronto, ON M5S 1A1, Canada	University of Toronto	Moody, A (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON M5S 1A1, Canada.	alan.moody@sunnybrook.ca	moody, alan/M-9258-2019; András, Telcs/B-7756-2008; Cornell, Sarah/F-7003-2014; Berkovits, Nathan/C-4662-2012	András, Telcs/0000-0002-3861-3553; Cornell, Sarah/0000-0003-4367-1296; 					0	7	7	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S95	S95		10.1038/502S95a	http://dx.doi.org/10.1038/502S95a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187705	Bronze			2022-12-28	WOS:000326293200008
J	Ning, MM; Gonzalez, RG				Ning, MingMing; Gonzalez, R. Gilberto			Case 34-2013: A 69-Year-Old Man with Dizziness and Vomiting Dissection of the left vertebral artery and cerebellar infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR; POOLED ANALYSIS; HEART; BRAIN; ATLANTIS; OPPORTUNITIES; THROMBOLYSIS; ASSOCIATION; ALTEPLASE	A 69-year-old man was admitted to this hospital because of dizziness and vomiting, which had begun abruptly 9 hours earlier, on awakening. Examination revealed nystagmus and a wide-based gait. CT revealed no intracranial hemorrhage. A diagnostic procedure was performed. Presentation of CaseDr. Minjee Kim (Neurology): A 69-year-old man was admitted to this hospital because of dizziness and vomiting. The patient had been well until 4:15 a.m. on the day of admission, when he became dizzy, diaphoretic, and weak and had sensations of rocking and counterclockwise movement after he rolled onto his stomach in bed. The symptoms improved when he rolled into the supine position, and he slept until 7 a.m.; on awakening, the symptoms recurred. When walking, he sensed he was tilting to the left but did not fall. The symptoms worsened throughout the morning; they were most ...	[Ning, MingMing] Massachusetts Gen Hosp, Dept Neurol, Cardioneurol Clin, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ning, MingMing] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ning, MM (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Cardioneurol Clin, Boston, MA 02114 USA.				Harvard Medical School Office of Continuing Education	Harvard Medical School Office of Continuing Education	This case was presented at the postgraduate course Primary Care Internal Medicine Principles and Practice 2011 (directed by John D. Goodson, M. D., Charles J. Hatem, M. D., Richard J. Pels, M. D., and Jennifer E. Potter, M. D., and sponsored by the Harvard Medical School Office of Continuing Education)<INF>.</INF>	Albers GW, 2002, STROKE, V33, P493, DOI 10.1161/hs0202.102599; Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 2012, NEW ENGL J MED, V366, P2306; AWADA A, 1991, J NEUROL NEUROSUR PS, V54, P277, DOI 10.1136/jnnp.54.3.277; Baloh RW, 1998, OTOLARYNG HEAD NECK, V119, P55, DOI 10.1016/S0194-5998(98)70173-1; Bluhmki E, 2009, LANCET NEUROL, V8, P1095, DOI 10.1016/S1474-4422(09)70264-9; Brandt T, 2000, CEREBROVASC DIS, V10, P170, DOI 10.1159/000016053; Buttner U, 1999, ACTA OTO-LARYNGOL, V119, P1; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; FISHER CM, 1977, J NEUROL NEUROSUR PS, V40, P1182, DOI 10.1136/jnnp.40.12.1182; FISHER CM, 1961, J NEUROPATH EXP NEUR, V20, P323, DOI 10.1097/00005072-196107000-00001; Foerch C, 2009, NEUROLOGY, V73, P393, DOI 10.1212/WNL.0b013e3181b05ef9; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Hill MD, 2001, CAN J NEUROL SCI, V28, P232, DOI 10.1017/S0317167100001384; IST-3 Collaborative Grp, 2012, LANCET, V380, P730; KASE CS, 1993, STROKE, V24, P1096, DOI 10.1161/str.24.7.1096b; Kasner SE, 2004, PREVENTION TREATMENT; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; KISTLER JP, 1995, NEW ENGL J MED, V332, P1238; Kittner SJ, 1998, NEUROLOGY, V50, P890, DOI 10.1212/WNL.50.4.890; KORPELAINEN JT, 1993, NEUROLOGY, V43, P1211, DOI 10.1212/WNL.43.6.1211; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lopez MF, 2012, J INVEST MED, V60, P1122, DOI 10.2310/JIM.0b013e318276de0e; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Ng YS, 2007, STROKE, V38, P2309, DOI 10.1161/STROKEAHA.106.475483; Ning MM, 2013, PHARMACOL THERAPEUT, V139, P111, DOI 10.1016/j.pharmthera.2013.03.007; Ning MM, 2012, ELECTROPHORESIS, V33, P3582, DOI 10.1002/elps.201200481; Ning MingMing, 2004, Top Stroke Rehabil, V11, P40; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Qureshi AI, 2011, ARCH NEUROL-CHICAGO, V68, P1536, DOI 10.1001/archneurol.2011.213; Roger, 2011, CIRCULATION, V124, pE426, DOI 10.1161/CIR.0b013e3182365a06; Roger, 2011, CIRCULATION, V123, pE240, DOI 10.1161/CIR.0b013e3182117650; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; SASAKI O, 1991, J NEUROSURG, V75, P874, DOI 10.3171/jns.1991.75.6.0874; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Schwamm L, 2010, STROKE, V41, P1051, DOI 10.1161/STR.0b013e3181d2da7d; Silva GS, 2012, STROKE, V43, P2078, DOI 10.1161/STROKEAHA.111.645861; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Tanne D, 1999, NEUROLOGY, V53, P424, DOI 10.1212/WNL.53.2.424; Wallenberg A., 1922, DTSCH Z NERVENHEILKD, V73, P189; YONAS H, 1977, SURG NEUROL, V8, P407; Zinkstok SM, 2011, STROKE, V42, P2515, DOI 10.1161/STROKEAHA.111.617282	49	9	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1736	1748		10.1056/NEJMcpc1302431	http://dx.doi.org/10.1056/NEJMcpc1302431			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24171520				2022-12-28	WOS:000326311300012
J	Savage, N				Savage, Neil			TECHNOLOGY Multiple exposure	NATURE			English	Editorial Material																		Yang JM, 2012, NAT MED, V18, P1297, DOI 10.1038/nm.2823; Ziegler DA, 2013, JAMA NEUROL, V70, P241, DOI 10.1001/jamaneurol.2013.597	2	3	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S90	S91		10.1038/502S90a	http://dx.doi.org/10.1038/502S90a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187703	Bronze			2022-12-28	WOS:000326293200006
J	Alesina, A				Alesina, Alberto			Women, Fertility, and the Rise of Modern Capitalism	SCIENCE			English	Editorial Material									Harvard Univ, Dept Econ, Cambridge, MA 02138 USA	Harvard University	Alesina, A (corresponding author), Harvard Univ, Dept Econ, Cambridge, MA 02138 USA.	aalesina@harvard.edu						Alesina A, 2013, Q J ECON, V128, P469, DOI 10.1093/qje/qjt005; Alesina A, 2011, AM ECON REV, V101, P499, DOI 10.1257/aer.101.3.499; Becker SO, 2009, Q J ECON, V124, P531, DOI 10.1162/qjec.2009.124.2.531; Voigtlander N, 2013, AM ECON REV, V103, P79, DOI 10.1257/aer.103.3.79	4	3	3	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					427	428		10.1126/science.1246228	http://dx.doi.org/10.1126/science.1246228			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239RH	24159032				2022-12-28	WOS:000326042600025
J	Bhandari, S				Bhandari, Sunil			PERSONAL VIEW South Asian hospitals that lack DNAR orders deny patients holistic care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bhandari, Sunil] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull HU3 2JZ, Yorks, England; [Bhandari, Sunil] Hull Royal Infirm, Dept Renal Med, Hull York Med Sch, Kingston Upon Hull HU3 2JZ, Yorks, England	University of Hull; University of York - UK	Bhandari, S (corresponding author), Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull HU3 2JZ, Yorks, England.	sunil.bhandari@hey.nhs.uk		bhandari, sunil/0000-0002-0996-9622					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2013	347								f6300	10.1136/bmj.f6300	http://dx.doi.org/10.1136/bmj.f6300			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CM	24163086				2022-12-28	WOS:000326294200006
J	Huber, D; Carter, JA; Barbieri, M; Miglio, A; Deck, KM; Fabrycky, DC; Montet, BT; Buchhave, LA; Chaplin, WJ; Hekker, S; Montalban, J; Sanchis-Ojeda, R; Basu, S; Bedding, TR; Campante, TL; Christensen-Dalsgaard, J; Elsworth, YP; Stello, D; Arentoft, T; Ford, EB; Gilliland, RL; Handberg, R; Howard, AW; Isaacson, H; Johnson, JA; Karoff, C; Kawaler, SD; Kjeldsen, H; Latham, DW; Lund, MN; Lundkvist, M; Marcy, GW; Metcalfe, TS; Aguirre, VS; Winn, JN				Huber, Daniel; Carter, Joshua A.; Barbieri, Mauro; Miglio, Andrea; Deck, Katherine M.; Fabrycky, Daniel C.; Montet, Benjamin T.; Buchhave, Lars A.; Chaplin, William J.; Hekker, Saskia; Montalban, Josefina; Sanchis-Ojeda, Roberto; Basu, Sarbani; Bedding, Timothy R.; Campante, Tiago L.; Christensen-Dalsgaard, Jorgen; Elsworth, Yvonne P.; Stello, Dennis; Arentoft, Torben; Ford, Eric B.; Gilliland, Ronald L.; Handberg, Rasmus; Howard, Andrew W.; Isaacson, Howard; Johnson, John Asher; Karoff, Christoffer; Kawaler, Steven D.; Kjeldsen, Hans; Latham, David W.; Lund, Mikkel N.; Lundkvist, Mia; Marcy, Geoffrey W.; Metcalfe, Travis S.; Aguirre, Victor Silva; Winn, Joshua N.			Stellar Spin-Orbit Misalignment in a Multiplanet System	SCIENCE			English	Article							ROTATION AXIS; ALIGNMENT; KEPLER; STARS; OBLIQUITIES; PLANETS; TRANSIT; MODES	Stars hosting hot Jupiters are often observed to have high obliquities, whereas stars with multiple coplanar planets have been seen to have low obliquities. This has been interpreted as evidence that hot-Jupiter formation is linked to dynamical disruption, as opposed to planet migration through a protoplanetary disk. We used asteroseismology to measure a large obliquity for Kepler-56, a red giant star hosting two transiting coplanar planets. These observations show that spin-orbit misalignments are not confined to hot-Jupiter systems. Misalignments in a broader class of systems had been predicted as a consequence of torques from wide-orbiting companions, and indeed radial velocity measurements revealed a third companion in a wide orbit in the Kepler-56 system.	[Huber, Daniel] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Carter, Joshua A.; Latham, David W.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Barbieri, Mauro] Univ Padua, CISAS, I-35131 Padua, Italy; [Miglio, Andrea; Chaplin, William J.; Campante, Tiago L.; Elsworth, Yvonne P.; Handberg, Rasmus] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Miglio, Andrea; Chaplin, William J.; Bedding, Timothy R.; Campante, Tiago L.; Christensen-Dalsgaard, Jorgen; Elsworth, Yvonne P.; Stello, Dennis; Arentoft, Torben; Handberg, Rasmus; Karoff, Christoffer; Kjeldsen, Hans; Lund, Mikkel N.; Lundkvist, Mia; Metcalfe, Travis S.; Aguirre, Victor Silva] Aarhus Univ, Dept Phys & Astron, Stellar Astrophys Ctr, DK-8000 Aarhus C, Denmark; [Deck, Katherine M.; Sanchis-Ojeda, Roberto; Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Fabrycky, Daniel C.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Montet, Benjamin T.; Johnson, John Asher] CALTECH, Dept Astrophys, Pasadena, CA 91125 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Buchhave, Lars A.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Hekker, Saskia] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Hekker, Saskia] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Montalban, Josefina] Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium; [Basu, Sarbani] Yale Univ, Dept Astron, New Haven, CT 06520 USA; [Bedding, Timothy R.; Stello, Dennis] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Ford, Eric B.; Gilliland, Ronald L.] Penn State Univ, Ctr Exoplanets & Habitable Worlds, University Pk, PA 16802 USA; [Ford, Eric B.] Univ Florida, Dept Astron, Gainesville, FL 32111 USA; [Howard, Andrew W.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Isaacson, Howard; Marcy, Geoffrey W.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Kawaler, Steven D.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Metcalfe, Travis S.] Space Sci Inst, Boulder, CO 80301 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Padua; University of Birmingham; Aarhus University; Massachusetts Institute of Technology (MIT); University of Chicago; California Institute of Technology; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; University of Amsterdam; Max Planck Society; University of Liege; Yale University; University of Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University System of Florida; University of Florida; University of Hawaii System; University of California System; University of California Berkeley; Iowa State University	Huber, D (corresponding author), NASA, Ames Res Ctr, MS 244-30, Moffett Field, CA 94035 USA.	daniel.huber@nasa.gov	Ford, Eric B./AAB-5479-2019; Miglio, Andrea/M-5789-2018; Marcy, Geoff/AAC-6050-2019; Karoff, Christoffer/L-1007-2013; Huber, Daniel/AAE-9440-2019; Barbieri, Mauro/W-4602-2017; Lund, Mikkel Nørup/AAJ-2112-2021; Stello, Dennis/Q-9754-2019; Buchhave, Lars A./ABF-2000-2020; Basu, Sarbani/B-8015-2014; miglio, andrea/O-9594-2019; Bedding, Timothy/AAU-9400-2021; Chaplin, William/M-9160-2018; Metcalfe, Travis/A-9388-2008	Ford, Eric B./0000-0001-6545-639X; Miglio, Andrea/0000-0001-5998-8533; Karoff, Christoffer/0000-0003-2009-7965; Huber, Daniel/0000-0001-8832-4488; Barbieri, Mauro/0000-0001-8362-3462; Lund, Mikkel Nørup/0000-0001-9214-5642; Stello, Dennis/0000-0002-4879-3519; Buchhave, Lars A./0000-0003-1605-5666; Basu, Sarbani/0000-0002-6163-3472; miglio, andrea/0000-0001-5998-8533; Bedding, Timothy/0000-0001-5222-4661; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; Fabrycky, Daniel/0000-0003-3750-0183; Handberg, Rasmus/0000-0001-8725-4502; Bedding, Timothy/0000-0001-5943-1460; Hekker, Saskia/0000-0002-1463-726X; Montet, Benjamin/0000-0001-7516-8308; Lundkvist, Mia Sloth/0000-0002-8661-2571; Campante, Tiago/0000-0002-4588-5389; Chaplin, William/0000-0002-5714-8618; Kawaler, Steven/0000-0002-6536-6367; Metcalfe, Travis/0000-0003-4034-0416; Aguirre Borsen-Koch, Victor/0000-0002-6137-903X	NASA's Science Mission Directorate; NASA; NSF [DGE1144469, AST-1105930]; Netherlands Organisation for Scientific Research; BELSPO for contract PRODEX COROT; NASA Kepler Participating Scientist program; David and Lucile Packard foundation; Alfred P. Sloan foundation; Danish National Research Foundation [DNRF106]; ASTERISK; European Research Council [267864]; Science and Technology Facilities Council [ST/J001163/1] Funding Source: researchfish; STFC [ST/J001163/1] Funding Source: UKRI	NASA's Science Mission Directorate; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BELSPO for contract PRODEX COROT; NASA Kepler Participating Scientist program; David and Lucile Packard foundation(The David & Lucile Packard Foundation); Alfred P. Sloan foundation(Alfred P. Sloan Foundation); Danish National Research Foundation(Danmarks Grundforskningsfond); ASTERISK; European Research Council(European Research Council (ERC)European Commission); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We gratefully acknowledge the entire Kepler team for making this paper possible. Funding for the Kepler Mission is provided by NASA's Science Mission Directorate. We thank E. Agol and D. Raggozine for helpful comments on the manuscript. Supported by an appointment to the NASA Postdoctoral Program at Ames Research Center, administered by Oak Ridge Associated Universities through a contract with NASA (D. H.); a NSF Graduate Research Fellowship (K. M. D.); a NSF Graduate Research Fellowship under grant DGE1144469 (B. T. M.); the Netherlands Organisation for Scientific Research (S. H.); BELSPO for contract PRODEX COROT (J.M.); the NASA Kepler Participating Scientist program (R.S.-O., J.N.W., and E. B. F.); NSF grant AST-1105930 (S. B.); and the David and Lucile Packard and Alfred P. Sloan foundations (J.A.J.). J.A.C. is a Hubble Fellow of the Harvard-Smithsonian Center for Astrophysics. Funding for the Stellar Astrophysics Centre is provided by Danish National Research Foundation grant DNRF106. The research is supported by the ASTERISK (Asteroseismic Investigations with SONG and Kepler) project funded by the European Research Council (grant agreement 267864).	Albrecht S, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/18; Batalha NM, 2010, ASTROPHYS J LETT, V713, pL109, DOI 10.1088/2041-8205/713/2/L109; Bate MR, 2010, MON NOT R ASTRON SOC, V401, P1505, DOI 10.1111/j.1365-2966.2009.15773.x; Batygin K, 2012, NATURE, V491, P418, DOI 10.1038/nature11560; Beck PG, 2011, SCIENCE, V332, P205, DOI 10.1126/science.1201939; Beck PG, 2012, NATURE, V481, P55, DOI 10.1038/nature10612; Bedding TR, 2011, NATURE, V471, P608, DOI 10.1038/nature09935; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Chaplin WJ, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/101; De Ridder J, 2009, NATURE, V459, P398, DOI 10.1038/nature08022; Dziembowski WA, 2001, MON NOT R ASTRON SOC, V328, P601, DOI 10.1046/j.1365-8711.2001.04894.x; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Gizon L, 2003, ASTROPHYS J, V589, P1009, DOI 10.1086/374715; Hirano T, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/2/L36; Johnson JA, 2009, PUBL ASTRON SOC PAC, V121, P1104, DOI 10.1086/644604; Le Bouquin JB, 2009, ASTRON ASTROPHYS, V498, pL41, DOI 10.1051/0004-6361/200911854; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Montalban J, 2010, ASTROPHYS J LETT, V721, pL182, DOI 10.1088/2041-8205/721/2/L182; Nagasawa M, 2008, ASTROPHYS J, V678, P498, DOI 10.1086/529369; Queloz D, 2000, ASTRON ASTROPHYS, V359, pL13; Rogers TM, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/1/L6; Sanchis-Ojeda R, 2012, NATURE, V487, P449, DOI 10.1038/nature11301; Steffen JH, 2013, MON NOT R ASTRON SOC, V428, P1077, DOI 10.1093/mnras/sts090; Triaud AHMJ, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201014525; Watson CA, 2011, MON NOT R ASTRON SOC, V413, pL71, DOI 10.1111/j.1745-3933.2011.01036.x; Winn JN, 2005, ASTROPHYS J, V631, P1215, DOI 10.1086/432571; Winn JN, 2010, ASTROPHYS J LETT, V718, pL145, DOI 10.1088/2041-8205/718/2/L145	30	207	208	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					331	334		10.1126/science.1242066	http://dx.doi.org/10.1126/science.1242066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136961	Green Submitted, Green Accepted			2022-12-28	WOS:000325755100036
J	Liu, XC; Zhang, HW; Lu, K				Liu, X. C.; Zhang, H. W.; Lu, K.			Strain-Induced Ultrahard and Ultrastable Nanolaminated Structure in Nickel	SCIENCE			English	Article							DYNAMIC PLASTIC-DEFORMATION; MICROSTRUCTURAL PARAMETERS; COPPER; EVOLUTION; RECRYSTALLIZATION; TEMPERATURE; REFINEMENT; CRYSTALS; STRESSES; TEXTURE	Heavy plastic deformation may refine grains of metals and make them very strong. But the strain-induced refinement saturates at large strains, forming three-dimensional ultrafine-grained (3D UFG) structures with random orientations. Further refinement of this microstructure is limited because of the enhanced mobility of grain boundaries. Very-high-rate shear deformation with high strain gradients was applied in the top surface layer of bulk nickel, where a 2D nanometer-scale laminated structure was induced. The strongly textured nanolaminated structure (average lamellar thickness of 20 nanometers) with low-angle boundaries among the lamellae is ultrahard and ultrastable: It exhibits a hardness of 6.4 gigapascal-which is higher than any reported hardness of the UFG nickel-and a coarsening temperature of 40 kelvin above that in UFG nickel.	[Liu, X. C.; Zhang, H. W.; Lu, K.] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; [Lu, K.] Nanjing Univ Sci & Technol, Herbert Gleiter Inst Nanosci, Nanjing 210094, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Metal Research, CAS; Nanjing University of Science & Technology	Lu, K (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.	lu@imr.ac.cn	刘, 小春/L-6922-2013; Lu, K/I-4810-2014	刘, 小春/0000-0002-1599-9959; 	Ministry of Science and Technology of China [2012CB932201]; National Natural Science Foundation [51231006, 51171182]; Danish-Chinese Center for Nanometals [51261130091, DNRF86-5]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Danish-Chinese Center for Nanometals	We thank X. Si for assistance in sample preparation and X. X. Huang for critical comments. We are grateful for fiancial support of the Ministry of Science and Technology of China (grant 2012CB932201), the National Natural Science Foundation (grants 51231006 and 51171182), and the Danish-Chinese Center for Nanometals (grants 51261130091 and DNRF86-5).	[Anonymous], 1934, P R SOC LOND A, DOI [10.1098/rspa.1934.0107, DOI 10.1098/RSPA.1934.0107, DOI 10.1098/RSPA.1934.0106]; ASHBY MF, 1970, PHILOS MAG, V21, P399, DOI 10.1080/14786437008238426; Chen B, 2012, SCIENCE, V338, P1448, DOI 10.1126/science.1228211; Dalla Torre F, 2002, ACTA MATER, V50, P3957, DOI 10.1016/S1359-6454(02)00198-2; Dalla Torre F, 2005, ACTA MATER, V53, P2337, DOI 10.1016/j.actamat.2005.01.041; Doherty RD, 1997, MAT SCI ENG A-STRUCT, V238, P219, DOI 10.1016/S0921-5093(97)00424-3; Fang TH, 2011, SCIENCE, V331, P1587, DOI 10.1126/science.1200177; Farbaniec L, 2012, ADV ENG MATER, V14, P1027, DOI 10.1002/adem.201200034; GERTSMAN VY, 1994, SCRIPTA METALL MATER, V30, P577, DOI 10.1016/0956-716X(94)90432-4; Gil J. Sevillano, 2004, EVOLUTION OF DEFORMA, P1; Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Huang Y, 2000, ACTA MATER, V48, P2017, DOI 10.1016/S1359-6454(99)00418-8; Hughes DA, 2000, ACTA MATER, V48, P2985, DOI 10.1016/S1359-6454(00)00082-3; Humphreys F. J., 2004, RECRYSTALLIZATION AN; Kamikawa N, 2009, ACTA MATER, V57, P4198, DOI 10.1016/j.actamat.2009.05.017; Li WL, 2008, SCRIPTA MATER, V59, P546, DOI 10.1016/j.scriptamat.2008.05.003; Li YS, 2008, ACTA MATER, V56, P230, DOI 10.1016/j.actamat.2007.09.020; Luo ZP, 2012, ACTA MATER, V60, P1322, DOI 10.1016/j.actamat.2011.11.035; MONTHEILLET F, 1984, ACTA METALL MATER, V32, P2077, DOI 10.1016/0001-6160(84)90187-1; Niewczas M, 2004, ACTA MATER, V52, P539, DOI 10.1016/j.actamat.2003.09.048; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Pippan R, 2010, ANNU REV MATER RES, V40, P319, DOI 10.1146/annurev-matsci-070909-104445; Pippan R, 2006, ADV ENG MATER, V8, P1046, DOI 10.1002/adem.200600133; Rupert TJ, 2009, SCIENCE, V326, P1686, DOI 10.1126/science.1178226; Schafler E, 1999, PHYS STATUS SOLIDI A, V175, P501, DOI 10.1002/(SICI)1521-396X(199910)175:2<501::AID-PSSA501>3.0.CO;2-A; Wei Q, 2002, APPL PHYS LETT, V81, P1240, DOI 10.1063/1.1501158; Yan F, 2011, J MATER SCI TECHNOL, V27, P673; Zhang HW, 2008, ACTA MATER, V56, P5451, DOI 10.1016/j.actamat.2008.07.040; Zhilyaev AP, 2003, ACTA MATER, V51, P753, DOI 10.1016/S1359-6454(02)00466-4	30	389	417	56	969	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					337	340		10.1126/science.1242578	http://dx.doi.org/10.1126/science.1242578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136963				2022-12-28	WOS:000325755100038
J	Bauer, DC				Bauer, Douglas C.			Calcium Supplements and Fracture Prevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VITAMIN-D SUPPLEMENTATION; CALCIUM/VITAMIN-D SUPPLEMENTATION; CORONARY-ARTERY CALCIFICATION; ISCHEMIC-HEART-DISEASE; DIETARY CALCIUM; MYOCARDIAL-INFARCTION; CARDIOVASCULAR MORTALITY; RISK; OSTEOPOROSIS; METAANALYSIS	A 62-year-old healthy woman presents for routine care. She has no history of fracture, but she is worried about osteoporosis because her mother had a hip fracture at 72 years of age. She exercises regularly and has taken over-the-counter calcium carbonate at a dose of 1000 mg three times a day since her menopause at 54 years of age. This regimen provides 1200 mg of elemental calcium per day. She eats a healthy diet with multiple servings of fruits and vegetables and consumes one 8-oz serving of low-fat yogurt and one glass of low-fat milk almost every day. She recently heard that calcium supplements could increase her risk of cardiovascular disease and wants your opinion about whether or not she should receive them. What would you advise?	[Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94105 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bauer, DC (corresponding author), Univ Calif San Francisco, 185 Berry St,Suite 5700, San Francisco, CA 94105 USA.	dbauer@psg.ucsf.edu			Amgen; Novartis; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR051895] Funding Source: NIH RePORTER	Amgen(Amgen); Novartis(Novartis); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Bauer reports receiving grant support through his institution from Amgen and Novartis. No other potential conflict of interest relevant to this article was reported.	Abrahamsen B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2080; Al-Delaimy WK, 2003, AM J CLIN NUTR, V77, P814, DOI 10.1093/ajcn/77.4.814; [Anonymous], 2013, USDA NAT NUTR DAT ST; [Anonymous], 2012, VIT D CALC IN PRESS; Bailey RL, 2010, J NUTR, V140, P817, DOI 10.3945/jn.109.118539; Bockman RS, 2012, J CLIN DENSITOM, V15, P130, DOI 10.1016/j.jocd.2011.10.002; Bolland MJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3520; Bolland MJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2040; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; Cauley J, J WOMENS HL IN PRESS; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; DawsonHughes B, 1996, OSTEOPOROSIS INT, V6, P37, DOI 10.1007/BF01623763; Gahche Jamie, 2011, NCHS Data Brief, P1; Gallagher JC, 2012, J CLIN ENDOCR METAB, V97, P3550, DOI 10.1210/jc.2012-2020; Hennekens CH, 2011, AM J MED, V124, P1097, DOI 10.1016/j.amjmed.2011.05.001; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Hunt CD, 2007, AM J CLIN NUTR, V86, P1054, DOI 10.1093/ajcn/86.4.1054; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kaluza J, 2010, AM J EPIDEMIOL, V171, P801, DOI 10.1093/aje/kwp467; LaCroix AZ, 2009, J GERONTOL A-BIOL, V64, P559, DOI 10.1093/gerona/glp006; Langsetmo L, 2013, J CLIN ENDOCR METAB, V98, P3010, DOI 10.1210/jc.2013-1516; Lappe JM, 2012, DERM-ENDOCRINOL, V4, P95, DOI 10.4161/derm.19833; Lewis JR, 2011, J BONE MINER RES, V26, P35, DOI 10.1002/jbmr.176; Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345; Manson JE, 2010, MENOPAUSE, V17, P683, DOI 10.1097/gme.0b013e3181d683b5; Michaelsson K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f228; Moyer Virginia A, 2013, Ann Intern Med, V158, P691, DOI 10.7326/0003-4819-158-9-201305070-00603; Nordin BEC, 2011, OSTEOPOROSIS INT, V22, P3073, DOI 10.1007/s00198-011-1680-4; PRINCE R, 1995, J BONE MINER RES, V10, P1068, DOI 10.1002/jbmr.5650100711; Rafferty K, 2007, J FOOD SCI, V72, pR152, DOI 10.1111/j.1750-3841.2007.00521.x; Reid IR, 2008, OSTEOPOROSIS INT, V19, P1119, DOI 10.1007/s00198-008-0563-9; Reid IR, 2012, AM J MED, V125, pE15, DOI 10.1016/j.amjmed.2011.09.006; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Samelson EJ, 2012, AM J CLIN NUTR, V96, P1274, DOI 10.3945/ajcn.112.044230; Shea B, 2002, ENDOCR REV, V23, P552, DOI 10.1210/er.2001-7002; Straub DA, 2007, NUTR CLIN PRACT, V22, P286, DOI 10.1177/0115426507022003286; Tang BMP, 2012, LANCET, V380, P806; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Taylor EN, 2013, J UROL; Wallace RB, 2011, AM J CLIN NUTR, V94, P270, DOI 10.3945/ajcn.110.003350; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Warensjo E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1473; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283	46	69	74	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1537	1543		10.1056/NEJMcp1210380	http://dx.doi.org/10.1056/NEJMcp1210380			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24131178	Green Accepted			2022-12-28	WOS:000328101700011
J	Gungor, T; Teira, P; Slatter, M; Stussi, G; Stepensky, P; Moshous, D; Vermont, C; Ahmad, I; Shaw, PJ; da Cunha, JMT; Schlegel, PG; Hough, R; Fasth, A; Kentouche, K; Gruhn, B; Fernandes, JF; Lachance, S; Bredius, R; Resnick, IB; Belohradsky, BH; Gennery, A; Fischer, A; Gaspar, HB; Schanz, U; Seger, R; Rentsch, K; Veys, P; Haddad, E; Albert, MH; Hassan, M				Guengoer, Tayfun; Teira, Pierre; Slatter, Mary; Stuessi, Georg; Stepensky, Polina; Moshous, Despina; Vermont, Clementien; Ahmad, Imran; Shaw, Peter J.; Telles da Cunha, Jose Marcos; Schlegel, Paul G.; Hough, Rachel; Fasth, Anders; Kentouche, Karim; Gruhn, Bernd; Fernandes, Juliana F.; Lachance, Silvy; Bredius, Robbert; Resnick, Igor B.; Belohradsky, Bernd H.; Gennery, Andrew; Fischer, Alain; Gaspar, H. Bobby; Schanz, Urs; Seger, Reinhard; Rentsch, Katharina; Veys, Paul; Haddad, Elie; Albert, Michael H.; Hassan, Moustapha		Inborn Errors Working Party Europe	Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study	LANCET			English	Article							BONE-MARROW-TRANSPLANTATION; UNRELATED DONOR; NONMALIGNANT DISEASES; INTRAVENOUS BUSULFAN; EUROPEAN EXPERIENCE; EXCELLENT SURVIVAL; NADPH OXIDASE; IN-VITRO; CHILDREN; RECONSTITUTION	Background In chronic granulomatous disease allogeneic haemopoietic stem-cell transplantation (HSCT) in adolescents and young adults and patients with high-risk disease is complicated by graft-failure, graft-versus-host disease (GVHD), and transplant-related mortality. We examined the effect of a reduced-intensity conditioning regimen designed to enhance myeloid engraftment and reduce organ toxicity in these patients. Methods This prospective study was done at 16 centres in ten countries worldwide. Patients aged 0-40 years with chronic granulornatous disease were assessed and enrolled at the discretion of individual centres. Reduced-intensity conditioning consisted of high-dose fludarabine (30 mg/m2 [infants <9 kg 1-2 mg/kg]; one dose per day on days 8 to 3), serotherapy (anti-thymocyte globulin [10 mg/kg, one dose per day on days 4 to 1; or thymoglobuline 2-5 mg/kg, one dose per day on days 5 to 3]; or low-dose alerntuzurnab [<1 mg/kg on days 8 to 6]), and low-dose (50-72% of myeloablative dose) or targeted busulfan administration (recommended cumulative area under the curve: 45-65 mg/L xh). Busulfan was administered mainly intravenously and exceptionally orally from days 5 to 3. Intravenous busulfan was dosed according to weight-based recommendations and was administered in most centres (ten) twice daily over 4 h. Unmanipulated bone marrow or peripheral blood stem cells from HLA-matched relateddonors or HLA-9/10 or HLA-10/10 matched unrelated-donors were infused. The primary endpoints were overall survival and event-free survival (EFS), probabilities of overall survival and EFS at 2 years, incidence of acute and chronic GVHD, achievement of at least 90% myeloid donor chimerisrn, and incidence of graft failure after at least 6 months of follow-up. Findings 56 patients (median age 12-7 years; IQR 6-8-17-3) with chronic granulornatous disease were enrolled from June 15,2003, to Dec 15,2012.42 patients (75%) had high-risk features (ie, intractable infections and autoinflammation), 25(45%) were adolescents and young adults (age 14-39 years). 21 HLA-matched related-donor and 35 HLA-rnatched unrelated-donor transplants were done. Median time to engraftrnent was 19 days (IQR 16-22) for neutrophils and 21 days (IQR 16-25) for platelets. At median follow-up of 21 months (IQR 13-35) overall survival was 93% (52 of 56) and EFS was 89% (50 of 56). The 2-year probability of overall survival was 96% (95% CI 86-46-99.09) and of EFS was 91% (79-78-96-17). Graft-failure occurred in 5% (three of 56) of patients. The cumulative incidence of acute GVHD of grade III IV was 4% (two of 56) and of chronic graft-versus-host disease was 7% (four of 56). Stable (90%) myeloid donor chimerism was documented in 52 (93%) surviving patients. Interpretation This reduced-intensity conditioning regimen is safe and efficacious in high-risk patients with chronic granulomatous disease.	[Guengoer, Tayfun; Seger, Reinhard] Univ Childrens Hosp, Div Blood & Marrow Transplantat, CH-8032 Zurich, Switzerland; [Teira, Pierre; Haddad, Elie] Univ Montreal, Dept Pediat, Ctr Rech CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Slatter, Mary; Gennery, Andrew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Stuessi, Georg; Schanz, Urs] Univ Zurich Hosp, Div Hematol & Blood & Marrow Transplantat, CH-8091 Zurich, Switzerland; [Stepensky, Polina; Resnick, Igor B.] Hadassah Hebrew Univ, Med Ctr, Dept Blood & Marrow Transplantat, Jerusalem, Israel; [Moshous, Despina; Fischer, Alain] Univ Paris 05, AP HP, Hop Necker Enfants Malades, Sorbonne Paris Cite,Imagine Inst, Paris, France; [Vermont, Clementien; Bredius, Robbert] Leiden Univ, Med Ctr, Dept Paediat, Leiden, Netherlands; [Ahmad, Imran; Lachance, Silvy] Univ Montreal, Blood & Marrow Transplantat Program, Hop Maisonneuve Rosemont, Montreal, PQ, Canada; [Shaw, Peter J.] Childrens Hosp, Div Blood & Marrow Transplantat, Sydney, NSW, Australia; [Telles da Cunha, Jose Marcos] Hosp Albert Einstein, Haematol & Hematopoiet Stem Cell Transplantat Uni, Sao Paulo, Brazil; [Schlegel, Paul G.] Univ Childrens Hosp, Div Blood & Marrow Transplantat, Wurzburg, Germany; [Hough, Rachel] Univ Coll London Hosp NHS Fdn Trust, London, England; [Fasth, Anders] Univ Gothenburg, Dept Pediat, Gothenburg, Sweden; [Kentouche, Karim; Gruhn, Bernd] Jena Univ Hosp, Dept Paediat, Jena, Germany; [Fernandes, Juliana F.] Univ Sao Paulo, Inst Crianca, Sao Paulo, Brazil; [Belohradsky, Bernd H.; Albert, Michael H.] Dr von Hauner Univ, Childrens Hosp, Munich, Germany; [Gaspar, H. Bobby; Veys, Paul] Great Ormond St Childrens Hosp, Div Blood & Marrow Transplantat, London, England; [Gaspar, H. Bobby; Veys, Paul] UCL Inst Child Hlth, Mol Immunol Unit, London, England; [Rentsch, Katharina] Karolinska Univ Hosp Huddinge Stockholm, Univ Hosp, Div Clin Chem, Stockholm, Sweden; [Hassan, Moustapha] Karolinska Univ Hosp Huddinge Stockholm, Div Expt Canc Med, Stockholm, Sweden; [Hassan, Moustapha] Karolinska Univ Hosp Huddinge Stockholm, Novum, KFC, Lab Med, Stockholm, Sweden; [Hassan, Moustapha] Karolinska Inst, Stockholm, Sweden	University Children's Hospital Zurich; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Newcastle University - UK; University of Zurich; University Zurich Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite de Montreal; University of Sydney; Hospital Israelita Albert Einstein; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Gothenburg; Friedrich Schiller University of Jena; Universidade de Sao Paulo; University of Munich; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Gungor, T (corresponding author), Univ Childrens Hosp, Div Blood & Marrow Transplantat, CH-8032 Zurich, Switzerland.	tayfun.guengoer@kispi.uzh.ch	Cunha, Jose Marcos/J-7030-2014; shaw, peter John/D-8255-2011; Bredius, Robbert/AAF-2592-2019; Vermont, Clementien/GVT-8580-2022; Ahmad, Imran/GRJ-0536-2022; Güngör, Tayfun/ABF-4256-2020; Hassan, Moustapha/H-9260-2015; Haddad, Elie/AAQ-4971-2020; Fasth, Anders/I-1109-2019; Moshous, Despina/B-7507-2017; Ahmad, Imran/AAT-7007-2021	Cunha, Jose Marcos/0000-0003-3264-0929; shaw, peter John/0000-0003-0101-4482; Güngör, Tayfun/0000-0002-3261-1186; Hassan, Moustapha/0000-0003-1927-5859; Moshous, Despina/0000-0001-6719-3693; Ahmad, Imran/0000-0003-1899-0164; Bredius, Robbert/0000-0001-8151-1539; Gungor, Tayfun/0000-0002-7869-9662; Fasth, Anders/0000-0002-0033-740X; Haddad, Elie/0000-0003-2446-6879	Great Ormond Street Hospital Childrens Charity [V1242] Funding Source: researchfish	Great Ormond Street Hospital Childrens Charity		Bartelink IH, 2008, BIOL BLOOD MARROW TR, V14, P88, DOI 10.1016/j.bbmt.2007.09.015; Bresters D, 2010, BONE MARROW TRANSPL, V45, P79, DOI 10.1038/bmt.2009.92; Chakraverty R, 2010, BLOOD, V116, P3080, DOI 10.1182/blood-2010-05-286856; Deffert C, 2012, J PATHOL, V228, P341, DOI 10.1002/path.4061; Freudenberg F, 2010, J ALLERGY CLIN IMMUN, V125, P943, DOI 10.1016/j.jaci.2010.01.035; Gungor T, 2012, BONE MARROW TRANSPL, V47, pS67; Gungor T, 2005, TRANSPLANTATION, V79, P1596, DOI 10.1097/01.TP.0000163466.73485.5E; HASSAN M, 1994, BLOOD, V84, P2144; Hassan Z, 2002, BONE MARROW TRANSPL, V30, P141, DOI 10.1038/sj.bmt.1703615; Hassan Z, 2001, LEUKEMIA, V15, P1240, DOI 10.1038/sj.leu.2402193; Honig M, 2010, BONE MARROW TRANSPL, V45, P209, DOI 10.1038/bmt.2009.115; Horwitz ME, 2001, NEW ENGL J MED, V344, P881, DOI 10.1056/NEJM200103223441203; Jacobsohn DA, 2004, LANCET, V364, P156, DOI 10.1016/S0140-6736(04)16628-2; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Malar R, 2011, PEDIATR TRANSPLANT, V15, P580, DOI 10.1111/j.1399-3046.2011.01529.x; Martinez CA, 2012, J ALLERGY CLIN IMMUN, V129, P176, DOI 10.1016/j.jaci.2011.10.005; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Olavarria E, 2000, LEUKEMIA, V14, P1954, DOI 10.1038/sj.leu.2401921; Rao K, 2005, BLOOD, V105, P879, DOI 10.1182/blood-2004-03-0960; Reichenbach J, 2009, CLIN INFECT DIS, V49, P1703, DOI 10.1086/647945; Schuetz C, 2009, IMMUNOL RES, V44, P35, DOI 10.1007/s12026-008-8068-3; Segal BH, 2011, BIOL BLOOD MARROW TR, V17, pS123, DOI 10.1016/j.bbmt.2010.09.008; Seger RA, 2002, BLOOD, V100, P4344, DOI 10.1182/blood-2002-02-0583; Seger RA, 2011, CURR OPIN HEMATOL, V18, P36, DOI 10.1097/MOH.0b013e32834115e7; Slavin S, 1998, BLOOD, V91, P756, DOI 10.1182/blood.V91.3.756.756_756_763; Soncini E, 2009, BRIT J HAEMATOL, V145, P73, DOI 10.1111/j.1365-2141.2009.07614.x; Tewari P, 2012, BIOL BLOOD MARROW TR, V18, P1368, DOI 10.1016/j.bbmt.2012.02.002; The Westminster Hospitals Bone-Marrow Transplant Team, 1977, LANCET, V309, P210; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Vassal G, 2008, CANCER CHEMOTH PHARM, V61, P113, DOI 10.1007/s00280-007-0455-2; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; World Health Organisation, 1979, HDB REP RES CANC TRE	32	229	235	2	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					436	448		10.1016/s0140-6736(13)62069-3	http://dx.doi.org/10.1016/s0140-6736(13)62069-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303KS	24161820				2022-12-28	WOS:000330673700033
J	Tyrer, P; Cooper, S; Salkovskis, P; Tyrer, H; Crawford, M; Byford, S; Dupont, S; Finnis, S; Green, J; McLaren, E; Murphy, D; Reid, S; Smith, G; Wang, DL; Warwick, H; Petkova, H; Barrett, B				Tyrer, Peter; Cooper, Sylvia; Salkovskis, Paul; Tyrer, Helen; Crawford, Michael; Byford, Sarah; Dupont, Simon; Finnis, Sarah; Green, John; McLaren, Elenor; Murphy, David; Reid, Steven; Smith, Georgina; Wang, Duolao; Warwick, Hilary; Petkova, Hristina; Barrett, Barbara			Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial	LANCET			English	Article							HYPOCHONDRIASIS; PREVALENCE	Background Health anxiety has been treated by therapists expert in cognitive behaviour therapy with some specific benefit in some patients referred to psychological services. Those in hospital care have been less often investigated. Following a pilot trial suggesting efficacy we carried out a randomised study in hospital medical clinics. Methods We undertook a multicentre, randomised trial on health anxious patients attending cardiac, endocrine, gastroenterological, neurological, and respiratory medicine clinics in secondary care. We included those aged 16-75 years, who satisfied the criteria for excessive health anxiety, and were resident in the area covered by the hospital, were not under investigation for new pathology or too medically unwell to take part. We used a computer-generated random scheme to allocate eligible medical patients to an active treatment group of five-to-ten sessions of adapted cognitive behaviour therapy (CBT-HA group) delivered by hospital-based therapists or to standard care in the clinics. The primary outcome was change in health anxiety symptoms measured by the Health Anxiety Inventory at 1 year and the main secondary hypothesis was equivalence of total health and social care costs over 2 years, with an equivalence margin of 150 pound. Analysis was by intention to treat. The study is registered with controlled-trials.com, ISRCTN14565822. Findings Of 28 991 patients screened, 444 were randomly assigned to receive either adapted cognitive behaviour therapy (CBT-HA group, 219 participants) or standard care (standard care group, 225), with 205 participants in the CBT-HA group and 212 in the standard care group included in the analyses of the primary endpoints. At 1 year, improvement in health anxiety in the patients in the CBT-HA group was 2.98 points greater than in those in the standard care group (95% CI 1.64-4.33, p<0.0001), and twice as many patients receiving cognitive behaviour therapy achieved normal levels of health anxiety compared with those in the control group (13.9% vs 7.3%; odds ratio 2.15, 95% CI 1.09-4.23, p=0.0273). Similar differences were observed at 6 months and 2 years, and there were concomitant reductions in generalised anxiety and, to a lesser extent, depression. Of nine deaths, six were in the control group; all were due to pre-existing illness. Social functioning or health-related quality of life did not differ significantly between groups. Equivalence in total 2-year costs was not achieved, but the difference was not significant (adjusted mean difference 156 pound, 95% CI -1446 to 1758, p=0.848). Interpretation This form of adapted cognitive behaviour therapy for health anxiety led to sustained symptomatic benefit over 2 years, with no significant effect on total costs. It deserves wider application in medical care.	[Tyrer, Peter; Cooper, Sylvia; Tyrer, Helen; Crawford, Michael; Warwick, Hilary] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8LN, England; [Salkovskis, Paul] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Green, John; Reid, Steven; Smith, Georgina] Cent & North West London NHS Fdn Trust, London, England; [Dupont, Simon; Finnis, Sarah] Hillingdon Hosp, Greenacres Ctr, Uxbridge, Middx, England; [McLaren, Elenor; Murphy, David] Charing Cross Hosp, Dept Clin Psychol, London, England; [Byford, Sarah; Petkova, Hristina; Barrett, Barbara] Kings Coll London, Ctr Econ Mental & Phys Hlth, London WC2R 2LS, England; [Wang, Duolao] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England	Imperial College London; University of Bath; Imperial College London; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Tyrer, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, Claybrook Rd, London W6 8LN, England.	p.tyrer@imperial.ac.uk	Byford, Sarah/D-1699-2010; Barrett, Barbara M/F-7606-2010	Byford, Sarah/0000-0001-7084-1495; Barrett, Barbara M/0000-0002-0270-6256; Crawford, Mike/0000-0003-3137-5772; Green, John/0000-0002-5469-973X; Salkovskis, Paul/0000-0002-2951-2283; Dupont, Simon/0000-0002-1467-8037	National Institute for Health Research Health; National Institute for Health Research [07/01/26] Funding Source: researchfish	National Institute for Health Research Health; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research Health Technology Assessment Programme.	Barber JA, 1998, BRIT MED J, V317, P1195, DOI 10.1136/bmj.317.7167.1195; Barrett B, 2006, DRUG ALCOHOL DEPEN, V81, P47, DOI 10.1016/j.drugalcdep.2005.05.015; BARSKY AJ, 1990, SOC PSYCH PSYCH EPID, V25, P89; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; Barsky AJ, 2004, JAMA-J AM MED ASSOC, V291, P1464, DOI 10.1001/jama.291.12.1464; British Medical Association & Royal Pharmaceutical Society of Great Britain, 2010, BNF 59; Clark DM, 1998, BRIT J PSYCHIAT, V173, P218, DOI 10.1192/bjp.173.3.218; Curtis L, 2015, UNIT COSTS HLTH SOCI; Department of Health, 2011, NHS REF COSTS; Efron B., 1994, MONOGRAPHS STAT APPL; Escobar JI, 1998, GEN HOSP PSYCHIAT, V20, P155, DOI 10.1016/S0163-8343(98)00018-8; First M.B., 2014, STRUCTURED CLIN INTE; Hedman E, 2013, PSYCHOL MED, V43, P363, DOI 10.1017/S0033291712001079; Hedman E, 2011, BRIT J PSYCHIAT, V198, P230, DOI 10.1192/bjp.bp.110.086843; McManus F, 2012, J CONSULT CLIN PSYCH, V80, P817, DOI 10.1037/a0028782; National Institute for Health and Care Excellence, 2018, GUID METH TECHN APPR; Olatunji BO, 2010, PSYCHIAT CLIN N AM, V33, P557, DOI 10.1016/j.psc.2010.04.002; Salkovskis P. M., 2003, BRIEF TREATMENT CRIS, V3, P353, DOI [DOI 10.1093/BRIEF-TREATMENT/MHG026, 10.1093/brief-treatment/mhg026]; Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822; Seivewright H, 2009, THESIS IMPERIAL COLL; Seivewright H, 2008, BRIT J PSYCHIAT, V193, P332, DOI 10.1192/bjp.bp.108.052936; Sorensen P, 2011, PSYCHOL MED, V41, P431, DOI 10.1017/S0033291710000292; Sunderland M, 2013, BRIT J PSYCHIAT, V202, P56, DOI 10.1192/bjp.bp.111.103960; Thomson AB, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006520.pub2; Tyrer H, 2013, TACKLING HLTH ANXIET; Tyrer H, 2013, INT J SOC PSYCHIATR, V59, P281, DOI 10.1177/0020764012438484; Tyrer P, 2005, INT J SOC PSYCHIATR, V51, P265, DOI 10.1177/0020764005057391; Tyrer P, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-99; TYRER PJ, 1973, LANCET, V1, P915; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Young J., 1980, COGNITIVE THERAPY SC; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	95	96	0	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					219	225		10.1016/S0140-6736(13)61905-4	http://dx.doi.org/10.1016/S0140-6736(13)61905-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294FC	24139977	Green Accepted			2022-12-28	WOS:000330027500030
J	Alenghat, T; Osborne, LC; Saenz, SA; Kobuley, D; Ziegler, CGK; Mullican, SE; Choi, I; Grunberg, S; Sinha, R; Wynosky-Dolfi, M; Snyder, A; Giacomin, PR; Joyce, KL; Hoang, TB; Bewtra, M; Brodsky, IE; Sonnenberg, GF; Bushman, FD; Won, KJ; Lazar, MA; Artis, D				Alenghat, Theresa; Osborne, Lisa C.; Saenz, Steven A.; Kobuley, Dmytro; Ziegler, Carly G. K.; Mullican, Shannon E.; Choi, Inchan; Grunberg, Stephanie; Sinha, Rohini; Wynosky-Dolfi, Meghan; Snyder, Annelise; Giacomin, Paul R.; Joyce, Karen L.; Hoang, Tram B.; Bewtra, Meenakshi; Brodsky, Igor E.; Sonnenberg, Gregory F.; Bushman, Frederic D.; Won, Kyoung-Jae; Lazar, Mitchell A.; Artis, David			Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis	NATURE			English	Article							EXPRESSION; CELLS; HDAC3; MAINTENANCE; METABOLISM; MICROBIOTA; DISEASE; UNIFRAC; ENERGY	The development and severity of inflammatory bowel diseases and other chronic inflammatory conditions can be influenced by host genetic and environmental factors, including signals derived from commensal bacteria(1-6). However, the mechanisms that integrate these diverse cues remain undefined. Here we demonstrate that mice with an intestinal epithelial cell (IEC)-specific deletion of the epigenome-modifying enzyme histone deacetylase 3 (HDAC3(Delta IEC) mice) exhibited extensive dysregulation of IEC-intrinsic gene expression, including decreased basal expression of genes associated with antimicrobial defence. Critically, conventionally housed HDAC3(Delta IEC) mice demonstrated loss of Paneth cells, impaired IEC function and alterations in the composition of intestinal commensal bacteria. In addition, HDAC3(Delta IEC) mice showed significantly increased susceptibility to intestinal damage and inflammation, indicating that epithelial expression of HDAC3 has a central role in maintaining intestinal homeostasis. Re-derivation of HDAC3(Delta IEC) mice into germ-free conditions revealed that dysregulated IEC gene expression, Paneth cell homeostasis and intestinal barrier function were largely restored in the absence of commensal bacteria. Although the specific mechanisms through which IEC-intrinsic HDAC3 expression regulates these complex phenotypes remain to be determined, these data indicate that HDAC3 is a critical factor that integrates commensal-bacteria-derived signals to calibrate epithelial cell responses required to establish normal host-commensal relationships and maintain intestinal homeostasis.	[Alenghat, Theresa; Osborne, Lisa C.; Saenz, Steven A.; Kobuley, Dmytro; Ziegler, Carly G. K.; Grunberg, Stephanie; Sinha, Rohini; Giacomin, Paul R.; Joyce, Karen L.; Bushman, Frederic D.; Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Alenghat, Theresa; Osborne, Lisa C.; Saenz, Steven A.; Kobuley, Dmytro; Wynosky-Dolfi, Meghan; Giacomin, Paul R.; Joyce, Karen L.; Brodsky, Igor E.; Sonnenberg, Gregory F.; Artis, David] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Alenghat, Theresa; Wynosky-Dolfi, Meghan; Snyder, Annelise; Brodsky, Igor E.; Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Mullican, Shannon E.; Lazar, Mitchell A.] Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Mullican, Shannon E.; Choi, Inchan; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Choi, Inchan; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Hoang, Tram B.; Bewtra, Meenakshi; Sonnenberg, Gregory F.] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Bewtra, Meenakshi] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Artis, D (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Osborne, Lisa/K-3027-2015; Lazar, Mitchell A/AAF-3738-2019	Osborne, Lisa/0000-0002-7170-3235; Bushman, Frederic/0000-0003-4740-4056; Giacomin, Paul/0000-0002-6326-6792; Artis, David/0000-0002-1753-4100; Won, Kyoung Jae/0000-0002-2924-9630; Ziegler, Carly/0000-0002-8279-7150	National Institutes of Health [AI061570, AI095608, AI087990, AI074878, AI095466, AI106697, AI102942, AI097333, DK043806, T32-RR007063, K08-DK093784, DP5OD012116, F31-GM082187, K08-DK084347, R21-AI105346]; Crohns and Colitis Foundation of America; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Irvington Institute Postdoctoral Fellowship of the Cancer Research Institute; Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory; NCI Comprehensive Cancer Center Support Grant [2-P30 CA016520]; National Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106697, R01AI097333, R01AI095466, R21AI087990, R01AI102942, R01AI061570, R21AI083480, U01AI095608, R21AI105346, R01AI074878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084347, P30DK050306, R01DK043806, K08DK093784, R37DK043806, P30DK019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM082187] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohns and Colitis Foundation of America; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Irvington Institute Postdoctoral Fellowship of the Cancer Research Institute; Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory; NCI Comprehensive Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Artis laboratory for discussions and critical reading of the manuscript. This research is supported by the National Institutes of Health (AI061570, AI095608, AI087990, AI074878, AI095466, AI106697, AI102942 and AI097333 to D. A.; DK043806 to M. A. L.; T32-RR007063, K08-DK093784 to T. A.; DP5OD012116 to G. F. S.; F31-GM082187 to S. A. S.; K08-DK084347 to M. B.; R21-AI105346 to I. E. B.), the Crohns and Colitis Foundation of America (T. A. and D. A.), the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D. A.), and the Irvington Institute Postdoctoral Fellowship of the Cancer Research Institute (L.C.O.). We also thank S. Lukovac and R. Aoki for technical assistance, the University of Pennsylvania Matthew J. Ryan Veterinary Hospital Pathology Lab, Center for AIDS Research, the Penn Microarray Facility, the NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306) and its core facilities (Molecular Pathology and Imaging; Molecular Biology; Cell Culture; Transgenic and Chimeric Mouse), the Functional Genomics Core of the Penn Diabetes Research Center (DRC) (P30-DK19525), the Pathology Core at the Stokes Institute, the Electron Microscopy Resource Laboratory, the Penn IBD Immunology Initiative (I<SUP>3</SUP>), and the Mucosal Immunology Studies Team (MIST) of the NIAID for sharing expertise and resources. The authors would also like to thank the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory for technical advice and support. The ACC Flow Cytometry and Cell Sorting Shared Resource is partially supported by NCI Comprehensive Cancer Center Support Grant (2-P30 CA016520). Some human tissue samples were provided by the Cooperative Human Tissue Network (funded by the National Cancer Institute).	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; Denson LA, 2013, INFLAMM BOWEL DIS, V19, P677, DOI 10.1097/MIB.0b013e31828134b3; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Donohoe DR, 2012, J CELL PHYSIOL, V227, P3169, DOI 10.1002/jcp.24054; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kim Go-Woon, 2010, Int J Cell Biol, V2010, P632739, DOI 10.1155/2010/632739; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Slomko H, 2012, ENDOCRINOLOGY, V153, P1025, DOI 10.1210/en.2011-1759; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476	39	151	162	4	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					153	+		10.1038/nature12687	http://dx.doi.org/10.1038/nature12687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24185009	Green Accepted			2022-12-28	WOS:000327851700050
J	Harris, KD; Mrsic-Flogel, TD				Harris, Kenneth D.; Mrsic-Flogel, Thomas D.			Cortical connectivity and sensory coding	NATURE			English	Review							PRIMARY VISUAL-CORTEX; PRIMARY SOMATOSENSORY CORTEX; CALLOSAL PROJECTION NEURONS; INHIBITORY NEURONS; IN-VIVO; PYRAMIDAL NEURONS; AUDITORY-CORTEX; GABAERGIC NEURONS; BARREL CORTEX; LAYER-V	The sensory cortex contains a wide array of neuronal types, which are connected together into complex but partially stereotyped circuits. Sensory stimuli trigger cascades of electrical activity through these circuits, causing specific features of sensory scenes to be encoded in the firing patterns of cortical populations. Recent research is beginning to reveal how the connectivity of individual neurons relates to the sensory features they encode, how differences in the connectivity patterns of different cortical cell classes enable them to encode information using different strategies, and how feedback connections from higher-order cortex allow sensory information to be integrated with behavioural context.	[Harris, Kenneth D.] UCL Inst Neurol, London WC1N 3BG, England; [Harris, Kenneth D.; Mrsic-Flogel, Thomas D.] UCL Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England; [Mrsic-Flogel, Thomas D.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of London; University College London; University of London; University College London; University of Basel	Harris, KD (corresponding author), UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.	kenneth.harris@ucl.ac.uk; thomas.mrsic-flogel@unibas.ch		Mrsic-Flogel, Tom/0000-0002-8947-408X; Harris, Kenneth/0000-0002-5930-6456	Wellcome Trust; Engineering and Physical Sciences Research Council; US National Institutes of Health; European Research Council; EPSRC [EP/I005102/2, EP/I005102/1, EP/K015141/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I005102/2, EP/I005102/1, EP/K015141/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank B. Rudy, G. Buzsaki, M. Hausser, B. Haider, S. Hofer, R. Bruno and M. Carandini for comments on the manuscript. K. D. H. is supported by the Wellcome Trust, Engineering and Physical Sciences Research Council and US National Institutes of Health. T.M.-F. is supported by the Wellcome Trust and European Research Council.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Bathellier B, 2012, NEURON, V76, P435, DOI 10.1016/j.neuron.2012.07.008; Beltramo R, 2013, NAT NEUROSCI, V16, P227, DOI 10.1038/nn.3306; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Callaway EM, 2011, J NEUROSCI, V31, P7456, DOI 10.1523/JNEUROSCI.5222-10.2011; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Christophe E, 2005, J NEUROPHYSIOL, V94, P3357, DOI 10.1152/jn.00076.2005; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; Constantinople CM, 2013, SCIENCE, V340, P1591, DOI 10.1126/science.1236425; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Gao P, 2013, DEVELOPMENT, V140, P2645, DOI 10.1242/dev.087668; GARDNERMEDWIN AR, 1976, PROC R SOC SER B-BIO, V194, P375, DOI 10.1098/rspb.1976.0084; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Harris KD, 2008, TRENDS NEUROSCI, V31, P130, DOI 10.1016/j.tins.2007.12.002; Harwell CC, 2012, NEURON, V73, P1116, DOI 10.1016/j.neuron.2012.02.009; Hebb Donald O., 1949, ORG BEHAV; Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626, DOI 10.1152/jn.2000.83.5.2626; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jabaudon D, 2012, CEREB CORTEX, V22, P996, DOI 10.1093/cercor/bhr182; Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lee CC, 2009, CEREB CORTEX, V19, P2281, DOI 10.1093/cercor/bhn246; Lee S., NATURE NEUR IN PRESS; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Maruoka H, 2011, J NEUROSCI, V31, P18522, DOI 10.1523/JNEUROSCI.3117-11.2011; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Narboux-Neme N, 2012, J NEUROSCI, V32, P6183, DOI 10.1523/JNEUROSCI.0343-12.2012; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Otsuka T, 2011, J NEUROSCI, V31, P3862, DOI 10.1523/JNEUROSCI.5795-10.2011; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Quiroga RQ, 2013, PRINCIPLES OF NEURAL CODING, P1, DOI 10.1201/b14756; Reiner A, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00142; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Runyan CA, 2013, J NEUROSCI, V33, P11724, DOI 10.1523/JNEUROSCI.2196-12.2013; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Saleem A. B., NATURE NEUR IN PRESS; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Sherman SM, 2012, CURR OPIN NEUROBIOL, V22, P575, DOI 10.1016/j.conb.2012.03.005; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Smith PH, 2012, J COMP NEUROL, V520, P34, DOI 10.1002/cne.22682; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Srinivasan K, 2012, P NATL ACAD SCI USA, V109, P19071, DOI 10.1073/pnas.1216793109; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; Sun YJ, 2013, J NEUROSCI, V33, P5326, DOI 10.1523/JNEUROSCI.4810-12.2013; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Taniguchi H, 2011, NEURON, V72, P1091, DOI 10.1016/j.neuron.2011.12.010; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Thomson AM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00013; Van Hooser SD, 2006, J NEUROSCI, V26, P7680, DOI 10.1523/JNEUROSCI.0108-06.2006; Watakabe A, 2012, J COMP NEUROL, V520, P3553, DOI 10.1002/cne.23160; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Yger P., PLOS COMPUT IN PRESS; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958	125	323	324	5	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					51	58		10.1038/nature12654	http://dx.doi.org/10.1038/nature12654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201278				2022-12-28	WOS:000326585600031
J	Smith, JM				Smith, Jeanette M.			Yellow Calla Lilies Anne Goldthwaite	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1774	1775		10.1001/jama.2013.5392	http://dx.doi.org/10.1001/jama.2013.5392			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193062				2022-12-28	WOS:000326550900001
J	Fierer, N; Ladau, J; Clemente, JC; Leff, JW; Owens, SM; Pollard, KS; Knight, R; Gilbert, JA; McCulley, RL				Fierer, Noah; Ladau, Joshua; Clemente, Jose C.; Leff, Jonathan W.; Owens, Sarah M.; Pollard, Katherine S.; Knight, Rob; Gilbert, Jack A.; McCulley, Rebecca L.			Reconstructing the Microbial Diversity and Function of Pre-Agricultural Tallgrass Prairie Soils in the United States	SCIENCE			English	Article							COMMUNITIES; VERRUCOMICROBIA; DISTRIBUTIONS; CULTIVATION; BACTERIA	Native tallgrass prairie once dominated much of the midwestern United States, but this biome and the soil microbial diversity that once sustained this highly productive system have been almost completely eradicated by decades of agricultural practices. We reconstructed the soil microbial diversity that once existed in this biome by analyzing relict prairie soils and found that the biogeographical patterns were largely driven by changes in the relative abundance of Verrucomicrobia, a poorly studied bacterial phylum that appears to dominate many prairie soils. Shotgun metagenomic data suggested that these spatial patterns were associated with strong shifts in carbon dynamics. We show that metagenomic approaches can be used to reconstruct below-ground biogeochemical and diversity gradients in endangered ecosystems; such information could be used to improve restoration efforts, given that even small changes in below-ground microbial diversity can have important impacts on ecosystem processes.	[Fierer, Noah; Leff, Jonathan W.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Fierer, Noah; Leff, Jonathan W.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Ladau, Joshua; Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94158 USA; [Clemente, Jose C.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Clemente, Jose C.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Owens, Sarah M.; Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Owens, Sarah M.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Francisco; The J David Gladstone Institutes; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Chicago; University of Kentucky	Fierer, N (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	noah.fierer@colorado.edu	Knight, Rob/D-1299-2010; Gilbert, Jack/AAF-3270-2019	Owens, Sarah/0000-0002-9946-2787; Knight, Rob/0000-0002-0975-9019	NSF [DEB-0953331, DMS-1069303]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [3300]; U.S. Department of Energy [DE-AC02-06CH11357]; USDA National Research Initiative [2005-35101-15335/17371]	NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. Department of Energy(United States Department of Energy (DOE)); USDA National Research Initiative(United States Department of Agriculture (USDA))	We thank K. McLauchlan and three anonymous reviewers for their critical feedback on earlier versions of the manuscript; R. Jackson for his help with soil collection and analyses; and J. Henley for her help with the laboratory analyses. Supported by NSF grants DEB-0953331 (N.F.) and DMS-1069303 (K. S. P.), the Howard Hughes Medical Institute (R. K.), Gordon and Betty Moore Foundation grant 3300 (K. S. P.), U.S. Department of Energy contract DE-AC02-06CH11357 (J. A. G.), and USDA National Research Initiative 2005-35101-15335/17371 (R. L. M.). All amplicon data have been deposited in the European Nucleotide Archive under accession number ERP003610; the accession number for the shotgun metagenomic data is ERP003954. Data have also been made available through the Dryad data depository.	Allison VJ, 2007, SOIL BIOL BIOCHEM, V39, P505, DOI 10.1016/j.soilbio.2006.08.021; [Anonymous], 2010, MAPPING SPECIES DIST; Baer SG, 2002, ECOL APPL, V12, P1688, DOI 10.1890/1051-0761(2002)012[1688:CIESAF]2.0.CO;2; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bradford MA, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P189; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; da Rocha UN, 2010, J SOIL SEDIMENT, V10, P326, DOI 10.1007/s11368-009-0160-3; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2012, NAT METHODS, V9, P549, DOI 10.1038/nmeth.2041; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Gilbert Jack A, 2011, Microb Inform Exp, V1, P5, DOI 10.1186/2042-5783-1-5; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Huggins DR, 1998, SOIL TILL RES, V47, P219, DOI 10.1016/S0167-1987(98)00108-1; Jangid K, 2010, SOIL BIOL BIOCHEM, V42, P302, DOI 10.1016/j.soilbio.2009.11.008; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Martinson EJ, 2011, PHYS GEOGR, V32, P583, DOI 10.2747/0272-3646.32.6.583; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; Sims P. L., 2000, N AM TERRESTRIAL VEG, P325	29	327	355	27	517	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					621	624		10.1126/science.1243768	http://dx.doi.org/10.1126/science.1243768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179225				2022-12-28	WOS:000326334300049
J	Briggs, ADM; Mytton, OT; Kehlbacher, A; Tiffin, R; Rayner, M; Scarborough, P				Briggs, Adam D. M.; Mytton, Oliver T.; Kehlbacher, Ariane; Tiffin, Richard; Rayner, Mike; Scarborough, Peter			Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in UK: econometric and comparative risk assessment modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-WEIGHT; BEVERAGE CONSUMPTION; REDUCE CONSUMPTION; FOOD-PRICES; HEALTH; DEMAND; IMPACT; INTERVENTION; STRATEGIES; NUTRITION	Objective To model the overall and income specific effect of a 20% tax on sugar sweetened drinks on the prevalence of overweight and obesity in the UK. Design Econometric and comparative risk assessment modelling study. Setting United Kingdom. Population Adults aged 16 and over. Intervention A 20% tax on sugar sweetened drinks. Main outcome measures The primary outcomes were the overall and income specific changes in the number and percentage of overweight (body mass index >= 25) and obese (>= 30) adults in the UK following the implementation of the tax. Secondary outcomes were the effect by age group (16-29, 30-49, and >= 50 years) and by UK constituent country. The revenue generated from the tax and the income specific changes in weekly expenditure on drinks were also estimated. Results A 20% tax on sugar sweetened drinks was estimated to reduce the number of obese adults in the UK by 1.3% (95% credible interval 0.8% to 1.7%) or 180 000 (110 000 to 247 000) people and the number who are overweight by 0.9% (0.6% to 1.1%) or 285 000 (201 000 to 364 000) people. The predicted reductions in prevalence of obesity for income thirds 1 (lowest income), 2, and 3 (highest income) were 1.3% (0.3% to 2.0%), 0.9% (0.1% to 1.6%), and 2.1% (1.3% to 2.9%). The effect on obesity declined with age. Predicted annual revenue was 276m pound (272m pound to 279m) pound, with estimated increases in total expenditure on drinks for income thirds 1, 2, and 3 of 2.1% (1.4% to 3.0%), 1.7% (1.2% to 2.2%), and 0.8% (0.4% to 1.2%). Conclusions A 20% tax on sugar sweetened drinks would lead to a reduction in the prevalence of obesity in the UK of 1.3% (around 180 000 people). The greatest effects may occur in young people, with no significant differences between income groups. Both effects warrant further exploration. Taxation of sugar sweetened drinks is a promising population measure to target population obesity, particularly among younger adults.	[Briggs, Adam D. M.; Mytton, Oliver T.; Rayner, Mike; Scarborough, Peter] Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Hlth Promot Res Grp, Oxford OX3 7LF, England; [Mytton, Oliver T.] UK Hlth Forum, London WC1B 4AD, England; [Kehlbacher, Ariane; Tiffin, Richard] Univ Reading, Ctr Food Secur, Reading RG6 6AR, Berks, England	University of Oxford; University of Reading	Rayner, M (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Hlth Promot Res Grp, Oxford OX3 7LF, England.	mike.rayner@dph.ox.ac.uk	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Briggs, Adam/0000-0002-2314-1039; Tiffin, Richard/0000-0002-4455-5572; Mytton, Oliver/0000-0003-3218-9912	British Heart Foundation; National Institute for Health Research; MRC [G0701865] Funding Source: UKRI; Medical Research Council [G0701865] Funding Source: researchfish; National Institute for Health Research [ACF-2010-13-011, ACF-2011-13-012] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	No explicit funding for this work was sought. MR and PS are funded by the British Heart Foundation. ADMB and OTM are National Institute for Health Research funded academic clinical fellows in public health.	Academy of Medical Royal Colleges, 2013, MEAS MED PROF PRESCR; Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], 2013, DRAFT SCI OP REEV AS; [Anonymous], 2011, HLTH SURV NO IR 1 RE; [Anonymous], 2013, GUARDIAN; Armfield JM, 2013, AM J PUBLIC HEALTH, V103, P494, DOI 10.2105/AJPH.2012.300889; Bahl R., 2003, PUBLIC FINANCE REV, V31; Berardi N., 2012, IMPACT SODA TAX PRIC; Block JP, 2010, AM J PUBLIC HEALTH, V100, P1427, DOI 10.2105/AJPH.2009.175687; BLUNDELL R, 1987, J ECONOMETRICS, V34, P179, DOI 10.1016/0304-4076(87)90072-8; Briggs A., 2012, PROPOSED SUGAR SWEET, P116; British Heart Foundation Health Promotion Research Group, 2012, COR HEART DIS STAT C; British Soft Drinks Association, 2012, LONG TERM COMM LONG; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Christiansen E, 2002, EUR J CLIN INVEST, V32, P826, DOI 10.1046/j.1365-2362.2002.01036.x; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; DEATON A, 1980, AM ECON REV, V70, P312; Department for Environment Food and Rural Affairs, 2010, EXP HOUS EAT OUT FOO; Department for Environment Food and Rural Affairs, 2011, FAM FOOD DAT UK HOUS; Department for the Environment Food and Rural Affairs, 2011, LIV COSTS FOOD SURV; Dharmasena S, 2012, HEALTH ECON, V21, P669, DOI 10.1002/hec.1738; Duffey KJ, 2010, ARCH INTERN MED, V170, P420, DOI 10.1001/archinternmed.2009.545; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Edgerton DL, 1997, AM J AGR ECON, V79, P62, DOI 10.2307/1243943; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Finkelstein EA, 2013, J HEALTH ECON, V32, P219, DOI 10.1016/j.jhealeco.2012.10.005; Green R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3703; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Kim D, 2006, AM J PREV MED, V30, P430, DOI 10.1016/j.amepre.2005.12.007; Kosinska M, 2011, OPEN LETT; Lentschner K, 2012, FIGARO; Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Meier PS, 2013, ALCOHOL ALCOHOLISM, V48, P241, DOI 10.1093/alcalc/agt001; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; NatCen Social Research and Royal Free and University College Medical School. Department of Epidemiology and Public Health Health Survey for England, 2010, HLTH SURV ENGL 2010; National Centre for Social Research. National Diet and Nutrition Survey, 2008, NUTR DIET NUTR SURV; National Centre for Social Research Welsh Health Survey, 2010, WELSH HLTH SURV 2010; National Records of Scotland, 2012, CENS DAY US RES POP; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Nichols M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000957; Northern Ireland Neighbourhood Information Service, 2011, CENS 2011 NO IR; Office for National Statistics, 2012, POP EST ENGL WAL MID; Pomeranz JL, 2012, J PUBLIC HEALTH POL, V33, P75, DOI 10.1057/jphp.2011.46; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Scarborough P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000263; Scarborough P, 2011, BRIT J NUTR, V105, P1399, DOI 10.1017/S0007114510005076; ScotCen Social Research and University College London. Department of Epidemiology and Public Health Scottish Health Survey, 2010, SCOTT HLTH SURV 2010; Shiely F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-560; Sustain, 2013, CHILDR FUT FUND FOOD; TANNER MA, 1987, J AM STAT ASSOC, V82, P528, DOI 10.2307/2289457; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Waterlander WE, 2013, AM J CLIN NUTR, V97, P886, DOI 10.3945/ajcn.112.041632; Wojcicki JM, 2013, ACTA PAEDIATR, V102, P560, DOI 10.1111/apa.12216; Zhen C, 2013, AM J AGR EC	61	110	110	0	101	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2013	347								f6189	10.1136/bmj.f6189	http://dx.doi.org/10.1136/bmj.f6189			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247EX	24179043	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000326599700003
J	Korenstein, D; Kale, M; Levinson, W				Korenstein, Deborah; Kale, Minal; Levinson, Wendy			Teaching Value in Academic Environments Shifting the Ivory Tower	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COST-CONSCIOUS CARE; PHYSICIANS		[Korenstein, Deborah] Amer Coll Physicians, Philadelphia, PA 19106 USA; [Kale, Minal] Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY USA; [Levinson, Wendy] Univ Toronto, Dept Med, Toronto, ON, Canada	American College of Physicians; Icahn School of Medicine at Mount Sinai; University of Toronto	Korenstein, D (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	dkorenstein@mail.acponline.org						Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Brook RH, 2011, JAMA-J AM MED ASSOC, V306, P650, DOI 10.1001/jama.2011.1136; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Felman LS, 2013, JAMA INTERN MED, V173, P903; Rosenbaum L, 2012, NEW ENGL J MED, V367, P99, DOI 10.1056/NEJMp1205634; Smith CD, 2012, ANN INTERN MED, V157, P284, DOI 10.7326/0003-4819-157-4-201208210-00496; Tilburt JC, 2013, JAMA-J AM MED ASSOC, V310, P380, DOI 10.1001/jama.2013.8278; Weinberger SE, 2011, ANN INTERN MED, V155, P386, DOI 10.7326/0003-4819-155-6-201109200-00007	8	18	18	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1671	1672		10.1001/jama.2013.280380	http://dx.doi.org/10.1001/jama.2013.280380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24150461				2022-12-28	WOS:000325948500018
J	Fites, JS; Ramsey, JP; Holden, WM; Collier, SP; Sutherland, DM; Reinert, LK; Gayek, AS; Dermody, TS; Aune, TM; Oswald-Richter, K; Rollins-Smith, LA				Fites, J. Scott; Ramsey, Jeremy P.; Holden, Whitney M.; Collier, Sarah P.; Sutherland, Danica M.; Reinert, Laura K.; Gayek, A. Sophia; Dermody, Terence S.; Aune, Thomas M.; Oswald-Richter, Kyra; Rollins-Smith, Louise A.			The Invasive Chytrid Fungus of Amphibians Paralyzes Lymphocyte Responses	SCIENCE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; SACCHAROMYCES-CEREVISIAE; IMMUNE DEFENSES; CELL-DEATH; CHYTRIDIOMYCOSIS; DECLINES; FROGS; PATHOGENESIS; EXPRESSION; INFECTION	The chytrid fungus, Batrachochytrium dendrobatidis, causes chytridiomycosis and is a major contributor to global amphibian declines. Although amphibians have robust immune defenses, clearance of this pathogen is impaired. Because inhibition of host immunity is a common survival strategy of pathogenic fungi, we hypothesized that B. dendrobatidis evades clearance by inhibiting immune functions. We found that B. dendrobatidis cells and supernatants impaired lymphocyte proliferation and induced apoptosis; however, fungal recognition and phagocytosis by macrophages and neutrophils was not impaired. Fungal inhibitory factors were resistant to heat, acid, and protease. Their production was absent in zoospores and reduced by nikkomycin Z, suggesting that they may be components of the cell wall. Evasion of host immunity may explain why this pathogen has devastated amphibian populations worldwide.	[Fites, J. Scott; Rollins-Smith, Louise A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Ramsey, Jeremy P.; Holden, Whitney M.; Collier, Sarah P.; Sutherland, Danica M.; Reinert, Laura K.; Gayek, A. Sophia; Dermody, Terence S.; Aune, Thomas M.; Oswald-Richter, Kyra; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Dermody, Terence S.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Aune, Thomas M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Rollins-Smith, LA (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	louise.rollins-smith@vanderbilt.edu		Sutherland, Danica/0000-0001-9328-4994	NSF [IOS-0619536, IOS-0843207, IOS-1121758]; NIH [AI044924, AI007281, AI038296, 1K01HL103179-01]; The Foundation for Sarcoidosis Research; Vanderbilt University; NSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044924, R01AI038296, R37AI038296, T32AI007281, R56AI044924] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Foundation for Sarcoidosis Research; Vanderbilt University; NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NSF grants IOS-0619536, IOS-0843207, and IOS-1121758 (to L. A. R-S.); NIH grants AI044924 (to T. M. A.), AI007281 (to D. M. S.), AI038296 (to T. S. D.), 1K01HL103179-01, The Foundation for Sarcoidosis Research (to K.O-R.) and a dissertation enhancement grant from Vanderbilt University (to J.S.F.). W. M. H. was supported by an individual NSF Graduate Research Fellowship. We thank J. Galgiani, director of the Valley Fever Center for Excellence of the University of Arizona, for the gift of nikkomycin Z under a Materials Transfer Agreement. Anti-Xenopus monoclonal antibodies were provided by the University of Rochester Xenopus laevis Research Resource for Immunobiology. All data necessary to understand this manuscript are presented in the main text or supplementary materials.	Ben-Ami R, 2010, BRIT J HAEMATOL, V150, P406, DOI 10.1111/j.1365-2141.2010.08283.x; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Campanelli AP, 2003, J INFECT DIS, V187, P1496, DOI 10.1086/374646; Collette JR, 2011, CURR OPIN MICROBIOL, V14, P668, DOI 10.1016/j.mib.2011.09.007; Collins JP, 2010, DIS AQUAT ORGAN, V92, P93, DOI 10.3354/dao02307; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; GAUGHRAN JP, 1994, J BACTERIOL, V176, P5857, DOI 10.1128/JB.176.18.5857-5860.1994; Joneson S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002338; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Mazzoni R, 2003, EMERG INFECT DIS, V9, P995; Morales H, 2003, CELL STRESS CHAPERON, V8, P265, DOI 10.1379/1466-1268(2003)008<0265:BSUTSE>2.0.CO;2; Pericolini E, 2009, J IMMUNOL, V182, P6003, DOI 10.4049/jimmunol.0803833; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; ROLLINSSMITH LA, 1984, IMMUNOLOGY, V52, P491; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Vecchiarelli A, 2012, MYCOPATHOLOGIA, V173, P375, DOI 10.1007/s11046-011-9513-8; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Woodhams Douglas C., 2008, Herpetological Review, V39, P66	29	129	130	0	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					366	369		10.1126/science.1243316	http://dx.doi.org/10.1126/science.1243316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136969	Green Accepted			2022-12-28	WOS:000325755100047
J	Jaramillo, E; Tan, A; Yang, L; Kuo, YF; Goodwin, JS				Jaramillo, Elizabeth; Tan, Alai; Yang, Liu; Kuo, Yong-Fang; Goodwin, James S.			Variation Among Primary Care Physicians in Prostate-Specific Antigen Screening of Older Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							QUALITY INDICATORS		[Jaramillo, Elizabeth; Tan, Alai; Yang, Liu; Kuo, Yong-Fang; Goodwin, James S.] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Goodwin, JS (corresponding author), Univ Texas Med Branch, Sealy Ctr Aging, 301 Univ Blvd, Galveston, TX 77555 USA.	jsgoodwi@utmb.edu			NATIONAL CANCER INSTITUTE [K05CA134923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER; AHRQ HHS [R24 HS022134] Funding Source: Medline; NCATS NIH HHS [UL1 TR000071, UL1TR00007] Funding Source: Medline; NCI NIH HHS [K05CA134923, K05 CA134923] Funding Source: Medline; NIA NIH HHS [P30 AG024832] Funding Source: Medline; PHS HHS [R24H5022134] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Atlas SJ, 2006, J GEN INTERN MED, V21, P973, DOI 10.1007/BF02743147; Goodwin JS, 2013, JNCI-J NATL CANCER I, V105, P743, DOI 10.1093/jnci/djt039; Lee SJ, 2011, JAMA-J AM MED ASSOC, V306, P1481, DOI 10.1001/jama.2011.1418; Singal AK, 2013, HEALTH SERV RES, V48, P95, DOI 10.1111/j.1475-6773.2012.01433.x; Tan A, 2013, J AM GERIATR SOC, V61, P380, DOI 10.1111/jgs.12151; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336	6	28	29	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1622	1624		10.1001/jama.2013.277514	http://dx.doi.org/10.1001/jama.2013.277514			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129467	Green Accepted			2022-12-28	WOS:000325624800026
J	Park, E; Menetret, JF; Gumbart, JC; Ludtke, SJ; Li, WK; Whynot, A; Rapoport, TA; Akey, CW				Park, Eunyong; Menetret, Jean-Francois; Gumbart, James C.; Ludtke, Steven J.; Li, Weikai; Whynot, Andrew; Rapoport, Tom A.; Akey, Christopher W.			Structure of the SecY channel during initiation of protein translocation	NATURE			English	Article							ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; MESSENGER-RNA; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; RIBOSOME BINDING; ER MEMBRANE; COMPLEX; INSERTION; VISUALIZATION	Many secretory proteins are targeted by signal sequences to a protein-conducting channel, formed by prokaryotic SecY or eukaryotic Sec61 complexes, and are translocated across the membrane during their synthesis(1,2). Crystal structures of the inactive channel show that the SecY subunit of the heterotrimeric complex consists of two halves that form an hourglass-shaped pore with a constriction in the middle of the membrane and a lateral gate that faces the lipid phase(3-5). The closed channel has an empty cytoplasmic funnel and an extracellular funnel that is filled with a small helical domain, called the plug. During initiation of translocation, a ribosome-nascent chain complex binds to the SecY (or Sec61) complex, resulting in insertion of the nascent chain. However, the mechanism of channel opening during translocation is unclear. Here we have addressed this question by determining structures of inactive and active ribosome-channel complexes with cryo-electron microscopy. Non-translating ribosome-SecY channel complexes derived from Methanocaldococcus jannaschii or Escherichia coli show the channel in its closed state, and indicate that ribosome binding per se causes only minor changes. The structure of an active E. coli ribosome-channel complex demonstrates that the nascent chain opens the channel, causing mostly rigid body movements of the amino- and carboxy-terminal halves of SecY. In this early translocation intermediate, the polypeptide inserts as a loop into the SecY channel with the hydrophobic signal sequence intercalated into the open lateral gate. The nascent chain also forms a loop on the cytoplasmic surface of SecY rather than entering the channel directly.	[Park, Eunyong; Li, Weikai; Whynot, Andrew; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Park, Eunyong; Li, Weikai; Whynot, Andrew; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Menetret, Jean-Francois; Akey, Christopher W.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Gumbart, James C.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Ludtke, Steven J.] Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Boston University; University System of Georgia; Georgia Institute of Technology; Baylor College of Medicine	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	Tom_Rapoport@hms.harvard.edu; cakey@bu.edu	Ludtke, Steven/A-4478-2008	Ludtke, Steven/0000-0002-1903-1574; Akey, Christopher/0000-0002-3059-3121	National Institutes of Health [GM067887, GM080139, GM052586, GM45377]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL097083, K99HL097083, R01HL121718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080139, R01GM052586, R01GM045377, R01GM067887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Matlack and T. Guettler for reading the manuscript. This work was supported by National Institutes of Health grants GM067887 to J.C.G., GM080139 to S.J.L., GM052586 to T.A.R. and GM45377 to C.W.A. T.A.R. is a Howard Hughes Institute investigator.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Armache JP, 2013, NUCLEIC ACIDS RES, V41, P1284, DOI 10.1093/nar/gks1259; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Hizlan D, 2012, CELL REPORTS, V1, P21, DOI 10.1016/j.celrep.2011.11.003; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; Nijeholt JALA, 2010, J BIOL CHEM, V285, P23747, DOI 10.1074/jbc.M110.124636; Park E, 2012, J CELL BIOL, V198, P881, DOI 10.1083/jcb.201205140; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	39	117	121	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					102	+		10.1038/nature12720	http://dx.doi.org/10.1038/nature12720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24153188	Green Accepted, Green Submitted			2022-12-28	WOS:000330648100040
J	Shingai, M; Nishimura, Y; Klein, F; Mouquet, H; Donau, OK; Plishka, R; Buckler-White, A; Seaman, M; Piatak, M; Lifson, JD; Dimitrov, DS; Nussenzweig, MC; Martin, MA				Shingai, Masashi; Nishimura, Yoshiaki; Klein, Florian; Mouquet, Hugo; Donau, Olivia K.; Plishka, Ronald; Buckler-White, Alicia; Seaman, Michael; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Dimitrov, Dimiter S.; Nussenzweig, Michel C.; Martin, Malcolm A.			Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia	NATURE			English	Article							SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; NEUTRALIZING ANTIBODIES; PASSIVE TRANSFER; RHESUS MACAQUES; POTENT NEUTRALIZATION; HIV-1; BROAD; PROTECTION; CHALLENGE; THERAPY	Neutralizing antibodies can confer immunity to primate lentiviruses by blocking infection in macaque models of AIDS(1-4). However, earlier studies of anti-human immunodeficiency virus type 1 (HIV-1) neutralizing antibodies administered to infected individuals or humanized mice reported poor control of virus replication and the rapid emergence of resistant variants(5-7). A new generation of anti-HIV-1 monoclonal antibodies, possessing extraordinary potency and breadth of neutralizing activity, has recently been isolated from infected individuals(8). These neutralizing antibodies target different regions of the HIV-1 envelope glycoprotein including the CD4-binding site, glycans located in the V1/V2, V3 and V4 regions, and the membrane proximal external region of gp41 (refs 9-14). Here we have examined two of the new antibodies, directed to the CD4-binding site and the V3 region (3BNC117 and 10-1074, respectively), for their ability to block infection and suppress viraemia in macaques infected with the R5 tropic simian-human immunodeficiency virus (SHIV)-AD8, which emulates many of the pathogenic and immunogenic properties of HIV-1 during infections of rhesus macaques(15,16). Either antibody alone can potently block virus acquisition. When administered individually to recently infected macaques, the 10-1074 antibody caused a rapid decline in virus load to undetectable levels for 4-7 days, followed by virus rebound during which neutralization-resistant variants became detectable. When administered together, a single treatment rapidly suppressed plasma viraemia for 3-5 weeks in some long-term chronically SHIV-infected animals with low CD41 T-cell levels. A second cycle of anti-HIV-1 monoclonal antibody therapy, administered to two previously treated animals, successfully controlled virus rebound. These results indicate that immunotherapy or a combination of immunotherapy plus conventional antiretroviral drugs might be useful as a treatment for chronically HIV-1-infected individuals experiencing immune dysfunction.	[Shingai, Masashi; Nishimura, Yoshiaki; Donau, Olivia K.; Plishka, Ronald; Buckler-White, Alicia; Martin, Malcolm A.] NIAID, Lab Mol Microbiol, NIH, Bethesda, MD 20892 USA; [Klein, Florian; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Mouquet, Hugo] Inst Pasteur, Dept Immunol, Lab Humoral Response Pathogens, F-75015 Paris, France; [Seaman, Michael] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Dimitrov, Dimiter S.; Nussenzweig, Michel C.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rockefeller University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu; malm@nih.gov	Mouquet, Hugo/M-2750-2014; Nussenzweig, Michel/AAE-7292-2019	Mouquet, Hugo/0000-0002-4230-610X; 	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148, ZIAAI000998] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Tomioka and R. Kruthers for determining plasma viral RNA loads and B. Skopets, W. Magnanelli and R. Petros for diligently assisting in the maintenance of animals and assisting with procedures. We also thank D. R. Burton, The Scripps Institute, for providing anti-dengue virus neutralizing monoclonal antibody (DEN-3). This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) and, in part, with federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E.	Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Endo Y, 2000, J VIROL, V74, P6935, DOI 10.1128/JVI.74.15.6935-6945.2000; Gautam R, 2012, J VIROL, V86, P8516, DOI 10.1128/JVI.00644-12; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Horwitz J. A., 2013, P NATL ACAD SCI US; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Nishimura Y, 2010, J VIROL, V84, P4769, DOI 10.1128/JVI.02279-09; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Polis MA, 2001, LANCET, V358, P1760, DOI 10.1016/S0140-6736(01)06802-7; Sadjadpour R, 2013, J VIROL, V87, P8798, DOI 10.1128/JVI.00878-13; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	30	348	379	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					277	+		10.1038/nature12746	http://dx.doi.org/10.1038/nature12746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24172896	Green Accepted			2022-12-28	WOS:000326894200054
J	Demirors, AF; Pillai, PP; Kowalczyk, B; Grzybowski, BA				Demiroers, Ahmet F.; Pillai, Pramod P.; Kowalczyk, Bartlomiej; Grzybowski, Bartosz A.			Colloidal assembly directed by virtual magnetic moulds	NATURE			English	Article							CRYSTALS; ARRAYS; MOLECULES; SYMMETRY; FORCES; GROWTH; FIELD	Interest in assemblies of colloidal particles(1-4) has long been motivated by their applications in photonics(5,6), electronics(7,8), sensors(8) and microlenses(9). Existing assembly schemes(10-15) can position colloids of one type relatively flexibly into a range of desired structures, but it remains challenging to produce multicomponent lattices, clusters with precisely controlled symmetries and three-dimensional assemblies(16). A few schemes can efficiently produce complex colloidal structures(2,17,18), but they require system-specific procedures. Here we show that magnetic field microgradients established in a paramagnetic fluid(19,20) can serve as 'virtual moulds' to act as templates for the assembly of large numbers (similar to 10(8)) of both non-magnetic and magnetic colloidal particles with micrometre precision and typical yields of 80 to 90 per cent. We illustrate the versatility of this approach by producing single-component and multicomponent colloidal arrays, complex three-dimensional structures and a variety of colloidal molecules from polymeric particles, silica particles and live bacteria and by showing that all of these structures can be made permanent. In addition, although our magnetic moulds currently resemble optical traps in that they are limited to the manipulation of micrometre-sized objects, they are massively parallel and can manipulate non-magnetic and magnetic objects simultaneously in two and three dimensions.	[Demiroers, Ahmet F.; Pillai, Pramod P.; Kowalczyk, Bartlomiej; Grzybowski, Bartosz A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Demiroers, Ahmet F.; Pillai, Pramod P.; Kowalczyk, Bartlomiej; Grzybowski, Bartosz A.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Grzybowski, BA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	grzybor@northwestern.edu	Pillai, Pramod/G-8334-2015; Grzybowski, Bartosz A/H-5741-2017; Demirörs, Ahmet/R-9614-2019	Grzybowski, Bartosz/0000-0001-6613-4261; Demirors, Ahmet/0000-0002-2748-1516	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0000989]; Non-equilibrium Energy Research Center, Energy Frontier Research Center	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Non-equilibrium Energy Research Center, Energy Frontier Research Center	We thank P. E. Fuller for his Matlab scripts. This work was supported by the Non-equilibrium Energy Research Center, which is an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under award number DE-SC0000989.	Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Aizenberg J, 2000, PHYS REV LETT, V84, P2997, DOI 10.1103/PhysRevLett.84.2997; Bakker CJG, 2006, MAGN RESON MED, V56, P1107, DOI 10.1002/mrm.21069; Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Coey JMD, 2009, P NATL ACAD SCI USA, V106, P8811, DOI 10.1073/pnas.0900561106; Dong AG, 2011, NANO LETT, V11, P1804, DOI 10.1021/nl200468p; Erb RM, 2009, NATURE, V457, P999, DOI 10.1038/nature07766; Hochbaum AI, 2005, NANO LETT, V5, P457, DOI 10.1021/nl047990x; Hoogenboom JP, 2004, NANO LETT, V4, P205, DOI 10.1021/nl034867h; Jiang P, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2218832; Lu Y, 2001, ADV MATER, V13, P34, DOI 10.1002/1521-4095(200101)13:1<34::AID-ADMA34>3.3.CO;2-T; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Mirica KA, 2009, J AM CHEM SOC, V131, P10049, DOI 10.1021/ja900920s; Miszta K, 2011, NAT MATER, V10, P872, DOI [10.1038/NMAT3121, 10.1038/nmat3121]; Perro A, 2009, ANGEW CHEM INT EDIT, V48, P361, DOI 10.1002/anie.200802562; Rosensweig RE, 1997, FERROHYDRODYNAMICS; Shevkoplyas SS, 2007, LAB CHIP, V7, P1294, DOI 10.1039/b705045c; Shipway AN, 2000, CHEMPHYSCHEM, V1, P18, DOI 10.1002/1439-7641(20000804)1:1<18::AID-CPHC18>3.0.CO;2-L; Sun Z, 2011, J APPL PHYS, V109, DOI 10.1063/1.3579426; van Blaaderen A, 2003, SCIENCE, V301, P470; vanBlaaderen A, 1997, NATURE, V385, P321, DOI 10.1038/385321a0; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Xia YN, 2001, ADV MATER, V13, P409, DOI 10.1002/1521-4095(200103)13:6<409::AID-ADMA409>3.0.CO;2-C; Yang JC, 2010, NANO LETT, V10, P3173, DOI 10.1021/nl102078j; Yellen BB, 2005, P NATL ACAD SCI USA, V102, P8860, DOI 10.1073/pnas.0500409102; Yethiraj A, 2004, ADV MATER, V16, P596, DOI 10.1002/adma.200306192	27	145	145	3	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					99	103		10.1038/nature12591	http://dx.doi.org/10.1038/nature12591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24141949				2022-12-28	WOS:000326585600039
J	Sultan, AA; West, J; Tata, LJ; Fleming, KM; Nelson-Piercy, C; Grainge, MJ				Sultan, Alyshah Abdul; West, Joe; Tata, Laila J.; Fleming, Kate M.; Nelson-Piercy, Catherine; Grainge, Matthew J.			Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPISODE STATISTICS; PUERPERIUM; THROMBOSIS	Objective To examine the potential for preventing venous thromboembolism during and after antepartum hospital admissions in pregnant women. Design Cohort study using linked primary (Clinical Practice Research Datalink) and secondary (Hospital Episode Statistics) care records. Setting Primary and secondary care centres, England. Participants 206 785 women aged 15-44 who had one or more pregnancies from 1997 up to 2010. Main outcome measure Risk of first venous thromboembolism in pregnant women admitted to hospital for one or more days for reasons other than delivery or venous thromboembolism. Risk was assessed by calculating the absolute rate of venous thromboembolism and comparing these rates with those observed during follow-up time not associated with hospital admission using a Poisson regression model to estimate incidence rate ratios. Results Admission to hospital in pregnancy was associated with an increased risk of venous thromboembolism (absolute rate 1752/100 000 person years; incidence rate ratio 17.5, 95% confidence interval 7.69 to 40.0) compared with time outside hospital. The rate of venous thromboembolism was also high during the 28 days after discharge (absolute rate 676; 6.27, 3.74 to 10.5). The rate during and after admission combined was highest in the third trimester (961; 5.57, 3.32 to 9.34) and in those aged >= 35 years (1756; 21.7, 9.62 to 49.0). While the absolute rate in the combined period was highest for those with three or more days in hospital (1511; 12.2, 6.65 to 22.7), there was also a fourfold increase (558; 4.05, 2.23 to 7.38) in the risk of venous thromboembolism for those admitted to hospital for less than three days. Conclusion The overall risk of first venous thromboembolism in pregnant women increased during admissions to hospital not related to delivery, and remained significantly higher in the 28 days after discharge. During these periods need for thromboprophylaxis should receive careful consideration.	[Sultan, Alyshah Abdul; West, Joe; Tata, Laila J.; Fleming, Kate M.; Grainge, Matthew J.] Univ Nottingham, City Hosp, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England; [Nelson-Piercy, Catherine] St Thomas Hosp, Guys & St Thomas Fdn Trust, Womens Hlth Acad Ctr, London SE1 7EH, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Guy's & St Thomas' NHS Foundation Trust	Sultan, AA (corresponding author), Univ Nottingham, City Hosp, Div Epidemiol & Publ Hlth, Clin Sci Bldg Phase 2, Nottingham NG5 1PB, England.	alyshah.sultan@hotmail.com	West, Joe/M-3867-2019; West, Joe/I-6637-2012; Fleming, Kate M/A-6475-2010; Tata, Laila/J-5227-2012	West, Joe/0000-0002-1135-9356; West, Joe/0000-0002-1135-9356; Fleming, Kate M/0000-0002-6572-5016; Grainge, Matthew/0000-0001-7181-4042; Tata, Laila/0000-0002-6404-8658	Aga Khan Foundation; University of Nottingham	Aga Khan Foundation; University of Nottingham	AAS is funded by a scholarship awarded by the Aga Khan Foundation. JW is funded by a University of Nottingham senior clinical research fellowship, which also contributes to AAS's funding.	Burns H, 2011, BJOG-INT J OBSTET GY, V118, P5, DOI 10.1111/j.1471-0528.2010.02847.x; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Crooks C, 2013, THESIS U NOTTINGHAM; Dattani N, 2012, HLTH STAT Q, P53; Department of Health, 2013, VEN THROMB PREV PAT; Drife J, 2003, BRIT MED BULL, V67, P177, DOI 10.1093/bmb/ldg010; Eaton SC, 2008, PHARMACOEPIDEM DR S, V17, pS214; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Heit JA, 2001, MAYO CLIN PROC, V76, P1102, DOI 10.4065/76.11.1102; Jacobsen AF, 2008, J THROMB HAEMOST, V6, P905, DOI 10.1111/j.1538-7836.2008.02961.x; Knight M, 2008, BJOG-INT J OBSTET GY, V115, P453, DOI 10.1111/j.1471-0528.2007.01622.x; Larsen TB, 2007, THROMB RES, V120, P505, DOI 10.1016/j.thromres.2006.12.003; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; National Institute for Health and Clinical Excellence, 2008, DIAB PREGN MAN DIAB; National Institute for Health and Clinical Excellence, 2010, VEN THROMB RED RISK; Royal College of Obstetricians and Gynaecologist, 2010, AC MAN THROMB EMB PR, V37b; Royal College of Obstetricians and Gynaecologists, 2009, RED RISK THROMB EMB; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Sultan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070310; Thompson A, 2004, BRIT J PSYCHIAT, V185, P334, DOI 10.1192/bjp.185.4.334; Walker RL, 2009, CAN J CARDIOL, V25, pE284, DOI 10.1016/S0828-282X(09)70125-4; Wik HS, 2012, J THROMB HAEMOST, V10, P840, DOI 10.1111/j.1538-7836.2012.04690.x; Zhang J, 1997, EPIDEMIOL REV, V19, P218, DOI 10.1093/oxfordjournals.epirev.a017954	24	54	56	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2013	347								f6099	10.1136/bmj.f6099	http://dx.doi.org/10.1136/bmj.f6099			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XQ	24201164	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000326890500001
J	Turk-Browne, NB				Turk-Browne, Nicholas B.			Functional Interactions as Big Data in the Human Brain	SCIENCE			English	Review							PRIMARY VISUAL-CORTEX; FMRI CONNECTIVITY; ATTENTION; MEMORY; AREAS; NETWORKS; REPRESENTATIONS; ARCHITECTURE; SELECTION; OBJECTS	Noninvasive studies of human brain function hold great potential to unlock mysteries of the human mind. The complexity of data generated by such studies, however, has prompted various simplifying assumptions during analysis. Although this has enabled considerable progress, our current understanding is partly contingent upon these assumptions. An emerging approach embraces the complexity, accounting for the fact that neural representations are widely distributed, neural processes involve interactions between regions, interactions vary by cognitive state, and the space of interactions is massive. Because what you see depends on how you look, such unbiased approaches provide the greatest flexibility for discovery.	[Turk-Browne, Nicholas B.] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Turk-Browne, Nicholas B.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA	Princeton University; Princeton University	Turk-Browne, NB (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA.	ntb@princeton.edu			Princeton University; John Templeton Foundation; NSF [MRI BCS1229597]; NIH [R01 EY021755]; NATIONAL EYE INSTITUTE [R01EY021755] Funding Source: NIH RePORTER	Princeton University(Princeton University); John Templeton Foundation; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The author thanks N. Hindy, V. Jackson-Hanen, and Y. Wang for help with manuscript preparation; J. Cohen, K. Li, and Y. Wang for formative discussions; and A. Ghazanfar, U. Hasson, C. Honey, and K. Norman for insightful comments on an earlier draft. This work was supported by the Pyne fund from Princeton University, the John Templeton Foundation, NSF grant MRI BCS1229597, and NIH grant R01 EY021755. The opinions expressed in this paper are those of the author and do not necessarily reflect the official views of these funding sources.	Al-Aidroos N, 2012, P NATL ACAD SCI USA, V109, P14675, DOI 10.1073/pnas.1202095109; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Buckner RL, 2012, NEUROIMAGE, V62, P1137, DOI 10.1016/j.neuroimage.2011.10.035; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Kok P, 2012, NEURON, V75, P265, DOI 10.1016/j.neuron.2012.04.034; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mumford JA, 2010, NEUROIMAGE, V52, P1465, DOI 10.1016/j.neuroimage.2010.05.047; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Norman-Haignere SV, 2012, CEREB CORTEX, V22, P391, DOI 10.1093/cercor/bhr118; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Pantazatos SP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002441; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Sheppard JP, 2012, J COGNITIVE NEUROSCI, V24, P1087, DOI 10.1162/jocn_a_00210; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Stevens WD, 2010, CEREB CORTEX, V20, P1997, DOI 10.1093/cercor/bhp270; Summerfield C, 2006, PLOS BIOL, V4, P855, DOI 10.1371/journal.pbio.0040128; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Uehara T., 2013, CEREB CORTEX; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Wang L, 2012, NEURON, V76, P1010, DOI 10.1016/j.neuron.2012.09.033; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Worsley KJ, 2005, PHILOS T R SOC B, V360, P913, DOI 10.1098/rstb.2005.1637	44	115	122	3	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					580	584		10.1126/science.1238409	http://dx.doi.org/10.1126/science.1238409			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179218	Green Accepted			2022-12-28	WOS:000326334300037
J	Wang, L; Meric, I; Huang, PY; Gao, Q; Gao, Y; Tran, H; Taniguchi, T; Watanabe, K; Campos, LM; Muller, DA; Guo, J; Kim, P; Hone, J; Shepard, KL; Dean, CR				Wang, L.; Meric, I.; Huang, P. Y.; Gao, Q.; Gao, Y.; Tran, H.; Taniguchi, T.; Watanabe, K.; Campos, L. M.; Muller, D. A.; Guo, J.; Kim, P.; Hone, J.; Shepard, K. L.; Dean, C. R.			One-Dimensional Electrical Contact to a Two-Dimensional Material	SCIENCE			English	Article							BORON-NITRIDE; GRAPHENE DEVICES; DIRAC FERMIONS; METAL-GRAPHENE; HETEROSTRUCTURES; SUPERLATTICES; RESISTANCE; ELECTRONICS; INTERFACES; GROWTH	Heterostructures based on layering of two-dimensional (2D) materials such as graphene and hexagonal boron nitride represent a new class of electronic devices. Realizing this potential, however, depends critically on the ability to make high-quality electrical contact. Here, we report a contact geometry in which we metalize only the 1D edge of a 2D graphene layer. In addition to outperforming conventional surface contacts, the edge-contact geometry allows a complete separation of the layer assembly and contact metallization processes. In graphene heterostructures, this enables high electronic performance, including low-temperature ballistic transport over distances longer than 15 micrometers, and room-temperature mobility comparable to the theoretical phonon-scattering limit. The edge-contact geometry provides new design possibilities for multilayered structures of complimentary 2D materials.	[Wang, L.; Meric, I.; Shepard, K. L.; Dean, C. R.] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Wang, L.; Gao, Y.; Hone, J.; Dean, C. R.] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Huang, P. Y.; Muller, D. A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Gao, Q.; Guo, J.] Univ Florida, Dept Elect & Comp Engn, Gainesville, FL 32611 USA; [Tran, H.; Campos, L. M.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Taniguchi, T.; Watanabe, K.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Kim, P.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Dean, C. R.] CUNY City Coll, Dept Phys, New York, NY 10031 USA	Columbia University; Columbia University; Cornell University; State University System of Florida; University of Florida; Columbia University; National Institute for Materials Science; Columbia University; City University of New York (CUNY) System; City College of New York (CUNY)	Shepard, KL (corresponding author), Columbia Univ, Dept Elect Engn, New York, NY 10027 USA.	shepard@ee.columbia.edu; cdean@ccny.cuny.edu	TANIGUCHI, Takashi/H-2718-2011; Hone, James C/E-1879-2011; Wang, Lei/K-1160-2012; Gao, Qun/C-6960-2014; Gao, Qun/AAF-5151-2021; Muller, David/A-7745-2010; Kim, Philip/N-1886-2013; Campos, Luis/B-4757-2010; WATANABE, Kenji/H-2825-2011	Hone, James C/0000-0002-8084-3301; Wang, Lei/0000-0002-1919-9107; Muller, David/0000-0003-4129-0473; Kim, Philip/0000-0002-8255-0086; WATANABE, Kenji/0000-0003-3701-8119; Huang, Pinshane/0000-0002-1095-1833	Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program; National Science Foundation [DMR-1124894]; Air Force Office of Scientific Research [FA9550-09-1-0705]; Office of Naval Research (ONR) [N000141310662, N000141110633]; Defense Advanced Research Projects Agency (under ONR) [N000141210814]; Nano Material Technology Development Program through the National Research Foundation of Korea [2012M3A7B4049966]	Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research (ONR)(Office of Naval Research); Defense Advanced Research Projects Agency (under ONR); Nano Material Technology Development Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work is supported by the Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program, the National Science Foundation (DMR-1124894), the Air Force Office of Scientific Research (FA9550-09-1-0705), the Office of Naval Research (ONR) (N000141310662 and N000141110633), the Defense Advanced Research Projects Agency (under ONR Grant N000141210814), and the Nano Material Technology Development Program through the National Research Foundation of Korea (2012M3A7B4049966). We thank E. H. Hwang and S. Das Sarma for helpful discussion.	Bennett BR, 2005, SOLID STATE ELECTRON, V49, P1875, DOI 10.1016/j.sse.2005.09.008; Berdebes D, 2011, IEEE T ELECTRON DEV, V58, P3925, DOI 10.1109/TED.2011.2163800; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Chen JH, 2008, NAT NANOTECHNOL, V3, P206, DOI 10.1038/nnano.2008.58; Cho K., 2010, MRS P, V1259, pS14; Choi MS, 2011, J APPL PHYS, V110, DOI 10.1063/1.3646506; Datta S., 1997, ELECT TRANSPORT MESO; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Georgiou T, 2013, NAT NANOTECHNOL, V8, P100, DOI [10.1038/NNANO.2012.224, 10.1038/nnano.2012.224]; Giovannetti G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026803; Gong C, 2010, J APPL PHYS, V108, DOI 10.1063/1.3524232; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Hwang EH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115449; Ishigami M, 2007, NANO LETT, V7, P1643, DOI 10.1021/nl070613a; Leonard F, 2011, NAT NANOTECHNOL, V6, P773, DOI [10.1038/nnano.2011.196, 10.1038/NNANO.2011.196]; Lindvall N, 2012, J APPL PHYS, V111, DOI 10.1063/1.3695451; Liu Z, 2011, NANO LETT, V11, P2032, DOI 10.1021/nl200464j; Matsuda Y, 2010, J PHYS CHEM C, V114, P17845, DOI 10.1021/jp806437y; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Moon JS, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4719579; Orr JMS, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165334; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Robinson JA, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3549183; Smith JT, 2013, ACS NANO, V7, P3661, DOI 10.1021/nn400671z; Wang L, 2012, ACS NANO, V6, P9314, DOI 10.1021/nn304004s; Wu YH, 2012, AIP ADV, V2, DOI 10.1063/1.3684617; Xia FN, 2011, NAT NANOTECHNOL, V6, P179, DOI [10.1038/nnano.2011.6, 10.1038/NNANO.2011.6]; Xu MS, 2013, CHEM REV, V113, P3766, DOI 10.1021/cr300263a; Yamaguchi J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801927; Yang W, 2013, NAT MATER, V12, P792, DOI [10.1038/NMAT3695, 10.1038/nmat3695]	34	1805	1828	102	1520	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					614	617		10.1126/science.1244358	http://dx.doi.org/10.1126/science.1244358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179223				2022-12-28	WOS:000326334300047
J	Balewski, JB; Krupp, AT; Gaj, A; Peter, D; Buchler, HP; Low, R; Hofferberth, S; Pfau, T				Balewski, Jonathan B.; Krupp, Alexander T.; Gaj, Anita; Peter, David; Buechler, Hans Peter; Loew, Robert; Hofferberth, Sebastian; Pfau, Tilman			Coupling a single electron to a Bose-Einstein condensate	NATURE			English	Article							CREATION; ION	The coupling of electrons to matter lies at the heart of our understanding of material properties such as electrical conductivity. Electron-phonon coupling can lead to the formation of a Cooper pair out of two repelling electrons, which forms the basis for Bardeen-Cooper-Schrieffer superconductivity(1). Here we study the interaction of a single localized electron with a Bose-Einstein condensate and show that the electron can excite phonons and eventually trigger a collective oscillation of the whole condensate. We find that the coupling is surprisingly strong compared to that of ionic impurities, owing to the more favourable mass ratio. The electron is held in place by a single charged ionic core, forming a Rydberg bound state. This Rydberg electron is described by a wavefunction extending to a size of up to eight micrometres, comparable to the dimensions of the condensate. In such a state, corresponding to a principal quantum number of n = 202, the Rydberg electron is interacting with several tens of thousands of condensed atoms contained within its orbit. We observe surprisingly long lifetimes and finite size effects caused by the electron exploring the outer regions of the condensate. We anticipate future experiments on electron orbital imaging, the investigation of phonon-mediated coupling of single electrons, and applications in quantum optics.	[Balewski, Jonathan B.; Krupp, Alexander T.; Gaj, Anita; Loew, Robert; Hofferberth, Sebastian; Pfau, Tilman] Univ Stuttgart, Phys Inst 5, D-70569 Stuttgart, Germany; [Peter, David; Buechler, Hans Peter] Univ Stuttgart, Inst Theoret Phys 3, D-70569 Stuttgart, Germany	University of Stuttgart; University of Stuttgart	Pfau, T (corresponding author), Univ Stuttgart, Phys Inst 5, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.	t.pfau@physik.uni-stuttgart.de	Loew, Robert/I-8206-2014; Pfau, Tilman/G-1774-2011; Büchler, Hans Peter/M-6543-2018; Hofferberth, Sebastian/G-7076-2019; Peter, David/A-2669-2013	Pfau, Tilman/0000-0003-3272-3468; Büchler, Hans Peter/0000-0002-7233-6828; Hofferberth, Sebastian/0000-0003-0309-9715; Peter, David/0000-0001-7950-9915	Deutsche Forschungsgemeinschaft (DFG) [SFB/TRR21, PF 381/4-2]; ERC [267100]; EU Marie Curie programme ITN-Coherence [265031]; DFG [HO 4787/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); EU Marie Curie programme ITN-Coherence; DFG(German Research Foundation (DFG))	We thank K. Rzazewski and J. Hecker Denschlag for discussions and C. Tresp for setting up the Rydberg laser system. This work was funded by the Deutsche Forschungsgemeinschaft (DFG) within SFB/TRR21 and project PF 381/4-2. We also acknowledge support by the ERC under contract number 267100, and A. G. acknowledges support from EU Marie Curie programme ITN-Coherence 265031. S. H. is supported by the DFG through project HO 4787/1-1.	Amaldi E, 1934, NATURE, V133, P141, DOI 10.1038/133141a0; Bahrim C, 2001, J PHYS B-AT MOL OPT, V34, pL195, DOI 10.1088/0953-4075/34/6/107; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Bendkowsky V, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.163201; Bendkowsky V, 2009, NATURE, V458, P1005, DOI 10.1038/nature07945; Beterov II, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052504; Butscher B, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/18/184004; Ciampini D, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043409; Fermi E., 1934, NUOVO CIMENTO, V11, P157, DOI DOI 10.1007/BF02959829; FISHER DS, 1979, PHYS REV LETT, V42, P798, DOI 10.1103/PhysRevLett.42.798; Greene CH, 2000, PHYS REV LETT, V85, P2458, DOI 10.1103/PhysRevLett.85.2458; Harter A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.123201; Honer J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.093601; Low R, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/11/113001; Massignan P, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.023606; Platzman PM, 1999, SCIENCE, V284, P1967, DOI 10.1126/science.284.5422.1967; Ratschbacher L, 2012, NAT PHYS, V8, P649, DOI [10.1038/nphys2373, 10.1038/NPHYS2373]; RAYFIELD GW, 1963, PHYS REV LETT, V11, P305, DOI 10.1103/PhysRevLett.11.305; REIF F, 1960, PHYS REV, V119, P1164, DOI 10.1103/PhysRev.119.1164; Reinhard A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.233201; Robert A, 2001, SCIENCE, V292, P461, DOI 10.1126/science.1060622; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schirotzek A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230402; Shin Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.090403; Zipkes C, 2010, NATURE, V464, P388, DOI 10.1038/nature08865	25	115	115	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					664	667		10.1038/nature12592	http://dx.doi.org/10.1038/nature12592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24172977	Green Submitted			2022-12-28	WOS:000326293200043
J	Johnson, A				Johnson, Andy			Radiation and Atomic Literacy for Nonscientists	SCIENCE			English	Editorial Material									Black Hills State Univ, Ctr Adv Math & Sci Educ CAMSE, Spearfish, SD 57799 USA	Black Hills State University	Johnson, A (corresponding author), Black Hills State Univ, Ctr Adv Math & Sci Educ CAMSE, 1200 Univ St, Spearfish, SD 57799 USA.	andy.johnson@bhsu.edu			Direct For Education and Human Resources [0942699] Funding Source: National Science Foundation	Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		Brewe E, 2009, PHYS REV SPEC TOP-PH, V5, DOI 10.1103/PhysRevSTPER.5.013102; Curtright A, 2010, IEEE I SYMP SUST SYS; Eijkelhof H. M. C., 1990, RADIATION AND RISK I; Etkina E, 2010, J LEARN SCI, V19, P54, DOI 10.1080/10508400903452876; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Maidl R., 2012, PROCEEDINGS OF THE 2; Malone KL, 2008, PHYS REV SPEC TOP-PH, V4, DOI 10.1103/PhysRevSTPER.4.020107; Millar R., 1996, Physics Education, V31, P27, DOI 10.1088/0031-9120/31/1/019; Prather E., 2001, J COLL SCI TEACH, V31, P89	9	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					436	437		10.1126/science.1230003	http://dx.doi.org/10.1126/science.1230003			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159038				2022-12-28	WOS:000326042600031
J	Ellis, O				Ellis, Oliver			Cheap doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Mersey Deanery, Liverpool L3 4BL, Merseyside, England		Ellis, O (corresponding author), Mersey Deanery, Liverpool L3 4BL, Merseyside, England.	oli.ellis@googlemail.com						BMA, NEG PROF BMA CALLS P; Borland S, 2013, DAILY MAIL; Hope C, 2013, TELEGRAPH	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2013	347								f6301	10.1136/bmj.f6301	http://dx.doi.org/10.1136/bmj.f6301			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CF	24144969				2022-12-28	WOS:000326293500004
J	Hodes, G				Hodes, Gary			Perovskite-Based Solar Cells	SCIENCE			English	Editorial Material							DEPOSITION		Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Hodes, G (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	gary.hodes@weizmann.ac.il	HODES, GARY/K-1579-2012					Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Cartwright J., 2013, SCIENCENOW; Edri E, 2013, J PHYS CHEM LETT, V4, P897, DOI 10.1021/jz400348q; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Mitzi DB, 2001, J CHEM SOC DALTON, P1, DOI 10.1039/b007070j; Nayak PK, 2011, ADV MATER, V23, P2870, DOI 10.1002/adma.201100877; Stoumpos CC, 2013, INORG CHEM, V52, P9019, DOI 10.1021/ic401215x; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167	11	633	650	18	1199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					317	318		10.1126/science.1245473	http://dx.doi.org/10.1126/science.1245473			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136955				2022-12-28	WOS:000325755100029
J	Hill, MD				Hill, Michael D.			Adding clopidogrel to aspirin after TIA or minor ischemic stroke reduced stroke without increasing bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ATTACK; TRIAL; RISK		Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary	Hill, MD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.		Hill, Michael D/C-9073-2012	Hill, Michael D/0000-0002-6269-1543				Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Wu CM, 2007, ARCH INTERN MED, V167, P2417, DOI 10.1001/archinte.167.22.2417	5	0	0	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC5	10.7326/0003-4819-159-8-201310150-02005	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126666				2022-12-28	WOS:000326751200004
J	Padwal, R				Padwal, Raj			Review: Bariatric surgery improves weight and glycemia in nonmorbidly obese adults with diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GASTRIC BYPASS; MELLITUS		Univ Alberta, Edmonton, AB, Canada	University of Alberta	Padwal, R (corresponding author), Univ Alberta, Edmonton, AB, Canada.							Arterburn DE, 2013, OBES SURG, V23, P93, DOI 10.1007/s11695-012-0802-1; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC3	10.7326/0003-4819-159-8-201310150-02003	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126664				2022-12-28	WOS:000326751200002
J	Tardiff, DF; Jui, NT; Khurana, V; Tambe, MA; Thompson, ML; Chung, CY; Kamadurai, HB; Kim, HT; Lancaster, AK; Caldwell, KA; Caldwell, GA; Rochet, JC; Buchwald, SL; Lindquist, S				Tardiff, Daniel F.; Jui, Nathan T.; Khurana, Vikram; Tambe, Mitali A.; Thompson, Michelle L.; Chung, Chee Yeun; Kamadurai, Hari B.; Kim, Hyoung Tae; Lancaster, Alex K.; Caldwell, Kim A.; Caldwell, Guy A.; Rochet, Jean-Christophe; Buchwald, Stephen L.; Lindquist, Susan			Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates alpha-Synuclein Toxicity in Neurons	SCIENCE			English	Article							VESICLE TRAFFICKING; PROTEIN; PHOSPHORYLATION; CEREVISIAE; DEFECTS; VPS35	alpha-Synuclein (alpha-syn) is a small lipid-binding protein implicated in several neurodegenerative diseases, including Parkinson's disease, whose pathobiology is conserved from yeast to man. There are no therapies targeting these underlying cellular pathologies, or indeed those of any major neurodegenerative disease. Using unbiased phenotypic screens as an alternative to target-based approaches, we discovered an N-aryl benzimidazole (NAB) that strongly and selectively protected diverse cell types from alpha-syn toxicity. Three chemical genetic screens in wild-type yeast cells established that NAB promoted endosomal transport events dependent on the E3 ubiquitin ligase Rsp5/Nedd4. These same steps were perturbed by alpha-syn itself. Thus, NAB identifies a druggable node in the biology of alpha-syn that can correct multiple aspects of its underlying pathology, including dysfunctional endosomal and endoplasmic reticulum-to-Golgi vesicle trafficking.	[Tardiff, Daniel F.; Khurana, Vikram; Chung, Chee Yeun; Lancaster, Alex K.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jui, Nathan T.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Khurana, Vikram] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Khurana, Vikram] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Tambe, Mitali A.; Rochet, Jean-Christophe] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Thompson, Michelle L.; Caldwell, Kim A.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Kamadurai, Hari B.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38018 USA; [Kim, Hyoung Tae] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alabama System; University of Alabama Tuscaloosa; St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Tambe, Mitali/AGX-3558-2022; Lancaster, Alexander K/K-2855-2013; Kamadurai, Hari/K-4056-2013	Tambe, Mitali/0000-0001-9389-2308; Lancaster, Alexander K/0000-0002-0002-9263; Thompson, Michelle/0000-0001-8134-9017; Khurana, Vikram/0000-0002-4018-5527; Caldwell, Kim/0000-0003-1580-6122; Caldwell, Guy/0000-0002-8283-9090; Kamadurai, Hari/0000-0001-8218-7777; Rochet, Jean-Christophe/0000-0002-6484-1541; Kim, Hyoung Tae/0000-0002-0270-2749; HyoungTae, Kim/0000-0002-2482-6064; Kamadurai, Hari/0000-0001-9021-0279	NIH [5R01GM069530, GM58160]; National Research Service Award (NRSA) fellowship [F32NS061419, F32GM099817]; JPB Foundation; Eleanor Schwartz Charitable Foundation; HHMI; Bachmann-Strauss Dystonia & Parkinson Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530, R01GM058160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061419, R15NS075684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG038546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award (NRSA) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Eleanor Schwartz Charitable Foundation; HHMI(Howard Hughes Medical Institute); Bachmann-Strauss Dystonia & Parkinson Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Kumar for providing the plasmid Tn7 library; B. Wendland and L. Hicke for the Rsp5 antibody; the WIBR Genome Technology Core for Illumina Sequencing; B. Schulman (B. Schulman and H.B.K. were funded by NIH grant 5R01GM069530) and A. Goldberg for help with in vitro ubiquitination assays; T. DiCesare for graphics support; and members of the Lindquist Lab for helpful comments on the manuscript. S.L. is an investigator for HHMI. D.F.T. was funded by a National Research Service Award (NRSA) fellowship F32NS061419 and research supported by the JPB Foundation (D.F.T. and S.L.), the Eleanor Schwartz Charitable Foundation, and an HHMI Collaborative Innovation Award (D.F.T., V.K., C.Y.C., and S.L.; G.A.C., K.A.C., and M.L.T.; and J.-C.R. and M.A.T.). N.T.J. was funded by a NRSA fellowship (F32GM099817), and N.T.J. and S.L.B. were funded by NIH grant GM58160. H.T.K. was funded by the Bachmann-Strauss Dystonia & Parkinson Foundation. Genome sequencing data are deposited in the National Center for Biotechnology Information under BioProject accession number PRJNA222476. WIBR and MIT have filed a patent application, on which D.F.T., N.T.J., S.L.B., and S.L. are inventors, relating to use of compounds described here in treatment of neurodegenerative diseases. In addition, S.L. is an inventor on patents and patent applications filed by the University of Chicago relating to methods of screening for compounds that decrease alpha-syn-associated toxicity using yeast that express alpha-syn. All the yeast plasmids and strains and NAB are available under a Uniform Biological Material Transfer Agreement from the Whitehead Institute.	Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Esposito G, 2012, DEV NEUROBIOL, V72, P134, DOI 10.1002/dneu.20916; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kumar Anuj, 2008, V416, P117, DOI 10.1007/978-1-59745-321-9_8; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; MacDonald C, 2012, TRAFFIC, V13, P586, DOI 10.1111/j.1600-0854.2011.01326.x; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Menant A, 2006, EMBO J, V25, P4436, DOI 10.1038/sj.emboj.7601330; Omura F, 2001, FEMS MICROBIOL LETT, V194, P207, DOI 10.1016/S0378-1097(00)00532-2; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sancenon V, 2012, HUM MOL GENET, V21, P2432, DOI 10.1093/hmg/dds058; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith AM, 2010, PHARMACOL THERAPEUT, V127, P156, DOI 10.1016/j.pharmthera.2010.04.012; Soper JH, 2011, J MOL NEUROSCI, V43, P391, DOI 10.1007/s12031-010-9455-5; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	25	189	194	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					979	983		10.1126/science.1245321	http://dx.doi.org/10.1126/science.1245321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24158909	Green Accepted, Green Submitted			2022-12-28	WOS:000327223500043
J	Nakamura, Y; Oscherwitz, J; Cease, KB; Chan, SM; Munoz-Planillo, R; Hasegawa, M; Villaruz, AE; Cheung, GYC; McGavin, MJ; Travers, JB; Otto, M; Inohara, N; Nunez, G				Nakamura, Yuumi; Oscherwitz, Jon; Cease, Kemp B.; Chan, Susana M.; Munoz-Planillo, Raul; Hasegawa, Mizuho; Villaruz, Amer E.; Cheung, Gordon Y. C.; McGavin, Martin J.; Travers, Jeffrey B.; Otto, Michael; Inohara, Naohiro; Nunez, Gabriel			Staphylococcus delta-toxin induces allergic skin disease by activating mast cells	NATURE			English	Article							AUREUS; VIRULENCE; IGE; MICE; IDENTIFICATION; DEFICIENT; RESPONSES; RELEASE; GROWTH; PHASE	Atopic dermatitis is a chronic inflammatory skin disease that affects 15-30% of children and approximately 5% of adults in industrialized countries(1). Although the pathogenesis of atopic dermatitis is not fully understood, the disease is mediated by an abnormal immunoglobulin E immune response in the setting of skin barrier dysfunction(2). Mast cells contribute to immunoglobulin-E-mediated allergic disorders including atopic dermatitis(3). Upon activation, mast cells release their membrane-bound cytosolic granules leading to the release of several molecules that are important in the pathogenesis of atopic dermatitis and host defence(4). More than 90% of patients with atopic dermatitis are colonized with Staphylococcus aureus in the lesional skin whereas most healthy individuals do not harbour the pathogen(5). Several staphylococcal exotoxins can act as superantigens and/or antigens in models of atopic dermatitis(6). However, the role of these staphylococcal exotoxins in disease pathogenesis remains unclear. Here we report that culture supernatants of S. aureus contain potent mast-cell degranulation activity. Biochemical analysis identified delta-toxin as the mast cell degranulation-inducing factor produced by S. aureus. Mast cell degranulation induced by delta-toxin depended on phosphoinositide 3-kinase and calcium (Ca2+) influx; however, unlike that mediated by immunoglobulin-E crosslinking, it did not require the spleen tyrosine kinase. In addition, immunoglobulin-E enhanced delta-toxin-induced mast cell degranulation in the absence of antigen. Furthermore, S. aureus isolates recovered from patients with atopic dermatitis produced large amounts of delta-toxin. Skin colonization with S. aureus, but not a mutant deficient in delta-toxin, promoted immunoglobulin-E and interleukin-4 production, as well as inflammatory skin disease. Furthermore, enhancement of immunoglobulin E production and dermatitis by delta-toxin was abrogated in Kit(W-sh/W-sh) mast-cell-deficient mice and restored by mast cell reconstitution. These studies identify delta-toxin as a potent inducer of mast cell degranulation and suggest a mechanistic link between S. aureus colonization and allergic skin disease.	[Nakamura, Yuumi; Chan, Susana M.; Munoz-Planillo, Raul; Hasegawa, Mizuho; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Nakamura, Yuumi; Chan, Susana M.; Munoz-Planillo, Raul; Hasegawa, Mizuho; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Oscherwitz, Jon; Cease, Kemp B.] Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Oscherwitz, Jon; Cease, Kemp B.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA; [Villaruz, Amer E.; Cheung, Gordon Y. C.; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, US Natl Inst Hlth, Bethesda, MD 20892 USA; [McGavin, Martin J.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [McGavin, Martin J.] Univ Western Ontario, Ctr Human Immunol, London, ON N6A 5C1, Canada; [Travers, Jeffrey B.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Western University (University of Western Ontario); Western University (University of Western Ontario); Indiana University System; Indiana University Bloomington	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Nakamura, Yuumi/H-8459-2017; Nuñez, Gabriel/A-7160-2014	Nakamura, Yuumi/0000-0001-6256-8302; McGavin, Martin/0000-0001-5955-0689; Travers, Jeffrey/0000-0001-7232-1039; Otto, Michael/0000-0002-2222-4115	Chiba University Global COE Program; Cell Science Research Foundation; Kanae Foundation for the Promotion of Medical Science; Department of Veterans Affairs [I01BX000429]; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIH [R01AR059688, R01HL062996]; University of Michigan's Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059688] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000429] Funding Source: NIH RePORTER	Chiba University Global COE Program; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Kanae Foundation for the Promotion of Medical Science; Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center(University of Michigan System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank S. Koonse for animal husbandry, J. Whitfield for enzyme-linked immunosorbent assays, S. Meshinchi for electron microscopy, V. Basrur for mass spectrometry, K. Kidwell for advice with statistical analysis, M. K. Oyoshi and R. S. Geha for experimental advice, V. Y. Tan for help with constructing the LAC P3-lux strain and A. Burberry for reviewing the manuscript. Y.N. was supported by fellowships from the Chiba University Global COE Program, the Cell Science Research Foundation and the Kanae Foundation for the Promotion of Medical Science. J.O. and K.B.C. were supported by Department of Veterans Affairs Merit Award I01BX000429. A.E.V., G.Y.C.C. and M.O. were supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). This work supported by NIH grants R01AR059688 to G.N. and R01HL062996 to J.B.T. and funds to the Michigan Comprehensive Cancer Center Immunology Monitoring Core from the University of Michigan's Cancer Center Support Grant.	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Elias PM, 2008, J INVEST DERMATOL, V128, P1067, DOI 10.1038/jid.2008.88; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; LEUNG DYM, 1993, J INVEST DERMATOL, V100, P225, DOI 10.1111/1523-1747.ep12468941; LEUNG DYM, 1990, J ALLERGY CLIN IMMUN, V85, P927, DOI 10.1016/0091-6749(90)90079-J; Liu FT, 2011, CLIN REV ALLERG IMMU, V41, P298, DOI 10.1007/s12016-011-8252-4; Luong TT, 2007, J MICROBIOL METH, V70, P186, DOI 10.1016/j.mimet.2007.04.007; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; MILLER RD, 1973, APPL MICROBIOL, V25, P800, DOI 10.1128/AEM.25.5.800-806.1973; Morfeldt E, 1996, MOL MICROBIOL, V21, P1227, DOI 10.1046/j.1365-2958.1996.751447.x; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rudikoff D, 1998, LANCET, V351, P1715, DOI 10.1016/S0140-6736(97)12082-7; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Seidl K, 2011, ANTIMICROB AGENTS CH, V55, P5631, DOI 10.1128/AAC.05251-11; Selander C, 2009, J IMMUNOL, V182, P4208, DOI 10.4049/jimmunol.0800885; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Sugiyama Y, 2009, J CLIN MICROBIOL, V47, P1528, DOI 10.1128/JCM.01497-08; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Travers JB, 2010, J ALLERGY CLIN IMMUN, V125, P146, DOI 10.1016/j.jaci.2009.09.052; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Williams H, 2006, J ALLERGY CLIN IMMUN, V118, P209, DOI 10.1016/j.jaci.2006.04.043; Yamada N, 2003, J INVEST DERMATOL, V121, P1425, DOI 10.1046/j.1523-1747.2003.12613.x; Yeung M, 2011, MICROBES INFECT, V13, P189, DOI 10.1016/j.micinf.2010.10.023	34	309	329	6	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					397	+		10.1038/nature12655	http://dx.doi.org/10.1038/nature12655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24172897	Green Accepted			2022-12-28	WOS:000327163200041
J	Kilpinen, H; Waszak, SM; Gschwind, AR; Raghav, SK; Witwicki, RM; Orioli, A; Migliavacca, E; Wiederkehr, M; Gutierrez-Arcelus, M; Panousis, NI; Yurovsky, A; Lappalainen, T; Romano-Palumbo, L; Planchon, A; Bielser, D; Bryois, J; Padioleau, I; Udin, G; Thurnheer, S; Hacker, D; Core, LJ; Lis, JT; Hernandez, N; Reymond, A; Deplancke, B; Dermitzakis, ET				Kilpinen, Helena; Waszak, Sebastian M.; Gschwind, Andreas R.; Raghav, Sunil K.; Witwicki, Robert M.; Orioli, Andrea; Migliavacca, Eugenia; Wiederkehr, Michael; Gutierrez-Arcelus, Maria; Panousis, Nikolaos I.; Yurovsky, Alisa; Lappalainen, Tuuli; Romano-Palumbo, Luciana; Planchon, Alexandra; Bielser, Deborah; Bryois, Julien; Padioleau, Ismael; Udin, Gilles; Thurnheer, Sarah; Hacker, David; Core, Leighton J.; Lis, John T.; Hernandez, Nouria; Reymond, Alexandre; Deplancke, Bart; Dermitzakis, Emmanouil T.			Coordinated Effects of Sequence Variation on DNA Binding, Chromatin Structure, and Transcription	SCIENCE			English	Article								DNA sequence variation has been associated with quantitative changes in molecular phenotypes such as gene expression, but its impact on chromatin states is poorly characterized. To understand the interplay between chromatin and genetic control of gene regulation, we quantified allelic variability in transcription factor binding, histone modifications, and gene expression within humans. We found abundant allelic specificity in chromatin and extensive local, short-range, and long-range allelic coordination among the studied molecular phenotypes. We observed genetic influence on most of these phenotypes, with histone modifications exhibiting strong context-dependent behavior. Our results implicate transcription factors as primary mediators of sequence-specific regulation of gene expression programs, with histone modifications frequently reflecting the primary regulatory event.	[Kilpinen, Helena; Gutierrez-Arcelus, Maria; Panousis, Nikolaos I.; Yurovsky, Alisa; Lappalainen, Tuuli; Romano-Palumbo, Luciana; Planchon, Alexandra; Bielser, Deborah; Bryois, Julien; Padioleau, Ismael; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Kilpinen, Helena; Waszak, Sebastian M.; Gschwind, Andreas R.; Migliavacca, Eugenia; Gutierrez-Arcelus, Maria; Panousis, Nikolaos I.; Yurovsky, Alisa; Lappalainen, Tuuli; Bryois, Julien; Padioleau, Ismael; Deplancke, Bart; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Kilpinen, Helena; Gutierrez-Arcelus, Maria; Panousis, Nikolaos I.; Yurovsky, Alisa; Lappalainen, Tuuli; Bryois, Julien; Padioleau, Ismael; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Waszak, Sebastian M.; Raghav, Sunil K.; Udin, Gilles; Deplancke, Bart] Swiss Fed Inst Technol EPFL, Sch Life Sci, Inst Bioengn, Lab Syst Biol & Genet, CH-1015 Lausanne, Switzerland; [Gschwind, Andreas R.; Witwicki, Robert M.; Orioli, Andrea; Migliavacca, Eugenia; Wiederkehr, Michael; Hernandez, Nouria; Reymond, Alexandre] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1011 Lausanne, Switzerland; [Thurnheer, Sarah; Hacker, David] Swiss Fed Inst Technol EPFL, Sch Life Sci, Prot Express Core Facil, CH-1015 Lausanne, Switzerland; [Core, Leighton J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Dermitzakis, Emmanouil T.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia	University of Geneva; Swiss Institute of Bioinformatics; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; King Abdulaziz University	Hernandez, N (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1011 Lausanne, Switzerland.	nouria.hernandez@unil.ch; alexandre.reymond@unil.ch; bart.deplancke@epfl.ch; emmanouil.dermitzakis@unige.ch	Waszak, Sebastian M./D-7828-2015; Kutalik, Zoltan/HHZ-5697-2022; Padioleau, Ismaël/AAE-8927-2019; Lappalainen, Tuuli/AAE-6532-2020; Raghav, Sunil/AAL-1121-2021	Waszak, Sebastian M./0000-0003-3042-9521; Kutalik, Zoltan/0000-0001-8285-7523; Padioleau, Ismaël/0000-0003-4935-3248; Lappalainen, Tuuli/0000-0002-7746-8109; Gschwind, Andreas/0000-0002-0769-6907; Hernandez, Nouria/0000-0003-1465-4585; Deplancke, Bart/0000-0001-9935-843X; Kilpinen, Helena/0000-0001-6692-6154; Bryois, Julien/0000-0002-4747-2166; Panousis, Nikolaos/0000-0003-2890-5592; Reymond, Alexandre/0000-0003-1030-8327	Swiss National Science Foundation [CRSI33_130326, 31003A_132958, 31003A_130342, 31003A_129835]; European Research Council; Louis-Jeantet Foundation; European Molecular Biology Organization fellowship ALTF [2010-337]; doctoral school of the Faculty of Biology and Medicine, University of Lausanne; NCCR Frontiers in Genetics Program; Japanese-Swiss Science and Technology Cooperation Program (Japan Science and Technology Agency/ETH Zurich); Ecole Polytechnique Federale de Lausanne; NIH [HG004845, GM25232]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025232, R01GM025232] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Louis-Jeantet Foundation; European Molecular Biology Organization fellowship ALTF; doctoral school of the Faculty of Biology and Medicine, University of Lausanne; NCCR Frontiers in Genetics Program; Japanese-Swiss Science and Technology Cooperation Program (Japan Science and Technology Agency/ETH Zurich); Ecole Polytechnique Federale de Lausanne; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by Swiss National Science Foundation grants CRSI33_130326 (E. T. D., B. D., A. R., N.H.), 31003A_132958 (N. H.), 31003A_130342 (E. T. D.), and 31003A_129835 (A. R.); the European Research Council (E. T. D.); the Louis-Jeantet Foundation (E. T. D.); European Molecular Biology Organization fellowship ALTF 2010-337 (H. K.); a fellowship from the doctoral school of the Faculty of Biology and Medicine, University of Lausanne (R. M. W.); the NCCR Frontiers in Genetics Program (M. G.-A., J.B., E. T. D., B. D.); the Japanese-Swiss Science and Technology Cooperation Program (Japan Science and Technology Agency/ETH Zurich) (B. D.); Ecole Polytechnique Federale de Lausanne (B. D.); and NIH grants HG004845 and GM25232 (J.T.L.). The computations were performed at the Vital-IT (www.vital-it.ch) Center for High-Performance Computing of the Swiss Institute of Bioinformatics. All data in this publication are available through ArrayExpress (www.ebi.ac.uk/arrayexpress/) under accession numbers E-MTAB-1883 (RNA-seq), E-MTAB-1884 (CHiP-seq), and E-MTAB-1885 (GRO-seq). The authors declare no competing financial interests.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hobert O, 2011, CURR BIOL, V21, pR146, DOI 10.1016/j.cub.2011.01.005; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006	22	248	251	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					744	747		10.1126/science.1242463	http://dx.doi.org/10.1126/science.1242463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24136355	Green Accepted, Green Submitted			2022-12-28	WOS:000326647600045
J	Hofmann, GE				Hofmann, Gretchen E.			The long shadow of the shutdown	NATURE			English	Editorial Material							ECOSYSTEM; IMPACT		Univ Calif Santa Barbara, Santa Barbara, CA 93016 USA	University of California System; University of California Santa Barbara	Hofmann, GE (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93016 USA.	hofmann@lifesci.ucsb.edu						Barrett JE, 2008, GLOBAL CHANGE BIOL, V14, P1734, DOI 10.1111/j.1365-2486.2008.01611.x; Chambert T, 2012, P ROY SOC B-BIOL SCI, V279, P4532, DOI 10.1098/rspb.2012.1733; Doran PT, 2002, NATURE, V415, P517, DOI 10.1038/nature710; Hansen SE, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002576; Hofmann GE, 2013, OCEANOGRAPHY, V26, P140, DOI 10.5670/oceanog.2013.56; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; Munday PL, 2012, J EXP BIOL, V215, P3865, DOI 10.1242/jeb.074765	8	1	1	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					431	432		10.1038/502431a	http://dx.doi.org/10.1038/502431a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	238YN	24159622	Bronze			2022-12-28	WOS:000325988400017
J	Long, H; Zhang, GY; Lu, QJ				Long, Hai; Zhang, Guiying; Lu, Qianjin			A Persistent Red Crusted Plaque on the Back	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHROMOBLASTOMYCOSIS		[Long, Hai; Zhang, Guiying; Lu, Qianjin] Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha, Hunan, Peoples R China	Central South University	Lu, QJ (corresponding author), Second Xiangya Hosp, Dept Dermatol, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.	qianlu5860@gmail.com						Ameen M, 2009, CLIN EXP DERMATOL, V34, P849, DOI 10.1111/j.1365-2230.2009.03415.x; Bonifaz A, 2004, EXPERT OPIN PHARMACO, V5, P247, DOI 10.1517/14656566.5.2.247; Gupta AK, 2002, MED MYCOL, V40, P529; Jamil A, 2012, MED MYCOL, V50, P99, DOI 10.3109/13693786.2011.571295; Lu S, 2013, MYCOPATHOLOGIA, V175, P489, DOI 10.1007/s11046-012-9586-z; Martinez RL, 2007, CLIN DERMATOL, V25, P188, DOI 10.1016/j.clindermatol.2006.05.007; Queiroz-Telles F, 2009, MED MYCOL, V47, P3, DOI 10.1080/13693780802538001; Tamura Kana, 2012, Tokai J Exp Clin Med, V37, P6	8	2	3	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1730	1731		10.1001/jama.2013.280288	http://dx.doi.org/10.1001/jama.2013.280288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24150469				2022-12-28	WOS:000325948500029
J	Boseley, S				Boseley, Sarah			Esther Madudu: standing up for mothers in Africa	LANCET			English	Biographical-Item																		MADUDU E, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1321	1321		10.1016/S0140-6736(13)62128-5	http://dx.doi.org/10.1016/S0140-6736(13)62128-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	24139112				2022-12-28	WOS:000325975700010
J	Thiruchelvam, PTR; McNeill, F; Jallali, N; Harris, P; Hogben, K				Thiruchelvam, Paul T. R.; McNeill, Fiona; Jallali, Navid; Harris, Paul; Hogben, Katy			Post-mastectomy breast reconstruction	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONTRALATERAL PROPHYLACTIC MASTECTOMY; SKIN-SPARING MASTECTOMY; NIPPLE-AREOLAR COMPLEX; NEOADJUVANT CHEMOTHERAPY; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATIONS; IMMEDIATE RECONSTRUCTION; ADJUVANT CHEMOTHERAPY; CANCER PREVALENCE; TISSUE EXPANDER		[Thiruchelvam, Paul T. R.; Jallali, Navid; Hogben, Katy] Charing Cross Hosp, Imperial Coll NHS Trust, London W6 8RF, England; [McNeill, Fiona; Harris, Paul] Royal Marsden Hosp, London SW3 6JJ, England	Imperial College London; Royal Marsden NHS Foundation Trust	Thiruchelvam, PTR (corresponding author), Charing Cross Hosp, Imperial Coll NHS Trust, London W6 8RF, England.	paul.thiruchelvam@imperial.ac.uk						Albornoz C, 2012, PLAST RECONSTR SURG, V130, P3441; Albornoz CR, 2012, PLAST RECONSTR SURG, V129, P1071, DOI 10.1097/PRS.0b013e31824a29c5; Alderman AK, 2002, PLAST RECONSTR SURG, V109, P2265, DOI 10.1097/00006534-200206000-00015; Alderman AK, 2010, CANCER-AM CANCER SOC, V116, P1791, DOI 10.1002/cncr.24891; Allweis TM, 2002, AM J SURG, V183, P218, DOI 10.1016/S0002-9610(02)00793-6; [Anonymous], 2011, NATL MASTECTOMY BREA; Bates T, 2009, BRIT J CANCER, V101, P395, DOI 10.1038/sj.bjc.6605155; Behranwala KA, 2006, J PLAST RECONSTR AES, V59, P1043, DOI 10.1016/j.bjps.2006.01.051; BENTZEN SM, 1989, INT J RADIAT BIOL, V56, P711, DOI 10.1080/09553008914551941; Blondeel PN, 2003, CLIN PLAST SURG, V30, P371, DOI 10.1016/S0094-1298(03)00038-5; BORGER JH, 1994, INT J RADIAT ONCOL, V30, P1073, DOI 10.1016/0360-3016(94)90312-3; Buck DW, 2010, BREAST, V19, P521, DOI 10.1016/j.breast.2010.05.017; Carlson GW, 2011, INT J SURG ONCOL, V2011, DOI 10.1155/2011/396901; Chen CM, 2007, PLAST RECONSTR SURG, V120, P1477, DOI 10.1097/01.prs.0000288014.76151.f7; Christensen BO, 2011, ACTA ONCOL, V50, P1053, DOI 10.3109/0284186X.2011.584554; Clough KB, 2002, PLAST RECONSTR SURG, V109, P1904, DOI 10.1097/00006534-200205000-00020; Cold S, 2005, BRIT J CANCER, V93, P627, DOI 10.1038/sj.bjc.6602734; Collette S, 2008, EUR J CANCER, V44, P2587, DOI 10.1016/j.ejca.2008.07.032; Cowen D, 2010, BREAST CANCER RES TR, V121, P627, DOI 10.1007/s10549-010-0791-5; D'Souza N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008674.pub2; Didier F, 2009, BREAST CANCER RES TR, V118, P623, DOI 10.1007/s10549-008-0238-4; Fischer JP, 2013, PLAST RECONSTR SURG, V131, P928, DOI 10.1097/PRS.0b013e3182865977; Gagnon AR, 2006, SEMIN PLAST SURG, V20, P79, DOI DOI 10.1055/S-2006-941714; Gart MS, 2013, J AM COLL SURGEONS, V216, P229, DOI 10.1016/j.jamcollsurg.2012.11.003; Garvey PB, 2006, PLAST RECONSTR SURG, V117, P1711, DOI 10.1097/01.prs.0000210679.77449.7d; Goh SCJ, 2011, J PLAST RECONSTR AES, V64, P360, DOI 10.1016/j.bjps.2010.05.010; Gould DJ, 2013, PLAST RECONSTR SURG, V132, p330E, DOI 10.1097/PRS.0b013e31829ace49; Habermann EB, 2010, J CLIN ONCOL, V28, P3437, DOI 10.1200/JCO.2009.27.6774; Hamahata A, 2013, BREAST CANC; Health Do, 2013, PROGR REPORT ONE YEA; Hu ES, 2009, PLAST RECONSTR SURG, V124, P1, DOI 10.1097/PRS.0b013e3181ab10b2; Hu YY, 2011, CANCER-AM CANCER SOC, V117, P2833, DOI 10.1002/cncr.25872; Illouz YG, 2009, AESTHET PLAST SURG, V33, P706, DOI 10.1007/s00266-009-9377-1; Jeevan R, 2009, 2 ANN REPORT NATL MA, P2009; Jeevan R, 2008, 1 ANN REPORT NATL MA; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jensen JA, 2012, ANN SURG ONCOL, V19, P3171, DOI 10.1245/s10434-012-2528-7; Kronowitz SJ, 2009, PLAST RECONSTR SURG, V124, P395, DOI 10.1097/PRS.0b013e3181aee987; Lambert PA, 2000, J AM COLL SURGEONS, V191, P354, DOI 10.1016/S1072-7515(00)00689-X; Lee C, 2009, J AM COLL SURGEONS, V209, P123, DOI 10.1016/j.jamcollsurg.2009.02.061; Lee J, 2011, J BREAST CANCER, V14, P322, DOI 10.4048/jbc.2011.14.4.322; Loewen MJ, 2008, AM J SURG, V195, P391, DOI 10.1016/j.amjsurg.2007.12.020; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; Lostumbo L, 2004, COCHRANE DB SYST REV, V11; LoTempio MM, 2010, PLAST RECONSTR SURG, V126, P393, DOI 10.1097/PRS.0b013e3181de236a; Maddams J, 2012, BRIT J CANCER, V107, P1195, DOI 10.1038/bjc.2012.366; Maddams J, 2009, BRIT J CANCER, V101, P541, DOI 10.1038/sj.bjc.6605148; Mahmood U, 2013, ANN SURG ONCOL, V20, P1436, DOI 10.1245/s10434-012-2732-5; Metcalfe KA, 2008, J CLIN ONCOL, V26, P1093, DOI 10.1200/JCO.2007.12.6078; Momoh AO, 2012, ANN PLAS SURG, V69, P389, DOI 10.1097/SAP.0b013e318246e572; Monrigal E, 2011, EJSO-EUR J SURG ONC, V37, P864, DOI 10.1016/j.ejso.2011.07.009; Nahabedian MY, 2006, PLAST RECONSTR SURG, V117, P1083, DOI 10.1097/01.prs.0000202103.78284.97; Nahabedian MY, 2002, PLAST RECONSTR SURG, V110, P466, DOI 10.1097/00006534-200208000-00015; Nahabedian MY, 2002, PLAST RECONSTR SURG, V110, P76; National Institute for Health and Care Excellence, 2009, EARL LOC ADV BREAST; National Institute for Health and Care Excellence, 2013, FAM BREAST CANC CLAS; Neuburger J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003179; Peled AW, 2010, ARCH SURG-CHICAGO, V145, P880, DOI 10.1001/archsurg.2010.163; Petit JY, 2011, PLAST RECONSTR SURG, V128, P341, DOI 10.1097/PRS.0b013e31821e713c; Prabhu R, 2012, INT J RADIAT ONCOL, V82, pE587, DOI 10.1016/j.ijrobp.2011.09.024; Pusic AL, 2012, EXPERT REV PHARM OUT, V12, P149, DOI [10.1586/ERP.11.105, 10.1586/erp.11.105]; Romics L, 2012, BRIT J SURG, V99, P799, DOI 10.1002/bjs.8704; Rusby JE, 2010, BRIT J SURG, V97, P305, DOI 10.1002/bjs.6970; Salzberg CA, 2013, J PLAST RECONSTR AES, V66, P323, DOI 10.1016/j.bjps.2012.10.015; Salzberg CA, 2011, PLAST RECONSTR SURG, V127, P514, DOI 10.1097/PRS.0b013e318200a961; Sbitany H, 2011, PLAST RECONSTR SURG, V128, P1162, DOI 10.1097/PRS.0b013e318230c29e; Schmitz M, 2013, J PLAST RECONSTR AES, V33, P675; Spear SL, 2008, PLAST RECONSTR SURG, V122, P340, DOI 10.1097/PRS.0b013e31817d6009; Spear SL, 2007, PLAST RECONSTR SURG, V119, P788, DOI 10.1097/01.prs.0000252003.14537.d2; Spear SL, 2005, PLAST RECONSTR SURG, V115, P84, DOI 10.1097/01.PRS.0000145723.05286.F7; Sullivan SR, 2008, PLAST RECONSTR SURG, V122, P19, DOI 10.1097/PRS.0b013e3181774267; Tallet AV, 2003, INT J RADIAT ONCOL, V57, P136, DOI 10.1016/S0360-3016(03)00526-1; Taylor CW, 2005, BREAST, V14, P18, DOI 10.1016/j.breast.2004.07.004; Thomson HJ, 2008, ANN SURG ONCOL, V15, P1081, DOI 10.1245/s10434-007-9772-2; Tuttle TM, 2007, J CLIN ONCOL, V25, P5203, DOI 10.1200/JCO.2007.12.3141; Wilson CR, 2004, EJSO-EUR J SURG ONC, V30, P624, DOI 10.1016/j.ejso.2004.04.006; Yao K, 2008, AM J SURG, V195, P394; Yueh JH, 2010, PLAST RECONSTR SURG, V125, P1585, DOI 10.1097/PRS.0b013e3181cb6351	78	17	18	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2013	347								f5903	10.1136/bmj.f5903	http://dx.doi.org/10.1136/bmj.f5903			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WK	24128977				2022-12-28	WOS:000325982200008
J	Garrett, GL; Davies, JB; Fiandeiro, PT; Smith, CH				Garrett, Giorgia L.; Davies, Joseph Benjamin; Fiandeiro, Pamela Terezinha; Smith, Catherine H.			A difficult case of atopic eczema	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Garrett, Giorgia L.] Univ Hosp Lewisham, Lewisham Hosp NHS Trust, London, England; [Davies, Joseph Benjamin] Barts Hlth NHS Trust, Dept Radiol, London, England; [Fiandeiro, Pamela Terezinha] Kings Coll Hosp NHS Trust, Dept Dermatol, London, England; [Smith, Catherine H.] St Thomas Hosp NHS Trust, Skin Therapy Res Unit, St Johns Inst Dermatol, London, England	University of London; King's College London; Barts Health NHS Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Smith, CH (corresponding author), St Thomas Hosp NHS Trust, Skin Therapy Res Unit, St Johns Inst Dermatol, London, England.	catherine.smith@kcl.ac.uk	Smith, Catherine/G-5268-2012	Smith, Catherine/0000-0001-9918-1144				Agha A, 2006, J CLIN ENDOCR METAB, V91, P43, DOI 10.1210/jc.2005-1131; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Arlt W, 2009, J CLIN ENDOCR METAB, V94, P1059, DOI 10.1210/jc.2009-0032; Baid SK, 2006, ORAL DIS, V12, P436, DOI 10.1111/j.1601-0825.2006.01290.x; Beer Kenneth, 2007, J Drugs Dermatol, V6, P550; BORZYSKOWSKI M, 1976, CLIN EXP DERMATOL, V1, P337, DOI 10.1111/j.1365-2230.1976.tb01440.x; Castela E, 2012, J EUR ACAD DERMATOL, V26, P47, DOI 10.1111/j.1468-3083.2012.04523.x; Dinsen S, 2013, EUR J INTERN MED; Global Initiative for Asthma, 2012, GLOB STRAT ASTHM MAN; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Hittle K, 2010, J PEDIATR HEALTH CAR, V24, P48, DOI 10.1016/j.pedhc.2009.09.007; Kwinter J, 2007, J AM ACAD DERMATOL, V56, P236, DOI 10.1016/j.jaad.2006.08.017; National Institute for Health and Care Excellence, 2004, FREQ APPL TOP CORT A; NHS Choices, CORT TOP DOS; Papierska L, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/482370; Primary Care Dermatology and British Association of Dermatologists, 2009, GUID MAN AT ECZ; Samarasekera EJ, 2013, BR J DERMATOL; Tempark T, 2010, ENDOCRINE, V38, P328, DOI 10.1007/s12020-010-9393-6; TURPEINEN M, 1986, BRIT J DERMATOL, V115, P475, DOI 10.1111/j.1365-2133.1986.tb06242.x; Wass JAH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6333	20	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2013	347								f6010	10.1136/bmj.f6010	http://dx.doi.org/10.1136/bmj.f6010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238VR	24126859				2022-12-28	WOS:000325980100002
J	Froidevaux, P; Baechler, S; Bailat, CJ; Castella, V; Augsburger, M; Michaud, K; Mangin, P; Bochud, FO				Froidevaux, Pascal; Baechler, Sebastien; Bailat, Claude J.; Castella, Vincent; Augsburger, Marc; Michaud, Katarzyna; Mangin, Patrice; Bochud, Francois O.			Improving forensic investigation for polonium poisoning	LANCET			English	Editorial Material									[Froidevaux, Pascal; Baechler, Sebastien; Bailat, Claude J.; Bochud, Francois O.] Univ Lausanne Hosp, Inst Radiat Phys, CH-1007 Lausanne, Switzerland; [Castella, Vincent; Augsburger, Marc; Michaud, Katarzyna; Mangin, Patrice] Univ Ctr Legal Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bochud, FO (corresponding author), Univ Lausanne Hosp, Inst Radiat Phys, Rue Grand Pre 1, CH-1007 Lausanne, Switzerland.	francois.bochud@chuv.ch	Castella, Vincent/AAE-8918-2019; Bailat, Claude/HIR-1763-2022	Bochud, Francois/0000-0003-2076-0296; Bailat, Claude/0000-0002-0386-4782; Castella, Vincent/0000-0001-9029-1945; Augsburger, Marc/0000-0002-5606-3831; Froidevaux, Pascal/0000-0003-0077-0294				[Anonymous], 2004, MED RECORDS PERCY HO; CASARETT GEORGE W., 1964, RADIAT RES, VSuppl.5, P322, DOI 10.2307/3583495; Chatal JF, 1999, LANCET, V354, P931, DOI 10.1016/S0140-6736(99)06002-X; Harrison J, 2007, J RADIOL PROT, V27, P17, DOI 10.1088/0952-4746/27/1/001; Watchman CJ, 2007, J NUCL MED, V48, P645, DOI 10.2967/jnumed.106.035337	5	5	7	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1308	1308		10.1016/S0140-6736(13)61834-6	http://dx.doi.org/10.1016/S0140-6736(13)61834-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	24120205				2022-12-28	WOS:000325756400033
J	Russell, AJ				Russell, Alan J.			The end of the beginning for tissue engineering	LANCET			English	Editorial Material									[Russell, Alan J.] Carnegie Mellon Univ, Disrupt Hlth Technol Inst, Pittsburgh, PA 15213 USA; [Russell, Alan J.] Allegheny Hlth Network, Pittsburgh, PA USA	Carnegie Mellon University	Russell, AJ (corresponding author), Carnegie Mellon Univ, Disrupt Hlth Technol Inst, Pittsburgh, PA 15213 USA.	alanrussell@cmu.edu		Russell, Alan/0000-0001-5101-4371				Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Butler DL, 2009, TISSUE ENG PART B-RE, V15, P477, DOI 10.1089/ten.TEB.2009.0340; Gilbert TW, 2013, J PLAST RECONSTR AES, V66, P414, DOI 10.1016/j.bjps.2012.09.029; Gonfiotti A, 2013, LANCET; Lee SJ, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/010201; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309	8	12	12	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					193	195		10.1016/S0140-6736(13)62110-8	http://dx.doi.org/10.1016/S0140-6736(13)62110-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294FC	24161822				2022-12-28	WOS:000330027500007
J	Lyumkis, D; Julien, JP; de Val, N; Cupo, A; Potter, CS; Klasse, PJ; Burton, DR; Sanders, RW; Moore, JP; Carragher, B; Wilson, IA; Ward, AB				Lyumkis, Dmitry; Julien, Jean-Philippe; de Val, Natalia; Cupo, Albert; Potter, Clinton S.; Klasse, Per-Johan; Burton, Dennis R.; Sanders, Rogier W.; Moore, John P.; Carragher, Bridget; Wilson, Ian A.; Ward, Andrew B.			Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer	SCIENCE			English	Article							NEUTRALIZING ANTIBODIES; MOLECULAR ARCHITECTURE; GLYCOPROTEIN COMPLEX; CRYSTAL-STRUCTURE; GP120; VIRUS; RESOLUTION; RECOGNITION; DISPLAY; BINDING	The HIV-1 envelope glycoprotein (Env) trimer contains the receptor binding sites and membrane fusion machinery that introduce the viral genome into the host cell. As the only target for broadly neutralizing antibodies (bnAbs), Env is a focus for rational vaccine design. We present a cryo-electron microscopy reconstruction and structural model of a cleaved, soluble Env trimer (termed BG505 SOSIP.664 gp140) in complex with a CD4 binding site (CD4bs) bnAb, PGV04, at 5.8 angstrom resolution. The structure reveals the spatial arrangement of Env components, including the V1/V2, V3, HR1, and HR2 domains, as well as shielding glycans. The structure also provides insights into trimer assembly, gp120-gp41 interactions, and the CD4bs epitope cluster for bnAbs, which covers a more extensive area and defines a more complex site of vulnerability than previously described.	[Lyumkis, Dmitry; Potter, Clinton S.; Carragher, Bridget] Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Lyumkis, Dmitry; Julien, Jean-Philippe; de Val, Natalia; Potter, Clinton S.; Carragher, Bridget; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Julien, Jean-Philippe; de Val, Natalia; Burton, Dennis R.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Julien, Jean-Philippe; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cupo, Albert; Klasse, Per-Johan; Sanders, Rogier W.; Moore, John P.] Cornell Univ, Weill Med Coll, York, NY 10021 USA; [Burton, Dennis R.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat IAVI, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Amsterdam; Academic Medical Center Amsterdam	Carragher, B (corresponding author), Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA.	bcarr@scripps.edu; wilson@scripps.edu; abward@scripps.edu	de Val, Natalia/AAF-4822-2019; Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014; Klasse, P.J./AEX-0142-2022	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Klasse, P.J./0000-0001-8222-278X; Julien, Jean-Philippe/0000-0001-7602-3995; Carragher, Bridget/0000-0002-0624-5020	NIH [HIVRAD P01 AI82362, R01 AI36082]; International AIDS Vaccine Initiative Neutralizing Antibody Consortium; Scripps CHAVI-ID [UM1 AI100663]; Netherlands Organization for Scientific Research; European Research Council; Canadian Institutes of Health Research fellowship; Biomedical Technology Research Center program of the National Institute of General Medical Sciences [GM103310]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036082, UM1AI100663, P01AI082362, R01AI084817, R01AI036082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative Neutralizing Antibody Consortium; Scripps CHAVI-ID; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); Biomedical Technology Research Center program of the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Cheng and X. Li for providing raw frame alignment scripts prior to publication, R. Henderson for making the makestack_HRnoise.exe program available for use to assess the overfitting of the EM data, J. Korzun for technical assistance, J.-C. Ducom (TSRI) for support with computational resources, and C. R. King and W. Koff for support and encouragement. Supported by NIH grants HIVRAD P01 AI82362 (J. P. M., I. A. W., and A. B. W.) and R01 AI36082 (I. A. W.); the International AIDS Vaccine Initiative Neutralizing Antibody Consortium (D. R. B., J. P. M., I. A. W., A. B. W.); Scripps CHAVI-ID (UM1 AI100663) (D. R. B., I. A. W., A. B. W.); a Vidi grant from the Netherlands Organization for Scientific Research (R. W. S.); a Starting Investigator Grant from the European Research Council (R. W. S.); and a Canadian Institutes of Health Research fellowship (J.-P.J.). The EM work was conducted at the National Resource for Automated Molecular Microscopy at The Scripps Research Institute, which is supported by the Biomedical Technology Research Center program (GM103310) of the National Institute of General Medical Sciences (B. C., C. S. P.). 3D visualizations were generated using the UCSF Chimera package. The EM reconstructions have been deposited in the Electron Microscopy Data Bank under accession codes EMD-5779, EMD-5780, EMD-5781, and EMD-5782. The structure coordinates have been deposited in the Protein Data Bank under accession code 3J5M. Sharing of other materials will be subject to standard material transfer agreements. Raw EM data will be provided upon request. The content is the responsibility of the authors and does not necessarily reflect the official views of NIGMS or NIH. IAVI has previously filed a patent relating to the BG505 SOSIP.664 trimer: U.S. Prov. Appln. No. 61/772,739, titled "HIV-1 envelope glycoprotein," with inventors M. Caulfield, A. C., H. Dean, S. Hoffenberg, C. R. King, P.-J.K., A. Marozsan, J. P. M., R. W. S., A. B. W., I. A. W., and J.-P.J. This is manuscript 25060 from The Scripps Research Institute.	Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cohen J, 2013, SCIENCE, V341, P443, DOI 10.1126/science.341.6145.443; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Henderson R, 2013, P NATL ACAD SCI USA, V110, P18037, DOI 10.1073/pnas.1314449110; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Mao YD, 2013, P NATL ACAD SCI USA, V110, pE4178, DOI 10.1073/pnas.1316666110; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Subramaniam S, 2013, P NATL ACAD SCI USA, V110, pE4172, DOI 10.1073/pnas.1313802110; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; van Heel M, 2013, P NATL ACAD SCI USA, V110, pE4175, DOI 10.1073/pnas.1314353110; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003	51	535	559	3	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1484	1490		10.1126/science.1245627	http://dx.doi.org/10.1126/science.1245627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24179160	Green Accepted			2022-12-28	WOS:000328644300051
J	Steinhubl, SR; Muse, ED; Topol, EJ				Steinhubl, Steven R.; Muse, Evan D.; Topol, Eric J.			Can Mobile Health Technologies Transform Health Care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Steinhubl, Steven R.; Muse, Evan D.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Steinhubl, SR (corresponding author), Scripps Translat Sci Inst, 3344 N Torrey Pines Ct,Ste 300, La Jolla, CA 92037 USA.	steinhub@scripps.edu		Topol, Eric/0000-0002-1478-4729	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000110, UL1TR000109] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		[Anonymous], BRIT MED J; [Anonymous], HEALTH CARE EXPENSES; [Anonymous], NCI CANCER BULLETIN; Centers for Disease Control and Prevention, NATIONAL AMBULATORY; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Sinsky CA, 2013, ANN FAM MED, V11, P272, DOI 10.1370/afm.1531; Wolf JA, 2013, JAMA DERMATOL, V149, P422, DOI 10.1001/jamadermatol.2013.2382	8	258	262	3	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2395	2396		10.1001/jama.2013.281078	http://dx.doi.org/10.1001/jama.2013.281078			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24158428				2022-12-28	WOS:000328030900015
J	Steg, PG; Van 't Hof, A; Hamm, CW; Clemmensen, P; Lapostolle, F; Coste, P; Ten Berg, J; Van Grunsven, P; Eggink, GJ; Nibbe, L; Zeymer, U; dell' Orto, MC; Nef, H; Steinmetz, J; Soulat, L; Huber, K; Deliargyris, EN; Bernstein, D; Schuette, D; Prats, J; Clayton, T; Pocock, S; Hamon, M; Goldstein, P				Steg, Philippe Gabriel; Van 't Hof, Arnoud; Hamm, Christian W.; Clemmensen, Peter; Lapostolle, Frederic; Coste, Pierre; Ten Berg, Jurrien; Van Grunsven, Pierre; Eggink, Gerrit Jan; Nibbe, Lutz; Zeymer, Uwe; dell' Orto, Marco Campo; Nef, Holger; Steinmetz, Jacob; Soulat, Louis; Huber, Kurt; Deliargyris, Efthymios N.; Bernstein, Debra; Schuette, Diana; Prats, Jayne; Clayton, Tim; Pocock, Stuart; Hamon, Martial; Goldstein, Patrick		EUROMAX Investigators	Bivalirudin Started during Emergency Transport for Primary PCI	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; POSITION PAPER; PRASUGREL; TICAGRELOR; THROMBOSIS; ASSOCIATION; CLOPIDOGREL; MANAGEMENT	BackgroundBivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI). Whether these benefits persist in contemporary practice characterized by prehospital initiation of treatment, optional use of glycoprotein IIb/IIIa inhibitors and novel P2Y(12) inhibitors, and radial-artery PCI access use is unknown. MethodsWe randomly assigned 2218 patients with ST-segment elevation myocardial infarction (STEMI) who were being transported for primary PCI to receive either bivalirudin or unfractionated or low-molecular-weight heparin with optional glycoprotein IIb/IIIa inhibitors (control group). The primary outcome at 30 days was a composite of death or major bleeding not associated with coronary-artery bypass grafting (CABG), and the principal secondary outcome was a composite of death, reinfarction, or non-CABG major bleeding. ResultsBivalirudin, as compared with the control intervention, reduced the risk of the primary outcome (5.1% vs. 8.5%; relative risk, 0.60; 95% confidence interval [CI], 0.43 to 0.82; P=0.001) and the principal secondary outcome (6.6% vs. 9.2%; relative risk, 0.72; 95% CI, 0.54 to 0.96; P=0.02). Bivalirudin also reduced the risk of major bleeding (2.6% vs. 6.0%; relative risk, 0.43; 95% CI, 0.28 to 0.66; P<0.001). The risk of acute stent thrombosis was higher with bivalirudin (1.1% vs. 0.2%; relative risk, 6.11; 95% CI, 1.37 to 27.24; P=0.007). There was no significant difference in rates of death (2.9% vs. 3.1%) or reinfarction (1.7% vs. 0.9%). Results were consistent across subgroups of patients. ConclusionsBivalirudin, started during transport for primary PCI, improved 30-day clinical outcomes with a reduction in major bleeding but with an increase in acute stent thrombosis. (Funded by the Medicines Company; EUROMAX ClinicalTrials.gov number, NCT01087723.)	[Steg, Philippe Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U698,Dept Hosp Univ Fibrosis Inflammat Remodeling, Paris, France; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Lapostolle, Frederic] Univ Paris 13, SAMU 93, Unite Fonct Rech Enseignement Qualite, Sorbonne Paris Cite,Hop Avicenne, Paris, France; [Coste, Pierre] Univ Bordeaux, Hop Cardiol, Ctr Hosp Univ Bordeaux, Pessac, France; [Soulat, Louis] Ctr Hosp, Serv Aide Med Urgente, Serv Mobile Urgence & Reanimat Urgences, Chateauroux, France; [Hamon, Martial] Univ Caen, Dept Clin Res, F-14032 Caen, France; [Goldstein, Patrick] Lille Univ Hosp, Emergency Dept, Lille, France; [Goldstein, Patrick] Lille Univ Hosp, SAMU, Lille, France; [Steg, Philippe Gabriel] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Inst Cardiovasc Med & Sci, Royal Brompton Hosp, London SW7 2AZ, England; [Clayton, Tim; Pocock, Stuart] London Sch Hyg & Trop Med, London, England; [Van 't Hof, Arnoud] Isala Klin, Dept Cardiol, Zwolle, Netherlands; [Eggink, Gerrit Jan] Reg Ambulancevoorziening Ijsselvecht, Zwolle, Netherlands; [Ten Berg, Jurrien] St Antonius Hosp, Nieuwegein, Netherlands; [Van Grunsven, Pierre] RAV Gelderland Zuid, Nijmegen, Netherlands; [Hamm, Christian W.; dell' Orto, Marco Campo] Kerckhoff Clin, Bad Nauheim, Germany; [Hamm, Christian W.; dell' Orto, Marco Campo] Thoraxctr, Dept Cardiol, Bad Nauheim, Germany; [Nibbe, Lutz] Univ Med Berlin, Campus Virchow Klinikum, Dept Nephrol & Med Intens Care, Berlin, Germany; [Zeymer, Uwe] Klinikum Stadt Ludwigshafen, Ludwigshafen, Germany; [Nef, Holger] Univ Giessen, Med Klin 1, D-35390 Giessen, Germany; [Clemmensen, Peter] Univ Copenhagen, Rigshosp, Dept Cardiol, Inst Clin Med, DK-2100 Copenhagen, Denmark; [Steinmetz, Jacob] Copenhagen Univ Hosp, Capital Reg Rigshosp, Dept Anesthesia, Head & Orthoped Ctr, Copenhagen, Denmark; [Steinmetz, Jacob] Copenhagen Univ Hosp, Capital Reg Rigshosp, Emergency Med Serv Capital Reg, Copenhagen, Denmark; [Huber, Kurt] Wilhelminenhosp, Dept Med 3, Vienna, Austria; [Deliargyris, Efthymios N.; Bernstein, Debra; Schuette, Diana; Prats, Jayne] Med Co, Parsippany, NJ USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universite de Caen Normandie; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Imperial College London; Royal Brompton Hospital; University of London; London School of Hygiene & Tropical Medicine; Isala Clinics; St. Antonius Hospital Utrecht; Kerckhoff Clinic; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ludwigshafen Hospital; Justus Liebig University Giessen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Wilhelminenspital	Steg, PG (corresponding author), Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, 46 Rue Henri Huchard, F-75877 Paris, France.	gabriel.steg@bch.aphp.fr	Steinmetz, Jacob/O-6014-2017; Mikkelsen, Soren/R-1890-2019; STEG, Philippe Gabriel/Z-1567-2019; Verheugt, F.W.A./H-8105-2014; Steinmetz, Jacob/AAY-6076-2020; Widimsky, Petr/P-8088-2016; Hamm, Christian W./I-3155-2017	Steinmetz, Jacob/0000-0001-9620-8911; Mikkelsen, Soren/0000-0002-5187-7027; Steinmetz, Jacob/0000-0001-9620-8911; Widimsky, Petr/0000-0001-5686-7752; Hamm, Christian W./0000-0001-6763-4161; tazarourte, karim/0000-0002-3376-1258; STEG, Philippe Gabriel/0000-0001-6896-2941; TEIGER, emmanuel/0000-0001-7515-4344; Reiffen, Hans-Peter/0000-0002-4462-1496; CARRIE, didier/0000-0003-2479-8144; Clayton, Tim/0000-0002-1266-3288	Medicines Company	Medicines Company	Funded by the Medicines Company; EUROMAX ClinicalTrials.gov number, NCT01087723.	Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dangas GD, 2011, CIRCULATION, V123, P1745, DOI 10.1161/CIRCULATIONAHA.110.981688; Hamon M, 2013, EUROINTERVENTION, V8, P1242, DOI 10.4244/EIJV8I11A192; Hirschl MM, 2012, AM J EMERG MED, V30, P12, DOI 10.1016/j.ajem.2010.09.010; Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7; Mehta SR, 2012, J AM COLL CARDIOL, V60, P2490, DOI 10.1016/j.jacc.2012.07.050; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; Sejersten M, 2009, AM J CARDIOL, V103, P1635, DOI 10.1016/j.amjcard.2009.02.015; Shahzad A, 2013, EUROINTERVENTION, V9, P423, DOI 10.4244/EIJV9I4A69; Steg PG, 2013, AM HEART J; Steg PG, 2013, LANCET; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steg PG, 2011, EUR HEART J, V32, P1854, DOI 10.1093/eurheartj/ehr204; Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2011, LANCET, V377, P2193, DOI 10.1016/S0140-6736(11)60764-2; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Valgimigli M, 2012, JACC-CARDIOVASC INTE, V5, P268, DOI 10.1016/j.jcin.2012.01.006	22	379	394	1	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2207	2217		10.1056/NEJMoa1311096	http://dx.doi.org/10.1056/NEJMoa1311096			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24171490	Bronze			2022-12-28	WOS:000327801100007
J	Khan, Z; Ford, MJ; Cusanovich, DA; Mitrano, A; Pritchard, JK; Gilad, Y				Khan, Zia; Ford, Michael J.; Cusanovich, Darren A.; Mitrano, Amy; Pritchard, Jonathan K.; Gilad, Yoav			Primate Transcript and Protein Expression Levels Evolve Under Compensatory Selection Pressures	SCIENCE			English	Article							GENE-EXPRESSION; RAPID EVOLUTION; ABUNDANCE; HUMANS; DROSOPHILA; SILAC	Changes in gene regulation have likely played an important role in the evolution of primates. Differences in messenger RNA (mRNA) expression levels across primates have often been documented; however, it is not yet known to what extent measurements of divergence in mRNA levels reflect divergence in protein expression levels, which are probably more important in determining phenotypic differences. We used high-resolution, quantitative mass spectrometry to collect protein expression measurements from human, chimpanzee, and rhesus macaque lymphoblastoid cell lines and compared them to transcript expression data from the same samples. We found dozens of genes with significant expression differences between species at the mRNA level yet little or no difference in protein expression. Overall, our data suggest that protein expression levels evolve under stronger evolutionary constraint than mRNA levels.	[Khan, Zia; Cusanovich, Darren A.; Mitrano, Amy; Pritchard, Jonathan K.; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ford, Michael J.] MS Bioworks LLC, Ann Arbor, MI 48108 USA; [Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; Howard Hughes Medical Institute; University of Chicago	Khan, Z (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	zia@uchicago.edu; pritch@stanford.edu; gilad@uchicago.edu		Khan, Zia/0000-0002-7859-3489; Cusanovich, Darren/0000-0001-6889-0095	NIH [GM077959]; Howard Hughes Medical Institute; National Research Service Award [F32HG006972]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG006972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077959] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our labs for helpful discussions. Funded by NIH grant GM077959 to Y.G. and by Howard Hughes Medical Institute funds to J.K.P. Z.K. is supported by National Research Service Award F32HG006972. Z.K., J.K.P., and Y.G. conceived of the study and designed it; M.J.F. acquired the mass spectrometry data; Z.K. conducted the computational analyses with input from D.A.C., J.K.P., and Y.G. M.J.F. acknowledges assistance from colleagues at MS Bioworks LLC. A.M. cultured cells and prepared protein samples. Z.K., J.K.P., and Y.G. wrote the paper with contributions from all authors. RNA-seq data have been deposited to the Gene Expression Omnibus (GSE49682). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (PXD000419). J.K.P. is on the scientific advisory boards for 23andMe and DNANexus with stock options.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cox B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100151; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000216; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Hanke S, 2008, J PROTEOME RES, V7, P1118, DOI 10.1021/pr7007175; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Romero IG, 2012, NAT REV GENET, V13, P505, DOI 10.1038/nrg3229; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223	20	149	149	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1100	1104		10.1126/science.1242379	http://dx.doi.org/10.1126/science.1242379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24136357	Green Accepted			2022-12-28	WOS:000327518600059
J	Gallagher, TH; Mello, MM; Levinson, W; Wynia, MK; Sachdeva, AK; Sulmasy, LS; Truog, RD; Conway, J; Mazor, K; Lembitz, A; Bell, SK; Sokol-Hessner, L; Shapiro, J; Puopolo, AL; Arnold, R				Gallagher, Thomas H.; Mello, Michelle M.; Levinson, Wendy; Wynia, Matthew K.; Sachdeva, Ajit K.; Sulmasy, Lois Snyder; Truog, Robert D.; Conway, James; Mazor, Kathleen; Lembitz, Alan; Bell, Sigall K.; Sokol-Hessner, Lauge; Shapiro, Jo; Puopolo, Ann-Louise; Arnold, Robert			Talking with Patients about Other Clinicians' Errors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HARMFUL MEDICAL ERRORS; PHYSICIANS; PROFESSIONALISM; DISCLOSURE; VIEWS	The authors discuss the challenges facing a clinician who discovers that her patient has been harmed by another health care worker's medical error. They provide guidance to help clinicians and institutions disclose such errors to patients. You are a young neurologist practicing in a small hospital. You admit a 55-year-old woman with hypertension and type 2 diabetes mellitus who had an embolic stroke at home. On reviewing the patient's medical record, you notice that she appears to have been in atrial fibrillation during two electrocardiographic (ECG) tests during visits to the office of her primary care physician (PCP) for palpitations. Her PCP, an internist who provides many of your referrals, read both ECGs as normal and attributed her palpitations to probable mitral-valve prolapse and anxiety. The patient is currently in normal sinus rhythm. You show the ...	[Gallagher, Thomas H.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Gallagher, Thomas H.] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Truog, Robert D.] Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; [Bell, Sigall K.; Sokol-Hessner, Lauge] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Shapiro, Jo] Brigham & Womens Hosp, Div Otolaryngol, Boston, MA 02115 USA; [Levinson, Wendy] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wynia, Matthew K.] Amer Med Assoc, Inst Eth, Chicago, IL 60610 USA; [Sachdeva, Ajit K.] Amer Coll Surg, Div Educ, Chicago, IL USA; [Sulmasy, Lois Snyder] Amer Coll Physicians, Ctr Eth & Professionalism, Philadelphia, PA USA; [Conway, James] Inst Healthcare Improvement, Cambridge, MA USA; [Mazor, Kathleen] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Lembitz, Alan] COP Insurance, Denver, CO USA; [Puopolo, Ann-Louise] CVS Caremark, Woonsocket, RI USA; [Arnold, Robert] Univ Pittsburgh, Sch Med, Inst Doctor Patient Commun, Pittsburgh, PA USA; [Arnold, Robert] Univ Pittsburgh, Sch Med, Sect Palliat Care & Med Eth, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; University of Toronto; American Medical Association; American College of Surgeons; American College of Physicians; Institute for Healthcare Improvement; University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gallagher, TH (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.		Wynia, Matthew/T-2210-2019	Mello, Michelle/0000-0003-2877-4270; Sokol-Hessner, Lauge/0000-0002-9895-5176				*AM MED ASS COUNC, 2004, COD MED ETH ANN CURR; American College of Physicians Ethics and Human Rights Committee, 2003, MUST YOU DISCL MIST; Bell SK, 2011, CHEST, V140, P519, DOI 10.1378/chest.10-2533; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Bosk CL, 2003, FORGIVE REMEMBER MAN; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Carrier ER, 2010, HEALTH AFFAIR, V29, P1585, DOI 10.1377/hlthaff.2010.0135; Conway J, 2011, IHI INNOVATION SERIE; DesRoches CM, 2010, JAMA-J AM MED ASSOC, V304, P187, DOI 10.1001/jama.2010.921; Full Disclosure Working Group, 2006, THINGS GO WRONG RESP; Gallagher TH, 2003, JAMA-J AM MED ASSOC, V289, P1001, DOI 10.1001/jama.289.8.1001; Gallagher TH, 2007, NEW ENGL J MED, V356, P2713, DOI 10.1056/NEJMra070568; Gallagher TH, 2006, ARCH INTERN MED, V166, P1585, DOI 10.1001/archinte.166.15.1585; Hickson GB, 2002, JAMA-J AM MED ASSOC, V287, P2951, DOI 10.1001/jama.287.22.2951; Iedema R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4423; Iezzoni LI, 2012, HEALTH AFFAIR, V31, P383, DOI 10.1377/hlthaff.2010.1137; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Kachalia A, 2010, ANN INTERN MED, V153, P213, DOI 10.7326/0003-4819-153-4-201008170-00002; Lesser CS, 2010, JAMA-J AM MED ASSOC, V304, P2732, DOI 10.1001/jama.2010.1864; LO B, 2005, RESOLVING ETHICAL DI; Marx D, 2009, WHACK MOLE PRICE WE; Marx D, 2001, PATIENT SAFETY JUST; Mastroianni AC, 2010, HEALTH AFFAIR, V29, P1611, DOI 10.1377/hlthaff.2009.0134; MORREIM EH, 1993, HASTINGS CENT REP, V23, P19, DOI 10.2307/3563363; National Association for Healthcare Quality, 2012, CALL ACT SAF INT HEA; Rudolph Jenny W, 2007, Anesthesiol Clin, V25, P361, DOI 10.1016/j.anclin.2007.03.007; Safe practices for better healthcare, 2009, SAF PRACT BETT HEALT; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Srivastava R, 2013, NEW ENGL J MED, V368, P302, DOI 10.1056/NEJMp1212410; Truog RD, 2011, TALKING PATIENTS FAM; Wachter RM, 2012, UNDERSTANDING PATIEN; Wu AW, 1997, J GEN INTERN MED, V12, P770, DOI 10.1046/j.1525-1497.1997.07163.x; Wynia MK, 2010, JAMA-J AM MED ASSOC, V304, P210, DOI 10.1001/jama.2010.945	34	58	59	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1752	1757		10.1056/NEJMsb1303119	http://dx.doi.org/10.1056/NEJMsb1303119			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243IY	24171522	Bronze			2022-12-28	WOS:000326311300014
J	Kachalia, A				Kachalia, Allen			Improving Patient Safety through Transparency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CLAIMS	U.S. health care organizations still have a ways to go to achieve a culture in which all errors are openly identified and investigated. The goal should be to reveal facts and facilitate discussion in order to prevent the repetition of similar mistakes. Transparency especially when things go wrong is increasingly considered necessary to improving the quality of health care. By being candid with both patients and clinicians, health care organizations can promote their leaders' accountability for safer systems, better engage clinicians in improvement efforts, and engender greater patient trust. Today, many institutions have initiated efforts to improve the sharing of information on publicly reported performance measures, but transparency regarding medical errors has proved much more difficult to achieve. U.S. health care organizations still have a ways to go to achieve a culture in which all errors are openly identified and ...	[Kachalia, Allen] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kachalia, Allen] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kachalia, A (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.		Callahan, Charles D/L-1641-2013					Agency for Healthcare Research and Quality, SURV PAT SAF CULT; Kachalia A, 2010, ANN INTERN MED, V153, P213, DOI 10.7326/0003-4819-153-4-201008170-00002; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Wachter RM, 2009, NEW ENGL J MED, V361, P1401, DOI 10.1056/NEJMsb0903885	4	40	40	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1677	1679		10.1056/NEJMp1303960	http://dx.doi.org/10.1056/NEJMp1303960			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243IY	24171515				2022-12-28	WOS:000326311300004
J	Henderson, RA; Bath, PMW				Henderson, Robert A.; Bath, Philip M. W.			Is closure of patent foramen ovale to prevent ischaemic stroke ever justified?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL THERAPY; CRYPTOGENIC STROKE; TRANSCATHETER CLOSURE; RISK; METAANALYSIS; DEVICES; EVENTS	This is one of a series of occasional articles that highlight areas of practice where management lacks convincing supporting evidence. The series adviser is David Tovey, editor in chief, the Cochrane Library. To suggest a topic, please email us at practice@ bmj.com.	[Henderson, Robert A.] Univ Nottingham Hosp, Trent Cardiac Ctr, Nottingham NG5 1PB, England; [Bath, Philip M. W.] Univ Nottingham, Stroke Trials Unit, Univ Nottingham Hosp, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Henderson, RA (corresponding author), Univ Nottingham Hosp, Trent Cardiac Ctr, City Hosp Campus, Nottingham NG5 1PB, England.	robert.henderson@nuh.nhs.uk	Bath, Philip/F-9020-2011	Bath, Philip/0000-0003-2734-5132	National Institute for Health Research [NF-SI-0611-10003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abaci A, 2013, CATHETER CARDIO INTE, V82, P1123, DOI 10.1002/ccd.24875; Agarwal S, 2012, JACC-CARDIOVASC INTE, V5, P777, DOI 10.1016/j.jcin.2012.02.021; Almekhlafi MA, 2009, NEUROLOGY, V73, P89, DOI 10.1212/WNL.0b013e3181aa2a19; Alsheikh-Ali AA, 2009, STROKE, V40, P2349, DOI 10.1161/STROKEAHA.109.547828; Botto N, 2007, STROKE, V38, P2070, DOI 10.1161/STROKEAHA.106.480863; Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; Di Tullio MR, 2007, J AM COLL CARDIOL, V49, P797, DOI 10.1016/j.jacc.2006.08.063; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Homma S, 2005, CIRCULATION, V112, P1063, DOI 10.1161/CIRCULATIONAHA.104.524371; Hornung M, 2013, EUR HEART J; Kent DM, 2010, STROKE, V41, pS26, DOI 10.1161/STROKEAHA.110.595140; Khairy P, 2003, ANN INTERN MED, V139, P753, DOI 10.7326/0003-4819-139-9-200311040-00010; Kitsios GD, 2012, STROKE, V43, P422, DOI 10.1161/STROKEAHA.111.631648; Krumsdorf U, 2004, J AM COLL CARDIOL, V43, P302, DOI 10.1016/j.jacc.2003.10.030; MAS JL, 1994, EUR HEART J, V15, P446, DOI 10.1093/oxfordjournals.eurheartj.a060524; Meier B, 2013, NEW ENGL J MED, V368, P1083, DOI 10.1056/NEJMoa1211716; Meissner I, 2006, J AM COLL CARDIOL, V47, P440, DOI 10.1016/j.jacc.2005.10.044; Myers PO, 2010, CHEST, V137, P164, DOI 10.1378/chest.09-0961; O'Gara PT, 2009, J AM COLL CARDIOL, V53, P2014, DOI 10.1016/j.jacc.2009.04.001; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Stackhouse KA, 2012, J INVASIVE CARDIOL, V24, P608; STOLLBERGER C, 1993, ANN INTERN MED, V119, P461, DOI 10.7326/0003-4819-119-6-199309150-00003; Taaffe M, 2008, AM J CARDIOL, V101, P1353, DOI 10.1016/j.amjcard.2007.12.040; Taggart NW, 2011, J THORAC CARDIOV SUR, V142, P221, DOI 10.1016/j.jtcvs.2011.03.006; Thaler DE, 2013, STROKE, V44, P675, DOI 10.1161/STROKEAHA.112.677039	26	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2013	347								f6193	10.1136/bmj.f6193	http://dx.doi.org/10.1136/bmj.f6193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247ES	24167203				2022-12-28	WOS:000326599200004
J	Cunningham, P				Cunningham, Patrick			Set research priorities in a time of recession	NATURE			English	Editorial Material									Trinity Coll Dublin, Dublin, Ireland	Trinity College Dublin	Cunningham, P (corresponding author), Trinity Coll Dublin, Dublin, Ireland.	epcnnghm@tcd.ie						European Commission, 2013, INN UN SCOR 2013; Lane J, 2010, NATURE, V464, P488, DOI 10.1038/464488a; Marburger JH, 2005, SCIENCE, V308, P1087, DOI 10.1126/science.1114801; Mazzucato M., 2013, ENTREPRENEURIAL STAT; World Bank, 2011, ENVIRON DEV, P1, DOI 10.1596/978-0-8213-8488-6; World Bank, 2006, IS WEALTH NAT	6	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					433	434		10.1038/502433a	http://dx.doi.org/10.1038/502433a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	238YN	24159623	Bronze			2022-12-28	WOS:000325988400018
J	Zhang, FR; Liu, H; Irwanto, A; Fu, XA; Li, Y; Yu, GQ; Yu, YX; Chen, MF; Low, HQ; Li, JH; Bao, FF; Foo, JN; Bei, JX; Jia, XM; Liu, J; Liany, H; Wang, N; Niu, GY; Wang, ZZ; Shi, BQ; Tian, HQ; Liu, HX; Ma, SS; Zhou, Y; You, JB; Yang, Q; Wang, C; Chu, TS; Liu, DC; Yu, XL; Sun, YH; Ning, Y; Wei, ZH; Chen, SL; Chen, XC; Zhang, ZX; Liu, YX; Pulit, SL; Wu, WB; Zheng, ZY; Yang, RD; Long, H; Liu, ZS; Wang, JQ; Li, M; Zhang, LH; Wang, H; Wang, LM; Xiao, P; Li, JL; Huang, ZM; Huang, JX; Li, Z; Liu, J; Xiong, L; Yang, J; Wang, XD; Yu, DB; Lu, XM; Zhou, GZ; Yan, LB; Shen, JP; Zhang, GC; Zeng, YX; de Bakker, PIW; Chen, SM; Liu, JJ				Zhang, Fu-Ren; Liu, Hong; Irwanto, Astrid; Fu, Xi-An; Li, Yi; Yu, Gong-Qi; Yu, Yong-Xiang; Chen, Ming-Fei; Low, Hui-Qi; Li, Jing-Hui; Bao, Fang-Fang; Foo, Jia-Nee; Bei, Jin-Xin; Jia, Xiao-Ming; Liu, Jian; Liany, Herty; Wang, Na; Niu, Gui-Ye; Wang, Zhen-Zhen; Shi, Ben-Qing; Tian, Hong-Qing; Liu, Hua-Xu; Ma, Shan-Shan; Zhou, Yan; You, Jia-Bao; Yang, Qing; Wang, Chuan; Chu, Tong-Sheng; Liu, Dian-Chang; Yu, Xiu-Lu; Sun, Yong-Hu; Ning, Yong; Wei, Zhong-He; Chen, Sheng-Li; Chen, Xue-Chao; Zhang, Zhao-Xia; Liu, Yong-Xia; Pulit, Sara L.; Wu, Wen-Bin; Zheng, Zhong-Yi; Yang, Rong-De; Long, Heng; Liu, Zuo-Sheng; Wang, Jing-Quan; Li, Ming; Zhang, Lian-Hua; Wang, Hong; Wang, La-Mei; Xiao, Peng; Li, Jin-Lan; Huang, Zhi-Ming; Huang, Jun-Xin; Li, Zhen; Liu, Jian; Xiong, Li; Yang, Jun; Wang, Xiao-Dong; Yu, De-Bao; Lu, Xian-Mei; Zhou, Gui-Zhi; Yan, Liang-Bin; Shen, Jian-Ping; Zhang, Guo-Cheng; Zeng, Yi-Xin; de Bakker, Paul I. W.; Chen, Shu-Min; Liu, Jian-Jun			HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHOLE-GENOME ASSOCIATION; HLA-B; CHINA; LOCI; POPULATION; HAPLOTYPES; ALLELES; LEPROSY	BackgroundDapsone is used in the treatment of infections and inflammatory diseases. The dapsone hypersensitivity syndrome, which is associated with a reported mortality of 9.9%, develops in about 0.5 to 3.6% of persons treated with the drug. Currently, no tests are available to predict the risk of the dapsone hypersensitivity syndrome. MethodsWe performed a genomewide association study involving 872 participants who had received dapsone as part of multidrug therapy for leprosy (39 participants with the dapsone hypersensitivity syndrome and 833 controls), using log-additive tests of single-nucleotide polymorphisms (SNPs) and imputed HLA molecules. For a replication analysis, we genotyped 24 SNPs in an additional 31 participants with the dapsone hypersensitivity syndrome and 1089 controls and performed next-generation sequencing for HLA-B and HLA-C typing at four-digit resolution in an independent series of 37 participants with the dapsone hypersensitivity syndrome and 201 controls. ResultsGenomewide association analysis showed that SNP rs2844573, located between the HLA-B and MICA loci, was significantly associated with the dapsone hypersensitivity syndrome among patients with leprosy (odds ratio, 6.18; P=3.84x10(-13)). HLA-B*13:01 was confirmed to be a risk factor for the dapsone hypersensitivity syndrome (odds ratio, 20.53; P=6.84x10(-25)). The presence of HLA-B*13:01 had a sensitivity of 85.5% and a specificity of 85.7% as a predictor of the dapsone hypersensitivity syndrome, and its absence was associated with a reduction in risk by a factor of 7 (from 1.4% to 0.2%). HLA-B*13:01 is present in about 2 to 20% of Chinese persons, 1.5% of Japanese persons, 1 to 12% of Indians, and 2 to 4% of Southeast Asians but is largely absent in Europeans and Africans. ConclusionsHLA-B*13:01 was associated with the development of the dapsone hypersensitivity syndrome among patients with leprosy. (Funded by the National Natural Science Foundation of China and others.)	[Zhang, Fu-Ren; Liu, Hong; Fu, Xi-An; Yu, Gong-Qi; Yu, Yong-Xiang; Chen, Ming-Fei; Li, Jing-Hui; Bao, Fang-Fang; Liu, Jian; Wang, Na; Niu, Gui-Ye; Wang, Zhen-Zhen; Shi, Ben-Qing; Tian, Hong-Qing; Liu, Hua-Xu; Ma, Shan-Shan; Zhou, Yan; You, Jia-Bao; Yang, Qing; Wang, Chuan; Chu, Tong-Sheng; Liu, Dian-Chang; Yu, Xiu-Lu; Sun, Yong-Hu; Chen, Sheng-Li; Chen, Xue-Chao; Zhang, Zhao-Xia; Liu, Yong-Xia; Lu, Xian-Mei; Zhou, Gui-Zhi; Chen, Shu-Min] Shangdong Prov Inst Dermatol & Venereol, Jinan, Peoples R China; [Ning, Yong] Sichuan Prov Inst Dermatol, Chengdu, Peoples R China; [Wei, Zhong-He] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Wu, Wen-Bin] Fujian Ctr Dis Control & Prevent, Fuzhou, Peoples R China; [Zheng, Zhong-Yi] Honghe Inst Dermatol, Honghe, Yunnan, Peoples R China; [Yang, Rong-De; Long, Heng] Wenshan Inst Dermatol, Wenshan, Yunnan, Peoples R China; [Liu, Zuo-Sheng] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Wang, Jing-Quan] Zhejiang Prov Inst Dermatol, Deqing, Peoples R China; [Li, Ming] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Zeng, Yi-Xin] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Lian-Hua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Wang, Hong] Guangxi Prov Inst Dermatol, Nanning, Peoples R China; [Wang, La-Mei] Jiangxi Inst Parasit Dis, Nanchang, Peoples R China; [Xiao, Peng] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Li, Jin-Lan] Guizhou Prov Ctr Dis Control & Prevent, Guizhou, Peoples R China; [Huang, Zhi-Ming] Shenzhen Baoshan Chron Dis Control Ctr, Shenzhen, Peoples R China; [Huang, Jun-Xin] Shenzhen Chron Dis Control Ctr, Shenzhen, Peoples R China; [Li, Zhen] Shenzhen Nanshan Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Liu, Jian] Beijing Friendship Hosp, Res Inst Trop Med, Beijing, Peoples R China; [Yan, Liang-Bin; Shen, Jian-Ping; Zhang, Guo-Cheng] Chinese Acad Med Sci, Inst Dermatol, Beijing 100730, Peoples R China; [Yan, Liang-Bin; Shen, Jian-Ping; Zhang, Guo-Cheng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xiong, Li; Yang, Jun] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Wang, Xiao-Dong; Yu, De-Bao] Jinan Inst Dermatol, Jinan, Peoples R China; [Irwanto, Astrid; Li, Yi; Low, Hui-Qi; Foo, Jia-Nee; Bei, Jin-Xin; Liany, Herty; Liu, Jian-Jun] Natl Univ Singapore, Genome Inst Singapore, Singapore 117548, Singapore; [Irwanto, Astrid; Liu, Jian-Jun] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Jia, Xiao-Ming] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA; [Pulit, Sara L.; de Bakker, Paul I. W.] Broad Inst Harvard & Massachusetts Inst Technol, Program Med & Populat Genet, Cambridge, MA USA; [Pulit, Sara L.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; State Key Lab Oncology South China; Sun Yat Sen University; Jiangsu Provincial Center for Disease Control & Prevention; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zhang, FR (corresponding author), Shangdong Prov Inst Dermatol & Venereol, Jinan, Peoples R China.	zhangfuren@hotmail.com; liuj3@gis.a-star.edu.sg	de Bakker, Paul IW/B-8730-2009; Bei, Jin-Xin/AAO-1259-2020; Foo, Jia Nee/D-6069-2014	de Bakker, Paul IW/0000-0001-7735-7858; Foo, Jia Nee/0000-0001-9899-2308; Jia, Xiaoming/0000-0002-5104-5431; Sun, Yonghu/0000-0003-4553-2871; Pulit, Sara/0000-0002-2502-3669; Liu, Jianjun/0000-0002-3255-3019	National Natural Science Foundation of China [81071288, 81072391, 81101187, 81271746, 31200933]; 973 Program [2011CB512105]; National Clinical Key Project of Dermatology and Venereology; Taishan Scholar Project; Medical Leading Scholar of Shandong Province Project; Natural Science Foundation of Shandong Province [ZR2011HQ003, ZR2012HQ031]; Agency for Science, Technology, and Research of Singapore; Netherlands Organization for Scientific Research (NWO project) [016.126.354]; Singapore International Graduate Award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Clinical Key Project of Dermatology and Venereology; Taishan Scholar Project; Medical Leading Scholar of Shandong Province Project; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Agency for Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Netherlands Organization for Scientific Research (NWO project)(Netherlands Organization for Scientific Research (NWO)); Singapore International Graduate Award	Supported by grants from the National Natural Science Foundation of China (81071288, 81072391, 81101187, 81271746, and 31200933), the 973 Program (2011CB512105), the National Clinical Key Project of Dermatology and Venereology, the Taishan Scholar Project, the Medical Leading Scholar of Shandong Province Project, the Natural Science Foundation of Shandong Province (ZR2011HQ003 and ZR2012HQ031), and the Agency for Science, Technology, and Research of Singapore. Dr. de Bakker is the recipient of the Vidi award from the Netherlands Organization for Scientific Research (NWO project 016.126.354). Ms. Irwanto was supported by the Singapore International Graduate Award.	ALLDAY EJ, 1951, LANCET, V261, P205; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P365; Bade-Doeding C, 2007, IMMUNOGENETICS, V59, P253, DOI 10.1007/s00251-007-0197-7; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Fromm E, 1908, BER DTSCH CHEM GES, V41, P2264, DOI 10.1002/cber.190804102131; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Leslie KS, 2003, CLIN EXP DERMATOL, V28, P496, DOI 10.1046/j.1365-2230.2003.01336.x; Lorenz M, 2012, ACTA DERM-VENEREOL, V92, P194, DOI 10.2340/00015555-1268; LOWE J, 1949, Int J Lepr, V17, P181; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao PN, 2001, LEPROSY REV, V72, P57; RICHARDUS JH, 1989, LEPROSY REV, V60, P267; Shi L, 2006, TISSUE ANTIGENS, V67, P38, DOI 10.1111/j.1399-0039.2005.00526.x; Tian WW, 2012, LEPROSY REV, V83, P370; Wozel VEG, 2010, DERMATOL CLIN, V28, P599, DOI 10.1016/j.det.2010.03.014; Yang G, 2006, TISSUE ANTIGENS, V67, P146, DOI 10.1111/j.1399-0039.2006.00529.x; Zhu YI, 2001, J AM ACAD DERMATOL, V45, P420, DOI 10.1067/mjd.2001.114733	26	201	216	0	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1620	1628		10.1056/NEJMoa1213096	http://dx.doi.org/10.1056/NEJMoa1213096			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	24152261				2022-12-28	WOS:000326031100011
J	Stranks, SD; Eperon, GE; Grancini, G; Menelaou, C; Alcocer, MJP; Leijtens, T; Herz, LM; Petrozza, A; Snaith, HJ				Stranks, Samuel D.; Eperon, Giles E.; Grancini, Giulia; Menelaou, Christopher; Alcocer, Marcelo J. P.; Leijtens, Tomas; Herz, Laura M.; Petrozza, Annamaria; Snaith, Henry J.			Electron-Hole Diffusion Lengths Exceeding 1 Micrometer in an Organometal Trihalide Perovskite Absorber	SCIENCE			English	Article							ALL-SOLID-STATE; SOLAR-CELLS; PHOTOVOLTAIC CELLS; HALIDE PEROVSKITES; EFFICIENT; EXCITON; DEPOSITION; COMPOUND	Organic-inorganic perovskites have shown promise as high-performance absorbers in solar cells, first as a coating on a mesoporous metal oxide scaffold and more recently as a solid layer in planar heterojunction architectures. Here, we report transient absorption and photoluminescence-quenching measurements to determine the electron-hole diffusion lengths, diffusion constants, and lifetimes in mixed halide (CH3NH3PbI3-xClx) and triiodide (CH3NH3PbI3) perovskite absorbers. We found that the diffusion lengths are greater than 1 micrometer in the mixed halide perovskite, which is an order of magnitude greater than the absorption depth. In contrast, the triiodide absorber has electron-hole diffusion lengths of similar to 100 nanometers. These results justify the high efficiency of planar heterojunction perovskite solar cells and identify a critical parameter to optimize for future perovskite absorber development.	[Stranks, Samuel D.; Eperon, Giles E.; Menelaou, Christopher; Leijtens, Tomas; Herz, Laura M.; Snaith, Henry J.] Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; [Grancini, Giulia; Alcocer, Marcelo J. P.; Petrozza, Annamaria] Ist Italiano Tecnol, Ctr Nano Sci & Technol PoliMi, I-20133 Milan, Italy	University of Oxford; Istituto Italiano di Tecnologia - IIT	Snaith, HJ (corresponding author), Univ Oxford, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	h.snaith1@physics.ox.ac.uk	Snaith, Henry J/A-7367-2016; Herz, Laura/B-9789-2008; Eperon, Giles/J-2316-2015; Petrozza, Annamaria/A-1065-2014; Stranks, Samuel D/M-7837-2015; Grancini, Giulia/AAH-3557-2019	Snaith, Henry J/0000-0001-8511-790X; Herz, Laura/0000-0001-9621-334X; Eperon, Giles/0000-0001-9600-4847; Petrozza, Annamaria/0000-0001-6914-4537; Stranks, Samuel D/0000-0002-8303-7292; Grancini, Giulia/0000-0001-8704-4222; Africa, Josephine/0000-0002-8117-9211; Alcocer, Marcelo/0000-0002-6600-1335	Engineering and Physical Sciences Research Council; European Research Council (ERC-StG 2011 HYPER project) [279881]; Oxford Photovoltaics through a Nanotechnology KTN CASE award; Royal Society Wolfson exchange grant; Worcester College, Oxford; EPSRC [EP/H015701/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1511477, EP/H015701/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council (ERC-StG 2011 HYPER project)(European Research Council (ERC)); Oxford Photovoltaics through a Nanotechnology KTN CASE award; Royal Society Wolfson exchange grant; Worcester College, Oxford; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This project was funded by the Engineering and Physical Sciences Research Council, the European Research Council (ERC-StG 2011 HYPER project 279881), Oxford Photovoltaics through a Nanotechnology KTN CASE award, and by a Royal Society Wolfson exchange grant. The authors thank V. D'Innocenzo for technical support and J. Alexander-Webber for atomic force microscopy supporting measurements. A. P. and H. J. S. thank "The Royal Society International Exchanges Scheme 2012/R2." S. D. S. thanks Worcester College, Oxford, for additional financial support. Solar cells based on the perovskite materials studied in this report are being commercialized by Oxford Photovoltaics, a spin-out company from the University of Oxford.	Abrusci A, 2013, NANO LETT, V13, P3124, DOI 10.1021/nl401044q; Ball JM, 2013, ENERG ENVIRON SCI, V6, P1739, DOI 10.1039/c3ee40810h; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Chu S, 2012, NATURE, V488, P294, DOI 10.1038/nature11475; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Graetzel M, 2012, NATURE, V488, P304, DOI 10.1038/nature11476; HALLS JJM, 1995, NATURE, V376, P498, DOI 10.1038/376498a0; He ZC, 2012, NAT PHOTONICS, V6, P591, DOI [10.1038/nphoton.2012.190, 10.1038/NPHOTON.2012.190]; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI [10.1038/NPHOTON.2013.80, 10.1038/nphoton.2013.80]; HIRASAWA M, 1994, PHYSICA B, V201, P427, DOI 10.1016/0921-4526(94)91130-4; Hodes G, 2012, ACCOUNTS CHEM RES, V45, P705, DOI 10.1021/ar200219h; ISHIHARA T, 1994, J LUMIN, V60-1, P269, DOI 10.1016/0022-2313(94)90145-7; Janssen RAJ, 2013, ADV MATER, V25, P1847, DOI 10.1002/adma.201202873; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Mikhnenko OV, 2012, ENERG ENVIRON SCI, V5, P6960, DOI 10.1039/c2ee03466b; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Sargent EH, 2012, NAT PHOTONICS, V6, P133, DOI 10.1038/nphoton.2012.33; Shaw PE, 2008, ADV MATER, V20, P3516, DOI 10.1002/adma.200800982; Tanaka K, 2003, SOLID STATE COMMUN, V127, P619, DOI 10.1016/S0038-1098(03)00566-0; Todorov T, 2010, EUR J INORG CHEM, P17, DOI 10.1002/ejic.200900837; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Zhang W, 2013, NANO LETT, V13, P4505, DOI 10.1021/nl4024287	27	7502	7630	188	4830	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					341	344		10.1126/science.1243982	http://dx.doi.org/10.1126/science.1243982			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136964	Green Submitted			2022-12-28	WOS:000325755100039
J	Rees, M				Rees, Martin			Time for global statistics we can count on	NATURE			English	Editorial Material									[Rees, Martin] Univ Cambridge, Trinity Coll, Cambridge CB2 1TN, England	University of Cambridge	Rees, M (corresponding author), Univ Cambridge, Trinity Coll, Cambridge CB2 1TN, England.	mjr36@cam.ac.uk							0	1	1	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					273	273		10.1038/502273a	http://dx.doi.org/10.1038/502273a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132252				2022-12-28	WOS:000325706300012
J	Greer, N; Foman, NA; MacDonald, R; Dorrian, J; Fitzgerald, P; Rutks, I; Wilt, TJ				Greer, Nancy; Foman, Neal A.; MacDonald, Roderick; Dorrian, James; Fitzgerald, Patrick; Rutks, Indulis; Wilt, Timothy J.			Advanced Wound Care Therapies for Nonhealing Diabetic, Venous, and Arterial Ulcers	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; HYPERBARIC-OXYGEN THERAPY; VACUUM-ASSISTED CLOSURE; PLATELET-RICH PLASMA; CHRONIC LEG ULCERS; FOOT ULCERS; DOUBLE-BLIND; GROWTH-FACTOR; CLINICAL-EVALUATION; HEALING RATE	Background: Nonhealing ulcers affect patient quality of life and impose a substantial financial burden on the health care system. Purpose: To systematically evaluate benefits and harms of advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers. Data Sources: MEDLINE (1995 to June 2013), the Cochrane Library, and reference lists. Study Selection: English-language randomized trials reporting ulcer healing or time to complete healing in adults with nonhealing ulcers treated with advanced therapies. Data Extraction: Study characteristics, outcomes, adverse events, study quality, and strength of evidence were extracted by trained researchers and confirmed by the principal investigator. Data Synthesis: For diabetic ulcers, 35 trials (9 therapies) met eligibility criteria. There was moderate-strength evidence for improved healing with a biological skin equivalent (relative risk [RR], 1.58 [95% CI, 1.20 to 2.08]) and negative pressure wound therapy (RR, 1.49 [CI, 1.11 to 2.01]) compared with standard care and low-strength evidence for platelet-derived growth factors and silver cream compared with standard care. For venous ulcers, 20 trials (9 therapies) met eligibility criteria. There was moderate-strength evidence for improved healing with keratinocyte therapy (RR, 1.57 [CI, 1.16 to 2.11]) compared with standard care and low-strength evidence for biological dressing and a biological skin equivalent compared with standard care. One small trial of arterial ulcers reported improved healing with a biological skin equivalent compared with standard care. Overall, strength of evidence was low for ulcer healing and low or insufficient for time to complete healing. Limitations: Only studies of products approved by the U.S. Food and Drug Administration were reviewed. Studies were predominantly of fair or poor quality. Few trials compared 2 advanced therapies. Conclusion: Compared with standard care, some advanced wound care therapies may improve the proportion of ulcers healed and reduce time to healing, although evidence is limited.	[Greer, Nancy] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA; Univ Minnesota, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Greer, N (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, 1 Vet Dr,Mail Code 152, Minneapolis, MN 55417 USA.	nancy.greer@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative(US Department of Veterans Affairs)	This article is based on research conducted by the Minneapolis Evidence-based Synthesis Program and was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative.	Abidia A, 2003, EUR J VASC ENDOVASC, V25, P513, DOI 10.1053/ejvs.2002.1911; Agrawal RP, 2009, DIABETIC FOOT J, V12, P80; Aminian B, 2000, ARCH IRAN MED, V3, P55; Ayello Elizabeth A, 2005, Adv Skin Wound Care, V18, P98, DOI 10.1097/00129334-200503000-00014; Belcaro G, 2010, Panminerva Med, V52, P37; Bhansali Anil, 2009, Diabetes Res Clin Pract, V83, pe13, DOI 10.1016/j.diabres.2008.10.005; BISHOP JB, 1992, J VASC SURG, V16, P251, DOI 10.1016/0741-5214(92)90115-O; BLAIR SD, 1988, PHLEBOLOGY, V3, P129; Blume P, 2011, WOUND REPAIR REGEN, V19, P302, DOI 10.1111/j.1524-475X.2011.00669.x; Blume PA, 2008, DIABETES CARE, V31, P631, DOI 10.2337/dc07-2196; Carter MJ, 2009, ADV SKIN WOUND CARE, V22, P316, DOI 10.1097/01.ASW.0000305486.06358.e0; Chang DW, 2000, ANN VASC SURG, V14, P44, DOI 10.1007/s100169910008; d'Hemecourt PA, 1998, WOUNDS, V10, P69; DiDomenico L, 2011, WOUNDS, V23, P184; Dimakakos E, 2009, WOUNDS, V21, P4; Donaghue V M, 1998, Adv Wound Care, V11, P114; Driver VR, 2006, OSTOMY WOUND MANAG, V52, P68; Duzgun AP, 2008, J FOOT ANKLE SURG, V47, P515, DOI 10.1053/j.jfas.2008.08.002; Edmonds M, 2009, INT J LOW EXTR WOUND, V8, P11, DOI 10.1177/1534734609331597; Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293; Falanga V, 1999, WOUND REPAIR REGEN, V7, P201, DOI 10.1046/j.1524-475X.1999.00201.x; Gentzkow GD, 1996, DIABETES CARE, V19, P350, DOI 10.2337/diacare.19.4.350; HAMMARLUND C, 1994, PLAST RECONSTR SURG, V93, P829, DOI 10.1097/00006534-199404000-00026; Hardikar JV, 2005, WOUNDS, V17, P141; Harding K, 2012, INT WOUND J, V9, P285, DOI 10.1111/j.1742-481X.2011.00881.x; Harding KG, 2005, WOUND REPAIR REGEN, V13, P138, DOI 10.1111/j.1067-1927.2005.130204.x; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; IERAN M, 1990, J ORTHOPAED RES, V8, P276, DOI 10.1002/jor.1100080217; Jacobs Allen M, 2008, Adv Skin Wound Care, V21, P461, DOI 10.1097/01.ASW.0000323573.57206.7b; Jaiswal SS, 2010, INDIAN J SURG, V72, P31, DOI 10.1007/s12262-010-0005-8; Jones Katherine R, 2007, Adv Skin Wound Care, V20, P591; Jude EB, 2007, DIABETIC MED, V24, P280, DOI 10.1111/j.1464-5491.2007.02079.x; Karatepe O, 2011, ACTA CHIR BELG, V111, P298, DOI 10.1080/00015458.2011.11680757; Kenkre JE, 1996, FAM PRACT, V13, P236, DOI 10.1093/fampra/13.3.236; Kessler L, 2003, DIABETES CARE, V26, P2378, DOI 10.2337/diacare.26.8.2378; Krishnamoorthy L, 2003, PHLEBOLOGY, V18, P12, DOI 10.1258/026835503321236858; Landsman A, 2008, WOUNDS, V20, P111; Lindgren C, 1998, BRIT J DERMATOL, V139, P271; Londahl M, 2010, DIABETES CARE, V33, P998, DOI 10.2337/dc09-1754; Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701; MAYBERRY JC, 1991, SURGERY, V109, P575; McCallon S K, 2000, Ostomy Wound Manage, V46, P28; McCallon SK, 2000, OSTOMY WOUND MANAG, V46, P28; McCulloch DK, 2012, UPTODATE; Michaels JA, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13560; Michaels JA, 2009, BRIT J SURG, V96, P1147, DOI 10.1002/bjs.6786; Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042; Naughton G, 1997, ARTIF ORGANS, V21, P1203; Navratilova Z, 2004, J EUR ACAD DERMATOL, V18, P173, DOI 10.1111/j.1468-3083.2004.00873.x; Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012; Omar AA, 2004, EUR J VASC ENDOVASC, V27, P666, DOI 10.1016/j.ejvs.2004.03.001; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Reyzelman A, 2009, INT WOUND J, V6, P196, DOI 10.1111/j.1742-481X.2009.00585.x; Schuler JJ, 1996, PHLEBOLOGY, V11, P111, DOI 10.1177/026835559601100309; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Setta HS, 2011, INT WOUND J, V8, P307, DOI 10.1111/j.1742-481X.2011.00797.x; Spentzouris Georgios, 2009, Semin Intervent Radiol, V26, P286, DOI 10.1055/s-0029-1242204; Stacey MC, 2000, EUR J VASC ENDOVASC, V20, P296, DOI 10.1053/ejvs.2000.1134; Steed DL, 2006, PLAST RECONSTR SURG, V117, p143S, DOI 10.1097/01.prs.0000222526.21512.4c; STEED DL, 1995, J VASC SURG, V21, P71, DOI 10.1016/S0741-5214(95)70245-8; Sullivan N, 2009, NEGATIVE PRESSURE WO; Vanscheidt W, 2007, WOUND REPAIR REGEN, V15, P308, DOI 10.1111/j.1524-475X.2007.00231.x; Veves A, 2002, ARCH SURG-CHICAGO, V137, P822, DOI 10.1001/archsurg.137.7.822; Veves A, 2001, DIABETES CARE, V24, P290, DOI 10.2337/diacare.24.2.290; Vin F, 2002, J Wound Care, V11, P335; Viswanathan V, 2011, INDIAN J MED RES, V134, P168; Wang CJ, 2011, DIABETES RES CLIN PR, V92, P187, DOI 10.1016/j.diabres.2011.01.019; Weinstein J, 2011, DIABETES TECHNOL THE, V13, P1255, DOI 10.1089/dia.2011.0018; Wieman TJ, 1998, DIABETES CARE, V21, P822, DOI 10.2337/diacare.21.5.822; Wu SC, 2010, J AM PODIAT MED ASSN, V100, P385, DOI 10.7547/1000385	71	106	107	1	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					532	+		10.7326/0003-4819-159-8-201310150-00006	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00006			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126647				2022-12-28	WOS:000326751200016
J	Ammannito, E; De Sanctis, MC; Palomba, E; Longobardo, A; Mittlefehldt, DW; McSween, HY; Marchi, S; Capria, MT; Capaccioni, F; Frigeri, A; Pieters, CM; Ruesch, O; Tosi, F; Zambon, F; Carraro, F; Fonte, S; Hiesinger, H; Magni, G; McFadden, LA; Raymond, CA; Russell, CT; Sunshine, JM				Ammannito, E.; De Sanctis, M. C.; Palomba, E.; Longobardo, A.; Mittlefehldt, D. W.; McSween, H. Y.; Marchi, S.; Capria, M. T.; Capaccioni, F.; Frigeri, A.; Pieters, C. M.; Ruesch, O.; Tosi, F.; Zambon, F.; Carraro, F.; Fonte, S.; Hiesinger, H.; Magni, G.; McFadden, L. A.; Raymond, C. A.; Russell, C. T.; Sunshine, J. M.			Olivine in an unexpected location on Vesta's surface	NATURE			English	Article							ASTEROID 4 VESTA; REFLECTANCE; GEOCHEMISTRY; DIOGENITES; PYROXENES; MIXTURES; CORE; SIZE	Olivine is a major component of the mantle of differentiated bodies, including Earth. Howardite, eucrite and diogenite (HED) meteorites represent regolith, basaltic-crust, lower-crust and possibly ultramafic-mantle samples of asteroid Vesta, which is the lone surviving, large, differentiated, basaltic rocky protoplanet in the Solar System(1). Only a few of these meteorites, the orthopyroxene-rich diogenites, contain olivine, typically with a concentration of less than 25 per cent by volume(2). Olivine was tentatively identified on Vesta(3,4), on the basis of spectral and colour data, but other observations did not confirm its presence(5). Here we report that olivine is indeed present locally on Vesta's surface but that, unexpectedly, it has not been found within the deep, south-pole basins, which are thought to be excavated mantle rocks(6-8). Instead, it occurs as near-surface materials in the northern hemisphere. Unlike the meteorites, the olivine-rich (more than 50 per cent by volume) material is not associated with diogenite but seems to be mixed with howardite, the most common(7,9) surface material. Olivine is exposed in crater walls and in ejecta scattered diffusely over a broad area. The size of the olivine exposures and the absence of associated diogenite favour a mantle source, but the exposures are located far from the deep impact basins. The amount and distribution of observed olivine-rich material suggest a complex evolutionary history for Vesta.	[Ammannito, E.; De Sanctis, M. C.; Palomba, E.; Longobardo, A.; Marchi, S.; Capria, M. T.; Capaccioni, F.; Frigeri, A.; Tosi, F.; Zambon, F.; Carraro, F.; Fonte, S.; Magni, G.] INAF, Ist Astrofis & Planetol Spaziali, I-00133 Rome, Italy; [Mittlefehldt, D. W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [McSween, H. Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Marchi, S.] NASA, Lunar Sci Inst, Boulder, CO 80302 USA; [Pieters, C. M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Ruesch, O.; Hiesinger, H.] Univ Munster, Inst Planetol, D-48149 Munster, Germany; [McFadden, L. A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Russell, C. T.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Sunshine, J. M.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); Brown University; University of Munster; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles; University System of Maryland; University of Maryland College Park	De Sanctis, MC (corresponding author), INAF, Ist Astrofis & Planetol Spaziali, I-00133 Rome, Italy.	eleonora.ammannito@iaps.inaf.it; mariacristina.desanctis@iaps.inaf.it	Tosi, Federico/F-2321-2018; Frigeri, Alessandro/F-2151-2010; Frigeri, Alessandro/K-9679-2019; Zambon, Francesca/J-2855-2018; Palomba, Ernesto/E-8287-2017; Russell, Christopher T/E-7745-2012; De Sanctis, Maria Cristina/G-5232-2013; McFadden, Lucy/I-4902-2013	Tosi, Federico/0000-0003-4002-2434; Frigeri, Alessandro/0000-0002-9140-3977; Frigeri, Alessandro/0000-0002-9140-3977; Zambon, Francesca/0000-0002-4190-6592; Palomba, Ernesto/0000-0002-9101-6774; Russell, Christopher T/0000-0003-1639-8298; De Sanctis, Maria Cristina/0000-0002-3463-4437; McFadden, Lucy/0000-0002-0537-9975; Longobardo, Andrea/0000-0002-1797-2741; capria, maria teresa/0000-0002-9814-9588; Capaccioni, Fabrizio/0000-0003-1631-4314; Sunshine, Jessica/0000-0002-9413-8785	Dawn Instrument, Operations and Science teams; Dawn Framing Camera team; Italian Space Agency [I/004/12/0]; NASA through the Dawn mission; Dawn at Vesta Participating Scientists Program	Dawn Instrument, Operations and Science teams; Dawn Framing Camera team; Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NASA through the Dawn mission; Dawn at Vesta Participating Scientists Program	We gratefully acknowledge the support of the Dawn Instrument, Operations and Science teams, and, in particular, the Dawn Framing Camera team. This work was supported by Italian Space Agency grant I/004/12/0 and by NASA through the Dawn mission and the Dawn at Vesta Participating Scientists Program.	ADAMS JB, 1974, J GEOPHYS RES, V79, P4829, DOI 10.1029/JB079i032p04829; Ammannito E, 2013, METEORIT PLANET SCI, V48, P2185, DOI 10.1111/maps.12192; Barrat JA, 2010, GEOCHIM COSMOCHIM AC, V74, P6218, DOI 10.1016/j.gca.2010.07.028; Beck AW, 2012, METEORIT PLANET SCI, V47, P947, DOI 10.1111/j.1945-5100.2012.01360.x; Beck AW, 2011, METEORIT PLANET SCI, V46, P1133, DOI 10.1111/j.1945-5100.2011.01219.x; Beck AW, 2010, METEORIT PLANET SCI, V45, P850, DOI 10.1111/j.1945-5100.2010.01061.x; Binzel RP, 1997, ICARUS, V128, P95, DOI 10.1006/icar.1997.5734; Burns Roger George, 1970, MINERALOGICAL APPL C; CLOUTIS EA, 1986, J GEOPHYS RES-SOLID, V91, P1641, DOI 10.1029/JB091iB11p11641; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; De Sanctis MC, 2011, SPACE SCI REV, V163, P329, DOI 10.1007/s11214-010-9668-5; De Sanctis M. C., 2013, METEORIT PLANET SCI; DELANEY JS, 1984, J GEOPHYS RES, V89, pC251, DOI 10.1029/JB089iS01p0C251; Demeo FE, 2009, ICARUS, V202, P160, DOI 10.1016/j.icarus.2009.02.005; Gaffey MJ, 1997, ICARUS, V127, P130, DOI 10.1006/icar.1997.5680; GAFFEY MJ, 1993, ICARUS, V106, P573, DOI 10.1006/icar.1993.1194; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; Jutzi M, 2013, NATURE, V494, P207, DOI 10.1038/nature11892; Li JY, 2010, ICARUS, V208, P238, DOI 10.1016/j.icarus.2010.02.008; Marchi S, 2013, NAT GEOSCI, V6, P303, DOI [10.1038/ngeo1769, 10.1038/NGEO1769]; Marchi S, 2012, SCIENCE, V336, P690, DOI 10.1126/science.1218757; McSween HY, 2013, J GEOPHYS RES-PLANET, V118, P335, DOI 10.1002/jgre.20057; Mittlefehldt DW, 2000, METEORIT PLANET SCI, V35, P901, DOI 10.1111/j.1945-5100.2000.tb01479.x; Righter K, 1997, METEORIT PLANET SCI, V32, P929, DOI 10.1111/j.1945-5100.1997.tb01582.x; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Ruzicka A, 1997, METEORIT PLANET SCI, V32, P825, DOI 10.1111/j.1945-5100.1997.tb01573.x; Shearer CK, 2010, GEOCHIM COSMOCHIM AC, V74, P4865, DOI 10.1016/j.gca.2010.05.015; SINGER RB, 1981, J GEOPHYS RES, V86, P7967, DOI 10.1029/JB086iB09p07967; Sunshine JM, 1998, J GEOPHYS RES-PLANET, V103, P13675, DOI 10.1029/98JE01217; WATTS AW, 1991, ICARUS, V93, P159, DOI 10.1016/0019-1035(91)90170-X	30	71	71	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					122	+		10.1038/nature12665	http://dx.doi.org/10.1038/nature12665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24196707				2022-12-28	WOS:000327851700043
J	Brantut, JP; Grenier, C; Meineke, J; Stadler, D; Krinner, S; Kollath, C; Esslinger, T; Georges, A				Brantut, Jean-Philippe; Grenier, Charles; Meineke, Jakob; Stadler, David; Krinner, Sebastian; Kollath, Corinna; Esslinger, Tilman; Georges, Antoine			A Thermoelectric Heat Engine with Ultracold Atoms	SCIENCE			English	Article							FERMI GAS; CONDUCTION	Thermoelectric effects, such as the generation of a particle current by a temperature gradient, have their origin in a reversible coupling between heat and particle flows. These effects are fundamental probes for materials and have applications to cooling and power generation. Here, we demonstrate thermoelectricity in a fermionic cold atoms channel in the ballistic and diffusive regimes, connected to two reservoirs. We show that the magnitude of the effect and the efficiency of energy conversion can be optimized by controlling the geometry or disorder strength. Our observations are in quantitative agreement with a theoretical model based on the Landauer-Buttiker formalism. Our device provides a controllable model system to explore mechanisms of energy conversion and realizes a cold atom-based heat engine.	[Brantut, Jean-Philippe; Meineke, Jakob; Stadler, David; Krinner, Sebastian; Esslinger, Tilman] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Grenier, Charles; Georges, Antoine] Ecole Polytech, CNRS, Ctr Phys Theor, F-91128 Palaiseau, France; [Kollath, Corinna] Univ Bonn, HISKP, D-53115 Bonn, Germany; [Georges, Antoine] Coll France, F-75005 Paris, France; [Georges, Antoine] Univ Geneva, DPMC MaNEP, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; University of Bonn; UDICE-French Research Universities; PSL Research University Paris; College de France; University of Geneva	Esslinger, T (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Georges, Antoine/H-4855-2012; Esslinger, Tilman/M-9022-2016; Brantut, Jean-Philippe/G-2793-2013	Georges, Antoine/0000-0001-9479-9682; Esslinger, Tilman/0000-0002-8333-107X; Brantut, Jean-Philippe/0000-0002-4610-6682	Swiss National Science Foundation; National Centres of Competence in Research Materials with Novel Electronic Properties (MaNEP); Quantum Science and Technology (QSIT); European Research Council Project SQMS; FP7 Project Nanodesigning of Atomic and Molecular Quantum Matter (NAME-QUAM); ETH Zurich Schrodinger chair; Defense Advanced Research Projects Agency-OLE program; Agence Nationale de la Recherche (Far From Equilibrium Quantum Systems); ETH Zurich; European Union through a Marie Curie Fellowship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centres of Competence in Research Materials with Novel Electronic Properties (MaNEP); Quantum Science and Technology (QSIT); European Research Council Project SQMS; FP7 Project Nanodesigning of Atomic and Molecular Quantum Matter (NAME-QUAM); ETH Zurich Schrodinger chair; Defense Advanced Research Projects Agency-OLE program; Agence Nationale de la Recherche (Far From Equilibrium Quantum Systems)(French National Research Agency (ANR)); ETH Zurich(ETH Zurich); European Union through a Marie Curie Fellowship(European Commission)	We acknowledge fruitful discussions with J. Blatter, M. Buttiker, D. Papoular, and S. Stringari. We acknowledge funding from the Swiss National Science Foundation, National Centres of Competence in Research Materials with Novel Electronic Properties (MaNEP) and Quantum Science and Technology (QSIT), the European Research Council Project SQMS, the FP7 Project Nanodesigning of Atomic and Molecular Quantum Matter (NAME-QUAM), the ETH Zurich Schrodinger chair, the Defense Advanced Research Projects Agency-OLE program, Agence Nationale de la Recherche (Far From Equilibrium Quantum Systems), and ETH Zurich. J.-P.B. is partially supported by the European Union through a Marie Curie Fellowship. The data presented in this paper are available upon request to T.E.	Albiez M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010402; Ashcroft N.W., 1976, SOLID STATE PHYS; Behnia K, 2004, J PHYS-CONDENS MAT, V16, P5187, DOI 10.1088/0953-8984/16/28/037; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Brantut JP, 2012, SCIENCE, V337, P1069, DOI 10.1126/science.1223175; BUTTIKER M, 1988, IBM J RES DEV, V32, P317, DOI 10.1147/rd.323.0317; DiSalvo FJ, 1999, SCIENCE, V285, P703, DOI 10.1126/science.285.5428.703; Entin-Wohlman O, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115314; Esslinger T, 2010, ANNU REV CONDEN MA P, V1, P129, DOI 10.1146/annurev-conmatphys-070909-104059; Goldsmid H. J., 2009, SPRINGER SERIES MAT; HEREMANS JD, 2006, NANOMATERIALS HDB, P739; Imry Y, 1999, REV MOD PHYS, V71, pS306, DOI 10.1103/RevModPhys.71.S306; Karpiuk T, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.033619; Kim H, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.053607; Micklitz T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.036405; Mokashi A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.096405; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; Papoular DJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.084501; Pezze L, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/095015; Ramanathan A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130401; Sanchez R, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085428; Sidorenkov LA, 2013, NATURE, V498, P78, DOI 10.1038/nature12136; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Stadler D, 2012, NATURE, V491, P736, DOI 10.1038/nature11613; Terasaki I, 2011, J APPL PHYS, V110, DOI 10.1063/1.3626459; Wong CH, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.063613; Zhang XB, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/045011	28	186	188	4	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					713	715		10.1126/science.1242308	http://dx.doi.org/10.1126/science.1242308			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24158905	Green Submitted			2022-12-28	WOS:000326647600036
J	Jonsson, R; Theander, E; Sjostrom, B; Brokstad, K; Henriksson, G				Jonsson, Roland; Theander, Elke; Sjostrom, Bitte; Brokstad, Karl; Henriksson, Gunnel			Autoantibodies Present Before Symptom Onset in Primary Sjogren Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jonsson, Roland; Brokstad, Karl] Univ Bergen, Broegelmann Res Lab, Bergen, Norway; [Theander, Elke] Lund Univ, Dept Rheumatol, S-20502 Malmo, Sweden; [Sjostrom, Bitte; Henriksson, Gunnel] Lund Univ, Dept Lab Med Malmo, S-20502 Malmo, Sweden	University of Bergen; Lund University; Lund University	Henriksson, G (corresponding author), Lund Univ, Jan Waldenstroms St 59, S-20502 Malmo, Sweden.	gunnel.henriksson@med.lu.se	Brokstad, Karl Albert/AAU-9639-2020; Brokstad, Karl Albert/N-8096-2015	Brokstad, Karl Albert/0000-0003-0593-2731; Brokstad, Karl Albert/0000-0003-0593-2731				Jonsson R, 2005, ARTHRITIS ALLIED CON, P1681; Jonsson R, 2007, ANN NY ACAD SCI, V1108, P433, DOI 10.1196/annals.1422.046; Mignogna MD, 2005, J ORAL PATHOL MED, V34, P1, DOI 10.1111/j.1600-0714.2004.00264.x; Pukkala E, 2007, ACTA ONCOL, V46, P286, DOI 10.1080/02841860701203545; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	6	142	147	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1854	1855		10.1001/jama.2013.278448	http://dx.doi.org/10.1001/jama.2013.278448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193084	Bronze			2022-12-28	WOS:000326550900020
J	Eyal, N; Kuritzkes, DR				Eyal, Nir; Kuritzkes, Daniel R.			Challenges in clinical trial design for HIV-1 cure research	LANCET			English	Editorial Material							INTERRUPTION		[Eyal, Nir] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Div Med Eth, Boston, MA 02139 USA; [Kuritzkes, Daniel R.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02139 USA; [Kuritzkes, Daniel R.] Harvard Univ, Sch Med, Boston, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kuritzkes, DR (corresponding author), Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02139 USA.	dkuritzkes@partners.org						Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Cooper DA, 2008, J INFECT DIS, V197, P775, DOI 10.1086/527399; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Elliott J, 2013, 20 C RETR OPP INF AT; Eyal N, 2014, J MED ETHICS, V40, P437, DOI 10.1136/medethics-2012-100490; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Lawrence J, 2003, NEW ENGL J MED, V349, P837, DOI 10.1056/NEJMoa035103; Lo B, 2013, CURR OPIN HIV AIDS, V8, P243, DOI 10.1097/COH.0b013e32835ea1c5; Persaud D, 2013, 20 C RETR OPP INF AT; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Tolstrup M, 2013, HIV CUR S KUAL LUMP; Worthington MG, 2003, AIDS, V17, P2145, DOI 10.1097/00002030-200309260-00026	12	32	32	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1464	1465		10.1016/S0140-6736(13)62040-1	http://dx.doi.org/10.1016/S0140-6736(13)62040-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	24182529				2022-12-28	WOS:000326622500006
J	Caron, SJC				Caron, Sophie J. C.			Brains Don't Play Dice-or Do They?	SCIENCE			English	Editorial Material							IMAGING REVEALS; MUSHROOM BODY; DROSOPHILA; MAP; REPRESENTATION		NYU, Dept Neurosci, New York, NY 10032 USA	New York University	Caron, SJC (corresponding author), NYU, Dept Neurosci, 701 W 168th St, New York, NY 10032 USA.	sc2992@columbia.edu						Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	14	1	1	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158								10.1126/science.1245982	http://dx.doi.org/10.1126/science.1245982			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179216	Bronze			2022-12-28	WOS:000326334300033
J	Sabelstrom, H; Stenudd, M; Reu, P; Dias, DO; Elfineh, M; Zdunek, S; Damberg, P; Goritz, C; Frisen, J				Sabelstrom, Hanna; Stenudd, Moa; Reu, Pedro; Dias, David O.; Elfineh, Marta; Zdunek, Sofia; Damberg, Peter; Goritz, Christian; Frisen, Jonas			Resident Neural Stem Cells Restrict Tissue Damage and Neuronal Loss After Spinal Cord Injury in Mice	SCIENCE			English	Article							CILIARY NEUROTROPHIC FACTOR; CENTRAL-NERVOUS-SYSTEM; DIFFERENTIATION; GROWTH; ORIGIN; BRAIN; RATS; SCAR; PROLIFERATION; EXPRESSION	Central nervous system injuries are accompanied by scar formation. It has been difficult to delineate the precise role of the scar, as it is made by several different cell types, which may limit the damage but also inhibit axonal regrowth. We show that scarring by neural stem cell-derived astrocytes is required to restrict secondary enlargement of the lesion and further axonal loss after spinal cord injury. Moreover, neural stem cell progeny exerts a neurotrophic effect required for survival of neurons adjacent to the lesion. One distinct component of the glial scar, deriving from resident neural stem cells, is required for maintaining the integrity of the injured spinal cord.	[Sabelstrom, Hanna; Stenudd, Moa; Reu, Pedro; Dias, David O.; Elfineh, Marta; Zdunek, Sofia; Goritz, Christian; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Reu, Pedro] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Damberg, Peter] Karolinska Inst, Dept Clin Sci Intervent & Technol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Universidade de Coimbra; Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Göritz, Christian/AAK-5348-2021	Göritz, Christian/0000-0003-0799-766X; Oliveira Dias, David/0000-0002-2144-6621; Sabelstrom, Hanna/0000-0002-1736-7234; Reu, Pedro/0000-0001-7454-7189	Swedish Research Council; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; AFA Forsakringar; StratRegen; Knut och Alice Wallenbergs Stiftelse; Foundation for Science and Technology from the Portuguese government [SFRH/BD/63164/2009, SFRH/BD/33465/2008]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; AFA Forsakringar; StratRegen; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Foundation for Science and Technology from the Portuguese government	We thank F. Barnabe-Heider and O. Bergmann for discussions and M. Barbacid for providing Ras mutant mice through a materials transfer agreement with Centro Nacional de Investigaciones Oncologicas (Spanish National Cancer Institute, CNIO), Spain. Requests for mice should be directed to M. Barbacid (CNIO, Spain). This study was supported by the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, AFA Forsakringar, StratRegen, and Knut och Alice Wallenbergs Stiftelse. D.O.D. and P.R. were supported by the Foundation for Science and Technology from the Portuguese government (SFRH/BD/63164/2009 and SFRH/BD/33465/2008).	Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hung KS, 2007, J NEUROSURG-SPINE, V6, P35, DOI 10.3171/spi.2007.6.1.35; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; NIETOSAMPEDRO M, 1982, SCIENCE, V217, P860, DOI 10.1126/science.7100931; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pfenninger CV, 2011, GLIA, V59, P68, DOI 10.1002/glia.21077; Sabelstrom H, 2014, EXP NEUROL, V260, P44, DOI 10.1016/j.expneurol.2013.01.026; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tripathi RB, 2008, J COMP NEUROL, V510, P129, DOI 10.1002/cne.21787; Yan J, 2004, J COMP NEUROL, V480, P101, DOI 10.1002/cne.20344; Yasuda A, 2011, STEM CELLS, V29, P1983, DOI 10.1002/stem.767; Ye JL, 2004, BRAIN RES, V997, P30, DOI 10.1016/j.brainres.2003.10.036	27	185	193	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					637	640		10.1126/science.1242576	http://dx.doi.org/10.1126/science.1242576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179227				2022-12-28	WOS:000326334300053
J	Lanternier, F; Pathan, S; Vincent, QB; Liu, LY; Cypowyj, S; Prando, C; Migaud, M; Taibi, L; Ammar-Khodja, A; Boudghene Stambouli, O; Guellil, B; Jacobs, F; Goffard, JC; Schepers, K; del Marmol, V; Boussofara, L; Denguezli, M; Larif, M; Bachelez, H; Michel, L; Lefranc, G; Hay, R; Jouvion, G; Chretien, F; Fraitag, S; Bougnoux, ME; Boudia, M; Abel, L; Lortholary, O; Casanova, JL; Picard, C; Grimbacher, B; Puel, A				Lanternier, Fanny; Pathan, Saad; Vincent, Quentin B.; Liu, Luyan; Cypowyj, Sophie; Prando, Carolina; Migaud, Melanie; Taibi, Lynda; Ammar-Khodja, Aomar; Boudghene Stambouli, Omar; Guellil, Boumediene; Jacobs, Frederique; Goffard, Jean-Christophe; Schepers, Kinda; del Marmol, Veronique; Boussofara, Lobna; Denguezli, Mohamed; Larif, Molka; Bachelez, Herve; Michel, Laurence; Lefranc, Gerard; Hay, Rod; Jouvion, Gregory; Chretien, Fabrice; Fraitag, Sylvie; Bougnoux, Marie-Elisabeth; Boudia, Merad; Abel, Laurent; Lortholary, Olivier; Casanova, Jean-Laurent; Picard, Capucine; Grimbacher, Bodo; Puel, Anne			Deep Dermatophytosis and Inherited CARD9 Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; ADAPTER PROTEIN CARD9; NF-KAPPA-B; TRICHOPHYTON-RUBRUM; ANTIFUNGAL IMMUNITY; IMMUNOCOMPROMISED PATIENT; STAT1 MUTATIONS; DISEASE; INNATE; INFECTION	BackgroundDeep dermatophytosis is a severe and sometimes life-threatening fungal infection caused by dermatophytes. It is characterized by extensive dermal and subcutaneous tissue invasion and by frequent dissemination to the lymph nodes and, occasionally, the central nervous system. The condition is different from common superficial dermatophyte infection and has been reported in patients with no known immunodeficiency. Patients are mostly from North African, consanguineous, multiplex families, which strongly suggests a mendelian genetic cause. MethodsWe studied the clinical features of deep dermatophytosis in 17 patients with no known immunodeficiency from eight unrelated Tunisian, Algerian, and Moroccan families. Because CARD9 (caspase recruitment domain-containing protein 9) deficiency has been reported in an Iranian family with invasive fungal infections, we also sequenced CARD9 in the patients. ResultsFour patients died, at 28, 29, 37, and 39 years of age, with clinically active deep dermatophytosis. No other severe infections, fungal or otherwise, were reported in the surviving patients, who ranged in age from 37 to 75 years. The 15 Algerian and Tunisian patients, from seven unrelated families, had a homozygous Q289X CARD9 allele, due to a founder effect. The 2 Moroccan siblings were homozygous for the R101C CARD9 allele. Both alleles are rare deleterious variants. The familial segregation of these alleles was consistent with autosomal recessive inheritance and complete clinical penetrance. ConclusionsAll the patients with deep dermatophytosis had autosomal recessive CARD9 deficiency. Deep dermatophytosis appears to be an important clinical manifestation of CARD9 deficiency. (Funded by Agence Nationale pour la Recherche and others.) Dermatophyte infections are unusual but can cause serious invasive disease. In this report, autosomal recessive CARD9 deficiency indicated a potential genetic susceptibility to deep dermatophytosis, a severe invasive fungal infection. Deep dermatophytosis is a rare, invasive, sometimes life-threatening, fungal infection caused by dermatophytes.(1) These filamentous fungi are ubiquitous and usually cause benign infections that are limited to keratinized tissues and lead to onychomycosis, tinea corporis, tinea cruris, tinea pedis, or tinea capitis.(2) In deep dermatophytosis, dermatophytes invade the dermis and hypodermis and disseminate to the skin, hair, nails, lymph nodes, and brain.(3) Deep dermatophytosis has been reported in patients with the human immunodeficiency virus and patients who are receiving immunosuppressive therapy.(3) It was first described in 1959 in otherwise apparently healthy persons as dermatophytic disease.(1) Forty-five cases have been reported ...	[Lanternier, Fanny; Vincent, Quentin B.; Liu, Luyan; Migaud, Melanie; Abel, Laurent; Casanova, Jean-Laurent; Picard, Capucine; Puel, Anne] Necker Med Sch, INSERM, U980, Lab Human Genet Infect Dis,Necker Branch,Imagine, F-75015 Paris, France; [Lanternier, Fanny; Vincent, Quentin B.; Liu, Luyan; Migaud, Melanie; Abel, Laurent; Casanova, Jean-Laurent; Picard, Capucine; Puel, Anne] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Lanternier, Fanny; Lortholary, Olivier] Necker Enfants Malades Hosp, AP HP, Infect Dis & Trop Med Unit, Paris, France; [Casanova, Jean-Laurent] Necker Enfants Malades Hosp, AP HP, Pediat Hematol Immunol Unit, Paris, France; [Bachelez, Herve] Univ Paris 05, Dermatol Unit, Paris, France; [Bachelez, Herve] Skin Res Inst, INSERM, U697, Necker Enfants Malades Hosp,U781, Paris, France; [Jouvion, Gregory; Chretien, Fabrice] Inst Pasteur, Infect & Epidemiol Dept, Paris, France; [Lortholary, Olivier] Inst Pasteur, Natl Reference Ctr Invas Mycoses & Antifungals, Mol Mycol Unit, Paris, France; [Fraitag, Sylvie] Necker Enfants Malades Hosp, AP HP, Pathol Unit, Paris, France; [Bougnoux, Marie-Elisabeth] Necker Enfants Malades Hosp, AP HP, Microbiol Unit, Paris, France; [Picard, Capucine] Necker Enfants Malades Hosp, AP HP, Study Ctr Immunodeficiency, Paris, France; [Pathan, Saad; Grimbacher, Bodo] UCL, Royal Free Hosp, London, England; [Hay, Rod] Willan House, Int Fdn Dermatol, London, England; [Cypowyj, Sophie; Prando, Carolina; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Taibi, Lynda; Ammar-Khodja, Aomar] Mustapha Hosp, Dermatol Unit, Algiers, Algeria; [Taibi, Lynda; Ammar-Khodja, Aomar] Fac Med, Algiers, Algeria; [Boudghene Stambouli, Omar; Boudia, Merad] Dr T Damerdji Tlemcen Hosp, Dermatol Unit, Tilimsen, Algeria; [Boudghene Stambouli, Omar; Boudia, Merad] Aboubakr Belkaid Univ, Tilimsen, Algeria; [Guellil, Boumediene] Hassani Abdelkader Hosp, Dermatol Unit, Sidi Bel Abbes, Algeria; [Guellil, Boumediene] Fac Med, Djillali Liabes Univ, Sidi Bel Abbes, Algeria; [Jacobs, Frederique; Goffard, Jean-Christophe; Schepers, Kinda] Univ Libre Brussels, Erasme Hosp, Infect Dis Unit, B-1050 Brussels, Belgium; [del Marmol, Veronique] Univ Libre Brussels, Erasme Hosp, Dermatol Unit, B-1050 Brussels, Belgium; [Boussofara, Lobna; Denguezli, Mohamed; Larif, Molka] Farhat Hached Hosp, Dermatol Unit, Sousse, Tunisia; [Lefranc, Gerard] Inst Human Genet, Mol Immunogenet Unit, Natl Ctr Sci Res, UPR 1142, Montpellier, France; [Lefranc, Gerard] Univ Montpellier 2, Montpellier, France; [Grimbacher, Bodo] Univ Hosp Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Rockefeller University; Universite Abou Bekr Belkaid; University Djillali Liabes Sidi Bel Abbes; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite de Sousse; Hopital Farhat Hached; Universite de Montpellier; Universite de Montpellier; University of Freiburg	Puel, A (corresponding author), Necker Med Sch, INSERM, U980, Lab Human Genet Infect Dis,Necker Branch,Imagine, 156 Rue Vaugirard, F-75015 Paris, France.	jean-laurent.casanova@mail.rockefeller.edu; anne.puel@inserm.fr	Boussofara, Lobna/K-6428-2019; Jouvion, Grégory/AAL-2620-2021; del marmol, veronique/AAZ-8117-2020; Picard, Capucine/H-3914-2017; Puel, Anne/H-7305-2017; Abel, Laurent/H-8888-2017; Michel, Laurence/E-8605-2017; Casanova, Jean-Laurent/I-3418-2017; Migaud, Mélanie/H-8044-2017; Prando, Carolina/C-4689-2015; Lanternier, Fanny/AAQ-2815-2021; Chretien, fabrice B/D-4035-2018	Boussofara, Lobna/0000-0003-0041-8741; Picard, Capucine/0000-0001-8788-5056; Puel, Anne/0000-0003-2603-0323; Abel, Laurent/0000-0001-7016-6493; Migaud, Mélanie/0000-0003-3062-1214; Prando, Carolina/0000-0002-9570-9770; Chretien, fabrice B/0000-0002-2794-1383; sharma, vishnu/0000-0001-8266-8167; Pathan, Saad/0000-0003-3312-9049; Goffard, Jean-Christophe/0000-0002-2730-7673; PATHAN, SAAD/0000-0001-6818-8765; Casanova, Jean-Laurent/0000-0002-7782-4169; bachelez, herve/0000-0003-3567-9095; Vincent, Quentin/0000-0001-6030-5912; Denguezli, Mohamed/0000-0002-4176-2744	l'Agence Nationale pour la Recherche [ANR GENCMCD 11-BSV3-005-01]; European Commission [EURO-GENE-SCAN 223293, EURO-PADnet HEALTH-F2-2008-201549]; Marie Curie Excellence program [MEXT-CT-2006-042316]; German Federal Ministry of Education and Research [BMBF 01 EO 0308]; National Center for Research Resources; National Center for Advancing Translational Sciences [8UL1TR00004]; National Institutes of Health; Rockefeller University; INSERM, Paris Descartes University; St. Giles Foundation; French Government Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]; CMIT (French Faculties College of Infectious Diseases); INSERM; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043, UL1TR000004] Funding Source: NIH RePORTER	l'Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Curie Excellence program; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; INSERM, Paris Descartes University; St. Giles Foundation; French Government Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases(French National Research Agency (ANR)); CMIT (French Faculties College of Infectious Diseases); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by grants from l'Agence Nationale pour la Recherche (ANR GENCMCD 11-BSV3-005-01, to Dr. Puel); the European Commission Sixth and Seventh Framework Programs (EURO-GENE-SCAN 223293 and EURO-PADnet HEALTH-F2-2008-201549); the Marie Curie Excellence program (MEXT-CT-2006-042316); the German Federal Ministry of Education and Research (BMBF 01 EO 0308); the National Center for Research Resources and the National Center for Advancing Translational Sciences (8UL1TR00004), National Institutes of Health; Rockefeller University; INSERM, Paris Descartes University; the St. Giles Foundation; the French Government Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID); and the CMIT (French Faculties College of Infectious Diseases) and INSERM (both to Dr. Lanternier). Janssen-Cilag France provided itraconazole for compassionate use in the treatment of some patients, thanks to the intervention of Dr. Bessis.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; ARAVIYSKY AN, 1975, MYCOPATHOLOGIA, V56, P47, DOI 10.1007/BF00493584; BEIRANA L., 1959, Dermatologia, Mexico, V3, P4; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; BLANK F, 1957, Dermatologica, V115, P40; BOUDGHENE-STAMBOULI O, 1992, Journal de Mycologie Medicale, V2, P106; Boudghene-Stambouli O, 1998, ANN DERMATOL VENER, V125, P705; BOUDGHENESTAMBOULI O, 1991, ANN DERMATOL VENER, V118, P17; BOUDGHENESTAMBOULI O, 1990, B SOC PATHOL EXOT, V83, P170; BOUDGHENESTAMBOULI O, 1989, ANN DERMATOL VENER, V116, P725; Casanova JL, 2013, ANNU REV GENOM HUM G, V14, P215, DOI 10.1146/annurev-genom-091212-153448; Chastain MA, 2001, CUTIS, V67, P457; Cheikhrouhou F, 2010, ANN DERMATOL VENER, V137, P208, DOI 10.1016/j.annder.2010.01.006; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; DEMIDOVICH CW, 1995, CUTIS, V55, P237; Destombes P, 1975, Bull Soc Pathol Exot Filiales, V68, P443; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; HADIDA E., 1959, Algerie eed., V63, P303; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; HIRONAGA M, 1983, ARCH DERMATOL, V119, P482, DOI 10.1001/archderm.119.6.482; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Ilkit M, 2012, MED MYCOL, V50, P449, DOI 10.3109/13693786.2012.669503; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LIAUTAUD B, 1984, B SOC PATHOL EXOT, V77, P637; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Majocchi D., 1883, B R ACAD MED ROMA, V9, P220; Marconi VC, 2010, MED MYCOL, V48, P518, DOI 10.3109/13693780903213512; Nir-Paz R, 2003, J CLIN MICROBIOL, V41, P5298, DOI 10.1128/JCM.41.11.5298-5301.2003; Oliveira H, 1960, J MEDICO, V41, P626; Pelevine A., 1927, ANN DERMATOL SYPHIL, V8, P403; Pruszkowski A, 1995, ANN DERMATOL VENER S, V122, P55; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Seebacher C, 2008, MYCOPATHOLOGIA, V166, P335, DOI 10.1007/s11046-008-9100-9; Sequeira JH., 1912, BRIT J DERMATOL, P207; Smith KJ, 2001, BRIT J DERMATOL, V145, P344, DOI 10.1046/j.1365-2133.2001.04331.x; Tejasvi T, 2005, CLIN EXP DERMATOL, V30, P506, DOI 10.1111/j.1365-2230.2005.01839.x; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Vinh DC, 2011, LANCET INFECT DIS, V11, P780, DOI 10.1016/S1473-3099(11)70217-1	49	227	234	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1704	1714		10.1056/NEJMoa1208487	http://dx.doi.org/10.1056/NEJMoa1208487			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24131138	Green Accepted			2022-12-28	WOS:000326311300008
J	El-Khoury, F; Cassou, B; Charles, MA; Dargent-Molina, P				El-Khoury, Fabienne; Cassou, Bernard; Charles, Marie-Aline; Dargent-Molina, Patricia			The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE COSTS; ELDERLY PERSONS; REDUCES FALLS; HIP FRACTURE; RISK-FACTORS; TAI-CHI; BALANCE; INTERVENTIONS; OSTEOPOROSIS; PEOPLE	Objective To determine whether, and to what extent, fall prevention exercise interventions for older community dwelling people are effective in preventing different types of fall related injuries. Data sources Electronic databases (PubMed, the Cochrane Library, Embase, and CINAHL) and reference lists of included studies and relevant reviews from inception to July 2013. Study selection Randomised controlled trials of fall prevention exercise interventions, targeting older (>60 years) community dwelling people and providing quantitative data on injurious falls, serious falls, or fall related fractures. Data synthesis Based on a systematic review of the case definitions used in the selected studies, we grouped the definitions of injurious falls into more homogeneous categories to allow comparisons of results across studies and the pooling of data. For each study we extracted or calculated the rate ratio of injurious falls. Depending on the available data, a given study could contribute data relevant to one or more categories of injurious falls. A pooled rate ratio was estimated for each category of injurious falls based on random effects models. Results 17 trials involving 4305 participants were eligible for meta-analysis. Four categories of falls were identified: all injurious falls, falls resulting in medical care, severe injurious falls, and falls resulting in fractures. Exercise had a significant effect in all categories, with pooled estimates of the rate ratios of 0.63 (95% confidence interval 0.51 to 0.77, 10 trials) for all injurious falls, 0.70 (0.54 to 0.92, 8 trials) for falls resulting in medical care, 0.57 (0.36 to 0.90, 7 trials) for severe injurious falls, and 0.39 (0.22 to 0.66, 6 trials) for falls resulting in fractures, but significant heterogeneity was observed between studies of all injurious falls (I-2=50%, P=0.04). Conclusions Exercise programmes designed to prevent falls in older adults also seem to prevent injuries caused by falls, including the most severe ones. Such programmes also reduce the rate of falls leading to medical care.	[El-Khoury, Fabienne; Charles, Marie-Aline; Dargent-Molina, Patricia] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France; [El-Khoury, Fabienne; Charles, Marie-Aline; Dargent-Molina, Patricia] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, F-94807 Villejuif, France; [Cassou, Bernard] Univ Versailles, EA 25 06, Lab Sante Environm Vieillissement, F-78035 Versailles, France; [Cassou, Bernard] Hop St Perrine, AP HP, Ctr Gerontol, F-75016 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Sainte-Perine - APHP	El-Khoury, F (corresponding author), Hop Paul Brousse, INSERM, CESP, Equipe10, Batiment 15-16,16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	fabienne.khoury@gmail.com	Khoury, Fabienne/AAB-2123-2020; Charles, Marie Aline/F-8567-2017; Charles, Marie Aline/S-1866-2019; Dargent-Molina, Patricia/N-3887-2017	Khoury, Fabienne/0000-0002-6915-6850; Charles, Marie Aline/0000-0003-4025-4390; Charles, Marie Aline/0000-0003-4025-4390; Dargent-Molina, Patricia/0000-0001-8596-6899				Babitsch Birgit, 2012, Psychosoc Med, V9, pDoc11, DOI 10.3205/psm000089; Barnett A, 2003, AGE AGEING, V32, P407, DOI 10.1093/ageing/32.4.407; Bischoff-Ferrari HA, 2010, ARCH INTERN MED, V170, P813, DOI 10.1001/archinternmed.2010.67; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Cheung AM, 2008, JAMA-J AM MED ASSOC, V299, P1468, DOI 10.1001/jama.299.12.1468; Cornillon E., 2002, Annales de Readaptation et de Medecine Physique, V45, P493, DOI 10.1016/S0168-6054(02)00302-1; CUMMINGS P, 1995, ANNU REV PUBL HEALTH, V16, P381; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Davis JC, 2010, OSTEOPOROSIS INT, V21, P1295, DOI 10.1007/s00198-009-1162-0; de Kam D, 2009, OSTEOPOROSIS INT, V20, P2111, DOI 10.1007/s00198-009-0938-6; Fitzharris MP, 2010, AGE AGEING, V39, P728, DOI 10.1093/ageing/afq109; Freiberger E, 2012, J AM GERIATR SOC, V60, P437, DOI 10.1111/j.1532-5415.2011.03859.x; Gill TM, 2013, AM J EPIDEMIOL, V178, P418, DOI 10.1093/aje/kws554; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Haines TP, 2009, CLIN REHABIL, V23, P973, DOI 10.1177/0269215509338998; Hannan MT, 2010, AM J EPIDEMIOL, V171, P1031, DOI 10.1093/aje/kwq024; Hartholt KA, 2011, J TRAUMA, V71, P748, DOI 10.1097/TA.0b013e3181f6f5e5; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Howe TE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004963.pub2; Iwamoto J, 2009, OSTEOPOROSIS INT, V20, P1233, DOI 10.1007/s00198-008-0794-9; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Kannus P, 2005, AM J PUBLIC HEALTH, V95, P422, DOI 10.2105/AJPH.2004.047779; Kemmler W, 2010, ARCH INTERN MED, V170, P179, DOI 10.1001/archinternmed.2009.499; Korpelainen R, 2005, OSTEOPOROSIS INT, V17, P109; Lamb SE, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-125; Laybourne AH, 2008, AGE AGEING, V37, P10, DOI 10.1093/ageing/afm190; Li FZ, 2005, J GERONTOL A-BIOL, V60, P187, DOI 10.1093/gerona/60.2.187; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; LORD SR, 1995, J AM GERIATR SOC, V43, P1198, DOI 10.1111/j.1532-5415.1995.tb07394.x; Luukinen H, 2006, SCAND J PRIM HEALTH, V24, P199, DOI 10.1080/02813430600958476; MacRae PG, 1994, J AGING PHYS ACTIV, V2, P127, DOI DOI 10.1123/JAPA.2.2.127; Martin FC, 2009, AGE AGEING, V38, P640, DOI 10.1093/ageing/afp185; McMurdo MET, 1997, BRIT MED J, V314, P569, DOI 10.1136/bmj.314.7080.569; Means KM, 2005, AM J PHYS MED REHAB, V84, P238, DOI 10.1097/01.PHM.0000151944.22116.5A; Morrison A, 2013, CLINICOECONOMIC OUTC, V5, P9, DOI 10.2147/CEOR.S38721; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.273.17.1341; Quant S, 2001, NEUROREPORT, V12, P2821, DOI 10.1097/00001756-200109170-00014; Robertson MC, 2002, J AM GERIATR SOC, V50, P905, DOI 10.1046/j.1532-5415.2002.50218.x; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Schwenk M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-50; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Sherrington Catherine, 2011, N S W Public Health Bull, V22, P78, DOI 10.1071/NB10056; Shumway-Cook A, 2009, PHYS THER, V89, P324, DOI 10.2522/ptj.20070107; Sjosten N, 2008, AGING MENT HEALTH, V12, P30, DOI 10.1080/13607860701366079; Skelton D, 2005, AGE AGEING, V34, P636, DOI 10.1093/ageing/afi174; Skelton DA, 2003, SCAND J MED SCI SPOR, V13, P77, DOI 10.1034/j.1600-0838.2003.00300.x; Smulders E, 2010, ARCH PHYS MED REHAB, V91, P1705, DOI 10.1016/j.apmr.2010.08.004; Stevens JA, 2008, J SAFETY RES, V39, P345, DOI 10.1016/j.jsr.2008.05.002; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Thomas S, 2010, AGE AGEING, V39, P681, DOI 10.1093/ageing/afq102; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x	57	294	300	5	72	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2013	347								f6234	10.1136/bmj.f6234	http://dx.doi.org/10.1136/bmj.f6234			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247EV	24169944	Green Submitted, Green Published			2022-12-28	WOS:000326599500005
J	Naaktgeboren, CA; Bertens, LCM; van Smeden, M; de Groot, JAH; Moons, KGM; Reitsma, JB				Naaktgeboren, Christiana A.; Bertens, Loes C. M.; van Smeden, Maarten; de Groot, Joris A. H.; Moons, Karel G. M.; Reitsma, Johannes B.			Value of composite reference standards in diagnostic research	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TEST ACCURACY; TESTS; PERFORMANCE; BIAS		[Naaktgeboren, Christiana A.; Bertens, Loes C. M.; van Smeden, Maarten; de Groot, Joris A. H.; Moons, Karel G. M.; Reitsma, Johannes B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Naaktgeboren, CA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Universiteitsweg 100, NL-3584 CG Utrecht, Netherlands.	c.naaktgeboren@umcutrecht.nl	van Smeden, Maarten/Y-7034-2019; Bertens, Loes CM/AAV-4664-2020	van Smeden, Maarten/0000-0002-5529-1541; Bertens, Loes CM/0000-0003-0897-0709; Reitsma, Johannes/0000-0003-4026-4345; de Groot, Joris/0000-0002-4846-5697	Netherlands Organization for Scientific Research [918.10.615]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	All authors read and understood the BMJ policy on declaration of interests and declare financial support from Netherlands Organization for Scientific Research (project 918.10.615).	Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; de Groot JAH, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4770; de Groot JAH, 2011, ANN EPIDEMIOL, V21, P139, DOI 10.1016/j.annepidem.2010.10.004; Ewer AK, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16020; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; Geersing GJ, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6564; Hadgu A, 1996, LANCET, V348, P592, DOI 10.1016/S0140-6736(96)05122-7; Hadgu A, 2012, EPIDEMIOLOGY, V23, P72, DOI 10.1097/EDE.0b013e31823b506b; Hegazy MM, 2012, DIAGN MICR INFEC DIS, V74, P49, DOI 10.1016/j.diagmicrobio.2012.05.003; Hilden J., 2009, ENCYCLOPEDIA OF MEDI, P94; Kerl JM, 2011, EUR RADIOL, V21, P1895, DOI 10.1007/s00330-011-2134-2; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Lord SJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4684; Macaskill P, 2002, STAT MED, V21, P2527, DOI 10.1002/sim.1227; Naaktgeboren CA, 2013, ANN INTERN MED, V159, P195, DOI 10.7326/0003-4819-159-3-201308060-00009; Nicolau I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045913; Pepe MS, 2007, BIOSTATISTICS, V8, P474, DOI 10.1093/biostatistics/kxl038; Rutjes A W S, 2007, Health Technol Assess, V11, pix; Siba V, 2012, CLIN VACCINE IMMUNOL, V19, P1833, DOI 10.1128/CVI.00380-12; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; Walter SD, 2012, STAT MED, V31, P1129, DOI 10.1002/sim.4444; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	23	53	53	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2013	347								f5605	10.1136/bmj.f5605	http://dx.doi.org/10.1136/bmj.f5605			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CM	24162938	Bronze			2022-12-28	WOS:000326294200001
J	Uzzi, B; Mukherjee, S; Stringer, M; Jones, B				Uzzi, Brian; Mukherjee, Satyam; Stringer, Michael; Jones, Ben			Atypical Combinations and Scientific Impact	SCIENCE			English	Article							TEAMS; COLLABORATION; INNOVATION; CREATIVITY; SCIENCE; MODEL	Novelty is an essential feature of creative ideas, yet the building blocks of new ideas are often embodied in existing knowledge. From this perspective, balancing atypical knowledge with conventional knowledge may be critical to the link between innovativeness and impact. Our analysis of 17.9 million papers spanning all scientific fields suggests that science follows a nearly universal pattern: The highest-impact science is primarily grounded in exceptionally conventional combinations of prior work yet simultaneously features an intrusion of unusual combinations. Papers of this type were twice as likely to be highly cited works. Novel combinations of prior work are rare, yet teams are 37.7% more likely than solo authors to insert novel combinations into familiar knowledge domains.	[Uzzi, Brian; Mukherjee, Satyam; Jones, Ben] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA; [Uzzi, Brian; Mukherjee, Satyam; Stringer, Michael] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA; [Stringer, Michael] Datascope Analyt, Chicago, IL 60603 USA; [Jones, Ben] Natl Bur Econ Res, Cambridge, MA 02138 USA	Northwestern University; Northwestern University; National Bureau of Economic Research	Jones, B (corresponding author), Northwestern Univ, Kellogg Sch Management, 2001 Sheridan Rd, Evanston, IL 60208 USA.	bjones@kellogg.northwestern.edu	Barau, Maria/AAH-4003-2019		Northwestern University Institute on Complex Systems; Army Research Laboratory [W911NF-09-2-0053]; Defense Advanced Research Projects Agency [BAA-11-64]	Northwestern University Institute on Complex Systems; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	Sponsored by the Northwestern University Institute on Complex Systems and by the Army Research Laboratory under Cooperative Agreement Number W911NF-09-2-0053 and Defense Advanced Research Projects Agency grant BAA-11-64, Social Media in Strategic Communication. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Laboratory or the U. S. government. All our summary statistics and programs are freely available on request. Our access to the WOS comes through a contract with Thomson Reuters that forbids redistribution of their database; researchers who desire the raw data on which to run our analytics can obtain it via a paid subscription to Thomson Reuters.	Azoulay P, 2011, RAND J ECON, V42, P527, DOI 10.1111/j.1756-2171.2011.00140.x; Becker H. S., 1982, ART WORLDS; Collins Randall, 1998, SOCIOLOGY PHILOS GLO; Committee on Facilitating Interdisciplinary Research Committee on Science Engineering and Public Policy, 2004, FAC INT RES; EINSTEIN A, 1949, WORLD I SEE IT; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Falk-Krzesinski H. J., 2011, RES EVALUAT, V20, P145; Fiore SM, 2008, SMALL GR RES, V39, P251, DOI 10.1177/1046496408317797; Fleming L, 2001, MANAGE SCI, V47, P117, DOI 10.1287/mnsc.47.1.117.10671; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; HENDERSON RM, 1990, ADMIN SCI QUART, V35, P9, DOI 10.2307/2393549; Itzkovitz S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026127; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Jones BF, 2009, REV ECON STUD, V76, P283, DOI 10.1111/j.1467-937X.2008.00531.x; Schilling MA, 2005, CREATIVITY RES J, V17, P131, DOI 10.1207/s15326934crj1702&3_2; Schilling MA, 2011, RES POLICY, V40, P1321, DOI 10.1016/j.respol.2011.06.009; Schumpeter J.A., 1939, BUSINESS CYCLES, VVolume 1; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Stringer MJ, 2010, J AM SOC INF SCI TEC, V61, P1377, DOI 10.1002/asi.21335; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683; Usher A. P., 1954, HIST MECH INVENTION; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Weitzman ML, 1998, Q J ECON, V113, P331, DOI 10.1162/003355398555595; Whiteside D.T., 1970, J HIST ASTRON, V1, P116, DOI [10.1177/002182867000100203, DOI 10.1177/002182867000100203]; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	26	543	553	36	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					468	472		10.1126/science.1240474	http://dx.doi.org/10.1126/science.1240474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239RH	24159044				2022-12-28	WOS:000326042600040
J	Schreiber, A; Lombardi, D				Schreiber, Alberto; Lombardi, Davide			Dental Implant in the Ethmoid Sinus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 57-year-old woman presented with recurrent sinusitis of the left maxillary sinus. Computed tomography showed the presence of a foreign body in the left ethmoid sinus. A 57-year-old woman presented with recurrent sinusitis of the left maxillary sinus. Computed tomography showed the presence of a foreign body in the left ethmoid sinus (Panel A). The patient had received an endosseous implant in the upper jaw 2 years earlier without complication. On transoral examination, the implant was unexpectedly absent; the mucosa covering the alveolar process was intact, and the remaining teeth were healthy. During endoscopic surgery, a dental implant in the ostiomeatal complex was visualized (Panel B; LW denotes lateral nasal wall, MT middle turbinate, and NS nasal septum) and extracted (Panel C; units of measurement are ...	[Schreiber, Alberto; Lombardi, Davide] Univ Brescia, Brescia, Italy	University of Brescia	Schreiber, A (corresponding author), Univ Brescia, Brescia, Italy.	albertoschreiber@excite.it	Lombardi, Davide/R-1082-2016; Schreiber, Alberto/AAB-6722-2020	Lombardi, Davide/0000-0001-8430-4789; Schreiber, Alberto/0000-0002-1580-3928					0	4	4	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					E23	E23		10.1056/NEJMicm1305466	http://dx.doi.org/10.1056/NEJMicm1305466			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	24152282				2022-12-28	WOS:000326031100001
J	Grayson, M				Grayson, Michelle			CHEMISTRY MASTERCLASS	NATURE			English	Editorial Material																			0	8	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					S49	S49		10.1038/502S49a	http://dx.doi.org/10.1038/502S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132330	Bronze			2022-12-28	WOS:000325706300001
J	Pinnock, H; Hanley, J; McCloughan, L; Todd, A; Krishan, A; Lewis, S; Stoddart, A; van der Pol, M; MacNee, W; Sheikh, A; Pagliari, C; McKinstry, B				Pinnock, Hilary; Hanley, Janet; McCloughan, Lucy; Todd, Allison; Krishan, Ashma; Lewis, Stephanie; Stoddart, Andrew; van der Pol, Marjon; MacNee, William; Sheikh, Aziz; Pagliari, Claudia; McKinstry, Brian			Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-STATUS; TELEMEDICINE; TELEHEALTH; CARE; QUESTIONNAIRE; MANAGEMENT; ANXIETY; COST	Objective To test the effectiveness of telemonitoring integrated into existing clinical services such that intervention and control groups have access to the same clinical care. Design Researcher blind, multicentre, randomised controlled trial. Setting UK primary care (Lothian, Scotland). Participants Adults with at least one admission for chronic obstructive pulmonary disease (COPD) in the year before randomisation. We excluded people who had other significant lung disease, who were unable to provide informed consent or complete the study, or who had other significant social or clinical problems. Interventions Participants were recruited between 21 May 2009 and 28 March 2011, and centrally randomised to receive telemonitoring or conventional self monitoring. Using a touch screen, telemonitoring participants recorded a daily questionnaire about symptoms and treatment use, and monitored oxygen saturation using linked instruments. Algorithms, based on the symptom score, generated alerts if readings were omitted or breached thresholds. Both groups received similar care from existing clinical services. Main outcome measures The primary outcome was time to hospital admission due to COPD exacerbation up to one year after randomisation. Other outcomes included number and duration of admissions, and validated questionnaire assessments of health related quality of life (using St George's respiratory questionnaire (SGRQ)), anxiety or depression (or both), self efficacy, knowledge, and adherence to treatment. Analysis was intention to treat. Results Of 256 patients completing the study, 128 patients were randomised to telemonitoring and 128 to usual care; baseline characteristics of each group were similar. The number of days to admission did not differ significantly between groups (adjusted hazard ratio 0.98, 95% confidence interval 0.66 to 1.44). Over one year, the mean number of COPD admissions was similar in both groups (telemonitoring 1.2 admissions per person (standard deviation 1.9) v control 1.1 (1.6); P=0.59). Mean duration of COPD admissions over one year was also similar between groups (9.5 days per person (standard deviation 19.1) v 8.8 days (15.9); P=0.88). The intervention had no significant effect on SGRQ scores between groups (68.2 (standard deviation 16.3) v 67.3 (17.3); adjusted mean difference 1.39 (95% confidence interval - 1.57 to 4.35)), or on other questionnaire outcomes. Conclusions In participants with a history of admission for exacerbations of COPD, telemonitoring was not effective in postponing admissions and did not improve quality of life. The positive effect of telemonitoring seen in previous trials could be due to enhancement of the underpinning clinical service rather than the telemonitoring communication.	[Pinnock, Hilary; Sheikh, Aziz] Univ Edinburgh, Allergy & Resp Res Grp, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Hanley, Janet] Edinburgh Napier Univ, Sch Nursing Midwifery & Social Care, Edinburgh, Midlothian, Scotland; [McCloughan, Lucy; Todd, Allison; Pagliari, Claudia; McKinstry, Brian] Ctr Populat Hlth Sci, eHlth Res Grp, Edinburgh, Midlothian, Scotland; [Krishan, Ashma] Univ Edinburgh, Edinburgh Clin Trials Unit, Edinburgh EH8 9AG, Midlothian, Scotland; [Lewis, Stephanie] Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Stoddart, Andrew] Univ Edinburgh, Hlth Serv Res Unit, Edinburgh EH8 9AG, Midlothian, Scotland; [van der Pol, Marjon] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; [MacNee, William] Univ Edinburgh, Ctr Inflammat Res, Edinburgh EH8 9AG, Midlothian, Scotland; [Sheikh, Aziz] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA	University of Edinburgh; Edinburgh Napier University; University of Edinburgh; University of Edinburgh; University of Aberdeen; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pinnock, H (corresponding author), Univ Edinburgh, Allergy & Resp Res Grp, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland.	hilary.pinnock@ed.ac.uk	Pagliari, Claudia C/P-6412-2018; Sheikh, Aziz/D-2818-2009	Pagliari, Claudia C/0000-0001-5791-7723; Sheikh, Aziz/0000-0001-7022-3056; Stoddart, Andrew/0000-0002-1958-3897; McKinstry, Brian/0000-0001-9581-0468; van der Pol, Marjon/0000-0003-0636-1184; Hanley, Janet/0000-0003-1728-0136; MacNee, William/0000-0002-3692-1448	NHS applied research programme grant from the Chief Scientist Office of the Scottish government [ARPG/07/03]; MRC [G0901697, G0800803] Funding Source: UKRI; Medical Research Council [G0800803, G0901697] Funding Source: researchfish; Chief Scientist Office [PCRCA/08/01, ARPG/07/03] Funding Source: researchfish	NHS applied research programme grant from the Chief Scientist Office of the Scottish government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The trial was funded by an NHS applied research programme grant from the Chief Scientist Office of the Scottish government (ARPG/07/03). The funder had no role in study design and the collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication. NHS Lothian supported the telemonitoring service and the clinical services	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bartoli L, 2009, TELEMED J E-HEALTH, V15, P877, DOI 10.1089/tmj.2009.0044; Bolton CE, 2011, J EVAL CLIN PRACT, V17, P1216, DOI 10.1111/j.1365-2753.2010.01536.x; British Lung Foundation, 2013, LIV COPD; Brooks R, 2003, MEASURMENT VALUATION; Casas A, 2006, EUR RESPIR J, V28, P123, DOI 10.1183/09031936.06.00063205; COX DR, 1972, J R STAT SOC B, V34, P187; Fairbrother P, 2013, PATIENT EDUC COUNS, V93, P403, DOI 10.1016/j.pec.2013.04.003; Fairbrother P, 2012, PRIM CARE RESP J, V21, P322, DOI 10.4104/pcrj.2012.00068; Global Initiative for Obstructive Lung Disease, 2013, GLOBAL STRATEGY DIAG; Gudmundsson G, 2005, EUR RESPIR J, V26, P414, DOI 10.1183/09031936.05.00078504; Henderson C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1035; Horne R, 2002, PSYCHOL HEALTH, V17, P17, DOI 10.1080/08870440290001502; Hurst JR, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-52; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Hyland ME, 2006, RESP MED, V100, P1807, DOI 10.1016/j.rmed.2006.01.018; Jaana M, 2009, AM J MANAG CARE, V15, P313; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Liddell A., 2008, TECHNOLOGY NHS TRANS; Lorig KR, 2001, EFF CLIN PRACT, V4, P256; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McKinstry B, 2009, LANCET, V374, P672, DOI 10.1016/S0140-6736(09)61542-7; McLean S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007718.pub2; National Institute for Clinical Excellence, 2004, THORAX S1, V59, pS1; Pinnock Hilary, 2009, Prim Care Respir J, V18, P233, DOI 10.4104/pcrj.2009.00040; Polisena J, 2010, J TELEMED TELECARE, V16, P120, DOI 10.1258/jtt.2009.090812; Royal College of Physicians British Thoracic Society and British Lung Foundation. National COPD Resources and Outcomes Project, 2008, NAT COPD RES OUTC PR; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Steventon Adam, 2012, BMJ, V344, pe3874, DOI 10.1136/bmj.e3874; Takahashi PY, 2012, ARCH INTERN MED, V172, P773, DOI 10.1001/archinternmed.2012.256; Trappenburg JCA, 2008, TELEMED J E-HEALTH, V14, P138, DOI 10.1089/tmj.2007.0037; Ure J, 2012, PRIM CARE RESP J, V21, P57, DOI 10.4104/pcrj.2011.00065; Vontetsianos T, 2005, J TELEMED TELECARE, V11, P86, DOI 10.1258/1357633054461697; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wilkinson TMA, 2004, AM J RESP CRIT CARE, V169, P1298, DOI 10.1164/rccm.200310-1443OC; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	201	201	1	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2013	347								f6070	10.1136/bmj.f6070	http://dx.doi.org/10.1136/bmj.f6070			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WP	24136634	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000325982700004
J	Smith, DA				Smith, Donald A.			A lifestyle intervention did not reduce cardiovascular outcomes in overweight or obese patients with type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Smith, DA (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.							Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC4	10.7326/0003-4819-159-8-201310150-02004	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126665				2022-12-28	WOS:000326751200003
J	Stanbrook, MB				Stanbrook, Matthew B.			Mandibular advancement device and CPAP did not differ for health outcomes in obstructive sleep apnea	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.		Phillips, Craig L/H-7636-2019	Phillips, Craig L/0000-0002-9126-6757				Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8							JC10	10.7326/0003-4819-159-8-201310150-02010	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126659				2022-12-28	WOS:000326751200009
J	Anglemyer, A; Horvath, T; Rutherford, G				Anglemyer, Andrew; Horvath, Tara; Rutherford, George			Antiretroviral Therapy for Prevention of HIV Transmission in HIV-Discordant Couples	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION		[Anglemyer, Andrew; Horvath, Tara; Rutherford, George] Univ Calif San Francisco, AIDS Res Inst, Cochrane HIV AIDS Grp, San Francisco, CA 94105 USA	University of California System; University of California San Francisco	Anglemyer, A (corresponding author), Univ Calif San Francisco, AIDS Res Inst, Box 1224,50 Beale St,Ste 1200, San Francisco, CA 94105 USA.	andrew.anglemyer@ucsf.edu		Anglemyer, Andrew/0000-0002-9091-496X; Egger, Matthias/0000-0001-7462-5132; Horvath, Hacsi/0000-0001-7569-3524	NIAID NIH HHS [U01 AI069924, 5U01-AI069924-05] Funding Source: Medline; NIMH NIH HHS [P30 MH062246] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anglemyer A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009153.pub3; Coburn BJ, 2011, LANCET INFECT DIS, V11, P263, DOI 10.1016/S1473-3099(11)70080-9; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Grinsztejn B, 2011, ANTIVIR THER, V16, P1057, DOI 10.3851/IMP1872; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; World Health Organization, GUIDANCE ON COUPLES	7	64	68	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1619	1620		10.1001/jama.2013.278328	http://dx.doi.org/10.1001/jama.2013.278328			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129466	Green Published, Green Accepted			2022-12-28	WOS:000325624800025
